PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Siripala, AD; Welch, MD				Siripala, Anosha D.; Welch, Matthew D.			SnapShot: Actin regulators II	CELL			English	Editorial Material														Siripala, Anosha/0000-0003-4073-9195	NIGMS NIH HHS [R01 GM059609, R01 GM059609-07] Funding Source: Medline; NIGMS NIH HHS [R01 GM059609-07, R01 GM059609] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059609] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	23	23	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2007	128	5					1014	1014		10.1016/j.cell.2007.02.021	http://dx.doi.org/10.1016/j.cell.2007.02.021			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350583	Bronze			2022-12-01	WOS:000245073400023
J	Li, W; Tu, DQ; Brunger, AT; Ye, YH				Li, Wei; Tu, Daqi; Brunger, Axel T.; Ye, Yihong			A ubiquitin ligase transfers preformed polyubiquitin chains from a conjugating enzyme to a substrate	NATURE			English	Article							ENDOPLASMIC-RETICULUM STRESS; PROTEIN LIGASE; DEGRADATION; DOMAIN; HERP; COMPLEX; CDC34; PATHWAY; LYSINE; GP78	In eukaryotic cells, many short-lived proteins are conjugated with Lys48-linked ubiquitin chains and degraded by the proteasome(1). Ubiquitination requires an activating enzyme (E1), a conjugating enzyme (E2) and a ligase (E3)(2). Most ubiquitin ligases use either a HECT (homologous to E6-associated protein C terminus) or a RING (really interesting new gene) domain to catalyse polyubiquitination(3), but the mechanism of E3 catalysis is poorly defined(4). Here we dissect this process using mouse Ube2g2 (E2; identical at the amino acid level to human Ube2g2) and human gp78 (E3), an endoplasmic reticulum (ER)-associated conjugating system essential for the degradation of misfolded ER proteins(5,6). We demonstrate by expressing recombinant proteins in Escherichia coli that Ube2g2/gp78-mediated polyubiquitination involves preassembly of Lys48-linked ubiquitin chains at the catalytic cysteine of Ube2g2. The growth of Ube2g2-anchored ubiquitin chains seems to be mediated by an aminolysis-based transfer reaction between two Ube2g2 molecules that each carries a ubiquitin moiety in its active site. Intriguingly, polyubiquitination of a substrate can be achieved by transferring preassembled ubiquitin chains from Ube2g2 to a lysine residue in a substrate.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; Stanford Univ, Howard Hughes Med Inst, Dept Mol & Cellular Physiol Neurol & Neurol Sci S, Stanford, CA 94305 USA; Stanford Univ, SSRL, Stanford, CA 94305 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Howard Hughes Medical Institute; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Ye, YH (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	yihongy@mail.nih.gov		Brunger, Axel/0000-0001-5121-2036	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036137, Z01DK036137] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arai R, 2006, ACTA CRYSTALLOGR F, V62, P330, DOI 10.1107/S1744309106009006; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; CHEN JZ, 1993, J THERM SPRAY TECHN, V2, P357; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Gazdoiu S, 2005, P NATL ACAD SCI USA, V102, P15053, DOI 10.1073/pnas.0507646102; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Hori O, 2004, GENES CELLS, V9, P457, DOI 10.1111/j.1356-9597.2004.00735.x; Huang HK, 2000, J BIOL CHEM, V275, P26661; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Sai XR, 2003, FEBS LETT, V553, P151, DOI 10.1016/S0014-5793(03)01009-3; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; SILVER ET, 1992, EMBO J, V11, P3091, DOI 10.1002/j.1460-2075.1992.tb05381.x; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; VANNOCKER S, 1993, J BIOL CHEM, V268, P24766; Varelas X, 2003, MOL CELL BIOL, V23, P5388, DOI 10.1128/MCB.23.15.5388-5400.2003; Vong QP, 2005, SCIENCE, V310, P1499, DOI 10.1126/science.1120160; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169	26	171	176	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2007	446	7133					333	337		10.1038/nature05542	http://dx.doi.org/10.1038/nature05542			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17310145				2022-12-01	WOS:000244892900049
J	Dy, S; Lynn, J				Dy, Sydney; Lynn, Joanne			Getting services right for those sick enough to die	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE; PROGRAM		Johns Hopkins Univ, Baltimore, MD 21205 USA; RAND Corp, Arlington, VA 22202 USA	Johns Hopkins University; RAND Corporation	Dy, S (corresponding author), Johns Hopkins Univ, Baltimore, MD 21205 USA.	sdy@jhsph.edu						Aiken LS, 2006, J PALLIAT MED, V9, P111, DOI 10.1089/jpm.2006.9.111; *CMS, 2004, MED BEN POL MAN; Federal Interagency Foram on Aging-Related Statistics, 2006, OLD AM UPD 2006 KEY; FORD PE, 2003, J PALLIAT MED, V6, P645; Gotay CC, 2004, J PALLIAT MED, V33, P126; GYSELS M, 2003, IMPROVING SUPPORTIVE; *HAST CTR, 1987, GUID TERM LIF SUST T; King N, 2005, PALLIATIVE MED, V19, P619, DOI 10.1191/0269216305pm1084oa; Kodner DL, 2006, HEALTH SOC CARE COMM, V14, P384, DOI 10.1111/j.1365-2524.2006.00655.x; LORENZ K, 2004, END OF LIFE CARE OUT; Lunney JR, 2002, J AM GERIATR SOC, V50, P1108, DOI 10.1046/j.1532-5415.2002.50268.x; LYNN J, 2004, SICK DEATH NOT GOING; *MEDPAC, 2006, REP C INCR VAL MED W, P59; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; *NAT I HLTH STAT O, 2005, J PALLIAT MED S, V8; *ONS, 2004, NAT POP PROJ; Temkin-Greener H, 2002, J AM GERIATR SOC, V50, P125, DOI 10.1046/j.1532-5415.2002.50018.x	17	20	20	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2007	334	7592					511	513		10.1136/bmj.39127.653704.80	http://dx.doi.org/10.1136/bmj.39127.653704.80			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148VV	17347238	Green Published			2022-12-01	WOS:000245106400039
J	Co, C; Wong, DT; Gierke, S; Chang, V; Taunton, J				Co, Carl; Wong, Derek T.; Gierke, Sarah; Chang, Vicky; Taunton, Jack			Mechanism of actin network attachment to moving membranes: Barbed end capture by N-WASP WH2 domains	CELL			English	Article							ALDRICH-SYNDROME PROTEIN; ARP2/3 COMPLEX; LISTERIA-MONOCYTOGENES; FORCE GENERATION; DENDRITIC ORGANIZATION; N-WASP-ARP2/3 COMPLEX; FILAMENT ELONGATION; ENA/VASP PROTEINS; ATP HYDROLYSIS; LIPID VESICLES	Actin filament networks exert protrusive and attachment forces on membranes and thereby drive membrane deformation and movement. Here, we show that N-WASP WH2 domains play a previously unanticipated role in vesicle movement by transiently attaching actin filament barbed ends to the membrane. To dissect the attachment mechanism, we reconstituted the propulsive motility of lipid-coated glass beads, using purified soluble proteins. N-WASP WH2 mutants assembled actin comet tails and initiated movement, but the comet tails catastrophically detached from the membrane. When presented on the surface of a lipid-coated bead, WH2 domains were sufficient to maintain comet tail attachment. In v-Src-transformed fibroblasts, N-WASP WH2 mutants were severely defective in the formation of circular podosome arrays. In addition to creating an attachment force, interactions between WH2 domains and barbed ends may locally amplify signals for dendritic actin nucleation.	Univ Calif San Francisco, UCB Cell Prop Lab, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Program Biol Sci, UCB Cell Prop Lab, San Francisco, CA 94158 USA; Univ Calif Berkeley, Joint Grad Grp Bioengn, Berkeley, CA 94720 USA; Univ Calif San Francisco, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Taunton, J (corresponding author), Univ Calif San Francisco, UCB Cell Prop Lab, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	taunton@cmp.ucsf.edu			NEI NIH HHS [PN2 EY 016546, PN2 EY016546] Funding Source: Medline; NIGMS NIH HHS [GM 066229, R01 GM066229, R01 GM066229-05] Funding Source: Medline; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066229] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alberts JB, 2004, PLOS BIOL, V2, P2054, DOI 10.1371/journal.pbio.0020412; Bailly M, 1999, J CELL BIOL, V145, P331, DOI 10.1083/jcb.145.2.331; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Bernheim-Groswasser A, 2002, NATURE, V417, P308, DOI 10.1038/417308a; Boukellal H, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.061906; Cameron LA, 1999, P NATL ACAD SCI USA, V96, P4908, DOI 10.1073/pnas.96.9.4908; Cameron LA, 2001, CURR BIOL, V11, P130, DOI 10.1016/S0960-9822(01)00022-7; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Dayel MJ, 2004, PLOS BIOL, V2, P476, DOI 10.1371/journal.pbio.0020091; Dickinson RB, 2004, BIOPHYS J, V87, P2838, DOI 10.1529/biophysj.104.045211; Dickinson RB, 2002, BIOPHYS J, V82, P605, DOI 10.1016/S0006-3495(02)75425-8; Dutartre H, 1996, J CELL SCI, V109, P367; Egile C, 2005, PLOS BIOL, V3, P1902, DOI 10.1371/journal.pbio.0030383; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Gerbal F, 2000, EUR BIOPHYS J BIOPHY, V29, P134, DOI 10.1007/s002490050258; Giardini PA, 2003, P NATL ACAD SCI USA, V100, P6493, DOI 10.1073/pnas.1031670100; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; HOFFMAN GR, 2004, CELL, V110, P345; Hufner K, 2001, J BIOL CHEM, V276, P35761, DOI 10.1074/jbc.M106520200; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kaksonen M, 2000, J CELL SCI, V113, P4421; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; Kuo SC, 2000, NATURE, V407, P1026, DOI 10.1038/35039544; Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Marcy Y, 2004, P NATL ACAD SCI USA, V101, P5992, DOI 10.1073/pnas.0307704101; Martin AC, 2006, NAT CELL BIOL, V8, P826, DOI 10.1038/ncb1443; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Mizutani K, 2002, CANCER RES, V62, P669; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Olbris DJ, 2000, BBA-MOL CELL RES, V1495, P140, DOI 10.1016/S0167-4889(99)00156-1; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Samarin S, 2003, J CELL BIOL, V163, P131, DOI 10.1083/jcb.200303191; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Soo FS, 2005, P NATL ACAD SCI USA, V102, P16233, DOI 10.1073/pnas.0507022102; Spinardi L, 2004, EXP CELL RES, V295, P360, DOI 10.1016/j.yexcr.2004.01.007; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Upadhyaya A, 2003, CURR BIOL, V13, pR734, DOI 10.1016/j.cub.2003.08.051; Upadhyaya A, 2003, P NATL ACAD SCI USA, V100, P4521, DOI 10.1073/pnas.0837027100; Uruno T, 2003, J BIOL CHEM, V278, P26086, DOI 10.1074/jbc.M301997200; van der Gucht J, 2005, P NATL ACAD SCI USA, V102, P7847, DOI 10.1073/pnas.0502121102; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133; Wiesner S, 2003, J CELL BIOL, V160, P387, DOI 10.1083/jcb.200207148; Yamaguchi H, 2000, P NATL ACAD SCI USA, V97, P12631, DOI 10.1073/pnas.190351397; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.E04-09-0774; Yarar D, 1999, CURR BIOL, V9, P555, DOI 10.1016/S0960-9822(99)80243-7; Zamanian JL, 2003, MOL BIOL CELL, V14, P1624, DOI 10.1091/mbc.E02-08-0494	64	140	142	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2007	128	5					901	913		10.1016/j.cell.2006.12.049	http://dx.doi.org/10.1016/j.cell.2006.12.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350575	Green Accepted, Bronze			2022-12-01	WOS:000245073400015
J	Coovadia, HM; Rollins, NC; Bland, RM; Little, K; Coutsoudis, A; Bennish, ML; Newell, ML				Coovadia, Hoosen M.; Rollins, Nigel C.; Bland, Ruth M.; Little, Kirsty; Coutsoudis, Anna; Bennish, Michael L.; Newell, Marie-Louise			Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POSTNATAL TRANSMISSION; SOUTH-AFRICA; PREVENT; ZIDOVUDINE; EFFICACY; INFANTS; WOMEN; POPULATIONS; NEVIRAPINE	Background Exclusive breastfeeding, though better than other forms of infant feeding and associated with improved child survival, is uncommon. We assessed the HIV-1 transmission risks and survival associated with exclusive breastfeeding and other types of infant feeding. Methods 2722 HIV-infected and uninfected pregnant women attending antenatal clinics in KwaZulu Natal, South Africa (seven rural, one semiurban, and one urban), were enrolled into a non-randomised intervention cohort study. Infant feeding data were obtained every week from mothers, and blood samples from infants were taken monthly at clinics to establish HIV infection status. Kaplan-Meier analyses conditional on exclusive breastfeeding were used to estimate transmission risks at 6 weeks and 22 weeks of age, and Cox's proportional hazard was used to quantify associations with maternal and infant factors. Findings 1132 of 1372 (83%) infants born to HIV-infected mothers initiated exclusive breastfeeding from birth. of 1276 infants with complete feeding data, median duration of cumulative exclusive breastfeeding was 159 days (first quartile [Q1] to third quartile [Q3], 122-174 days). 14.1% (95% Cl 12.0-16.4) of exclusively breastfed infants were infected with HIV-1 by age 6 weeks and 19.5% (17.0-22.4) by 6 months; risk was significantly associated with maternal CD4-cell counts below 200 cells per mu L (adjusted hazard ratio [HR] 3.79; 2.35-6.12) and birthweight less than 2500 g (1.81, 1.07-3.06). Kaplan-Meier estimated risk of acquisition of infection at 6 months of age was 4.04% (2.29-5.76). Breastfed infants who also received solids were significantly more likely to acquire infection than were exclusively breastfed children (HR 10.87, 1.51-78.00, p=0.018), as were infants who at 12 weeks received both breastmilk and formula milk (1.82, 0.98-3.36, p=0.057). Cumulative 3-month mortality in exclusively breastfed infants was 6.1% (4.74-7.92) versus 15.1% (7.63-28.73) in infants given replacement feeds (HR 2.06, 1.00-4.27; p=0.051). Interpretation The association between mixed breastfeeding and increased HIV transmission risk, together with evidence that exclusive breastfeeding can be successfully supported in HIV-infected women, warrant revision of the present UNICEF, WHO, and UNAIDS infant feeding guidelines.	Univ Kwazulu Natal, Dept Paediat & Child Hlth, Nelson Mandela Sch Med, ZA-4013 Congella, South Africa; Univ Kwazulu Natal, Africa Ctr Hlth & Populat Studies, ZA-4013 Congella, South Africa; Univ Kwazulu Natal, Ctr HIV AIDS Networking, ZA-4013 Congella, South Africa; UCL, Ctr Paediat Epidemiol & Biostat, Inst Child Hlth, London, England; Univ Oxford, Nuffield Dept Clin Med, Oxford, England	University of Kwazulu Natal; University of Kwazulu Natal; University of Kwazulu Natal; University of London; University College London; University of Oxford	Rollins, NC (corresponding author), Univ Kwazulu Natal, Dept Paediat & Child Hlth, Nelson Mandela Sch Med, Private Bag 7, ZA-4013 Congella, South Africa.	rollins@ukzn.ac.za	Newell, Marie-Louise/AAE-8222-2019	Newell, Marie-Louise/0000-0002-1074-7699; Bland, Ruth/0000-0003-1675-9268				Alioum A, 2003, AM J EPIDEMIOL, V158, P596, DOI 10.1093/aje/kwg188; Alioum A, 2001, STAT MED, V20, P3539, DOI 10.1002/sim.1076; Becquet R, 2006, 16 INT AIDS C TOR CA; Blackard JT, 2001, VIROLOGY, V287, P261, DOI 10.1006/viro.2001.1059; Bland RM, 2003, ARCH DIS CHILD, V88, P778, DOI 10.1136/adc.88.9.778; Brambilla D, 2003, J CLIN MICROBIOL, V41, P1888, DOI 10.1128/JCM.41.5.1888-1893.2003; Cassol S, 1997, J CLIN MICROBIOL, V35, P2795, DOI 10.1128/JCM.35.11.2795-2801.1997; Coovadia H, 2004, NEW ENGL J MED, V351, P289, DOI 10.1056/NEJMe048128; Coutsoudis A, 1999, LANCET, V354, P471, DOI 10.1016/S0140-6736(99)01101-0; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; Coutsoudis A, 2002, HEALTH POLICY PLANN, V17, P154, DOI 10.1093/heapol/17.2.154; Coutsoudis A, 2001, AIDS, V15, P379, DOI 10.1097/00002030-200102160-00011; Cox DR., 1984, ANAL SURVIVAL DATA; Creek T, 2006, 2006 HIV AIDS IMPL M; Dabis F, 2005, AIDS, V19, P309; Doherty T, 2006, B WORLD HEALTH ORGAN, V84, P90, DOI 10.2471/BLT.04.019448; Fawzi W, 2002, JAIDS-J ACQ IMM DEF, V31, P331, DOI 10.1097/00126334-200211010-00010; Hilderbrand K, 2003, SAMJ S AFR MED J, V93, P779; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KwaZulu Natal Provincial Department of Health, 2003, PROT PHAS IMPL COMPR; Lallemant M, 2004, NEW ENGL J MED, V351, P217, DOI 10.1056/NEJMoa033500; Leroy V, 2005, AIDS, V19, P1865, DOI 10.1097/01.aids.0000188423.02786.55; Leroy V, 2003, AIDS, V17, P1493, DOI 10.1097/00002030-200307040-00010; Mbori-Ngacha D, 2001, JAMA-J AM MED ASSOC, V286, P2413, DOI 10.1001/jama.286.19.2413; Miotti PG, 1999, JAMA-J AM MED ASSOC, V282, P744, DOI 10.1001/jama.282.8.744; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Renjifo B, 2004, AIDS, V18, P1629, DOI 10.1097/01.aids.0000131392.68597.34; Renjifo B, 2001, J HUMAN VIROL, V4, P16; Rollins N, 2004, JAIDS-J ACQ IMM DEF, V35, P188, DOI 10.1097/00126334-200402010-00014; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Thorne Claire, 2005, Curr Opin Investig Drugs, V6, P804; *UNAIDS WHO, 2005, AIDS EP UPD; WHO, 2006, ANT DRUGS TREAT PREG; *WHO, 2001, WHORHR0112WHOCAH0121; WHO, 2001, NEW DAT PREV MOTH CH; *WHO UNICEF UNAIDS, 1998, WHOFRHNUTCHD98LED; *WHO UNICEF UNAIDS, 2000, WHOSCHCAH004; World Health Organization, 1991, WHOCDDSER9114; [No title captured]	42	445	453	0	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2007	369	9567					1107	1116		10.1016/S0140-6736(07)60283-9	http://dx.doi.org/10.1016/S0140-6736(07)60283-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151XF	17398310				2022-12-01	WOS:000245323700031
J	Juliano, R				Juliano, Rudy			Clinical implications of basic research: Bugging tumors to put drugs on target	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA; Univ N Carolina, Sch Med, Carolina Ctr Canc Nanotechnol Excellence, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Juliano, R (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA.							Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Cheong I, 2006, SCIENCE, V314, P1308, DOI 10.1126/science.1130651; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Rolland JP, 2005, J AM CHEM SOC, V127, P10096, DOI 10.1021/ja051977c	4	7	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2007	356	9					954	955		10.1056/NEJMcibr067638	http://dx.doi.org/10.1056/NEJMcibr067638			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	140HV	17329705				2022-12-01	WOS:000244496400014
J	Ohlstein, B; Spradling, A				Ohlstein, Benjamin; Spradling, Allan			Multipotent Drosophila intestinal stem cells specify daughter cell fates by differential Notch signaling	SCIENCE			English	Article							SELF-RENEWAL; NICHE; MAINTENANCE; DIVISION; EXOCYST	The adult Drosophila midgut contains multipotent intestinal stem cells (ISCs) scattered along its basement membrane that have been shown by lineage analysis to generate both enterocytes and enteroendocrine cells. ISCs containing high levels of cytoplasmic Delta-rich vesicles activate the canonical Notch pathway and down-regulate Delta within their daughters, a process that programs these daughters to become enterocytes. ISCs that express little vesiculate Delta, or are genetically impaired in Notch signaling, specify their daughters to become enteroendocrine cells. Thus, ISCs control daughter cell fate by modulating Notch signaling over time. Our studies suggest that ISCs actively coordinate cell production with local tissue requirements by this mechanism.	Carnegie Inst Sci, Dept Embryol, Howard Hughes Med Inst, Baltimore, MD 21218 USA	Carnegie Institution for Science; Howard Hughes Medical Institute	Spradling, A (corresponding author), Carnegie Inst Sci, Dept Embryol, Howard Hughes Med Inst, 3520 San Martin Dr, Baltimore, MD 21218 USA.	spradling@ciwemb.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK090078] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [R56 DK090078] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bjerknes M, 2005, AM J PHYSIOL-GASTR L, V289, pG381, DOI 10.1152/ajpgi.00160.2005; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Crittenden SL, 2006, MOL BIOL CELL, V17, P3051, DOI 10.1091/mbc.E06-03-0170; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Jafar-Nejad H, 2005, DEV CELL, V9, P351, DOI 10.1016/j.devcel.2005.06.010; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Le Borgne R, 2005, PLOS BIOL, V3, P688, DOI 10.1371/journal.pbio.0030096; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Nystul TG, 2006, CURR OPIN GENET DEV, V16, P463, DOI 10.1016/j.gde.2006.08.003; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Pavlopoulos E, 2001, DEV CELL, V1, P807, DOI 10.1016/S1534-5807(01)00093-4; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Song XQ, 2003, DEVELOPMENT, V130, P3259, DOI 10.1242/dev.00524; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	21	460	470	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2007	315	5814					988	992		10.1126/science.1136606	http://dx.doi.org/10.1126/science.1136606			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303754				2022-12-01	WOS:000244229800042
J	Bagchi, A; Papazoglu, C; Wu, Y; Capurso, D; Brodt, M; Francis, D; Bredel, M; Vogel, H; Mills, AA				Bagchi, Anindya; Papazoglu, Cristian; Wu, Ying; Capurso, Daniel; Brodt, Michael; Francis, Dailia; Bredel, Markus; Vogel, Hannes; Mills, Alea A.			CHD5 is a tumor suppressor at human 1p36	CELL			English	Article							SUSCEPTIBILITY GENE; CELL-PROLIFERATION; BREAST-CANCER; IN-VIVO; IDENTIFICATION; DELETION; P53; SENESCENCE; SEQUENCE; REGIONS	Cancer gene discovery has relied extensively on analyzing tumors for gains and losses to reveal the location of oncogenes and tumor suppressor genes, respectively. Deletions of 1p36 are extremely common genetic lesions in human cancer, occurring in malignancies of epithelial, neural, and hematopoietic origin. Although this suggests that 1p36 harbors a gene that drives tumorigenesis when inactivated, the identity of this tumor suppressor has remained elusive. Here we use chromosome engineering to generate mouse models with gain and loss of a region corresponding to human 1p36. This approach functionally identifies chromodomain helicase DNA binding domain 5 (Chd5) as a tumor suppressor that controls proliferation, apoptosis, and senescence via the p19(Arf)/p53 pathway. We demonstrate that Chd5 functions as a tumor suppressor in vivo and implicate deletion of CHD5 in human cancer. Identification of this tumor suppressor provides new avenues for exploring innovative clinical interventions for cancer.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; Stanford Univ, Palo Alto, CA 94304 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Stanford University	Mills, AA (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	mills@cshl.edu		Vogel, Otto Hannes/0000-0002-0960-3508	NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NCI NIH HHS [CA45508] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BELLE SH, 1995, CLIN TRANSPL, V1, P19; BIECHE I, 1993, CANCER RES, V53, P1990; Bredel M, 2005, CANCER RES, V65, P8679, DOI 10.1158/0008-5472.CAN-05-1204; Bredel M, 2005, CANCER RES, V65, P4088, DOI 10.1158/0008-5472.CAN-04-4229; BRODEUR GM, 1977, CANCER-AM CANCER SOC, V40, P2256, DOI 10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO;2-1; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; Chen W, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-85; Cheung TH, 2005, GYNECOL ONCOL, V96, P510, DOI 10.1016/j.ygyno.2004.10.035; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Esteller M, 2001, CANCER RES, V61, P3225; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; FRIEND SH, 1987, P NATL ACAD SCI USA, V84, P9059, DOI 10.1073/pnas.84.24.9059; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; Gonzalez S, 2006, CELL CYCLE, V5, P1382, DOI 10.4161/cc.5.13.2901; Hemann MT, 2004, P NATL ACAD SCI USA, V101, P9333, DOI 10.1073/pnas.0403286101; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; Juric Dejan, 2007, Methods Mol Biol, V377, P187; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Kleer CG, 2000, ENDOCR PATHOL, V11, P137, DOI 10.1385/EP:11:2:137; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Law ME, 2005, CANCER GENET CYTOGEN, V160, P1, DOI 10.1016/j.cancergencyto.2004.11.012; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Melendez B, 2003, LEUKEMIA RES, V27, P627, DOI 10.1016/S0145-2126(02)00278-3; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Mills AA, 2001, TRENDS GENET, V17, P331, DOI 10.1016/S0168-9525(01)02321-6; MOLEY JF, 1992, CANCER RES, V52, P770; Mori N, 2003, BRIT J HAEMATOL, V122, P226, DOI 10.1046/j.1365-2141.2003.04434.x; Mori N, 1998, BLOOD, V92, P3405, DOI 10.1182/blood.V92.9.3405.421k44_3405_3409; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Piaskowski S, 2005, CANCER GENET CYTOGEN, V162, P63, DOI 10.1016/j.cancergencyto.2005.02.009; Poetsch M, 2003, MELANOMA RES, V13, P29, DOI 10.1097/00008390-200302000-00006; PRAML C, 1995, ONCOGENE, V11, P1357; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thompson PM, 2003, ONCOGENE, V22, P1002, DOI 10.1038/sj.onc.1206211; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; White PS, 2005, ONCOGENE, V24, P2684, DOI 10.1038/sj.onc.1208306; WHITE PS, 1995, P NATL ACAD SCI USA, V92, P5520, DOI 10.1073/pnas.92.12.5520; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815	53	253	278	1	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2007	128	3					459	475		10.1016/j.cell.2006.11.052	http://dx.doi.org/10.1016/j.cell.2006.11.052			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289567	Bronze			2022-12-01	WOS:000244842700014
J	Vergassola, M; Villermaux, E; Shraiman, BI				Vergassola, Massimo; Villermaux, Emmanuel; Shraiman, Boris I.			'Infotaxis' as a strategy for searching without gradients	NATURE			English	Article							FINE-SCALE STRUCTURE; ODOR PLUMES; INSECT ORIENTATION; MOBILE ROBOT; PHEROMONE; CHEMOTAXIS; TRACKING; MOTHS	Chemotactic bacteria rely on local concentration gradients to guide them towards the source of a nutrient(1). Such local cues pointing towards the location of the source are not always available at macroscopic scales because mixing in a flowing medium breaks up regions of high concentration into random and disconnected patches. Thus, animals sensing odours in air or water detect them only intermittently as patches sweep by on the wind or currents(2-6). A macroscopic searcher must devise a strategy of movement based on sporadic cues and partial information. Here we propose a search algorithm, which we call 'infotaxis', designed to work under such conditions. Any search process can be thought of as acquisition of information on source location; for infotaxis, information plays a role similar to concentration in chemotaxis. The infotaxis strategy locally maximizes the expected rate of information gain. We demonstrate its efficiency using a computational model of odour plume propagation and experimental data on mixing flows(7). Infotactic trajectories feature 'zigzagging' and 'casting' paths similar to those observed in the flight of moths(8). The proposed search algorithm is relevant to the design of olfactory robots(9-11), but the general idea of infotaxis can be applied more broadly in the context of searching with sparse information.	Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; Inst Pasteur, CNRS, URA 2171, F-75724 Paris 15, France; Univ Aix Marseille 1, F-13384 Marseille, France	University of California System; University of California Santa Barbara; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Aix-Marseille Universite	Shraiman, BI (corresponding author), Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA.	shraiman@kitp.ucsb.edu		Villermaux, Emmanuel/0000-0001-5130-4862; Vergassola, Massimo/0000-0002-7212-8244				Balkovsky E, 2002, P NATL ACAD SCI USA, V99, P12589, DOI 10.1073/pnas.192393499; Barto A, 1998, REINFORCEMENT LEARNI, V1st; Belanger JH, 1998, J COMP PHYSIOL A, V183, P345, DOI 10.1007/s003590050261; Berg B.C., 1993, RANDOM WALKS BIOL; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; COVER TM, 1991, SERIES TELECOMMUNICA; Dusenbery D.B., 1992, SENSORY ECOLOGY ORGA; Falkovich G, 2001, REV MOD PHYS, V73, P913, DOI 10.1103/RevModPhys.73.913; Farrell JA, 2005, IEEE J OCEANIC ENG, V30, P428, DOI 10.1109/JOE.2004.838066; Farrell JA, 2003, IEEE T SYST MAN CY B, V33, P850, DOI 10.1109/TSMCB.2003.810873; Grasso FW, 2000, ROBOT AUTON SYST, V30, P115, DOI 10.1016/S0921-8890(99)00068-8; Hansson B.S., 1999, INSECT OLFACTION; Ishida H, 2005, IEEE SENS J, V5, P537, DOI 10.1109/JSEN.2004.839597; Ishida H, 1996, SENSOR ACTUAT B-CHEM, V33, P115, DOI 10.1016/0925-4005(96)01907-7; Kaupp UB, 2003, NAT CELL BIOL, V5, P109, DOI 10.1038/ncb915; Kennedy JS, 1983, PHYSIOL ENTOMOL, V27, P58; Kuwana Y, 1999, BIOSENS BIOELECTRON, V14, P195, DOI 10.1016/S0956-5663(98)00106-7; Li W, 2001, ADAPT BEHAV, V9, P143, DOI 10.1177/10597123010093003; MAFRANETO A, 1994, NATURE, V369, P142, DOI 10.1038/369142a0; Marques L, 2006, AUTON ROBOT, V20, P183, DOI 10.1007/s10514-006-7536-7; MURLIS J, 1981, PHYSIOL ENTOMOL, V6, P71, DOI 10.1111/j.1365-3032.1981.tb00262.x; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; PANG S, IN PRESS IEEE T SY B; Payne T.L., 1986, MECH INSECT OLFACTIO; Russell R.A., 1999, ODOR DETECTION MOBIL; Russell RA, 2003, ROBOT AUTON SYST, V45, P83, DOI 10.1016/S0921-8890(03)00120-9; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shraiman BI, 2000, NATURE, V405, P639, DOI 10.1038/35015000; Villermaux E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.184501; Webb B, 2002, NATURE, V417, P359, DOI 10.1038/417359a	31	476	492	5	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2007	445	7126					406	409		10.1038/nature05464	http://dx.doi.org/10.1038/nature05464			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	128WD	17251974				2022-12-01	WOS:000243689500034
J	Mizuno, D; Tardin, C; Schmidt, CF; MacKintosh, FC				Mizuno, Daisuke; Tardin, Catherine; Schmidt, C. F.; MacKintosh, F. C.			Nonequilibrium mechanics of active cytoskeletal networks	SCIENCE			English	Article							2-POINT MICRORHEOLOGY; MYOSIN; VISCOELASTICITY; ELASTICITY; MOTION; MODULI	Cells both actively generate and sensitively react to forces through their mechanical framework, the cytoskeleton, which is a nonequilibrium composite material including polymers and motor proteins. We measured the dynamics and mechanical properties of a simple three-component model system consisting of myosin II, actin filaments, and cross-linkers. In this system, stresses arising from motor activity controlled the cytoskeletal network mechanics, increasing stiffness by a factor of nearly 100 and qualitatively changing the viscoelastic response of the network in an adenosine triphosphate-dependent manner. We present a quantitative theoretical model connecting the large-scale properties of this active gel to molecular force generation.	Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; Univ Gottingen, Fak Phys, Inst Phys 3, D-37077 Gottingen, Germany	Vrije Universiteit Amsterdam; University of Gottingen	MacKintosh, FC (corresponding author), Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands.	cfs@nat.vu.nl; fcm@nat.vu.nl	MacKintosh, Frederick/AAB-9332-2021; 水野, 大介/O-1812-2018; Schmidt, Christoph F/G-3787-2011; MacKintosh, Fred C/A-9450-2008	MacKintosh, Frederick/0000-0002-2607-9541; 水野, 大介/0000-0001-7749-3681; Schmidt, Christoph F/0000-0003-2864-6973; MacKintosh, Fred C/0000-0002-2607-9541				Bray D., 2001, CELL MOVEMENTS MOL M; Buchanan M, 2005, MACROMOLECULES, V38, P8840, DOI 10.1021/ma0500990; Caspi A, 1998, PHYS REV LETT, V80, P1106, DOI 10.1103/PhysRevLett.80.1106; Crocker JC, 2000, PHYS REV LETT, V85, P888, DOI 10.1103/PhysRevLett.85.888; D'Anna G, 2003, NATURE, V424, P909, DOI 10.1038/nature01867; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Gittes F, 1997, PHYS REV LETT, V79, P3286, DOI 10.1103/PhysRevLett.79.3286; Gittes F, 1998, PHYS REV E, V58, pR1241, DOI 10.1103/PhysRevE.58.R1241; HAYASHI T, 1975, J BIOCHEM-TOKYO, V78, P1031, DOI 10.1093/oxfordjournals.jbchem.a130980; Hough LA, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.021906; Humphrey D, 2002, NATURE, V416, P413, DOI 10.1038/416413; Janmey PA, 2004, TRENDS BIOCHEM SCI, V29, P364, DOI 10.1016/j.tibs.2004.05.003; Koenderink GH, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysLettRev.96.138307; Laevsky G, 2003, J CELL SCI, V116, P3761, DOI 10.1242/jcs.00684; Lau AWC, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.198101; Le Goff L, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.018101; Levine AJ, 2000, PHYS REV LETT, V85, P1774, DOI 10.1103/PhysRevLett.85.1774; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250; Mizuno D, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.088104; Morse DC, 1998, MACROMOLECULES, V31, P7044, DOI 10.1021/ma980304u; REISLER E, 1980, J MOL BIOL, V143, P129, DOI 10.1016/0022-2836(80)90127-8; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104	26	648	654	5	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2007	315	5810					370	373		10.1126/science.1134404	http://dx.doi.org/10.1126/science.1134404			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126SI	17234946				2022-12-01	WOS:000243535400040
J	Scharfman, HE; Hen, R				Scharfman, Helen E.; Hen, Rene			Is more Neurogenesis always better?	SCIENCE			English	Editorial Material							SEIZURE-INDUCED NEUROGENESIS; HIPPOCAMPAL NEUROGENESIS; DENTATE GYRUS; ADULT; REPLACEMENT; PRECURSORS; NEOCORTEX; NEURONS; MEMORY; STROKE		Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; Columbia Univ, Dept Neurol, New York, NY 10032 USA; Helen Hayes Hosp, Ctr Neural Recovery & Rehabil Res, W Haverstraw, NY 10993 USA; Columbia Univ, Dept Psychiat, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University	Scharfman, HE (corresponding author), Columbia Univ, Dept Pharmacol, New York, NY 10032 USA.	scharfmanh@helenhayeshosp.org			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037562] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS037562] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Dayer AG, 2005, J CELL BIOL, V168, P415, DOI 10.1083/jcb.200407053; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Jin K, 2006, BRAIN RES, V1085, P183, DOI 10.1016/j.brainres.2006.02.081; Keilhoff G, 2004, BIOL PSYCHIAT, V56, P317, DOI 10.1016/j.biopsych.2004.06.010; KEMPERMANN G, 2006, ADULT NEUROGENESIS S; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Kuhn HG, 2001, EUR ARCH PSY CLIN N, V251, P152, DOI 10.1007/s004060170035; Longo Frank M., 2006, Current Alzheimer Research, V3, P5, DOI 10.2174/156720506775697089; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Parent JM, 2006, ANN NEUROL, V59, P81, DOI 10.1002/ana.20699; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Rakic P, 2002, NAT REV NEUROSCI, V3, P65, DOI 10.1038/nrn700; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; SAXE M, 2006, 2666 SOC NEUR; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Scharfman HE, 2004, ADV EXP MED BIOL, V548, P192; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Zhao M, 2003, P NATL ACAD SCI USA, V100, P7925, DOI 10.1073/pnas.1131955100	24	93	99	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 19	2007	315	5810					336	338		10.1126/science.1138711	http://dx.doi.org/10.1126/science.1138711			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126SI	17234934	Green Accepted			2022-12-01	WOS:000243535400025
J	Brouilette, SW; Moore, JS; D McMahon, A; Thompson, JR; Ford, I; Shepherd, J; Packard, CJ; Samani, NJ				Brouilette, Scott W.; Moore, Jasbir S.; D McMahon, Alex; Thompson, John R.; Ford, Ian; Shepherd, James; Packard, Chris J.; Samani, Nilesh J.		W Scotland Coronary Prevention Stu	Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study	LANCET			English	Article							WHITE BLOOD-CELLS; ATHEROSCLEROSIS; ENDOTHELIUM; MORTALITY; THERAPY; PLAQUES	Background Inter-individual differences in biological ageing could affect susceptibility to coronary heart disease. Our aim was to determine whether mean leucocyte telomere length is a predictor of the development of coronary heart disease. Methods We compared telomere lengths at recruitment in 484 individuals in the West of Scotland Primary Prevention Study (WOSCOPS) who went on to develop coronary heart disease events with those from 1058 matched controls who remained event free. We also investigated whether there was any association between telomere length and observed clinical benefit of statin treatment in WOSCOPS. Findings Mean telomere length decreased with age by 9% per decade (95% CI 3.6-14.1; p=0.001) in controls; much the same trend was seen in cases (-5.9% per decade, -3.1 to 14.1; p=0.1902). Individuals in the middle and the lowest tertiles of telomere length were more at risk of developing a coronary heart disease event than were individuals in the highest tertile (odds ratio [OR] for coronary heart disease: 1.51, 95% CI 1.15-1.98; p=0.0029 in the middle tertile; 1.44, 1.10-1.90, p=0.0090 in the lowest). In placebo-treated patients, the risk of coronary heart disease was almost double in those in the lower two tertiles of telomere length compared with those in the highest tertile (1.93, 1.33-2.80, p=0.0005 in the middle tertile; 1.94, 1.33-2.84, p=0.0006 in the lowest). By contrast, in patients treated with pravastatin, the increased risk with shorter telomeres was substantially attenuated (1.12, 0.75-1.69, p=0.5755 in the middle tertile; 1.02, 0.68-1.52, p=0.9380 in the lowest). Interpretation Mean leucocyte telomere length is a predictor of future coronary heart disease events in middle-aged, high-risk men and could identify individuals who would benefit most from statin treatment. Our findings lend support to the hypothesis that differences in biological ageing might contribute to the risk-and variability in age of onset-of coronary heart disease.	Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; Univ Glasgow, Dept Vasc Biochem, Glasgow, Lanark, Scotland	University of Leicester; University of Leicester; University of Glasgow; University of Glasgow	Samani, NJ (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Glenfield Hosp, Clin Sci Wing,Groby Rd, Leicester LE3 9QP, Leics, England.	njs@le.ac.uk	Ford, Ian/ABE-6145-2020					ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; ALLSOPP RC, 1995, EXP CELL RES, V219, P130, DOI 10.1006/excr.1995.1213; Andrew T, 2006, AM J HUM GENET, V78, P480, DOI 10.1086/500052; [Anonymous], 1995, Am J Cardiol, V76, P485; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; BURRIG KF, 1991, ARTERIOSCLER THROMB, V11, P1678, DOI 10.1161/01.ATV.11.6.1678; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chan SRWL, 2004, PHILOS T R SOC B, V359, P109, DOI 10.1098/rstb.2003.1370; CHANG E, 1995, P NATL ACAD SCI USA, V92, P11190, DOI 10.1073/pnas.92.24.11190; DAVIES MJ, 1988, BRIT HEART J, V60, P459; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Harrison D, 1998, Can J Cardiol, V14 Suppl D, p30D; Jeanclos E, 1998, DIABETES, V47, P482, DOI 10.2337/diabetes.47.3.482; Martin-Ruiz C, 2004, J BIOL CHEM, V279, P17826, DOI 10.1074/jbc.M311980200; Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Packard CJ, 2000, NEW ENGL J MED, V343, P1148, DOI 10.1056/NEJM200010193431603; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Spyridopoulos I, 2004, CIRCULATION, V110, P3136, DOI 10.1161/01.CIR.0000142866.50300.EB; Takubo K, 2002, EXP GERONTOL, V37, P523, DOI 10.1016/S0531-5565(01)00218-2; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Von Zglinicki T, 2000, ANN NY ACAD SCI, V908, P99, DOI 10.1111/j.1749-6632.2000.tb06639.x; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Warton K, 2004, GENE, V342, P85, DOI 10.1016/j.gene.2004.07.027; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	34	576	599	0	49	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 13	2007	369	9556					107	114		10.1016/S0140-6736(07)60071-3	http://dx.doi.org/10.1016/S0140-6736(07)60071-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126TK	17223473				2022-12-01	WOS:000243538200029
J	Shen, WH; Balajee, AS; Wang, JL; Wu, H; Eng, C; Pandolfi, PP; Yin, YX				Shen, Wen Hong; Balajee, Adayabalam S.; Wang, Jianli; Wu, Hong; Eng, Charis; Pandolfi, Pier Paolo; Yin, Yuxin			Essential role for nuclear PTEN in maintaining chromosomal integrity	CELL			English	Article							TUMOR-SUPPRESSOR GENE; CENP-C; CELL-SURVIVAL; KINETOCHORE; PROTEIN; AMPLIFICATION; INSTABILITY; NEOPLASIA; CANCER; REPAIR	A broad spectrum of mutations in PTEN, encoding a lipid phosphatase that inactivates the P13-K/AKT pathway, is found associated with primary tumors. Some of these mutations occur outside the phosphatase domain, suggesting that additional activities of PTEN function in tumor suppression. We report a nuclear function for PTEN in controlling chromosomal integrity. Disruption of Pten leads to extensive centromere breakage and chromosomal translocations. PTEN was found localized at centromeres and physically associated with CENP-C, an integral component of the kinetochore. C-terminal PTEN mutants disrupt the association of PTEN with centromeres and cause centromeric instability. Furthermore, Pten null cells exhibit spontaneous DNA double-strand breaks (DSBs). We show that PTEN acts on chromatin and regulates expression of Rad51, which reduces the incidence of spontaneous DSBs. Our results demonstrate that PTEN plays a fundamental role in the maintenance of chromosomal stability through the physical interaction with centromeres and control of DNA repair. We propose that PTEN acts as a guardian of genome integrity.	Columbia Univ, Coll Phys & Surg, Dept Radiat Oncol, New York, NY 10032 USA; Univ Calif Los Angeles, Sch Med, Dept Med & Mol Pharmacol, Los Angeles, CA 90095 USA; Cleveland Clin Fdn, Genom Med Inst, Cleveland, OH 44195 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10021 USA	Columbia University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cleveland Clinic Foundation; Memorial Sloan Kettering Cancer Center	Yin, YX (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Radiat Oncol, 630 W 168th St, New York, NY 10032 USA.	yy151@columbia.edu	wang, jian/GVS-0711-2022	SHEN, WEN/0000-0002-5830-6518; Eng, Charis/0000-0002-3693-5145	NCI NIH HHS [R01 CA093677, R01 CA102447] Funding Source: Medline; NIGMS NIH HHS [R01 GM100478] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA102447, R01CA093677] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agrawal S, 2005, HUM MOL GENET, V14, P2459, DOI 10.1093/hmg/ddi246; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Carroll CW, 2006, TRENDS CELL BIOL, V16, P70, DOI 10.1016/j.tcb.2005.12.008; Choo KHA, 2000, TRENDS CELL BIOL, V10, P182, DOI 10.1016/S0962-8924(00)01739-6; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Foster ER, 2005, FEBS J, V272, P3231, DOI 10.1111/j.1742-4658.2005.04741.x; Fukagawa T, 1999, EMBO J, V18, P4196, DOI 10.1093/emboj/18.15.4196; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; HAYS SL, 1995, P NATL ACAD SCI USA, V92, P6925, DOI 10.1073/pnas.92.15.6925; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Kalitsis P, 1998, P NATL ACAD SCI USA, V95, P1136, DOI 10.1073/pnas.95.3.1136; Levine AJ, 1995, ANN NY ACAD SCI, V768, P111, DOI 10.1111/j.1749-6632.1995.tb12115.x; Li G, 2002, DEVELOPMENT, V129, P4159; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; MOROI Y, 1980, P NATL ACAD SCI-BIOL, V77, P1627, DOI 10.1073/pnas.77.3.1627; Pastink A, 2001, MUTAT RES-FUND MOL M, V480, P37, DOI 10.1016/S0027-5107(01)00167-1; Pierce AJ, 2001, TRENDS CELL BIOL, V11, pS52, DOI 10.1016/S0962-8924(01)02149-3; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Puc J, 2005, CANCER CELL, V7, P193, DOI 10.1016/j.ccr.2005.01.009; Regnier V, 2005, MOL CELL BIOL, V25, P3967, DOI 10.1128/MCB.25.10.3967-3981.2005; SAITOH H, 1992, CELL, V70, P115, DOI 10.1016/0092-8674(92)90538-N; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Smiraldo PG, 2005, CANCER RES, V65, P2089, DOI 10.1158/0008-5472.CAN-04-2079; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stambolic V, 2000, CANCER RES, V60, P3605; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Thacker J, 2005, CANCER LETT, V219, P125, DOI 10.1016/j.canlet.2004.08.018; Thiriet C, 2005, MOL CELL, V18, P617, DOI 10.1016/j.molcel.2005.05.008; TOMKIEL J, 1994, J CELL BIOL, V125, P531, DOI 10.1083/jcb.125.3.531; Tutt A, 2002, TRENDS MOL MED, V8, P571, DOI 10.1016/S1471-4914(02)02434-6; Vlietstra RJ, 1998, CANCER RES, V58, P2720; Waite KA, 2002, AM J HUM GENET, V70, P829, DOI 10.1086/340026; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7; Yuen KWY, 2005, CURR OPIN CELL BIOL, V17, P576, DOI 10.1016/j.ceb.2005.09.012	48	737	779	2	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 12	2007	128	1					157	170		10.1016/j.cell.2006.11.042	http://dx.doi.org/10.1016/j.cell.2006.11.042			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GN	17218262	Bronze			2022-12-01	WOS:000244420400020
J	Rasmussen, JN; Chong, A; Alter, DA				Rasmussen, Jeppe N.; Chong, Alice; Alter, David A.			Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DRUG-THERAPY; MEDICATION NONADHERENCE; SECONDARY PREVENTION; PHARMACY RECORDS; ELDERLY-PATIENTS; STATIN THERAPY; BLOOD-PRESSURE; BETA-BLOCKERS; IMPACT; CARE	Context The extent to which drug adherence may affect survival remains unclear, in part because mortality differences may be attributable to "healthy adherer" behavioral attributes more so than to pharmacological benefits. Objective To explore the relationship between drug adherence and mortality in survivors of acute myocardial infarction (AMI). Design, Setting, and Participants Population-based, observational, longitudinal study of 31 455 elderly AMI survivors between 1999 and 2003 in Ontario. All patients filled a prescription for statins, beta-blockers, or calcium channel blockers, with the latter drug considered a control given the absence of clinical trial-proven survival benefits. Main Outcome Measures Patient adherence was subdivided a priori into 3 categories - high (proportion of days covered, >= 80%), intermediate (proportion of days covered, 40%-79%), and low (proportion of days covered, <40%) - and compared with long-term mortality (median of 2.4 years of follow-up) using multivariable survival models (and propensity analyses) adjusted for sociodemographic factors, illness severity, comorbidities, and concomitant use of evidence-based therapies. Results Among statin users, compared with their high-adherence counterparts, the risk of mortality was greatest for low adherers (deaths in 261/1071 (24%) vs 2310/14345 (16%); adjusted hazard ratio, 1.25; 95% confidence interval, 1.09-1.42; P = .001) and was intermediary for intermediate adherers (deaths in 472/2407 (20%); adjusted hazard ratio, 1.12; 95% confidence interval, 1.01-1.25; P = .03). A similar but less pronounced dose-response - type adherence-mortality association was observed for beta-blockers. Mortality was not associated with adherence to calcium channel blockers. Moreover, sensitivity analyses demonstrated no relationships between drug adherence and cancer-related admissions, outcomes for which biological plausibility do not exist. Conclusion The long-term survival advantages associated with improved drug adherence after AMI appear to be class-specific, suggesting that adherence outcome benefits are mediated by drug effects and do not merely reflect an epiphenomenon of "healthy adherer" behavioral attributes.	Univ Toronto, Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Univ Toronto, Sunnybrook Hlth Sci Ctr, Clin Epidemiol Unit, Toronto, ON M4N 3M5, Canada; Univ Toronto, Div Cardiol, Li Ka Shing Knowledge Inst, St Michaels Hosp, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Med & Hlth Policy, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Management, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Evaluat, Toronto, ON M4N 3M5, Canada; Natl Inst Publ Hlth, Copenhagen, Denmark	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto	Alter, DA (corresponding author), Univ Toronto, Inst Clin Evaluat Sci, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	david.alter@ices.on.ca						Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; Alter DA, 2004, JAMA-J AM MED ASSOC, V291, P1100, DOI 10.1001/jama.291.9.1100; ANDRADE SE, 1995, NEW ENGL J MED, V332, P1125, DOI 10.1056/NEJM199504273321703; Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Bertolet BD, 1999, DRUG AGING, V15, P461, DOI 10.2165/00002512-199915060-00006; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; DiMatteo MR, 2002, MED CARE, V40, P794, DOI 10.1097/01.MLR.0000024612.61915.2D; Dobbels F, 2004, J HEART LUNG TRANSPL, V23, P1245, DOI 10.1016/j.healun.2003.09.016; Freemantle N, 1999, BMJ-BRIT MED J, V318, P1730, DOI 10.1136/bmj.318.7200.1730; FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707; Garcia R, 2002, ENZYME MICROB TECH, V30, P110, DOI 10.1016/S0141-0229(01)00462-8; Gislason GH, 2006, EUR HEART J, V27, P1153, DOI 10.1093/eurheartj/ehi705; Ho PM, 2006, ARCH INTERN MED, V166, P1836, DOI 10.1001/archinte.166.17.1836; Ho PM, 2006, ARCH INTERN MED, V166, P1842, DOI 10.1001/archinte.166.17.1842; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Johnson ES, 2002, AM J MANAG CARE, V8, pS249; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Lau HS, 1997, J CLIN EPIDEMIOL, V50, P619, DOI 10.1016/S0895-4356(97)00040-1; Law M, 2006, AM J CARDIOL, V97, p52C, DOI 10.1016/j.amjcard.2005.12.010; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Lee JK, 2006, JAMA-J AM MED ASSOC, V296, P2563, DOI 10.1001/jama.296.21.joc60162; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Mackillop WJ, 2000, CANCER-AM CANCER SOC, V89, P901, DOI 10.1002/1097-0142(20000815)89:4<901::AID-CNCR25>3.0.CO;2-I; McDermott MM, 1997, ARCH INTERN MED, V157, P1921, DOI 10.1001/archinte.157.17.1921; Mickley H, 2004, EUR HEART J, V25, P96, DOI 10.1016/j.ehj.2003.06.011; Newby LK, 2006, CIRCULATION, V113, P203, DOI 10.1161/CIRCULATIONAHA.105.505636; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Peterson AM, 2005, PHARMACOECONOMICS, V23, P13, DOI 10.2165/00019053-200523010-00002; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Simpson E, 2003, AM HEART J, V145, P438, DOI 10.1067/mhj.2003.143; Simpson SH, 2006, BMJ-BRIT MED J, V333, P15, DOI 10.1136/bmj.38875.675486.55; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Tu JV, 2001, J AM COLL CARDIOL, V37, P992, DOI 10.1016/S0735-1097(01)01109-3; Tu JV., 1999, CARDIOVASCULAR HLTH, P83; Wei L, 2002, HEART, V88, P229, DOI 10.1136/heart.88.3.229; Wei L, 2004, PHARMACOEPIDEM DR S, V13, P761, DOI 10.1002/pds.963; WEST SL, 1995, AM J EPIDEMIOL, V142, P1103, DOI 10.1093/oxfordjournals.aje.a117563	40	735	754	0	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 10	2007	297	2					177	186		10.1001/jama.297.2.177	http://dx.doi.org/10.1001/jama.297.2.177			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	124GI	17213401				2022-12-01	WOS:000243355900027
J	Smogorzewska, A; Matsuoka, S; Vinciguerra, P; McDonald, ER; Hurov, KE; Luo, J; Ballif, BA; Gygi, SP; Hofmann, K; D'Andrea, AD; Elledge, SJ				Smogorzewska, Agata; Matsuoka, Shuhei; Vinciguerra, Patrizia; McDonald, E. Robert, III; Hurov, Kristen E.; Luo, Ji; Ballif, Bryan A.; Gygi, Steven P.; Hofmann, Kay; D'Andrea, Alan D.; Elledge, Stephen J.			Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair	CELL			English	Article							HOMOLOGOUS RECOMBINATION; DAMAGE RESPONSE; ANEMIA PATHWAY; COMPLEX; CHROMATIN; CANCER; BRCA2; PALB2; PHOSPHORYLATION; EXPRESSION	Fanconi anemia (FA) is a developmental and cancer-predisposition syndrome caused by mutations in genes controlling DNA interstrand crosslink repair. Several FA proteins form a ubiquitin ligase that controls monoubiquitination of the FANCD2 protein in an ATR-dependent manner. Here we describe the FA protein FANCI, identified as an ATM/ATR kinase substrate required for resistance to mitomycin C. FANCI shares sequence similarity with FANCD2, likely evolving from a common ancestral gene. The FANCI protein associates with FANCD2 and, together, as the FANCI-FANCD2 (ID) complex, localize to chromatin in response to DNA damage. Like FANCD2, FANCI is monoubiquitinated and unexpectedly, ubiquitination of each protein is important for the maintenance of ubiquitin on the other, indicating the existence of a dual ubiquitin-locking mechanism required for ID complex function. Mutation in FANCI is responsible for loss of a functional FA pathway in a patient with Fanconi anemia complementation group I.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Howard Hughes Med Inst,Ctr Genet & Genom,Dept Gen, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02214 USA; Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02215 USA; Miltenyi Biotec GmbH, D-50829 Cologne, Germany	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Miltenyi Biotec	Elledge, SJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Howard Hughes Med Inst,Ctr Genet & Genom,Dept Gen, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu	Smogorzewska, Agata/B-8891-2011; Hofmann, Kay/D-6714-2011	Hofmann, Kay/0000-0002-2289-9083; Smogorzewska, Agata/0000-0001-6285-1562	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [T32CA09216, T32 CA009216] Funding Source: Medline; NHLBI NIH HHS [R37 HL052725] Funding Source: Medline; NIAID NIH HHS [U19 AI067751-020002, U19 AI067751-01, U19 AI067751] Funding Source: Medline; NIGMS NIH HHS [R37 GM044664-18, R37 GM044664-19, R37 GM044664] Funding Source: Medline; PHS HHS [1U19A1067751] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009216] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL052725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM044664] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Addison CL, 1997, J GEN VIROL, V78, P1653, DOI 10.1099/0022-1317-78-7-1653; Alter BP, 2003, BLOOD, V101, P2072, DOI 10.1182/blood-2002-11-3597; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; BUTTURINI A, 1994, BLOOD, V84, P1650, DOI 10.1182/blood.V84.5.1650.bloodjournal8451650; de Oca RM, 2005, BLOOD, V105, P1003, DOI 10.1182/blood-2003-11-3997; ELLEDGE SJ, 1991, P NATL ACAD SCI USA, V88, P1731, DOI 10.1073/pnas.88.5.1731; FANCONI G., 1967, SEMINARS HAMATOL, V4, P233; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gurtan AM, 2006, DNA REPAIR, V5, P1119, DOI 10.1016/j.dnarep.2006.05.009; Ho GPH, 2006, MOL CELL BIOL, V26, P7005, DOI 10.1128/MCB.02018-05; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; JAKOBS PM, 1996, CELL MOL GENET, V22, P151; Levitus M, 2004, BLOOD, V103, P2498, DOI 10.1182/blood-2003-08-2915; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Matsushita N, 2005, MOL CELL, V19, P841, DOI 10.1016/j.molcel.2005.08.018; Meetei AR, 2004, CELL CYCLE, V3, P179; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; SCHMID W, 1978, CYTOGENET CELL GENET, V20, P141, DOI 10.1159/000130845; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Tagwerker C, 2006, MOL CELL PROTEOMICS, V5, P737, DOI 10.1074/mcp.M500368-MCP200; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Yamamoto K, 2005, MOL CELL BIOL, V25, P34, DOI 10.1128/MCB.25.1.34-43.2005; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302	38	528	543	0	38	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2007	129	2					289	301		10.1016/j.cell.2007.03.009	http://dx.doi.org/10.1016/j.cell.2007.03.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17412408	Green Accepted, Bronze			2022-12-01	WOS:000246474600017
J	Zhao, Y; Ransom, JF; Li, A; Vedantham, V; von Drehle, M; Muth, AN; Tsuchihashi, T; McManus, MT; Schwartz, RJ; Srivastava, D				Zhao, Yong; Ransom, Joshua F.; Li, Ankang; Vedantham, Vasanth; von Drehle, Morgan; Muth, Alecia N.; Tsuchihashi, Takatoshi; McManus, Michael T.; Schwartz, Robert J.; Srivastava, Deepak			Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2	CELL			English	Article							BHLH TRANSCRIPTION FACTOR; MUSCLE-SPECIFIC MICRORNA; C-ELEGANS; CARDIOVASCULAR DEVELOPMENT; CAENORHABDITIS-ELEGANS; HEART-DISEASE; DIFFERENTIATION; MORPHOGENESIS; RNA; HYPERTROPHY	MicroRNAs (miRNAs) are genomically encoded small RNAs used by organisms to regulate the expression of proteins generated from messenger RNA transcripts. The in vivo requirement of specific miRNAs in mammals through targeted deletion remains unknown, and reliable prediction of mRNA targets is still problematic. Here, we show that miRNA biogenesis in the mouse heart is essential for cardiogenesis. Furthermore, targeted deletion of the muscle-specific miRNA, miR-1-2, revealed numerous functions in the heart, including regulation of cardiac morphogenesis, electrical conduction, and cellcycle control. Analyses of miR-1 complementary sequences in mRNAs upregulated upon miR-1-2 deletion revealed an enrichment of miR-1 '' seed matches '' and a strong tendency for potential miR-1 binding sites to be located in physically accessible regions. These findings indicate that subtle alteration of miRNA dosage can have profound consequences in mammals and demonstrate the utility of mammalian lossof-function models in revealing physiologic miRNA targets.	Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Pediat Cardiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Internal Med Cardiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA; Baylor Coll Med, Grad Program Cardiovasc Sci, Houston, TX 77030 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Srivastava, D (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, 1650 Owens St, San Francisco, CA 94158 USA.	dsrivastava@gladstone.ucsf.edu	mcmanus, michael/AAB-1239-2020	mcmanus, michael/0000-0003-3013-6569; Vedantham, Vasanth/0000-0003-1032-700X; Ransom, Joshua/0000-0002-3591-0288	NCRR NIH HHS [C06 RR018928] Funding Source: Medline; NHLBI NIH HHS [T32HL007731] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007731] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cheng CF, 2003, TRENDS MOL MED, V9, P59, DOI 10.1016/S1471-4914(03)00004-2; Cohen SM, 2006, GENE DEV, V20, P2769, DOI 10.1101/gad.1484606; Costantini DL, 2005, CELL, V123, P347, DOI 10.1016/j.cell.2005.08.004; Desai AD, 2006, AM J MED, V119, P600, DOI 10.1016/j.amjmed.2005.08.028; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Fischer A, 2003, TRENDS CARDIOVAS MED, V13, P221, DOI 10.1016/S1050-1738(03)00082-3; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Gourdie RG, 1999, TRENDS CARDIOVAS MED, V9, P18, DOI 10.1016/S1050-1738(98)00035-8; HAFE BD, 2005, P NATL ACAD SCI USA, V102, P10898; Hoffman JIE, 2004, AM HEART J, V147, P425, DOI 10.1016/j.ahj.2003.05.003; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Liao J, 2004, HUM MOL GENET, V13, P1577, DOI 10.1093/hmg/ddh176; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; MacLellan WR, 2000, ANNU REV PHYSIOL, V62, P289, DOI 10.1146/annurev.physiol.62.1.289; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; Mendez-Ferrer S, 2006, NAT CLIN PRACT CARD, V3, pS8; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; RAO PK, 2006, IN PRESS P NATL ACAD; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Shin CH, 2002, CELL, V110, P725, DOI 10.1016/S0092-8674(02)00933-9; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; SRIVASTAVA D, 1995, SCIENCE, V270, P1995, DOI 10.1126/science.270.5244.1995; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Wei Y, 1998, P NATL ACAD SCI USA, V95, P7480, DOI 10.1073/pnas.95.13.7480; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xin M, 2006, P NATL ACAD SCI USA, V103, P11189, DOI 10.1073/pnas.0604604103; Yamagishi H, 2003, GENE DEV, V17, P269, DOI 10.1101/gad.1048903; Yamagishi H, 2001, DEV BIOL, V239, P190, DOI 10.1006/dbio.2001.0417; Yelon D, 2000, DEVELOPMENT, V127, P2573; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; ZHAO Y, 2007, IN PRESS TRENDS BIOC; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	69	1069	1182	2	82	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2007	129	2					303	317		10.1016/j.cell.2007.03.030	http://dx.doi.org/10.1016/j.cell.2007.03.030			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17397913	Bronze			2022-12-01	WOS:000246474600018
J	Rodriguez, RA; Sen, S; Mehta, K; Moody-Ayers, S; Bacchetti, P; O'Hare, AM				Rodriguez, Rudolph A.; Sen, Saunak; Mehta, Kala; Moody-Ayers, Sandra; Bacchetti, Peter; O'Hare, Ann M.			Geography matters: Relationships among urban residential segregation, dialysis facilities, and patient outcomes	ANNALS OF INTERNAL MEDICINE			English	Article							STAGE RENAL-DISEASE; PAY-FOR-PERFORMANCE; HEMODIALYSIS-PATIENTS; REPLACEMENT THERAPY; RACIAL DISPARITIES; SURVIVAL ANALYSIS; HEALTH-CARE; TRANSPLANTATION; MORTALITY; QUALITY	Background: End-stage renal disease disproportionately affects black Americans. However, the impact of residential segregation by race-a prominent feature of many U.S. cities-on outcomes of patients receiving dialysis and on facility performance has not been evaluated. Objective: To examine the relationship among racial composition of ZIP codes in metropolitan areas, outcomes of patients receiving dialysis, and characteristics of dialysis facilities. Design: Retrospective cohort study of patients receiving dialysis and cross-sectional study of dialysis facilities. Setting: U.S. metropolitan ZIP codes with differing percentages of black residents. Patients: Black and non-Hispanic white patients who initiated long-term dialysis between 1 January 1995 and 31 December 2002 (n = 399 424) and dialysis facilities in operation in December 2004 (n = 3244). Measurements: Mortality and time to transplantation among patients receiving dialysis, and performance of dialysis facilities on the basis of quality indicators (anemia management, dialysis adequacy, and facility-level mortality rates). Results: Most black patients (50.3%) but few white patients (5%) lived in the 3% (n = 769) of ZIP codes in which most residents were black. in analyses adjusted for patient and ZIP code characteristics, mortality rates were higher among white patients but not among black patients living in areas with a higher percentage of black residents (adjusted hazard ratio for ZIP codes with 75% black residents vs. < 10% black residents, 1.14 [95% Cl, 1.07 to 1.21] for white patients and 1.02 [Cl, 0.99 to 1.06] for black patients). Time to transplantation was longer among both black and white patients (adjusted hazard ratio for ZIP codes with >= 75% black residents vs. < 10% black residents, 0.84 [Cl, 0.78 to 0.92] and 0.63 [Cl, 0.57 to 0.71] for black patients and white patients, respectively). Dialysis facilities located in areas with a higher percentage of black residents were more likely to have higher-than-expected mortality rates and were less likely to meet performance targets. Limitations: Patient-level analyses were restricted to black and non-Hispanic white patients. Patient-level and facility-level analyses focused only on the percentage of black residents in each ZIP code. Conclusions: The racial composition of urban residential areas is associated with time to transplantation and dialysis facility performance on standard quality measures. Closer scrutiny of care provided to patients receiving dialysis who live in predominantly black residential areas and to dialysis facilities operating in these areas may be warranted.	Univ Calif San Francisco, San Francisco Gen Hosp, Vet Affairs Med Ctr, San Francisco, CA 94110 USA; Vet Affairs San Francisco Res Enhancement Award P, San Francisco, CA USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Rodriguez, RA (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Vet Affairs Med Ctr, Renal Ctr Bldg 100,Room 350,Box 1341, San Francisco, CA 94110 USA.	rrodriguez@medsfgh.ucsf.edu			NIA NIH HHS [K23 AG 028980-01] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K23AG028980] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; Alexander GC, 1998, JAMA-J AM MED ASSOC, V280, P1148, DOI 10.1001/jama.280.13.1148; Alexander GC, 2002, AM J KIDNEY DIS, V40, P824, DOI 10.1053/ajkd.2002.35695; [Anonymous], 2004, DIABETES EDUCATOR, V30, P196, DOI 10.1177/014572170403000209; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Bleyer AJ, 1996, AM J KIDNEY DIS, V28, P72, DOI 10.1016/S0272-6386(96)90133-X; BLOEMBERGEN WE, 1994, J AM SOC NEPHROL, V5, P1231; Brown WW, 2003, KIDNEY INT S, V83, pS50; COWIE CC, 1994, DIABETES CARE, V17, P681, DOI 10.2337/diacare.17.7.681; *CTR MED MED SERV, 2003, NEPHROL DIAL TRANSPL, V18, P147; EGGERS PW, 1990, AM J KIDNEY DIS, V15, P414, DOI 10.1016/S0272-6386(12)70359-1; Epstein AM, 2004, NEW ENGL J MED, V350, P406, DOI 10.1056/NEJMsb035374; Epstein AM, 2000, NEW ENGL J MED, V343, P1537, DOI 10.1056/NEJM200011233432106; Epstein AM, 2004, NEW ENGL J MED, V351, P603, DOI 10.1056/NEJMe048181; Fang L, 2003, AM J MED, V115, P448, DOI 10.1016/S0002-9343(03)00446-7; Ford B.L., 1983, INCOMPLETE DATA SAMP, V2, P185; Frankenfield DL, 1999, AM J KIDNEY DIS, V34, P721, DOI 10.1016/S0272-6386(99)70399-9; Frederick PR, 2002, HEALTH CARE FINANC R, V23, P37; Garg PP, 1999, NEW ENGL J MED, V341, P1653, DOI 10.1056/NEJM199911253412205; HELD PJ, 1987, JAMA-J AM MED ASSOC, V257, P645, DOI 10.1001/jama.257.5.645; Himmelfarb J, 2004, J AM SOC NEPHROL, V15, P3263, DOI 10.1097/01.ASN.0000145893.61791.7B; Hirth RA, 1996, JAMA-J AM MED ASSOC, V276, P1303; Isaacs SL, 2004, NEW ENGL J MED, V351, P1137, DOI 10.1056/NEJMsb040329; Leggat JE, 1998, AM J KIDNEY DIS, V32, P139, DOI 10.1053/ajkd.1998.v32.pm9669435; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Longenecker JC, 2000, J AM SOC NEPHROL, V11, P520, DOI 10.1681/ASN.V113520; McGill JB, 2004, DIABETES ED, V30, P200; McGill JB, 2004, DIABETES ED, V30, P206; *MED PAYM ADV COMM, 2006, REP C MED PAYM POL; Milgate K, 2006, HEALTH AFFAIR, V25, P413, DOI 10.1377/hlthaff.25.2.413; *NAT ESRD CPM WORK, 2002, J AM SOC NEPHROL, V13, P2117; O'Riordan E, 2003, QJM-INT J MED, V96, P739, DOI 10.1093/qjmed/hcg127; Owen WF, 1998, JAMA-J AM MED ASSOC, V280, P1764, DOI 10.1001/jama.280.20.1764; Pei YPC, 2000, KIDNEY INT, V58, P1293, DOI 10.1046/j.1523-1755.2000.00285.x; Powe NR, 2003, KIDNEY INT, V64, P763, DOI 10.1046/j.1523-1755.2003.00138.x; PUGH JA, 1994, AM J KIDNEY DIS, V23, P803; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Saran R, 2003, KIDNEY INT, V64, P254, DOI 10.1046/j.1523-1755.2003.00064.x; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Sehgal AR, 2000, AM J KIDNEY DIS, V35, pS148, DOI 10.1016/S0272-6386(00)70242-3; Sehgal AR, 2003, JAMA-J AM MED ASSOC, V289, P996, DOI 10.1001/jama.289.8.996; Stack AG, 2002, J AM SOC NEPHROL, V13, P1279, DOI 10.1681/ASN.V1351279; Tanna MM, 2000, AM J KIDNEY DIS, V36, P1175, DOI 10.1053/ajkd.2000.19832; Werner RM, 2005, CIRCULATION, V111, P1257, DOI 10.1161/01.CIR.0000157729.59754.09; WHITEIS DG, 1992, PUBLIC HEALTH REP, V107, P409; Williams DR, 2001, PUBLIC HEALTH REP, V116, P404, DOI 10.1016/S0033-3549(04)50068-7	47	145	150	1	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2007	146	7					493	501		10.7326/0003-4819-146-7-200704030-00005	http://dx.doi.org/10.7326/0003-4819-146-7-200704030-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153VB	17404351				2022-12-01	WOS:000245463200003
J	Davis, CC; Latvis, M; Nickrent, DL; Wurdack, KJ; Baum, DA				Davis, Charles C.; Latvis, Maribeth; Nickrent, Daniel L.; Wurdack, Kenneth J.; Baum, David A.			Floral gigantism in rafflesiaceae	SCIENCE			English	Article							FLOWERING PLANTS; GENE-TRANSFER		Harvard Univ Hebaria, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; So Illinois Univ, Dept Plant Biol, Carbondale, IL 62901 USA; Smithsonian Inst, Dept Bot, Washington, DC 20013 USA; Univ Wisconsin, Dept Bot, Madison, WI 53706 USA	Harvard University; Southern Illinois University System; Southern Illinois University; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Wisconsin System; University of Wisconsin Madison	Davis, CC (corresponding author), Harvard Univ Hebaria, Dept Organism & Evolutionary Biol, 22 Divin Ave, Cambridge, MA 02138 USA.	cdavis@oeb.harvard.edu	Baum, David/D-6804-2015; Nickrent, Daniel/AAA-8411-2020	Baum, David/0000-0001-8334-6311; 				[Anonymous], 1969, BIOL PARASITIC FLOWE; Barkman TJ, 2004, P NATL ACAD SCI USA, V101, P787, DOI 10.1073/pnas.0305562101; BROWN R, 1822, T LINN SOC LOND, V13, P201, DOI DOI 10.1111/J.1095-8339.1821.TB00062.X; Davis CC, 2005, AM NAT, V165, pE36, DOI 10.1086/428296; Davis CC, 2004, SCIENCE, V305, P676, DOI 10.1126/science.1100671; Nickrent Daniel L., 1998, P211; Nickrent DL, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-40; Nickrent DL, 1997, PLANT MOL BIOL, V34, P717, DOI 10.1023/A:1005860632601; O'Meara BC, 2006, EVOLUTION, V60, P922; OMEARA BC, BROWNIE 2 06B	10	100	104	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1812	1812		10.1126/science.1135260	http://dx.doi.org/10.1126/science.1135260			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17218493				2022-12-01	WOS:000245280100033
J	Stobbart, L; Murtagh, MJ; Rapley, T; Ford, GA; Louw, SJ; Rodgers, H				Stobbart, L.; Murtagh, M. J.; Rapley, T.; Ford, G. A.; Louw, S. J.; Rodgers, H.			"We saw human guinea pigs explode"	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Newcastle, Dept Hlth Res Capac Dev, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Royal Victoria Infirm, Stroke Res Grp, Inst Ageing & Hlth, Clin Res Facil, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Freeman Rd Hosp, Newcastle upon Tyne Hosp NHS Fdn Trust, Dept Hen Internal Med, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle Freeman Hospital; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Murtagh, MJ (corresponding author), Univ Newcastle, Dept Hlth Res Capac Dev, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	m.j.murtagh@newcastle.ac.uk	Ford, Gary/AAY-6405-2020; Ford, Gary A/A-6353-2012	Ford, Gary/0000-0001-8719-4968; 	Department of Health [RDA/01/05/091] Funding Source: Medline	Department of Health			0	7	8	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 17	2007	334	7593					566	567		10.1136/bmj.39150.488264.47	http://dx.doi.org/10.1136/bmj.39150.488264.47			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AP	17363826	Green Published			2022-12-01	WOS:000245404400031
J	Prall, OWJ; Menon, MK; Solloway, MJ; Watanabe, Y; Zaffran, S; Bajolle, F; Biben, C; McBride, JJ; Robertson, BR; Chaulet, H; Stennard, FA; Wise, N; Schaft, D; Wolstein, O; Furtado, MB; Shiratori, H; Chien, KR; Hamada, H; Black, BL; Saga, Y; Robertson, EJ; Buckingham, ME; Harvey, RP				Prall, Owen W. J.; Menon, Mary K.; Solloway, Mark J.; Watanabe, Yusuke; Zaffran, Stephane; Bajolle, Fanny; Biben, Christine; McBride, Jim J.; Robertson, Bronwyn R.; Chaulet, Herve; Stennard, Fiona A.; Wise, Natalie; Schaft, Daniel; Wolstein, Orit; Furtado, Milena B.; Shiratori, Hidetaka; Chien, Kenneth R.; Hamada, Hiroshi; Black, Brian L.; Saga, Yumiko; Robertson, Elizabeth J.; Buckingham, Margaret E.; Harvey, Richard P.			An Nkx2-5/Bmp2/Smad1 negative feedback loop controls heart progenitor specification and proliferation	CELL			English	Article							HOMEOBOX GENE NKX2-5; TRANSCRIPTION FACTOR NKX2-5; OUTFLOW TRACT; ASYMMETRIC EXPRESSION; SIGNALING PATHWAY; EMBRYOS LACKING; FIELD; MUTATIONS; CELLS; DISEASE	During heart development the second heart field (SHF) provides progenitor cells for most cardiomyocytes and expresses the homeodomain factor Nkx2-5. We now show that feedback repression of Bmp2/Smad1 signaling by Nkx2-5 critically regulates SHF proliferation and outflow tract (OFT) morphology. In the cardiac fields of Nkx2-5 mutants, genes controlling cardiac specification (including Bmp2) and maintenance of the progenitor state were upregulated, leading initially to progenitor overspecification, but subsequently to failed SHF proliferation and OFT truncation. In Smad1 mutants, SHF proliferation and deployment to the OFT were increased, while Smad1 deletion in Nkx2-5 mutants rescued SHF proliferation and OFT development. In Nkx2-5 hyponnorphic mice, which recapitulate human congenital heart disease (CHD), OFT anomalies were also rescued by Smad1 deletion. Our findings demonstrate that Nkx2-5 orchestrates the transition between periods of cardiac induction, progenitor proliferation, and OFT morphogenesis via a Smadl dependent negative feedback loop, which may be a frequent molecular target in CHD.	Victor Chang Cardiac Res Inst, Sydney, NSW 2010, Australia; Univ New S Wales, Fac Life Sci, Kensington, NSW 2053, Australia; Univ New S Wales, Fac Med, Kensington, NSW 2053, Australia; Inst Pasteur, Dept Dev Biol, CNRS, URA 2578, Paris, France; Garvan Inst Med Res, Sydney, NSW 2010, Australia; Univ New S Wales, Ramaciotti Ctr Gene Funct Anal, Sydney, NSW, Australia; Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Natl Inst Genet, Div Mammalian Dev, Mishima, Shizuoka 4118540, Japan; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	Victor Chang Cardiac Research Institute; University of New South Wales Sydney; University of New South Wales Sydney; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Garvan Institute of Medical Research; University of New South Wales Sydney; Osaka University; Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Oxford; Wellcome Centre for Human Genetics	Harvey, RP (corresponding author), Victor Chang Cardiac Res Inst, Sydney, NSW 2010, Australia.	r.harvey@victorchang.unsw.edu.au	Zaffran, Stéphane/I-2955-2016; Hamada, Hiroshi/N-6374-2015; Zaffran, Stéphane/S-7454-2019	Zaffran, Stéphane/0000-0002-0811-418X; Hamada, Hiroshi/0000-0002-7196-5948; Zaffran, Stéphane/0000-0002-0811-418X; Harvey, Richard/0000-0002-9950-9792; Black, Brian/0000-0002-6664-8913	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD047858] Funding Source: NIH RePORTER; NICHD NIH HHS [R21 HD047858, R21 HD047858-01, HD 047858] Funding Source: Medline; Wellcome Trust [059312] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission)		Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; Biben C, 1997, GENE DEV, V11, P1357, DOI 10.1101/gad.11.11.1357; Biben C, 2000, CIRC RES, V87, P888, DOI 10.1161/01.RES.87.10.888; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elliott DA, 2003, J AM COLL CARDIOL, V41, P2072, DOI 10.1016/S0735-1097(03)00420-0; Elliott DA, 2006, DEVELOPMENT, V133, P1311, DOI 10.1242/dev.02305; Foley AC, 2005, GENE DEV, V19, P387, DOI 10.1101/gad.1279405; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Hu TH, 2004, DEVELOPMENT, V131, P5491, DOI 10.1242/dev.01399; Jay PY, 2004, J CLIN INVEST, V113, P1130, DOI 10.1172/JCI200419846; Kelly RG, 1997, DEV BIOL, V187, P183, DOI 10.1006/dbio.1997.8577; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Kelly RG, 2005, TRENDS CARDIOVAS MED, V15, P51, DOI 10.1016/j.tcm.2005.02.001; Liberatore CM, 2002, DEV BIOL, V244, P243, DOI 10.1006/dbio.2002.0604; Lien CL, 2002, DEV BIOL, V244, P257, DOI 10.1006/dbio.2002.0603; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; McElhinney DB, 2003, J AM COLL CARDIOL, V42, P1650, DOI 10.1016/j.jacc.2003.05.004; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Ross RS, 1996, DEVELOPMENT, V122, P1799; Saga Y, 1999, DEVELOPMENT, V126, P3437; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Shiratori H, 2001, MOL CELL, V7, P137, DOI 10.1016/S1097-2765(01)00162-9; Stanley EG, 2002, INT J DEV BIOL, V46, P431; Stennard FA, 2005, DEVELOPMENT, V132, P2451, DOI 10.1242/dev.01799; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Tanaka M, 2001, MOL CELL BIOL, V21, P4391, DOI 10.1128/MCB.21.13.4391-4398.2001; Tremblay KD, 2001, DEVELOPMENT, V128, P3609; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; Vitelli F, 2002, DEVELOPMENT, V129, P4605; von Both I, 2004, DEV CELL, V7, P331, DOI 10.1016/j.devcel.2004.07.023; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Ward C, 2005, DEV BIOL, V284, P72, DOI 10.1016/j.ydbio.2005.05.003; Xu HS, 2004, DEVELOPMENT, V131, P3217, DOI 10.1242/dev.01174; Yelbuz TM, 2002, CIRCULATION, V106, P504, DOI 10.1161/01.CIR.0000023044.44974.8A; Zaffran S, 2004, CIRC RES, V95, P261, DOI 10.1161/01.RES.0000136815.73623.BE; Zhang WJ, 2002, J BIOL CHEM, V277, P45435, DOI 10.1074/jbc.M208056200	41	381	399	1	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2007	128	5					947	959		10.1016/j.cell.2007.01.042	http://dx.doi.org/10.1016/j.cell.2007.01.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350578	Green Accepted, Bronze, Green Submitted			2022-12-01	WOS:000245073400018
J	Garner, EC; Campbell, CS; Weibel, DB; Mullins, RD				Garner, Ethan C.; Campbell, Christopher S.; Weibel, Douglas B.; Mullins, R. Dyche			Reconstitution of DNA segregation driven by assembly of a prokaryotic actin homolog	SCIENCE			English	Article							DYNAMIC INSTABILITY; PLASMID; MREB	Multiple unrelated polymer systems have evolved to partition DNA molecules between daughter cells at division. To better understand polymer-driven DNA segregation, we reconstituted the three-component segregation system of the R1 plasmid from purified components. We found that the ParR/parC complex can construct a simple bipolar spindle by binding the ends of ParM filaments, inhibiting dynamic instability, and acting as a ratchet permitting incorporation of new monomers and riding on the elongating filament ends. Under steady-state conditions, the dynamic instability of unattached ParM filaments provides the energy required to drive DNA segregation.	Univ Calif San Francisco, UCB Nanomed Dev Ctr, San Francisco, CA 94158 USA; Marine Biol Lab, Physiol Course, Woods Hole, MA 02543 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of California System; University of California San Francisco; Marine Biological Laboratory - Woods Hole; University of Wisconsin System; University of Wisconsin Madison	Mullins, RD (corresponding author), Univ Calif San Francisco, UCB Nanomed Dev Ctr, San Francisco, CA 94158 USA.	dyche@mullinslab.ucsf.edu	Garner, Ethan/J-4025-2014	Garner, Ethan/0000-0003-0141-3555; Campbell, Christopher/0000-0002-3927-344X	NIGMS NIH HHS [R01GM61010, R01 GM061010-07, R01GM675287, R01 GM061010] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061010] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; GERDES K, 1986, J MOL BIOL, V190, P269, DOI 10.1016/0022-2836(86)90001-X; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; HOLY TE, 1994, P NATL ACAD SCI USA, V91, P5682, DOI 10.1073/pnas.91.12.5682; INOUE S, 1967, J GEN PHYSIOL, V50, P259, DOI 10.1085/jgp.50.6.259; Kruse T, 2006, GENE DEV, V20, P113, DOI 10.1101/gad.366606; Lim GE, 2005, P NATL ACAD SCI USA, V102, P17658, DOI 10.1073/pnas.0507222102; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; MORITZ M, 1995, J CELL BIOL, V130, P1149, DOI 10.1083/jcb.130.5.1149; Theriot JA, 2000, TRAFFIC, V1, P19, DOI 10.1034/j.1600-0854.2000.010104.x; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5	15	169	172	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816					1270	1274		10.1126/science.1138527	http://dx.doi.org/10.1126/science.1138527			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332412	Green Accepted			2022-12-01	WOS:000244564700048
J	Burns, B; Watkins, L; Goadsby, PJ				Burns, Brian; Watkins, Laurence; Goadsby, Peter J.			Treatment of medically intractable cluster headache by occipital nerve stimulation: long-term follow-up of eight patients	LANCET			English	Article							PERIPHERAL NEUROSTIMULATION; HYPOTHALAMIC-STIMULATION; SURGICAL-TREATMENT; INJECTION; EFFICACY; ACTIVATION; MANAGEMENT; NEURALGIA; BLOCKADE; SECTION	Background Cluster headache is a form of primary headache that features repeated attacks of excruciatingly severe headache usually occurring several times a day. Patients with chronic cluster headache have unremitting illness that necessitates daily preventive medical treatment for years. When medically intractable, the condition has previously been treatable only with cranially invasive or neurally destructive methods. Methods Eight patients with medically intractable chronic cluster headache were implanted in the suboccipital region with electrodes for occipital nerve stimulation. Other than the first patient, who was initially stimulated unilaterally before being stimulated bilaterally, all patients were stimulated bilaterally during treatment. Findings At a median follow-up of 20 months (range 6-27 months for bilateral stimulation), six of eight patients reported responses that were sufficiently meaningful for them to recommend the treatment to similarly affected patients with chronic cluster headache. Two patients noticed a substantial improvement (90% and 95%) in their attacks; three patients noticed a moderate improvement (40%, 60%, and 20-80%) and one reported mild improvement (25%). Improvements occurred in both frequency and severity of attacks. These changes took place over weeks or months, although attacks returned in days when the device malfunctioned (eg, with battery depletion). Adverse events of concern were lead migrations in one patient and battery depletion requiring replacement in four. Interpretation Occipital nerve stimulation in cluster headache seems to offer a safe, effective treatment option that could begin a new era of neurostimulation therapy for primary headache syndromes.	UCL Natl Hosp Neurol & Neurosurg, Inst Neurol, Headache Grp, London WC1N 3BG, England; UCL Natl Hosp Neurol & Neurosurg, Inst Neurol, Div Neurosurg, London WC1N 3BG, England; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of California System; University of California San Francisco	Goadsby, PJ (corresponding author), UCL Natl Hosp Neurol & Neurosurg, Inst Neurol, Headache Grp, London WC1N 3BG, England.	peterg@ion.ucl.ac.uk	Goadsby, Peter J/Z-1970-2019; Goadsby, Peter J/B-2267-2009; Watkins, Laurence/AAH-6973-2021	Goadsby, Peter J/0000-0003-3260-5904; Watkins, Laurence/0000-0003-0678-3774				Afridi SK, 2006, PAIN, V122, P126, DOI 10.1016/j.pain.2006.01.016; Ambrosini A, 2005, PAIN, V118, P92, DOI 10.1016/j.pain.2005.07.015; Anthony m, 1985, MIGRAINE CLIN RES AD, P169; Bahra A, 2002, NEUROLOGY, V58, P354, DOI 10.1212/WNL.58.3.354; Bartsch T, 2002, BRAIN, V125, P1496, DOI 10.1093/brain/awf166; Bartsch T, 2003, BRAIN, V126, P1801, DOI 10.1093/brain/awg190; Bartsch T, 2005, HEADACHE CURRENTS, V2, P42, DOI DOI 10.1111/J.1743-5013.2005.20201.X; Dodick D, 2003, CEPHALALGIA, V23, P701; Donnet A, 2005, J NEUROL NEUROSUR PS, V76, P218, DOI 10.1136/jnnp.2004.041202; EKBOM K, 1987, CEPHALALGIA, V7, P21, DOI 10.1046/j.1468-2982.1987.0701021.x; Felisati G, 2006, LARYNGOSCOPE, V116, P1447, DOI 10.1097/01.mlg.0000227997.48020.44; Franzini A, 2003, NEUROSURGERY, V52, P1095, DOI 10.1227/01.NEU.0000057698.29634.D6; Goadsby PJ, 2006, CEPHALALGIA, V26, P1168, DOI 10.1111/j.1468-2982.2006.01173.x; Goadsby PJ, 2002, LANCET NEUROL, V1, P251, DOI 10.1016/S1474-4422(02)00104-7; Green MW, 2003, HEADACHE, V43, P479, DOI 10.1046/j.1526-4610.2003.03093.x; Jarrar RG, 2003, NEUROLOGY, V60, P1360, DOI 10.1212/01.WNL.0000055902.23139.16; Johnstone CSH, 2006, NEUROMODULATION, V9, P41, DOI 10.1111/j.1525-1403.2006.00041.x; Kapural L, 2005, ANESTH ANALG, V101, P171, DOI 10.1213/01.ANE.0000156207.73396.8E; KIRKPATRICK PJ, 1993, BRIT J NEUROSURG, V7, P483, DOI 10.3109/02688699308995070; Lance JW, 2005, MECH MANAGEMENT HEAD; Leone M, 2004, CEPHALALGIA, V24, P934, DOI 10.1111/j.1468-2982.2004.00742.x; Leone M, 2006, NEUROLOGY, V67, P150, DOI 10.1212/01.wnl.0000223319.56699.8a; Lovely TJ, 1998, HEADACHE, V38, P590, DOI 10.1046/j.1526-4610.1998.3808590.x; Magis D, 2006, CEPHALALGIA, V26, P1398; Magis D, 2005, CEPHALALGIA, V25, P1197; Matharu Manjit S, 2004, Expert Rev Neurother, V4, P895, DOI 10.1586/14737175.4.5.895; Matharu MS, 2006, ANN NEUROL, V59, P535, DOI 10.1002/ana.20763; Matharu MS, 2004, BRAIN, V127, P220, DOI 10.1093/brain/awh022; Matharu MS, 2003, DRUGS, V63, P1637, DOI 10.2165/00003495-200363160-00002; Matharu MS, 2002, BRAIN, V125, P976, DOI 10.1093/brain/awf118; MATHEW NT, 1988, HEADACHE, V28, P328, DOI 10.1111/j.1526-4610.1988.hed2805328.x; May A, 2005, LANCET, V366, P843, DOI 10.1016/S0140-6736(05)67217-0; May A, 1999, NAT MED, V5, P836, DOI 10.1038/10561; May A, 1998, LANCET, V352, P275, DOI 10.1016/S0140-6736(98)02470-2; MORGENLANDER JC, 1990, J NEUROSURG, V72, P866, DOI 10.3171/jns.1990.72.6.0866; Peres MFP, 2002, CEPHALALGIA, V22, P520, DOI 10.1046/j.1468-2982.2002.00410.x; Piovesan EJ, 2001, CEPHALALGIA, V21, P107, DOI 10.1046/j.1468-2982.2001.00166.x; Popeney CA, 2003, HEADACHE, V43, P369, DOI 10.1046/j.1526-4610.2003.03072.x; Remahl AIMN, 2003, CEPHALALGIA, V23, P504, DOI 10.1046/j.1468-2982.2003.00531.x; ROWED DW, 1990, HEADACHE, V30, P401, DOI 10.1111/j.1526-4610.1990.hed3007401.x; Sanders M, 1997, J NEUROSURG, V87, P876, DOI 10.3171/jns.1997.87.6.0876; Schoenen J, 2005, BRAIN, V128, P940, DOI 10.1093/brain/awh411; Schwedt TJ, 2006, CEPHALALGIA, V26, P1025, DOI 10.1111/j.1468-2982.2006.01142.x; Shields KG, 2004, NEUROLOGY, V63, P2193, DOI 10.1212/01.WNL.0000145832.26051.3C; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Sjaastad O, 2003, CEPHALALGIA, V23, P528, DOI 10.1046/j.1468-2982.2003.00585.x; Slavin KV, 2006, NEUROSURGERY, V58, P112, DOI 10.1227/01.NEU.0000192163.55428.62; SOLOMON S, 1986, ARCH NEUROL-CHICAGO, V43, P479, DOI 10.1001/archneur.1986.00520050055022; Stojanovic M P, 2001, Curr Pain Headache Rep, V5, P130, DOI 10.1007/s11916-001-0081-3; SWEET WH, 1988, HEADACHE, V28, P669, DOI 10.1111/j.1526-4610.1988.hed2810669.x; Weiner RL, 2006, PAIN MED, V7, pS137, DOI 10.1111/j.1526-4637.2006.00129.x; Weiner RL, 1999, NEUROMODULATION, V2, P217, DOI 10.1046/j.1525-1403.1999.00217.x	52	222	231	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2007	369	9567					1099	1106		10.1016/S0140-6736(07)60328-6	http://dx.doi.org/10.1016/S0140-6736(07)60328-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151XF	17398309				2022-12-01	WOS:000245323700030
J	Lifson, AR; Rybicki, SL				Lifson, Alan R.; Rybicki, Sarah L.			Routine opt-out HIV testing	LANCET			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; INFECTION		Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Lifson, AR (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	lifso001@umn.edu						*CA STD HIV PREV T, ASK SCREEN INT RISK; Cunningham WE, 2006, MED CARE, V44, P1038, DOI 10.1097/01.mlr.0000242942.17968.69; Duffus W., 2006, Morbidity and Mortality Weekly Report, V55, P1269; Gielen AC, 1997, WOMEN HEALTH, V25, P19, DOI 10.1300/J013v25n03_02; Jenkins TC, 2006, SEX TRANSM DIS, V33, P329, DOI 10.1097/01.olq.0000194617.91454.3f; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Lo B, 2000, J ACQ IMMUN DEF SYND, V25, pS136, DOI 10.1097/00126334-200012152-00008; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; *MONT MED CTR AD A, ASS CONS TEST SUPP; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P1	10	20	21	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	2007	369	9561					539	540		10.1016/S0140-6736(07)60249-9	http://dx.doi.org/10.1016/S0140-6736(07)60249-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	138MZ	17307085				2022-12-01	WOS:000244368000007
J	Newton, ILG; Woyke, T; Auchtung, TA; Dilly, GF; Dutton, RJ; Fisher, MC; Fontanez, KM; Lau, E; Stewart, FJ; Richardson, PM; Barry, KW; Saunders, E; Detter, JC; Wu, D; Eisen, JA; Cavanaugh, CM				Newton, I. L. G.; Woyke, T.; Auchtung, T. A.; Dilly, G. F.; Dutton, R. J.; Fisher, M. C.; Fontanez, K. M.; Lau, E.; Stewart, F. J.; Richardson, P. M.; Barry, K. W.; Saunders, E.; Detter, J. C.; Wu, D.; Eisen, J. A.; Cavanaugh, C. M.			The Calyptogena magnifica chemoautotrophic symbiont genome	SCIENCE			English	Article							GALAPAGOS SPREADING CENTER; HYDROTHERMAL VENT CLAM; GENE-CLUSTER; SULFIDE	Chemoautotrophic endosymbionts are the metabolic cornerstone of hydrothermal vent communities, providing invertebrate hosts with nearly all of their nutrition. The Calyptogena magnifica (Bivalvia: Vesicomyidae) symbiont, Candidatus Ruthia magnifica, is the first intracellular sulfur-oxidizing endosymbiont to have its genome sequenced, revealing a suite of metabolic capabilities. The genome encodes major chemoautotrophic pathways as well as pathways for biosynthesis of vitamins, cofactors, and all 20 amino acids required by the clam.	Harvard Univ, Biolabs 4080, Cambridge, MA 02138 USA; Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Inst Genom Res, Rockville, MD 20850 USA; Univ Calif Davis, Genome Ctr, Genome & Biomed Sci Facil, Davis, CA 95616 USA	Harvard University; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Harvard University; Harvard Medical School; J. Craig Venter Institute; University of California System; University of California Davis	Cavanaugh, CM (corresponding author), Harvard Univ, Biolabs 4080, 16 Divin Ave, Cambridge, MA 02138 USA.	cavanaug@fas.harvard.edu	Barry, Kerrie Whitelaw/AAA-5500-2020; Newton, Irene/H-5939-2019; Eisen, Jonathan A./H-2706-2019	Barry, Kerrie Whitelaw/0000-0002-8999-6785; Newton, Irene/0000-0002-7118-0374; Eisen, Jonathan A./0000-0002-0159-2197; Lau, Evan/0000-0002-7434-4362; Dilly, Geoffrey/0000-0003-2140-4955; Auchtung, Thomas/0000-0002-0135-6266				BOSS KJ, 1980, MALACOLOGIA, V20, P161; CAVANAUGH CM, 1983, NATURE, V302, P58, DOI 10.1038/302058a0; Cavanaugh CM, 1996, MICROBIAL GROWTH ON C(1) COMPOUNDS, P285; CAVANAUGH CM, 2004, PROKARYOTES; CHILDRESS JJ, 1991, PHYSIOL ZOOL, V64, P1444, DOI 10.1086/physzool.64.6.30158224; Dahl C, 2005, J BACTERIOL, V187, P1392, DOI 10.1128/JB.187.4.1392-1404.2005; FIALAMEDIONI A, 1986, MAR BIOL, V92, P65, DOI 10.1007/BF00392747; FISHER CR, 1988, DEEP-SEA RES, V35, P1811, DOI 10.1016/0198-0149(88)90051-9; JOHNSON KS, 1988, DEEP-SEA RES, V35, P1723, DOI 10.1016/0198-0149(88)90046-5; Kumagai H, 1997, BIOCHEMISTRY-US, V36, P5509, DOI 10.1021/bi970014q; ROBINSON JJ, 1997, THESIS HARVARD U CAM; Shively JM, 1998, ANNU REV MICROBIOL, V52, P191, DOI 10.1146/annurev.micro.52.1.191; Verte F, 2002, BIOCHEMISTRY-US, V41, P2932, DOI 10.1021/bi011404m; Wernegreen JJ, 2002, NAT REV GENET, V3, P850, DOI 10.1038/nrg931; Wood AP, 2004, FEMS MICROBIOL REV, V28, P335, DOI 10.1016/j.femsre.2003.12.001; Zal F, 2000, CAH BIOL MAR, V41, P413	16	138	377	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2007	315	5814					998	1000		10.1126/science.1138438	http://dx.doi.org/10.1126/science.1138438			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303757	Green Submitted			2022-12-01	WOS:000244229800045
J	Watters, AL; Deka, P; Corrent, C; Callender, D; Varani, G; Sosnick, T; Baker, D				Watters, Alexander L.; Deka, Pritilekha; Corrent, Colin; Callender, David; Varani, Gabriele; Sosnick, Tobin; Baker, David			The highly cooperative folding of small naturally occurring proteins is likely the result of natural selection	CELL			English	Article							ENERGY LANDSCAPES; BINDING DOMAIN; EVOLUTION; 2-STATE; DESIGN; AGGREGATION; KINETICS; NMR; STABILITY; INTERMEDIATE	To illuminate the evolutionary pressure acting on the folding free energy landscapes of naturally occurring proteins, we have systematically characterized the folding free energy landscape of Top7, a computationally designed protein lacking an evolutionary history. Stopped-flow kinetics, circular dichroism, and NMR experiments reveal that there are at least three distinct phases in the folding of Top7, that a nonnative conformation is stable at equilibrium, and that multiple fragments of Top7 are stable in isolation. These results indicate that the folding of Top7 is significantly less cooperative than the folding of similarly sized naturally occurring proteins, suggesting that the cooperative folding and smooth free energy landscapes observed for small naturally occurring proteins are not general properties of polypeptide chains that fold to unique stable structures but are instead a product of natural selection.	Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Chicago, Dept Biochem & Mol Biol, Inst Biophys Dynam, Chicago, IL 60637 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Chicago; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Baker, David/K-8941-2012; Freed, Karl F/J-7764-2018	Baker, David/0000-0001-7896-6217; Freed, Karl F/0000-0001-6240-2599				ABKEVICH VI, 1995, J MOL BIOL, V252, P460, DOI 10.1006/jmbi.1995.0511; Bai YW, 2003, BIOCHEM BIOPH RES CO, V305, P785, DOI 10.1016/S0006-291X(03)00800-3; BAKER D, 1992, NATURE, V356, P263, DOI 10.1038/356263a0; Baldwin RL, 1996, FOLD DES, V1, pR1, DOI 10.1016/S1359-0278(96)00003-X; Bolon DN, 2001, BIOCHEMISTRY-US, V40, P10047, DOI 10.1021/bi010427y; Calloni G, 2003, J MOL BIOL, V330, P577, DOI 10.1016/S0022-2836(03)00627-2; Camarero JA, 2001, J MOL BIOL, V308, P1045, DOI 10.1006/jmbi.2001.4631; Chamberlain AK, 1998, BIOCHEMISTRY-US, V37, P1736, DOI 10.1021/bi972692i; Chan HS, 2000, PROTEINS, V40, P543, DOI 10.1002/1097-0134(20000901)40:4<543::AID-PROT20>3.0.CO;2-O; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; Dantas G, 2006, J MOL BIOL, V362, P1004, DOI 10.1016/j.jmb.2006.07.092; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dobson N, 2006, STRUCTURE, V14, P847, DOI 10.1016/j.str.2006.02.011; Ferguson N, 2005, J MOL BIOL, V353, P427, DOI 10.1016/j.jmb.2005.08.031; Ferguson N, 2004, J MOL BIOL, V344, P295, DOI 10.1016/j.jmb.2004.09.069; Ferguson N, 1999, J MOL BIOL, V286, P1597, DOI 10.1006/jmbi.1998.2548; FLANAGAN JM, 1992, P NATL ACAD SCI USA, V89, P748, DOI 10.1073/pnas.89.2.748; Fukunishi Y, 1998, PROTEINS, V33, P408, DOI 10.1002/(SICI)1097-0134(19981115)33:3<408::AID-PROT9>3.0.CO;2-2; Gillespie B, 2003, J MOL BIOL, V330, P813, DOI 10.1016/S0022-2836(03)00616-8; GO N, 1978, P NATL ACAD SCI USA, V75, P559, DOI 10.1073/pnas.75.2.559; GO N, 1984, ADV BIOPHYS, V18, P149, DOI 10.1016/0065-227X(84)90010-8; GOVINDARAJAN S, 1995, PROTEINS, V22, P413, DOI 10.1002/prot.340220411; GRANT JS, 1997, J FAMILY NURSING, V3, P36; GU HD, 1995, PROTEIN SCI, V4, P1108, DOI 10.1002/pro.5560040609; Horwich A, 2002, J CLIN INVEST, V110, P1221, DOI 10.1172/JCI200216781; IKAI A, 1973, J MOL BIOL, V73, P145, DOI 10.1016/0022-2836(73)90320-3; Jack CIA, 2001, AGE AGEING, V30, P428, DOI 10.1093/ageing/30.5.428; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Jacob J, 2004, J MOL BIOL, V338, P369, DOI 10.1016/j.jmb.2004.02.065; JERNTH P, 2004, P NATL ACAD SCI USA, V101, P6450; Jewett AI, 2003, J MOL BIOL, V326, P247, DOI 10.1016/S0022-2836(02)01356-6; Kaya H, 2003, J MOL BIOL, V326, P911, DOI 10.1016/S0022-2836(02)01434-1; Krantz BA, 2000, BIOCHEMISTRY-US, V39, P11696, DOI 10.1021/bi000792+; Krantz BA, 2002, J MOL BIOL, V324, P359, DOI 10.1016/S0022-2836(02)01029-X; Krishna MMG, 2005, P NATL ACAD SCI USA, V102, P1053, DOI 10.1073/pnas.0409114102; Kuhlman B, 1998, BIOCHEMISTRY-US, V37, P1025, DOI 10.1021/bi972352x; Kuhlman B, 2004, CURR OPIN STRUC BIOL, V14, P89, DOI 10.1016/j.sbi.2004.01.002; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Ladurner AG, 1997, J MOL BIOL, V273, P317, DOI 10.1006/jmbi.1997.1303; MATOUSCHEK A, 1991, METHOD ENZYMOL, V202, P82; Maxwell KL, 2005, PROTEIN SCI, V14, P602, DOI 10.1110/ps.041205405; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Plaxco KW, 1999, NAT STRUCT BIOL, V6, P554; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Riddle DS, 1997, NAT STRUCT BIOL, V4, P805, DOI 10.1038/nsb1097-805; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sadqi M, 2006, NATURE, V442, P317, DOI 10.1038/nature04859; SALI A, 1994, NATURE, V369, P248, DOI 10.1038/369248a0; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Scalley ML, 1997, BIOCHEMISTRY-US, V36, P3373, DOI 10.1021/bi9625758; Scalley-Kim M, 2004, J MOL BIOL, V338, P573, DOI 10.1016/j.jmb.2004.02.055; Silow M, 1999, BIOCHEMISTRY-US, V38, P13006, DOI 10.1021/bi9909997; Silow M, 1997, P NATL ACAD SCI USA, V94, P6084, DOI 10.1073/pnas.94.12.6084; Srimathi T, 2002, J BIOL CHEM, V277, P47507, DOI 10.1074/jbc.M203407200; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Van Mierlo CPM, 2000, PROTEIN SCI, V9, P145; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195; Yahara I, 1999, GENES CELLS, V4, P375, DOI 10.1046/j.1365-2443.1999.00271.x; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413	64	109	111	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2007	128	3					613	624		10.1016/j.cell.2006.12.042	http://dx.doi.org/10.1016/j.cell.2006.12.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289578	Bronze			2022-12-01	WOS:000244842700025
J	Greenamyre, JT				Greenamyre, J. Timothy			Huntington's disease - Making connections	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NEURODEGENERATION; DEFECTS		Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Greenamyre, JT (corresponding author), Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA.		Greenamyre, J. Timothy/B-4049-2011	Greenamyre, J. Timothy/0000-0003-3468-7878				Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Kwong JQ, 2006, J NEUROCHEM, V97, P1659, DOI 10.1111/j.1471-4159.2006.03990.x; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004	7	20	20	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2007	356	5					518	520		10.1056/NEJMcibr067022	http://dx.doi.org/10.1056/NEJMcibr067022			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131HW	17267914				2022-12-01	WOS:000243860700016
J	Irion, U; St Johnston, D				Irion, Uwe; St Johnston, Daniel			bicoid RNA localization requires specific binding of an endosomal sorting complex	NATURE			English	Article							MESSENGER-RNA; ESCRT-II; DROSOPHILA EMBRYO; ANTERIOR LOCALIZATION; DEPENDENT MANNER; PROTEIN; STAUFEN; GENE; TRANSPORT; OOCYTES	bicoid messenger RNA localizes to the anterior of the Drosophila egg, where it is translated to form a morphogen gradient of Bicoid protein that patterns the head and thorax of the embryo. Although bicoid was the first localized cytoplasmic determinant to be identified(1-4), little is known about how the mRNA is coupled to the microtubule-dependent transport pathway that targets it to the anterior, and it has been proposed that the mRNA is recognized by a complex of many redundant proteins, each of which binds to the localization element in the 3' untranslated region (UTR) with little or no specificity(5). Indeed, the only known RNA-binding protein that co-localizes with bicoid mRNA is Staufen, which binds non-specifically to double-stranded RNA in vitro(6,7). Here we show that mutants in all subunits of the ESCRT-II complex (VPS22, VPS25 and VPS36) abolish the final Staufen-dependent step in bicoid mRNA localization. ESCRT-II is a highly conserved component of the pathway that sorts ubiquitinated endosomal proteins into internal vesicles(8,9), and functions as a tumour-suppressor by removing activated receptors from the cytoplasm(10,11). However, the role of ESCRT-II in bicoid localization seems to be independent of endosomal sorting, because mutations in ESCRT-I and III components do not affect the targeting of bicoid mRNA. Instead, VPS36 functions by binding directly and specifically to stem-loop V of the bicoid 39 UTR through its amino-terminal GLUE domain(12), making it the first example of a sequence-specific RNA-binding protein that recognizes the bicoid localization signal. Furthermore, VPS36 localizes to the anterior of the oocyte in a bicoid-mRNA-dependent manner, and is required for the subsequent recruitment of Staufen to the bicoid complex. This function of ESCRT-II as an RNA-binding complex is conserved in vertebrates and may clarify some of its roles that are independent of endosomal sorting.	Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; Univ Cambridge, Dept Genet, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	St Johnston, D (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	ds139@mole.bio.cam.ac.uk	Irion, Uwe/ABC-8635-2020; St Johnston, Daniel/C-9568-2009	St Johnston, Daniel/0000-0001-5582-3301; Irion, Uwe/0000-0003-2823-5840	Cancer Research UK [A14492] Funding Source: Medline; Wellcome Trust [092096, 049818] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		Arn EA, 2003, DEV CELL, V4, P41, DOI 10.1016/S1534-5807(02)00397-0; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; FROHNHOFER HG, 1986, NATURE, V324, P120, DOI 10.1038/324120a0; FROHNHOFER HG, 1987, GENE DEV, V1, P880, DOI 10.1101/gad.1.8.880; Jin Y, 2005, DEV CELL, V9, P63, DOI 10.1016/j.devcel.2005.04.016; Kamura T, 2001, J BIOL CHEM, V276, P16528, DOI 10.1074/jbc.M010142200; MACDONALD PM, 1991, GENE DEV, V5, P2455, DOI 10.1101/gad.5.12b.2455; MACDONALD PM, 1993, DEVELOPMENT, V118, P1233; Martin SG, 2003, DEVELOPMENT, V130, P4201, DOI 10.1242/dev.00630; Micklem DR, 2000, EMBO J, V19, P1366, DOI 10.1093/emboj/19.6.1366; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Moon WJ, 2004, CURR BIOL, V14, P1957, DOI 10.1016/j.cub.2004.10.023; Putz U, 1996, NUCLEIC ACIDS RES, V24, P4838, DOI 10.1093/nar/24.23.4838; Ramos A, 2000, EMBO J, V19, P997, DOI 10.1093/emboj/19.5.997; Schmidt AE, 1999, J BIOL CHEM, V274, P21981, DOI 10.1074/jbc.274.31.21981; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; STJOHNSTON D, 1989, DEVELOPMENT S, V107, P131; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Teo HL, 2006, CELL, V125, P99, DOI 10.1016/j.cell.2006.01.047; Theurkauf WE, 1998, DEVELOPMENT, V125, P3655; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Vogt N, 2006, DEVELOPMENT, V133, P3963, DOI 10.1242/dev.02570; Weil TT, 2006, DEV CELL, V11, P251, DOI 10.1016/j.devcel.2006.06.006; Wilhelm JE, 2000, J CELL BIOL, V148, P427, DOI 10.1083/jcb.148.3.427	30	140	146	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2007	445	7127					554	558		10.1038/nature05503	http://dx.doi.org/10.1038/nature05503			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17268469	Green Accepted			2022-12-01	WOS:000243867300047
J	Barabash, S; Fedorov, A; Lundin, R; Sauvaud, JA				Barabash, Stas; Fedorov, Andrei; Lundin, Rickard; Sauvaud, Jean-Andre			Martian atmospheric erosion rates	SCIENCE			English	Article							MARS; PLASMA; ENVIRONMENT; EVOLUTION; ASPERA-3; OUTFLOW; EXPRESS	Mars was once wet but is now dry, and the fate of its ancient carbon dioxide atmosphere is one of the biggest puzzles in martian planetology. We have measured the current loss rate due to the solar wind interaction for different species: Q(O+) = 1.6 . 10(23) per second = 4 grams per second ( g s(-1)), Q(O-2(+)) = 1.5 . 10(23) s(-1) = 8 g s(-1), and Q(CO2+) = 8 . 10(22) s(-1) = 6 g s(-1) in the energy range of 30 to 30,000 electron volts per charge. These rates can be propagated backward over a period of 3.5 billion years, resulting in the total removal of 0.2 to 4 millibar of carbon dioxide and a few centimeters of water. The escape rate is low, and thus one has to continue searching for water reservoirs and carbon dioxide stores on or beneath the planetary surface and investigate other escape channels.	Swedish Inst Space Phys, S-98128 Kiruna, Sweden; Ctr Etud Spatiale Rayonnements, F-31028 Toulouse, France		Barabash, S (corresponding author), Swedish Inst Space Phys, Box 812, S-98128 Kiruna, Sweden.	stas@irf.se						Acuna MH, 1998, SCIENCE, V279, P1676, DOI 10.1126/science.279.5357.1676; BARABASH S, 2004, ESA SPECIAL PUBLICAT, P121; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; Carlsson E, 2006, ICARUS, V182, P320, DOI 10.1016/j.icarus.2005.09.020; DUBININ E, 1993, J GEOPHYS RES-SPACE, V98, P3991, DOI 10.1029/92JA02233; Dubinin E, 2006, ICARUS, V182, P343, DOI 10.1016/j.icarus.2005.08.023; Fedorov A, 2006, ICARUS, V182, P329, DOI 10.1016/j.icarus.2005.09.021; Fox JL, 1997, GEOPHYS RES LETT, V24, P2901, DOI 10.1029/97GL52842; Kallio E, 1996, J GEOPHYS RES-SPACE, V101, P11133, DOI 10.1029/96JA00164; KASTING JF, 1991, ICARUS, V94, P1, DOI 10.1016/0019-1035(91)90137-I; Lammer H, 2003, ICARUS, V165, P9, DOI 10.1016/S0019-1035(03)00170-2; Lundin R, 2004, SCIENCE, V305, P1933, DOI 10.1126/science.1101860; LUNDIN R, 1990, GEOPHYS RES LETT, V17, P873, DOI 10.1029/GL017i006p00873; Ma YJ, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010367; MCKAY CP, 1989, REV GEOPHYS, V27, P189, DOI 10.1029/RG027i002p00189; Modolo R, 2005, ANN GEOPHYS-GERMANY, V23, P433, DOI 10.5194/angeo-23-433-2005; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; VENGIN M, 1991, PLANET SPACE SCI, V39, P131	18	210	214	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2007	315	5811					501	503		10.1126/science.1134358	http://dx.doi.org/10.1126/science.1134358			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255508				2022-12-01	WOS:000243726600042
J	Sinclair, AH; Schofield, PR				Sinclair, Andrew H.; Schofield, Peter R.			Human embryonic stem cell research: An Australian perspective	CELL			English	Editorial Material							DONATION	A conscience vote of individual parliamentarians in the Australian government last month regarding amendments to current legislation regulating human embryonic stem cell research yielded a surprising outcome. Despite opposition by the Australian Prime Minister, the Senate and House of Representatives voted to adopt the recommendations of the Lockhart Review and approve human somatic cell nuclear transfer, thus providing a consistent national policy for all researchers in Australia.	Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Parkville, Vic 3052, Australia; Prince Wales Med Res Inst, Sydney, NSW 2031, Australia; Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Prince Wales Medical Research Institute; University of New South Wales Sydney	Sinclair, AH (corresponding author), Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	andrew.sinclair@mcri.edu.au; p.schofield@unsw.edu.au	Sinclair, Andrew H/A-3598-2010; Schofield, Peter/C-9669-2011	Sinclair, Andrew H/0000-0003-2741-7992; Schofield, Peter/0000-0003-2967-9662				Leeton J, 2004, AUST NZ J OBSTET GYN, V44, P495, DOI 10.1111/j.1479-828X.2004.00305.x; Magnus D, 2005, SCIENCE, V308, P1747, DOI 10.1126/science.1114454; Steinbrook R, 2006, NEW ENGL J MED, V354, P324, DOI 10.1056/NEJMp058313; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0	4	8	8	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2007	128	2					221	223		10.1016/j.cell.2007.01.008	http://dx.doi.org/10.1016/j.cell.2007.01.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254957	Bronze			2022-12-01	WOS:000244420500004
J	Young, DW; Hassan, MQ; Pratap, J; Galindo, M; Zaidi, SK; Lee, SH; Yang, XQ; Xie, RL; Javed, A; Underwood, JM; Furcinitti, P; Imbalzano, AN; Penman, S; Nickerson, JA; Montecino, MA; Lian, JB; Stein, JL; van Wijnen, AJ; Stein, GS				Young, Daniel W.; Hassan, Mohammad Q.; Pratap, Jitesh; Galindo, Mario; Zaidi, Sayyed K.; Lee, Suk-hee; Yang, Xiaoqing; Xie, Ronglin; Javed, Amjad; Underwood, Jean M.; Furcinitti, Paul; Imbalzano, Anthony N.; Penman, Sheldon; Nickerson, Jeffrey A.; Montecino, Martin A.; Lian, Jane B.; Stein, Janet L.; van Wijnen, Andre J.; Stein, Gary S.			Mitotic occupancy and lineage-specific transcriptional control of rRNA genes by Runx2	NATURE			English	Article							POLYMERASE-I TRANSCRIPTION; CELL-CYCLE; RDNA TRANSCRIPTION; NUCLEAR-MATRIX; UBF; PROTEINS; DNA; RB; DIFFERENTIATION; CHROMOSOMES	Regulation of ribosomal RNA genes is a fundamental process that supports the growth of cells and is tightly coupled with cell differentiation. Although rRNA transcriptional control by RNA polymerase I (Pol I) and associated factors is well studied, the lineage-specific mechanisms governing rRNA expression remain elusive(1). Runt-related transcription factors Runx1, Runx2 and Runx3 establish and maintain cell identity(2), and convey phenotypic information through successive cell divisions for regulatory events that determine cell cycle progression or exit in progeny cells(3). Here we establish that mammalian Runx2 not only controls lineage commitment and cell proliferation by regulating genes transcribed by RNA Pol II, but also acts as a repressor of RNA Pol I mediated rRNA synthesis. Within the condensed mitotic chromosomes we find that Runx2 is retained in large discrete foci at nucleolar organizing regions where rRNA genes reside. These Runx2 chromosomal foci are associated with open chromatin, colocalize with the RNA Pol I transcription factor UBF1, and undergo transition into nucleoli at sites of rRNA synthesis during interphase. Ribosomal RNA transcription and protein synthesis are enhanced by Runx2 deficiency that results from gene ablation or RNA interference, whereas induction of Runx2 specifically and directly represses rDNA promoter activity. Runx2 forms complexes containing the RNA Pol I transcription factors UBF1 and SL1, co-occupies the rRNA gene promoter with these factors in vivo, and affects local chromatin histone modifications at rDNA regulatory regions. Thus Runx2 is a critical mechanistic link between cell fate, proliferation and growth control. Our results suggest that lineage-specific control of ribosomal biogenesis may be a fundamental function of transcription factors that govern cell fate.	Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01655 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Concepcion, Dept Biol Mol, Fac Ciencias Biol, Concepcion, Chile	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Massachusetts Institute of Technology (MIT); Universidad de Concepcion	Stein, GS (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA.	gary.stein@umassmed.edu	van Wijnen, Andre J./AAG-3578-2019; Zaidi, Sayyed Kaleem/I-5596-2019; Hassan, Mohammad/GZA-7507-2022	van Wijnen, Andre J./0000-0002-4458-0946; Zaidi, Sayyed Kaleem/0000-0001-6664-5168; Hassan, Mohammad/0000-0002-1712-0004; Javed, Amjad/0000-0002-0847-8266	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049069] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR049069] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Budde A, 1999, ONCOGENE, V18, P1119, DOI 10.1038/sj.onc.1202402; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; Cheutin T, 2002, J CELL SCI, V115, P3297; Galindo M, 2005, J BIOL CHEM, V280, P20274, DOI 10.1074/jbc.M413665200; GebraneYounes J, 1997, J CELL SCI, V110, P2429; Gonzalez IL, 2001, GENOMICS, V73, P255, DOI 10.1006/geno.2001.6540; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Hannan KM, 2000, ONCOGENE, V19, P3487, DOI 10.1038/sj.onc.1203690; Hannan KM, 2000, ONCOGENE, V19, P4988, DOI 10.1038/sj.onc.1203875; Hovhannisyan H, 2003, MOL CELL BIOL, V23, P1460, DOI 10.1128/MCB.23.4.1460-1469.2003; Javed A, 2005, P NATL ACAD SCI USA, V102, P1454, DOI 10.1073/pnas.0409121102; Javed A, 2000, J CELL SCI, V113, P2221; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Mais C, 2005, GENE DEV, V19, P50, DOI 10.1101/gad.310705; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; Muchardt C, 1996, EMBO J, V15, P3394, DOI 10.1002/j.1460-2075.1996.tb00705.x; NICKERSON JA, 1990, P NATL ACAD SCI USA, V87, P2259, DOI 10.1073/pnas.87.6.2259; Nuthall HN, 2002, J BIOL CHEM, V277, P51049, DOI 10.1074/jbc.M111660200; Otto F, 2002, HUM MUTAT, V19, P209, DOI 10.1002/humu.10043; Poortinga G, 2004, EMBO J, V23, P3325, DOI 10.1038/sj.emboj.7600335; Prasanth KV, 2003, MOL BIOL CELL, V14, P1043, DOI 10.1091/mbc.E02-10-0669; ROUSSEL P, 1993, J CELL SCI, V104, P327; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; Valdez BC, 2004, P NATL ACAD SCI USA, V101, P10709, DOI 10.1073/pnas.0402492101; Voit R, 1997, MOL CELL BIOL, V17, P4230, DOI 10.1128/MCB.17.8.4230; Zaidi SK, 2001, J CELL SCI, V114, P3093; Zaidi SK, 2003, P NATL ACAD SCI USA, V100, P14852, DOI 10.1073/pnas.2533076100	30	182	187	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2007	445	7126					442	446		10.1038/nature05473	http://dx.doi.org/10.1038/nature05473			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	128WD	17251981				2022-12-01	WOS:000243689500043
J	Abramson, J; Wright, JM				Abramson, J.; Wright, J. M.			Are lipid-lowering guidelines evidence-based?	LANCET			English	Editorial Material							CORONARY-HEART-DISEASE; WOMEN; MEN		Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut & Med, Vancouver, BC V6T 1Z3, Canada; Harvard Univ, Sch Med, Cambridge, MA 02138 USA	University of British Columbia; Harvard University	Wright, JM (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut & Med, Vancouver, BC V6T 1Z3, Canada.	jmwright@interchange.ubc.ca						Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Chiuve SE, 2006, CIRCULATION, V114, P160, DOI 10.1161/CIRCULATIONAHA.106.621417; JAUCA C, 2003, INT SOC DRUG B NEWSL, V17, P7; Manuel DG, 2006, BMJ-BRIT MED J, V332, P1419, DOI 10.1136/bmj.38849.487546.DE; National Cholesterol Education Program (NCEP), 2002, 3 NCEP; Savoie I, 2002, J CLIN EPIDEMIOL, V55, P95, DOI 10.1016/S0895-4356(01)00436-X; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Walsh JME, 2004, JAMA-J AM MED ASSOC, V291, P2243, DOI 10.1001/jama.291.18.2243	8	94	96	1	14	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 20	2007	369	9557					168	169		10.1016/S0140-6736(07)60084-1	http://dx.doi.org/10.1016/S0140-6736(07)60084-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	128XG	17240267				2022-12-01	WOS:000243692400006
J	Fomenko, DE; Xing, WB; Adair, BM; Thomas, DJ; Gladyshev, VN				Fomenko, Dmitri E.; Xing, Weibing; Adair, Blakely M.; Thomas, David J.; Gladyshev, Vadim N.			High-throughput identification of catalytic redox-active cysteine residues	SCIENCE			English	Article							SELENOCYSTEINE INSERTION; ESCHERICHIA-COLI; PROTEIN; METHYLTRANSFERASE; OXIDATION; INSIGHT; CLUSTER	Cysteine (Cys) residues often play critical roles in proteins; however, identification of their specific functions has been limited to case-by-case experimental approaches. We developed a procedure for high-throughput identification of catalytic redox-active Cys in proteins by searching for sporadic selenocysteine-Cys pairs in sequence databases. This method is independent of protein family, structure, and taxon. We used it to selectively detect the majority of known proteins with redox-active Cys and to make additional predictions, one of which was verified. Rapid accumulation of sequence information from genomic and metagenomic projects should allow detection of many additional oxidoreductase families as well as identification of redox-active Cys in these proteins.	Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; Univ N Carolina, Curriculum Toxicol, Chapel Hill, NC 27599 USA; US EPA, Expt Toxicol Div, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA	University of Nebraska System; University of Nebraska Lincoln; University of North Carolina; University of North Carolina Chapel Hill; United States Environmental Protection Agency	Gladyshev, VN (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.	vgladyshev1@unl.edu	Gladyshev, Vadim N/J-6187-2013; Gladyshev, Vadim N/A-9894-2013	Gladyshev, Vadim/0000-0002-0372-7016	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021518] Funding Source: NIH RePORTER; NIA NIH HHS [AG021518] Funding Source: Medline; NIGMS NIH HHS [GM061603] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adair BM, 2005, ENVIRON CHEM, V2, P161, DOI 10.1071/EN05054; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beeby M, 2005, PLOS BIOL, V3, P1549, DOI 10.1371/journal.pbio.0030309; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Copeland PR, 2001, MOL CELL BIOL, V21, P1491, DOI 10.1128/MCB.21.5.1491-1498.2001; Cupp-Vickery JR, 2004, J MOL BIOL, V338, P127, DOI 10.1016/j.jmb.2004.02.027; Dahl C, 2005, J BACTERIOL, V187, P1392, DOI 10.1128/JB.187.4.1392-1404.2005; Fetrow JS, 2001, PROTEIN SCI, V10, P1005, DOI 10.1110/ps.49201; Fomenko DE, 2003, BIOCHEMISTRY-US, V42, P11214, DOI 10.1021/bi034459s; Hatfield D.L., 2002, SELENIUM ITS MOL BIO, V36, P235, DOI 10.1080/10715760290006394; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Kim HY, 2005, PLOS BIOL, V3, P2080, DOI 10.1371/journal.pbio.0030375; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Leichert LI, 2004, PLOS BIOL, V2, P1723, DOI 10.1371/journal.pbio.0020333; Leimkuhler S, 2001, J BIOL CHEM, V276, P34695, DOI 10.1074/jbc.M102787200; Li JX, 2005, TOXICOL APPL PHARM, V204, P164, DOI 10.1016/j.taap.2004.12.002; Madadi-Kahkesh S, 2001, EUR J BIOCHEM, V268, P2566, DOI 10.1046/j.1432-1327.2001.02141.x; Novoselov SV, 2002, EMBO J, V21, P3681, DOI 10.1093/emboj/cdf372; Rosen BP, 2002, FEBS LETT, V529, P86, DOI 10.1016/S0014-5793(02)03186-1; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; Waters SB, 2004, CHEM RES TOXICOL, V17, P404, DOI 10.1021/tx0342161	22	146	151	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 19	2007	315	5810					387	389		10.1126/science.1133114	http://dx.doi.org/10.1126/science.1133114			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126SI	17234949	Green Submitted			2022-12-01	WOS:000243535400045
J	Kibar, Z; Torban, E; McDearmid, JR; Reynolds, A; Berghout, J; Mathieu, M; Kirillova, I; De Marco, P; Merello, E; Hayes, JM; Wallingford, JB; Drapeau, P; Capra, V; Gros, P				Kibar, Zoha; Torban, Elena; McDearmid, Jonathan R.; Reynolds, Annie; Berghout, Joanne; Mathieu, Melissa; Kirillova, Irena; De Marco, Patrizia; Merello, Elisa; Hayes, Julie M.; Wallingford, John B.; Drapeau, Pierre; Capra, Valeria; Gros, Philippe			Mutations in VANGL1 associated with neural-tube defects	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLANAR CELL POLARITY; TISSUE POLARITY; GENE; STRABISMUS; GOGH	Neural-tube defects such as anencephaly and spina bifida constitute a group of common congenital malformations caused by complex genetic and environmental factors. We have identified three mutations in the VANGL1 gene in patients with familial types (V239I and R274Q) and a sporadic type (M328T) of the disease, including a spontaneous mutation (V239I) appearing in a familial setting. In a protein-protein interaction assay V239I abolished interaction of VANGL1 protein with its binding partners, disheveled-1, -2, and -3. These findings implicate VANGL1 as a risk factor in human neural-tube defects.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Ctr Hlth, Res Inst, Neurosci Res Ctr, Montreal, PQ, Canada; Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ, Canada; Inst Hereditary Dis, Minsk, BELARUS; Ist Giannina Gaslini, Unita Operat Neurochirurg, I-16148 Genoa, Italy; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA	McGill University; McGill University; Universite de Montreal; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Texas System; University of Texas Austin	Gros, P (corresponding author), McGill Univ, Dept Biochem, 3655 Promenade Sir William Osler,Rm 907, Montreal, PQ H3G 1Y6, Canada.	philippe.gros@mcgill.ca	Berghout, Joanne/M-5493-2017; De Marco, Patrizia/AAB-3172-2019; Valeria, Capra/AAB-1501-2019; capra, valeria/N-4367-2013	Berghout, Joanne/0000-0002-9250-9159; De Marco, Patrizia/0000-0001-8498-3750; capra, valeria/0000-0002-3097-0388	NIGMS NIH HHS [R01 GM074104] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074104] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Doudney K, 2005, AM J MED GENET A, V136A, P90, DOI 10.1002/ajmg.a.30766; Doudney K, 2005, AM J MED GENET A, V138A, P415, DOI 10.1002/ajmg.a.30931; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; PANG D, 1993, NEUROSURGERY, V32, P755, DOI 10.1227/00006123-199305000-00009; STEIN KF, 1953, J HERED, V44, P59, DOI 10.1093/oxfordjournals.jhered.a106356; Strutt H, 2005, BIOESSAYS, V27, P1218, DOI 10.1002/bies.20318; Taylor J, 1998, GENETICS, V150, P199; Torban E, 2004, J BIOL CHEM, V279, P52703, DOI 10.1074/jbc.M408675200; Torban E, 2004, TRENDS GENET, V20, P570, DOI 10.1016/j.tig.2004.09.003; Tortori-Donati P, 2000, NEURORADIOLOGY, V42, P471, DOI 10.1007/s002340000325; van der Linden IJM, 2006, P NUTR SOC, V65, P204, DOI 10.1079/PNS2006495; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Wolff T, 1998, DEVELOPMENT, V125, P1149	18	210	257	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 5	2007	356	14					1432	1437		10.1056/NEJMoa060651	http://dx.doi.org/10.1056/NEJMoa060651			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153GG	17409324	Bronze			2022-12-01	WOS:000245419600006
J	Colquhoun, D				Colquhoun, David			Science degrees without the science	NATURE			English	Editorial Material									UCL, Dept Pharmacol, London WC1E 6BT, England	University of London; University College London	Colquhoun, D (corresponding author), UCL, Dept Pharmacol, London WC1E 6BT, England.		Colquhoun, David/C-1664-2008	Colquhoun, David/0000-0002-4263-017X				Barry CA, 2006, SOC SCI MED, V62, P2646, DOI 10.1016/j.socscimed.2005.11.025; Desmond Adrian, 1992, POLITICS EVOLUTION M; GOLDACRE B, 2007, GUARDIAN        0217; HARRIS M, 2003, U NHS PARTNERS CARE; HOLMES OW, 1842, HOM ITS KINDR DEL; Lancet, 2005, LANCET, V336, P690; 2000, QAA OTHER SUBJECTS A	7	25	25	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2007	446	7134					373	374		10.1038/446373a	http://dx.doi.org/10.1038/446373a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17377563				2022-12-01	WOS:000245079500018
J	Reineke, J; Tenzer, S; Rupnik, M; Koschinski, A; Hasselmayer, O; Schrattenholz, A; Schild, H; von Eichel-Streiber, C				Reineke, Jessica; Tenzer, Stefan; Rupnik, Maja; Koschinski, Andreas; Hasselmayer, Oliver; Schrattenholz, Andre; Schild, Hansjoerg; von Eichel-Streiber, Christoph			Autocatalytic cleavage of Clostridium difficile toxin	NATURE			English	Article							INOSITOL HEXAKISPHOSPHATE; PSEUDOMEMBRANOUS COLITIS; RHO-PROTEINS; CELLS; GENE; INTERNALIZATION; GLUCOSYLATION; HOMOLOGY; DISEASE; SITE	Clostridium difficile, the causative agent of nosocomial antibiotic-associated diarrhoea and pseudomembranous colitis, possesses two main virulence factors: the large clostridial cytotoxins A and B. It has been proposed that toxin B is cleaved by a cytosolic factor of the eukaryotic target cell during its cellular uptake. Here we report that cleavage of not only toxin B, but also all other large clostridial cytotoxins, is an autocatalytic process dependent on host cytosolic inositolphosphate cofactors. A covalent inhibitor of aspartate proteases, 1,2-epoxy-3-(p-nitrophenoxy)propane, completely blocked toxin B function on cultured cells and was used to identify its catalytically active protease site. To our knowledge this is the first report on a bacterial toxin that uses eukaryotic signals for induced autoproteolysis to deliver its toxic domain into the cytosol of target cells. On the basis of our data, we present an integrated model for the uptake and inositolphosphate-induced activation of toxin B.	Johannes Gutenberg Univ Mainz, Inst Med Mikrobiol & Hyg, D-55131 Mainz, Germany; Johannes Gutenberg Univ Mainz, Inst Immunol, D-55131 Mainz, Germany; Univ Maribor, Fac Med, SLO-2000 Maribor, Slovenia; Inst Publ Hlth Maribor, SLO-2000 Maribor, Slovenia; Univ Giessen, Rudolf Buchheim Inst Pharmakol, D-35392 Giessen, Germany; ProteoSys AG, D-55129 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Maribor; Justus Liebig University Giessen; ProteoSys AG	von Eichel-Streiber, C (corresponding author), Johannes Gutenberg Univ Mainz, Inst Med Mikrobiol & Hyg, Hochhaus Augustuspl, D-55131 Mainz, Germany.	schild@uni-mainz.de; veichel@uni-mainz.de	Tenzer, Stefan/AAE-2180-2020	Tenzer, Stefan/0000-0003-3034-0017				Barth H, 2001, J BIOL CHEM, V276, P10670, DOI 10.1074/jbc.M009445200; BARTLETT JG, 1978, NEW ENGL J MED, V298, P531, DOI 10.1056/NEJM197803092981003; Braun V, 1996, GENE, V181, P29, DOI 10.1016/S0378-1119(96)00398-8; BRAUN V, 1999, PATHOGENICITY ISLAND; Byrum J, 2004, NUCLEIC ACIDS RES, V32, P2776, DOI 10.1093/nar/gkh592; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P1201; Davey P, 2006, EMERG INFECT DIS, V12, P211, DOI 10.3201/eid1202.05145; EICHELSTREIBER C, 1992, J BACTERIOL, V174, P6707; FERNANDEZPATRON C, 1995, ANAL BIOCHEM, V224, P263, DOI 10.1006/abio.1995.1039; Fishman N, 2006, AM J MED, V119, pS62, DOI 10.1016/j.amjmed.2006.04.004; FLORIN I, 1983, BIOCHIM BIOPHYS ACTA, V763, P383, DOI 10.1016/0167-4889(83)90100-3; FLORIN I, 1986, MICROB PATHOGENESIS, V1, P373, DOI 10.1016/0882-4010(86)90069-0; GEORGE RH, 1978, BRIT MED J, V1, P695, DOI 10.1136/bmj.1.6114.695; Giesemann T, 2006, J BIOL CHEM, V281, P10808, DOI 10.1074/jbc.M512720200; Gorbach SL, 1999, NEW ENGL J MED, V341, P1690, DOI 10.1056/NEJM199911253412211; GREEN GA, 1995, GENE, V161, P57, DOI 10.1016/0378-1119(95)00263-6; HENRIQUES B, 1987, MICROB PATHOGENESIS, V2, P455, DOI 10.1016/0882-4010(87)90052-0; HOFMANN F, 1995, MOL GEN GENET, V247, P670, DOI 10.1007/BF00290398; Hofmann F, 1997, J BIOL CHEM, V272, P11074; Hsu FF, 2003, J MASS SPECTROM, V38, P447, DOI 10.1002/jms.457; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; KARLSSON KA, 1995, CURR OPIN STRUC BIOL, V5, P622, DOI 10.1016/0959-440X(95)80054-9; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; LYERLY D M, 1988, Clinical Microbiology Reviews, V1, P1; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; McDonald L Clifford, 2005, Infect Control Hosp Epidemiol, V26, P672, DOI 10.1086/502600; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Moos M, 2000, METHOD ENZYMOL, V325, P114; Pfeifer G, 2003, J BIOL CHEM, V278, P44535, DOI 10.1074/jbc.M307540200; Qa'Dan M, 2000, INFECT IMMUN, V68, P2470, DOI 10.1128/IAI.68.5.2470-2474.2000; Rao MB, 1998, MICROBIOL MOL BIOL R, V62, P597, DOI 10.1128/MMBR.62.3.597-635.1998; Rupnik M, 2005, J MED MICROBIOL, V54, P113, DOI 10.1099/jmm.0.45810-0; Rupnik M, 2005, MICROBIOL-SGM, V151, P199, DOI 10.1099/mic.0.27474-0; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; SAUERBORN M, 1994, INT J MED MICROBIO S, V24, P510; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Sehr P, 1998, BIOCHEMISTRY-US, V37, P5296, DOI 10.1021/bi972592c; Shears SB, 2001, CELL SIGNAL, V13, P151, DOI 10.1016/S0898-6568(01)00129-2; Tenover FC, 2006, AM J INFECT CONTROL, V34, pS3, DOI 10.1016/j.ajic.2006.05.219; TUCKER KD, 1991, INFECT IMMUN, V59, P73, DOI 10.1128/IAI.59.1.73-78.1991; vonEichelStreiber C, 1996, TRENDS MICROBIOL, V4, P375, DOI 10.1016/0966-842X(96)10061-5; VONEICHELSTREIBER C, 1992, MOL GEN GENET, V233, P260, DOI 10.1007/BF00587587; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; York JD, 2001, ADV ENZYME REGUL, V41, P57, DOI 10.1016/S0065-2571(00)00025-X	46	181	197	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2007	446	7134					415	419		10.1038/nature05622	http://dx.doi.org/10.1038/nature05622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17334356				2022-12-01	WOS:000245079500034
J	Chaves, SS; Gargiullo, P; Zhang, JX; Civen, R; Guris, D; Mascola, MPHL; Seward, JF				Chaves, Sandra S.; Gargiullo, Paul; Zhang, John X.; Civen, Rachel; Guris, Dalya; Mascola, M. P. H. Laurene; Seward, Jane F.			Loss of vaccine-induced immunity to varicella over time	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OUTBREAK; RESPONSES; POSTLICENSURE; CHILDREN; DECLINE; SAFETY; IMPACT	BACKGROUND: The introduction of universal varicella vaccination in 1995 has substantially reduced varicella-related morbidity and mortality in the United States. However, it remains unclear whether vaccine-induced immunity wanes over time, a condition that may result in increased susceptibility later in life, when the risk of serious complications may be greater than in childhood. METHODS: We examined 10 years (1995 to 2004) of active surveillance data from a sentinel population of 350,000 subjects to determine whether the severity and incidence of breakthrough varicella (with an onset of rash >42 days after vaccination) increased with the time since vaccination. We used multivariate logistic regression to adjust for the year of disease onset (calendar year) and the subject's age at both disease onset and vaccination. RESULTS: A total of 11,356 subjects were reported to have varicella during the surveillance period, of whom 1080 (9.5%) had breakthrough disease. Children between the ages of 8 and 12 years who had been vaccinated at least 5 years previously were significantly more likely to have moderate or severe disease than were those who had been vaccinated less than 5 years previously (risk ratio, 2.6; 95% confidence interval [CI], 1.2 to 5.8). The annual rate of breakthrough varicella significantly increased with the time since vaccination, from 1.6 cases per 1000 person-years (95% CI, 1.2 to 2.0) within 1 year after vaccination to 9.0 per 1000 person-years (95% CI, 6.9 to 11.7) at 5 years and 58.2 per 1000 person-years (95% CI, 36.0 to 94.0) at 9 years. CONCLUSIONS: A second dose of varicella vaccine, now recommended for all children, could improve protection from both primary vaccine failure and waning vaccine-induced immunity.	Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Los Angeles Cty Dept Hlth Serv, Los Angeles, CA USA	Centers for Disease Control & Prevention - USA	Chaves, SS (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop A-47, Atlanta, GA 30333 USA.	bev8@cdc.gov						Ampofo K, 2002, CLIN INFECT DIS, V34, P774, DOI 10.1086/338959; Arvin AM, 1996, INFECT DIS CLIN N AM, V10, P529, DOI 10.1016/S0891-5520(05)70312-3; Brisson M., 2003, Journal of Medical Virology, V70, pS31, DOI 10.1002/jmv.10317; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P389; Clements DA, 1999, PEDIATR INFECT DIS J, V18, P1047, DOI 10.1097/00006454-199912000-00004; Davis MM, 2004, PEDIATRICS, V114, P786, DOI 10.1542/peds.2004-0012; Galil K, 2002, NEW ENGL J MED, V347, P1909, DOI 10.1056/NEJMoa021662; Haddad MB, 2005, PEDIATRICS, V115, P1488, DOI 10.1542/peds.2004-1826; Izurieta HS, 1997, JAMA-J AM MED ASSOC, V278, P1495, DOI 10.1001/jama.278.18.1495; Krause PR, 2001, ARCH VIR S, V17, P7; Kuter B, 2004, PEDIATR INFECT DIS J, V23, P132, DOI 10.1097/01.inf.0000109287.97518.67; Lee BR, 2004, J INFECT DIS, V190, P477, DOI 10.1086/422041; Li S, 2002, PEDIATR INFECT DIS J, V21, P337, DOI 10.1097/00006454-200204000-00014; Lopez AS, 2006, PEDIATRICS, V117, pE1070, DOI 10.1542/peds.2005-2085; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Mullooly JP, 2004, VACCINE, V22, P1480, DOI 10.1016/j.vaccine.2003.10.021; Ngai AL, 1996, PEDIATR INFECT DIS J, V15, P49, DOI 10.1097/00006454-199601000-00011; Nguyen HQ, 2005, NEW ENGL J MED, V352, P450, DOI 10.1056/NEJMoa042271; Seward JF, 2002, JAMA-J AM MED ASSOC, V287, P606, DOI 10.1001/jama.287.5.606; Tugwell BD, 2004, PEDIATRICS, V113, P455, DOI 10.1542/peds.113.3.455; Vazquez M, 2004, JAMA-J AM MED ASSOC, V291, P851, DOI 10.1001/jama.291.7.851; Vazquez M, 2001, NEW ENGL J MED, V344, P955, DOI 10.1056/NEJM200103293441302; Verstraeten T, 2003, PEDIATRICS, V112, P1039, DOI 10.1542/peds.112.2.e98; WATSON B, 1995, CLIN INFECT DIS, V20, P316, DOI 10.1093/clinids/20.2.316; WATSON B, 1995, J INFECT DIS, V172, P217, DOI 10.1093/infdis/172.1.217; Zhou FJ, 2005, JAMA-J AM MED ASSOC, V294, P797, DOI 10.1001/jama.294.7.797	26	214	240	2	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2007	356	11					1121	1129		10.1056/NEJMoa064040	http://dx.doi.org/10.1056/NEJMoa064040			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	145PO	17360990				2022-12-01	WOS:000244877200005
J	Levenson, R				Levenson, Ros			A patient's journey - Whooping cough	BRITISH MEDICAL JOURNAL			English	Editorial Material												ros@roslevenson.demon.co.uk							0	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2007	334	7592					532	533		10.1136/bmj.39120.556296.AE	http://dx.doi.org/10.1136/bmj.39120.556296.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148VV	17347240	Bronze, Green Published			2022-12-01	WOS:000245106400045
J	Gordon, DM				Gordon, Deborah M.			Control without hierarchy	NATURE			English	Editorial Material									Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Gordon, DM (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.							GORDON DM, 2000, ANTS WORK; Haraway Donna J., 1976, CRYSTALS FABRICS FIE; Lewontin Richard, 2000, TRIPLE HELIX GENE OR	3	38	38	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2007	446	7132					143	143		10.1038/446143a	http://dx.doi.org/10.1038/446143a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17344838				2022-12-01	WOS:000244718100025
J	Chen, YMA; Kuo, SHS				Chen, Yi-Ming Arthur; Kuo, Steve Hsu-Sung			HIV-1 in Taiwan	LANCET			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; INFECTIONS; CHINA; RECOMBINANT; STRAIN		Natl Yang Ming Univ, AIDS Prevent & Res Ctr, Taipei 112, Taiwan; Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; Ctr Dis Control, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Centers For Disease Control - Taiwan	Chen, YMA (corresponding author), Natl Yang Ming Univ, AIDS Prevent & Res Ctr, Taipei 112, Taiwan.	Arthur@ym.edu.tw						Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; *CDC, 2006, HIV AIDS DAT; Chen QF, 2005, CHINESE PHYS LETT, V22, P2005, DOI 10.1088/0256-307X/22/8/051; CHEN YM, 2002, J ACQ IMMUN DEF SYND, V26, P274; Chen YMA, 2006, EMERG INFECT DIS, V12, P703, DOI 10.3201/eid1204.050762; Cohen J, 2004, SCIENCE, V304, P1932, DOI 10.1126/science.304.5679.1932; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Hsieh SM, 1996, J FORMOS MED ASSOC, V95, P923; Hsueh PR, 2000, J INFECT DIS, V181, P1706, DOI 10.1086/315432; Hung CC, 2000, J ACQ IMMUN DEF SYND, V24, P378, DOI 10.1097/00126334-200008010-00013; Ko NY, 2006, SEX TRANSM DIS, V33, P467, DOI 10.1097/01.olq.0000204512.15297.5f; LAI SF, 2004, 15 INT AIDS C BANGK; Law WP, 2003, AIDS, V17, P2191, DOI 10.1097/00002030-200310170-00007; Lim WL, 2004, AIDS RES HUM RETROV, V20, P259, DOI 10.1089/088922204322996473; LIN YT, IN PRESS J INFECT DI; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; *WHO JOINT UN PROG, 2005, 2005 UPD HIV AIDS EP	18	90	90	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	2007	369	9562					623	625		10.1016/S0140-6736(07)60291-8	http://dx.doi.org/10.1016/S0140-6736(07)60291-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	141RO	17321295				2022-12-01	WOS:000244596600007
J	Patton, C				Patton, Cindy			Bullets, balance, or both: medicalisation in HIV treatment	LANCET			English	Article; Proceedings Paper	Meeting on Medicalisation in the 21st Century	JUN, 2005	New York, NY						Simon Fraser Univ, Hlth Res & Methods Training Facil, Vancouver, BC V6B 5K3, Canada	Simon Fraser University	Patton, C (corresponding author), Simon Fraser Univ, Hlth Res & Methods Training Facil, Vancouver, BC V6B 5K3, Canada.	healthlab@gmail.com						Epstein Steven, 1996, IMPURE SCI AIDS ACTI; Patton C., 1996, FATAL ADVICE; Patton Cindy, 1990, INVENTING AIDS	3	8	8	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	2007	369	9562					706	707		10.1016/S0140-6736(07)60322-5	http://dx.doi.org/10.1016/S0140-6736(07)60322-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	141RO	17321320				2022-12-01	WOS:000244596600036
J	Sugiyama, T; Cam, HP; Sugiyama, R; Noma, K; Zofall, M; Kobayashi, R; Grewal, SIS				Sugiyama, Tomoyasu; Cam, Hugh P.; Sugiyama, Rie; Noma, Ken-ichi; Zofall, Martin; Kobayashi, Ryuji; Grewal, Shiv I. S.			SHREC, an effector complex for heterochromatic transcriptional silencing	CELL			English	Article							DIRECTED DNA METHYLATION; H3 LYSINE-9 METHYLATION; GENOME-WIDE ANALYSIS; MATING-TYPE LOCI; FISSION YEAST; HISTONE H3; SCHIZOSACCHAROMYCES-POMBE; DOMAIN PROTEIN; RNA-POLYMERASE; PERICENTRIC HETEROCHROMATIN	Transcriptional gene silencing (TGS) is the mechanism generally thought by which heterochromatin effects silencing. However, recent discovery in fission yeast of a cis-acting posttranscriptional gene-silencing (cis-PTGS) pathway operated by the RNAi machinery at heterochromatin challenges the role of TGS in heterochromatic silencing. Here, we describe a multienzyme effector complex (termed SHREC) that mediates heterochromatic TGS in fission yeast. SHREC consists of a core quartet of proteins-Clr1, Clr2, Clr3, and Mit1-which distribute throughout all major heterochromatin domains to effect TGS via distinct activities associated with the histone deacetylase Clr3 and the SNF2 chromatin-remodeling factor homolog Mit1. SHREG is also recruited to the telomeres by multiple independent mechanisms involving telomere binding protein Ccq1 cooperating with Taz1 and the RNAi machinery, and to euchromatic sites, via mechanism(s) distinct from its heterochromatin localization aided by Swi6/HP1. Our analyses suggest that SHREC regulates nucleosome positioning to assemble higher-order chromatin structures critical for heterochromatin functions.	NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center	Grewal, SIS (corresponding author), NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov		Sugiyama, Tomoyasu/0000-0001-5704-6606; Grewal, Shiv/0000-0002-4552-9261	NATIONAL CANCER INSTITUTE [Z01BC010523] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Aufsatz W, 2002, EMBO J, V21, P6832, DOI 10.1093/emboj/cdf663; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bjerling P, 2004, NUCLEIC ACIDS RES, V32, P4421, DOI 10.1093/nar/gkh780; Bowen NJ, 2004, CELL MOL LIFE SCI, V61, P2163, DOI 10.1007/s00018-004-4177-x; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Chan SWL, 2006, PLOS GENET, V2, P791, DOI 10.1371/journal.pgen.0020083; Cheutin T, 2004, MOL CELL BIOL, V24, P3157, DOI 10.1128/MCB.24.8.3157-3167.2004; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Cryderman DE, 1998, CHROMOSOMA, V107, P277, DOI 10.1007/s004120050309; Dennis K, 2001, GENE DEV, V15, P2940, DOI 10.1101/gad.929101; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Eissenberg JC, 2001, BIOESSAYS, V23, P767, DOI 10.1002/bies.1111; EKWALL K, 1994, GENETICS, V136, P53; Ekwall K, 2005, TRENDS GENET, V21, P608, DOI 10.1016/j.tig.2005.08.009; Feng Q, 2003, CURR TOP MICROBIOL, V274, P269; Festenstein R, 2003, SCIENCE, V299, P719, DOI 10.1126/science.1078694; Flory MR, 2004, MOL CELL, V16, P619, DOI 10.1016/j.molcel.2004.10.027; Freeman-Cook LL, 2005, GENETICS, V169, P1243, DOI 10.1534/genetics.104.032714; Gibbons RJ, 2000, NAT GENET, V24, P368, DOI 10.1038/74191; Grewal SIS, 1998, GENETICS, V150, P563; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hall Ira M., 2003, P205; Hansen KR, 2005, MOL CELL BIOL, V25, P590, DOI 10.1128/MCB.25.2.590-601.2005; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hong Eun-Jin Erica, 2005, RNA Biol, V2, P106, DOI 10.4161/rna.2.3.2131; Horn PJ, 2005, GENE DEV, V19, P1705, DOI 10.1101/gad.1328005; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Huisinga KL, 2006, CHROMOSOMA, V115, P110, DOI 10.1007/s00412-006-0052-x; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Jia ST, 2004, CELL, V119, P469, DOI 10.1016/j.cell.2004.10.020; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kanno T, 2005, EMBO REP, V6, P649, DOI 10.1038/sj.embor.7400446; Kanno T, 2004, CURR BIOL, V14, P801, DOI 10.1016/j.cub.2004.04.037; Kanoh J, 2005, CURR BIOL, V15, P1808, DOI 10.1016/j.cub.2005.09.041; Kanoh J, 2003, CELL MOL LIFE SCI, V60, P2295, DOI 10.1007/s00018-003-3245-y; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Mellone BG, 2003, CURR BIOL, V13, P1748, DOI 10.1016/j.cub.2003.09.031; Mellor J, 2006, CELL, V126, P22, DOI 10.1016/j.cell.2006.06.028; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Partridge JF, 2000, GENE DEV, V14, P783; Petrie VJ, 2005, MOL CELL BIOL, V25, P2331, DOI 10.1128/MCB.25.6.2331-2346.2005; Pidoux AL, 2004, CHROMOSOME RES, V12, P521, DOI 10.1023/B:CHRO.0000036586.81775.8b; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Schulte KM, 2001, THYROID, V11, P3, DOI 10.1089/10507250150500603; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shankaranarayana GD, 2003, CURR BIOL, V13, P1240, DOI 10.1016/S0960-9822(03)00489-5; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Sun FL, 2001, MOL CELL BIOL, V21, P2867, DOI 10.1128/MCB.21.8.2867-2879.2001; Thon G, 2000, GENETICS, V155, P551; THON G, 1992, GENETICS, V131, P287; THON G, 1994, GENETICS, V138, P29; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Walfridsson J, 2005, NUCLEIC ACIDS RES, V33, P2868, DOI 10.1093/nar/gki579; Wiren M, 2005, EMBO J, V24, P2906, DOI 10.1038/sj.emboj.7600758; Yamada T, 2005, MOL CELL, V20, P173, DOI 10.1016/j.molcel.2005.10.002; Zofall M, 2006, MOL CELL, V22, P681, DOI 10.1016/j.molcel.2006.05.010	71	234	243	3	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2007	128	3					491	504		10.1016/j.cell.2006.12.035	http://dx.doi.org/10.1016/j.cell.2006.12.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289569	Bronze			2022-12-01	WOS:000244842700016
J	Grine, FE; Bailey, RM; Harvati, K; Nathan, RP; Morris, AG; Henderson, GM; Ribot, I; Pike, AWG				Grine, F. E.; Bailey, R. M.; Harvati, K.; Nathan, R. P.; Morris, A. G.; Henderson, G. M.; Ribot, I.; Pike, A. W. G.			Late Pleistocene human skull from Hofmeyr, South Africa, and modern human origins	SCIENCE			English	Article							MITOCHONDRIAL GENOMES; CHRONOLOGY; DISPERSALS	The lack of Late Pleistocene human fossils from sub-Saharan Africa has limited paleontological testing of competing models of recent human evolution. We have dated a skull from Hofmeyr, South Africa, to 36.2 +/- 3.3 thousand years ago through a combination of optically stimulated luminescence and uranium-series dating methods. The skull is morphologically modern overall but displays some archaic features. Its strongest morphometric affinities are with Upper Paleolithic ( UP) Eurasians rather than recent, geographically proximate people. The Hofmeyr cranium is consistent with the hypothesis that UP Eurasians descended from a population that emigrated from sub-Saharan Africa in the Late Pleistocene.	SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; Univ Oxford, Sch Geog & Environm, Oxford OX1 3QY, England; Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; Univ Oxford, Res Lab Archaeol & Hist Art, Oxford OX1 3QY, England; Univ Cape Town, Dept Human Biol, ZA-7925 Cape Town, South Africa; Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; Univ Montreal, Dept Anthropol, Montreal, PQ H3C 3J7, Canada; Univ Bristol, Dept Archaeol & Anthropol, Bristol BS8 1UU, Avon, England	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; University of Oxford; Max Planck Society; University of Oxford; University of Cape Town; University of Oxford; Universite de Montreal; University of Bristol	Grine, FE (corresponding author), SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA.	fgrine@notes.cc.sunysb.edu	Rohlf, F J/A-8710-2008; Harvati, Katerina/A-5197-2008; Morris, Alan G/V-7363-2019	Pike, Alistair/0000-0002-5610-8948; Henderson, Gideon/0000-0002-6279-7137				Aitken MJ., 1998, INTRO OPTICAL DATING; Ambrose SH, 1998, J ARCHAEOL SCI, V25, P377, DOI 10.1006/jasc.1997.0277; BRIESMEISTER JF, LA13709M LOS AL NAT; deVilliers H., 1968, SKULL S AFRICAN NEGR; Eswaran V, 2005, J HUM EVOL, V49, P1, DOI 10.1016/j.jhevol.2005.02.006; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Garrigan D, 2005, MOL BIOL EVOL, V22, P189, DOI 10.1093/molbev/msi013; Harvati K, 2006, ANAT REC PART A, V288A, P1225, DOI 10.1002/ar.a.20395; Hawks JD, 2001, QUATERN INT, V75, P41, DOI 10.1016/S1040-6182(00)00076-8; HIGHARN T, COMMUNICATION; Howells WW, 1989, PAPERS PEABODY MUSEU, V79; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Lahr M. M, 1996, EVOLUTION MODERN HUM; LUDWIG KR, 1993, 93531 USGS; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Mellars P, 2006, NATURE, V439, P931, DOI 10.1038/nature04521; Nathan RP, 2003, RADIAT MEAS, V37, P305, DOI 10.1016/S1350-4487(03)00008-8; Ray N, 2005, GENOME RES, V15, P1161, DOI 10.1101/gr.3708505; Ribot Isabelle, 2004, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V16, P143; Roseman CC, 2004, AM J PHYS ANTHROPOL, V125, P257, DOI 10.1002/ajpa.10424; SMITH FH, 1989, HUMAN REVOLUTION, P172; Szilvassy JV, 1987, ANN VIENNA NAT HIST, V89, P313; Takasaka T, 2006, AM J PHYS ANTHROPOL, V129, P465, DOI 10.1002/ajpa.20208; Trinkaus E, 2006, CURR ANTHROPOL, V47, P597, DOI 10.1086/504165; Turbon D, 1997, J HUM EVOL, V32, P449, DOI 10.1006/jhev.1996.0119; VOGEL JC, 1969, S AFRICAN ARCHAEOLOG, V24, P56	27	86	90	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2007	315	5809					226	229		10.1126/science.1136294	http://dx.doi.org/10.1126/science.1136294			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	124XZ	17218524				2022-12-01	WOS:000243407400043
J	Schlaitz, AL; Srayko, M; Dammermann, A; Quintin, S; Wielsch, N; MacLeod, I; de Robillard, Q; Zinke, A; Yates, JR; Muller-Reichert, T; Shevchenko, A; Oegema, K; Hyman, AA				Schlaitz, Anne-Lore; Srayko, Martin; Dammermann, Alexander; Quintin, Sohie; Wielsch, Natalie; MacLeod, Ian; de Robillard, Quentin; Zinke, Andrea; Yates, John R., III; Mueller-Reichert, Thomas; Shevchenko, Andrei; Oegema, Karen; Hyman, Anthony A.			The C-elegans RSA complex localizes protein phosphatase 2A to centrosomes and regulates mitotic spindle assembly	CELL			English	Article							AURORA-A KINASE; MICROTUBULE DYNAMICS; CAENORHABDITIS-ELEGANS; PHOSPHORYLATION; KINETOCHORE; MATURATION; MCAK; TARGET; GROWTH	Microtubule behavior changes during the cell cycle and during spindle assembly. However, it remains unclear how these changes are regulated and coordinated. We describe a complex that targets the Protein Phosphatase 2A holoenzyme (PP2A) to centrosomes in C. elegans embryos. This complex includes Regulator of Spindle Assembly 1 (RSA-1), a targeting subunit for PP2A, and RSA-2, a protein that binds and recruits RSA-1 to centrosomes. In contrast to the multiple functions of the PP2A catalytic subunit, RSA-1 and RSA-2 are specifically required for microtubule outgrowth from centrosomes and for spindle assembly. The centrosomally localized RSA-PP2A complex mediates these functions in part by regulating two critical mitotic effectors: the microtubule destabilizer KLP-7 and the C. elegans regulator of spindle assembly TPXL-1. By regulating a subset of PP2A functions at the centrosome, the RSA complex could therefore provide a means of coordinating microtubule outgrowth from centrosomes and kinetochore microtubule stability during mitotic spindle assembly.	MPI CBG, D-01307 Dresden, Germany; Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Max Planck Society; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Scripps Research Institute	Hyman, AA (corresponding author), MPI CBG, Pfotenhauerstr 108, D-01307 Dresden, Germany.	hyman@mpi-cbg.de	Hyman, Tony/F-1923-2011; Srayko, Martin/A-3755-2014; Hyman, Anthony A/B-3917-2017	Hyman, Anthony A/0000-0003-3664-154X; Srayko, Martin/0000-0003-0196-0364; Dammermann, Alexander/0000-0002-1251-0978; QUINTIN, Sophie/0000-0003-4059-5486	NIGMS NIH HHS [R01 GM074207-01A2, R01 GM074207] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074207] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; BRENNER S, 1974, GENETICS, V77, P71; Camilleri C, 2002, PLANT CELL, V14, P833, DOI 10.1105/tpc.010402; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Cassimeris L, 1999, CURR OPIN CELL BIOL, V11, P134, DOI 10.1016/S0955-0674(99)80017-9; Cassimeris L, 2001, INT REV CYTOL, V210, P163; Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; Dagda RK, 2003, J BIOL CHEM, V278, P24976, DOI 10.1074/jbc.M302832200; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Desai A, 2003, GENE DEV, V17, P2421, DOI 10.1101/gad.1126303; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Faux MC, 1996, TRENDS BIOCHEM SCI, V21, P312, DOI 10.1016/0968-0004(96)10040-2; GLIKSMAN NR, 1992, J CELL BIOL, V119, P1271, DOI 10.1083/jcb.119.5.1271; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; Hannak E, 2002, J CELL BIOL, V157, P591, DOI 10.1083/jcb.200202047; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Harlow E LD, 1988, ANTIBODIES LAB MANUA, V1st; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kao GT, 2004, DEVELOPMENT, V131, P755, DOI 10.1242/dev.00987; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; O'Toole ET, 2003, J CELL BIOL, V163, P451, DOI 10.1083/jcb.200304035; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; OEGEMA K, 2006, C ELEGANS, DOI DOI 10.1895/WORMBOOK.1.72.1; Ohi R, 2004, MOL BIOL CELL, V15, P2895, DOI 10.1091/mbc.E04-02-0082; Ozlu N, 2005, DEV CELL, V9, P237, DOI 10.1016/j.devcel.2005.07.002; Praitis V, 2001, GENETICS, V157, P1217; Siddiqui SS, 2002, TRAFFIC, V3, P20, DOI 10.1034/j.1600-0854.2002.30104.x; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; SONTAG E, 1995, J CELL BIOL, V128, P1131, DOI 10.1083/jcb.128.6.1131; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003; Srayko M, 2006, CURR BIOL, V16, P1944, DOI 10.1016/j.cub.2006.08.029; Stemple DL, 2004, NAT REV GENET, V5, P145, DOI 10.1038/nrg1273; Sumiyoshi E, 2002, J CELL SCI, V115, P1403; Tournebize R, 1997, EMBO J, V16, P5537, DOI 10.1093/emboj/16.18.5537; VERDE F, 1990, NATURE, V343, P233, DOI 10.1038/343233a0; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669	44	71	87	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 12	2007	128	1					115	127		10.1016/j.cell.2006.10.050	http://dx.doi.org/10.1016/j.cell.2006.10.050			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GN	17218259	Green Accepted, Bronze			2022-12-01	WOS:000244420400017
J	Stark, J; Andl, T; Millar, SE				Stark, Jaroslav; Andl, Thomas; Millar, Sarah E.			Hairy math: Insights into hair-follicle spacing and orientation	CELL			English	Editorial Material							POLARITY; WNT	Hair follicles in the skin have a characteristic spacing and orientation. Two recent papers (Sick et al., 2006; Wang et al., 2006) report the use of contrasting mathematical models and experimental manipulations to gain insight into the mechanisms underlying patterns of hair-follicle distribution and orientation.	Univ Penn, Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Univ London Imperial Coll Sci Technol & Med, Dept Math, London SW7 2AZ, England; Univ London Imperial Coll Sci Technol & Med, Ctr Integrat Syst Biol, London SW7 2AZ, England	University of Pennsylvania; University of Pennsylvania; Imperial College London; Imperial College London	Millar, SE (corresponding author), Univ Penn, Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA.	millars@mail.med.upenn.edu		Andl, Thomas/0000-0002-5555-468X; Millar, Sarah/0000-0001-8792-6890				Amonlirdviman K, 2005, SCIENCE, V307, P423, DOI 10.1126/science.1105471; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Barrow JR, 2006, SEMIN CELL DEV BIOL, V17, P185, DOI 10.1016/j.semcdb.2006.04.002; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Jung HS, 1998, DEV BIOL, V196, P11, DOI 10.1006/dbio.1998.8850; Kuraguchi M, 2006, PLOS GENET, V2, P1362, DOI 10.1371/journal.pgen.0020146; Mao BY, 2003, GENE, V302, P179, DOI 10.1016/S0378-1119(02)01106-X; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Wang YS, 2006, P NATL ACAD SCI USA, V103, P19800, DOI 10.1073/pnas.0609712104	10	22	22	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 12	2007	128	1					17	20		10.1016/j.cell.2006.12.020	http://dx.doi.org/10.1016/j.cell.2006.12.020			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GN	17218249	Bronze			2022-12-01	WOS:000244420400007
J	Wegener, KL; Partridge, AW; Han, J; Pickford, AR; Liddington, RC; Ginsberg, MH; Campbell, ID				Wegener, Kate L.; Partridge, Anthony W.; Han, Jaewon; Pickford, Andrew R.; Liddington, Robert C.; Ginsberg, Mark H.; Campbell, Iain D.			Structural basis of integrin activation by talin	CELL			English	Article							MEMBRANE-PROXIMAL REGION; LIGAND-BINDING AFFINITY; FERM DOMAIN; TRANSMEMBRANE DOMAIN; SECONDARY STRUCTURE; CRYSTAL-STRUCTURE; CYTOPLASMIC FACE; PROTEIN; LINKAGE; COMPLEX	Regulation of integrin affinity (activation) is essential for metazoan development and for many pathological processes. Binding of the talin phosphotyrosine-binding (PTB) domain to integrin beta subunit cytoplasmic domains (tails) causes activation, whereas numerous other PTB-domain-containing proteins bind integrins without activating them. Here we define the structure of a complex between talin and the membrane-proximal integrin beta 3 cytoplasmic domain and identify specific contacts between talin and the integrin tail required for activation. We used structure-based mutagenesis to engineer talin and beta 3 variants that interact with comparable affinity to the wild-type proteins but inhibit integrin activation by competing with endogenous talin. These results reveal the structural basis of talin's unique ability to activate integrins, identify an interaction that could aid in the design of therapeutics to block integrin activation, and enable engineering of cells with defects in the activation of multiple classes of integrins.	Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Burnham Inst, Ctr Canc, Program Cell Adhes, La Jolla, CA 92037 USA; Univ Portsmouth, Portsmouth PO1 2DY, Hants, England	University of Oxford; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; University of Portsmouth	Ginsberg, MH (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	mhginsberg@ucsd.edu; iain.campbell@bioch.ox.ac.uk	Pickford, Andy/AGB-6901-2022; Wegener, Kate/E-5077-2010	Wegener, Kate/0000-0002-1562-6060; Ginsberg, Mark/0000-0002-5685-5417; Pickford, Andy/0000-0002-7237-0030	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABRAMS C, 1994, J BIOL CHEM, V269, P18781; Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Baker EK, 1997, P NATL ACAD SCI USA, V94, P1973, DOI 10.1073/pnas.94.5.1973; Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989; Bersch B, 2003, J BIOMOL NMR, V27, P57, DOI 10.1023/A:1024746306675; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Campbell ID, 2004, TRENDS BIOCHEM SCI, V29, P429, DOI 10.1016/j.tibs.2004.06.005; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Critchley DR, 2005, BIOCHEM SOC T, V33, P1308, DOI 10.1042/BST0331308; de Pereda JM, 2005, J BIOL CHEM, V280, P8381, DOI 10.1074/jbc.M413180200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Edwards SD, 2001, BIOCHEMISTRY-US, V40, P7061, DOI 10.1021/bi010419h; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Gottschalk KE, 2005, STRUCTURE, V13, P703, DOI 10.1016/j.str.2005.02.014; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; Han BG, 2000, NAT STRUCT BIOL, V7, P871; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; Huang CL, 2004, J BIOL CHEM, V279, P42279, DOI 10.1074/jbc.M402540200; HUGHES PE, 1995, J BIOL CHEM, V270, P12411, DOI 10.1074/jbc.270.21.12411; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; KORADI R, 1996, J MOL GRAPHICS, V14, P29; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li W, 2005, P NATL ACAD SCI USA, V102, P1424, DOI 10.1073/pnas.0409334102; Luo BH, 2005, P NATL ACAD SCI USA, V102, P3679, DOI 10.1073/pnas.0409440102; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; PARDI A, 1984, J MOL BIOL, V180, P741, DOI 10.1016/0022-2836(84)90035-4; Partridge AW, 2005, J BIOL CHEM, V280, P7294, DOI 10.1074/jbc.M412701200; Pickford AR, 2001, EMBO J, V20, P1519, DOI 10.1093/emboj/20.7.1519; REDFIELD C, 1991, BIOCHEMISTRY-US, V30, P11029, DOI 10.1021/bi00110a004; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Smith WJ, 2003, J BIOL CHEM, V278, P4949, DOI 10.1074/jbc.M210601200; Stefansson A, 2004, J BIOL CHEM, V279, P21200, DOI 10.1074/jbc.M400771200; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tanentzapf G, 2006, NAT CELL BIOL, V8, P601, DOI 10.1038/ncb1411; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Ulmer TS, 2003, BIOCHEMISTRY-US, V42, P8307, DOI 10.1021/bi034384s; Vinogradova O, 2004, P NATL ACAD SCI USA, V101, P4094, DOI 10.1073/pnas.0400742101; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Weljie AM, 2002, P NATL ACAD SCI USA, V99, P5878, DOI 10.1073/pnas.092515799	47	506	521	3	54	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 12	2007	128	1					171	182		10.1016/j.cell.2006.10.048	http://dx.doi.org/10.1016/j.cell.2006.10.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GN	17218263	Bronze			2022-12-01	WOS:000244420400021
J	Ishii, N; Nakahigashi, K; Baba, T; Robert, M; Soga, T; Kanai, A; Hirasawa, T; Naba, M; Hirai, K; Hoque, A; Ho, PY; Kakazu, Y; Sugawara, K; Igarashi, S; Harada, S; Masuda, T; Sugiyama, N; Togashi, T; Hasegawa, M; Takai, Y; Yugi, K; Arakawa, K; Iwata, N; Toya, Y; Nakayama, Y; Nishioka, T; Shimizu, K; Mori, H; Tomita, M				Ishii, Nobuyoshi; Nakahigashi, Kenji; Baba, Tomoya; Robert, Martin; Soga, Tomoyoshi; Kanai, Akio; Hirasawa, Takashi; Naba, Miki; Hirai, Kenta; Hoque, Aminul; Ho, Pei Yee; Kakazu, Yuji; Sugawara, Kaori; Igarashi, Saori; Harada, Satoshi; Masuda, Takeshi; Sugiyama, Naoyuki; Togashi, Takashi; Hasegawa, Miki; Takai, Yuki; Yugi, Katsuyuki; Arakawa, Kazuharu; Iwata, Nayuta; Toya, Yoshihiro; Nakayama, Yoichi; Nishioka, Takaaki; Shimizu, Kazuyuki; Mori, Hirotada; Tomita, Masaru			Multiple high-throughput analyses monitor the response of E-coli to perturbations	SCIENCE			English	Article							METABOLIC NETWORK; INTEGRATION; ROBUSTNESS; GENOMICS; STRESS; SYSTEM	Analysis of cellular components at multiple levels of biological information can provide valuable functional insights. We performed multiple high-throughput measurements to study the response of Escherichia coli cells to genetic and environmental perturbations. Analysis of metabolic enzyme gene disruptants revealed unexpectedly small changes in messenger RNA and proteins for most disruptants. Overall, metabolite levels were also stable, reflecting the rerouting of fluxes in the metabolic network. In contrast, E. coli actively regulated enzyme levels to maintain a stable metabolic state in response to changes in growth rate. E. coli thus seems to use complementary strategies that result in a metabolic network robust against perturbations.	Keio Univ, Inst Adv Biosci, Yamagata 9970017, Japan; Keio Univ, Grad Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa 2528520, Japan; Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; Kyoto Univ, Grad Sch Agr, Kyoto 6068502, Japan; Kyushu Inst Technol, Dept Biosci & Bioinformat, Fukuoka 8208502, Japan; Human Metabolome Technol Inc, Tsuruoka, Japan	Keio University; Keio University; Nara Institute of Science & Technology; Kyoto University; Kyushu Institute of Technology	Tomita, M (corresponding author), Keio Univ, Inst Adv Biosci, Yamagata 9970017, Japan.	mt@sfc.keio.ac.jp	Shimizu, Kazuyuki/GVT-4698-2022; Kanai, Akio/C-4921-2014; Robert, Martin/B-3970-2009; Mori, Hirotada/B-4934-2011; Soga, Tomoyoshi/B-8105-2014; Hirasawa, Takashi/G-4458-2016; Ho, Pei Yee/G-6841-2012	Shimizu, Kazuyuki/0000-0002-4847-0197; Kanai, Akio/0000-0002-6362-2419; Robert, Martin/0000-0002-7082-5142; Soga, Tomoyoshi/0000-0001-9502-2509; Hirasawa, Takashi/0000-0002-5183-2953; Sugiyama, Naoyuki/0000-0001-7633-8495; Arakawa, Kazuharu/0000-0002-2893-4919; Toya, Yoshihiro/0000-0001-9670-6961				Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; DALDAL F, 1983, J MOL BIOL, V168, P285, DOI 10.1016/S0022-2836(83)80019-9; Fong SS, 2006, J BIOL CHEM, V281, P8024, DOI 10.1074/jbc.M510016200; Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Hirai MY, 2004, P NATL ACAD SCI USA, V101, P10205, DOI 10.1073/pnas.0403218101; Hoskisson PA, 2005, MICROBIOL-SGM, V151, P3153, DOI 10.1099/mic.0.27924-0; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; Mukhopadhyay A, 2006, J BACTERIOL, V188, P4068, DOI 10.1128/JB.01921-05; SKINNER AJ, 1974, J BACTERIOL, V118, P1183, DOI 10.1128/JB.118.3.1183-1185.1974; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; Toyoda T, 2004, BIOINFORMATICS, V20, P1759, DOI 10.1093/bioinformatics/bth165; Vemuri GN, 2005, MICROBIOL MOL BIOL R, V69, P197, DOI 10.1128/MMBR.69.2.197-216.2005	19	503	515	3	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2007	316	5824					593	597		10.1126/science.1132067	http://dx.doi.org/10.1126/science.1132067			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17379776				2022-12-01	WOS:000245983100044
J	Lee, YS; Mulugu, S; York, JD; O'Shea, EK				Lee, Young-Sam; Mulugu, Sashidhar; York, John D.; O'Shea, Erin K.			Regulation of a cyclin-CDK-CDK inhibitor complex by inositol pyrophosphates	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; TELOMERE LENGTH; PROTEIN-KINASES; YEAST; PHO80-PHO85; HEXAKISPHOSPHATE; PHOSPHORYLATION; POLYPHOSPHATES; DICTYOSTELIUM; ENZYMES	In budding yeast, phosphate starvation triggers inhibition of the Pho80-Pho85 cyclin-cyclin-dependent kinase (CDK) complex by the CDK inhibitor Pho81, leading to expression of genes involved in nutrient homeostasis. We isolated myo-D-inositol heptakisphosphate (IP7) as a cellular component that stimulates Pho81-dependent inhibition of Pho80-Pho85. IP7 is necessary for Pho81- dependent inhibition of Pho80-Pho85 in vitro. Moreover, intracellular concentrations of IP7 increased upon phosphate starvation, and yeast mutants defective in IP7 production failed to inhibit Pho80-Pho85 in response to phosphate starvation. These observations reveal regulation of a cyclin-CDK complex by a metabolite and suggest that a complex metabolic network mediates signaling of phosphate availability.	Harvard Univ, Howard Hughes Med Inst, Fac Arts & Sci, Ctr Syst Biol,Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Harvard University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute	O'Shea, EK (corresponding author), Harvard Univ, Howard Hughes Med Inst, Fac Arts & Sci, Ctr Syst Biol,Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	erin_oshea@harvard.edu	Lee, Young-Sam/A-2499-2013		NHLBI NIH HHS [HL055672] Funding Source: Medline; NIDDK NIH HHS [DK070272] Funding Source: Medline; NIGMS NIH HHS [R01 GM051377-15, R01 GM051377] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051377] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Auesukaree C, 2005, J BIOL CHEM, V280, P25127, DOI 10.1074/jbc.M414579200; Carroll AS, 2002, TRENDS BIOCHEM SCI, V27, P87, DOI 10.1016/S0968-0004(01)02040-0; Dubois E, 2002, J BIOL CHEM, V277, P23755, DOI 10.1074/jbc.M202206200; FLEISCHER B, 1994, J BIOL CHEM, V269, P17826; Flick JS, 1998, GENETICS, V148, P33; Huang SD, 2005, GENETICS, V169, P1859, DOI 10.1534/genetics.104.038695; Huang SD, 2001, MOL CELL BIOL, V21, P6695, DOI 10.1128/MCB.21.19.6695-6705.2001; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; KAFFMAN A, 1994, SCIENCE, V263, P1153, DOI 10.1126/science.8108735; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/0968-0004(96)10048-7; Luo HBR, 2003, CELL, V114, P559, DOI 10.1016/S0092-8674(03)00640-8; Luo HBR, 2002, BIOCHEMISTRY-US, V41, P2509, DOI 10.1021/bi0118153; MAYR GW, 1992, CARBOHYD RES, V234, P247, DOI 10.1016/0008-6215(92)85052-2; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Saiardi A, 2005, P NATL ACAD SCI USA, V102, P1911, DOI 10.1073/pnas.0409322102; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Schell MJ, 1999, FEBS LETT, V461, P169, DOI 10.1016/S0014-5793(99)01462-3; SCHNEIDER KR, 1994, SCIENCE, V266, P122, DOI 10.1126/science.7939631; Seeds AM, 2005, J BIOL CHEM, V280, P27654, DOI 10.1074/jbc.M505089200; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Wilson WA, 2002, CELL, V111, P155, DOI 10.1016/S0092-8674(02)01043-7; YE WL, 1995, J BIOL CHEM, V270, P1564, DOI 10.1074/jbc.270.4.1564; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200	25	214	222	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2007	316	5821					109	112		10.1126/science.1139080	http://dx.doi.org/10.1126/science.1139080			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412959	Green Accepted			2022-12-01	WOS:000245470500043
J	Ota, KG; Kuraku, S; Kuratani, S				Ota, Kinya G.; Kuraku, Shigehiro; Kuratani, Shigeru			Hagfish embryology with reference to the evolution of the neural crest	NATURE			English	Article							VERTEBRATE EVOLUTION; HEAD; MIGRATION; SEQUENCES; ORIGIN; SLUG	Hagfish, which lack both jaws and vertebrae, have long been the subject of intense interest owing to their position at a crucial point in the evolutionary transition to a truly vertebrate body plan(1-4). However, unlike the comparatively well characterized vertebrate agnathan lamprey, little is known about hagfish development. The inability to analyse hagfish at early embryonic stages has frustrated attempts to resolve questions with important phylogenetic implications, including fundamental ones relating to the emergence of the neural crest(1,5,6). Here we report the obtainment of multiple pharyngula-stage embryos of the hagfish species Eptatretus burgeri and our preliminary analyses of their early development. We present histological evidence of putative neural crest cells, which appear as delaminated cells that migrate along pathways corresponding to neural crest cells in fish and amphibians(2,7-11). Molecular cloning studies further revealed the expression of several regulatory genes, including cognates of Pax6, Pax3/7, SoxEa and Sox9, suggesting that the hagfish neural crest is specified by molecular mechanisms that are general to vertebrates. We propose that the neural crest emerged as a population of de-epithelialized migratory cells in a common vertebrate ancestor, and suggest that the possibility of classical and molecular embryology in hagfish opens up new approaches to clarifying the evolutionary history of vertebrates.	RIKEN, Ctr Dev Biol, Lab Evolutionary Morphol, Kobe, Hyogo 6500047, Japan	RIKEN	Kuratani, S (corresponding author), RIKEN, Ctr Dev Biol, Lab Evolutionary Morphol, Kobe, Hyogo 6500047, Japan.	saizo@cdb.riken.jp	Kuraku, Shigehiro/B-2801-2009; Kuratani, Shigeru/J-4146-2014	Kuraku, Shigehiro/0000-0003-1464-8388; Kuratani, Shigeru/0000-0001-9717-7221				BRONNERFRASER M, 1993, J NEUROBIOL, V24, P233, DOI 10.1002/neu.480240209; Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; COLLAZO A, 1993, DEVELOPMENT, V118, P363; Conel JL, 1942, J COMP NEUROL, V76, P191, DOI 10.1002/cne.900760202; Dean B., 1899, EMBRYOLOGY BDELLOSTO, P220; EISEN JS, 1993, DEV BIOL, V159, P50, DOI 10.1006/dbio.1993.1220; Furlong RF, 2002, ZOOL SCI, V19, P593, DOI 10.2108/zsj.19.593; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; Goodrich ES., 1930, STUDIES STRUCTURE DE, DOI [DOI 10.5962/BHL.TITLE.82144, 10.5962/bhl.title.82144]; Gorbman A, 1997, ZOOL SCI, V14, P375, DOI 10.2108/zsj.14.375; GORBMAN A, 1985, EVOLUTIONARY BIOL PR, P165; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; Hall BK, 1999, NEURAL CREST DEV EVO; Holmgren N., 1946, ACTA ZOOLOGICA, V27, P1, DOI [10.1111/j.1463-6395.1946.tb00019.x, DOI 10.1111/J.1463-6395.1946.TB00019.X]; JANVIER P., 1996, EARLY VERTEBRATES; Jeffery WR, 2004, NATURE, V431, P696, DOI 10.1038/nature02975; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Le Douarin N.M., 1999, NEURAL CREST; Locascio A, 2002, P NATL ACAD SCI USA, V99, P16841, DOI 10.1073/pnas.262525399; Lovtrup S., 1977, PHYLOGENY VERTEBRATA; Mallat J, 1998, MOL BIOL EVOL, V15, P1706, DOI 10.1093/oxfordjournals.molbev.a025897; McCauley DW, 2006, NATURE, V441, P750, DOI 10.1038/nature04691; McCauley DW, 2003, DEVELOPMENT, V130, P2317, DOI 10.1242/dev.00451; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Ota KG, 2006, ZOOL SCI, V23, P403, DOI 10.2108/zsj.23.403; Shu DG, 2003, NATURE, V421, P526, DOI 10.1038/nature01264; Takezaki N, 2003, MOL BIOL EVOL, V20, P287, DOI 10.1093/molbev/msg040; WICHT H, 1995, PHILOS T ROY SOC B, V349, P119, DOI 10.1098/rstb.1995.0098; Wicht H, 1998, BIOLOGY OF HAGFISHES, P431	30	155	162	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2007	446	7136					672	675		10.1038/nature05633	http://dx.doi.org/10.1038/nature05633			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17377535				2022-12-01	WOS:000245438300041
J	Palla, G; Barabasi, AL; Vicsek, T				Palla, Gergely; Barabasi, Albert-Laszlo; Vicsek, Tamas			Quantifying social group evolution	NATURE			English	Article							COMMUNITY STRUCTURE; NETWORK STRUCTURE; COLLABORATION	The rich set of interactions between individuals in society(1-7) results in complex community structure, capturing highly connected circles of friends, families or professional cliques in a social network(3,7-10). Thanks to frequent changes in the activity and communication patterns of individuals, the associated social and communication network is subject to constant evolution(7,11-16). Our knowledge of the mechanisms governing the underlying community dynamics is limited, but is essential for a deeper understanding of the development and self-optimization of society as a whole(17-22). We have developed an algorithm based on clique percolation(23,24) that allows us to investigate the time dependence of overlapping communities on a large scale, and thus uncover basic relationships characterizing community evolution. Our focus is on networks capturing the collaboration between scientists and the calls between mobile phone users. We find that large groups persist for longer if they are capable of dynamically altering their membership, suggesting that an ability to change the group composition results in better adaptability. The behaviour of small groups displays the opposite tendency - the condition for stability is that their composition remains unchanged. We also show that knowledge of the time commitment of members to a given community can be used for estimating the community's lifetime. These findings offer insight into the fundamental differences between the dynamics of small groups and large institutions.	HAS, Stat & Biol Phys Res Grp, H-1117 Budapest, Hungary; Univ Notre Dame, Ctr Complex Network Res, Notre Dame, IN 46566 USA; Univ Notre Dame, Dept Phys, Notre Dame, IN 46566 USA; Univ Notre Dame, Dept Comp Sci, Notre Dame, IN 46566 USA; Eotvos Lorand Univ, Dept Biol Phys, H-1117 Budapest, Hungary	Hungarian Academy of Sciences; University of Notre Dame; University of Notre Dame; University of Notre Dame; Eotvos Lorand University	Vicsek, T (corresponding author), HAS, Stat & Biol Phys Res Grp, Pazmany P Stny 1A, H-1117 Budapest, Hungary.	vicsek@angel.elte.hu	Palla, Gergely/H-1767-2016; Barabasi, Albert-Laszlo/S-6474-2017; Vicsek, Tamas/A-3305-2009	Palla, Gergely/0000-0002-3406-4200; Barabasi, Albert/0000-0002-4028-3522				Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Csermely P., 2006, WEAK LINKS; Derenyi I, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.160202; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; Ebel Holger, 2002, Complexity, V8, P24, DOI 10.1002/cplx.10066; Everett M., 1998, CONNECTIONS, V21, P49; FAUST K, 2005, MODELS METHODS SOCIA, pCH7; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; Guimera R, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.065103; Holme P, 2004, SOC NETWORKS, V26, P155, DOI 10.1016/j.socnet.2004.01.007; Hopcroft J, 2004, P NATL ACAD SCI USA, V101, P5249, DOI 10.1073/pnas.0307750100; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Li CG, 2005, J PHYS A-MATH GEN, V38, P9741, DOI 10.1088/0305-4470/38/45/002; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Newman MEJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.036122; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; ONNEAL JP, 2006, STRUCTURE TIE STRENG; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pollner P, 2006, EUROPHYS LETT, V73, P478, DOI 10.1209/epl/i2005-10414-6; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Scott J., 2000, SOCIAL NETWORK ANAL; Shiffrin RM, 2004, P NATL ACAD SCI USA, V101, P5183, DOI 10.1073/pnas.0307852100; Wagner CS, 2005, RES POLICY, V34, P1608, DOI 10.1016/j.respol.2005.08.002; Warner S., 2003, Library Hi Tech, V21, P151, DOI 10.1108/07378830310479794; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Watts DJ, 2002, SCIENCE, V296, P1302, DOI 10.1126/science.1070120; Yeung YY, 2005, AM J PHYS, V73, P145, DOI 10.1119/1.1775799	29	1001	1090	10	316	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 5	2007	446	7136					664	667		10.1038/nature05670	http://dx.doi.org/10.1038/nature05670			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	153LZ	17410175	Green Submitted			2022-12-01	WOS:000245438300039
J	Mason, KD; Carpinelli, MR; Fletcher, JI; Collinge, JE; Hilton, AA; Ellis, S; Kelly, PN; Ekert, PG; Metcalf, D; Roberts, AW; Huang, DCS; Kile, BT				Mason, Kylie D.; Carpinelli, Marina R.; Fletcher, Jamie I.; Collinge, Janelle E.; Hilton, Adrienne A.; Ellis, Sarah; Kelly, Priscilla N.; Ekert, Paul G.; Metcalf, Donald; Roberts, Andrew W.; Huang, David C. S.; Kile, Benjamin T.			Programmed anuclear cell death delimits platelet life span	CELL			English	Article							BCL-X; IN-VIVO; APOPTOSIS; SURVIVAL; BAX; PROTEINS; INHIBITION; ACTIVATION; PATHWAYS; EXPOSURE	Platelets are anuclear cytoplasmic fragments essential for blood clotting and wound healing. Despite much speculation, the factors determining their life span in the circulation are unknown. We show here that an intrinsic program for apoptosis, controls platelet survival and dictates their life span. Pro-survival Bcl-X-L constrains the pro-apoptotic activity of Bak to maintain platelet survival, but as Bcl-X-L degrades, aged platelets are primed for cell death. Genetic ablation or pharmacological inactivation of Bcl-X-L reduces platelet half-life and causes thrombocytopenia in a dose-dependent manner. Deletion of Bak corrects these defects, and platelets from Bak-deficient mice live longer than normal. Thus, platelets are, by default, genetically programmed to die by apoptosis. The antagonistic balance between Bcl-X-L and Bak constitutes a molecular clock that determines platelet life span: this represents an important paradigm for cellular homeostasis, and has profound implications for the diagnosis and treatment of disorders that affect platelet number and function.	Walter & Eliza Hall Inst Med Res, Mol Genet Canc Div, Melbourne, Vic 3050, Australia; Walter & Eliza Hall Inst Med Res, Div Mol Med, Melbourne, Vic 3050, Australia; Walter & Eliza Hall Inst Med Res, Canc & Hematol Div, Melbourne, Vic 3050, Australia; Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; Peter MacCallum Canc Ctr, Trescowthick Res Labs, Melbourne, Vic 3002, Australia; Royal Childrens Hosp, Childrens Canc Ctr, Parkville, Vic 3052, Australia	Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; University of Melbourne; Peter Maccallum Cancer Center; Royal Children's Hospital Melbourne	Huang, DCS (corresponding author), Walter & Eliza Hall Inst Med Res, Mol Genet Canc Div, Melbourne, Vic 3050, Australia.	huang_d@wehi.edu.au; kile@wehi.edu.au	Ekert, Paul/Q-1842-2015; Fletcher, Jamie/V-4667-2019; Kile, Benjamin/GNP-3246-2022; Huang, David C. S./C-7586-2013; Roberts, Andrew W/C-6736-2012; Kile, Benjamin T/F-6593-2011; Ekert, Paul G/C-7247-2013	Ekert, Paul/0000-0002-2976-8617; Kile, Benjamin/0000-0002-8836-8947; Huang, David C. S./0000-0002-3101-4873; Roberts, Andrew W/0000-0002-7341-5720; Kile, Benjamin T/0000-0002-8836-8947; Ekert, Paul G/0000-0002-2976-8617; Ellis, Sarah/0000-0002-5772-6051; Carpinelli, Marina/0000-0001-5115-7831; Fletcher, Jamie/0000-0003-2949-9469; Mason, Kylie/0000-0002-6238-4092				Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; AULT KA, 1995, EXP HEMATOL, V23, P996; Berger G, 1998, BLOOD, V92, P4446, DOI 10.1182/blood.V92.11.4446; Bertino AM, 2003, TRANSFUSION, V43, P857, DOI 10.1046/j.1537-2995.2003.t01-4-00431.x; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Brown SB, 2000, J BIOL CHEM, V275, P5987, DOI 10.1074/jbc.275.8.5987; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Clarke MCH, 2003, J CELL BIOL, V160, P577, DOI 10.1083/jcb.200210111; Cohen Z, 2004, THROMB RES, V113, P387, DOI 10.1016/j.thromres.2004.03.020; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; de Botton S, 2002, BLOOD, V100, P1310, DOI 10.1182/blood-2002-03-0686; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; George JN, 1998, ANN INTERN MED, V129, P886, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00009; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; JACOBSON MD, 1994, EMBO J, V13, P1899, DOI 10.1002/j.1460-2075.1994.tb06459.x; Kaluzhny Y, 2002, BLOOD, V100, P1670, DOI 10.1182/blood-2001-12-0263; Kasai S, 2003, DEV BIOL, V264, P202, DOI 10.1016/S0012-1606(03)00400-7; Kaushansky K, 2005, J CLIN INVEST, V115, P3339, DOI 10.1172/JCI26674; KIENAST J, 1990, BLOOD, V75, P116; LEEKSMA CHW, 1955, NATURE, V175, P552, DOI 10.1038/175552b0; Li JZ, 2000, TRANSFUSION, V40, P1320, DOI 10.1046/j.1537-2995.2000.40111320.x; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Methot N, 2004, J EXP MED, V199, P199, DOI 10.1084/jem.20031791; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; MUSTARD JF, 1966, BRIT J HAEMATOL, V12, P1, DOI 10.1111/j.1365-2141.1966.tb00121.x; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Patel SR, 2005, J CLIN INVEST, V115, P3348, DOI 10.1172/JCI26891; Pereira J, 2002, THROMB HAEMOSTASIS, V87, P905; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Rand ML, 2004, J THROMB HAEMOST, V2, P651, DOI 10.1111/j.1538-7836.2004.00670.x; Rathmell JC, 2002, NAT IMMUNOL, V3, P932, DOI 10.1038/ni834; Rudin CM, 1997, ANNU REV MED, V48, P267; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vanags DM, 1997, BRIT J HAEMATOL, V99, P824, DOI 10.1046/j.1365-2141.1997.4813284.x; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; ZHANG H, 2007, IN PRESS CELL DEATH; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	44	729	766	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1173	1186		10.1016/j.cell.2007.01.037	http://dx.doi.org/10.1016/j.cell.2007.01.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382885	Bronze			2022-12-01	WOS:000245396200022
J	Melcak, I; Hoelz, A; Blobel, G				Melcak, Ivo; Hoelz, Andre; Blobel, Guenter			Structure of Nup58/45 suggests flexible nuclear pore diameter by intermolecular sliding	SCIENCE			English	Article							IMPORTIN-BETA; P62 COMPLEX; FG REPEAT; EXPORT; TRANSPORT; PROTEINS; CONFIGURATIONS; VISUALIZATION; GLYCOPROTEINS; NUCLEOPORINS	The nucleoporins Nup58 and Nup45 are part of the central transport channel of the nuclear pore complex, which is thought to have a flexible diameter. In the crystal structure of an alpha-helical region of mammalian Nup58/45, we identified distinct tetramers, each consisting of two antiparallel hairpin dimers. The intradimeric interface is hydrophobic, whereas dimer-dimer association occurs through large hydrophilic residues. These residues are laterally displaced in various tetramer conformations, which suggests an intermolecular sliding by 11 angstroms. We propose that circumferential sliding plays a role in adjusting the diameter of the central transport channel.	Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Hoelz, A (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, 1230 York Ave, New York, NY 10021 USA.	hoelza@rockefeller.edu; blobel@rockefeller.edu	Hoelz, Andre/AAB-6978-2021		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111461] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM111461] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKEY CW, 1989, J CELL BIOL, V109, P971, DOI 10.1083/jcb.109.3.971; AKEY CW, 1990, BIOPHYS J, V58, P341, DOI 10.1016/S0006-3495(90)82381-X; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411; Bernad R, 2006, J BIOL CHEM, V281, P19378, DOI 10.1074/jbc.M512585200; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; FINLAY DR, 1991, J CELL BIOL, V114, P169, DOI 10.1083/jcb.114.1.169; Fribourg S, 2001, MOL CELL, V8, P645, DOI 10.1016/S1097-2765(01)00348-3; GRANDI P, 1995, EMBO J, V14, P76, DOI 10.1002/j.1460-2075.1995.tb06977.x; GUAN TL, 1995, MOL BIOL CELL, V6, P1591, DOI 10.1091/mbc.6.11.1591; Hu TH, 1998, GENE, V221, P245, DOI 10.1016/S0378-1119(98)00467-3; Hu TH, 1996, J CELL BIOL, V134, P589, DOI 10.1083/jcb.134.3.589; Hurt E, 1999, J CELL BIOL, V144, P389, DOI 10.1083/jcb.144.3.389; HURT EC, 1988, EMBO J, V7, P4323, DOI 10.1002/j.1460-2075.1988.tb03331.x; Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007; Kiseleva E, 1996, J MOL BIOL, V260, P304, DOI 10.1006/jmbi.1996.0401; Kiseleva E, 1998, J CELL SCI, V111, P223; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; REICHELT R, 1990, J CELL BIOL, V110, pB83; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Slutsky M, 2004, BIOPHYS J, V87, P4021, DOI 10.1529/biophysj.104.050765; STOFFTER D, 2003, J MOL BIOL, V32, P119; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; WENTE SR, 1992, J CELL BIOL, V119, P705, DOI 10.1083/jcb.119.4.705	28	93	94	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2007	315	5819					1729	1732		10.1126/science.1135730	http://dx.doi.org/10.1126/science.1135730			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379812				2022-12-01	WOS:000245106900045
J	Erkko, H; Xia, B; Nikkilae, J; Schleutker, J; Syrjaekoski, K; Mannermaa, A; Kallioniemi, A; Pylkas, K; Karppinen, SM; Rapakko, K; Miron, A; Sheng, Q; Li, GL; Mattila, H; Bell, DW; Haber, DA; Grip, M; Reiman, M; Jukkola-Vuorinen, A; Mustonen, A; Kere, J; Aaltonen, LA; Kosma, VM; Kataja, V; Soini, Y; Drapkin, RI; Livingston, DM; Winqvist, R				Erkko, Hannele; Xia, Bing; Nikkilae, Jenni; Schleutker, Johanna; Syrjaekoski, Kirsi; Mannermaa, Arto; Kallioniemi, Anne; Pylkas, Katri; Karppinen, Sanna-Maria; Rapakko, Katrin; Miron, Alexander; Sheng, Qing; Li, Guilan; Mattila, Henna; Bell, Daphne W.; Haber, Daniel A.; Grip, Mervi; Reiman, Mervi; Jukkola-Vuorinen, Arja; Mustonen, Aki; Kere, Juha; Aaltonen, Lauri A.; Kosma, Veli-Matti; Kataja, Vesa; Soini, Ylermi; Drapkin, Ronny I.; Livingston, David M.; Winqvist, Robert			A recurrent mutation in PALB2 in Finnish cancer families	NATURE			English	Article							SENSITIVE GEL-ELECTROPHORESIS; BREAST; BRCA2	BRCA1, BRCA2 and other known susceptibility genes account for less than half of the detectable hereditary predisposition to breast cancer(1-3). Other relevant genes therefore remain to be discovered. Recently a new BRCA2-binding protein, PALB2, was identified(4). The BRCA2-PALB2 interaction is crucial for certain key BRCA2 DNA damage response functions as well as its tumour suppression activity(4). Here we show, by screening for PALB2 mutations in Finland that a frameshift mutation, c.1592delT, is present at significantly elevated frequency in familial breast cancer cases compared with ancestry-matched population controls. The truncated PALB2 protein caused by this mutation retained little BRCA2-binding capacity and was deficient in homologous recombination and crosslink repair. Further screening of c.1592delT in unselected breast cancer individuals revealed a roughly fourfold enrichment of this mutation in patients compared with controls. Most of the mutation-positive unselected cases had a familial pattern of disease development. In addition, one multigenerational prostate cancer family that segregated the c.1592delT truncation allele was observed. These results indicate that PALB2 is a breast cancer susceptibility gene that, in a suitably mutant form, may also contribute to familial prostate cancer development.	Univ Kuopio, Inst Clin Med, FIN-70211 Kuopio, Finland; Karolinska Inst, Dept Biosci, SE-17177 Huddinge, Sweden; Karolinska Inst, Clin Res Ctr, SE-17177 Huddinge, Sweden; Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; Biomedicum Helsinki, FIN-00014 Helsinki, Finland; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Dept Pathol, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Kuopio Univ Hosp, Dept Clin Pathol, FIN-70211 Kuopio, Finland; Univ Kuopio, Inst Clin Med Pathol & Forens Med, FIN-70211 Kuopio, Finland; Univ Tampere, Inst Med technol, Canc Genet Lab, FIN-33520 Tampere, Finland; Tampere Univ Hosp, Tampere, Finland; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Oulu Univ Hosp, FIN-90029 OYS, Finland; Univ Oulu, Dept Pathol, Oulu, Finland; Univ Oulu, Dept Oncol, Oulu, Finland; Univ Oulu, Dept Surg, Oulu, Finland; Univ Oulu, Dept Clin Genet, Oulu, Finland	University of Eastern Finland; Karolinska Institutet; Karolinska Institutet; University of Helsinki; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Kuopio University Hospital; University of Eastern Finland; Tampere University; Tampere University; Tampere University Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu	Winqvist, R (corresponding author), Kuopio Univ Hosp, Dept Oncol, FIN-70211 Kuopio, Finland.	david_livingston@dfci.harvard.edu; robert.winqvist@oulu.fi	Aaltonen, Lauri/A-5375-2010; xin, xp/C-7350-2009; Drapkin, Ronny/E-9944-2016; Kere, Juha/AAX-9117-2021; Kere, Juha/A-9179-2008	Aaltonen, Lauri/0000-0001-6839-4286; Drapkin, Ronny/0000-0002-6912-6977; Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Kallioniemi, Anne/0000-0003-3552-8158; Pylkas, Katri/0000-0002-2449-0521; Kataja, Vesa/0000-0003-4846-4843; Karppinen, Sanna/0000-0001-6233-9075; Winqvist, Robert/0000-0003-0932-9104; Schleutker, Johanna/0000-0002-1863-0305				Alter BP, 2007, J MED GENET, V44, P1, DOI 10.1136/jmg.2006.043257; Borg A, 2001, SEMIN CANCER BIOL, V11, P375, DOI 10.1006/scbi.2001.0393; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Hedenfalk I, 2003, P NATL ACAD SCI USA, V100, P2532, DOI 10.1073/pnas.0533805100; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Korkko J, 1998, P NATL ACAD SCI USA, V95, P1681, DOI 10.1073/pnas.95.4.1681; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Sarantaus L, 2000, EUR J HUM GENET, V8, P757, DOI 10.1038/sj.ejhg.5200529; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Shivji MKK, 2004, DNA REPAIR, V3, P835, DOI 10.1016/j.dnarep.2004.03.008; Syrjakoski K, 2000, J NATL CANCER I, V92, P1529, DOI 10.1093/jnci/92.18.1529; Wooster R, 2003, NEW ENGL J MED, V348, P2339, DOI 10.1056/NEJMra012284; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022	16	338	347	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2007	446	7133					316	319		10.1038/nature05609	http://dx.doi.org/10.1038/nature05609			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17287723				2022-12-01	WOS:000244892900045
J	Abbott, A				Abbott, Alison			A place in the sun	NATURE			English	News Item								Novartis has declared it's intention to become he world leader in vaccines since it took over Chiron and continued with it's vaccine research. Now Novartis aims to double last years sales by 2011. The business today has half-a-dozen vaccines in late-stage clinical trials for diseases such as meningitis and influenza.											0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2007	446	7132					124	125		10.1038/446124a	http://dx.doi.org/10.1038/446124a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17344823	Bronze			2022-12-01	WOS:000244718100010
J	Savaldi-Goldstein, S; Peto, C; Chory, J				Savaldi-Goldstein, Sigal; Peto, Charles; Chory, Joanne			The epidermis both drives and restricts plant shoot growth	NATURE			English	Article							ARABIDOPSIS-THALIANA; BRASSINOSTEROID BIOSYNTHESIS; STEM ELONGATION; LEAF-SHAPE; GENE; EXPRESSION; CYTOCHROME-P450; CELLS; WALL	The size of an organism is genetically determined, yet how a plant or animal achieves its final size is largely unknown. The shoot of higher plants has a simple conserved body plan based on three major tissue systems: the epidermal (L1), sub-epidermal (L2) and inner ground and vascular (L3) tissues. Which tissue system drives or restricts growth has been a subject of debate for over a century(1-4). Here, we use dwarf, brassinosteroid biosynthesis and brassinosteroid response mutants in conjunction with tissue-specific expression of these components as tools to examine the role of the epidermis in shoot growth. We show that expression of the brassinosteroid receptor or a brassinosteroid biosynthetic enzyme in the epidermis, but not in the vasculature, of null mutants is sufficient to rescue their dwarf phenotypes. Brassinosteroid signalling from the epidermis is not sufficient to establish normal vascular organization. Moreover, shoot growth is restricted when brassinosteroids are depleted from the epidermis and brassinosteroids act locally within a leaf. We conclude that the epidermis both promotes and restricts shoot growth by providing a nonautonomous signal to the ground tissues.	Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Neuronal Struct & Funct Lab, La Jolla, CA 92037 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute; Salk Institute	Chory, J (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	chory@salk.edu						Baima S, 1995, DEVELOPMENT, V121, P4171; Bishop GJ, 1996, PLANT CELL, V8, P959, DOI 10.1105/tpc.8.6.959; Cano-Delgado A, 2004, DEVELOPMENT, V131, P5341, DOI 10.1242/dev.01403; Choe SW, 1999, PLANT CELL, V11, P207, DOI 10.1105/tpc.11.2.207; DALE JE, 1988, ANNU REV PLANT PHYS, V39, P267, DOI 10.1146/annurev.arplant.39.1.267; Fujioka S, 2003, ANNU REV PLANT BIOL, V54, P137, DOI 10.1146/annurev.arplant.54.031902.134921; Gallagher KL, 2005, GENE DEV, V19, P189, DOI 10.1101/gad.1271005; Gendreau E, 1997, PLANT PHYSIOL, V114, P295, DOI 10.1104/pp.114.1.295; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; GREEN PB, 1994, J EXP BOT, V45, P1775, DOI 10.1093/jxb/45.Special_Issue.1775; Kurata T, 2005, CURR OPIN PLANT BIOL, V8, P600, DOI 10.1016/j.pbi.2005.09.005; Kutschera U, 2001, PLANT BIOLOGY, V3, P466, DOI 10.1055/s-2001-17731; Nakamura S, 2003, REC RES DEV MAGNET M, V1, P1; Nakaya M, 2002, PLANT CELL PHYSIOL, V43, P239, DOI 10.1093/pcp/pcf024; Neff MM, 1999, P NATL ACAD SCI USA, V96, P15316, DOI 10.1073/pnas.96.26.15316; Peters WS, 1996, BOT ACTA, V109, P264, DOI 10.1111/j.1438-8677.1996.tb00572.x; Pien S, 2001, P NATL ACAD SCI USA, V98, P11812, DOI 10.1073/pnas.191380498; Sessions A, 1999, PLANT J, V20, P259, DOI 10.1046/j.1365-313x.1999.00594.x; Symons GM, 2004, PLANT PHYSIOL, V135, P2196, DOI 10.1104/pp.104.043034; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Tsukaya H, 2006, ANNU REV PLANT BIOL, V57, P477, DOI 10.1146/annurev.arplant.57.032905.105320; Turk EM, 2003, PLANT PHYSIOL, V133, P1643, DOI 10.1104/pp.103.030882; Turner S, 2003, ARABIDOPSIS BOOK, pe0073, DOI 10.1199/tab.0073; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3	26	309	321	2	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2007	446	7132					199	202		10.1038/nature05618	http://dx.doi.org/10.1038/nature05618			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17344852				2022-12-01	WOS:000244718100043
J	Hinson, JT; Fantin, VR; Schonberger, J; Breivik, N; Siem, G; McDonough, B; Sharma, P; Keogh, I; Godinho, R; Santos, F; Esparza, A; Nicolau, Y; Selvaag, E; Cohen, BH; Hoppel, CL; Tranebjaerg, L; Eavey, RD; Seidman, JG; Seidman, CE				Hinson, J. Travis; Fantin, Valeria R.; Schoenberger, Jost; Breivik, Noralv; Siem, Geir; McDonough, Barbara; Sharma, Pankaj; Keogh, Ivan; Godinho, Ricardo; Santos, Felipe; Esparza, Alfonso; Nicolau, Yamileth; Selvaag, Edgar; Cohen, Bruce H.; Hoppel, Charles L.; Tranebjaerg, Lisbeth; Eavey, Roland D.; Seidman, J. G.; Seidman, Christine E.			Missense mutations in the BCS1L gene as a cause of the Bjornstad syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MITOCHONDRIAL RESPIRATORY-CHAIN; SENSORINEURAL HEARING-LOSS; LETHAL METABOLIC-DISORDER; PILI TORTI; GRACILE SYNDROME; IRON OVERLOAD; PROTEIN; COMPLEX; MEMBRANE; DISEASE	Background: The Bjornstad syndrome, an autosomal recessive disorder associated with sensorineural hearing loss and pili torti, is caused by mutation of a previously unidentified gene on chromosome 2q34-36. Methods: Refined genetic mapping and DNA sequencing of 44 genes between D2S2210 and D2S2244 revealed BCS1L mutations. Functional analyses elucidated how BCS1L mutations cause the Bjornstad syndrome. Results: BCS1L encodes a member of the AAA family of ATPases that is necessary for the assembly of complex III in the mitochondria. In addition to the Bjornstad syndrome, BCS1L mutations cause complex III deficiency and the GRACILE syndrome, which in neonates are lethal conditions that have multisystem and neurologic manifestations typifying severe mitochondrial disorders. Patients with the Bjornstad syndrome have mutations that alter residues involved in protein-protein interactions, whereas mutations in patients with complex III deficiency alter ATP-binding residues, as deduced from the crystal structure of a related AAA-family ATPase. Biochemical studies provided evidence to support this model: complex III deficiency mutations prevented ATP-dependent assembly of BCS1L-associated complexes. All mutant BCS1L proteins disrupted the assembly of complex III, reduced the activity of the mitochondrial electron-transport chain, and increased the production of reactive oxygen species. However, only mutations associated with complex III deficiency increased mitochondrial content, which further increased the production of reactive oxygen species. Conclusions: BCS1L mutations cause disease phenotypes ranging from highly restricted pili torti and sensorineural hearing loss (the Bjornstad syndrome) to profound multisystem organ failure (complex III deficiency and the GRACILE syndrome). All BCS1L mutations disrupted the assembly of mitochondrial respirasomes (the basic unit for respiration in human mitochondria), but the clinical expression of the mutations was correlated with the production of reactive oxygen species. Mutations that cause the Bjornstad syndrome illustrate the exquisite sensitivity of ear and hair tissues to mitochondrial function, particularly to the production of reactive oxygen species.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Univ Hosp Wurzburg, Wurzburg, Germany; Inst Clin Biochem & Pathobiochem, Wurzburg, Germany; Aalesund Hosp, Alesund, Norway; Hammersmith Hosp, London, England; Univ London Imperial Coll Sci Technol & Med, London, England; Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; Pontificia Univ Catholica Minas Gerais, Belo Horizonte, MG, Brazil; Univ Washington, Seattle, WA 98195 USA; Bispebjerg Hosp, DK-2400 Copenhagen, Denmark; Cleveland Clin, Brain Tumor Inst, Cleveland, OH 44106 USA; Louis Stokes Vet Affairs Med Ctr, Cleveland, OH USA; Univ Copenhagen, Inst Med Biochem & Genet, Copenhagen, Denmark; Univ Tromso Hosp, N-9012 Tromso, Norway	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Wurzburg; Imperial College London; Imperial College London; Harvard University; Massachusetts Eye & Ear Infirmary; Pontificia Universidade Catolica de Minas Gerais; University of Washington; University of Washington Seattle; University of Copenhagen; Bispebjerg Hospital; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; University of Copenhagen; UiT The Arctic University of Tromso; University Hospital of North Norway	Seidman, CE (corresponding author), Harvard Univ, Sch Med, Dept Genet, Room 256 NRB,77 Ave Louis Pasteur, Boston, MA 02115 USA.	cseidman@genetics.med.harvard.edu	KEOGH, IVAN J/M-2704-2016	KEOGH, IVAN J/0000-0001-6358-6377; Santos, Felipe/0000-0002-3523-665X				Armstrong JS, 2004, J BIOL CHEM, V279, P50420, DOI 10.1074/jbc.M408882200; Bodemer C, 1999, PEDIATRICS, V103, P428, DOI 10.1542/peds.103.2.428; *CEL GEN, 2005, CEL DISC SYST; Cruciat CM, 1999, EMBO J, V18, P5226, DOI 10.1093/emboj/18.19.5226; de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706; Fellman V, 2002, BLOOD CELL MOL DIS, V29, P444, DOI 10.1006/bcmd.2002.0582; Folsch H, 1996, EMBO J, V15, P479, DOI 10.1002/j.1460-2075.1996.tb00380.x; Frickey T, 2004, J STRUCT BIOL, V146, P2, DOI 10.1016/j.jsb.2003.11.020; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; HILL JE, 1986, YEAST, V2, P13; KREGEL KC, IN PRESS AM J PHYSL; Lefebvre PP, 2002, AUDIOL NEURO-OTOL, V7, P165, DOI 10.1159/000058304; Lesnefsky EJ, 2004, J BIOL CHEM, V279, P47961, DOI 10.1074/jbc.M409720200; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; *NAT HUM GEN RES I, 2005, DBSNP DAT SINGL NUCL; Neto JFL, 1998, AM J HUM GENET, V62, P1107, DOI 10.1086/301837; NOBREGA FG, 1992, EMBO J, V11, P3821, DOI 10.1002/j.1460-2075.1992.tb05474.x; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Petruzzella V, 1998, GENOMICS, V54, P494, DOI 10.1006/geno.1998.5580; Puchowicz MA, 2004, MITOCHONDRION, V4, P377, DOI 10.1016/j.mito.2004.07.004; Ronchese F, 1932, ARCH DERMATOL SYPH, V26, P98, DOI 10.1001/archderm.1932.01450030101015; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schagger H, 2001, J BIOL CHEM, V276, P37861; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Selvaag E, 2000, EUR J DERMATOL, V10, P91; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; Stan T, 2003, MOL CELL BIOL, V23, P2239, DOI 10.1128/MCB.23.7.2239-2250.2003; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Visapaa I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773; WALKER B, 1994, PROTEIN ENG, V7, P91, DOI 10.1093/protein/7.1.91; Wenchich L, 2003, PHYSIOL RES, V52, P781; Yamada K, 2001, P NATL ACAD SCI USA, V98, P1442, DOI 10.1073/pnas.031470598; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	33	135	143	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2007	356	8					809	819		10.1056/NEJMoa055262	http://dx.doi.org/10.1056/NEJMoa055262			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137XQ	17314340				2022-12-01	WOS:000244326700007
J	Tyson, JJ				Tyson, John J.			Bringing cartoons to life	NATURE			English	Editorial Material									Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Tyson, JJ (corresponding author), Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA.		Tyson, John J/A-2942-2014	Tyson, John J/0000-0001-7560-6013				Goldbeter A., 1996, BIOCH OSCILLATIONS C; Legewie S, 2006, PLOS COMPUT BIOL, V2, P1061, DOI 10.1371/journal.pcbi.0020120; Locke JCW, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100018; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016	4	21	21	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					823	823		10.1038/445823a	http://dx.doi.org/10.1038/445823a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	138CR	17314960				2022-12-01	WOS:000244341200024
J	Prytkova, TR; Kurnikov, IV; Beratan, DN				Prytkova, Tatiana R.; Kurnikov, Igor V.; Beratan, David N.			Coupling coherence distinguishes structure sensitivity in protein electron transfer	SCIENCE			English	Article							TRANSFER RATES; BIOLOGICAL MOLECULES; TRANSFER PATHWAYS; DYNAMICS; INTERFERENCE; INTERFACE; MEDIA	Quantum mechanical analysis of electron tunneling in nine thermally fluctuating cytochrome b(562) derivatives reveals two distinct protein-mediated coupling limits. A structure-insensitive regime arises for redox partners coupled through dynamically averaged multiple-coupling pathways (in seven of the nine derivatives) where heme-edge coupling leads to the multiple-pathway regime. A structure-dependent limit governs redox partners coupled through a dominant pathway (in two of the nine derivatives) where axial-ligand coupling generates the single-pathway limit and slower rates. This two-regime paradigm provides a unified description of electron transfer rates in 26 ruthenium-modified heme and blue-copper proteins, as well as in numerous photosynthetic proteins.	Duke Univ, Dept Chem & Biochem, Durham, NC 27708 USA	Duke University	Beratan, DN (corresponding author), Duke Univ, Dept Chem & Biochem, Durham, NC 27708 USA.	david.beratan@duke.edu	Beratan, David N/C-5098-2011	Beratan, David N/0000-0003-4758-8676	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048043] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM048043] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antony J, 2000, J AM CHEM SOC, V122, P1057, DOI 10.1021/ja993784t; Babini E, 2000, J AM CHEM SOC, V122, P4532, DOI 10.1021/ja994472t; Balabin IA, 2000, SCIENCE, V290, P114, DOI 10.1126/science.290.5489.114; BERATAN DN, 1991, SCIENCE, V252, P1285, DOI 10.1126/science.1656523; Daizadeh I, 1997, P NATL ACAD SCI USA, V94, P3703, DOI 10.1073/pnas.94.8.3703; Francisco WA, 2004, J AM CHEM SOC, V126, P13168, DOI 10.1021/ja046888z; Gray HB, 2003, Q REV BIOPHYS, V36, P341, DOI 10.1017/S0033583503003913; Gray HB, 2005, P NATL ACAD SCI USA, V102, P3534, DOI 10.1073/pnas.0408029102; Hoffman BM, 2005, P NATL ACAD SCI USA, V102, P3564, DOI 10.1073/pnas.0408767102; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P3640, DOI 10.1073/pnas.71.9.3640; Improta R, 2006, CHEMPHYSCHEM, V7, P1211, DOI 10.1002/cphc.200600069; Jones ML, 2002, J PHYS CHEM A, V106, P2002, DOI 10.1021/jp0133743; Kang SA, 2005, P NATL ACAD SCI USA, V102, P15465, DOI 10.1073/pnas.0505176102; Kawatsu T, 2002, J PHYS CHEM B, V106, P11356, DOI 10.1021/jp026035y; Lin JP, 2005, SCIENCE, V310, P1311, DOI 10.1126/science.1118316; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; MCLENDON G, 1992, CHEM REV, V92, P481, DOI 10.1021/cr00011a007; Nishioka H, 2005, J PHYS CHEM B, V109, P1978, DOI 10.1021/jp046282x; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Prytkova TR, 2007, P NATL ACAD SCI USA, V104, P802, DOI 10.1073/pnas.0605319104; Prytkova TR, 2005, J PHYS CHEM B, V109, P1618, DOI 10.1021/jp0457491; Ramirez BE, 1995, P NATL ACAD SCI USA, V92, P11949, DOI 10.1073/pnas.92.26.11949; Regan JJ, 1999, ADV CHEM PHYS, V107, P497; Skourtis SS, 1999, ADV CHEM PHYS, V106, P377, DOI 10.1002/9780470141656.ch8; Skourtis SS, 2005, P NATL ACAD SCI USA, V102, P3552, DOI 10.1073/pnas.0409047102; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; STUCHEBRUKHOV AA, 1995, J PHYS CHEM-US, V99, P7581, DOI 10.1021/j100019a044; Tan ML, 2004, BIOPHYS J, V86, P1813, DOI 10.1016/S0006-3495(04)74248-4; Troisi A, 2003, J CHEM PHYS, V119, P5782, DOI 10.1063/1.1601600; van Amsterdam IMC, 2002, NAT STRUCT BIOL, V9, P48, DOI 10.1038/nsb736; Winkler JR, 1999, PURE APPL CHEM, V71, P1753, DOI 10.1351/pac199971091753; Zheng YJ, 2003, J PHYS CHEM B, V107, P7288, DOI 10.1021/jp027092u; [No title captured]	33	158	159	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2007	315	5812					622	625		10.1126/science.1134862	http://dx.doi.org/10.1126/science.1134862			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272715	Green Accepted, Green Published			2022-12-01	WOS:000243909400036
J	Guo, DG; Tan, YC; Wang, DW; Madhusoodanan, KS; Zheng, Y; Maack, T; Zhang, JJ; Huang, XY				Guo, Dagang; Tan, Ying-cai; Wang, Dawei; Madhusoodanan, K. S.; Zheng, Yi; Maack, Thomas; Zhang, J. Jillian; Huang, Xin-Yun			A Rac-cGMP signaling pathway	CELL			English	Article							GUANYLATE-CYCLASE ACTIVITY; CYCLIC-GMP; KINASE; ACTIVATION; GROWTH; PAK1; MEMBRANE; RECEPTOR; COMPLEX; ORGANIZATION	The small GTPase Rac and the second messenger cGMP (guanosine 3',5'-cyclic monophosphate) are critical regulators of diverse cell functions. When activated by extracellular signals via membrane signaling receptors, Rac executes its functions through engaging downstream effectors such as p21-activated kinase (PAK), a serine/threonine protein kinase. However, the molecular mechanism by which membrane signaling receptors regulate cGMP levels is not known. Here we have uncovered a signaling pathway linking Rac to the increase of cellular cGMP. We show that Rac uses PAK to directly activate transmembrane guanylyl cyclases (GCs), leading to increased cellular cGMP levels. This Rac/PAK/GC/cGMP pathway is involved in platelet-derived growth factor-induced fibroblast cell migration and lamellipodium formation. Our findings connect two important regulators of cellular physiological functions and provide a general mechanism for diverse receptors to modulate physiological responses through elevating cellular cGMP levels.	Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10021 USA; Univ Cincinnati, Childrens Hosp, Res Fdn, Div Expt Hematol, Cincinnati, OH 45229 USA	Cornell University; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Huang, XY (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10021 USA.	xyhuang@med.cornell.edu	Maack, Thomas/AAN-7878-2020; Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084191, R01GM056904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014563, R01AG023202] Funding Source: NIH RePORTER; NIA NIH HHS [AG23202, R01 AG014563, AG14563, R01 AG023202] Funding Source: Medline; NIGMS NIH HHS [R01 GM056904, R01 GM084191, GM56904] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ayoob JC, 2004, J NEUROSCI, V24, P6639, DOI 10.1523/JNEUROSCI.1104-04.2004; BENTLEY JK, 1986, CELL, V45, P281, DOI 10.1016/0092-8674(86)90392-2; Birnby DA, 2000, GENETICS, V155, P85; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bosgraaf L, 2002, EMBO J, V21, P4560, DOI 10.1093/emboj/cdf438; Carter JH, 2004, CLIN CANCER RES, V10, P3448, DOI 10.1158/1078-0432.CCR-03-0210; COFFEY RG, 1988, J IMMUNOL, V140, P2695; Daniels RH, 1998, EMBO J, V17, P754, DOI 10.1093/emboj/17.3.754; Elferink JGR, 1996, GEN PHARMACOL-VASC S, V27, P387, DOI 10.1016/0306-3623(95)00070-4; ESTENSEN RD, 1973, NATURE, V245, P458, DOI 10.1038/245458a0; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Frost JA, 1998, J BIOL CHEM, V273, P28191, DOI 10.1074/jbc.273.43.28191; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Hou YL, 2004, CELL SIGNAL, V16, P1061, DOI 10.1016/j.cellsig.2004.03.002; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lowry WE, 2002, DEV CELL, V2, P733, DOI 10.1016/S1534-5807(02)00175-2; Lucas KA, 2000, PHARMACOL REV, V52, P375; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; MANEER E, 1997, MOL CELL BIOL, V17, P1129; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; SCHEVING LA, 1985, ENDOCRINOLOGY, V116, P332, DOI 10.1210/endo-116-1-332; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Schmidt H, 2002, J CELL BIOL, V159, P489, DOI 10.1083/jcb.200207058; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Shan DD, 2005, P NATL ACAD SCI USA, V102, P3772, DOI 10.1073/pnas.0500658102; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Vadlamudi RK, 2000, J BIOL CHEM, V275, P36238, DOI 10.1074/jbc.M002138200; Wan Y, 1996, NATURE, V380, P541, DOI 10.1038/380541a0; Yang SY, 2005, J BIOL CHEM, V280, P27130, DOI 10.1074/jbc.M501625200; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	44	81	87	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2007	128	2					341	355		10.1016/j.cell.2006.11.048	http://dx.doi.org/10.1016/j.cell.2006.11.048			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254971	Green Accepted, Bronze			2022-12-01	WOS:000244420500018
J	Braiteh, F; Cohen, PR; Kurzrock, R				Braiteh, Fadi; Cohen, Philip R.; Kurzrock, Razelle			CAT scan reveals BAT sign	LANCET			English	Editorial Material									Univ Texas, MD Anderson Canc Ctr, Div Canc Med, Phase Program 1, Houston, TX 77030 USA; Univ Texas, Houston Med Sch, Dept Dermatol, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Braiteh, F (corresponding author), Univ Texas, MD Anderson Canc Ctr, Div Canc Med, Phase Program 1, 1515 Holcombe Blvd, Houston, TX 77030 USA.	fbraiteh@mdanderson.org	Kurzrock, Razelle/AAU-9782-2020					[Anonymous], 2005, GRAYS ANATOMY ANATOM, V39th; Rogers LF, 2003, AM J ROENTGENOL, V180, P1501, DOI 10.2214/ajr.180.6.1801501	2	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 20	2007	369	9557					217	217		10.1016/S0140-6736(07)60110-X	http://dx.doi.org/10.1016/S0140-6736(07)60110-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	128XG	17240288				2022-12-01	WOS:000243692400030
J	Wolfson, LJ; Strebel, PM; Gacic-Dobo, M; Hoekstra, EJ; McFarland, JW; Hersh, BS				Wolfson, Lara J.; Strebel, Peter M.; Gacic-Dobo, Marta; Hoekstra, Edward J.; McFarland, Jeffrey W.; Hersh, Bradley S.		Measles Initiative	Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study	LANCET			English	Article							UPPER RIVER DIVISION; CHILD-MORTALITY; RESPIRATORY-INFECTIONS; VACCINATION CAMPAIGN; CASE-FATALITY; RURAL AREA; DEATHS; ERADICATION; COMMUNITY; OUTBREAK	Background In 2002, the UN General Assembly Special Session on Children adopted a goal to reduce deaths owing to measles by half by the end of 2005, compared with 1999 estimates. We describe efforts and progress made towards this goal. Methods We assessed trends in immunisation against measles on the basis of national implementation of the WHO/UNICEF comprehensive strategy for measles mortality reduction, and the provision of a second opportunity for measles immunisation. We used a natural history model to evaluate trends in mortality due to measles. Results Between 1999 and 2005, according to our model mortality owing to measles was reduced by 60%, from an estimated 873 000 deaths (uncertainty bounds 634000-1140 000) in 1999 to 345 000 deaths (247 000-458 000) in 2005. The largest percentage reduction in estimated measles mortality during this period was in the western Pacific region (81%), followed by Africa (75%) and the eastern Mediterranean region (62%). Africa achieved the largest total reduction, contributing 72% of the global reduction in measles mortality. Nearly 7.5 million deaths from measles were prevented through immunisation between 1999 and 2005, with supplemental immunisation activities and improved routine immunisation accounting for 2.3 million of these prevented deaths. Interpretation The achievement of the 2005 global measles mortality reduction goal is evidence of what can be accomplished for child survival in countries with high childhood mortality when safe, cost-effective, and affordable interventions are backed by country-level political commitment and an effective international partnership.	WHO, Initiat Vaccine Res, CH-1211 Geneva 27, Switzerland; WHO, Dept Immunisat Vaccines & Biol, CH-1211 Geneva 27, Switzerland; UNICEF, New York, NY USA; US Ctr Dis Control & Prevent, Phnom Penh, Cambodia	World Health Organization; World Health Organization; UNICEF	Wolfson, LJ (corresponding author), WHO, Initiat Vaccine Res, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	wolfsonl@who.int	Wolfson, Lara/AAC-1400-2019	Wolfson, Lara/0000-0002-6454-3368				ANDERSON R M, 1991; ANDERSON RM, 1983, J HYG-CAMBRIDGE, V90, P259, DOI 10.1017/S002217240002893X; ANDERSON RM, 1985, J HYG-CAMBRIDGE, V94, P365, DOI 10.1017/S002217240006160X; [Anonymous], 2004, Wkly Epidemiol Rec, V79, P130; [Anonymous], WHO UNICEF EST NAT I; Antunes JLF, 2002, B WORLD HEALTH ORGAN, V80, P391; ASSAAD F, 1983, REV INFECT DIS, V5, P452; ATKINSON WL, 1991, SEMIN PEDIATR INFECT, V2, P100; Awasthi Shally, 1996, Indian Journal of Pediatrics, V63, P363, DOI 10.1007/BF02751529; BAGENHOLM GC, 1989, ANN TROP PAEDIATR, V9, P75, DOI 10.1080/02724936.1989.11748602; BANG AT, 1990, LANCET, V336, P201, DOI 10.1016/0140-6736(90)91733-Q; Baqui AH, 1998, B WORLD HEALTH ORGAN, V76, P161; Baqui AH, 2001, ACTA PAEDIATR, V90, P682, DOI 10.1080/080352501750258775; BARCLAY AJG, 1987, BMJ-BRIT MED J, V294, P296; BARKIN RM, 1975, AM J EPIDEMIOL, V102, P341, DOI 10.1093/oxfordjournals.aje.a112170; BHATIA S, 1989, STUD FAMILY PLANN, V20, P136, DOI 10.2307/1966568; BHUIYA A, 1987, SOC SCI MED, V24, P439, DOI 10.1016/0277-9536(87)90217-6; Bilous J, 2006, LANCET, V367, P1464, DOI 10.1016/S0140-6736(06)68625-X; BLACK FL, 1959, J IMMUNOL, V83, P74; Brenzel L, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P389; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; BURSTROM B, 1993, SCAND J INFECT DIS, V25, P763, DOI 10.3109/00365549309008576; CHEN RT, 1994, INT J EPIDEMIOL, V23, P185, DOI 10.1093/ije/23.1.185; CHOUDHARY S R, 1989, Indian Pediatrics, V26, P544; Christensen R., 1990, LOG LINEAR MODELS; CLEMENS JD, 1988, AM J EPIDEMIOL, V128, P1330, DOI 10.1093/oxfordjournals.aje.a115086; Clements C. J., 2004, GLOBAL EPIDEMIOLOGY; CUTTS FT, 1995, BIOLOGICALS, V23, P95; de Quadros CA, 2004, B WORLD HEALTH ORGAN, V82, P134; de Quadros CA, 2004, J INFECT DIS, V189, pS227, DOI 10.1086/377741; DEFRANCISCO A, 1993, ANN TROP PAEDIATR, V13, P345, DOI 10.1080/02724936.1993.11747669; degli Atti MLC, 2006, VACCINE, V24, P1332, DOI 10.1016/j.vaccine.2005.09.031; deQuadros CA, 1996, JAMA-J AM MED ASSOC, V275, P224, DOI 10.1001/jama.275.3.224; Dowdle W R, 1998, Bull World Health Organ, V76 Suppl 2, P22; EKANEM EE, 1994, TROP GEOGR MED, V46, P305; FAUVEAU V, 1991, INT J EPIDEMIOL, V20, P729, DOI 10.1093/ije/20.3.729; *GAVI, IFFIM PROGR OV; GESSNER BD, 1994, JAMA-J AM MED ASSOC, V272, P382, DOI 10.1001/jama.272.5.382; Gounder C, 1998, HEALTH POLICY PLANN, V13, P212, DOI 10.1093/heapol/13.3.212; Grabowsky M, 2005, TROP MED INT HEALTH, V10, P1151, DOI 10.1111/j.1365-3156.2005.01502.x; Hammersley J.M., 1964, MONTE CARLO METHODS; Hedrich AW, 1933, AM J HYG, V17, P613, DOI 10.1093/oxfordjournals.aje.a117929; Henao-Restrepo AM, 2003, J INFECT DIS, V187, pS15, DOI 10.1086/368273; HETHCOTE HW, 1995, MODELS INFECTIOUS HU, P215; HINMAN AR, 1982, REV INFECT DIS, V4, P933; Hirve S, 1997, Indian Pediatr, V34, P995; Hodges M, 1998, West Afr J Med, V17, P95; HOPKINS DR, 1982, LANCET, V1, P1396; Hussain A, 1999, TROP MED INT HEALTH, V4, P758, DOI 10.1046/j.1365-3156.1999.00485.x; Jaffar S, 1997, TROP MED INT HEALTH, V2, P28, DOI 10.1046/j.1365-3156.1997.d01-131.x; Kabir Z, 2002, J TROP PEDIATRICS, V48, P178, DOI 10.1093/tropej/48.3.178; Kadane JB, 1998, J ROY STAT SOC D-STA, V47, P3; Kahn K, 1999, TROP MED INT HEALTH, V4, P433, DOI 10.1046/j.1365-3156.1999.00415.x; KEJA K, 1988, World Health Statistics Quarterly, V41, P59; KHAN AJ, 1990, B WORLD HEALTH ORGAN, V68, P577; LANGMUIR AD, 1962, AM J DIS CHILD, V103, P224, DOI 10.1001/archpedi.1962.02080020236005; Lindsey J.K., 2000, APPL GEN LINEAR MODE; McCullagh P, 2019, GEN LINEAR MODELS; *MEASL PARTN, 2005, MEASL INV CAS 2; Meissner HC, 2004, PEDIATRICS, V114, P1065, DOI 10.1542/peds.2004-0440; MIRZA NM, 1990, E AFR MED J, V67, P823; MOLBAK K, 1992, T ROY SOC TROP MED H, V86, P216, DOI 10.1016/0035-9203(92)90580-6; Morris SS, 2003, INT J EPIDEMIOL, V32, P1041, DOI 10.1093/ije/dyg241; Orenstein WA, 2000, AM J PUBLIC HEALTH, V90, P1521, DOI 10.2105/AJPH.90.10.1521; Otten M, 2005, LANCET, V366, P832, DOI 10.1016/S0140-6736(05)67216-9; *PAHO, 2005, SCI TECHN PUBL PAHO, V605; PANDEY MR, 1991, LANCET, V338, P993, DOI 10.1016/0140-6736(91)91847-N; Perry Robert T., 2004, Journal of Infectious Diseases, V189, pS4, DOI 10.1086/377712; PISON G, 1993, INT J EPIDEMIOL, V22, P72, DOI 10.1093/ije/22.1.72; PREBLUD SR, 1982, JAMA-J AM MED ASSOC, V247, P1134, DOI 10.1001/jama.247.8.1134; Reddaiah V. P., 1992, Indian Journal of Pediatrics, V59, P567, DOI 10.1007/BF02832992; ROSS DA, 1993, LANCET, V342, P7, DOI 10.1016/0140-6736(93)91879-Q; Samb B, 1997, AM J EPIDEMIOL, V145, P51, DOI 10.1093/oxfordjournals.aje.a009031; SHAMEBO D, 1991, J TROP PEDIATRICS, V37, P254, DOI 10.1093/tropej/37.5.254; Slutsker L, 1996, AM J TROP MED HYG, V55, P77, DOI 10.4269/ajtmh.1996.55.77; SMEDMAN L, 1986, ANN TROP PAEDIATR, V6, P67, DOI 10.1080/02724936.1986.11748414; SNYDER MJ, 1962, AM J DIS CHILD, V103, P250, DOI 10.1001/archpedi.1962.02080020262012; SPENCER H C, 1987, Annals of Tropical Medicine and Parasitology, V81, P36; SPIKA JS, 1989, ANN TROP PAEDIATR, V9, P33, DOI 10.1080/02724936.1989.11748592; Stein CE, 2003, J INFECT DIS, V187, pS8, DOI 10.1086/368114; Stittelaar Koert J, 2002, Expert Rev Vaccines, V1, P151, DOI 10.1586/14760584.1.2.151; Strebel P, 2003, J INFECT DIS, V187, pS1, DOI 10.1086/368226; SUTRISNA B, 1993, LANCET, V342, P787, DOI 10.1016/0140-6736(93)91545-W; UN, MILL DEV GOALS; UNICEF, 2002, WORLD FIT CHILDR; UNPD, 2005, WORLD POP PROSP 2004; VANDENBROECK J, 1993, LANCET, V341, P1491, DOI 10.1016/0140-6736(93)90632-Q; *WHO, 1974, HDB RES, V1, P1; *WHO, 2006, WKLY EPIDEMIOL REC, V81, P365; *WHO, 2003, 5220 WHO; *WHO, 2002, STAT WORLDS VACC IMM; *WHO, 2005, WHO VACC PREV DIS MO; *WHO UNICEF, 2005, GLOB IMM VIS STRAT; WHO (World Health Organization), 2004, WKLY EPIDEMIOL REC; World Health Organization, MEASL REP CAS; World Health Organization United Nations Children's Fund, 2001, MEASL MORT RED REG E; World Health Organization (WHO), 2005, WORLD HLTH REP 2005; Yameogo KR, 2005, INT J EPIDEMIOL, V34, P556, DOI 10.1093/ije/dyi001	98	180	189	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 20	2007	369	9557					191	200		10.1016/S0140-6736(07)60107-X	http://dx.doi.org/10.1016/S0140-6736(07)60107-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	128XG	17240285				2022-12-01	WOS:000243692400027
J	Mason, MF; Norton, MI; Van Horn, JD; Wegner, DM; Grafton, ST; Macrae, CN				Mason, Malia F.; Norton, Michael I.; Van Horn, John D.; Wegner, Daniel M.; Grafton, Scott T.; Macrae, C. Neil			Wandering minds: The default network and stimulus-independent thought	SCIENCE			English	Article							BRAIN ACTIVITY; MEMORY; CONSCIOUSNESS; SELF; MODE; FMRI	Despite evidence pointing to a ubiquitous tendency of human minds to wander, little is known about the neural operations that support this core component of human cognition. Using both thought sampling and brain imaging, the current investigation demonstrated that mind-wandering is associated with activity in a default network of cortical regions that are active when the brain is "at rest." In addition, individuals' reports of the tendency of their minds to wander were correlated with activity in this network.	Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; Harvard Univ, Harvard Business Sch, Boston, MA 02163 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; Univ Aberdeen, Sch Psychol, Aberdeen AB24 2UB, Scotland	Dartmouth College; Harvard University; Harvard University; University of Aberdeen	Mason, MF (corresponding author), Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA.	malia@nmr.mgh.harvard.edu	Macrae, Neil/C-4761-2008; Kennedy, Kristen M/B-4699-2008	Kennedy, Kristen M/0000-0001-5373-9026; Van Horn, John Darrell/0000-0003-1537-0816	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033504] Funding Source: NIH RePORTER; NIMH NIH HHS [MH49127] Funding Source: Medline; NINDS NIH HHS [R01 NS050614, R01 NS033504] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANTROBUS JS, 1966, PERCEPT MOTOR SKILL, V23, P399, DOI 10.2466/pms.1966.23.2.399; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Cabeza R, 2004, J COGNITIVE NEUROSCI, V16, P1583, DOI 10.1162/0898929042568578; Christoff K, 2004, CORTEX, V40, P623, DOI 10.1016/S0010-9452(08)70158-8; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; DAMASIO AR, 1983, NEUROPSYCHOLOGY HUMA, P85; GIAMBRA LM, 1989, PSYCHOL AGING, V4, P136, DOI 10.1037/0882-7974.4.2.136; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Klinger E., 1971, STRUCTURE FUNCTIONS; Maguire EA, 2001, PHILOS T R SOC B, V356, P1441, DOI 10.1098/rstb.2001.0944; McGuire PK, 1996, NEUROREPORT, V7, P2095; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Schooler JW, 2004, THINKING AND SEEING, P203; Schooler JW, 2002, TRENDS COGN SCI, V6, P339, DOI 10.1016/S1364-6613(02)01949-6; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Singer J. L., 1972, FUNCTION NATURE IMAG, P175; SINGER JL, 1962, INT J SOC PSYCHIATR, V8, P272, DOI 10.1177/002076406200800404; Singer JL., 1966, DAYDREAMING; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; TEASDALE JD, 1995, MEM COGNITION, V23, P551, DOI 10.3758/BF03197257; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Wegner DM, 1997, CARN S COGN, P295	27	1855	1894	7	358	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 19	2007	315	5810					393	395		10.1126/science.1131295	http://dx.doi.org/10.1126/science.1131295			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	126SI	17234951	Green Submitted, Green Accepted			2022-12-01	WOS:000243535400047
J	Lohse, N; Hansen, ABE; Pedersen, G; Kronborg, G; Gerstoft, J; Sorensen, HT; Vaeth, M; Obel, N				Lohse, Nicolai; Hansen, Ann-Brit Eg; Pedersen, Gitte; Kronborg, Gifte; Gerstoft, Jan; Sorensen, Henrik Toft; Vaeth, Michael; Obel, Niels			Survival of persons with and without HIV infection in Denmark, 1995-2005	ANNALS OF INTERNAL MEDICINE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; ALL-CAUSE MORTALITY; GENERAL-POPULATION; COHORT; INDIVIDUALS; DEMOGRAPHICS; EUROSIDA; DEATH; RISK	Background: The expected survival of HIV-infected patients is of major public health interest. Objective: To estimate survival time and age-specific mortality rates of an HIV-infected population compared with that of the general population. Design: Population-based cohort study. Setting: All HIV-infected persons receiving care in Denmark from 1995 to 2005. Patients: Each member of the nationwide Danish HIV Cohort Study was matched with as many as 99 persons from the general population according to sex, date of birth, and municipality of residence. Measurements: The authors computed Kaplan-Meier life tables with age as the time scale to estimate survival from age 25 years. Patients with HIV infection and corresponding persons from the general population were observed from the date of the patient's HIV diagnosis until death, emigration, or 1 May 2005. Results: 3990 HIV-infected patients and 379 872 persons from the general population were included in the study, yielding 22 744 (median, 5.8 y/person) and 2 689 287 (median, 8.4 years/person) person-years of observation. Three percent of participants were lost to follow-up. From age 25 years, the median survival was 19.9 years (95% CI, 18.5 to 21.3) among patients with HIV infection and 51.1 years (CI, 50.9 to 51.5) among the general population. For HIV-infected patients, survival increased to 32.5 years (CI, 29.4 to 34.7) during the 2000 to 2005 period. In the subgroup that excluded persons with known hepatitis C coinfection (16%), median survival was 38.9 years (CI, 35.4 to 40.1) during this same period. The relative mortality rates for patients with HIV infection compared with those for the general population decreased with increasing age, whereas the excess mortality rate increased with increasing age. Limitations: The observed mortality rates are assumed to apply beyond the current maximum observation time of 10 years. Conclusions: The estimated median survival is more than 35 years for a young person diagnosed with HIV infection in the late highly active antiretroviral therapy era. However, an ongoing effort is still needed to further reduce mortality rates for these persons compared with the general population.	Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense C, Denmark; Univ So Denmark, Odense, Denmark; Aarhus Univ Hosp, DK-8000 Aarhus, Denmark; Univ Aarhus, Aarhus, Denmark; Hvidovre Univ Hosp, Hvidovre, Denmark; Rigshosp, DK-2100 Copenhagen, Denmark; Boston Univ, Boston, MA 02215 USA	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Aarhus University; Aarhus University; University of Copenhagen; Rigshospitalet; University of Copenhagen; Boston University	Lohse, N (corresponding author), Odense Univ Hosp, Dept Infect Dis, Sdr Blvd 29, DK-5000 Odense C, Denmark.	nl@dce.au.dk	Hansen, Ann-Brit/ABA-1921-2020; Lohse, Nicolai/ABE-5884-2020; Kronborg, Gitte/E-4757-2010; Sorensen, Henrik Toft/Z-6181-2019; Vaeth, Michael/T-6882-2017	Sorensen, Henrik Toft/0000-0003-4299-7040; Vaeth, Michael/0000-0002-0134-5006; Lohse, Nicolai/0000-0001-8403-8759; Hansen, Ann-Brit Eg/0000-0003-4228-3822				Braithwaite RS, 2005, AM J MED, V118, P890, DOI 10.1016/j.amjmed.2004.12.034; Christensen P B, 1998, Ugeskr Laeger, V160, P3529; Dorrucci M, 2005, AIDS, V19, P331; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Galvan FH, 2002, J STUD ALCOHOL, V63, P179, DOI 10.15288/jsa.2002.63.179; Jaggy C, 2003, LANCET, V362, P877, DOI 10.1016/S0140-6736(03)14307-3; Jensen-Fangel S, 2004, AIDS, V18, P89, DOI 10.1097/00002030-200401020-00011; Jensen-Fangel S, 2001, SCAND J INFECT DIS, V33, P765, DOI 10.1080/003655401317074590; Keiser O, 2004, AIDS, V18, P1835, DOI 10.1097/00002030-200409030-00013; Laing SP, 1999, DIABETIC MED, V16, P459, DOI 10.1046/j.1464-5491.1999.00075.x; Lohse N, 2005, AIDS, V19, P815, DOI 10.1097/01.aids.0000168976.51843.9f; Lohse N, 2005, SCAND J INFECT DIS, V37, P338, DOI 10.1080/00365540510031692; Lohse N, 2004, SCAND J INFECT DIS, V36, P738, DOI 10.1080/00365540410020974a; Lundgren JD, 2002, J INFECT DIS, V185, P178, DOI 10.1086/338267; Mamary EM, 2002, AIDS PATIENT CARE ST, V16, P39, DOI 10.1089/108729102753429389; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; *NAT CTR HLTH STAT, 2002, UN STAT LIF TABL; Press N, 2002, JAIDS-J ACQ IMM DEF, V31, pS112, DOI 10.1097/00126334-200212153-00005; Saves M, 2003, CLIN INFECT DIS, V37, P292, DOI 10.1086/375844; van Sighem A, 2005, JAIDS-J ACQ IMM DEF, V40, P212, DOI 10.1097/01.qai.0000165911.97085.d0; Zwahlen M, 2005, INT J EPIDEMIOL, V34, P130, DOI 10.1093/ije./dyh402	21	561	589	0	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2007	146	2					87	95		10.7326/0003-4819-146-2-200701160-00003	http://dx.doi.org/10.7326/0003-4819-146-2-200701160-00003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131WF	17227932				2022-12-01	WOS:000243901000002
J	Wallace, HAC; Marques-Kranc, F; Richardson, M; Luna-Crespo, F; Sharpe, JA; Hughes, J; Wood, WG; Higgs, DR; Smith, AJH				Wallace, Helen A. C.; Marques-Kranc, Fatima; Richardson, Melville; Luna-Crespo, Francisco; Sharpe, Jackie A.; Hughes, Jim; Wood, William G.; Higgs, Douglas R.; Smith, Andrew J. H.			Manipulating the mouse genome to engineer precise functional syntenic replacements with human sequence	CELL			English	Article							EMBRYONIC STEM-CELLS; BACTERIAL ARTIFICIAL CHROMOSOMES; GENE-EXPRESSION; ES CELLS; REGULATORY ELEMENTS; GLOBIN CLUSTER; RECOMBINATION; DNA; MICE; IDENTIFICATION	We have devised a strategy (called recombinase-mediated genomic replacement, RMGR) to allow the replacement of large segments (> 100 kb) of the mouse genome with the equivalent human syntenic region. The technique involves modifying a mouse ES cell chromosome and a human BAC by inserting heterotypic lox sites to flank the proposed exchange interval and then using Cre recombinase to achieve segmental exchange. We have demonstrated the feasibility of this approach by replacing the mouse alpha globin regulatory domain with the human syntenic region and generating homozygous mice that produce only human a globin chains. Furthermore, modified ES cells can be used iteratively for functional studies, and here, as an example, we have used RMGR to produce an accurate mouse model of human alpha thalassemia. RMGR has general applicability and will overcome limitations inherent in current transgenic technology when studying the expression of human genes and modeling human genetic diseases.	Univ Edinburgh, Inst Stem Cell Res, Edinburgh EH9 3JQ, Midlothian, Scotland; Univ Oxford, John Radcliffe Hosp, MRC, Weatherall Inst Mol Med,Mol Haematol Unit, Oxford OX3 9DS, England	University of Edinburgh; University of Oxford	Smith, AJH (corresponding author), Univ Edinburgh, Inst Stem Cell Res, Kings Bldg,W Mains Rd, Edinburgh EH9 3JQ, Midlothian, Scotland.	andrew.smith@ed.ac.uk		Higgs, Douglas/0000-0003-3579-8705	Medical Research Council [G0300058B] Funding Source: researchfish; MRC [MC_U137961145, MC_U137961144] Funding Source: UKRI; Medical Research Council [MC_U137961145, MC_U137961144] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alami R, 2000, HUM MOL GENET, V9, P631, DOI 10.1093/hmg/9.4.631; Anguita E, 2004, EMBO J, V23, P2841, DOI 10.1038/sj.emboj.7600274; Anguita E, 2002, BLOOD, V100, P3450, DOI 10.1182/blood-2002-05-1409; Anguita E, 2001, P NATL ACAD SCI USA, V98, P12114, DOI 10.1073/pnas.201413098; Baer A, 2001, CURR OPIN BIOTECH, V12, P473, DOI 10.1016/S0958-1669(00)00248-2; Behringer R., 2003, MANIPULATING MOUSE E; Belteki G, 2003, NAT BIOTECHNOL, V21, P321, DOI 10.1038/nbt787; Bethke B, 1997, NUCLEIC ACIDS RES, V25, P2828, DOI 10.1093/nar/25.14.2828; Brown JM, 2006, J CELL BIOL, V172, P177, DOI 10.1083/jcb.200507073; COLLEDGE WH, 1995, NAT GENET, V10, P445, DOI 10.1038/ng0895-445; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; De Gobbi M, 2006, SCIENCE, V312, P1215, DOI 10.1126/science.1126431; Engle SJ, 1996, HUM MOL GENET, V5, P1607, DOI 10.1093/hmg/5.10.1607; Flint J, 1997, NAT GENET, V15, P252, DOI 10.1038/ng0397-252; Flint J, 2001, HUM MOL GENET, V10, P371, DOI 10.1093/hmg/10.4.371; Garrick D, 2006, PLOS GENET, V2, P438, DOI 10.1371/journal.pgen.0020058; Higgs DR, 1998, SEMIN HEMATOL, V35, P93; Hughes JR, 2005, P NATL ACAD SCI USA, V102, P9830, DOI 10.1073/pnas.0503401102; Kaufman RM, 1999, BLOOD, V94, P3178, DOI 10.1182/blood.V94.9.3178.421k23_3178_3184; Kielman MF, 1996, GENOMICS, V32, P341, DOI 10.1006/geno.1996.0128; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; Muyrers JPP, 2001, TRENDS BIOCHEM SCI, V26, P325, DOI 10.1016/S0968-0004(00)01757-6; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; PASZTY C, 1995, NAT GENET, V11, P33, DOI 10.1038/ng0995-33; Peterson KR, 1998, HUM MOL GENET, V7, P2079, DOI 10.1093/hmg/7.13.2079; Schaft J, 2001, GENESIS, V31, P6, DOI 10.1002/gene.1076; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Shen W, 2005, MOL BIOTECHNOL, V31, P181, DOI 10.1385/MB:31:3:181; Smith AJH, 2002, ONCOGENE, V21, P4521, DOI 10.1038/sj.onc.1205530; SMITH AJH, 1995, NAT GENET, V9, P376, DOI 10.1038/ng0495-376; Testa G, 2003, NAT BIOTECHNOL, V21, P443, DOI 10.1038/nbt804; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; Yang Y, 2003, NAT BIOTECHNOL, V21, P447, DOI 10.1038/nbt803; Yu YJ, 2001, NAT REV GENET, V2, P780, DOI 10.1038/35093564	37	120	151	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 12	2007	128	1					197	209		10.1016/j.cell.2006.11.044	http://dx.doi.org/10.1016/j.cell.2006.11.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GN	17218265	Bronze			2022-12-01	WOS:000244420400023
J	Wilcken, B; Haas, M; Joy, P; Wiley, V; Chaplin, M; Black, C; Fletcher, J; McGill, J; Boneh, A				Wilcken, Bridget; Haas, Marion; Joy, Pamela; Wiley, Veronica; Chaplin, Meredyth; Black, Carly; Fletcher, Janice; McGill, Jim; Boneh, Avihu			Outcome of neonatal screening for medium-chain aryl-CoA dehydrogenase deficiency in Australia: a cohort study	LANCET			English	Article							TANDEM MASS-SPECTROMETRY; INBORN-ERRORS; CLINICAL SYMPTOMS; METABOLISM; MUTATION; IDENTIFICATION; POPULATION; EXPERIENCE; NEWBORNS	Background Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is the disorder thought most to justify neonatal screening by tandem-mass spectrometry because, without screening, there seems to be substantial morbidity and mortality. Our aim was to assess the overall effectiveness of neonatal screening for MCAD deficiency in Australia. Methods We identified MCAD-deficient patients from a total population of 2495000 Australian neonates (810000 screened) born between April 1, 1994, and March 31, 2004. Those from a cohort of 1995000 (460000 screened) were followed up for at least 4 years, and we recorded number of deaths and severe episodes, medical and neuropsychological outcome, and hospital admissions within the screened and unscreened groups. Findings In cohorts aged at least 4 years there were 35 MCAD-deficient patients in those not screened (2.28 per 100 000 total population) and 24 in the screened population (5.2 per 100000). We estimated that patients with this disorder in the unscreened cohort remained undiagnosed. Before 4 years of age, three screened patients had an episode of severe decompensation (including one neonatal death) versus 23 unscreened patients (including five deaths). At the most conservative estimate, relative risk of an adverse event was 0.44 (95% CI 0.13-1.45). In the larger cohort the relative risk (screened vs unscreened) of an adverse event by age 2 years was 0.26 (95% CI 0.07-0.97), also a conservative estimate. 38 of 52 living patients had neuropsychological testing, with no suggestions of significant differences in general cognitive outcome between the groups. Interpretation Screening is effective in patients with MCAD deficiency since early diagnosis reduces deaths and severe adverse events in children up to the age of 4 years.	Childrens Hosp Westmead, Westmead, NSW 2145, Australia; Univ Sydney, Sydney, NSW 2006, Australia; Univ Technol Sydney, Ctr Hlth Econ Res & Evaluat, Sydney, NSW 2007, Australia; Womens & Childrens Hosp, Adelaide, SA, Australia; Royal Childrens Hosp, Brisbane, Qld, Australia; Univ Melbourne, Melbourne, Vic, Australia; Murdoch Childrens Res Inst, Genet Hlth Serv Victoria, Melbourne, Vic, Australia	University of Sydney; University of Sydney; University of Technology Sydney; Womens & Childrens Hospital Australia; Royal Children's Hospital Brisbane; University of Melbourne; Murdoch Children's Research Institute	Wilcken, B (corresponding author), Childrens Hosp Westmead, Locked Bag 4001, Westmead, NSW 2145, Australia.	bridgetw@chw.edu.au	Haas, Marion Ruth/H-2732-2017					Andresen BS, 2001, AM J HUM GENET, V68, P1408, DOI 10.1086/320602; Derks TGJ, 2006, J PEDIATR-US, V148, P665, DOI 10.1016/j.jpeds.2005.12.028; Dezateux C, 2003, EUR J PEDIATR, V162, pS25, DOI 10.1007/s00431-003-1346-0; Ensenauer R, 2005, GENET MED, V7, P339, DOI 10.1097/01.GIM.0000164548.54482.9D; Frazier DM, 2006, J INHERIT METAB DIS, V29, P76, DOI 10.1007/s10545-006-0228-9; Grosse SD, 2006, GENET MED, V8, P205, DOI 10.1097/01.gim.0000204472.25153.8d; IAFOLLA AK, 1994, J PEDIATR-US, V124, P409, DOI 10.1016/S0022-3476(94)70363-9; Maier EM, 2005, HUM MUTAT, V25, P443, DOI 10.1002/humu.20163; *MAT CHILD HLTH BU, 2005, NEWB SCREEN UN SCREE; MATSUBARA Y, 1991, LANCET, V338, P552, DOI 10.1016/0140-6736(91)91110-G; Nennstiel-Ratzel U, 2005, MOL GENET METAB, V85, P157, DOI 10.1016/j.ymgme.2004.12.010; Pandor A, 2004, HEALTH TECHNOL ASSES, V8, P1; Pollitt RI, 1997, HEALTH TECHNOL ASSES, V1, pi; Pollitt RJ, 1998, ARCH DIS CHILD, V79, P116, DOI 10.1136/adc.79.2.116; Pourfarzam M, 2001, LANCET, V358, P1063, DOI 10.1016/S0140-6736(01)06199-2; ROE CR, 2005, METABOLIC MOL BASES, P2297; Schulze A, 2003, PEDIATRICS, V111, P1399, DOI 10.1542/peds.111.6.1399; SEYMOUR CA, 2001, HEALTH TECHNOL ASSES, V1, P23; Sparrow S. S., 2016, VINELAND ADAPTIVE BE; Tanaka K., 1992, Human Mutation, V1, P271, DOI 10.1002/humu.1380010402; TOUMA EH, 1992, ARCH DIS CHILD, V67, P142, DOI 10.1136/adc.67.1.142; Waddell L, 2006, MOL GENET METAB, V87, P32, DOI 10.1016/j.ymgme.2005.09.020; Waisbren SE, 2002, J INHERIT METAB DIS, V25, P599, DOI 10.1023/A:1022003726224; WILCKEN B, 1994, ARCH DIS CHILD, V70, P410, DOI 10.1136/adc.70.5.410; Wilcken B, 2003, NEW ENGL J MED, V348, P2304, DOI 10.1056/NEJMoa025225; Wiley V, 1999, ACTA PAEDIATR, V88, P48, DOI 10.1080/080352599750029376; Wilson CJ, 1999, ARCH DIS CHILD, V80, P459, DOI 10.1136/adc.80.5.459; Woodcock R. W., 2001, WOODCOCK JOHNSON; ZIADEH R, 1995, PEDIATR RES, V37, P675, DOI 10.1203/00006450-199505000-00021; Zytkovicz TH, 2001, CLIN CHEM, V47, P1945	30	117	120	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 6	2007	369	9555					37	42		10.1016/S0140-6736(07)60029-4	http://dx.doi.org/10.1016/S0140-6736(07)60029-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	125AK	17208640				2022-12-01	WOS:000243413700027
J	Hwang, HW; Wentzel, EA; Mendell, JT				Hwang, Hun-Way; Wentzel, Erik A.; Mendell, Joshua T.			A hexanucleotide element directs microRNA nuclear import	SCIENCE			English	Article							BIOGENESIS; TARGETS; SIRNAS; MIRNAS	MicroRNAs ( miRNAs) negatively regulate partially complementary target messenger RNAs. Target selection in animals is dictated primarily by sequences at the miRNA 5' end. We demonstrated that despite their small size, specific miRNAs contain additional sequence elements that control their posttranscriptional behavior, including their subcellular localization. We showed that human miR-29b, in contrast to other studied animal miRNAs, is predominantly localized to the nucleus. The distinctive hexanucleotide terminal motif of miR-29b acts as a transferable nuclear localization element that directs nuclear enrichment of miRNAs or small interfering RNAs to which it is attached. Our results indicate that miRNAs sharing common 5' sequences, considered to be largely redundant, might have distinct functions because of the influence of cis-acting regulatory motifs.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Program Human Genet & Mol Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Mendell, JT (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Program Human Genet & Mol Biol, Baltimore, MD 21205 USA.	jmendell@jhmi.edu		Hwang, Hun-Way/0000-0003-0522-1577				Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lai EC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-115; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pauley KM, 2006, EMBO REP, V7, P904, DOI 10.1038/sj.embor.7400783; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806	16	511	555	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 5	2007	315	5808					97	100		10.1126/science.1136235	http://dx.doi.org/10.1126/science.1136235			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17204650				2022-12-01	WOS:000243259100044
J	Vijayanand, P; Seumois, G; Pickard, C; Powell, RM; Angco, G; Sammut, D; Gadola, SD; Friedmann, PS; Djukanovic, R				Vijayanand, Pandurangan; Seumois, Gregory; Pickard, Chris; Powell, Robert M.; Angco, Gilbert; Sammut, David; Gadola, Stephan D.; Friedmann, Peter S.; Djukanovic, Ratko			Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BRONCHOALVEOLAR LAVAGE; BRONCHIAL-ASTHMA; FLOW-CYTOMETRY; FREQUENCY	BACKGROUND The number of type 2 helper CD4+ T cells is increased in the airways of persons with asthma. Whether the majority of these cells are class II major-histocompatibility-complex-restricted cells or are among the recently identified CD1d-restricted invariant natural killer T cells is a matter of controversy. We studied the frequency of invariant natural killer T cells in the airways of subjects with mild or moderately severe asthma to investigate the possibility of an association between the number of invariant natural killer T cells in the airway and disease severity. We also studied whether an increased number of these cells is a feature of chronic obstructive pulmonary disease (COPD). METHODS We enumerated invariant natural killer T cells by flow cytometry with the use of CD1d tetramers loaded with alpha-galactosylceramide and antibodies specific to the invariant natural killer T-cell receptor in samples of bronchoalveolar-lavage fluid, induced sputum, and bronchial-biopsy specimens obtained from subjects with mild or moderately severe asthma, subjects with COPD, and healthy control subjects. Real-time polymerase-chain-reaction analysis was performed on bronchoalveolar-lavage cells for evidence of gene expression of the invariant natural killer T-cell receptor. RESULTS Fewer than 2% of the T cells obtained from all subjects on airway biopsy, bronchoalveolar lavage, and sputum induction were invariant natural killer T cells, with no significant differences among the three groups of subjects. No expression of messenger RNA for the invariant natural killer T-cell-receptor domains V alpha 24 and V beta 11 was detected in bronchoalveolar-lavage cells from subjects with asthma. CONCLUSIONS Invariant natural killer T cells are found in low numbers in the airways of subjects with asthma, subjects with COPD, and controls.	Univ Southampton, Southampton Gen Hosp, Inflammatory Cell Biol Grp, Div Infect Inflammat & Repair, Southampton SO16 6YD, Hants, England; Univ Southampton, Southampton Gen Hosp, Roger Brooke Lab, PrimerDesign, Southampton, Hants, England; Univ Bern, Inselspital, CH-3010 Bern, Switzerland	University of Southampton; University of Southampton; University of Bern	Vijayanand, P (corresponding author), Univ Southampton, Southampton Gen Hosp, Inflammatory Cell Biol Grp, Div Infect Inflammat & Repair, Level F,S Block,Mail Point 810,Tremona Rd, Southampton SO16 6YD, Hants, England.	vijay@soton.ac.uk	Sammut, David/AAM-9164-2021	Djukanovic, Ratko/0000-0001-6039-5612				Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; Bousquet J, 2000, CLIN EXP ALLERGY, V30, P2; DJUKANOVIC R, 1991, AM REV RESPIR DIS, V143, P772, DOI 10.1164/ajrccm/143.4_Pt_1.772; Gunther U, 2005, J IMMUNOL, V174, P8219, DOI 10.4049/jimmunol.174.12.8219-a; Gunther U, 2005, J IMMUNOL, V174, P5414, DOI 10.4049/jimmunol.174.9.5414; Hamzaoui A, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/71214; Ho LP, 2005, LANCET, V365, P1062, DOI 10.1016/S0140-6736(05)71143-0; Karadimitris A, 2001, P NATL ACAD SCI USA, V98, P3294, DOI 10.1073/pnas.051604498; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Larche M, 2003, J ALLERGY CLIN IMMUN, V111, P450, DOI 10.1067/mai.2003.169; Lucas M, 2003, J VIROL, V77, P2251, DOI 10.1128/JVI.77.3.2251-2257.2003; Metelitsa LS, 2004, CLIN IMMUNOL, V110, P267, DOI 10.1016/j.clim.2003.11.005; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Pham-Thi N, 2006, J ALLERGY CLIN IMMUN, V117, P217, DOI 10.1016/j.jaci.2005.09.052; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Soethout EC, 2004, CLIN DIAGN LAB IMMUN, V11, P795, DOI 10.1128/CDLI.11.4.795-798.2004; Thomas SY, 2006, NEW ENGL J MED, V354, P2613; VIGNOLA RM, 2002, EUR RESPIR J, V37, pS51; Weyde J, 1997, J IMMUNOL METHODS, V207, P115, DOI 10.1016/S0022-1759(97)00103-8; Yang S, 2005, J IMMUNOL, V175, P4914, DOI 10.4049/jimmunol.175.8.4914; 1997, THORAX S, V52, pS1	22	157	167	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 5	2007	356	14					1410	1422		10.1056/NEJMoa064691	http://dx.doi.org/10.1056/NEJMoa064691			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153GG	17409322				2022-12-01	WOS:000245419600004
J	Albert, I; Mavrich, TN; Tomsho, LP; Qi, J; Zanton, SJ; Schuster, SC; Pugh, BF				Albert, Istvan; Mavrich, Travis N.; Tomsho, Lynn P.; Qi, Ji; Zanton, Sara J.; Schuster, Stephan C.; Pugh, B. Franklin			Translational and rotational settings of H2A.Z nucleosomes across the Saccharomyces cerevisiae genome	NATURE			English	Article							HISTONE H2A; EUKARYOTIC GENOME; YEAST; VARIANT; GENES; WIDE; IDENTIFICATION; PROMOTERS; CORE; MAP	The nucleosome is the fundamental building block of eukaryotic chromosomes. Access to genetic information encoded in chromosomes is dependent on the position of nucleosomes along the DNA. Alternative locations just a few nucleotides apart can have profound effects on gene expression(1). Yet the nucleosomal context in which chromosomal and gene regulatory elements reside remains ill-defined on a genomic scale. Here we sequence the DNA of 322,000 individual Saccharomyces cerevisiae nucleosomes, containing the histone variant H2A.Z, to provide a comprehensive map of H2A.Z nucleosomes in functionally important regions. With a median 4-base-pair resolution, we identify new and established signatures of nucleosome positioning. A single predominant rotational setting and multiple translational settings are evident. Chromosomal elements, ranging from telomeres to centromeres and transcriptional units, are found to possess characteristic nucleosomal architecture that may be important for their function. Promoter regulatory elements, including transcription factor binding sites and transcriptional start sites, show topological relationships with nucleosomes, such that transcription factor binding sites tend to be rotationally exposed on the nucleosome surface near its border. Transcriptional start sites tended to reside about one helical turn inside the nucleosome border. These findings reveal an intimate relationship between chromatin architecture and the underlying DNA sequence it regulates.	Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; Penn State Univ, Dept Biochem & Mol Biol, Ctr Gene Regulat, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Pugh, BF (corresponding author), Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA.	bfp2@psu.edu	QI, JI/E-2797-2016; Albert, Istvan/J-3734-2015	Mavrich, Travis/0000-0001-9252-5020; Albert, Istvan/0000-0001-8366-984X				Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Boeger H, 2004, MOL CELL, V14, P667, DOI 10.1016/j.molcel.2004.05.013; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Gavin IM, 1997, EMBO J, V16, P6263, DOI 10.1093/emboj/16.20.6263; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kim JM, 1998, GENOME RES, V8, P464, DOI 10.1101/gr.8.5.464; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Lipford JR, 2001, MOL CELL, V7, P21, DOI 10.1016/S1097-2765(01)00151-4; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Malave TM, 2006, BIOCHEM CELL BIOL, V84, P437, DOI 10.1139/O06-073; Martinez-Campa C, 2004, MOL CELL, V15, P69, DOI 10.1016/j.molcel.2004.05.022; Nieduszynski CA, 2006, GENE DEV, V20, P1874, DOI 10.1101/gad.385306; Pinto I, 2000, EMBO J, V19, P1598, DOI 10.1093/emboj/19.7.1598; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036	30	519	536	2	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2007	446	7135					572	576		10.1038/nature05632	http://dx.doi.org/10.1038/nature05632			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392789				2022-12-01	WOS:000245242900056
J	Ohtake, F; Baba, A; Takada, I; Okada, M; Iwasaki, K; Miki, H; Takahashi, S; Kouzmenko, A; Nohara, K; Chiba, T; Fujii-Kuriyama, Y; Kato, S				Ohtake, Fumiaki; Baba, Atsushi; Takada, Ichiro; Okada, Maiko; Iwasaki, Kei; Miki, Hiromi; Takahashi, Sayuri; Kouzmenko, Alexander; Nohara, Keiko; Chiba, Tomoki; Fujii-Kuriyama, Yoshiaki; Kato, Shigeaki			Dioxin receptor is a ligand-dependent E3 ubiquitin ligase	NATURE			English	Article							ARYL-HYDROCARBON RECEPTOR; BOX PROTEIN TIR1; AUXIN RECEPTOR; AH-RECEPTOR; TRANSCRIPTION; ALPHA; PROTEOLYSIS; EXPRESSION; PROMOTERS; COMPLEX	Fat-soluble ligands, including sex steroid hormones and environmental toxins, activate ligand-dependent DNA-sequence-specific transcriptional factors that transduce signals through target-gene-selective transcriptional regulation(1). However, the mechanisms of cellular perception of fat-soluble ligand signals through other target-selective systems remain unclear. The ubiquitin-proteasome system regulates selective protein degradation, in which the E3 ubiquitin ligases determine target specificity(2-4). Here we characterize a fat-soluble ligand-dependent ubiquitin ligase complex in human cell lines, in which dioxin receptor ( AhR)(5-9) is integrated as a component of a novel cullin 4B ubiquitin ligase complex, CUL4B(AhR). Complex assembly and ubiquitin ligase activity of CUL4B(AhR) in vitro and in vivo are dependent on the AhR ligand. In the CUL4B(AhR) complex, ligand-activated AhR acts as a substrate-specific adaptor component that targets sex steroid receptors for degradation. Thus, our findings uncover a function for AhR as an atypical component of the ubiquitin ligase complex and demonstrate a non-genomic signalling pathway in which fat-soluble ligands regulate target-protein-selective degradation through a ubiquitin ligase complex.	Japan Sci & Technol Agcy, ERATO, Kawaguchi, Saitama 3320012, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Univ Tokyo, Fac Med, Dept Urol, Bunkyo Ku, Tokyo 1138655, Japan; Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; Univ Tsukuba, TARA Ctr, Tsukuba, Ibaraki 3058577, Japan; Japan Sci & Technol Agcy, SORST, Kawaguchi, Saitama 3320012, Japan	Japan Science & Technology Agency (JST); University of Tokyo; University of Tokyo; National Institute for Environmental Studies - Japan; University of Tsukuba; University of Tsukuba; Japan Science & Technology Agency (JST)	Kato, S (corresponding author), Japan Sci & Technol Agcy, ERATO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan.	uskato@mail.ecc.u-tokyo.ac.jp						Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Baba T, 2005, MOL CELL BIOL, V25, P10040, DOI 10.1128/MCB.25.22.10040-10051.2005; Beischlag TV, 2005, J BIOL CHEM, V280, P21607, DOI 10.1074/jbc.C500090200; Brunnberg S, 2003, P NATL ACAD SCI USA, V100, P6517, DOI 10.1073/pnas.1136688100; Carlson DB, 2002, J BIOCHEM MOL TOXIC, V16, P317, DOI 10.1002/jbt.10051; Davarinos NA, 1999, J BIOL CHEM, V274, P28708, DOI 10.1074/jbc.274.40.28708; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pa.35.040195.001515; Harper JW, 2002, TRENDS CELL BIOL, V12, P104, DOI 10.1016/S0962-8924(01)02238-3; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kitagawa H, 2003, CELL, V113, P905, DOI 10.1016/S0092-8674(03)00436-7; Lin TM, 2002, TOXICOL SCI, V68, P479, DOI 10.1093/toxsci/68.2.479; Matthews J, 2005, MOL CELL BIOL, V25, P5317, DOI 10.1128/MCB.25.13.5317-5328.2005; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3; Ohtake F, 2003, NATURE, V423, P545, DOI 10.1038/nature01606; Poellinger L, 2000, FOOD ADDIT CONTAM A, V17, P261, DOI 10.1080/026520300283333; Roberts BJ, 1999, J BIOL CHEM, V274, P36351, DOI 10.1074/jbc.274.51.36351; ROMKES M, 1987, TOXICOL APPL PHARM, V87, P306, DOI 10.1016/0041-008X(87)90292-4; SWANSON HI, 1993, PHARMACOGENETICS, V3, P213, DOI 10.1097/00008571-199310000-00001; Valley CC, 2005, MOL CELL BIOL, V25, P5417, DOI 10.1128/MCB.25.13.5417-5428.2005; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747	30	400	419	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2007	446	7135					562	566		10.1038/nature05683	http://dx.doi.org/10.1038/nature05683			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392787				2022-12-01	WOS:000245242900054
J	Cawthorne, P; Ford, N; Limpananont, J; Tienudom, N; Purahong, W				Cawthorne, Paul; Ford, Nathan; Limpananont, Jiraporn; Tienudom, Nimit; Purahong, Wirat			WHO must defend patients' interests, not industry	LANCET			English	Editorial Material									Med Sans Frontieres, Bangkok 10240, Thailand; Chulalongkorn Univ, Fac Pharmaceut Sci, Bangkok, Thailand; AIDS Access Fdn, Bangkok, Thailand; Thai Network People Living HIV AIDS, Bangkok, Thailand	Chulalongkorn University	Cawthorne, P (corresponding author), Med Sans Frontieres, Bangkok 10240, Thailand.	msfb-bangkok@brussels.msf.org						*ABB, 2006, ABB REP STRONG 4 Q R; [Anonymous], 2001, DECL TRIPS AGR PUBL; *BRIST MYERS SQUIB, BRIST MYERS SQUIBB C; CHAN M, 2007, COMMUNICATION   0212; Okie S, 2006, NEW ENGL J MED, V354, P1977, DOI 10.1056/NEJMp068069; Pinheiro E, 2006, AIDS, V20, P1745, DOI 10.1097/01.aids.0000242821.67001.65; REVENGA A, 2006, EC EFF AIDS TREATM E; SCHWAB S, 2007, COMMUNICATION   0117; TREERUTKUARKUL A, 2007, BANGKOK POST    0213; TREERUTKUARKUL A, 2007, BANGKOK POST    0202; *WHO, 2005, EXT REV HLTH SECT RE; Wilson D, 1999, LANCET, V354, P1893, DOI 10.1016/S0140-6736(99)06114-0; ZAMISKA N, 2007, WALL STREET J   0314	13	12	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2007	369	9566					974	975		10.1016/S0140-6736(07)60473-5	http://dx.doi.org/10.1016/S0140-6736(07)60473-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	151JO	17382809				2022-12-01	WOS:000245286500009
J	Chang, JT; Palanivel, VR; Kinjyo, I; Schambach, F; Intlekofer, AM; Banerjee, A; Longworth, SA; Vinup, KE; Mrass, P; Oliaro, J; Killeen, N; Orange, JS; Russell, SM; Weninger, W; Reiner, SL				Chang, John T.; Palanivel, Vikram R.; Kinjyo, Ichiko; Schambach, Felix; Intlekofer, Andrew M.; Banerjee, Arnob; Longworth, Sarah A.; Vinup, Kristine E.; Mrass, Paul; Oliaro, Jane; Killeen, Nigel; Orange, Jordan S.; Russell, Sarah M.; Weninger, Wolfgang; Reiner, Steven L.			Asymmetric T lymphocyte division in the initiation of adaptive immune responses	SCIENCE			English	Article							DENDRITIC CELL-INTERACTIONS; ANTIGEN-PRESENTING CELLS; IN-VIVO; IMMUNOLOGICAL SYNAPSE; CUTTING EDGE; STEM-CELLS; DIFFERENTIATION; NODES; EFFECTOR; BET	A hallmark of mammalian immunity is the heterogeneity of cell fate that exists among pathogen-experienced lymphocytes. We show that a dividing T lymphocyte initially responding to a microbe exhibits unequal partitioning of proteins that mediate signaling, cell fate specification, and asymmetric cell division. Asymmetric segregation of determinants appears to be coordinated by prolonged interaction between the T cell and its antigen-presenting cell before division. Additionally, the first two daughter T cells displayed phenotypic and functional indicators of being differentially fated toward effector and memory lineages. These results suggest a mechanism by which a single lymphocyte can apportion diverse cell fates necessary for adaptive immunity.	Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Wistar Inst Anat & Biol, Program Immunol, Philadelphia, PA 19104 USA; Peter MacCallum Canc Inst, Immune Signalling Lab, Melbourne, Vic 2002, Australia; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; Swinburne Univ Technol, Ctr Microphoton, Fac Engn & Ind Sci, Hawthorn, Vic 3122, Australia	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; The Wistar Institute; Peter Maccallum Cancer Center; University of California System; University of California San Francisco; University of Pennsylvania; Swinburne University of Technology	Reiner, SL (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	sreiner@mail.med.upenn.edu	Russell, Sarah M/B-9341-2009; Orange, Jordan S/D-5239-2009; Schambach, Felix/B-9055-2009	Russell, Sarah M/0000-0001-5826-9641; Oliaro, Jane/0000-0002-2097-6428; Chang, John/0000-0003-0873-6218; Kinjyo, Ichiko/0000-0001-7051-3790; Intlekofer, Andrew/0000-0001-9046-6549; orange, jordan/0000-0001-7117-7725	NATIONAL CANCER INSTITUTE [R25CA087812, R21CA114114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI069380, R01AI061699, T32AI007532, R01AI053827, T32AI055428, R01AI042370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007066] Funding Source: NIH RePORTER; NCI NIH HHS [CA87812, CA114114] Funding Source: Medline; NIAID NIH HHS [AI055428, AI061699, AI069380, AI007532, AI053827, R01 AI061699, AI042370, T32 AI055428] Funding Source: Medline; NIDDK NIH HHS [DK007066] Funding Source: Medline; NIGMS NIH HHS [GM007170] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; AMIGORENA S, COMMUNICATION; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Anderson AC, 2005, J IMMUNOL, V174, P890, DOI 10.4049/jimmunol.174.2.890; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Celli S, 2005, J EXP MED, V202, P1271, DOI 10.1084/jem.20051018; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Frucht DM, 2001, TRENDS IMMUNOL, V22, P556, DOI 10.1016/S1471-4906(01)02005-1; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Hommel M, 2003, J EXP MED, V197, P269, DOI 10.1084/jem.20021512; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Lin J, 2005, J CELL BIOL, V170, P177, DOI 10.1083/jcb.200503032; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Ludford-Menting MJ, 2005, IMMUNITY, V22, P737, DOI 10.1016/j.immuni.2005.04.009; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; Martin P, 2005, P NATL ACAD SCI USA, V102, P9866, DOI 10.1073/pnas.0501202102; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; Reichert P, 2001, J IMMUNOL, V166, P4278, DOI 10.4049/jimmunol.166.7.4278; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004	40	620	635	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2007	315	5819					1687	1691		10.1126/science.1139393	http://dx.doi.org/10.1126/science.1139393			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17332376				2022-12-01	WOS:000245106900032
J	Wharam, JF; Landon, BE; Galbraith, AA; Kleinman, KP; Soumerai, SB; Ross-Degnan, D				Wharam, J. Frank; Landon, Bruce E.; Galbraith, Alison A.; Kleinman, Ken P.; Soumerai, Stephen B.; Ross-Degnan, Dennis			Emergency department use and subsequent hospitalizations among members of a high-deductible health plan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC DISEASE SCORE; INSURANCE STATUS; CLAIMS DATA; CARE; COST; ASSOCIATION; MORTALITY; ADMISSION; COVERAGE; EVENTS	Context Patients evaluated at emergency departments often present with nonemergency conditions that can be treated in other clinical settings. High-deductible health plans have been promoted as a means of reducing overutilization but could also be related to worse outcomes if patients defer necessary care. Objectives To determine the relationship between transition to a high-deductible health plan and emergency department use for low- and high-severity conditions and to examine changes in subsequent hospitalizations. Design, Setting, and Participants Analysis of emergency department visits and subsequent hospitalizations among 8724 individuals for 1 year before and after their employers mandated a switch from a traditional health maintenance organization plan to a high-deductible health plan, compared with 59 557 contemporaneous controls who remained in the traditional plan. All persons were aged 1 to 64 years and insured by a Massachusetts health plan between March 1, 2001, and June 30, 2005. Main Outcome Measures Rates of first and repeat emergency department visits classified as low, indeterminate, or high severity during the baseline and follow-up periods, as well as rates of inpatient admission after emergency department visits. Results Between the baseline and follow-up periods, emergency department visits among members who switched to high-deductible coverage decreased from 197.5 to 178.1 per 1000 members, while visits among controls remained at approximately 220 per 1000(- 10.0% adjusted difference in difference; 95% confidence interval [CI],- 16.6% to- 2.8%; P=. 007). The high-deductible plan was not associated with a change in the rate of first visits occurring during the study period (- 4.1% adjusted difference in difference; 95% CI, - 11.8% to 4.3%). Repeat visits in the high-deductible group decreased from 334.6 to 255.3 visits per 1000 members and increased from 321.1 to 334.4 per 1000 members in controls(- 24.9% difference in difference; 95% CI, - 37.5% to - 9.7%; P=. 002). Low-severity repeat emergency department visits decreased in the high-deductible group from 142.5 to 92.1 per 1000 members and increased in controls from 128.0 to 132.5 visits per 1000 members(- 36.4% adjusted difference in difference; 95% CI, - 51.1% to - 17.2%; P <. 001), whereas a small decrease in high-severity visits in the high-deductible group could not be excluded. The percentage of patients admitted from the emergency department in the high-deductible group decreased from 11.8% to 10.9% and increased from 11.9% to 13.6% among controls (- 24.7% adjusted difference in difference; 95% CI, - 41.0% to - 3.9%; P=. 02). Conclusions Traditional health plan members who switched to high-deductible coverage visited the emergency department less frequently than controls, with reductions occurring primarily in repeat visits for conditions that were not classified as high severity, and had decreases in the rate of hospitalizations from the emergency department. Further research is needed to determine long-term health care utilization patterns under high-deductible coverage and to assess risks and benefits related to clinical outcomes.	Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; Harvard Pilgrim Hlth Care, Boston, MA USA; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Wharam, JF (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	jwharam@partners.org		Kleinman, Ken/0000-0002-5600-5834; Wharam, James/0000-0003-2053-0757	AHRQ HHS [U 18 HS 11843] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS011843] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Ash AS, 2003, HEALTH SERV RES, V38, P1253, DOI 10.1111/1475-6773.00175; BAKER LC, 1994, HEALTH AFFAIR, V13, P162, DOI 10.1377/hlthaff.13.5.162; Bamezai A, 2005, ANN EMERG MED, V45, P483, DOI 10.1016/j.annemergmed.2004.08.029; Billings J, 2000, Issue Brief (Commonw Fund), P1; BILLINGS J, 2000, ISSUE BRIEF COMMONW, V433, P1; BINDMAN AB, 1991, JAMA-J AM MED ASSOC, V266, P1091, DOI 10.1001/jama.266.8.1091; BLUSTEIN J, 1995, NEW ENGL J MED, V332, P1138, DOI 10.1056/NEJM199504273321706; BUNTIN MB, 2006, HLTH AFF MILLWOOD, V25, pS516; BUSH GW, PRESIDENTS PROPOSAL; CANNON MF, HLTH SAVINGS ACCOUNT; CLARK DO, 1995, MED CARE, V33, P783, DOI 10.1097/00005650-199508000-00004; Cogan JF, 2005, HEALTH AFFAIR, V24, P1447, DOI 10.1377/hlthaff.24.6.1447; Cowen ME, 2002, MED CARE, V40, P650, DOI 10.1097/00005650-200208000-00004; Cowen ME, 1998, MED CARE, V36, P1108, DOI 10.1097/00005650-199807000-00016; *CTR MED MED SERV, FACT SHEET 2007 MED; Davis Karen, 2004, Issue Brief (Commonw Fund), P1; Derlet RW, 2000, ANN EMERG MED, V35, P63, DOI 10.1016/S0196-0644(00)70105-3; Fishman PA, 1999, MED CARE, V37, P874, DOI 10.1097/00005650-199909000-00004; Ginsburg PB, 2004, NEW ENGL J MED, V351, P1591, DOI 10.1056/NEJMp048159; Herzlinger RE, 2002, HARVARD BUS REV, V80, P44; Hsu J, 2006, HEALTH SERV RES, V41, P1801, DOI 10.1111/j.1475-6773.2006.00562.x; *I MED COMM FUT EM, FUT EM CAR KEY FIND; JOHNSON RE, 1994, J CLIN EPIDEMIOL, V47, P1191, DOI 10.1016/0895-4356(94)90106-6; *KAIS FAM FDN HLTH, EMPL HLTH BEN 2006 A; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Krieger N, 2003, AM J PUBLIC HEALTH, V93, P1655, DOI 10.2105/AJPH.93.10.1655; LANDA AS, MEDICAID OFFER HSA P; Lee TH, 2005, NEW ENGL J MED, V353, P1202, DOI 10.1056/NEJMp058209; Magid DJ, 1997, NEW ENGL J MED, V336, P1722, DOI 10.1056/NEJM199706123362406; Newhouse JP, 1996, FREE ALL LESSONS RAN; OGRADY KF, 1985, NEW ENGL J MED, V313, P484, DOI 10.1056/NEJM198508223130806; Palmisano DJ, 2004, JAMA-J AM MED ASSOC, V291, P2237, DOI 10.1001/jama.291.18.2237; RASELL ME, 1995, NEW ENGL J MED, V332, P1164, DOI 10.1056/NEJM199504273321711; Richardson DB, 2006, MED J AUSTRALIA, V184, P213, DOI 10.5694/j.1326-5377.2006.tb00204.x; Roblin DW, 2005, MED CARE, V43, P951, DOI 10.1097/01.mlr.0000178216.23514.b7; Ruger JP, 2003, ACAD EMERG MED, V10, P1285, DOI 10.1197/S1069-6563(03)00500-1; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Selby JV, 1996, NEW ENGL J MED, V334, P635, DOI 10.1056/NEJM199603073341006; Shearer G, 2004, HEALTH SERV RES, V39, P1159, DOI 10.1111/j.1475-6773.2004.00280.x; SOUMERAI SB, 1991, NEW ENGL J MED, V325, P1072, DOI 10.1056/NEJM199110103251505; Sox CM, 1998, AM J MED, V105, P506, DOI 10.1016/S0002-9343(98)00324-6; Sprivulis PC, 2006, MED J AUSTRALIA, V184, P208, DOI 10.5694/j.1326-5377.2006.tb00203.x; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; Travers DA, 2003, ACAD EMERG MED, V10, P1337, DOI 10.1197/S1069-6563(03)00536-0; Trzeciak S, 2003, EMERG MED J, V20, P402, DOI 10.1136/emj.20.5.402; US Census Bureau, 1994, GEOGR AR REF MAN; WUERZ RC, 1992, ANN EMERG MED, V21, P669, DOI 10.1016/S0196-0644(05)82777-5; YOO H, JANUARY CENSUS SHOWS; Yu W, 2004, AM J MANAG CARE, V10, P909; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhan CL, 2003, JAMA-J AM MED ASSOC, V290, P1868, DOI 10.1001/jama.290.14.1868	51	123	126	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2007	297	10					1093	1102		10.1001/jama.297.10.1093	http://dx.doi.org/10.1001/jama.297.10.1093			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	145KZ	17356030	Green Published, Bronze			2022-12-01	WOS:000244865200023
J	Coulibaly, F; Chiu, E; Ikeda, K; Gutmann, S; Haebel, PW; Schulze-Briese, C; Mori, H; Metcalf, P				Coulibaly, Fasseli; Chiu, Elaine; Ikeda, Keiko; Gutmann, Sascha; Haebel, Peter W.; Schulze-Briese, Clemens; Mori, Hajime; Metcalf, Peter			The molecular organization of cypovirus polyhedra	NATURE			English	Article							X-RAY-DIFFRACTION; CRYSTAL-STRUCTURE; PROTEIN; BODIES	Cypoviruses and baculoviruses are notoriously difficult to eradicate because the virus particles are embedded in micrometresized protein crystals called polyhedra(1,2). The remarkable stability of polyhedra means that, like bacterial spores, these insect viruses remain infectious for years in soil. The environmental persistence of polyhedra is the cause of significant losses in silkworm cocoon harvests but has also been exploited against pests in biological alternatives to chemical insecticides(3,4). Although polyhedra have been extensively characterized since the early 1900s(5), their atomic organization remains elusive(6). Here we describe the 2 angstrom crystal structure of both recombinant and infectious silkworm cypovirus polyhedra determined using crystals 5 - 12 micrometres in diameter purified from insect cells. These are the smallest crystals yet used for de novo X-ray protein structure determination(7). We found that polyhedra are made of trimers of the viral polyhedrin protein and contain nucleotides. Although the shape of these building blocks is reminiscent of some capsid trimers, polyhedrin has a new fold and has evolved to assemble in vivo into three-dimensional cubic crystals rather than icosahedral shells. The polyhedrin trimers are extensively cross-linked in polyhedra by non-covalent interactions and pack with an exquisite molecular complementarity similar to that of antigen - antibody complexes. The resulting ultrastable and sealed crystals shield the virus particles from environmental damage. The structure suggests that polyhedra can serve as the basis for the development of robust and versatile nanoparticles for biotechnological applications 8 such as microarrays(9) and biopesticides(4).	Univ Auckland, Sch Biol Sci, Auckland 1010, New Zealand; Prot Crystal Corp, Osaka 5410053, Japan; Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; Altana Pharma AG, D-78467 Constance, Germany; Kyoto Inst Technol, Kyoto 6068585, Japan	University of Auckland; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Altana; Kyoto Institute of Technology	Metcalf, P (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1010, New Zealand.	peter.metcalf@auckland.ac.nz	Metcalf, Peter/B-4598-2011	Gutmann, Sascha/0000-0002-4242-8510; Mori, Hajime/0000-0001-9219-6140; Coulibaly, Fasseli/0000-0003-3380-2117				Anduleit K, 2005, PROTEIN SCI, V14, P2741, DOI 10.1110/ps.051516405; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belloncik S, 1998, VIRUSES, P337; Chang JH, 2003, J INVERTEBR PATHOL, V84, P30, DOI 10.1016/S0022-2011(03)00121-6; Cohen JISS., 2001, FIELDS VIROLOGY, P2707; Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Douglas T, 2006, SCIENCE, V312, P873, DOI 10.1126/science.1123223; Doye JPK, 2006, CURR OPIN COLLOID IN, V11, P40, DOI 10.1016/j.cocis.2005.10.002; FUJIWARA T, 1984, APPL ENTOMOL ZOOL, V19, P402, DOI 10.1303/aez.19.402; Glaser RW, 1916, BIOL BULL-US, V30, P367, DOI 10.2307/1536363; GRIMES J, 1995, NATURE, V373, P167, DOI 10.1038/373167a0; Hill CL, 1999, NAT STRUCT BIOL, V6, P565, DOI 10.1038/9347; Ikeda K, 2006, PROTEOMICS, V6, P54, DOI 10.1002/pmic.200500022; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Liemann S, 2002, CELL, V108, P283, DOI 10.1016/S0092-8674(02)00612-8; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Miller L.K., 1997, BACULOVIRUSES; MORI H, 1993, J GEN VIROL, V74, P99, DOI 10.1099/0022-1317-74-1-99; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Riekel C, 2005, CURR OPIN STRUC BIOL, V15, P556, DOI 10.1016/j.sbi.2005.08.013; ROHRMANN GF, 1986, J GEN VIROL, V67, P1499, DOI 10.1099/0022-1317-67-8-1499; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Summers MD, 2006, ADV VIRUS RES, V68, P3, DOI 10.1016/S0065-3527(06)68001-9; Thorne RE, 2003, J APPL CRYSTALLOGR, V36, P1455, DOI 10.1107/S0021889803018375; Wodak SJ, 2003, ADV PROTEIN CHEM, V61, P9; Zhang H, 1999, J VIROL, V73, P1624, DOI 10.1128/JVI.73.2.1624-1629.1999	30	148	161	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2007	446	7131					97	101		10.1038/nature05628	http://dx.doi.org/10.1038/nature05628			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17330045				2022-12-01	WOS:000244525600045
J	Iwasaki, A				Iwasaki, Akiko			Division of labor by dendritic cells	CELL			English	Editorial Material							CROSS-PRESENTATION; LYMPH-NODE; T-CELLS; ANTIGEN; IMMUNITY; CD8(+)		Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Yale University	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	akiko.iwasaki@yale.edu	Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856				Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; WITMER MD, 1984, AM J ANAT, V170, P465, DOI 10.1002/aja.1001700318; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	10	7	7	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2007	128	3					435	436		10.1016/j.cell.2007.01.024	http://dx.doi.org/10.1016/j.cell.2007.01.024			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289563	Bronze			2022-12-01	WOS:000244842700010
J	Todd, JD; Rogers, R; Li, YG; Wexler, M; Bond, PL; Sun, L; Curson, ARJ; Malin, G; Steinke, M; Johnston, AWB				Todd, Jonathan D.; Rogers, Rachel; Li, You Guo; Wexler, Margaret; Bond, Philip L.; Sun, Lei; Curson, Andrew R. J.; Malin, Gill; Steinke, Michael; Johnston, Andrew W. B.			Structural and regulatory genes required to make the gas dimethyl sulfide in bacteria	SCIENCE			English	Article							HIGHER-PLANTS; DMSP; DIMETHYLSULFONIOPROPIONATE; DIMETHYLSULPHONIOPROPIONATE; ENVIRONMENT; METABOLISM; RHIZOBIUM; SULFUR; FLUX	Dimethyl sulfide (DMS) is a key compound in global sulfur and carbon cycles. DMS oxidation products cause cloud nucleation and may affect weather and climate. DMS is generated largely by bacterial catabolism of dimethylsulfoniopropionate (DMSP), a secondary metabolite made by marine algae. We demonstrate that the bacterial gene dddD is required for this process and that its transcription is induced by the DMSP substrate. Cloned dddD from the marine bacterium Marinomonas and from two bacterial strains that associate with higher plants, the N-2-fixing symbiont Rhizobium NGR234 and the root-colonizing Burkholderia cepacia AMMD, conferred to Escherichia coli the ability to make DMS from DMSP. The inferred enzymatic mechanism for DMS liberation involves an initial step in which DMSP is modified by addition of acyl coenzyme A, rather than the immediate release of DMS by a DMSP lyase, the previously suggested mechanism.	Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	University of East Anglia; University of East Anglia	Johnston, AWB (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	a.johnston@uea.ac.uk	Todd, Jonathan/B-8967-2009; Johnston, Andrew W B/D-1859-2009; Wexler, Margaret/G-3423-2011; Bond, Philip/N-6649-2017; Rogers, Rachel/GVT-5579-2022; Steinke, Michael/A-6137-2012; Malin, Gill/C-6985-2009; Curson, Andrew RJ/B-8964-2009; Bond, Philip/C-6046-2009	Todd, Jonathan/0000-0003-0777-9312; Bond, Philip/0000-0002-9025-4797; Steinke, Michael/0000-0001-6820-0154; Malin, Gill/0000-0002-3639-9215; 	BBSRC [BB/E01688X/1] Funding Source: UKRI; Natural Environment Research Council [NER/T/S/2001/00253, NE/B500282/1, NE/B501039/1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/E01688X/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Ansede JH, 2001, APPL ENVIRON MICROB, V67, P1210, DOI 10.1128/AEM.67.3.1210-1217.2001; Ansede JH, 2001, APPL ENVIRON MICROB, V67, P3134, DOI 10.1128/AEM.67.7.3134-3139.2001; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; Kettle AJ, 2000, J GEOPHYS RES-ATMOS, V105, P26793, DOI 10.1029/2000JD900252; Kiene RP, 2000, J SEA RES, V43, P209, DOI 10.1016/S1385-1101(00)00023-X; KIENE RP, 1990, APPL ENVIRON MICROB, V56, P3292, DOI 10.1128/AEM.56.11.3292-3297.1990; Miller TR, 2004, APPL ENVIRON MICROB, V70, P3383, DOI 10.1128/AEM.70.6.3383-3391.2004; Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170; NEVITT GA, 1995, NATURE, V376, P680, DOI 10.1038/376680ao; Otte ML, 2004, J EXP BOT, V55, P1919, DOI 10.1093/jxb/erh178; Pueppke SG, 1999, MOL PLANT MICROBE IN, V12, P293, DOI 10.1094/MPMI.1999.12.4.293; Ramette A, 2005, APPL ENVIRON MICROB, V71, P1193, DOI 10.1128/AEM.71.3.1193-1201.2005; Rangarajan ES, 2005, BIOCHEMISTRY-US, V44, P5728, DOI 10.1021/bi047656f; REED RH, 1983, MAR BIOL LETT, V4, P173; Stefels J, 2000, J SEA RES, V43, P183, DOI 10.1016/S1385-1101(00)00030-7; STEFELS J, IN PRESS BIOGEOCHEMI; Steinke M, 2006, LIMNOL OCEANOGR, V51, P1925, DOI 10.4319/lo.2006.51.4.1925; TRINICK MJ, 1973, NATURE, V244, P459, DOI 10.1038/244459a0; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Yoch DC, 2002, APPL ENVIRON MICROB, V68, P5804, DOI 10.1128/AEM.68.12.5804-5815.2002	21	200	209	5	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2007	315	5812					666	669		10.1126/science.1135370	http://dx.doi.org/10.1126/science.1135370			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272727				2022-12-01	WOS:000243909400049
J	Perry, B; Sones, K				Perry, Brian; Sones, Keith			Science for development - Poverty reduction through animal health	SCIENCE			English	Editorial Material							EPIDEMIOLOGY; VIRUS		Int Livestock Res Inst, Nairobi 00100, Kenya; Keith Sones Associates, Nairobi 00502, Kenya	CGIAR; International Livestock Research Institute (ILRI)	Perry, B (corresponding author), Int Livestock Res Inst, POB 30709, Nairobi 00100, Kenya.	b.perry@cgiar.org		Perry, Brian/0000-0002-6962-2102				ANDERSON R M, 1991; Baylis M, 2006, EFFECTS CLIMATE CHAN; Calvete C, 2006, VET REC, V158, P130, DOI 10.1136/vr.158.4.130; Catley A, 2004, PREV VET MED, V65, P17, DOI 10.1016/j.prevetmed.2004.06.007; Delgado CL, 2003, J NUTR, V133, p3907S, DOI 10.1093/jn/133.11.3907S; *DFID, 2004, 2 DFID; *DFID, AN HLTH PROGR; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Gardner MJ, 2005, SCIENCE, V309, P134, DOI 10.1126/science.1110439; Gulati A., 2005, S HIGH VAL AGR VERT; Hall A., 2002, Agricultural research policy in an era of privatization, P155, DOI 10.1079/9780851996004.0155; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Jones P. G., COMMUNICATION; *LIV DEV, 1999, LIV POV FOC DEV; Mariner JC, 2003, VET REC, V152, P641, DOI 10.1136/vr.152.21.641; MCLEOD A, AN HLTH PROGR; Perry B, 2001, PREV VET MED, V48, P231, DOI 10.1016/S0167-5877(00)00203-8; Perry B. D, 2002, INVESTING ANIMAL HLT; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; Thornton P.K., 2002, MAPPING POVERTY LIVE; *U PRET FAC VET EQ, 2006, IMP AFR HORS SICKN S; *UK FOR PROGR, 2006, INF DIS PREP FUT F 1; *UN FAO, AN PROD HLTH PROGR; WEARVER J, 2006, PARTICIPATORY DIS SU; *WOODD MACK LTD, 2005, ANN REP INT FED AN H	25	54	57	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2007	315	5810					333	334		10.1126/science.1138614	http://dx.doi.org/10.1126/science.1138614			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	126SI	17234933				2022-12-01	WOS:000243535400023
J	Joshi, P; Islam, S; Pais, P; Reddy, S; Dorairaj, P; Kazmi, K; Pandey, MR; Haque, S; Mendis, S; Rangarajan, S; Yusuf, S				Joshi, Prashant; Islam, Shofiqul; Pais, Prem; Reddy, Srinath; Dorairaj, Prabhakaran; Kazmi, Khawar; Pandey, Mrigendra Raj; Haque, Sirajul; Mendis, Shanthi; Rangarajan, Sumathy; Yusuf, Salim			Risk factors for early myocardial infarction in South Asians compared with individuals in other countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; APOLIPOPROTEIN-A-I; CARDIOVASCULAR-DISEASE; PHYSICAL-ACTIVITY; ARTERY-DISEASE; FOLLOW-UP; ATTRIBUTABLE RISK; GLOBAL BURDEN; ETHNIC-GROUPS; HOMOCYSTEINE	Context South Asians have high rates of acute myocardial infarction ( AMI) at younger ages compared with individuals from other countries but the reasons for this are unclear. Objective To evaluate the association of risk factors for AMI in native South Asians, especially at younger ages, compared with individuals from other countries. Design, Setting, and Participants Standardized case-control study of 1732 cases with first AMI and 2204 controls matched by age and sex from 15 medical centers in 5 South Asian countries and 10 728 cases and 12 431 controls from other countries. Individuals were recruited to the study between February 1999 and March 2003. Main Outcome Measure Association of risk factors for AMI. Results The mean(SD) age for first AMI was lower in South Asian countries ( 53.0 [11.4] years) than in other countries ( 58.8 [12.2] years; P <. 001). Protective factors were lower in South Asian controls than in controls from other countries (moderate- or high-intensity exercise, 6.1% vs 21.6%; daily intake of fruits and vegetables, 26.5% vs 45.2%; alcohol consumption >= once/wk, 10.7% vs 26.9%). However, some harmful factors were more common in native South Asians than in individuals from other countries ( elevated apolipoprotein B-100/ apolipoprotein A-I ratio, 43.8% vs31.8%; history of diabetes, 9.5% vs 7.2%). Similar relative associations were found in South Asians compared with individuals from other countries for the risk factors of current and former smoking, apolipoprotein B100/ apolipoprotein A-I ratio for the top vs lowest tertile, waist-to-hip ratio for the top vs lowest tertile, history of hypertension, history of diabetes, psychosocial factors such as depression and stress at work or home, regular moderate- or high-intensity exercise, and daily intake of fruits and vegetables. Alcohol consumption was not found to be a risk factor for AMI in South Asians. The combined odds ratio for all 9 risk factors was similar in South Asians (123.3; 95% confidence interval [CI], 38.7-400.2] and in individuals from other countries (125.7; 95% CI, 88.5-178.4). The similarities in the odds ratios for the risk factors explained a high and similar degree of population attributable risk in both groups (85.8%[ 95% CI, 78.0%-93.7%] vs 88.2% [ 95% CI, 86.3%-89.9%], respectively). When stratified by age, South Asians had more risk factors at ages younger than 60 years. After adjusting for all 9 risk factors, the predictive probability of classifying an AMI case as being younger than 40 years was similar in individuals from South Asian countries and those from other countries. Conclusion The earlier age of AMI in South Asians can be largely explained by higher risk factor levels at younger ages.	Govt Med Coll, Dept Med, Nagpur, Maharashtra, India; McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; Hamilton Hlth Sci, Hamilton, ON, Canada; St Johns Med Coll, Dept Med, Bangalore, Karnataka, India; All India Inst Med Sci, New Delhi, India; Aga Khan Univ, Dept Cardiol, Karachi, Pakistan; Sheikh Med Univ, Dept Cardiol, Sheilkh, Bangladesh; WHO, CH-1211 Geneva, Switzerland	McMaster University; Population Health Research Institute; McMaster University; St. John's National Academy of Health Sciences; St. John's Medical College; All India Institute of Medical Sciences (AIIMS) New Delhi; Aga Khan University; World Health Organization	Yusuf, S (corresponding author), Hamilton Gen Hosp, Populat Hlth Res Inst, McMaster Clin, 2nd Floor,237 Barton St E, Hamilton, ON L8L 2X2, Canada.	yusufs@mcmaster.ca	Prabhakaran, Dorairaj/B-4147-2011; Mendis, Shanthi/GLT-0465-2022	Prabhakaran, Dorairaj/0000-0002-3172-834X; Yusuf, Salim/0000-0003-4776-5601; mendis, shanthi/0000-0002-8959-5738				Anand SS, 2000, LANCET, V356, P279, DOI 10.1016/S0140-6736(00)02502-2; BALARAJAN R, 1991, BMJ-BRIT MED J, V302, P560, DOI 10.1136/bmj.302.6776.560; BENICHOU J, 1990, BIOMETRICS, V46, P991, DOI 10.2307/2532443; Bhopal R, 1999, BRIT MED J, V319, P215, DOI 10.1136/bmj.319.7204.215; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Brunner E, 1996, LANCET, V347, P1008, DOI 10.1016/S0140-6736(96)90147-6; ENAS EA, 1992, AM J CARDIOL, V70, P945, DOI 10.1016/0002-9149(92)90744-J; Ghiadoni L, 2000, CIRCULATION, V102, P2473, DOI 10.1161/01.CIR.102.20.2473; Hambrecht R, 2000, NEW ENGL J MED, V342, P454, DOI 10.1056/NEJM200002173420702; Ismail J, 2004, HEART, V90, P259, DOI 10.1136/hrt.2003.013631; JOSHI PP, 2003, S ASIAN J PREV CARDI, V7, P195; Joshipura KJ, 2001, ANN INTERN MED, V134, P1106, DOI 10.7326/0003-4819-134-12-200106190-00010; Krauss RM, 1996, CIRCULATION, V94, P1795, DOI 10.1161/01.CIR.94.7.1795; Lamarche B, 1996, CIRCULATION, V94, P273, DOI 10.1161/01.CIR.94.3.273; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Luepker RV, 1996, JAMA-J AM MED ASSOC, V276, P241; MATTHEWS JH, 1984, CLIN LAB HAEMATOL, V6, P1; MCKEIGUE PM, 1988, BRIT MED J, V297, P903, DOI 10.1136/bmj.297.6653.903; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Moss AJ, 1999, CIRCULATION, V99, P2517, DOI 10.1161/01.CIR.99.19.2517; Murray C.J, 1994, GLOBAL COMP ASSESSME; Murray C.J.L., 1996, GLOBAL BURDEN DIS IN, VII, P906; Pais P, 1996, LANCET, V348, P358, DOI 10.1016/S0140-6736(96)02507-X; Panagiotakos DB, 2003, NUTR J, V2, DOI 10.1186/1475-2891-2-2; Patil SS, 2004, NATL MED J INDIA, V17, P189; Pratt LA, 1996, CIRCULATION, V94, P3123, DOI 10.1161/01.CIR.94.12.3123; Rastogi T, 2004, INT J EPIDEMIOL, V33, P759, DOI 10.1093/ije/dyh042; Rastogi T, 2004, AM J CLIN NUTR, V79, P582; Reddy KS, 1998, CIRCULATION, V97, P596; Reddy KS, 2004, NEW ENGL J MED, V350, P2438, DOI 10.1056/NEJMp048024; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Rosengren A, 1997, ANN EPIDEMIOL, V7, P69, DOI 10.1016/S1047-2797(96)00106-8; Rugulies R, 2002, AM J PREV MED, V23, P51, DOI 10.1016/S0749-3797(02)00439-7; Sniderman AD, 2003, LANCET, V361, P777, DOI 10.1016/S0140-6736(03)12663-3; Talmud PJ, 2002, ARTERIOSCL THROM VAS, V22, P1918, DOI 10.1161/01.ATV.0000035521.22199.C7; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; van't Veer P, 2000, PUBLIC HEALTH NUTR, V3, P103, DOI 10.1017/S1368980000000136; von Kanel R, 2001, PSYCHOSOM MED, V63, P531, DOI 10.1097/00006842-200107000-00003; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; WALTER SD, 1975, BIOMETRIKA, V62, P371, DOI 10.2307/2335374; Wannamethee SG, 2000, ARCH INTERN MED, V160, P2108, DOI 10.1001/archinte.160.14.2108; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	46	559	567	0	27	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2007	297	3					286	294		10.1001/jama.297.3.286	http://dx.doi.org/10.1001/jama.297.3.286			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	125VT	17227980	Bronze			2022-12-01	WOS:000243472300023
J	Beukeboom, LW; Kamping, A; Louter, M; Pijnacker, LP; Katju, V; Ferree, PM; Werren, JH				Beukeboom, Leo W.; Kamping, Albert; Louter, Marina; Pijnacker, Laas P.; Katju, Vaishali; Ferree, Patrick M.; Werren, John H.			Haploid females in the parasitic wasp Nasonia vitripennis	SCIENCE			English	Article									Univ Groningen, Ctr Ecol & Evolut Studies, NL-9750 AA Haren, Netherlands; Univ Rochester, Dept Biol, Rochester, NY 14627 USA; Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	University of Groningen; University of Rochester; University of California System; University of California Santa Cruz	Beukeboom, LW (corresponding author), Univ Groningen, Ctr Ecol & Evolut Studies, POB 14, NL-9750 AA Haren, Netherlands.	l.w.beukeboom@rug.nl	Beukeboom, Leo W/D-1808-2012	Werren, John/0000-0001-9353-2070; Louter, Marina/0000-0002-9368-512X	NIGMS NIH HHS [5 RO1 GM070026-02] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070026] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beukeboom LW, 2006, GENETICS, V172, P981, DOI 10.1534/genetics.105.044743; Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; COOK JM, 1995, TRENDS ECOL EVOL, V10, P281, DOI 10.1016/0169-5347(95)90011-X; Weeks AR, 2001, SCIENCE, V292, P2479, DOI 10.1126/science.1060411	4	28	33	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2007	315	5809					206	206		10.1126/science.1133388	http://dx.doi.org/10.1126/science.1133388			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124XZ	17218519	Green Submitted			2022-12-01	WOS:000243407400036
J	Maerkl, SJ; Quake, SR				Maerkl, Sebastian J.; Quake, Stephen R.			A systems approach to measuring the binding energy landscapes of transcription factors	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; DNA; DISCOVERY; RECOGNITION; NETWORK; MOTIFS; SITES; MAX	A major goal of systems biology is to predict the function of biological networks. Although network topologies have been successfully determined in many cases, the quantitative parameters governing these networks generally have not. Measuring affinities of molecular interactions in high-throughput format remains problematic, especially for transient and low-affinity interactions. We describe a high-throughput microfluidic platform that measures such properties on the basis of mechanical trapping of molecular interactions. With this platform we characterized DNA binding energy landscapes for four eukaryotic transcription factors; these landscapes were used to test basic assumptions about transcription factor binding and to predict their in vivo function.	Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; CALTECH, Pasadena, CA 91125 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; California Institute of Technology	Quake, SR (corresponding author), Stanford Univ, Dept Bioengn, 318 Campus Dr, Stanford, CA 94305 USA.	quake@stanford.edu	Maerkl, Sebastian J. J/C-5438-2008	Maerkl, Sebastian J. J/0000-0003-1917-5268				BAKER RE, 1990, MOL CELL BIOL, V10, P2458, DOI 10.1128/MCB.10.6.2458; Benos PV, 2002, NUCLEIC ACIDS RES, V30, P4442, DOI 10.1093/nar/gkf578; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Bulyk ML, 2001, P NATL ACAD SCI USA, V98, P7158, DOI 10.1073/pnas.111163698; CAI MJ, 1990, CELL, V61, P437, DOI 10.1016/0092-8674(90)90525-J; Carroll AS, 2001, P NATL ACAD SCI USA, V98, P12578, DOI 10.1073/pnas.211195798; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Djordjevic M, 2003, GENOME RES, V13, P2381, DOI 10.1101/gr.1271603; Elemento O, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r18; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Granek JA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r87; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kent NA, 2004, J BIOL CHEM, V279, P27116, DOI 10.1074/jbc.M403818200; Levens DL, 2003, GENE DEV, V17, P1071, DOI 10.1101/gad.1095203; Man TK, 2001, NUCLEIC ACIDS RES, V29, P2471, DOI 10.1093/nar/29.12.2471; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Mayo AE, 2006, PLOS BIOL, V4, P555, DOI 10.1371/journal.pbio.0040045; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; Park S, 2004, BBA-GEN SUBJECTS, V1670, P217, DOI 10.1016/j.bbagen.2003.12.007; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shimizu T, 1997, EMBO J, V16, P4689, DOI 10.1093/emboj/16.15.4689; Sinha S, 2002, NUCLEIC ACIDS RES, V30, P5549, DOI 10.1093/nar/gkf669; Spinner DS, 2002, J MOL BIOL, V317, P431, DOI 10.1006/jmbi.2002.5440; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Warren CL, 2006, P NATL ACAD SCI USA, V103, P867, DOI 10.1073/pnas.0509843102; Workman CT, 2006, SCIENCE, V312, P1054, DOI 10.1126/science.1122088; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	36	409	439	0	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2007	315	5809					233	237		10.1126/science.1131007	http://dx.doi.org/10.1126/science.1131007			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124XZ	17218526	Green Submitted			2022-12-01	WOS:000243407400045
J	Gibney, EM				Gibney, Eric M.			Concurrent sentences - Dialysis in the state penitentiary	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Virginia Commonwealth Univ, Div Nephrol, Richmond, VA 23284 USA; Virginia Commonwealth Univ, Hume Lee Transplant Ctr, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University	Gibney, EM (corresponding author), Virginia Commonwealth Univ, Div Nephrol, Med Coll Virginia Campus, Richmond, VA 23284 USA.								0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 11	2007	356	2					108	110		10.1056/NEJMp068102	http://dx.doi.org/10.1056/NEJMp068102			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	124NE	17215527				2022-12-01	WOS:000243373700002
J	Huang, B; Wu, HK; Bhaya, D; Grossman, A; Granier, S; Kobilka, BK; Zare, RN				Huang, Bo; Wu, Hongkai; Bhaya, Devaki; Grossman, Arthur; Granier, Sebastien; Kobilka, Brian K.; Zare, Richard N.			Counting low-copy number proteins in a single cell	SCIENCE			English	Article							CAPILLARY-ELECTROPHORESIS; ELECTROKINETIC TRANSPORT; FLUORESCENCE DETECTION; MOLECULE DETECTION; PHYCOBILISOME; POLY(DIMETHYLSILOXANE); NANOCHANNELS; ARCHITECTURE; CONFINEMENT; EXPRESSION	We have designed a microfluidic device in which we can manipulate, lyse, label, separate, and quantify the protein contents of a single cell using single-molecule fluorescence counting. Generic labeling of proteins is achieved through fluorescent-antibody binding. The use of cylindrical optics enables high-efficiency (approximate to 60%) counting of molecules in micrometer-sized channels. We used this microfluidic device to quantify beta(2) adrenergic receptors expressed in insect cells (SF9). We also analyzed phycobiliprotein contents in individual cyanobacterial cells ( Synechococcus sp. PCC 7942) and observed marked differences in the levels of specific complexes in cell populations that were grown under nitrogen-depleted conditions.	Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Carnegie Inst Washington, Dept Plant Biol, Stanford, CA 94305 USA; Stanford Univ, Dept Mol & Cellular Physiol & Med, Stanford, CA 94305 USA	Stanford University; Carnegie Institution for Science; Stanford University	Zare, RN (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	zare@stanford.edu	Granier, Sebastien/J-1089-2016; Zare, Richard N./A-8410-2009; Huang, Bo/D-4854-2009	Kobilka, Brian/0000-0001-5958-3990; Zare, Richard/0000-0001-5266-4253				Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; CASTRO A, 1993, ANAL CHEM, V65, P849, DOI 10.1021/ac00055a004; Chen DY, 1996, ANAL CHEM, V68, P690, DOI 10.1021/ac950651r; Cottingham K, 2004, ANAL CHEM, V76, p235A, DOI 10.1021/ac041584g; Foquet M, 2004, ANAL CHEM, V76, P1618, DOI 10.1021/ac035088o; GLAZER AN, 1983, ANN INST PASTEUR MIC, VB134, P159, DOI 10.1016/S0769-2609(83)80103-3; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; Haab BB, 1999, ANAL CHEM, V71, P5137, DOI 10.1021/ac990644t; Hong JW, 2004, NAT BIOTECHNOL, V22, P435, DOI 10.1038/nbt951; Hu S, 2004, ANAL CHEM, V76, P4044, DOI 10.1021/ac0498314; Huang B, 2005, LAB CHIP, V5, P1005, DOI 10.1039/b509251e; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Lundqvist A, 2003, ELECTROPHORESIS, V24, P1737, DOI 10.1002/elps.200305429; Lyon WA, 1997, ANAL CHEM, V69, P3400, DOI 10.1021/ac9700742; Ma YF, 2001, ELECTROPHORESIS, V22, P421, DOI 10.1002/1522-2683(200102)22:3<421::AID-ELPS421>3.0.CO;2-W; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ocvirk G, 2000, ELECTROPHORESIS, V21, P107, DOI 10.1002/(SICI)1522-2683(20000101)21:1<107::AID-ELPS107>3.0.CO;2-Y; Pennathur S, 2005, ANAL CHEM, V77, P6772, DOI 10.1021/ac052141v; Pennathur S, 2005, ANAL CHEM, V77, P6782, DOI 10.1021/ac0508346; Whelan RJ, 2002, ANAL CHEM, V74, P4570, DOI 10.1021/ac025669y; Wu HK, 2004, P NATL ACAD SCI USA, V101, P12809, DOI 10.1073/pnas.0405299101; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; YAMANAKA G, 1980, ARCH MICROBIOL, V124, P39, DOI 10.1007/BF00407026; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	24	315	339	1	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 5	2007	315	5808					81	84		10.1126/science.1133992	http://dx.doi.org/10.1126/science.1133992			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17204646				2022-12-01	WOS:000243259100039
J	Skewgar, E; Boersma, PD; Harris, G; Caille, G				Skewgar, Elizabeth; Boersma, P. Dee; Harris, Graham; Caille, Guillermo			Sustainability - Anchovy fishery threat to Patagonian ecosystem	SCIENCE			English	Editorial Material								Unsustainable anchovy harvest could disrupt ecosystem function, other fisheries, and ecotourism revenues.	Univ Washington, Dept Biol, Seattle, WA 98195 USA; Fdn Patagonia Nat, RA-9120 Puerto Madryn, Chubut, Argentina	University of Washington; University of Washington Seattle	Skewgar, E (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	skewes@u.washington.edu	Caille, Guillermo Martín/AAU-4135-2021					Bakun A, 2006, PROG OCEANOGR, V68, P271, DOI 10.1016/j.pocean.2006.02.004; DELCHUBUT G, 2006, TURISMO CHUBUT GENER; *FAO FISH DEP, 2001, INF ORD PESQ REP ARG; *FAO FISH DEP, 2004, STAT WORLD FISH AQ S; Frere E., 1996, Ornitologia Neotropical, V7, P35; Koen-Alonso M, 2005, CAN J FISH AQUAT SCI, V62, P1490, DOI 10.1139/F05-087; MAGNUSON JJ, 2006, DYNAMIC CHANGES MARI; *PRES REP OR UR, 2002, ADJ LIC PUBL FIRM IB; SCHONBERGER SN, 2001, 22816 WORLD BANK; *SECR AGR, 2006, DES CAPT MAR TOT	10	38	39	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2007	315	5808					45	45		10.1126/science.1135767	http://dx.doi.org/10.1126/science.1135767			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17204628				2022-12-01	WOS:000243259100021
J	Koizumi, S; Shigemoto-Mogami, Y; Nasu-Tada, K; Shinozaki, Y; Ohsawa, K; Tsuda, M; Joshi, BV; Jacobson, KA; Kohsaka, S; Inoue, K				Koizumi, Schuichi; Shigemoto-Mogami, Yukari; Nasu-Tada, Kaoru; Shinozaki, Yoichi; Ohsawa, Keiko; Tsuda, Makoto; Joshi, Bhalchandra V.; Jacobson, Kenneth A.; Kohsaka, Shinichi; Inoue, Kazuhide			UDP acting at P2Y(6) receptors is a mediator of microglial phagocytosis	NATURE			English	Article							NUCLEOTIDE RECEPTOR; APOPTOTIC CELLS; IN-VIVO; RELEASE; ATP; INVOLVEMENT; CHEMOTAXIS; ACTIVATION; MIGRATION; CLONING	Microglia, brain immune cells, engage in the clearance of dead cells or dangerous debris, which is crucial to the maintenance of brain functions. When a neighbouring cell is injured, microglia move rapidly towards it or extend a process to engulf the injured cell. Because cells release or leak ATP when they are stimulated(1,2) or injured(3,4), extracellular nucleotides are thought to be involved in these events. In fact, ATP triggers a dynamic change in the motility of microglia in vitro(5,6) and in vivo(3,4), a previously unrecognized mechanism underlying microglial chemotaxis(5,6); in contrast, microglial phagocytosis has received only limited attention. Here we show that microglia express the metabotropic P2Y(6) receptor whose activation by endogenous agonist UDP triggers microglial phagocytosis. UDP facilitated the uptake of microspheres in a P2Y(6)-receptor-dependent manner, which was mimicked by the leakage of endogenous UDP when hippocampal neurons were damaged by kainic acid in vivo and in vitro. In addition, systemic administration of kainic acid in rats resulted in neuronal cell death in the hippocampal CA1 and CA3 regions, where increases in messenger RNA encoding P2Y(6) receptors that colocalized with activated microglia were observed. Thus, the P2Y(6) receptor is upregulated when neurons are damaged, and could function as a sensor for phagocytosis by sensing diffusible UDP signals, which is a previously unknown pathophysiological function of P2 receptors in microglia.	Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol & Syst Pharmacol, Fukuoka 8128582, Japan; Natl Inst Hlth Sci, Div Pharmacol, Setagaya Ku, Tokyo 1588501, Japan; Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Pharmacol, Yamanashi 4093893, Japan; Natl Inst Neurosci, Dept Neurochem, Tokyo 1878502, Japan; NIDDKD, Mol Recognit Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA	Kyushu University; National Institute of Health Sciences - Japan; University of Yamanashi; National Center for Neurology & Psychiatry - Japan; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Inoue, K (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol & Syst Pharmacol, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	inoue@phar.kyushu-u.ac.jp	Shinozaki, Youichi/E-8594-2010; Shinozaki, Youichi/AAC-9431-2019; Tsuda, Makoto/AAE-7256-2020; Jacobson, Kenneth Alan/A-1530-2009; Koizumi, Schuichi/E-8568-2010	Shinozaki, Youichi/0000-0002-6448-1304; Shinozaki, Youichi/0000-0002-6448-1304; Jacobson, Kenneth Alan/0000-0001-8104-1493; Koizumi, Schuichi/0000-0001-6184-3106	Intramural NIH HHS [Z01 DK031116-20] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK031116] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; CHANG KG, 1995, J BIOL CHEM, V270, P26152, DOI 10.1074/jbc.270.44.26152; Communi D, 1996, BIOCHEM BIOPH RES CO, V222, P303, DOI 10.1006/bbrc.1996.0739; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Erlinge D, 2005, INT J CARDIOL, V100, P427, DOI 10.1016/j.ijcard.2004.10.005; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; GREENBERG S, 1995, TRENDS CELL BIOL, V5, P93, DOI 10.1016/S0962-8924(00)88957-6; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Koizumi S, 2003, P NATL ACAD SCI USA, V100, P11023, DOI 10.1073/pnas.1834448100; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lazarowski ER, 2000, J BIOL CHEM, V275, P31061, DOI 10.1074/jbc.M003255200; Lazarowski ER, 2003, MOL PHARMACOL, V63, P1190, DOI 10.1124/mol.63.5.1190; Lazarowski ER, 1997, J BIOL CHEM, V272, P24348, DOI 10.1074/jbc.272.39.24348; Mamedova LK, 2004, BIOCHEM PHARMACOL, V67, P1763, DOI 10.1016/j.bcp.2004.01.011; Mellor EA, 2001, P NATL ACAD SCI USA, V98, P7964, DOI 10.1073/pnas.141221498; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; NAKAJIMA K, 1992, J NEUROCHEM, V58, P1401, DOI 10.1111/j.1471-4159.1992.tb11356.x; Nasu-Tada K, 2005, GLIA, V52, P98, DOI 10.1002/glia.20224; Nicholas RA, 1996, J AUTON PHARMACOL, V16, P319, DOI 10.1111/j.1474-8673.1996.tb00044.x; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ohsawa K, 2000, J CELL SCI, V113, P3073; Ravichandran KS, 2003, CELL, V113, P817, DOI 10.1016/S0092-8674(03)00471-9; SPERK G, 1983, NEUROSCIENCE, V10, P1301, DOI 10.1016/0306-4522(83)90113-6; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786	28	569	600	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					1091	1095		10.1038/nature05704	http://dx.doi.org/10.1038/nature05704			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17410128	Green Accepted			2022-12-01	WOS:000245950400052
J	Wang, XD; Song, JH; Liu, J; Wang, ZL				Wang, Xudong; Song, Jinhui; Liu, Jin; Wang, Zhong Lin			Direct-current nanogenerator driven by ultrasonic waves	SCIENCE			English	Article							PIEZOELECTRIC NANOGENERATORS; NANOWIRE; GROWTH; TRANSISTOR	We have developed a nanowire nanogenerator that is driven by an ultrasonic wave to produce continuous direct-current output. The nanogenerator was fabricated with vertically aligned zinc oxide nanowire arrays that were placed beneath a zigzag metal electrode with a small gap. The wave drives the electrode up and down to bend and/or vibrate the nanowires. A piezoelectric-semiconducting coupling process converts mechanical energy into electricity. The zigzag electrode acts as an array of parallel integrated metal tips that simultaneously and continuously create, collect, and output electricity from all of the nanowires. The approach presents an adaptable, mobile, and cost-effective technology for harvesting energy from the environment, and it offers a potential solution for powering nanodevices and nanosystems.	Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Wang, ZL (corresponding author), Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.	zhong.wang@mse.gatech.edu	wang, jie/GRS-0942-2022; Dee, Chang Fu/G-4842-2010; Wang, Zhong Lin/E-2176-2011; Song, Jinhui/C-7524-2013; Wang, Xudong/A-7067-2009	Dee, Chang Fu/0000-0003-1015-9181; Wang, Zhong Lin/0000-0002-5530-0380; Song, Jinhui/0000-0002-0042-2014; 				Bachtold A, 2001, SCIENCE, V294, P1317, DOI 10.1126/science.1065824; Bai XD, 2003, APPL PHYS LETT, V82, P4806, DOI 10.1063/1.1587878; Chen J, 2005, SCIENCE, V310, P1171, DOI 10.1126/science.1119177; Fruhauf J, 2005, MICROSYST TECHNOL, V11, P1287, DOI 10.1007/s00542-005-0612-7; Gao PX, 2007, ADV MATER, V19, P67, DOI 10.1002/adma.200601162; Hsu JWP, 2005, NANO LETT, V5, P83, DOI 10.1021/nl048322e; Huang Y, 2001, SCIENCE, V294, P1313, DOI 10.1126/science.1066192; Javey A, 2003, NATURE, V424, P654, DOI 10.1038/nature01797; LI V, 2006, MATER TODAY, V9, P18; Mitcheson PD, 2004, J MICROELECTROMECH S, V13, P429, DOI 10.1109/JMEMS.2004.830151; Pan ZW, 2001, SCIENCE, V291, P1947, DOI 10.1126/science.1058120; Paradiso JA, 2005, IEEE PERVAS COMPUT, V4, P18, DOI 10.1109/MPRV.2005.9; Patolsky F, 2005, MATER TODAY, V8, P20, DOI 10.1016/S1369-7021(05)00791-1; Patolsky F, 2006, SCIENCE, V313, P1100, DOI 10.1126/science.1128640; Song JH, 2006, NANO LETT, V6, P1656, DOI 10.1021/nl060820v; Tian ZRR, 2003, NAT MATER, V2, P821, DOI 10.1038/nmat1014; Wang XD, 2005, J AM CHEM SOC, V127, P7920, DOI 10.1021/ja050807x; Wang XD, 2004, NANO LETT, V4, P423, DOI 10.1021/nl035102c; Wang XD, 2006, NANO LETT, V6, P2768, DOI 10.1021/nl061802g; Wang ZL, 2007, MRS BULL, V32, P109, DOI 10.1557/mrs2007.42; Wang ZL, 2006, SCIENCE, V312, P242, DOI 10.1126/science.1124005	21	1905	1994	57	1384	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2007	316	5821					102	105		10.1126/science.1139366	http://dx.doi.org/10.1126/science.1139366			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412957				2022-12-01	WOS:000245470500041
J	Lo, I; Denef, VJ; VerBerkmoes, NC; Shah, MB; Goltsman, D; DiBartolo, G; Tyson, GW; Allen, EE; Ram, RJ; Detter, JC; Richardson, P; Thelen, MP; Hettich, RL; Banfield, JF				Lo, Ian; Denef, Vincent J.; VerBerkmoes, Nathan C.; Shah, Manesh B.; Goltsman, Daniela; DiBartolo, Genevieve; Tyson, Gene W.; Allen, Eric E.; Ram, Rachna J.; Detter, J. Chris; Richardson, Paul; Thelen, Michael P.; Hettich, Robert L.; Banfield, Jillian F.			Strain-resolved community proteomics reveals recombining genomes of acidophilic bacteria	NATURE			English	Article							HOMOLOGOUS RECOMBINATION; MICROBIAL COMMUNITY; SP-NOV; MICROORGANISMS; LEPTOSPIRILLUM; POPULATION; PROTEINS; BIOFILM; OCEAN	Microbes comprise the majority of extant organisms, yet much remains to be learned about the nature and driving forces of microbial diversification. Our understanding of how microorganisms adapt and evolve can be advanced by genome-wide documentation of the patterns of genetic exchange, particularly if analyses target coexisting members of natural communities. Here we use community genomic data sets to identify, with strain specificity, expressed proteins from the dominant member of a genomically uncharacterized, natural, acidophilic biofilm. Proteomics results reveal a genome shaped by recombination involving chromosomal regions of tens to hundreds of kilobases long that are derived from two closely related bacterial populations. Inter-population genetic exchange was confirmed by multilocus sequence typing of isolates and of uncultivated natural consortia. The findings suggest that exchange of large blocks of gene variants is crucial for the adaptation to specific ecological niches within the very acidic, metal-rich environment. Mass-spectrometry-based discrimination of expressed protein products that differ by as little as a single amino acid enables us to distinguish the behaviour of closely related coexisting organisms. This is important, given that microorganisms grouped together as a single species may have quite distinct roles in natural systems(1-3) and their interactions might be key to ecosystem optimization. Because proteomic data simultaneously convey information about genome type and activity, strain-resolved community proteomics is an important complement to cultivation-independent genomic ( metagenomic) analysis(4-6) of microorganisms in the natural environment.	Univ Calif Berkeley, Berkeley, CA 94720 USA; Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; Joint Genome Inst, Walnut Creek, CA 94598 USA; Lawrence Livermore Natl Lab, Livermore, CA 94550 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Banfield, JF (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	jbanfield@berkeley.edu	Hettich, Robert L/N-1458-2016; Thelen, Michael/C-6834-2008; Thelen, Michael P/G-2032-2014; Tyson, Gene W/C-6558-2013	Hettich, Robert L/0000-0001-7708-786X; Thelen, Michael/0000-0002-2479-5480; Thelen, Michael P/0000-0002-2479-5480; Tyson, Gene W/0000-0001-8559-9427; Banfield, Jill/0000-0001-8203-8771				Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Bond PL, 2000, APPL ENVIRON MICROB, V66, P3842, DOI 10.1128/AEM.66.9.3842-3849.2000; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Coram NJ, 2002, APPL ENVIRON MICROB, V68, P838, DOI 10.1128/AEM.68.2.838-845.2002; Dalluge JJ, 2002, CURR PROTEIN PEPT SC, V3, P181, DOI 10.2174/1389203024605377; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; JOHNSON DB, 1995, J MICROBIOL METH, V23, P205, DOI 10.1016/0167-7012(95)00015-D; Johnson DB, 2003, RES MICROBIOL, V154, P466, DOI 10.1016/S0923-2508(03)00114-1; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Majewski J, 1999, GENETICS, V152, P1459; Majewski J, 1999, GENETICS, V153, P1525; Manabe T, 1999, ELECTROPHORESIS, V20, P3116, DOI 10.1002/(SICI)1522-2683(19991001)20:15/16<3116::AID-ELPS3116>3.0.CO;2-0; Mau B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r44; Nesbo CL, 2006, GENETICS, V172, P759, DOI 10.1534/genetics.105.049312; Papke RT, 2004, SCIENCE, V306, P1928, DOI 10.1126/science.1103289; Ram RJ, 2005, SCIENCE, V308, P1915, DOI 10.1126/science. 1109070; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Syvanen AC, 2001, NAT REV GENET, V2, P930, DOI 10.1038/35103535; Tyson GW, 2005, APPL ENVIRON MICROB, V71, P6319, DOI 10.1128/AEM.71.10.6319-6324.2005; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Whitaker RJ, 2005, MOL BIOL EVOL, V22, P2354, DOI 10.1093/molbev/msi233	25	179	185	3	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2007	446	7135					537	541		10.1038/nature05624	http://dx.doi.org/10.1038/nature05624			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17344860				2022-12-01	WOS:000245242900049
J	Shimizu, K; Phan, T; Mansuy, IM; Storm, DR				Shimizu, Kimiko; Phan, Trongha; Mansuy, Isabelle M.; Storm, Daniel R.			Proteolytic degradation of SCOP in the hippocampus contributes to activation of MAP kinase and memory	CELL			English	Article							LONG-TERM-MEMORY; MEDIATED GENE-EXPRESSION; SIGNAL-REGULATED KINASE; ELEMENT-BINDING PROTEIN; SYNAPTIC PLASTICITY; NEUROTRANSMITTER RELEASE; SUPRACHIASMATIC NUCLEUS; DEPENDENT ACTIVATION; NEURONAL PLASTICITY; NEUROTROPHIC FACTOR	Because activation of ERK1/2 MAP kinase (MAPK) is critical for hippocampus-dependent memory, there is considerable interest in mechanisms for regulation of MAPK during memory formation. Here we report that MAPK and CREB-mediated transcription are negatively regulated by SCOP (suprachiasmatic nucleus [SCN] circadian oscillatory protein) and that SCOP is proteolyzed by calpain when hippocampal neurons are stimulated by brain-derived neurotrophic factor (BDNF), KCl depolarization, or NMDA. Moreover, training for novel object memory decreases SCOP in the hippocampus. To determine if hippocampus-dependent memory is influenced by SCOP in vivo, we generated a transgenic mouse strain for the inducible overexpression of SCOP in the forebrain. Overexpression of SCOP completely blocked memory for novel objects. We conclude that degradation of SCOP by calpain contributes to activation of MAPK during memory formation.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Zurich, Swiss Fed Inst Technol, Brain Res Inst, CH-8057 Zurich, Switzerland	University of Washington; University of Washington Seattle; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Storm, DR (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	dstorm@u.washington.edu	Mansuy, Isabelle M/N-3042-2015; Kimiko, Shimizu/ACS-9013-2022; Shimizu, Kimiko/G-4956-2014	Mansuy, Isabelle M/0000-0001-7785-5371; Kimiko, Shimizu/0000-0003-4943-2552; Shimizu, Kimiko/0000-0003-4943-2552	NIMH NIH HHS [R01 MH073601] Funding Source: Medline; NINDS NIH HHS [R01 NS020498, NS 20498] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Athos J, 2002, NAT NEUROSCI, V5, P1119, DOI 10.1038/nn951; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; BERNINGER B, 1993, NEUROREPORT, V4, P1303, DOI 10.1097/00001756-199309150-00004; Blum S, 1999, J NEUROSCI, V19, P3535; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; Chan D, 1998, NETW COMPUT, V9, P18; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.0.CO;2-K; Cline H, 2003, CURR BIOL, V13, pR514, DOI 10.1016/S0960-9822(03)00443-3; Coogan AN, 1999, J NEUROPHYSIOL, V81, P103, DOI 10.1152/jn.1999.81.1.103; Dash PK, 2000, NEUROREPORT, V11, P2811, DOI 10.1097/00001756-200008210-00040; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DINGLEDINE R, 1983, FED PROC, V42, P2881; DIVIRGILIO F, 1987, J BIOL CHEM, V262, P9189; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Frankland PW, 2003, NEUROSCIENTIST, V9, P104, DOI 10.1177/1073858403252225; Grammer M, 2005, NEUROBIOL LEARN MEM, V84, P222, DOI 10.1016/j.nlm.2005.07.007; Heerssen HM, 2002, TRENDS NEUROSCI, V25, P160, DOI 10.1016/S0166-2236(02)02144-6; Hegde AN, 2004, PROG NEUROBIOL, V73, P311, DOI 10.1016/j.pneurobio.2004.05.005; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Hetman M, 2000, ACTA NEUROBIOL EXP, V60, P531; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kelly A, 2003, J NEUROSCI, V23, P5354; Li YX, 1998, J NEUROSCI, V18, P10231; Lopez-Salon M, 2001, EUR J NEUROSCI, V14, P1820, DOI 10.1046/j.0953-816x.2001.01806.x; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; Mazzucchelli C, 2000, CELL MOL LIFE SCI, V57, P604, DOI 10.1007/PL00000722; Mazzucchelli C, 2002, NEURON, V34, P807, DOI 10.1016/S0896-6273(02)00716-X; NIXON RA, 1986, J NEUROSCI, V6, P1264; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; Ohno M, 2001, NAT NEUROSCI, V4, P1238, DOI 10.1038/nn771; ONIZUKA K, 1995, BRAIN RES, V697, P179, DOI 10.1016/0006-8993(95)00838-H; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Shimizu K, 2003, J BIOL CHEM, V278, P14920, DOI 10.1074/jbc.M213214200; Shimizu K, 1999, FEBS LETT, V458, P363, DOI 10.1016/S0014-5793(99)01190-4; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; Sindreu CB, 2007, NEURON, V53, P79, DOI 10.1016/j.neuron.2006.11.024; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wang HB, 2003, MOL PHARMACOL, V63, P463, DOI 10.1124/mol.63.3.463; Watt WC, 2004, NEURON, V41, P955, DOI 10.1016/S0896-6273(04)00075-3; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002	51	89	91	1	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2007	128	6					1219	1229		10.1016/j.cell.2006.12.047	http://dx.doi.org/10.1016/j.cell.2006.12.047			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382888	Green Accepted, Bronze			2022-12-01	WOS:000245396200025
J	Triboulet, R; Mari, B; Lin, YL; Chable-Bessia, C; Bennasser, Y; Lebrigand, K; Cardinaud, B; Maurin, T; Barbry, P; Baillat, V; Reynes, J; Corbeau, P; Jeang, KT; Benkirane, M				Triboulet, Robinson; Mari, Bernard; Lin, Yea-Lih; Chable-Bessia, Christine; Bennasser, Yamina; Lebrigand, Kevin; Cardinaud, Bruno; Maurin, Thomas; Barbry, Pascal; Baillat, Vincent; Reynes, Jacques; Corbeau, Pierre; Jeang, Kuan-Teh; Benkirane, Monsef			Suppression of microRNA-silencing pathway by HIV-1 during virus replication	SCIENCE			English	Article							CLUSTER; LATENCY; SIRNA; GENE	MicroRNAs ( miRNAs) are single-stranded noncoding RNAs of 19 to 25 nucleotides that function as gene regulators and as a host cell defense against both RNA and DNA viruses. We provide evidence for a physiological role of the miRNA-silencing machinery in controlling HIV-1 replication. Type III RNAses Dicer and Drosha, responsible for miRNA processing, inhibited virus replication both in peripheral blood mononuclear cells from HIV-1-infected donors and in latently infected cells. In turn, HIV-1 actively suppressed the expression of the polycistronic miRNA cluster miR-17/92. This suppression was found to be required for efficient viral replication and was dependent on the histone acetyltransferase Tat cofactor PCAF. Our results highlight the involvement of the miRNA-silencing pathway in HIV-1 replication and latency.	Inst Genet Humaine, Mol Virol Lab, Montpellier, France; Inst Genet Humaine, Lab Lentivirus & Transfert Genes, Montpellier, France; UNSA, CNRS, UMR 6097, Inst Pharmacol Mol & Cellulaire, Sophia Antipolis, France; Hop Gui de Chauliac, Serv Malad Infect & Trop, Montpellier, France; NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA	Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Universite de Montpellier; CHU de Montpellier; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Benkirane, M (corresponding author), Inst Genet Humaine, Mol Virol Lab, Montpellier, France.	bmonsef@igh.cnrs.fr	Bennasser, Yamina/M-4833-2017; Mari, Bernard P/D-7445-2015; Mari, Bernard P/GVS-3100-2022; Mari, Bernard P/F-8960-2013; Mari, Bernard/Q-5832-2019; Jeang, Kuan-Teh/A-2424-2008; maurin, thomas O/O-7494-2016; Barbry, Pascal/O-5021-2016	Mari, Bernard P/0000-0002-0422-9182; Mari, Bernard P/0000-0002-0422-9182; Mari, Bernard P/0000-0002-0422-9182; Mari, Bernard/0000-0002-0422-9182; maurin, thomas O/0000-0002-8467-3135; Barbry, Pascal/0000-0001-9632-6483	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000547, ZIAAI000547] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Benkirane M, 1998, J BIOL CHEM, V273, P24898, DOI 10.1074/jbc.273.38.24898; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Bennasser Yamina, 2004, Retrovirology, V1, P43, DOI 10.1186/1742-4690-1-43; Emiliani S, 1998, J VIROL, V72, P1666, DOI 10.1128/JVI.72.2.1666-1670.1998; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lassen K, 2004, TRENDS MOL MED, V10, P525, DOI 10.1016/j.molmed.2004.09.006; MACKEWICZ C, 1992, AIDS RES HUM RETROV, V8, P1039, DOI 10.1089/aid.1992.8.1039; Marcello A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-7; Omoto S, 2005, J GEN VIROL, V86, P751, DOI 10.1099/vir.0.80449-0; Ott Melanie, 2004, Novartis Found Symp, V259, P182; Pomerantz Roger J, 2002, Curr Opin Investig Drugs, V3, P1133; Qu F, 2005, FEBS LETT, V579, P5958, DOI 10.1016/j.febslet.2005.08.041; Saumet A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-3; Tagawa H, 2005, LEUKEMIA, V19, P2013, DOI 10.1038/sj.leu.2403942; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Voinnet O, 2002, CURR OPIN PLANT BIOL, V5, P444, DOI 10.1016/S1369-5266(02)00291-1; Yeung ML, 2005, CELL RES, V15, P935, DOI 10.1038/sj.cr.7290371; Yeung ML, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-81	22	496	558	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1579	1582		10.1126/science.1136319	http://dx.doi.org/10.1126/science.1136319			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17322031				2022-12-01	WOS:000244934800054
J	Ijspeert, AJ; Crespi, A; Ryczko, D; Cabelguen, JM				Ijspeert, Auke Jan; Crespi, Alessandro; Ryczko, Dimitri; Cabelguen, Jean-Marie			From swimming to walking with a salamander robot driven by a spinal cord model	SCIENCE			English	Article							CENTRAL PATTERN GENERATOR; COUPLED NONLINEAR OSCILLATORS; NEURAL-NETWORKS; LOCOMOTION; TERRESTRIAL; LAMPREY; COORDINATION; GAITS; NEWT	The transition from aquatic to terrestrial locomotion was a key development in vertebrate evolution. We present a spinal cord model and its implementation in an amphibious salamander robot that demonstrates how a primitive neural circuit for swimming can be extended by phylogenetically more recent limb oscillatory centers to explain the ability of salamanders to switch between swimming and walking. The model suggests neural mechanisms for modulation of velocity, direction, and type of gait that are relevant for all tetrapods. It predicts that limb oscillatory centers have lower intrinsic frequencies than body oscillatory centers, and we present biological data supporting this.	Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, Stn 14, CH-1015 Lausanne, Switzerland; Univ Bordeaux 2, F-33077 Bordeaux, France; INSERM, U862, F-33077 Bordeaux, France	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Ijspeert, AJ (corresponding author), Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, Stn 14, CH-1015 Lausanne, Switzerland.	auke.ijspeert@epfl.ch	Crespi, Alessandro/M-6777-2014	Ryczko, Dimitri/0000-0003-3948-7728; Ijspeert, Auke/0000-0003-1417-9980; Crespi, Alessandro/0000-0001-9863-5220				Ashley-Ross MA, 2004, J EXP BIOL, V207, P461, DOI 10.1242/jeb.00769; Bem T, 2003, BIOL CYBERN, V88, P79, DOI 10.1007/s00422-002-0340-3; Cabelguen JM, 2003, J NEUROSCI, V23, P2434; Cheng JG, 1998, J NEUROSCI, V18, P4295; COHEN AH, 1980, EXP BRAIN RES, V41, P11; Cohen AH., 1988, NEURAL CONTROL RHYTH, P129; COLLINS JJ, 1994, BIOL CYBERN, V71, P375, DOI 10.1007/BF00198915; Combes D, 2004, J PHYSIOL-LONDON, V559, P17, DOI 10.1113/jphysiol.2004.069542; Delvolve I, 1997, J NEUROPHYSIOL, V78, P638, DOI 10.1152/jn.1997.78.2.638; Delvolve I, 1999, J NEUROPHYSIOL, V82, P1074, DOI 10.1152/jn.1999.82.2.1074; ERMENTROUT GB, 1994, SIAM J APPL MATH, V54, P478, DOI 10.1137/S0036139992231964; FROLICH LM, 1992, J EXP BIOL, V162, P107; Gao KQ, 2001, NATURE, V410, P574, DOI 10.1038/35069051; Golubitsky M, 1999, NATURE, V401, P693, DOI 10.1038/44416; GRILLNER S, 1995, TRENDS NEUROSCI, V18, P270, DOI 10.1016/0166-2236(95)93914-J; Grillner S, 1998, BRAIN RES REV, V26, P184, DOI 10.1016/S0165-0173(98)00002-2; Grillner S., 1997, NEURONS NETWORKS MOT, P3; Ijspeert AJ, 2005, NEUROINFORMATICS, V3, P171, DOI 10.1385/NI:3:3:171; Ijspeert AJ, 2001, BIOL CYBERN, V84, P331, DOI 10.1007/s004220000211; Roos P. R., 1964, Proceedings Akademie van Wetenschappen Amsterdam, V67C, P223; SCHONER G, 1988, SCIENCE, V239, P1513, DOI 10.1126/science.3281253; Szekely G., 1976, P765; TUNSTALL MJ, 1994, J PHYSIOL-LONDON, V474, P393, DOI 10.1113/jphysiol.1994.sp020031; Webb B, 2002, NATURE, V417, P359, DOI 10.1038/417359a; WHEATLEY M, 1994, J NEUROPHYSIOL, V71, P2025, DOI 10.1152/jn.1994.71.6.2025; WILLIAMS TL, 1990, J NEUROPHYSIOL, V64, P862, DOI 10.1152/jn.1990.64.3.862	26	695	743	18	214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2007	315	5817					1416	1420		10.1126/science.1138353	http://dx.doi.org/10.1126/science.1138353			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347441	Green Submitted			2022-12-01	WOS:000244752200035
J	Csete, J				Csete, Joanne			AIDS and public security: the other side of the coin	LANCET			English	Editorial Material									Canadian HIV AIDS Legal Network, Toronto, ON M5R 2A7, Canada		Csete, J (corresponding author), Canadian HIV AIDS Legal Network, Toronto, ON M5R 2A7, Canada.	jcsete@aidslaw.ca						Azimi Negar, 2006, NEW YORK TIMES  1203, P63; PANT S, 2006, 16 INT AIDS C TOR CA; *UN DEV PROGR, 2004, THAIL RESP HIV AIDS, P54; *UNAIDS, 2006, UNAIDSPCB19067; *UNAIDS, 2006, RUSS FED COUNTR UPD; WOLFE D, 2004, NATION          0408; 2004, HUMAN RIGHTS WAT APR; 2002, HUMAN RIGHTS WAT JUL; 2004, PRAVDA          1019; 2004, ISN SECURITY WA 1018	10	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 3	2007	369	9563					720	721		10.1016/S0140-6736(07)60334-1	http://dx.doi.org/10.1016/S0140-6736(07)60334-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	143MP	17336630				2022-12-01	WOS:000244726700006
J	Lipscombe, LL; Hux, JE				Lipscombe, Lorraine L.; Hux, Janet E.			Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study	LANCET			English	Article							IMPAIRED GLUCOSE-TOLERANCE; RISING PREVALENCE; OBESITY; MELLITUS; BURDEN; RISK; LIFE	Background The prevalence of diabetes has been increasing greatly, but WHO's predicted 39% rise in the global rate of diabetes from 2000 to 2030 might be an underestimate. We aimed to assess diabetes trends in Ontario, Canada. Methods Using population-based data, including a validated diabetes database from the province of Ontario, Canada, we examined trends in diabetes prevalence and mortality from 1995 to 2005, and incidence from 1997 to 2003, in adults aged 20 years or older. Findings Age-adjusted and sex-adjusted diabetes prevalence increased by 69%, from 5.2% in a population of 7908 562 in 1995 to 8.8% of 9 276 945 in 2005. Prevalence increased by 27% from 6.9% in a population of 8 457 720 in 2000 to 8.8% of 9 276 945 in 2005. Although prevalence rates have remained higher in people aged 50 years or older (7.1% of 3 675 554) than in those aged 20-49 years (3.5% of 5 601391), rates increased to a greater extent in the younger population (94% vs 63%, p<0.0001). A 31% increase occurred in yearly incidence over 6 years, from 6.6 per 1000 in 1997 to 8.2 per 1000 in 2003. The adjusted mortality rate in people with diabetes fell by 25% from 1995 to 2005. Interpretation The prevalence of diabetes in Ontario, Canada increased substantially during the past 10 years, and by 2005 already exceeded the global rate that was predicted for 2030. This increase in prevalence is attributable to both rising incidence and declining mortality. Effective public-health interventions aimed at diabetes prevention are needed, as well as improved resources to manage the greater number of people living longer with the disease.	Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; Womens Coll Hosp, Toronto, ON M5S 1B2, Canada	University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Womens College Hospital	Lipscombe, LL (corresponding author), Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada.	Lorraine.Lipscombe@ices.on.ca	Northe, Hilda/I-1916-2012; Greiver, Michelle/N-8764-2015	Northe, Hilda/0000-0002-8873-5014; Greiver, Michelle/0000-0001-8957-0285; Lipscombe, Lorraine/0000-0001-7412-7993				American Diabetes Association, 2004, DIABETES CARE, V27, pS11, DOI [10.2337/diacare.27.2007.S11, DOI 10.2337/DIACARE.27.2007.S11]; American Diabetes Association: Diagnosis and classification of diabetes mellitus, 2005, DIABETES CARE S1, V28, P537; Anand SS, 2000, LANCET, V356, P279, DOI 10.1016/S0140-6736(00)02502-2; [Anonymous], 2006, GLOB STRAT DIET PHYS; ATKINS RC, 2005, KIDNEY INT S, V94, P14, DOI DOI 10.1111/J.1523-1755.2005.09403.X; Congdon NG, 2003, JAMA-J AM MED ASSOC, V290, P2057, DOI 10.1001/jama.290.15.2057; Dunstan DW, 2002, DIABETES CARE, V25, P829, DOI 10.2337/diacare.25.5.829; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Gregg EW, 2004, DIABETES CARE, V27, P2806, DOI 10.2337/diacare.27.12.2806; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Katzmarzyk PT, 2006, CAN MED ASSOC J, V174, P156, DOI 10.1503/cmaj.050806; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Luo J, 2002, INT J OBESITY, V26, P553, DOI 10.1038/sj.ijo.0801944; Manuel DG, 2004, DIABETES CARE, V27, P407, DOI 10.2337/diacare.27.2.407; McBean AM, 2004, DIABETES CARE, V27, P2317, DOI 10.2337/diacare.27.10.2317; Meltzer S, 1998, CAN MED ASSOC J, V159, pS1; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; *OTT STAT CAN, 2006, ANN DEM STAT 2005; Ramachandran A, 2001, DIABETOLOGIA, V44, P1094, DOI 10.1007/s001250100627; Rennie KL, 2005, OBES REV, V6, P11, DOI 10.1111/j.1467-789X.2005.00164.x; *STAT CAN, 2002, IMM CIT; *STAT CAN, 2006, HLTH STAT HLTH IND; *STAT CAN, 2002, 2001 COMM PROF; Stovring H, 2003, LANCET, V362, P537, DOI 10.1016/S0140-6736(03)14116-5; Tavani A, 2002, J CLIN EPIDEMIOL, V55, P1082, DOI 10.1016/S0895-4356(02)00486-9; Thomas RJ, 2003, ARCH INTERN MED, V163, P445, DOI 10.1001/archinte.163.4.445; *US BUR CENS, 2003, CURR POP REP; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	29	461	475	2	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2007	369	9563					750	756		10.1016/S0140-6736(07)60361-4	http://dx.doi.org/10.1016/S0140-6736(07)60361-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143MP	17336651				2022-12-01	WOS:000244726700031
J	Brueckner, F; Hennecke, U; Carell, T; Cramer, P				Brueckner, Florian; Hennecke, Ulrich; Carell, Thomas; Cramer, Patrick			CPD damage recognition by transcribing RNA polymerase II	SCIENCE			English	Article							TRANSCRIPTION-COUPLED REPAIR; NUCLEOTIDE EXCISION-REPAIR; CYCLOBUTANE PYRIMIDINE DIMER; SYN THYMINE DIMER; ELONGATION COMPLEX; STRUCTURAL BASIS; DNA-DAMAGE; COCKAYNE-SYNDROME; YEAST; RESOLUTION	Cells use transcription-coupled repair (TCR) to efficiently eliminate DNA lesions such as ultraviolet light-induced cyclobutane pyrimidine dimers (CPDs). Here we present the structure-based mechanism for the first step in eukaryotic TCR, CPD-induced stalling of RNA polymerase (Pol)II. A CPD in the transcribed strand slowly passes a translocation barrier and enters the polymerase active site. The CPD 5'-thymine then directs uridine misincorporation into messenger RNA, which blocks translocation. Artificial replacement of the uridine by adenosine enables CPD bypass; thus, Pol II stalling requires CPD-directed misincorporation. In the stalled complex, the lesion is inaccessible, and the polymerase conformation is unchanged. This is consistent with nonallosteric recruitment of repair factors and excision of a lesion-containing DNA fragment in the presence of Pol II.	Univ Munich, Munich Ctr Integrated Prot Sci, CiPSm, D-81377 Munich, Germany; Univ Munich, Dept Chem & Biochem, D-81377 Munich, Germany; Univ Munich, Gene Ctr Munich, D-81377 Munich, Germany	University of Munich; University of Munich; University of Munich	Carell, T (corresponding author), Univ Munich, Munich Ctr Integrated Prot Sci, CiPSm, D-81377 Munich, Germany.	thomas.carell@cup.uni-muenchen.de; cramer@lmb.uni-muenchen.de	Hennecke, Ulrich/A-7723-2010; Carell, Thomas/G-4799-2012	Hennecke, Ulrich/0000-0002-4904-6793; Carell, Thomas/0000-0001-7898-2831				ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; DONAHUE BA, 1994, P NATL ACAD SCI USA, V91, P8502, DOI 10.1073/pnas.91.18.8502; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Kwei JSM, 2004, BIOCHEM BIOPH RES CO, V320, P1133, DOI 10.1016/j.bbrc.2004.06.066; Laine JP, 2006, EMBO J, V25, P387, DOI 10.1038/sj.emboj.7600933; Lee SK, 2002, MOL CELL BIOL, V22, P4383, DOI 10.1128/MCB.22.12.4383-4389.2002; Li Y, 2004, NAT STRUCT MOL BIOL, V11, P784, DOI 10.1038/nsmb792; Ling H, 2003, NATURE, V424, P1083, DOI 10.1038/nature01919; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Mitchell JR, 2003, CURR OPIN CELL BIOL, V15, P232, DOI 10.1016/S0955-0674(03)00018-8; Mu D, 1997, J BIOL CHEM, V272, P7570, DOI 10.1074/jbc.272.12.7570; Prakash S, 2000, MUTAT RES-FUND MOL M, V451, P13, DOI 10.1016/S0027-5107(00)00037-3; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; Saxowsky TT, 2006, CHEM REV, V106, P474, DOI 10.1021/cr040466q; Selby CP, 1997, NUCLEIC ACIDS RES, V25, P787, DOI 10.1093/nar/25.4.787; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Selby CP, 1997, J BIOL CHEM, V272, P1885, DOI 10.1074/jbc.272.3.1885; Svejstrup JQ, 2003, J CELL SCI, V116, P447, DOI 10.1242/jcs.00271; Tornaletti S, 1997, J BIOL CHEM, V272, P31719, DOI 10.1074/jbc.272.50.31719; Tremeau-Bravard A, 2004, J BIOL CHEM, V279, P7751, DOI 10.1074/jbc.M309853200; Verhage RA, 1997, MOL GEN GENET, V254, P284, DOI 10.1007/s004380050417; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a	28	180	182	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2007	315	5813					859	862		10.1126/science.1135400	http://dx.doi.org/10.1126/science.1135400			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17290000	Green Published			2022-12-01	WOS:000244069000073
J	Himmel, ME; Ding, SY; Johnson, DK; Adney, WS; Nimlos, MR; Brady, JW; Foust, TD				Himmel, Michael E.; Ding, Shi-You; Johnson, David K.; Adney, William S.; Nimlos, Mark R.; Brady, John W.; Foust, Thomas D.			Biomass recalcitrance: Engineering plants and enzymes for biofuels production	SCIENCE			English	Editorial Material							DILUTE-SULFURIC-ACID; HYDROGEN-BONDING SYSTEM; SYNCHROTRON X-RAY; TRICHODERMA-REESEI; CRYSTAL-STRUCTURE; CORN STOVER; PRETREATMENT; HYDROLYSIS; XYLAN; CELLULOSOMES	Lignocellulosic biomass has long been recognized as a potential sustainable source of mixed sugars for fermentation to biofuels and other biomaterials. Several technologies have been developed during the past 80 years that allow this conversion process to occur, and the clear objective now is to make this process cost-competitive in today's markets. Here, we consider the natural resistance of plant cell walls to microbial and enzymatic deconstruction, collectively known as "biomass recalcitrance." It is this property of plants that is largely responsible for the high cost of lignocellulose conversion. To achieve sustainable energy production, it will be necessary to overcome the chemical and structural properties that have evolved in biomass to prevent its disassembly.	Natl Renewable Energy Lab, Chem & Biosci Ctr, Golden, CO 80401 USA; Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA; Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Cornell University; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Himmel, ME (corresponding author), Natl Renewable Energy Lab, Chem & Biosci Ctr, Golden, CO 80401 USA.	mike_himmel@nrel.gov	Johnson, David K/G-4959-2011; DING, SHIYOU/ABD-8519-2021; Ding, Shi-You/O-1209-2013	Johnson, David K/0000-0003-4815-8782; DING, SHIYOU/0000-0002-1102-1507; Foust, Thomas/0000-0002-3995-8254				Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Bayer EA, 1998, J STRUCT BIOL, V124, P221, DOI 10.1006/jsbi.1998.4065; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Ding SY, 2006, J AGR FOOD CHEM, V54, P597, DOI 10.1021/jf051851z; Doblin MS, 2002, PLANT CELL PHYSIOL, V43, P1407, DOI 10.1093/pcp/pcf164; Esteghlalian A, 1997, BIORESOURCE TECHNOL, V59, P129, DOI 10.1016/S0960-8524(97)81606-9; European Commission, 2006, BIOF EUR UN VIS 2030; Faaij APC, 2006, ENERG POLICY, V34, P322, DOI 10.1016/j.enpol.2004.03.026; GAUSS W, 1976, Patent No. 39909444; Himmel ME, 1999, CURR OPIN BIOTECH, V10, P358, DOI 10.1016/S0958-1669(99)80065-2; Himmel ME, 1997, ACS SYM SER, V666, P2; HOUGHTON J, 2005, BREAKING BIOL BARRIE; IIYAMA K, 1994, PLANT PHYSIOL, V104, P315, DOI 10.1104/pp.104.2.315; KIM SB, 1987, BIOTECHNOL BIOENG S, V17, P71; Kipper K, 2005, BIOCHEM J, V385, P527, DOI 10.1042/BJ20041144; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Liu CG, 2004, IND ENG CHEM RES, V43, P2781, DOI 10.1021/ie030754x; Lu YP, 2006, P NATL ACAD SCI USA, V103, P16165, DOI 10.1073/pnas.0605381103; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; MALONEY MT, 1985, BIOTECHNOL BIOENG, V27, P355, DOI 10.1002/bit.260270321; Matthews JF, 2006, CARBOHYD RES, V341, P138, DOI 10.1016/j.carres.2005.09.028; Mayans O, 1997, STRUCTURE, V5, P677, DOI 10.1016/S0969-2126(97)00222-0; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; Nishiyama Y, 2003, J AM CHEM SOC, V125, P14300, DOI 10.1021/ja037055w; Nonhebel S, 2005, RENEW SUST ENERG REV, V9, P191, DOI 10.1016/j.rser.2004.02.003; *OBP, 2005, MULT PROGR PLAN 2007; PERLACK RD, 2005, TM2005 ORNL; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; SHIANG M, 1991, BIOTECHNOL PROGR, V7, P315, DOI 10.1021/bp00010a005; SUN Y, IN PRESS BIORESOUR T; Teymouri F, 2005, BIORESOURCE TECHNOL, V96, P2014, DOI 10.1016/j.biortech.2005.01.016; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; TORGET R, 1992, APPL BIOCHEM BIOTECH, V34-5, P115, DOI 10.1007/BF02920538; TORGET R, 1991, BIORESOURCE TECHNOL, V35, P239, DOI 10.1016/0960-8524(91)90120-9; *US DEP EN OFF BIO, 2006, 30 X 30 WORKSH WASH; *USDA NAT RES CONS, 2003, NAT RES INV 2001 ANN; VRSANSKA M, 1992, CARBOHYD RES, V227, P19, DOI 10.1016/0008-6215(92)85058-8; Wyman CE, 2005, BIORESOURCE TECHNOL, V96, P1959, DOI 10.1016/j.biortech.2005.01.010; Yang B, 2004, BIOTECHNOL BIOENG, V86, P88, DOI 10.1002/bit.20043	39	3211	3390	30	1682	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2007	315	5813					804	807		10.1126/science.1137016	http://dx.doi.org/10.1126/science.1137016			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289988				2022-12-01	WOS:000244069000056
J	Moerke, NJ; Aktas, H; Chen, H; Cantel, S; Reibarkh, MY; Fahmy, A; Gross, JD; Degterev, A; Yuan, JY; Chorev, M; Halperin, JA; Wagner, G				Moerke, Nathan J.; Aktas, Huseyin; Chen, Han; Cantel, Sonia; Reibarkh, Mikhail Y.; Fahmy, Amr; Gross, John D.; Degterev, Alexei; Yuan, Junying; Chorev, Michael; Halperin, Jose A.; Wagner, Gerhard			Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G	CELL			English	Article							CAP-DEPENDENT TRANSLATION; BINDING PROTEIN EIF4E; MESSENGER-RNA CAP; FACTOR EIF-4E; MALIGNANT-TRANSFORMATION; MTOR INHIBITORS; CANCER; PHOSPHORYLATION; STIMULATION; REGULATORS	Assembly of the eIF4E/eIF4G complex has a central role in the regulation of gene expression at the level of translation initiation. This complex is regulated by the 4E-BPs, which compete with eIF4G for binding to eIF4E and which have tumor-suppressor activity. To pharmacologically mimic 4E-BP function we developed a high-throughput screening assay for identifying small-molecule inhibitors of the eIF4E/eIF4G interaction. The most potent compound identified, 4EGI-1, binds eIF4E, disrupts eIF4E/eIF4G association, and inhibits cap-dependent translation but not initiation factor-independent translation. While 4EGI-1 displaces eIF4G from eIF4E, it effectively enhances 4E-BP1 association both in vitro and in cells. 4EGI-1 inhibits cellular expression of oncogenic proteins encoded by weak mRNAs, exhibits activity against multiple cancer cell lines, and appears to have a preferential effect on transformed versus nontransformed cells. The identification of this compound provides a new tool for studying translational control and establishes a possible new strategy for cancer therapy.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Lab Translat Res, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School	Wagner, G (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	gerhard_wagner@hms.harvard.edu	cantel, sonia/C-7121-2012	Reibarkh, Mikhail/0000-0002-6589-707X	NATIONAL CANCER INSTITUTE [R01CA078411, U19CA087427, R01CA068262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047467] Funding Source: NIH RePORTER; NCI NIH HHS [CA87427, CA68262, CA078411] Funding Source: Medline; NIBIB NIH HHS [EB002026] Funding Source: Medline; NIGMS NIH HHS [P01 GM047467, GM47467] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altmann M, 1997, EMBO J, V16, P1114, DOI 10.1093/emboj/16.5.1114; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Avdulov S, 2004, CANCER CELL, V5, P553, DOI 10.1016/j.ccr.2004.05.024; Averous J, 2006, ONCOGENE, V25, P6423, DOI 10.1038/sj.onc.1209887; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Bordeleau ME, 2005, P NATL ACAD SCI USA, V102, P10460, DOI 10.1073/pnas.0504249102; DALEY GQ, 1988, P NATL ACAD SCI USA, V85, P9312, DOI 10.1073/pnas.85.23.9312; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; DeFatta RJ, 2000, LARYNGOSCOPE, V110, P928, DOI 10.1097/00005537-200006000-00007; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; EDERY I, 1988, GENE, V74, P517, DOI 10.1016/0378-1119(88)90184-9; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Fan YH, 2004, BIOORG MED CHEM LETT, V14, P2547, DOI 10.1016/j.bmcl.2004.02.087; FukuchiShimogori T, 1997, CANCER RES, V57, P5041; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 2001, GENE DEV, V15, P2852; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; Herbert TP, 2000, CURR BIOL, V10, P793, DOI 10.1016/S0960-9822(00)00567-4; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Hershey PEC, 1999, J BIOL CHEM, V274, P21297, DOI 10.1074/jbc.274.30.21297; Huang S, 2003, CURR OPIN PHARMACOL, V3, P371, DOI 10.1016/S1471-4892(03)00071-7; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Keller R., 2004, COMPUTER AIDED RESON; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Lee CH, 2007, ANNU REV PHARMACOL, V47, P443, DOI 10.1146/annurev.pharmtox.47.120505.105359; Li SN, 2002, MOL CELL BIOL, V22, P2853, DOI 10.1128/MCB.22.8.2853-2861.2002; LODISH HF, 1976, ANNU REV BIOCHEM, V45, P39, DOI 10.1146/annurev.bi.45.070176.000351; MADER S, 1995, MOL CELL BIOL, V15, P4990; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Miura T, 2003, J BIOMOL NMR, V27, P279, DOI 10.1023/A:1025442322316; Novac O, 2004, NUCLEIC ACIDS RES, V32, P902, DOI 10.1093/nar/gkh235; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Petroulakis E, 2006, BRIT J CANCER, V94, P195, DOI 10.1038/sj.bjc.6602902; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; Polunovsky VA, 2000, J BIOL CHEM, V275, P24776, DOI 10.1074/jbc.M001938200; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16056, DOI 10.1021/bi048233g; Rousseau D, 1996, ONCOGENE, V13, P2415; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Sawyers CL, 2003, CANCER CELL, V4, P343, DOI 10.1016/S1535-6108(03)00275-7; Svitkin YV, 2001, RNA, V7, P1743; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Tomoo K, 2006, J BIOCHEM, V140, P237, DOI 10.1093/jb/mvj143; von der Haar T, 2004, NAT STRUCT MOL BIOL, V11, P503, DOI 10.1038/nsmb779; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244	58	401	417	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2007	128	2					257	267		10.1016/j.cell.2006.11.046	http://dx.doi.org/10.1016/j.cell.2006.11.046			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254965	Bronze			2022-12-01	WOS:000244420500012
J	Goldenfeld, N; Woese, C				Goldenfeld, Nigel; Woese, Carl			Biology's next revolution	NATURE			English	Editorial Material									Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Goldenfeld, N (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.							Frigaard NU, 2006, NATURE, V439, P847, DOI 10.1038/nature04435; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Vetsigian K, 2006, P NATL ACAD SCI USA, V103, P10696, DOI 10.1073/pnas.0603780103	4	169	180	1	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2007	445	7126					369	369		10.1038/445369a	http://dx.doi.org/10.1038/445369a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	128WD	17251963	Green Submitted			2022-12-01	WOS:000243689500021
J	Myers, RA; Baum, JK; Shepherd, TD; Powers, SP; Peterson, CH				Myers, Ransom A.; Baum, Julia K.; Shepherd, Travis D.; Powers, Sean P.; Peterson, Charles H.			Cascading effects of the loss of apex predatory sharks from a coastal ocean	SCIENCE			English	Article							LOWER CHESAPEAKE BAY; TROPHIC CASCADES; INTERACTION STRENGTH; RHINOPTERA-BONASUS; MARINE ECOSYSTEMS; COWNOSE RAY; FOOD WEBS; SCALLOPS; EXTINCTIONS; COLLAPSE	Impacts of chronic overfishing are evident in population depletions worldwide, yet indirect ecosystem effects induced by predator removal from oceanic food webs remain unpredictable. As abundances of all 11 great sharks that consume other elasmobranchs (rays, skates, and small sharks) fell over the past 35 years, 12 of 14 of these prey species increased in coastal northwest Atlantic ecosystems. Effects of this community restructuring have cascaded downward from the cownose ray, whose enhanced predation on its bay scallop prey was sufficient to terminate a century-long scallop fishery. Analogous top-down effects may be a predictable consequence of eliminating entire functional groups of predators.	Univ N Carolina, Inst Marine Sci, Morehead City, NC 28557 USA; Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada; Univ S Alabama, Dept Marine Sci, Dauphin Isl, AL 36528 USA; Dauphin Isl Sea Lab, Dauphin Isl, AL 36528 USA	University of North Carolina; University of North Carolina Chapel Hill; Dalhousie University; University of South Alabama; Dauphin Island Sea Lab	Baum, JK (corresponding author), Univ N Carolina, Inst Marine Sci, Morehead City, NC 28557 USA.	baum@mscs.dal.ca; cpeters@email.unc.edu	Baum, Julia K/A-4693-2008	Baum, Julia/0000-0002-9827-1612; Powers, Sean/0000-0002-4770-9944				Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; BLAYLOCK RA, 1993, ESTUARIES, V16, P255, DOI 10.2307/1352498; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Duffy JE, 2002, OIKOS, V99, P201, DOI 10.1034/j.1600-0706.2002.990201.x; Dulvy NK, 2000, CONSERV BIOL, V14, P283, DOI 10.1046/j.1523-1739.2000.98540.x; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; FAHRENTHOLD DA, 2004, WASHINGTON POST 0824; FOWLER SL, 2005, RAYS CHIMAERAS STATU; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Grusha, 2005, THESIS COLL WILLIAM; Ha D., 2006, THESIS COLL WILLIAM; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; ORTH R J, 1975, Chesapeake Science, V16, P205, DOI 10.2307/1350896; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; PAINE RT, 1980, J ANIM ECOL, V49, P667; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Peterson CH, 1996, MAR ECOL PROG SER, V132, P93, DOI 10.3354/meps132093; PETERSON CH, 1989, J EXP MAR BIOL ECOL, V127, P121, DOI 10.1016/0022-0981(89)90179-2; Peterson CH, 2001, OECOLOGIA, V129, P349, DOI 10.1007/s004420100742; Rogers SI, 2000, ICES J MAR SCI, V57, P866, DOI 10.1006/jmsc.2000.0574; SMITH JW, 1985, ESTUARIES, V8, P305, DOI 10.2307/1351491; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; STRONG DR, 1992, ECOLOGY, V73, P747, DOI 10.2307/1940154; Yamaguchi A, 2005, ENVIRON BIOL FISH, V74, P229, DOI 10.1007/s10641-005-0217-0	26	875	896	20	1151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1846	1850		10.1126/science.1138657	http://dx.doi.org/10.1126/science.1138657			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395829				2022-12-01	WOS:000245280100044
J	van Swinderen, B				van Swinderen, Bruno			Attention-like processes in Drosophila require short-term memory genes	SCIENCE			English	Article							MELANOGASTER; MUTANTS; BRAIN; DUNCE; CONTEXT; SYSTEM	Although there is much behavioral evidence for complex brain functions in insects, it is not known whether insects have selective attention. In humans, selective attention is a dynamic process restricting perception to a succession of salient stimuli, while less relevant competing stimuli are suppressed. Local field potential recordings in the brains of flies responding to visual novelty revealed attention-like processes with stereotypical temporal properties. These processes were modulated by genes involved in short-term memory formation, namely dunce and rutabaga. Attention defects in these mutants were associated with distinct optomotor effects in behavioral assays.	Inst Neurosci, San Diego, CA 92121 USA		van Swinderen, B (corresponding author), Inst Neurosci, 10640 John Jay Hopkins Dr, San Diego, CA 92121 USA.	van@nsi.edu		van Swinderen, Bruno/0000-0001-6552-7418				Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Brembs B, 2006, LEARN MEMORY, V13, P618, DOI 10.1101/lm.318606; DAUWALDER B, 1995, J NEUROSCI, V15, P3490; DAVIS RL, 1995, MOL CELL BIOCHEM, V149, P271, DOI 10.1007/BF01076588; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; Engel JE, 1996, J NEUROSCI, V16, P3486; FOLKERS E, 1982, J INSECT PHYSIOL, V28, P535, DOI 10.1016/0022-1910(82)90034-8; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Gong ZF, 1998, J INSECT PHYSIOL, V44, P1149, DOI 10.1016/S0022-1910(98)00076-6; Guo FZ, 2005, SCIENCE, V309, P307, DOI 10.1126/science.1111280; HEISENBERG M, 1948, STUDIES BRAIN FUNCTI; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Tang SM, 2004, SCIENCE, V305, P1020, DOI 10.1126/science.1099839; Tang SM, 2001, SCIENCE, V294, P1543, DOI 10.1126/science.1058237; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; van Swinderen B, 2005, BIOESSAYS, V27, P321, DOI 10.1002/bies.20195; van Swinderen B, 2003, NAT NEUROSCI, V6, P579, DOI 10.1038/nn1054; van Swinderen B, 2006, J NEUROBIOL, V66, P1195, DOI 10.1002/neu.20300; VANSWINDEREN B, 2006, J NEUROBIOL     1207, DOI DOI 10.1002/NEU.20334; WOLF R, 1980, J COMP PHYSIOL, V140, P69, DOI 10.1007/BF00613749	24	75	76	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1590	1593		10.1126/science.1137931	http://dx.doi.org/10.1126/science.1137931			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363675				2022-12-01	WOS:000244934800057
J	Krzemien, J; Dubois, L; Makki, R; Meister, M; Vincent, A; Crozatier, M				Krzemien, Joanna; Dubois, Laurence; Makki, Rami; Meister, Marie; Vincent, Alain; Crozatier, Michele			Control of blood cell homeostasis in Drosophila larvae by the posterior signalling centre	NATURE			English	Article							STEM-CELLS; HEMATOPOIESIS; NICHE; MELANOGASTER; INSIGHTS; DELTA	Drosophila haemocytes ( blood cells) originate from a specialized haematopoietic organ - the lymph gland. Larval haematopoietic progenitors (prohaemocytes) give rise to three types of circulating haemocytes: plasmatocytes, crystal cells and lamellocytes. Lamellocytes, which are devoted to encapsulation of large foreign bodies, only differentiate in response to specific immune threats, such as parasitization by wasps. Here we show that a small cluster of signalling cells, termed the PSC ( posterior signalling centre)(1), controls the balance between multipotent prohaemocytes and differentiating haemocytes, and is necessary for the massive differentiation of lamellocytes that follows parasitization. Communication between the PSC and haematopoietic progenitors strictly depends on the PSC-restricted expression of Collier, the Drosophila orthologue of mammalian early B-cell factor. PSC cells act, in a non-cell-autonomous manner, to maintain JAK/STAT signalling activity in prohaemocytes, preventing their premature differentiation. Serrate-mediated Notch signalling from the PSC is required to maintain normal levels of col transcription. The key role of the PSC in controlling blood cell homeostasis is reminiscent of interactions between haematopoietic progenitors and their microenvironment in vertebrates(2 - 4), thus further highlighting the interest of Drosophila as a model system for studying the evolution of haematopoiesis and cellular innate immunity.	Univ Toulouse 3, CNRS, UMR 5547, Ctr Dev Biol, F-31062 Toulouse 09, France; Univ Toulouse 3, CNRS, IFR 109, Ctr Dev Biol, F-31062 Toulouse, France; Jagiellonian Univ, Inst Zool, PL-30060 Krakow, Poland; CNRS, UPR 9022, IBMC, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Jagiellonian University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Crozatier, M (corresponding author), Univ Toulouse 3, CNRS, UMR 5547, Ctr Dev Biol, 118 Route Narbonne, F-31062 Toulouse 09, France.	crozat@cict.fr	Makki, Rami/F-9236-2012; Vincent, Alain/AAE-4712-2019					Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411; Bataille L, 2005, DEVELOPMENT, V132, P4635, DOI 10.1242/dev.02034; Bourbon HM, 2002, MECH DEVELOP, V110, P71, DOI 10.1016/S0925-4773(01)00566-4; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Crozatier M, 2004, PLOS BIOL, V2, P1107, DOI 10.1371/journal.pbio.0020196; Crozatier M, 1999, DEVELOPMENT, V126, P1495; de Joussineau C, 2003, NATURE, V426, P555, DOI 10.1038/nature02157; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Holz A, 2003, DEVELOPMENT, V130, P4955, DOI 10.1242/dev.00702; Hombria JCG, 2005, DEV BIOL, V288, P420, DOI 10.1016/j.ydbio.2005.09.040; Irving P, 2005, CELL MICROBIOL, V7, P335, DOI 10.1111/j.1462-5822.2004.00462.x; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; KIMBLE J, 2005, WORMBOOK; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lebestky T, 2003, GENE DEV, V17, P348, DOI 10.1101/gad.1052803; Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952; Meister M, 2003, CELL MICROBIOL, V5, P573, DOI 10.1046/j.1462-5822.2003.00302.x; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; RIZKI RM, 1984, P NATL ACAD SCI-BIOL, V81, P6154, DOI 10.1073/pnas.81.19.6154; Rolff J, 2003, SCIENCE, V301, P472, DOI 10.1126/science.1080623; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Sepp KJ, 1999, GENETICS, V151, P1093; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Sun X, 1996, DEVELOPMENT, V122, P2465; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	28	241	250	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2007	446	7133					325	328		10.1038/nature05650	http://dx.doi.org/10.1038/nature05650			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17361184				2022-12-01	WOS:000244892900047
J	Tenoever, BR; Ng, SL; Chua, MA; McWhirter, SM; Garcia-Sastre, A; Maniatis, T				tenOever, Benjamin R.; ng, Sze-Li Ng; Chua, Mark A.; McWhirter, Sarah M.; Garcia-Sastre, Adolfo; Maniatis, Tom			Multiple functions of the IKK-related kinase IKK epsilon in interferon-mediated antiviral immunity	SCIENCE			English	Article							STAT1; LIPOPOLYSACCHARIDE; INFECTION	IKK epsilon is an IKK ( inhibitor of nuclear factor kappa B kinase)-related kinase implicated in virus induction of interferon-beta (IFN beta). We report that, although mice lacking IKK epsilon produce normal amounts of IFN beta, they are hypersusceptible to viral infection because of a defect in the IFN signaling pathway. Specifically, a subset of type I IFN-stimulated genes are not activated in the absence of IKK epsilon because the interferon-stimulated gene factor 3 complex (ISGF3) does not bind to promoter elements of the affected genes. We demonstrate that IKK epsilon is activated by IFN beta and that IKK epsilon directly phosphorylates signal transducer and activator of transcription 1 (STAT1), a component of ISGF3. We conclude that IKK epsilon plays a critical role in the IFN-inducible antiviral transcriptional response.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; Mt Sinai Sch Med, Microbiol Grad Sch Training Program, New York, NY 10029 USA; Mt Sinai Sch Med, Emerging Pathogens Inst, New York, NY 10029 USA	Harvard University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Maniatis, T (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	maniatis@mcb.harvard.edu		Garcia-Sastre, Adolfo/0000-0002-6551-1827	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062623, F31AI056678, P01AI058113, R01AI046954] Funding Source: NIH RePORTER; NIAID NIH HHS [F31 AI056678, P01AI058113, R01AI46954, U19AI62623] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; FU XY, 1990, P NATL ACAD SCI USA, V87, P8555, DOI 10.1073/pnas.87.21.8555; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; George CX, 2005, J BIOL CHEM, V280, P15020, DOI 10.1074/jbc.M500476200; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Kim TK, 1996, SCIENCE, V273, P1717, DOI 10.1126/science.273.5282.1717; LEVY DE, 1988, GENE DEV, V2, P383, DOI 10.1101/gad.2.4.383; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; McWhirter SM, 2005, CELL, V122, P645, DOI 10.1016/j.cell.2005.08.026; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; QURESHI SA, 1995, P NATL ACAD SCI USA, V92, P3829, DOI 10.1073/pnas.92.9.3829; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; Sweeney SE, 2006, ANN RHEUM DIS, V65, pA32; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9	19	272	284	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816					1274	1278		10.1126/science.1136567	http://dx.doi.org/10.1126/science.1136567			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332413				2022-12-01	WOS:000244564700049
J	Von Drygalski, A; Curtis, BR; Bougie, DW; McFarland, JG; Ahl, S; Limbu, I; Baker, KR; Aster, RH				Von Drygalski, Annette; Curtis, Brian R.; Bougie, Daniel W.; McFarland, Janice G.; Ahl, Scott; Limbu, Indra; Baker, Kelty R.; Aster, Richard H.			Vancomycin-induced immune thrombocytopenia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPARIN-INDUCED THROMBOCYTOPENIA; DEPENDENT ANTIBODIES; NEUTROPENIA	BACKGROUND: Vancomycin has only rarely been implicated as a cause of thrombocytopenia, and there is only limited evidence that this complication is caused by immune mechanisms. We conducted a study to determine whether thrombocytopenia is caused by vancomycin-dependent antibodies in patients being treated with vancomycin. METHODS: We identified and characterized vancomycin-dependent, platelet-reactive antibodies in patients who had been referred for testing during a 5-year period because of a clinical suspicion of vancomycin-induced thrombocytopenia. We obtained clinical information about the patients from their referring physicians. RESULTS: Drug-dependent, platelet-reactive antibodies of the IgG class, the IgM class, or both were identified in 34 patients, and clinical follow-up information was obtained from 29 of these patients. The mean nadir platelet count in these patients was 13,600 per cubic millimeter, and severe bleeding occurred in 10 patients (34%). Platelet levels returned to baseline in all 26 surviving patients after vancomycin was stopped. In 15 patients, the drug was continued for 1 to 14 days while other possible causes of thrombocytopenia were investigated. Vancomycin-dependent antibodies were not found in 25 patients who had been given vancomycin and in whom thrombocytopenia did not develop. CONCLUSIONS: Severe bleeding can occur in patients with vancomycin-induced immune thrombocytopenia. The detection of vancomycin-dependent antiplatelet antibodies in patients receiving the antibiotic in whom thrombocytopenia develops, and the absence of antibodies in patients given the drug in whom platelet counts remain stable, indicate that these antibodies are the cause of the thrombocytopenia.	Blood Ctr Wisonsin, Blood Res Inst, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Versiti Blood Center of Wisconsin; Medical College of Wisconsin; Baylor College of Medicine	Aster, RH (corresponding author), Blood Ctr Wisonsin, Blood Res Inst, 8727 Watertown Plank Rd, Milwaukee, WI 53226 USA.	richard.aster@bcw.edu	Curtis, Brian R/AAT-7861-2020		NHLBI NIH HHS [R01 HL013629, HL-13629] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL013629, R01HL013629, R56HL013629] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aster RH, 2005, TOXICOLOGY, V209, P149, DOI 10.1016/j.tox.2004.12.031; Bougie DW, 2006, BLOOD, V108, P922, DOI 10.1182/blood-2006-01-009803; Bougie DW, 2002, BLOOD, V100, P2071, DOI 10.1182/blood.V100.6.2071.h81802002071_2071_2076; CHRISTIE DJ, 1990, BLOOD, V75, P518; Crowther MA, 2005, J CRIT CARE, V20, P348, DOI 10.1016/j.jcrc.2005.09.008; CURTIS BR, 1994, BLOOD, V84, P176, DOI 10.1182/blood.V84.1.176.bloodjournal841176; Curtis BR, 2002, BLOOD, V99, P2054, DOI 10.1182/blood.V99.6.2054; Davoren A, 2006, AM J HEMATOL, V81, P36, DOI 10.1002/ajh.20490; DeLoughery TG, 2005, CRIT CARE CLIN, V21, P531, DOI 10.1016/j.ccc.2005.05.003; Garner SF, 2005, BRIT J HAEMATOL, V129, P279, DOI 10.1111/j.1365-2141.2005.05430.x; George JN, 1998, ANN INTERN MED, V129, P886, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00009; Kojouri K, 2000, J Okla State Med Assoc, V93, P519; Kuruppu JC, 1999, AM J HEMATOL, V60, P249, DOI 10.1002/(SICI)1096-8652(199903)60:3<249::AID-AJH20>3.3.CO;2-8; Lo GK, 2006, J THROMB HAEMOST, V4, P759, DOI 10.1111/j.1538-7836.2006.01787.x; Marraffa J, 2003, PHARMACOTHERAPY, V23, P1195, DOI 10.1592/phco.23.10.1195.32765; Michelson A., 2002, PLATELETS, P593; MILSTEEN S, 1987, AM J MED SCI, V294, P110, DOI 10.1097/00000441-198708000-00010; Mizon P, 1997, VOX SANG, V73, P49, DOI 10.1046/j.1423-0410.1997.7310049.x; MORRIS A, 1991, J INFECTION, V22, P217, DOI 10.1016/S0163-4453(05)80002-7; PARKER CW, 1981, ARTHRITIS RHEUM, V24, P1024, DOI 10.1002/art.1780240808; Peterson JA, 2005, TRANSFUSION, V45, P1487, DOI 10.1111/j.1537-2995.2005.00561.x; Reddy JC, 2004, ARCH INTERN MED, V164, P218, DOI 10.1001/archinte.164.2.218; Rybak MJ, 2006, CLIN INFECT DIS, V42, pS35, DOI 10.1086/491712; Segarra-Newnham M, 2004, ANN PHARMACOTHER, V38, P1855, DOI 10.1345/aph.1E187; Shulman N. Raphael, 1993, Transfusion Medicine Reviews, V7, P215; VISENTIN GP, 1991, BLOOD, V77, P2668; Warkentin TE, 2004, SEMIN THROMB HEMOST, V30, P273, DOI 10.1055/s-2004-831039	28	110	113	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2007	356	9					904	910		10.1056/NEJMoa065066	http://dx.doi.org/10.1056/NEJMoa065066			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	140HV	17329697				2022-12-01	WOS:000244496400005
J	Wakabayashi, Y; Mao, JH; Brown, K; Girardi, M; Balmain, A				Wakabayashi, Yuichi; Mao, Jian-Hua; Brown, Ken; Girardi, Michael; Balmain, Allan			Promotion of Hras-induced squamous carcinomas by a polymorphic variant of the Patched gene in FVB mice	NATURE			English	Article							BASAL-CELL CARCINOMAS; HUMAN HOMOLOG; SKIN TUMORS; SIGNALING PATHWAY; INDUCED APOPTOSIS; SONIC HEDGEHOG; DROSOPHILA; MUTATIONS; CANCER; RAS	Mice of the C57BL/6 strain are resistant to the development of skin squamous carcinomas (SCCs) induced by an activated Ras oncogene, whereas FVB/N mice are highly susceptible(1). The genetic basis of this difference in phenotype is unknown. Here we show that susceptibility to SCC is under the control of a carboxyterminal polymorphism in the mouse Ptch gene. F-1 hybrids between C57BL/6 and FVB/N strains ((B6FVB)F-1) are resistant to Ras-induced SCCs, but resistance can be overcome either by elimination of the C57BL/6 Ptch allele (Ptch(B6)) or by overexpression of the FVB/N Ptch allele (Ptch(FVB)) in the epidermis of K5Hras-transgenic (B6FVB) F-1 hybrid mice. The human Patched (PTCH) gene is a classical tumour suppressor gene for basal cell carcinomas and medulloblastomas, the loss of which causes increased signalling through the Sonic Hedgehog (SHH) pathway(2-5). SCCs that develop in Ptch(B6+/-) mice do not lose the wild-type Ptch gene or show evidence of increased SHH signalling. Although Ptch(FVB) overexpression can promote SCC formation, continued expression is not required for tumour maintenance, suggesting a role at an early stage of tumour cell lineage commitment. The Ptch polymorphism affects Hras-induced apoptosis, and binding to Tid1, the mouse homologue of the Drosophila l( 2) tid tumour suppressor gene. We propose that Ptch occupies a critical niche in determining basal or squamous cell lineage, and that both tumour types can arise from the same target cell depending on carcinogen exposure and host genetic background.	Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; Univ Glasgow, CRC Dept Med Oncol, Glasgow G61 1BD, Lanark, Scotland; Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06520 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of Glasgow; Yale University; University of California System; University of California San Francisco	Balmain, A (corresponding author), Univ Calif San Francisco, Canc Res Inst, 2340 Sutter St, San Francisco, CA 94143 USA.	abalmain@cc.ucsf.edu	Mao, Jian-Hua/EIZ-8595-2022	Mao, Jian-Hua/0000-0001-9320-6021; Girardi, Michael/0000-0003-1887-9343				ARBEIT JM, 1994, J VIROL, V68, P4358, DOI 10.1128/JVI.68.7.4358-4368.1994; Aszterbaum M, 1999, NAT MED, V5, P1285, DOI 10.1038/15242; Barnes EA, 2001, EMBO J, V20, P2214, DOI 10.1093/emboj/20.9.2214; Brown K, 1998, CURR BIOL, V8, P516, DOI 10.1016/S0960-9822(98)70203-9; Canamasas I, 2003, J BIOL CHEM, V278, P30952, DOI 10.1074/jbc.M304225200; Cheng H, 2005, MOL CELL BIOL, V25, P44, DOI 10.1128/MCB.25.1.44-59.2005; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Guerrero I, 2003, SCIENCE, V301, P774, DOI 10.1126/science.1088625; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; HENNINGS H, 1993, CARCINOGENESIS, V14, P2353, DOI 10.1093/carcin/14.11.2353; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Li XX, 2005, BLOOD, V105, P3465, DOI 10.1182/blood-2004-06-2483; Mao JH, 2003, CURR OPIN GENET DEV, V13, P14, DOI 10.1016/S0959-437X(03)00005-4; NAGASE H, 1995, NAT GENET, V10, P424, DOI 10.1038/ng0895-424; Perez-Losada J, 2003, NAT REV CANCER, V3, P434, DOI 10.1038/nrc1095; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Sarkar S, 2001, J BIOL CHEM, V276, P49034, DOI 10.1074/jbc.M103683200; Syken J, 1999, P NATL ACAD SCI USA, V96, P8499, DOI 10.1073/pnas.96.15.8499; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Tarunina M, 2004, MOL CELL BIOL, V24, P10792, DOI 10.1128/MCB.24.24.10792-10801.2004; Thibert C, 2003, SCIENCE, V301, P843, DOI 10.1126/science.1085405; Trentin GA, 2001, J BIOL CHEM, V276, P13087, DOI 10.1074/jbc.M009267200; Unden AB, 1996, CANCER RES, V56, P4562; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096	29	89	90	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2007	445	7129					761	765		10.1038/nature05489	http://dx.doi.org/10.1038/nature05489			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17230190				2022-12-01	WOS:000244205200044
J	Sane, SP; Dieudonne, A; Willis, MA; Daniel, TL				Sane, Sanjay P.; Dieudonne, Alexandre; Willis, Mark A.; Daniel, Thomas L.			Antennal mechanosensors mediate flight control in moths	SCIENCE			English	Article							AGLAIS-URTICAE L; CURRENT SENSE-ORGANS; MECHANICAL-PROPERTIES; BLOWFLY CALLIPHORA; LOCUSTA-MIGRATORIA; VISUAL CONTROL; L-LEPIDOPTERA; ORGANIZATION; EQUILIBRIUM; MOVEMENT	Flying insects have evolved sophisticated sensory capabilities to achieve rapid course control during aerial maneuvers. Among two-winged insects such as houseflies and their relatives, the hind wings are modified into club-shaped, mechanosensory halteres, which detect Coriolis forces and thereby mediate flight stability during maneuvers. Here, we show that mechanosensory input from the antennae serves a similar role during flight in hawk moths, which are four-winged insects. The antennae of flying moths vibrate and experience Coriolis forces during aerial maneuvers. The antennal vibrations are transduced by individual units of Johnston's organs at the base of their antennae in a frequency range characteristic of the Coriolis input. Reduction of the mechanical input to Johnston's organs by removing the antennal flagellum of these moths severely disrupted their flight stability, but reattachment of the flagellum restored their flight control. The antennae thus play a crucial role in maintaining flight stability of moths.	Univ Washington, Dept Biol, Seattle, WA 98195 USA; Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA	University of Washington; University of Washington Seattle; Case Western Reserve University	Sane, SP (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	sane@u.washington.edu						Chan WP, 1998, SCIENCE, V280, P289, DOI 10.1126/science.280.5361.289; COLLETT TS, 1975, J COMP PHYSIOL, V99, P1, DOI 10.1007/BF01464710; Dayan P., 2005, THEORETICAL NEUROSCI; Dickinson MH, 1999, PHILOS T ROY SOC B, V354, P903, DOI 10.1098/rstb.1999.0442; Field LH, 1998, ADV INSECT PHYSIOL, V27, P1, DOI 10.1016/S0065-2806(08)60013-2; GEWECKE M, 1980, J COMP PHYSIOL, V139, P357, DOI 10.1007/BF00610466; Gewecke M., 1974, P100; GEWECKE M, 1970, NATURE, V225, P1263, DOI 10.1038/2251263a0; GEWECKE M, 1981, J COMP PHYSIOL, V145, P249, DOI 10.1007/BF00605037; HEINZEL HG, 1987, J COMP PHYSIOL A, V161, P671, DOI 10.1007/BF00605008; Kloppenburg P, 1997, CELL TISSUE RES, V287, P425, DOI 10.1007/s004410050767; NALBACH G, 1994, J COMP PHYSIOL A, V175, P695; NALBACH G, 1993, J COMP PHYSIOL A, V173, P293, DOI 10.1007/BF00212693; NIEHAUS M, 1978, ZOOMORPHOLOGIE, V91, P19, DOI 10.1007/BF00994151; NIEHAUS M, 1981, J COMP PHYSIOL, V145, P257, DOI 10.1007/BF00605038; OLBERG RM, 1981, J COMP PHYSIOL, V141, P327, DOI 10.1007/BF00609935; PIX W, 1993, NATURWISSENSCHAFTEN, V80, P371, DOI 10.1007/BF01138795; PRINGLE JWS, 1948, PHILOS T ROY SOC B, V233, P347, DOI 10.1098/rstb.1948.0007; Robert D, 2002, J INSECT PHYSIOL, V48, P189, DOI 10.1016/S0022-1910(01)00163-9; Sane SP, 2006, J EXP BIOL, V209, P43, DOI 10.1242/jeb.01958; SCHNEIDER D, 1964, ANNU REV ENTOMOL, V9, P103, DOI 10.1146/annurev.en.09.010164.000535; Schneider D., 1956, Zoologische Jahrbuecher Jena Anatomie, V75, P287; VANDEBERG JS, 1971, J MORPHOL, V133, P439, DOI 10.1002/jmor.1051330407; WAGNER H, 1986, PHILOS T ROY SOC B, V312, P553, DOI 10.1098/rstb.1986.0018; Warrant EJ, 1999, VISION RES, V39, P1611, DOI 10.1016/S0042-6989(98)00262-4; WIGGLESWORTH VB, 1946, NATURE, V157, P655, DOI 10.1038/157655a0	26	198	208	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2007	315	5813					863	866		10.1126/science.1133598	http://dx.doi.org/10.1126/science.1133598			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17290001				2022-12-01	WOS:000244069000074
J	Nicholls, SJ; Tuzcu, EM; Sipahi, I; Grasso, AW; Schoenhagen, P; Hu, T; Wolski, K; Crowe, T; Desai, MY; Hazen, SL; Kapadia, SR; Nissen, SE				Nicholls, Stephen J.; Tuzcu, E. Murat; Sipahi, Ilke; Grasso, Adam W.; Schoenhagen, Paul; Hu, Tingfei; Wolski, Kathy; Crowe, Tim; Desai, Milind Y.; Hazen, Stanley L.; Kapadia, Samir R.; Nissen, Steven E.			Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							APOLIPOPROTEIN-A-I; C-REACTIVE PROTEIN; HEART-DISEASE; SECONDARY PREVENTION; INTRAVASCULAR ULTRASOUND; MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; ESTER TRANSFER; THERAPY; HDL	Context Statins reduce low-density lipoprotein cholesterol (LDL-C) levels and slow progression of coronary atherosclerosis. However, no data exist describing the relationship between statin-induced changes in high-density lipoprotein cholesterol (HDL-C) and disease progression. Objective To investigate the relationship between changes in LDL-C and HDL-C levels and atheroma burden. Design, Setting, and Patients Post-hoc analysis combining raw data from 4 prospective randomized trials ( performed in the United States, North America, Europe, and Australia between 1999 and 2005), in which 1455 patients with angiographic coronary disease underwent serial intravascular ultrasonography while receiving statin treatment for 18 months or for 24 months. Ultrasound analysis was performed in the same core laboratory for all of the studies. Main Outcome Measure Relationship between changes in lipoprotein levels and coronary artery atheroma volume. Results During statin therapy, mean (SD) LDL-C levels were reduced from 124.0 (38.3) mg/dL (3.2 [0.99] mmol/L) to 87.5 (28.8) mg/dL (2.3 [0.75] mmol/L) (a 23.5% decrease; P <. 001), and HDL-C levels increased from 42.5 (11.0) mg/dL(1.1 [0.28] mmol/L) to 45.1 (11.4) mg/dL(1.2 [0.29] mmol/L)(a 7.5% increase; P <. 001). The ratio of LDL-C to HDL-C was reduced from a mean ( SD) of 3.0 ( 1.1) to 2.1 (0.9) (a 26.7% decrease; P <. 001). These changes were accompanied by a mean ( SD) increase in percent atheroma volume from 39.7% (9.8%) to 40.1% (9.7%) ( a 0.5% [3.9%] increase; P=. 001) and a mean ( SD) decrease in total atheroma volume of 2.4 (23.6) mm(3) ( P <. 001). In univariate analysis, mean levels and treatment-mediated changes in LDL-C, total cholesterol, non-HDL cholesterol, apolipoprotein B, and ratio of apolipoprotein B to apolipoprotein A-I were significantly correlated with the rate of atherosclerotic progression, whereas treatment-mediated changes in HDL-C were inversely correlated with atheroma progression. In multivariate analysis, mean levels of LDL-C ( beta coefficient, 0.11 [95% confidence interval, 0.07-0.15]) and increases in HDL-C( beta coefficient,- 0.26[ 95% confidence interval,- 0.41 to - 0.10]) remained independent predictors of atheroma regression. Substantial atheroma regression ( >= 5% reduction in atheroma volume) was observed in patients with levels of LDL-C less than the mean( 87.5 mg/dL) during treatment and percentage increases of HDL-C greater than the mean( 7.5%; P <. 001). No significant differences were found with regard to clinical events. Conclusions Statin therapy is associated with regression of coronary atherosclerosis when LDL-C is substantially reduced and HDL-C is increased by more than 7.5%. These findings suggest that statin benefits are derived from both reductions in atherogenic lipoprotein levels and increases in HDL-C, although it remains to be determined whether the atherosclerotic regression associated with these changes in lipid levels will translate to meaningful reductions in clinical events and improved clinical outcomes.	Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; Cleveland Clin, Dept Cell Biol, Cleveland, OH 44195 USA; Cleveland Clin, Dept Diagnost Radiol, Cleveland, OH 44195 USA; Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Nicholls, SJ (corresponding author), Cleveland Clin, Dept Cardiovasc Med, Mail Code JJ65,9500 Euclid Ave, Cleveland, OH 44195 USA.	nichols1@ccf.org	SIPAHI, ILKE/K-9745-2013; Schoenhagen, Paul/A-2808-2012; Hazen, Stanley L/ABD-5845-2021	SIPAHI, ILKE/0000-0001-8581-9557; Schoenhagen, Paul/0000-0002-7751-5243; Nicholls, Stephen/0000-0002-9668-4368				Aikawa M, 2001, CIRCULATION, V103, P276; AMAUD C, 2005, ARTERIOSCLER THROMB, V25, P1231, DOI DOI 10.1161/01.ATV.0000163840.63685.0; BADIMON JJ, 1990, J CLIN INVEST, V85, P1234, DOI 10.1172/JCI114558; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Bays H, 2003, EXPERT OPIN PHARMACO, V4, P1901, DOI 10.1517/14656566.4.11.1901; Brousseau ME, 2004, NEW ENGL J MED, V350, P1505, DOI 10.1056/NEJMoa031766; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; CANNER PL, 1986, J AM COLL CARDIOL, V8, P1245, DOI 10.1016/S0735-1097(86)80293-5; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Guerin M, 2000, ARTERIOSCL THROM VAS, V20, P189, DOI 10.1161/01.ATV.20.1.189; Jensen LO, 2004, CIRCULATION, V110, P265, DOI 10.1161/01.CIR.0000135215.75876.41; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Luc G, 2002, ARTERIOSCL THROM VAS, V22, P1155, DOI 10.1161/01.ATV.0000022850.59845.E0; Martin G, 2001, J CLIN INVEST, V107, P1423, DOI 10.1172/JCI10852; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Nissen SE, 2006, NEW ENGL J MED, V354, P1253, DOI 10.1056/NEJMoa054699; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217; Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Okazaki S, 2004, CIRCULATION, V110, P1061, DOI 10.1161/01.CIR.0000140261.58966.A4; Otvos JD, 2006, CIRCULATION, V113, P1556, DOI 10.1161/CIRCULATIONAHA.105.565135; PEDERSEN TR, 1994, LANCET, V344, P1383; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; PLUMP AS, 1994, P NATL ACAD SCI USA, V91, P9607, DOI 10.1073/pnas.91.20.9607; Ray KK, 2005, J AM COLL CARDIOL, V46, P1425, DOI 10.1016/j.jacc.2005.05.086; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schlesinger Z, 2000, CIRCULATION, V102, P21, DOI 10.1161/01.CIR.102.1.21; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823; Steiner G, 2001, LANCET, V357, P905; Taylor AJ, 2004, CIRCULATION, V110, P3512, DOI 10.1161/01.CIR.0000148955.19792.8D; Tonkin A, 1998, NEW ENGL J MED, V339, P1349	43	540	572	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2007	297	5					499	508		10.1001/jama.297.5.499	http://dx.doi.org/10.1001/jama.297.5.499			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133FP	17284700				2022-12-01	WOS:000243999100027
J	Farooqi, IS; Wangensteen, T; Collins, S; Kimber, W; Matarese, G; Keogh, JM; Lank, E; Bottomley, B; Lopez-Fernandez, J; Ferraz-Amaro, I; Dattani, MT; Ercan, O; Myhre, AG; Retterstol, L; Stanhope, R; Edge, JA; McKenzie, S; Lessan, N; Ghodsi, M; De Rosa, V; Perna, F; Fontana, S; Barroso, I; Undlien, DE; O'Rahilly, S				Farooqi, I. Sadaf; Wangensteen, Teresia; Collins, Stephan; Kimber, Wendy; Matarese, Giuseppe; Keogh, Julia M.; Lank, Emma; Bottomley, Bill; Lopez-Fernandez, Judith; Ferraz-Amaro, Ivan; Dattani, Mehul T.; Ercan, Oya; Myhre, Anne Grethe; Retterstol, Lars; Stanhope, Richard; Edge, Julie A.; McKenzie, Sheila; Lessan, Nader; Ghodsi, Maryam; De Rosa, Veronica; Perna, Francesco; Fontana, Silvia; Barroso, Ines; Undlien, Dag E.; O'Rahilly, Stephen			Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EARLY-ONSET OBESITY; BODY-MASS INDEX; MORBID-OBESITY; MISSENSE MUTATION; METABOLIC-RATE; HYPOGONADISM; DYSFUNCTION; HUMANS; GROWTH; ASSOCIATION	BACKGROUND: A single family has been described in which obesity results from a mutation in the leptin-receptor gene (LEPR), but the prevalence of such mutations in severe, early-onset obesity has not been systematically examined. METHODS: We sequenced LEPR in 300 subjects with hyperphagia and severe early-onset obesity, including 90 probands from consanguineous families, and investigated the extent to which mutations cosegregated with obesity and affected receptor function. We evaluated metabolic, endocrine, and immune function in probands and affected relatives. RESULTS: Of the 300 subjects, 8 (3%) had nonsense or missense LEPR mutations -- 7 were homozygotes, and 1 was a compound heterozygote. All missense mutations resulted in impaired receptor signaling. Affected subjects were characterized by hyperphagia, severe obesity, alterations in immune function, and delayed puberty due to hypogonadotropic hypogonadism. Serum leptin levels were within the range predicted by the elevated fat mass in these subjects. Their clinical features were less severe than those of subjects with congenital leptin deficiency. CONCLUSIONS: The prevalence of pathogenic LEPR mutations in a cohort of subjects with severe, early-onset obesity was 3%. Circulating levels of leptin were not disproportionately elevated, suggesting that serum leptin cannot be used as a marker for leptin-receptor deficiency. Congenital leptin-receptor deficiency should be considered in the differential diagnosis in any child with hyperphagia and severe obesity in the absence of developmental delay or dysmorphism.	Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge Inst Med Res, Cambridge CB2 2QQ, England; Wellcome Trust Sanger Inst, Cambridge, England; Inst Child Hlth, London, England; Great Ormond St Hosp Sick Children, London WC1N 3JH, England; UCL, London, England; John Radcliffe Hosp, Oxford OX3 9DU, England; Royal London Hosp, London E1 1BB, England; Univ Oslo, Ulleval Univ Hosp, Oslo, Norway; Rikshosp Radiumhosp Med Ctr, Oslo, Norway; Univ Naples Federico 2, Naples, Italy; CNR, Ist Endocrinol & Oncol Sperimentale, I-80125 Naples, Italy; Hosp Univ Canarias, Tenerife, Spain; Istanbul Univ, Cerrahpasa Med Fac, Fatih Istanbul, Turkey; Univ Tehran Med Sci, Shariati Hosp, Tehran, Iran	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of Oxford; Barts Health NHS Trust; Royal London Hospital; University of Oslo; University of Oslo; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); Universidad de la Laguna; Istanbul University; Istanbul University - Cerrahpasa; Tehran University of Medical Sciences	Farooqi, IS (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge Inst Med Res, Hills Rd,Box 232, Cambridge CB2 2QQ, England.	isf20@cam.ac.uk	Matarese, Giuseppe/AAO-4077-2021; Ferraz-Amaro, Ivan/X-1489-2019; Ercan, Oya/A-9654-2018; collins, stephan c/P-4409-2016; Farooqi, Ismaa Sadaf/AAZ-3046-2020; De Rosa, Veronica/K-6534-2016; Ghodsi, Maryam/HGB-1575-2022; DATTANI, MEHUL/C-5401-2008; O'Rahilly, Stephen/ABF-6509-2020; Ghodsi, Masoud/A-9403-2017; ercan, oya/AAS-5035-2020	Matarese, Giuseppe/0000-0001-9429-0616; Ferraz-Amaro, Ivan/0000-0003-0197-5267; Ercan, Oya/0000-0001-7397-2837; collins, stephan c/0000-0002-1533-3380; De Rosa, Veronica/0000-0002-9477-0991; Ghodsi, Maryam/0000-0001-8940-3970; O'Rahilly, Stephen/0000-0003-2199-4449; Ghodsi, Masoud/0000-0002-9127-8635; Farooqi, Sadaf/0000-0001-7609-3504; PERNA, Francesco/0000-0001-5319-0977; Barroso, Ines/0000-0001-5800-4520	Medical Research Council [G0502115] Funding Source: Medline; Telethon [GJT04008] Funding Source: Medline; Wellcome Trust [077016, 067457, 068086] Funding Source: Medline; MRC [G0502115] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Telethon(Fondazione Telethon); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BRAY GA, 1990, PROG NEUROENDOCRINOL, V4, P128; Casanueva FF, 1998, BAILLIERE CLIN ENDOC, V12, P297, DOI 10.1016/S0950-351X(98)80024-4; Chung WK, 1998, AM J PHYSIOL-REG I, V274, pR985, DOI 10.1152/ajpregu.1998.274.4.R985; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; CUNNINGHAM JJ, 1991, AM J CLIN NUTR, V54, P963, DOI 10.1093/ajcn/54.6.963; Echwald SM, 1997, BIOCHEM BIOPH RES CO, V233, P248, DOI 10.1006/bbrc.1997.6430; Farooqi IS, 2005, ANNU REV MED, V56, P443, DOI 10.1146/annurev.med.56.062904.144924; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Farooqi IS, 2001, NATURE, V414, P34, DOI 10.1038/35102112; FOMON SJ, 1982, AM J CLIN NUTR    S1, V35, P169; Gibson WT, 2004, J CLIN ENDOCR METAB, V89, P4821, DOI 10.1210/jc.2004-0376; HAMILL PVV, 1979, AM J CLIN NUTR, V32, P607, DOI 10.1093/ajcn/32.3.607; HAYTER JE, 1993, EUR J CLIN NUTR, V47, P724; Heo M, 2002, INT J OBESITY, V26, P640, DOI 10.1038/sj.ijo.0801990; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Kelestimur F, 2006, CLIN ENDOCRINOL, V64, P667, DOI 10.1111/j.1365-2265.2006.02525.x; Kiess W, 2001, Obes Rev, V2, P29, DOI 10.1046/j.1467-789x.2001.00017.x; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Lahlou N, 2000, DIABETES, V49, P1347, DOI 10.2337/diabetes.49.8.1347; Licinio J, 2004, P NATL ACAD SCI USA, V101, P4531, DOI 10.1073/pnas.0308767101; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; MOLNAR D, 1995, J PEDIATR-US, V127, P571, DOI 10.1016/S0022-3476(95)70114-1; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Ozata M, 2000, J CLIN ENDOCR METAB, V85, P416; Ozata M, 1999, J CLIN ENDOCR METAB, V84, P3686, DOI 10.1210/jc.84.10.3686; Semple RK, 2005, J CLIN ENDOCR METAB, V90, P1849, DOI 10.1210/jc.2004-1418; Speiser PW, 2005, J CLIN ENDOCR METAB, V90, P1871, DOI 10.1210/jc.2004-1389; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; WILLIAMS DRR, 1995, DIABETIC MED, V12, P30, DOI 10.1111/j.1464-5491.1995.tb02058.x	32	425	445	1	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 18	2007	356	3					237	247		10.1056/NEJMoa063988	http://dx.doi.org/10.1056/NEJMoa063988			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126BV	17229951	Green Accepted			2022-12-01	WOS:000243488100006
J	Huttenlocher, A; Horwitz, AR				Huttenlocher, Anna; Horwitz, Alan Rick			Wound healing with electric potential	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Wisconsin, Sch Med, Dept Pediat, Madison, WI 53706 USA; Univ Wisconsin, Sch Med, Dept Pharmacol, Madison, WI USA; Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Virginia	Huttenlocher, A (corresponding author), Univ Wisconsin, Sch Med, Dept Pediat, Madison, WI 53706 USA.							Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; Mycielska ME, 2004, J CELL SCI, V117, P1631, DOI 10.1242/jcs.01125; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925	5	48	51	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 18	2007	356	3					303	304		10.1056/NEJMcibr066496	http://dx.doi.org/10.1056/NEJMcibr066496			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126BV	17229960				2022-12-01	WOS:000243488100016
J	Wilson, JF				Wilson, Jennifer Fisher			Facing an uncertain climate	ANNALS OF INTERNAL MEDICINE			English	News Item							HUMAN HEALTH					jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Epstein PR, 2005, NEW ENGL J MED, V353, P1433, DOI 10.1056/NEJMp058079; Houghton J. T., 2001, CLIMATE CHANGE 2001; Kovats RS, 2000, CLIMATE CHANGE HUMAN; Lindgren E, 2000, ENVIRON HEALTH PERSP, V108, P119, DOI 10.2307/3454509; McMichael A. J, 1996, WHOEHG967; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; MCMICHAEL AJ, 2006, CLIMATE CHANGE HUMAN; Mohan JE, 2006, P NATL ACAD SCI USA, V103, P9086, DOI 10.1073/pnas.0602392103; Stern N., 2006, STERN REV EC CLIMATE STERN REV EC CLIMATE; Stott PA, 2004, NATURE, V432, P610, DOI 10.1038/nature03089; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Wayne P, 2002, ANN ALLERG ASTHMA IM, V88, P279, DOI 10.1016/S1081-1206(10)62009-1	12	7	7	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2007	146	2					153	156		10.7326/0003-4819-146-2-200701160-00022	http://dx.doi.org/10.7326/0003-4819-146-2-200701160-00022			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131WF	17227946				2022-12-01	WOS:000243901000017
J	Ueki, Y; Lin, CY; Senoo, M; Ebihara, T; Agata, N; Onji, M; Saheki, Y; Kawai, T; Mukherjee, PM; Reichenberger, E; Olsen, BR				Ueki, Yasuyoshi; Lin, Chin-Yu; Senoo, Makoto; Ebihara, Takeshi; Agata, Naoki; Onji, Masahiro; Saheki, Yasunori; Kawai, Toshihisa; Mukherjee, Padma M.; Reichenberger, Ernst; Olsen, Bjorn R.			Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 "cherubism" mice	CELL			English	Article							ADAPTER PROTEIN 3BP2; COLONY-STIMULATING FACTOR; TYROSINE KINASE; KAPPA-B; TRANSCRIPTION FACTOR; ANTIGEN RECEPTOR; LINKER REGION; IMMUNE-SYSTEM; ACTIVATION; SYK	While studies of the adaptor SH3BP2 have implicated a role in receptor-mediated signaling in mast cells and lymphocytes, they have failed to identify its function or explain why SH3BP2 missense mutations cause bone loss and inflammation in patients with cherubism. We demonstrate that Sh3bp2 "cherubism" mice exhibit trabecular bone loss, TNF-alpha-dependent systemic inflammation, and cortical bone erosion. The mutant phenotype is lymphocyte independent and can be transferred to mice carrying wild-type Sh3bp2 alleles through mutant fetal liver cells. Mutant myeloid cells show increased responses to M-CSF and RANKL stimulation, and, through mechanisms of increased ERK 1/2 and SYK phosphorylation/activation, they form macrophages that express high levels of TNF-alpha and osteoclasts; that are unusually large. M-CSF and RANKL stimulation of myeloid cells that overexpress wild-type SH3BP2 results in similar large osteoclasts. This indicates that the mutant phenotype reflects gain of SH3BP2 function and suggests that SH3BP2 is a critical regulator of myeloid cell responses to M-CSF and RANKL stimulation.	Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Forsyth Inst, Dept Immunol, Boston, MA 02115 USA; Univ Connecticut, Ctr Hlth, Ctr Restorat Med & Skeletal Dev, Dept Oral Rehabil Biomat & Skeletal Dev, Farmington, CT 06030 USA	Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Forsyth Institute; University of Connecticut	Olsen, BR (corresponding author), Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA.	bjorn_olsen@hms.harvard.edu	Saheki, Yasunori/D-5430-2016; Ebihara, Takeshi/GYU-7579-2022	Saheki, Yasunori/0000-0002-1229-6668; Senoo, Makoto/0000-0002-0155-0683	NIAMS NIH HHS [AR36820, AR36819] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR036819, R01AR036820, R01AR036819, R37AR036820] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; CHITU V, 2005, CURR OPIN IMMUNOL, V17, P1; de la Fuente MA, 2006, MOL CELL BIOL, V26, P5214, DOI 10.1128/MCB.00087-06; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; Deckert M, 1998, IMMUNITY, V9, P595, DOI 10.1016/S1074-7613(00)80657-3; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Eliopoulos AG, 2006, J BIOL CHEM, V281, P1371, DOI 10.1074/jbc.M506790200; Faccio R, 2003, J CELL BIOCHEM, V90, P871, DOI 10.1002/jcb.10694; Faccio R, 2005, NAT MED, V11, P284, DOI 10.1038/nm1194; Foucault I, 2005, BLOOD, V105, P1106, DOI 10.1182/blood-2003-08-2965; Foucault I, 2003, J BIOL CHEM, V278, P7146, DOI 10.1074/jbc.M209509200; Hong JJ, 2002, J BIOL CHEM, V277, P31703, DOI 10.1074/jbc.M201362200; Humphrey MB, 2005, IMMUNOL REV, V208, P50, DOI 10.1111/j.0105-2896.2005.00325.x; Jevremovic D, 2001, J IMMUNOL, V166, P7219, DOI 10.4049/jimmunol.166.12.7219; Jimi E, 2005, IMMUNOL REV, V208, P80, DOI 10.1111/j.0105-2896.2005.00329.x; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; Kitaura H, 2005, J CLIN INVEST, V115, P3418, DOI 10.1172/JCI26132; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Law CL, 1996, MOL CELL BIOL, V16, P1305; Maeno K, 2003, J BIOL CHEM, V278, P24912, DOI 10.1074/jbc.M301201200; Miah SMS, 2004, GENES CELLS, V9, P993, DOI 10.1111/j.1365-2443.2004.00784.x; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Niida S, 2005, P NATL ACAD SCI USA, V102, P14016, DOI 10.1073/pnas.0503544102; Qu XJ, 2005, BIOCHEMISTRY-US, V44, P3891, DOI 10.1021/bi048353o; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Ross FP, 2005, IMMUNOL REV, V208, P88, DOI 10.1111/j.0105-2896.2005.00331.x; Sada K, 2002, BLOOD, V100, P2138, DOI 10.1182/blood-2001-12-0340; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; Smolen JS, 2003, NAT REV DRUG DISCOV, V2, P473, DOI 10.1038/nrd1109; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takeshita S, 2002, NAT MED, V8, P943, DOI 10.1038/nm752; Tanaka S, 2005, IMMUNOL REV, V208, P30, DOI 10.1111/j.0105-2896.2005.00327.x; Tiziani V, 1999, AM J HUM GENET, V65, P158, DOI 10.1086/302456; Ueki Y, 2001, NAT GENET, V28, P125, DOI 10.1038/88832; Xing LP, 2005, IMMUNOL REV, V208, P19, DOI 10.1111/j.0105-2896.2005.00336.x; Yao ZQ, 2006, J BIOL CHEM, V281, P11846, DOI 10.1074/jbc.M512624200; Zollino M, 2000, AM J MED GENET, V94, P254, DOI 10.1002/1096-8628(20000918)94:3<254::AID-AJMG13>3.0.CO;2-7	38	139	146	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 12	2007	128	1					71	83		10.1016/j.cell.2006.10.047	http://dx.doi.org/10.1016/j.cell.2006.10.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GN	17218256	Bronze			2022-12-01	WOS:000244420400014
J	Grantham-McGregor, S; Cheung, YB; Cueto, S; Glewwe, P; Richter, L; Strupp, B				Grantham-McGregor, Sally; Cheung, Yin Bun; Cueto, Santiago; Glewwe, Paul; Richter, Linda; Strupp, Barbara		Int Child Dev Steering Grp	Child development in developing countries 1 - Developmental potential in the first 5 years for children in developing countries	LANCET			English	Review							COGNITIVE-DEVELOPMENT; PRIMARY-SCHOOL; ZINC SUPPLEMENTATION; SOCIOECONOMIC-STATUS; MENTAL-DEVELOPMENT; MOTOR DEVELOPMENT; MATERNAL-CARE; FAMILY CHARACTERISTICS; NUTRITIONAL-STATUS; JAMAICAN CHILDREN	Many children younger than 5 years in developing countries are exposed to multiple risks, including poverty, malnutrition, poor health, and unstimulating home environments, which detrimentally affect their cognitive, motor, and social-emotional development. There are few national statistics on the development of young children in developing countries. We therefore identified two factors with available worldwide data-the prevalence of early childhood stunting and the number of people living in absolute poverty-to use as indicators of poor development. We show that both indicators are closely associated with poor cognitive and educational performance in children and use them to estimate that over 200 million children under 5 years are not fulfilling their developmental potential. Most of these children live in south Asia and sub-Saharan Africa. These disadvantaged children are likely to do poorly in school and subsequently have low incomes, high fertility, and provide poor care for their children, thus contributing to the intergenerational transmission of poverty.	UCL, Inst Child Hlth, Ctr Int Child Hlth, London WC1N 1EH, England; London Sch Hyg & Trop Med, London WC1, England; Grp Anal Dev, Lima, Peru; Univ Minnesota, Dept Appl Econ, Minneapolis, MN 55455 USA; Human Sci Res Council, Cape Town, South Africa; Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA; Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of Minnesota System; University of Minnesota Twin Cities; Human Sciences Research Council-South Africa; Cornell University; Cornell University	Grantham-McGregor, S (corresponding author), UCL, Inst Child Hlth, Ctr Int Child Hlth, London WC1N 1EH, England.	s.mcgregor@ich.ucl.ac.uk	Fahimifar, Sepideh/M-5303-2019; Cueto, Santiago/Q-7168-2019	Cueto, Santiago/0000-0002-0639-3429	Medical Research Council [G0700837] Funding Source: Medline; Wellcome Trust [068599] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Adair LS, 1999, J NUTR, V129, P1140, DOI 10.1093/jn/129.6.1140; AGARWAL DK, 1987, 6 NUTR FDN IND; Aldaz-Carroll E., 2001, CUAD ECON, V38, P155, DOI [10.4067/S0717-68212001011400003, DOI 10.4067/S0717-68212001011400003]; Alderman H, 1997, ECON DEV CULT CHANGE, V46, P97, DOI 10.1086/452323; [Anonymous], 2005, STAT WORLDS CHILDR 2; Baker-Henningham H, 2003, EUR J CLIN NUTR, V57, P786, DOI 10.1038/sj.ejcn.1601611; BAKERHENNINGHAM H, 2006, SPECIAL ED NEEDS STU; Basilio CS, 2005, REV SAUDE PUBL, V39, P725, DOI 10.1590/S0034-89102005000500005; Beasley NMR, 2000, ACTA TROP, V76, P223, DOI 10.1016/S0001-706X(00)00101-7; Behrman JR, 1999, WORLD BANK ECON REV, V13, P211, DOI 10.1093/wber/13.2.211; BEHRMAN JR, 2005, WHAT DETERMINES ADUL; Berkman DS, 2002, LANCET, V359, P564, DOI 10.1016/S0140-6736(02)07744-9; Bhandari N, 2002, B WORLD HEALTH ORGAN, V80, P189; Bhargava A, 2000, AM J PHYS ANTHROPOL, V111, P89, DOI 10.1002/(SICI)1096-8644(200001)111:1&lt;89::AID-AJPA6&gt;3.0.CO;2-X; BLACK J, 1998, HDB CHILD ADOLESCENT, V1, P31; Black MM, 2004, PEDIATRICS, V113, P1297, DOI 10.1542/peds.113.5.1297; BOGIN B, 1983, CHILD DEV, V54, P115, DOI 10.1111/j.1467-8624.1983.tb00340.x; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Bredy TW, 2003, NEUROSCIENCE, V118, P571, DOI 10.1016/S0306-4522(02)00918-1; Brito GNO, 2004, ARQ NEURO-PSIQUIAT, V62, P949, DOI 10.1590/S0004-282X2004000600004; Brooker S, 1999, SOC SCI MED, V48, P675, DOI 10.1016/S0277-9536(98)00382-7; BrooksGunn J, 1997, FUTURE CHILD, V7, P55, DOI 10.2307/1602387; BYAMUGISHA A, 2005, SACMEQ II PROJECT UG; CHEN S, 2004, 3341 WPS; Cheung YB, 2001, INT J EPIDEMIOL, V30, P66, DOI 10.1093/ije/30.1.66; Cheung YB, 2006, STAT MED, V25, P3011, DOI 10.1002/sim.2467; CHIMOMBO J, 2005, SACMEQ II PROJECT MA; *CHRON POV RES CTR, 2006, CHRON POV REP 2004 0; CLARKE NMA, 1990, ECOL FOOD NUTR, V26, P1; *COMM INT SCI CHIL, 2000, NEUR NEIGHB SCI CHIL; Cueto Santiago, 2005, Food and Nutrition Bulletin, V26, pS251; Currie J., 1999, 6943 NAT BUR EC RES; Daniels MC, 2004, J NUTR, V134, P1439, DOI 10.1093/jn/134.6.1439; de Onis M, 2004, INT J EPIDEMIOL, V33, P1260, DOI 10.1093/ije/dyh202; De Onis M, 2006, WHO CHILD GROWTH STA; Deaton A, 2001, WORLD BANK RES OBSER, V16, P125, DOI 10.1093/wbro/16.2.125; Drewett R, 2001, J CHILD PSYCHOL PSYC, V42, P181, DOI 10.1111/1469-7610.00709; Duflo E, 2001, AM ECON REV, V91, P795, DOI 10.1257/aer.91.4.795; Espy KA, 2001, MERRILL PALMER QUART, V47, P42, DOI 10.1353/mpq.2001.0001; Feinstein L, 2003, ECONOMICA, V70, P73, DOI 10.1111/1468-0335.t01-1-00272; Filmer D, 1999, POPUL DEV REV, V25, P85, DOI 10.1111/j.1728-4457.1999.00085.x; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; FLORENCIO C, 1988, NUTR HLTH OTHER DETE; FRANKENBERG E, 1995, J POPULAT, V1, P21; Garza C, 2006, ACTA PAEDIATR, V95, P56, DOI 10.1080/08035320500495514; GLEWWE P, 1995, REV ECON STAT, V77, P156, DOI 10.2307/2110001; Glewwe P, 2001, J PUBLIC ECON, V81, P345, DOI 10.1016/S0047-2727(00)00118-3; GONZALEZ P, 2004, HIGHLIGHTS TRENDS IN; GORDON G, 2003, CHILD POVERTY DEV WO; Gorman KS, 1996, CHILD DEV, V67, P314; Grantham-McGregor SM., 2004, REPORT FAMILY CARE I, DOI [10.7249/rb4545-1, DOI 10.7249/RB4545-1]; Griffiths R., 1970, ABILITIES YOUNG CHIL; GUNNAR M, IN PRESS W ED; Hall A, 2001, EUR J CLIN NUTR, V55, P801, DOI 10.1038/sj.ejcn.1601229; Hamadani JD, 2001, AM J CLIN NUTR, V74, P381; Hamadani JD, 2002, LANCET, V360, P290, DOI 10.1016/S0140-6736(02)09551-X; Hamill PV, 1977, VITAL HLTH STAT 11, V11, P1; Hatt LE, 2006, SOC SCI MED, V62, P375, DOI 10.1016/j.socscimed.2005.06.007; Hutchinson SE, 1997, EUR J CLIN NUTR, V51, P729, DOI 10.1038/sj.ejcn.1600473; Ivanovic DA, 2004, NUTRITION, V20, P878, DOI 10.1016/j.nut.2004.06.009; JAMISON DT, 1986, J DEV ECON, V20, P299, DOI 10.1016/0304-3878(86)90026-X; JOHNSTON FE, 1987, AM J PHYS ANTHROPOL, V73, P501, DOI 10.1002/ajpa.1330730412; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kariger PK, 2005, J NUTR, V135, P814; KEITHEILE M, 2005, SACMEQ II PROJECT BO; KIRKSEY A, 1994, AM J CLIN NUTR, V60, P782, DOI 10.1093/ajcn/60.5.782; Kuklina EV, 2004, J NUTR, V134, P3296; KULPOO D, 2005, SACMEQ II PROJECT MA; Lam D, 1999, J HUM RESOUR, V34, P160, DOI 10.2307/146306; LASKY RE, 1981, CHILD DEV, V52, P219; Liddell C, 2001, BRIT J EDUC PSYCHOL, V71, P413, DOI 10.1348/000709901158596; Lima MC, 2004, ACTA PAEDIATR, V93, P969, DOI 10.1111/j.1651-2227.2004.tb18257.x; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Lozoff B, 2004, PEDIATR RES, V55, p23A; Maitra P, 2004, J HEALTH POPUL NUTR, V22, P84; MAKUWA D, 2005, SACMEQ II PROJECT NA; MARTORELL R, 1995, J NUTR, V125, pS1060; Martorell R, 1992, HUMAN GROWTH BASIC C, P143; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; MEANEY MJ, 1991, PSYCHONEUROENDOCRINO, V16, P85, DOI 10.1016/0306-4530(91)90072-2; Mendez MA, 1999, J NUTR, V129, P1555, DOI 10.1093/jn/129.8.1555; Mistry RS, 2004, DEV PSYCHOL, V40, P727, DOI 10.1037/0012-1649.40.5.727; MOLO I, 2005, SACMEQ II PROJECT S; MONCKEBERG F, 1972, SCI PUBLICATION, V251, P48; MOOCK PR, 1986, J DEV ECON, V20, P33, DOI 10.1016/0304-3878(86)90004-0; Morgan RE, 2001, NEUROTOXICOL TERATOL, V23, P519, DOI 10.1016/S0892-0362(01)00171-4; MOTHIBELI A, 2005, SACMEQ II PROJECT LE; MRUTU AS, 2005, SACMEQ II PROJECT TA; NASSOR SM, 2005, SACMEQ II PROJECT ZA; *NICHD EARL CHILD, 2001, EARLY ED DEV, V0012; ONSOMU E, 2005, SACMEQ II PROJECT KE; Ozmert EN, 2005, J TROP PEDIATRICS, V51, P25, DOI 10.1093/tropej/fmh070; PASSOS A, 2005, SACMEQ II PROJECT MO; Pianta RC, 1997, J APPL DEV PSYCHOL, V18, P1, DOI 10.1016/S0193-3973(97)90011-3; POLLITT E, 1993, MON SOC CHILD DEV, V58; POPKIN BM, 1982, SOC SCI MED, V16, P53, DOI 10.1016/0277-9536(82)90423-3; POWELL CA, 1985, AM J CLIN NUTR, V41, P1322, DOI 10.1093/ajcn/41.6.1322; PSACHAROPOULOS G, 1989, ECON DEV CULT CHANGE, V37, P683, DOI 10.1086/451755; Psacharopoulos G., 2004, EDUC ECON, V12, P111, DOI [DOI 10.1080/0964529042000239140, 10.1080/0964529042000239140]; Raven J., 1998, COLOURED PROGR MATRI; RICHTER L, 1998, VIEW SCH PREPARATION; RICHTER LM, 1995, PAEDIATR PERINAT EP, V9, P109, DOI 10.1111/j.1365-3016.1995.tb00124.x; Rodier PM, 2004, PEDIATRICS, V113, P1076; ROSENZWEIG MR, 1994, J HUM RESOUR, V29, P670, DOI 10.2307/146115; Rutter M, 2004, DEV PSYCHOL, V40, P81, DOI 10.1037/0012-1649.40.1.81; RUTTER M, 1989, J CHILD PSYCHOL PSYC, V30, P23, DOI 10.1111/j.1469-7610.1989.tb00768.x; Schady N, 2005, 3605 WORLD BANK; SHABALALA J, 2005, SACMEQ II PROJECT SW; Shariff ZM, 2000, ASIA PAC J CLIN NUTR, V9, P264, DOI 10.1046/j.1440-6047.2000.00191.x; Shrimpton R, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e75; Siegel EH, 2005, J NUTR, V135, P2840, DOI 10.1093/jn/135.12.2840; SIGMAN M, 1989, J PEDIATR-US, V115, P357, DOI 10.1016/S0022-3476(89)80832-7; SIGMAN M, 1991, J CHILD PSYCHOL PSYC, V32, P307, DOI 10.1111/j.1469-7610.1991.tb00309.x; SIGMAN M, 1989, CHILD DEV, V60, P1463, DOI 10.2307/1130935; STEEGMANN AT, 1992, AM J HUM BIOL, V4, P247, DOI 10.1002/ajhb.1310040209; Stein Aryeh D., 2005, Food and Nutrition Bulletin, V26, pS46; Stith AY, 2003, APPL PSYCHOL-INT REV, V52, P614, DOI 10.1111/1464-0597.00154; Thompson RA, 2001, AM PSYCHOL, V56, P5, DOI 10.1037//0003-066X.56.1.5; Thorndike R.L., 1986, STANFORD BINET INTEL; *UN, 2002, ROAD MAP IMPL UN MIL; UNESCO, 2005, EFA GLOBAL MONITORIN; *UNICEF, 2006, MULT IND CLUST SURV, V2; Vazir S, 1998, Indian Pediatr, V35, P959; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; VICTORA CG, 2003, CAD SAUDE PUBLICA, P1241; VICTORA MD, 1990, CHILD CARE HLTH DEV, V16, P151, DOI 10.1111/j.1365-2214.1990.tb00647.x; Wachs T., 2000, NECESSARY NOT SUFFIC; WALKER SP, 1990, W INDIAN MED J, V39, P12; Walker SP, 2005, LANCET, V366, P1804, DOI 10.1016/S0140-6736(05)67574-5; Webb KE, 2005, EUR J CLIN NUTR, V59, P618, DOI 10.1038/sj.ejcn.1602103; Webb SJ, 2001, DEV NEUROPSYCHOL, V19, P147, DOI 10.1207/S15326942DN1902_2; Wechsler, 2012, WECHSLER ADULT INTEL, DOI 10.1037/t15169-000; Wechsler D., 1997, WECHSLER INTELLIGENC; WHO, 2006, GLOB DAT CHILD GROWT; Wilson MA, 2000, P NATL ACAD SCI USA, V97, P5540, DOI 10.1073/pnas.97.10.5540; *WORLD BANK, 2005, WORLD DEV IND 2005; World Health Organization, 2006, INT STAT CLASS DIS R; *YOUNG LIV, 2002, JUST CONT 7 5 8 5 YE	138	1777	1831	16	351	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 6	2007	369	9555					60	70		10.1016/S0140-6736(07)60032-4	http://dx.doi.org/10.1016/S0140-6736(07)60032-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	125AK	17208643	Green Accepted, Green Published			2022-12-01	WOS:000243413700030
J	Keidan, J				Keidan, Jane			Medicine and the media - Sucked into the Herceptin maelstrom	BRITISH MEDICAL JOURNAL			English	Editorial Material									Queen Elizabeth Hosp, Kings Lynn NHS Trust, Kings Lynn, England		Keidan, J (corresponding author), Queen Elizabeth Hosp, Kings Lynn NHS Trust, Kings Lynn, England.	Jane.Keidan@qehkl.nhs.uk							0	6	6	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 6	2007	334	7583					18	18		10.1136/bmj.39080.481551.47	http://dx.doi.org/10.1136/bmj.39080.481551.47			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	125CH	17204797	Green Published			2022-12-01	WOS:000243418600029
J	Gange, AC; Gange, EG; Sparks, TH; Boddy, L				Gange, A. C.; Gange, E. G.; Sparks, T. H.; Boddy, L.			Rapid and recent changes in fungal fruiting patterns	SCIENCE			English	Article							PLANTS; EUROPE		Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England; Belvedere, Salisbury SP5 3DZ, Wilts, England; NERC, Ctr Ecol & Hydrol, Monks Wood PE28 2LS, Cambs, England; Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3TL, S Glam, Wales	University of London; Royal Holloway University London; UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); Cardiff University	Gange, AC (corresponding author), Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England.	a.gange@rhul.ac.uk	Boddy, Lynne/A-7250-2010	Sparks, Tim/0000-0003-4382-7051; Boddy, Lynne/0000-0003-1845-6738	Natural Environment Research Council [CEH010021] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; LAST FT, 1979, NATURE, V280, P168, DOI 10.1038/280168a0; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233	6	155	165	2	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2007	316	5821					71	71		10.1126/science.1137489	http://dx.doi.org/10.1126/science.1137489			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412949				2022-12-01	WOS:000245470500032
J	Fine, M; Tchernov, D				Fine, Maoz; Tchernov, Dan			Scleractinian coral species survive and recover from decalcification	SCIENCE			English	Article							EVOLUTION; CARBON		Bar Ilan Univ, Fac Life Sci, IL-52900 Ramat Gan, Israel; Hebrew Univ Jerusalem, Dept Evolut Systemat & Ecol, IL-91904 Jerusalem, Israel; Interuniv Inst Marine Sci, IL-88103 Elat, Israel	Bar Ilan University; Hebrew University of Jerusalem	Fine, M (corresponding author), Bar Ilan Univ, Fac Life Sci, IL-52900 Ramat Gan, Israel.	finema@mail.biu.ac.il	Fine, Maoz/S-5582-2019; Tchernov, Dan/AAE-2545-2021	Fine, Maoz/0000-0003-4911-4562; Tchernov, Dan/0000-0003-1135-8270				Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Hoegh-Guldberg O, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002528; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; Medina M, 2006, P NATL ACAD SCI USA, V103, P9096, DOI 10.1073/pnas.0602444103; Romano SL, 1996, SCIENCE, V271, P640, DOI 10.1126/science.271.5249.640; Stanley GD, 2003, EARTH-SCI REV, V60, P195, DOI 10.1016/S0012-8252(02)00104-6; Stanley GD, 2001, SCIENCE, V291, P1913, DOI 10.1126/science.1056632	8	201	213	5	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1811	1811		10.1126/science.1137094	http://dx.doi.org/10.1126/science.1137094			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395821				2022-12-01	WOS:000245280100032
J	Kurtovic, A; Widmer, A; Dickson, BJ				Kurtovic, Amina; Widmer, Alexandre; Dickson, Barry J.			A single class of olfactory neurons mediates behavioural responses to a Drosophila sex pheromone	NATURE			English	Article							MALE COURTSHIP BEHAVIOR; SILKMOTH BOMBYX-MORI; ANTENNAL LOBE; HELIOTHIS-VIRESCENS; MELANOGASTER; RECEPTOR; BRAIN; REPRESENTATION; SYSTEM; MOTH	Insects, like many other animals, use sex pheromones to coordinate their reproductive behaviours(1). Volatile pheromones are detected by odorant receptors expressed in olfactory receptor neurons ( ORNs). Whereas fruit odours typically activate multiple ORN classes(2), pheromones are thought to act through single dedicated classes of ORN3. This model predicts that activation of such an ORN class should be sufficient to trigger the appropriate behavioural response. Here we show that the Drosophila melanogaster male-specific pheromone 11-cis-vaccenyl acetate ( cVA) acts through the receptor Or67d to regulate both male and female mating behaviour. Mutant males that lack Or67d inappropriately court other males, whereas mutant females are less receptive to courting males. These data suggest that cVA has opposite effects in the two sexes: inhibiting mating behaviour in males but promoting mating behaviour in females. Replacing Or67d with moth pheromone receptors renders these ORNs sensitive to the corresponding moth pheromones. In such flies, moth pheromones elicit behavioural responses that mimic the normal response to cVA. Thus, activation of a single ORN class is both necessary and sufficient to mediate behavioural responses to the Drosophila sex pheromone cVA.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Dickson, BJ (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	dickson@imp.ac.at	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X; Kozaric, Amina/0000-0002-6063-7260				Broome BM, 2006, NEURON, V51, P467, DOI 10.1016/j.neuron.2006.07.018; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; JEFFERIS GSX, 2007, IN PRESS CELL; Kondoh Y, 2003, P ROY SOC B-BIOL SCI, V270, P1005, DOI 10.1098/rspb.2003.2331; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Krieger J, 2005, EUR J NEUROSCI, V21, P2167, DOI 10.1111/j.1460-9568.2005.04058.x; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MANE SD, 1983, SCIENCE, V222, P419, DOI 10.1126/science.222.4622.419; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; ROELOFS WL, 1974, LIFE SCI, V14, P1555, DOI 10.1016/0024-3205(74)90166-0; Rollmann SM, 2005, J NEUROBIOL, V63, P146, DOI 10.1002/neu.20123; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Schurmann FW, 2000, ACTA BIOL HUNG, V51, P355; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Syed Z, 2006, P NATL ACAD SCI USA, V103, P16538, DOI 10.1073/pnas.0607874103; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yasuyama K, 2003, J COMP NEUROL, V466, P299, DOI 10.1002/cne.10867; Zou ZH, 2006, SCIENCE, V311, P1477, DOI 10.1126/science.1124755	30	485	503	5	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2007	446	7135					542	546		10.1038/nature05672	http://dx.doi.org/10.1038/nature05672			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392786				2022-12-01	WOS:000245242900050
J	Bianchi, A; Shore, D				Bianchi, Alessandro; Shore, David			Early replication of short telomeres in budding yeast	CELL			English	Article							ORIGIN ACTIVATION; LENGTH REGULATION; DNA; PROTEIN; SEQUENCES; TIME; COMPLEX; CENTROMERES; DYNAMICS; REQUIRES	The maintenance of an appropriate number of telomere repeats by telomerase is essential for proper chromosome protection. The action of telomerase at the telomere terminus is regulated by opposing activities that either recruit/activate the enzyme at shorter telomeres or inhibit it at longer ones, thus achieving a stable average telomere length. To elucidate the mechanistic details of telomerase regulation we engineered specific chromosome ends in yeast so that a single telomere could be suddenly shortened and, as a consequence of its reduced length, elongated by telomerase. We show that shortened telomeres replicate early in S phase, unlike normal-length telomeres, due to the early firing of origins of DNA replication in subtelomeric regions. Early telomere replication correlates with increased telomere length and telomerase activity. These data reveal an epigenetic effect of telomere length on the activity of nearby replication origins and an unanticipated link between telomere replication timing and telomerase action.	Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; Univ Geneva, NCCR, Frontiers Genet Program, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Bianchi, A (corresponding author), Univ Geneva, Dept Mol Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland.	alessandro.bianchi@molbio.unige.ch	Shore, David/F-6240-2015	Shore, David/0000-0002-9859-143X; Bianchi, Alessandro/0000-0001-6583-1671				Aparicio JG, 2004, MOL CELL BIOL, V24, P4769, DOI 10.1128/MCB.24.11.4769-4780.2004; Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Bianchi A, 2004, MOL CELL, V16, P139, DOI 10.1016/j.molcel.2004.09.009; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Cosgrove AJ, 2002, GENE DEV, V16, P2485, DOI 10.1101/gad.231602; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dionne I, 1998, NUCLEIC ACIDS RES, V26, P5365, DOI 10.1093/nar/26.23.5365; FERGUSON BM, 1991, CELL, V65, P507, DOI 10.1016/0092-8674(91)90468-E; FERGUSON BM, 1992, CELL, V68, P333, DOI 10.1016/0092-8674(92)90474-Q; Fisher TS, 2004, NAT STRUCT MOL BIOL, V11, P1198, DOI 10.1038/nsmb854; Grossi S, 2001, MOL CELL BIOL, V21, P8117, DOI 10.1128/MCB.21.23.8117-8128.2001; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Hultdin M, 2001, EXP CELL RES, V271, P223, DOI 10.1006/excr.2001.5391; Kim SM, 2003, GENE DEV, V17, P330, DOI 10.1101/gad.1046203; KYRION G, 1993, GENE DEV, V7, P1146, DOI 10.1101/gad.7.7a.1146; Louis EJ, 2005, BIOESSAYS, V27, P685, DOI 10.1002/bies.20259; Makovets S, 2004, MOL CELL BIOL, V24, P4019, DOI 10.1128/MCB.24.9.4019-4031.2004; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Marcand S, 1999, EMBO J, V18, P3509, DOI 10.1093/emboj/18.12.3509; MCCARROLL RM, 1988, CELL, V54, P505, DOI 10.1016/0092-8674(88)90072-4; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; NIMMO ER, 1994, EMBO J, V13, P3801, DOI 10.1002/j.1460-2075.1994.tb06691.x; Ofir R, 1999, P NATL ACAD SCI USA, V96, P11434, DOI 10.1073/pnas.96.20.11434; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poloumienko A, 2001, MOL BIOL CELL, V12, P3317, DOI 10.1091/mbc.12.11.3317; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Raghuraman MK, 1997, SCIENCE, V276, P806, DOI 10.1126/science.276.5313.806; Smith ZE, 1999, HUM MOL GENET, V8, P1373, DOI 10.1093/hmg/8.8.1373; Stevenson JB, 1999, GENE DEV, V13, P146, DOI 10.1101/gad.13.2.146; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Tanaka S, 1996, YEAST, V12, P101, DOI 10.1002/(SICI)1097-0061(199602)12:2<101::AID-YEA885>3.0.CO;2-2; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; TENHAGEN KG, 1990, MOL CELL BIOL, V10, P6348, DOI 10.1128/MCB.10.12.6348; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; WELLINGER RJ, 1993, MOL CELL BIOL, V13, P4057, DOI 10.1128/MCB.13.7.4057; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; Wright WE, 1999, EXP CELL RES, V251, P492, DOI 10.1006/excr.1999.4602; Zappulla DC, 2002, CURR BIOL, V12, P869, DOI 10.1016/S0960-9822(02)00871-0; Zou Y, 2004, P NATL ACAD SCI USA, V101, P12928, DOI 10.1073/pnas.0404106101	47	67	68	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1051	1062		10.1016/j.cell.2007.01.041	http://dx.doi.org/10.1016/j.cell.2007.01.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382879	Bronze			2022-12-01	WOS:000245396200013
J	Jefferis, GSXE; Potter, CJ; Chan, AI; Marin, EC; Rohlfing, T; Maurer, CR; Luo, LQ				Jefferis, Gregory S. X. E.; Potter, Christopher J.; Chan, Alexander Im.; Marin, Elizabeth C.; Rohlfing, Torsten; Maurer, Calvin R., Jr.; Luo, Liqun			Comprehensive maps of Drosophila higher offactory centers: Spatially segregated fruit and pheromone representation	CELL			English	Article							MALE COURTSHIP BEHAVIOR; ANTENNAL LOBE; MUSHROOM BODY; OLFACTORY CORTEX; MOSAIC ANALYSIS; BOMBYX-MORI; NEURONS; MELANOGASTER; BRAIN; ORGANIZATION	In Drosophila, similar to 50 classes of olfactory receptor neurons (ORNs) send axons to 50 corresponding glomeruli in the antennal lobe. Uniglomerular projection neurons (PNs) relay olfactory information to the mushroom body (MB) and lateral horn (LH). Here, we combine single-cell labeling and image registration to create high-resolution, quantitative maps of the MB and LH for 35 input PN channels and several groups of LH neurons. We find (1) PN inputs to the MB are stereotyped as previously shown for the LH; (2) PN partners of ORNs from different sensillar groups are clustered in the LH; (3) fruit odors are represented mostly in the posterior-dorsal LH, whereas candidate pheromone-responsive PNs project to the anterior-ventral LH; (4) dendrites of single LH neurons each overlap with specific subsets of PN axons. Our results suggest that the LH is organized according to biological values of olfactory input.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Univ Cambridge, Dept Zool, Cambridge CB2 2EJ, England; SRI Int, Program Neurosci, Menlo Pk, CA 94025 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; University of Cambridge; SRI International	Jefferis, GSXE (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	gsxej2@cam.ac.uk	Jefferis, Gregory/C-6386-2012; Potter, Christopher John/H-5884-2019; Rohlfing, Torsten/A-1146-2007	Potter, Christopher John/0000-0002-5223-8112; Jefferis, Gregory/0000-0002-0587-9355; Luo, Liqun/0000-0001-5467-9264	NIAAA NIH HHS [R37 AA005965, AA05965, R01 AA005965, U01 AA013521, AA13521] Funding Source: Medline; NIDCD NIH HHS [R01-DC005982, R01 DC005982] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA005965, U01AA013521, R37AA005965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005982] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Clyne PJ, 1999, NEURON, V22, P339, DOI 10.1016/S0896-6273(00)81094-6; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Cowan WM, 1998, NEURON, V20, P413, DOI 10.1016/S0896-6273(00)80985-X; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Dulac C, 2006, ANNU REV GENET, V40, P449, DOI 10.1146/annurev.genet.39.073003.093937; Ferveur JF, 1996, P ROY SOC B-BIOL SCI, V263, P967, DOI 10.1098/rspb.1996.0143; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Ito K, 1997, DEVELOPMENT, V124, P761; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; KURTOVIC A, 2007, IN PRESS NATURE; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Penfield W., 1950, CEREBRAL CORTEX MAN; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Ramon y Cajal S, 1911, HISTOLOGY NERVOUS SY; Rein K, 2002, CURR BIOL, V12, P227, DOI 10.1016/S0960-9822(02)00656-5; Rohlfing T, 2003, IEEE T INF TECHNOL B, V7, P16, DOI 10.1109/TITB.2003.808506; SCALIA F, 1975, J COMP NEUROL, V161, P31, DOI 10.1002/cne.901610105; Schafer WR, 2005, CURR BIOL, V15, pR723, DOI 10.1016/j.cub.2005.08.020; Seki Y, 2005, J COMP NEUROL, V481, P340, DOI 10.1002/cne.20392; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; Stocker RF, 2001, MICROSC RES TECHNIQ, V55, P284, DOI 10.1002/jemt.1178; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Strausfeld NJ, 2003, MICROSC RES TECHNIQ, V62, P151, DOI 10.1002/jemt.10368; Suster ML, 2003, J NEUROBIOL, V55, P233, DOI 10.1002/neu.10202; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yasuyama K, 2003, J COMP NEUROL, V466, P299, DOI 10.1002/cne.10867; Young P, 2004, CURR OPIN NEUROBIOL, V14, P642, DOI 10.1016/j.conb.2004.08.007; Zhu SJ, 2003, DEVELOPMENT, V130, P2603, DOI 10.1242/dev.00466; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012; Zou ZH, 2006, SCIENCE, V311, P1477, DOI 10.1126/science.1124755; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	51	409	417	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1187	1203		10.1016/j.cell.2007.01.040	http://dx.doi.org/10.1016/j.cell.2007.01.040			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382886	Green Published, hybrid			2022-12-01	WOS:000245396200023
J	Lin, HH; Lai, JSY; Chin, AL; Chen, YC; Chiang, AS				Lin, Hui-Hao; Lai, Jason Sih-Yu; Chin, An-Lun; Chen, Yung-Chang; Chiang, Ann-Shyn			A map of olfactory representation in the Drosophila mushroom body	CELL			English	Article							SHORT-TERM-MEMORY; NEURONS; BODIES; ORGANIZATION; RECEPTORS; NEUROTRANSMISSION; LOCALIZATION; ABLATION; SLEEP; BRAIN	Neural coding for olfactory sensory stimuli has been mapped near completion in the Drosophila first-order center, but little is known in the higher brain centers. Here, we report that the antenna lobe (AL) spatial map is transformed further in the calyx of the mushroom body (MB), an essential olfactory associated learning center, by stereotypic connections with projection neurons (PNs). We found that Kenyon cell (KC) dendrites are segregated into 17 complementary domains according to their neuroblast clonal origins and birth orders. Aligning the PN axonal map with the KC dendritic map and ultrastructural observation suggest a positional ordering such that inputs from the different AL glomeruli have distinct representations in the MB calyx, and these representations might synapse on functionally distinct KCs. Our data suggest that olfactory coding at the AL is decoded in the MB and then transferred via distinct lobes to separate higher brain centers.	Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 30013, Taiwan; Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan; Natl Tsing Hua Univ, Brain Res Ctr, Hsinchu 30013, Taiwan; Natl Tsing Hua Univ, Dept Elect Engn, Engn & Syst Sci Grp, Hsinchu 30013, Taiwan; Natl Cent Univ, Dept Life Sci, Tao Yuan 32001, Taiwan; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Central University; Cold Spring Harbor Laboratory	Chiang, AS (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 30013, Taiwan.	aschiang@life.nthu.edu.tw		Chiang, Ann-Shyn/0000-0001-9668-7115				Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Chiang AS, 2001, J COMP NEUROL, V440, P1, DOI 10.1002/cne.1365; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Ito K, 1998, LEARN MEMORY, V5, P52; Ito K, 1997, DEVELOPMENT, V124, P761; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee T, 1999, DEVELOPMENT, V126, P4065; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Manoli DS, 2004, NATURE, V430, P564, DOI 10.1038/nature02713; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Rein K, 2002, CURR BIOL, V12, P227, DOI 10.1016/S0960-9822(02)00656-5; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Stopfer M, 2005, CURR BIOL, V15, pR996, DOI 10.1016/j.cub.2005.11.052; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Tang SM, 2001, SCIENCE, V294, P1543, DOI 10.1126/science.1058237; TECHNAU G, 1982, NATURE, V295, P405, DOI 10.1038/295405a0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Vosshall LB, 2000, CURR OPIN NEUROBIOL, V10, P498, DOI 10.1016/S0959-4388(00)00111-2; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; Wang YL, 2003, CURR BIOL, V13, P1900, DOI 10.1016/j.cub.2003.10.003; Watts RJ, 2004, CURR BIOL, V14, P678, DOI 10.1016/j.cub.2004.03.035; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Xia SZ, 2005, CURR BIOL, V15, P603, DOI 10.1016/j.cub.2005.02.059; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zhu SJ, 2003, DEVELOPMENT, V130, P2603, DOI 10.1242/dev.00466	50	158	164	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1205	1217		10.1016/j.cell.2007.03.006	http://dx.doi.org/10.1016/j.cell.2007.03.006			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382887	Bronze			2022-12-01	WOS:000245396200024
J	Oliveri, P; Davidson, EH				Oliveri, Paola; Davidson, Eric H.			Built to run, not fail	SCIENCE			English	Editorial Material							GENE REGULATORY NETWORKS		CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Oliveri, P (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	poliveri@caltech.edu; davidson@caltech.edu		Oliveri, Paola/0000-0002-3477-8529	NICHD NIH HHS [HD-37105] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD037105] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502; Davidson E. H., 2006, REGULATORY GENOME GE; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Davidson EH, 2001, GENOMIC REGULATORY S; Kiefer JC, 2007, DEV BIOL, V303, P611, DOI 10.1016/j.ydbio.2006.11.042; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Minokawa T, 2004, GENE EXPR PATTERNS, V4, P449, DOI 10.1016/j.modgep.2004.01.009; Oliveri P, 2006, DEVELOPMENT, V133, P4173, DOI 10.1242/dev.02577	8	38	38	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1510	1511		10.1126/science.1140979	http://dx.doi.org/10.1126/science.1140979			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363653				2022-12-01	WOS:000244934800029
J	Wilker, EW; van Vugt, MATM; Artim, SA; Huang, PH; Petersen, CP; Reinhardt, HC; Feng, Y; Sharp, PA; Sonenberg, N; White, FM; Yaffe, MB				Wilker, Erik W.; van Vugt, Marcel A. T. M.; Artim, Steven A.; Huang, Paul H.; Petersen, Christian P.; Reinhardt, H. Christian; Feng, Yun; Sharp, Phillip A.; Sonenberg, Nahum; White, Forest M.; Yaffe, Michael B.			14-3-3 sigma controls mitotic translation to facilitate cytokinesis	NATURE			English	Article							RIBOSOME ENTRY SITE; BREAST-CANCER; CELL-CYCLE; MAMMALIAN-CELLS; EARLY EVENT; SIGMA GENE; HYPERMETHYLATION; PROTEIN; EXPRESSION; INITIATION	14-3-3 proteins are crucial in a wide variety of cellular responses including cell cycle progression, DNA damage checkpoints and apoptosis. One particular 14-3-3 isoform, sigma, is a p53-responsive gene, the function of which is frequently lost in human tumours, including breast and prostate cancers as a result of either hypermethylation of the 14-3-3 sigma promoter or induction of an oestrogen-responsive ubiquitin ligase that specifically targets 14-3-3 sigma for proteasomal degradation(1-9). Loss of 14-3-3 sigma protein occurs not only within the tumours themselves but also in the surrounding pre-dysplastic tissue (so-called field cancerization), indicating that 14-3-3 sigma might have an important tumour suppressor function that becomes lost early in the process of tumour evolution(3,9). The molecular basis for the tumour suppressor function of 14-3-3 sigma is unknown. Here we report a previously unknown function for 14-3-3 sigma as a regulator of mitotic translation through its direct mitosis-specific binding to a variety of translation/ initiation factors, including eukaryotic initiation factor 4B in a stoichiometric manner. Cells lacking 14-3-3 sigma, in marked contrast to normal cells, cannot suppress cap-dependent translation and do not stimulate cap-independent translation during and immediately after mitosis. This defective switch in the mechanism of translation results in reduced mitotic-specific expression of the endogenous internal ribosomal entry site (IRES)-dependent form of the cyclin-dependent kinase Cdk11 (p58 PITSLRE), leading to impaired cytokinesis, loss of Polo-like kinase-1 at the midbody, and the accumulation of binucleate cells. The aberrant mitotic phenotype of 14-3-3 sigma-depleted cells can be rescued by forced expression of p58 PITSLRE or by extinguishing cap-dependent translation and increasing cap-independent translation during mitosis by using rapamycin. Our findings show how aberrant mitotic translation in the absence of 14-3-3 sigma impairs mitotic exit to generate binucleate cells and provides a potential explanation of how 14-3-3 sigma-deficient cells may progress on the path to aneuploidy and tumorigenesis.	MIT, Ctr Canc Res, Dept Biol, Cambridge, MA 02139 USA; McGill Univ, McGill Canc Ctr, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	Massachusetts Institute of Technology (MIT); McGill University	Yaffe, MB (corresponding author), MIT, Ctr Canc Res, Dept Biol, Cambridge, MA 02139 USA.	myaffe@mit.edu	Huang, Paul H./H-8591-2015; Petersen, Christian P./GZG-4541-2022	Huang, Paul H./0000-0003-3972-5087; Petersen, Christian P./0000-0001-7552-6865; /0000-0003-4503-9024; White, Forest/0000-0002-1545-1651				Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Brasey A, 2003, J VIROL, V77, P3939, DOI 10.1128/JVI.77.7.3939-3949.2003; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Ferguson AT, 2000, P NATL ACAD SCI USA, V97, P6049, DOI 10.1073/pnas.100566997; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Gasco M, 2002, ONCOGENE, V21, P1876, DOI 10.1038/sj.onc.1205256; HERSHEY JWB, 1994, BIOCHIMIE, V76, P847, DOI 10.1016/0300-9084(94)90186-4; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Iwata N, 2000, ONCOGENE, V19, P5298, DOI 10.1038/sj.onc.1203898; Kullmann M, 2002, GENE DEV, V16, P3087, DOI 10.1101/gad.248902; Li TY, 2004, MOL CELL BIOL, V24, P3188, DOI 10.1128/MCB.24.8.3188-3197.2004; Liu XQ, 2004, J CELL SCI, V117, P3233, DOI 10.1242/jcs.01173; Merrick WC, 2004, GENE, V332, P1, DOI 10.1016/j.gene.2004.02.051; Moreira JMA, 2004, MOL CELL PROTEOMICS, V3, P410, DOI 10.1074/mcp.M300134-MCP200; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Petretti C, 2006, EMBO REP, V7, P418, DOI 10.1038/sj.embor.7400639; PRESCOTT DM, 1962, EXP CELL RES, V26, P260, DOI 10.1016/0014-4827(62)90176-3; Pyronnet S, 2000, MOL CELL, V5, P607, DOI 10.1016/S1097-2765(00)80240-3; Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201; Qin XL, 2004, J BIOL CHEM, V279, P13721, DOI 10.1074/jbc.M312854200; Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Suzuki H, 2000, CANCER RES, V60, P4353; Umbricht CB, 2001, ONCOGENE, V20, P3348, DOI 10.1038/sj.onc.1204438; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; Vercoutter-Edouart AS, 2001, CANCER RES, V61, P76; Villaret DB, 2000, LARYNGOSCOPE, V110, P374, DOI 10.1097/00005537-200003000-00008; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200	30	172	184	2	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2007	446	7133					329	332		10.1038/nature05584	http://dx.doi.org/10.1038/nature05584			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17361185				2022-12-01	WOS:000244892900048
J	Fisher, RD; Chung, HY; Zhai, QT; Robinson, H; Sundquist, WI; Hill, CP				Fisher, Robert D.; Chung, Hyo-Young; Zhai, Qianting; Robinson, Howard; Sundquist, Wesley I.; Hill, Christopher P.			Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding	CELL			English	Article							BINDING PARTNER; HUMAN HOMOLOG; PROTEIN; ALIX; TSG101; DOMAIN; PATHWAY; BRO1; GAG; P6	ALIX/AIP1 functions in enveloped virus budding, endosomal protein sorting, and many other cellular processes. Retroviruses, including HIV-1, SIV, and EIAV, bind and recruit ALIX through YPXnL late-domain motifs (X = any residue; In = 1-3). Crystal structures reveal that human ALIX is composed of an N-terminal Bro1 domain and a central domain that is composed of two extended three-helix bundles that form elongated arms that fold back into a "V." The structures also reveal conformational flexibility in the arms that suggests that the V domain may act as a flexible hinge in response to ligand binding. YPXnL late domains bind in a conserved hydrophobic pocket on the second arm near the apex of the V, whereas CHMP4/ ESCRT-III proteins bind a conserved hydrophobic patch on the Bro1 domain, and both interactions are required for virus budding. ALIX therefore serves as a flexible, extended scaffold that connects retroviral Gag proteins to ESCRT-III and other cellular-budding machinery.	Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Utah System of Higher Education; University of Utah; United States Department of Energy (DOE); Brookhaven National Laboratory	Sundquist, WI (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	wes@biochem.utah.edu; chris@biochem.utah.edu	zhai, qianting/G-1301-2013		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082545, P01GM066521] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI051174, AI 051174] Funding Source: Medline; NIGMS NIH HHS [P50 GM082545, GM 066521] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alroy I, 2005, P NATL ACAD SCI USA, V102, P1478, DOI 10.1073/pnas.0408717102; Bibollet-Ruche F, 2004, J VIROL, V78, P7748, DOI 10.1128/JVI.78.14.7748-7762.2004; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Cabezas A, 2005, J CELL SCI, V118, P2625, DOI 10.1242/jcs.02382; Chatellard-Causse C, 2002, J BIOL CHEM, V277, P29108, DOI 10.1074/jbc.M204019200; Chen CP, 2005, J BIOL CHEM, V280, P40474, DOI 10.1074/jbc.M509317200; DEJOURNETT RE, 2006, BIOCHEM J, V401, P521; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Demirov DG, 2002, J VIROL, V76, P105, DOI 10.1128/JVI.76.1.105-117.2002; Gallop JL, 2005, BIOCHEM SOC SYMP, V72, P223, DOI 10.1042/bss0720223; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Geminard C, 2004, TRAFFIC, V5, P181, DOI 10.1111/j.1600-0854.2004.0167.x; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HUANG MJ, 1995, J VIROL, V69, P6810, DOI 10.1128/JVI.69.11.6810-6818.1995; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Ichioka F, 2005, BIOSCI BIOTECH BIOCH, V69, P861, DOI 10.1271/bbb.69.861; Katoh K, 2003, J BIOL CHEM, V278, P39104, DOI 10.1074/jbc.M301604200; Kim JW, 2005, DEV CELL, V8, P937, DOI 10.1016/j.devcel.2005.04.001; Langelier C, 2006, J VIROL, V80, P9465, DOI 10.1128/JVI.01049-06; Luhtala N, 2004, J CELL BIOL, V166, P717, DOI 10.1083/jcb.200403139; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Odorizzi G, 2003, J CELL SCI, V116, P1893, DOI 10.1242/jcs.00395; Odorizzi G, 2006, J CELL SCI, V119, P3025, DOI 10.1242/jcs.03072; Olsen JC, 1998, GENE THER, V5, P1481, DOI 10.1038/sj.gt.3300768; Pineda-Molina E, 2006, TRAFFIC, V7, P1007, DOI 10.1111/j.1600-0854.2006.00440.x; Puffer BA, 1997, J VIROL, V71, P6541, DOI 10.1128/JVI.71.9.6541-6546.1997; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Sadoul R, 2006, BIOL CELL, V98, P69, DOI 10.1042/BC20050007; Schmidt MHH, 2003, J CELL SCI, V116, P2845, DOI 10.1242/jcs.00522; Schmidt MHH, 2004, MOL CELL BIOL, V24, P8981, DOI 10.1128/MCB.24.20.8981-8993.2004; Schmidt MHH, 2005, J BIOL CHEM, V280, P3414, DOI 10.1074/jbc.M409839200; Segura-Morales C, 2005, J BIOL CHEM, V280, P27004, DOI 10.1074/jbc.M413735200; Shibata H, 2004, J BIOCHEM, V135, P117, DOI 10.1093/jb/mvh014; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Tsuda M, 2006, FEBS LETT, V580, P3296, DOI 10.1016/j.febslet.2006.05.005; van der Goot FG, 2006, TRENDS CELL BIOL, V16, P514, DOI 10.1016/j.tcb.2006.08.003; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; Vincent O, 2003, MOL CELL BIOL, V23, P1647, DOI 10.1128/MCB.23.5.1647-1655.2003; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Wang Margaret Q, 2003, J Biol, V3, P4, DOI 10.1186/1475-4924-3-4	43	250	259	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2007	128	5					841	852		10.1016/j.cell.2007.01.035	http://dx.doi.org/10.1016/j.cell.2007.01.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350572	Bronze			2022-12-01	WOS:000245073400010
J	Sheen, J; He, P				Sheen, Jen; He, Ping			Nuclear actions in innate immune signaling	CELL			English	Editorial Material							RESISTANCE PROTEIN	Innate immunity in plants and animals is mediated through pattern recognition receptors, which were thought to initiate signaling in the cytoplasm to activate defense pathways. Shen et al. (2006) and Burch-Smith et al. (2007) now provide compelling evidence that certain plant disease resistance proteins, which detect specific pathogenic effectors, act in the nucleus to trigger downstream signaling and defense pathways.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol,Dept Genet, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Sheen, J (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol,Dept Genet, Boston, MA 02114 USA.	sheen@molbio.mgh.harvard.edu		He, Ping/0000-0002-5926-8349				Burch-Smith TM, 2007, PLOS BIOL, V5, P501, DOI 10.1371/journal.pbio.0050068; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Mestre P, 2006, PLANT CELL, V18, P491, DOI 10.1105/tpc.105.037234; SHEN QH, 2006, SCIENCE         1221; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Ueda H, 2006, PLANT MOL BIOL, V61, P31, DOI 10.1007/s11103-005-5817-8; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Xu XP, 2006, PLANT CELL, V18, P1310, DOI 10.1105/tpc.105.037523	10	7	8	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2007	128	5					821	823		10.1016/j.cell.2007.02.019	http://dx.doi.org/10.1016/j.cell.2007.02.019			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350565	Bronze			2022-12-01	WOS:000245073400003
J	Hitchins, MP; Wong, JJL; Suthers, G; Suter, CM; Martin, DIK; Hawkins, NJ; Ward, RL				Hitchins, Megan P.; Wong, Justin J. L.; Suthers, Graerne; Suter, Catherine M.; Martin, David I. K.; Hawkins, Nicholas J.; Ward, Robyn L.			Brief report: Inheritance of a cancer-associated MLH1 germ-line epimutation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; DNA METHYLATION; PROMOTER HYPERMETHYLATION; EPIGENETIC INHERITANCE; PATERNAL GENOME; MOUSE; GENE; ALLELE; HUMAN-CHROMOSOME-15; DEMETHYLATION	Persons who have hypermethylation of one allele of MLH1 in somatic cells throughout the body (a germ-line epimutation) have a predisposition for the development of cancer in a pattern typical of hereditary nonpolyposis colorectal cancer. By studying the families of two such persons, we found evidence that the epimutation was transmitted from a mother to her son but was erased in his spermatozoa. The affected maternal allele was inherited by three other siblings from these two families, but in those offspring the allele had reverted to the normal active state. These findings demonstrate a novel pattern of inheritance of cancer susceptibility and are consistent with transgenerational epigenetic inheritance.	St Vincents Hosp, Dept Med Oncol, Darlinghurst, NSW 2010, Australia; Univ New S Wales, Sch Med, Sydney, NSW, Australia; Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; Victor Chang Cardiac Res Inst, Sydney, NSW, Australia; Womens & Childrens Hosp, Dept Med Genet, Adelaide, SA, Australia; Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA	St Vincents Hospital Sydney; University of New South Wales Sydney; University of New South Wales Sydney; Victor Chang Cardiac Research Institute; Womens & Childrens Hospital Australia; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Ward, RL (corresponding author), St Vincents Hosp, Dept Med Oncol, Victoria St, Darlinghurst, NSW 2010, Australia.	robyn@unsw.edu.au	Hawkins, Nicholas J/A-8461-2008; Wong, Justin/AAE-7986-2020; Ward, Robyn L/I-2313-2013; Hitchins, Megan/GXH-4566-2022	Hawkins, Nicholas J/0000-0002-2204-3189; Wong, Justin/0000-0002-7038-5079; Ward, Robyn L/0000-0002-6877-8906; 				Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; Chan TL, 2006, NAT GENET, V38, P1178, DOI 10.1038/ng1866; Dittrich B, 1996, NAT GENET, V14, P163, DOI 10.1038/ng1096-163; El-Maarri O, 2001, NAT GENET, V27, P341, DOI 10.1038/85927; Gazzoli I, 2002, CANCER RES, V62, P3925; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hegde M, 2005, J MOL DIAGN, V7, P525, DOI 10.1016/S1525-1578(10)60584-3; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hitchins M, 2005, GASTROENTEROLOGY, V129, P1392, DOI 10.1053/j.gastro.2005.09.003; Kubota T, 1997, NAT GENET, V16, P16, DOI 10.1038/ng0597-16; Lynch HT, 2005, ONCOLOGY-NY, V19, P455; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Miyakura Y, 2004, CLIN GASTROENTEROL H, V2, P147, DOI 10.1016/S1542-3565(03)00314-8; MORALES P, 1991, HUM REPROD, V6, P401; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; *NAT CTR BIOT INF, UNISTS DAT; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Roemer I, 1997, CURR BIOL, V7, P277, DOI 10.1016/S0960-9822(06)00124-2; Schoell WMJ, 1999, OBSTET GYNECOL, V94, P623, DOI 10.1016/S0029-7844(99)00373-7; Stoger R, 1997, HUM MOL GENET, V6, P1791, DOI 10.1093/hmg/6.11.1791; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Trinh BN, 2001, METHODS, V25, P456, DOI 10.1006/meth.2001.1268	25	300	321	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2007	356	7					697	705		10.1056/NEJMoa064522	http://dx.doi.org/10.1056/NEJMoa064522			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135ZV	17301300				2022-12-01	WOS:000244193300007
J	Dhallan, R; Guo, X; Emche, S; Damewood, M; Bayliss, P; Cronin, M; Barry, J; Betz, J; Franz, K; Gold, K; Vallecillo, B; Varney, J				Dhallan, Ravinder; Guo, Xin; Emche, Sarah; Damewood, Marian; Bayliss, Philip; Cronin, Michael; Barry, Julie; Betz, Jordan; Franz, Kara; Gold, Katie; Vallecillo, Brett; Varney, John			A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study	LANCET			English	Article							CELLS; PLASMA; CIRCULATION	Background Use of free fetal DNA to diagnose fetal chromosomal abnormalities has been hindered by the inability to distinguish fetal DNA from maternal DNA. Our aim was to establish whether single nucleotide polymorphisms (SNPs) can be used to distinguish fetal DNA from maternal DNA-and to determine the number of fetal chromosomes-in maternal blood samples. Methods Formaldehyde-treated blood samples from 60 pregnant women and the stated biological fathers were analysed. Maternal plasma fractions were quantified at multiple SNPs, and the ratio of the unique fetal allele signal to the combined maternal and fetal allele signal calculated. The mean ratios of SNPs on chromosomes 13 and 21 were compared to test for potential fetal chromosomal abnormalities. Findings The mean proportion of free fetal DNA was 34.0% (median 32.5%, range 17.0-93-8). We identified three samples with significant differences in the fetal DNA ratios for chromosome 13 and chromosome 21,. indicative of trisomy 21; the remaining 57 samples were deemed to be normal. Amniocentesis or newborn reports from the clinical sites confirmed that the copy number of fetal chromosomes 13 and 21 was established correctly for 58 of the 60 samples, identifying 56 of the 57 normal samples, and two of the three trisomy 21 samples. Of the incorrectly identified samples, one was a false negative and one was a false positive. The sensitivity and positive predictive value were both 66.7% (95% CI 12.5-98.2) and the specificity and negative predictive values were both 98.2% (89.4-99.9). Interpretation The copy number of chromosomes of interest can be directly established from maternal plasma. Such a non-invasive prenatal test could provide a useful complement to currently used screening tests.	Ravgen Inc, Columbia, MD 21045 USA; York Hosp Wellspan Hlth, Dept Obstet & Gynecol, York, PA USA; Lancaster Gen Women & Babies Hosp, Dept Maternal Fetal Med, Lancaster, PA USA; Whyte Hirschboeck Dudek SC, Madison, WI USA		Dhallan, R (corresponding author), Ravgen Inc, 9241 Rumsey Rd, Columbia, MD 21045 USA.	rdhallan@ravgen.com	Betz, Jordan F/A-8833-2010	Betz, Jordan F/0000-0002-1257-2204				ACOG Committee on Practice Bulletins, 2007, Obstet Gynecol, V109, P217; Alfirevic Z, 2004, BMJ-BRIT MED J, V329, P811, DOI 10.1136/bmj.329.7470.811; Alfirevic Z, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD003252, 10.1002/14651858]; Amicucci P, 2000, CLIN CHEM, V46, P301; Avent ND, 2006, PRENATAL DIAG, V26, P598, DOI 10.1002/pd.1493; Benn PA, 2004, OBSTET GYNECOL, V103, P1255, DOI 10.1097/01.AOG.0000127008.14792.14; Berkowitz RL, 2006, OBSTET GYNECOL, V107, P715, DOI 10.1097/01.AOG.0000201976.00299.d2; Bianchi DW, 2005, OBSTET GYNECOL, V106, P841, DOI 10.1097/01.AOG.0000179477.59385.93; Bianchi DW, 2002, PRENATAL DIAG, V22, P609, DOI 10.1002/pd.347; BIANCHI DW, 1990, P NATL ACAD SCI USA, V87, P3279, DOI 10.1073/pnas.87.9.3279; d'Ercole C, 2003, CHILD NERV SYST, V19, P444, DOI 10.1007/s00381-003-0788-z; de Graaf IM, 1999, PRENATAL DIAG, V19, P648, DOI 10.1002/(SICI)1097-0223(199907)19:7<648::AID-PD600>3.0.CO;2-X; Dhallan R, 2004, JAMA-J AM MED ASSOC, V291, P1114, DOI 10.1001/jama.291.9.1114; DHALLAN RS, 2005, Patent No. 6977162; DHALLAN RS, 2004, Patent No. 10661165; Fuchs KM, 2005, SEMIN PERINATOL, V29, P267, DOI 10.1053/j.semperi.2005.05.003; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Malone FD, 2005, NEW ENGL J MED, V353, P2001, DOI 10.1056/NEJMoa043693; Papp C, 2003, CURR OPIN OBSTET GYN, V15, P159, DOI 10.1097/00001703-200304000-00011; Pont-Kingdon G, 2003, CLIN CHEM, V49, P1087, DOI 10.1373/49.7.1087; Saito H, 2000, LANCET, V356, P1170, DOI 10.1016/S0140-6736(00)02767-7; SIMPSON JL, 1993, JAMA-J AM MED ASSOC, V270, P2357, DOI 10.1001/jama.270.19.2357; Torricelli F, 2001, CLIN CHEM LAB MED, V39, P494, DOI 10.1515/CCLM.2001.082; Wilson RD, 2005, J OBSTET GYNAECOL CA, V27, P54, DOI 10.1016/S1701-2163(16)30173-6	25	89	174	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2007	369	9560					474	481		10.1016/S0140-6736(07)60115-9	http://dx.doi.org/10.1016/S0140-6736(07)60115-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135XX	17292767				2022-12-01	WOS:000244188300030
J	Kurella, M; Covinsky, KE; Collins, AJ; Chertow, GM				Kurella, Manjula; Covinsky, Kenneth E.; Collins, Alan J.; Chertow, Glenn M.			Octogenarians and nonagenarians starting dialysis in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							STAGE RENAL-DISEASE; REPLACEMENT THERAPY; DECISION-MAKING; INITIATION; SURVIVAL; HEMODIALYSIS; PREVALENCE; VALIDATION; COHORT	Background: The elderly constitute the fastest-growing segment of the end-stage renal disease (ESRD) population, but the epidemiology and outcomes of dialysis among the very elderly, that is, those 80 years of age and older, have not been previously examined at a national level. Objective: To describe recent trends in the incidence and outcomes of octogenarians and nonagenarians starting dialysis. Design: Observational study. Setting: U.S. Renal Data System, a comprehensive, national registry of patients with ESRD. Participants: Octogenarians and nonagenarians initiating dialysis between 1996 and 2003. Measurements: Rates of dialysis initiation and survival. Results: The number of octogenarians and nonagenarians starting dialysis increased from 7054 persons in 1996 to 13 577 persons in 2003, corresponding to an average annual increase in dialysis initiation of 9.8%. After we accounted for population growth, the rate of dialysis initiation increased by 57% (rate ratio, 1.57 [95% CI, 1.53 to 1.62]) between 1996 and 2003. One-year mortality for octogenarians and nonagenarians after dialysis initiation was 46%. Compared with octogenarians and nonagenarians initiating dialysis in 1996, those starting dialysis in 2003 had a higher glomerular filtration rate and less morbidity related to chronic kidney disease but no difference in 1-year survival. Clinical characteristics strongly associated with death were older age, nonambulatory status, and more comorbid conditions. Limitations: Survival of patients with incident ESRD who did not begin dialysis could not be assessed. Conclusions: The number of octogenarians and nonagenarians initiating dialysis has increased considerably over the past decade, while overall survival for patients on dialysis remains modest. Estimates of prognosis based on patient characteristics, when considered in conjunction with individual values and preferences, may aid in dialysis decision making for the very elderly.	Univ Calif San Francisco, Div Nephrol, San Francisco, CA 94143 USA; San Francisco VA Med Ctr, San Francisco, CA 94143 USA; US Renal Data Syst, Minneapolis, MN USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Kurella, M (corresponding author), Univ Calif San Francisco, Div Nephrol, UCSF Laurel Heights,Suite 430,3333 Calif St, San Francisco, CA 94143 USA.	manjula.kurella@ucsf.edu	Tamura, Manjula Kurella/C-8284-2014	Tamura, Manjula Kurella/0000-0001-5227-2479; Chertow, Glenn/0000-0002-7599-0534	NIA NIH HHS [K24 AG029812] Funding Source: Medline; NIDDK NIH HHS [R01 DK58411, R01 DK01005] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K24AG029812] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arias Elizabeth, 2004, Natl Vital Stat Rep, V53, P1; Beddhu S, 2003, J AM SOC NEPHROL, V14, P2305, DOI 10.1097/01.ASN.0000080184.67406.11; BURNS A, 2005, AM SOC NEPHR REN WEE; Centers for Disease Control and Prevention, NAT CTR HLTH STAT NC; CHESTER AC, 1979, ARCH INTERN MED, V139, P1001, DOI 10.1001/archinte.139.9.1001; Collins AJ, 2005, AM J KIDNEY DIS, V45, pV, DOI 10.1053/j.ajkd.2004.10.009; Cooper BA, 2004, PERITON DIALYSIS INT, V24, P176; Hsu CY, 2004, ANN INTERN MED, V141, P95, DOI 10.7326/0003-4819-141-2-200407200-00007; Joly D, 2003, J AM SOC NEPHROL, V14, P1012, DOI 10.1097/01.ASN.0000054493.04151.80; Korevaar JC, 2001, LANCET, V358, P1046, DOI 10.1016/S0140-6736(01)06180-3; Lamping DL, 2000, LANCET, V356, P1543, DOI 10.1016/S0140-6736(00)03123-8; Lee SJ, 2006, JAMA-J AM MED ASSOC, V295, P801, DOI 10.1001/jama.295.7.801; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Longenecker JC, 2000, J AM SOC NEPHROL, V11, P520, DOI 10.1681/ASN.V113520; McDonald S, 2005, ADV CHRONIC KIDNEY D, V12, P32, DOI 10.1053/j.ackd.2004.10.011; Moss AH, 2001, AM J KIDNEY DIS, V37, P1081; Munshi SK, 2001, NEPHROL DIAL TRANSPL, V16, P128, DOI 10.1093/ndt/16.1.128; Muntner P, 2003, J AM SOC NEPHROL, V14, P1568, DOI 10.1097/01.ASN.0000067420.83632.C1; Peri UN, 2001, NEPHROL DIAL TRANSPL, V16, P2201, DOI 10.1093/ndt/16.11.2201; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; PORT FK, 1992, AM J KIDNEY DIS, V20, P3; Rohrich B, 1996, NEPHROL DIAL TRANSPL, V11, P2412, DOI 10.1093/oxfordjournals.ndt.a027205; Smith C, 2003, NEPHRON CLIN PRACT, V95, pC40, DOI 10.1159/000073708; Traynor JP, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000025294.40179.E8; Vandelli L, 1996, NEPHROL DIAL TRANSPL, V11, P89	25	399	419	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 6	2007	146	3					177	183		10.7326/0003-4819-146-3-200702060-00006	http://dx.doi.org/10.7326/0003-4819-146-3-200702060-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132QN	17283348				2022-12-01	WOS:000243957400003
J	Lim, MLM; Land, MF; Li, DQ				Lim, Matthew L. M.; Land, Michael F.; Li, Daiqin			Sex-specific UV and fluorescence signals in jumping spiders	SCIENCE			English	Article							SALTICIDAE; ARANEAE; SENSITIVITY		Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; Univ Sussex, Dept Biol & Environm Sci, Brighton BN1 9QG, E Sussex, England; Hubei Univ, Coll Life Sci, Wuhan 430062, Hubei, Peoples R China	National University of Singapore; University of Sussex; Hubei University	Li, DQ (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbslidq@nus.edu.sg	Lim, Matthew/Q-7406-2019; Lim, Matthew LM/D-4154-2011; Li, Daiqin/CAH-3746-2022; Li, Daiqin/D-6922-2013	Lim, Matthew/0000-0002-0888-3595; Lim, Matthew LM/0000-0002-0888-3595; Li, Daiqin/0000-0001-8269-7734; Li, Daiqin/0000-0001-8269-7734				Arnold KE, 2002, SCIENCE, V295, P92, DOI 10.1126/science.295.5552.92; BLEST AD, 1981, J COMP PHYSIOL, V145, P227, DOI 10.1007/BF00605035; Land M.F., 1985, P53; Lim MLM, 2006, BIOL J LINN SOC, V89, P397, DOI 10.1111/j.1095-8312.2006.00704.x; Lim MLM, 2006, J COMP PHYSIOL A, V192, P871, DOI 10.1007/s00359-006-0126-5; Mazel CH, 2004, SCIENCE, V303, P51, DOI 10.1126/science.1089803; PEASLEE AG, 1989, J COMP PHYSIOL A, V164, P359, DOI 10.1007/BF00612995; TOVEE MJ, 1995, TRENDS ECOL EVOL, V10, P455, DOI 10.1016/S0169-5347(00)89179-X	8	107	112	4	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2007	315	5811					481	481		10.1126/science.1134254	http://dx.doi.org/10.1126/science.1134254			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255504				2022-12-01	WOS:000243726600036
J	Markert, S; Arndt, C; Felbeck, H; Becher, D; Sievert, SM; Hugler, M; Albrecht, D; Robidart, J; Bench, S; Feldman, RA; Hecker, M; Schweder, T				Markert, Stephanie; Arndt, Cordelia; Felbeck, Horst; Becher, Dorte; Sievert, Stefan M.; Huegler, Michael; Albrecht, Dirk; Robidart, Julie; Bench, Shellie; Feldman, Robert A.; Hecker, Michael; Schweder, Thomas			Physiological proteomics of the uncultured endosymbiont of Riftia pachyptila	SCIENCE			English	Article							DEEP-SEA VENTS; CHEMOAUTOTROPHIC SYMBIONTS; CARBON FIXATION; PURIFICATION; TROPHOSOME; BACTERIA; ANIMALS; JONES; WORM	The bacterial endosymbiont of the deep-sea tube worm Riftia pachyptila has never been successfully cultivated outside its host. In the absence of cultivation data, we have taken a proteomic approach based on the metagenome sequence to study the metabolism of this peculiar microorganism in detail. As one result, we found that three major sulfide oxidation proteins constitute similar to 12% of the total cytosolic proteome, which highlights the essential role of these enzymes for the symbiont's energy metabolism. Unexpectedly, the symbiont uses the reductive tricarboxylic acid cycle in addition to the previously identified Calvin cycle for CO2 fixation.	Scripps Inst Oceanog, La Jolla, CA 92093 USA; Inst Marine Biotechnol, D-17489 Greifswald, Germany; Max Planck Inst Infect Biol, D-10117 Berlin, Germany; Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; Univ Greifswald, D-17487 Greifswald, Germany; Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; Synbio Corp, Menlo Pk, CA 94025 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Max Planck Society; Woods Hole Oceanographic Institution; Ernst Moritz Arndt Universitat Greifswald; University of California System; University of California Santa Cruz	Schweder, T (corresponding author), Scripps Inst Oceanog, La Jolla, CA 92093 USA.	schweder@uni-greifswald.de	Becher, Doerte/B-4454-2015; Markert, Stephanie/AAL-5591-2021; Hügler, Michael/A-9155-2018; Bench, Shellie R/E-7679-2010	Becher, Doerte/0000-0002-9630-5735; Markert, Stephanie/0000-0003-0923-3305; Hügler, Michael/0000-0002-2820-0333; Schweder, Thomas/0000-0002-7213-3596; Robidart, Julie/0000-0001-9805-3570; Sievert, Stefan/0000-0002-9541-2707				BLUM J, 1984, ARCH BIOCHEM BIOPHYS, V228, P617, DOI 10.1016/0003-9861(84)90030-4; CAVANAUGH CM, 1981, SCIENCE, V213, P340, DOI 10.1126/science.213.4505.340; CHILDRESS JJ, 1992, OCEANOGR MAR BIOL, V30, P337; DISTEL DL, 1988, J EXP ZOOL, V247, P1, DOI 10.1002/jez.1402470102; FELBECK H, 1981, NATURE, V293, P291, DOI 10.1038/293291a0; Felbeck Horst, 1988, Oceanologica Acta Special Issue, V8, P131; FISHER CR, 1989, BIOL BULL, V177, P372, DOI 10.2307/1541597; JANNASCH HW, 1985, SCIENCE, V229, P717, DOI 10.1126/science.229.4715.717; JONES ML, 1981, SCIENCE, V213, P333, DOI 10.1126/science.213.4505.333; LUTZ RA, 1994, NATURE, V371, P663, DOI 10.1038/371663a0; Nelson D.C., 1995, DEEP SEA HYDROTHERMA, P125; Pflugfelder B, 2005, MAR BIOL, V146, P895, DOI 10.1007/s00227-004-1500-x; Robinson JJ, 2003, LIMNOL OCEANOGR, V48, P48, DOI 10.4319/lo.2003.48.1.0048; SCHEDEL M, 1979, ARCH MICROBIOL, V121, P29, DOI 10.1007/BF00409202; Sorgo A, 2002, MAR ECOL PROG SER, V231, P115, DOI 10.3354/meps231115; STAHL DA, 1984, SCIENCE, V224, P409, DOI 10.1126/science.224.4647.409; TABITA FR, 1988, MICROBIOL REV, V52, P155, DOI 10.1128/MMBR.52.2.155-189.1988; WILMOT DB, 1990, MAR BIOL, V106, P273, DOI 10.1007/BF01314811	18	153	159	6	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2007	315	5809					247	250		10.1126/science.1132913	http://dx.doi.org/10.1126/science.1132913			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124XZ	17218528	Green Submitted			2022-12-01	WOS:000243407400049
J	Nenci, A; Becker, C; Wullaert, A; Gareus, R; van Loo, G; Danese, S; Huth, M; Nikolaev, A; Neufert, C; Madison, B; Gumucio, D; Neurath, MF; Pasparakis, M				Nenci, Arianna; Becker, Christoph; Wullaert, Andy; Gareus, Ralph; van Loo, Geert; Danese, Silvio; Huth, Marion; Nikolaev, Alexei; Neufert, Clemens; Madison, Blair; Gumucio, Deborah; Neurath, Markus F.; Pasparakis, Manolis			Epithelial NEMO links innate immunity to chronic intestinal inflammation	NATURE			English	Article							NF-KAPPA-B; DEFICIENT MICE; CANCER DEVELOPMENT; COLON-CANCER; DISEASE; GAMMA; ACTIVATION; EXPRESSION; DELETION; COLITIS	Deregulation of intestinal immune responses seems to have a principal function in the pathogenesis of inflammatory bowel disease(1-4). The gut epithelium is critically involved in the maintenance of intestinal immune homeostasis-acting as a physical barrier separating luminal bacteria and immune cells, and also expressing antimicrobial peptides(3,5,6). However, the molecular mechanisms that control this function of gut epithelial cells are poorly understood. Here we show that the transcription factor NF kappa B, a master regulator of pro-inflammatory responses(7,8), functions in gut epithelial cells to control epithelial integrity and the interaction between the mucosal immune system and gut microflora. Intestinal epithelial-cell-specific inhibition of NF-kappa B through conditional ablation of NEMO ( also called I kappa B kinase-gamma ( IKK gamma)) or both IKK1 ( IKK alpha) and IKK2 ( IKK beta)-IKK subunits essential for NF-kappa B activation(7-9)-spontaneously caused severe chronic intestinal inflammation in mice. NF-kappa B deficiency led to apoptosis of colonic epithelial cells, impaired expression of antimicrobial peptides and translocation of bacteria into the mucosa. Concurrently, this epithelial defect triggered a chronic inflammatory response in the colon, initially dominated by innate immune cells but later also involving T lymphocytes. Deficiency of the gene encoding the adaptor protein MyD88 prevented the development of intestinal inflammation, demonstrating that Toll-like receptor activation by intestinal bacteria is essential for disease pathogenesis in this mouse model. Furthermore, NEMO deficiency sensitized epithelial cells to tumour-necrosis factor ( TNF)-induced apoptosis, whereas TNF receptor-1 inactivation inhibited intestinal inflammation, demonstrating that TNF receptor-1 signalling is crucial for disease induction. These findings demonstrate that a primary NF-kappa B signalling defect in intestinal epithelial cells disrupts immune homeostasis in the gastrointestinal tract, causing an inflammatory-bowel-disease-like phenotype. Our results identify NF-kappa B signalling in the gut epithelium as a critical regulator of epithelial integrity and intestinal immune homeostasis, and have important implications for understanding the mechanisms controlling the pathogenesis of human inflammatory bowel disease.	Univ Cologne, Inst Genet, D-50674 Cologne, Germany; EMBL, Mouse Biol Unit, I-00016 Monterotondo, Italy; Johannes Gutenberg Univ Mainz, Dept Med, Lab Clin Immunol 1, D-55131 Mainz, Germany; IRCCS Gastroenterol, Ist Clin Humanitas, Div Gastroenterol, I-20089 Milan, Italy; Univ Michigan, Dept Cell & Dev Biol, Ctr Organogenesis, Ann Arbor, MI 48109 USA	University of Cologne; European Molecular Biology Laboratory (EMBL); Johannes Gutenberg University of Mainz; IRCCS Humanitas Research Hospital; University of Michigan System; University of Michigan	Pasparakis, M (corresponding author), Univ Cologne, Inst Genet, Zulpicher Str 47, D-50674 Cologne, Germany.	pasparakis@uni-koeln.de	, van Loo Geert/AAD-1220-2019; Wullaert, Andy/D-2975-2018; Becker, Christoph/L-2996-2016; Danese, Silvio/ABH-9571-2020; Pasparakis, Manolis/N-4350-2019; Becker, Christoph/A-6694-2008; Pasparakis, Manolis/H-9292-2017; Wullaert, Andy/R-1924-2019; van Loo, Geert/C-1505-2009; Eckhardt, Erik/G-1567-2010	, van Loo Geert/0000-0002-8427-4775; Wullaert, Andy/0000-0001-5012-654X; Danese, Silvio/0000-0001-7341-1351; Pasparakis, Manolis/0000-0002-9870-0966; Becker, Christoph/0000-0002-1388-1041; Pasparakis, Manolis/0000-0002-9870-0966; Wullaert, Andy/0000-0001-5012-654X; 				Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Darmoul D, 1996, AM J PHYSIOL-GASTR L, V271, pG68, DOI 10.1152/ajpgi.1996.271.1.G68; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; GAREUS R, IN PRESS NATURE CELL; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hanauer SB, 2006, INFLAMM BOWEL DIS, V12, pS3, DOI 10.1097/01.MIB.0000195385.19268.68; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Lan JG, 2005, WORLD J GASTROENTERO, V11, P3375, DOI 10.3748/wjg.v11.i22.3375; Li QT, 2000, GENE DEV, V14, P1729; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Neurath MF, 2002, NAT MED, V8, P567, DOI 10.1038/nm0602-567; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Rudolph D, 2000, GENE DEV, V14, P854; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Wehkamp J, 2005, NAT CLIN PRACT GASTR, V2, P406, DOI 10.1038/ncpgasthep0265	29	792	826	0	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2007	446	7135					557	561		10.1038/nature05698	http://dx.doi.org/10.1038/nature05698			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17361131	Green Published			2022-12-01	WOS:000245242900053
J	Morrish, TA; Garcia-Perez, JL; Stamato, TD; Taccioli, GE; Sekiguchi, J; Moran, JV				Morrish, Tammy A.; Garcia-Perez, Jose Luis; Stamato, Thomas D.; Taccioli, Guillermo E.; Sekiguchi, JoAnn; Moran, John V.			Endonuclease-independent LINE-1 retrotransposition at mammalian telomeres	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; CULTURED HUMAN-CELLS; CATALYTIC SUBUNIT; DNA-REPAIR; SCID MOUSE; CHROMOSOMES; MECHANISM; MUTATION; FUSIONS; PKCS	Long interspersed element-1 (LINE-1 or L1) elements are abundant, non-long-terminal-repeat (non-LTR) retrotransposons that comprise 17% of human DNA(1). The average human genome contains similar to 80-100 retrotransposition- competent L1s (ref. 2), and they mobilize by a process that uses both the L1 endonuclease and reverse transcriptase, termed target-site primed reverse transcription(3-5). We have previously reported an efficient, endonuclease-independent L1 retrotransposition pathway (ENi) in certain Chinese hamster ovary (CHO) cell lines that are defective in the non-homologous end-joining (NHEJ) pathway of DNA double-strand-break repair(6). Here we have characterized ENi retrotransposition events generated in V3 CHO cells, which are deficient in DNA-dependent protein kinase catalytic subunit (DNA-PKcs) activity and have both dysfunctional telomeres and an NHEJ defect. Notably, similar to 30% of ENi retrotransposition events insert in an orientation-specific manner adjacent to a perfect telomere repeat (5'-TTAGGG-3'). Similar insertions were not detected among ENi retrotransposition events generated in controls or in XR-1 CHO cells deficient for XRCC4, an NHEJ factor that is required for DNA ligation but has no known function in telomere maintenance. Furthermore, transient expression of a dominant-negative allele of human TRF2 ( also called TERF2) in XRCC4-deficient XR-1 cells, which disrupts telomere capping, enables telomere-associated ENi retrotransposition events. These data indicate that L1s containing a disabled endonuclease can use dysfunctional telomeres as an integration substrate. The findings highlight similarities between the mechanism of ENi retrotransposition and the action of telomerase, because both processes can use a 3' OH for priming reverse transcription at either internal DNA lesions or chromosome ends(7,8). Thus, we propose that ENi retrotransposition is an ancestral mechanism of RNA-mediated DNA repair associated with non-LTR retrotransposons that may have been used before the acquisition of an endonuclease domain.	Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Lankenau Inst Med Res, Wynnewood, PA 19096 USA; Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Lankenau Medical Center; Lankenau Institute for Medical Research; Boston University	Moran, JV (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.	morrisht@jhmi.edu; moranj@umich.edu		Sekiguchi, JoAnn/0000-0002-7178-4258; Garcia-Perez, Jose Luis/0000-0002-8132-9849; Morrish, Tammy/0000-0002-6725-0253				Bailey SM, 1999, P NATL ACAD SCI USA, V96, P14899, DOI 10.1073/pnas.96.26.14899; Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Beamish HJ, 2000, NUCLEIC ACIDS RES, V28, P1506, DOI 10.1093/nar/28.7.1506; Blunt T, 1996, P NATL ACAD SCI USA, V93, P10285, DOI 10.1073/pnas.93.19.10285; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; Faravelli M, 2002, GENE, V283, P11, DOI 10.1016/S0378-1119(01)00877-0; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Gilbert N, 2005, MOL CELL BIOL, V25, P7780, DOI 10.1128/MCB.25.17.7780-7795.2005; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Gilley D, 2001, P NATL ACAD SCI USA, V98, P15084, DOI 10.1073/pnas.261574698; Goytisolo FA, 2001, MOL CELL BIOL, V21, P3642, DOI 10.1128/MCB.21.11.3642-3651.2001; Hao LY, 2004, J BIOL CHEM, V279, P45148, DOI 10.1074/jbc.M403924200; Kulpa DA, 2006, NAT STRUCT MOL BIOL, V13, P655, DOI 10.1038/nsmb1107; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Pardue ML, 2003, ANNU REV GENET, V37, P485, DOI 10.1146/annurev.genet.38.072902.093115; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Taccioli GE, 1998, IMMUNITY, V9, P355, DOI 10.1016/S1074-7613(00)80618-4; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Wei W, 2000, ANAL BIOCHEM, V284, P435, DOI 10.1006/abio.2000.4675; WHITMORE GF, 1989, INT J RADIAT BIOL, V56, P657, DOI 10.1080/09553008914551881	30	125	130	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2007	446	7132					208	212		10.1038/nature05560	http://dx.doi.org/10.1038/nature05560			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17344853	Green Published			2022-12-01	WOS:000244718100045
J	Zheng, Y; Josefowicz, SZ; Kas, A; Chu, TT; Gavin, MA; Rudensky, AY				Zheng, Ye; Josefowicz, Steven Z.; Kas, Arnold; Chu, Tin-Tin; Gavin, Marc A.; Rudensky, Alexander Y.			Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells	NATURE			English	Article							TRANSCRIPTION FACTOR FOXP3; PHOSPHORYLATION; OCCUPANCY; LYMPHOMAS; BINDING; MICE; RNA	Transcription factor Foxp3 ( forkhead box P3), restricted in its expression to a specialized regulatory CD4(+) T-cell subset (T-R) with a dedicated suppressor function, controls T-R lineage development. In humans and mice, Foxp3 deficiency results in a paucity of T-R cells and a fatal breach in immunological tolerance, causing highly aggressive multi-organ autoimmune pathology(1-3). Here, through genome-wide analysis combining chromatin immunoprecipitation with mouse genome tiling array profiling, we identify Foxp3 binding regions for 700 genes and for an intergenically encoded microRNA. We find that a large number of Foxp3-bound genes are up-or downregulated in Foxp3(+) T cells, suggesting that Foxp3 acts as both a transcriptional activator and repressor. Foxp3-mediated regulation unique to the thymus affects, among others, genes encoding nuclear factors that control gene expression and chromatin remodelling. In contrast, Foxp3 target genes shared by the thymic and peripheral T-R cells encode primarily plasma membrane proteins, as well as cell signalling proteins. Together, our studies suggest that distinct transcriptional sub-programmes implemented by Foxp3 establish T-R lineage during differentiation and its proliferative and functional competence in the periphery.	Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rudensky, AY (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	aruden@u.washington.edu	Zheng, Ye/G-4866-2015; Josefowicz, Steven Z/B-8716-2011	Zheng, Ye/0000-0001-5012-4309; josefowicz, steven/0000-0001-7453-779X				Beima KM, 2006, J BIOL CHEM, V281, P11992, DOI 10.1074/jbc.M513613200; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Couronne O, 2003, GENOME RES, V13, P73, DOI 10.1101/gr.762503; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; GAVIN MA, IN PRESS NATURE; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Michael LF, 2000, MOL CELL BIOL, V20, P1596, DOI 10.1128/MCB.20.5.1596-1603.2000; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Tam W, 2002, J VIROL, V76, P4275, DOI 10.1128/JVI.76.9.4275-4286.2002; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	18	651	694	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					936	940		10.1038/nature05563	http://dx.doi.org/10.1038/nature05563			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17237761				2022-12-01	WOS:000244341200054
J	Baker, DW; Persell, SD; Thompson, JA; Soman, NS; Burgner, KM; Liss, D; Kmetik, KS				Baker, David W.; Persell, Stephen D.; Thompson, Jason A.; Soman, Neilesh S.; Burgner, Karen M.; Liss, David; Kmetik, Karen S.			Automated review of electronic health records to assess quality of care for outpatients with heart failure	ANNALS OF INTERNAL MEDICINE			English	Article							PAY-FOR-PERFORMANCE; PRACTICE GUIDELINES; PITFALLS	Background: Electronic health records (EHRs) may be used to assess quality of care. Objective: To evaluate the accuracy of automated review of EHR data to measure quality of care for outpatients with heart failure. Design: Observational study of quality of care for heart failure comparing automated review of EHR data with automated review followed by manual review of electronic notes for patients with apparent quality deficits (hybrid review). Setting: An academic general internal medicine clinic with several years' experience using a commercial EHR. Patients: 517 adults with a qualifying International Classification of Diseases, Ninth Revision, diagnosis of heart failure in their EHR data and 2 or more clinic visits over the past 18 months. Measurements: Left ventricular ejection fraction (LVEF), prescription of a G-blocker and an angiotensin-converting enzyme (ACE) inhibitor or angiotensin-receptor blocker (ARB) for patients with left ventricular systolic dysfunction (LVEF < 0.40) and prescription of warfarin for patients with comorbid atrial fibrillation. Results: Performance based on automated review of EHR data was similar to that based on hybrid review for assessing LVEF measurement (94.6% vs. 97.3%), prescription of beta-blockers (90.9% vs. 92.8%), and prescription of ACE inhibitors or ARBs (93.9% vs. 98.7%). However, performance based on automated review was lower than that based on hybrid review for prescription of warfarin for atrial fibrillation (70.4% vs. 93.6%), primarily because automated review did not detect documentation of accepted reasons for not prescribing warfarin. Limitations: The findings may not be applicable to other practices and other EHRs. The authors used EHR data to identify eligible patients, so the study may have excluded some patients with heart failure. Patient charts were manually reviewed only if a provider appeared to fail a quality measure on automated review and did not determine the sensitivity and specificity of automated review according to standard definitions. Conclusions: Automated review of EHR data to measure the quality of care of outpatients with heart failure missed many exclusion criteria for medications documented only in providers' notes. As a result, it sometimes underestimated performance on medication-based quality measures.	Northwestern Univ, Chicago, IL 60611 USA	Northwestern University	Baker, DW (corresponding author), 676 N St,Clair St,Suite 200, Chicago, IL 60611 USA.	dwbaker@northwestern.edu		Liss, David/0000-0001-5505-2922	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS013690] Funding Source: NIH RePORTER; AHRQ HHS [5 U18 HS013690] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*AM MED ASS, 2006, CPT 2 COD; [Anonymous], 2005, J AM COLL CARDIOL, V46, P1144, DOI 10.1016/j.jacc.2005.07.012; Borzecki AM, 2004, AM J MANAG CARE, V10, P473; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; *CTR MED MED SERV, 2006, QUAL IN GEN INF; *CTR MED MED SERV, 2006, PHSY FOC QUAL IN; *DOQIT, 2006, DOCT OFF QUAL INF TE; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Epstein AM, 2004, NEW ENGL J MED, V350, P406, DOI 10.1056/NEJMsb035374; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; Franks P, 2002, MED CARE, V40, P717, DOI 10.1097/00005650-200208000-00011; IOM (Institute of Medicine), 2002, LEAD EX COORD GOV RO; Jha AK, 2005, NEW ENGL J MED, V353, P265, DOI 10.1056/NEJMsa051249; Kerr Eve A, 2002, Jt Comm J Qual Improv, V28, P555; *MED PAYM ADV COMM, 2003, REP C VAR INN MED; Milgate K, 2006, HEALTH AFFAIR, V25, P413, DOI 10.1377/hlthaff.25.2.413; Parameswaran AC, 2005, AM HEART J, V149, P921, DOI 10.1016/j.ahj.2004.07.026; Persell SD, 2006, ARCH INTERN MED, V166, P2272, DOI 10.1001/archinte.166.20.2272; *PHYS CONS PERF IM, 2006, PERF MEAS HEART FAIL; Santell JP, 2006, JT COMM J QUAL PATIE, V32, P225, DOI 10.1016/S1553-7250(06)32029-6; *SNOMED, 2006, SYST NOM MED CLIN TE; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458; Walter LC, 2004, JAMA-J AM MED ASSOC, V291, P2466, DOI 10.1001/jama.291.20.2466	23	66	66	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2007	146	4					270	277		10.7326/0003-4819-146-4-200702200-00006	http://dx.doi.org/10.7326/0003-4819-146-4-200702200-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137CS	17310051				2022-12-01	WOS:000244271000005
J	Heinze, S; Homberg, U				Heinze, Stanley; Homberg, Uwe			Maplike representation of celestial E-vector orientations in the brain of an insect	SCIENCE			English	Article							LOCUST SCHISTOCERCA-GREGARIA; LIGHT-SENSITIVE NEURONS; ANTERIOR OPTIC TUBERCLE; TETHERED FLYING LOCUSTS; CENTRAL COMPLEX; HEAD-DIRECTION; DROSOPHILA-MELANOGASTER; POLARIZATION VISION; CONNECTIONS; CORTEX	For many insects, the polarization pattern of the blue sky serves as a compass cue for spatial navigation. E-vector orientations are detected by photoreceptors in a dorsal rim area of the eye. Polarized-light signals from both eyes are finally integrated in the central complex, a brain area consisting of two subunits, the protocerebral bridge and the central body. Here we show that a topographic representation of zenithal E-vector orientations underlies the columnar organization of the protocerebral bridge in a locust. The maplike arrangement is highly suited to signal head orientation under the open sky.	Univ Marburg, Dept Biol, D-35032 Marburg, Germany	Philipps University Marburg	Homberg, U (corresponding author), Univ Marburg, Dept Biol, D-35032 Marburg, Germany.	homberg@staff.uni-marburg.de	Heinze, Stanley/I-4440-2019; Homberg, Uwe/AFH-8214-2022	Heinze, Stanley/0000-0002-8145-3348; Homberg, Uwe/0000-0002-8229-7236				BATSCHELET E., 1981, CIRCULAR STAT BIOL M; Blenau W, 2001, ARCH INSECT BIOCHEM, V48, P13, DOI 10.1002/arch.1055; Chisum HJ, 2004, NEURAL NETWORKS, V17, P681, DOI 10.1016/j.neunet.2004.05.002; HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838; Homberg U, 2003, J COMP NEUROL, V462, P415, DOI 10.1002/cne.10771; Homberg U, 1997, J COMP NEUROL, V386, P329; HorvuYth G., 2004, POLARIZED LIGHT ANIM; KNUDSEN EI, 1987, ANNU REV NEUROSCI, V10, P41, DOI 10.1146/annurev.ne.10.030187.000353; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Mappes M, 2004, J COMP PHYSIOL A, V190, P61, DOI 10.1007/s00359-003-0473-4; Mappes M, 2007, J COMP PHYSIOL A, V193, P43, DOI 10.1007/s00359-006-0166-x; Mittelstaedt H, 2000, BIOL CYBERN, V83, P261, DOI 10.1007/s004220000169; Mooser F, 2004, NAT NEUROSCI, V7, P872, DOI 10.1038/nn1287; Muller M, 1997, CELL TISSUE RES, V288, P159, DOI 10.1007/s004410050803; Pfeiffer K, 2005, J NEUROPHYSIOL, V94, P3903, DOI 10.1152/jn.00276.2005; PFEIFFER K, P 6 M GERM NEUR SOC, P218; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Sharp PE, 2001, TRENDS NEUROSCI, V24, P289, DOI 10.1016/S0166-2236(00)01797-5; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Taube JS, 2003, CEREB CORTEX, V13, P1162, DOI 10.1093/cercor/bhg102; Vitzthum H, 2002, J NEUROSCI, V22, P1114, DOI 10.1523/JNEUROSCI.22-03-01114.2002; Wehner R, 2001, J EXP BIOL, V204, P2589; WILLIAMS JLD, 1975, J ZOOL, V176, P67; Zar JH., 1999, BIOSTAT ANAL	25	239	248	3	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2007	315	5814					995	997		10.1126/science.1135531	http://dx.doi.org/10.1126/science.1135531			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303756				2022-12-01	WOS:000244229800044
J	Park, HH; Logette, E; Raunser, S; Cuenin, S; Walz, T; Tschopp, J; Wu, H				Park, Hyun Ho; Logette, Emmanuelle; Raunser, Stefan; Cuenin, Solange; Walz, Thomas; Tschopp, Jurg; Wu, Hao			Death domain assembly mechanism revealed by crystal structure of the oligomeric PIDDosome core complex	CELL			English	Article							MUTATIONAL ANALYSIS; PROVIDES INSIGHTS; CELL-DEATH; CASPASE-2; PROTEIN; APOPTOSIS; ACTIVATION; PIDD; SUPERFAMILY; MODEL	Proteins of the death domain (DD) superfamily mediate assembly of oligomeric signaling complexes for the activation of caspases and kinases via unknown mechanisms. Here we report the crystal structure of the PIDD DD and RAIDD DD complex, which forms the core of the caspase-2-activating complex PIDDo-some. Although RAIDD DD and PIDD DD are monomers, they assemble into a complex that comprises seven RAIDD DDs and five PIDD DDs. Despite the use of an asymmetric assembly mechanism, all DDs in the complex are in quasi-equivalent environments. The structure provided eight unique asymmetric interfaces, which can be classified into three types. These three types of interactions together cover a majority of the DD surface. Mutagenesis on almost all interfaces leads to disruption of the assembly, resulting in defective caspase-2 activation. The three types of interactions may represent most, if not all, modes of interactions in the DD superfamily for assembling complexes of different stoichiometry.	Univ Cordoba, Weill Med Coll, New York, NY 10021 USA; Univ Cordoba, Grad Sch Med Sci, New York, NY 10021 USA; Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Cornell University; University of Lausanne; Harvard University; Harvard Medical School	Wu, H (corresponding author), Univ Cordoba, Weill Med Coll, New York, NY 10021 USA.	haowu@med.cornell.edu	park, hyun ho/D-2627-2011; Raunser, Stefan/AHE-1573-2022	park, hyun ho/0000-0001-9928-0847; Raunser, Stefan/0000-0001-9373-3016; Walz, Thomas/0000-0003-2606-2835	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050872] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI050872, R01 AI050872-06A1] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baliga BC, 2004, CELL DEATH DIFFER, V11, P1234, DOI 10.1038/sj.cdd.4401492; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Hill JM, 2004, J BIOL CHEM, V279, P1474, DOI 10.1074/jbc.M304996200; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Janssens S, 2005, CELL, V123, P1079, DOI 10.1016/j.cell.2005.09.036; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kohl A, 2004, CR BIOL, V327, P1077, DOI 10.1016/j.crvi.2004.08.006; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Li FY, 2006, J BIOL CHEM, V281, P2960, DOI 10.1074/jbc.M511074200; Lin YP, 2000, NAT GENET, V26, P122, DOI 10.1038/79102; Martin DA, 1999, P NATL ACAD SCI USA, V96, P4552, DOI 10.1073/pnas.96.8.4552; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park A, 1996, J BIOL CHEM, V271, P9858, DOI 10.1074/jbc.271.16.9858; Park HH, 2006, J MOL BIOL, V357, P358, DOI 10.1016/j.jmb.2005.12.082; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pick R, 2006, BIOCHEM BIOPH RES CO, V349, P1329, DOI 10.1016/j.bbrc.2006.08.176; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Read SH, 2002, J CELL BIOL, V159, P739, DOI 10.1083/jcb.200209004; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Salvesen GS, 2002, ESSAYS BIOCHEM, V38, P9, DOI 10.1042/bse0380009; Sandu C, 2005, J BIOL CHEM, V280, P31974, DOI 10.1074/jbc.M506938200; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; Telliez JB, 2000, BBA-PROTEIN STRUCT M, V1478, P280, DOI 10.1016/S0167-4838(00)00029-7; Telliez JB, 2000, J MOL BIOL, V300, P1323, DOI 10.1006/jmbi.2000.3899; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Thakar J, 2006, PROTEINS, V63, P413, DOI 10.1002/prot.20895; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Tinel A, 2007, EMBO J, V26, P197, DOI 10.1038/sj.emboj.7601473; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Weber CH, 2001, FEBS LETT, V492, P171, DOI 10.1016/S0014-5793(01)02162-7; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1; Yan N, 2005, NATURE, V437, P831, DOI 10.1038/nature04002; Yang JK, 2005, MOL CELL, V20, P939, DOI 10.1016/j.molcel.2005.10.023; Yin Q, 2006, MOL CELL, V22, P259, DOI 10.1016/j.molcel.2006.03.030; Yu XC, 2006, J MOL BIOL, V355, P577, DOI 10.1016/j.jmb.2005.10.040; Yu XC, 2005, STRUCTURE, V13, P1725, DOI 10.1016/j.str.2005.09.006	44	209	210	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2007	128	3					533	546		10.1016/j.cell.2007.01.019	http://dx.doi.org/10.1016/j.cell.2007.01.019			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289572	Green Accepted, Bronze, Green Submitted			2022-12-01	WOS:000244842700019
J	Kurakawa, T; Ueda, N; Maekawa, M; Kobayashi, K; Kojima, M; Nagato, Y; Sakakibara, H; Kyozuka, J				Kurakawa, Takashi; Ueda, Nanae; Maekawa, Masahiko; Kobayashi, Kaoru; Kojima, Mikiko; Nagato, Yasuo; Sakakibara, Hitoshi; Kyozuka, Junko			Direct control of shoot meristem activity by a cytokinin-activating enzyme	NATURE			English	Article							RESPONSE REGULATORS; ARABIDOPSIS; BIOSYNTHESIS; EXPRESSION; GENES; RICE; METABOLISM; PLANTS; ISOPENTENYLTRANSFERASE; ENCODES	The growth of plants depends on continuous function of the meristems. Shoot meristems are responsible for all the post-embryonic aerial organs, such as leaves, stems and flowers(1). It has been assumed that the phytohormone cytokinin has a positive role in shoot meristem function(2-4). A severe reduction in the size of meristems in a mutant that is defective in all of its cytokinin receptors has provided compelling evidence that cytokinin is required for meristem activity(5,6). Here, we report a novel regulation of meristem activity, which is executed by the meristem-specific activation of cytokinins. The LONELY GUY ( LOG) gene of rice is required to maintain meristem activity and its loss of function causes premature termination of the shoot meristem. LOG encodes a novel cytokinin-activating enzyme that works in the final step of bioactive cytokinin synthesis. Revising the long-held idea of multistep reactions, LOG directly converts inactive cytokinin nucleotides to the free-base forms, which are biologically active, by its cytokinin-specific phosphoribohydrolase activity. LOG messenger RNA is specifically localized in shoot meristem tips, indicating the activation of cytokinins in a specific developmental domain. We propose the fine-tuning of concentrations and the spatial distribution of bioactive cytokinins by a cytokinin-activating enzyme as a mechanism that regulates meristem activity.	Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138652, Japan; RIKEN, Plant Sci Ctr, Yokohama, Kanagawa 2300045, Japan; Okayama Univ, Res inst Bioresources, Okayama 7100046, Japan	University of Tokyo; RIKEN; Okayama University	Kyozuka, J (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138652, Japan.	sakaki@riken.jp; akyozuka@mail.ecc.u-tokyo.ac.jp	Ding, Cheng-Qiang/B-6287-2011; Sakakibara, Hitoshi/A-6040-2010; Kyozuka, Junko/E-7844-2012; Kojima, Mikiko/D-1459-2017	Sakakibara, Hitoshi/0000-0001-5449-6492; Kyozuka, Junko/0000-0003-2242-7171				Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; CHEN CM, 1981, PLANT PHYSIOL, V68, P1020, DOI 10.1104/pp.68.5.1020; CHEN CM, 1981, PLANT PHYSIOL, V67, P494, DOI 10.1104/pp.67.3.494; CRESPI M, 1994, J BACTERIOL, V176, P2492, DOI 10.1128/JB.176.9.2492-2501.1994; Faiss M, 1997, PLANT J, V12, P401, DOI 10.1046/j.1365-313X.1997.12020401.x; Ferreira FJ, 2005, CURR OPIN PLANT BIOL, V8, P518, DOI 10.1016/j.pbi.2005.07.013; Giulini A, 2004, NATURE, V430, P1031, DOI 10.1038/nature02778; Helliwell CA, 2001, PLANT CELL, V13, P2115, DOI 10.1105/tpc.13.9.2115; Higuchi M, 2004, P NATL ACAD SCI USA, V101, P8821, DOI 10.1073/pnas.0402887101; Howell SH, 2003, TRENDS PLANT SCI, V8, P453, DOI 10.1016/S1360-1385(03)00191-2; Jain M, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-1; Jasinski S, 2005, CURR BIOL, V15, P1560, DOI 10.1016/j.cub.2005.07.023; KOUCHI H, 1995, PLANT CELL, V7, P1143, DOI 10.1105/tpc.7.8.1143; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Miyawaki K, 2004, PLANT J, V37, P128, DOI 10.1046/j.1365-313X.2003.01945.x; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; Moriguchi K, 2001, J MOL BIOL, V307, P771, DOI 10.1006/jmbi.2001.4488; Nishimura C, 2004, PLANT CELL, V16, P1365, DOI 10.1105/tpc.021477; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; Sakamoto T, 2006, PLANT PHYSIOL, V142, P54, DOI 10.1104/pp.106.085811; Sentoku N, 1999, PLANT CELL, V11, P1651, DOI 10.1105/tpc.11.9.1651; Steeves TA, 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; Takei K, 2004, PLANT CELL PHYSIOL, V45, P1053, DOI 10.1093/pcp/pch119; Takei K, 2001, J BIOL CHEM, V276, P26405, DOI 10.1074/jbc.M102130200; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Werner T, 2006, PLANT BIOLOGY, V8, P371, DOI 10.1055/s-2006-923928; Yanai O, 2005, CURR BIOL, V15, P1566, DOI 10.1016/j.cub.2005.07.060	30	606	674	11	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2007	445	7128					652	655		10.1038/nature05504	http://dx.doi.org/10.1038/nature05504			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17287810				2022-12-01	WOS:000244039400045
J	Komiyama, T; Sweeney, LB; Schuldiner, O; Garcia, KC; Luo, LQ				Komiyama, Takaki; Sweeney, Lora B.; Schuldiner, Oren; Garcia, K. Christopher; Luo, Liqun			Graded expression of Semaphorin-1a cell-autonomously directs dendritic targeting of olfactory projection neurons	CELL			English	Article							REPULSIVE GUIDANCE MOLECULE; DROSOPHILA ANTENNAL LOBE; TRANSMEMBRANE SEMAPHORIN; WIRING SPECIFICITY; AXON GUIDANCE; BRANCH EXTENSION; RETINAL AXONS; RECEPTOR; SYSTEM; MAP	Gradients of axon guidance molecules instruct the formation of continuous neural maps, such as the retinotopic map in the vertebrate visual system. Here we show that molecular gradients can also instruct the formation of a discrete neural map. In the fly olfactory system, axons of 50 classes of olfactory receptor neurons (ORNs) and dendrites of 50 classes of projection neurons (PNs) form one-to-one connections at discrete units called glomeruli. We provide expression, loss- and gain-of-function data to demonstrate that the levels of transmembrane Semaphorin-la (Sema-la), acting cell-autonomously as a receptor or part of a receptor complex, direct the dendritic targeting of PNs along the dorsolateral to ventromedial axis of the antennal lobe. Sema-1a also regulates PN axon targeting in higher olfactory centers. Thus, graded expression of Sema-1a contributes to connection specificity from ORNs to PNs and then to higher brain centers, ensuring proper representation of olfactory information in the brain.	Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Neurosci Program, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University	Luo, LQ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA.	lluo@stanford.edu	Schuldiner, Oren/K-1353-2012	Schuldiner, Oren/0000-0002-7350-9380; Sweeney, Lora/0000-0001-9242-5601; Komiyama, Takaki/0000-0001-9609-4600; Luo, Liqun/0000-0001-5467-9264	NIDCD NIH HHS [R01-DC005982] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005982] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; Cafferty P, 2006, J NEUROSCI, V26, P3999, DOI 10.1523/JNEUROSCI.3845-05.2006; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Cramer KS, 2005, HEARING RES, V206, P42, DOI 10.1016/j.heares.2004.11.024; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Ebrahimi FAW, 2000, CURR BIOL, V10, P219, DOI 10.1016/S0960-9822(00)00342-0; Eckhardt F, 1997, MOL CELL NEUROSCI, V9, P409, DOI 10.1006/mcne.1997.0644; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; Godenschwege TA, 2002, NAT NEUROSCI, V5, P1294, DOI 10.1038/nn976; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Klostermann A, 2000, J BIOL CHEM, V275, P39647, DOI 10.1074/jbc.M006316200; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Komiyama T, 2006, CURR OPIN NEUROBIOL, V16, P67, DOI 10.1016/j.conb.2005.12.002; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; KOMIYAMA T, 2007, IN PRESS CURR BIOL; Kumanogoh A, 2004, CELL MOL LIFE SCI, V61, P292, DOI 10.1007/s00018-003-3257-7; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Mann F, 2002, NEURON, V35, P461, DOI 10.1016/S0896-6273(02)00786-9; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; MCGUIRE SE, 2004, SCI STKE, V220, P16; McLaughlin T, 2003, DEVELOPMENT, V130, P2407, DOI 10.1242/dev.00467; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; Norlin EM, 2001, MOL CELL NEUROSCI, V18, P283, DOI 10.1006/mcne.2001.1019; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Toyofuku T, 2004, NAT CELL BIOL, V6, P1204, DOI 10.1038/ncb1193; Vanderhaeghen P, 2000, NAT NEUROSCI, V3, P358, DOI 10.1038/73929; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4	57	132	134	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2007	128	2					399	410		10.1016/j.cell.2006.12.028	http://dx.doi.org/10.1016/j.cell.2006.12.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254975	Bronze			2022-12-01	WOS:000244420500022
J	Vallina, SM; Simo, R				Vallina, Sergio M.; Simo, Rafel			Strong relationship between DMS and the solar radiation dose over the global surface ocean	SCIENCE			English	Article							ATMOSPHERIC SULFUR; DIMETHYLSULFIDE; CLIMATE; SEA	Marine biogenic dimethylsulfide (DMS) is the main natural source of tropospheric sulfur, which may play a key role in cloud formation and albedo over the remote ocean. Through a global data analysis, we found that DMS concentrations are highly positively correlated with the solar radiation dose in the upper mixed layer of the open ocean, irrespective of latitude, plankton biomass, or temperature. This is a necessary condition for the feasibility of a negative feedback in which light-attenuating DMS emissions are in turn driven by the light dose received by the pelagic ecosystem.	CSIC, Inst Ciencias Mar, E-08003 Barcelona, Catalonia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Vallina, SM (corresponding author), CSIC, Inst Ciencias Mar, Passeig Maritim Barceloneta 37-49, E-08003 Barcelona, Catalonia, Spain.	sergio.vallina@icm.csic.es; rsimo@icm.csic.es		Simo, Rafel/0000-0003-3276-7663; VALLINA, Sergio/0000-0002-1335-9237				Andreae MO, 1997, SCIENCE, V276, P1052, DOI 10.1126/science.276.5315.1052; BATES TS, 1987, NATURE, V329, P319, DOI 10.1038/329319a0; BROCK TD, 1981, ECOL MODEL, V14, P1, DOI 10.1016/0304-3800(81)90011-9; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Chuck AL, 2002, SCIENCE, V297, P1151, DOI 10.1126/science.1073896; Dacey JWH, 1998, DEEP-SEA RES PT I, V45, P2085, DOI 10.1016/S0967-0637(98)00048-X; de Boyer Montegut C, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002378; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Hirsch AI, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2004GB002443; Kettle AJ, 1999, GLOBAL BIOGEOCHEM CY, V13, P399, DOI 10.1029/1999GB900004; Kiehl JT, 1997, B AM METEOROL SOC, V78, P197, DOI 10.1175/1520-0477(1997)078<0197:EAGMEB>2.0.CO;2; Lenton TM, 2000, GLOBAL BIOGEOCHEM CY, V14, P225, DOI 10.1029/1999GB900065; Meir P, 2006, TRENDS ECOL EVOL, V21, P254, DOI 10.1016/j.tree.2006.03.005; O'Dowd CD, 2002, NATURE, V417, P632, DOI 10.1038/nature00775; Simo R, 1999, NATURE, V402, P396, DOI 10.1038/46516; Simo R, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001829; Simo R, 2004, CAN J FISH AQUAT SCI, V61, P673, DOI 10.1139/F04-030; Simo R, 2001, TRENDS ECOL EVOL, V16, P287, DOI 10.1016/S0169-5347(01)02152-8; Singh H, 2001, NATURE, V410, P1078, DOI 10.1038/35074067; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; Toole DA, 2006, DEEP-SEA RES PT I, V53, P136, DOI 10.1016/j.dsr.2005.09.003; Toole DA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019581; Vallina SM, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002597	24	209	220	7	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2007	315	5811					506	508		10.1126/science.1133680	http://dx.doi.org/10.1126/science.1133680			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255509				2022-12-01	WOS:000243726600044
J	Huang, DT; Hunt, HW; Zhuang, M; Ohi, MD; Holton, JM; Schulman, BA				Huang, Danny T.; Hunt, Harold W.; Zhuang, Min; Ohi, Melanie D.; Holton, James M.; Schulman, Brenda A.			Basis for a ubiquitin-like protein thioester switch toggling E1-E2 affinity	NATURE			English	Article							ACTIVATING ENZYME; CRYSTAL-STRUCTURE; MECHANISM; BINDING; E1; NEDD8; CONJUGATION; INSIGHTS; COMPLEX; SYSTEM	Ubiquitin-like proteins (UBLs) are conjugated by dynamic E1-E2-E3 enzyme cascades. E1 enzymes activate UBLs by catalysing UBL carboxy-terminal adenylation, forming a covalent E1, UBL thioester intermediate, and generating a thioester-linked E2 similar to UBL product, which must be released for subsequent reactions. Here we report the structural analysis of a trapped UBL activation complex for the human NEDD8 pathway, containing NEDD8's heterodimeric E1 (APPBP1-UBA3), two NEDD8s ( one thioester-linked to E1, one noncovalently associated for adenylation), a catalytically inactive E2 (Ubc12), and MgATP. The results suggest that a thioester switch toggles E1 - E2 affinities. Two E2 binding sites depend on NEDD8 being thioester-linked to E1. One is unmasked by a striking E1 conformational change. The other comes directly from the thioester-bound NEDD8. After NEDD8 transfer to E2, reversion to an alternate E1 conformation would facilitate release of the E2, NEDD8 thioester product. Thus, transferring the UBL's thioester linkage between successive conjugation enzymes can induce conformational changes and alter interaction networks to drive consecutive steps in UBL cascades.	St Jude Childrens Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Struct Biol & Genet, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA; Univ Tennessee, Ctr Hlth Sci, Interdisciplinary Program, Memphis, TN 38163 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Harvard University; Harvard Medical School; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Schulman, BA (corresponding author), St Jude Childrens Hosp, Howard Hughes Med Inst, 332 N Lauderdale St, Memphis, TN 38105 USA.	brenda.schulman@stjude.org	Huang, Danny/AAM-3631-2021	Huang, Danny/0000-0002-6192-259X	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077053, R01GM069530] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P30 CA021765, P30 CA021765-31] Funding Source: Medline; NIGMS NIH HHS [R01 GM077053, R01 GM069530, R01 GM069530-04, R01 GM077053-02] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Bohnsack RN, 2003, J BIOL CHEM, V278, P26823, DOI 10.1074/jbc.M303177200; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1982, J BIOL CHEM, V257, P329; HAAS AL, 1988, J BIOL CHEM, V263, P13268; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Harper JW, 2006, CELL, V124, P1133, DOI 10.1016/j.cell.2006.03.009; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Hochstrasser M, 2000, SCIENCE, V289, P563, DOI 10.1126/science.289.5479.563; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Huang DT, 2004, NAT STRUCT MOL BIOL, V11, P927, DOI 10.1038/nsmb826; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Miura T, 1999, J MOL BIOL, V290, P213, DOI 10.1006/jmbi.1999.2859; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; PICKART CM, 1985, J BIOL CHEM, V260, P1573; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; PICKART CM, 1994, J BIOL CHEM, V269, P7115; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Szczepanowski RH, 2005, J BIOL CHEM, V280, P22006, DOI 10.1074/jbc.M502583200; Tokgoz Z, 2006, J BIOL CHEM, V281, P14729, DOI 10.1074/jbc.M513562200; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Whitby FG, 1998, J BIOL CHEM, V273, P34983, DOI 10.1074/jbc.273.52.34983	34	164	167	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2007	445	7126					394	398		10.1038/nature05490	http://dx.doi.org/10.1038/nature05490			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	128WD	17220875	Green Accepted			2022-12-01	WOS:000243689500031
J	Wang, RN; He, GG; Nelman-Gonzalez, M; Ashorn, CL; Gallick, GE; Stukenberg, PT; Kirschner, MW; Kuang, J				Wang, Ruoning; He, Guangan; Nelman-Gonzalez, Mayra; Ashorn, Cheryl L.; Gallick, Gary E.; Stukenberg, P. Todd; Kirschner, Marc W.; Kuang, Jian			Regulation of Cdc25C by ERK-MAP kinases during the G(2)/M transition	CELL			English	Article							ACTIVATED PROTEIN-KINASE; XENOPUS-OOCYTE MATURATION; CELL-CYCLE; M-PHASE; MEIOTIC MATURATION; MPF ACTIVATION; EGG EXTRACTS; OKADAIC ACID; POLO KINASE; PHOSPHORYLATION	Induction of G(2)/M phase transition in mitotic and meiotic cell cycles requires activation by phosphorylation of the protein phosphatase Cdc25. Although Cdc2/cyclin B and polo-like kinase (PLK) can phosphorylate and activate Cdc25 in vitro, phosphorylation by these two kinases is insufficient to account for Cdc25 activation during M phase induction. Here we demonstrate that p42 MAP kinase (MAPK), the Xenopus ortholog of ERK2, is a major Cdc25 phosphorylating kinase in extracts of M phase-arrested Xenopus eggs. In Xenopus oocytes, p42 MAPK interacts with hypophosphorylated Cdc25 before meiotic induction. During meiotic induction, p42 MAPK phosphorylates Cdc25 at T48, T138, and S205, increasing Cdc25's phosphatase activity. In a mammalian cell line, ERK1/2 interacts with Cdc25C in interphase and phosphorylates Cdc25C at T48 in mitosis. Inhibition of ERK activation partially inhibits T48 phosphorylation, Cdc25C activation, and mitotic induction. These findings demonstrate that ERK-MAP kinases; are directly involved in activating Cdc25 during the G2/M transition.	Univ Texas, MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; Univ Texas, Grad Sch Biomed Sci, Program Genes & Dev, Houston, TX 77030 USA; Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Virginia; Harvard University; Harvard Medical School	Kuang, J (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Expt Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jkuang@mdanderson.org	Wang, Ruoning/C-1683-2014	Ashorn, Cheryl/0000-0003-1207-7323; Stukenberg, Todd/0000-0002-6788-2111	NATIONAL CANCER INSTITUTE [P30CA016672, R01CA093941] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA93941, CA-16672] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Castro A, 2001, MOL BIOL CELL, V12, P2660, DOI 10.1091/mbc.12.9.2660; Che SL, 1999, J BIOL CHEM, V274, P5522, DOI 10.1074/jbc.274.9.5522; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; Dupre A, 2002, EMBO J, V21, P4026, DOI 10.1093/emboj/cdf400; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Ferrell JE, 1999, BIOESSAYS, V21, P833, DOI 10.1002/(SICI)1521-1878(199910)21:10<833::AID-BIES5>3.0.CO;2-P; Fisher DL, 1999, DEVELOPMENT, V126, P4537; Foijer F, 2005, CANCER CELL, V8, P455, DOI 10.1016/j.ccr.2005.10.021; Gavin AC, 1999, MOL BIOL CELL, V10, P2971, DOI 10.1091/mbc.10.9.2971; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; GORIS J, 1989, FEBS LETT, V245, P91, DOI 10.1016/0014-5793(89)80198-X; Gotoh Y, 1995, Prog Cell Cycle Res, V1, P287; GOTOH Y, 1991, EMBO J, V10, P2661, DOI 10.1002/j.1460-2075.1991.tb07809.x; GOTOH Y, 1995, J BIOL CHEM, V270, P25898, DOI 10.1074/jbc.270.43.25898; Gottlin EB, 1996, J BIOL CHEM, V271, P27445, DOI 10.1074/jbc.271.44.27445; Gross SD, 2000, CURR BIOL, V10, P430, DOI 10.1016/S0960-9822(00)00425-5; He GG, 2005, ONCOGENE, V24, P2929, DOI 10.1038/sj.onc.1208474; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; HSIAO KM, 1994, P NATL ACAD SCI USA, V91, P5480, DOI 10.1073/pnas.91.12.5480; Huang CYF, 1996, EMBO J, V15, P2169, DOI 10.1002/j.1460-2075.1996.tb00570.x; IZUMI T, 1992, MOL BIOL CELL, V3, P927, DOI 10.1091/mbc.3.8.927; IZUMI T, 1993, MOL BIOL CELL, V4, P1337, DOI 10.1091/mbc.4.12.1337; Karaiskou A, 1999, J CELL SCI, V112, P3747; Karaiskou A, 1998, EXP CELL RES, V244, P491, DOI 10.1006/excr.1998.4220; KING RW, 1994, CELL, V79, P563, DOI 10.1016/0092-8674(94)90542-8; KOSAKO H, 1994, EMBO J, V13, P2131, DOI 10.1002/j.1460-2075.1994.tb06489.x; KUANG J, 1993, J CELL BIOL, V123, P859, DOI 10.1083/jcb.123.4.859; KUANG J, 1991, DEV BIOL, V144, P54, DOI 10.1016/0012-1606(91)90478-L; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; LEWIS T, 1995, J CELL SCI, V108, P2885; Liu X, 2004, ONCOGENE, V23, P763, DOI 10.1038/sj.onc.1207188; Margolis SS, 2006, MOL BIOL CELL, V17, P1779, DOI 10.1091/mbc.E05-08-0751; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; NEBREDA AR, 1993, EMBO J, V12, P1979, DOI 10.1002/j.1460-2075.1993.tb05847.x; NEBREDA AR, 1995, EMBO J, V14, P5597, DOI 10.1002/j.1460-2075.1995.tb00247.x; Okano-Uchida T, 2003, EMBO J, V22, P5633, DOI 10.1093/emboj/cdg535; Palmer A, 2000, Prog Cell Cycle Res, V4, P131; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Perdiguero E, 2004, CELL CYCLE, V3, P733; RIME H, 1990, CELL DIFFER DEV, V29, P47, DOI 10.1016/0922-3371(90)90023-P; Roberts EC, 2002, MOL CELL BIOL, V22, P7226, DOI 10.1128/MCB.22.20.7226-7241.2002; SHIBUYA EK, 1992, P NATL ACAD SCI USA, V89, P9831, DOI 10.1073/pnas.89.20.9831; Sillje HHW, 2003, SCIENCE, V299, P1190; Sohaskey ML, 2002, MOL BIOL CELL, V13, P454, DOI 10.1091/mbc.01-11-0553; STRAUSFELD U, 1994, J BIOL CHEM, V269, P5989; Tanoue TJ, 2003, CELL SIGNAL, V15, P455, DOI 10.1016/S0898-6568(02)00112-2; Toyoshima-Morimoto F, 2002, EMBO REP, V3, P341, DOI 10.1093/embo-reports/kvf069; Wright JH, 1999, P NATL ACAD SCI USA, V96, P11335, DOI 10.1073/pnas.96.20.11335; WU M, 1980, DEV BIOL, V79, P455; Wu Y, 2001, DIFFERENTIATION, V67, P139, DOI 10.1046/j.1432-0436.2001.670406.x; Yue JB, 2004, CURR BIOL, V14, P1581, DOI 10.1016/j.cub.2004.08.056	56	101	106	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2007	128	6					1119	1132		10.1016/j.cell.2006.11.053	http://dx.doi.org/10.1016/j.cell.2006.11.053			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382881	Bronze, Green Submitted			2022-12-01	WOS:000245396200018
J	Uemura, S; Dorywalska, M; Lee, TH; Kim, HD; Puglisi, JD; Chu, S				Uemura, Sotaro; Dorywalska, Magdalena; Lee, Tae-Hee; Kim, Harold D.; Puglisi, Joseph D.; Chu, Steven			Peptide bond formation destabilizes Shine-Dalgarno interaction on the ribosome	NATURE			English	Article							TRANSFER-RNA; MESSENGER-RNA; A-SITES; P-SITES; TRANSLOCATION; SPECTROSCOPY; TRANSLATION; ELONGATION	The ribosome is a molecular machine that translates the genetic code contained in the messenger RNA into an amino acid sequence through repetitive cycles of transfer RNA selection, peptide bond formation and translocation(1-3). Here we demonstrate an optical tweezer assay to measure the rupture force between a single ribosome complex and mRNA. The rupture force was compared between ribosome complexes assembled on an mRNA with and without a strong Shine-Dalgarno (SD) sequence - a sequence found just upstream of the coding region of bacterial mRNAs, involved in translation initiation(4,5). The removal of the SD sequence significantly reduced the rupture force in complexes carrying an aminoacyl tRNA, Phe-tRNA(Phe), in the A site, indicating that the SD interactions contribute significantly to the stability of the ribosomal complex on the mRNA before peptide bond formation. In contrast, the presence of a peptidyl tRNA analogue, N-acetyl-Phe-tRNA(Phe), in the A site, which mimicked the post-peptidyl transfer state, weakened the rupture force as compared to the complex with Phe-tRNA(Phe), and the resultant force was the same for both the SD-containing and SD-deficient mRNAs. These results suggest that formation of the first peptide bond destabilizes the SD interaction, resulting in the weakening of the force with which the ribosome grips an mRNA. This might be an important requirement to facilitate movement of the ribosome along mRNA during the first translocation step.	Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Dept Phys, Stanford, CA 94305 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA	Stanford University; Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Puglisi, JD (corresponding author), Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA.	puglisi@stanford.edu; schu@lbl.gov	Lee, Tae-Hee/A-1266-2010					Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; CALOGERO RA, 1988, P NATL ACAD SCI USA, V85, P6427, DOI 10.1073/pnas.85.17.6427; Dorywalska M, 2005, NUCLEIC ACIDS RES, V33, P182, DOI 10.1093/nar/gki151; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Fredrick K, 2002, MOL CELL, V9, P1125, DOI 10.1016/S1097-2765(02)00523-3; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; Katunin VI, 2002, BIOCHEMISTRY-US, V41, P12806, DOI 10.1021/bi0264871; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; MOAZED D, 1990, J MOL BIOL, V211, P135, DOI 10.1016/0022-2836(90)90016-F; NOLLER HF, 1984, ANNU REV BIOCHEM, V53, P119, DOI 10.1146/annurev.bi.53.070184.001003; Semenkov YP, 2000, NAT STRUCT BIOL, V7, P1027; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; van Dijk MA, 2004, J PHYS CHEM B, V108, P6479, DOI 10.1021/jp049805+; Wintermeyer W, 2004, BIOCHEM SOC T, V32, P733, DOI 10.1042/BST0320733; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	16	82	83	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2007	446	7134					454	457		10.1038/nature05625	http://dx.doi.org/10.1038/nature05625			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17377584				2022-12-01	WOS:000245079500043
J	Mandal, L; Martinez-Agosto, JA; Evans, CJ; Hartenstein, V; Banerjee, U				Mandal, Lolitika; Martinez-Agosto, Julian A.; Evans, Cory J.; Hartenstein, Volker; Banerjee, Utpal			A Hedgehog- and Antennapedia-dependent niche maintains Drosophila haematopoietic precursors	NATURE			English	Article							STEM-CELL NICHE; LYMPH-GLAND; MEIS1; BLOOD; AORTA	The Drosophila melanogaster lymph gland is a haematopoietic organ(1-3) in which pluripotent blood cell progenitors proliferate and mature into differentiated haemocytes. Previous work(4) has defined three domains, the medullary zone, the cortical zone and the posterior signalling centre (PSC), within the developing third-instar lymph gland. The medullary zone is populated by a core of undifferentiated, slowly cycling progenitor cells, whereas mature haemocytes comprising plasmatocytes, crystal cells and lamellocytes are peripherally located in the cortical zone. The PSC comprises a third region that was first defined as a small group of cells expressing the Notch ligand Serrate(5). Here we show that the PSC is specified early in the embryo by the homeotic gene Antennapedia (Antp) and expresses the signalling molecule Hedgehog. In the absence of the PSC or the Hedgehog signal, the precursor population of the medullary zone is lost because cells differentiate prematurely. We conclude that the PSC functions as a haematopoietic niche that is essential for the maintenance of blood cell precursors in Drosophila. Identification of this system allows the opportunity for genetic manipulation and direct in vivo imaging of a haematopoietic niche interacting with blood precursors.	Univ Calif Los Angeles, Inst Mol Biol, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Mattel Childrens Hosp, Dept Pediat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Banerjee, U (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	banerjee@mbi.ucla.edu	Martinez-Agosto, Julian A/I-9435-2019	Martinez-Agosto, Julian A/0000-0001-6776-6949; MANDAL, LOLITIKA/0000-0002-7711-6090	NHLBI NIH HHS [K08 HL087026-01, L40 HL090710, L40 HL090710-02, K08 HL087026] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL087026] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABBOTT MK, 1986, GENETICS, V114, P919; Abramovich C, 2005, CURR OPIN HEMATOL, V12, P210, DOI 10.1097/01.moh.0000160737.52349.aa; Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Casares F, 2001, SCIENCE, V293, P1477, DOI 10.1126/science.1062542; Chuang PT, 2000, CURR OPIN GENET DEV, V10, P515, DOI 10.1016/S0959-437X(00)00121-0; Crittenden SL, 2006, MOL BIOL CELL, V17, P3051, DOI 10.1091/mbc.E06-03-0170; Crozatier M, 2004, PLOS BIOL, V2, P1107, DOI 10.1371/journal.pbio.0020196; El Shatoury H. H., 1955, Roux Archiv fuer Entwicklungsmechanik Organismen, V147, P489, DOI 10.1007/BF00576000; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Kieusseian A, 2006, BLOOD, V107, P492, DOI 10.1182/blood-2005-02-0529; Kimble Judith, 2005, WormBook, P1; Lebestky T, 2003, GENE DEV, V17, P348, DOI 10.1101/gad.1052803; Lo PCH, 2002, DEV BIOL, V251, P307, DOI 10.1006/dbio.2002.0839; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Mandal L, 2004, NAT GENET, V36, P1019, DOI 10.1038/ng1404; Rizki T.M., 1978, P397; Ryan KM, 2005, MECH DEVELOP, V122, P1023, DOI 10.1016/j.mod.2005.04.007; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Schnabel CA, 2000, ONCOGENE, V19, P608, DOI 10.1038/sj.onc.1203371; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang Y, 2001, NATURE, V410, P599, DOI 10.1038/35069099	30	214	220	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2007	446	7133					320	324		10.1038/nature05585	http://dx.doi.org/10.1038/nature05585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17361183	Green Accepted			2022-12-01	WOS:000244892900046
J	Hollenstein, K; Frei, DC; Locher, KP				Hollenstein, Kaspar; Frei, Dominik C.; Locher, Kaspar P.			Structure of an ABC transporter in complex with its binding protein	NATURE			English	Article							ATP-BINDING; AZOTOBACTER-VINELANDII; CASSETTE TRANSPORTER; MOLYBDATE TRANSPORT; MALTOSE TRANSPORT; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; P-GLYCOPROTEIN; MECHANISM; HYDROLYSIS	ATP-binding cassette (ABC) transporter proteins carry diverse substrates across cell membranes(1). Whereas clinically relevant ABC exporters are implicated in various diseases or cause multidrug resistance of cancer cells(2,3), bacterial ABC importers are essential for the uptake of nutrients(4), including rare elements such as molybdenum. A detailed understanding of their mechanisms requires direct visualization at high resolution and in distinct conformations. Our recent structure of the multidrug ABC exporter Sav1866 has revealed an outward-facing conformation of the transmembrane domains coupled to a closed conformation of the nucleotide-binding domains, reflecting the ATP-bound state(5). Here we present the 3.1 angstrom crystal structure of a putative molybdate transporter (ModB(2)C(2)) from Archaeoglobus fulgidus in complex with its binding protein ( ModA). Twelve transmembrane helices of the ModB subunits provide an inward-facing conformation, with a closed gate near the external membrane boundary. The ATP-hydrolysing ModC subunits reveal a nucleotide-free, open conformation, whereas the attached binding protein aligns the substrate-binding cleft with the entrance to the presumed translocation pathway. Structural comparison of ModB(2)C(2)A with Sav1866 suggests a common alternating access and release mechanism, with binding of ATP promoting an outward-facing conformation and dissociation of the hydrolysis products promoting an inward-facing conformation.	ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Locher, KP (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	kaspar.locher@mol.biol.ethz.ch		Hollenstein, Kaspar/0000-0001-7606-4105				Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Davidson AL, 2002, J BACTERIOL, V184, P1225, DOI 10.1128/JB.184.5.1225-1233.2002; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Holland I. B., 2003, ABC PROTEINS BACTERI; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hu YL, 1997, NAT STRUCT BIOL, V4, P703, DOI 10.1038/nsb0997-703; Janas E, 2003, J BIOL CHEM, V278, P26862, DOI 10.1074/jbc.M301227200; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; Lawson DM, 1998, STRUCTURE, V6, P1529, DOI 10.1016/S0969-2126(98)00151-8; Liu CE, 1999, J BIOL CHEM, V274, P739, DOI 10.1074/jbc.274.2.739; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Loo TW, 2005, J MEMBRANE BIOL, V206, P173, DOI 10.1007/s00232-005-0792-1; Mannering DE, 2001, J BIOL CHEM, V276, P12362, DOI 10.1074/jbc.M011686200; MOUNCEY NJ, 1995, J BACTERIOL, V177, P5294, DOI 10.1128/jb.177.18.5294-5302.1995; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; Nikaido H, 1998, METHOD ENZYMOL, V292, P3; Patzlaff JS, 2003, J BIOL CHEM, V278, P29546, DOI 10.1074/jbc.M304796200; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; PROSSNITZ E, 1991, J BIOL CHEM, V266, P9673; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; RECH S, 1995, J BACTERIOL, V177, P1023, DOI 10.1128/jb.177.4.1023-1029.1995; Sauna ZE, 2000, P NATL ACAD SCI USA, V97, P2515, DOI 10.1073/pnas.97.6.2515; Schneider E, 1998, FEMS MICROBIOL REV, V22, P1; Sebulsky MT, 2003, J BIOL CHEM, V278, P49890, DOI 10.1074/jbc.M305073200; Self WT, 2001, RES MICROBIOL, V152, P311, DOI 10.1016/S0923-2508(01)01202-5; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2	30	378	396	0	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2007	446	7132					213	216		10.1038/nature05626	http://dx.doi.org/10.1038/nature05626			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17322901				2022-12-01	WOS:000244718100046
J	Painter, HJ; Morrisey, JM; Mather, MW; Vaidya, AB				Painter, Heather J.; Morrisey, Joanne M.; Mather, Michael W.; Vaidya, Akhil B.			Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum	NATURE			English	Article							CRYPTOSPORIDIUM-PARVUM; MALARIA PARASITES; GENOME SEQUENCE; GENE-TRANSFER; EVOLUTION; DIHYDROOROTATE; BIOSYNTHESIS; ATOVAQUONE; INHIBITORS; YEASTS	The origin of all mitochondria can be traced to the symbiotic arrangement that resulted in the emergence of eukaryotes in a world that was exclusively populated by prokaryotes(1-3). This arrangement, however, has been in continuous genetic flux: the varying degrees of gene loss and transfer from the mitochondrial genome in different eukaryotic lineages seem to signify an ongoing 'conflict' between the host and the symbiont. Eukaryotic parasites belonging to the phylum Apicomplexa provide an excellent example to support this view. These organisms contain the smallest mitochondrial genomes known(4,5), with an organization that differs among various genera; one genus, Cryptosporidium, seems to have lost the entire mitochondrial genome(6,7). Here we show that erythrocytic stages of the human malaria parasite Plasmodium falciparum seem to maintain an active mitochondrial electron transport chain to serve just one metabolic function: regeneration of ubiquinone required as the electron acceptor for dihydroorotate dehydrogenase, an essential enzyme for pyrimidine biosynthesis. Transgenic P. falciparum parasites expressing Saccharomyces cerevisiae dihydroorotate dehydrogenase, which does not require ubiquinone as an electron acceptor(8), were completely resistant to inhibitors of mitochondrial electron transport. Maintenance of mitochondrial membrane potential, however, was essential in these parasites, as indicated by their hypersensitivity to proguanil, a drug that collapsed the membrane potential in the presence of electron transport inhibitors. Thus, acquisition of just one enzyme can render mitochondrial electron transport nonessential in erythrocytic stages of P. falciparum.	Drexel Univ, Coll Med, Dept Microbiol & Immunol, Ctr Mol Parasitol, Philadelphia, PA 19129 USA	Drexel University	Vaidya, AB (corresponding author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Ctr Mol Parasitol, Philadelphia, PA 19129 USA.	avaidya@drexelmed.edu		Mather, Michael/0000-0002-1062-0137	NIAID NIH HHS [R01 AI028398] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028398] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Allen RJW, 2004, J BIOL CHEM, V279, P11264, DOI 10.1074/jbc.M311110200; Baldwin J, 2005, J BIOL CHEM, V280, P21847, DOI 10.1074/jbc.M501100200; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; FRY M, 1990, COMP BIOCHEM PHYS B, V96, P775, DOI 10.1016/0305-0491(90)90230-Q; FRY M, 1992, BIOCHEM PHARMACOL, V43, P1545, DOI 10.1016/0006-2952(92)90213-3; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Giraud MF, 1997, EUR J BIOCHEM, V245, P813, DOI 10.1111/j.1432-1033.1997.00813.x; Gojkovic Z, 2004, MOL GENET GENOMICS, V271, P387, DOI 10.1007/s00438-004-0995-7; GUTTERIDGE WE, 1979, BIOCHIM BIOPHYS ACTA, V582, P390, DOI 10.1016/0304-4165(79)90131-4; Keithly JS, 2005, J EUKARYOT MICROBIOL, V52, P132, DOI 10.1111/j.1550-7408.2005.04-3317.x; LANE N, 2005, POWER SEX SUICIDE MI; Lill R, 2005, TRENDS BIOCHEM SCI, V30, P133, DOI 10.1016/j.tibs.2005.01.006; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; NAGY M, 1992, P NATL ACAD SCI USA, V89, P8966, DOI 10.1073/pnas.89.19.8966; Nicholls D., 2002, BIOENERGETICS, V3; O'Donnell RA, 2002, EMBO J, V21, P1231, DOI 10.1093/emboj/21.5.1231; Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862; Srivastava IK, 1999, ANTIMICROB AGENTS CH, V43, P1334, DOI 10.1128/AAC.43.6.1334; Striepen B, 2004, P NATL ACAD SCI USA, V101, P3154, DOI 10.1073/pnas.0304686101; VAIDYA AB, 1987, MOL BIOCHEM PARASIT, V22, P249, DOI 10.1016/0166-6851(87)90056-9; VAIDYA AB, 1989, MOL BIOCHEM PARASIT, V35, P97, DOI 10.1016/0166-6851(89)90112-6; Vaidya AB, 2005, CURR TOP MICROBIOL, V295, P233; VAIDYA AB, 1993, MOL BIOCHEM PARASIT, V58, P33, DOI 10.1016/0166-6851(93)90088-F; Vaidya AB, 2000, DRUG RESIST UPDATE, V3, P283, DOI 10.1054/drup.2000.0157; Vaidya Akhil B., 1998, P355; van der Giezen M, 2005, EMBO REP, V6, P525, DOI 10.1038/sj.embor.7400440; Wilson RJM, 1997, MICROBIOL MOL BIOL R, V61, P1; Wilson RJM, 2002, J MOL BIOL, V319, P257, DOI 10.1016/S0022-2836(02)00303-0; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977	30	347	355	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2007	446	7131					88	91		10.1038/nature05572	http://dx.doi.org/10.1038/nature05572			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17330044				2022-12-01	WOS:000244525600043
J	Daemen, J; Wenaweser, P; Tsuchida, K; Abrecht, L; Sophia, V; Morger, C; Kukreja, N; Juni, P; Sianos, G; Hellige, G; Domburg, RT; Hess, OM; Boersma, E; Meier, B; Windecker, S; Serruys, PW				Daemen, Joost; Wenaweser, Peter; Tsuchida, Keiichi; Abrecht, Linda; Sophia, Vaina; Morger, Cyrill; Kukreja, Neville; Jueni, Peter; Sianos, Georgios; Hellige, Gerrit; van Domburg, Ron T.; Hess, Otto M.; Boersma, Eric; Meier, Bernhard; Windecker, Stephan; Serruys, Patrick W.			Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study	LANCET			English	Article							BARE-METAL STENT; HOSPITAL RESEARCH REGISTRY; LATE ANGIOGRAPHIC STENT; ARTERY-DISEASE; DIABETIC-PATIENTS; MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; CIGARETTE-SMOKING; STANDARD STENT; REAL-WORLD	Background Stent thrombosis is a safety concern associated with use of drug-eluting stents. Little is known about occurrence of stent thrombosis more than 1 year after implantation of such stents. Methods Between April, 2002, and Dec, 2005, 8146 patients underwent percutaneous coronary intervention with sirolimus-eluting stents (SES; n=3823) or paclitaxel-eluting stents (PES; n=4323) at two academic hospitals. We assessed data from this group to ascertain the incidence, time course, and correlates of stent thrombosis, and the differences between early (0-30 days) and late (>30 days) stent thrombosis and between SES and PES. Findings Angiographically documented stent thrombosis occurred in 152 patients (incidence density 1.3 per 100 person-years; cumulative incidence at 3 years 2.9%). Early stent thrombosis was noted in 91 (60%) patients, and late stent thrombosis in 61 (40%) patients. Late stent thrombosis occurred steadily at a constant rate of 0.6% per year up to 3 years after stent implantation. incidence of early stent thrombosis was similar for SES (1.1%) and PES (1.3%), but late stent thrombosis was more frequent with PES (1.8%) than with SES (1.4%; p=0.031). At the time of stent thrombosis, dual antiplatelet therapy was being taken by 87% (early) and 23% (late) of patients (p<0.0001). Independent predictors of overall stent thrombosis were acute coronary syndrome at presentation (hazard ratio 2.28, 95% CI 1.29-4.03) and diabetes (2.03, 1.07-3.83). Interpretation Late stent thrombosis was encountered steadily with no evidence of diminution up to 3 years of follow-up. Early and late stent thrombosis were observed with SES and with PES. Acute coronary syndrome at presentation and diabetes were independent predictors of stent thrombosis.	Erasmus MC, Dept Cardiol, Thoraxctr, NL-3015 GD Rotterdam, Netherlands; Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland; Univ Bern, Div Epidemiol & Biostat, Dept Social & Prevent Med, Bern, Switzerland	Erasmus University Rotterdam; Erasmus MC; University of Bern; University Hospital of Bern; University of Bern	Serruys, PW (corresponding author), Erasmus MC, Dept Cardiol, Thoraxctr, Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands.	p.w.j.c.serruys@erasmusmc.nl	Wenaweser, Peter/AAN-7009-2021; Juni, Peter/Q-8700-2016	Juni, Peter/0000-0002-5985-0670				Aronson D, 1996, J AM COLL CARDIOL, V27, P528, DOI 10.1016/0735-1097(95)00496-3; Babapulle MN, 2004, LANCET, V364, P583, DOI 10.1016/S0140-6736(04)16850-5; BARBASH GI, 1993, CIRCULATION, V87, P53, DOI 10.1161/01.CIR.87.1.53; Bavry AA, 2005, J AM COLL CARDIOL, V45, P941, DOI 10.1016/j.jacc.2004.11.064; Blais L, 1996, AM J EPIDEMIOL, V144, P1161; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; CELERMAJER DS, 1993, CIRCULATION, V88, P2149, DOI 10.1161/01.CIR.88.5.2149; Colombo A, 2003, CIRCULATION, V108, P788, DOI 10.1161/01.CIR.0000086926.62288.A6; Farb A, 1999, CIRCULATION, V99, P44, DOI 10.1161/01.CIR.99.1.44; Glynn RJ, 1996, BMJ-BRIT MED J, V312, P364; Granados JAT, 1997, J CLIN EPIDEMIOL, V50, P891, DOI 10.1016/S0895-4356(97)00105-4; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1827, DOI 10.1016/j.jacc.2005.07.056; Hofma SH, 2006, EUR HEART J, V27, P166, DOI 10.1093/eurheartj/ehi571; Honda Y, 2003, CIRCULATION, V108, P2, DOI 10.1161/01.CIR.0000075929.79964.D8; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Kaiser C, 2005, LANCET, V366, P921, DOI 10.1016/S0140-6736(05)67221-2; Kaluza GL, 2000, J AM COLL CARDIOL, V35, P1288, DOI 10.1016/S0735-1097(00)00521-0; Kotani J, 2006, J AM COLL CARDIOL, V47, P2108, DOI 10.1016/j.jacc.2005.11.092; Kuchulakanti PK, 2006, CIRCULATION, V113, P1108, DOI 10.1161/CIRCULATIONAHA.105.600155; Lee CH, 2006, HEART, V92, P551, DOI 10.1136/hrt.2005.073619; Lemos PA, 2004, CIRCULATION, V109, P190, DOI 10.1161/01.CIR.0000109138.84579.FA; Lemos PA, 2003, J AM COLL CARDIOL, V41, P2093, DOI 10.1016/S0735-1097(03)00429-7; LEON M, 2006, J AM COLL CARDIOL SB, V47; Levin AD, 2004, P NATL ACAD SCI USA, V101, P9463, DOI 10.1073/pnas.0400918101; Lincoff AM, 2003, CIRCULATION, V107, P1556, DOI 10.1161/01.CIR.0000055653.52489.E9; Lincoff AM, 1999, NEW ENGL J MED, V341, P319, DOI 10.1056/NEJM199907293410503; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; Moreno R, 2005, J AM COLL CARDIOL, V45, P954, DOI 10.1016/j.jacc.2004.11.065; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Nebeker JR, 2006, J AM COLL CARDIOL, V47, P175, DOI 10.1016/j.jacc.2005.07.071; Niles NW, 2001, J AM COLL CARDIOL, V37, P1008, DOI 10.1016/S0735-1097(00)01205-5; Nilsen DWT, 2006, INT J CARDIOL, V109, P398, DOI 10.1016/j.ijcard.2005.05.029; Ong ATL, 2005, J AM COLL CARDIOL, V45, P2088, DOI 10.1016/j.jacc.2005.02.086; Ong ATL, 2005, J AM COLL CARDIOL, V45, P947, DOI 10.1016/j.jacc.2004.09.079; Ong ATL, 2005, J AM COLL CARDIOL, V45, P1135, DOI 10.1016/j.jacc.2005.01.008; Park DW, 2006, AM J CARDIOL, V98, P352, DOI 10.1016/j.amjcard.2006.02.039; Perimenis P, 2005, EXPERT OPIN PHARMACO, V6, P1, DOI 10.1517/14656566.6.1.1; Rodriguez Alfredo E, 2006, EuroIntervention, V2, P53; Rogers Campbell D K, 2005, Rev Cardiovasc Med, V6 Suppl 1, pS3; Roiron C, 2006, HEART, V92, P641, DOI 10.1136/hrt.2005.061622; Sabate M, 2005, CIRCULATION, V112, P2175, DOI 10.1161/CIRCULATIONAHA.105.562421; STONE G, 2006, INDEPENDENT PHYS LED; Stone GW, 2005, JAMA-J AM MED ASSOC, V294, P1215, DOI 10.1001/jama.294.10.1215; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Togni M, 2005, J AM COLL CARDIOL, V46, P231, DOI 10.1016/j.jacc.2005.01.062; Urban P, 2006, CIRCULATION, V113, P1434, DOI 10.1161/CIRCULATIONAHA.104.532242; Violaris AG, 2000, HEART, V84, P299, DOI 10.1136/heart.84.3.299; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4; Wenaweser P, 2005, J AM COLL CARDIOL, V45, P1748, DOI 10.1016/j.jacc.2005.01.058; Wenaweser P, 2005, EUR HEART J, V26, P1180, DOI 10.1093/eurheartj/ehi135; West NEJ, 2004, CIRCULATION, V109, P867, DOI 10.1161/01.CIR.0000116750.63158.94; Windecker S, 2005, NEW ENGL J MED, V353, P653, DOI 10.1056/NEJMoa051175; ZEIHER AM, 1995, CIRCULATION, V92, P1094, DOI 10.1161/01.CIR.92.5.1094	56	1371	1455	1	77	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2007	369	9562					667	678		10.1016/S0140-6736(07)60314-6	http://dx.doi.org/10.1016/S0140-6736(07)60314-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	141RO	17321312				2022-12-01	WOS:000244596600028
J	Leduc, G; Vidal, L; Tachikawa, K; Rostek, F; Sonzogni, C; Beaufort, L; Bard, E				Leduc, Guillaume; Vidal, Laurence; Tachikawa, Kazuyo; Rostek, Frauke; Sonzogni, Corinne; Beaufort, Luc; Bard, Edouard			Moisture transport across Central America as a positive feedback on abrupt climatic changes	NATURE			English	Article							SCALE CHANGES; RAPID CHANGES; ATLANTIC; OCEAN; SALINITY; TEMPERATURE; SIMULATIONS; CIRCULATION; SEDIMENTS	Moisture transport from the Atlantic to the Pacific ocean across Central America leads to relatively high salinities in the North Atlantic Ocean(1) and contributes to the formation of North Atlantic Deep Water(2). This deep water formation varied strongly between Dansgaard/ Oeschger interstadials and Heinrich events millennial- scale abrupt warm and cold events, respectively, during the last glacial period(3). Increases in the moisture transport across Central America have been proposed to coincide with northerly shifts of the Intertropical Convergence Zone and with Dansgaard/ Oeschger interstadials, with opposite changes for Heinrich events(4). Here we reconstruct sea surface salinities in the eastern equatorial Pacific Ocean over the past 90,000 years by comparing palaeotemperature estimates from alkenones and Mg/Ca ratios with foraminiferal oxygen isotope ratios that vary with both temperature and salinity. We detect millennial- scale fluctuations of sea surface salinities in the eastern equatorial Pacific Ocean of up to two to four practical salinity units. High salinities are associated with the southward migration of the tropical Atlantic Intertropical Convergence Zone, coinciding with Heinrich events and with Greenland stadials(5). The amplitudes of these salinity variations are significantly larger on the Pacific side of the Panama isthmus, as inferred from a comparison of our data with a palaeoclimate record from the Caribbean basin(6). We conclude that millennial-scale fluctuations of moisture transport constitute an important feedback mechanism for abrupt climate changes, modulating the North Atlantic freshwater budget and hence North Atlantic Deep Water formation.	Univ Aix Marseille 3, Coll France, CNRS,UMR 6635, CEREGE, F-13545 Aix En Provence 04, France	UDICE-French Research Universities; Aix-Marseille Universite; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD)	Leduc, G (corresponding author), Univ Aix Marseille 3, Coll France, CNRS,UMR 6635, CEREGE, Europole Arbois,BP 80, F-13545 Aix En Provence 04, France.	leduc@cerege.fr; bard@cerege.fr	Beaufort, Luc/ABG-2289-2021; Beaufort, Luc/AAH-5305-2021; Bard, Edouard/G-7717-2014; Vidal, Laurence/C-1860-2019; Sonzogni, Corinne/AAG-5816-2019; Leduc, Guillaume/A-8930-2008	Beaufort, Luc/0000-0001-6055-9373; 				Arz HW, 1998, QUATERNARY RES, V50, P157, DOI 10.1006/qres.1998.1992; Bard E, 2002, PHYS TODAY, V55, P32, DOI 10.1063/1.1537910; Benway HM, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001208; Benway HM, 2004, EARTH PLANET SC LETT, V224, P493, DOI 10.1016/j.epsl.2004.05.014; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; Broecker WS, 1990, PALEOCEANOGRAPHY, V5, P469, DOI 10.1029/PA005i004p00469; Broecker WS, 2003, SCIENCE, V300, P1519, DOI 10.1126/science.1083797; Ganopolski A, 2001, NATURE, V409, P153, DOI 10.1038/35051500; Hostetler SW, 1999, NATURE, V399, P673, DOI 10.1038/21401; Ivanochko TS, 2005, EARTH PLANET SC LETT, V235, P302, DOI 10.1016/j.epsl.2005.04.002; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Liu WT, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005300; Manabe S, 1988, J CLIMATE, V1, P841, DOI 10.1175/1520-0442(1988)001<0841:TSEOAC>2.0.CO;2; Masson S, 2001, PHYS CHEM EARTH PT B, V26, P137, DOI 10.1016/S1464-1909(00)00230-6; Masson-Delmotte V, 2005, SCIENCE, V309, P118, DOI 10.1126/science.1108575; Mignot J, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002005; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Schmidt GA, 1999, PALEOCEANOGRAPHY, V14, P422, DOI 10.1029/1999PA900008; Schmidt MW, 2006, NATURE, V443, P561, DOI 10.1038/nature05121; Schmidt MW, 2004, NATURE, V428, P160, DOI 10.1038/nature02346; Schmittner A, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000633; Sonzogni C, 1997, QUATERNARY RES, V47, P344, DOI 10.1006/qres.1997.1885; Stuiver M, 2000, QUATERNARY RES, V53, P277, DOI 10.1006/qres.2000.2127; Vidal L, 2004, DEV PALEOENVIRON RES, V6, P31; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Wang XF, 2004, NATURE, V432, P740, DOI 10.1038/nature03067; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; ZAUCKER F, 1992, J GEOPHYS RES-ATMOS, V97, P2765, DOI 10.1029/91JD01699	28	169	174	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					908	911		10.1038/nature05578	http://dx.doi.org/10.1038/nature05578			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17314978				2022-12-01	WOS:000244341200047
J	Robinson, DJ; O'Neill, D				Robinson, David J.; O'Neill, Desmond			Access to health care records after death - Balancing confidentiality with appropriate disclosure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICAL CONFIDENTIALITY		Adelaide & Meath Hosp, Dept Med Gerontol, Dublin 24, Ireland	Trinity College Dublin	O'Neill, D (corresponding author), Adelaide & Meath Hosp, Dept Med Gerontol, Dublin 24, Ireland.	arhc@amnch.ie	O'Neill, Desmond/D-1486-2013	O'Neill, Desmond/0000-0002-5542-9897				Annas GJ, 2005, NEW ENGL J MED, V352, P501, DOI 10.1056/NEJMlim042648; Behnke SH, 1998, J AM ACAD PSYCHIATRY, V26, P639; Billings J A, 1999, J Palliat Med, V2, P33, DOI 10.1089/jpm.1999.2.33; BISHOP L, 2005, NATL CONSUMER HEALTH; Caulfield H, 1998, Nurs Stand, V13, P47; Comijs HC, 1998, J AM GERIATR SOC, V46, P885, DOI 10.1111/j.1532-5415.1998.tb02724.x; deCinque N, 2004, J PAEDIATR CHILD H, V40, P131, DOI 10.1111/j.1440-1754.2004.00313.x; Dimond Bridgit, 2005, Br J Nurs, V14, P391; Glen S, 1997, NURS ETHICS, V4, P403; Kipnis K, 2006, AM J BIOETHICS, V6, P7, DOI 10.1080/15265160500506308; Lucassen AM, 2004, BMJ-BRIT MED J, V328, P952, DOI 10.1136/bmj.328.7445.952; McGuire W., 1978, CG JUNG SPEAKING INT; medical council, 2004, GUID ETH COND BEH; Phukan JFM, 2004, IR J MED SCI S1, V173, P47; RHODES H, 2003, PROTECTING PATIENT I; Sankar P, 2003, J GEN INTERN MED, V18, P659, DOI 10.1046/j.1525-1497.2003.20823.x; WORTHINGTON R, 2004, BMJ             0420	17	7	7	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2007	297	6					634	636		10.1001/jama.297.6.634	http://dx.doi.org/10.1001/jama.297.6.634			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	135TU	17299198				2022-12-01	WOS:000244177400026
J	Ventura, A; Kirsch, DG; McLaughlin, ME; Tuveson, DA; Grimm, J; Lintault, L; Newman, J; Reczek, EE; Weissleder, R; Jacks, T				Ventura, Andrea; Kirsch, David G.; McLaughlin, Margaret E.; Tuveson, David A.; Grimm, Jan; Lintault, Laura; Newman, Jamie; Reczek, Elizabeth E.; Weissleder, Ralph; Jacks, Tyler			Restoration of p53 function leads to tumour regression in vivo	NATURE			English	Article							LUNG-CANCER; MUTANT P53; SUPPRESSION; MICE; ANGIOGENESIS; RECOMBINASES; EXPRESSION; MUTATIONS; GEFITINIB; EFFICACY	Tumorigenesis is a multi-step process that requires activation of oncogenes and inactivation of tumour suppressor genes(1). Mouse models of human cancers have recently demonstrated that continuous expression of a dominantly acting oncogene ( for example, Hras, Kras and Myc) is often required for tumour maintenance(2-5); this phenotype is referred to as oncogene addiction(6). This concept has received clinical validation by the development of active anticancer drugs that specifically inhibit the function of oncoproteins such as BCR-ABL, c-KIT and EGFR(7-10). Identifying additional gene mutations that are required for tumour maintenance may therefore yield clinically useful targets for new cancer therapies. Although loss of p53 function is a common feature of human cancers(11), it is not known whether sustained inactivation of this or other tumour suppressor pathways is required for tumour maintenance. To explore this issue, we developed a Cre-loxP-based strategy to temporally control tumour suppressor gene expression in vivo. Here we show that restoring endogenous p53 expression leads to regression of autochthonous lymphomas and sarcomas in mice without affecting normal tissues. The mechanism responsible for tumour regression is dependent on the tumour type, with the main consequence of p53 restoration being apoptosis in lymphomas and suppression of cell growth with features of cellular senescence in sarcomas. These results support efforts to treat human cancers by way of pharmacological reactivation of p53.	MIT, Ctr Canc Res, Cambridge, MA 02142 USA; Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02129 USA; Massachusetts Gen Hosp, Ctr Mol Imaging Res, Boston, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Jacks, T (corresponding author), MIT, Ctr Canc Res, Cambridge, MA 02142 USA.	tjacks@mit.edu	Ventura, Andrea/F-1789-2011; Grimm, Jan/B-1937-2008	/0000-0003-0828-4143; Ventura, Andrea/0000-0003-4320-9907				Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haupt S, 2004, SEMIN CANCER BIOL, V14, P244, DOI 10.1016/j.semcancer.2004.04.003; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; KEMP CJ, 1994, NAT GENET, V8, P66, DOI 10.1038/ng0994-66; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Snyder EL, 2004, PLOS BIOL, V2, P186, DOI 10.1371/journal.pbio.0020036; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Teodoro JG, 2006, SCIENCE, V313, P968, DOI 10.1126/science.1126391; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; XUE W, 2007, NATURE          0124; Zhang LL, 2000, CANCER RES, V60, P3655	31	1335	1390	1	189	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2007	445	7128					661	665		10.1038/nature05541	http://dx.doi.org/10.1038/nature05541			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17251932				2022-12-01	WOS:000244039400047
J	Pinton, P; Rimessi, A; Marchi, S; Orsini, F; Migliaccio, E; Giorgio, M; Contursi, C; Minucci, S; Mantovani, F; Wieckowski, MR; Del Sal, G; Pelicci, PG; Rizzuto, R				Pinton, Paolo; Rimessi, Alessandro; Marchi, Saverio; Orsini, Francesca; Migliaccio, Enrica; Giorgio, Marco; Contursi, Cristina; Minucci, Saverio; Mantovani, Fiamma; Wieckowski, Mariusz R.; Del Sal, Giannino; Pelicci, Pier Giuseppe; Rizzuto, Rosario			Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66(Shc)	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; OXIDATIVE STRESS; CA2+ SIGNALS; APOPTOSIS; MECHANISM	The 66-kilodalton isoform of the growth factor adapter Shc (p66(Shc)) translates oxidative damage into cell death by acting as reactive oxygen species (ROS) producer within mitochondria. However, the signaling link between cellular stress and mitochondrial proapoptotic activity of p66(Shc) was not known. We demonstrate that protein kinase C beta, activated by oxidative conditions in the cell, induces phosphorylation of p66Shc and triggers mitochondrial accumulation of the protein after it is recognized by the prolyl isomerase Pin1. Once imported, p66(Shc) causes alterations of mitochondrial Ca2+ responses and three-dimensional structure, thus inducing apoptosis. These data identify a signaling route that activates an apoptotic inducer shortening the life span and could be a potential target of pharmacological approaches to inhibit aging.	Univ Ferrara, Dept Expt & Diagnost Med, Sect Gen Pathol, I-44100 Ferrara, Italy; Univ Ferrara, ICSI, I-44100 Ferrara, Italy; Univ Ferrara, Emilia Romagna Lab Genom & Biotechnol, I-44100 Ferrara, Italy; European Inst Oncol, Dept Expt Oncol, Milan, Italy; FIRC, Inst Mol Oncol, Milan, Italy; Congenia SrL, Milan, Italy; Consorzio Interuniv Biotechnol, Lab Nazl, Trieste, Italy; Univ Trieste, Dept Biochim Biofis Chim Macromol, I-34127 Trieste, Italy; Polish Acad Sci, M Nencki Inst Expt Biol, Dept Cellular Biochem, PL-00901 Warsaw, Poland; Univ Milan, Dept Med & Surg, I-20122 Milan, Italy	University of Ferrara; University of Ferrara; University of Ferrara; IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology; University of Trieste; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Milan	Rizzuto, R (corresponding author), Univ Ferrara, Dept Expt & Diagnost Med, Sect Gen Pathol, I-44100 Ferrara, Italy.	r.rizzuto@unife.it	Migliaccio, Enrica/AAQ-8880-2020; Pinton, Paolo/J-8025-2012; Rimessi, Alessandro/K-5420-2016; Rizzuto, Rosario/B-6312-2008; Minucci, Saverio/J-9669-2012; Marchi, Saverio/AAK-3308-2021; rimessi, alessandro/O-3335-2019; Giorgio, Marco/I-9425-2012; Pelicci, Pier Giuseppe/AAL-6572-2020; Marchi, Saverio/K-5997-2016	Pinton, Paolo/0000-0001-7108-6508; Rimessi, Alessandro/0000-0001-7091-5765; Marchi, Saverio/0000-0003-2708-1843; rimessi, alessandro/0000-0001-7091-5765; Giorgio, Marco/0000-0002-5842-6042; Marchi, Saverio/0000-0003-2708-1843; Rizzuto, Rosario/0000-0001-7044-5097; Wieckowski, Mariusz/0000-0003-0789-4521; DEL SAL, GIANNINO/0000-0003-2185-6003	Telethon [GGP05284] Funding Source: Medline	Telethon(Fondazione Telethon)		Bernardi P, 2001, TRENDS BIOCHEM SCI, V26, P112, DOI 10.1016/S0968-0004(00)01745-X; Bootman MD, 2001, J CELL SCI, V114, P2213; Brini M, 1999, NAT MED, V5, P951, DOI 10.1038/11396; Duchen MR, 2000, CELL CALCIUM, V28, P339, DOI 10.1054/ceca.2000.0170; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Gonindard C, 1997, CELL BIOL TOXICOL, V13, P141, DOI 10.1023/A:1007321227010; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Nemoto S, 2006, J BIOL CHEM, V281, P10555, DOI 10.1074/jbc.M511626200; Orsini F, 2004, J BIOL CHEM, V279, P25689, DOI 10.1074/jbc.M401844200; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Pinton P, 2004, J CELL BIOL, V165, P223, DOI 10.1083/jcb.200311061; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rizzuto R, 2000, J PHYSIOL-LONDON, V529, P37, DOI 10.1111/j.1469-7793.2000.00037.x; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120	20	388	412	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2007	315	5812					659	663		10.1126/science.1135380	http://dx.doi.org/10.1126/science.1135380			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272725				2022-12-01	WOS:000243909400047
J	Scott, LM; Tong, W; Levine, RL; Scott, MA; Beer, PA; Stratton, MR; Futreal, PA; Erber, WN; McMullin, MF; Harrison, CN; Warren, AJ; Gilliland, DG; Lodish, HF; Green, AR				Scott, Linda M.; Tong, Wei; Levine, Ross L.; Scott, Mike A.; Beer, Philip A.; Stratton, Michael R.; Futreal, P. Andrew; Erber, Wendy N.; McMullin, Mary Frances; Harrison, Claire N.; Warren, Alan J.; Gilliland, D. Gary; Lodish, Harvey F.; Green, Anthony R.			JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TYROSINE KINASE JAK2; V617F MUTATION; MYELOPROLIFERATIVE-DISORDERS; ESSENTIAL THROMBOCYTHEMIA; DIAGNOSTIC-CRITERIA; ACTIVATING MUTATION; MYELOID METAPLASIA; MYELOFIBROSIS; DISEASE; JAK2V617F	BACKGROUND: The V617F mutation, which causes the substitution of phenylalanine for valine at position 617 of the Janus kinase (JAK) 2 gene (JAK2), is often present in patients with polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis. However, the molecular basis of these myeloproliferative disorders in patients without the V617F mutation is unclear. METHODS: We searched for new mutations in members of the JAK and signal transducer and activator of transcription (STAT) gene families in patients with V617F-negative polycythemia vera or idiopathic erythrocytosis. The mutations were characterized biochemically and in a murine model of bone marrow transplantation. RESULTS: We identified four somatic gain-of-function mutations affecting JAK2 exon 12 in 10 V617F-negative patients. Those with a JAK2 exon 12 mutation presented with an isolated erythrocytosis and distinctive bone marrow morphology, and several also had reduced serum erythropoietin levels. Erythroid colonies could be grown from their blood samples in the absence of exogenous erythropoietin. All such erythroid colonies were heterozygous for the mutation, whereas colonies homozygous for the mutation occur in most patients with V617F-positive polycythemia vera. BaF3 cells expressing the murine erythropoietin receptor and also carrying exon 12 mutations could proliferate without added interleukin-3. They also exhibited increased phosphorylation of JAK2 and extracellular regulated kinase 1 and 2, as compared with cells transduced by wild-type JAK2 or V617F JAK2. Three of the exon 12 mutations included a substitution of leucine for lysine at position 539 of JAK2. This mutation resulted in a myeloproliferative phenotype, including erythrocytosis, in a murine model of retroviral bone marrow transplantation. CONCLUSIONS: JAK2 exon 12 mutations define a distinctive myeloproliferative syndrome that affects patients who currently receive a diagnosis of polycythemia vera or idiopathic erythrocytosis.	Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 2XY, England; Addenbrookes Natl Hlth Serv Trust, Cambridge, England; Whitehead Inst Biomed Res, Cambridge, England; MIT, Cambridge, England; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA USA; Wellcome Trust Sanger Inst, Hinxton, England; Queens Univ Belfast, Belfast, Antrim, North Ireland; St Thomas Hosp, London, England	University of Cambridge; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Wellcome Trust Sanger Institute; Queens University Belfast; Guy's & St Thomas' NHS Foundation Trust	Green, AR (corresponding author), Cambridge Inst Med Res, Dept Haematol, Hills Rd, Cambridge CB2 2XY, England.	arg1000@cam.ac.uk	Scott, Linda/D-9777-2012; Erber, Wendy/A-1955-2012; levine, ross/AAE-7658-2019; McMullin, Mary F/AAF-6472-2020; McMullin, Mary Frances/AAG-6078-2021	Scott, Linda/0000-0003-0334-1479; McMullin, Mary Frances/0000-0002-0773-0204; Green, Anthony/0000-0002-9795-0218; Beer, Philip/0000-0003-3056-5419; Tong, Wei/0000-0001-9951-2273; Erber, Wendy/0000-0002-1028-9376	MRC [MC_U105161083, G0300497] Funding Source: UKRI; Medical Research Council [G0300723B] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [K01CA115679, P01CA066996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK050654] Funding Source: NIH RePORTER; Medical Research Council [MC_U105161083, G0300497] Funding Source: Medline; NCI NIH HHS [P01 CA066996, K01 CA115679] Funding Source: Medline; NHLBI NIH HHS [P01 HL032262] Funding Source: Medline; NIDDK NIH HHS [P01 DK050654] Funding Source: Medline; Wellcome Trust [077012] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome Trust)		ADAMSON JW, 1976, NEW ENGL J MED, V295, P913, DOI 10.1056/NEJM197610212951702; Antonioli E, 2005, LEUKEMIA, V19, P1847, DOI 10.1038/sj.leu.2403902; Barosi G, 1999, BRIT J HAEMATOL, V104, P730, DOI 10.1046/j.1365-2141.1999.01262.x; Baxter EJ, 2005, LANCET, V366, P122; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Campbell PJ, 2006, BLOOD, V107, P2098, DOI 10.1182/blood-2005-08-3395; Campbell PJ, 2005, LANCET, V366, P1945, DOI 10.1016/S0140-6736(05)67785-9; DAMESHEK W, 1951, BLOOD, V6, P372, DOI 10.1182/blood.V6.4.372.372; DANDREA AD, 1991, MOL CELL BIOL, V11, P1980, DOI 10.1128/MCB.11.4.1980; Giordanetto F, 2002, PROTEIN ENG, V15, P727, DOI 10.1093/protein/15.9.727; Horn T, 2006, J MOL DIAGN, V8, P299, DOI 10.2353/jmoldx.2006.050128; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jamieson CHM, 2006, P NATL ACAD SCI USA, V103, P6224, DOI 10.1073/pnas.0601462103; Jelinek J, 2005, BLOOD, V106, P3370, DOI 10.1182/blood-2005-05-1800; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kralovics R, 2006, BLOOD, V108, P1377, DOI 10.1182/blood-2005-11-009605; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Levine RL, 2005, BLOOD, V106, P3377, DOI 10.1182/blood-2005-05-1898; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Levine RL, 2006, BLOOD, V107, P4139, DOI 10.1182/blood-2005-09-3900; Lucet IS, 2006, BLOOD, V107, P176, DOI 10.1182/blood-2005-06-2413; Murphy S, 1997, SEMIN HEMATOL, V34, P29; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Pearson TC, 2001, SEMIN HEMATOL, V38, P21, DOI 10.1053/shem.2001.23043; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; PRCHAL JF, 1974, NEW ENGL J MED, V290, P1382; Schwaller J, 1998, EMBO J, V17, P5321, DOI 10.1093/emboj/17.18.5321; Scott LM, 2006, BLOOD, V108, P2435, DOI 10.1182/blood-2006-04-018259; Scott LM, 2005, BLOOD, V106, P2920, DOI 10.1182/blood-2005-05-2087; Steensma DP, 2005, BLOOD, V106, P1207, DOI 10.1182/blood-2005-03-1183; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	34	885	985	1	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2007	356	5					459	468		10.1056/NEJMoa065202	http://dx.doi.org/10.1056/NEJMoa065202			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131HW	17267906	Bronze, Green Accepted			2022-12-01	WOS:000243860700006
J	Grimmler, M; Wang, YF; Mund, T; Cilensek, Z; Keidel, EM; Waddell, MB; Jakel, H; Kullmann, M; Kriwacki, RW; Hengst, L				Grimmler, Matthias; Wang, Yuefeng; Mund, Thomas; Cilensek, Zoran; Keidel, Eva-Maria; Waddell, M. Brett; Jaekel, Heidelinde; Kullmann, Michael; Kriwacki, Richard W.; Hengst, Ludger			Cdk-inhibitory activity and stability of p27(Kip1) are directly regulated by oncogenic tyrosine kinases	CELL			English	Article							MYELOGENOUS LEUKEMIA-CELLS; DEPENDENT KINASES; UBIQUITIN LIGASE; CYCLIN-A; P27; PHOSPHORYLATION; PROGRESSION; DEGRADATION; ACTIVATION; PATHWAY	P27(Kip1) controls cell proliferation by binding to and regulating the activity of cyclin-dependent kinases (Cdks). Here we show that Cdk inhibition and p27 stability are regulated through direct phosphorylation by tyrosine kinases. A conserved tyrosine residue (Y88) in the Cdk-binding domain of p27 can be phosphorylated by the Src-family kinase Lyn and the oncogene product BCR-ABL. Y88 phosphorylation does not prevent p27 binding to cyclin A/Cdk2. Instead, it causes phosphorylated Y88 and the entire inhibitory 3(10)-helix of p27 to be ejected from the Cdk2 active site, thus restoring partial Cdk activity. Importantly, this allows Y88-phosphorylated p27 to be efficiently phosphorylated on threonine 187 by Cdk2 which in turn promotes its SCF-Skp2-dependent degradation. This direct link between transforming tyrosine kinases and p27 may provide an explanation for Cdk kinase activities observed in p27 complexes and for premature p27 elimination in cells that have been transformed by activated tyrosine kinases.	St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; Univ Innsbruck, Bioctr, Div Med Biochem, A-6020 Innsbruck, Austria; Max Planck Inst Biochem, D-82152 Martinsried, Germany; Univ Tennessee, Hlth Sci Ctr, Dept Mol Sci, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Innsbruck; Max Planck Society; University of Tennessee System; University of Tennessee Health Science Center	Kriwacki, RW (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA.	richard.kriwacki@stjude.org; ludger.hengst@i-med.ac.at	WANG, YUE/GWQ-9256-2022; Kriwacki, Richard/N-8154-2018; Kullmann, Michael Keith/AGY-4711-2022	Kriwacki, Richard/0000-0002-9798-6018; Mund, Thomas/0000-0002-3957-1105; Grimmler, Matthias/0000-0003-2860-3391; Kullmann, Michael Keith/0000-0003-3567-3806; Hengst, Ludger/0000-0002-0605-0223	NCI NIH HHS [R01 CA82491, P30 CA21765] Funding Source: Medline; NCRR NIH HHS [RR014675] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA082491, P30CA021765] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR014675] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Andreu EJ, 2005, CANCER RES, V65, P3264, DOI 10.1158/0008-5472.CAN-04-1357; Blain SW, 2003, CANCER CELL, V3, P111, DOI 10.1016/S1535-6108(03)00026-6; Blain SW, 1997, J BIOL CHEM, V272, P25863, DOI 10.1074/jbc.272.41.25863; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Ciarallo S, 2002, MOL CELL BIOL, V22, P2993, DOI 10.1128/MCB.22.9.2993-3002.2002; Coutts M, 2000, ONCOGENE, V19, P801, DOI 10.1038/sj.onc.1203398; DanhauserRiedl S, 1996, CANCER RES, V56, P3589; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Dong F, 1998, MOL BIOL CELL, V9, P2081, DOI 10.1091/mbc.9.8.2081; Gesbert F, 2000, J BIOL CHEM, V275, P39223, DOI 10.1074/jbc.M007291200; HALL M, 1995, ONCOGENE, V11, P1581; Hallek M, 1997, EXP HEMATOL, V25, P1367; Hengst L, 1998, GENE DEV, V12, P3882, DOI 10.1101/gad.12.24.3882; Hengst L, 1998, CURR TOP MICROBIOL, V227, P25; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Huettner CS, 2000, NAT GENET, V24, P57, DOI 10.1038/71691; Jonuleit T, 2000, BLOOD, V96, P1933, DOI 10.1182/blood.V96.5.1933.h8001933_1933_1939; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kardinal C, 2006, BLOOD, V107, P1133, DOI 10.1182/blood-2005-05-1771; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; Kotoshiba S, 2005, J BIOL CHEM, V280, P17694, DOI 10.1074/jbc.M500866200; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lacy ER, 2004, NAT STRUCT MOL BIOL, V11, P358, DOI 10.1038/nsmb746; Moeller SJ, 2003, MOL CELL BIOL, V23, P3735, DOI 10.1128/MCB.23.11.3735-3752.2003; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Radeva G, 1997, J BIOL CHEM, V272, P13937, DOI 10.1074/jbc.272.21.13937; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Sabile A, 2006, MOL CELL BIOL, V26, P5994, DOI 10.1128/MCB.01630-05; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sivakolundu SG, 2005, J MOL BIOL, V353, P1118, DOI 10.1016/j.jmb.2005.08.074; Soos TJ, 1996, CELL GROWTH DIFFER, V7, P135; Sugiyama Y, 2001, J BIOL CHEM, V276, P12084, DOI 10.1074/jbc.M010811200; Wang YF, 2005, CHEMBIOCHEM, V6, P2242, DOI 10.1002/cbic.200500260; Waugh DS, 1996, J BIOMOL NMR, V8, P184; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753	42	266	276	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2007	128	2					269	280		10.1016/j.cell.2006.11.047	http://dx.doi.org/10.1016/j.cell.2006.11.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254966	Bronze			2022-12-01	WOS:000244420500013
J	Kesselheim, AS; Avorn, J				Kesselheim, Aaron S.; Avorn, Jerry			The role of litigation in defining drug risks	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kesselheim, AS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666	PHS HHS [6T32HP1101] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Avorn J., 2005, POWERFUL MED BENEFIT; BACIU A, 2006, FUTURE DRUG SAFETY P; BERENSON A, 2003, NY TIMES        0921, pA1; Berenson Alex, 2006, N Y Times Web, pC2; BRENT RL, 1995, REPROD TOXICOL, V9, P337, DOI 10.1016/0890-6238(95)00020-B; Curfman GD, 2005, NEW ENGL J MED, V353, P2813, DOI 10.1056/NEJMe058314; DeAngelis CD, 2006, JAMA-J AM MED ASSOC, V296, P996, DOI 10.1001/jama.296.8.jed60051; Food and Drug Administration HHS, 2006, Fed Regist, V71, P3921; FR (Federal Register), 1985, FED REGISTER, V50, P7452; HARRIS G, 2005, NY TIMES        0827, pA1; JOHANNES L, 1997, WALL ST J       1211, pA1; JOHANNES L, 1999, WALL ST J       0928, pA1; KAY J, 2003, MIAMI DAILY BUS 0226; Koller EA, 2002, PHARMACOTHERAPY, V22, P841, DOI 10.1592/phco.22.11.841.33629; Struve Catherine T, 2005, Yale J Health Policy Law Ethics, V5, P587; U.S. Food and Drug Administration, 2004, FDA PUBL HLTH ADV WO; Watkins PB, 1998, NEW ENGL J MED, V338, P916, DOI 10.1056/NEJM199803263381314; 2004, PUBLIC CITIZEN WORST	18	49	50	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2007	297	3					308	311		10.1001/jama.297.3.308	http://dx.doi.org/10.1001/jama.297.3.308			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	125VT	17227983				2022-12-01	WOS:000243472300027
J	Samokhvalov, IM; Samokhvalova, NI; Nishikawa, S				Samokhvalov, Igor M.; Samokhvalova, Natalia I.; Nishikawa, Shin-ichi			Cell tracing shows the contribution of the yolk sac to adult haematopoiesis	NATURE			English	Article							STEM-CELLS; DEFINITIVE HEMATOPOIESIS; INTERFERON-GAMMA; REPORTER STRAIN; MOUSE EMBRYO; EXPRESSION; MICE; RECONSTITUTION; RECOMBINATION; CIRCULATION	The first haematopoietic stem cells (HSCs) appear in the aorta-gonad-mesonephros ( AGM) region, major vitelline and umbilical vessels, and placenta; however, whether they arise locally or from immigrant yolk sac precursor cells remains unclear. This issue is best addressed by measuring cell-lineage relationships rather than cell potentials. To undertake long-term in vivo tracing of yolk sac cells, we designed a non-invasive pulse-labelling system based on Cre/loxP recombination. Here we show that in Runx1(+/-) (runt-related transcription factor 1) heterozygous mice, yolk sac cells expressing Runx1 at embryonic day 7.5 develop into fetal lymphoid progenitors and adult HSCs. During mid-gestation the labelled ( embryonic day 7.5) yolk sac cells colonize the umbilical cord, the AGM region and subsequently the embryonic liver. This raises the possibility that some HSCs associated with major embryonic vasculature are derived from yolk sac precursors. We observed virtually no contribution of the labelled cells towards the yolk sac vasculature, indicating early segregation of endothelial and haematopoietic lineages.	RIKEN Kobe, Ctr Dev Biol, Lab Stem Cell Biol, Kobe, Hyogo 6500047, Japan	RIKEN	Samokhvalov, IM (corresponding author), RIKEN Kobe, Ctr Dev Biol, Lab Stem Cell Biol, Kobe, Hyogo 6500047, Japan.	igors@cdb.riken.jp						BROTHERTON TW, 1979, P NATL ACAD SCI USA, V76, P2853, DOI 10.1073/pnas.76.6.2853; Cai ZL, 2000, IMMUNITY, V13, P423, DOI 10.1016/S1074-7613(00)00042-X; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; Cumano A, 2001, IMMUNITY, V15, P477, DOI 10.1016/S1074-7613(01)00190-X; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Gekas C, 2005, DEV CELL, V8, P365, DOI 10.1016/j.devcel.2004.12.016; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Igarashi H, 2001, P NATL ACAD SCI USA, V98, P15131, DOI 10.1073/pnas.011513098; Kellendonk C, 1999, J MOL BIOL, V285, P175, DOI 10.1006/jmbi.1998.2307; Kisanga ER, 2003, J STEROID BIOCHEM, V84, P361, DOI 10.1016/S0960-0760(03)00051-7; LIEN EA, 1991, CANCER RES, V51, P4837; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MINOT CS, 1912, MANUAL HUMAN EMBRYOL, P498; MullerSieburg CE, 1996, J EXP MED, V183, P1141, DOI 10.1084/jem.183.3.1141; Nishikawa S, 1998, IMMUNITY, V8, P761, DOI 10.1016/S1074-7613(00)80581-6; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Palis J, 1999, DEVELOPMENT, V126, P5073; Samokhvalov IM, 2006, GENESIS, V44, P115, DOI 10.1002/gene.20190; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STEINER R, 1973, J CELL PHYSIOL, V81, P323, DOI 10.1002/jcp.1040810305; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Weissman I, 1978, FETAL HEMATOPOIETIC; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6; Young HA, 1997, BLOOD, V89, P583, DOI 10.1182/blood.V89.2.583; Yu JM, 1999, EXP HEMATOL, V27, P895, DOI 10.1016/S0301-472X(99)00009-0; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543	30	329	345	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2007	446	7139					1056	1061		10.1038/nature05725	http://dx.doi.org/10.1038/nature05725			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17377529				2022-12-01	WOS:000245950400044
J	Pappu, R; Schwab, SR; Cornelissen, I; Pereira, JP; Regard, JB; Xu, Y; Camerer, E; Zheng, YW; Huang, Y; Cyster, JG; Coughlin, SR				Pappu, Rajita; Schwab, Susan R.; Cornelissen, Ivo; Pereira, Joao P.; Regard, Jean B.; Xu, Ying; Camerer, Eric; Zheng, Yao-Wu; Huang, Yong; Cyster, Jason G.; Coughlin, Shaun R.			Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate	SCIENCE			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTOR; T-CELLS; MIGRATION; METABOLISM; FTY720; SYSTEM; THYMUS; ORGANS; S1P(1); MICE	Lymphocytes require sphingosine-1-phosphate (S1P) receptor-1 to exit lymphoid organs, but the source(s) of extracellular S1P and whether S1P directly promotes egress are unknown. By using mice in which the two kinases that generate S1P were conditionally ablated, we find that plasma S1P is mainly hematopoietic in origin, with erythrocytes a major contributor, whereas lymph S1P is from a distinct radiation-resistant source. Lymphocyte egress from thymus and secondary lymphoid organs was markedly reduced in kinase-deficient mice. Restoration of S1P to plasma rescued egress to blood but not lymph, and the rescue required lymphocyte expression of S1P-receptor-1. Thus, separate sources provide S1P to plasma and lymph to help lymphocytes exit the low-S1P environment of lymphoid organs. Disruption of compartmentalized S1P signaling is a plausible mechanism by which S1P-receptor-1 agonists function as immunosuppressives.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94143 USA; Univ Calif San Francisco, Drug Studies Unit, Dept Biopharmaceut Sci, San Francisco, CA 94080 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Coughlin, SR (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 513 Parnassus Ave, San Francisco, CA 94143 USA.	Jason.Cyster@ucsf.edu; Shaun.Coughlin@ucsf.edu	Camerer, Eric/K-4161-2017	Schwab, Susan/0000-0002-0834-0822; Camerer, Eric/0000-0002-6271-7125; Pereira, Joao/0000-0002-5694-4938	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065590] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Allende ML, 2002, BBA-MOL CELL BIOL L, V1582, P222, DOI 10.1016/S1388-1981(02)00175-0; Aoki S, 2005, J BIOCHEM, V138, P47, DOI 10.1093/jb/mvi100; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Foss FW, 2007, BIOORGAN MED CHEM, V15, P663, DOI 10.1016/j.bmc.2006.10.060; Hla T, 2003, PHARMACOL RES, V47, P401, DOI 10.1016/S1043-6618(03)00046-X; Kato S, 1997, MICROSC RES TECHNIQ, V38, P287, DOI 10.1002/(SICI)1097-0029(19970801)38:3<287::AID-JEMT9>3.0.CO;2-J; KOTANI M, 1967, Okajimas Folia Anatomica Japonica, V43, P61; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Leuker CE, 2001, J EXP MED, V193, P755, DOI 10.1084/jem.193.6.755; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; SHIVDASANI RA, 1995, CELL, V81, P695, DOI 10.1016/0092-8674(95)90531-6; SLOOP CH, 1987, J LIPID RES, V28, P225; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; USHIKI T, 1986, CELL TISSUE RES, V244, P285; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Yang LB, 1999, BRIT J HAEMATOL, V107, P282, DOI 10.1046/j.1365-2141.1999.01697.x; Yatomi Y, 1997, J BIOL CHEM, V272, P5291, DOI 10.1074/jbc.272.8.5291; Yatomi Y, 2001, PROSTAG OTH LIPID M, V64, P107, DOI 10.1016/S0090-6980(01)00103-4; Zemann B, 2006, BLOOD, V107, P1454, DOI 10.1182/blood-2005-07-2628	26	685	708	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					295	298		10.1126/science.1139221	http://dx.doi.org/10.1126/science.1139221			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17363629				2022-12-01	WOS:000245654500056
J	Alonso, MC; Drummond, DR; Kain, S; Hoeng, J; Amos, L; Cross, RA				Alonso, Maria C.; Drummond, Douglas R.; Kain, Susan; Hoeng, Julia; Amos, Linda; Cross, Robert A.			An ATP gate controls tubulin binding by the tethered head of kinesin-1	SCIENCE			English	Article							HAND-OVER-HAND; NECK-LINKER; DIMERIC KINESIN; CATALYTIC CORE; MECHANISM; STEPS; HYDROLYSIS; MICROTUBULES; MOLECULES; MOTILITY	Kinesin-1 is a two-headed molecular motor that walks along microtubules, with each step gated by adenosine triphosphate (ATP) binding. Existing models for the gating mechanism propose a role for the microtubule lattice. We show that unpolymerized tubulin binds to kinesin-1, causing tubulin-activated release of adenosine diphosphate (ADP). With no added nucleotide, each kinesin-1 dimer binds one tubulin heterodimer. In adenylyl-imidodiphosphate (AMP-PNP), a nonhydrolyzable ATP analog, each kinesin-1 dimer binds two tubulin heterodimers. The data reveal an ATP gate that operates independently of the microtubule lattice, by ATP-dependent release of a steric or allosteric block on the tubulin binding site of the tethered kinesin-ADP head.	Marie Curie Res Inst, Mol Motors Grp, Surrey RH8 0TL, England; MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Cross, RA (corresponding author), Marie Curie Res Inst, Mol Motors Grp, Surrey RH8 0TL, England.	r.cross@mcri.ac.uk	Cross, Robert A/F-1798-2011	Cross, Robert A/0000-0002-0004-7832; Drummond, Douglas/0000-0003-4155-3747; Amos, Linda/0000-0001-8305-5346	Medical Research Council [MC_U105184313, G0200542(63814), G0200542, U.1051.04.002(78842)] Funding Source: Medline; MRC [G0200542, MC_U105184313] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Asenjo AB, 2006, NAT STRUCT MOL BIOL, V13, P648, DOI 10.1038/nsmb1109; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Carter NJ, 2006, CURR OPIN CELL BIOL, V18, P61, DOI 10.1016/j.ceb.2005.12.009; Case RB, 2000, CURR BIOL, V10, P157, DOI 10.1016/S0960-9822(00)00316-X; Crevel I, 1999, EMBO J, V18, P5863, DOI 10.1093/emboj/18.21.5863; Cross RA, 2000, PHILOS T ROY SOC B, V355, P459, DOI 10.1098/rstb.2000.0587; Cross RA, 2004, TRENDS BIOCHEM SCI, V29, P301, DOI 10.1016/j.tibs.2004.04.010; Gilbert SP, 1998, BIOCHEMISTRY-US, V37, P792, DOI 10.1021/bi971117b; Guydosh NR, 2006, P NATL ACAD SCI USA, V103, P8054, DOI 10.1073/pnas.0600931103; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Hackney DD, 2002, BIOCHEMISTRY-US, V41, P4437, DOI 10.1021/bi0159229; Hahlen K, 2006, J BIOL CHEM, V281, P18868, DOI 10.1074/jbc.M508019200; Hirose K, 1999, MOL BIOL CELL, V10, P2063, DOI 10.1091/mbc.10.6.2063; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; Kaseda K, 2003, NAT CELL BIOL, V5, P1079, DOI 10.1038/ncb1067; Ma YZ, 1997, J BIOL CHEM, V272, P724, DOI 10.1074/jbc.272.2.724; Mather WH, 2006, BIOPHYS J, V91, P2416, DOI 10.1529/biophysj.106.087049; Nishiyama M, 2002, NAT CELL BIOL, V4, P790, DOI 10.1038/ncb857; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rice S, 2003, BIOPHYS J, V84, P1844, DOI 10.1016/S0006-3495(03)74992-3; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; Rosenfeld SS, 2001, J BIOL CHEM, V276, P40167, DOI 10.1074/jbc.M103899200; Sugata K, 2004, BIOCHEM BIOPH RES CO, V314, P447, DOI 10.1016/j.bbrc.2003.12.093; TORNISHIGE M, 2000, J CELL BIOL, V151, P1081; VILDIZ A, 2005, TRENDS CELL BIOL, V15, P112; Walczak CE, 2006, NAT CELL BIOL, V8, P903, DOI 10.1038/ncb0906-903; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753	29	90	93	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2007	316	5821					120	123		10.1126/science.1136985	http://dx.doi.org/10.1126/science.1136985			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412962	Green Accepted			2022-12-01	WOS:000245470500046
J	Chen, NJ; Mirtsos, C; Suh, D; Lu, YC; Lin, WJ; McKerlie, C; Lee, T; Baribault, H; Tian, H; Yeh, WC				Chen, Nien-Jung; Mirtsos, Christine; Suh, Daniel; Lu, Yong-Chen; Lin, Wen-Jye; McKerlie, Colin; Lee, Taeweon; Baribault, Helene; Tian, Hui; Yeh, Wen-Chen			C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a	NATURE			English	Article							CHEMOATTRACTANT RECEPTOR; COMPLEMENT; COMPONENT; NEUTROPHILS; ACTIVATION; PROTEIN; CLONING; REVEAL	Complement-derived anaphylatoxins regulate immune and inflammatory responses through G-protein-coupled receptor ( GPCR)mediated signalling(1-4). C5L2 ( also known as GPR77) is a relatively new GPCR thought to be a non-signalling receptor binding to C5a, on the basis of sequence information and experimental evidence(5-7). Here we show, using gene targeting, that C5L2 is required to facilitate C5a signalling in neutrophils, macrophages and fibroblasts in vitro. Deficiency of C5L2 results in reduced inflammatory cell infiltration, suggesting that C5L2 is critical for optimal C5a-mediated cell infiltration in certain in vivo settings. C5L2 is also involved in optimizing C3a-induced signals. Furthermore, like mice incapable of C3a/complement 3a receptor (C3aR) signalling(4,8,9), C5L2-deficient mice are hypersensitive to lipopolysaccharide (LPS)-induced septic shock, show reduced ovalbumin (OVA)-induced airway hyperresponsiveness and inflammation, and are mildly delayed in haematopoietic cell regeneration after gamma-irradiation. Our data indicate that C5L2 can function as a positive modulator for both C5a- and C3a-anaphylatoxin-induced responses.	Univ Toronto, Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Amgen San Francisco, San Francisco, CA 94080 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Amgen	Yeh, WC (corresponding author), Univ Toronto, Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada.	weny@amgen.com	Lin, Wen-Jye/D-1028-2016; Mohammed, Imran/J-8271-2012; Lu, Yong-Chen/G-4520-2014	Mohammed, Imran/0000-0002-8412-0768; Lu, Yong-Chen/0000-0002-0275-9825; McKerlie, Colin/0000-0002-2232-0967				BOKISCH VA, 1969, J EXP MED, V129, P1109, DOI 10.1084/jem.129.5.1109; Cain SA, 2002, J BIOL CHEM, V277, P7165, DOI 10.1074/jbc.C100714200; Duncan GS, 1999, J IMMUNOL, V162, P3022; Gao HW, 2005, FASEB J, V19, P1003, DOI 10.1096/fj.04-3424fje; Gavrilyuk V, 2005, J NEUROCHEM, V92, P1140, DOI 10.1111/j.1471-4159.2004.02942.x; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; Guo RF, 2004, SHOCK, V21, P1, DOI 10.1097/01.shk.0000105502.75189.5e; Hawlisch H, 2005, IMMUNITY, V22, P415, DOI 10.1016/j.immuni.2005.02.006; Hopken UE, 1996, NATURE, V383, P86, DOI 10.1038/383086a0; Hsu MH, 1997, IMMUNOGENETICS, V47, P64, DOI 10.1007/s002510050327; Humbles AA, 2000, NATURE, V406, P998, DOI 10.1038/35023175; Kalant D, 2005, J BIOL CHEM, V280, P23936, DOI 10.1074/jbc.M406921200; Kalant D, 2003, J BIOL CHEM, V278, P11123, DOI 10.1074/jbc.M206169200; Kildsgaard J, 2000, J IMMUNOL, V165, P5406, DOI 10.4049/jimmunol.165.10.5406; Ohno M, 2000, MOL IMMUNOL, V37, P407, DOI 10.1016/S0161-5890(00)00067-5; Okinaga S, 2003, BIOCHEMISTRY-US, V42, P9406, DOI 10.1021/bi034489v; Perianayagam MC, 2002, KIDNEY INT, V61, P456, DOI 10.1046/j.1523-1755.2002.00139.x; PERRET JJ, 1992, BIOCHEM J, V288, P911, DOI 10.1042/bj2880911; Ratajczak MZ, 2004, LEUKEMIA, V18, P1482, DOI 10.1038/sj.leu.2403446; Riedemann NC, 2003, FASEB J, V17, P370, DOI 10.1096/fj.03-0708fje; Riedemann NC, 2003, IMMUNITY, V19, P193, DOI 10.1016/S1074-7613(03)00206-1; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; SHIN HS, 1968, SCIENCE, V162, P361, DOI 10.1126/science.162.3851.361; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354	24	184	196	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2007	446	7132					203	207		10.1038/nature05559	http://dx.doi.org/10.1038/nature05559			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17322907				2022-12-01	WOS:000244718100044
J	Dalley, JW; Fryer, TD; Brichard, L; Robinson, ESJ; Theobald, DEH; Laane, K; Pena, Y; Murphy, ER; Shah, Y; Probst, K; Abakumova, I; Aigbirhio, FI; Richards, HK; Hong, Y; Baron, JC; Everitt, BJ; Robbins, TW				Dalley, Jeffrey W.; Fryer, Tim D.; Brichard, Laurent; Robinson, Emma S. J.; Theobald, David E. H.; Laeaene, Kristjan; Pena, Yolanda; Murphy, Emily R.; Shah, Yasmene; Probst, Katrin; Abakumova, Irina; Aigbirhio, Franklin I.; Richards, Hugh K.; Hong, Young; Baron, Jean-Claude; Everitt, Barry J.; Robbins, Trevor W.			Nucleus Accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement	SCIENCE			English	Article							SUBSTANCE USE; DRUG-ADDICTION; DOPAMINE; RATS; AVAILABILITY; PERSONALITY; STRIATUM; REINSTATEMENT; VULNERABILITY; ASSOCIATION	Stimulant addiction is often linked to excessive risk taking, sensation seeking, and impulsivity, but in ways that are poorly understood. We report here that a form of impulsivity in rats predicts high rates of intravenous cocaine self-administration and is associated with changes in dopamine (DA) function before drug exposure. Using positron emission tomography, we demonstrated that D2/3 receptor availability is significantly reduced in the nucleus accumbens of impulsive rats that were never exposed to cocaine and that such effects are independent of DA release. These data demonstrate that trait impulsivity predicts cocaine reinforcement and that D2 receptor dysfunction in abstinent cocaine addicts may, in part, be determined by premorbid influences.	Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England; Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Wolfson Brain Imaging Ctr, Cambridge CB2 2QQ, England; Univ Nottingham, Sch Phys & Astron, Sir Peter Mansfield Magnet Resonance Ctr, Nottingham NG7 2RD, England; Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Neurosurg Unit, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Neurol Unit, Cambridge CB2 2QQ, England	University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Nottingham; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Dalley, JW (corresponding author), Univ Cambridge, Behav & Clin Neurosci Inst, Downing St, Cambridge CB2 3EB, England.	jwd20@cam.ac.uk	Robinson, Emma/A-4572-2010; Robbins, Trevor W/A-7551-2008	Robinson, Emma/0000-0002-1299-6541; Robbins, Trevor/0000-0003-0642-5977; Murphy, Emily/0000-0002-8162-5306; baron, jean-claude/0000-0002-5264-2588; Everitt, Barry/0000-0003-4431-6536; Dalley, Jeffrey/0000-0002-2282-3660	MRC [G0600196, G0600986, G0001237, G9439390, G0401068] Funding Source: UKRI; Medical Research Council [G0001354B] Funding Source: researchfish; Medical Research Council [G0001237, G0600986, G0401068, G9439390, G0600196, G0001354] Funding Source: Medline; Wellcome Trust [076244] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Adams JB, 2003, AM J DRUG ALCOHOL AB, V29, P691, DOI 10.1081/ADA-120023465; BOLIA KI, 1999, J NEUROPSYCHIATRY CL, V11, P361; Caine SB, 2002, J NEUROSCI, V22, P2977, DOI 10.1523/JNEUROSCI.22-07-02977.2002; CAINE SB, 1994, J EXP ANAL BEHAV, V61, P213, DOI 10.1901/jeab.1994.61-213; Chakroun N, 2004, ENCEPHALE, V30, P564; Comings DE, 2000, PROG BRAIN RES, V126, P325; Dalley JW, 2005, PSYCHOPHARMACOLOGY, V182, P579, DOI 10.1007/s00213-005-0107-3; Dalley JW, 2005, NEUROPSYCHOPHARMACOL, V30, P525, DOI 10.1038/sj.npp.1300590; Dawe S, 2004, NEUROSCI BIOBEHAV R, V28, P343, DOI 10.1016/j.neubiorev.2004.03.007; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Gosnell BA, 2000, PSYCHOPHARMACOLOGY, V149, P286, DOI 10.1007/s002130000375; Gunn RN, 1997, NEUROIMAGE, V6, P279, DOI 10.1006/nimg.1997.0303; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; HOOKS MS, 1994, J NEUROSCI, V14, P6144; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Larson EB, 2005, PHARMACOL BIOCHEM BE, V82, P590, DOI 10.1016/j.pbb.2005.10.015; Laruelle M, 1997, NEUROPSYCHOPHARMACOL, V17, P162, DOI 10.1016/S0893-133X(97)00043-2; Lyvers M, 2000, EXP CLIN PSYCHOPHARM, V8, P225, DOI 10.1037/1064-1297.8.2.225; Mach RH, 1997, PHARMACOL BIOCHEM BE, V57, P477, DOI 10.1016/S0091-3057(96)00449-2; Mantsch JR, 2001, PSYCHOPHARMACOLOGY, V157, P31, DOI 10.1007/s002130100744; Martinez D, 2004, NEUROPSYCHOPHARMACOL, V29, P1190, DOI 10.1038/sj.npp.1300420; Morgan AD, 2005, PSYCHOPHARMACOLOGY, V178, P41, DOI 10.1007/s00213-004-1979-3; Morgan D, 2002, NAT NEUROSCI, V5, P169, DOI 10.1038/nn798; Mukherjee J, 1999, NUCL MED BIOL, V26, P519, DOI 10.1016/S0969-8051(99)00012-8; Nader MA, 2002, NEUROPSYCHOPHARMACOL, V27, P35, DOI 10.1016/S0893-133X(01)00427-4; Nader MA, 2006, NAT NEUROSCI, V9, P1050, DOI 10.1038/nn1737; Najafabadi MS, 2005, AM J MED GENET B, V134B, P39, DOI 10.1002/ajmg.b.30117; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Paine TA, 2003, BEHAV BRAIN RES, V147, P135, DOI 10.1016/S0166-4328(03)00156-6; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perry JL, 2005, PSYCHOPHARMACOLOGY, V178, P193, DOI 10.1007/s00213-004-1994-4; Persico AM, 1996, BIOL PSYCHIAT, V40, P776, DOI 10.1016/0006-3223(95)00483-1; PETTIT HO, 1984, PSYCHOPHARMACOLOGY, V84, P167, DOI 10.1007/BF00427441; PIAZZA PV, 1989, SCIENCE, V245, P1511, DOI 10.1126/science.2781295; PIAZZA PV, 1991, BRAIN RES, V567, P169, DOI 10.1016/0006-8993(91)91452-7; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; ROBERTS DCS, 1977, PHARMACOL BIOCHEM BE, V6, P615, DOI 10.1016/0091-3057(77)90084-3; Sher KJ, 2000, J CONSULT CLIN PSYCH, V68, P818, DOI 10.1037/0022-006X.68.5.818; Toissaar M, 2006, NEUROSCI LETT, V403, P119, DOI 10.1016/j.neulet.2006.04.023; Uhl GR, 2004, ANN NY ACAD SCI, V1025, P1, DOI 10.1196/annals.1316.001; van der Kam EL, 2005, NEUROPHARMACOLOGY, V48, P685, DOI 10.1016/j.neuropharm.2004.12.014; Vanderschuren LJMJ, 2005, J NEUROSCI, V25, P8665, DOI 10.1523/JNEUROSCI.0925-05.2005; VOLKOW ND, 1993, SYNAPSE, V14, P169, DOI 10.1002/syn.890140210; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	45	878	897	0	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816					1267	1270		10.1126/science.1137073	http://dx.doi.org/10.1126/science.1137073			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332411	Green Accepted			2022-12-01	WOS:000244564700047
J	Berkowitz, SA; Gerstenblith, G; Anderson, GF				Berkowitz, Scott A.; Gerstenblith, Gary; Anderson, Gerard F.			Medicare prescription drug coverage gap - Navigating the "doughnut hole" with patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Anderson, GF (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Hampton House 302, Baltimore, MD 21205 USA.	ganderso@jhsph.edu						Berlowitz DR, 1998, NEW ENGL J MED, V339, P1957, DOI 10.1056/NEJM199812313392701; Centers for Medicare and Medicaid Services, MED YOU; CUBANSKI J, 2006, HLTH AFF MILLWO 1121, pW1; *DEST RX, PART D OPT; *KAIS FAM FDN, 2006, PRESCR DRUG COV MED; *KAIS FAM FDN, 2006, KAIS DAIL HLTH POL R; Mitka M, 2006, JAMA-J AM MED ASSOC, V296, P1720; *PRICEWATERHOUSECO, 2006, SIGN COV GAP MED PAR; SIMON S, 2006, NATL PUBLIC RAD 1007; Tseng CW, 2004, JAMA-J AM MED ASSOC, V292, P952, DOI 10.1001/jama.292.8.952; *US DEP HHS, 2006, MEDICARE        1013; *US FDA, 2005, INF IMP DRUGS; *US FDA, OR BOOK	13	9	9	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2007	297	8					868	870		10.1001/jama.297.8.868	http://dx.doi.org/10.1001/jama.297.8.868			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	140DS	17327528				2022-12-01	WOS:000244485000029
J	Stranger, BE; Forrest, MS; Dunning, M; Ingle, CE; Beazley, C; Thorne, N; Redon, R; Bird, CP; de Grassi, A; Lee, C; Tyler-Smith, C; Carter, N; Scherer, SW; Tavare, S; Deloukas, P; Hurles, ME; Dermitzakis, ET				Stranger, Barbara E.; Forrest, Matthew S.; Dunning, Mark; Ingle, Catherine E.; Beazley, Claude; Thorne, Natalie; Redon, Richard; Bird, Christine P.; de Grassi, Anna; Lee, Charles; Tyler-Smith, Chris; Carter, Nigel; Scherer, Stephen W.; Tavare, Simon; Deloukas, Panagiotis; Hurles, Matthew E.; Dermitzakis, Emmanouil T.			Relative impact of nucleotide and copy number variation on gene expression phenotypes	SCIENCE			English	Article							HUMAN GENOME; LINKAGE DISEQUILIBRIUM; DELETION; POLYMORPHISMS; LANDSCAPE; DISEASE; LOCUS; YEAST	Extensive studies are currently being performed to associate disease susceptibility with one form of genetic variation, namely, single-nucleotide polymorphisms (SNPs). In recent years, another type of common genetic variation has been characterized, namely, structural variation, including copy number variants (CNVs). To determine the overall contribution of CNVs to complex phenotypes, we have performed association analyses of expression levels of 14,925 transcripts with SNPs and CNVs in individuals who are part of the International HapMap project. SNPs and CNVs captured 83.6% and 17.7% of the total detected genetic variation in gene expression, respectively, but the signals from the two types of variation had little overlap. Interrogation of the genome for both types of variants may be an effective way to elucidate the causes of complex phenotypes and disease in humans.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Cambridge, Dept Oncol, Canc Res UK, Cambridge Res Inst,Li Ka Shing Ctr, Cambridge CB2 0RE, England; CNR, Ist Tecnol Biomed, Sez Bari, I-70126 Bari, Italy; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1L7, Canada; Hosp Sick Children, Program Genet & Genom Biol, MaRS Ctr, Toronto, ON M5G 1L7, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Univ So Calif, Program Mol & Computat Biol, Los Angeles, CA 90089 USA	Wellcome Trust Sanger Institute; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Southern California	Hurles, ME (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	meh@sanger.ac.uk; md4@sanger.ac.uk	Dermitzakis, Emmanouil/B-7687-2013; Redon, Richard/F-3303-2014; Deloukas, Panos/B-2922-2013; De Grassi, Anna/AAE-6036-2020; Scherer, Stephen/B-3785-2013	Redon, Richard/0000-0001-7751-2280; Deloukas, Panos/0000-0001-9251-070X; De Grassi, Anna/0000-0001-7273-4263; Scherer, Stephen/0000-0002-8326-1999; Dunning, Mark/0000-0002-8853-9435; Forrest, Matthew/0000-0002-2141-0303; Fosker, Christine/0000-0002-3799-9474; Stranger, Barbara/0000-0001-9021-7331	Wellcome Trust [077014, 065535, 077009, 077046, 076113] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Dermitzakis ET, 2006, MAMM GENOME, V17, P503, DOI 10.1007/s00335-006-0005-y; Doerge RW, 1996, GENETICS, V142, P285; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Feuk L, 2006, HUM MOL GENET, V15, pR57, DOI 10.1093/hmg/ddl057; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Lee JA, 2006, ANN NEUROL, V59, P398, DOI 10.1002/ana.20732; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Merla G, 2006, AM J HUM GENET, V79, P332, DOI 10.1086/506371; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Oleksiak MF, 2005, NAT GENET, V37, P67, DOI 10.1038/ng1483; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Somerville MJ, 2005, NEW ENGL J MED, V353, P1694, DOI 10.1056/NEJMoa051962; Stankiewicz P, 2006, GENOMIC DISORDERS: THE GENOMIC BASIS OF DISEASE, P357, DOI 10.1007/978-1-59745-039-3_25; Storey JD, 2005, PLOS BIOL, V3, P1380, DOI 10.1371/journal.pbio.0030267; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562	28	1294	1372	0	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2007	315	5813					848	853		10.1126/science.1136678	http://dx.doi.org/10.1126/science.1136678			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289997	Green Accepted			2022-12-01	WOS:000244069000070
J	Strickfaden, SC; Winters, MJ; Ben-Ari, G; Lamson, RE; Tyers, M; Pryciak, PM				Strickfaden, Shelly C.; Winters, Matthew J.; Ben-Ari, Giora; Lamson, Rachel E.; Tyers, Mike; Pryciak, Peter M.			A mechanism for cell-cycle regulation of MAP kinase signaling in a yeast differentiation pathway	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; MATING FACTOR; PHEROMONE RESPONSE; BUDDING YEAST; G-BETA; PROTEIN-KINASES; MEKK STE11; G1 CYCLIN; IN-VIVO; PHOSPHORYLATION	Yeast cells arrest in the G1 phase of the cell cycle upon exposure to mating pheromones. As cells commit to a new cycle, G1 CDK activity (Cln/CDK) inhibits signaling through the mating MAPK cascade. Here we show that the target of this inhibition is Ste5, the MAPK cascade scaffold protein. Cln/CDK disrupts Ste5 membrane localization by phosphorylating a cluster of sites that flank a small, basic, membrane-binding motif in Ste5. Effective inhibition of Ste5 signaling requires multiple phosphorylation sites and a substantial accumulation of negative charge, which suggests that Ste5 acts as a sensor for high G1 CDK activity. Thus, Ste5 is an integration point for both external and internal signals. When Ste5 cannot be phosphorylated, pheromone triggers an aberrant arrest of cells outside G1 either in the presence or absence of the CDK-inhibitor protein Far1. These findings define a mechanism and physiological benefit of restricting antiproliferative signaling to G1.	Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01605 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada	University of Massachusetts System; University of Massachusetts Worcester; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Pryciak, PM (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01605 USA.	peter.pryciak@umassmed.edu	Pryciak, Peter/P-7205-2019; Tyers, Michael/ABE-3194-2021	Pryciak, Peter/0000-0001-9142-1369; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057769] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM57769, R01 GM057769] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Breitkreutz A, 2001, CURR BIOL, V11, P1266, DOI 10.1016/S0960-9822(01)00370-0; CHANG F, 1990, CELL, V63, P999, DOI 10.1016/0092-8674(90)90503-7; CHANG F, 1992, MOL BIOL CELL, V3, P445, DOI 10.1091/mbc.3.4.445; Cherkasova V, 1999, GENETICS, V151, P989; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; Feng YY, 1998, CURR BIOL, V8, P267, DOI 10.1016/S0960-9822(98)70108-3; Flotho A, 2004, J BIOL CHEM, V279, P47391, DOI 10.1074/jbc.M405681200; Gartner A, 1998, MOL CELL BIOL, V18, P3681, DOI 10.1128/MCB.18.7.3681; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; Harvey SL, 2005, CELL, V122, P407, DOI 10.1016/j.cell.2005.05.029; Henchoz S, 1997, GENE DEV, V11, P3046, DOI 10.1101/gad.11.22.3046; Jeoung DI, 1998, MOL CELL BIOL, V18, P433, DOI 10.1128/MCB.18.1.433; KRANZ JE, 1994, GENE DEV, V8, P313, DOI 10.1101/gad.8.3.313; Lamson RE, 2006, CURR BIOL, V16, P618, DOI 10.1016/j.cub.2006.02.060; Lamson RE, 2002, MOL CELL BIOL, V22, P2939, DOI 10.1128/MCB.22.9.2939-2951.2002; Leeuw T, 1998, NATURE, V391, P191, DOI 10.1038/34448; Mahanty SK, 1999, CELL, V98, P501, DOI 10.1016/S0092-8674(00)81978-9; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; MCKINNEY JD, 1993, GENE DEV, V7, P833, DOI 10.1101/gad.7.5.833; MCKINNEY JD, 1995, MOL CELL BIOL, V15, P2509; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Oehlen LJWM, 1998, MOL GEN GENET, V258, P183, DOI 10.1007/s004380050722; OEHLEN LJWM, 1994, GENE DEV, V8, P1058, DOI 10.1101/gad.8.9.1058; Oehlen LJWM, 1998, J BIOL CHEM, V273, P25089, DOI 10.1074/jbc.273.39.25089; PETER M, 1994, SCIENCE, V265, P1228, DOI 10.1126/science.8066461; Pryciak PM, 1998, GENE DEV, V12, P2684, DOI 10.1101/gad.12.17.2684; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Tyers M, 1996, P NATL ACAD SCI USA, V93, P7772, DOI 10.1073/pnas.93.15.7772; VALDIVIESO MH, 1993, MOL CELL BIOL, V13, P1013, DOI 10.1128/MCB.13.2.1013; van Drogen F, 2000, CURR BIOL, V10, P630, DOI 10.1016/S0960-9822(00)00511-X; van Drogen F, 2001, NAT CELL BIOL, V3, P1051, DOI 10.1038/ncb1201-1051; Vidwans SJ, 2001, NAT CELL BIOL, V3, pE35, DOI 10.1038/35050681; Wassmann K, 1997, J BIOL CHEM, V272, P13180, DOI 10.1074/jbc.272.20.13180; WHITEWAY M, 1990, MOL CELL BIOL, V10, P217, DOI 10.1128/MCB.10.1.217; Winters MJ, 2005, MOL CELL, V20, P21, DOI 10.1016/j.molcel.2005.08.020; Wu CL, 1998, J BIOL CHEM, V273, P28107, DOI 10.1074/jbc.273.43.28107	42	173	175	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2007	128	3					519	531		10.1016/j.cell.2006.12.032	http://dx.doi.org/10.1016/j.cell.2006.12.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289571	Green Accepted, Bronze			2022-12-01	WOS:000244842700018
J	Kreitzer, AC; Malenka, RC				Kreitzer, Anatol C.; Malenka, Robert C.			Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models	NATURE			English	Article							TERM SYNAPTIC DEPRESSION; DOPAMINE D2 RECEPTORS; BASAL GANGLIA; GENE-EXPRESSION; PLASTICITY; NEURONS; HYDROLYSIS; MICE; INTERNEURONS; INHIBITION	The striatum is a major forebrain nucleus that integrates cortical and thalamic afferents and forms the input nucleus of the basal ganglia(1,2). Striatal projection neurons target the substantia nigra pars reticulata ( direct pathway) or the lateral globus pallidus ( indirect pathway). Imbalances between neural activity in these two pathways have been proposed to underlie the profound motor deficits observed in Parkinson's disease and Huntington's disease(3,4). However, little is known about differences in cellular and synaptic properties in these circuits. Indeed, current hypotheses suggest that these cells express similar forms of synaptic plasticity(5,6). Here we show that excitatory synapses onto indirect-pathway medium spiny neurons (MSNs) exhibit higher release probability and larger N-methyl-D-aspartate receptor currents than direct-pathway synapses. Moreover, indirect-pathway MSNs selectively express endocannabinoid-mediated long-term depression (eCB-LTD), which requires dopamine D2 receptor activation. In models of Parkinson's disease, indirect-pathway eCB-LTD is absent but is rescued by a D2 receptor agonist or inhibitors of endocannabinoid degradation. Administration of these drugs together in vivo reduces parkinsonian motor deficits, suggesting that endocannabinoid-mediated depression of indirect-pathway synapses has a critical role in the control of movement. These findings have implications for understanding the normal functions of the basal ganglia, and also suggest approaches for the development of therapeutic drugs for the treatment of striatal-based brain disorders.	Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Stanford University	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.	malenka@stanford.edu						ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Betarbet R, 2002, BIOESSAYS, V24, P308, DOI 10.1002/bies.10067; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; CALABRESI P, 1992, J NEUROSCI, V12, P4224; Calabresi P, 1997, J NEUROSCI, V17, P4536; Compton DR, 1996, J PHARMACOL EXP THER, V277, P586; Di Marzo V, 2000, FASEB J, V14, P1432, DOI 10.1096/fj.14.10.1432; Dingledine R, 1999, PHARMACOL REV, V51, P7; Gerdeman GL, 2003, TRENDS NEUROSCI, V26, P184, DOI 10.1016/S0166-2236(03)00065-1; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Gubellini P, 2002, J NEUROSCI, V22, P6900; Jenner P, 2003, CURR OPIN NEUROL, V16, pS3, DOI 10.1097/00019052-200312001-00002; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Makara JK, 2005, NAT NEUROSCI, V8, P1139, DOI 10.1038/nn1521; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; Obeso JA, 2000, NEUROLOGY, V55, pS7; Saario SM, 2006, CHEM BIOL, V13, P811, DOI 10.1016/j.chembiol.2006.07.008; Schwarting RKW, 1996, PROG NEUROBIOL, V49, P215, DOI 10.1016/S0301-0082(96)00015-9; Tang KC, 2001, P NATL ACAD SCI USA, V98, P1255, DOI 10.1073/pnas.031374698; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; Wilson C.J., 1998, SYNAPTIC ORG BRAIN, P329; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	30	552	576	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2007	445	7128					643	647		10.1038/nature05506	http://dx.doi.org/10.1038/nature05506			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17287809				2022-12-01	WOS:000244039400043
J	Pan, F; Sun, L; Kardian, DB; Whartenby, KA; Pardoll, DM; Liu, JO				Pan, Fan; Sun, Luo; Kardian, David B.; Whartenby, Katharine A.; Pardoll, Drew M.; Liu, Jun O.			Feedback inhibition of calcineurin and Ras by a dual inhibitory protein Carabin	NATURE			English	Article							T-CELL-ACTIVATION; IDENTIFICATION; STIMULATION; LYMPHOCYTES; SELECTION; GTPASES; P21RAS; KINASE; FAMILY; CABIN1	Feedback regulation of adaptive immunity is a fundamental mechanism for controlling the overall output of different signal transduction pathways, including that mediated by the T-cell antigen receptor (TCR)(1). Calcineurin(2-4) and Ras(5-7) are known to have essential functions during T-cell activation. However, how the calcineurin signalling pathway is terminated in the process is still largely unknown. Although several endogenous inhibitors of calcineurin have been reported(8-13), none fulfils the criteria of a feedback inhibitor, as their expression is not responsive to TCR signalling. Here we identify an endogenous inhibitor of calcineurin, named Carabin, which also inhibits the Ras signalling pathway through its intrinsic Ras GTPase-activating protein (GAP) activity. Expression of Carabin is upregulated on TCR signalling in a manner that is sensitive to inhibitors of calcineurin, indicating that Carabin constitutes part of a negative regulatory loop for the intracellular TCR signalling pathway. Knockdown of Carabin by short interfering RNA led to a significant enhancement of interleukin-2 production by antigen-specific T cells in vitro and in vivo. Thus, Carabin is a negative feedback inhibitor of the calcineurin signalling pathway that also mediates crosstalk between calcineurin and Ras.	Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Immunol & Hematopoiesis Div, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Liu, JO (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	joliu@jhu.edu						Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; Anderson DH, 2005, METHOD ENZYMOL, V403, P552, DOI 10.1016/S0076-6879(05)03048-X; Cantrell DA, 2003, IMMUNOL REV, V192, P122, DOI 10.1034/j.1600-065X.2003.00028.x; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; Cui Y, 2003, NAT MED, V9, P952, DOI 10.1038/nm882; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; FEARON ER, 1992, P NATL ACAD SCI USA, V89, P7958, DOI 10.1073/pnas.89.17.7958; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Gorlach J, 2000, EMBO J, V19, P3618, DOI 10.1093/emboj/19.14.3618; Han AD, 2003, NATURE, V422, P730, DOI 10.1038/nature01555; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Lai MM, 1998, J BIOL CHEM, V273, P18325, DOI 10.1074/jbc.273.29.18325; LEEVERS SJ, 1992, EMBO J, V11, P569, DOI 10.1002/j.1460-2075.1992.tb05088.x; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu Jun O, 2005, Sci STKE, V2005, pre1; MANALAN AS, 1983, P NATL ACAD SCI-BIOL, V80, P4291, DOI 10.1073/pnas.80.14.4291; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Pan F, 2005, EMBO J, V24, P2104, DOI 10.1038/sj.emboj.7600685; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Ryeom S, 2003, NAT IMMUNOL, V4, P874, DOI 10.1038/ni966; SHAW KTY, 1995, P NATL ACAD SCI USA, V92, P11205, DOI 10.1073/pnas.92.24.11205; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; Sun L, 1998, IMMUNITY, V8, P703, DOI 10.1016/S1074-7613(00)80575-0; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; WOODROW M, 1993, J EXP MED, V178, P1517, DOI 10.1084/jem.178.5.1517; Youn HD, 1999, SCIENCE, V286, P790, DOI 10.1126/science.286.5440.790	27	44	49	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2007	445	7126					433	436		10.1038/nature05476	http://dx.doi.org/10.1038/nature05476			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	128WD	17230191				2022-12-01	WOS:000243689500041
J	Huang, YH; Grasis, JA; Miller, AT; Xu, R; Soonthornvacharin, S; Andreotti, AH; Tsoukas, CD; Cooke, MP; Sauer, K				Huang, Yina H.; Grasis, Juris A.; Miller, Andrew T.; Xu, Ruo; Soonthornvacharin, Stephen; Andreotti, Amy H.; Tsoukas, Constantine D.; Cooke, Michael P.; Sauer, Karsten			Positive regulation of ltk PH domain function by soluble IP4	SCIENCE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; T-LYMPHOCYTE DEVELOPMENT; INOSITOL 1,3,4,5-TETRAKISPHOSPHATE; GAP1 FAMILY; PROTEIN; KINASE; CELLS; ACTIVATION; SELECTION	Pleckstrin homology (PH) domain-mediated protein recruitment to cellular membranes is of paramount importance for signal transduction. The recruitment of many PH domains is controlled through production and turnover of their membrane ligand, phosphatidylinositol 3,4,5-trisphosphate (PIP3). We show that phosphorylation of the second messenger inositol 1,4,5-trisphosphate (IP3) into inositol 1,3,4,5-tetrakisphosphate (IP4) establishes another mode of PH domain regulation through a soluble ligand. At physiological concentrations, IP4 promoted PH domain binding to PIP3. In primary mouse CD4(+)CD8(+) thymocytes, this was required for full activation of the protein tyrosine kinase Itk after T cell receptor engagement. Our data suggest that IP4 establishes a feedback loop of phospholipase C-gamma 1 activation through Itk that is essential for T cell development.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; San Diego State Univ, Ctr Microbial Studies, San Diego, CA 92182 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Iowa State Univ Sci & Technol, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Scripps Research Institute; California State University System; San Diego State University; California State University System; San Diego State University; Novartis; Iowa State University	Sauer, K (corresponding author), Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ksauer@scripps.edu	Grasis, Juris A./K-2568-2012	Grasis, Juris A./0000-0002-3945-0135; Huang, Yina/0000-0002-0125-9351	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048848] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR048848] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		August A, 1997, P NATL ACAD SCI USA, V94, P11227, DOI 10.1073/pnas.94.21.11227; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Ching KA, 1999, J IMMUNOL, V163, P6006; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; CULLEN PJ, 1995, NATURE, V376, P527, DOI 10.1038/376527a0; Fukuda M, 1996, J BIOL CHEM, V271, P18838, DOI 10.1074/jbc.271.31.18838; Fukuda M, 1996, J BIOL CHEM, V271, P30303, DOI 10.1074/jbc.271.48.30303; GUSE AH, 1993, J BIOL CHEM, V268, P7129; Kojima T, 1997, BIOCHEM BIOPH RES CO, V236, P333, DOI 10.1006/bbrc.1997.6947; Miller AT, 2007, NAT IMMUNOL, V8, P514, DOI 10.1038/ni1458; Pouillon V, 2003, NAT IMMUNOL, V4, P1136, DOI 10.1038/ni980; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Serrano CJ, 2005, J IMMUNOL, V174, P6233, DOI 10.4049/jimmunol.174.10.6233; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stricker R, 1999, EUR J BIOCHEM, V265, P815, DOI 10.1046/j.1432-1327.1999.00795.x; Wen BG, 2004, P NATL ACAD SCI USA, V101, P5604, DOI 10.1073/pnas.0306907101; Yarwood S, 2006, BIOCHEM SOC T, V34, P846, DOI 10.1042/BST0340846	17	68	68	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2007	316	5826					886	889		10.1126/science.1138684	http://dx.doi.org/10.1126/science.1138684			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17412921				2022-12-01	WOS:000246369800037
J	Koussevitzky, S; Nott, A; Mockler, TC; Hong, F; Sachetto-Martins, G; Surpin, M; Lim, IJ; Mittler, R; Chory, J				Koussevitzky, Shai; Nott, Ajit; Mockler, Todd C.; Hong, Fangxin; Sachetto-Martins, Gilberto; Surpin, Marci; Lim, Il Jason; Mittler, Ron; Chory, Joanne			Signals from chloroplasts converge to regulate nuclear gene expression	SCIENCE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; CHELATASE H-SUBUNIT; ABSCISIC-ACID; BINDING PROTEIN; ARABIDOPSIS; STRESS; MITOCHONDRIAL; PATHWAYS; REVEALS; GLUCOSE	Plastid-to-nucleus retrograde signaling coordinates nuclear gene expression with chloroplast function and is essential for the photoautotrophic life-style of plants. Three retrograde signals have been described, but little is known of their signaling pathways. We show here that GUN1, a chloroplast-localized pentatricopeptide-repeat protein, and ABI4, an Apetala 2 (AP2)-type transcription factor, are common to all three pathways. ABI4 binds the promoter of a retrograde-regulated gene through a conserved motif found in close proximity to a light-regulatory element. We propose a model in which multiple indicators of aberrant plastid function in Arabidopsis are integrated upstream of GUN1 within plastids, which leads to ABI4-mediated repression of nuclear-encoded genes.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA; Hebrew Univ Jerusalem, Dept Plant Sci, IL-91904 Jerusalem, Israel	Howard Hughes Medical Institute; Salk Institute; Salk Institute; Nevada System of Higher Education (NSHE); University of Nevada Reno; Hebrew University of Jerusalem	Chory, J (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	chory@salk.edu	Mittler, Ron/ABE-6496-2020; Sachetto-Martins, Gilberto/AAT-4095-2021; Sachetto-Martins, Gilberto/AAN-6328-2020		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM018172, F32GM069090] Funding Source: NIH RePORTER; NIGMS NIH HHS [F32 GM 18172, F32 GM 69090] Funding Source: Medline; PHS HHS [DRG-1865-05] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Arroyo A, 2003, PLANT PHYSIOL, V133, P231, DOI 10.1104/pp.103.021089; Aubourg S, 2000, PLANT MOL BIOL, V42, P603, DOI 10.1023/A:1006352315928; Avonce N, 2004, PLANT PHYSIOL, V136, P3649, DOI 10.1104/pp.104.052084; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Davletova S, 2005, PLANT PHYSIOL, V139, P847, DOI 10.1104/pp.105.068254; Dijkwel PP, 1997, PLANT CELL, V9, P583, DOI 10.1105/tpc.9.4.583; Dojcinovic D, 2005, PLANT MOL BIOL, V58, P159, DOI 10.1007/s11103-005-5390-1; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Gray JC, 2003, PHILOS T R SOC B, V358, P135, DOI 10.1098/rstb.2002.1180; Gray JC, 2003, TRENDS GENET, V19, P526, DOI 10.1016/j.tig.2003.08.001; Hattori T, 2002, PLANT CELL PHYSIOL, V43, P136, DOI 10.1093/pcp/pcf014; Himmelbach A, 2003, CURR OPIN PLANT BIOL, V6, P470, DOI 10.1016/S1369-5266(03)00090-6; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Ikeda TM, 1999, MOL CELL BIOL, V19, P8113; Kazan K, 2006, TRENDS PLANT SCI, V11, P109, DOI 10.1016/j.tplants.2006.01.004; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Leister D, 2005, GENE, V354, P110, DOI 10.1016/j.gene.2005.03.039; Leister D, 2003, TRENDS GENET, V19, P47, DOI 10.1016/S0168-9525(02)00003-3; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; McCormac AC, 2004, PLANT J, V40, P672, DOI 10.1111/j.1365-313X.2004.02243.x; Mili S, 2003, MOL CELL BIOL, V23, P4972, DOI 10.1128/MCB.23.14.4972-4982.2003; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Moreira D, 1999, TRENDS BIOCHEM SCI, V24, P298, DOI 10.1016/S0968-0004(99)01419-X; Niu XP, 2002, PLANT CELL, V14, P2565, DOI 10.1105/tpc.003400; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; OELMULLER R, 1986, PLANTA, V168, P482, DOI 10.1007/BF00392267; Oswald O, 2001, P NATL ACAD SCI USA, V98, P2047, DOI 10.1073/pnas.021449998; Pfalz J, 2006, PLANT CELL, V18, P176, DOI 10.1105/tpc.105.036392; Richly E, 2003, EMBO REP, V4, P491, DOI 10.1038/sj.embor.embor828; Rizhsky L, 2004, J BIOL CHEM, V279, P11736, DOI 10.1074/jbc.M313350200; Rock CD, 2000, NEW PHYTOL, V148, P357, DOI 10.1046/j.1469-8137.2000.00769.x; Schmitz-Linneweber C, 2006, PLANT CELL, V18, P2650, DOI 10.1105/tpc.106.046110; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Soderman EM, 2000, PLANT PHYSIOL, V124, P1752, DOI 10.1104/pp.124.4.1752; Strand A, 2003, NATURE, V421, P79, DOI 10.1038/nature01204; TERZAGHI WB, 1995, ANNU REV PLANT PHYS, V46, P445, DOI 10.1146/annurev.pp.46.060195.002305; Tsuchiya N, 2004, BIOCHEM BIOPH RES CO, V317, P736, DOI 10.1016/j.bbrc.2004.03.103; Vinti G, 2000, PLANT J, V24, P883, DOI 10.1046/j.1365-313x.2000.00936.x; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x	40	648	694	8	166	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2007	316	5825					715	719		10.1126/science. 1140516	http://dx.doi.org/10.1126/science. 1140516			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17395793				2022-12-01	WOS:000246181400037
J	Collins, SR; Miller, KM; Maas, NL; Roguev, A; Fillingham, J; Chu, CS; Schuldiner, M; Gebbia, M; Recht, J; Shales, M; Ding, HM; Xu, H; Han, JH; Ingvarsdottir, K; Cheng, B; Andrews, B; Boone, C; Berger, SL; Hieter, P; Zhang, ZG; Brown, GW; Ingles, CJ; Emili, A; Allis, CD; Toczyski, DP; Weissman, JS; Greenblatt, JF; Krogan, NJ				Collins, Sean R.; Miller, Kyle M.; Maas, Nancy L.; Roguev, Assen; Fillingham, Jeffrey; Chu, Clement S.; Schuldiner, Maya; Gebbia, Marinella; Recht, Judith; Shales, Michael; Ding, Huiming; Xu, Hong; Han, Junhong; Ingvarsdottir, Kristin; Cheng, Benjamin; Andrews, Brenda; Boone, Charles; Berger, Shelley L.; Hieter, Phil; Zhang, Zhiguo; Brown, Grant W.; Ingles, C. James; Emili, Andrew; Allis, C. David; Toczyski, David P.; Weissman, Jonathan S.; Greenblatt, Jack F.; Krogan, Nevan J.			Functional dissection of protein complexes involved in yeast chromosome biology using a genetic interaction map	NATURE			English	Article							H3 LYSINE-56 ACETYLATION; HISTONE H3; H3K56 ACETYLATION; CELL-CYCLE; MEDIATOR; DNA; INTEGRITY; PATHWAY; HST3; ASF1	Defining the functional relationships between proteins is critical for understanding virtually all aspects of cell biology. Large-scale identification of protein complexes has provided one important step towards this goal; however, even knowledge of the stoichiometry, affinity and lifetime of every protein - protein interaction would not reveal the functional relationships between and within such complexes. Genetic interactions can provide functional information that is largely invisible to protein - protein interaction data sets. Here we present an epistatic miniarray profile (E-MAP)(1) consisting of quantitative pairwise measurements of the genetic interactions between 743 Saccharomyces cerevisiae genes involved in various aspects of chromosome biology ( including DNA replication/ repair, chromatid segregation and transcriptional regulation). This E-MAP reveals that physical interactions fall into two well-represented classes distinguished by whether or not the individual proteins act coherently to carry out a common function. Thus, genetic interaction data make it possible to dissect functionally multi-protein complexes, including Mediator, and to organize distinct protein complexes into pathways. In one pathway defined here, we show that Rtt109 is the founding member of a novel class of histone acetyltransferases responsible for Asf1-dependent acetylation of histone H3 on lysine 56. This modification, in turn, enables a ubiquitin ligase complex containing the cullin Rtt101 to ensure genomic integrity during DNA replication.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Canc Res Inst, San Francisco, CA 94115 USA; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; Rockefeller Univ, Lab Cromatin Biol, New York, NY 10021 USA; Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Wistar Inst Anat & Biol, Gene Express & REgulat Program, Philadelphia, PA 19104 USA; Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Toronto; Rockefeller University; Mayo Clinic; The Wistar Institute; University of British Columbia; University of Toronto	Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA.	weissman@cmp.ucsf.edu; jack.greenblatt@utoronto.ca	Han, Junhong/L-5264-2013; Schuldiner, Maya/C-9488-2009	Recht, Judith/0000-0003-3572-0457; Miller, Kyle/0000-0002-4544-0013; Weissman, Jonathan/0000-0003-2445-670X; Ingvarsdottir, Kristin/0000-0001-9915-1164; Brown, Grant/0000-0002-9002-5003; Han, Junhong/0000-0002-3371-8698; Berger, Shelley/0000-0001-5398-4400; Collins, Sean/0000-0002-4276-5840; Schuldiner, Maya/0000-0001-9947-115X				Adkins MW, 2007, J BIOL CHEM, V282, P1334, DOI 10.1074/jbc.M608025200; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Davierwala AP, 2005, NAT GENET, V37, P1147, DOI 10.1038/ng1640; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Hastie T., 2001, ELEMENTS STAT LEARNI; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Luke B, 2006, CURR BIOL, V16, P786, DOI 10.1016/j.cub.2006.02.071; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Michel JJ, 2003, J BIOL CHEM, V278, P22828, DOI 10.1074/jbc.M210358200; Mizzen CA, 1999, METHOD ENZYMOL, V304, P675; Ozdemir A, 2005, J BIOL CHEM, V280, P25949, DOI 10.1074/jbc.C500181200; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Schuldiner M, 2006, METHODS, V40, P344, DOI 10.1016/j.ymeth.2006.07.034; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Takagi Y, 2006, MOL CELL, V23, P355, DOI 10.1016/j.molcel.2006.06.007; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tyler JK, 2002, EUR J BIOCHEM, V269, P2268, DOI 10.1046/j.1432-1033.2002.02890.x; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; Ye P, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100034; [No title captured]	30	691	696	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2007	446	7137					806	810		10.1038/nature05649	http://dx.doi.org/10.1038/nature05649			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17314980				2022-12-01	WOS:000245626800043
J	Evans, MJ; von Hahn, T; Tscherne, DM; Syder, AJ; Panis, M; Wolk, B; Hatziioannou, T; McKeating, JA; Bieniasz, PD; Rice, CM				Evans, Matthew J.; von Hahn, Thomas; Tscherne, Donna M.; Syder, Andrew J.; Panis, Maryline; Woelk, Benno; Hatziioannou, Theodora; McKeating, Jane A.; Bieniasz, Paul D.; Rice, Charles M.			Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry	NATURE			English	Article							TIGHT JUNCTIONS; CELL ENTRY; LIVER-TRANSPLANTATION; CHOLESTATIC HEPATITIS; VIRAL-INFECTION; RECEPTOR; GLYCOPROTEINS; REPLICATION; CD81; TETRASPANIN	Hepatitis C virus (HCV) is a leading cause of cirrhosis and liver cancer worldwide. A better understanding of the viral life cycle, including the mechanisms of entry into host cells, is needed to identify novel therapeutic targets. Although HCV entry requires the CD81 co-receptor, and other host molecules have been implicated, at least one factor critical to this process remains unknown (reviewed in refs 1 - 3). Using an iterative expression cloning approach we identified claudin-1 (CLDN1), a tight junction component that is highly expressed in the liver(4), as essential for HCV entry. CLDN1 is required for HCV infection of human hepatoma cell lines and is the first factor to confer susceptibility to HCV when ectopically expressed in non-hepatic cells. Discrete residues within the first extracellular loop (EL1) of CLDN1, but not protein interaction motifs in intracellular domains, are critical for HCV entry. Moreover, antibodies directed against an epitope inserted in the CLDN1 EL1 block HCV infection. The kinetics of this inhibition indicate that CLDN1 acts late in the entry process, after virus binding and interaction with the HCV co-receptor CD81. With CLDN1 we have identified a novel key factor for HCV entry and a new target for antiviral drug development.	Rockefeller Univ, Ctr Study Hepatitis C, New York, NY 10021 USA; Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA	Rockefeller University; Rockefeller University	Rice, CM (corresponding author), Rockefeller Univ, Ctr Study Hepatitis C, 1230 York Ave, New York, NY 10021 USA.	ricec@mail.rockefeller.edu		McKeating, Jane/0000-0002-7229-5886; Evans, Matthew/0000-0002-4991-3877	Medical Research Council [G0400802, G0801976] Funding Source: Medline; Medical Research Council [G9818340B] Funding Source: researchfish; MRC [G0400802] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barth H, 2006, HEPATOLOGY, V44, P527, DOI 10.1002/hep.21321; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; Bartosch B, 2006, VIROLOGY, V348, P1, DOI 10.1016/j.virol.2005.12.027; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Borlak J, 2005, ONCOGENE, V24, P1809, DOI 10.1038/sj.onc.1208196; Cocquerel L, 2006, J GEN VIROL, V87, P1075, DOI 10.1099/vir.0.81646-0; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Doughty AL, 1998, LIVER TRANSPLANT SUR, V4, P15, DOI 10.1002/lt.500040102; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Heiskala M, 2001, TRAFFIC, V2, P92, DOI 10.1034/j.1600-0854.2001.020203.x; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Kato T, 2005, J VIROL, V79, P592, DOI 10.1128/JVI.79.1.592-596.2005; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; McKeating JA, 2004, J VIROL, V78, P8496, DOI 10.1128/JVI.78.16.8496-8505.2004; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Schluger LK, 1996, HEPATOLOGY, V23, P971, DOI 10.1002/hep.510230505; Swisshelm K, 2005, ADV DRUG DELIVER REV, V57, P919, DOI 10.1016/j.addr.2005.01.006; Tiwari-Woodruff SK, 2001, J CELL BIOL, V153, P295, DOI 10.1083/jcb.153.2.295; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004	29	924	997	0	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2007	446	7137					801	805		10.1038/nature05654	http://dx.doi.org/10.1038/nature05654			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17325668				2022-12-01	WOS:000245626800042
J	Mukherjee, R; Eastman, N; Turk, J; Hollins, S				Mukherjee, Raja; Eastman, Nigel; Turk, Jeremy; Hollins, Sheila			Fetal alcohol syndrome: law and ethics	LANCET			English	Editorial Material									Bracketts Resource Ctr, Surrey Border Partnership Trust, Surrey RH8 0QA, England; Univ London, St Georges, Div Mental Hlth, London SW17 0RE, England; Univ London, St Georges, Div Clin Dev Sci, London SW17 0RE, England	St Georges University London; University of London; St Georges University London; University of London	Mukherjee, R (corresponding author), Bracketts Resource Ctr, Surrey Border Partnership Trust, Surrey RH8 0QA, England.	rmukherj@sgul.ac.uk		Mukherjee, Raja/0000-0002-2171-928X				ABEL EL, 1988, NEUROTOXICOL TERATOL, V10, P1, DOI 10.1016/0892-0362(88)90060-8; Armstrong EM, 1998, SOC SCI MED, V47, P2025, DOI 10.1016/S0277-9536(98)00308-6; GOVARGUE S, 1998, MED LAW REV, V6, P265; Kesmodel U, 2002, ALCOHOL CLIN EXP RES, V26, P1553, DOI 10.1097/01.ALC.0000034702.14322.25; May PA, 2007, DRUG ALCOHOL DEPEN, V88, P259, DOI 10.1016/j.drugalcdep.2006.11.007; NANSON JL, 1995, CAN MED ASSOC J, V152, P1071; *PRIM MIN STRAT GR, 2004, ALC HARM RED STRAT E; Sayal K, 2007, PEDIATRICS, V119, pE426, DOI 10.1542/peds.2006-1840; SMITH JC, 2002, HOGAN CRIMINAL LAW	9	9	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2007	369	9568					1149	1150		10.1016/S0140-6736(07)60542-X	http://dx.doi.org/10.1016/S0140-6736(07)60542-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	155RH	17416245				2022-12-01	WOS:000245595100008
J	Chang, L; Huang, L; Gau, SS; Wu, Y; Hsia, S; Fan, T; Lin, K; Huang, Y; Lu, C; Lin, T				Chang, Luan-Yin; Huang, Li-Min; Gau, Susan Shur-Fen; Wu, Yu-Yu; Hsia, Shao-Hsuan; Fan, Tsui-Yen; Lin, Kuang-Lin; Huang, Yhu-Chering; Lu, Chun-Yi; Lin, Tzou-Yien			Neurodevelopment and cognition in children after enterovirus 71 infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFLUENZAE MENINGITIS; BACTERIAL-MENINGITIS; MOUTH-DISEASE; EPIDEMIC; OUTBREAK; TAIWAN; OUTCOMES; ENCEPHALOMYELITIS; ENCEPHALITIS; MANAGEMENT	Background: Enterovirus 71 is a common cause of hand, foot, and mouth disease and encephalitis in Asia and elsewhere. The long-term neurologic and psychiatric effects of this viral infection on the central nervous system (CNS) are not well understood. Methods: We conducted long-term follow-up of 142 children after enterovirus 71 infection with CNS involvement - 61 who had aseptic meningitis, 53 who had severe CNS involvement, and 28 who had cardiopulmonary failure after CNS involvement. At a median follow-up of 2.9 years (range, 1.0 to 7.4) after infection, the children received physical and neurologic examinations. We administered the Denver Developmental Screening Test (DDST II) to children 6 years of age or younger and the Wechsler intelligence test to children 4 years of age or older. Results: Nine of the 16 patients with a poliomyelitis-like syndrome (56%) and 1 of the 5 patients with encephalomyelitis (20%) had sequelae involving limb weakness and atrophy. Eighteen of the 28 patients with cardiopulmonary failure after CNS involvement (64%) had limb weakness and atrophy, 17 (61%) required tube feeding, and 16 (57%) required ventilator support. Among patients who underwent DDST II assessment, delayed neurodevelopment was found in only 1 of 20 patients (5%) with severe CNS involvement and in 21 of 28 patients (75%) with cardiopulmonary failure (P<0.001 for the overall comparison). Children with cardiopulmonary failure after CNS involvement scored lower on intelligence tests than did children with CNS involvement alone (P=0.003). Conclusions: Enterovirus 71 infection with CNS involvement and cardiopulmonary failure may be associated with neurologic sequelae, delayed neurodevelopment, and reduced cognitive functioning. Children with CNS involvement without cardiopulmonary failure did well on neurodevelopment tests. (ClinicalTrials. gov number, NCT00172393.)	Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Pediat, Taipei, Taiwan; Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Psychiat, Taipei, Taiwan; Chang Gung Univ, Chang Gung Childrens Hosp, Dept Child Psychiat, Tao Yuan, Taiwan; Chang Gung Univ, Chang Gung Childrens Hosp, Dept Pediat, Tao Yuan, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Chang, L (corresponding author), Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Pediat, 7 Chung Shan S Rd, Taipei, Taiwan.	ly7077@tpts6.seed.net.tw	Gau, Susan Shur-Fen/P-4726-2017	Gau, Susan Shur-Fen/0000-0002-2718-8221; HUANG, LI-MIN/0000-0002-9291-260X; CHANG, LUAN-YIN/0000-0003-2632-1956; LU, CHUN-YI/0000-0002-5240-2808				ALLEN SR, 1995, J CLIN PSYCHOL, V51, P648, DOI 10.1002/1097-4679(199509)51:5<648::AID-JCLP2270510510>3.0.CO;2-R; BARAFF LJ, 1993, PEDIATR INFECT DIS J, V12, P389, DOI 10.1097/00006454-199305000-00008; Baruah H C, 2002, Indian Pediatr, V39, P1143; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chang LY, 2004, PEDIATR INFECT DIS J, V23, P327, DOI 10.1097/00006454-200404000-00010; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Dolin R, 1999, NEW ENGL J MED, V341, P984, DOI 10.1056/NEJM199909233411309; EMMETT M, 1980, AUST PAEDIATR J, V16, P90; FRANKENBURG WK, 1992, PEDIATRICS, V89, P91; GRIMWOOD K, 1995, PEDIATRICS, V95, P646; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hsueh C, 2000, MODERN PATHOL, V13, P1200, DOI 10.1038/modpathol.3880222; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Kari K, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-8; Lahat E, 1999, ARCH DIS CHILD, V80, P69, DOI 10.1136/adc.80.1.69; Lin TY, 2002, CLIN INFECT DIS, V34, pS52, DOI 10.1086/338819; Mekan Sabeen F., 2005, JPMA Journal of the Pakistan Medical Association, V55, P146; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Shen WC, 1999, AM J NEURORADIOL, V20, P1889; SHINDAROV LM, 1979, J HYG EPID MICROB IM, V23, P284; Taylor HG, 2000, NEUROPSYCHOLOGY, V14, P509, DOI 10.1037/0894-4105.14.4.509; Wong KT, 2000, NEUROPATH APPL NEURO, V26, P313, DOI 10.1046/j.1365-2990.2000.00256.x	22	256	316	0	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2007	356	12					1226	1234		10.1056/NEJMoa065954	http://dx.doi.org/10.1056/NEJMoa065954			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148UP	17377160				2022-12-01	WOS:000245101900007
J	Kales, SN; Soteriades, ES; Christophi, CA; Christiani, DC				Kales, Stefanos N.; Soteriades, Elpidoforos S.; Christophi, Costas A.; Christiani, David C.			Emergency duties and deaths from heart disease among firefighters in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; BODY-MASS INDEX; RISK-FACTORS; CARDIOVASCULAR-DISEASE; HEALTH; RESPONSES; FITNESS; PROFILE; TIME; ECG	Background: Heart disease causes 45% of the deaths that occur among U.S. firefighters while they are on duty. We examined duty-specific risks of death from coronary heart disease among on-duty U.S. firefighters from 1994 to 2004. Methods: We reviewed summaries provided by the Federal Emergency Management Agency of the deaths of all on-duty firefighters between 1994 and 2004, except for deaths associated with the September 11, 2001, terrorist attacks. Estimates of the proportions of time spent by firefighters each year performing various duties were obtained from a municipal fire department, from 17 large metropolitan fire departments, and from a national database. Odds ratios and 95% confidence intervals for death from coronary heart disease during specific duties were calculated from the ratios of the observed odds to the expected odds, with nonemergency duties as the reference category. Results: Deaths from coronary heart disease were associated with suppressing a fire (32.1% of all such deaths), responding to an alarm (13.4%), returning from an alarm (17.4%), engaging in physical training (12.5%), responding to nonfire emergencies (9.4%), and performing nonemergency duties (15.4%). As compared with the odds of death from coronary heart disease during nonemergency duties, the odds were 12.1 to 136 times as high during fire suppression, 2.8 to 14.1 times as high during alarm response, 2.2 to 10.5 times as high during alarm return, and 2.9 to 6.6 times as high during physical training. These odds were based on three estimates of the time that firefighters spend on their duties. Conclusions: Certain emergency firefighting duties were associated with a risk of death from coronary heart disease that was markedly higher than the risk associated with nonemergency duties. Fire suppression was associated with the highest risk, which was approximately 10 to 100 times as high as that for nonemergency duties.	Harvard Univ, Sch Med, Cambridge Hlth Alliance, Employee Hlth & Ind Med, Cambridge, MA 02139 USA; Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; Massachusetts Gen Hosp, Pulm & Crit Care Unit, Boston, MA 02114 USA; Kindred Hosp NE, Ctr Occupat & Environm Med, Braintree, MA USA; Harvard Univ, Sch Publ Hlth, Cyprus Inst Inst Environm & Publ Hlth, Nicosia, Cyprus	Harvard University; Cambridge Health Alliance; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Kales, SN (corresponding author), Harvard Univ, Sch Med, Cambridge Hlth Alliance, Employee Hlth & Ind Med, Lee B Macht Bldg,Rm 427,1493 Cambridge St, Cambridge, MA 02139 USA.	skales@challiance.org			PHS HHS [T42/CCT122961-02] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Austin CC, 2001, AM J IND MED, V40, P683, DOI 10.1002/ajim.10023; BARNARD RJ, 1975, J OCCUP ENVIRON MED, V17, P247; Burgess JL, 2001, J OCCUP ENVIRON MED, V43, P467, DOI 10.1097/00043764-200105000-00007; Clark S, 2002, J OCCUP ENVIRON MED, V44, P940, DOI 10.1097/00043764-200210000-00013; Cohen, 1998, AM J CARDIOL, V81, P260; Cohen MC, 1997, AM J CARDIOL, V79, P1512, DOI 10.1016/S0002-9149(97)00181-1; Fahy RF., 2005, ANAL NFPA FIRE ANAL; Fisher Nicholas G, 2005, J R Nav Med Serv, V91, P112; FRANKE WD, 1994, J OCCUP ENVIRON MED, V36, P1127, DOI 10.1097/00043764-199410000-00016; Franklin BA, 1996, AM J CARDIOL, V77, P855, DOI 10.1016/S0002-9149(97)89181-3; FRIEL JK, 1992, AM J PUBLIC HEALTH, V82, P1175, DOI 10.2105/AJPH.82.8.1175-a; Glueck CJ, 1996, AM J IND MED, V30, P331, DOI 10.1002/ajim.4700300313; Guidotti TL, 1995, J OCCUP ENVIRON MED, V37, P1348, DOI 10.1097/00043764-199512000-00004; GUIDOTTI TL, 1992, INT ARCH OCC ENV HEA, V64, P1, DOI 10.1007/BF00625945; Haas NS, 2003, INT J OCCUP ENV HEAL, V9, P95, DOI 10.1179/oeh.2003.9.2.95; Holder JD, 2006, J OCCUP ENVIRON MED, V48, P1047, DOI 10.1097/01.jom.0000235909.31632.46; Ide CW, 2000, SCOT MED J, V45, P79, DOI 10.1177/003693300004500307; *INT ASS FIR FIGHT, PRES LEG; Johnstone MT, 1996, AM J HYPERTENS, V9, pS22, DOI 10.1016/0895-7061(95)00403-3; Kales SN, 1999, J OCCUP ENVIRON MED, V41, P589, DOI 10.1097/00043764-199907000-00007; Kales SN, 2000, J OCCUP ENVIRON MED, V42, P467, DOI 10.1097/00043764-200005000-00001; Kales Stefanos N, 2003, Environ Health, V2, P14, DOI 10.1186/1476-069X-2-14; KARTER MJ, 2001, US FIR DEP PROF 2000; KAWACHI I, 1995, CIRCULATION, V92, P3178, DOI 10.1161/01.CIR.92.11.3178; KUORINKA I, 1981, J OCCUP ENVIRON MED, V23, P762, DOI 10.1097/00043764-198111000-00010; LEMON PWR, 1977, J OCCUP ENVIRON MED, V19, P337; Maguire BJ, 2002, ANN EMERG MED, V40, P625, DOI 10.1067/mem.2002.128681; Melius J, 2001, OCCUP MED-STATE ART, V16, P101; MITTLEMAN MA, 1993, NEW ENGL J MED, V329, P1677, DOI 10.1056/NEJM199312023292301; *NAT FIR PROT ASS, FIR STAT; Roberts MA, 2002, J STRENGTH COND RES, V16, P271; Smith DL, 2001, ERGONOMICS, V44, P244, DOI 10.1080/00140130121115; Soteriades ES, 2005, OBES RES, V13, P1756, DOI 10.1038/oby.2005.214; Soteriades ES, 2002, J OCCUP ENVIRON MED, V44, P840, DOI 10.1097/00043764-200209000-00006; Spencer FA, 1998, J AM COLL CARDIOL, V31, P1226, DOI 10.1016/S0735-1097(98)00098-9; Steenland K, 1996, AM J IND MED, V30, P495, DOI 10.1002/(SICI)1097-0274(199610)30:4<495::AID-AJIM16>3.3.CO;2-I; TriData Corporation, 2002, FIR FAT RETR STUD; *US FIR ADM, FIR FAT; Willich SN, 1998, EUR HEART J, V19, pC12	39	338	342	0	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2007	356	12					1207	1215		10.1056/NEJMoa060357	http://dx.doi.org/10.1056/NEJMoa060357			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148UP	17377158	Bronze, Green Published			2022-12-01	WOS:000245101900005
J	Labandeira-Rey, M; Couzon, F; Boisset, S; Brown, EL; Bes, M; Benito, Y; Barbu, EM; Vazquez, V; Hook, M; Etienne, J; Vandenesch, F; Bowden, MG				Labandeira-Rey, Maria; Couzon, Florence; Boisset, Sandrine; Brown, Eric L.; Bes, Michele; Benito, Yvonne; Barbu, Elena M.; Vazquez, Vanessa; Hoeoek, Magnus; Etienne, Jerome; Vandenesch, Francois; Bowden, M. Gabriela			Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia	SCIENCE			English	Article							PROTEIN-A; EXPRESSION; RESISTANCE; REGULATOR; SIGMA(B); STRAINS; GENE	The Staphylococcus aureus Panton-Valentine leukocidin (PVL) is a pore-forming toxin secreted by strains epidemiologically associated with the current outbreak of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) and with the often-lethal necrotizing pneumonia. To investigate the role of PVL in pulmonary disease, we tested the pathogenicity of clinical isolates, isogenic PVL-negative and PVL-positive S. aureus strains, as well as purified PVL, in a mouse acute pneumonia model. Here we show that PVL is sufficient to cause pneumonia and that the expression of this leukotoxin induces global changes in transcriptional levels of genes encoding secreted and cell wall-anchored staphylococcal proteins, including the lung inflammatory factor staphylococcal protein A ( Spa).	Univ Lyon, F-69008 Lyon, France; Texas A&M Univ Syst, Hlth Sci Ctr, Inst Biosci & Technol, Ctr Extracellular Matrix Biol, Houston, TX 77030 USA; Univ Lyon 1, Fac Laennec, F-69008 Lyon, France; INSERM, Natl Reference Staphylocoques, E0230, F-69008 Lyon, France; Hop Edouard Herriot, Hosp Civils Lyon, F-69003 Lyon, France	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon	Vandenesch, F (corresponding author), Univ Lyon, F-69008 Lyon, France.	denesch@univ-lyon1.fr; gbowden@ibt.tamhsc.edu	Sarathy, Vanessa V./U-7803-2019; Vandenesch, Francois/C-7209-2014; Boisset, Sandrine/C-3106-2011; Boisset, Sandrine SB/D-8144-2014; ETIENNE, Jerome/C-5471-2014	Sarathy, Vanessa V./0000-0002-1262-2101; Vandenesch, Francois/0000-0001-9412-7106; Boisset, Sandrine SB/0000-0001-8717-8749; ETIENNE, Jerome/0000-0002-3348-3315	NIAID NIH HHS [AI020624] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020624] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chambers HF, 2005, NEW ENGL J MED, V352, P1485, DOI 10.1056/NEJMe058023; Cheung AL, 1997, INFECT IMMUN, V65, P2243, DOI 10.1128/IAI.65.6.2243-2249.1997; de Bentzmann S, 2004, J INFECT DIS, V190, P1506, DOI 10.1086/424521; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Genestier AL, 2005, J CLIN INVEST, V115, P3117, DOI 10.1172/JCI22684; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Huntzinger E, 2005, EMBO J, V24, P824, DOI 10.1038/sj.emboj.7600572; KONIG B, 1995, J INFECT DIS, V171, P607, DOI 10.1093/infdis/171.3.607; Kullik I, 1998, J BACTERIOL, V180, P4814, DOI 10.1128/JB.180.18.4814-4820.1998; OBrien L, 2002, MOL MICROBIOL, V44, P1033, DOI 10.1046/j.1365-2958.2002.02935.x; Oscarsson J, 2005, INT J MED MICROBIOL, V295, P253, DOI 10.1016/j.ijmm.2005.05.003; Palmqvist N, 2002, MICROB PATHOGENESIS, V33, P239, DOI 10.1006/mpat.2002.0533; Panton PN, 1932, LANCET, V1, P506; Said-Salim B, 2005, J CLIN MICROBIOL, V43, P3373, DOI 10.1128/JCM.43.7.3373-3379.2005; Thomas P, 2003, PEDIATR INFECT DIS J, V22, P201; Vojtov N, 2002, P NATL ACAD SCI USA, V99, P10102, DOI 10.1073/pnas.152152499	19	554	601	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2007	315	5815					1130	1133		10.1126/science.1137165	http://dx.doi.org/10.1126/science.1137165			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138UA	17234914				2022-12-01	WOS:000244387600038
J	Sakakura, A; Ukai, A; Ishihara, K				Sakakura, Akira; Ukai, Atsushi; Ishihara, Kazuaki			Enantioselective halocyclization of polyprenoids induced by nucleophilic phosphoramidites	NATURE			English	Article							MARINE NATURAL-PRODUCTS; CYCLIZATION; TERPENES	Polycyclic bio-active natural products that contain halogen atoms have been isolated from a number of different marine organisms(1). The biosynthesis of these natural products appears to be initiated by an electrophilic halogenation reaction at a carbon - carbon double bond(2-4) via a mechanism that is similar to a proton-induced olefin polycyclization(5-8). Enzymes such as haloperoxidases generate an electrophilic halonium ion ( or its equivalent), which reacts with the terminal carbon - carbon double bond of the polyprenoid, enantioselectively inducing a cyclization reaction that produces a halogenated polycyclic terpenoid. Use of an enantioselective halocyclization reaction is one possible way to chemically synthesize these halogenated cyclic terpenoids; although several brominated cyclic terpenoids have been synthesized via a diastereoselective halocyclization reaction that uses stoichiometric quantities of a brominating reagent(9-12), the enantioselective halocyclization of isoprenoids induced by a chiral promoter has not yet been reported. Here we report the enantioselective halocyclization of simple polyprenoids using a nucleophilic promoter. Achiral nucleophilic phosphorus compounds are able to promote the diastereoselective halocyclization reaction to give a halogenated cyclic product in excellent yields. Moreover, chiral phosphoramidites promote the enantioselective halocyclization of simple polyprenoids with N-iodosuccinimide to give iodinated cyclic products in up to 99% enantiomeric excess and diastereomeric excess. To the best of our knowledge, this is the first successful example of the enantioselective halopolycyclization of polyprenoids.	Nagoya Univ, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Nagoya University	Ishihara, K (corresponding author), Nagoya Univ, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan.	ishihara@cc.nagoya-u.ac.jp	Sakakura, Akira/A-6319-2013	Sakakura, Akira/0000-0002-2995-1251				Blunt JW, 2006, NAT PROD REP, V23, P26, DOI 10.1039/b502792f; Butler A, 2004, NAT PROD REP, V21, P180, DOI 10.1039/b302337k; Carter-Franklin JN, 2003, J AM CHEM SOC, V125, P3688, DOI 10.1021/ja029271v; Cui XL, 2000, J ORG CHEM, V65, P5653, DOI 10.1021/jo000449a; Fukuzumi T, 2006, J FLUORINE CHEM, V127, P548, DOI 10.1016/j.jfluchem.2006.01.004; GONZALEZ AG, 1976, TETRAHEDRON LETT, V17, P137; Grossman RB, 1998, CAN J CHEM, V76, P1233, DOI 10.1139/cjc-76-9-1233; Haas J, 2002, ORG LETT, V4, P297, DOI 10.1021/ol0171113; Huang AX, 1999, J AM CHEM SOC, V121, P9999, DOI 10.1021/ja992411p; Ishibashi H, 2004, J AM CHEM SOC, V126, P11122, DOI 10.1021/ja0472026; JOHNSON WS, 1976, BIOORG CHEM, V5, P51, DOI 10.1016/0045-2068(76)90016-X; Kang SH, 2003, J AM CHEM SOC, V125, P15748, DOI 10.1021/ja0369921; WOLINSKY LE, 1976, J ORG CHEM, V41, P597, DOI 10.1021/jo00866a003; YAMAGUCHI Y, 1985, TETRAHEDRON LETT, V26, P343, DOI 10.1016/S0040-4039(01)80813-3; YAMAMURA S, 1977, TETRAHEDRON LETT, P2171; Yarnell A, 2006, CHEM ENG NEWS, V84, P12, DOI 10.1021/cen-v084n012.p012; Yoder RA, 2005, CHEM REV, V105, P4730, DOI 10.1021/cr040623l; Zhang Y, 2004, J AM CHEM SOC, V126, P15038, DOI 10.1021/ja0454485	18	323	323	1	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					900	903		10.1038/nature05553	http://dx.doi.org/10.1038/nature05553			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	138CR	17314976				2022-12-01	WOS:000244341200045
J	Leutgeb, JK; Leutgeb, S; Moser, MB; Moser, EI				Leutgeb, Jill K.; Leutgeb, Stefan; Moser, May-Britt; Moser, Edvard I.			Pattern separation in the dentate gyrus and CA3 of the hippocampus	SCIENCE			English	Article							COMPLEX-SPIKE CELLS; PLACE CELLS; ENTORHINAL CORTEX; GRANULE CELLS; UNIT-ACTIVITY; SPATIAL MAP; REPRESENTATION; ENVIRONMENT; DISTINCT; RECALL	Theoretical models have long pointed to the dentate gyrus as a possible source of neuronal pattern separation. In agreement with predictions from these models, we show that minimal changes in the shape of the environment in which rats are exploring can substantially alter correlated activity patterns among place-modulated granule cells in the dentate gyrus. When the environments are made more different, new cell populations are recruited in CA3 but not in the dentate gyrus. These results imply a dual mechanism for pattern separation in which signals from the entorhinal cortex can be decorrelated both by changes in coincidence patterns in the dentate gyrus and by recruitment of nonoverlapping cell assemblies in CA3.	Norwegian Univ Sci & Technol, Ctr Biol Memory, N-7489 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Ctr Biol Memory, N-7489 Trondheim, Norway.	edvard.moser@ntnu.no		Leutgeb, Jill/0000-0002-2014-842X				ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; BOSS BD, 1985, BRAIN RES, V338, P144, DOI 10.1016/0006-8993(85)90257-4; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; FYHN MH, IN PRESS NATURE; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; HASSELMO ME, 1995, J NEUROSCI, V15, P5249; Hayman RMA, 2003, EUR J NEUROSCI, V18, P2825, DOI 10.1111/j.1460-9568.2003.03035.x; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Leutgeb JK, 2005, NEURON, V48, P345, DOI 10.1016/j.neuron.2005.09.007; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCNAUGHTON BL, 1989, NEUROSCIENCE CONNECT, P1; MULLER RU, 1987, J NEUROSCI, V7, P1951; MULLER RU, 1987, J NEUROSCI, V7, P1935; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; QUIRK GJ, 1990, J NEUROSCI, V10, P2008; Rapp PR, 2002, CEREB CORTEX, V12, P1171, DOI 10.1093/cercor/12.11.1171; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Tsodyks M, 1999, HIPPOCAMPUS, V9, P481, DOI 10.1002/(SICI)1098-1063(1999)9:4<481::AID-HIPO14>3.3.CO;2-J; Vazdarjanova A, 2004, J NEUROSCI, V24, P6489, DOI 10.1523/JNEUROSCI.0350-04.2004; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905	36	1027	1039	3	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2007	315	5814					961	966		10.1126/science.1135801	http://dx.doi.org/10.1126/science.1135801			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303747				2022-12-01	WOS:000244229800034
J	Wan, YSY; Flavell, RA				Wan, Yisong Y.; Flavell, Richard A.			Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression	NATURE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; TRANSCRIPTION FACTOR FOXP3; SCURFY MOUSE; INTERLEUKIN-2; INFLAMMATION; CD25(+); PROTEIN	The naturally occurring regulatory T cell (T-R) is the pivotal cell type that maintains self-tolerance and exerts active immune suppression. The development and function of T-R cells is controlled by Foxp3 (refs 1, 2), a lack of which results in loss of T-R cells and massive multi-organ autoimmunity in scurfy mice and IPEX ( immune dysregulation, polyendocrinopathy, enteropathy, X-linked) patients(3,4). It is generally thought that, through a binary mechanism, Foxp3 expression serves as an on-and-off switch to regulate positively the physiology of T-R cells; however, emerging evidence associates decreased Foxp3 expression in T-R cells with various immune disorders(5-7). We hypothesized that Foxp3 regulates T(R)cell development and function in a dose-dependent, nonbinary manner, and that decreased Foxp3 expression can cause immune disease. Here, by generating a mouse model in which endogenous Foxp3 gene expression is attenuated in T-R cells, we show that decreased Foxp3 expression results in the development of an aggressive autoimmune syndrome similar to that of scurfy mice, but does not affect thymic development, homeostatic expansion/maintenance or transforming-growth-factor-beta-induced de novo generation of Foxp3-expressing cells. The immune-suppressive activities of T cells with attenuated Foxp3 expression were nearly abolished in vitro and in vivo, whereas their anergic properties in vitro were maintained. This was accompanied by decreased expression of T(R)cell 'signature genes'. Notably, T cells expressing decreased Foxp3 preferentially became T-helper 2 (T(H)2)-type effectors even in a T(H)1-polarizing environment. These cells instructed T(H)2 differentiation of conventional T cells, which contributed to the immune diseases observed in these mice. Thus, decreased Foxp3 expression causes immune disease by subverting the suppressive function of T-R cells and converting T-R cells into effector cells; these findings are important for understanding the regulation of T-R cell function and the aetiology of various human immune diseases.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 300 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Wan, Yisong/ABE-1200-2021	Wan, Yisong/0000-0003-4346-9717				Balandina A, 2005, BLOOD, V105, P735, DOI 10.1182/blood-2003-11-3900; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Huan J, 2005, J NEUROSCI RES, V81, P45, DOI 10.1002/jnr.20522; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; LYON MF, 1990, P NATL ACAD SCI USA, V87, P2433, DOI 10.1073/pnas.87.7.2433; Miura Y, 2004, BLOOD, V104, P2187, DOI 10.1182/blood-2004-03-1040; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.iy.07.040189.001045; Ono M, 2006, J IMMUNOL, V176, P4748, DOI 10.4049/jimmunol.176.8.4748; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707	27	659	709	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2007	445	7129					766	770		10.1038/nature05479	http://dx.doi.org/10.1038/nature05479			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17220876	Bronze			2022-12-01	WOS:000244205200045
J	Shang, YH; Claridge-Chang, A; Sjulson, L; Pypaert, M; Miesenbock, G				Shang, Yuhua; Claridge-Chang, Adam; Sjulson, Lucas; Pypaert, Marc; Miesenbock, Gero			Excitatory local circuits and their implications for olfactory processing in the fly antennal lobe	CELL			English	Article							ODOR REPRESENTATIONS; MOLECULAR-BASIS; DROSOPHILA; MAP; TRANSMISSION; INFORMATION; DYNAMICS; BEHAVIOR; SYSTEM; NOISE	Conflicting views exist of how circuits of the antennal lobe, the insect equivalent of the olfactory bulb, translate input from olfactory receptor neurons (ORNs) into projection-neuron (PN) output. Synaptic connections between ORNs and PNs are one-to-one, yet PNs are more broadly tuned to odors than ORNs. The basis for this difference in receptive range remains unknown. Analyzing a Drosophila mutant lacking ORN input to one glomerulus, we show that some of the apparent complexity in the antennal lobe's output arises from lateral, inter-glomerular excitation of PNs. We describe a previously unidentified population of cholinergic local neurons (LNs) with multiglomerular processes. These excitatory LNs respond broadly to odors but exhibit little glomerular specificity in their synaptic output, suggesting that PNs are driven by a combination of glomerulus-specific ORN afferents and diffuse LN excitation. Lateral excitation may boost PN signals and enhance their transmission to third-order neurons in a mechanism akin to stochastic resonance.	Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University	Miesenbock, G (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.	gero.miesenboeck@yale.edu		Miesenboeck, Gero/0000-0003-2940-3228; Claridge-Chang, Adam/0000-0002-4583-3650	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005810] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC005810, R01 DC005810-05] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Berdnik D, 2006, J NEUROSCI, V26, P3367, DOI 10.1523/JNEUROSCI.4941-05.2006; BORST A, 1983, J COMP PHYSIOL, V152, P373, DOI 10.1007/BF00606242; BUCHNER E, 1991, J NEUROGENET, V7, P153, DOI 10.3109/01677069109167432; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; BUONVISO N, 1991, J COMP NEUROL, V307, P57, DOI 10.1002/cne.903070106; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; DOUGLASS JK, 1993, NATURE, V365, P337, DOI 10.1038/365337a0; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; KITAMOTO T, 1992, J NEUROSCI, V12, P1628; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; KNIGHT BW, 1972, J GEN PHYSIOL, V59, P734, DOI 10.1085/jgp.59.6.734; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; LAURENT G, 1994, J NEUROSCI, V14, P2993; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Levin JE, 1996, NATURE, V380, P165, DOI 10.1038/380165a0; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; LONGTIN A, 1991, PHYS REV LETT, V67, P656, DOI 10.1103/PhysRevLett.67.656; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Perez-Orive J, 2004, J NEUROSCI, V24, P6037, DOI 10.1523/JNEUROSCI.1084-04.2004; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Roorda RD, 2004, J NEUROPHYSIOL, V92, P609, DOI 10.1152/jn.00087.2004; Schoppa NE, 2002, NAT NEUROSCI, V5, P1194, DOI 10.1038/nn953; STEMMLER M, 1995, SCIENCE, V269, P1877, DOI 10.1126/science.7569930; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Takagawa K, 1996, NEUROSCI RES, V24, P237, DOI 10.1016/0168-0102(95)00999-X; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782	53	238	242	3	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2007	128	3					601	612		10.1016/j.cell.2006.12.034	http://dx.doi.org/10.1016/j.cell.2006.12.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289577	Bronze, Green Accepted			2022-12-01	WOS:000244842700024
J	Daley, GQ; Ahrlund-Richter, L; Auerbach, JM; Benvenisty, N; Charo, RA; Chen, G; Deng, HK; Goldstein, LS; Hudson, KL; Hyun, I; Junn, SC; Love, J; Lee, EH; McLaren, A; Mummery, CL; Nakatsuji, N; Racowsky, C; Rooke, H; Rossant, J; Scholer, HR; Solbakk, JH; Taylor, P; Trounson, AO; Weissman, IL; Wilmut, I; Yu, J; Zoloth, L				Daley, George Q.; Ahrlund-Richter, Lars; Auerbach, Jonathan M.; Benvenisty, Nissim; Charo, R. Alta; Chen, Grace; Deng, Hong-kui; Goldstein, Lawrence S.; Hudson, Kathy L.; Hyun, Insoo; Junn, Sung Chull; Love, Jane; Lee, Eng Hin; McLaren, Anne; Mummery, Christine L.; Nakatsuji, Norio; Racowsky, Catherine; Rooke, Heather; Rossant, Janet; Schoeler, Hans R.; Solbakk, Jan Helge; Taylor, Patrick; Trounson, Alan O.; Weissman, Irving L.; Wilmut, Ian; Yu, John; Zoloth, Laurie			The ISSCR guidelines for human embryonic stem cell research	SCIENCE			English	Editorial Material							PARTICIPATION; PAYMENT		Childrens Hosp, Boston, MA 02115 USA; Karolinska Inst, S-10401 Stockholm, Sweden; Hebrew Univ Jerusalem, IL-91905 Jerusalem, Israel; Univ Wisconsin, Sch Law, Madison, WI 53706 USA; Bird & Bird, Beijing, Peoples R China; Peking Univ, Beijing 100871, Peoples R China; Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Johns Hopkins Univ, Berman Bioeth Inst, Baltimore, MD 21218 USA; Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA; Inst Global Management, Seoul, South Korea; Wilmer Cutler Pickering Hale & Dorr LLP, Washington, DC USA; Natl Univ Singapore, Singapore 117548, Singapore; Univ Cambridge, Cambridge CB2 1TN, England; Univ Utrecht, Sch Med, NL-3508 TC Utrecht, Netherlands; Kyoto Univ, Kyoto, Japan; Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Univ Toronto, Toronto, ON, Canada; Max Planck Inst Mol Biomed, Munster, Germany; Univ Oslo, N-0316 Oslo, Norway; Univ Bergen, N-5020 Bergen, Norway; Monash Univ, Clayton, Vic 3168, Australia; Stanford Univ, Sch Med, Stanford, CA 94305 USA; Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland; Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA	Harvard University; Boston Children's Hospital; Karolinska Institutet; Hebrew University of Jerusalem; University of Wisconsin System; University of Wisconsin Madison; Peking University; Howard Hughes Medical Institute; University of California System; University of California San Diego; Johns Hopkins University; Case Western Reserve University; National University of Singapore; University of Cambridge; Utrecht University; Kyoto University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Toronto; Max Planck Society; University of Oslo; University of Bergen; Monash University; Stanford University; University of Edinburgh; Academia Sinica - Taiwan; Northwestern University; Feinberg School of Medicine	Daley, GQ (corresponding author), Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	YU, JOHN/G-8954-2012; , HS/AAB-4434-2019; yu, john/AAA-9255-2021; Ahrlund-Richter, Lars/C-6226-2012; Lee, Eng Hin/I-3325-2019	, HS/0000-0003-2643-5136; Trounson, Alan/0000-0001-5469-0500; Mummery, Christine/0000-0002-4549-6535; Charo, Robin Alta/0000-0003-3710-1043; Yu, John/0000-0002-3237-4272				Bentley JP, 2004, J MED ETHICS, V30, P293, DOI 10.1136/jme.2002.001594; Ethics Comm Am Soc Reprod Med, 2000, FERTIL STERIL, V74, P216; Grady C, 2005, J CLIN INVEST, V115, P1681, DOI 10.1172/JCI25694; Halpern SD, 2004, ARCH INTERN MED, V164, P801, DOI 10.1001/archinte.164.7.801; *UK COMM HUM FERT, HUM FERT EMBR; Wendler D, 2002, J PEDIATR-US, V141, P166, DOI 10.1067/mpd.2002.124381	6	82	85	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2007	315	5812					603	604		10.1126/science.1139337	http://dx.doi.org/10.1126/science.1139337			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	131YR	17272706				2022-12-01	WOS:000243909400027
J	Miller, KA; Siscovick, DS; Sheppard, L; Shepherd, K; Sullivan, JH; Anderson, GL; Kaufman, JD				Miller, Kristin A.; Siscovick, David S.; Sheppard, Lianne; Shepherd, Kristen; Sullivan, Jeffrey H.; Anderson, Garnet L.; Kaufman, Joel D.			Long-term exposure to air pollution and incidence of cardiovascular events in women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MORTALITY; ASSOCIATION; PARTICLES; DISEASE; LINES	BACKGROUND: Fine particulate air pollution has been linked to cardiovascular disease, but previous studies have assessed only mortality and differences in exposure between cities. We examined the association of long-term exposure to particulate matter of less than 2.5 microm in aerodynamic diameter (PM(sub 2.5)) with cardiovascular events. METHODS: We studied 65,893 postmenopausal women without previous cardiovascular disease in 36 U.S. metropolitan areas from 1994 to 1998, with a median follow-up of 6 years. We assessed the women's exposure to air pollutants using the monitor located nearest to each woman's residence. Hazard ratios were estimated for the first cardiovascular event, adjusting for age, race or ethnic group, smoking status, educational level, household income, body-mass index, and presence or absence of diabetes, hypertension, or hypercholesterolemia. RESULTS: A total of 1816 women had one or more fatal or nonfatal cardiovascular events, as confirmed by a review of medical records, including death from coronary heart disease or cerebrovascular disease, coronary revascularization, myocardial infarction, and stroke. In 2000, levels of PM(sub 2.5) exposure varied from 3.4 to 28.3 microg per cubic meter (mean, 13.5). Each increase of 10 microg per cubic meter was associated with a 24% increase in the risk of a cardiovascular event (hazard ratio, 1.24; 95% confidence interval [CI], 1.09 to 1.41) and a 76% increase in the risk of death from cardiovascular disease (hazard ratio, 1.76; 95% CI, 1.25 to 2.47). For cardiovascular events, the between-city effect appeared to be smaller than the within-city effect. The risk of cerebrovascular events was also associated with increased levels of PM(sub 2.5) (hazard ratio, 1.35; 95% CI, 1.08 to 1.68). CONCLUSIONS: Long-term exposure to fine particulate air pollution is associated with the incidence of cardiovascular disease and death among postmenopausal women. Exposure differences within cities are associated with the risk of cardiovascular disease.	Univ Washington, Occupat & Environm Med Program, Dept Epidemiol, Seattle, WA 98105 USA; Univ Washington, Dept Med, Seattle, WA 98105 USA; Univ Washington, Dept Biostat, Seattle, WA 98105 USA; Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98105 USA; Fred Hutchinson Canc Res Ctr, Initiat Clin Coordinating Ctr, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Kaufman, JD (corresponding author), Univ Washington, Occupat & Environm Med Program, Dept Epidemiol, 4225 Roosevelt Way NE,Suite 100, Seattle, WA 98105 USA.	joelk@u.washington.edu	Sheppard, Lianne/AAF-6304-2021; Kaufman, Joel D/B-5761-2008	Sheppard, Lianne/0000-0003-1622-508X; Kaufman, Joel D/0000-0003-4174-9037; Anderson, Garnet/0000-0001-5087-7837	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K24ES013195, K23ES011139, P30ES007033, T32ES007262] Funding Source: NIH RePORTER; NIEHS NIH HHS [P30ES07033, K24ES013195, K24 ES013195-01A1, K24 ES013195, K24 ES013195-02, K23ES011139, T32ES07262] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abbey DE, 1999, AM J RESP CRIT CARE, V159, P373, DOI 10.1164/ajrccm.159.2.9806020; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Chen LH, 2005, ENVIRON HEALTH PERSP, V113, P1723, DOI 10.1289/ehp.8190; Chow JC, 2006, J AIR WASTE MANAGE, V56, P1368, DOI 10.1080/10473289.2006.10464545; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Heckbert SR, 2004, AM J EPIDEMIOL, V160, P1152, DOI 10.1093/aje/kwh314; Hoek G, 2002, LANCET, V360, P1203, DOI 10.1016/S0140-6736(02)11280-3; Jerrett M, 2005, EPIDEMIOLOGY, V16, P727, DOI 10.1097/01.ede.0000181630.15826.7d; Kaiser J, 1997, SCIENCE, V277, P466, DOI 10.1126/science.277.5325.466; Krewski D., 2000, REANALYSIS HARVARD 6; Kunzli N, 2005, ENVIRON HEALTH PERSP, V113, P201, DOI 10.1289/ehp.7523; Kunzli N, 2001, AM J EPIDEMIOL, V153, P1050, DOI 10.1093/aje/153.11.1050; McMichael AJ, 1998, INT J EPIDEMIOL, V27, P450, DOI 10.1093/ije/27.3.450; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Samet J M, 2000, Res Rep Health Eff Inst, V94, P5; Vedal S, 1997, J AIR WASTE MANAGE, V47, P551, DOI 10.1080/10473289.1997.10463922	18	1288	1357	3	393	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2007	356	5					447	458		10.1056/NEJMoa054409	http://dx.doi.org/10.1056/NEJMoa054409			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131HW	17267905				2022-12-01	WOS:000243860700005
J	Martin-Belmonte, F; Gassama, A; Datta, A; Yu, W; Rescher, U; Gerke, V; Mostov, K				Martin-Belmonte, Fernando; Gassama, Ama; Datta, Anirban; Yu, Wei; Rescher, Ursula; Gerke, Volker; Mostov, Keith			PTEN-mediated apical segregation of phosphoinositides controls epithelial morphogenesis through Cdc42	CELL			English	Article							BASOLATERAL PLASMA-MEMBRANE; CELL-POLARITY; BINDING-PROTEIN; EXCHANGE FACTOR; MDCK CELLS; IN-VIVO; COMPLEX; ACTIVATION; RAC1; DYNAMICS	Formation of the apical surface and lumen is a fundamental, yet poorly understood, step in epithelial organ development. We show that PTEN localizes to the apical plasma membrane during epithelial morphogenesis to mediate the enrichment of Ptdlns(4,5)P-2 at this domain during cyst development in three-dimensional culture. Ectopic Ptdlns(4,5)P-2 at the basolateral surface causes apical proteins to relocalize to the basolateral surface. Annexin 2 (Anx2) binds Ptdlns(4,5)P-2 and is recruited to the apical surface. Anx2 binds Cdc42, recruiting it to the apical surface. Cdc42 recruits aPKC to the apical surface. Loss of function of PTEN, Anx2, Cdc42, or aPKC prevents normal development of the apical surface and lumen. We conclude that the mechanism of PTEN, Ptdlns(4,5)P-2, Anx2, Cdc42, and aPKC controls apical plasma membrane and lumen formation.	Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Inst Med Biochem, D-48149 Munster, Germany	University of California System; University of California San Francisco	Martin-Belmonte, F (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	fernando.martin-belmonte@ucsf.edu	Gassama, Ama/M-8832-2017; Martin-Belmonte, Fernando/J-8029-2014	Martin-Belmonte, Fernando/0000-0002-2564-4430; mostov, keith/0000-0002-8123-6247	NIAID NIH HHS [P01 AI053194] Funding Source: Medline; NIDDK NIH HHS [R01 DK067153] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI053194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067153] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Bayless KJ, 2002, J CELL SCI, V115, P1123; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Hansen MDH, 2002, J BIOL CHEM, V277, P45371, DOI 10.1074/jbc.M207747200; Hansen MDH, 2001, CURR BIOL, V11, P356, DOI 10.1016/S0960-9822(01)00091-4; HARDER T, 1993, J CELL BIOL, V123, P1119, DOI 10.1083/jcb.123.5.1119; Harris TJC, 2005, J CELL BIOL, V170, P813, DOI 10.1083/jcb.200505127; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Horne-Badovinac S, 2001, CURR BIOL, V11, P1492, DOI 10.1016/S0960-9822(01)00458-4; Hurd TW, 2003, CURR BIOL, V13, P2082, DOI 10.1016/j.cub.2003.11.020; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Kawakatsu T, 2002, J BIOL CHEM, V277, P50749, DOI 10.1074/jbc.M209846200; Kazmierczak BI, 2004, MOL BIOL CELL, V15, P411, DOI 10.1091/mbc.E03-08-0559; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Lacalle RA, 2004, J CELL SCI, V117, P6207, DOI 10.1242/jcs.01545; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Malacombe M, 2006, EMBO J, V25, P3494, DOI 10.1038/sj.emboj.7601247; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Merrifield CJ, 2001, CURR BIOL, V11, P1136, DOI 10.1016/S0960-9822(01)00321-9; Mertens AEE, 2005, J CELL BIOL, V170, P1029, DOI 10.1083/jcb.200502129; MONTESANO R, 1991, CELL, V66, P697, DOI 10.1016/0092-8674(91)90115-F; Munro EM, 2006, CURR OPIN CELL BIOL, V18, P86, DOI 10.1016/j.ceb.2005.12.007; Musch A, 2001, EMBO J, V20, P2171, DOI 10.1093/emboj/20.9.2171; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Nunbhakdi-Craig V, 2002, J CELL BIOL, V158, P967, DOI 10.1083/jcb.200206114; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; Puisieux A, 1996, BIOCHEM J, V313, P51, DOI 10.1042/bj3130051; Rescher U, 2004, J CELL SCI, V117, P3473, DOI 10.1242/jcs.01208; Schmid AC, 2004, FEBS LETT, V566, P35, DOI 10.1016/j.febslet.2004.03.102; Snyder JT, 2001, J BIOL CHEM, V276, P45868, DOI 10.1074/jbc.M106731200; Suzuki N, 2001, EMBO REP, V2, P530, DOI 10.1093/embo-reports/kve110; VEGASALAS DE, 1987, J CELL BIOL, V104, P1249, DOI 10.1083/jcb.104.5.1249; von Stein W, 2005, DEVELOPMENT, V132, P1675, DOI 10.1242/dev.01720; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; Yu W, 2003, MOL BIOL CELL, V14, P748, DOI 10.1091/mbc.e02-06-0350	47	532	540	1	29	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2007	128	2					383	397		10.1016/j.cell.2006.11.051	http://dx.doi.org/10.1016/j.cell.2006.11.051			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254974	Bronze, Green Accepted			2022-12-01	WOS:000244420500021
J	Kobasa, D; Jones, SM; Shinya, K; Kash, JC; Copps, J; Ebihara, H; Hatta, Y; Kim, JH; Halfmann, P; Hatta, M; Feldmann, F; Alimonti, JB; Fernando, L; Li, Y; Katze, MG; Feldmann, H; Kawaoka, Y				Kobasa, Darwyn; Jones, Steven M.; Shinya, Kyoko; Kash, John C.; Copps, John; Ebihara, Hideki; Hatta, Yasuko; Kim, Jin Hyun; Halfmann, Peter; Hatta, Masato; Feldmann, Friederike; Alimonti, Judie B.; Fernando, Lisa; Li, Yan; Katze, Michael G.; Feldmann, Heinz; Kawaoka, Yoshihiro			Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus	NATURE			English	Article							A VIRUSES; HEMAGGLUTININ; EXPRESSION; DISEASE; ORIGIN; GENES; ROLES	The 1918 influenza pandemic was unusually severe, resulting in about 50 million deaths worldwide(1). The 1918 virus is also highly pathogenic in mice, and studies have identified a multigenic origin of this virulent phenotype in mice(2-4). However, these initial characterizations of the 1918 virus did not address the question of its pathogenic potential in primates. Here we demonstrate that the 1918 virus caused a highly pathogenic respiratory infection in a cynomolgus macaque model that culminated in acute respiratory distress and a fatal outcome. Furthermore, infected animals mounted an immune response, characterized by dysregulation of the antiviral response, that was insufficient for protection, indicating that atypical host innate immune responses may contribute to lethality. The ability of influenza viruses to modulate host immune responses, such as that demonstrated for the avian H5N1 influenza viruses(5), may be a feature shared by the virulent influenza viruses.	Univ Tokyo, Dept Microbiol & Immunol, Div Virol, Tokyo 1088639, Japan; Publ Hlth Agcy Canada, Special Pathogens Program Natl Microbiol Lab, Winnipeg, MB R3E 3R2, Canada; Univ Manitoba, Dept Immunol, Winnipeg, MB R3E 3R2, Canada; Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3E 3R2, Canada; Tottori Univ, Avian Zoonosis Res Ctr, Tottori 6808550, Japan; Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Canadian Sci Ctr Human & Anim Hlth, Winnipeg, MB R3E 3M4, Canada; Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Tokyo 1088639, Japan; Japan Sci & Technol Agcy, CREST, Saitama 3220012, Japan; Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA	University of Tokyo; Public Health Agency of Canada; University of Manitoba; University of Manitoba; Tottori University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Canadian Food Inspection Agency; Canadian Science Centre for Human & Animal Health; University of Tokyo; Japan Science & Technology Agency (JST); University of Wisconsin System; University of Wisconsin Madison	Kawaoka, Y (corresponding author), Univ Tokyo, Dept Microbiol & Immunol, Div Virol, Tokyo 1088639, Japan.	kawaokay@svm.vetmed.wisc.edu	Kash, John/ABE-8280-2021; Halfmann, Peter/W-8084-2019	Ebihara, Hideki/0000-0002-2576-9735				Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; Baas T, 2006, J VIROL, V80, P10813, DOI 10.1128/JVI.00851-06; Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kash JC, 2006, J VIROL, V80, P3009, DOI 10.1128/JVI.80.6.3009-3020.2006; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Krug RM, 2003, VIROLOGY, V309, P181, DOI 10.1016/S0042-6822(03)00119-3; Kuiken T, 2003, VET PATHOL, V40, P304, DOI 10.1354/vp.40-3-304; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; Matikainen S, 2006, J VIROL, V80, P3515, DOI 10.1128/JVI.80.7.3515-3522.2006; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reid AH, 2000, P NATL ACAD SCI USA, V97, P6785, DOI 10.1073/pnas.100140097; Reid AH, 2004, J VIROL, V78, P12462, DOI 10.1128/JVI.78.22.12462-12470.2004; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Reid AH, 2002, J VIROL, V76, P10717, DOI 10.1128/JVI.76.21.10717-10723.2002; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Skoner DP, 1999, J INFECT DIS, V180, P10, DOI 10.1086/314823; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Tumpey TM, 2002, P NATL ACAD SCI USA, V99, P13849, DOI 10.1073/pnas.212519699; Winternitz MC, 1920, PATHOLOGY INFLUENZA	30	729	766	0	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2007	445	7125					319	323		10.1038/nature05495	http://dx.doi.org/10.1038/nature05495			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126HT	17230189				2022-12-01	WOS:000243504700046
J	Willett, WC; Collins, FS; Manolio, TA				Willett, Walter C.; Collins, Francis S.; Manolio, Teri A.			Merging and emerging cohorts	NATURE			English	Editorial Material							PROSTATE-CANCER; GENE; BREAST		Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Willett, WC (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.	walter.willett@channing.harvard.edu	Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291	NATIONAL CANCER INSTITUTE [R01CA092447] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA092447] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Collins FS, 2004, NATURE, V429, P475, DOI 10.1038/nature02628; Feigelson HS, 2006, CANCER RES, V66, P2468, DOI 10.1158/0008-5472.CAN-05-3574; Hunter DJ, 2005, NAT REV CANCER, V5, P977, DOI 10.1038/nrc1754; Land CE, 2003, RADIAT RES, V160, P707, DOI 10.1667/RR3082; LANGHOLZ B, 1999, MONOGR NATL CANC I, V26, P39; National Heart Lung and Blood Institute, NAT HEART LUNG BLOOD; Samet JM, 1998, EPIDEMIOL REV, V20, P1; Smith-Warner SA, 2006, AM J EPIDEMIOL, V163, P1053, DOI 10.1093/aje/kwj127; Spivey A, 2006, ENVIRON HEALTH PERSP, V114, pA466, DOI 10.1289/ehp.114-a466; Watts G, 2006, BRIT MED J, V332, P1052	11	56	61	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2007	445	7125					257	258		10.1038/445257a	http://dx.doi.org/10.1038/445257a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126HT	17230171				2022-12-01	WOS:000243504700021
J	Grijalva, CG; Nuorti, JP; Arbogast, PG; Martin, SW; Edwards, KM; Griffin, MR				Grijalva, Carlos G.; Nuorti, J. Pekka; Arbogast, Patrick G.; Martin, Stacey W.; Edwards, Kathryn M.; Griffin, Marie R.			Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis	LANCET			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; STREPTOCOCCUS-PNEUMONIAE; CHILDREN YOUNGER; DISEASE; PREVENTION; INFLUENZA; EFFICACY; IMPACT; TRIAL; HIV	Background Routine infant immunisation with seven-valent pneumococcal conjugate vaccine (PCV7) began in the USA in 2000. Although invasive pneumococcal disease has declined substantially, the programme's effect on hospital admissions for pneumonia is unknown. We therefore assessed the effect of the programme on rates of all-cause and pneumococcal pneumonia admissions. Methods Data from the Nationwide Inpatient Sample, the largest inpatient database available in the USA, were analysed with an interrupted time-series analysis that used pneumonia (all-cause and pneumococcal) admission rates as the main outcomes. Monthly admission rates estimated for years after the introduction of PCV7 vaccination (2001-2004) were compared with expected rates calculated from pre-PCV7 years (1997-1999). The year of vaccine introduction (2000) was excluded, and rates of admission for dehydration were assessed for comparison. Findings At the end of 2004, all-cause pneumonia admission rates had declined by 39% (95% CI 22-52) for children younger than 2 years, who were the target population of the vaccination programme. This annual decline in all-cause pneumonia admissions of 506 (291-675) per 100 000 children younger than 2 years represented about 41000 pneumonia admissions prevented in 2004. During the 8 study years, 10 659 (2%) children younger than 2 years admitted with pneumonia were coded as having pneumococcal disease; these rates declined by 65% (47-77). This decline represented about 17 fewer admissions per 100 000 children in 2004. Admission rates for dehydration for children younger than 2 years remained stable over the study period. Interpretation The reduction in all-cause pneumonia admissions in children younger than 2 years provides an estimate of the proportion of childhood pneumonias attributable to Streptococcus pneumoniae in the USA that are vaccine preventable. Our results contribute to the growing body of evidence supporting the beneficial effects of the pneumococcal conjugate vaccines in children.	Vanderbilt Univ, Sch Med, Dept Prevent Med, Village Vanderbilt,Suite 2600,1500 21st Ave, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Ctr Educ & Res Therapeut, Nashville, TN 37212 USA; VA TN Valley Hlth Care Syst, Mids Geriatr Res Educ, Nashville, TN USA; VA TN Valley Hlth Care Syst, Clin Res Ctr Excellence, Nashville, TN USA; Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Centers for Disease Control & Prevention - USA	Griffin, MR (corresponding author), Vanderbilt Univ, Sch Med, Dept Prevent Med, Village Vanderbilt,Suite 2600,1500 21st Ave, Nashville, TN 37212 USA.	marie.griffin@vanderbilt.edu		Grijalva, Carlos/0000-0002-2329-7797	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R03HS016784] Funding Source: NIH RePORTER; AHRQ HHS [1R03 HS016784] Funding Source: Medline; PHS HHS [U38/CCU417958] Funding Source: Medline; ATSDR CDC HHS [TS-0825, TS-1392] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); ATSDR CDC HHS		Abramson JS, 2000, PEDIATRICS, V106, P362; *AG HEALTHC RES QU, HEALTHC COST UT PR; *AG HEALTHC RES QU, 1996, HEALTHC COST UT PROJ; Agency for Healthcare Research and Quality U.S. Department of Health & Human Services, HEALTHC COST UT PROJ; *AHRQ, 2002, HCUP FACT BOOK; Anderson Robert N, 2005, Natl Vital Stat Rep, V53, P1; ANDREWS BE, 1987, Q J MED, V62, P195; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 2005, MMWR MORB MORTAL WKL, V54, P893; [Anonymous], 2006, MMWR-MORBID MORTAL W, V55, P1065; Black SB, 2002, PEDIATR INFECT DIS J, V21, P810, DOI 10.1097/00006454-200209000-00005; *CDCP, COV IND VACC VACC SE; *CDCP, NAT IMM PROGR VACC C; *CDCP, INFL ACT; Cook T.D., 1979, QUASIEXPERIMENTATION; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Drummond P, 2000, ARCH DIS CHILD, V83, P408, DOI 10.1136/adc.83.5.408; Farha Talal, 2005, Paediatr Respir Rev, V6, P76, DOI 10.1016/j.prrv.2005.03.001; Grijalva CG, 2006, PEDIATRICS, V118, P865, DOI 10.1542/peds.2006-0492; Grijalva CG, 2006, CLIN INFECT DIS, V43, P680, DOI 10.1086/506945; Guevara RE, 1999, AM J EPIDEMIOL, V149, P282, DOI 10.1093/oxfordjournals.aje.a009804; Hansen J, 2006, PEDIATR INFECT DIS J, V25, P779, DOI 10.1097/01.inf.0000232706.35674.2f; Hebert PL, 2005, MED CARE RES REV, V62, P560, DOI 10.1177/1077558705279310; Heffernan RT, 2005, J INFECT DIS, V191, P2038, DOI 10.1086/430356; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jackson ML, 2004, CLIN INFECT DIS, V39, P1642, DOI 10.1086/425615; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Levine OS, 2006, LANCET, V367, P1880, DOI 10.1016/S0140-6736(06)68703-5; Little RJ., 2019, STAT ANAL MISSING DA, VVolume 793; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709; McIntosh K, 2002, NEW ENGL J MED, V346, P429, DOI 10.1056/NEJMra011994; Melegaro A, 2004, EUR J EPIDEMIOL, V19, P353, DOI 10.1023/B:EJEP.0000024701.94769.98; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; Mulholland K, 2005, TROP MED INT HEALTH, V10, P497, DOI 10.1111/j.1365-3156.2005.01430.x; Nuorti JP, 2000, ANN INTERN MED, V132, P182, DOI 10.7326/0003-4819-132-3-200002010-00003; NUORTI JP, 2006, 5 INT S PNEUM PNEUM; O'Brien KL, 2003, VACCINE, V21, P1815, DOI 10.1016/S0264-410X(02)00807-1; Obaro SK, 2006, LANCET INFECT DIS, V6, P150, DOI 10.1016/S1473-3099(06)70411-X; Poehling KA, 2004, PEDIATRICS, V114, P755, DOI 10.1542/peds.2003-0592-F; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wardlaw T, 2006, LANCET, V368, P1048, DOI 10.1016/S0140-6736(06)69334-3; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; 1998, MMWR MORB MORTAL WKL, V47, P797	45	502	533	0	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2007	369	9568					1179	1186		10.1016/S0140-6736(07)60564-9	http://dx.doi.org/10.1016/S0140-6736(07)60564-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155RH	17416262				2022-12-01	WOS:000245595100029
J	Li, QJ; Chau, J; Ebert, PJR; Sylvester, G; Min, H; Liu, G; Braich, R; Manoharan, M; Soutschek, J; Skare, P; Klein, LO; Davis, MM; Chen, CZ				Li, Qi-Jing; Chau, Jacqueline; Ebert, Peter J. R.; Sylvester, Giselle; Min, Hyeyoung; Liu, Gwen; Braich, Ravi; Manoharan, Muthiah; Soutschek, Juergen; Skare, Petra; Klein, Lawrence O.; Davis, Mark M.; Chen, Chang-Zheng			miR-181a is an intrinsic modulator of T cell sensitivity and selection	CELL			English	Article							TYROSINE-PHOSPHATASE; LIGAND RECOGNITION; IN-VIVO; RECEPTOR; MICRORNAS; DISCRIMINATION; ANTIGEN; TCR; ANTAGONISM; MECHANISM	T cell sensitivity to antigen is intrinsically regulated during maturation to ensure proper development of immunity and tolerance, but how this is accomplished remains elusive. Here we show that increasing miR-181a expression in mature T cells augments the sensitivity to peptide antigens, while inhibiting miR-181a expression in the immature T cells reduces sensitivity and impairs both positive and negative selection. Moreover, quantitative regulation of T cell sensitivity by miR-181a enables mature T cells to recognize antagonists-the inhibitory peptide antigens-as agonists. These effects are in part achieved by the downregulation of multiple phosphatases, which leads to elevated steady-state levels of phosphorylated intermediates and a reduction of the T cell receptor signaling threshold. Importantly, higher miR-181a expression correlates with greater T cell sensitivity in immature T cells, suggesting that miR-181a acts as an intrinsic antigen sensitivity "rheostat" during T cell development.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Baxter Lab, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Grad Program Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Grad Program Biophys, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Inst Stem Cell Canc & Med, Stanford, CA 94305 USA; Alnylam Pharmaceut, Cambridge, MA 02142 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	mdavis@pmgm2.stanford.edu; czchen@stanford.edu		Chen, Chang-Zheng/0000-0002-1620-242X; Davis, Mark/0000-0001-6868-657X	NHLBI NIH HHS [R01 HL081612, R01 HL081612-03, R01-HL081612, R01 HL081612-02, R01 HL081612-01] Funding Source: Medline; NIAID NIH HHS [R01 AI073724, T32 AI007328] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328, R01AI073724] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BODMER H, 1994, SCIENCE, V263, P1284, DOI 10.1126/science.7510069; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; DEMAGISTRIS MT, 1992, CELL, V68, P625, DOI 10.1016/0092-8674(92)90139-4; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Dittel BN, 1999, IMMUNITY, V11, P289, DOI 10.1016/S1074-7613(00)80104-1; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Gudmundsdottir H, 1999, J IMMUNOL, V162, P5212; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Kersh GJ, 1996, J EXP MED, V184, P1259, DOI 10.1084/jem.184.4.1259; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; Mandl M, 2005, MOL CELL BIOL, V25, P1830, DOI 10.1128/MCB.25.5.1830-1845.2005; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; PIRCHER H, 1991, NATURE, V351, P482, DOI 10.1038/351482a0; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Rabinowitz JD, 1996, P NATL ACAD SCI USA, V93, P1401, DOI 10.1073/pnas.93.4.1401; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Salmond RJ, 2005, J IMMUNOL, V175, P6498, DOI 10.4049/jimmunol.175.10.6498; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Sumen C, 2004, J CELL BIOL, V166, P579, DOI 10.1083/jcb.200404059; Theodosiou A, 2002, GENOME BIOL, V3; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; WINKLER DG, 1993, P NATL ACAD SCI USA, V90, P5176, DOI 10.1073/pnas.90.11.5176; Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Yamasaki S, 2006, NAT IMMUNOL, V7, P67, DOI 10.1038/ni1290	44	947	1060	0	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 6	2007	129	1					147	161		10.1016/j.cell.2007.03.008	http://dx.doi.org/10.1016/j.cell.2007.03.008			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17382377	Bronze			2022-12-01	WOS:000245661100018
J	Luo, JL; Tan, W; Ricono, JM; Korchynskyi, O; Zhang, M; Gonias, SL; Cheresh, DA; Karin, M				Luo, Jun-Li; Tan, Wei; Ricono, Jill M.; Korchynskyi, Olexandr; Zhang, Ming; Gonias, Steven L.; Cheresh, David A.; Karin, Michael			Nuclear cytokine-activated IKK alpha controls prostate cancer metastasis by repressing Maspin	NATURE			English	Article							NF-KAPPA-B; MAMMARY-GLAND DEVELOPMENT; TRANSCRIPTION FACTOR; TRANSGENIC MOUSE; BONE METASTASIS; TUMOR-GROWTH; EXPRESSION; CELLS; INFLAMMATION; PROGRESSION	Inflammation enhances tumour promotion through NF-kappa B-dependent mechanisms(1). NF-kappa B was also proposed to promote metastatogenesis through epithelial - mesenchymal transition(2). Yet a mechanistic link between inflammation and metastasis is missing. We identified a role for I kappa B kinase alpha (IKK alpha), activated by receptor activator of NF-kappa B (RANK/TNFRSF11A), in mammary epithelial proliferation during pregnancy(3). Owing to similarities between mammary and prostate epithelia, we examined IKK alpha involvement in prostate cancer and its progression. Here we show that a mutation that prevents IKK alpha activation slows down CaP growth and inhibits metastatogenesis in TRAMP mice, which express SV40 T antigen in the prostate epithelium(4). Decreased metastasis correlated with elevated expression of the metastasis suppressor Maspin(5), the ablation of which restored metastatic activity. IKK alpha activation by RANK ligand (RANKL/TNFSF11) inhibits Maspin expression in prostate epithelial cells, whereas repression of Maspin transcription requires nuclear translocation of active IKK alpha. The amount of active nuclear IKK alpha in mouse and human prostate cancer correlates with metastatic progression, reduced Maspin expression and infiltration of prostate tumours with RANKL-expressing inflammatory cells. We propose that tumour-infiltrating RANKL-expressing cells lead to nuclear IKK alpha activation and inhibition of Maspin transcription, thereby promoting the metastatic phenotype.	Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Baylor College of Medicine	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Korchynskyi, Olexandr/ADA-6398-2022; Tan, Weihong/AAA-4536-2020; Tan, Weihong/A-5412-2008	Tan, Weihong/0000-0002-8066-1524; Luo, Jun-Li/0000-0002-7625-4766; Korchynskyi, Olexandr/0000-0002-4557-4003	NATIONAL CANCER INSTITUTE [R01CA127923] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA127923] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Chen EI, 2006, IUBMB LIFE, V58, P25, DOI 10.1080/15216540500531721; Cher ML, 2003, P NATL ACAD SCI USA, V100, P7847, DOI 10.1073/pnas.1331360100; Chuang CK, 2003, J FORMOS MED ASSOC, V102, P480; DeMarzo AM, 2003, LANCET, V361, P955, DOI 10.1016/S0140-6736(03)12779-1; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Lockett J, 2006, J CELL BIOCHEM, V97, P651, DOI 10.1002/jcb.20721; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Montironi R, 2006, BJU INT, V97, P485, DOI 10.1111/j.1464-410X.2005.05972.x; Morimoto-Tomita M, 2005, CLIN EXP METASTAS, V22, P513, DOI 10.1007/s10585-005-3585-0; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Sato N, 2004, ONCOGENE, V23, P1531, DOI 10.1038/sj.onc.1207269; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Sil AK, 2004, NATURE, V428, P660, DOI 10.1038/nature02421; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Zhang M, 2000, ONCOGENE, V19, P6053, DOI 10.1038/sj.onc.1204006; Zhang M, 1999, DEV BIOL, V215, P278, DOI 10.1006/dbio.1999.9442; Zou ZQ, 2002, CLIN CANCER RES, V8, P1172; Zou ZQ, 2000, J BIOL CHEM, V275, P6051, DOI 10.1074/jbc.275.9.6051; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	30	347	368	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2007	446	7136					690	694		10.1038/nature05656	http://dx.doi.org/10.1038/nature05656			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17377533				2022-12-01	WOS:000245438300045
J	Fukami, T; Beaumont, HJE; Zhang, XX; Rainey, PB				Fukami, Tadashi; Beaumont, Hubertus J. E.; Zhang, Xue-Xian; Rainey, Paul B.			Immigration history controls diversification in experimental adaptive radiation	NATURE			English	Article							SPECIES-AREA RELATIONSHIP; PSEUDOMONAS-FLUORESCENS; SPECIATION; EVOLUTION; DETERMINISM; CONTINGENCY; ADAPTATION; DIVERGENCE; DIVERSITY; ISLANDS	Diversity in biological communities is a historical product of immigration, diversification and extinction(1-4), but the combined effect of these processes is poorly understood. Here we show that the order and timing of immigration controls the extent of diversification. When an ancestral bacterial genotype was introduced into a spatially structured habitat, it rapidly diversified into multiple niche-specialist types(5). However, diversification was suppressed when a niche-specialist type was introduced before, or shortly after, introduction of the ancestral genotype. In contrast, little suppression occurred when the same niche specialist was introduced relatively late. The negative impact of early arriving immigrants was attributable to the historically sensitive outcome of interactions involving neutral competition(3) and indirect facilitation. Ultimately, the entire boom-and-bust dynamics of adaptive radiation were altered. These results demonstrate that immigration and diversification are tightly linked processes, with small differences in immigration history greatly affecting the evolutionary emergence of diversity.	Univ Hawaii Manoa, Dept Zool, Honolulu, HI 96822 USA; Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of Hawaii System; University of Hawaii Manoa; University of Auckland	Fukami, T (corresponding author), Univ Hawaii Manoa, Dept Zool, Honolulu, HI 96822 USA.	tfukami@hawaii.edu	Zhang, Xue-Xian/B-8143-2008; Fukami, Tadashi/A-2934-2010; Zhang, Xue-Xian/AAP-1415-2020; Rainey, Paul/A-3207-2008	Zhang, Xue-Xian/0000-0002-6536-3529; Fukami, Tadashi/0000-0001-5654-4785; Rainey, Paul/0000-0003-0879-5795				Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Cowie RH, 1995, EVOLUTION, V49, P1191, DOI [10.2307/2410444, 10.1111/j.1558-5646.1995.tb04446.x]; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; DRAKE JA, 1991, AM NAT, V137, P1, DOI 10.1086/285143; Emerson BC, 2005, EVOLUTION, V59, P586; Emerson BC, 2005, NATURE, V434, P1015, DOI 10.1038/nature03450; Emerson BC, 2002, MOL ECOL, V11, P951, DOI 10.1046/j.1365-294X.2002.01507.x; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Fukami T, 2003, NATURE, V424, P423, DOI 10.1038/nature01785; Gavrilets S, 2005, P NATL ACAD SCI USA, V102, P18040, DOI 10.1073/pnas.0506330102; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; GILLESPIE RG, 1994, P NATL ACAD SCI USA, V91, P2290, DOI 10.1073/pnas.91.6.2290; Goymer P, 2006, GENETICS, V173, P515, DOI 10.1534/genetics.106.055863; Hubbell Stephen P., 2001, V32, pi; Kassen R, 2004, NATURE, V431, P984, DOI 10.1038/nature02923; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; Losos JB, 2003, TRENDS ECOL EVOL, V18, P220, DOI 10.1016/S0169-5347(03)00037-5; MAC ARTHUR ROBERT H., 1967; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rainey PB, 1999, ENVIRON MICROBIOL, V1, P243, DOI 10.1046/j.1462-2920.1999.00040.x; RAINEY PB, 2005, INFLUENCE COOPERATIV, P83; Ricklefs R.E., 1993, J EVOLUTION BIOL, DOI DOI 10.1046/J.1420-9101.1993.6020171.X; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Seehausen O, 2006, P ROY SOC B-BIOL SCI, V273, P1987, DOI 10.1098/rspb.2006.3539; Taylor EB, 2000, P ROY SOC B-BIOL SCI, V267, P2375, DOI 10.1098/rspb.2000.1294; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Weiher E., 1999, ECOLOGICAL ASSEMBLY	30	171	172	3	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2007	446	7134					436	439		10.1038/nature05629	http://dx.doi.org/10.1038/nature05629			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17377582				2022-12-01	WOS:000245079500039
J	Taga, ME; Larsen, NA; Howard-Jones, AR; Walsh, CT; Walker, GC				Taga, Michiko E.; Larsen, Nicholas A.; Howard-Jones, Annaleise R.; Walsh, Christopher T.; Walker, Graham C.			BluB cannibalizes flavin to form the lower ligand of vitamin B-12	NATURE			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; REDUCED FLAVIN; COENZYME B-12; BIOSYNTHESIS; 5,6-DIMETHYLBENZIMIDAZOLE; TRANSFORMATION; MONOOXYGENASE; RIBOFLAVIN; MECHANISM	Vitamin B-12 (cobalamin) is among the largest known non-polymeric natural products, and the only vitamin synthesized exclusively by microorganisms(1). The biosynthesis of the lower ligand of vitamin B-12, 5,6-dimethylbenzimidazole (DMB), is poorly understood(1-3). Recently, we discovered that a Sinorhizobium meliloti gene, bluB, is necessary for DMB biosynthesis(4). Here we show that BluB triggers the unprecedented fragmentation and contraction of the bound flavin mononucleotide cofactor and cleavage of the ribityl tail to form DMB and D-erythrose 4-phosphate. Our structural analysis shows that BluB resembles an NAD(P)H-flavin oxidoreductase, except that its unusually tight binding pocket accommodates flavin mononucleotide but not NAD( P) H. We characterize crystallographically an early intermediate along the reaction coordinate, revealing molecular oxygen poised over reduced flavin. Thus, BluB isolates and directs reduced flavin to activate molecular oxygen for its own cannibalization. This investigation of the biosynthesis of DMB provides clarification of an aspect of vitamin B-12 that was otherwise incomplete, and may contribute to a better understanding of vitamin B-12-related disease.	MIT, Dept Biol, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Walsh, CT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	christopher_walsh@hms.harvard.edu		/0000-0001-7243-8261	NIGMS NIH HHS [R01 GM031030-25, R01 GM020011-30, R01 GM031030, R01 GM020011] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020011, R01GM031030] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; Campbell GRO, 2006, P NATL ACAD SCI USA, V103, P4634, DOI 10.1073/pnas.0509384103; Cicchillo RM, 2005, J AM CHEM SOC, V127, P2860, DOI 10.1021/ja042428u; Dong CJ, 2005, SCIENCE, V309, P2216, DOI 10.1126/science.1116510; Eichhorn E, 1999, J BIOL CHEM, V274, P26639, DOI 10.1074/jbc.274.38.26639; Eswaramoorthy S, 2006, P NATL ACAD SCI USA, V103, P9832, DOI 10.1073/pnas.0602398103; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Gatti DL, 1996, BIOCHEMISTRY-US, V35, P567, DOI 10.1021/bi951344i; HECHT HJ, 1995, NAT STRUCT BIOL, V2, P1109, DOI 10.1038/nsb1295-1109; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HORIG JA, 1980, EUR J BIOCHEM, V105, P587, DOI 10.1111/j.1432-1033.1980.tb04536.x; Keck K, 1998, ARCH MICROBIOL, V171, P66, DOI 10.1007/s002030050679; Koike H, 1998, J MOL BIOL, V280, P259, DOI 10.1006/jmbi.1998.1871; KOLONKO B, 1992, Z NATURFORSCH C, V47, P171; Larsen NA, 2006, BIOCHEMISTRY-US, V45, P10184, DOI 10.1021/bi060950i; Lei BF, 1998, BIOCHEMISTRY-US, V37, P14623, DOI 10.1021/bi981841+; LINGENS B, 1992, EUR J BIOCHEM, V207, P981, DOI 10.1111/j.1432-1033.1992.tb17133.x; Lovering AL, 2001, J MOL BIOL, V309, P203, DOI 10.1006/jmbi.2001.4653; Maggio-Hall LA, 2003, ORG LETT, V5, P2211, DOI 10.1021/ol034530m; Malito E, 2004, P NATL ACAD SCI USA, V101, P13157, DOI 10.1073/pnas.0404538101; Renz P., 1999, Chemistry and biochemistry of B12., P557; RENZ P, 1970, FEBS LETT, V6, P187, DOI 10.1016/0014-5793(70)80053-9; RENZ P, 1972, FEBS LETT, V22, P124, DOI 10.1016/0014-5793(72)80236-9; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; Tanner JJ, 1996, BIOCHEMISTRY-US, V35, P13531, DOI 10.1021/bi961400v; Tu SC, 2001, ANTIOXID REDOX SIGN, V3, P881, DOI 10.1089/15230860152665046; Warren MJ, 2006, P NATL ACAD SCI USA, V103, P4799, DOI 10.1073/pnas.0601030103	29	123	129	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2007	446	7134					449	453		10.1038/nature05611	http://dx.doi.org/10.1038/nature05611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	148MO	17377583	Green Accepted			2022-12-01	WOS:000245079500042
J	Simon, A; Frisen, J				Simon, Andras; Frisen, Jonas			From stem cell to progenitor and back again	CELL			English	Editorial Material							REGENERATION	Under normal homeostatic conditions, tissue stem cells undergo long-term self renewal and produce progeny that differentiate into several different cell types. But what happens if the stem cells are lost? In a recent issue of Developmental Cell, Nakagawa et W. (2007) propose that the progeny of stem cells, called transit-amplifying progenitor cells, are able to replace lost stem cells.	Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden	Karolinska Institutet	Frisen, J (corresponding author), Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	jonas.frisen@ki.se		Simon, Andras/0000-0002-1018-1891				Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Brinster RL, 2002, SCIENCE, V296, P2174, DOI 10.1126/science.1071607; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X	5	13	13	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2007	128	5					825	826		10.1016/j.cell.2007.02.026	http://dx.doi.org/10.1016/j.cell.2007.02.026			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350567	Bronze			2022-12-01	WOS:000245073400005
J	Dunne, EF; Unger, ER; Sternberg, M; McQuillan, G; Swan, DC; Patel, SS; Markowitz, LE				Dunne, Eileen F.; Unger, Elizabeth R.; Sternberg, Maya; McQuillan, Geraldine; Swan, David C.; Patel, Sonya S.; Markowitz, Lauri E.			Prevalence of HPV infection among females in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; YOUNG-WOMEN; SELF; TYPE-16; SAMPLES; SEROPREVALENCE; ACCEPTABILITY; EPIDEMIOLOGY; ADOLESCENT	Context Human papillomavirus (HPV) infection is estimated to be the most common sexually transmitted infection. Baseline population prevalence data for HPV infection in the United States before widespread availability of a prophylactic HPV vaccine would be useful. Objective To determine the prevalence of HPV among females in the United States. Design, Setting, and Participants The National Health and Nutrition Examination Survey ( NHANES) uses a representative sample of the US noninstitutionalized civilian population. Females aged 14 to 59 years who were interviewed at home for NHANES 2003-2004 were examined in a mobile examination center and provided a self-collected vaginal swab specimen. Swabs were analyzed for HPV DNA by L1 consensus polymerase chain reaction followed by type-specific hybridization. Demographic and sexual behavior information was obtained from all participants. Main Outcome Measures HPV prevalence by polymerase chain reaction. Results The overall HPV prevalence was 26.8% (95% confidence interval [CI], 23.3%-30.9%) among US females aged 14 to 59 years (n= 1921). HPV prevalence was 24.5% ( 95% CI, 19.6%-30.5%) among females aged 14 to 19 years, 44.8% ( 95% CI, 36.3%-55.3%) among women aged 20 to 24 years, 27.4% ( 95% CI, 21.9%-34.2%) among women aged 25 to 29 years, 27.5% ( 95% CI, 20.8%-36.4%) among women aged 30 to 39 years, 25.2% ( 95% CI, 19.7%-32.2%) among women aged 40 to 49 years, and 19.6% (95% CI, 14.3%-26.8%) among women aged 50 to 59 years. There was a statistically significant trend for increasing HPV prevalence with each year of age from 14 to 24 years ( P <. 001), followed by a gradual decline in prevalence through 59 years (P=. 06). HPV vaccine types 6 and 11 (low-risk types) and 16 and 18 (high-risk types) were detected in 3.4% of female participants; HPV-6 was detected in 1.3% ( 95% CI, 0.8%-2.3%), HPV-11 in 0.1% ( 95% CI, 0.03%-0.3%), HPV-16 in 1.5% ( 95% CI, 0.9%-2.6%), and HPV-18 in 0.8% ( 95% CI, 0.4%-1.5%) of female participants. Independent risk factors for HPV detection were age, marital status, and increasing numbers of lifetime and recent sex partners. Conclusions HPV is common among females in the United States. Our data indicate that the burden of prevalent HPV infection among females was greater than previous estimates and was highest among those aged 20 to 24 years. However, the prevalence of HPV vaccine types was relatively low.	Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Bethesda, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Dunne, EF (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,MS E-02, Atlanta, GA 30333 USA.	dde9@cdc.gov		Unger, Elizabeth/0000-0002-2925-5635				[Anonymous], 2000, Vital Health Stat 2, P1; Baldwin S, 2005, GYNECOL ONCOL, V97, P612, DOI 10.1016/j.ygyno.2005.02.001; Bosch F Xavier, 2003, J Natl Cancer Inst Monogr, P3; Casella G., 2021, STAT INFERENCE; Castle PE, 2004, J INFECT DIS, V190, P458, DOI 10.1086/421916; *CDCP, ACIP PROV REC US QUA; Dzuba IG, 2002, J WOMEN HEALTH GEN-B, V11, P265, DOI 10.1089/152460902753668466; Franco EL, 1999, J INFECT DIS, V180, P1415, DOI 10.1086/315086; Gravitt PE, 1998, J CLIN MICROBIOL, V36, P3020, DOI 10.1128/JCM.36.10.3020-3027.1998; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Gravitt PE, 2001, CANCER EPIDEM BIOMAR, V10, P95; Kahn JA, 2005, SEX TRANSM INFECT, V81, P408, DOI 10.1136/sti.2004.012047; Korn E, 1999, ANAL HLTH SURVEYS; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; Lorenzato FR, 2002, AM J OBSTET GYNECOL, V186, P962, DOI 10.1067/mob.2002.122390; Manhart LE, 2006, SEX TRANSM DIS, V33, P502, DOI 10.1097/01.olq.0000204545.89516.0a; Moscicki AB, 1998, J PEDIATR-US, V132, P277, DOI 10.1016/S0022-3476(98)70445-7; Ogilvie GS, 2005, SEX TRANSM INFECT, V81, P207, DOI 10.1136/sti.2004.011858; Peyton CL, 2001, J INFECT DIS, V183, P1554, DOI 10.1086/320696; Revzina NV, 2005, INT J STD AIDS, V16, P528, DOI 10.1258/0956462054679214; *SAS I INC, 2002, SAS COMP MICR WIND E; Sellors JW, 2000, CAN MED ASSOC J, V163, P513; SHAH BV, 2004, SUDAAN USERS MANUAL; Stone KM, 2002, J INFECT DIS, V186, P1396, DOI 10.1086/344354; Tarkowski TA, 2004, J INFECT DIS, V189, P46, DOI 10.1086/380466; Trottier H, 2006, VACCINE, V24, P4, DOI 10.1016/j.vaccine.2005.09.054; U.S. Census Bureau, RAT INC POV LEV; Vernon SD, 2000, J CLIN MICROBIOL, V38, P651, DOI 10.1128/JCM.38.2.651-655.2000; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Weinstock H, 2004, PERSPECT SEX REPRO H, V36, P6, DOI 10.1111/j.1931-2393.2004.tb00002.x; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964	33	1028	1072	5	59	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2007	297	8					813	819		10.1001/jama.297.8.813	http://dx.doi.org/10.1001/jama.297.8.813			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	140DS	17327523	Bronze			2022-12-01	WOS:000244485000024
J	Hellman, A; Chess, A				Hellman, Asaf; Chess, Andrew			Gene body-specific methylation on the active X chromosome	SCIENCE			English	Article							DNA METHYLATION; HPRT GENE; INACTIVATION; CELLS; SITES; WIDE; ARABIDOPSIS	Differential DNA methylation is important for the epigenetic regulation of gene expression. Allele-specific methylation of the inactive X chromosome has been demonstrated at promoter CpG islands, but the overall pattern of methylation on the active X (Xa) and inactive X ( Xi) chromosomes is unknown. We performed allele-specific analysis of more than 1000 informative loci along the human X chromosome. The Xa displays more than two times as much allele-specific methylation as Xi. This methylation is concentrated at gene bodies, affecting multiple neighboring CpGs. Before X inactivation, all of these Xa gene body-methylated sites are biallelically methylated. Thus, a bipartite methylation-demethylation program results in Xa-specific hypomethylation at gene promoters and hypermethylation at gene bodies. These results suggest a relationship between global methylation and expression potentiality.	Harvard Univ, Sch Med, Ctr Human Genet Res, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Hellman, A (corresponding author), Harvard Univ, Sch Med, Ctr Human Genet Res, 185 Cambridge St, Boston, MA 02114 USA.	hellman@chgr.mgh.harvard.edu; chess@chgr.mgh.harvard.edu						ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; FRANK D, 1991, NATURE, V351, P239, DOI 10.1038/351239a0; Gilbert SL, 1999, P NATL ACAD SCI USA, V96, P13825, DOI 10.1073/pnas.96.24.13825; Hashimshony T, 2003, NAT GENET, V34, P187, DOI 10.1038/ng1158; Heard E, 2004, CURR OPIN CELL BIOL, V16, P247, DOI 10.1016/j.ceb.2004.03.005; Hoffman LM, 2005, STEM CELLS, V23, P1468, DOI 10.1634/stemcells.2004-0371; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; LOCK LF, 1987, CELL, V48, P39, DOI 10.1016/0092-8674(87)90353-9; LOCK LF, 1986, MOL CELL BIOL, V6, P914, DOI 10.1128/MCB.6.3.914; MOHANDAS T, 1981, SCIENCE, V211, P393, DOI 10.1126/science.6164095; Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Schumacher A, 2006, NUCLEIC ACIDS RES, V34, P528, DOI 10.1093/nar/gkj461; Valley CM, 2006, CURR OPIN GENET DEV, V16, P240, DOI 10.1016/j.gde.2006.04.008; VIEGASPEQUIGNOT E, 1988, P NATL ACAD SCI USA, V85, P7657, DOI 10.1073/pnas.85.20.7657; VUAN E, 2006, CANCER RES, V66, P3443; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; WOLF SF, 1984, P NATL ACAD SCI-BIOL, V81, P2806, DOI 10.1073/pnas.81.9.2806; YEN PH, 1984, P NATL ACAD SCI-BIOL, V81, P1759, DOI 10.1073/pnas.81.6.1759; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	24	497	512	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2007	315	5815					1141	1143		10.1126/science.1136352	http://dx.doi.org/10.1126/science.1136352			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138UA	17322062				2022-12-01	WOS:000244387600041
J	Mullan, F				Mullan, Fitzhugh			Responding to the global HIV/AIDS crisis - A peace corps for health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									George Washington Univ, Dept Hlth Policy, Washington, DC 20006 USA	George Washington University	Mullan, F (corresponding author), George Washington Univ, Dept Hlth Policy, Suite 800,2021 K St NW, Washington, DC 20006 USA.	fmullan@gwu.edu						*AM INT HLTH ALL, WHAT IS TWINN; *ASS AM MED COLL, MED SCH GRAD QUEST 1; *BAYL INT PED AIDS, PED AIDS CORPS; *CTR GLOB DEV, COMM DEV IND 2006; *HJ KAIS FAM FDN, 2006, US FED FUND HIV AIDS; *I MED, 2005, HEAL ABROAD RESP HUM; *MED STUD ED, COST DEBT RES STIP F; PEPFAR, US PRES EM PLAN AIDS; WHO, 2006, WORLD HLTH REP 20O6, P190; *WHO, 2006, AFR REG REP HLTH PEO; WOLK M, 2006, COST IRAQ WAR COULD; World Health Organization, 2006, TREAT TRAIN RET AIDS	12	16	17	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2007	297	7					744	746		10.1001/jama.297.7.744	http://dx.doi.org/10.1001/jama.297.7.744			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	137KI	17312295				2022-12-01	WOS:000244291100028
J	Striemer, CC; Gaborski, TR; McGrath, JL; Fauchet, PM				Striemer, Christopher C.; Gaborski, Thomas R.; McGrath, James L.; Fauchet, Philippe M.			Charge- and size-based separation of macromolecules using ultrathin silicon membranes	NATURE			English	Article							MOLECULAR-TRANSPORT; ULTRAFILTRATION; CRYSTALLIZATION; NANOCOMPOSITE; DIFFUSION	Commercial ultrafiltration and dialysis membranes have broad pore size distributions and are over 1,000 times thicker than the molecules they are designed to separate, leading to poor size cutoff properties, filtrate loss within the membranes, and low transport rates(1,2). Nanofabricated membranes have great potential in molecular separation applications by offering more precise structural control(3,4), yet transport is also limited by micrometre-scale thicknesses(5). This limitation can be addressed by a new class of ultrathin nanostructured membranes where the membrane is roughly as thick (similar to 10 nm) as the molecules being separated, but membrane fragility and complex fabrication have prevented the use of ultrathin membranes for molecular separations(1). Here we report the development of an ultrathin porous nanocrystalline silicon (pnc-Si) membrane using straightforward silicon fabrication techniques that provide control over average pore sizes from approximately 5 nm to 25 nm. Our pnc-Si membranes can retain proteins while permitting the transport of small molecules at rates an order of magnitude faster than existing materials, separate differently sized proteins under physiological conditions, and separate similarly sized molecules carrying different charges. Despite being only 15 nm thick, pnc-Si membranes that are free-standing over 40,000 mu m(2) can support a full atmosphere of differential pressure without plastic deformation or fracture. By providing efficient, low-loss macromolecule separations, pnc-Si membranes are expected to enable a variety of new devices, including membrane-based chromatography systems and both analytical and preparative microfluidic systems that require highly efficient separations.	Univ Rochester, Dept Elect & Comp Engn, Rochester, NY 14627 USA; Univ Rochester, Dept Biomed Engn, Rochester, NY 14620 USA	University of Rochester; University of Rochester	Striemer, CC (corresponding author), Univ Rochester, Dept Elect & Comp Engn, 601 Elmwood Ave, Rochester, NY 14627 USA.	striemer@ece.rochester.edu	Gaborski, Thomas/F-4306-2012	McGrath, James/0000-0003-2017-8335				BERG HC, 1993, RANDOM WALKS BIOL, P34; Grom GF, 2000, NATURE, V407, P358, DOI 10.1038/35030062; Jiang CY, 2004, NAT MATER, V3, P721, DOI 10.1038/nmat1212; Karlsson D, 2002, BIOTECHNOL PROGR, V18, P1423, DOI 10.1021/bp0255659; Ku JR, 2004, LANGMUIR, V20, P2030, DOI 10.1021/la0357662; Kuiper S, 1998, J MEMBRANE SCI, V150, P1, DOI 10.1016/S0376-7388(98)00197-5; Lee SB, 2002, J AM CHEM SOC, V124, P11850, DOI 10.1021/ja027494f; Letant SE, 2003, NAT MATER, V2, P391, DOI 10.1038/nmat888; Li QY, 1997, J MEMBRANE SCI, V136, P181, DOI 10.1016/S0376-7388(97)00159-2; Mace CR, 2006, ANAL CHEM, V78, P5578, DOI 10.1021/ac060473+; Martin F, 2005, J CONTROL RELEASE, V102, P123, DOI 10.1016/j.jconrel.2004.09.024; Ouyang H, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2196069; Palik ED, 1985, HDB OPTICAL CONSTANT, DOI 10.1016/C2009-0-20920-2; Pujar NS, 1998, J CHROMATOGR A, V796, P229, DOI 10.1016/S0021-9673(97)01003-0; REISMAN A, 1979, J ELECTROCHEM SOC, V126, P1406, DOI 10.1149/1.2129289; Spinella C, 1998, J APPL PHYS, V84, P5383, DOI 10.1063/1.368873; Tong HD, 2004, NANO LETT, V4, P283, DOI 10.1021/nl0350175; Yamaguchi A, 2004, NAT MATER, V3, P337, DOI 10.1038/nmat1107; Zacharias M, 1999, APPL PHYS LETT, V74, P2614, DOI 10.1063/1.123914; Zacharias M, 2001, PHYSICA E, V11, P245, DOI 10.1016/S1386-9477(01)00212-0	20	596	626	9	419	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2007	445	7129					749	753		10.1038/nature05532	http://dx.doi.org/10.1038/nature05532			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17301789				2022-12-01	WOS:000244205200041
J	Rivera, MN; Kim, WJ; Wells, J; Driscoll, DR; Brannigan, BW; Han, M; Kim, JC; Feinberg, AP; Gerald, WL; Vargas, SO; Chin, L; Iafrate, AJ; Bell, DW; Haber, DA				Rivera, Miguel N.; Kim, Woo Jae; Wells, Julie; Driscoll, David R.; Brannigan, Brian W.; Han, Moonjoo; Kim, James C.; Feinberg, Andrew P.; Gerald, William L.; Vargas, Sara O.; Chin, Lynda; Iafrate, A. John; Bell, Daphne W.; Haber, Daniel A.			An X chromosome gene, WTX, is commonly inactivated in Wilms tumor	SCIENCE			English	Article							FANCONI-ANEMIA; HUMAN GENOME; CANCER; KIDNEY; MUTATIONS	Wilms tumor is a pediatric kidney cancer associated with inactivation of the WT1 tumor-suppressor gene in 5 to 10% of cases. Using a high-resolution screen for DNA copy-number alterations in Wilms tumor, we identified somatic deletions targeting a previously uncharacterized gene on the X chromosome. This gene, which we call WTX, is inactivated in approximately one-third of Wilms tumors (15 of 51 tumors). Tumors with mutations in WTX lack WT1 mutations, and both genes share a restricted temporal and spatial expression pattern in normal renal precursors. In contrast to biallelic inactivation of autosomal tumor-suppressor genes, WTX is inactivated by a monoallelic "single-hit" event targeting the single X chromosome in tumors from males and the active X chromosome in tumors from females.	Massachusetts Gen Hosp, Ctr Canc, Harvard Med Ctr, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; Johns Hopkins Univ, Sch Med, Dept Med, Div Mol Med, Baltimore, MD 21205 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Johns Hopkins University; Memorial Sloan Kettering Cancer Center; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Haber, DA (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Harvard Med Ctr, Boston, MA 02114 USA.	haber@helix.mgh.harvard.edu	Feinberg, Andrew/AAY-7666-2020	Feinberg, Andrew/0000-0002-8364-1991	NCI NIH HHS [P01-CA101942, T32-CA009216, R01 CA054358, R37 CA054358-17, R37 CA054358, R37-CA058596] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA101942, R01CA054358, T32CA009216, R37CA054358, R37CA058596] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brennan C, 2004, CANCER RES, V64, P4744, DOI 10.1158/0008-5472.CAN-04-1241; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Dome JS, 2002, CURR OPIN PEDIATR, V14, P5, DOI 10.1097/00008480-200202000-00002; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; Heard E, 1999, MOL CELL BIOL, V19, P3156; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; KNUDSON AG, 1972, J NATL CANCER I, V48, P313; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Maiti S, 2000, CANCER RES, V60, P6288; Meetei AR, 2004, NAT GENET, V36, P1219, DOI 10.1038/ng1458; Moore AW, 1999, DEVELOPMENT, V126, P1845; Nichols KE, 2005, IMMUNOL REV, V203, P180, DOI 10.1111/j.0105-2896.2005.00230.x; Pilia G, 1996, NAT GENET, V12, P241, DOI 10.1038/ng0396-241; PRITCHARDJONES K, 1990, NATURE, V346, P194, DOI 10.1038/346194a0; Rahman N, 2004, NAT GENET, V36, P1142, DOI 10.1038/ng1104-1142; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Rivera MN, 2005, NAT REV CANCER, V5, P699, DOI 10.1038/nrc1696; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Spatz A, 2004, NAT REV CANCER, V4, P617, DOI 10.1038/nrc1413; Yuan E, 2005, MOL CANCER RES, V3, P493, DOI 10.1158/1541-7786.MCR-05-0082	22	244	300	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2007	315	5812					642	645		10.1126/science.1137509	http://dx.doi.org/10.1126/science.1137509			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17204608				2022-12-01	WOS:000243909400042
J	Lathem, WW; Price, PA; Miller, VL; Goldman, WE				Lathem, Wyndham W.; Price, Paul A.; Miller, Virginia L.; Goldman, William E.			A plasminogen-activating protease specifically controls the development of primary pneumonic plague	SCIENCE			English	Article							YERSINIA-PESTIS; ESCHERICHIA-COLI; SURFACE PROTEASE; INFECTION; VIRULENCE; SEQUENCE; STRAINS; AGENT	Primary pneumonic plague is transmitted easily, progresses rapidly, and causes high mortality, but the mechanisms by which Yersinia pestis overwhelms the lungs are largely unknown. We show that the plasminogen activator Pla is essential for Y. pestis to cause primary pneumonic plague but is less important for dissemination during pneumonic plague than during bubonic plague. Experiments manipulating its temporal expression showed that Pla allows Y. pestis to replicate rapidly in the airways, causing a lethal fulminant pneumonia; if unexpressed, inflammation is aborted, and lung repair is activated. Inhibition of Pla expression prolonged the survival of animals with the disease, offering a therapeutic option to extend the period during which antibiotics are effective.	Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Goldman, WE (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	goldman@wustl.edu		Goldman, William/0000-0002-1551-6718; Lathem, Wyndham/0000-0003-4347-089X; Miller, Virginia/0000-0002-9522-1767	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI069688, R21AI053298, U54AI057160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER; NIAID NIH HHS [U54 AI057160, AI53298, F32 AI069688-01] Funding Source: Medline; NIDDK NIH HHS [DK52574] Funding Source: Medline; NIGMS NIH HHS [NRSA T32 GM07067] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		*APPL BIOS, 1977, ABI PRISM 7700 SEQ D; CELIS JE, 1987, FEBS LETT, V220, P1, DOI 10.1016/0014-5793(87)80865-7; COVER TL, 1989, NEW ENGL J MED, V321, P16, DOI 10.1056/NEJM198907063210104; DOLL JM, 1994, AM J TROP MED HYG, V51, P109, DOI 10.4269/ajtmh.1994.51.109; Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741; Huang XZ, 2006, CLIN MED RES, V4, P189, DOI 10.3121/cmr.4.3.189; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Johnson LL, 2003, J EXP MED, V197, P801, DOI 10.1084/jem.20021493; Kukkonen M, 2001, MOL MICROBIOL, V40, P1097, DOI 10.1046/j.1365-2958.2001.02451.x; Lathem WW, 2005, P NATL ACAD SCI USA, V102, P17786, DOI 10.1073/pnas.0506840102; LINDLER IE, 2004, ENCY MED GENOMICS PR, P1355; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mullarky IK, 2005, INFECT IMMUN, V73, P3888, DOI 10.1128/IAI.73.7.3888-3895.2005; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Samoilova SV, 1996, J MED MICROBIOL, V45, P440, DOI 10.1099/00222615-45-6-440; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; SODEINDE OA, 1989, INFECT IMMUN, V57, P1517, DOI 10.1128/IAI.57.5.1517-1523.1989; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Welkos S, 2002, VACCINE, V20, P2206, DOI 10.1016/S0264-410X(02)00119-6; Welkos SL, 1997, MICROB PATHOGENESIS, V23, P211, DOI 10.1006/mpat.1997.0154; WU LT, 1926, TREATISE PNEUMONIC P, P466	22	227	237	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2007	315	5811					509	513		10.1126/science.1137195	http://dx.doi.org/10.1126/science.1137195			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255510				2022-12-01	WOS:000243726600045
J	Torres-Padilla, ME; Parfitt, DE; Kouzarides, T; Zernicka-Goetz, M				Torres-Padilla, Maria-Elena; Parfitt, David-Emlyn; Kouzarides, Tony; Zernicka-Goetz, Magdalena			Histone arginine methylation regulates pluripotency in the early mouse embryo	NATURE			English	Article							PROTEIN METHYLTRANSFERASE; STEM-CELLS; BLASTOMERES; EXPRESSION; CLEAVAGE; RECEPTOR; H3; SPECIFICATION; EMBRYOGENESIS; TRANSCRIPTION	It has been generally accepted that the mammalian embryo starts its development with all cells identical, and only when inside and outside cells form do differences between cells first emerge. However, recent findings show that cells in the mouse embryo can differ in their developmental fate and potency as early as the four-cell stage(1-4). These differences depend on the orientation and order of the cleavage divisions that generated them(2,5). Because epigenetic marks are suggested to be involved in sustaining pluripotency(6,7), we considered that such developmental properties might be achieved through epigenetic mechanisms. Here we show that modification of histone H3, through the methylation of specific arginine residues, is correlated with cell fate and potency. Levels of H3 methylation at specific arginine residues are maximal in four-cell blastomeres that will contribute to the inner cell mass (ICM) and polar trophectoderm and undertake full development when combined together in chimaeras. Arginine methylation of H3 is minimal in cells whose progeny contributes more to the mural trophectoderm and that show compromised development when combined in chimaeras. This suggests that higher levels of H3 arginine methylation predispose blastomeres to contribute to the pluripotent cells of the ICM. We confirm this prediction by overexpressing the H3-specific arginine methyltransferase CARM1 in individual blastomeres and show that this directs their progeny to the ICM and results in a dramatic upregulation of Nanog and Sox2. Thus, our results identify specific histone modifications as the earliest known epigenetic marker contributing to development of ICM and show that manipulation of epigenetic information influences cell fate determination.	Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England	University of Cambridge	Zernicka-Goetz, M (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	mzg@mole.bio.cam.ac.uk		Kouzarides, Tony/0000-0002-8918-4162; Zernicka-Goetz, Magdalena/0000-0002-7004-2471	Medical Research Council [G0300723, G0800784] Funding Source: Medline; Wellcome Trust [064421] Funding Source: Medline; MRC [G0300723] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048; Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cheng DH, 2004, J BIOL CHEM, V279, P23892, DOI 10.1074/jbc.M401853200; Deb K, 2006, SCIENCE, V311, P992, DOI 10.1126/science.1120925; Fujimori T, 2003, DEVELOPMENT, V130, P5113, DOI 10.1242/dev.00725; Gardner RL, 2001, DEVELOPMENT, V128, P839; Gardner RL, 2002, HUM REPROD, V17, P3178, DOI 10.1093/humrep/17.12.3178; Lee YH, 2002, MOL CELL BIOL, V22, P3621, DOI 10.1128/MCB.22.11.3621-3632.2002; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Ma H, 2001, CURR BIOL, V11, P1981, DOI 10.1016/S0960-9822(01)00600-5; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Piotrowska K, 2001, DEVELOPMENT, V128, P3739; Piotrowska-Nitsche K, 2005, DEVELOPMENT, V132, P479, DOI 10.1242/dev.01602; Piotrowska-Nitsche K, 2005, MECH DEVELOP, V122, P487, DOI 10.1016/j.mod.2004.11.014; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Tassy O, 2006, CURR BIOL, V16, P345, DOI 10.1016/j.cub.2005.12.044; Torres-Padilla ME, 2006, J CELL BIOL, V174, P329, DOI 10.1083/jcb.200603146; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781	25	430	455	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2007	445	7124					214	218		10.1038/nature05458	http://dx.doi.org/10.1038/nature05458			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QF	17215844	Green Accepted			2022-12-01	WOS:000243384300053
J	Goldsmith, BR; Coroneus, JG; Khalap, VR; Kane, AA; Weiss, GA; Collins, PG				Goldsmith, Brett R.; Coroneus, John G.; Khalap, Vaikunth R.; Kane, Alexander A.; Weiss, Gregory A.; Collins, Philip G.			Conductance-controlled point functionalization of single-walled carbon nanotubes	SCIENCE			English	Article							CHEMICAL FUNCTIONALIZATION; ELECTRONIC-STRUCTURE; CHEMISTRY; FABRICATION; TRANSISTORS; DEFECTS; TRANSPORT; OXIDATION; GRAPHITE; BUNDLES	We used covalent attachments to single-walled carbon nanotubes (SWNTs) to fabricate single-molecule electronic devices. The technique does not rely on submicrometer lithography or precision mechanical manipulation, but instead uses circuit conductance to monitor and control covalent attachment to an electrically connected SWNT. Discrete changes in the circuit conductance revealed chemical processes happening in real time and allowed the SWNT sidewalls to be deterministically broken, reformed, and conjugated to target species. By controlling the chemistry through electronically controlled electrochemical potentials, we were able to achieve single chemical attachments. We routinely functionalized pristine, defect-free SWNTs at one, two, or more sites and demonstrated three-terminal devices in which a single attachment controls the electronic response.	Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Collins, PG (corresponding author), Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA.	collinsp@uci.edu	Weiss, Gregory/AEN-4604-2022	Kane, Alexander/0000-0002-5901-5296	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078528] Funding Source: NIH RePORTER; NIAID NIH HHS [R43 AI58365-01] Funding Source: Medline; NIGMS NIH HHS [R01 GM078528-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bachtold A, 2000, PHYS REV LETT, V84, P6082, DOI 10.1103/PhysRevLett.84.6082; Banerjee S, 2005, ADV MATER, V17, P17, DOI 10.1002/adma.200401340; BESENHARD JO, 1981, SYNTHETIC MET, V3, P187, DOI 10.1016/0379-6779(81)90007-2; Bockrath M, 2001, SCIENCE, V291, P283, DOI 10.1126/science.291.5502.283; Burghard M, 2005, SURF SCI REP, V58, P1, DOI 10.1016/j.surfrep.2005.07.001; Chiu PW, 2002, APPL PHYS LETT, V80, P3811, DOI 10.1063/1.1480487; Diehl MR, 2003, CHEMPHYSCHEM, V4, P1335, DOI 10.1002/cphc.200300871; Eom JH, 2006, PHYSICA B, V376, P7, DOI 10.1016/j.physb.2005.12.005; Fan YW, 2005, NAT MATER, V4, P906, DOI 10.1038/nmat1516; Freitag M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.216801; Graupner R, 2003, PHYS CHEM CHEM PHYS, V5, P5472, DOI 10.1039/b311016h; Guo XF, 2006, SCIENCE, V311, P356, DOI 10.1126/science.1120986; Heller I, 2005, NANO LETT, V5, P137, DOI 10.1021/nl048200m; Ho W, 2002, J CHEM PHYS, V117, P11033, DOI 10.1063/1.1521153; Kinoshita K, 1988, CARBON ELECTROCHEMIC, DOI DOI 10.1016/j.jpowsour.2007.12.091; Kruger M, 2001, APPL PHYS LETT, V78, P1291, DOI 10.1063/1.1350427; Lee YS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.116801; Lee YS, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.076804; Lu X, 2005, CHEM REV, V105, P3643, DOI 10.1021/cr030093d; Mannik J, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.016601; Maruccio G, 2004, ELECTROANAL, V16, P1853, DOI 10.1002/elan.200403073; METROT A, 1981, SYNTHETIC MET, V3, P201, DOI 10.1016/0379-6779(81)90009-6; Pan H, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.245425; Park H, 1999, APPL PHYS LETT, V75, P301, DOI 10.1063/1.124354; Park H, 2005, NANOTECHNOLOGY, V16, P635, DOI 10.1088/0957-4484/16/6/003; Rosenblatt S, 2002, NANO LETT, V2, P869, DOI 10.1021/nl025639a; Son YW, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.216602; Star A, 2003, NANO LETT, V3, P459, DOI 10.1021/nl0340172; STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4; Strachan DR, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1857095; Sumanasekera GU, 1999, J PHYS CHEM B, V103, P4292, DOI 10.1021/jp984362t; Tans SJ, 2000, NATURE, V404, P834, DOI 10.1038/35009026; Tao NJ, 2005, J MATER CHEM, V15, P3260, DOI 10.1039/b503307a; Tseng AA, 2005, J VAC SCI TECHNOL B, V23, P877, DOI 10.1116/1.1926293; Wong SS, 1998, NATURE, V394, P52, DOI 10.1038/27873; Zhao JJ, 2005, CHEMPHYSCHEM, V6, P598, DOI 10.1002/cphc.200400593; Zhou YX, 2003, NANO LETT, V3, P1371, DOI 10.1021/nl034512y	37	202	216	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 5	2007	315	5808					77	81		10.1126/science.1135303	http://dx.doi.org/10.1126/science.1135303			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17204645	Green Published			2022-12-01	WOS:000243259100038
J	Wang, JX; Scully, K; Zhu, X; Cai, L; Zhang, J; Prefontaine, GG; Krones, A; Ohgi, KA; Zhu, P; Garcia-Bassets, I; Liu, F; Taylor, H; Lozach, J; Jayes, FL; Korach, KS; Glass, CK; Fu, XD; Rosenfeld, MG				Wang, Jianxun; Scully, Kathleen; Zhu, Xiaoyan; Cai, Ling; Zhang, Jie; Prefontaine, Gratien G.; Krones, Anna; Ohgi, Kenneth A.; Zhu, Ping; Garcia-Bassets, Ivan; Liu, Forrest; Taylor, Havilah; Lozach, Jean; Jayes, Friederike L.; Korach, Kenneth S.; Glass, Christopher K.; Fu, Xiang-Dong; Rosenfeld, Michael G.			Opposing LSD1 complexes function in developmental gene activation and repression programmes	NATURE			English	Article							POLYCOMB PROTEIN; PITUITARY-GLAND; HISTONE; RECEPTOR; EXPRESSION; ESTROGEN; MICE; PIT-1; IDENTIFICATION; TRANSCRIPTION	Precise control of transcriptional programmes underlying metazoan development is modulated by enzymatically active co-regulatory complexes, coupled with epigenetic strategies. One thing that remains unclear is how specific members of histone modification enzyme families, such as histone methyltransferases and demethylases, are used in vivo to simultaneously orchestrate distinct developmental gene activation and repression programmes. Here, we report that the histone lysine demethylase, LSD1 - a component of the CoREST-CtBP co- repressor complex - is required for late cell-lineage determination and differentiation during pituitary organogenesis. LSD1 seems to act primarily on target gene activation programmes, as well as in gene repression programmes, on the basis of recruitment of distinct LSD1-containing co- activator or co- repressor complexes. LSD1-dependent gene repression programmes can be extended late in development with the induced expression of ZEB1, a Kruppel-like repressor that can act as a molecular beacon for recruitment of the LSD1-containing CoREST-CtBP co- repressor complex, causing repression of an additional cohort of genes, such as Gh, which previously required LSD1 for activation. These findings suggest that temporal patterns of expression of specific components of LSD1 complexes modulate gene regulatory programmes in many mammalian organs.	Univ Calif San Diego, Howard Hughes Med Inst, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, Sch Med, La Jolla, CA 92093 USA; Natl Inst Environm Hlth Sci, Res Triangle Pk, NC 27709 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, Grad Program, La Jolla, CA 92093 USA; Univ Calif San Diego, Mol Pathol Grad Program, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept Med, 9500 Gilman Dr,Room 345, La Jolla, CA 92093 USA.	mrosenfeld@ucsd.edu	Garcia-Bassets, Ivan/F-5075-2010; Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592; Korach, Kenneth/0000-0002-7765-418X; Jayes, Friederike/0000-0001-8862-9345; Garcia-Bassets, Ivan/0000-0002-6941-9585	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES070065, Z01ES070065] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; BEHRINGER RR, 1988, GENE DEV, V2, P453, DOI 10.1101/gad.2.4.453; BORRELLI E, 1989, NATURE, V339, P538, DOI 10.1038/339538a0; Botz J, 1996, MOL CELL BIOL, V16, P3401; Chamberlain EM, 1999, MOL CELL BIOL, V19, P3600; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; DAY RN, 1990, MOL ENDOCRINOL, V4, P1964, DOI 10.1210/mend-4-12-1964; Fernandes I, 2003, MOL CELL, V11, P139, DOI 10.1016/S1097-2765(03)00014-5; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Gage PJ, 1996, DEVELOPMENT, V122, P151; GODFREY P, 1993, NAT GENET, V4, P227, DOI 10.1038/ng0793-227; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; HU NP, 1994, ONCOGENE, V9, P1021; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Keegan CE, 2003, GENE DEV, V17, P677, DOI 10.1101/gad.1085903; KORACH KS, 1994, SCIENCE, V266, P1524, DOI 10.1126/science.7985022; Lasorella A, 2005, MOL CELL BIOL, V25, P3563, DOI 10.1128/MCB.25.9.3563-3574.2005; LIEBERMAN ME, 1983, J STEROID BIOCHEM, V19, P275, DOI 10.1016/S0022-4731(83)80037-5; LIN CJ, 1992, NATURE, V360, P765, DOI 10.1038/360765a0; Long JY, 2005, J BIOL CHEM, V280, P35477, DOI 10.1074/jbc.M504477200; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Maier MM, 2000, BIOCHEM BIOPH RES CO, V275, P652, DOI 10.1006/bbrc.2000.3354; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; MAYO KE, 1992, MOL ENDOCRINOL, V6, P1734, DOI 10.1210/me.6.10.1734; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Ooi GT, 2004, MOL CELL ENDOCRINOL, V228, P1, DOI 10.1016/j.mce.2004.07.018; Oswald F, 2005, MOL CELL BIOL, V25, P10379, DOI 10.1128/MCB.25.23.10379-10390.2005; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; Satijn DPE, 1997, MOL CELL BIOL, V17, P6076, DOI 10.1128/MCB.17.10.6076; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127; Scully KM, 2002, SCIENCE, V295, P2231, DOI 10.1126/science.1062736; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Ward RD, 2005, MOL ENDOCRINOL, V19, P698, DOI 10.1210/me.2004-0341; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; WILLIAMS TM, 1991, SCIENCE, V254, P1791, DOI 10.1126/science.1840704; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zhu XY, 2006, GENE DEV, V20, P2739, DOI 10.1101/gad.1444706	50	410	432	3	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2007	446	7138					882	887		10.1038/nature05671	http://dx.doi.org/10.1038/nature05671			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IR	17392792				2022-12-01	WOS:000245785700035
J	Liu, S; Li, P; Dybkov, O; Nottrott, S; Hartmuth, K; Luhrmann, R; Carlomagno, T; Wahl, MC				Liu, Sunbin; Li, Ping; Dybkov, Olexandr; Nottrott, Stephanie; Hartmuth, Klaus; Luehrmann, Reinhard; Carlomagno, Teresa; Wahl, Markus C.			Binding of the human Prp31 nop domain to a composite RNA-protein platform in U4 snRNP	SCIENCE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; TRI-SNRNP; MOLECULAR-BASIS; HUMAN U4/U6.U5; SPLICEOSOME; COMPLEX; RECOGNITION; ASSOCIATION; INTERACT; GENE	Although highly homologous, the spliceosomal hPrp31 and the nucleolar Nop56 and Nop58 (Nop56/58) proteins recognize different ribonucleoprotein (RNP) particles. hPrp31 interacts with complexes containing the 15.5K protein and U4 or U4atac small nuclear RNA (snRNA), whereas Nop56/58 associate with 15.5K-box C/D small nucleolar RNA complexes. We present structural and biochemical analyses of hPrp31-15.5K-U4 snRNA complexes that show how the conserved Nop domain in hPrp31 maintains high RNP binding selectivity despite relaxed RNA sequence requirements. The Nop domain is a genuine RNP binding module, exhibiting RNA and protein binding surfaces. Yeast two-hybrid analyses suggest a link between retinitis pigmentosa and an aberrant hPrp31-hPrp6 interaction that blocks U4/U6-U5 tri-snRNP formation.	Max Planck Inst Biophys Chem, Abt Zellulaire Biochem, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, AG Flussig NMR Spektroskopie, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, AG Makromol Rontgenkristallog, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society; Max Planck Society	Luhrmann, R (corresponding author), Max Planck Inst Biophys Chem, Abt Zellulaire Biochem, Fassberg 11, D-37077 Gottingen, Germany.	Reinhard.Luehrmann@mpi-bpc.mpg.de; taco@nmr.mpibpc.mpg.de; mwahl@gwdg.de	Wahl, Markus C./D-6365-2017	Wahl, Markus C./0000-0002-2811-5307; Carlomagno, Teresa/0000-0002-2437-2760				Agalarov SC, 2000, SCIENCE, V288, P107, DOI 10.1126/science.288.5463.107; Aittaleb M, 2003, NAT STRUCT BIOL, V10, P256, DOI 10.1038/nsb905; BRINGMANN P, 1984, EMBO J, V3, P1357, DOI 10.1002/j.1460-2075.1984.tb01977.x; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Burge C.B., 1999, RNA WORLD, V37, P525; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; Gornemann J, 2005, MOL CELL, V19, P53, DOI 10.1016/j.molcel.2005.05.007; HASHIMOTO C, 1984, NUCLEIC ACIDS RES, V12, P3283, DOI 10.1093/nar/12.7.3283; Kuhn-Holsken E, 2005, RNA, V11, P1915, DOI 10.1261/rna.2176605; Liu SB, 2006, RNA, V12, P1418, DOI 10.1261/rna.55406; Makarova OV, 2002, EMBO J, V21, P1148, DOI 10.1093/emboj/21.5.1148; Moore T, 2004, STRUCTURE, V12, P807, DOI 10.1016/j.str.2004.02.033; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Nottrott S, 1999, EMBO J, V18, P6119, DOI 10.1093/emboj/18.21.6119; Nottrott S, 2002, EMBO J, V21, P5527, DOI 10.1093/emboj/cdf544; REED R, 1997, EUKARYOTIC MRNA PROC, P103; Schneider C, 2002, MOL CELL BIOL, V22, P3219, DOI 10.1128/MCB.22.10.3219-3229.2002; Schultz A, 2006, J BIOL CHEM, V281, P28278, DOI 10.1074/jbc.M603350200; Schultz A, 2006, MOL CELL BIOL, V26, P5146, DOI 10.1128/MCB.02374-05; SHAKKED Z, 1994, NATURE, V368, P469, DOI 10.1038/368469a0; Small EC, 2006, MOL CELL, V23, P389, DOI 10.1016/j.molcel.2006.05.043; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Szewczak LBW, 2005, RNA, V11, P1407, DOI 10.1261/rna.2830905; Vidovic I, 2000, MOL CELL, V6, P1331, DOI 10.1016/S1097-2765(00)00131-3; Vithana EN, 2001, MOL CELL, V8, P375, DOI 10.1016/S1097-2765(01)00305-7; Watkins NJ, 2000, CELL, V103, P457, DOI 10.1016/S0092-8674(00)00137-9; Watkins NJ, 2002, MOL CELL BIOL, V22, P8342, DOI 10.1128/MCB.22.23.8342-8352.2002; Will CL, 2006, COLD SPRING HARB MON, V43, P369; Williamson JR, 2000, NAT STRUCT BIOL, V7, P834, DOI 10.1038/79575; WU JC, 1983, J BIOL CHEM, V258, P4694	31	101	103	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2007	316	5821					115	120		10.1126/science.1137924	http://dx.doi.org/10.1126/science.1137924			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412961	Green Published			2022-12-01	WOS:000245470500045
J	Giocomo, LM; Zilli, EA; Fransen, E; Hasselmo, ME				Giocomo, Lisa M.; Zilli, Eric A.; Fransen, Erik; Hasselmo, Michael E.			Temporal frequency of subthreshold oscillations scales with entorhinal grid cell field spacing	SCIENCE			English	Article							CORTEX LAYER-II; HEAD DIRECTION CELLS; PATH-INTEGRATION; PLACE CELLS; NEURONS; MODEL; REPRESENTATION; HIPPOCAMPUS; MECHANISMS; DYNAMICS	Grid cells in layer II of rat entorhinal cortex fire to spatial locations in a repeating hexagonal grid, with smaller spacing between grid fields for neurons in more dorsal anatomical locations. Data from in vitro whole-cell patch recordings showed differences in frequency of subthreshold membrane potential oscillations in entorhinal neurons that correspond to different positions along the dorsal-to-ventral axis, supporting a model of physiological mechanisms for grid cell responses.	Boston Univ, Dept Psychol, Ctr Memory & Brain, Program Neurosci, Boston, MA 02215 USA; Royal Inst Technol, Sch Comp Sci & Commun, SE-10044 Stockholm, Sweden; Stockholm Brain Inst, SE-10044 Stockholm, Sweden	Boston University; Royal Institute of Technology	Giocomo, LM (corresponding author), Boston Univ, Dept Psychol, Ctr Memory & Brain, Program Neurosci, 2 Cummington St, Boston, MA 02215 USA.	giocomo@bu.edu; hasselmo@bu.edu		Giocomo, Lisa/0000-0003-0416-2528; Hasselmo, Michael/0000-0002-9925-6377	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH071702, R01MH061492, R01MH060013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016454] Funding Source: NIH RePORTER; NIDA NIH HHS [DA16454, R01 DA016454-04, R01 DA016454-05, R01 DA016454] Funding Source: Medline; NIMH NIH HHS [R01 MH060013-05, MH71702, R01 MH060013, MH60013, R01 MH061492, R01 MH060013-06, P50 MH071702-01A20004, R01 MH061492-05, P50 MH071702] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Acker CD, 2003, J COMPUT NEUROSCI, V15, P71, DOI 10.1023/A:1024474819512; ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; [Anonymous], CONDITIONING CONSCIO; BLAIR HT, IN PRESS J NEUROSCI; BURGESS N, IN PRESS HIPPOCAMPUS; Dickson CT, 2000, J NEUROPHYSIOL, V83, P2562, DOI 10.1152/jn.2000.83.5.2562; Erchova I, 2004, J PHYSIOL-LONDON, V560, P89, DOI 10.1113/jphysiol.2004.069930; Fransen E, 2006, NEURON, V49, P735, DOI 10.1016/j.neuron.2006.01.036; Fransen E, 2004, HIPPOCAMPUS, V14, P368, DOI 10.1002/hipo.10198; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hasselmo ME, 2005, NEURAL NETWORKS, V18, P1172, DOI 10.1016/j.neunet.2005.08.007; Knierim JJ, 1998, J NEUROPHYSIOL, V80, P425, DOI 10.1152/jn.1998.80.1.425; Lengyel M, 2003, HIPPOCAMPUS, V13, P700, DOI 10.1002/hipo.10116; Maurer AP, 2005, HIPPOCAMPUS, V15, P841, DOI 10.1002/hipo.20114; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; PAKINOS G, 1998, RAT BRAIN STEREOTAXI; Redish AD, 1997, HIPPOCAMPUS, V7, P15; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Sharp PE, 2001, TRENDS NEUROSCI, V24, P289, DOI 10.1016/S0166-2236(00)01797-5; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; Taube JS, 2003, CEREB CORTEX, V13, P1162, DOI 10.1093/cercor/bhg102; White JA, 1998, J NEUROPHYSIOL, V80, P262, DOI 10.1152/jn.1998.80.1.262	28	282	290	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2007	315	5819					1719	1722		10.1126/science.1139207	http://dx.doi.org/10.1126/science.1139207			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379810	Green Accepted			2022-12-01	WOS:000245106900042
J	Lee, MG; Norman, J; Shilatifard, A; Shiekhattar, R				Lee, Min Gyu; Norman, Jessica; Shilatifard, Ali; Shiekhattar, Ramin			Physical and functional association of a trimethyl H3K4 demethylase and Ring6a/MBLR, a polycomb-like protein	CELL			English	Article							HISTONE LYSINE METHYLATION; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; SACCHAROMYCES-CEREVISIAE; ARGININE METHYLATION; PHD FINGER; COMPLEX; METHYLTRANSFERASE; DOMAIN; DEACETYLASE	Histone methylation is a posttranslational modification regulating chromatin structure and gene regulation. BHC110/LSD1 was the first histone demethylase described to reverse dimethyl histone H3 lysine 4 (H3K4). Here we show that JARID1 d, a JmjC-domain-containing protein, specifically demethylates trimethyl H3K4. Detailed mapping analysis revealed that besides the JmjC domain, the BRIGHT and zinc-finger-like C5HC2 domains are required for maximum catalytic activity. Importantly, iso-lation of native JARID1 d complexes from human cells revealed the association of the demethylase with a polycomb-like protein Ring6a/MBLR. Ring6a/MBLR not only directly interacts with JARID1d but also regulates its enzymatic activity. We show that JARID1d and Ring6a occupy human Engrailed 2 gene and regulate its expression and H3K4 methylation levels. Depletion of JARID1d enhanced recruitment of the chromatin remodeling complex, NURF, and the basal transcription machinery near the transcriptional start site, revealing a role for JARID1d in regulation of transcriptional initiation through H3K4 demethylation.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; St Louis Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, St Louis, MO 63104 USA	The Wistar Institute; Saint Louis University	Shiekhattar, R (corresponding author), Ctr Regulacio Genom, Dr Aiguader,88, Barcelona 08003, Spain.	ramin.shiekhattar@crg.es			NATIONAL CANCER INSTITUTE [R01CA090758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069905] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 090758] Funding Source: Medline; NIGMS NIH HHS [R01 GM069905] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akasaka T, 2002, GENES CELLS, V7, P835, DOI 10.1046/j.1365-2443.2002.00565.x; Barak O, 2003, EMBO J, V22, P6089, DOI 10.1093/emboj/cdg582; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Gildea JJ, 2000, GENETICS, V156, P645; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; Gregory Richard I., 2006, V342, P33, DOI 10.1385/1-59745-123-1:33; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lee MG, 2006, METHODS, V40, P327, DOI 10.1016/j.ymeth.2006.07.030; Lee MG, 2006, MOL CELL BIOL, V26, P6395, DOI 10.1128/MCB.00723-06; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; VAQUERO A, 2003, SCI AGING KNOWLEDGE, pRE4, DOI DOI 10.1126/SAGEKE.2003.14.RE4; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004	54	187	193	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2007	128	5					877	887		10.1016/j.cell.2007.02.004	http://dx.doi.org/10.1016/j.cell.2007.02.004			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17320162	Bronze			2022-12-01	WOS:000245073400013
J	Clayton, E; Doupe, DP; Klein, AM; Winton, DJ; Simons, BD; Jones, PH				Clayton, Elizabeth; Doupe, David P.; Klein, Allon M.; Winton, Douglas J.; Simons, Benjamin D.; Jones, Philip H.			A single type of progenitor cell maintains normal epidermis	NATURE			English	Article							LABEL-RETAINING CELLS; STEM-CELLS; MOUSE EPIDERMIS; IN-VIVO; DIVISIONS; SKIN; FOLLICLE; PROLIFERATION; NEUROGENESIS; EPITHELIUM	According to the current model of adult epidermal homeostasis, skin tissue is maintained by two discrete populations of progenitor cells: self-renewing stem cells; and their progeny, known as transit amplifying cells, which differentiate after several rounds of cell division(1-3). By making use of inducible genetic labelling, we have tracked the fate of a representative sample of progenitor cells in mouse tail epidermis at single-cell resolution in vivo at time intervals up to one year. Here we show that clone-size distributions are consistent with a new model of homeostasis involving only one type of progenitor cell. These cells are found to undergo both symmetric and asymmetric division at rates that ensure epidermal homeostasis. The results raise important questions about the potential role of stem cells on tissue maintenance in vivo.	Hutchison MRC Res Ctr, MRC Canc Cell Unit, Cambridge CB2 0XZ, England; Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute	Jones, PH (corresponding author), Hutchison MRC Res Ctr, MRC Canc Cell Unit, Cambridge CB2 0XZ, England.	phj20@hutchison-mrc.cam.ac.uk	Simons, Benjamin/AAY-8920-2020; Jones, Philip/D-2464-2009; Doupe, David/M-7914-2017	Simons, Benjamin/0000-0002-3875-7071; Jones, Philip/0000-0002-5904-795X; Doupe, David/0000-0002-9748-9388	Medical Research Council [G0300723B] Funding Source: researchfish; MRC [MC_U105370181] Funding Source: UKRI; Medical Research Council [MC_U105370181] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alonso L, 2003, P NATL ACAD SCI USA, V100, P11830, DOI 10.1073/pnas.1734203100; Birner P, 2001, AM J PATHOL, V158, P1991, DOI 10.1016/S0002-9440(10)64670-6; Braun KM, 2004, J INVEST DERM SYMP P, V9, P196, DOI 10.1111/j.1087-0024.2004.09313.x; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Das T, 2003, NEURON, V37, P597, DOI 10.1016/S0896-6273(03)00066-7; Gambardella L, 2003, CURR OPIN CELL BIOL, V15, P771, DOI 10.1016/j.ceb.2003.10.011; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Kameda T, 2003, EXP CELL RES, V283, P167, DOI 10.1016/S0014-4827(02)00031-9; Kemp R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh090; LAJTHA LG, 1979, DIFFERENTIATION, V14, P23, DOI 10.1111/j.1432-0436.1979.tb01007.x; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; MACKENZIE IC, 1970, NATURE, V226, P653, DOI 10.1038/226653a0; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Potten C S, 1981, Int Rev Cytol, V69, P271; POTTEN CS, 1974, CELL TISSUE KINET, V7, P77, DOI 10.1111/j.1365-2184.1974.tb00401.x; Ro S, 2005, EXP DERMATOL, V14, P838, DOI 10.1111/j.1600-0625.2005.00366.x; Ro S, 2004, EMBO REP, V5, P914, DOI 10.1038/sj.embor.7400218; Smart FM, 2000, J EXP MED, V191, P737, DOI 10.1084/jem.191.4.737; SMART IHM, 1970, BRIT J DERMATOL, V82, P276, DOI 10.1111/j.1365-2133.1970.tb12437.x; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Williams GH, 1998, P NATL ACAD SCI USA, V95, P14932, DOI 10.1073/pnas.95.25.14932; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	29	600	614	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2007	446	7132					185	189		10.1038/nature05574	http://dx.doi.org/10.1038/nature05574			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17330052				2022-12-01	WOS:000244718100040
J	Loque, D; Lalonde, S; Looger, LL; von Wiren, N; Frommer, WB				Loque, D.; Lalonde, S.; Looger, L. L.; von Wiren, N.; Frommer, W. B.			A cytosolic trans-activation domain essential for ammonium uptake	NATURE			English	Article							TRANSPORTER AMTB; PLASMA-MEMBRANE; AUTOINHIBITORY DOMAIN; SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI; NH4+; IDENTIFICATION; PROTEIN; EXPRESSION; MECHANISM	Polytopic membrane proteins are essential for cellular uptake and release of nutrients. To prevent toxic accumulation, rapid shut-off mechanisms are required. Here we show that the soluble cytosolic carboxy terminus of an oligomeric ammonium transporter from Arabidopsis thaliana serves as an allosteric regulator essential for function; mutations in the C-terminal domain, conserved between bacteria, fungi and plants, led to loss of transport activity. When co-expressed with intact transporters, mutants inactivated functional subunits, but left their stability unaffected. Co-expression of two inactive transporters, one with a defective pore, the other with an ablated C terminus, reconstituted activity. The crystal structure of an Archaeoglobus fulgidus ammonium transporter (AMT)(1) suggests that the C terminus interacts physically with cytosolic loops of the neighbouring subunit. Phosphorylation of conserved sites in the C terminus(2) are proposed as the cognate control mechanism. Conformational coupling between monomers provides a mechanism for tight regulation, for increasing the dynamic range of sensing and memorizing prior events, and may be a general mechanism for transporter regulation.	Carnegie Inst Washington, Stanford, CA 94305 USA; Univ Hohenheim, Inst Plant Nutr, D-70593 Stuttgart, Germany	Carnegie Institution for Science; University Hohenheim	Frommer, WB (corresponding author), Carnegie Inst Washington, 290 Panama St, Stanford, CA 94305 USA.	wfrommer@stanford.edu	Frommer, Wolf B/K-5042-2017; Loque, Dominique/A-8153-2008; Frommer, Wolf B/A-8256-2008	Frommer, Wolf B/0000-0001-6465-0115; Frommer, Wolf B/0000-0001-6465-0115; von Wiren, Nicolaus/0000-0002-4966-425X				Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102; Blakey D, 2002, BIOCHEM J, V364, P527, DOI 10.1042/BJ20011761; Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Conroy MJ, 2004, EMBO REP, V5, P1153, DOI 10.1038/sj.embor.7400296; Coutts G, 2002, EMBO J, V21, P536, DOI 10.1093/emboj/21.4.536; Curran AC, 2000, J BIOL CHEM, V275, P30301, DOI 10.1074/jbc.M002047200; GRASBERGER B, 1986, P NATL ACAD SCI USA, V83, P6258, DOI 10.1073/pnas.83.17.6258; Hamill S, 1999, BIOCHEMISTRY-US, V38, P16974, DOI 10.1021/bi9918792; Javelle A, 2004, J BIOL CHEM, V279, P8530, DOI 10.1074/jbc.M312399200; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Kronzucker HJ, 1996, PLANT PHYSIOL, V110, P773, DOI 10.1104/pp.110.3.773; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Ludewig U, 2003, J BIOL CHEM, V278, P45603, DOI 10.1074/jbc.M307424200; Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200; Marini AM, 2000, MOL MICROBIOL, V35, P378, DOI 10.1046/j.1365-2958.2000.01704.x; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Marini AM, 2006, CURR GENET, V49, P364, DOI 10.1007/s00294-006-0062-5; NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; PALMGREN MG, 1991, J BIOL CHEM, V266, P20470; Pittman JK, 2001, PLANT PHYSIOL, V127, P1020, DOI 10.1104/pp.010409; Rawat SR, 1999, PLANT J, V19, P143, DOI 10.1046/j.1365-313X.1999.00505.x; Reinders A, 2002, STRUCTURE, V10, P763, DOI 10.1016/S0969-2126(02)00773-6; SCHULMAN H, 1992, CELL CALCIUM, V13, P401, DOI 10.1016/0143-4160(92)90053-U; Schulze Waltraud X, 2003, BMC Biochem, V4, P3, DOI 10.1186/1471-2091-4-3; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Veenhoff LM, 2002, TRENDS BIOCHEM SCI, V27, P242, DOI 10.1016/S0968-0004(02)02077-7; ZEN KH, 1994, BIOCHEMISTRY-US, V33, P8198, DOI 10.1021/bi00193a005	30	205	219	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2007	446	7132					195	198		10.1038/nature05579	http://dx.doi.org/10.1038/nature05579			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17293878				2022-12-01	WOS:000244718100042
J	Schwickert, TA; Lindquist, RL; Shakhar, G; Livshits, G; Skokos, D; Kosco-Vilbois, MH; Dustin, ML; Nussenzweig, MC				Schwickert, Tanja A.; Lindquist, Randall L.; Shakhar, Guy; Livshits, Geulah; Skokos, Dimitris; Kosco-Vilbois, Marie H.; Dustin, Michael L.; Nussenzweig, Michel C.			In vivo imaging of germinal centres reveals a dynamic open structure	NATURE			English	Article							PRIMARY IMMUNE-RESPONSE; LYMPH-NODES; B-CELLS; DENDRITIC CELLS; ANTIGEN; SELECTION; (4-HYDROXY-3-NITROPHENYL)ACETYL; ACTIVATION; MICROSCOPY; MECHANISM	Germinal centres are specialized structures wherein B lymphocytes undergo clonal expansion, class switch recombination, antibody gene diversification and affinity maturation. Three to four antigen-specific B cells colonize a follicle to establish a germinal centre and become rapidly dividing germinal-centre centroblasts that give rise to dark zones(1-4). Centroblasts produce non-proliferating centrocytes that are thought to migrate to the light zone of the germinal centre, which is rich in antigen-trapping follicular dendritic cells and CD4(+) T cells(5-7). It has been proposed that centrocytes are selected in the light zone on the basis of their ability to bind cognate antigen(5-8). However, there have been no studies of germinal-centre dynamics or the migratory behaviour of germinal-centre cells in vivo. Here we report the direct visualization of B cells in lymph node germinal centres by two-photon laser-scanning microscopy in mice. Nearly all antigen-specific B cells participating in a germinal-centre reaction were motile and physically restricted to the germinal centre but migrated bidirectionally between dark and light zones. Notably, follicular B cells were frequent visitors to the germinal-centre compartment, suggesting that all B cells scan antigen trapped in germinal centres. Consistent with this observation, we found that high-affinity antigen-specific B cells can be recruited to an ongoing germinal-centre reaction. We conclude that the open structure of germinal centres enhances competition and ensures that rare high-affinity B cells can participate in antibody responses.	NYU, Sch Med, Program Mol Pathogenesis, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med, Dept Pathol, New York, NY 10016 USA; Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; NovImmune SA, CH-1211 Geneva 4, Switzerland	New York University; New York University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; NovImmune SA	Dustin, ML (corresponding author), NYU, Sch Med, Program Mol Pathogenesis, New York, NY 10016 USA.	mikeroscope@nyc.rr.com; nussen@rockefeller.edu	Dustin, Michael/AAM-4611-2020; Nussenzweig, Michel/AAE-7292-2019	Schwickert, Tanja/0000-0002-3371-2376; Dustin, Michael/0000-0003-4983-6389				Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Deshmukh US, 2005, CLIN IMMUNOL, V117, P112, DOI 10.1016/j.clim.2005.07.002; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; FOSSUM S, 1983, SCAND J IMMUNOL, V17, P551; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Han SB, 2005, IMMUNITY, V22, P343, DOI 10.1016/j.immuni.2005.01.017; HANNA MG, 1964, LAB INVEST, V13, P95; JACOB J, 1993, J EXP MED, V178, P1293, DOI 10.1084/jem.178.4.1293; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; KOSCO MH, 1992, J IMMUNOL, V148, P2331; KROESE FGM, 1987, EUR J IMMUNOL, V17, P1069, DOI 10.1002/eji.1830170726; KUPPERS R, 1993, EMBO J, V12, P4955, DOI 10.1002/j.1460-2075.1993.tb06189.x; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; NOSSAL GJV, 1965, IMMUNOLOGY, V9, P349; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Oprea M, 1997, J IMMUNOL, V158, P5155; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; SZAKAL AK, 1988, J IMMUNOL, V140, P341	30	349	351	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2007	446	7131					83	87		10.1038/nature05573	http://dx.doi.org/10.1038/nature05573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17268470				2022-12-01	WOS:000244525600042
J	Marson, A; Kretschmer, K; Frampton, GM; Jacobsen, ES; Polansky, JK; Maclsaac, KD; Levine, SS; Fraenkel, E; von Boehmer, H; Young, RA				Marson, Alexander; Kretschmer, Karsten; Frampton, Garrett M.; Jacobsen, Elizabeth S.; Polansky, Julia K.; Maclsaac, Kenzie D.; Levine, Stuart S.; Fraenkel, Ernest; von Boehmer, Harald; Young, Richard A.			Foxp3 occupancy and regulation of key target genes during T-cell stimulation	NATURE			English	Article							LYMPHOID TYROSINE PHOSPHATASE; TRANSCRIPTION; SCURFIN; ENTEROPATHY; EXPRESSION; PROTEIN	Foxp3(+) CD4(+) CD25(+) regulatory T (T-reg) cells are essential for the prevention of autoimmunity(1,2). T-reg cells have an attenuated cytokine response to T-cell receptor stimulation, and can suppress the proliferation and effector function of neighbouring T cells(3,4). The forkhead transcription factor Foxp3 ( forkhead box P3) is selectively expressed in T-reg cells, is required for T-reg development and function, and is sufficient to induce a Treg phenotype in conventional CD4(+) CD25(-) T cells(5-8). Mutations in Foxp3 cause severe, multi-organ autoimmunity in both human and mouse(9-11). FOXP3 can cooperate in a DNA-binding complex with NFAT ( nuclear factor of activated T cells) to regulate the transcription of several known target genes(12). However, the global set of genes regulated directly by Foxp3 is not known and consequently, how this transcription factor controls the gene expression programme for T-reg function is not understood. Here we identify Foxp3 target genes and report that many of these are key modulators of T-cell activation and function. Remarkably, the predominant, although not exclusive, effect of Foxp3 occupancy is to suppress the activation of target genes on T-cell stimulation. Foxp3 suppression of its targets appears to be crucial for the normal function of T-reg cells, because overactive variants of some target genes are known to be associated with autoimmune disease.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; MIT, Biol Engn Div, Cambridge, MA 02139 USA; MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	Harald_von_Boehmer@dfci.harvard.edu; young@wi.mit.edu	Kretschmer, Karsten/E-8174-2010; Young, Richard A/F-6495-2012; Polansky-Biskup, Julia K./J-5937-2017	Kretschmer, Karsten/0000-0001-6770-4078; Young, Richard A/0000-0001-8855-8647; Polansky-Biskup, Julia K./0000-0003-4727-2540; Frampton, Garrett/0000-0002-2361-2750; Fraenkel, Ernest/0000-0001-9249-8181; Levine, Stuart/0000-0001-7363-562X	NCI NIH HHS [P01 CA109901-067138, P01 CA109901] Funding Source: Medline; NHGRI NIH HHS [R01 HG002668-04A1, R01 HG002668] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA109901] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Baecher-Allan C, 2006, IMMUNOL REV, V212, P203, DOI 10.1111/j.0105-2896.2006.00417.x; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Bottini N, 2006, SEMIN IMMUNOL, V18, P207, DOI 10.1016/j.smim.2006.03.008; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bruder D, 2004, EUR J IMMUNOL, V34, P623, DOI 10.1002/eji.200324799; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Myers LM, 2005, TRENDS IMMUNOL, V26, P440, DOI 10.1016/j.it.2005.06.003; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Stanford WL, 1997, J EXP MED, V186, P705, DOI 10.1084/jem.186.5.705; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042	30	551	598	0	36	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					931	935		10.1038/nature05478	http://dx.doi.org/10.1038/nature05478			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17237765	Green Accepted			2022-12-01	WOS:000244341200053
J	Sladek, R; Rocheleau, G; Rung, J; Dina, C; Shen, L; Serre, D; Boutin, P; Vincent, D; Belisle, A; Hadjadj, S; Balkau, B; Heude, B; Charpentier, G; Hudson, TJ; Montpetit, A; Pshezhetsky, AV; Prentki, M; Posner, BI; Balding, DJ; Meyre, D; Polychronakos, C; Froguel, P				Sladek, Robert; Rocheleau, Ghislain; Rung, Johan; Dina, Christian; Shen, Lishuang; Serre, David; Boutin, Philippe; Vincent, Daniel; Belisle, Alexandre; Hadjadj, Samy; Balkau, Beverley; Heude, Barbara; Charpentier, Guillaume; Hudson, Thomas J.; Montpetit, Alexandre; Pshezhetsky, Alexey V.; Prentki, Marc; Posner, Barry I.; Balding, David J.; Meyre, David; Polychronakos, Constantin; Froguel, Philippe			A genome-wide association study identifies novel risk loci for type 2 diabetes	NATURE			English	Article							TRANSCRIPTION-FACTOR-7-LIKE-2 TCF7L2 GENE; NUCLEAR FACTOR-4-ALPHA GENE; ENZYME IDE GENE; POPULATION-STRUCTURE; INSULIN-SECRETION; LARGE-SCALE; SUSCEPTIBILITY; GLUCOSE; POLYMORPHISMS; VARIANTS	Type 2 diabetes mellitus results from the interaction of environmental factors with a combination of genetic variants, most of which were hitherto unknown. A systematic search for these variants was recently made possible by the development of high-density arrays that permit the genotyping of hundreds of thousands of polymorphisms. We tested 392,935 single-nucleotide polymorphisms in a French case - control cohort. Markers with the most significant difference in genotype frequencies between cases of type 2 diabetes and controls were fast-tracked for testing in a second cohort. This identified four loci containing variants that confer type 2 diabetes risk, in addition to confirming the known association with the TCF7L2 gene. These loci include a non-synonymous polymorphism in the zinc transporter SLC30A8, which is expressed exclusively in insulin-producing beta-cells, and two linkage disequilibrium blocks that contain genes potentially involved in beta-cell development or function (IDE - KIF11 - HHEX and EXT2 - ALX4). These associations explain a substantial portion of disease risk and constitute proof of principle for the genome-wide approach to the elucidation of complex genetic traits.	McGill Univ, Dept Human Genet, Fac Med, Montreal, PQ H3H 1P3, Canada; McGill Univ, Dept Med, Fac Med, Montreal, PQ H3H 1P3, Canada; McGill Univ, Dept Pediat, Fac Med, Montreal, PQ H3H 1P3, Canada; McGill Univ, Montreal, PQ H3A 1A4, Canada; Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; Inst Pasteur, CNRS 8090, Inst Biol, F-59019 Lille, France; Univ Hosp, F-86021 Poitiers, France; INSERM, U780, IFR69, F-94807 Villejuif, France; Corbeil Essonnes Hosp, Endocrinol Diabetol Unit, F-91100 Corbeil Essonnes, France; Ontario Inst Canc Res, Toronto, ON M5G 1L7, Canada; Montreal Diabet Res Ctr, Montreal, PQ H2L 4M1, Canada; Univ Montreal, Mol Nutr Unit, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Ctr Hosp, Montreal, PQ H3C 3J7, Canada; Polypeptide Hormone Lab, Montreal, PQ H3A 2B2, Canada; Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; Univ London Imperial Coll Sci & Technol, Dept Epidemiol & Publ Hlth, London W2 1PG, England; Univ London Imperial Coll Sci & Technol, Sect Genom Med, London W12 0NN, England; Hammersmith Hosp, London W12 0HS, England	McGill University; McGill University; McGill University; McGill University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre Hospitalier Sud Francilien; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Imperial College London; Imperial College London; Imperial College London	Polychronakos, C (corresponding author), McGill Univ, Dept Human Genet, Fac Med, Montreal, PQ H3H 1P3, Canada.	Constantin.Polychronakos@McGill.ca	Polychronakos, Constantin/B-8151-2008; Heude, Barbara/G-3095-2016; Meyre, David/D-7315-2011; Posner, Barry/B-6733-2008; Shen, Lishuang/B-3040-2013; Heude, Barbara/GLU-9626-2022; Sladek, Robert/R-2391-2019; Dina, Christian R/D-3535-2015; Balding, David/G-9898-2011; FROGUEL, Philippe/O-6799-2017	Heude, Barbara/0000-0002-1565-1629; Meyre, David/0000-0003-4850-7444; Heude, Barbara/0000-0002-1565-1629; Sladek, Robert/0000-0002-2730-1204; Dina, Christian R/0000-0002-7722-7348; Balding, David/0000-0002-1480-6115; FROGUEL, Philippe/0000-0003-2972-0784; Polychronakos, Constantin/0000-0002-7624-6635; Shen, Lishuang/0000-0002-0436-0199; Hudson, Thomas/0000-0002-1376-4849; A, Pshezhetsky/0000-0002-6612-1062; Rung, Johan/0000-0001-5875-8429				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; Balkau B, 1996, REV EPIDEMIOL SANTE, V44, P373; Bennett RG, 2003, DIABETES, V52, P2315, DOI 10.2337/diabetes.52.9.2315; Boras-Granic K, 2006, INT J DEV BIOL, V50, P601, DOI 10.1387/ijdb.062153kb; Bort R, 2006, DEV BIOL, V290, P44, DOI 10.1016/j.ydbio.2005.11.006; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Cauchi S, 2006, DIABETES, V55, P3189, DOI 10.2337/db06-0692; Chandak GR, 2007, DIABETOLOGIA, V50, P63, DOI 10.1007/s00125-006-0502-2; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Damcott CM, 2006, DIABETES, V55, P2654, DOI 10.2337/db06-0338; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Di Rienzo A, 2005, TRENDS GENET, V21, P596, DOI 10.1016/j.tig.2005.08.007; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fingerlin TE, 2004, AM J HUM GENET, V74, P432, DOI 10.1086/381652; Florez JC, 2006, DIABETES, V55, P128, DOI 10.2337/diabetes.55.01.06.db05-0954; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Foley AC, 2005, GENE DEV, V19, P387, DOI 10.1101/gad.1279405; Ghosh S, 2000, AM J HUM GENET, V67, P1174, DOI 10.1016/S0002-9297(07)62948-6; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Groves CJ, 2006, DIABETES, V55, P2640, DOI 10.2337/db06-0355; Groves CJ, 2003, DIABETES, V52, P1300, DOI 10.2337/diabetes.52.5.1300; Hallaq H, 2004, DEVELOPMENT, V131, P5197, DOI 10.1242/dev.01393; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Humphries SE, 2006, J MOL MED, V84, P1005, DOI 10.1007/s00109-006-0108-7; Karamohamed S, 2003, DIABETES, V52, P1562, DOI 10.2337/diabetes.52.6.1562; Kohler K, 2006, ANN HUM GENET, V70, P98, DOI 10.1111/j.1529-8817.2005.00214.x; Love-Gregory LD, 2004, DIABETES, V53, P1134, DOI 10.2337/diabetes.53.4.1134; Meigs JB, 2002, DIABETES, V51, P833, DOI 10.2337/diabetes.51.3.833; Meyre D, 2005, NAT GENET, V37, P863, DOI 10.1038/ng1604; Parton LE, 2006, AM J PHYSIOL-ENDOC M, V291, pE982, DOI 10.1152/ajpendo.00067.2006; Permutt MA, 2005, J CLIN INVEST, V115, P1431, DOI 10.1172/JCI24758; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2000, GENETICS, V155, P945; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Saxena R, 2006, DIABETES, V55, P2890, DOI 10.2337/db06-0381; Scott LJ, 2006, DIABETES, V55, P2649, DOI 10.2337/db06-0341; Silander K, 2004, DIABETES, V53, P1141, DOI 10.2337/diabetes.53.4.1141; Stickens D, 1996, NAT GENET, V14, P25, DOI 10.1038/ng0996-25; Thomas MK, 2000, DIABETES, V49, P2039, DOI 10.2337/diabetes.49.12.2039; Vasseur F, 2002, HUM MOL GENET, V11, P2607, DOI 10.1093/hmg/11.21.2607; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Wiltshire S, 2001, AM J HUM GENET, V69, P553, DOI 10.1086/323249; Zhang CL, 2006, DIABETES, V55, P2645, DOI 10.2337/db06-0643	50	2217	2343	1	223	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					881	885		10.1038/nature05616	http://dx.doi.org/10.1038/nature05616			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17293876				2022-12-01	WOS:000244341200041
J	Coombes, R				Coombes, Rebecca			Hunting down the H5N1 virus	BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmjgroup.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 17	2007	334	7589					342	+		10.1136/bmj.39126.577488.59	http://dx.doi.org/10.1136/bmj.39126.577488.59			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	141EJ	17303878	Green Published			2022-12-01	WOS:000244560400027
J	Kao, G; Nordenson, C; Still, M; Ronnlund, A; Tuck, S; Naredi, P				Kao, Gautam; Nordenson, Cecilia; Still, Maria; Ronnlund, Agneta; Tuck, Simon; Naredi, Peter			ASNA-1 positively regulates insulin secretion in C-elegans and mammalian cells	CELL			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; SIGNALING PATHWAY; TRANSCRIPTION FACTOR; DAF-16; ATPASE; LONGEVITY; ARREST; MEMBER; GENE; SUPERFAMILY	C. elegans worms hatching in the absence of food show growth arrest during the first larval stage (U). While much has been learned about the later diapause, dauer, which worms enter under adverse conditions, much less is known about the mechanisms governing L1 arrest. Here we show that worms lacking activity of the asna-1 gene arrest growth reversibly at the L1 stage even when food is abundant. asna-1 encodes an ATPase that functions nonautonomously to regulate growth. asna-1 is expressed in a restricted set of sensory neurons and in insulin-producing intestinal cells. asna-1 mutants are reduced in insulin secretion while overexpression of asna-1 mimics the effects of insulin overexpression. Human ASNA1 is highly expressed in pancreatic beta cells, but not in other pancreatic endocrine cell types, and regulates insulin secretion in cultured cells. We propose that ASNA1 is an evolutionarily conserved modulator of insulin signaling.	Umea Univ, Umea Ctr Mol Pathogenesis, SE-90187 Umea, Sweden; Umea Univ Hosp, Dept Surg, SE-90185 Umea, Sweden	Umea University; Umea University	Tuck, S (corresponding author), Umea Univ, Umea Ctr Mol Pathogenesis, SE-90187 Umea, Sweden.	simon.tuck@ucmp.umu.se; peter.naredi@surgery.umu.se	Naredi, Peter/AAG-1504-2019	Naredi, Peter/0000-0002-5652-0422				Ailion M, 1999, P NATL ACAD SCI USA, V96, P7394, DOI 10.1073/pnas.96.13.7394; ALBERT PS, 1981, J COMP NEUROL, V198, P435, DOI 10.1002/cne.901980305; Auld KL, 2006, GENETICS, V174, P215, DOI 10.1534/genetics.106.058362; AVERY L, 1993, GENETICS, V133, P897; Avery Leon, 1993, Genetics, V134, P455; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Berwin B, 1998, NEURON, V21, P137, DOI 10.1016/S0896-6273(00)80521-8; BRENNER S, 1974, GENETICS, V77, P71; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Collet J, 1998, GENETICS, V148, P187; Fares H, 2001, GENETICS, V159, P133; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; Fukuyama M, 2006, CURR BIOL, V16, P773, DOI 10.1016/j.cub.2006.02.073; Gems D, 1998, GENETICS, V150, P129; HAMAGUCHI K, 1991, DIABETES, V40, P842, DOI 10.2337/diabetes.40.7.842; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hong Y, 1998, DEVELOPMENT, V125, P3585; JOHNSON TE, 1984, MECH AGEING DEV, V28, P23, DOI 10.1016/0047-6374(84)90150-7; Kao GT, 2004, DEVELOPMENT, V131, P755, DOI 10.1242/dev.00987; KARKARIA CE, 1990, J BIOL CHEM, V265, P7832; KOONIN EV, 1993, J MOL BIOL, V229, P1165, DOI 10.1006/jmbi.1993.1115; Kurdi-Haidar B, 1998, J HISTOCHEM CYTOCHEM, V46, P1243, DOI 10.1177/002215549804601104; KurdiHaidar B, 1996, GENOMICS, V36, P486, DOI 10.1006/geno.1996.0494; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Mukhopadhyay R, 2006, FEBS LETT, V580, P3889, DOI 10.1016/j.febslet.2006.06.017; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Patterson GI, 2000, TRENDS GENET, V16, P27, DOI 10.1016/S0168-9525(99)01916-2; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Priess J. R., 1997, C ELEGANS 2; Rosen BP, 1999, TRENDS MICROBIOL, V7, P207, DOI 10.1016/S0966-842X(99)01494-8; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; THOMAS JH, 1993, GENETICS, V134, P1105; Tissenbaum HA, 2000, P NATL ACAD SCI USA, V97, P460, DOI 10.1073/pnas.97.1.460; VOGEL G, 1976, BIOCHEMISTRY-US, V15, P208, DOI 10.1021/bi00646a032	41	84	131	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2007	128	3					577	587		10.1016/j.cell.2006.12.031	http://dx.doi.org/10.1016/j.cell.2006.12.031			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289575	Bronze			2022-12-01	WOS:000244842700022
J	Mignot, T; Shaevitz, JW; Hartzell, PL; Zusman, DR				Mignot, Tam; Shaevitz, Joshua W.; Hartzell, Patricia L.; Zusman, David R.			Evidence that focal adhesion complexes power bacterial gliding motility	SCIENCE			English	Article								The bacterium Myxococcus xanthus has two motility systems: S motility, which is powered by type IV pilus retraction, and A motility, which is powered by unknown mechanism(s). We found that A motility involved transient adhesion complexes that remained at fixed positions relative to the substratum as cells moved forward. Complexes assembled at leading cell poles and dispersed at the rear of the cells. When cells reversed direction, the A-motility clusters relocalized to the new leading poles together with S-motility proteins. The Frz chemosensory system coordinated the two motility systems. The dynamics of protein cluster localization suggest that intracellular motors and force transmission by dynamic focal adhesions can power bacterial motility.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Idaho, Dept Microbiol Mol Biol & Biochem, Moscow, ID 83844 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Idaho; University of Idaho	Mignot, T (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	tmignot@berkeley.edu; zusman@berkeley.edu		Mignot, Tam/0000-0003-4338-9063	NIGMS NIH HHS [R01 GM020509, R01 GM075242-03, GM20509] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075242, R01GM020509] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baum J, 2006, NAT REV MICROBIOL, V4, P621, DOI 10.1038/nrmicro1465; GODWIN SL, 1989, J BACTERIOL, V171, P4589, DOI 10.1128/jb.171.9.4589-4594.1989; Hoiczyk E, 1998, CURR BIOL, V8, P1161, DOI 10.1016/S0960-9822(07)00487-3; Kruse T, 2003, EMBO J, V22, P5283, DOI 10.1093/emboj/cdg504; Li YN, 2003, P NATL ACAD SCI USA, V100, P5443, DOI 10.1073/pnas.0836639100; Mignot T, 2005, SCIENCE, V310, P855, DOI 10.1126/science.1119052; Soufo HJD, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-10; Spormann AM, 1999, MICROBIOL MOL BIOL R, V63, P621, DOI 10.1128/MMBR.63.3.621-641.1999; Sun H, 1999, P NATL ACAD SCI USA, V96, P15178, DOI 10.1073/pnas.96.26.15178; Wolgemuth C, 2002, CURR BIOL, V12, P369, DOI 10.1016/S0960-9822(02)00716-9; Wolgemuth CW, 2005, BIOPHYS J, V89, P945, DOI 10.1529/biophysj.105.062513; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Yang RF, 2004, J BACTERIOL, V186, P6168, DOI 10.1128/jb.186.18.6168-6178.2004	13	171	175	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2007	315	5813					853	856		10.1126/science.1137223	http://dx.doi.org/10.1126/science.1137223			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289998	Green Accepted			2022-12-01	WOS:000244069000071
J	Smith, NL; Hindorff, LA; Heckbert, SR; Lemaitre, RN; Marciante, KD; Rice, K; Lumley, T; Bis, JC; Wiggins, KL; Rosendaal, FR; Psaty, BM				Smith, Nicholas L.; Hindorff, Lucia A.; Heckbert, Susan R.; Lemaitre, Rozenn N.; Marciante, Kristin D.; Rice, Kenneth; Lumley, Thomas; Bis, Joshua C.; Wiggins, Kerri L.; Rosendaal, Frits R.; Psaty, Bruce M.			Association of genetic variations with nonfatal venous thrombosis in postmenopausal women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FACTOR-V-LEIDEN; DEEP-VEIN-THROMBOSIS; ACTIVATED PROTEIN-C; MARBURG-I POLYMORPHISM; PATHWAY INHIBITOR GENE; BETA-FIBRINOGEN-GENE; FACTOR-XIII VA134LEU; FALSE DISCOVERY RATE; MYOCARDIAL-INFARCTION; PULMONARY-EMBOLISM	Context Although the roles of clotting proteins and enzymes that activate or inhibit fibrin production and lysis are well characterized, the underlying contribution of genetic variation in these constituents to risk of venous thrombosis (VT) has not been fully investigated. Objective To describe the association of common genetic variation in 24 coagulation, anticoagulation, fibrinolysis, and antifibrinolysis candidate genes with risk of incident nonfatal VT in postmenopausal women. Design, Setting, and Participants Population-based case-control study conducted in a large integrated health care system in Washington State. Participants were perimenopausal and postmenopausal women aged 30 to 89 years who sustained a first VT event between January 1995 and December 2002 ( n= 349) and 1680 controls matched on age, hypertension status, and calendar year ( n= 1680). Main Outcome Measure Risk of venous thrombosis associated with global variation within a gene as measured by common haplotypes and with individual haplotypes and single nucleotide polymorphisms ( SNPs). Significance of the associations was assessed by a .20 threshold of the false-discovery rate q value, which accounts for multiple testing. Results Only the tissue factor pathway inhibitor gene demonstrated global association with risk (q=. 13). Five significant SNP associations were identified across 3 of the candidate genes ( factors V, XI, and protein C) in SNP analyses. Two associations have been previously reported. Another 22 variants across 15 genes had P values less than .05 but q values between .20 and .35. Five of these confirm previously reported associations ( fibrinogen genes and protein C), 2 were inconsistent with earlier reports ( thrombomodulin and plasminogen activator inhibitor 1), and 15 were new discoveries. Conclusions After accounting for multiple testing, 5 SNPs associated with VT risk were identified, 3 of which have not been previously reported. Replication of these novel associations in other populations is necessary to corroborate these findings and identify which genetic factors may influence VT risk in postmenopausal women.	Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; Univ Washington, Dept Med, Seattle, WA 98101 USA; Univ Washington, Dept Biostat, Seattle, WA 98101 USA; Univ Washington, Dept Hlth Serv, Seattle, WA 98101 USA; Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Hematol, Leiden, Netherlands	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Smith, NL (corresponding author), Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, 1730 Minor Ave,Suite 1360, Seattle, WA 98101 USA.	nlsmith@u.washington.edu	Rice, Kenneth M/A-4150-2013; Rosendaal, Frits/Q-3842-2017	Rice, Kenneth M/0000-0001-5779-4495; Rosendaal, Frits/0000-0003-2558-7496; Wiggins, Kerri L/0000-0003-2749-1279	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068639, R01HL068986, R01HL060739, R01HL073410, R01HL074745, R01HL043201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009556] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL43201, HL60739, HL68639, HL73410, HL74745, HL68986] Funding Source: Medline; NIA NIH HHS [AG09556] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aiach M, 1999, ARTERIOSCL THROM VAS, V19, P1573, DOI 10.1161/01.ATV.19.6.1573; Ameziane N, 2002, THROMB HAEMOSTASIS, V88, P195; Amini-Nekoo A, 2001, BRIT J HAEMATOL, V113, P537, DOI 10.1046/j.1365-2141.2001.02752.x; Arnaud E, 2000, ARTERIOSCL THROM VAS, V20, P892, DOI 10.1161/01.ATV.20.3.892; Arnaud E, 1999, THROMB HAEMOSTASIS, V82, P159, DOI 10.1055/s-0037-1614654; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertina RM, 2005, J THROMB HAEMOST, V3, P597, DOI 10.1111/j.1538-7836.2005.01198.x; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Blake GJ, 2001, EUR HEART J, V22, P2262, DOI 10.1053/euhj.2001.2692; Camilleri RS, 2005, BLOOD COAGUL FIBRIN, V16, P193, DOI 10.1097/01.mbc.0000164428.13417.e2; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Carter AM, 2000, BLOOD, V96, P1177, DOI 10.1182/blood.V96.3.1177.015k25_1177_1179; Castaman G, 2003, HAEMATOLOGICA, V88, P1182; Catto AJ, 1999, BLOOD, V93, P906, DOI 10.1182/blood.V93.3.906.403k24_906_908; de Visser MCH, 2000, THROMB HAEMOSTASIS, V83, P577; de Willige SU, 2005, BLOOD, V106, P4176, DOI 10.1182/blood-2005-05-2180; Emmerich J, 2001, THROMB HAEMOSTASIS, V86, P809; Evans GD, 2000, THROMB HAEMOSTASIS, V83, P511, DOI 10.1055/s-0037-1613847; Franco RF, 2001, HAEMATOLOGICA, V86, P510; Franco RF, 2000, BRIT J HAEMATOL, V111, P118, DOI 10.1046/j.1365-2141.2000.02338.x; French B, 2006, GENET EPIDEMIOL, V30, P485, DOI 10.1002/gepi.20161; Heit JA, 2005, J THROMB HAEMOST, V3, P710, DOI 10.1111/j.1538-7836.2005.01187.x; Hoppe B, 2005, BLOOD, V105, P1549, DOI 10.1182/blood-2004-08-3328; Kleesiek K, 1999, THROMB HAEMOSTASIS, V82, P1; Ko YL, 2006, HUM GENET, V119, P84, DOI 10.1007/s00439-005-0102-0; Komanasin N, 2005, J THROMB HAEMOST, V3, P2487, DOI 10.1111/j.1538-7836.2005.01624.x; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; PSATY BM, 1994, ARCH INTERN MED, V154, P1333, DOI 10.1001/archinte.154.12.1333; PSATY BM, 1995, JAMA-J AM MED ASSOC, V274, P620, DOI 10.1001/jama.274.8.620; Renner W, 2000, THROMB RES, V99, P35, DOI 10.1016/S0049-3848(00)00219-X; Renner W, 2002, EUR J CLIN INVEST, V32, P755, DOI 10.1046/j.1365-2362.2002.01070.x; Ridker PM, 1997, CIRCULATION, V95, P59, DOI 10.1161/01.CIR.95.1.59; ROSENDAAL FR, 1995, BLOOD, V85, P1504, DOI 10.1182/blood.V85.6.1504.bloodjournal8561504; Scanavini D, 2005, THROMB HAEMOSTASIS, V93, P453, DOI 10.1160/TH04-09-0629; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; SPEK CA, 1995, ARTERIOSCL THROM VAS, V15, P214, DOI 10.1161/01.ATV.15.2.214; Stegnar M, 1998, THROMB HAEMOSTASIS, V79, P975; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tirado I, 2004, THROMB HAEMOSTASIS, V91, P899, DOI 10.1160/TH03-10-0620; van Minkelen R, 2005, BLOOD, V105, P4898, DOI 10.1182/blood-2005-02-0576; Vlieg AV, 2002, BRIT J HAEMATOL, V119, P169; Nossent AY, 2006, THROMB HAEMOSTASIS, V95, P942, DOI 10.1160/TH06-01-0024; Zee RYL, 2006, CIRCULATION, V113, P2193, DOI 10.1161/CIRCULATIONAHA.106.615401; Zee RYL, 2005, J THROMB HAEMOST, V3, P2819, DOI 10.1111/j.1538-7836.2005.01665.x; Zidane M, 2003, THROMB HAEMOSTASIS, V90, P439, DOI 10.1160/TH03-01-0035	47	142	145	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2007	297	5					489	498		10.1001/jama.297.5.489	http://dx.doi.org/10.1001/jama.297.5.489			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133FP	17284699	Bronze			2022-12-01	WOS:000243999100026
J	Suttle, KB; Thomsen, MA; Power, ME				Suttle, K. B.; Thomsen, Meredith A.; Power, Mary E.			Species interactions reverse grassland responses to changing climate	SCIENCE			English	Article							ENVIRONMENTAL-CHANGE; CALIFORNIA; ECOSYSTEM; VEGETATION; MOUNTAIN; DIVERSITY; COMMUNITY; PATTERNS; RANGES; SHIFTS	Predictions of ecological response to climate change are based largely on direct climatic effects on species. We show that, in a California grassland, species interactions strongly influence responses to changing climate, overturning direct climatic effects within 5 years. We manipulated the seasonality and intensity of rainfall over large, replicate plots in accordance with projections of leading climate models and examined responses across several trophic levels. Changes in seasonal water availability had pronounced effects on individual species, but as precipitation regimes were sustained across years, feedbacks and species interactions overrode autecological responses to water and reversed community trajectories. Conditions that sharply increased production and diversity through 2 years caused simplification of the food web and deep reductions in consumer abundance after 5 years. Changes in these natural grassland communities suggest a prominent role for species interactions in ecosystem response to climate change.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Wisconsin, Dept Biol, La Crosse, WI 54601 USA	University of California System; University of California Berkeley; University of Wisconsin System	Suttle, KB (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	kbsuttle@socrates.berkeley.edu		Thomsen, Meredith/0000-0001-9843-5202				BARTOLOME JW, 1979, J ECOL, V67, P273, DOI 10.2307/2259350; BEEBEE TJC, 1995, NATURE, V374, P219, DOI 10.1038/374219a0; BENTLEY J. R., 1958, JOUR RANGE MANAGEMENT, V11, P133, DOI 10.2307/3893716; BENTLEY J. R., 1954, JOUR RANGE MANAGEMENT, V7, P25, DOI 10.2307/3894622; Burns CE, 2003, P NATL ACAD SCI USA, V100, P11474, DOI 10.1073/pnas.1635115100; Crick HQP, 1997, NATURE, V388, P526, DOI 10.1038/41453; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; FIELD CB, 1999, CONFRONTING GLOBAL C; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Gasith A, 1999, ANNU REV ECOL SYST, V30, P51, DOI 10.1146/annurev.ecolsys.30.1.51; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; HEADY HF, 1958, ECOLOGY, V39, P402, DOI 10.2307/1931750; HOBBS RJ, 1988, OECOLOGIA, V75, P291, DOI 10.1007/BF00378612; HUENNEKE LF, 1990, ECOLOGY, V71, P478, DOI 10.2307/1940302; IVES AR, 1995, ECOLOGY, V76, P926, DOI 10.2307/1939357; JACKSON LE, 1986, ACTA OECOL-OEC PLANT, V7, P191; JONES MB, 1990, J PROD AGRIC, V3, P534, DOI 10.2134/jpa1990.0534; Lensing JR, 2006, P NATL ACAD SCI USA, V103, P15502, DOI 10.1073/pnas.0607064103; *NAT ASS SYNTH TEA, 2002, CLIM CHANG IMP US PO; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; PITT MD, 1978, ECOLOGY, V59, P336, DOI 10.2307/1936378; Pope VD, 2000, CLIM DYNAM, V16, P123, DOI 10.1007/s003820050009; Post E, 1999, NATURE, V401, P905, DOI 10.1038/44814; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Rothley KD, 2006, CAN J ZOOL, V84, P1053, DOI 10.1139/Z06-076; Sanz-Elorza M, 2003, ANN BOT-LONDON, V92, P273, DOI 10.1093/aob/mcg130; Schmitz OJ, 2003, BIOSCIENCE, V53, P1199, DOI 10.1641/0006-3568(2003)053[1199:ERTGCC]2.0.CO;2; STEPHENSON NL, 1990, AM NAT, V135, P649, DOI 10.1086/285067; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Voigt W, 2003, ECOLOGY, V84, P2444, DOI 10.1890/02-0266; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Winder M, 2004, ECOLOGY, V85, P2100, DOI 10.1890/04-0151	35	549	574	14	522	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2007	315	5812					640	642		10.1126/science.1136401	http://dx.doi.org/10.1126/science.1136401			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272720				2022-12-01	WOS:000243909400041
J	Deutsch, C; Sarmiento, JL; Sigman, DM; Gruber, N; Dunne, JP				Deutsch, Curtis; Sarmiento, Jorge L.; Sigman, Daniel M.; Gruber, Nicolas; Dunne, John P.			Spatial coupling of nitrogen inputs and losses in the ocean	NATURE			English	Article							PACIFIC SUBTROPICAL GYRE; TROPICAL NORTH PACIFIC; ATLANTIC OCEAN; FIXATION; DENITRIFICATION; NITRATE; REMINERALIZATION; TRICHODESMIUM; CYCLES; SEA	Nitrogen fixation is crucial for maintaining biological productivity in the oceans, because it replaces the biologically available nitrogen that is lost through denitrification. But, owing to its temporal and spatial variability, the global distribution of marine nitrogen fixation is difficult to determine from direct shipboard measurements. This uncertainty limits our understanding of the factors that influence nitrogen fixation, which may include iron, nitrogen-to-phosphorus ratios, and physical conditions such as temperature. Here we determine nitrogen fixation rates in the world's oceans through their impact on nitrate and phosphate concentrations in surface waters, using an ocean circulation model. Our results indicate that nitrogen fixation rates are highest in the Pacific Ocean, where water column denitrification rates are high but the rate of atmospheric iron deposition is low. We conclude that oceanic nitrogen fixation is closely tied to the generation of nitrogen-deficient waters in denitrification zones, supporting the view that nitrogen fixation stabilizes the oceanic inventory of fixed nitrogen over time.	Univ Washington, Sch Oceanog, Program Climate Change, Seattle, WA 98195 USA; Princeton Univ, Atmospher & Ocean Sci Program, Princeton, NJ 08544 USA; Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; Univ Calif Los Angeles, IGPP, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA; NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08542 USA	University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; Princeton University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; National Oceanic Atmospheric Admin (NOAA) - USA	Deutsch, C (corresponding author), Univ Washington, Sch Oceanog, Program Climate Change, Seattle, WA 98195 USA.	cdeutsch@ocean.washington.edu	Dunne, John P/F-8086-2012; Deutsch, Curtis A/D-1703-2011; Sigman, Daniel M/A-2649-2008; Gruber, Nicolas/B-7013-2009	Dunne, John P/0000-0002-8794-0489; Sigman, Daniel M/0000-0002-7923-1973; Gruber, Nicolas/0000-0002-2085-2310				Abell J, 2000, J MAR RES, V58, P203, DOI 10.1357/002224000321511142; ANDERSON LA, 1994, GLOBAL BIOGEOCHEM CY, V8, P65, DOI 10.1029/93GB03318; Brandes JA, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001856; Brandes JA, 1998, LIMNOL OCEANOGR, V43, P1680, DOI 10.4319/lo.1998.43.7.1680; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; Capone DG, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002331; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; CODISPOTI LA, 1976, LIMNOL OCEANOGR, V21, P379, DOI 10.4319/lo.1976.21.3.0379; Codispoti LA, 2001, SCI MAR, V65, P85, DOI 10.3989/scimar.2001.65s285; CODISPOTI LA, 1995, NATURE, V376, P724, DOI 10.1038/376724a0; Conkright M. E., 2002, WORLD OCEAN ATLAS 20, P1; Deutsch C, 2001, GLOBAL BIOGEOCHEM CY, V15, P483, DOI 10.1029/2000GB001291; Deutsch C, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002189; Dunne JP, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002390; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Gnanadesikan A, 2001, DEEP-SEA RES PT II, V49, P363; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Gruber N, 2003, CARBON CLIMATE INTER, P97; Hansell DA, 2004, MAR CHEM, V84, P243, DOI 10.1016/j.marchem.2003.08.004; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Lehmann MF, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002508; Letelier RM, 1998, AQUAT MICROB ECOL, V15, P265, DOI 10.3354/ame015265; Mahowald N, 1999, J GEOPHYS RES-ATMOS, V104, P15895, DOI 10.1029/1999JD900084; Redfield AC., 1963, SEA, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; SARMIENTO JL, 2006, OCEAN BIOGEOCHEMICAL, P118; Sigman DM, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002458; Tanaka T, 2004, CONT SHELF RES, V24, P1271, DOI 10.1016/j.csr.2004.04.004; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	30	512	526	8	258	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2007	445	7124					163	167		10.1038/nature05392	http://dx.doi.org/10.1038/nature05392			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QF	17215838				2022-12-01	WOS:000243384300042
J	Halperin, SA				Halperin, Scott A.			The control of pertussis - 2007 and beyond	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Halperin, SA (corresponding author), Dalhousie Univ, Dept Pediat, Halifax, NS, Canada.			Halperin, Scott/0000-0003-0525-589X				Lievano FA, 2002, J CLIN MICROBIOL, V40, P2801, DOI 10.1128/JCM.40.8.2801-2805.2002; Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC, 2006, MMWR RECOMM REP, V55, P1; Skowronski DM, 2002, J INFECT DIS, V185, P1696; Skowronski DM, 2002, J INFECT DIS, V185, P1448, DOI 10.1086/340280; SMITH S, 2006, BOSTON GLOBE    1102; TALBOT EA, 2006, ANN M INF DIS SOC AM	6	74	81	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 11	2007	356	2					110	113		10.1056/NEJMp068288	http://dx.doi.org/10.1056/NEJMp068288			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	124NE	17215528				2022-12-01	WOS:000243373700003
J	McFall-Ngai, M				McFall-Ngai, Margaret			Adaptive immunity - Care for the community	NATURE			English	Editorial Material									Univ Wisconsin, Symbiosis Cluster, Madison, WI 53706 USA; Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	McFall-Ngai, M (corresponding author), Univ Wisconsin, Symbiosis Cluster, Madison, WI 53706 USA.							Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013; Hedrick SM, 2004, IMMUNITY, V21, P607, DOI 10.1016/j.immuni.2004.08.020; Weng L, 2006, GENOME RES, V16, P316, DOI 10.1101/gr.3676406	4	248	253	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 11	2007	445	7124					153	153		10.1038/445153a	http://dx.doi.org/10.1038/445153a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QF	17215830				2022-12-01	WOS:000243384300032
J	Tylianakis, JM; Tscharntke, T; Lewis, OT				Tylianakis, Jason M.; Tscharntke, Teja; Lewis, Owen T.			Habitat modification alters the structure of tropical host-parasitoid food webs	NATURE			English	Article							BIOLOGICAL-CONTROL; LAND-USE; COMMUNITY; DIVERSITY; DESCRIPTORS; STABILITY; SERVICES; GRADIENT; INSECTS; BEES	Global conversion of natural habitats to agriculture has led to marked changes in species diversity and composition(1). However, it is less clear how habitat modification affects interactions among species(2). Networks of feeding interactions ( food webs) describe the underlying structure of ecological communities, and might be crucially linked to their stability and function(3-7). Here, we analyse 48 quantitative food webs(8,9) for cavity-nesting bees, wasps and their parasitoids across five tropical habitat types. We found marked changes in food-web structure(10,11) across the modification gradient, despite little variation in species richness. The evenness of interaction frequencies declined with habitat modification, with most energy flowing along one or a few pathways in intensively managed agricultural habitats. In modified habitats there was a higher ratio of parasitoid to host species and increased parasitism rates, with implications for the important ecosystem services, such as pollination and biological control, that are performed by host bees and wasps(12). The most abundant parasitoid species was more specialized in modified habitats, with reduced attack rates on alternative hosts. Conventional community descriptors failed to discriminate adequately among habitats, indicating that perturbation of the structure and function of ecological communities might be overlooked in studies that do not document and quantify species interactions. Altered interaction structure therefore represents an insidious and functionally important hidden effect of habitat modification by humans.	Univ Gottingen, D-37073 Gottingen, Germany; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Gottingen; University of Oxford	Tylianakis, JM (corresponding author), Univ Canterbury, Sch Biol Sci, Private Bag 4800, Christchurch 8020, New Zealand.	jason.tylianakis@canterbury.ac.nz	Tylianakis, Jason/B-6634-2011; Tscharntke, Teja/N-5123-2014; Lewis, Owen T/B-9531-2011	Tylianakis, Jason/0000-0001-7402-5620; Lewis, Owen/0000-0001-7935-6111				Banasek-Richter C, 2004, J THEOR BIOL, V226, P23, DOI 10.1016/S0022-5193(03)00305-9; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.2307/3071801; COHEN JE, 1993, ECOLOGY, V74, P252, DOI 10.2307/1939520; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Goldwasser L, 1997, ECOLOGY, V78, P41; Hawkins BA, 1999, OIKOS, V86, P493, DOI 10.2307/3546654; Henneman ML, 2001, SCIENCE, V293, P1314, DOI 10.1126/science.1060788; Ives AR, 2004, NATURE, V429, P174, DOI 10.1038/nature02515; JANZEN DH, 1974, NAT HIST, V83, P48; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Lewis OT, 2002, J ANIM ECOL, V71, P855, DOI 10.1046/j.1365-2656.2002.00651.x; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Martinez ND, 1999, ECOLOGY, V80, P1044, DOI 10.1890/0012-9658(1999)080[1044:EOSEOC]2.0.CO;2; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Melian CJ, 2002, ECOL LETT, V5, P37, DOI 10.1046/j.1461-0248.2002.00280.x; Memmott J, 1999, ECOL LETT, V2, P276, DOI 10.1046/j.1461-0248.1999.00087.x; MEMMOTT J, 1994, J ANIM ECOL, V63, P521, DOI 10.2307/5219; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Morris RJ, 2004, NATURE, V428, P310, DOI 10.1038/nature02394; Muller CB, 1999, J ANIM ECOL, V68, P346, DOI 10.1046/j.1365-2656.1999.00288.x; PAINE RT, 1988, ECOLOGY, V69, P1648, DOI 10.2307/1941141; Rand TA, 2006, ECOL LETT, V9, P603, DOI 10.1111/j.1461-0248.2006.00911.x; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tylianakis JM, 2006, ECOLOGY, V87, P3047, DOI 10.1890/0012-9658(2006)87[3047:DEFASO]2.0.CO;2; Tylianakis JM, 2006, J BIOGEOGR, V33, P1295, DOI 10.1111/j.1365-2699.2006.01493.x; Tylianakis JM, 2005, ECOLOGY, V86, P3296, DOI 10.1890/05-0371; van der Putten WH, 2004, BASIC APPL ECOL, V5, P487, DOI 10.1016/j.baae.2004.09.003	30	614	638	10	455	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 11	2007	445	7124					202	205		10.1038/nature05429	http://dx.doi.org/10.1038/nature05429			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QF	17215842				2022-12-01	WOS:000243384300050
J	Sutter, NB; Bustamante, CD; Chase, K; Gray, MM; Zhao, KY; Zhu, L; Padhukasahasram, B; Karlins, E; Davis, S; Jones, PG; Quignon, P; Johnson, GS; Parker, HG; Fretwell, N; Mosher, DS; Lawler, DF; Satyaraj, E; Nordborg, M; Lark, KG; Wayne, RK; Ostrander, EA				Sutter, Nathan B.; Bustamante, Carlos D.; Chase, Kevin; Gray, Melissa M.; Zhao, Keyan; Zhu, Lan; Padhukasahasram, Badri; Karlins, Eric; Davis, Sean; Jones, Paul G.; Quignon, Pascale; Johnson, Gary S.; Parker, Heidi G.; Fretwell, Neale; Mosher, Dana S.; Lawler, Dennis F.; Satyaraj, Ebenezer; Nordborg, Magnus; Lark, K. Gordon; Wayne, Robert K.; Ostrander, Elaine A.			A single IGF1 allele is a major determinant of small size in dogs	SCIENCE			English	Article							BODY-SIZE; WILD CANIDS; GROWTH; MORPHOLOGY; ORIGINS	The domestic dog exhibits greater diversity in body size than any other terrestrial vertebrate. We used a strategy that exploits the breed structure of dogs to investigate the genetic basis of size. First, through a genome-wide scan, we identified a major quantitative trait locus (QTL) on chromosome 15 influencing size variation within a single breed. Second, we examined genetic variation in the 15-megabase interval surrounding the QTL in small and giant breeds and found marked evidence for a selective sweep spanning a single gene (IGF1), encoding insulin-like growth factor 1. A single IGF1 single-nucleotide polymorphism haplotype is common to all small breeds and nearly absent from giant breeds, suggesting that the same causal sequence variant is a major contributor to body size in all small dogs.	NHGRI, Bethesda, MD 20892 USA; Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14850 USA; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Univ Calif Los Angeles, Dept Ecol & Environm Biol, Los Angeles, CA 90095 USA; Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA 90089 USA; WALTHAM Ctr Pet Nutr, Melton Mowbray LE14 4RT, Leics, England; Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA; Nestle Res Ctr NRC STL, St Louis, MO 63164 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Cornell University; Utah System of Higher Education; University of Utah; University of California System; University of California Los Angeles; University of Southern California; Mars; WALTHAM Petcare Science Institute; University of Missouri System; University of Missouri Columbia	Ostrander, EA (corresponding author), NHGRI, Bldg 50,Room 5349,50 S Dr MSC 8000, Bethesda, MD 20892 USA.	eostrand@mail.nih.gov	Fiumefreddo, Andrea/T-2977-2019; Gray, Melissa/B-5025-2008; Parker, Heidi/C-6954-2008; Davis, Sean/AAD-1801-2021	Gray, Melissa/0000-0002-1756-5468; Davis, Sean/0000-0002-8991-6458; Nordborg, Magnus/0000-0001-7178-9748; Ostrander, Elaine/0000-0001-6075-9738; Parker, Heidi G./0000-0002-9707-6380; Karlins, Eric/0000-0002-7541-393X; Bustamante, Carlos D./0000-0002-4187-7920; Zhao, Keyan/0000-0002-8800-2304	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790, Z01HG200325, T32HG002536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063056] Funding Source: NIH RePORTER; NHGRI NIH HHS [P50 HG002790, 5T32 HG002536] Funding Source: Medline; NIGMS NIH HHS [R01 GM063056, R01 GM063056-06] Funding Source: Medline; PHS HHS [063056] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Chase K, 2005, GENOME RES, V15, P1820, DOI 10.1101/gr.3712705; Chase K, 2002, P NATL ACAD SCI USA, V99, P9930, DOI 10.1073/pnas.152333099; Cohen P, 2006, HORM RES, V65, P3, DOI 10.1159/000090640; EIGENMANN JE, 1984, ACTA ENDOCRINOL-COP, V106, P448, DOI 10.1530/acta.0.1060448; Epstein H., 1971, ORIGIN DOMESTIC ANIM; Favier RP, 2001, J ENDOCRINOL, V170, P479, DOI 10.1677/joe.0.1700479; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Kooijman R, 2006, CYTOKINE GROWTH F R, V17, P305, DOI 10.1016/j.cytogfr.2006.02.002; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Olsen S, 1985, ORIGINS DOMESTIC DOG; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Pollinger JP, 2005, GENOME RES, V15, P1809, DOI 10.1101/gr.4374505; Sablin MV, 2002, CURR ANTHROPOL, V43, P795, DOI 10.1086/344372; Saetre P, 2004, MOL BRAIN RES, V126, P198, DOI 10.1016/j.molbrainres.2004.05.003; Sampson J, 2006, COLD SPRING HARB MON, V44, P19; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; TCHERNOV E, 1991, J ANTHROPOL ARCHAEOL, V10, P54, DOI 10.1016/0278-4165(91)90021-O; Van Valkenburgh B, 2004, SCIENCE, V306, P101, DOI 10.1126/science.1102417; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; Wang W, 2005, GENOME RES, V15, P1798, DOI 10.1101/gr.3765505; WAYNE RK, 1986, J ZOOL, V210, P381; WAYNE RK, 1986, EVOLUTION, V40, P243, DOI 10.1111/j.1558-5646.1986.tb00467.x; WAYNE RK, 1986, J MORPHOL, V187, P301, DOI 10.1002/jmor.1051870304; Webber C, 2005, GENOME RES, V15, P1787, DOI 10.1101/gr.3896805; Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805; Woods KA, 1997, ACTA PAEDIATR, V86, P39	28	462	482	1	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2007	316	5821					112	115		10.1126/science.1137045	http://dx.doi.org/10.1126/science.1137045			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412960	Green Accepted			2022-12-01	WOS:000245470500044
J	Tan, X; Calderon-Villalobos, LIA; Sharon, M; Zheng, CX; Robinson, CV; Estelle, M; Zheng, N				Tan, Xu; Calderon-Villalobos, Luz Irina A.; Sharon, Michal; Zheng, Changxue; Robinson, Carol V.; Estelle, Mark; Zheng, Ning			Mechanism of auxin perception by the TIR1 ubiquitin ligase	NATURE			English	Article							FUNCTIONAL GENOMIC ANALYSIS; GENE FAMILY-MEMBERS; BOX PROTEIN TIR1; INOSITOL HEXAKISPHOSPHATE; AUX/IAA PROTEINS; PLANT-GROWTH; DEGRADATION; PATHWAY	Auxin is a pivotal plant hormone that controls many aspects of plant growth and development. Perceived by a small family of F-box proteins including transport inhibitor response 1 (TIR1), auxin regulates gene expression by promoting SCF ubiquitin-ligase-catalysed degradation of the Aux/IAA transcription repressors, but how the TIR1 F-box protein senses and becomes activated by auxin remains unclear. Here we present the crystal structures of the Arabidopsis TIR1 - ASK1 complex, free and in complexes with three different auxin compounds and an Aux/IAA substrate peptide. These structures show that the leucine-rich repeat domain of TIR1 contains an unexpected inositol hexakisphosphate co-factor and recognizes auxin and the Aux/IAA polypeptide substrate through a single surface pocket. Anchored to the base of the TIR1 pocket, auxin binds to a partially promiscuous site, which can also accommodate various auxin analogues. Docked on top of auxin, the Aux/IAA substrate peptide occupies the rest of the TIR1 pocket and completely encloses the hormone-binding site. By filling in a hydrophobic cavity at the protein interface, auxin enhances the TIR1 - substrate interactions by acting as a 'molecular glue'. Our results establish the first structural model of a plant hormone receptor.	Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	University of Washington; University of Washington Seattle; University of Cambridge; Indiana University System; Indiana University Bloomington	Zheng, N (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Box 357280, Seattle, WA 98195 USA.	nzheng@u.washington.edu	Villalobos, Luz Irina A Calderón/L-5876-2016; Estelle, Mark/ABD-6742-2021; Tan, Xu/E-7170-2011	Tan, Xu/0000-0003-4861-4573; robinson, carol/0000-0001-7829-5505; Calderon Villalobos, Luz Irina A./0000-0002-6093-1478; Sharon, Michal/0000-0003-3933-0595				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Dharmasiri N, 2003, CURR BIOL, V13, P1418, DOI 10.1016/S0960-9822(03)00536-0; Dharmasiri N, 2004, TRENDS PLANT SCI, V9, P302, DOI 10.1016/j.tplants.2004.04.003; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; FARRIMOND JA, 1978, NATURE, V274, P401, DOI 10.1038/274401a0; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; Hoy M, 2002, P NATL ACAD SCI USA, V99, P6773, DOI 10.1073/pnas.102157499; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JONSSON A, 1961, ENCY PLANT PHYSL, V14, P959; KAETHNER TM, 1977, NATURE, V267, P19, DOI 10.1038/267019a0; Kepinski S, 2004, P NATL ACAD SCI USA, V101, P12381, DOI 10.1073/pnas.0402868101; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; KOBE B, 1993, J MOL BIOL, V231, P137, DOI 10.1006/jmbi.1993.1263; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Moon J, 2004, PLANT CELL, V16, P3181, DOI 10.1105/tpc.104.161220; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Overvoorde PJ, 2005, PLANT CELL, V17, P3282, DOI 10.1105/tpc.105.036723; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Reed JW, 2001, TRENDS PLANT SCI, V6, P420, DOI 10.1016/S1360-1385(01)02042-8; Remington DL, 2004, PLANT PHYSIOL, V135, P1738, DOI 10.1104/pp.104.039669; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; Zenser N, 2001, P NATL ACAD SCI USA, V98, P11795, DOI 10.1073/pnas.211312798; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	43	1049	1132	13	244	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2007	446	7136					640	645		10.1038/nature05731	http://dx.doi.org/10.1038/nature05731			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17410169				2022-12-01	WOS:000245438300033
J	Zhang, F; Wang, LP; Brauner, M; Liewald, JF; Kay, K; Watzke, N; Wood, PG; Bamberg, E; Nagel, G; Gottschalk, A; Deisseroth, K				Zhang, Feng; Wang, Li-Ping; Brauner, Martin; Liewald, Jana F.; Kay, Kenneth; Watzke, Natalie; Wood, Phillip G.; Bamberg, Ernst; Nagel, Georg; Gottschalk, Alexander; Deisseroth, Karl			Multimodal fast optical interrogation of neural circuitry	NATURE			English	Article							CHLORIDE PUMP HALORHODOPSIN; GREEN-ALGAE; IN-VIVO; MAMMALIAN NEURONS; EXCITABLE CELLS; REMOTE-CONTROL; ION CHANNELS; LIGHT; ACTIVATION; CHANNELRHODOPSIN-2	Our understanding of the cellular implementation of systems-level neural processes like action, thought and emotion has been limited by the availability of tools to interrogate specific classes of neural cells within intact, living brain tissue. Here we identify and develop an archaeal light-driven chloride pump (NpHR) from Natronomonas pharaonis for temporally precise optical inhibition of neural activity. NpHR allows either knockout of single action potentials, or sustained blockade of spiking. NpHR is compatible with ChR2, the previous optical excitation technology we have described, in that the two opposing probes operate at similar light powers but with well-separated action spectra. NpHR, like ChR2, functions in mammals without exogenous cofactors, and the two probes can be integrated with calcium imaging in mammalian brain tissue for bidirectional optical modulation and readout of neural activity. Likewise, NpHR and ChR2 can be targeted together to Caenorhabditis elegans muscle and cholinergic motor neurons to control locomotion bidirectionally. NpHR and ChR2 form a complete system for multimodal, high-speed, genetically targeted, all-optical interrogation of living neural circuits.	Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; Goethe Univ Frankfurt, Frankfurt Bioctr N220, Inst Biochem, D-60438 Frankfurt, Germany; Goethe Univ Frankfurt, Frankfurt Bioctr N220, Inst Biophys Chem, Dept Biochem Chem & Pharm, D-60438 Frankfurt, Germany; Max Planck Inst Biophys, D-60438 Frankfurt, Germany; Univ Wuezburg, D-97082 Wuezburg, Germany	Stanford University; Goethe University Frankfurt; Goethe University Frankfurt; Max Planck Society	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Gottschalk, Alexander/D-3155-2011; Ritter, Stefanie L/D-9312-2012; Macrae, Rhiannon/AAX-1536-2020; Wang, Liping/ABF-6317-2020; Wang, Liping/B-2827-2012	Gottschalk, Alexander/0000-0002-1197-6119; Wang, Liping/0000-0001-6893-3809; Nagel, Georg/0000-0001-8174-8712				ADAMS SR, 1993, ANNU REV PHYSIOL, V55, P755, DOI 10.1146/annurev.physiol.55.1.755; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; BAMBERG E, 1993, P NATL ACAD SCI USA, V90, P639, DOI 10.1073/pnas.90.2.639; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brun S, 2003, MOL THER, V7, P782, DOI 10.1016/S1525-0016(03)00097-2; Chambers JJ, 2006, J NEUROPHYSIOL, V96, P2792, DOI 10.1152/jn.00318.2006; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; DUSCHL A, 1988, J BIOL CHEM, V263, P17016; Ehrengruber MU, 1997, P NATL ACAD SCI USA, V94, P7070, DOI 10.1073/pnas.94.13.7070; Faumont S, 2006, J NEUROPHYSIOL, V95, P1976, DOI 10.1152/jn.01050.2005; GRYGORCZYK R, 1989, METHOD ENZYMOL, V173, P453; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; HEGEMANN P, 1985, BIOCHIM BIOPHYS ACTA, V819, P195, DOI 10.1016/0005-2736(85)90174-9; Helmchen F, 2001, NEURON, V31, P903, DOI 10.1016/S0896-6273(01)00421-4; Ibanez-Tallon I, 2004, NEURON, V43, P305, DOI 10.1016/j.neuron.2004.07.015; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Isles AR, 2001, J NEUROBIOL, V47, P183, DOI 10.1002/neu.1026; Jensen O, 1996, LEARN MEMORY, V3, P257, DOI 10.1101/lm.3.2-3.257; Johns DC, 1999, J NEUROSCI, V19, P1691; Kanold PO, 2003, SCIENCE, V301, P521, DOI 10.1126/science.1084152; Karpova AY, 2005, NEURON, V48, P727, DOI 10.1016/j.neuron.2005.11.015; KOBAYASHI K, 1995, J BIOL CHEM, V270, P27235, DOI 10.1074/jbc.270.45.27235; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Lechner HAE, 2002, J NEUROSCI, V22, P5287; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; MacLean JN, 2006, NAT METHODS, V3, P129, DOI 10.1038/NMETH849; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Pettit DL, 2000, J NEUROPHYSIOL, V84, P28, DOI 10.1152/jn.2000.84.1.28; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017; Shoham S, 2005, NAT METHODS, V2, P837, DOI 10.1038/nmeth793; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Wang SSH, 2000, P NATL ACAD SCI USA, V97, P8635, DOI 10.1073/pnas.130414597; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zennou V, 2001, NAT BIOTECHNOL, V19, P446, DOI 10.1038/88115; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	48	1246	1343	9	331	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2007	446	7136					633	U4		10.1038/nature05744	http://dx.doi.org/10.1038/nature05744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17410168				2022-12-01	WOS:000245438300032
J	Sano, M; Minamino, T; Toko, H; Miyauchi, H; Orimo, M; Qin, YJ; Akazawa, H; Tateno, K; Kayama, Y; Harada, M; Shimizu, I; Asahara, T; Hamada, H; Tomita, S; Molkentin, JD; Zou, YZ; Komuro, I				Sano, Masanori; Minamino, Tohru; Toko, Haruhiro; Miyauchi, Hideyuki; Orimo, Masayuki; Qin, Yingjie; Akazawa, Hiroshi; Tateno, Kaoru; Kayama, Yosuke; Harada, Mutsuo; Shimizu, Ippei; Asahara, Takayuki; Hamada, Hirofumi; Tomita, Shuhei; Molkentin, Jeffrey D.; Zou, Yunzeng; Komuro, Issei			p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload	NATURE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR-GROWTH; HYPOXIA; ANGIOGENESIS; HYPERTROPHY; P53; EXPRESSION; HEART; GENE; MICE	Cardiac hypertrophy occurs as an adaptive response to increased workload to maintain cardiac function(1). However, prolonged cardiac hypertrophy causes heart failure(2), and its mechanisms are largely unknown. Here we show that cardiac angiogenesis is crucially involved in the adaptive mechanism of cardiac hypertrophy and that p53 accumulation is essential for the transition from cardiac hypertrophy to heart failure. Pressure overload initially promoted vascular growth in the heart by hypoxia-inducible factor-1 (Hif-1)-dependent induction of angiogenic factors, and inhibition of angiogenesis prevented the development of cardiac hypertrophy and induced systolic dysfunction. Sustained pressure overload induced an accumulation of p53 that inhibited Hif-1 activity and thereby impaired cardiac angiogenesis and systolic function. Conversely, promoting cardiac angiogenesis by introducing angiogenic factors or by inhibiting p53 accumulation developed hypertrophy further and restored cardiac dysfunction under chronic pressure overload. These results indicate that the anti-angiogenic property of p53 may have a crucial function in the transition from cardiac hypertrophy to heart failure.	Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chuo Ku, Chiba 2608670, Japan; RIKEN, Ctr Dev Biol, Kobe Inst Biomed Res & Innovat, Stem Cell Translat Res,Chuo Ku, Kobe, Hyogo 6500047, Japan; Sapporo Med Univ, Dept Mol Med, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; Univ Tokushima, Inst Genome Res, Div Expt Immunol, Tokushima 7708503, Japan; Childrens Hosp, Med Ctr, Dept Pediat, Div Mol Cardiovasc Biol, Cincinnati, OH 45229 USA; Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Shanghai 200032, Peoples R China; Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China	Chiba University; Institute for Biomedical Research & Innovation (IBRI); RIKEN; Sapporo Medical University; Tokushima University; Cincinnati Children's Hospital Medical Center; Fudan University; Fudan University	Komuro, I (corresponding author), Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	komuro-tky@umin.ac.jp	Minamino, Tohru/P-8145-2018	Minamino, Tohru/0000-0003-1627-6151; Molkentin, Jeffery/0000-0002-3558-6529; Akazawa, Hiroshi/0000-0002-3574-9607; Shimizu, Ippei/0000-0003-3333-8131				Blagosklonny MV, 1998, J BIOL CHEM, V273, P11995, DOI 10.1074/jbc.273.20.11995; Fei PW, 2004, CANCER CELL, V6, P597, DOI 10.1016/j.ccr.2004.10.012; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; Goldman CK, 1998, P NATL ACAD SCI USA, V95, P8795, DOI 10.1073/pnas.95.15.8795; Gurova KV, 2005, P NATL ACAD SCI USA, V102, P17448, DOI 10.1073/pnas.0508888102; Harada M, 2005, NAT MED, V11, P305, DOI 10.1038/nm1199; INGBER D, 1990, NATURE, V348, P555, DOI 10.1038/348555a0; Kelly BD, 2003, CIRC RES, V93, P1074, DOI 10.1161/01.RES.0000102937.50486.1B; Kubasiak LA, 2002, P NATL ACAD SCI USA, V99, P12825, DOI 10.1073/pnas.202474099; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; MARCUS ML, 1983, AM J MED, V75, P62, DOI 10.1016/0002-9343(83)90120-1; Morani A, 2006, P NATL ACAD SCI USA, V103, P7165, DOI 10.1073/pnas.0602194103; Patel TH, 2005, CARDIOVASC RES, V68, P144, DOI 10.1016/j.cardiores.2005.05.002; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Ravi R, 2000, GENE DEV, V14, P34; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shizukuda Y, 2005, MOL CELL BIOCHEM, V273, P25, DOI 10.1007/s11010-005-5905-8; Shyu KG, 2005, J BIOMED SCI, V12, P409, DOI 10.1007/s11373-005-3008-x; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Takimoto E, 2002, FASEB J, V16, DOI 10.1096/fj.01-0735com; TOMANEK RJ, 1990, J AM COLL CARDIOL, V15, P528, DOI 10.1016/0735-1097(90)90620-5; Tomita S, 2003, MOL CELL BIOL, V23, P6739, DOI 10.1128/MCB.23.19.6739-6749.2003; Yoon YS, 2005, CIRCULATION, V111, P2073, DOI 10.1161/01.CIR.0000162472.52990.36	24	679	702	4	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2007	446	7134					444	448		10.1038/nature05602	http://dx.doi.org/10.1038/nature05602			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17334357				2022-12-01	WOS:000245079500041
J	Robertson, MP; Scott, WG				Robertson, Michael P.; Scott, William G.			The structural basis of ribozyme-catalyzed RNA assembly	SCIENCE			English	Article							IN-VITRO SELECTION; INTERVENING SEQUENCE; HAMMERHEAD RIBOZYME; LIGASE; POLYMERIZATION; OPTIMIZATION; TETRAHYMENA; CLEAVAGE; COMPLEX; ENZYME	Life originated, according to the RNA World hypothesis, from self-replicating ribozymes that catalyzed ligation of RNA fragments. We have solved the 2.6 angstrom crystal structure of a ligase ribozyme that catalyzes regiospecific formation of a 5' to 3' phosphodiester bond between the 5'-triphosphate and the 3'-hydroxyl termini of two RNA fragments. Invariant residues form tertiary contacts that stabilize a flexible stem of the ribozyme at the ligation site, where an essential magnesium ion coordinates three phosphates. The structure of the active site permits us to suggest how transition-state stabilization and a general base may catalyze the ligation reaction required for prebiotic RNA assembly.	Univ Calif Santa Cruz, Ctr Mol Biol RNA, Robert L Sinsheimer Labs, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Dept Chem & Biochem, Robert L Sinsheimer Labs, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Scott, WG (corresponding author), Univ Calif Santa Cruz, Ctr Mol Biol RNA, Robert L Sinsheimer Labs, Santa Cruz, CA 95064 USA.	wgscott@chemistry.ucsc.edu		Scott, William/0000-0002-9273-3564	NIGMS NIH HHS [R01 GM087721] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bandyopadhyay D, 2003, J BIOMOL STRUCT DYN, V21, P447, DOI 10.1080/07391102.2003.10506939; BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; Doudna JA, 2002, NATURE, V418, P222, DOI 10.1038/418222a; EKLAND EH, 1995, SCIENCE, V269, P364, DOI 10.1126/science.7618102; GERRIERTAKADA C, 1983, CELL, V35, P849; GESTELAND RF, 1993, RNA WORLD; Ikawa Y, 2004, P NATL ACAD SCI USA, V101, P13750, DOI 10.1073/pnas.0405886101; Jaeger L, 1999, P NATL ACAD SCI USA, V96, P14712, DOI 10.1073/pnas.96.26.14712; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Landweber LF, 1999, P NATL ACAD SCI USA, V96, P173, DOI 10.1073/pnas.96.1.173; Lawrence MS, 2005, RNA, V11, P1173, DOI 10.1261/rna.2110905; Lawrence MS, 2003, BIOCHEMISTRY-US, V42, P8748, DOI 10.1021/bi034228l; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; McGinness KE, 2003, CHEM BIOL, V10, P5, DOI 10.1016/S1074-5521(03)00003-6; PLEY HW, 1994, NATURE, V372, P68, DOI 10.1038/372068a0; Robertson MP, 2000, NUCLEIC ACIDS RES, V28, P1751, DOI 10.1093/nar/28.8.1751; Robertson MP, 2004, RNA, V10, P114, DOI 10.1261/rna.5900204; Robertson MP, 1999, NAT BIOTECHNOL, V17, P62, DOI 10.1038/5236; Robertson MP, 2001, NAT BIOTECHNOL, V19, P650, DOI 10.1038/90256; Robertson MP, 2001, RNA, V7, P513, DOI 10.1017/S1355838201002199; Rogers J, 1999, NATURE, V402, P323, DOI 10.1038/46335; SCOTT WG, 1995, CELL, V81, P991, DOI 10.1016/S0092-8674(05)80004-2; ZAUG AJ, 1986, SCIENCE, V231, P470, DOI 10.1126/science.3941911	24	73	78	2	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1549	1553		10.1126/science.1136231	http://dx.doi.org/10.1126/science.1136231			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363667	Green Submitted			2022-12-01	WOS:000244934800044
J	Saarela, JM; Rai, HS; Doyle, JA; Endress, PK; Mathews, S; Marchant, AD; Briggs, BG; Graham, SW				Saarela, Jeffery M.; Rai, Hardeep S.; Doyle, James A.; Endress, Peter K.; Mathews, Sarah; Marchant, Adam D.; Briggs, Barbara G.; Graham, Sean W.			Hydatellaceae identified as a new branch near the base of the angiosperm phylogenetic tree	NATURE			English	Article							EARLY EVOLUTION; GENES; MITOCHONDRIAL; FAMILIES; GENOME	Although the relationship of angiosperms to other seed plants remains controversial 1, great progress has been made in identifying the earliest extant splits in flowering-plant phylogeny, with the discovery that the New Caledonian shrub Amborella trichopoda, the water lilies (Nymphaeales), and the woody Austrobaileyales constitute a basal grade of lines that diverged before the main radiation in the clade(2-8). By focusing attention on these ancient lines, this finding has re-written our understanding of angiosperm structural and reproductive biology, physiology, ecology and taxonomy(9-12). The discovery of a new basal lineage would lead to further re-evaluation of the initial angiosperm radiation, but would also be unexpected, as nearly all of the 460 flowering-plant families have been surveyed in molecular studies(10). Here we show that Hydatellaceae, a small family of dwarf aquatics that were formerly interpreted as monocots, are instead a highly modified and previously unrecognized ancient lineage of angiosperms. Molecular phylogenetic analyses of multiple plastid genes and associated noncoding regions from the two genera of Hydatellaceae identify this overlooked family as the sister group of Nymphaeales. This surprising result is further corroborated by evidence from the nuclear gene phytochrome C (PHYC), and by numerous morphological characters. This indicates that water lilies are part of a larger lineage that evolved more extreme and diverse modifications for life in an aquatic habitat than previously recognized.	Univ British Columbia, Fac Land & Food Syst, Ctr Biodivers Res, Plant Res Ctr, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, UBC Bot Garden, Vancouver, BC V6T 1Z4, Canada; Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; Univ Zurich, Inst Systemat Bot, CH-8008 Zurich, Switzerland; Harvard Univ, Arnold Arboretum, Cambridge, MA 02138 USA; Royal Bot Gardens, Sydney, NSW 2000, Australia	University of British Columbia; University of British Columbia; University of California System; University of California Davis; University of Zurich; Harvard University	Graham, SW (corresponding author), Univ British Columbia, Fac Land & Food Syst, Ctr Biodivers Res, Plant Res Ctr, 2357 Main Mall, Vancouver, BC V6T 1Z4, Canada.	swgraham@interchange.ubc.ca	Mathews, Sarah/A-6513-2015; Graham, Sean W/L-3944-2014	Mathews, Sarah/0000-0002-5518-7541; Graham, Sean W/0000-0001-8209-5231; Saarela, Jeffery/0000-0003-1790-4332				[Anonymous], 1985, FAMILIES MONOCOTYLED, DOI DOI 10.1007/978-3-642-61663-1; APPEL O, 1998, FAMILIES GENERA VASC, V4, P208; Borsch T, 2003, J EVOLUTION BIOL, V16, P558, DOI 10.1046/j.1420-9101.2003.00577.x; Bremer K, 2002, EVOLUTION, V56, P1374, DOI 10.1111/j.0014-3820.2002.tb01451.x; Burleigh JG, 2004, AM J BOT, V91, P1599, DOI 10.3732/ajb.91.10.1599; Chase Mark W., 2006, Aliso, V22, P63; COOKE DA, 1998, FAMILIES GENERA VASC, V4, P106; Doyle JA, 2005, GRANA, V44, P227, DOI 10.1080/00173130500424557; Doyle JA, 2000, INT J PLANT SCI, V161, pS121, DOI 10.1086/317578; Feild TS, 2004, PALEOBIOLOGY, V30, P82, DOI 10.1666/0094-8373(2004)030<0082:DADANI>2.0.CO;2; Graham SW, 2000, AM J BOT, V87, P1712, DOI 10.2307/2656749; Graham SW, 2002, MOL BIOL EVOL, V19, P1769, DOI 10.1093/oxfordjournals.molbev.a003999; GRAHAM SW, 2006, MONOCOTS COMP BIOL E, P3; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAMANN U, 1976, New Zealand Journal of Botany, V14, P193; HAMANN U, 1975, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V96, P154; Hamann U., 1998, FAMILIES GENERA VASC, V4, P231, DOI [DOI 10.1007/978-3-662-03531-3_23, 10.1007/978-3-662-03531-3_23]; Harden GJ., 1993, FLORA NEW S WALES VO, V4; Kim S, 2004, MOL PHYLOGENET EVOL, V31, P16, DOI 10.1016/j.ympev.2003.07.017; Leebens-Mack J, 2005, MOL BIOL EVOL, V22, P1948, DOI 10.1093/molbev/msi191; Maddison DR, 2001, MACCLADE 4 ANAL PHYL; Mathews S, 2000, INT J PLANT SCI, V161, pS41, DOI 10.1086/317582; Michelangeli FA, 2003, AM J BOT, V90, P93, DOI 10.3732/ajb.90.1.93; Qiu YL, 2005, INT J PLANT SCI, V166, P815, DOI 10.1086/431800; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; Stevenson DW, 2000, MONOCOTS SYSTEMATICS, P17; Sun G, 2002, SCIENCE, V296, P899, DOI 10.1126/science.1069439; Swofford DL, 2002, PAUP PHYLOGENETIC AN; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; Williams JH, 2004, AM J BOT, V91, P332, DOI 10.3732/ajb.91.3.332; Zanis MJ, 2002, P NATL ACAD SCI USA, V99, P6848, DOI 10.1073/pnas.092136399	31	183	199	0	54	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 15	2007	446	7133					312	315		10.1038/nature05612	http://dx.doi.org/10.1038/nature05612			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17361182	Green Published			2022-12-01	WOS:000244892900044
J	Dion, MF; Kaplan, T; Kim, M; Buratowski, S; Friedman, N; Rando, OJ				Dion, Michael F.; Kaplan, Tommy; Kim, Minkyu; Buratowski, Stephen; Friedman, Nir; Rando, Oliver J.			Dynamics of replication-independent histone turnover in budding yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; GENOME-WIDE; PHO5 PROMOTER; IN-VIVO; CHROMATIN; BOUNDARIES; H2A.Z; MARKS; EUCHROMATIN; ELONGATION	Chromatin plays roles in processes governed by different time scales. To assay the dynamic behavior of chromatin in living cells, we used genomic tiling arrays to measure histone H3 turnover in G1-arrested Saccharomyces cerevisiae at single-nucleosome resolution over 4% of the genome, and at lower (similar to 265 base pair) resolution over the entire genome. We find that nucleosomes at promoters are replaced more rapidly than at coding regions and that replacement rates over coding regions correlate with polymerase density. In addition, rapid histone turnover is found at known chromatin boundary elements. These results suggest that rapid histone turnover serves to functionally separate chromatin domains and prevent spread of histone states.	Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA; Hebrew Univ Jerusalem, Sch Comp Sci & Engn, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Mol Genet & Biotechnol, Fac Med, IL-91120 Jerusalem, Israel; Harvard Univ, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Harvard University	Rando, OJ (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	Oliver.Rando@umassmed.edu	Friedman, Nir/H-9692-2012; Kaplan, Tommy/T-2528-2017; Kim, Minkyu/AAZ-8535-2021	Friedman, Nir/0000-0002-9678-3550; Kaplan, Tommy/0000-0002-1892-5461; Kim, Minkyu/0000-0001-9317-1658; Dion, Michael/0000-0002-0434-4236				Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Ahmad K, 2002, P NATL ACAD SCI USA, V99, P16477, DOI 10.1073/pnas.172403699; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Bi X, 2001, CURR OPIN GENET DEV, V11, P199, DOI 10.1016/S0959-437X(00)00179-9; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Chiu YH, 2003, GENETICS, V165, P115; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Linger J, 2006, EUKARYOT CELL, V5, P1780, DOI 10.1128/EC.00202-06; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Schermer UJ, 2005, MOL CELL, V19, P279, DOI 10.1016/j.molcel.2005.05.028; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Thiriet C, 2005, GENE DEV, V19, P677, DOI 10.1101/gad.1265205; Yu Q, 2003, NUCLEIC ACIDS RES, V31, P1224, DOI 10.1093/nar/gkg200; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	26	414	420	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2007	315	5817					1405	1408		10.1126/science.1134053	http://dx.doi.org/10.1126/science.1134053			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347438				2022-12-01	WOS:000244752200032
J	Lovering, AL; de Castro, LH; Lim, D; Strynadka, NCJ				Lovering, Andrew L.; de Castro, Liza H.; Lim, Daniel; Strynadka, Natalie C. J.			Structural insight into the transglycosylation step of bacterial cell-wall biosynthesis	SCIENCE			English	Article							KINETIC CHARACTERIZATION; CRYSTAL-STRUCTURE; GLYCOSYLTRANSFERASE MODULE; STAPHYLOCOCCUS-AUREUS; VANCOMYCIN RESISTANCE; BACTERIOPHAGE-LAMBDA; ESCHERICHIA-COLI; PROTEINS; PBP1B	Peptidoglycan glycosyltransferases (GTs) catalyze the polymerization step of cell-wall biosynthesis, are membrane-bound, and are highly conserved across all bacteria. Long considered the "holy grail" of antibiotic research, they represent an essential and easily accessible drug target for antibiotic-resistant bacteria, including methicillin-resistant Staphylococcus aureus. We have determined the 2.8 angstrom structure of a bifunctional cell-wall cross-linking enzyme, including its transpeptidase and GT domains, both unliganded and complexed with the substrate analog moenomycin. The peptidoglycan GTs adopt a fold distinct from those of other GT classes. The structures give insight into critical features of the catalytic mechanism and key interactions required for enzyme inhibition.	Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Ctr Blood Res, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V5Z 1M9, Canada.	natalie@byron.biochem.ubc.ca		Lovering, Andrew/0000-0002-1856-7975				Barrett D, 2005, J BACTERIOL, V187, P2215, DOI 10.1128/JB.187.6.2215-2217.2005; Barrett DS, 2004, BIOCHEMISTRY-US, V43, P12375, DOI 10.1021/bi049142m; BUGG TDH, 1991, BIOCHEMISTRY-US, V30, P10408, DOI 10.1021/bi00107a007; Butaye P, 2001, ANTIMICROB AGENTS CH, V45, P1374, DOI 10.1128/AAC.45.5.1374-1378.2001; Contreras-Martel C, 2006, J MOL BIOL, V355, P684, DOI 10.1016/j.jmb.2005.10.030; Evrard C, 1998, J MOL BIOL, V276, P151, DOI 10.1006/jmbi.1997.1499; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Goldman RC, 2000, CURR MED CHEM, V7, P801; Halliday J, 2006, BIOCHEM PHARMACOL, V71, P957, DOI 10.1016/j.bcp.2005.10.030; Holm L, 1999, NUCLEIC ACIDS RES, V27, P244, DOI 10.1093/nar/27.1.244; Leung AKW, 2001, BIOCHEMISTRY-US, V40, P5665, DOI 10.1021/bi0028035; Ritzeler O, 1997, TETRAHEDRON, V53, P1675, DOI 10.1016/S0040-4020(96)01115-5; Schwartz B, 2002, BIOCHEMISTRY-US, V41, P12552, DOI 10.1021/bi026205x; Terrak M, 1999, MOL MICROBIOL, V34, P350, DOI 10.1046/j.1365-2958.1999.01612.x; Terrak M, 2006, J BACTERIOL, V188, P2528, DOI 10.1128/JB.188.7.2528-2532.2006; WALSH CT, 1993, SCIENCE, V261, P308, DOI 10.1126/science.8392747; Welzel P, 2005, CHEM REV, V105, P4610, DOI 10.1021/cr040634e; WELZEL P, 1987, TETRAHEDRON, V43, P585, DOI 10.1016/S0040-4020(01)89992-0	18	222	233	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2007	315	5817					1402	1405		10.1126/science.1136611	http://dx.doi.org/10.1126/science.1136611			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347437				2022-12-01	WOS:000244752200031
J	Lamsa, KP; Heeroma, JH; Somogyi, P; Rusakov, DA; Kullmann, DM				Lamsa, Karri P.; Heeroma, Joost H.; Somogyi, Peter; Rusakov, Dmitri A.; Kullmann, Dimitri M.			Anti-Hebbian long-term potentiation in the hippocampal feedback inhibitory circuit	SCIENCE			English	Article							AMPA RECEPTORS; INWARD RECTIFICATION; THETA OSCILLATIONS; IN-VIVO; INTERNEURONS; EXPRESSION; ACTIVATION; SYNAPSES; INPUT; MODEL	Long-term potentiation (LTP), which approximates Hebb's postulate of associative learning, typically requires depolarization-dependent glutamate receptors of the NMDA (N-methyl-D-aspartate) subtype. However, in some neurons, LTP depends instead on calcium-permeable AMPA-type receptors. This is paradoxical because intracellular polyamines block such receptors during depolarization. We report that LTP at synapses on hippocampal interneurons mediating feedback inhibition is "anti-Hebbian": It is induced by presynaptic activity but prevented by postsynaptic depolarization. Anti-Hebbian LTP may occur in interneurons that are silent during periods of intense pyramidal cell firing, such as sharp waves, and lead to their altered activation during theta activity.	UCL, Inst Neurol, London WC1N 3BG, England; Univ Oxford, MRC, Anat Neuropharmacol Unit, Oxford OX1 3HT, England	University of London; University College London; University of Oxford	Kullmann, DM (corresponding author), UCL, Inst Neurol, Queen Sq, London WC1N 3BG, England.	d.kullmann@ion.ucl.ac.uk	Heeroma, Joost/AFI-8727-2022; Lamsa, Karri/T-2025-2019; Heeroma, Joost/AAF-4310-2022; Kullmann, Dimitri M/A-3162-2009; Heeroma, Joost/C-1749-2008; Rusakov, Dmitri A/E-1987-2011; Rusakov, Dmitri/AAH-4529-2021	Kullmann, Dimitri M/0000-0001-6696-3545; Rusakov, Dmitri A/0000-0001-9539-9947; Rusakov, Dmitri/0000-0001-9539-9947; Lamsa, Karri/0000-0002-4609-1337	MRC [MC_U138135973, G0501424, G0400627, G0600368, G116/147] Funding Source: UKRI; Medical Research Council [G0600368, G0501424, G116/147, MC_U138135973, G0400627(71256), G0400627(76527), G0400627, G0600368(77987)] Funding Source: Medline; Wellcome Trust [071179] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; BLASCOIBANEZ JM, 1995, EUR J NEUROSCI, V7, P2170, DOI 10.1111/j.1460-9568.1995.tb00638.x; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; DONEVAN SD, 1995, P NATL ACAD SCI USA, V92, P9298, DOI 10.1073/pnas.92.20.9298; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Gillies MJ, 2002, J PHYSIOL-LONDON, V543, P779, DOI 10.1113/jphysiol.2002.024588; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; Hebb D.O., 2002, CLIN PSYCHOL; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2004, NAT NEUROSCI, V7, P41, DOI 10.1038/nn1159; Laezza F, 2004, J NEUROPHYSIOL, V92, P3575, DOI 10.1152/jn.00425.2004; Laezza F, 1999, SCIENCE, V285, P1411, DOI 10.1126/science.285.5432.1411; Lamsa K, 2005, NAT NEUROSCI, V8, P916, DOI 10.1038/nn1486; Lei SB, 2002, NEURON, V33, P921, DOI 10.1016/S0896-6273(02)00608-6; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Mainen ZF, 1998, NAT NEUROSCI, V1, P579, DOI 10.1038/2812; Nyiri G, 2003, NEUROSCIENCE, V119, P347, DOI 10.1016/S0306-4522(03)00157-X; Perez Y, 2001, P NATL ACAD SCI USA, V98, P9401, DOI 10.1073/pnas.161493498; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Topolnik L, 2005, J NEUROSCI, V25, P990, DOI 10.1523/JNEUROSCI.4388-04.2005; Washburn MS, 1997, J NEUROSCI, V17, P9393	25	179	184	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2007	315	5816					1262	1266		10.1126/science.1137450	http://dx.doi.org/10.1126/science.1137450			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332410	Green Accepted			2022-12-01	WOS:000244564700046
J	Radoshitzky, SR; Abraham, J; Spiropoulou, CF; Kuhn, JH; Nguyen, D; Li, WH; Nagel, J; Schmidt, PJ; Nunberg, JH; Andrews, NC; Farzan, M; Choe, H				Radoshitzky, Sheli R.; Abraham, Jonathan; Spiropoulou, Christina F.; Kuhn, Jens H.; Nguyen, Dan; Li, Wenhui; Nagel, Jane; Schmidt, Paul J.; Nunberg, Jack H.; Andrews, Nancy C.; Farzan, Michael; Choe, Hyeryun			Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses	NATURE			English	Article							ALPHA-DYSTROGLYCAN; ENDOTHELIUM; VIRUSES; CELLS; JUNIN; ANTIBODIES; BIOLOGY; BINDING; ENTRY	At least five arenaviruses cause viral haemorrhagic fevers in humans. Lassa virus, an Old World arenavirus, uses the cellular receptor alpha-dystroglycan to infect cells(1). Machupo, Guanarito, Junin and Sabia viruses are New World haemorrhagic fever viruses that do not use alpha-dystroglycan(2). Here we show a specific, high-affinity association between transferrin receptor 1 (TfR1) and the entry glycoprotein ( GP) of Machupo virus. Expression of human TfR1, but not human transferrin receptor 2, in hamster cell lines markedly enhanced the infection of viruses pseudotyped with the GP of Machupo, Guanarito and Junin viruses, but not with those of Lassa or lymphocytic choriomeningitis viruses. An anti-TfR1 antibody efficiently inhibited the replication of Machupo, Guanarito, Junin and Sabia viruses, but not that of Lassa virus. Iron depletion of culture medium enhanced, and iron supplementation decreased, the efficiency of infection by Junin and Machupo but not Lassa pseudoviruses. These data indicate that TfR1 is a cellular receptor for New World haemorrhagic fever arenaviruses.	Harvard Univ, Sch Med, Dept Pediat, Childrens Hosp,Pulm Div, Boston, MA 02115 USA; Harvard Univ, Sch Med, New England Primate Res Ctr, Dept Microbiol & Mol Genet, Southborough, MA 01772 USA; Ctr Dis Control & Prevent, Special Pathogens Branch, Atlanta, GA 30333 USA; Free Univ Berlin, Dept Biol Chem Pharm, D-14195 Berlin, Germany; Harvard Univ, Sch Med, Dept Pediat, Childrens Hosp,Div Hematol Oncol, Boston, MA 02115 USA; Univ Montana, Montana Biotechnol Ctr, Missoula, MT 59812 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Centers for Disease Control & Prevention - USA; Free University of Berlin; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Montana System; University of Montana	Choe, H (corresponding author), Harvard Univ, Sch Med, Dept Pediat, Childrens Hosp,Pulm Div, Boston, MA 02115 USA.	hyeryun.choe@childrens.harvard.edu	Radoshitzky, Sheli S/F-2766-2019; Kuhn, Jens H./B-7615-2011; Radoshitzky, Sheli/L-8410-2019	Kuhn, Jens H./0000-0002-7800-6045; Radoshitzky, Sheli/0000-0001-8976-8056; Li, Wenhui/0000-0003-1305-7404; Farzan, Michael/0000-0002-2990-5319; Andrews, Nancy/0000-0003-0243-4462	NIAID NIH HHS [R01 AI074879] Funding Source: Medline; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON GJ, 1990, GASTROENTEROLOGY, V98, P576, DOI 10.1016/0016-5085(90)90276-7; Andrews N C, 1999, Curr Opin Hematol, V6, P61, DOI 10.1097/00062752-199903000-00001; Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; BUCHMEIER MJ, 1987, J VIROL, V61, P982, DOI 10.1128/JVI.61.4.982-985.1987; BURNS JW, 1991, VIROLOGY, V183, P620, DOI 10.1016/0042-6822(91)90991-J; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Castilla V, 1996, ARCH VIROL, V141, P1307, DOI 10.1007/BF01718832; Charrel RN, 2003, ANTIVIR RES, V57, P89, DOI 10.1016/S0166-3542(02)00202-4; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; JEFFERIES WA, 1984, NATURE, V312, P162, DOI 10.1038/312162a0; Kasvosve I, 2002, CLIN CHEM LAB MED, V40, P1014, DOI 10.1515/CCLM.2002.176; Kunz S, 2005, J VIROL, V79, P5979, DOI 10.1128/JVI.79.10.5979-5987.2005; Kunz S, 2002, CURR TOP MICROBIOL, V262, P111; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; MATTIA E, 1984, J BIOL CHEM, V259, P2689; MCGRAW TE, 1987, J CELL BIOL, V105, P207, DOI 10.1083/jcb.105.1.207; Oldstone MBA, 2002, CURR TOP MICROBIOL, V263, pV; Oldstone MBA, 2002, CURR TOP MICROBIOL, V262, pV; Parker JSL, 2001, J VIROL, V75, P3896, DOI 10.1128/JVI.75.8.3896-3902.2001; Peters CJ, 2002, CRIT CARE MED, V30, pS268, DOI 10.1097/00003246-200205001-00016; Raya G, 2001, CLIN CHEM LAB MED, V39, P1162, DOI 10.1515/CCLM.2001.183; Reignier T, 2006, VIROLOGY, V353, P111, DOI 10.1016/j.virol.2006.05.018; Rojek JM, 2006, VIROLOGY, V349, P476, DOI 10.1016/j.virol.2006.02.033; Ross SR, 2002, P NATL ACAD SCI USA, V99, P12386, DOI 10.1073/pnas.192360099; SODA R, 1984, BLOOD, V63, P270; Spiropoulou CF, 2002, J VIROL, V76, P5140, DOI 10.1128/JVI.76.10.5140-5146.2002; Templeton DM, 2003, BBA-GEN SUBJECTS, V1619, P113, DOI 10.1016/S0304-4165(02)00497-X; WARD JH, 1982, J BIOL CHEM, V257, P317; Wong SK, 2004, J BIOL CHEM, V279, P3197, DOI 10.1074/jbc.C300520200; York J, 2006, J VIROL, V80, P7775, DOI 10.1128/JVI.00642-06	30	300	313	0	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 1	2007	446	7131					92	96		10.1038/nature05539	http://dx.doi.org/10.1038/nature05539			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17287727	Bronze, Green Accepted, Green Published			2022-12-01	WOS:000244525600044
J	Hoffman, JI; Forcada, J; Trathan, PN; Amos, W				Hoffman, J. I.; Forcada, J.; Trathan, P. N.; Amos, W.			Female fur seals show active choice for males that are heterozygous and unrelated	NATURE			English	Article							ARCTOCEPHALUS-GAZELLA; LEK PARADOX; PARENTAL RELATEDNESS; MATE CHOICE; GREY SEAL; PATERNITY; SELECTION; EVOLUTION; FITNESS; CAPTURE	Much debate surrounds the exact rules that influence mating behaviour, and in particular the selective forces that explain the evolution of female preferences. A key example is the lek paradox, in which female choice is expected rapidly to become ineffective owing to loss of additive genetic variability for the preferred traits(1-3). Here we exploit a remarkable system in which female fur seals exert choice by moving across a crowded breeding colony to visit largely static males. We show that females move further to maximize the balance between male high multilocus heterozygosity and low relatedness. Such a system shows that female choice can be important even in a strongly polygynous species, and at the same time may help to resolve the lek paradox because heterozygosity has low heritability and inbreeding avoidance means there is no single 'best' male for all females.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; British Antarctic Survey, NERC, Cambridge CB3 0ET, England	University of Cambridge; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Hoffman, JI (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	jih24@cam.ac.uk	Hoffman, Joseph i/K-7725-2012; Forcada, Jaume/GYU-0677-2022	Hoffman, Joseph i/0000-0001-5895-8949; 	NERC [bas010017] Funding Source: UKRI; Natural Environment Research Council [bas010017] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Acevedo-Whitehouse K, 2003, NATURE, V422, P35, DOI 10.1038/422035a; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Andersson M, 1996, TRENDS ECOL EVOL, V11, P53, DOI 10.1016/0169-5347(96)81042-1; Arnould JPY, 1997, J ZOOL, V241, P649, DOI 10.1111/j.1469-7998.1997.tb05739.x; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; BIRKHEAD T, 1993, TRENDS ECOL EVOL, V8, P100, DOI 10.1016/0169-5347(93)90060-3; Borgia G., 1979, SEXUAL SELECTION REP, P19; BROWN JL, 1994, AM NAT, V143, P435, DOI 10.1086/285612; Goldsworthy SD, 1999, BEHAV ECOL SOCIOBIOL, V45, P253, DOI 10.1007/s002650050560; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; Hoffman JI, 2006, MOL ECOL, V15, P3841, DOI 10.1111/j.1365-294X.2006.03053.x; Hoffman JI, 2006, MOL ECOL, V15, P1995, DOI 10.1111/j.1365-294X.2006.02894.x; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Hoffman JI, 2003, EVOLUTION, V57, P1917; Hoffman JI, 2004, EVOLUTION, V58, P2087; Irwin AJ, 2000, EVOL ECOL RES, V2, P119; KIRKPATRICK M, 1991, NATURE, V350, P33, DOI 10.1038/350033a0; Lidgard DC, 2004, MOL ECOL, V13, P3543, DOI 10.1111/j.1365-294X.2004.02334.x; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; PARTRIDGE L, 1983, MATE CHOICE, P227; Pujolar JM, 2005, EVOLUTION, V59, P189; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Qvarnstrom A, 2006, NATURE, V441, P84, DOI 10.1038/nature04564; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Seddon N, 2004, P ROY SOC B-BIOL SCI, V271, P1823, DOI 10.1098/rspb.2004.2805; TAYLOR PD, 1982, THEOR POPUL BIOL, V22, P392, DOI 10.1016/0040-5809(82)90052-1; Tiira K, 2006, BEHAV ECOL SOCIOBIOL, V59, P657, DOI 10.1007/s00265-005-0094-8; Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029; Trivers R.L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Wilmer JW, 1999, MOL ECOL, V8, P1417, DOI 10.1046/j.1365-294x.1999.00705.x	30	152	155	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					912	914		10.1038/nature05558	http://dx.doi.org/10.1038/nature05558			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17287726				2022-12-01	WOS:000244341200048
J	Raby, CR; Alexis, DM; Dickinson, A; Clayton, NS				Raby, C. R.; Alexis, D. M.; Dickinson, A.; Clayton, N. S.			Planning for the future by western scrub-jays	NATURE			English	Article							MENTAL TIME-TRAVEL; HUMAN MIND; MEMORY; EVOLUTION; RECOVERY; ABILITY; MAZE	Knowledge of and planning for the future is a complex skill that is considered by many to be uniquely human. We are not born with it; children develop a sense of the future at around the age of two and some planning ability by only the age of four to five(1-3). According to the Bischof-Kohler hypothesis(4), only humans can dissociate themselves from their current motivation and take action for future needs: other animals are incapable of anticipating future needs, and any future-oriented behaviours they exhibit are either fixed action patterns or cued by their current motivational state. The experiments described here test whether a member of the corvid family, the western scrub-jay (Aphelocoma californica), plans for the future. We show that the jays make provision for a future need, both by preferentially caching food in a place in which they have learned that they will be hungry the following morning and by differentially storing a particular food in a place in which that type of food will not be available the next morning. Previous studies have shown that, in accord with the Bischof-Kohler hypothesis, rats(5) and pigeons(6) may solve tasks by encoding the future but only over very short time scales. Although some primates and corvids(7-9) take actions now that are based on their future consequences, these have not been shown to be selected with reference to future motivational states(10), or without extensive reinforcement of the anticipatory act(11). The results described here suggest that the jays can spontaneously plan for tomorrow without reference to their current motivational state, thereby challenging the idea that this is a uniquely human ability.	Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of Cambridge	Clayton, NS (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.	nsc22@cam.ac.uk	Clayton, Nicola s/A-2891-2010	Clayton, Nicola/0000-0003-1835-423X	Biotechnology and Biological Sciences Research Council [BB/D000335/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Atance CM, 2005, COGNITIVE DEV, V20, P341, DOI 10.1016/j.cogdev.2005.05.001; Atance CM, 2001, TRENDS COGN SCI, V5, P533, DOI 10.1016/S1364-6613(00)01804-0; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Clayton NS, 2005, J EXP PSYCHOL-ANIM B, V31, P115, DOI 10.1037/0097-7403.31.2.115; Clayton NS, 2003, NAT REV NEUROSCI, V4, P685, DOI 10.1038/nrn1180; Clayton NS, 1999, ANIM BEHAV, V57, P435, DOI 10.1006/anbe.1998.0989; COOK RG, 1985, J EXP PSYCHOL ANIM B, V11, P453, DOI 10.1037/0097-7403.11.3.453; Dally JM, 2006, SCIENCE, V312, P1662, DOI 10.1126/science.1126539; Klein SB, 2002, SOC COGNITION, V20, P353, DOI 10.1521/soco.20.5.353.21125; Mulcahy NJ, 2006, SCIENCE, V312, P1038, DOI 10.1126/science.1125456; Naqshbandi M, 2006, J COMP PSYCHOL, V120, P345, DOI 10.1037/0735-7036.120.4.345; Okuda J, 2003, NEUROIMAGE, V19, P1369, DOI 10.1016/S1053-8119(03)00179-4; PETROVICH GD, IN PRESS PHYSL BEHAV; Roberts WA, 2002, PSYCHOL BULL, V128, P473, DOI 10.1037//0033-2909.128.3.473; Roitman MF, 2001, BEHAV BRAIN RES, V122, P193, DOI 10.1016/S0166-4328(01)00189-9; Rosenbaum RS, 2005, NEUROPSYCHOLOGIA, V43, P989, DOI 10.1016/j.neuropsychologia.2004.10.007; Suddendorf T, 2005, LEARN MOTIV, V36, P110, DOI 10.1016/j.lmot.2005.02.010; Suddendorf T, 2006, SCIENCE, V312, P1006, DOI 10.1126/science.1129217; Suddendorf T, 1997, GENET SOC GEN PSYCH, V123, P133; ZENTALL TR, 1990, J EXP PSYCHOL ANIM B, V16, P358, DOI 10.1037/0097-7403.16.4.358	20	379	393	6	244	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					919	921		10.1038/nature05575	http://dx.doi.org/10.1038/nature05575			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	138CR	17314979				2022-12-01	WOS:000244341200050
J	Monje-Casas, F; Prabhu, VR; Lee, BH; Boselli, M; Amon, A				Monje-Casas, Fernando; Prabhu, Vineet R.; Lee, Brian H.; Boselli, Monica; Amon, Angelika			Kinetochore orientation during meiosis is controlled by Aurora B and the monopolin complex	CELL			English	Article							SISTER-CHROMATID COHESION; SACCHAROMYCES-CEREVISIAE; CENTROMERIC COHESION; PROTEIN-KINASE; CHROMOSOME SEGREGATION; BUDDING YEAST; MEIOTIC RECOMBINATION; SPINDLE; AIR-2; PHOSPHORYLATION	Kinetochores of sister chromatids attach to microtubules emanating from the same pole (coorientation) during meiosis I and microtubules emanating from opposite poles (biorientation) during meiosis II. We find that the Aurora B kinase IpI1 regulates kinetochore-microtubule attachment during both meiotic divisions and that a complex known as the monopolin complex ensures that the protein kinase coorients sister chromatids during meiosis I. Furthermore, the defining of conditions sufficient to induce sister kinetochore coorientation during mitosis provides insight into monopolin complex function. The monopolin complex joins sister kinetochores independently of cohesins, the proteins that hold sister chromatids together. We propose that this function of the monopolin complex helps Aurora B coorient sister chromatids during meiosis I.	MIT, Ctr Canc Res, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, Ctr Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	angelika@mit.edu	Monje-Casas, Fernando/M-3062-2014	Monje-Casas, Fernando/0000-0002-3587-2373; Lee, Brian/0000-0003-2497-5139; Amon, Angelika/0000-0001-9837-0314	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062207] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62207, R01 GM062207] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Bishop JD, 2005, MOL BIOL CELL, V16, P742, DOI 10.1091/mbc.E04-08-0682; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Dewar H, 2004, NATURE, V428, P93, DOI 10.1038/nature02328; Ducat D, 2004, EXP CELL RES, V301, P60, DOI 10.1016/j.yexcr.2004.08.016; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; GOLDSTEIN LSB, 1981, CELL, V25, P591, DOI 10.1016/0092-8674(81)90167-7; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Kaitna S, 2002, CURR BIOL, V12, P798, DOI 10.1016/S0960-9822(02)00820-5; Katis VL, 2004, CURR BIOL, V14, P2183, DOI 10.1016/j.cub.2004.12.020; Katis VL, 2004, CURR BIOL, V14, P560, DOI 10.1016/j.cub.2004.03.001; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; KLAPHOLZ S, 1985, GENETICS, V110, P187; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Lee BH, 2004, CURR BIOL, V14, P2168, DOI 10.1016/j.cub.2004.12.033; Lew DJ, 2003, ANNU REV GENET, V37, P251, DOI 10.1146/annurev.genet.37.042203.120656; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; Moore DP, 1998, CURR TOP DEV BIOL, V37, P263; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; Ohi R, 2004, MOL BIOL CELL, V15, P2895, DOI 10.1091/mbc.E04-02-0082; Parra MT, 2004, J CELL SCI, V117, P1221, DOI 10.1242/jcs.00947; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Pereira G, 2001, EMBO J, V20, P6359, DOI 10.1093/emboj/20.22.6359; Petronczki M, 2006, CELL, V126, P1049, DOI 10.1016/j.cell.2006.07.029; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Resnick TD, 2006, DEV CELL, V11, P57, DOI 10.1016/j.devcel.2006.04.021; Rogers E, 2002, J CELL BIOL, V157, P219, DOI 10.1083/jcb.200110045; Schumacher JM, 1998, J CELL BIOL, V143, P1635, DOI 10.1083/jcb.143.6.1635; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Winey M, 2005, MOL BIOL CELL, V16, P1178, DOI 10.1091/mbc.E04-09-0765; XU L, 1998, MOL CELL BIOL, V12, P6572; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013; Yu HG, 2005, CELL, V123, P397, DOI 10.1016/j.cell.2005.09.014	45	101	103	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2007	128	3					477	490		10.1016/j.cell.2006.12.040	http://dx.doi.org/10.1016/j.cell.2006.12.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289568	Green Accepted, Bronze			2022-12-01	WOS:000244842700015
J	Han, JH; Zhou, H; Horazdovsky, B; Zhang, KL; Xu, RM; Zhang, ZG				Han, Junhong; Zhou, Hui; Horazdovsky, Bruce; Zhang, Kangling; Xu, Rui-Ming; Zhang, Zhiguo			Rtt109 acetylates histone H3 lysine 56 and functions in DNA replication	SCIENCE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; S-PHASE; REPAIR; MAINTENANCE; COMPLEXES; INTEGRITY; NETWORK; HST3	Acetylation of histone H3 lysine 56 (H3-K56) occurs in S phase, and cells lacking H3-K56 acetylation are sensitive to DNA-damaging agents. However, the histone acetyltransferase (HAT) that catalyzes global H3-K56 acetylation has not been found. Here we show that regulation of Ty1 transposition gene product 109 (Rtt109) is an H3-K56 HAT. Cells lacking Rtt109 or expressing rtt109 mutants with alterations at a conserved aspartate residue lose H3-K56 acetylation and exhibit increased sensitivity toward genotoxic agents, as well as elevated levels of spontaneous chromosome breaks. Thus, Rtt109, which shares no sequence homology with any other known HATs, is a unique HAT that acetylates H3-K56.	Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Univ Calif Riverside, Mass Spectrometry Facil, Riverside, CA 92521 USA; NYU, Sch Med, Struct Biol Program,Skirball Inst Biomed, Helen L & Martin S Kimmel Ctr Biol & Med, New York, NY 10016 USA; NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA	Mayo Clinic; University of California System; University of California Riverside; New York University; New York University	Zhang, ZG (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.	Zhang.Zhiguo@mayo.edu	xu, rui/GRX-5734-2022; Han, Junhong/L-5264-2013	Han, Junhong/0000-0002-3371-8698				Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Eissenberg JC, 1997, MOL CELL BIOL, V17, P6367, DOI 10.1128/MCB.17.11.6367; Hyland EA, 2005, MOL CELL BIOL, V25, P10060, DOI 10.1128/MCB.25.22.10060-10070.2005; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Marmorstein Ronen, 2004, Novartis Found Symp, V259, P78; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Ozdemir A, 2005, J BIOL CHEM, V280, P25949, DOI 10.1074/jbc.C500181200; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Scholes DT, 2001, GENETICS, V159, P1449; Shor E, 2005, GENETICS, V169, P1275, DOI 10.1534/genetics.104.036764; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suter B, 2004, GENETICS, V167, P579, DOI 10.1534/genetics.103.024851; Sutton A, 2003, J BIOL CHEM, V278, P16887, DOI 10.1074/jbc.M210709200; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Wu JS, 2000, TRENDS BIOCHEM SCI, V25, P619, DOI 10.1016/S0968-0004(00)01718-7; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601; Zhou H, 2006, BIOCHEMISTRY-US, V45, P2852, DOI 10.1021/bi0521083	26	326	330	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2007	315	5812					653	655		10.1126/science.1133234	http://dx.doi.org/10.1126/science.1133234			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272723				2022-12-01	WOS:000243909400045
J	Kicheva, A; Pantazis, P; Bollenbach, T; Kalaidzidis, Y; Bittig, T; Julicher, F; Gonzalez-Gaitan, M				Kicheva, Anna; Pantazis, Periklis; Bollenbach, Tobias; Kalaidzidis, Yannis; Bittig, Thomas; Juelicher, Frank; Gonzalez-Gaitan, Marcos			Kinetics of morphogen gradient formation	SCIENCE			English	Article							WING IMAGINAL DISC; FLUORESCENT PROTEIN; PHOTOBLEACHING RECOVERY; DROSOPHILA DPP; CELLS; ENDOCYTOSIS; DIFFUSION; TRAFFICKING; RECEPTORS; MOBILITY	In the developing fly wing, secreted morphogens such as Decapentaplegic (Dpp) and Wingless (Wg) form gradients of concentration providing positional information. Dpp forms a longer-range gradient than Wg. To understand how the range is controlled, we measured the four key kinetic parameters governing morphogen spreading: the production rate, the effective diffusion coefficient, the degradation rate, and the immobile fraction. The four parameters had different values for Dpp versus Wg. In addition, Dynamin-dependent endocytosis was required for spreading of Dpp, but not Wg. Thus, the cellular mechanisms of Dpp and Wingless spreading are different: Dpp spreading requires endocytic, intracellular trafficking.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland; Max Planck Inst Phys Complex Syst, D-01187 Dresden, Germany; Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119899, Russia	Max Planck Society; University of Geneva; University of Geneva; Max Planck Society; Lomonosov Moscow State University	Julicher, F (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauer Str 109, D-01307 Dresden, Germany.	julicher@pks.mpg.de; marcos.gonzalez@biochem.unige.ch	Julicher, Frank/B-1828-2009; Kalaidzidis, Yannis/H-3094-2016; Bollenbach, Tobias/AAK-3206-2020; Pantazis, Periklis/AAR-1795-2021	Julicher, Frank/0000-0003-4731-9185; Kalaidzidis, Yannis/0000-0002-6137-1193; Bollenbach, Tobias/0000-0003-4398-476X; Gonzalez-Gaitan, Marcos/0000-0002-6295-7321; Pantazis, Periklis (Laki)/0000-0002-8367-9332				AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Baeg GH, 2004, DEV BIOL, V276, P89, DOI 10.1016/j.ydbio.2004.08.023; BASLER K, 1994, TRENDS GENET, V10, P187; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; Carrero G, 2003, METHODS, V29, P14, DOI 10.1016/S1046-2023(02)00288-8; Charpilienne A, 2001, J BIOL CHEM, V276, P29361, DOI 10.1074/jbc.M101935200; Ellenberg J, 1999, METHODS, V19, P362, DOI 10.1006/meth.1999.0872; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Groppe J, 1998, J BIOL CHEM, V273, P29052, DOI 10.1074/jbc.273.44.29052; Han C, 2005, DEVELOPMENT, V132, P667, DOI 10.1242/dev.01636; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Kruse K, 2004, DEVELOPMENT, V131, P4843, DOI 10.1242/dev.01335; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Lecuit T, 1998, DEVELOPMENT, V125, P4901; Lippincott-Schwartz J, 2003, NAT CELL BIOL, pS7, DOI 10.1038/ncb1032; Pfeiffer S, 2002, CURR BIOL, V12, P957, DOI 10.1016/S0960-9822(02)00867-9; Piddini E, 2005, DEVELOPMENT, V132, P5479, DOI 10.1242/dev.02145; Rives AF, 2006, DEV BIOL, V293, P268, DOI 10.1016/j.ydbio.2006.02.006; Seto ES, 2006, J CELL BIOL, V173, P95, DOI 10.1083/jcb.200510123; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611	23	284	287	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2007	315	5811					521	525		10.1126/science.1135774	http://dx.doi.org/10.1126/science.1135774			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255514				2022-12-01	WOS:000243726600049
J	Marquez, LM; Redman, RS; Rodriguez, RJ; Roossinck, MJ				Marquez, Luis M.; Redman, Regina S.; Rodriguez, Russell J.; Roossinck, Marilyn J.			A virus in a fungus in a plant: Three-way symbiosis required for thermal tolerance	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; HYPOVIRULENCE; DISRUPTION; CONVERSION; VIRULENCE	A mutualistic association between a fungal endophyte and a tropical panic grass allows both organisms to grow at high soil temperatures. We characterized a virus from this fungus that is involved in the mutualistic interaction. Fungal isolates cured of the virus are unable to confer heat tolerance, but heat tolerance is restored after the virus is reintroduced. The virus-infected fungus confers heat tolerance not only to its native monocot host but also to a eudicot host, which suggests that the underlying mechanism involves pathways conserved between these two groups of plants.	Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73402 USA; Univ Washington, Dept Bot, Seattle, WA 98195 USA; Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA; US Geol Survey, Seattle, WA 98115 USA	Noble Research Institute; University of Washington; University of Washington Seattle; Montana State University System; Montana State University Bozeman; United States Department of the Interior; United States Geological Survey	Roossinck, MJ (corresponding author), Samuel Roberts Noble Fdn Inc, Div Plant Biol, POB 2180, Ardmore, OK 73402 USA.	mroossinck@noble.org						Ahn IP, 2001, MOL PLANT MICROBE IN, V14, P496, DOI 10.1094/MPMI.2001.14.4.496; ANAGNOSTAKIS SL, 1979, PHYTOPATHOLOGY, V69, P1226, DOI 10.1094/Phyto-69-1226; Bordenstein SR, 2004, MOL BIOL EVOL, V21, P1981, DOI 10.1093/molbev/msh211; Chu YM, 2002, APPL ENVIRON MICROB, V68, P2529, DOI 10.1128/AEM.68.5.2529-2534.2002; Dawe AL, 2001, ANNU REV GENET, V35, P1, DOI 10.1146/annurev.genet.35.102401.085929; GHABRIAL SA, 1994, ADV VIRUS RES, V43, P303, DOI 10.1016/S0065-3527(08)60052-4; Kuznetsov YG, 2006, VIROLOGY, V352, P329, DOI 10.1016/j.virol.2006.04.008; Lorang JM, 2001, APPL ENVIRON MICROB, V67, P1987, DOI 10.1128/AEM.67.5.1987-1994.2001; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Redman RS, 1999, MOL PLANT MICROBE IN, V12, P969, DOI 10.1094/MPMI.1999.12.11.969; Redman RS, 2002, SCIENCE, V298, P1581, DOI 10.1126/science.1072191; Rodriguez R, 2005, P NATL ACAD SCI USA, V102, P3175, DOI 10.1073/pnas.0500367102; Rodriguez R. J., 2004, Mitigation and Adaptation Strategies for Global Change, V9, P261, DOI 10.1023/B:MITI.0000029922.31110.97; Zabalgogeazcoa I, 1998, MYCOL RES, V102, P914, DOI 10.1017/S0953756297005819; Zhou T, 1997, PHYTOPATHOLOGY, V87, P147, DOI 10.1094/PHYTO.1997.87.2.147; [No title captured]	16	503	568	13	280	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2007	315	5811					513	515		10.1126/science.1136237	http://dx.doi.org/10.1126/science.1136237			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255511				2022-12-01	WOS:000243726600046
J	Shuchman, M				Shuchman, Miriam			Debating the risks of drug-eluting stents	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002; ANTMAN EM, 2005, J AM COLL CARDIOL, V45, P1376; EISENSTEIN EL, IN PRESS JAMA; Hauser RG, 2005, CIRCULATION, V112, P2040, DOI 10.1161/CIRCULATIONAHA.105.580381; Shuchman M, 2006, NEW ENGL J MED, V355, P1949, DOI 10.1056/NEJMp068234; WALLENTIN L, 2006, M CIRC SYST DEV PAN	6	65	71	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 25	2007	356	4					325	328		10.1056/NEJMp068300	http://dx.doi.org/10.1056/NEJMp068300			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	128FT	17251527				2022-12-01	WOS:000243644300001
J	Bibbins-Domingo, K; Gupta, R; Na, B; Wu, AHB; Schiller, NB; Whooley, MA				Bibbins-Domingo, Kirsten; Gupta, Reena; Na, Beeya; Wu, Alan H. B.; Schiller, Nelson B.; Whooley, Mary A.			N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							C-REACTIVE PROTEIN; PROGNOSTIC VALUE; VENTRICULAR DYSFUNCTION; MYOCARDIAL-INFARCTION; ARTERY-DISEASE; RISK; FAILURE; PREDICTORS; PREVENTION; COMMITTEE	Context Identification of individuals at high risk for cardiovascular events is important for the optimal use of primary and secondary prevention measures. Objective To determine whether plasma levels of amino terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP) predict cardiovascular events or death independent of other available prognostic tests. Design, Setting, and Participants Prospective cohort study (2000-2002) of 987 individuals in California with stable coronary heart disease in the Heart and Soul Study, who were followed up for a mean of 3.7 (range, 0.1-5.3) years. Main Outcome Measures The association of baseline NT-proBNP levels with death or cardiovascular events (myocardial infarction, stroke, or heart failure). Traditional clinical risk factors, echocardiographic measures, ischemia, other biomarkers, and New York Heart Association classification were adjusted for to determine whether NT-proBNP levels were independent of other prognostic factors. Receiver operating characteristic (ROC) curves were used to assess the incremental prognostic value of adding NT-proBNP level to these other measures. Results A total of 256 participants (26.2%) had a cardiovascular event or died. Each increasing quartile of NT-proBNP level (range of quartile 1, 8.06-73.95 pg/mL; quartile 2, 74-174.5 pg/mL; quartile 3, 175.1-459 pg/mL; quartile 4, >= 460 pg/mL) was associated with a greater risk of cardiovascular events or death, ranging from 23 of 247 (annual event rate, 2.6%) in the lowest quartile to 134 of 246 (annual event rate, 19.6%) in the highest quartile (unadjusted hazard ratio [HR] for quartile 4 vs quartile 1, 7.8; 95% confidence interval [CI], 5.0-12.1; P < .001). Each SD increase in log NT-proBNP level (1.3 pg/mL) was associated with a 2.3-fold increased rate of adverse cardiovascular outcomes (unadjusted HR, 2.3; 95% CI, 2.0-2.6; P < .001), and this association persisted after adjustment for all of the other prognostic measures (adjusted HR, 1.7; 95% CI, 1.3-2.2; P < .001). The addition of NT-proBNP level to standard clinical assessment and complete echocardiographic parameters significantly improved the area under the ROC curves for predicting subsequent adverse cardiovascular outcomes (0.80 for clinical risk factors and echocardiographic parameters plus log NT-proBNP vs 0.76 for clinical risk factors and echocardiographic parameters only; P = .006). Conclusions Elevated levels of NT-proBNP predict cardiovascular morbidity and mortality, independent of other prognostic markers, and identify at-risk individuals even in the absence of systolic or diastolic dysfunction by echocardiography. Level of NT-proBNP may help guide risk stratification of high-risk individuals, such as those with coronary heart disease.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; San Francisco Gen Hosp, Div Gen Internal Med, San Francisco, CA USA; San Francisco Vet Adm Med Ctr, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Bibbins-Domingo, K (corresponding author), Univ Calif San Francisco, Dept Med, Box 1364, San Francisco, CA 94143 USA.	bibbinsk@medicine.ucsf.edu			DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095095] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079235] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL079235, N01HC95095, N01-HC-95095, R01 HL079235-01A1] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		American College of Sports Medicine, 2000, GUID EX TEST PRESCR; Berger R, 2002, CIRCULATION, V105, P2392, DOI 10.1161/01.CIR.0000016642.15031.34; Bibbins-Domingo K, 2003, CIRCULATION, V108, P2987, DOI 10.1161/01.CIR.0000103681.04726.9C; Blankenberg S, 2006, CIRCULATION, V114, P201, DOI 10.1161/CIRCULATIONAHA.105.590927; D'Souza SP, 2004, PHARMACOL THERAPEUT, V101, P113, DOI 10.1016/j.pharmthera.2003.11.001; de Lemos JA, 2001, NEW ENGL J MED, V345, P1014, DOI 10.1056/NEJMoa011053; Gardner RS, 2003, EUR HEART J, V24, P1735, DOI 10.1016/j.ehj.2003.07.005; Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15; Groenning BA, 2004, HEART, V90, P297, DOI 10.1136/hrt.2003.026021; James SK, 2003, CIRCULATION, V108, P275, DOI 10.1161/01.CIR.0000079170.10579.DC; Kistorp C, 2005, JAMA-J AM MED ASSOC, V293, P1609, DOI 10.1001/jama.293.13.1609; Kragelund C, 2005, NEW ENGL J MED, V352, P666, DOI 10.1056/NEJMoa042330; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; McDonagh TA, 2001, HEART, V86, P21, DOI 10.1136/heart.86.1.21; Mega JL, 2004, J AM COLL CARDIOL, V44, P335, DOI 10.1016/j.jacc.2004.04.033; Morrow DA, 2003, J AM COLL CARDIOL, V41, P1264, DOI 10.1016/S0735-1097(03)00168-2; Morrow DA, 2005, JAMA-J AM MED ASSOC, V294, P2866, DOI 10.1001/jama.294.22.2866; Ndrepepa G, 2005, CIRCULATION, V112, P2102, DOI 10.1161/CIRCULATIONAHA.105.550715; Omland T, 2002, CIRCULATION, V106, P2913, DOI 10.1161/01.CIR.0000041661.63285.AE; Omland T, 2005, AM J CARDIOL, V95, P24, DOI 10.1016/j.amjcard.2004.08.058; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Richards AM, 1998, CIRCULATION, V97, P1921, DOI 10.1161/01.CIR.97.19.1921; Rubattu S, 2004, STROKE, V35, P814, DOI 10.1161/01.STR.0000119381.52589.AB; Ruo B, 2003, JAMA-J AM MED ASSOC, V290, P215, DOI 10.1001/jama.290.2.215; Schnabel R, 2005, EUR HEART J, V26, P241, DOI 10.1093/eurheartj/ehi036; Tsutamoto T, 1997, CIRCULATION, V96, P509; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994	28	209	222	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 10	2007	297	2					169	176		10.1001/jama.297.2.169	http://dx.doi.org/10.1001/jama.297.2.169			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	124GI	17213400	Green Accepted, Bronze			2022-12-01	WOS:000243355900026
J	Brent, AE; Yucel, G; Small, S; Desplan, C				Brent, Ava E.; Yucel, Gozde; Small, Stephen; Desplan, Claude			Permissive and instructive anterior patterning rely on mRNA localization in the wasp embryo	SCIENCE			English	Article							DROSOPHILA EMBRYO; GRADIENT; NASONIA; PROTEIN; GIANT; HUNCHBACK; KRUPPEL; LONG; SEGMENTATION; EXPRESSION	The long-germ mode of embryogenesis, in which segments arise simultaneously along the anterior-posterior axis, has evolved several times in different lineages of the holometabolous, or fully metamorphosing, insects. Drosophila's long-germ fate map is established largely by the activity of the dipteran-specific Bicoid (Bcd) morphogen gradient, which operates both instructively and permissively to accomplish anterior patterning. By contrast, all nondipteran long-germ insects must achieve anterior patterning independently of bcd. We show that bcd's permissive function is mimicked in the wasp by a maternal repression system in which anterior localization of the wasp ortholog of giant represses anterior expression of the trunk gap genes so that head and thorax can properly form.	NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA	New York University	Desplan, C (corresponding author), NYU, Dept Biol, Ctr Dev Genet, 100 Washington Sq E, New York, NY 10003 USA.	cd38@nyu.edu		Desplan, Claude/0000-0002-6914-1413	NIGMS NIH HHS [GM51946, GM64864] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM051946, R01GM051946, R01GM064864] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bashirullah A, 1998, ANNU REV BIOCHEM, V67, P335, DOI 10.1146/annurev.biochem.67.1.335; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; Bucher G, 2005, EVOL DEV, V7, P142, DOI 10.1111/j.1525-142X.2005.05016.x; Davis GK, 2002, ANNU REV ENTOMOL, V47, P669, DOI 10.1146/annurev.ento.47.091201.145251; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; Hewitt GF, 1999, DEVELOPMENT, V126, P1201; HULSKAMP M, 1990, NATURE, V346, P577, DOI 10.1038/346577a0; KRAUT R, 1991, DEVELOPMENT, V111, P601; KRAUT R, 1991, DEVELOPMENT, V111, P611; Lynch J, 2003, CURR BIOL, V13, pR557, DOI 10.1016/S0960-9822(03)00472-X; Lynch JA, 2006, NATURE, V439, P728, DOI 10.1038/nature04445; Lynch JA, 2006, DEV GENES EVOL, V216, P493, DOI 10.1007/s00427-006-0076-5; Lynch JA, 2006, NAT PROTOC, V1, P486, DOI 10.1038/nprot.2006.70; Olesnicky EC, 2006, DEVELOPMENT, V133, P3973, DOI 10.1242/dev.02576; PREISS A, 1985, NATURE, V313, P27, DOI 10.1038/313027a0; Pultz MA, 2005, DEVELOPMENT, V132, P3705, DOI 10.1242/dev.01939; Savard J, 2006, GENOME RES, V16, P1334, DOI 10.1101/gr.5204306; Schroder R, 2000, P NATL ACAD SCI USA, V97, P6591, DOI 10.1073/pnas.100005497; STRUHL G, 1992, CELL, V69, P237, DOI 10.1016/0092-8674(92)90405-2; Wu XL, 1998, DEVELOPMENT, V125, P3765	20	46	46	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1841	1843		10.1126/science.1137528	http://dx.doi.org/10.1126/science.1137528			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395827				2022-12-01	WOS:000245280100042
J	Zaph, C; Troy, AE; Taylor, BC; Berman-Booty, LD; Guild, KJ; Du, YR; Yost, EA; Gruber, AD; May, MJ; Greten, FR; Eckmann, L; Karin, M; Artis, D				Zaph, Colby; Troy, Amy E.; Taylor, Betsy C.; Berman-Booty, Lisa D.; Guild, Katherine J.; Du, Yurong; Yost, Evan A.; Gruber, Achim D.; May, Michael J.; Greten, Florian R.; Eckmann, Lars; Karin, Michael; Artis, David			Epithelial-cell-intrinsic IKK-beta expression regulates intestinal immune homeostasis	NATURE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; KAPPA-B ACTIVATION; CHRONIC INFLAMMATION; DENDRITIC CELLS; INHIBITION; INVOLVEMENT; INFECTIONS; RESISTANCE; SURVIVAL	Intestinal epithelial cells ( IECs) provide a primary physical barrier against commensal and pathogenic microorganisms in the gastrointestinal ( GI) tract, but the influence of IECs on the development and regulation of immunity to infection is unknown(1). Here we show that IEC-intrinsic I kappa B kinase ( IKK)-beta-dependent gene expression is a critical regulator of responses of dendritic cells and CD4(+) T cells in the GI tract. Mice with an IEC-specific deletion of IKK-beta show a reduced expression of the epithelial-cell-restricted cytokine thymic stromal lymphopoietin in the intestine and, after infection with the gut-dwelling parasite Trichuris, fail to develop a pathogen-specific CD4(+) T helper type 2 (T(H)2) response and are unable to eradicate infection. Further, these animals show exacerbated production of dendritic-cell-derived interleukin-12/23p40 and tumour necrosis factor-alpha, increased levels of CD4(+) T-cell-derived interferon-gamma and interleukin-17, and develop severe intestinal inflammation. Blockade of proinflammatory cytokines during Trichuris infection ablates the requirement for IKK-beta in IECs to promote CD4(+) T(H)2 cell-dependent immunity, identifying an essential function for IECs in tissue-specific conditioning of dendritic cells and limiting type 1 cytokine production in the GI tract. These results indicate that the balance of IKK-beta-dependent gene expression in the intestinal epithelium is crucial in intestinal immune homeostasis by promoting mucosal immunity and limiting chronic inflammation.	Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA; Univ Penn, Dept Anim Biol, Philadelphia, PA 19104 USA; Free Univ Berlin, Dept Vet Pathol, D-14163 Berlin, Germany; Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of Pennsylvania; University of Pennsylvania; Free University of Berlin; University of California System; University of California San Diego; University of California System; University of California San Diego	Artis, D (corresponding author), Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA.	dartis@vet.upenn.edu	Greten, Florian R/AAF-5196-2020; Gruber, Achim D./ABA-4514-2021	Greten, Florian R/0000-0002-3928-6080; Zaph, Colby/0000-0002-9889-9848; Artis, David/0000-0002-1753-4100; May, Michael/0000-0002-2485-3716	NATIONAL CANCER INSTITUTE [T32CA009140] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; Artis D, 2002, J IMMUNOL, V169, P4481, DOI 10.4049/jimmunol.169.8.4481; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; Cliffe LJ, 2004, ADV PARASIT, V57, P255, DOI 10.1016/S0065-308X(04)57004-5; Egan LJ, 2004, P NATL ACAD SCI USA, V101, P2452, DOI 10.1073/pnas.0306734101; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Iwasaki A, 2001, J IMMUNOL, V166, P4884, DOI 10.4049/jimmunol.166.8.4884; Jang MH, 2004, P NATL ACAD SCI USA, V101, P6110, DOI 10.1073/pnas.0400969101; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kelsall BL, 2005, IMMUNOL REV, V206, P132, DOI 10.1111/j.0105-2896.2005.00292.x; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; Li ZW, 2003, J IMMUNOL, V170, P4630, DOI 10.4049/jimmunol.170.9.4630; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Schopf LR, 2002, J IMMUNOL, V168, P2383, DOI 10.4049/jimmunol.168.5.2383; Tilney LG, 2005, J EXP ZOOL PART A, V303A, P927, DOI 10.1002/jez.a.214; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Zhou YH, 2001, AM J RESP CELL MOL, V25, P486, DOI 10.1165/ajrcmb.25.4.4578; Ziegler SF, 2006, NAT IMMUNOL, V7, P709, DOI 10.1038/ni1360	28	414	428	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2007	446	7135					552	556		10.1038/nature05590	http://dx.doi.org/10.1038/nature05590			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17322906				2022-12-01	WOS:000245242900052
J	Ruan, DK; He, Q; Ding, Y; Hou, LS; Li, JY; Luk, KDK				Ruan, Dike; He, Qin; Ding, Yu; Hou, Lisheng; Li, Jingyun; Luk, Keith D. K.			Intervertebral disc transplantation in the treatment of degenerative spine disease: a preliminary study	LANCET			English	Article							FOLLOW-UP; ARTIFICIAL DISC; PROSTHESIS; REPLACEMENT	Background Spinal fusion can be complicated by accelerated degeneration of the adjacent segments. Artificial disc replacements have been developed, but results are variable. Successful transplantations of intervertebral disc autografts, fresh allografts, and fresh-frozen allografts-ie, a non-fusion strategy-in which the mobility and stability of the spinal segment were preserved have been done in a primate model. Our aim was to determine the feasibility, safety, and long-term clinical results of disc transplantation in human beings. Methods Five patients, average age 47 years, with cervical disc herniation underwent transplantation of fresh-frozen composite disc allografts after disc excision. Serial MRI and static and dynamic radiographs were used to monitor the status of the grafts and the sagittal stability and mobility of the segment. Findings Good union of the graft endplates was seen by the end of 3 months after surgery in all patients. At a minimum follow-up of 5 years, the neurological symptoms of all patients had improved from before surgery levels. No immunoreaction was encountered. There was no olisthesis and only mild degenerative changes of the transplanted discs. All except one of the discs showed preservation of 7.0-11.3 degrees of sagittal motion at the final follow-up. MRI at 5 years showed preservation of hydration in at least two discs. Interpretation Despite signs of mild disc degeneration, the motion and stability of the spinal unit was preserved after transplantation of fresh-frozen allogenic intervertebral discs in our patients. With further refinements, such transplantations could be an effective treatment for degenerative disc disease.	Univ Hong Kong, Dept Orthoped & Traumatol, Hong Kong, Peoples R China; Navy Gen Hosp, Dept Orthoped Surg, Beijing, Peoples R China	University of Hong Kong; Sixth Medical Center of Chinese PLA General Hospital	Luk, KDK (corresponding author), Univ Hong Kong, Dept Orthoped & Traumatol, Pokfulam Rd, Hong Kong, Peoples R China.	hrmoldk@hku.hk						BABA H, 1993, SPINE, V18, P2167, DOI 10.1097/00007632-199311000-00004; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403, DOI 10.2106/00004623-199072030-00013; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P1178, DOI 10.2106/00004623-199072080-00008; CLEMENTS DH, 1990, SPINE, V15, P1023, DOI 10.1097/00007632-199015100-00008; DVORAK J, 1991, J ORTHOPAED RES, V9, P828, DOI 10.1002/jor.1100090608; FRICK SL, 1994, SPINE, V19, P1826, DOI 10.1097/00007632-199408150-00006; Gillet P, 2003, J SPINAL DISORD TECH, V16, P338, DOI 10.1097/00024720-200308000-00005; Goffin J, 2003, SPINE, V28, P2673, DOI 10.1097/01.BRS.0000099392.90849.AA; GRIFFITH SL, 1994, SPINE, V19, P1842, DOI 10.1097/00007632-199408150-00009; Hilibrand AS, 1999, J BONE JOINT SURG AM, V81A, P519, DOI 10.2106/00004623-199904000-00009; LEHMANN TR, 1987, SPINE, V12, P97, DOI 10.1097/00007632-198703000-00004; Leivseth G, 2006, SPINE, V31, P1726, DOI 10.1097/01.brs.0000224213.45330.68; Lemaire JP, 2005, J SPINAL DISORD TECH, V18, P353, DOI 10.1097/01.bsd.0000172361.07479.6b; LUK KD, 1997, CLIN ORTHOP RELAT R, V337, P13; Luk KDK, 2003, SPINE, V28, P864, DOI 10.1097/00007632-200305010-00005; Matsunaga S, 1999, SPINE, V24, P670, DOI 10.1097/00007632-199904010-00011; OLSON EJ, 1991, SPINE, V16, P1081, DOI 10.1097/00007632-199109000-00013; PENTA M, 1995, SPINE, V20, P743, DOI 10.1097/00007632-199503150-00018; Putzier M, 2006, EUR SPINE J, V15, P183, DOI 10.1007/s00586-005-1022-3; SCHNEIDERMAN G, 1987, SPINE, V12, P276, DOI 10.1097/00007632-198704000-00016; Yonenobu K, 2001, SPINE, V26, P1890, DOI 10.1097/00007632-200109010-00014; Zeegers WS, 1999, EUR SPINE J, V8, P210, DOI 10.1007/s005860050160	22	80	101	1	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2007	369	9566					993	999		10.1016/S0140-6736(07)60496-6	http://dx.doi.org/10.1016/S0140-6736(07)60496-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151JO	17382826				2022-12-01	WOS:000245286500028
J	Brennecke, J; Aravin, AA; Stark, A; Dus, M; Kellis, M; Sachidanandam, R; Hannon, GJ				Brennecke, Julius; Aravin, Alexei A.; Stark, Alexander; Dus, Monica; Kellis, Manolis; Sachidanandam, Ravi; Hannon, Gregory J.			Discrete small RNA-generating loci as master regulators of transposon activity in Drosophila	CELL			English	Article							R HYBRID DYSGENESIS; P-ELEMENTS; SUBTELOMERIC HETEROCHROMATIN; CYTOTYPE DETERMINATION; MOLECULAR-BASIS; COPY NUMBER; MELANOGASTER; PIWI; GENE; FLAMENCO	Drosophila Piwi-family proteins have been implicated in transposon control. Here, we examine piwi-interacting RNAs (piRNAs) associated with each Drosophila Piwi protein and find that Piwi and Aubergine bind RNAs that are predominantly antisense to transposons, whereas Ago3 complexes contain predominantly sense piRNAs. As in mammals, the majority of Drosophila piRNAs are derived from discrete genomic loci. These loci comprise mainly defective transposon sequences, and some have previously been identified as master regulators of transposon activity. Our data suggest that heterochromatic piRNA loci interact with potentially active, euchromatic transposons to form an adaptive system for transposon control. Complementary relationships between sense and antisense piRNA populations suggest an amplification loop wherein each piRNA-directed cleavage event generates the 5' end of a new piRNA. Thus, sense piRNAs, formed following cleavage of transposon mRNAs may enhance production of antisense piRNAs, complementary to active elements, by directing cleavage of transcripts from master control loci.	Watson Sch Biol Sci, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; MIT, Broad Inst, Ctr Genome Res, Cambridge, MA 02141 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Hannon, GJ (corresponding author), Watson Sch Biol Sci, Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	Kellis, Manolis/ABE-7385-2020; Hannon, Gregory/AAB-3568-2019; Brennecke, Julius/C-1626-2015; sachidanandam, ravi/Q-6916-2019; Stark, Alexander/D-1473-2012; Brennecke, Julius/T-5883-2019	Kellis, Manolis/0000-0001-7113-9630; Brennecke, Julius/0000-0002-5141-0814; sachidanandam, ravi/0000-0001-9844-4459; Stark, Alexander/0000-0003-2611-0841; Brennecke, Julius/0000-0002-5141-0814				Abad JP, 2004, MOL BIOL EVOL, V21, P1613, DOI 10.1093/molbev/msh174; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; BIEMONT C, 1990, GENET RES, V56, P3, DOI 10.1017/S0016672300028822; Blumenstiel JP, 2005, P NATL ACAD SCI USA, V102, P15965, DOI 10.1073/pnas.0508192102; BREGLIANO JC, 1980, SCIENCE, V207, P606, DOI 10.1126/science.6766221; BUCHETON A, 1984, CELL, V38, P153, DOI 10.1016/0092-8674(84)90536-1; BUCHETON A, 1995, TRENDS GENET, V11, P349, DOI 10.1016/S0168-9525(00)89105-2; BUCHETON A, 1990, TRENDS GENET, V6, P16, DOI 10.1016/0168-9525(90)90044-7; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Castro JP, 2004, GENETICA, V121, P107, DOI 10.1023/B:GENE.0000040382.48039.a2; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Desset S, 2003, GENETICS, V164, P501; ENGELS WR, 1979, GENETICS, V92, P161; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Harris AN, 2001, DEVELOPMENT, V128, P2823; HOSKINS RA, 2002, GENOME BIOL, V0003; Kalmykova AI, 2005, NUCLEIC ACIDS RES, V33, P2052, DOI 10.1093/nar/gki323; KARPEN GH, 1992, GENETICS, V132, P737; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; KIDWELL MG, 1977, GENETICS, V86, P813; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lin HF, 1997, DEVELOPMENT, V124, P2463; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Marin L, 2000, GENETICS, V155, P1841; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; MISRA S, 1990, CELL, V62, P269, DOI 10.1016/0092-8674(90)90365-L; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; PalBhadra M, 1997, CELL, V90, P479, DOI 10.1016/S0092-8674(00)80508-5; PELISSON A, 1987, MOL GEN GENET, V207, P306, DOI 10.1007/BF00331594; PELISSON A, 1994, EMBO J, V13, P4401, DOI 10.1002/j.1460-2075.1994.tb06760.x; PELISSON A, 1981, MOL GEN GENET, V183, P123, DOI 10.1007/BF00270149; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; PRUDHOMME N, 1995, GENETICS, V139, P697; Reiss D, 2004, MOL GENET GENOMICS, V272, P336, DOI 10.1007/s00438-004-1061-1; Robert V, 2001, GENETICS, V158, P701; Roche SE, 1998, GENETICS, V149, P1839; Ronsseray S, 1998, GENETICS, V149, P1857; RONSSERAY S, 1991, GENETICS, V129, P501; RUBIN GM, 1982, CELL, V29, P987, DOI 10.1016/0092-8674(82)90462-7; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Savitsky M, 2006, GENE DEV, V20, P345, DOI 10.1101/gad.370206; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Smyth DR, 1997, CURR BIOL, V7, pR793, DOI 10.1016/S0960-9822(06)00407-6; Stuart JR, 2002, GENETICS, V162, P1641; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333	56	1715	1798	11	161	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1089	1103		10.1016/j.cell.2007.01.043	http://dx.doi.org/10.1016/j.cell.2007.01.043			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17346786	Bronze			2022-12-01	WOS:000245396200016
J	Christensen, J; Agger, K; Cloos, PAC; Pasini, D; Rose, S; Sennels, L; Rappsilber, J; Hansen, KH; Salcini, AE; Helin, K				Christensen, Jesper; Agger, Karl; Cloos, Paul A. C.; Pasini, Diego; Rose, Simon; Sennels, Lau; Rappsilber, Juri; Hansen, Klaus H.; Salcini, Anna Elisabetta; Helin, Kristian			RBP2 belongs to a family of demethylases, specific for tri- and dimethylated lysine 4 on histone 3	CELL			English	Article							ESCAPES X-INACTIVATION; BINDING; METHYLATION; GENE; PROTEINS; TRANSCRIPTION; TRITHORAX; HOMOLOG; METHYLTRANSFERASE; INTERACTS	Methylation of histones; has been regarded as a stable modification defining the epigenetic program of the cell, which regulates chromatin structure and transcription. However, the recent discovery of histone demethylases has challenged the stable nature of histone methylation. Here we demonstrate that the JARID1 proteins RBP2, PLU1, and SMCX are histone demethylases specific for di- and trimethylated histone 3 lysine 4 (H3K4). Consistent with a role for the JARID1 Drosophila homolog Lid in regulating expression of homeotic genes during development, we show that RBP2 is displaced from Hox genes during embryonic stem (ES) cell differentiation correlating with an increase of their H3K4me3 levels and expression. Furthermore, we show that mutation or RNAi depletion of the C. elegans JARID1 homolog rbr-2 leads to increased levels of H3K4me3 during larval development and defects in vulva formation. Taken together, these results suggest that H3K4me3/me2 demethylation regulated by the JARID1 family plays an important role during development.	Univ Copenhagen, Ctr Epigenet, DK-2200 Copenhagen, Denmark; Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark; Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Copenhagen; University of Copenhagen; University of Edinburgh	Helin, K (corresponding author), Univ Copenhagen, Ctr Epigenet, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark.	lisa.salcini@bric.dk; kristian.helin@bric.dk	Hu, Ruogu/B-2203-2008; Pasini, Diego/J-9674-2012; Rappsilber, Juri/B-7265-2015; Helin, Kristian/HDM-8306-2022; Rappsilber, Juri/ABF-3328-2020; Salcini, Anna Elisabetta/G-4472-2017; Helin, Kristian/K-2526-2019	Pasini, Diego/0000-0002-9879-6486; Rappsilber, Juri/0000-0001-5999-1310; Helin, Kristian/0000-0003-1975-6097; Hansen, Klaus/0000-0001-9657-8816; Salcini, Anna Elisabetta/0000-0001-5828-2512; Cloos, Paul/0000-0001-5863-0054				AGULNIK AI, 1994, HUM MOL GENET, V3, P879, DOI 10.1093/hmg/3.6.879; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; BRENNER S, 1974, GENETICS, V77, P71; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chan SW, 2001, J BIOL CHEM, V276, P28402, DOI 10.1074/jbc.M100313200; CLARK SG, 1994, GENETICS, V137, P987; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; FATTAEY AR, 1993, ONCOGENE, V8, P3149; Fay DS, 2000, GENESIS, V26, P279, DOI 10.1002/(SICI)1526-968X(200004)26:4<279::AID-GENE100>3.0.CO;2-C; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Gildea JJ, 2000, GENETICS, V156, P645; Greenfield A, 1998, HUM MOL GENET, V7, P737, DOI 10.1093/hmg/7.4.737; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Heard E, 2004, COLD SPRING HARB SYM, V69, P89, DOI 10.1101/sqb.2004.69.89; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Klymenko T, 2004, EMBO REP, V5, P373, DOI 10.1038/sj.embor.7400111; Mao SF, 1997, ONCOGENE, V14, P1531, DOI 10.1038/sj.onc.1200988; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Roesch A, 2005, MODERN PATHOL, V18, P1249, DOI 10.1038/modpathol.3800413; Roesch A, 2006, J INVEST DERMATOL, V126, P1850, DOI 10.1038/sj.jid.5700324; Roguev A, 2003, J BIOL CHEM, V278, P8487, DOI 10.1074/jbc.M209562200; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tan K, 2003, J BIOL CHEM, V278, P20507, DOI 10.1074/jbc.M301994200; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Vogt T, 1999, LAB INVEST, V79, P1615; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0	51	399	425	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1063	1076		10.1016/j.cell.2007.02.003	http://dx.doi.org/10.1016/j.cell.2007.02.003			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17320161	Bronze			2022-12-01	WOS:000245396200014
J	Wilcox, AJ; Lie, RT; Solvoll, K; Taylor, J; McConnaughey, DR; Abyholm, F; Vindenes, H; Vollset, SE; Drevon, CA				Wilcox, Allen J.; Lie, Rov Terje; Solvoll, Kari; Taylor, Jack; McConnaughey, D. Robert; Abyholm, Frank; Vindenes, Hallvard; Vollset, Stein Emil; Drevon, Christian A.			Folic acid supplements and risk of facial clefts: national population based case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOOD FREQUENCY QUESTIONNAIRE; OROFACIAL CLEFTS	Objective To explore the role of folic acid supplements, dietary folates, and multivitamins in the prevention of facial clefts. Design National population based case-control study. Setting Infants born 1996-2001 in Norway. Participants 377 infants with cleft lip with or without cleft palate; 196 infants with cleft palate alone; 763 controls. Main outcome measures Association of facial clefts with maternal intake of folic acid supplements, multivitamins, and folates in diet. Results Folic acid supplementation during early pregnancy (>= 400 mu g/day) was associated with a reduced risk of isolated cleft lip with or without cleft palate after adjustment for multivitamins, smoking, and other potential confounding factors (adjusted odds ratio 0.61, 95% confidence interval 0.39 to 0.96). Independent of supplements, diets rich in fruits, vegetables, and other high folate containing foods reduced the risk somewhat (adjusted odds ratio 0.75, 0.50 to 1.11). The lowest risk of cleft lip was among women with folate rich diets who also took folic acid supplements and multivitamins (0.36, 0.17 to 0.77). Folic acid provided no protection against cleft palate alone (1.07, 0.56 to 2.03). Conclusions Folic acid supplements during early pregnancy seem to reduce the risk of isolated cleft lip (with or without cleft palate) by about a third. Other vitamins and dietary factors may provide additional benefit.	NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA; Univ Bergen, Dept Publ Hlth & Primary Care, Sect Epidemiol & Med Stat, N-5020 Bergen, Norway; Univ Oslo, Fac Med, Inst Basic Med Sci, Dept Nutr, Oslo, Norway; WESTAT Corp, Durham, NC USA; Univ Oslo, Rikshosp, Dept Plast Surg, N-0027 Oslo, Norway; Haukeland Hosp, Dept Plast Surg, N-5021 Bergen, Norway	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Bergen; University of Oslo; Westat; University of Oslo; National Hospital Norway; University of Bergen; Haukeland University Hospital	Wilcox, AJ (corresponding author), NIEHS, Epidemiol Branch, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	wilcox@niehs.nih.gov	Wilcox, Allen J/C-7723-2019; taylor, jack a/C-7154-2019; Drevon, Christian A/F-6012-2010	Wilcox, Allen J/0000-0002-3376-1311; taylor, jack a/0000-0001-5303-6398; 	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES049027, Z01ES049033] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 ES999999] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Andersen LF, 2003, EUR J CLIN NUTR, V57, P279, DOI 10.1038/sj.ejcn.1601519; Bailey LB, 2005, AM J CLIN NUTR, V81, p1213S; Christensen K., 2002, CLEFT LIP PALATE ORI, P101; Hayes C, 1996, AM J EPIDEMIOL, V143, P1229, DOI 10.1093/oxfordjournals.aje.a008710; Itikala PR, 2001, TERATOLOGY, V63, P79, DOI 10.1002/1096-9926(200102)63:2&lt;79::AID-TERA1013&gt;3.0.CO;2-3; MOSSEY PA, 2002, CLEFT LIP PALATE ORI, P170; MUNGER RG, 2002, CLEFT LIP PALATE ORI, P170; NES M, 1992, EUR J CLIN NUTR, V46, P809; Rosenberg IH, 2005, AM J CLIN NUTR, V82, P279, DOI 10.1093/ajcn/82.2.279; Shaw GM, 2006, EPIDEMIOLOGY, V17, P285, DOI 10.1097/01.ede.0000208348.30012.35; SHAW GM, 1995, LANCET, V346, P393, DOI 10.1016/S0140-6736(95)92778-6; SOLVOLL K, 1993, SCAND J NUTR, V37, P150; van Rooij IALM, 2004, PREV MED, V39, P689, DOI 10.1016/j.ypmed.2004.02.036; Werler MM, 1999, AM J EPIDEMIOL, V150, P675, DOI 10.1093/oxfordjournals.aje.a010070	14	226	245	0	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2007	334	7591					464	467		10.1136/bmj.39079.618287.0B	http://dx.doi.org/10.1136/bmj.39079.618287.0B			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144NB	17259187	Green Published, Bronze			2022-12-01	WOS:000244802000033
J	Zhou, TQ; Xu, L; Dey, B; Hessell, AJ; Van Ryk, D; Xiang, SH; Yang, XZ; Zhang, MY; Zwick, MB; Arthos, J; Burton, DR; Dimitrov, DS; Sodroski, J; Wyatt, R; Nabel, GJ; Kwong, PD				Zhou, Tongqing; Xu, Ling; Dey, Barna; Hessell, Ann J.; Van Ryk, Donald; Xiang, Shi-Hua; Yang, Xinzhen; Zhang, Mei-Yun; Zwick, Michael B.; Arthos, James; Burton, Dennis R.; Dimitrov, Dimiter S.; Sodroski, Joseph; Wyatt, Richard; Nabel, Gary J.; Kwong, Peter D.			Structural definition of a conserved neutralization epitope on HIV-1 gp120	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN; MONOCLONAL-ANTIBODIES; RECEPTOR; RECOGNITION; ANTIGEN; PROTEIN; DOMAIN; IDENTIFICATION; REGIONS	The remarkable diversity, glycosylation and conformational flexibility of the human immunodeficiency virus type 1 (HIV-1) envelope (Env), including substantial rearrangement of the gp120 glycoprotein upon binding the CD4 receptor, allow it to evade antibody-mediated neutralization. Despite this complexity, the HIV-1 Env must retain conserved determinants that mediate CD4 binding. To evaluate how these determinants might provide opportunities for antibody recognition, we created variants of gp120 stabilized in the CD4-bound state, assessed binding of CD4 and of receptor-binding-site antibodies, and determined the structure at 2.3 angstrom resolution of the broadly neutralizing antibody b12 in complex with gp120. b12 binds to a conformationally invariant surface that overlaps a distinct subset of the CD4-binding site. This surface is involved in the metastable attachment of CD4, before the gp120 rearrangement required for stable engagement. A site of vulnerability, related to a functional requirement for efficient association with CD4, can therefore be targeted by antibody to neutralize HIV-1.	NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA; NCI, Ctr Canc Res, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kwong, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pdkwong@nih.gov	Zhou, Tongqing/A-6880-2010	Zhou, Tongqing/0000-0002-3935-4637; Hessell, Ann/0000-0001-7471-9366	Intramural NIH HHS Funding Source: Medline; NIAID NIH HHS [U19 AI067854, U19 AI067854-03] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC010701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005078, Z01AI005022, Z01AI000883, U19AI067854, Z01AI005068] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arthos J, 2002, J BIOL CHEM, V277, P11456, DOI 10.1074/jbc.M111191200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barouch DH, 2005, J VIROL, V79, P8828, DOI 10.1128/JVI.79.14.8828-8834.2005; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; BURTON DR, 1997, AIDS SA, V11, P587; Butters TD, 1999, PROTEIN SCI, V8, P1696, DOI 10.1110/ps.8.8.1696; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fleury D, 2000, PROTEINS, V40, P572; *JOINT UN PROGR HI, 2006, REP GLOB AIDS EP; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; KOWALSKI M, 1987, SCIENCE, V237, P1351, DOI 10.1126/science.3629244; Kwong PD, 1999, J BIOL CHEM, V274, P4115, DOI 10.1074/jbc.274.7.4115; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; LI Y, 2006, AIDS VACCINE 2006; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; Lusty CJ, 1999, J APPL CRYSTALLOGR, V32, P106, DOI 10.1107/S002188989801053X; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Parren PWHI, 1999, AIDS, V13, pS137; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Prabakaran P, 2006, J BIOL CHEM, V281, P15829, DOI 10.1074/jbc.M600697200; PROFY AT, 1990, J IMMUNOL, V144, P4641; Rits-Volloch S, 2006, EMBO J, V25, P5026, DOI 10.1038/sj.emboj.7601358; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; STARCICH BR, 1986, CELL, V45, P637, DOI 10.1016/0092-8674(86)90778-6; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; TRKOLA A, 1995, J VIROL, V69, P6609, DOI 10.1128/JVI.69.11.6609-6617.1995; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; WEISS RA, 1985, NATURE, V316, P69, DOI 10.1038/316069a0; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yang XZ, 2004, J VIROL, V78, P12975, DOI 10.1128/JVI.78.23.12975-12986.2004; Zhang MY, 2004, J MOL BIOL, V335, P209, DOI 10.1016/j.jmb.2003.09.055; Zwick MB, 2003, J VIROL, V77, P5863, DOI 10.1128/JVI.77.10.5863-5876.2003	50	627	659	1	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2007	445	7129					732	737		10.1038/nature05580	http://dx.doi.org/10.1038/nature05580			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17301785	Green Published			2022-12-01	WOS:000244205200037
J	Steinbrook, R				Steinbrook, Robert			Thailand and the compulsory licensing of efavirenz	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HIV					rsteinbrook@attglobal.net						Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Okie S, 2006, NEW ENGL J MED, V354, P1977, DOI 10.1056/NEJMp068069; WHO UNAIDS, 2006, PROGR GLOB ACC HIV A; World Health Organization, 2006, ANT THER HIV INF AD	4	29	29	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2007	356	6					544	546		10.1056/NEJMp068297	http://dx.doi.org/10.1056/NEJMp068297			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133KV	17287474				2022-12-01	WOS:000244012700002
J	Uchida, K; Beck, DC; Yamamoto, T; Berclaz, P; Abe, S; Staudt, MK; Carey, BC; Filippi, M; Wert, SE; Denson, LA; Puchalski, JT; Hauck, DM; Trapnell, BC				Uchida, Kanji; Beck, David C.; Yamamoto, Takashi; Berclaz, Pierre-Yves; Abe, Shuichi; Staudt, Margaret K.; Carey, Brenna C.; Filippi, Marie-Dominique; Wert, Susan E.; Denson, Lee A.; Puchalski, Jonathan T.; Hauck, Diane M.; Trapnell, Bruce C.			GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLONY-STIMULATING FACTOR; MACROPHAGE DIFFERENTIATION; AUTOIMMUNE-DISEASE; BONE-MARROW; PU.1; MICE; LUNG; PHAGOCYTOSIS; INNATE; ACTIVATION	BACKGROUND: Increased mortality from infection in patients with pulmonary alveolar proteinosis occurs in association with high levels of autoantibodies against granulocyte-macrophage colony-stimulating factor (GM-CSF). We tested the hypothesis that neutrophil functions are impaired in patients with pulmonary alveolar proteinosis and that GM-CSF autoantibodies cause the dysfunction. METHODS: We studied 12 subjects with pulmonary alveolar proteinosis, 61 healthy control subjects, and 12 control subjects with either cystic fibrosis or end-stage liver disease. We also studied GM-CSF(sup -/-) mice and wild-type mice. We evaluated basal neutrophil functions, neutrophil functions after priming by GM-CSF to augment antimicrobial functions, and the effects of highly purified GM-CSF autoantibodies on neutrophil functions in vitro and in vivo. RESULTS: Neutrophils from subjects with pulmonary alveolar proteinosis had normal ultrastructure and differentiation markers but impaired basal functions and antimicrobial functions after GM-CSF priming. GM-CSF(sup -/-) mice also had reduced basal neutrophil functions, but functions after GM-CSF priming were unimpaired. The neutrophil dysfunction characteristic of pulmonary alveolar proteinosis was reproduced in a dose-dependent fashion in blood specimens from healthy control subjects after incubation with affinity-purified GM-CSF autoantibodies isolated from patients with pulmonary alveolar proteinosis. The injection of mouse GM-CSF antibodies into wild-type mice also caused neutrophil dysfunction. CONCLUSIONS: The antimicrobial functions of neutrophils are impaired in patients with pulmonary alveolar proteinosis, owing to the presence of GM-CSF autoantibodies. The effects of these autoantibodies show that GM-CSF is an essential regulator of neutrophil functions.	Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA; Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, Cincinnati, OH 45229 USA; Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol, Cincinnati, OH 45229 USA; Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Div Pulm Crit Care & Sleep Med, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Trapnell, BC (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Rm 4029,TCHRF,3333 Burnet Ave, Cincinnati, OH 45229 USA.	bruce.trapnell@cchmc.org			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD043005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR019498] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071823, R01HL069459] Funding Source: NIH RePORTER; NCRR NIH HHS [RR019498] Funding Source: Medline; NHLBI NIH HHS [HL071823, HL69459] Funding Source: Medline; NICHD NIH HHS [T32HD043005] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BAINTON DF, 1971, J EXP MED, V134, P907, DOI 10.1084/jem.134.4.907; Berclaz PY, 2002, J IMMUNOL, V169, P6332, DOI 10.4049/jimmunol.169.11.6332; Berclaz PY, 2002, BLOOD, V100, P4193, DOI 10.1182/blood-2002-04-1102; Bonfield TL, 2003, AM J PHYSIOL-LUNG C, V285, pL1132, DOI 10.1152/ajplung.00216.2003; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; Bozinovski S, 2004, AM J PHYSIOL-LUNG C, V286, pL877, DOI 10.1152/ajplung.00275.2003; CLARK RA, 2005, CURRENT PROTOCOLS IM, P2; Condliffe AM, 1998, CLIN SCI, V94, P461, DOI 10.1042/cs0940461; DeForge LE, 2000, J IMMUNOL METHODS, V245, P79, DOI 10.1016/S0022-1759(00)00279-9; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; ENGLISH D, 1992, BLOOD, V80, P776; FLEISCHMANN J, 1986, BLOOD, V68, P708; Gonzalez-Juarrero M, 2005, J LEUKOCYTE BIOL, V77, P914, DOI 10.1189/jlb.1204723; GRAVES V, 1993, BLOOD, V81, P1668; Guthridge MA, 2006, EMBO J, V25, P479, DOI 10.1038/sj.emboj.7600948; HASSAN NF, 1988, J LEUKOCYTE BIOL, V43, P317, DOI 10.1002/jlb.43.4.317; Hellmich B, 2002, ARTHRITIS RHEUM, V46, P2384, DOI 10.1002/art.10497; Ikegami M, 1996, AM J PHYSIOL-LUNG C, V270, pL650, DOI 10.1152/ajplung.1996.270.4.L650; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Kitamura T, 1999, J EXP MED, V190, P875, DOI 10.1084/jem.190.6.875; KOLLER DY, 1995, AM J RESP CRIT CARE, V152, P629, DOI 10.1164/ajrccm.152.2.7633718; Krinner EM, 2007, MOL IMMUNOL, V44, P916, DOI 10.1016/j.molimm.2006.03.020; Mann BS, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-59; Meager A, 1999, IMMUNOLOGY, V97, P526; RIVKIND AI, 1991, CIRC SHOCK, V33, P48; Roberts AW, 2005, GROWTH FACTORS, V23, P33, DOI 10.1080/08977190500055836; ROSEN SH, 1958, NEW ENGL J MED, V258, P1123, DOI 10.1056/NEJM195806052582301; Rosenbloom AJ, 2005, CHEST, V127, P2139, DOI 10.1378/chest.127.6.2139; Rosenzweig SD, 2004, J ALLERGY CLIN IMMUN, V113, P620, DOI 10.1016/j.jaci.2004.02.001; Seymour JF, 1997, BLOOD, V90, P3037, DOI 10.1182/blood.V90.8.3037; Seymour JF, 2002, AM J RESP CRIT CARE, V166, P215, DOI 10.1164/rccm.2109105; Seymour John F, 2004, Treat Respir Med, V3, P229, DOI 10.2165/00151829-200403040-00003; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; Trapnell BC, 2003, NEW ENGL J MED, V349, P2527, DOI 10.1056/NEJMra023226; TREWEEKE AT, 1994, J LEUKOCYTE BIOL, V55, P612, DOI 10.1002/jlb.55.5.612; Uchida K, 2004, BLOOD, V103, P1089, DOI 10.1182/blood-2003-05-1565; Zhan YF, 1998, BLOOD, V91, P863, DOI 10.1182/blood.V91.3.863.863_863_869	38	187	197	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2007	356	6					567	579		10.1056/NEJMoa062505	http://dx.doi.org/10.1056/NEJMoa062505			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133KV	17287477				2022-12-01	WOS:000244012700005
J	Boudker, O; Ryan, RM; Yernool, D; Shimamoto, K; Gouaux, E				Boudker, Olga; Ryan, Renae M.; Yernool, Dinesh; Shimamoto, Keiko; Gouaux, Eric			Coupling substrate and ion binding to extracellular gate of a sodium-dependent aspartate transporter	NATURE			English	Article							SCANNING MUTAGENESIS REVEALS; AMINO-ACID TRANSPORTER; GLUTAMATE TRANSPORTERS; REENTRANT LOOP; GLT-1; NA+; EXPRESSION; CLONING; GENE; COTRANSPORT	Secondary transporters are integral membrane proteins that catalyse the movement of substrate molecules across the lipid bilayer by coupling substrate transport to one or more ion gradients, thereby providing a mechanism for the concentrative uptake of substrates. Here we describe crystallographic and thermodynamic studies of Glt(Ph), a sodium (Na+)-coupled aspartate transporter, defining sites for aspartate, two sodium ions and D, L-threo-beta-benzyloxyaspartate, an inhibitor. We further show that helical hairpin 2 is the extracellular gate that controls access of substrate and ions to the internal binding sites. At least two sodium ions bind in close proximity to the substrate and these sodium-binding sites, together with the sodium-binding sites in another sodium-coupled transporter, LeuT, define an unwound alpha-helix as the central element of the ion-binding motif, a motif well suited to the binding of sodium and to participation in conformational changes that accompany ion binding and unbinding during the transport cycle.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Suntory Inst Bioorgan Res, Osaka 6188503, Japan	Columbia University; Columbia University; Howard Hughes Medical Institute; Suntory Holdings Ltd	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019; Ryan, Renae/AAC-3540-2021	Gouaux, Eric/0000-0002-8549-2360; Ryan, Renae/0000-0002-8680-4610				ARRIZA JL, 1993, J BIOL CHEM, V268, P15329; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brocke L, 2002, J BIOL CHEM, V277, P3985, DOI 10.1074/jbc.M107735200; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; ENGELKE T, 1989, J BACTERIOL, V171, P5551, DOI 10.1128/jb.171.10.5551-5560.1989; Gaillard I, 1996, BIOCHEMISTRY-US, V35, P6150, DOI 10.1021/bi953005v; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Grewer C, 2005, J MEMBRANE BIOL, V203, P1, DOI 10.1007/s00232-004-0731-6; Grunewald M, 2002, J BIOL CHEM, V277, P26074, DOI 10.1074/jbc.M202248200; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; Hille B., 2001, ION CHANNELS EXCITAB, V3; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; Kanner BI, 2002, BBA-BIOENERGETICS, V1555, P92, DOI 10.1016/S0005-2728(02)00260-8; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Lauger P., 1991, ELECTROGENIC ION PUM; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Mudring AV, 2005, INORG CHEM, V44, P6240, DOI 10.1021/ic050547k; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; Ogawa W, 1998, J BACTERIOL, V180, P6749, DOI 10.1128/JB.180.24.6749-6752.1998; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; QUICK M, 2002, TRANSMEMBRANE TRANSP; Seal RP, 1998, NEURON, V21, P1487, DOI 10.1016/S0896-6273(00)80666-2; SHAFQAT S, 1993, J BIOL CHEM, V268, P15351; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Slotboom DJ, 1999, MICROBIOL MOL BIOL R, V63, P293, DOI 10.1128/MMBR.63.2.293-307.1999; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; Slotboom DJ, 1996, J BIOL CHEM, V271, P31317, DOI 10.1074/jbc.271.49.31317; Slotboom DJ, 2001, TRENDS BIOCHEM SCI, V26, P534, DOI 10.1016/S0968-0004(01)01925-9; Slotboom DJ, 2001, J BIOL CHEM, V276, P10775, DOI 10.1074/jbc.M011064200; Sobczak M, 2005, CURR OPIN MICROBIOL, V8, P161, DOI 10.1016/j.mib.2005.02.005; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Wilson TH, 2001, BBA-BIOENERGETICS, V1505, P121, DOI 10.1016/S0005-2728(00)00282-6; Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Yurgel SN, 2005, J BACTERIOL, V187, P1161, DOI 10.1128/JB.187.3.1161-1172.2005; Zarbiv R, 1998, J BIOL CHEM, V273, P14231, DOI 10.1074/jbc.273.23.14231; ZERANGUE N, 1995, J BIOL CHEM, V270, P6433, DOI 10.1074/jbc.270.12.6433; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710	45	386	393	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2007	445	7126					387	393		10.1038/nature05455	http://dx.doi.org/10.1038/nature05455			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	128WD	17230192				2022-12-01	WOS:000243689500030
J	Frith, L				Frith, Lucy			HIV self-testing: a time to revise current policy	LANCET			English	Article							HOME; NORMALIZATION; PREFERENCES; COLLECTION; PREVENTION		Univ Liverpool, Div Primary Care, Liverpool L69 3GB, Merseyside, England	University of Liverpool	Frith, L (corresponding author), Univ Liverpool, Div Primary Care, Whelan Bldg,Brownlow Hill, Liverpool L69 3GB, Merseyside, England.	L.J.Frith@liverpool.ac.uk	Frith, Lucy/AAW-6711-2020	Frith, Lucy/0000-0002-8506-0699				[Anonymous], 2000, CAN MED ASSOC J, V162, P1545; Branson BM, 1998, JAMA-J AM MED ASSOC, V280, P1699, DOI 10.1001/jama.280.19.1699; *BRIT ASS SEX HLTH, 2005, UK NAT GUID HIV TEST; De Cock KM, 1998, BMJ-BRIT MED J, V316, P290, DOI 10.1136/bmj.316.7127.290; *FDA, 2005, APPR VAL OV THE COUN; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Phillips KA, 2003, AM J PREV MED, V24, P340, DOI 10.1016/S0749-3797(03)00019-9; Rogstad KE, 2003, SEX TRANSM INFECT, V79, P243, DOI 10.1136/sti.79.3.243; Rosenbrock R, 2000, SOC SCI MED, V50, P1607, DOI 10.1016/S0277-9536(99)00469-4; Spielberg F, 2004, LANCET INFECT DIS, V4, P640, DOI 10.1016/S1473-3099(04)01150-8; Spielberg F, 2003, JAIDS-J ACQ IMM DEF, V32, P318, DOI 10.1097/00126334-200303010-00012; Spielberg F, 2001, SEX TRANSM DIS, V28, P51, DOI 10.1097/00007435-200101000-00012; Spielberg F, 2003, HOME SELF TESTING HI; *UK DEP HLTH, 2004, CHOOS HLTH MAK HLTH; *UK GEN MED COUNC, 2000, ANT TEST HIV; *UK HUM GEN COMM, 2005, NONC DNA TEST; US Food and Drug Administration, 2004, FDA APPR 1 OR FLUID; Wright AA, 2006, NEW ENGL J MED, V354, P437, DOI 10.1056/NEJMp058302	18	38	39	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 20	2007	369	9557					243	245		10.1016/S0140-6736(07)60113-5	http://dx.doi.org/10.1016/S0140-6736(07)60113-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	128XG	17240291				2022-12-01	WOS:000243692400033
J	Chaudhuri, O; Parekh, SH; Fletcher, DA				Chaudhuri, Ovijit; Parekh, Sapun H.; Fletcher, Daniel A.			Reversible stress softening of actin networks	NATURE			English	Article							ARP2/3 COMPLEX; DENDRITIC ORGANIZATION; MECHANICAL-PROPERTIES; CROSS-LINKING; CELLS; FILAMENTS; MICRORHEOLOGY; MICROTUBULES; ELASTICITY; MOTILITY	The mechanical properties of cells play an essential role in numerous physiological processes. Organized networks of semiflexible actin filaments determine cell stiffness and transmit force during mechanotransduction, cytokinesis, cell motility and other cellular shape changes(1-3). Although numerous actin-binding proteins have been identified that organize networks, the mechanical properties of actin networks with physiological architectures and concentrations have been difficult to measure quantitatively. Studies of mechanical properties in vitro have found that crosslinked networks of actin filaments formed in solution exhibit stress stiffening arising from the entropic elasticity of individual filaments or crosslinkers resisting extension(4-8). Here we report reversible stress-softening behaviour in actin networks reconstituted in vitro that suggests a critical role for filaments resisting compression. Using a modified atomic force microscope to probe dendritic actin networks ( like those formed in the lamellipodia of motile cells), we observe stress stiffening followed by a regime of reversible stress softening at higher loads. This softening behaviour can be explained by elastic buckling of individual filaments under compression that avoids catastrophic fracture of the network. The observation of both stress stiffening and softening suggests a complex interplay between entropic and enthalpic elasticity in determining the mechanical properties of actin networks.	Univ Calif Berkeley, UC San Francisco UC Berkeley Joint Grad Grp Bioen, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Fletcher, DA (corresponding author), Univ Calif Berkeley, UC San Francisco UC Berkeley Joint Grad Grp Bioen, Berkeley, CA 94720 USA.	fletch@berkeley.edu	Ladoux, Benoit/A-9879-2013	Chaudhuri, Ovijit/0000-0002-9287-3401	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072736, R01GM074751] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM074751, R01 GM072736-05, R01 GM074751-01A2, R01 GM072736] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alcaraz J, 2003, BIOPHYS J, V84, P2071, DOI 10.1016/S0006-3495(03)75014-0; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cameron LA, 1999, P NATL ACAD SCI USA, V96, P4908, DOI 10.1073/pnas.96.9.4908; Cameron LA, 2001, CURR BIOL, V11, P130, DOI 10.1016/S0960-9822(01)00022-7; Coughlin MF, 1998, J BIOMECH ENG-T ASME, V120, P770, DOI 10.1115/1.2834892; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; FRICKE J, 1988, J NON-CRYST SOLIDS, V100, P169, DOI 10.1016/0022-3093(88)90014-2; Gardel ML, 2006, P NATL ACAD SCI USA, V103, P1762, DOI 10.1073/pnas.0504777103; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Head DA, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.108102; Janmey PA, 2004, TRENDS BIOCHEM SCI, V29, P364, DOI 10.1016/j.tibs.2004.05.003; Kroy K, 1996, PHYS REV LETT, V77, P306, DOI 10.1103/PhysRevLett.77.306; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; Mahaffy RE, 2000, PHYS REV LETT, V85, P880, DOI 10.1103/PhysRevLett.85.880; Marcy Y, 2004, P NATL ACAD SCI USA, V101, P5992, DOI 10.1073/pnas.0307704101; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nakamura F, 2002, J BIOL CHEM, V277, P9148, DOI 10.1074/jbc.M111297200; Onck PR, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.178102; Parekh SH, 2005, NAT CELL BIOL, V7, P1219, DOI 10.1038/ncb1336; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Satcher RL, 1996, BIOPHYS J, V71, P109, DOI 10.1016/S0006-3495(96)79206-8; Stamenovic D, 2004, J APPL PHYSIOL, V96, P1600, DOI 10.1152/japplphysiol.00595.2003; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Tseng Y, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.258104; Xu JY, 2000, J BIOL CHEM, V275, P35886, DOI 10.1074/jbc.M002377200	30	289	300	8	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2007	445	7125					295	298		10.1038/nature05459	http://dx.doi.org/10.1038/nature05459			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126HT	17230186	Green Accepted			2022-12-01	WOS:000243504700040
J	Keays, DA; Tian, G; Poirier, K; Huang, GJ; Siebold, C; Cleak, J; Oliver, PL; Fray, M; Harvey, RJ; Molnar, Z; Pinon, MC; Dear, N; Valdar, W; Brown, SDM; Davies, KE; Rawlins, JNP; Cowan, NJ; Nolan, P; Chelly, J; Flint, J				Keays, David A.; Tian, Guoling; Poirier, Karine; Huang, Guo-Jen; Siebold, Christian; Cleak, James; Oliver, Peter L.; Fray, Martin; Harvey, Robert J.; Molnar, Zoltan; Pinon, Maria C.; Dear, Neil; Valdar, William; Brown, Steve D. M.; Davies, Kay E.; Rawlins, J. Nicholas P.; Cowan, Nicholas J.; Nolan, Patrick; Chelly, Jamel; Flint, Jonathan			Mutations in alpha-tubulin cause abnormal neuronal migration in mice and lissencephaly in humans	CELL			English	Article							CEREBELLAR HYPOPLASIA; CORTICAL DEVELOPMENT; BETA-TUBULIN; GENE; DOUBLECORTIN; PROTEIN; CHAPERONIN; MOUSE; HETERODIMER; HIPPOCAMPUS	The development of the mammalian brain is dependent on extensive neuronal migration. Mutations in mice and humans that affect neuronal migration result in abnormal lamination of brain structures with associated behavioral deficits. Here, we report the identification of a hyperactive N-ethyl-N-nitrosourea (ENU)induced mouse mutant with abnormalities in the laminar architecture of the hippocampus and cortex, accompanied by impaired neuronal migration. We show that the causative mutation lies in the guanosine triphosphate (GTP) binding pocket of alpha-1 tubulin (Tuba 1) and affects tubulin heterodimer formation. Phenotypic similarity with existing mouse models of lissencephaly led us to screen a cohort of patients with developmental brain anomalies. We identified two patients with cle novo mutations in TUBA3, the human homolog of Tubal. This study demonstrates the utility of ENU mutagenesis in the mouse as a means to discover the basis of human neurodevelopmental disorders.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; NYU, Med Ctr, Dept Biochem, New York, NY 10016 USA; MRC, Funct Genet Unit, Oxford OX1 3QX, England; MRC, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England; Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; Univ Paris 05, Fac Med Rene Descartes, Inst Cochin, INSERM,Unite 567,CNRS,UMR 8104, F-75014 Paris, France	University of Oxford; Wellcome Centre for Human Genetics; New York University; MRC Harwell; University of London; University College London; University of London School of Pharmacy; University of Oxford; University of Oxford; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Flint, J (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.	jf@well.ox.ac.uk	Molnar, Zoltan/J-7281-2012; Nolan, Patrick/W-3918-2019; Harvey, Robert J/D-3994-2016; Chelly, Jamel/J-7528-2015; POIRIER, Karine/N-3009-2018; Oliver, Peter/F-1453-2010; Valdar, William/AAE-4354-2019	Molnar, Zoltan/0000-0002-6852-6004; Nolan, Patrick/0000-0001-5550-0334; Harvey, Robert J/0000-0001-5956-6664; Chelly, Jamel/0000-0002-0939-8719; POIRIER, Karine/0000-0002-7928-2906; Flint, Jonathan/0000-0002-9427-4429; Oliver, Peter/0000-0003-3347-2461; Huang, Guo-Jen/0000-0002-6392-2155	MRC [MC_U142684172, MC_U142684173, MC_U137761449, G0300200, MC_U142684175, MC_UP_1502/1] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047234] Funding Source: NIH RePORTER; Medical Research Council [MC_U142684175, G0300200, MC_UP_1502/1, MC_U142684172, MC_U137761449, MC_U142684173] Funding Source: Medline; NIDDK NIH HHS [R01 DK047234, R01 DK47234] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome Trust)		ANGEVINE JAY B., 1965, EXP NEUROL SUPPL, V2, P1; Bannerman DM, 2004, BEHAV NEUROSCI, V118, P643, DOI 10.1037/0735-7044.118.3.643; Bartolini F, 2002, J BIOL CHEM, V277, P14629, DOI 10.1074/jbc.M200128200; BASTEN CJ, 1996, PLANT GENOME, V4; Boycott KM, 2005, AM J HUM GENET, V77, P477, DOI 10.1086/444400; Buhot MC, 2001, BEHAV NEUROSCI, V115, P455, DOI 10.1037/0735-7044.115.2.455; CHURCHILL GA, 1994, GENETICS, V138, P963; Corbo JC, 2002, J NEUROSCI, V22, P7548; Deacon RMJ, 2002, BEHAV BRAIN RES, V132, P203, DOI 10.1016/S0166-4328(01)00401-6; Demyanenko GP, 2004, NEURON, V44, P423, DOI 10.1016/j.neuron.2004.10.016; des Portes V, 1998, CELL, V92, P51; DOBYNS WB, 1995, NEUROPEDIATRICS, V26, P132, DOI 10.1055/s-2007-979744; Farr SA, 2002, PHYSIOL BEHAV, V76, P531, DOI 10.1016/S0031-9384(02)00749-7; Francis F, 2006, EUR J NEUROSCI, V23, P877, DOI 10.1111/j.1460-9568.2006.04649.x; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gloster A, 1999, J COMP NEUROL, V405, P45, DOI 10.1002/(SICI)1096-9861(19990301)405:1<45::AID-CNE4>3.0.CO;2-M; GU W, 1989, MOL CELL BIOL, V9, P3418, DOI 10.1128/MCB.9.8.3418; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Huang GJ, 2005, NEUROPSYCHOPHARMACOL, V30, P231, DOI 10.1038/sj.npp.1300609; Kappeler C, 2006, HUM MOL GENET, V15, P1387, DOI 10.1093/hmg/ddl062; Kikkawa M, 2006, EMBO J, V25, P4187, DOI 10.1038/sj.emboj.7601299; Leventer RJ, 2005, J CHILD NEUROL, V20, P307, DOI 10.1177/08830738050200040701; Lewis SA, 1996, J CELL BIOL, V132, P1, DOI 10.1083/jcb.132.1.1; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; Paylor R, 1999, LEARN MEMORY, V6, P521, DOI 10.1101/lm.6.5.521; Phillips JB, 2004, CELL MOTIL CYTOSKEL, V58, P112, DOI 10.1002/cm.20003; Pinheiro JC., 2000, MIXED EFFECTS MODELS, V43, P111; QIU S, 2005, NEUROBIOLOGY LEARNIN, V85, P228; R Development Core Team, 2004, LANG ENV STAT COMP; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Solberg LC, 2006, MAMM GENOME, V17, P129, DOI 10.1007/s00335-005-0112-1; SPIEGELMAN BM, 1977, CELL, V12, P587, DOI 10.1016/0092-8674(77)90259-8; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Takahashi T, 1999, J NEUROSCI, V19, P10357; Thornton CE, 1999, MAMM GENOME, V10, P987, DOI 10.1007/s003359901145; TIAN GL, 1995, J BIOL CHEM, V270, P23910, DOI 10.1074/jbc.270.41.23910; Tian GL, 1999, J BIOL CHEM, V274, P24054, DOI 10.1074/jbc.274.34.24054; Tian GL, 2006, P NATL ACAD SCI USA, V103, P13491, DOI 10.1073/pnas.0602798103; Vega LR, 1998, MOL BIOL CELL, V9, P2349, DOI 10.1091/mbc.9.9.2349; VILLASANTE A, 1986, MOL CELL BIOL, V6, P2409, DOI 10.1128/MCB.6.7.2409; WILLINS DA, 1995, GENETICS, V141, P1287; ZENG ZB, 1994, GENETICS, V136, P1457	46	318	325	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 12	2007	128	1					45	57		10.1016/j.cell.2006.12.017	http://dx.doi.org/10.1016/j.cell.2006.12.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GN	17218254	hybrid, Green Published			2022-12-01	WOS:000244420400012
J	Zanetti, R; Rosso, S				Zanetti, Roberto; Rosso, Stefano			Levodopa and the risk of melanoma	LANCET			English	Editorial Material							PARKINSONS-DISEASE; MALIGNANT-MELANOMA; L-DOPA; SMOKING		Piedmont Canc Registry CPO, I-10123 Turin, Italy		Zanetti, R (corresponding author), Piedmont Canc Registry CPO, I-10123 Turin, Italy.	roberto.zanetti@cpo.it						DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525; GURNEY H, 1991, J INVEST DERMATOL, V96, P85, DOI 10.1111/1523-1747.ep12515896; HAMMOND E. CUYLER, 1966, NAT CANCER INST MONOGR, V19, P127; *MEDL PLUS, LEV SYST; Olsen JH, 2005, BRIT J CANCER, V92, P201, DOI 10.1038/sj.bjc.6602279; Olsen JH, 2006, EPIDEMIOLOGY, V17, P582, DOI 10.1097/01.ede.0000229445.90471.5e; Quik M, 2004, TRENDS NEUROSCI, V27, P561, DOI 10.1016/j.tins.2004.06.008; SHOHAT B, 1975, EXPERIENTIA, V31, P110, DOI 10.1007/BF01924707; SKIBBA JL, 1972, ARCH PATHOL, V93, P556; Zanetti R, 2006, MELANOMA RES, V16, P201, DOI 10.1097/01.cmr.0000215043.61306.d7	10	10	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2007	369	9558					257	258		10.1016/S0140-6736(07)60125-1	http://dx.doi.org/10.1016/S0140-6736(07)60125-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131ZR	17258651				2022-12-01	WOS:000243912000009
J	Mulugu, S; Bai, WL; Fridy, PC; Bastidas, RJ; Otto, JC; Dollins, DE; Haystead, TA; Ribeiro, AA; York, JD				Mulugu, Sashidhar; Bai, Wenli; Fridy, Peter C.; Bastidas, Robert J.; Otto, James C.; Dollins, D. Eric; Haystead, Timothy A.; Ribeiro, Anthony A.; York, John D.			A conserved family of enzymes that phosphorylate inositol hexakisphosphate	SCIENCE			English	Article							MESSENGER-RNA EXPORT; ARP2/3 COMPLEX; SACCHAROMYCES-CEREVISIAE; ACTIN; PYROPHOSPHATES; PHOSPHATES; TETRAKISPHOSPHATE; POLYPHOSPHATES; DICTYOSTELIUM; METABOLISM	Inositol pyrophosphates are a diverse group of high-energy signaling molecules whose cellular roles remain an active area of study. We report a previously uncharacterized class of inositol pyrophosphate synthase and find it is identical to yeast Vip1 and Asp1 proteins, regulators of actin-related protein-2/3 (ARP 2/3) complexes. Vip1 and Asp1 acted as enzymes that encode inositol hexakisphosphate (IP6) and inositol heptakisphosphate (IP7) kinase activities. Alterations in kinase activity led to defects in cell growth, morphology, and interactions with ARP complex members. The functionality of Asp1 and Vip1 may provide cells with increased signaling capacity through metabolism of IP6.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, NMR Ctr, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University	York, JD (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Pharmacol & Canc Biol, DUMC 3813, Durham, NC 27710 USA.	yorkj@duke.edu		Fridy, Peter/0000-0002-8208-9154	NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070272] Funding Source: NIH RePORTER; NCI NIH HHS [2-P30-CA14236-3, P30-CA-14236] Funding Source: Medline; NHLBI NIH HHS [R01-HL-55672] Funding Source: Medline; NIDDK NIH HHS [R33-DK-070272] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bennett M, 2006, CELL MOL LIFE SCI, V63, P552, DOI 10.1007/s00018-005-5446-z; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; EUROPEFINNER GN, 1991, BIOCHEM BIOPH RES CO, V181, P191, DOI 10.1016/S0006-291X(05)81400-7; Feoktistova A, 1999, GENETICS, V152, P895; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GLENNON MC, 1993, BIOCHEM J, V293, P583, DOI 10.1042/bj2930583; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Grishin NV, 1999, J MOL BIOL, V291, P239, DOI 10.1006/jmbi.1999.2973; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Laussmann T, 1996, BIOCHEM J, V315, P715, DOI 10.1042/bj3150715; Laussmann T, 1998, FEBS LETT, V426, P145, DOI 10.1016/S0014-5793(98)00329-9; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; Mullaney EJ, 2003, BIOCHEM BIOPH RES CO, V312, P179, DOI 10.1016/j.bbrc.2003.09.176; Odom AR, 2000, SCIENCE, V287, P2026, DOI 10.1126/science.287.5460.2026; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2000, FEBS LETT, V468, P28, DOI 10.1016/S0014-5793(00)01194-7; Saiardi A, 2002, P NATL ACAD SCI USA, V99, P14206, DOI 10.1073/pnas.212527899; Seeds AM, 2005, J BIOL CHEM, V280, P27654, DOI 10.1074/jbc.M505089200; SHEARS SB, 1995, J BIOL CHEM, V270, P10489, DOI 10.1074/jbc.270.18.10489; Shears SB, 1998, BBA-MOL CELL BIOL L, V1436, P49, DOI 10.1016/S0005-2760(98)00131-3; STEPHENS L, 1993, J BIOL CHEM, V268, P4009; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; York JD, 2006, BBA-MOL CELL BIOL L, V1761, P552, DOI 10.1016/j.bbalip.2006.04.014; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200	30	181	190	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2007	316	5821					106	109		10.1126/science.1139099	http://dx.doi.org/10.1126/science.1139099			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412958				2022-12-01	WOS:000245470500042
J	Chait, R; Craney, A; Kishony, R				Chait, Remy; Craney, Allison; Kishony, Roy			Antibiotic interactions that select against resistance	NATURE			English	Article							TETRACYCLINE-RESISTANCE; ESCHERICHIA-COLI; EXPRESSION; ELEMENTS; PROMOTER; FITNESS; GENE	Multidrug combinations are increasingly important in combating the spread of antibiotic-resistance in bacterial pathogens(1-3). On a broader scale, such combinations are also important in understanding microbial ecology and evolution(4,5). Although the effects of multidrug combinations on bacterial growth have been studied extensively, relatively little is known about their impact on the differential selection between sensitive and resistant bacterial populations(1,6,7). Normally, the presence of a drug confers an advantage on its resistant mutants incompetition with the sensitive wild-type population(1). Here we show, by using a direct competition assay between doxycycline-resistant and doxycycline-sensitive Escherichia coli, that this differential selection can be inverted in a hyper-antagonistic class of drug combinations. Used in such a combination, a drug can render the combined treatment selective against the drug's own resistance allele. Further, this inversion of selection seems largely insensitive to the underlying resistance mechanism and occurs, at sublethal concentrations, while maintaining inhibition of the wild type. These seemingly paradoxical results can be rationalized in terms of a simple geometric argument. Our findings demonstrate a previously unappreciated feature of the fitness landscape for the evolution of resistance and point to a trade-off between the effect of drug interactions on absolute potency and the relative competitive selection that they impose on emerging resistant populations.	Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Kishony, R (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 200 Longwood Ave, Boston, MA 02115 USA.	roy_kishony@hms.harvard.edu		Chait, Remy/0000-0003-0876-3187				Bjarnason J, 2003, J BACTERIOL, V185, P4973, DOI 10.1128/JB.185.16.4973-4982.2003; CHAO L, 1978, NATURE, V271, P385, DOI 10.1038/271385a0; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Czaran TL, 2002, P NATL ACAD SCI USA, V99, P786, DOI 10.1073/pnas.012399899; Deeks SG, 2003, LANCET, V362, P2002, DOI 10.1016/S0140-6736(03)15022-2; Drlica K., 2003, QUINOLONE ANTIMICROB, P19; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fraser T R, 1872, Br Med J, V2, P485; Golan DE, 2005, PRINCIPLES PHARM PAT; Hegreness M, 2006, SCIENCE, V311, P1615, DOI 10.1126/science.1122469; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; KISHONY R, 2003, J BIOL, V2, DOI UNSP 14.1-14.10; KLEIN M, 1953, J BACTERIOL, V65, P454, DOI 10.1128/JB.65.4.454-465.1953; LENSKI RE, 1994, J BACTERIOL, V176, P3140, DOI 10.1128/jb.176.11.3140-3147.1994; LENSKI RE, 1994, MOL ECOL, V3, P127, DOI 10.1111/j.1365-294X.1994.tb00113.x; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lipsitch M, 1997, ANTIMICROB AGENTS CH, V41, P363, DOI 10.1128/AAC.41.2.363; LOEWE S, 1953, ARZNEIMITTEL-FORSCH, V3, P285; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Pillai SK., 2005, ANTIBIOTICS LAB MED, P365; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; SINGER M, 1989, MICROBIOL REV, V53, P1; Tsui WHW, 2004, CHEM BIOL, V11, P1307, DOI 10.1016/j.chembiol.2004.07.010; Walsh C., 2003, ANTIBIOTICS ACTIONS, P335; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Whittle G, 2003, APPL ENVIRON MICROB, V69, P4151, DOI 10.1128/AEM.69.7.4151-4158.2003; Yang WR, 2004, J BIOL CHEM, V279, P52346, DOI 10.1074/jbc.M409573200; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755; Yim G, 2006, INT J MED MICROBIOL, V296, P163, DOI 10.1016/j.ijmm.2006.01.039	30	312	323	4	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2007	446	7136					668	671		10.1038/nature05685	http://dx.doi.org/10.1038/nature05685			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17410176				2022-12-01	WOS:000245438300040
J	Suzuki, K; Okuno, T; Yamamoto, M; Pasterkamp, RJ; Takegahara, N; Takamatsu, H; Kitao, T; Takagi, J; Rennert, PD; Kolodkin, AL; Kumanogoh, A; Kikutani, H				Suzuki, Kazuhiro; Okuno, Tatsusada; Yamamoto, Midori; Pasterkamp, R. Jeroen; Takegahara, Noriko; Takamatsu, Hyota; Kitao, Tomoe; Takagi, Junichi; Rennert, Paul D.; Kolodkin, Alex L.; Kumanogoh, Atsushi; Kikutani, Hitoshi			Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha 1 beta 1 integrin	NATURE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; COLLAGEN-BINDING INTEGRINS; EXPRESSION; FAMILY; HYPERSENSITIVITY; ALPHA(1)BETA(1); TRANSMEMBRANE; ARTHRITIS; ADHESION; COLITIS	Semaphorins are axon guidance factors that assist growing axons in finding appropriate targets and forming synapses(1). Emerging evidence suggests that semaphorins are involved not only in embryonic development but also in immune responses(2). Semaphorin 7A (Sema7A; also known as CD108)(3,4), which is a glycosylphosphatidylinositol-anchored semaphorin, promotes axon outgrowth through beta 1-integrin receptors and contributes to the formation of the lateral olfactory tract(5). Although Sema7A has been shown to stimulate human monocytes(6), its function as a negative regulator of T-cell responses has also been reported(7). Thus, the precise function of Sema7A in the immune system remains unclear. Here we show that Sema7A, which is expressed on activated T cells, stimulates cytokine production in monocytes and macrophages through alpha 1 beta 1 integrin ( also known as very late antigen-1) as a component of the immunological synapse, and is critical for the effector phase of the inflammatory immune response. Sema7A-deficient (Sema7a(-/-)) mice are defective in cell-mediated immune responses such as contact hypersensitivity and experimental autoimmune encephalomyelitis. Although antigen-specific and cytokine-producing effector T cells can develop and migrate into antigen-challenged sites in Sema7a(-/-) mice, Sema7a(-/-) T cells fail to induce contact hypersensitivity even when directly injected into the antigen-challenged sites. Thus, the interaction between Sema7A and alpha 1 beta 1 integrin is crucial at the site of inflammation. These findings not only identify a function of Sema7A as an effector molecule in T-cell-mediated inflammation, but also reveal a mechanism of integrin-mediated immune regulation.	JST, Dept Mol Immunol, Suita, Osaka 5650871, Japan; JST, CREST Program, Suita, Osaka 5650871, Japan; Osaka Univ, Microbial Dis Res Inst, Dept Immunopathol, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka 5650871, Japan; Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Pharmacol & Anat, NL-3584 CG Utrecht, Netherlands; Osaka Univ, Inst Prot Res, Lab Prot Synth & Express, Suita, Osaka 5650871, Japan; Biogen Idec Inc, Cambridge, MA 01746 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA	Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Osaka University; Osaka University; Utrecht University; Utrecht University Medical Center; Osaka University; Biogen; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Kumanogoh, A (corresponding author), JST, Dept Mol Immunol, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	kumanogo@ragtime.biken.osaka-u.ac.jp; kikutani@ragtime.biken.osaka-u.ac.jp	Takegahara, Noriko/AAP-1694-2021; Kumanogoh, Atsushi/C-7354-2009; Kikutani, Hitoshi/C-9525-2009; Kitao, Tomoe/AHE-0728-2022; Suzuki, Kazuhiro/B-3886-2012	Kitao, Tomoe/0000-0003-1366-4861; Suzuki, Kazuhiro/0000-0002-9081-538X; Pasterkamp, Jeroen/0000-0003-1631-6440				Andreasen SO, 2003, J IMMUNOL, V171, P2804, DOI 10.4049/jimmunol.171.6.2804; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Ben-Horin S, 2004, CLIN IMMUNOL, V113, P119, DOI 10.1016/j.clim.2004.06.007; Czopik AK, 2006, IMMUNITY, V24, P591, DOI 10.1016/j.immuni.2006.03.013; de Fougerolles AR, 2000, J CLIN INVEST, V105, P721, DOI 10.1172/JCI7911; Fiorucci S, 2002, IMMUNITY, V17, P769, DOI 10.1016/S1074-7613(02)00476-4; Gardner H, 1996, DEV BIOL, V175, P301, DOI 10.1006/dbio.1996.0116; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; Holmes S, 2002, SCAND J IMMUNOL, V56, P270, DOI 10.1046/j.1365-3083.2002.01129.x; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kikutani H, 2003, NAT REV IMMUNOL, V3, P159, DOI 10.1038/nri1003; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Krieglstein CF, 2002, J CLIN INVEST, V110, P1773, DOI 10.1172/JCI200215256; Kuchroo VK, 2002, ANNU REV IMMUNOL, V20, P101, DOI 10.1146/annurev.immunol.20.081701.141316; Kumanogoh A, 2002, J IMMUNOL, V169, P1175, DOI 10.4049/jimmunol.169.3.1175; Lange C, 1998, GENOMICS, V51, P340, DOI 10.1006/geno.1998.5256; McInnes IB, 1997, NAT MED, V3, P189, DOI 10.1038/nm0297-189; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; RICHES DWH, 1991, J BIOL CHEM, V266, P24785; Riminton DS, 1998, J EXP MED, V187, P1517, DOI 10.1084/jem.187.9.1517; Schlaepfer DD, 1998, TRENDS CELL BIOL, V8, P151, DOI 10.1016/S0962-8924(97)01172-0; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Xu XM, 1998, J BIOL CHEM, V273, P22428, DOI 10.1074/jbc.273.35.22428	27	195	209	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2007	446	7136					680	684		10.1038/nature05652	http://dx.doi.org/10.1038/nature05652			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17377534				2022-12-01	WOS:000245438300043
J	Cohen, SB; Graham, ME; Lovrecz, GO; Bache, N; Robinson, PJ; Reddel, RR				Cohen, Scott B.; Graham, Mark E.; Lovrecz, George O.; Bache, Nicolai; Robinson, Phillip J.; Reddel, Roger R.			Protein composition of catalytically active human telomerase from immortal cells	SCIENCE			English	Article							DOMINANT DYSKERATOSIS-CONGENITA; REVERSE-TRANSCRIPTASE; RNA COMPONENT; PURIFICATION; SUBUNIT	Telomerase is a ribonucleoprotein enzyme complex that adds 5'-TTAGGG-3' repeats onto the ends of human chromosomes, providing a telomere maintenance mechanism for similar to 90% of human cancers. We have purified human telomerase similar to 10(8)-fold, with the final elution dependent on the enzyme's ability to catalyze nucleotide addition onto a DNA oligonucleotide of telomeric sequence, thereby providing specificity for catalytically active telomerase. Mass spectrometric sequencing of the protein components and molecular size determination indicated an enzyme composition of two molecules each of telomerase reverse transcriptase, telomerase RNA, and dyskerin.	Childrens Med Res Inst, Canc Res Unit, Westmead, NSW 2145, Australia; Childrens Med Res Inst, Cell Signalling Unit, Westmead, NSW 2145, Australia; CSIRO, Mol & Hlth Technol, Fermentat Lab, Parkville, Vic 3052, Australia; Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	Children's Medical Research Institute - Australia; Children's Medical Research Institute - Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Southern Denmark	Reddel, RR (corresponding author), Childrens Med Res Inst, Canc Res Unit, 214 Hawkesbury Rd, Westmead, NSW 2145, Australia.	rreddel@cmri.usyd.edu.au	Lovrecz, George/H-8602-2013; Reddel, Roger R/A-6635-2014; Graham, Mark E/A-6480-2014; Robinson, Phillip J/G-4008-2011	Reddel, Roger R/0000-0002-6302-6107; Graham, Mark E/0000-0002-7290-1217; Robinson, Phillip J/0000-0002-7878-0313				Arai K, 2002, J BIOL CHEM, V277, P8538, DOI 10.1074/jbc.M111068200; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Beattie TL, 2001, MOL CELL BIOL, V21, P6151, DOI 10.1128/MCB.21.18.6151-6160.2001; Bryan TM, 1998, EXP CELL RES, V239, P370, DOI 10.1006/excr.1997.3907; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Lingner J, 1996, P NATL ACAD SCI USA, V93, P10712, DOI 10.1073/pnas.93.20.10712; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Schnapp G, 1998, NUCLEIC ACIDS RES, V26, P3311, DOI 10.1093/nar/26.13.3311; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Wallweber G, 2003, BIOCHEMISTRY-US, V42, P589, DOI 10.1021/bi026914a; Wenz C, 2001, EMBO J, V20, P3526, DOI 10.1093/emboj/20.13.3526	19	495	521	3	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2007	315	5820					1850	1853		10.1126/science.1138596	http://dx.doi.org/10.1126/science.1138596			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395830				2022-12-01	WOS:000245280100045
J	Smith, BD				Smith, Bruce D.			The ultimate ecosystem engineers	SCIENCE			English	Editorial Material									Smithsonian Inst, Natl Museum Nat Hist, Archaeobiol Program, Washington, DC 20560 USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Smith, BD (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Archaeobiol Program, Washington, DC 20560 USA.	smithb@si.edu						Anderson M., 2005, TENDING WILD; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; Odling-Smee F., 2003, NICHE CONSTRUCTION; Weiss E, 2006, SCIENCE, V312, P1608, DOI 10.1126/science.1127235; Zeder MA, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P1; Zeder MA, 2006, EVOL ANTHROPOL, V15, P105, DOI 10.1002/evan.20101	6	86	92	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1797	1798		10.1126/science.1137740	http://dx.doi.org/10.1126/science.1137740			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395815				2022-12-01	WOS:000245280100025
J	Steinbrook, R				Steinbrook, Robert			HIV in India - A complex epidemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HIV/AIDS					rsteinbrook@attglobal.net						Chandrasekaran P, 2006, LANCET INFECT DIS, V6, P508, DOI 10.1016/S1473-3099(06)70551-5; Dandona L, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-31; Kumar R, 2006, LANCET, V367, P1164, DOI 10.1016/S0140-6736(06)68435-3; O'Neil J, 2004, SOC SCI MED, V59, P851, DOI 10.1016/j.socscimed.2003.11.032; SIMOES EAF, 1987, INDIAN J MED RES, V85, P335	5	83	85	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2007	356	11					1089	1093		10.1056/NEJMp078009	http://dx.doi.org/10.1056/NEJMp078009			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	145PO	17360986	Bronze			2022-12-01	WOS:000244877200001
J	Rocco, B; Djavan, B				Rocco, Bernardo; Djavan, Bob			Robotic prostatectomy: facts or fiction?	LANCET			English	Editorial Material							LAPAROSCOPIC RADICAL PROSTATECTOMY; OUTCOMES; CANCER		European Inst Oncol, Dept Urol, I-20141 Milan, Italy; Univ Vienna, Dept Urol, Vienna, Austria	IRCCS European Institute of Oncology (IEO); University of Vienna	Rocco, B (corresponding author), European Inst Oncol, Dept Urol, I-20141 Milan, Italy.	bernardo.rocco@ieo.it	Rocco, Bernardo/R-4041-2016	Rocco, Bernardo/0000-0002-9135-0035				Ahlering TE, 2004, UROLOGY, V63, P819, DOI 10.1016/j.urology.2004.01.038; Ahlering TE, 2003, J UROLOGY, V170, P1738, DOI 10.1097/01.ju.0000092881.24608.5e; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; Burgess SV, 2006, J ENDOUROL, V20, P827, DOI 10.1089/end.2006.20.827; Descazeaud A, 2007, EUR UROL, V51, P9, DOI 10.1016/j.eururo.2006.10.007; Ficarra V, 2007, EUR UROL, V51, P45, DOI 10.1016/j.eururo.2006.06.017; Han M, 2004, J UROLOGY, V171, P23, DOI 10.1097/01.ju.0000098604.09395.27; Lepor Herbert, 2005, Rev Urol, V7 Suppl 2, pS11; Lotan Y, 2004, J UROLOGY, V172, P1431, DOI 10.1097/01.ju.0000139714.09832.47; Menon M, 2005, UROLOGY, V66, P101, DOI 10.1016/j.urology.2005.06.008; Menon M, 2007, EUR UROL, V51, P648, DOI 10.1016/j.eururo.2006.10.055; Penson DF, 2005, J UROLOGY, V173, P1701, DOI 10.1097/01.ju.0000154637.38262.3a; Rassweiler J, 2006, EUR UROL, V49, P612, DOI 10.1016/j.eururo.2005.12.054; Smith JA, 2005, J CLIN ONCOL, V23, P8170, DOI 10.1200/JCO.2005.03.1963; Tewari Ashutosh, 2003, Rev Urol, V5 Suppl 6, pS33; *UK OFF NAT STAT, CANC INC MORT UK 200; *US NAT CANC I, SURV EP END RES CAND	17	14	14	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 3	2007	369	9563					723	724		10.1016/S0140-6736(07)60336-5	http://dx.doi.org/10.1016/S0140-6736(07)60336-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	143MP	17336632				2022-12-01	WOS:000244726700008
J	Pearse, RM; Young, JD				Pearse, Rupert M.; Young, J. Duncan			Steroids to prevent postextubation laryngeal oedema	LANCET			English	Editorial Material							MECHANICAL VENTILATION; DOUBLE-BLIND; DEXAMETHASONE; EXTUBATION; STRIDOR; ADULTS		Royal London Hosp, Barts & London Sch Med & Dent, London E1 1BB, England; John Radcliffe Hosp, Adult Intens Care Unit, Oxford OX3 9DU, England	Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London; University of Oxford	Pearse, RM (corresponding author), Royal London Hosp, Barts & London Sch Med & Dent, London E1 1BB, England.	rupert.pearse@bartsandthelondon.nhs.uk	Pearse, Rupert/H-5426-2011; Young, John D/M-9756-2016	Pearse, Rupert/0000-0002-4373-5934; Young, John Duncan/0000-0002-6838-4835				Anene O, 1996, CRIT CARE MED, V24, P1666, DOI 10.1097/00003246-199610000-00011; Cheng KC, 2006, CRIT CARE MED, V34, P1345, DOI 10.1097/01.CCM.0000214678.92134.BD; DARMON JY, 1992, ANESTHESIOLOGY, V77, P245, DOI 10.1097/00000542-199208000-00004; Epstein SK, 1997, CHEST, V112, P186, DOI 10.1378/chest.112.1.186; Esteban A, 1998, INTENS CARE MED, V24, P999, DOI 10.1007/s001340050708; Ferrara T B, 1989, J Perinatol, V9, P287; Francois B, 2007, LANCET, V369, P1083, DOI 10.1016/S0140-6736(07)60526-1; Ho LI, 1996, INTENS CARE MED, V22, P933; TELLEZ DW, 1991, J PEDIATR-US, V118, P289, DOI 10.1016/S0022-3476(05)80505-0	9	2	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR-APR	2007	369	9567					1060	1061		10.1016/S0140-6736(07)60503-0	http://dx.doi.org/10.1016/S0140-6736(07)60503-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151XF	17398289				2022-12-01	WOS:000245323700006
J	Coombes, R				Coombes, Rebecca			Medicine and the media - Having the last laugh at big pharma - How campaigners are creating humorous videos to hit back at the drug industry	BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmjgroup.com							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 24	2007	334	7590					396	397		10.1136/bmj.39133.480880.59	http://dx.doi.org/10.1136/bmj.39133.480880.59			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	142MQ	17322252	Green Published			2022-12-01	WOS:000244654400025
J	Charrel, RN; de Lamballerie, X; Raoult, D				Charrel, Remi N.; de Lamballerie, Xavier; Raoult, Didier			Chikungunya outbreaks - The globalization of vectorborne diseases	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VIRUS		Univ Aix Marseille 2, Fac Med, Unite Virus Emergents, Marseille, France; Univ Aix Marseille 2, Fac Med, Unite Rickettsies, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Universite de Franche-Comte; UDICE-French Research Universities; Aix-Marseille Universite; Universite de Franche-Comte	Charrel, RN (corresponding author), Univ Aix Marseille 2, Fac Med, Unite Virus Emergents, Marseille, France.		RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974; Charrel, Remi/0000-0002-7675-8251				Mudur Ganapati, 2006, BMJ, V333, P773, DOI 10.1136/bmj.333.7572.773-c; Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610; Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X; Shirley SM, 2006, PLOS BIOL, V4, P1311, DOI 10.1371/journal.pbio.0040279; Yergolkar PN, 2006, EMERG INFECT DIS, V12, P1580, DOI 10.3201/eid1210.060529	5	302	323	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2007	356	8					769	771		10.1056/NEJMp078013	http://dx.doi.org/10.1056/NEJMp078013			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137XQ	17314335				2022-12-01	WOS:000244326700002
J	Syntichaki, P; Troulinaki, K; Tavernarakis, N				Syntichaki, Popi; Troulinaki, Kostoula; Tavernarakis, Nektarios			eIF4E function in somatic cells modulates ageing in Caenorhabditis elegans	NATURE			English	Article							INITIATION-FACTOR 4E; CALORIC RESTRICTION; OXIDATIVE STRESS; C-ELEGANS; LIFE-SPAN; PROTEIN-SYNTHESIS; TRANSLATION; PHOSPHORYLATION; TURNOVER; KINASE	Regulation of protein synthesis is critical for cell growth and maintenance. Ageing in many organisms, including humans, is accompanied by marked alterations in both general and specific protein synthesis(1). Whether these alterations are simply a corollary of the ageing process or have a causative role in senescent decline remains unclear. An array of protein factors facilitates the tight control of messenger RNA translation initiation(2). The eukaryotic initiation factor 4E (eIF4E), which binds the 7-monomethyl guanosine cap at the 5' end of all nuclear mRNAs, is a principal regulator of protein synthesis(3). Here we show that loss of a specific eIF4E isoform (IFE-2) that functions in somatic tissues(4) reduces global protein synthesis, protects from oxidative stress and extends lifespan in Caenorhabditis elegans. Lifespan extension is independent of the forkhead transcription factor DAF-16, which mediates the effects of the insulin-like signalling pathway on ageing. Furthermore, IFE-2 deficiency further extends the lifespan of long-lived age and daf nematode mutants. Similarly, lack of IFE-2 enhances the long-lived phenotype of clk and dietary-restricted eat mutant animals. Knockdown of target of rapamycin ( TOR), a phosphatidylinositol kinase-related kinase that controls protein synthesis in response to nutrient cues, further increases the longevity of ife-2 mutants. Thus, signalling via eIF4E in the soma is a newly discovered pathway influencing ageing in C. elegans.	Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece	Foundation for Research & Technology - Hellas (FORTH)	Tavernarakis, N (corresponding author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece.	tavernarakis@imbb.forth.gr	Syntichaki, Popi/ABA-7218-2020; Tavernarakis, Nektarios/B-9684-2013	Tavernarakis, Nektarios/0000-0002-5253-1466; Syntichaki, Popi/0000-0001-9536-8905				Ahmed S, 2000, NATURE, V403, P159, DOI 10.1038/35003120; Amiri A, 2001, DEVELOPMENT, V128, P3899; Arquier N, 2005, CURR BIOL, V15, P19, DOI 10.1016/j.cub.2004.12.037; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; HANSEN M, 2006, AGEING CELL; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Keiper BD, 2000, J BIOL CHEM, V275, P10590, DOI 10.1074/jbc.275.14.10590; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; LIN SJ, 1995, P NATL ACAD SCI USA, V92, P3784, DOI 10.1073/pnas.92.9.3784; MAKRIDES SC, 1983, BIOL REV, V58, P343, DOI 10.1111/j.1469-185X.1983.tb00394.x; Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25; PAN KZ, 2006, AGEING CELL; Proud CG, 2002, EUR J BIOCHEM, V269, P5338, DOI 10.1046/j.1432-1033.2002.03292.x; Rattan SIS, 1996, EXP GERONTOL, V31, P33, DOI 10.1016/0531-5565(95)02022-5; Reiling JH, 2005, CURR BIOL, V15, P24, DOI 10.1016/j.cub.2004.12.034; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Tavernarakis N, 2002, MECH AGEING DEV, V123, P215, DOI 10.1016/S0047-6374(01)00341-4; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Ward WF, 2000, BIOGERONTOLOGY, V1, P195, DOI 10.1023/A:1010076818119; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723	32	253	277	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					922	926		10.1038/nature05603	http://dx.doi.org/10.1038/nature05603			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17277769				2022-12-01	WOS:000244341200051
J	Hibbeln, JR; Davis, JM; Steer, C; Emmett, P; Rogers, I; Williams, C; Golding, J				Hibbeln, Joseph R.; Davis, John M.; Steer, Colin; Emmett, Pauline; Rogers, Imogen; Williams, Cathy; Golding, Jean			Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study	LANCET			English	Article							POLYUNSATURATED FATTY-ACIDS; DIFFICULTIES QUESTIONNAIRE; UNITED-KINGDOM; BIRTH-WEIGHT; FISH INTAKE; SOUTH-WEST; POPULATION; STRENGTHS; CHILDREN; FOOD	Background Seafood is the predominant source of omega-3 fatty acids, which are essential for optimum neural development. However, in the USA, women are advised to limit their seafood intake during pregnancy to 340 g per week. We used the Avon Longitudinal Study of Parents and Children (ALSPAC) to assess the possible benefits and hazards to a child's development of different levels of maternal seafood intake during pregnancy. Methods 11875 pregnant women completed a food frequency questionnaire assessing seafood consumption at 32 weeks' gestation. Multivariable logistic regression models including 28 potential confounders assessing social disadvantage, perinatal, and dietary items were used to compare developmental, behavioural, and cognitive outcomes of the children from age 6 months to 8 years in women consuming none, some (1-340 g per week), and >340 g per week. Findings After adjustment, maternal seafood intake during pregnancy of less than 340 g per week was associated with increased risk of their children being in the lowest quartile for verbal intelligence quotient (IQ) (no seafood consumption, odds ratio [OR] 1.48, 95% Cl 1.16-1.90; some, 1.09, 0.92-1.29; overall trend, p=0.004), compared with mothers who consumed more than 340 g per week. Low maternal seafood intake was also associated with increased risk of suboptimum outcomes for prosocial behaviour, fine motor, communication, and social development scores. For each outcome measure, the lower the intake of seafood during pregnancy, the higher the risk of suboptimum developmental outcome. Interpretation Maternal seafood consumption of less than 340 g per week in pregnancy did not protect children from adverse outcomes; rather, we recorded beneficial effects on child development with maternal seafood intakes of more than 340 g per week, suggesting that advice to limit seafood consumption could actually be detrimental. These results show that risks from the loss of nutrients were greater than the risks of harm from exposure to trace contaminants in 340 g seafood eaten weekly.	US Natl Inst Alcohol Abuse & Alcoholism, Lab Membrane Biophys & Biochem, US Natl Inst Hlth, Bethesda, MD 20952 USA; Univ Illinois, Chicago, IL USA; Univ Bristol, Dept Community Based Med, Bristol BS8 1TH, Avon, England	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Bristol	Hibbeln, JR (corresponding author), US Natl Inst Alcohol Abuse & Alcoholism, Lab Membrane Biophys & Biochem, US Natl Inst Hlth, 31 Ctr Dr Rm 31,1B58,MSC 2088, Bethesda, MD 20952 USA.	jhibbeln@mail.nih.gov	Emmett, Pauline/AAL-6815-2021; Robles-Sardin, Alma E/M-7714-2015; Williams, Cathy/K-4919-2015	Robles-Sardin, Alma E/0000-0003-2044-7793; Emmett, Pauline/0000-0003-1076-4779; Williams, Cathy/0000-0002-9133-2021; Rogers, Imogen/0000-0001-7275-2437; Golding, Jean/0000-0003-2826-3307	NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH068580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000115] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; Medical Research Council [G9815508] Funding Source: Medline; NIMH NIH HHS [1 P01MH68580-01] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome Trust)		[Anonymous], [No title captured]; Calderon F, 2004, J NEUROCHEM, V90, P1540, DOI 10.1111/j.1471-4159.2004.02808.x; Caldwell B.M., 1979, HOME OBSERVATION MEA; Daniels JL, 2004, EPIDEMIOLOGY, V15, P394, DOI 10.1097/01.ede.0000129514.46451.ce; DWARKA S, 1995, HUM EXP TOXICOL, V14, P451, DOI 10.1177/096032719501400511; Eldho NV, 2003, J AM CHEM SOC, V125, P6409, DOI 10.1021/ja029029o; Emond Alan, 2005, Dev Med Child Neurol, V47, P646, DOI 10.1017/S0012162205001271; Erkkola M, 2001, AM J EPIDEMIOL, V154, P466, DOI 10.1093/aje/154.5.466; FAO/WHO, 1994, FAO FOOD NUTR PAP, V57, P1; FRANKENBURG WK, 1967, J PEDIATR-US, V71, P181, DOI 10.1016/S0022-3476(67)80070-2; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Goodman R, 1999, J ABNORM CHILD PSYCH, V27, P17, DOI 10.1023/A:1022658222914; Griffiths R, 1984, ABILITIES YOUNG CHIL; Helland IB, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e39; Heron J, 2004, PEDIATRICS, V114, P577, DOI 10.1542/peds.2003-1176-L; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Kodas E, 2004, J NEUROCHEM, V89, P695, DOI 10.1111/j.1471-4159.2004.02401.x; Mahaffey KR, 2004, ENVIRON HEALTH PERSP, V112, P562, DOI 10.1289/ehp.6587; Martinez M, 2001, J MOL NEUROSCI, V16, P309, DOI 10.1385/JMN:16:2-3:309; Ministry of Agriculture Fisheries and Food London (United Kingdom), 1998, FATT AC 7 SUPPL 5 ED, V7; National Research Council, 2000, TOX EFF METH; Newson R, 2003, STATA J, V3, P109, DOI 10.1177/1536867X0300300202; Niu SL, 2004, J BIOL CHEM, V279, P31098, DOI 10.1074/jbc.M404376200; Rice DC, 2003, RISK ANAL, V23, P107, DOI 10.1111/1539-6924.00294; Rogers I, 1998, EUR J CLIN NUTR, V52, P251, DOI 10.1038/sj.ejcn.1600544; Rogers I, 2003, EUR J CLIN NUTR, V57, P854, DOI 10.1038/sj.ejcn.1601619; Rogers I, 1998, EUR J CLIN NUTR, V52, P246, DOI 10.1038/sj.ejcn.1600543; Rogers I, 2004, J EPIDEMIOL COMMUN H, V58, P486, DOI 10.1136/jech.2003.013565; Rojas CV, 2003, INVEST OPHTH VIS SCI, V44, P3170, DOI 10.1167/iovs.02-1138; Rust, 1992, WISC IIIUK WECHSLER; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; *SCI ADV COMM NUTR, 2004, ADV SEAF CONS BEN RI, P80; Shatenstein B, 1999, ENVIRON RES, V80, pS71, DOI 10.1006/enrs.1998.3925; Simopoulos Artemis P., 1999, Journal of the American College of Nutrition, V18, P487, DOI 10.1046/j.1440-6047.1999.00123.x; *U BRIST SURV DEP, MERC IMP FISH SHELLF; *US DEP HHS, EPA823R04005 US DEP; Whalley LJ, 2004, AM J CLIN NUTR, V80, P1650, DOI 10.1093/ajcn/80.6.1650; Willatts P, 1998, LANCET, V352, P688, DOI 10.1016/S0140-6736(97)11374-5; Williams C, 2001, AM J CLIN NUTR, V73, P316	41	672	707	2	153	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	2007	369	9561					578	585		10.1016/S0140-6736(07)60277-3	http://dx.doi.org/10.1016/S0140-6736(07)60277-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	138MZ	17307104				2022-12-01	WOS:000244368000031
J	Creel, S; Christianson, D; Liley, S; Winnie, JA				Creel, Scott; Christianson, David; Liley, Stewart; Winnie, John A., Jr.			Predation risk affects reproductive physiology and demography of elk	SCIENCE			English	Article							NATIONAL-PARK; YELLOWSTONE; WOLVES		Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Creel, S (corresponding author), Montana State Univ, Dept Ecol, 310 Lewis Hall, Bozeman, MT 59717 USA.	screel@montana.edu						Barber Shannon M., 2005, Yellowstone Science, V13, P37; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Creel S, 2005, ANIM BEHAV, V69, P1181, DOI 10.1016/j.anbehav.2004.07.022; Hebblewhite M, 2002, CAN J ZOOL, V80, P789, DOI 10.1139/Z02-058; Ripple WJ, 2001, BIOL CONSERV, V102, P227, DOI 10.1016/S0006-3207(01)00107-0; Smith DW, 2003, BIOSCIENCE, V53, P330, DOI 10.1641/0006-3568(2003)053[0330:YAW]2.0.CO;2; Tollrian R, 1998, ECOLOGY AND EVOLUTION OF INDUCIBLE DEFENSES, P306; Varley N, 2006, ECOL MODEL, V193, P315, DOI 10.1016/j.ecolmodel.2005.09.001; White PJ, 2005, BIOL CONSERV, V125, P141, DOI 10.1016/j.biocon.2005.01.048; Winnie J, 2006, BEHAV ECOL SOCIOBIOL, V61, P277, DOI 10.1007/s00265-006-0258-1	10	381	388	3	203	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2007	315	5814					960	960		10.1126/science.1135918	http://dx.doi.org/10.1126/science.1135918			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303746				2022-12-01	WOS:000244229800033
J	Hsu, YC; Chern, JJ; Cai, Y; Liu, MY; Choi, KW				Hsu, Ya-Chieh; Chern, Joshua J.; Cai, Yi; Liu, Mingyao; Choi, Kwang-Wook			Drosophila TCTP is essential for growth and proliferation through regulation of dRheb GTPase	NATURE			English	Article							CONTROLLED TUMOR PROTEIN; CELL-GROWTH; DIRECT TARGET; RHEB GTPASE; ACTIVATION; EXCHANGE; HOMOLOG; TSC1; SIZE	Cellular growth and proliferation are coordinated during organogenesis. Misregulation of these processes leads to pathological conditions such as cancer. Tuberous sclerosis (TSC) is a benign tumour syndrome caused by mutations in either TSC1 or TSC2 tumour suppressor genes. Studies in Drosophila and other organisms have identified TSC signalling as a conserved pathway for growth control. Activation of the TSC pathway is mediated by Rheb (Ras homologue enriched in brain), a Ras superfamily GTPase(1,2). Rheb is a direct target of TSC2 and is negatively regulated by its GTPase-activating protein activity(3-5). However, molecules required for positive regulation of Rheb have not been identified. Here we show that a conserved protein, translationally controlled tumour protein ( TCTP), is an essential new component of the TSC - Rheb pathway. Reducing Drosophila TCTP (dTCTP) levels reduces cell size, cell number and organ size, which mimics Drosophila Rheb (dRheb) mutant phenotypes. dTCTP is genetically epistatic to Tsc1 and dRheb, but acts upstream of dS6k, a downstream target of dRheb. dTCTP directly associates with dRheb and displays guanine nucleotide exchange activity with it in vivo and in vitro. Human TCTP (hTCTP) shows similar biochemical properties compared to dTCTP and can rescue dTCTP mutant phenotypes, suggesting that the function of TCTP in the TSC pathway is evolutionarily conserved. Our studies identify TCTP as a direct regulator of Rheb and a potential therapeutic target for TSC disease.	Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Texas A&M Univ Syst Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Choi, KW (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	kchoi@bcm.tmc.edu	Choi, Kwang-Wook/C-1707-2011	Choi, Kwang-Wook/0000-0002-8997-3065; Liu, Mingyao/0000-0001-7339-5048				BRAND AH, 1993, DEVELOPMENT, V118, P401; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Guo XG, 2003, J BIOL CHEM, V278, P13207, DOI 10.1074/jbc.M208896200; Huang H, 1999, DEVELOPMENT, V126, P5365; Im E, 2002, ONCOGENE, V21, P6356, DOI 10.1038/sj.onc.1205792; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Liu H, 2005, MOL CELL BIOL, V25, P3117, DOI 10.1128/MCB.25.8.3117-3126.2005; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Patel PH, 2003, J CELL SCI, V116, P3601, DOI 10.1242/jcs.00661; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Sharma PM, 1998, J BIOL CHEM, V273, P18528, DOI 10.1074/jbc.273.29.18528; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Stowers RS, 1999, GENETICS, V152, P1631; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; Tuynder M, 2004, P NATL ACAD SCI USA, V101, P15364, DOI 10.1073/pnas.0406776101; Tuynder M, 2002, P NATL ACAD SCI USA, V99, P14976, DOI 10.1073/pnas.222470799; von Lintig FC, 2000, ONCOGENE, V19, P4029, DOI 10.1038/sj.onc.1203741; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	30	234	250	2	40	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 15	2007	445	7129					785	788		10.1038/nature05528	http://dx.doi.org/10.1038/nature05528			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17301792				2022-12-01	WOS:000244205200049
J	Goldemberg, J				Goldemberg, Jose			Ethanol for a sustainable energy future	SCIENCE			English	Editorial Material								Renewable energy is one of the most efficient ways to achieve sustainable development. Increasing its share in the world matrix will help prolong the existence of fossil fuel reserves, address the threats posed by climate change, and enable better security of the energy supply on a global scale. Most of the "new renewable energy sources" are still undergoing large-scale commercial development, but some technologies are already well established. These include Brazilian sugarcane ethanol, which, after 30 years of production, is a global energy commodity that is fully competitive with motor gasoline and appropriate for replication in many countries.	Univ Sao Paulo, Sao Paulo, Brazil	Universidade de Sao Paulo	Goldemberg, J (corresponding author), Univ Sao Paulo, Sao Paulo, Brazil.	goldemb@iee.usp.br						British Petroleum, BP STAT REV WORLD EN; COELHO ST, 2006, DEVELOPMENT, V10, P26; DASILVA JG, 1978, SCIENCE, V201, P903, DOI 10.1126/science.201.4359.903; ELOBEID A, 2006, 36WP427; Goldemberg J, 2004, ENERG POLICY, V32, P1141, DOI 10.1016/S0301-4215(03)00077-6; Goldemberg J, 2004, BIOMASS BIOENERG, V26, P301, DOI 10.1016/S0961-9534(03)00125-9; GOLDENBERG J, 2004, INT C REN EN BONN; HEALEY JR, 2006, USA TODAY       0330; IEA, 2005, KEY WORLD EN STAT; MACEDO IC, GREENHOUSE GAS EMISS; SHAPOURI H, 721 USDA EC RES SERV; *UN, 1987, UN GEN ASS 96 PLEN M; *UNDP UNDESA WEC, 2005, WORLD EN ASS OV 2004; USDA, 2006, EC FEASIBILITY ETHAN; WOODS J, BU200785REPURN03982; *WORLD BANK, 2006, WORLD BANKS EN FRAM; 2006, REN21 GLOB STAT REP	17	851	905	9	356	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2007	315	5813					808	810		10.1126/science.1137013	http://dx.doi.org/10.1126/science.1137013			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289989				2022-12-01	WOS:000244069000057
J	Knight, ZA; Shokat, KM				Knight, Zachary A.; Shokat, Kevan M.			Chemical genetics: Where genetics and pharmacology meet	CELL			English	Article							INSULIN-RESISTANCE; PRESSURE-OVERLOAD; CATALYTIC SUBUNIT; PROTEIN-KINASE; RECEPTOR; 3-KINASE; GAMMA; ACTIVATION; P110-ALPHA; PI3K-GAMMA		Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Shokat, KM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	shokat@cmp.ucsf.edu		Knight, Zachary/0000-0001-7621-1478				Bi L, 2002, MAMM GENOME, V13, P169, DOI 10.1007/s00335-001-2123-x; Bishop A, 2000, ANNU REV BIOPH BIOM, V29, P577, DOI 10.1146/annurev.biophys.29.1.577; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Brachmann SM, 2005, MOL CELL BIOL, V25, P1596, DOI 10.1128/MCB.25.5.1596-1607.2005; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dong BH, 1999, NUCLEIC ACIDS RES, V27, P439, DOI 10.1093/nar/27.2.439; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; KOBAYASHI M, 1983, FEBS LETT, V163, P50, DOI 10.1016/0014-5793(83)81160-0; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Kwak EL, 2005, P NATL ACAD SCI USA, V102, P7665, DOI 10.1073/pnas.0502860102; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Nienaber JJ, 2003, J CLIN INVEST, V112, P1067, DOI 10.1172/JCI200318213; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Stern Bodo, 1996, Trends in Genetics, V12, P345, DOI 10.1016/0168-9525(96)10036-6; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200	23	190	195	0	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2007	128	3					425	430		10.1016/j.cell.2007.01.021	http://dx.doi.org/10.1016/j.cell.2007.01.021			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289560	Bronze			2022-12-01	WOS:000244842700007
J	Grosenick, L; Clement, TS; Fernald, RD				Grosenick, Logan; Clement, Tricia S.; Fernald, Russell D.			Fish can infer social rank by observation alone	NATURE			English	Article							TRANSITIVE INFERENCE; HAPLOCHROMIS-BURTONI; INFORMATION; MEMORY; RATS	Transitive inference (TI) involves using known relationships to deduce unknown ones ( for example, using A. B and B. C to infer A. C), and is thus essential to logical reasoning. First described as a developmental milestone in children(1), TI has since been reported in nonhuman primates(2-4), rats(5,6) and birds(7-10). Still, how animals acquire and represent transitive relationships and why such abilities might have evolved remain open problems. Here we show that male fish (Astatotilapia burtoni) can successfully make inferences on a hierarchy implied by pairwise fights between rival males. These fish learned the implied hierarchy vicariously ( as 'bystanders'), by watching fights between rivals arranged around them in separate tank units. Our findings show that fish use TI when trained on socially relevant stimuli, and that they can make such inferences by using indirect information alone. Further, these bystanders seem to have both spatial and featural representations related to rival abilities, which they can use to make correct inferences depending on what kind of information is available to them. Beyond extending TI to fish and experimentally demonstrating indirect TI learning in animals, these results indicate that a universal mechanism underlying TI is unlikely. Rather, animals probably use multiple domain-specific representations adapted to different social and ecological pressures that they encounter during the course of their natural lives.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Ctr Study Language & Informat, Stanford, CA 94305 USA	Stanford University; Stanford University	Grosenick, L (corresponding author), Stanford Univ, Ctr Study Language & Informat, Ventura Hall,200 Panama St, Stanford, CA 94305 USA.	logang@stanford.edu						Allen C., 2006, RATIONAL ANIMALS, P175, DOI DOI 10.1093/ACPROF:OSO/9780198528272.003.0007; Bond AB, 2003, ANIM BEHAV, V65, P479, DOI 10.1006/anbe.2003.2101; BRYANT PE, 1971, NATURE, V232, P456, DOI 10.1038/232456a0; Chase ID, 2002, P NATL ACAD SCI USA, V99, P5744, DOI 10.1073/pnas.082104199; Clement TS, 2005, BEHAV ECOL, V16, P83, DOI 10.1093/beheco/arh134; DAVIS H, 1992, J COMP PSYCHOL, V106, P342, DOI 10.1037/0735-7036.106.4.342; DELILLO C, 2001, ANIMAL COGNITION, V4, P61, DOI DOI 10.1007/S100710100092; Dusek JA, 1997, P NATL ACAD SCI USA, V94, P7109, DOI 10.1073/pnas.94.13.7109; FERNALD R D, 1977, Environmental Biology of Fishes, V2, P299, DOI 10.1007/BF00005997; FERNALD RD, 1977, ANIM BEHAV, V25, P964, DOI 10.1016/0003-3472(77)90048-3; FERNALD RD, 1977, ANIM BEHAV, V25, P643, DOI 10.1016/0003-3472(77)90115-4; GILLAN DJ, 1981, J EXP PSYCHOL ANIM B, V7, P1, DOI 10.1037/0097-7403.7.1.1; Hofmann HA, 1999, P NATL ACAD SCI USA, V96, P14171, DOI 10.1073/pnas.96.24.14171; Lazareva OF, 2004, J EXP ANAL BEHAV, V82, P1, DOI 10.1901/jeab.2004.82-1; MCGONIGLE B, 1992, Q J EXP PSYCHOL-B, V45, P189; MCGONIGLE BO, 1977, NATURE, V267, P694, DOI 10.1038/267694a0; MCGONIGLE BO, 1986, REASONING DISCOURSE, P141; Oliveira RF, 1998, P ROY SOC B-BIOL SCI, V265, P1045, DOI 10.1098/rspb.1998.0397; Paz-y-Mino G, 2004, NATURE, V430, P778, DOI 10.1038/nature02723; Piaget J., 1928, JUDGEMENT REASONING; R_Development_Core_Team, 2006, R LANG ENV STAT COMP; Rapp PR, 1996, BEHAV NEUROSCI, V110, P887, DOI 10.1037/0735-7044.110.5.887; ROBERTS WA, 1994, PSYCHOL SCI, V5, P368, DOI 10.1111/j.1467-9280.1994.tb00287.x; STEIRN JN, 1995, ANIM LEARN BEHAV, V23, P76, DOI 10.3758/BF03198018; Vargas JP, 2004, J COMP PSYCHOL, V118, P206, DOI 10.1037/0735-7036.118.2.206; VONFERSEN L, 1991, J EXP PSYCHOL ANIM B, V17, P334, DOI 10.1037/0097-7403.17.3.334; White SA, 2002, J EXP BIOL, V205, P2567; Wynne CDL, 1998, MODELS OF ACTION: MECHANISMS FOR ADAPTIVE BEHAVIOR, P269; Zentall TR, 2001, BEHAV PROCESS, V54, P65, DOI 10.1016/S0376-6357(01)00150-4	29	329	336	10	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2007	445	7126					429	432		10.1038/nature05511	http://dx.doi.org/10.1038/nature05511			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	128WD	17251980				2022-12-01	WOS:000243689500040
J	Reddy, KS				Reddy, K. Srinath			The preventive polypill - Much promise, insufficent evidence	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARDIOVASCULAR-DISEASE		Publ Hlth Fdn India, New Delhi, India; All India Inst Med Sci, New Delhi, India	Public Health Foundation of India; All India Institute of Medical Sciences (AIIMS) New Delhi	Reddy, KS (corresponding author), Publ Hlth Fdn India, New Delhi, India.							Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; Reddy KS, 2004, NEW ENGL J MED, V350, P2438, DOI 10.1056/NEJMp048024; Wald NJ, 2003, BRIT MED J, V327, P586	3	35	40	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 18	2007	356	3					212	212		10.1056/NEJMp068219	http://dx.doi.org/10.1056/NEJMp068219			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126BV	17229947				2022-12-01	WOS:000243488100002
J	Hawkes, N				Hawkes, Nigel			Body politic - Fat chance of hitting obesity targets	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes@thetimes.co.uk							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 13	2007	334	7584					71	71		10.1136/bmj.39086.625822.59	http://dx.doi.org/10.1136/bmj.39086.625822.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	127DZ	17218708	Green Published			2022-12-01	WOS:000243566800025
J	Baumann, C; Korner, R; Hofmann, K; Nigg, EA				Baumann, Christoph; Koerner, Roman; Hofmann, Kay; Nigg, Erich A.			PICH, a centromere-associated SNF2 family ATPase, is regulated by Plk1 and required for the spindle checkpoint	CELL			English	Article							ANAPHASE-PROMOTING COMPLEX; PROTEIN PHOSPHATASE 2A; CELL-CYCLE CHECKPOINT; POLO-LIKE KINASES; TOPOISOMERASE-II; SACCHAROMYCES-CEREVISIAE; MITOTIC CHECKPOINT; BUDDING YEAST; BOX DOMAIN; KINETOCHORE	We identify PICH (PIk1 -interacting checkpoint "helicase"), a member of the SNF2 ATPase family, as an interaction partner and substrate of PIk1. Following phosphorylation of PICH on the Cdk1 site T1 063, PIk1 is recruited to PICH and controls its localization. Starting in prometaphase, PICH accumulates at kinetochores and inner centromeres. Moreover, it decorates threads that form during metaphase before increasing in length and progressively diminishing during anaphase. PICH-positive threads connect sister kinetochores and are dependent on tension, sensitive to DNase, and exacerbated in response to premature loss of cohesins or inhibition of topoisomerase II, suggesting that they represent stretched centromeric chromatin. Depletion of PICH causes the selective loss of Mad2 from kinetochores and completely abrogates the spindle checkpoint, resulting in massive chromosome missegregation. These data identify PICH as a novel essential component of checkpoint signaling. We propose that PICH binds to catenated centromere-related DNA to monitor tension developing between sister kinetochores.	Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany; Miltenyi Biotec GmbH, Bioinformat Grp, D-50829 Cologne, Germany	Max Planck Society; Miltenyi Biotec	Nigg, EA (corresponding author), Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany.	nigg@biochem.mpg.de	Hofmann, Kay/D-6714-2011; Körner, Roman/G-8565-2011	Hofmann, Kay/0000-0002-2289-9083; Körner, Roman/0000-0001-9285-9290; nigg, erich/0000-0003-4835-5719				Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Beerens N, 2005, J BIOL CHEM, V280, P4722, DOI 10.1074/jbc.M409147200; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; EARNSHAW WC, 1985, J CELL BIOL, V100, P1706, DOI 10.1083/jcb.100.5.1706; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; GASSER SM, 1986, J MOL BIOL, V188, P613, DOI 10.1016/S0022-2836(86)80010-9; Haering CH, 2003, BIOESSAYS, V25, P1178, DOI 10.1002/bies.10361; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Havas K, 2000, CELL, V103, P1133, DOI 10.1016/S0092-8674(00)00215-4; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Indjeian VB, 2005, SCIENCE, V307, P130, DOI 10.1126/science.1101366; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; LI XT, 1995, NATURE, V373, P630, DOI 10.1038/373630a0; Lia G, 2006, MOL CELL, V21, P417, DOI 10.1016/j.molcel.2005.12.013; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; NICKLAS RB, 1995, J CELL BIOL, V130, P929, DOI 10.1083/jcb.130.4.929; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Owen-Hughes T, 2006, E SCHERING RES FDN W, V57, P47; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; SHAMU CE, 1992, J CELL BIOL, V117, P921, DOI 10.1083/jcb.117.5.921; Shiratori A, 1999, YEAST, V15, P219, DOI 10.1002/(SICI)1097-0061(199902)15:3<219::AID-YEA349>3.0.CO;2-3; Stern BM, 2001, CURR BIOL, V11, P1462, DOI 10.1016/S0960-9822(01)00451-1; Stucke VM, 2004, CHROMOSOMA, V113, P1, DOI 10.1007/s00412-004-0288-2; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Svejstrup JQ, 2003, J CELL SCI, V116, P447, DOI 10.1242/jcs.00271; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Toyoda Y, 2006, MOL BIOL CELL, V17, P2287, DOI 10.1091/mbc.E05-11-1089; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; YANAGIDA N, 1995, BIOESSAYS, V17, P519, DOI 10.1002/bies.950170608; Yu HT, 2006, J CELL BIOL, V173, P153, DOI 10.1083/jcb.200601172	54	250	260	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 12	2007	128	1					101	114		10.1016/j.cell.2006.11.041	http://dx.doi.org/10.1016/j.cell.2006.11.041			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GN	17218258	Bronze			2022-12-01	WOS:000244420400016
J	Okie, S				Okie, Susan			Sex, drugs, prisons, and HIV	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		[Anonymous], 2006, CRIMINOL PUBLIC POL, DOI DOI 10.1111/J.1745-9133.2006.00101.X; Dolan K, 2003, ADDICTION, V98, P153, DOI 10.1046/j.1360-0443.2003.00309.x; Hammett TM, 2002, AM J PUBLIC HEALTH, V92, P1789, DOI 10.2105/AJPH.92.11.1789; MARUSCHAK LM, 2006, HIV PRISONS 2004; 2006, MMWR MORB MORTAL WKL, V55, P421	5	37	38	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 11	2007	356	2					105	108		10.1056/NEJMp068277	http://dx.doi.org/10.1056/NEJMp068277			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	124NE	17215526	Bronze			2022-12-01	WOS:000243373700001
J	Montanez, IP; Tabor, NJ; Niemeier, D; DiMichele, WA; Frank, TD; Fielding, CR; Isbell, JL; Birgenheier, LP; Rygel, MC				Montanez, Isabel P.; Tabor, Neil J.; Niemeier, Deb; DiMichele, William A.; Frank, Tracy D.; Fielding, Christopher R.; Isbell, John L.; Birgenheier, Lauren P.; Rygel, Michael C.			CO2-forced climate and vegetation instability during late paleozoic deglaciation	SCIENCE			English	Article							ATMOSPHERIC CO2; ISOTOPIC COMPOSITION; CARBON-DIOXIDE; NORTH-AMERICA; GLACIATION; RECORD; OXYGEN; EVOLUTION; PALEOCLIMATE; DELTA-O-18	The late Paleozoic deglaciation is the vegetated Earth's only recorded icehouse-to-greenhouse transition, yet the climate dynamics remain enigmatic. By using the stable isotopic compositions of soil-formed minerals, fossil-plant matter, and shallow-water brachiopods, we estimated atmospheric partial pressure of carbon dioxide (pCO(2)) and tropical marine surface temperatures during this climate transition. Comparison to southern Gondwanan glacial records documents covariance between inferred shifts in pCO(2), temperature, and ice volume consistent with greenhouse gas forcing of climate. Major restructuring of paleotropical flora in western Euramerica occurred in step with climate and pCO(2) shifts, illustrating the biotic impact associated with past CO2-forced turnover to a permanent ice-free world.	Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; So Methodist Univ, Dept Geol Sci, Dallas, TX 75275 USA; Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA; Smithsonian Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA; Univ Nebraska, Dept Geosci, Lincoln, NE 68588 USA; Univ Wisconsin, Dept Geosci, Milwaukee, WI 53201 USA	University of California System; University of California Davis; Southern Methodist University; University of California System; University of California Davis; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Nebraska System; University of Nebraska Lincoln; University of Wisconsin System; University of Wisconsin Milwaukee	Montanez, IP (corresponding author), Univ Calif Davis, Dept Geol, Davis, CA 95616 USA.	montanez@geology.ucdavis.edu	DiMichele, William/K-4301-2012	Birgenheier, Lauren/0000-0001-6951-0939; Frank, Tracy/0000-0002-8422-7389; Rygel, Michael/0000-0002-6453-6205; Montanez, Isabel/0000-0003-0492-3796				Arens NC, 2000, PALEOBIOLOGY, V26, P137, DOI 10.1666/0094-8373(2000)026&lt;0137:CCPFRT&gt;2.0.CO;2; Bangert B, 1999, J AFR EARTH SCI, V29, P33, DOI 10.1016/S0899-5362(99)00078-0; Banks M.R., 1981, EARTHS PREPLEISTOCEN, P495; Beck WC, 2005, GEOCHIM COSMOCHIM AC, V69, P3493, DOI 10.1016/j.gca.2005.02.003; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; Cecil C.B., 2003, CLIMATE CONTROLS STR, V77, P151, DOI 10.2110; Cerling T.E., 1999, SPECIAL PUBLICATIONS, V27, P43, DOI DOI 10.1002/9781444304190.CH2; Dickins JM, 1996, PALAEOGEOGR PALAEOCL, V125, P185, DOI 10.1016/S0031-0182(96)00030-2; DIMICHELE WA, 1992, EVOLUTION, V46, P807, DOI 10.1111/j.1558-5646.1992.tb02086.x; DiMichele WA, 2000, PALAIOS, V15, P524, DOI 10.2307/3515616; DiMichele WA, 2006, GEOL SOC AM SPEC PAP, V399, P223, DOI 10.1130/2006.2399(11); Ekart DD, 1999, AM J SCI, V299, P805, DOI 10.2475/ajs.299.10.805; FRAKES LA, 1992, CLIMATE MODES PHANER; GONZALEZ CR, 1990, PALAEOGEOGR PALAEOCL, V79, P275, DOI 10.1016/0031-0182(90)90022-Y; Gradstein F., 2005, GEOLOGIC TIME SCALE, DOI [10.1017/CBO9780511536045, DOI 10.1017/CBO9780511536045]; Isbell J.L., 2003, GEOL SOC AM SPEC PAP, V370, P5, DOI DOI 10.1130/0-8137-2370-1.5; Jones AT, 2004, GEOLOGY, V32, P153, DOI 10.1130/G20112.1; Kim ST, 1997, GEOCHIM COSMOCHIM AC, V61, P3461, DOI 10.1016/S0016-7037(97)00169-5; Korte C, 2005, PALAEOGEOGR PALAEOCL, V224, P333, DOI 10.1016/j.palaeo.2005.03.015; Kump LR, 2005, NATURE, V436, P333, DOI 10.1038/436333a; Kump LR, 2002, NATURE, V419, P188, DOI 10.1038/nature01087; Lopez-Gamundi O. R, 1997, LATE GLACIAL POSTGLA, P147; MAMAY SH, 1992, AM J BOT, V79, P1092, DOI 10.2307/2445207; MAMAY SH, 1967, 575C US GEOL SURV, P120; Mii HS, 1999, GEOL SOC AM BULL, V111, P960, DOI 10.1130/0016-7606(1999)111<0960:CISONA>2.3.CO;2; Mora CI, 1996, SCIENCE, V271, P1105, DOI 10.1126/science.271.5252.1105; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; Panchuk KM, 2006, J SEDIMENT RES, V76, P200, DOI 10.2110/jsr.2006.017; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Ross C. A., 1988, SEA LEVEL CHANGES IN, V42, P227, DOI 10.2110/pec.88.01.0227; Royer D.L., 2014, GSA TODAY, V14, P4, DOI [DOI 10.1130/1052-5173(2004)014, 10.1130/1052-5173(2004)0142.0.CO;2, DOI 10.1130/1052-5173(2004)0142.0.CO;2]; Royer DL, 2001, EARTH-SCI REV, V54, P349, DOI 10.1016/S0012-8252(00)00042-8; Saltzman MR, 2003, GEOLOGY, V31, P151, DOI 10.1130/0091-7613(2003)031<0151:LPIAOG>2.0.CO;2; Scheffler K, 2003, GEOLOGY, V31, P605, DOI 10.1130/0091-7613(2003)031<0605:GCDCGO>2.0.CO;2; Schrag DP, 2002, QUATERNARY SCI REV, V21, P331, DOI 10.1016/S0277-3791(01)00110-X; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Stollhofen H, 2000, PALAEOGEOGR PALAEOCL, V161, P127, DOI 10.1016/S0031-0182(00)00120-6; Tabor NJ, 2005, PALAEOGEOGR PALAEOCL, V223, P127, DOI 10.1016/j.palaeo.2005.04.009; Tabor NJ, 2004, SEDIMENTOLOGY, V51, P851, DOI 10.1111/j.1365-3091.2004.00655.x; Tabor NJ, 2004, GEOCHIM COSMOCHIM AC, V68, P1503, DOI 10.1016/S0016-7037(03)00497-6; TABOR NJ, IN PRESS EARTH PLANE; Tripati A, 2005, NATURE, V436, P341, DOI 10.1038/nature03874; Veizer J, 1999, CHEM GEOL, V161, P59, DOI 10.1016/S0009-2541(99)00081-9; Visser JNJ, 1997, SEDIMENTOLOGY, V44, P507, DOI 10.1046/j.1365-3091.1997.d01-35.x; Winguth AME, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000646; YAPP CJ, 1992, NATURE, V355, P342, DOI 10.1038/355342a0; Zhang H, 1999, ACTA GEOL SIN-ENGL, V73, P111	47	393	409	3	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2007	315	5808					87	91		10.1126/science.1134207	http://dx.doi.org/10.1126/science.1134207			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17204648	Green Published			2022-12-01	WOS:000243259100041
J	Inoue, D; Ohe, M; Kanemori, Y; Nobui, T; Sagata, N				Inoue, Daigo; Ohe, Munemichi; Kanemori, Yoshinori; Nobui, Toshiya; Sagata, Noriyuki			A direct link of the Mos-MAPK pathway to Erp1/Emi2 in meiotic arrest of Xenopus laevis eggs	NATURE			English	Article							CYTOSTATIC FACTOR ARREST; ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; MEIOSIS-II; METAPHASE ARREST; VERTEBRATE EGGS; CELL-CYCLE; KINASE; OOCYTES; INHIBITOR; EMI2	In vertebrates, unfertilized eggs ( or mature oocytes) are arrested at metaphase of meiosis II by a cytoplasmic activity called cytostatic factor (CSF)(1). The classical Mos - MAPK pathway has long been implicated in CSF arrest of vertebrate eggs, but exactly how it exerts CSF activity remains unclear(2-4). Recently, Erp1 ( also called Emi2), an inhibitor of the anaphase-promoting complex/cyclosome (APC/C) required for degradation of the mitotic regulator cyclin B (ref. 5), has also been shown to be a component of CSF in both Xenopus and mice(6-8). Erp1 is destroyed on fertilization or egg activation(9,10), like Mos(11). However, despite these similarities the Mos-MAPK (mitogen-activated protein kinase) pathway and Erp1 are thought to act rather independently in CSF arrest(3,6,8). Here, we show that p90rsk, the kinase immediately downstream from Mos MAPK, directly targets Erp1 for CSF arrest in Xenopus oocytes. Erp1 is synthesized immediately after meiosis I, and the Mos MAPK pathway or p90rsk is essential for CSF arrest by Erp1. p90rsk can directly phosphorylate Erp1 on Ser 335/Thr 336 both in vivo and in vitro, and upregulates both Erp1 stability and activity. Erp1 is also present in early embryos, but has little CSF activity owing, at least in part, to the absence of p90rsk activity. These results clarify the direct link of the classical Mos - MAPK pathway to Erp1 in meiotic arrest of vertebrate oocytes.	Kyushu Univ, Grad Sch Sci, Dept Biol, Fukuoka 8128581, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Kyushu University; Japan Science & Technology Agency (JST)	Sagata, N (corresponding author), Kyushu Univ, Grad Sch Sci, Dept Biol, Hakozaki 6-10-1, Fukuoka 8128581, Japan.	nsagascb@mbox.nc.kyushu-u.ac.jp						Bhatt RR, 1999, SCIENCE, V286, P1362, DOI 10.1126/science.286.5443.1362; Brunet S, 2005, REPRODUCTION, V130, P801, DOI 10.1530/rep.1.00364; Dumont J, 2005, J CELL BIOL, V169, P227, DOI 10.1083/jcb.200501027; Furuno N, 1997, EMBO J, V16, P3860, DOI 10.1093/emboj/16.13.3860; FURUNO N, 1994, EMBO J, V13, P2399, DOI 10.1002/j.1460-2075.1994.tb06524.x; Gross SD, 2000, CURR BIOL, V10, P430, DOI 10.1016/S0960-9822(00)00425-5; Gross SD, 1999, SCIENCE, V286, P1365, DOI 10.1126/science.286.5443.1365; Hansen DV, 2006, P NATL ACAD SCI USA, V103, P608, DOI 10.1073/pnas.0509549102; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Inoue D, 2005, EMBO J, V24, P1057, DOI 10.1038/sj.emboj.7600567; Lefebvre C, 2002, J CELL BIOL, V157, P603, DOI 10.1083/jcb.200202052; Liu JJ, 2006, J BIOL CHEM, V281, P34736, DOI 10.1074/jbc.M606607200; Madgwick S, 2006, J CELL BIOL, V174, P791, DOI 10.1083/jcb.200604140; Masui Y, 2000, NAT REV MOL CELL BIO, V1, P228, DOI 10.1038/35043096; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; Murakami MS, 1999, GENE DEV, V13, P620, DOI 10.1101/gad.13.5.620; Ohe M, 2007, DEV BIOL, V303, P157, DOI 10.1016/j.ydbio.2006.10.044; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Rauh NR, 2005, NATURE, V437, P1048, DOI 10.1038/nature04093; Reimann JDR, 2002, NATURE, V416, P850, DOI 10.1038/416850a; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; Sagata N, 1996, TRENDS CELL BIOL, V6, P22, DOI 10.1016/0962-8924(96)81034-8; Schmidt A, 2005, GENE DEV, V19, P502, DOI 10.1101/gad.320705; Shoji S, 2006, EMBO J, V25, P834, DOI 10.1038/sj.emboj.7600953; Smith JA, 2005, CANCER RES, V65, P1027; Tung JJ, 2005, P NATL ACAD SCI USA, V102, P4318, DOI 10.1073/pnas.0501108102; Tunquist BJ, 2003, GENE DEV, V17, P683, DOI 10.1101/gad.1071303; WATANABE N, 1991, NATURE, V352, P247, DOI 10.1038/352247a0; Yamamoto TM, 2005, DEV BIOL, V279, P345, DOI 10.1016/j.ydbio.2004.12.025	29	98	100	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2007	446	7139					1100	1104		10.1038/nature05688	http://dx.doi.org/10.1038/nature05688			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17410130				2022-12-01	WOS:000245950400054
J	Lareau, LF; Inada, M; Green, RE; Wengrod, JC; Brenner, SE				Lareau, Liana F.; Inada, Maki; Green, Richard E.; Wengrod, Jordan C.; Brenner, Steven E.			Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements	NATURE			English	Article							MESSENGER-RNA DECAY; PROTEIN-KINASE; HUMAN GENOME; IDENTIFICATION; EVENTS; EXPRESSION; ENHANCERS; DROSOPHILA; ROLES; EXON	The human and mouse genomes share a number of long, perfectly conserved nucleotide sequences, termed ultraconserved elements(1). Whereas these regions can act as transcriptional enhancers when upstream of genes, those within genes are less well understood. In particular, the function of ultraconserved elements that overlap alternatively spliced exons of genes encoding RNA-binding proteins is unknown(1,2). Here we report that in every member of the human SR family of splicing regulators, highly or ultraconserved elements are alternatively spliced, either as alternative 'poison cassette exons' containing early in-frame stop codons, or as alternative introns in the 3' untranslated region. These alternative splicing events target the resulting messenger RNAs for degradation by means of an RNA surveillance pathway called nonsense-mediated mRNA decay. Mouse orthologues of the human SR proteins exhibit the same unproductive splicing patterns. Three SR proteins have been previously shown to direct splicing of their own transcripts, and one of these is known to autoregulate its expression by coupling alternative splicing with decay(3-5); our results suggest that unproductive splicing is important for regulation of the entire SR family. We find that unproductive splicing associated with conserved regions has arisen independently in different SR genes, suggesting that splicing factors may readily acquire this form of regulation.	Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Brenner, SE (corresponding author), Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA.	brenner@compbio.berkeley.edu	Brenner, Steven E/A-8729-2008	Brenner, Steven E/0000-0001-7559-6185; Green, Richard/0000-0003-0516-5827				Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Duncan PI, 1997, MOL CELL BIOL, V17, P5996, DOI 10.1128/MCB.17.10.5996; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Garcia-Sacristan A, 2005, CELL RES, V15, P495, DOI 10.1038/sj.cr.7290319; GE H, 1991, CELL, V66, P373, DOI 10.1016/0092-8674(91)90626-A; Hillman RT, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r8; Hughes JR, 2005, P NATL ACAD SCI USA, V102, P9830, DOI 10.1073/pnas.0503401102; Iida K, 2006, MOL BIOL EVOL, V23, P1085, DOI 10.1093/molbev/msj118; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jumaa H, 1997, EMBO J, V16, P5077, DOI 10.1093/emboj/16.16.5077; Kalyna M, 2006, NUCLEIC ACIDS RES, V34, P4395, DOI 10.1093/nar/gkl570; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kumar S, 2005, EMBO J, V24, P2646, DOI 10.1038/sj.emboj.7600723; Lareau LF, 2004, CURR OPIN STRUC BIOL, V14, P273, DOI 10.1016/j.sbi.2004.05.002; Lejeune F, 2001, J BIOL CHEM, V276, P7850, DOI 10.1074/jbc.M009510200; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Morrison M, 1997, P NATL ACAD SCI USA, V94, P9782, DOI 10.1073/pnas.94.18.9782; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Paillusson A, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni052; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Sanford JR, 2005, BIOCHEM SOC T, V33, P443, DOI 10.1042/BST0330443; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Sureau A, 2001, EMBO J, V20, P1785, DOI 10.1093/emboj/20.7.1785; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zorio DAR, 1997, MOL CELL BIOL, V17, P946, DOI 10.1128/MCB.17.2.946	30	434	437	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2007	446	7138					926	929		10.1038/nature05676	http://dx.doi.org/10.1038/nature05676			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IR	17361132	Green Published			2022-12-01	WOS:000245785700045
J	Thulasiram, HV; Erickson, HK; Poulter, CD				Thulasiram, Hirekodathakallu V.; Erickson, Hans K.; Poulter, C. Dale			Chimeras of two isoprenoid synthases catalyze all four coupling reactions in isoprenoid biosynthesis	SCIENCE			English	Article							FARNESYL DIPHOSPHATE SYNTHASE; ABSOLUTE-CONFIGURATION; RECOMBINANT SQUALENE; CRYSTAL-STRUCTURE; SEX-PHEROMONE; PRESQUALENE; MONOTERPENES; MECHANISM; MEALYBUG; GENE	The carbon skeletons of over 55,000 naturally occurring isoprenoid compounds are constructed from four fundamental coupling reactions: chain elongation, cyclopropanation, branching, and cyclobutanation. Enzymes that catalyze chain elongation and cyclopropanation are well studied, whereas those that catalyze branching and cyclobutanation are unknown. We have catalyzed the four reactions with chimeric proteins generated by replacing segments of a chain-elongation enzyme with corresponding sequences from a cyclopropanation enzyme. Stereochemical and mechanistic considerations suggest that the four coupling enzymes could have evolved from a common ancestor through relatively small changes in the catalytic site.	Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Thulasiram, HV (corresponding author), Univ Utah, Dept Chem, 315 S 1400 E,Room 2020, Salt Lake City, UT 84112 USA.	poulter@chemistry.utah.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM021328, R56GM021328, R01GM021328] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 21328] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALEXANDER K, 1975, J ORG CHEM, V40, P2576, DOI 10.1021/jo00905a053; ALTMAN LF, 1972, J AM CHEM SOC, V94, P3257, DOI 10.1021/ja00764a073; ALTMAN LJ, 1978, J AM CHEM SOC, V100, P6174, DOI 10.1021/ja00487a037; BIERLLEONHARDT BA, 1981, TETRAHEDRON LETT, V22, P389, DOI 10.1016/0040-4039(81)80107-4; Blagg BSJ, 2002, J AM CHEM SOC, V124, P8846, DOI 10.1021/ja020411a; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; DOLENCE JM, 1999, COMPREHENSIVE NATURA, V5, P18473; Erickson HK, 2003, J AM CHEM SOC, V125, P6886, DOI 10.1021/ja034520g; Giner JL, 2000, J NAT PROD, V63, P267, DOI 10.1021/np990081g; Gunawardena K, 2002, PHYTOCHEMISTRY, V59, P197, DOI 10.1016/S0031-9422(01)00438-1; HEATHCOCK CH, 1985, SCIENCE, V229, P862, DOI 10.1126/science.3927485; Hemmerlin A, 2003, J BIOL CHEM, V278, P32132, DOI 10.1074/jbc.M213045200; Iwata-Reuyl D, 2003, BIOCHEMISTRY-US, V42, P3359, DOI 10.1021/bi0206614; Jarstfer MB, 2002, J AM CHEM SOC, V124, P8834, DOI 10.1021/ja020410i; Pandit J, 2000, J BIOL CHEM, V275, P30610, DOI 10.1074/jbc.M004132200; POPJAK G, 1973, J AM CHEM SOC, V95, P2713, DOI 10.1021/ja00789a066; Poulter C. Dale, 2006, Phytochemistry Reviews, V5, P17, DOI 10.1007/s11101-005-4887-1; RILLING HC, 1969, J AM CHEM SOC, V91, P1041, DOI 10.1021/ja01032a052; Rivera SB, 2001, P NATL ACAD SCI USA, V98, P4373, DOI 10.1073/pnas.071543598; SOUCEK M, 1959, COLLECT CZECH CHEM C, V24, P3802; TARSHIS LC, 1994, BIOCHEMISTRY-US, V33, P10871, DOI 10.1021/bi00202a004; Thulasiram HV, 2006, J AM CHEM SOC, V128, P15819, DOI 10.1021/ja065573b; Zhang AJ, 2004, P NATL ACAD SCI USA, V101, P9601, DOI 10.1073/pnas.0401298101	23	133	140	2	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2007	316	5821					73	76		10.1126/science.1137786	http://dx.doi.org/10.1126/science.1137786			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	153XD	17412950				2022-12-01	WOS:000245470500033
J	Vasudevan, S; Steitz, JA				Vasudevan, Shobha; Steitz, Joan A.			AU-rich-element-mediated upregulation of translation by FXR1 and argonaute 2	CELL			English	Article							TUMOR-NECROSIS-FACTOR; MESSENGER-RNA DEGRADATION; MICRORNA-DEPENDENT LOCALIZATION; MENTAL-RETARDATION PROTEIN; X-RELATED PROTEIN; FACTOR-ALPHA; CELL-CYCLE; GW BODIES; BINDING PROTEINS; EXPRESSION	AU-rich elements (AREs), present in mRNA 3'-UTRs, are potent posttranscriptional regulatory signals that can rapidly effect changes in mRNA stability and translation, thereby dramatically altering gene expression with clinical and developmental consequences. In human cell lines, the TNF alpha ARE enhances translation relative to mRNA levels upon serum starvation, which induces cell-cycle arrest. An in vivo crosslinking-coupled affinity purification method was developed to isolate ARE-associated complexes from activated versus basal translation conditions. We surprisingly found two microRNP-related proteins, fragile-X-mental-retardation-related protein 1 (FXR1) and Argonaute 2 (AGO2), that associate with the ARE exclusively during translation activation. Through tethering and shRNA-knockdown experiments, we provide direct evidence for the translation activation function of both FXR1 and AGO2 and demonstrate their interdependence for upregulation. This novel cell-growth-dependent translation activation role for FXR1 and AGO2 allows new insights into ARE-mediated signaling and connects two important posttranscriptional regulatory systems in an unexpected way.	Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biophys & Biochem,BCMM, New Haven, CT 06536 USA	Howard Hughes Medical Institute; Yale University	Steitz, JA (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biophys & Biochem,BCMM, 295 Congress Ave, New Haven, CT 06536 USA.	joan.steitz@yale.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026154, R37GM026154] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM026154, GM26154] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson K, 2000, CYTOKINE, V12, P1784, DOI 10.1006/cyto.2000.0784; Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Baron-Benhamou Julie, 2004, Methods Mol Biol, V257, P135, DOI 10.1385/1-59259-750-5:135; Barreau C, 2006, RNA, V12, P1790, DOI 10.1261/rna.191706; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Boonstra J, 2003, J CELL BIOCHEM, V90, P244, DOI 10.1002/jcb.10617; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Brewer G, 2002, AGEING RES REV, V1, P607, DOI 10.1016/S1568-1637(02)00023-5; Brooks SA, 2004, J IMMUNOL, V172, P7263, DOI 10.4049/jimmunol.172.12.7263; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Dube M, 2000, BMC Genet, V1, P4, DOI 10.1186/1471-2156-1-4; Espel E, 2005, SEMIN CELL DEV BIOL, V16, P59, DOI 10.1016/j.semcdb.2004.11.008; Eystathioy T, 2003, RNA, V9, P1171, DOI 10.1261/rna.5810203; Garnon J, 2005, J BIOL CHEM, V280, P5750, DOI 10.1074/jbc.M401988200; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; HASKILL S, 1988, J IMMUNOL, V140, P1690; Hofmann I, 2006, MOL BIOL CELL, V17, P1388, DOI 10.1091/mbc.e05-08-0708; Ikeda K, 2006, J IMMUNOL METHODS, V317, P38, DOI 10.1016/j.jim.2006.09.010; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; JEOUNG DI, 1995, J BIOL CHEM, V270, P18367, DOI 10.1074/jbc.270.31.18367; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kirkpatrick LL, 1999, GENOMICS, V59, P193, DOI 10.1006/geno.1999.5868; Kirkpatrick LL, 2001, GENOMICS, V78, P169, DOI 10.1006/geno.2001.6667; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; LERNER EA, 1981, P NATL ACAD SCI-BIOL, V78, P2737, DOI 10.1073/pnas.78.5.2737; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Lian SL, 2006, CELL CYCLE, V5, P242, DOI 10.4161/cc.5.3.2410; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mientjes EJ, 2004, HUM MOL GENET, V13, P1291, DOI 10.1093/hmg/ddh150; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Moneo V, 2003, J CELL BIOCHEM, V89, P484, DOI 10.1002/jcb.10529; Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Osman F, 1999, GENE DEV, V13, P3280, DOI 10.1101/gad.13.24.3280; Park-Lee S, 2003, J BIOL CHEM, V278, P39801, DOI 10.1074/jbc.M307105200; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Pomorski P, 2004, CELL MOTIL CYTOSKEL, V57, P143, DOI 10.1002/cm.10159; ROY AL, 1988, BIOCHEMISTRY-US, V27, P8203, DOI 10.1021/bi00421a033; Schafer KA, 1998, VET PATHOL, V35, P461, DOI 10.1177/030098589803500601; Sirenko OI, 1997, MOL CELL BIOL, V17, P3898, DOI 10.1128/MCB.17.7.3898; Srisawat C, 2002, METHODS, V26, P156, DOI 10.1016/S1046-2023(02)00018-X; Stoecklin G, 2000, MOL CELL BIOL, V20, P3753, DOI 10.1128/MCB.20.11.3753-3763.2000; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Stoecklin G, 2003, MOL CELL BIOL, V23, P3506, DOI 10.1128/MCB.23.10.3506-3515.2003; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wilhelm JE, 2005, BIOL CELL, V97, P235, DOI 10.1042/BC20040097; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Xu KY, 2004, CURR BIOL, V14, P1025, DOI 10.1016/j.cub.2004.05.055; Yang Z, 2004, J CELL SCI, V117, P5567, DOI 10.1242/jcs.01477; Zou C, 1998, GENE, V211, P187, DOI 10.1016/S0378-1119(98)00107-3	65	460	496	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1105	1118		10.1016/j.cell.2007.01.038	http://dx.doi.org/10.1016/j.cell.2007.01.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382880	Green Accepted, Bronze			2022-12-01	WOS:000245396200017
J	Jin, Y; Mailloux, CM; Gowan, K; Riccardi, SL; LaBerge, G; Bennett, DC; Fain, PR; Spritz, RA				Jin, Ying; Mailloux, Christina M.; Gowan, Katherine; Riccardi, Sheri L.; LaBerge, Greggory; Bennett, Dorothy C.; Fain, Pamela R.; Spritz, Richard A.			NALP1 in vitiligo-associated multiple autoimmune disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLD AUTOINFLAMMATORY SYNDROME; SUSCEPTIBILITY LOCI; GENE; EPIDEMIOLOGY; MUTATIONS; FAMILY; ONSET; SLEV1; HLA	Background: Autoimmune and autoinflammatory diseases involve interactions between genetic risk factors and environmental triggers. We searched for a gene on chromosome 17p13 that contributes to a group of epidemiologically associated autoimmune and autoinflammatory diseases. The group includes various combinations of generalized vitiligo, autoimmune thyroid disease, latent autoimmune diabetes in adults, rheumatoid arthritis, psoriasis, pernicious anemia, systemic lupus erythematosus, and Addison's disease. Methods: We tested 177 single-nucleotide polymorphisms (SNPs) spanning the 17p13 linkage peak for association with disease and identified a strong candidate gene. We then sequenced DNA in and around the gene to identify additional SNPs. We carried out a second round of tests of association using some of these additional SNPs, thus elucidating the association with disease in the gene and its extended promoter region in fine detail. Results: Association analyses resulted in our identifying as a candidate gene NALP1, which encodes NACHT leucine-rich-repeat protein 1, a regulator of the innate immune system. Fine-scale association mapping with the use of DNA from affected families and additional SNPs in and around NALP1 showed an association of specific variants with vitiligo alone, with an extended autoimmune and autoinflammatory disease phenotype, or with both. Conditional logistic-regression analysis of NALP1 SNPs indicated that at least two variants contribute independently to the risk of disease. Conclusions: DNA sequence variants in the NALP1 region are associated with the risk of several epidemiologically associated autoimmune and autoinflammatory diseases, implicating the innate immune system in the pathogenesis of these disorders.	Univ Colorado Denver, Human Med Genet Program, Aurora, CO 80045 USA; Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA; Hlth Sci Ctr, Aurora, CO USA; Univ London, St Georges, Div Basic Med Sci, London, England	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; St Georges University London; University of London	Spritz, RA (corresponding author), Univ Colorado Denver, Human Med Genet Program, POB 6511,Mailstop 8300, Aurora, CO 80045 USA.	richard.spritz@uchsc.edu	Bennett, Dorothy C/C-2418-2008	Bennett, Dorothy C/0000-0002-3639-7527	NIAID NIH HHS [AI46374] Funding Source: Medline; NIAMS NIH HHS [AR45584] Funding Source: Medline; NIDDK NIH HHS [DK57538] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI046374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057538] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Aganna E, 2002, ARTHRITIS RHEUM-US, V46, P2445, DOI 10.1002/art.10509; Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brand Oliver, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009981; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Chu ZL, 2001, J BIOL CHEM, V276, P9239, DOI 10.1074/jbc.M006309200; Cooper GS, 2003, AUTOIMMUN REV, V2, P119, DOI 10.1016/S1568-9972(03)00006-5; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Gregersen PK, 2006, NAT REV GENET, V7, P917, DOI 10.1038/nrg1944; Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523; Hlaing T, 2001, J BIOL CHEM, V276, P9230, DOI 10.1074/jbc.M009853200; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; Johansson CM, 2004, HUM GENET, V115, P230, DOI 10.1007/s00439-004-1145-3; Kufer TA, 2005, TRENDS MICROBIOL, V13, P381, DOI 10.1016/j.tim.2005.06.004; KUMMER JA, IN PRESS J HISTOCHEM; Laberge G, 2005, PIGM CELL RES, V18, P300, DOI 10.1111/j.1600-0749.2005.00242.x; Liu F, 2004, CELL SIGNAL, V16, P1013, DOI 10.1016/j.cellsig.2004.02.006; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Marrack P, 2001, NAT MED, V7, P899, DOI 10.1038/90935; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Nath SK, 2001, AM J HUM GENET, V69, P1401, DOI 10.1086/324470; NIH (National Institutes of Health), 2005, PROGR AUT DIS RES; Nordlund JJ, 2006, PIGMENTARY SYSTEM, P551, DOI DOI 10.1002/9780470987100.CH30.; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Petrilli V, 2005, CURR BIOL, V15, pR581, DOI 10.1016/j.cub.2005.07.049; Schug J, 1997, CBILTR19971001V00 U; Spritz RA, 2004, AM J HUM GENET, V74, P188, DOI 10.1086/381134; Stack JH, 2005, J IMMUNOL, V175, P2630, DOI 10.4049/jimmunol.175.4.2630; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tu CX, 2003, J DERMATOL SCI, V31, P73, DOI 10.1016/S0923-1811(02)00151-2; Walsh SJ, 2000, AM J PUBLIC HEALTH, V90, P1463, DOI 10.2105/AJPH.90.9.1463	38	459	483	1	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2007	356	12					1216	1225		10.1056/NEJMoa061592	http://dx.doi.org/10.1056/NEJMoa061592			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148UP	17377159	Green Accepted, Bronze			2022-12-01	WOS:000245101900006
J	Hadley, J				Hadley, Jack			Insurance coverage, medical care use, and short-term health changes following an unintentional injury or the onset of a chronic condition	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SELF-RATED HEALTH; PREMIUM INCREASES; MORTALITY; DECLINE; ADULTS; RISK; TRAUMA; OLDER	Context Given the large and increasing number of uninsured US individuals, identifying the health consequences of being uninsured has assumed increased importance. Objective To compare medical care use and short-term health changes among US uninsured individuals and insured nonelderly individuals following a health shock caused by either an unintentional injury or the onset of a chronic condition. Design, Setting, and Participants Multivariate logistic regression analysis of longitudinal data from Medical Expenditure Panel Surveys (1997-2004) limited to nonelderly individuals whose insurance status was established for 2 months prior to 1 or more unintentional injuries ( 20 783 cases among 15 866 individuals) and onset of 1 or more chronic conditions ( 10 485 cases among 7954 individuals). Main Outcome Measures Self-reported medical care use and change in short-term general health status following the health shock. Results After experiencing a health shock, uninsured individuals were less likely to obtain any medical care ( unintentional injury [UI] group: 78.8% uninsured vs 88.7% insured [ adjusted odds ratio {AOR}, 0.47; 95% confidence interval {CI}, 0.43-0.51]; new chronic condition [NCC] group: 81.7% uninsured vs 91.5% insured [ AOR, 0.45; 95% CI, 0.40-0.50]) and more likely not to have received any recommended follow-up care ( UI group: 19.3% uninsured vs 9.2% insured [ AOR, 2.59; 95% CI, 2.15-3.11]; NCC group: 9.4% uninsured vs 4.4% insured [ AOR, 1.65; 95% CI, 1.32-2.06]). Based on the AORs, uninsured individuals with UIs had fewer outpatient visits (6.1% uninsured vs 9.0% insured; AOR, 0.71 [ 95% CI, 0.63-0.80]), office-based visits (41.8% uninsured vs 57.3% insured; AOR, 0.59 [ 95% CI, 0.56-0.62]), and prescription medicines (35.5% uninsured vs 35.6% insured; AOR, 0.71 [ 95% CI, 0.67-0.75]). Uninsured individuals with an NCC had fewer office-based visits (58.9% uninsured vs 68.3% insured; AOR, 0.77 [ 95% CI, 0.72-0.82]) and prescription medicines (52.7% uninsured vs 61.7% insured; AOR, 0.66 [ 95% CI, 0.57-0.76]). Higher proportions of uninsured individuals reported a decrease in health status ( classified as much worse) approximately 3.5 months after the health shock ( UI group: 9.8% uninsured vs 6.7% insured; AOR, 0.86 [ 95% CI, 0.75-0.98]; NCC group: 12.3% uninsured vs 10.1% insured; AOR, 0.74 [ 95% CI, 0.68-0.80]). Uninsured individuals with UIs were more likely to report not being fully recovered and no longer receiving treatment. At approximately 7 months after the health shock, uninsured individuals with NCCs still reported worse health status. Conclusions Among individuals who experienced a health shock caused by an unintentional injury or a new chronic condition, uninsured individuals reported receiving less medical care and poorer short-term changes in health than those with insurance.	Urban Inst, Washington, DC 20037 USA	Urban Institute	Hadley, J (corresponding author), Urban Inst, 2100 M St NW, Washington, DC 20037 USA.	jhadley@ui.urban.org	Shadmi, Efrat/A-3954-2016					*AG HEALTHC RES QU, DET INF MED EXP PAN; *AG HEALTHC RES QU, MED EXP PAN SURV HC; [Anonymous], MEPS HC RESP RAT PAN; Baker DW, 2006, MED CARE, V44, P277, DOI 10.1097/01.mlr.0000199696.41480.45; Baker DW, 2002, MED CARE, V40, P1126, DOI 10.1097/00005650-200211000-00013; Baker DW, 2001, NEW ENGL J MED, V345, P1106, DOI 10.1056/NEJMsa002887; DeSalvo KB, 2005, HEALTH SERV RES, V40, P1234, DOI 10.1111/j.1475-6773.2005.00404.x; Diehr P, 2001, J AM GERIATR SOC, V49, P36, DOI 10.1046/j.1532-5415.2001.49007.x; Dor A, 2006, HEALTH SERV RES, V41, P759, DOI 10.1111/j.1475-6773.2006.00513.x; Doyle JJ, 2005, REV ECON STAT, V87, P256, DOI 10.1162/0034653053970348; ENGLE RF, 1983, ECONOMETRICA, V51, P277, DOI 10.2307/1911990; ERICSON P, 1995, 7 NAT CTR HLTH STAT; *FAM US, 2001, GETT LESS CAR UN CHR; FRANKS P, 1993, JAMA-J AM MED ASSOC, V270, P737, DOI 10.1001/jama.270.6.737; Gabel J, 2005, HEALTH AFFAIR, V24, P1273, DOI 10.1377/hlthaff.24.5.1273; HAAS JS, 1994, AM J PUBLIC HEALTH, V84, P1605, DOI 10.2105/AJPH.84.10.1605; Hadley J, 2006, HEALTH SERV RES, V41, P429, DOI 10.1111/j.1475-6773.2005.00491.x; Hadley J, 2006, MED CARE RES REV, V63, P447, DOI 10.1177/1077558706288841; Hwang W, 2001, HEALTH AFFAIR, V20, P267, DOI 10.1377/hlthaff.20.6.267; *I MED, 2002, CAR COV; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; KREIDER B, 2006, INF POL HLTH CAR COS; LEVY H, 2005, HLTH POLICY UNINSURE; LICHTENBERG FR, 2002, FRONTIERS HLTH POLIC, V5; McWilliams JM, 2004, HEALTH AFFAIR, V23, P223, DOI 10.1377/hlthaff.23.4.223; McWilliams JM, 2003, JAMA-J AM MED ASSOC, V290, P757, DOI 10.1001/jama.290.6.757; NEWHOUSE J, 1993, FREE ALL RAND HLTH I; Schoen C, 1998, J URBAN HEALTH, V75, P30, DOI 10.1007/BF02344923; Schoen C, 2000, HEALTH SERV RES, V35, P187; SORLIE PD, 1994, ARCH INTERN MED, V154, P2409, DOI 10.1001/archinte.154.21.2409; STAGNITTI M, 2000, MED CARE TREATMENT C; *STATACORP, BIN COUNT LTD DEP VA; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; 2003, MED CARE RES REV S, V60, pS3	34	142	142	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2007	297	10					1073	1084		10.1001/jama.297.10.1073	http://dx.doi.org/10.1001/jama.297.10.1073			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	145KZ	17356028	Bronze			2022-12-01	WOS:000244865200021
J	Holden, C				Holden, Constance			Stem cells - Data on adult stem cells questioned	SCIENCE			English	News Item																			0	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2007	315	5816					1207	1207		10.1126/science.315.5816.1207a	http://dx.doi.org/10.1126/science.315.5816.1207a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332385				2022-12-01	WOS:000244564700007
J	Liu, KJ; Arron, JR; Stankunas, K; Crabtree, GR; Longaker, MT				Liu, Karen J.; Arron, Joseph R.; Stankunas, Kryn; Crabtree, Gerald R.; Longaker, Michael T.			Chemical rescue of cleft palate and midline defects in conditional GSK-3 beta mice	NATURE			English	Article							MODEL	Glycogen synthase kinase-3 beta (GSK-3 beta) has integral roles in a variety of biological processes, including development, diabetes, and the progression of Alzheimer's disease(1-4). As such, a thorough understanding of GSK-3 beta function will have a broad impact on human biology and therapeutics. Because GSK-3 beta interacts with many different pathways, its specific developmental roles remain unclear(5). We have discovered a genetic requirement for GSK-3 beta in midline development. Homozygous null mice display cleft palate, incomplete fusion of the ribs at the midline and bifid sternum as well as delayed sternal ossification. Using a chemically regulated allele of GSK-3 beta ( ref. 6), we have defined requirements for GSK-3 beta activity during discrete temporal windows in palatogenesis and skeletogenesis. The rapamycin-dependent allele of GSK-3 beta produces GSK-3 beta fused to a tag, FRB* (FKBP/rapamycin binding), resulting in a rapidly destabilized chimaeric protein. In the absence of drug, GSK-3 beta(FRB*/FRB*) mutants appear phenotypically identical to GSK-3 beta(-/-) mutants. In the presence of drug, GSK-3 beta FRB* is rapidly stabilized, restoring protein levels and activity(6). Using this system, mutant phenotypes were rescued by restoring endogenous GSK-3 beta activity during two distinct periods in gestation. This technology provides a powerful tool for defining windows of protein function during development.	Stanford Univ, Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Liu, KJ (corresponding author), Kings Coll London, Dept Craniofacial Dev, London SE1 9RT, England.	karen.liu@kcl.ac.uk; longaker@stanford.edu	Liu, Karen/F-2870-2010	Liu, Karen/0000-0002-2483-2165; Arron, Joseph/0000-0001-7677-9979				Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; CHEN JM, 1952, J ANAT, V86, P373; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; FLAKE AW, 1987, J PEDIATR SURG, V22, P816, DOI 10.1016/S0022-3468(87)80643-7; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Hentges KE, 2001, P NATL ACAD SCI USA, V98, P13796, DOI 10.1073/pnas.241184198; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Liu J, 2005, ANGEW CHEM INT EDIT, V44, P1987, DOI 10.1002/anie.200462552; Murray JC, 2004, J CLIN INVEST, V113, P1676, DOI 10.1172/JCI200422154; Peterson RT, 2004, NAT BIOTECHNOL, V22, P595, DOI 10.1038/nbt963; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; SHARPE PM, 1988, J CELL SCI, P195; Stankunas K, 2003, MOL CELL, V12, P1615, DOI 10.1016/S1097-2765(03)00491-X	20	110	112	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2007	446	7131					79	82		10.1038/nature05557	http://dx.doi.org/10.1038/nature05557			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17293880				2022-12-01	WOS:000244525600041
J	Kawahara, Y; Zinshteyn, B; Sethupathy, P; Iizasa, H; Hatzigeorgiou, AG; Nishikura, K				Kawahara, Yukio; Zinshteyn, Boris; Sethupathy, Praveen; Iizasa, Hisashi; Hatzigeorgiou, Artemis G.; Nishikura, Kazuko			Redirection of silencing targets by adenosine-to-inosine editing of miRNAs	SCIENCE			English	Article							RNA; MICRORNA; BIOGENESIS; GENE; DEAMINASES; MUTATION; ADAR1	Primary transcripts of certain microRNA ( miRNA) genes are subject to RNA editing that converts adenosine to inosine. However, the importance of miRNA editing remains largely undetermined. Here we report that tissue-specific adenosine-to-inosine editing of miR-376 cluster transcripts leads to predominant expression of edited miR-376 isoform RNAs. One highly edited site is positioned in the middle of the 5'-proximal half "seed" region critical for the hybridization of miRNAs to targets. We provide evidence that the edited miR-376 RNA silences specifically a different set of genes. Repression of phosphoribosyl pyrophosphate synthetase 1, a target of the edited miR-376 RNA and an enzyme involved in the uric-acid synthesis pathway, contributes to tight and tissue-specific regulation of uric-acid levels, revealing a previously unknown role for RNA editing in miRNA-mediated gene silencing.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Engn & Appl Sci, Dept Comp & Informat Sci, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania; University of Pennsylvania	Kawahara, Y (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	ykawahara@wistar.org; kazuko@wistar.org	Iizasa, Hisashi/A-9821-2012; Hatzigeorgiou, Artemis/Z-1976-2019	Zinshteyn, Boris/0000-0003-0103-3501	NATIONAL CANCER INSTITUTE [P01CA072765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040536] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA072765, P01 CA072765-050002] Funding Source: Medline; NHLBI NIH HHS [R01 HL070045-04, R01 HL070045] Funding Source: Medline; NIGMS NIH HHS [R01 GM040536, R01 GM040536-16] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmed M, 1999, J BIOL CHEM, V274, P7482, DOI 10.1074/jbc.274.11.7482; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Reenan RA, 2001, TRENDS GENET, V17, P53, DOI 10.1016/S0168-9525(00)02169-7; Seeburg PH, 2002, NEURON, V35, P17, DOI 10.1016/S0896-6273(02)00760-2; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041	19	579	618	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2007	315	5815					1137	1140		10.1126/science.1138050	http://dx.doi.org/10.1126/science.1138050			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138UA	17322061	Green Accepted			2022-12-01	WOS:000244387600040
J	England, R; de Lay, P; Greener, R; Izazola, JA				England, Roger; de lay, Paul; Greener, Robert; Izazola, Jose Antonio			Are we spending too much on HIV?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									UNAIDS, Evaluat Dept, CH-1211 Geneva, Switzerland	UNAIDS		roger.england@healthsystemsworkshop.org; communications@unaids.org							0	63	63	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2007	334	7589					344	345		10.1136/bmj.39113.402361.94	http://dx.doi.org/10.1136/bmj.39113.402361.94			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	141EJ	17303881	Green Published			2022-12-01	WOS:000244560400029
J	Specht, S; Hoerauf, A				Specht, Sabine; Hoerauf, Achim			Does helminth elimination promote or prevent malaria?	LANCET			English	Editorial Material							FILARIAL NEMATODES; IMMUNE-RESPONSES; PARASITE GROWTH; CELLS; IMMUNOMODULATION; MODULATION; INFECTION; PROTECT		Univ Clin Bonn, Inst Med Microbiol Immunol & Parasitol, D-53105 Bonn, Germany	University of Bonn	Hoerauf, A (corresponding author), Univ Clin Bonn, Inst Med Microbiol Immunol & Parasitol, D-53105 Bonn, Germany.	hoerauf@parasit.meb.uni-bonn.de						BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; Boutlis CS, 2006, TRENDS PARASITOL, V22, P371, DOI 10.1016/j.pt.2006.06.002; Brattig NW, 2004, J IMMUNOL, V173, P437, DOI 10.4049/jimmunol.173.1.437; Brutus L, 2006, AM J TROP MED HYG, V75, P194, DOI 10.4269/ajtmh.2006.75.194; Chatterjee S, 2001, TROP MED INT HEALTH, V6, P578, DOI 10.1046/j.1365-3156.2001.00758.x; Druilhe P, 2005, TRENDS PARASITOL, V21, P359, DOI 10.1016/j.pt.2005.06.011; Hartgers FC, 2006, PARASITE IMMUNOL, V28, P497, DOI 10.1111/j.1365-3024.2006.00901.x; Hartmann S, 2003, INT J PARASITOL, V33, P1291, DOI 10.1016/S0020-7519(03)00163-2; Hoerauf A, 2005, PARASITE IMMUNOL, V27, P417, DOI 10.1111/j.1365-3024.2005.00792.x; Marshall FA, 2005, J IMMUNOL, V175, P5817, DOI 10.4049/jimmunol.175.9.5817; Satoguina JS, 2005, J IMMUNOL, V174, P4718, DOI 10.4049/jimmunol.174.8.4718; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; van der Kleij D, 2004, J INFECT DIS, V189, P1044, DOI 10.1086/382089; VELUPILLAI P, 1994, P NATL ACAD SCI USA, V91, P18, DOI 10.1073/pnas.91.1.18; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; WHO, 2005, MILL DEV GOALS EV IS	16	19	19	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 10	2007	369	9560					446	447		10.1016/S0140-6736(07)60210-4	http://dx.doi.org/10.1016/S0140-6736(07)60210-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135XX	17292747				2022-12-01	WOS:000244188300008
J	Hansen, SK; Rainey, PB; Haagensen, JAJ; Molin, S				Hansen, Susse Kirkelund; Rainey, Paul B.; Haagensen, Janus A. J.; Molin, Soren			Evolution of species interactions in a biofilm community	NATURE			English	Article							MICROBIAL BIOFILMS; PSEUDOMONAS-PUTIDA; DIVERSITY; BIODIVERSITY; COEXISTENCE; ENVIRONMENT; COMPETITION; ADAPTATION; DYNAMICS; ECOLOGY	Biofilms are spatially structured communities of microbes whose function is dependent on a complex web of symbiotic interactions(1,2). Localized interactions within these assemblages are predicted to affect the coexistence of the component species(3-5), community structure(6) and function(7-10), but there have been few explicit empirical analyses of the evolution of interactions(11). Here we show, with the use of a two-species community, that selection in a spatially structured environment leads to the evolution of an exploitative interaction. Simple mutations in the genome of one species caused it to adapt to the presence of the other, forming an intimate and specialized association. The derived community was more stable and more productive than the ancestral community. Our results show that evolution in a spatially structured environment can stabilize interactions between species, provoke marked changes in their symbiotic nature and affect community function.	Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; Tech Univ Denmark, Infect Microbiol Grp, Biocentrum DTU, DK-2800 Lyngby, Denmark	University of Auckland; Technical University of Denmark	Rainey, PB (corresponding author), Univ Auckland, Sch Biol Sci, Private Bag 92019, Auckland 1, New Zealand.	p.rainey@auckland.ac.nz	Rainey, Paul/A-3207-2008; Albers, Pieter/I-2563-2017	Rainey, Paul/0000-0003-0879-5795; Molin, Soren/0000-0002-7973-2639				An DD, 2006, P NATL ACAD SCI USA, V103, P3828, DOI 10.1073/pnas.0511323103; Battin TJ, 2003, NATURE, V426, P439, DOI 10.1038/nature02152; Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101; Christensen BB, 2002, APPL ENVIRON MICROB, V68, P2495, DOI 10.1128/AEM.68.5.2495-2502.2002; Christensen BB, 1999, METHOD ENZYMOL, V310, P20; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; Forde SE, 2004, NATURE, V431, P841, DOI 10.1038/nature02906; FRANKLIN FCH, 1981, P NATL ACAD SCI-BIOL, V78, P7458, DOI 10.1073/pnas.78.12.7458; HASSELL MP, 1994, NATURE, V370, P290, DOI 10.1038/370290a0; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Kareiva, 1997, SPATIAL ECOLOGY; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Kroes I, 1999, P NATL ACAD SCI USA, V96, P14547, DOI 10.1073/pnas.96.25.14547; Labrenz M, 2000, SCIENCE, V290, P1744, DOI 10.1126/science.290.5497.1744; LAM JS, 2004, PSEUDOMONAS, V3, P3; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Ley RE, 2006, APPL ENVIRON MICROB, V72, P3685, DOI 10.1128/AEM.72.5.3685-3695.2006; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Moller S, 1996, APPL ENVIRON MICROB, V62, P4632; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Newman DK, 2002, SCIENCE, V296, P1071, DOI 10.1126/science.1010716; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Ram RJ, 2005, SCIENCE, V308, P1915, DOI 10.1126/science. 1109070; Thompson J.N., 1994, COEVOLUTIONARY PROCE; Thompson JN, 2002, NATURE, V417, P735, DOI 10.1038/nature00810; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Turner PE, 1996, ECOLOGY, V77, P2119, DOI 10.2307/2265706; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Urban MC, 2006, ECOLOGY, V87, P1616, DOI 10.1890/0012-9658(2006)87[1616:EMTAEP]2.0.CO;2	30	370	382	8	237	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2007	445	7127					533	536		10.1038/nature05514	http://dx.doi.org/10.1038/nature05514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17268468				2022-12-01	WOS:000243867300042
J	Yamashita, YM; Mahowald, AP; Perlin, JR; Fuller, MT				Yamashita, Yukiko M.; Mahowald, Anthony P.; Perlin, Julie R.; Fuller, Margaret T.			Asymmetric inheritance of mother versus daughter centrosome in stem cell division	SCIENCE			English	Article							DROSOPHILA; PROTEIN	Adult stem cells often divide asymmetrically to produce one self-renewed stem cell and one differentiating cell, thus maintaining both populations. The asymmetric outcome of stem cell divisions can be specified by an oriented spindle and local self-renewal signals from the stem cell niche. Here we show that developmentally programmed asymmetric behavior and inheritance of mother and daughter centrosomes underlies the stereotyped spindle orientation and asymmetric outcome of stem cell divisions in the Drosophila male germ line. The mother centrosome remains anchored near the niche while the daughter centrosome migrates to the opposite side of the cell before spindle formation.	Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; University of Chicago; Stanford University	Yamashita, YM (corresponding author), Univ Michigan, Inst Life Sci, Room 5403,210 Washtenaw Ave, Ann Arbor, MI 48183 USA.	yukikomy@umich.edu; fuller@stanford.edu		Yamashita, Yukiko/0000-0001-5541-0216; Fuller, Margaret T/0000-0002-3804-4987	NIDDK NIH HHS [P01 DK053074, P01 DK53074] Funding Source: Medline; NIGMS NIH HHS [R01 GM080501] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK053074] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Martinez-Campos M, 2004, J CELL BIOL, V165, P673, DOI 10.1083/jcb.200402130; Megraw TL, 1999, DEVELOPMENT, V126, P2829; Megraw TL, 2001, CURR BIOL, V11, P116, DOI 10.1016/S0960-9822(01)00017-3; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Pereira G, 2001, EMBO J, V20, P6359, DOI 10.1093/emboj/20.22.6359; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Tracey WD, 2000, GENETICS, V154, P273; TUTINA N, 2001, SCIENCE, V294, P2546; Vaizel-Ohayon D, 1999, CURR BIOL, V9, P889, DOI 10.1016/S0960-9822(99)80393-5; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795	13	395	411	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2007	315	5811					518	521		10.1126/science.1134910	http://dx.doi.org/10.1126/science.1134910			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255513	Green Accepted			2022-12-01	WOS:000243726600048
J	Hossain, P; Kawar, B; Nahas, ME				Hossain, Parvez; Kawar, Bisher; Nahas, Meguid El			Obesity and diabetes in the developing world - A growing challenge	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Sheffield, Sheffield Kidney Inst, Acad Nephrol Unit, Sheffield, S Yorkshire, England	University of Sheffield	Hossain, P (corresponding author), Univ Sheffield, Sheffield Kidney Inst, Acad Nephrol Unit, Sheffield, S Yorkshire, England.							Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Lee G, 2003, SEMIN NEPHROL, V23, P107, DOI 10.1053/snep.2003.50009; WHO, 2006, WORLD HLTH REPORT 20; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	5	1376	1414	2	82	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 18	2007	356	3					213	215		10.1056/NEJMp068177	http://dx.doi.org/10.1056/NEJMp068177			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	126BV	17229948				2022-12-01	WOS:000243488100003
J	Not, F; Valentin, K; Romari, K; Lovejoy, C; Massana, R; Tobe, K; Vaulot, D; Medlin, LK				Not, Fabrice; Valentin, Klaus; Romari, Khadidja; Lovejoy, Connie; Massana, Ramon; Toebe, Kerstin; Vaulot, Daniel; Medlin, Linda K.			Picobiliphytes: A marine picoplanktonic algal group with unknown affinities to other eukaryotes	SCIENCE			English	Article							COASTAL SITE; 18S RDNA; DIVERSITY	Environmental sequencing has revealed unimagined diversity among eukaryotic picoplankton. A distinct picoplanktonic algal group, initially detected from 18S ribosomal DNA ( rDNA) sequences, was hybridized with rRNA lambda-targeted (rRNA-targeted) probes, detected by tyramide signal amplification-fluorescent in situ hybridization, and showed an organelle-like body with orange fluorescence indicative of phycobilins. Using this fluorescence signal, cells were sorted by flow cytometry and probed. Hybridized cells contained a 4',6'-diamidino-2-phenylindole-stained organelle resembling a plastid with a nucleomorph. This suggests that they may be secondary endosymbiotic algae. Pending the isolation of living cells and their formal description, these algae have been termed picobiliphytes.	CNRS, Stn Biol Roscoff, CNRS, UMR 7144, F-29682 Roscoff, France; Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; Univ Laval, Quebec Ocean, Dept Biol, Ste Foy, PQ G1K 7P4, Canada; Inst Ciencies Mar, Barcelona 08003, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Laval University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Not, F (corresponding author), Inst Ciencies Mar, Passeig Martim Barceloneta 37-49, Barcelona 08003, Spain.	not@icm.csic.es; lkmedlin@awi-bremerhaven.de	Lovejoy, Connie/A-3756-2008; Vaulot, Daniel/T-6649-2019; Valentin, Klaus/G-5862-2014; Massana, Ramon/F-4205-2016; medlin, linda k/G-4820-2010	Lovejoy, Connie/0000-0001-8027-2281; Vaulot, Daniel/0000-0002-0717-5685; Valentin, Klaus/0000-0001-7401-9423; Massana, Ramon/0000-0001-9172-5418				Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Countway PD, 2005, J EUKARYOT MICROBIOL, V52, P95, DOI 10.1111/j.1550-7408.2005.05202006.x; Diez B, 2001, APPL ENVIRON MICROB, V67, P2932, DOI 10.1128/AEM.67.7.2932-2941.2001; Jeffrey SW, 1997, PHYTOPLANKTON PIGMEN; Li WKW, 2001, CYTOMETRY, V44, P236, DOI 10.1002/1097-0320(20010701)44:3<236::AID-CYTO1116>3.0.CO;2-5; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Lovejoy C, 2006, APPL ENVIRON MICROB, V72, P3085, DOI 10.1128/AEM.72.5.3085-3095.2006; Marin B, 2005, PROTIST, V156, P425, DOI 10.1016/j.protis.2005.09.001; Massana R, 2004, FEMS MICROBIOL ECOL, V50, P231, DOI 10.1016/j.femsec.2004.07.001; Massana R, 2006, ENVIRON MICROBIOL, V8, P1515, DOI 10.1111/j.1462-2920.2006.01042.x; MCFADDEN G, 1995, TRENDS ECOL EVOL, V10, P12, DOI 10.1016/S0169-5347(00)88954-5; Medlin LK, 2006, MICROB ECOL, V167, P1432; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Moreira D, 2000, NATURE, V405, P69, DOI 10.1038/35011054; Not F, 2002, AQUAT MICROB ECOL, V28, P157, DOI 10.3354/ame028157; Romari K, 2004, LIMNOL OCEANOGR, V49, P784, DOI 10.4319/lo.2004.49.3.0784; Vaulot D, 2004, NOVA HEDWIGIA, V79, P49, DOI 10.1127/0029-5035/2004/0079-0049	17	153	160	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2007	315	5809					253	255		10.1126/science.1136264	http://dx.doi.org/10.1126/science.1136264			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124XZ	17218530	Green Published			2022-12-01	WOS:000243407400051
J	Shen, JS; Tareste, DC; Paumet, F; Rothman, JE; Melia, TJ				Shen, Jingshi; Tareste, David C.; Paumet, Fabienne; Rothman, James E.; Melia, Thomas J.			Selective activation of cognate SNAREpins by Sec1/Munc18 proteins	CELL			English	Article							MEMBRANE-FUSION; NEUROTRANSMITTER RELEASE; 3-DIMENSIONAL STRUCTURE; T-SNARE; SYNTAXIN; EXOCYTOSIS; COMPLEX; SPECIFICITY; BINDS; GOLGI	Sec1/Muncl 8 (SM) proteins are required for every step of intracellular membrane fusion, but their molecular mechanism of action has been unclear. In this work, we demonstrate a fundamental role of the SM protein: to act as a stimulatory subunit of its cognate SNARE fusion machinery. In a reconstituted system, mammalian SNARE pairs assemble between bilayers to drive a basal fusion reaction. Munc18-1/nSec1, a synaptic SM protein required for neurotransmitter release, strongly accelerates this reaction through direct contact with both t- and v-SNAREs. Munc18-1 accelerates fusion only for the cognate SNAREs for exocytosis, therefore enhancing fusion specificity.	Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Columbia University	Rothman, JE (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA.	jr2269@columbia.edu; tm2176@columbia.edu	Tareste, David/P-9249-2019; Tareste, David/L-2639-2017	Tareste, David/0000-0002-8744-7598; Tareste, David/0000-0002-8744-7598; SHEN, JINGSHI/0000-0001-9595-1148; Paumet, Fabienne/0000-0003-4466-6966				Antonin W, 2000, EMBO J, V19, P6453, DOI 10.1093/emboj/19.23.6453; Bhattacharya S, 2002, P NATL ACAD SCI USA, V99, P13867, DOI 10.1073/pnas.202335999; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696; Bracher A, 2002, EMBO J, V21, P6114, DOI 10.1093/emboj/cdf608; Brandhorst D, 2006, P NATL ACAD SCI USA, V103, P2701, DOI 10.1073/pnas.0511138103; BRENNER S, 1974, GENETICS, V77, P71; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Bryant NJ, 2001, EMBO J, V20, P3380, DOI 10.1093/emboj/20.13.3380; Carpp LN, 2006, J CELL BIOL, V173, P927, DOI 10.1083/jcb.200512024; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Ciufo LF, 2005, MOL BIOL CELL, V16, P470, DOI 10.1091/mbc.E04-08-0685; Dulubova I, 2003, P NATL ACAD SCI USA, V100, P32, DOI 10.1073/pnas.232701299; Dulubova I, 2002, EMBO J, V21, P3620, DOI 10.1093/emboj/cdf381; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fisher RJ, 2001, SCIENCE, V291, P875, DOI 10.1126/science.291.5505.875; Gallwitz D, 2003, TRENDS BIOCHEM SCI, V28, P113, DOI 10.1016/S0968-0004(03)00028-8; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Graham ME, 1997, J NEUROCHEM, V69, P2369; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Holthuis JCM, 1998, MOL BIOL CELL, V9, P3383, DOI 10.1091/mbc.9.12.3383; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Koh TW, 2003, TRENDS NEUROSCI, V26, P413, DOI 10.1016/S0166-2236(03)00195-4; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; Paumet F, 2005, J BIOL CHEM, V280, P21137, DOI 10.1074/jbc.M500841200; Paumet F, 2004, P NATL ACAD SCI USA, V101, P3376, DOI 10.1073/pnas.0400271101; Paumet F, 2001, J CELL BIOL, V155, P961, DOI 10.1083/jcb.200104092; Peng RW, 2005, THESCIENTIFICWORLDJO, V5, P471, DOI 10.1100/tsw.2005.53; Peng RW, 2004, EMBO J, V23, P3939, DOI 10.1038/sj.emboj.7600410; Peng RW, 2002, J CELL BIOL, V157, P645, DOI 10.1083/jcb.200202006; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Rickman C, 2005, CHEM BIOL, V12, P545, DOI 10.1016/j.chembiol.2005.03.004; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Schaub JR, 2006, NAT STRUCT MOL BIOL, V13, P748, DOI 10.1038/nsmb1124; SCHEKMAN R, 2004, CELL, V116, pS19; Schekman Randy, 2004, Cell, VS116, pS13, DOI 10.1016/S0092-8674(03)00972-3; Schutz D, 2005, EUR J NEUROSCI, V21, P2419, DOI 10.1111/j.1460-9568.2005.04095.x; Scott BL, 2004, J CELL BIOL, V167, P75, DOI 10.1083/jcb.200405018; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sorensen JB, 2002, P NATL ACAD SCI USA, V99, P1627, DOI 10.1073/pnas.251673298; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; ter Beest MBA, 2005, MOL BIOL CELL, V16, P5784, DOI 10.1091/mbc.E05-070-0661; Toonen RFG, 2005, J NEUROCHEM, V93, P1393, DOI 10.1111/j.1471-4159.2005.03128.x; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; Williams AL, 2004, MOL BIOL CELL, V15, P162, DOI 10.1091/mbc.E03-07-0535; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Yamaguchi T, 2002, DEV CELL, V2, P295, DOI 10.1016/S1534-5807(02)00125-9; Yang B, 2000, J CELL BIOL, V148, P247, DOI 10.1083/jcb.148.2.247; Zilly FE, 2006, PLOS BIOL, V4, P1789, DOI 10.1371/journal.pbio.0040330	70	348	364	0	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 12	2007	128	1					183	195		10.1016/j.cell.2006.12.016	http://dx.doi.org/10.1016/j.cell.2006.12.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GN	17218264	Bronze			2022-12-01	WOS:000244420400022
J	Xu, Y; Toh, KL; Jones, CR; Shin, JY; Fu, YH; Ptacek, LJ				Xu, Y.; Toh, K. L.; Jones, C. R.; Shin, J. -Y.; Fu, Y. -H.; Ptacek, L. J.			Modeling of a human circadian mutation yields insights into clock regulation by PER2	CELL			English	Article							MOLECULAR ANALYSIS; GENE-EXPRESSION; CKI-EPSILON; PHOSPHORYLATION; PERIOD; MPER2; TRANSCRIPTION; DELTA; DROSOPHILA; COMPONENT	Circadian rhythms are endogenous oscillations of physiological and behavioral phenomena with period length of -24 hr. A mutation in human Period 2 (hPER2), a gene crucial for resetting the central clock in response to light, is associated with familial advanced sleep phase syndrome (FASPS), an autosomal dominant condition with early morning awakening and early sleep times. The FASPS hPER2 S662G mutation resulted in PER2 being hypophosphorylated by casein kinase I (CKI) in vitro. We generated transgenic mice carrying the FASPS hPER2 S662G mutation and faithfully recapitulate the human phenotype. We show that phosphorylation at S662 leads to increased PER2 transcription and suggest that phosphorylation at another site leads to PER2 degradation. Altering CK1 delta dosage modulates the S662 phenotype demonstrating that CK1 delta can regulate period through PER2 in vivo. Modeling a naturally occurring human variant in mice has yielded novel insights into PER2 regulation.	Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; Univ Utah, Dept Neurol, Salt Lake City, UT 84132 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Fu, YH (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA.	yhf@neugenes.org; ljp@ucsf.edu	Xu, Ying/AAF-3081-2019; Xu, Ying/A-3009-2013	Xu, Ying/0000-0002-6689-7768; Xu, Ying/0000-0002-6689-7768	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074924] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL059596] Funding Source: Medline; NIMH NIH HHS [P50 MH074924] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABBONDANZO SJ, 1993, METHOD ENZYMOL, V225, P803; Akashi M, 2002, MOL CELL BIOL, V22, P1693, DOI 10.1128/MCB.22.6.1693-1703.2002; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; Camacho F, 2001, FEBS LETT, V489, P159, DOI 10.1016/S0014-5793(00)02434-0; Campbell S, 2000, SCIENCE, V288, P1174, DOI 10.1126/science.288.5469.1174; CZEISLER CA, 1999, SCIENCE, V284, P2177, DOI [10.1126/science.284.5423.2177, DOI 10.1126/SCIENCE.284.5423.2177, DOI 10.1126/science.284.5423.2177]; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Emery P, 2004, NEURON, V43, P443, DOI 10.1016/j.neuron.2004.08.009; Gallego M, 2006, P NATL ACAD SCI USA, V103, P10618, DOI 10.1073/pnas.0604511103; Harms E, 2004, J BIOL RHYTHM, V19, P361, DOI 10.1177/0748730404268111; Hastings MH, 2004, J BIOL RHYTHM, V19, P400, DOI 10.1177/0748730404268786; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Jones CR, 1999, NAT MED, V5, P1062, DOI 10.1038/12502; Klerman EB, 1996, AM J PHYSIOL-REG I, V270, pR271, DOI 10.1152/ajpregu.1996.270.1.R271; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Miyazaki K, 2004, BIOCHEM J, V380, P95, DOI 10.1042/BJ20031308; Nawathean P, 2004, MOL CELL, V13, P213, DOI 10.1016/S1097-2765(03)00503-3; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Tamanini F, 2005, METHOD ENZYMOL, V393, P418, DOI 10.1016/S0076-6879(05)93020-6; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yamamoto T, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-18; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Yu WJ, 2002, BIOCHEM BIOPH RES CO, V290, P933, DOI 10.1006/bbrc.2001.6300; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zylka MJ, 1998, NEURON, V21, P1115, DOI 10.1016/S0896-6273(00)80628-5	41	282	292	3	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 12	2007	128	1					59	70		10.1016/j.cell.2006.11.043	http://dx.doi.org/10.1016/j.cell.2006.11.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GN	17218255	Green Submitted, Green Accepted, Bronze			2022-12-01	WOS:000244420400013
J	Weber, F; Xu, YM; Zhang, L; Patocs, A; Shen, L; Platzer, P; Eng, C				Weber, Frank; Xu, Yaomin; Zhang, Li; Patocs, Attila; Shen, Lei; Platzer, Petra; Eng, Charis			Microenvironmental genomic alterations and clinicopathological behavior in head and neck squamous cell carcinoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROSTATE-CANCER-AGGRESSIVENESS; FIELD CANCERIZATION; TUMOR PROGRESSION; BREAST-CANCER; STROMA; EXPRESSION; PROTEIN; EPITHELIUM; LUNG; DIFFERENTIATION	Context Carcinogens associated with head and neck squamous cell carcinoma (SCC) genesis should inflict genomic alterations not only on the epithelium but also the mesenchyme of the aerodigestive tract. Therefore, the apparently nonmalignant stroma surrounding the tumor epithelium can acquire genomic alterations and contribute to cancer initiation and progression. Objectives To determine compartment-specific loci of loss of heterozygosity or allelic imbalance (LOH/AI) and to identify which genomic alterations restricted to the stroma cell population contribute to aggressiveness of head and neck SCC disease. Design, Setting, and Patients Tumor epithelium and surrounding stroma were isolated from 122 US patients with oral cavity and oropharyngeal or hypopharyngeal SCC and subjected to whole-genome LOH/AI analysis using 366 microsatellite markers. Samples, collected between 2001 and 2004, were pulled and transferred in batches of 10 to 30 between 2002 and 2005. Laser capture microdissection DNA extraction and technical genotyping occurred on a rolling model between 2002 and November 2005. Main Outcome Measures Compartment-specific frequency and distribution of LOH/AI were determined, and hot spots of genomic alterations identified. Compartment-specific LOH/AI events were correlated with presenting clinicopathologic characteristics. Results Tumor-associated stroma of head and neck SCC from smokers were found to have a high degree of genomic alterations. A correlation between tumor aggressiveness could be found for a specific set of 5 loci. Three stroma-specific loci (D4S2417, D3S360, and D19555) were associated with tumor size (pT) and regional nodal metastases (pN). Furthermore, 2 epithelial-specific LOH/AI hot spots were positively correlated with pN status and clinical stage. Conclusions Stroma-specific genetic alterations are associated with smoking-related head and neck SCC genesis. These findings suggest novel prognostic or diagnostic biomarkers and identify potential new molecular targets for therapeutic and preventive intervention.	Cleveland Clin Lerner Res Inst, Genom Med Inst, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Sect Stat Genet, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Taussig Canc Ctr, Cleveland, OH 44195 USA; Ohio State Univ, Div Biostat, Sch Publ Hlth, Columbus, OH 43210 USA; Case Western Reserve Univ, Dept Stat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, CASE Comprehens Canc Ctr, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Ohio State University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Eng, C (corresponding author), Cleveland Clin Lerner Res Inst, Genom Med Inst, 9500 Euclid Ave,NE-50, Cleveland, OH 44195 USA.	engc@ccf.org	Weber, Frank/A-1883-2012	Weber, Frank/0000-0002-0995-667X; Eng, Charis/0000-0002-3693-5145; Patocs, Attila/0000-0001-7506-674X				*AM CANC SOC, 2006, OR CANC FACTS FIG; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bockmuhl U, 2002, GENE CHROMOSOME CANC, V33, P29, DOI 10.1002/gcc.1209; Bockmuhl U, 1998, HEAD NECK-J SCI SPEC, V20, P145, DOI 10.1002/(SICI)1097-0347(199803)20:2<145::AID-HED8>3.0.CO;2-2; Braakhuis BJM, 2005, SEMIN CANCER BIOL, V15, P113, DOI 10.1016/j.semcancer.2004.08.004; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Climent J, 2002, CLIN CANCER RES, V8, P3863; Condon MS, 2005, SEMIN CANCER BIOL, V15, P132, DOI 10.1016/j.semcancer.2004.08.002; Dacic S, 2005, AM J SURG PATHOL, V29, P897, DOI 10.1097/01.pas.0000164367.96379.66; Dai MS, 2002, J BIOL CHEM, V277, P26327, DOI 10.1074/jbc.M201834200; Denison SR, 2003, GENE CHROMOSOME CANC, V38, P40, DOI 10.1002/gcc.10236; Edlund M, 2004, J CELL BIOCHEM, V91, P686, DOI 10.1002/jcb.10702; FARAWAY JJ, 2006, EXTENDING LINEAR MOD, V1; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Fukino K, 2004, CANCER RES, V64, P7231, DOI 10.1158/0008-5472.CAN-04-2866; Gotte A, 2005, ADV OTO-RHINO-LARYNG, V62, P38; GREEN FL, 1997, AJCC CANC STAGING MA; Hill R, 2005, CELL, V123, P1001, DOI 10.1016/j.cell.2005.09.030; Hoatlin ME, 1999, BLOOD, V94, P3737, DOI 10.1182/blood.V94.11.3737.423k39_3737_3747; Horvath B, 2005, HEAD NECK-J SCI SPEC, V27, P585, DOI 10.1002/hed.20188; Huang Q, 2002, GENE CHROMOSOME CANC, V34, P224, DOI 10.1002/gcc.10062; Hunter KD, 2005, NAT REV CANCER, V5, P127, DOI 10.1038/nrc1549; Hussain S, 2004, HUM MOL GENET, V13, P1241, DOI 10.1093/hmg/ddh135; Jang SJ, 2001, ONCOGENE, V20, P2235, DOI 10.1038/sj.onc.1204311; Jukkola T, 2004, GENE EXPR PATTERNS, V4, P755, DOI 10.1016/j.modgep.2004.03.006; Kurose K, 2001, HUM MOL GENET, V10, P1907, DOI 10.1093/hmg/10.18.1907; Leng K, 2006, J ORAL PATHOL MED, V35, P19, DOI 10.1111/j.1600-0714.2005.00365.x; Marsh DJ, 1997, CANCER RES, V57, P500; McCawley LJ, 2001, CURR BIOL, V11, pR25, DOI 10.1016/S0960-9822(00)00038-5; McCullagh P., 1983, GEN LINEAR MODELS, DOI [10.1007/978-1-4899-3242-6, DOI 10.1007/978-1-4899-3242-6]; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Nelson HH, 2005, CARCINOGENESIS, V26, P1770, DOI 10.1093/carcin/bgi125; Perez-Ordonez B, 2006, J CLIN PATHOL, V59, P445, DOI 10.1136/jcp.2003.007641; Riccil F, 2005, CANCER BIOL THER, V4, P302, DOI 10.4161/cbt.4.3.1501; Ries LAG, 2006, SEER CANC STAT REV 1; Rosenquist TA, 2003, DNA REPAIR, V2, P581, DOI 10.1016/S1568-7864(03)00025-9; Rosenthal E, 2004, MOL CARCINOGEN, V40, P116, DOI 10.1002/mc.20024; Slager SL, 2003, AM J HUM GENET, V72, P759, DOI 10.1086/368230; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Tran Y, 1998, ONCOGENE, V17, P3499, DOI 10.1038/sj.onc.1202258; van Oijen MGCT, 2000, CANCER EPIDEM BIOMAR, V9, P249; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Weber F, 2005, BRIT J CANCER, V92, P1922, DOI 10.1038/sj.bjc.6602557; Weber F, 2006, AM J HUM GENET, V78, P961, DOI 10.1086/504090; Williams HK, 2000, J CLIN PATHOL-MOL PA, V53, P165, DOI 10.1136/mp.53.4.165; Witte JS, 2000, AM J HUM GENET, V67, P92, DOI 10.1086/302960; Worsham MJ, 2006, ARCH OTOLARYNGOL, V132, P409, DOI 10.1001/archotol.132.4.409; XU Y, 2005, C NONP INF PROB APPL	51	71	74	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 10	2007	297	2					187	195		10.1001/jama.297.2.187	http://dx.doi.org/10.1001/jama.297.2.187			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	124GI	17213402	Bronze			2022-12-01	WOS:000243355900028
J	Mullighan, CG; Goorha, S; Radtke, I; Miller, CB; Coustan-Smith, E; Dalton, JD; Girtman, K; Mathew, S; Ma, J; Pounds, SB; Su, XP; Pui, CH; Relling, MV; Evans, WE; Shurtleff, SA; Downing, JR				Mullighan, Charles G.; Goorha, Salil; Radtke, Ina; Miller, Christopher B.; Coustan-Smith, Elaine; Dalton, James D.; Girtman, Kevin; Mathew, Susan; Ma, Jing; Pounds, Stanley B.; Su, Xiaoping; Pui, Ching-Hon; Relling, Mary V.; Evans, William E.; Shurtleff, Sheila A.; Downing, James R.			Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia	NATURE			English	Article							B-CELL DEVELOPMENT; ZINC-FINGER PROTEIN; IKAROS GENE; BSAP PAX-5; DELETION; LYMPHOMA; DNA; EXPRESSION; DIFFERENTIATION; TRANSLOCATION	Chromosomal aberrations are a hallmark of acute lymphoblastic leukaemia ( ALL) but alone fail to induce leukaemia. To identify cooperating oncogenic lesions, we performed a genome-wide analysis of leukaemic cells from 242 paediatric ALL patients using high-resolution, single-nucleotide polymorphism arrays and genomic DNA sequencing. Our analyses revealed deletion, amplification, point mutation and structural rearrangement in genes encoding principal regulators of B lymphocyte development and differentiation in 40% of B-progenitor ALL cases. The PAX5 gene was the most frequent target of somatic mutation, being altered in 31.7% of cases. The identified PAX5 mutations resulted in reduced levels of PAX5 protein or the generation of hypomorphic alleles. Deletions were also detected in TCF3 ( also known as E2A), EBF1, LEF1, IKZF1 (IKAROS) and IKZF3 (AIOLOS). These findings suggest that direct disruption of pathways controlling B-cell development and differentiation contributes to B-progenitor ALL pathogenesis. Moreover, these data demonstrate the power of high-resolution, genome-wide approaches to identify new molecular lesions in cancer.	St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Biostat, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; St Jude Childrens Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital	Downing, JR (corresponding author), St Jude Childrens Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA.	james.downing@stjude.org	Pui, Ching-Hon/N-8076-2018; Downing, James R./N-8102-2018; Pounds, Stanley B/N-2480-2018; Ganesh, Dunna Sai/AGX-5170-2022; Relling, Mary/N-5032-2018; Evans, William E./C-2069-2012; Mullighan, Charles/H-3253-2011	Pui, Ching-Hon/0000-0003-0303-5658; Pounds, Stanley B/0000-0002-9167-2114; Evans, William E./0000-0002-9333-5322; Mullighan, Charles/0000-0002-1871-1850				Bohlander SK, 2005, SEMIN CANCER BIOL, V15, P162, DOI 10.1016/j.semcancer.2005.01.008; Bond HM, 2004, BLOOD, V103, P2062, DOI 10.1182/blood-2003-07-2388; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Busslinger M, 1996, P NATL ACAD SCI USA, V93, P6129, DOI 10.1073/pnas.93.12.6129; Cave H, 2001, LEUKEMIA, V15, P371, DOI 10.1038/sj.leu.2402052; Cazzaniga G, 2001, CANCER RES, V61, P4666; Conte N, 2002, ONCOGENE, V21, P5619, DOI 10.1038/sj.onc.1205658; CZERNY T, 1995, MOL CELL BIOL, V15, P2858; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Heerema NA, 2000, J CLIN ONCOL, V18, P3837, DOI 10.1200/JCO.2000.18.22.3837; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Jackson A, 2000, CANCER RES, V60, P2775; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Maier H, 2003, MOL CELL BIOL, V23, P1946, DOI 10.1128/MCB.23.6.1946-1960.2003; Martoriati A, 2005, ONCOGENE, V24, P1461, DOI 10.1038/sj.onc.1208256; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Nutt SL, 1999, NAT GENET, V21, P390, DOI 10.1038/7720; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; OKUDA T, 1995, BLOOD, V85, P2321, DOI 10.1182/blood.V85.9.2321.bloodjournal8592321; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Peters UR, 1999, ONCOGENE, V18, P79, DOI 10.1038/sj.onc.1202256; RAIMONDI SC, 1995, BLOOD, V86, P1881, DOI 10.1182/blood.V86.5.1881.bloodjournal8651881; Raynaud S, 1996, BLOOD, V87, P2891, DOI 10.1182/blood.V87.7.2891.bloodjournal8772891; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Strehl S, 2003, LEUKEMIA, V17, P1121, DOI 10.1038/sj.leu.2402923; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Warming S, 2003, BLOOD, V101, P1934, DOI 10.1182/blood-2002-08-2652; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Wlodarska I, 2005, LEUKEMIA, V19, P1299, DOI 10.1038/sj.leu.2403813; Ying H, 1998, J IMMUNOL, V161, P4760	38	1305	1346	1	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2007	446	7137					758	764		10.1038/nature05690	http://dx.doi.org/10.1038/nature05690			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17344859				2022-12-01	WOS:000245626800032
J	Stefanovic, S; Hegde, RS				Stefanovic, Sandra; Hegde, Rarnanujan S.			Identification of a targeting factor for posttranslational membrane protein insertion into the ER	CELL			English	Article							SIGNAL RECOGNITION PARTICLE; TAIL-ANCHORED PROTEIN; ENDOPLASMIC-RETICULUM MEMBRANE; SACCHAROMYCES-CEREVISIAE; TRANSLOCATION COMPLEX; MECHANISM; SYNAPTOBREVIN; POLYPEPTIDE; TRANSPORTER; ELONGATION	Hundreds of proteins are anchored in intracellular membranes by a single transmembrane domain (TMD) close to the C terminus. Although these tail-anchored (TA) proteins serve numerous essential roles in cells, components of their targeting and insertion pathways have long remained elusive. Here we reveal a cytosolic TMD recognition complex (TRC) that targets TA proteins for insertion into the ER membrane. The highly conserved, 40 kDa ATPase subunit of TRC (which we termed TRC40) was identified as Asna-1. TRC40/Asna-1 interacts posttranslationally with TA proteins in a TMD-dependent manner for delivery to a proteinaceous receptor at the ER membrane. Subsequent release from TRC40/Asna-1 and insertion into the membrane depends on ATP hydrolysis. Consequently, an ATPase-deficient mutant of TRC40/Asna-1 dominantly inhibited TA protein insertion selectively without influencing other translocation pathways. Thus, TRC40/Asna-1 represents an integral component of a posttranslational pathway of membrane protein insertion whose targeting is mediated by TRC.	NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Hegde, RS (corresponding author), NICHHD, Cell Biol & Metab Branch, NIH, Room 101,Bldg 18T,18 Lib Dr, Bethesda, MD 20892 USA.	hegder@mail.nih.gov		Hegde, Ramanujan/0000-0001-8338-852X	Intramural NIH HHS Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD008862, ZIAHD008752, Z01HD008862, Z01HD008752] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abell BM, 2003, J BIOL CHEM, V278, P5669, DOI 10.1074/jbc.M209968200; Abell BM, 2004, EMBO J, V23, P2755, DOI 10.1038/sj.emboj.7600281; ANDREWS DW, 1989, J CELL BIOL, V108, P797, DOI 10.1083/jcb.108.3.797; Auld KL, 2006, GENETICS, V174, P215, DOI 10.1534/genetics.106.058362; Borgese N, 2001, MOL BIOL CELL, V12, P2482, DOI 10.1091/mbc.12.8.2482; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Brambillasca S, 2005, EMBO J, V24, P2533, DOI 10.1038/sj.emboj.7600730; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Gupta GD, 2003, FUNGAL GENET BIOL, V40, P271, DOI 10.1016/S1087-1845(03)00109-9; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; HARTMANN E, 1994, NATURE, V367, P654, DOI 10.1038/367654a0; High S, 2004, BIOCHEM SOC T, V32, P659, DOI 10.1042/BST0320659; Kim PK, 1999, J BIOL CHEM, V274, P36876, DOI 10.1074/jbc.274.52.36876; Kim PK, 1997, BIOCHEMISTRY-US, V36, P8873, DOI 10.1021/bi970090t; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; Kurdi-Haidar B, 1998, J BIOL CHEM, V273, P22173, DOI 10.1074/jbc.273.35.22173; KurdiHaidar B, 1996, GENOMICS, V36, P486, DOI 10.1006/geno.1996.0494; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Metz J, 2006, J BIOL CHEM, V281, P410, DOI 10.1074/jbc.M507481200; Mukhopadhyay R, 2006, FEBS LETT, V580, P3889, DOI 10.1016/j.febslet.2006.06.017; OGG SC, 1995, CELL, V81, P1075, DOI 10.1016/S0092-8674(05)80012-1; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shan SO, 2005, FEBS LETT, V579, P921, DOI 10.1016/j.febslet.2004.11.049; Shen J, 2003, BIOMETALS, V16, P369, DOI 10.1023/A:1022504311669; Steel GJ, 2002, BIOCHEMISTRY-US, V41, P11914, DOI 10.1021/bi026105r; Toikkanen J, 1996, YEAST, V12, P425, DOI 10.1002/(SICI)1097-0061(199604)12:5<425::AID-YEA924>3.3.CO;2-2; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; WALTER P, 1983, METHOD ENZYMOL, V266, P19599; Wattenberg B, 2001, TRAFFIC, V2, P66, DOI 10.1034/j.1600-0854.2001.20108.x; Whitley P, 1996, J BIOL CHEM, V271, P7583, DOI 10.1074/jbc.271.13.7583; Yabal M, 2003, J BIOL CHEM, V278, P3489, DOI 10.1074/jbc.M210253200	37	301	305	0	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2007	128	6					1147	1159		10.1016/j.cell.2007.01.036	http://dx.doi.org/10.1016/j.cell.2007.01.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382883	Bronze			2022-12-01	WOS:000245396200020
J	Cui, RT; Widlund, HR; Feige, E; Lin, JY; Wilensky, DL; Igras, VE; D'Orazio, J; Fung, CY; Schanbacher, CF; Granter, SR; Fisher, DE				Cui, Rutao; Widlund, Hans R.; Feige, Erez; Lin, Jennifer Y.; Wilensky, Dara L.; Igras, Viven E.; D'Orazio, John; Fung, Claire Y.; Schanbacher, Carl F.; Granter, Scott R.; Fisher, David E.			Central role of p53 in the suntan response and pathologic hyperpigmentation	CELL			English	Article							PROOPIOMELANOCORTIN GENE-EXPRESSION; MICROPHTHALMIA TRANSCRIPTION FACTOR; SQUAMOUS-CELL CARCINOMA; PLASMA BETA-ENDORPHIN; SKIN-CANCER; DNA-DAMAGE; MELANOCORTIN-1 RECEPTOR; ULTRAVIOLET-B; HUMAN MELANOCYTES; SV40-TRANSFORMED CELLS	UV-induced Pigmentation (suntanning) requires induction of a-melanocyte-stimulating hormone (alpha-MSH) secretion by keratinocytes- alpha-MSH and other bioactive pepticles are cleavage products Of pro-opiomelanocortin (POMC). Here we Provide biochemical and genetic evidence demonstrating that UV induction of POMC/MSH in skin is directly controlled by p53. Whereas p53 potently stimulates the POMC promoter in response to UV, the absence of p53, as in knockout mice, is associated with absence of the UV-tanning response. The same pathway produces beta-endorphin, another POMC derivative, which potentially contributes to sun-seeking behaviors. Furthermore, several instances of UV-independent pathologic Pigmentation are shown to involve p53 "mimicking" the tanning response. P53 thus functions as a sensor/effector for UV Pigmentation, which is a nearly constant environmental exposure. Moreover, this pathway is activated in numerous conditions of pathologic pigmentation and thus mimics the tanning response.	Harvard Univ, Sch Med, Melanoma Program Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat Hematol Oncol, Dana Farber Canc Inst,Childrens Hosp Boston, Boston, MA 02115 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dana Farber Canc Inst,Dept Dermatol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Fisher, DE (corresponding author), Harvard Univ, Sch Med, Melanoma Program Med Oncol, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	david_fisher@dfci.harvard.edu	Schanbacher, Carl/AAF-7641-2019	Cui, Rutao/0000-0002-4377-9988; Widlund, Hans/0000-0002-7506-2447				Abdel-Malek Z, 2000, PIGM CELL RES, V13, P156, DOI 10.1034/j.1600-0749.13.s8.28.x; Ananthaswamy HN, 1997, NAT MED, V3, P510, DOI 10.1038/nm0597-510; BARGONETTI J, 1991, CELL, V65, P1083, DOI 10.1016/0092-8674(91)90560-L; Barsh G, 2000, PIGM CELL RES, V13, P48, DOI 10.1034/j.1600-0749.13.s8.10.x; Bayerl C, 1995, PHOTODERMATOL PHOTO, V11, P149, DOI 10.1111/j.1600-0781.1995.tb00157.x; BLEEHEN SS, 1975, BRIT J DERMATOL, V93, P361, DOI 10.1111/j.1365-2133.1975.tb06509.x; BOUTILLIER AL, 1991, MOL ENDOCRINOL, V5, P1301, DOI 10.1210/mend-5-9-1301; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; Bykov VJ, 2000, J INVEST DERMATOL, V114, P40, DOI 10.1046/j.1523-1747.2000.00821.x; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; Chakraborty AK, 1996, BBA-MOL CELL RES, V1313, P130, DOI 10.1016/0167-4889(96)00063-8; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Commission Internationale de l'Eclairage (CIE), 1998, 007E1998 CIE S; Corre S, 2004, J BIOL CHEM, V279, P51226, DOI 10.1074/jbc.M409768200; Cui RT, 2005, J BIOL CHEM, V280, P39152, DOI 10.1074/jbc.M504655200; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; Diffey BL, 1997, PHOTODERMATOL PHOTO, V13, P64, DOI 10.1111/j.1600-0781.1997.tb00110.x; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Dunham WR, 1996, J INVEST DERMATOL, V107, P332, DOI 10.1111/1523-1747.ep12363174; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELLER MS, 1994, NATURE, V372, P413, DOI 10.1038/372413a0; Eller MS, 1996, P NATL ACAD SCI USA, V93, P1087, DOI 10.1073/pnas.93.3.1087; FARMER G, 1992, NATURE, V358, P83, DOI 10.1038/358083a0; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; FITZPATRICK TB, 1985, NEW ENGL J MED, V313, P818, DOI 10.1056/NEJM198509263131310; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; FRIEDMANN PS, 1987, J CELL PHYSIOL, V133, P88, DOI 10.1002/jcp.1041330111; Gambichler T, 2002, BRIT J DERMATOL, V147, P1207, DOI 10.1046/j.1365-2133.2002.04859.x; Gilchrest BA, 1996, PHOTOCHEM PHOTOBIOL, V63, P1, DOI 10.1111/j.1751-1097.1996.tb02988.x; Gottifredi V, 2000, COLD SPRING HARB SYM, V65, P483, DOI 10.1101/sqb.2000.65.483; Goukassian DA, 1999, J INVEST DERMATOL, V112, P25, DOI 10.1046/j.1523-1747.1999.00468.x; Granter SR, 2002, APPL IMMUNOHISTO M M, V10, P47, DOI 10.1097/00022744-200203000-00008; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Holick MF, 2001, LANCET, V357, P4, DOI 10.1016/S0140-6736(00)03560-1; Horikawa T, 1996, PIGM CELL RES, V9, P58, DOI 10.1111/j.1600-0749.1996.tb00089.x; Im SB, 1998, CANCER RES, V58, P47; Imokawa G, 2004, PIGM CELL RES, V17, P96, DOI 10.1111/j.1600-0749.2003.00126.x; IYENGAR B, 1994, MELANOMA RES, V4, P293; Kadekaro AL, 2003, ANN NY ACAD SCI, V994, P359, DOI 10.1111/j.1749-6632.2003.tb03200.x; Karalis KP, 2004, J BIOL CHEM, V279, P10837, DOI 10.1074/jbc.M313063200; KASTAN MB, 1991, CANCER RES, V51, P6304; Kaur M, 2006, J AM ACAD DERMATOL, V54, P919, DOI 10.1016/j.jaad.2006.01.062; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; Khlgatian MK, 2002, J INVEST DERMATOL, V118, P126, DOI 10.1046/j.0022-202x.2001.01667.x; Kichina J, 1996, PIGM CELL RES, V9, P85, DOI 10.1111/j.1600-0749.1996.tb00094.x; King R, 1999, AM J PATHOL, V155, P731, DOI 10.1016/S0002-9440(10)65172-3; Kippenberger S, 1996, PIGM CELL RES, V9, P179, DOI 10.1111/j.1600-0749.1996.tb00107.x; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; Lamonerie T, 1996, GENE DEV, V10, P1284, DOI 10.1101/gad.10.10.1284; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; LEVINS PC, 1983, LANCET, V2, P166; Li G, 1998, J INVEST DERMATOL, V110, P72, DOI 10.1046/j.1523-1747.1998.00090.x; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; LUBBE J, 1994, J INVEST DERMATOL, V102, P819, DOI 10.1111/1523-1747.ep12381544; LUNEC J, 1990, PATHOBIOLOGY, V58, P193, DOI 10.1159/000163583; MARCELO CL, 1978, J CELL BIOL, V79, P356, DOI 10.1083/jcb.79.2.356; Naysmith L, 2004, J INVEST DERMATOL, V122, P423, DOI 10.1046/j.0022-202X.2004.22221.x; Newell-Price J, 2003, J ENDOCRINOL, V177, P365, DOI 10.1677/joe.0.1770365; NORDLUND JJ, 1986, J INVEST DERMATOL, V86, P433, DOI 10.1111/1523-1747.ep12285717; PATHAK MA, 1983, J AM ACAD DERMATOL, V9, P724, DOI 10.1016/S0190-9622(83)70186-6; *PDR STAFF, 2005, PHYS DESK REF, P3267; Phillips A, 1997, MOL CELL BIOL, V17, P5952, DOI 10.1128/MCB.17.10.5952; Picon A, 1999, ONCOGENE, V18, P2627, DOI 10.1038/sj.onc.1202635; PICON A, 1995, J MOL ENDOCRINOL, V15, P187, DOI 10.1677/jme.0.0150187; Rees JL, 2004, AM J HUM GENET, V75, P739, DOI 10.1086/425285; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; Riley PA, 1997, INT J BIOCHEM CELL B, V29, P1235, DOI 10.1016/S1357-2725(97)00013-7; SANDS AT, 1995, NATURE, V377, P162, DOI 10.1038/377162a0; SCHAUER E, 1994, J CLIN INVEST, V93, P2258, DOI 10.1172/JCI117224; SCHWARZ A, 1995, J INVEST DERMATOL, V104, P922, DOI 10.1111/1523-1747.ep12606202; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; Sturm RA, 1998, MUTAT RES-FUND MOL M, V422, P69, DOI 10.1016/S0027-5107(98)00176-6; Suzuki I, 1999, J INVEST DERM SYMP P, V4, P29, DOI 10.1038/sj.jidsp.5640177; THERRIEN M, 1991, MOL CELL BIOL, V11, P3492, DOI 10.1128/MCB.11.7.3492; Tsatmali M, 2000, PIGM CELL RES, V13, P125, DOI 10.1034/j.1600-0749.13.s8.22.x; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wintzen M, 1996, J INVEST DERMATOL, V106, P673, DOI 10.1111/1523-1747.ep12345496; Wintzen M, 2001, EXP DERMATOL, V10, P305, DOI 10.1034/j.1600-0625.2001.100502.x; Zanello SB, 1999, ANN NY ACAD SCI, V885, P85; Zhang H, 2001, AM J PATHOL, V158, P381, DOI 10.1016/S0002-9440(10)63980-6; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0	85	419	436	5	35	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2007	128	5					853	864		10.1016/j.cell.2006.12.045	http://dx.doi.org/10.1016/j.cell.2006.12.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350573	Bronze			2022-12-01	WOS:000245073400011
J	Wang, JD; Sanders, GM; Grossman, AD				Wang, Jue D.; Sanders, Glenn M.; Grossman, Alan D.			Nutritional control of elongation of DNA replication by (p)ppGpp	CELL			English	Article							BACILLUS-SUBTILIS SPORULATION; STRINGENT RESPONSE; ESCHERICHIA-COLI; DEVELOPMENTAL REGULATION; STATIONARY-PHASE; CHECKPOINT; PRIMASE; FORK; PROTEIN; RECA	DNA replication is highly regulated in most organisms. Although much research has focused on mechanisms that regulate initiation of replication, mechanisms that regulate elongation of replication are less well understood. We characterized a mechanism that regulates replication elongation in the bacterium Bacillus subtilis. Replication elongation was inhibited within minutes after amino acid starvation, regardless of where the replication forks were located on the chromosome. We found that small nucleotides ppGpp and pppGpp, which are induced upon starvation, appeared to inhibit replication directly by inhibiting primase, an essential component of the replication machinery. The replication forks arrested with (p)ppGpp did not recruit the recombination protein RecA, indicating that the forks are not disrupted. (p)ppGpp appear to be part of a surveillance mechanism that links nutrient availability to replication by rapidly inhibiting replication in starved cells, thereby preventing replication-fork disruption. This control may be important for cells to maintain genomic integrity.	MIT, Dept Biol, Cambridge, MA 02139 USA; Replidyne Inc, Louisville, CO 80027 USA	Massachusetts Institute of Technology (MIT)	Grossman, AD (corresponding author), MIT, Dept Biol, Bldg 68-530, Cambridge, MA 02139 USA.	adg@mit.edu	Wang, Jue/GVU-0480-2022	Wang, Jue/0000-0003-1503-170X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084003, R01GM041934, R37GM041934] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM041934, R37 GM041934, R01 GM084003, GM 41934] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Autret S, 1999, MOL MICROBIOL, V31, P1665, DOI 10.1046/j.1365-2958.1999.01299.x; Baker TA, 1998, CELL, V92, P295, DOI 10.1016/S0092-8674(00)80923-X; Barnes MH, 1995, METHOD ENZYMOL, V262, P35; Belitskii B R, 1980, Mol Biol (Mosk), V14, P1342; Breier AM, 2005, P NATL ACAD SCI USA, V102, P3942, DOI 10.1073/pnas.0500812102; Britton RA, 2002, J BACTERIOL, V184, P4881, DOI 10.1128/JB.184.17.4881-4890.2002; BROWN NC, 1970, P NATL ACAD SCI USA, V67, P1454, DOI 10.1073/pnas.67.3.1454; BRUAND C, 1995, EMBO J, V14, P2642, DOI 10.1002/j.1460-2075.1995.tb07262.x; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; COPELAND JC, 1971, SCIENCE, V172, P159, DOI 10.1126/science.172.3979.159; Corn JE, 2006, NUCLEIC ACIDS RES, V34, P4082, DOI 10.1093/nar/gkl363; Courcelle J, 2003, ANNU REV GENET, V37, P611, DOI 10.1146/annurev.genet.37.110801.142616; Duggin I.G., 2002, BACILLUS SUBTILIS IT, P87; Dworkin J, 2002, P NATL ACAD SCI USA, V99, P14089, DOI 10.1073/pnas.182539899; Eymann C, 2002, J BACTERIOL, V184, P2500, DOI 10.1128/JB.184.9.2500-2520.2002; Foti JJ, 2005, MOL CELL, V17, P549, DOI 10.1016/j.molcel.2005.01.012; Gautam A, 2001, J BIOL CHEM, V276, P8771, DOI 10.1074/jbc.M009538200; Griffiths DJF, 2001, MOL BIOL CELL, V12, P115, DOI 10.1091/mbc.12.1.115; Harwood C.R., 1990, MOL BIOL METHODS BAC; Inaoka T, 2002, J BACTERIOL, V184, P3923, DOI 10.1128/JB.184.14.3923-3930.2002; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Khodursky AB, 2000, P NATL ACAD SCI USA, V97, P9419, DOI 10.1073/pnas.97.17.9419; Koc A, 2004, J BIOL CHEM, V279, P223, DOI 10.1074/jbc.M303952200; Krasny L, 2004, EMBO J, V23, P4473, DOI 10.1038/sj.emboj.7600423; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Lemon K.P., 2002, BACILLUS SUBTILIS IT, P73; Lemon KP, 2000, MOL CELL, V6, P1321, DOI 10.1016/S1097-2765(00)00130-1; LEVINE A, 1995, MOL MICROBIOL, V15, P287, DOI 10.1111/j.1365-2958.1995.tb02243.x; LEVINE A, 1991, J MOL BIOL, V219, P605, DOI 10.1016/0022-2836(91)90657-R; LOPEZ JM, 1981, J BACTERIOL, V146, P605, DOI 10.1128/JB.146.2.605-613.1981; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Maric C, 1999, J MOL BIOL, V291, P775, DOI 10.1006/jmbi.1999.3017; Michael WM, 2000, SCIENCE, V289, P2133, DOI 10.1126/science.289.5487.2133; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Milon P, 2006, P NATL ACAD SCI USA, V103, P13962, DOI 10.1073/pnas.0606384103; OCHI K, 1982, J BACTERIOL, V151, P1062, DOI 10.1128/JB.151.2.1062-1065.1982; Pages V, 2003, SCIENCE, V300, P1300, DOI 10.1126/science.1083964; Renzette N, 2005, MOL MICROBIOL, V57, P1074, DOI 10.1111/j.1365-2958.2005.04755.x; Schneider DA, 2003, METHOD ENZYMOL, V370, P606; SCHREIBER G, 1995, CURR MICROBIOL, V30, P27, DOI 10.1007/BF00294520; Simmons LA, 2007, P NATL ACAD SCI USA, V104, P1360, DOI 10.1073/pnas.0607123104; Soultanas P, 2005, STRUCTURE, V13, P839, DOI 10.1016/j.str.2005.04.006; Sung HM, 2002, J BACTERIOL, V184, P5641, DOI 10.1128/JB.184.20.5641-5653.2002; TIMSON J, 1975, MUTAT RES, V32, P115, DOI 10.1016/0165-1110(75)90002-0; Trautinger BW, 2005, MOL CELL, V19, P247, DOI 10.1016/j.molcel.2005.06.004; VASANTHA N, 1980, J BACTERIOL, V144, P1119, DOI 10.1128/JB.144.3.1119-1125.1980; Walker GC., 1996, E COLI SALMONELLA CE, V2, P1400; Wendrich TM, 1997, MOL MICROBIOL, V26, P65, DOI 10.1046/j.1365-2958.1997.5511919.x; WERNER R, 1971, NATURE-NEW BIOL, V233, P99, DOI 10.1038/newbio233099a0; Zhang Z, 1997, MOL CELL BIOL, V17, P6147, DOI 10.1128/MCB.17.10.6147; ZYSKIND JW, 1992, CELL, V69, P5, DOI 10.1016/0092-8674(92)90112-P	51	206	210	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2007	128	5					865	875		10.1016/j.cell.2006.12.043	http://dx.doi.org/10.1016/j.cell.2006.12.043			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350574	Green Accepted, Green Submitted, Bronze			2022-12-01	WOS:000245073400012
J	Fyhn, M; Hafting, T; Treves, A; Moser, MB; Moser, EI				Fyhn, Marianne; Hafting, Torkel; Treves, Alessandro; Moser, May-Britt; Moser, Edvard I.			Hippocampal remapping and grid realignment in entorhinal cortex	NATURE			English	Article							PLACE CELLS; PATH-INTEGRATION; MEMORY; REPRESENTATION; INPUT; MAPS; CODES; MODEL	A fundamental property of many associative memory networks is the ability to decorrelate overlapping input patterns before information is stored(1-5). In the hippocampus, this neuronal pattern separation is expressed as the tendency of ensembles of place cells 6 to undergo extensive 'remapping' in response to changes in the sensory or motivational inputs to the hippocampus(7-13). Remapping is expressed under some conditions as a change of firing rates in the presence of a stable place code ('rate remapping')(14), and under other conditions as a complete reorganization of the hippocampal place code in which both place and rate of firing take statistically independent values ('global remapping')(14). Here we show that the nature of hippocampal remapping can be predicted by ensemble dynamics in place-selective grid cells in the medial entorhinal cortex(15,16), one synapse upstream of the hippocampus. Whereas rate remapping is associated with stable grid fields, global remapping is always accompanied by a coordinate shift in the firing vertices of the grid cells. Grid fields of co-localized medial entorhinal cortex cells move and rotate in concert during this realignment. In contrast to the multiple environment-specific representations coded by place cells in the hippocampus, local ensembles of grid cells thus maintain a constant spatial phase structure, allowing position to be represented and updated by the same translation mechanism in all environments encountered by the animal.	Norwegian Univ Sci & Technol, Ctr Biol Memmory, NO-7489 Trondheim, Norway; SISSA, Int Sch Adv Studies, Cognit Neurosci Sector, I-34014 Trieste, Italy	Norwegian University of Science & Technology (NTNU); International School for Advanced Studies (SISSA)	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Ctr Biol Memmory, NO-7489 Trondheim, Norway.	edvard.moser@ntnu.no	Treves, Alessandro/B-2318-2009	TREVES, Alessandro/0000-0001-7246-5673; Hafting, Torkel/0000-0002-0928-3487				Anderson MI, 2003, J NEUROSCI, V23, P8827; Battaglia FP, 1998, PHYS REV E, V58, P7738, DOI 10.1103/PhysRevE.58.7738; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Kesner RP, 2000, CURR OPIN NEUROBIOL, V10, P260, DOI 10.1016/S0959-4388(00)00067-2; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2005, CURR OPIN NEUROBIOL, V15, P738, DOI 10.1016/j.conb.2005.10.002; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCNAUGHTON BL, 1989, NEUROSCIENCE CONNECT, P1; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Naber PA, 1997, NEUROREPORT, V8, P2617, DOI 10.1097/00001756-199707280-00039; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; QUIRK GJ, 1990, J NEUROSCI, V10, P2008; Redish AD, 1997, HIPPOCAMPUS, V7, P15; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Sharp PE, 1999, HIPPOCAMPUS, V9, P432, DOI 10.1002/(SICI)1098-1063(1999)9:4<432::AID-HIPO9>3.3.CO;2-G; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4	30	431	442	3	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2007	446	7132					190	194		10.1038/nature05601	http://dx.doi.org/10.1038/nature05601			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17322902				2022-12-01	WOS:000244718100041
J	Piccart, M; Goldhirsch, A				Piccart, Martine; Goldhirsch, Aron			Keeping faith with trial volunteers	NATURE			English	Editorial Material							POSTMENOPAUSAL WOMEN; TAMOXIFEN THERAPY; RANDOMIZED-TRIAL; LETROZOLE		European Breast Canc Coalit, Milan, Italy; Int Breast Canc Study Grp, Bern, Switzerland	International Breast Cancer Study Group								Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; ANGELL M, 2006, NEW YORK REV BOOKS, V53; Coombes RC, 2004, NEW ENGL J MED, V350, P1081, DOI 10.1056/NEJMoa040331; Drazen JM, 2002, NEW ENGL J MED, V347, P1362, DOI 10.1056/NEJMe020122; GILPIN K, 2004, NY TIMES        0602; Giordano SH, 2006, J CLIN ONCOL, V24, P2750, DOI 10.1200/JCO.2005.02.3028; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Mello MM, 2005, NEW ENGL J MED, V352, P2202, DOI 10.1056/NEJMsa044115; *NIH, 2000, ADJ THER BREAST CANC; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Regan MM, 2005, BREAST, V14, P582, DOI 10.1016/j.breast.2005.08.021; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747; World Medical Association, DECL HELS	13	19	21	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2007	446	7132					137	138		10.1038/446137a	http://dx.doi.org/10.1038/446137a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143JS	17344833				2022-12-01	WOS:000244718100021
J	McLean, DL; Fan, JY; Higashijima, S; Hale, ME; Fetcho, JR				McLean, David L.; Fan, Jingyi; Higashijima, Shin-ichi; Hale, Melina E.; Fetcho, Joseph R.			A topographic map of recruitment in spinal cord	NATURE			English	Article							LARVAL ZEBRAFISH; MOTONEURONS; INTERNEURONS; NEURONS; NETWORKS; MUSCLES; IDENTIFICATION; COORDINATION; ONTOGENY; IDENTITY	Animals move over a range of speeds by using rhythmic networks of neurons located in the spinal cord(1-6). Here we use electrophysiology and in vivo imaging in larval zebrafish ( Danio rerio) to reveal a systematic relationship between the location of a spinal neuron and the minimal swimming frequency at which the neuron is active. Ventral motor neurons and excitatory interneurons are rhythmically active at the lowest swimming frequencies, with increasingly more dorsal excitatory neurons engaged as swimming frequency rises. Inhibitory interneurons follow the opposite pattern. These inverted patterns of recruitment are independent of cell soma size among interneurons, but may be partly explained by concomitant dorso-ventral gradients in input resistance. Laser ablations of ventral, but not dorsal, excitatory interneurons perturb slow movements, supporting a behavioural role for the topography. Our results reveal an unexpected pattern of organization within zebrafish spinal cord that underlies the production of movements of varying speeds.	Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Okazaki Inst Integrat Biosci, Natl Inst Nat Sci, Aichi 4448787, Japan; Natl Inst Physiol Sci, Aichi 4448787, Japan	Cornell University; University of Chicago; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Fetcho, JR (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	jrf49@cornell.edu		Higashijima, Shin-ichi/0000-0001-6350-4992	NINDS NIH HHS [R01 NS026539, R01 NS026539-25] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026539] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bhatt DH, 2007, NEURON, V53, P91, DOI 10.1016/j.neuron.2006.11.011; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Budick SA, 2000, J EXP BIOL, V203, P2565; Combes D, 2004, J PHYSIOL-LONDON, V559, P17, DOI 10.1113/jphysiol.2004.069542; Drapeau P, 1999, J NEUROSCI METH, V88, P1, DOI 10.1016/S0165-0270(99)00008-4; FAN J, 2005, SOC NEUR ABSTR; FETCHO JR, 1987, BRAIN RES REV, V12, P243, DOI 10.1016/0165-0173(87)90001-4; FUIMAN LA, 1988, ANIM BEHAV, V36, P250, DOI 10.1016/S0003-3472(88)80268-9; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Hale ME, 2001, J COMP NEUROL, V437, P1, DOI 10.1002/cne.1266; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P560, DOI 10.1152/jn.1965.28.3.560; Higashijima S, 2004, J COMP NEUROL, V480, P19, DOI 10.1002/cne.20279; Higashijima S, 2004, J NEUROSCI, V24, P5827, DOI 10.1523/JNEUROSCI.5342-03.2004; Jankowska E, 2001, J PHYSIOL-LONDON, V533, P31, DOI 10.1111/j.1469-7793.2001.0031b.x; Kiehn O, 2003, PROG NEUROBIOL, V70, P347, DOI 10.1016/S0301-0082(03)00091-1; Kimura Y, 2006, J NEUROSCI, V26, P5684, DOI 10.1523/JNEUROSCI.4993-05.2006; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; Li WC, 2004, J NEUROSCI, V24, P5840, DOI 10.1523/JNEUROSCI.1633-04.2004; LIU DW, 1988, J PHYSIOL-LONDON, V403, P73, DOI 10.1113/jphysiol.1988.sp017239; MASINO MA, 2005, SOC NEUR ABSTR; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; Muller UK, 2004, J EXP BIOL, V207, P853, DOI 10.1242/jeb.00821; MYERS PZ, 1985, J COMP NEUROL, V236, P555, DOI 10.1002/cne.902360411; Ritter DA, 2001, J NEUROSCI, V21, P8956, DOI 10.1523/JNEUROSCI.21-22-08956.2001; ROBERTS A, 1990, SCI PROG, V74, P31; Stein PSG, 1998, ANN NY ACAD SCI, V860, P142, DOI 10.1111/j.1749-6632.1998.tb09045.x; Thorsen DH, 2004, J EXP BIOL, V207, P4175, DOI 10.1242/jeb.01285; WESTERFIELD M, 1986, J NEUROSCI, V6, P2267	30	256	257	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2007	446	7131					71	75		10.1038/nature05588	http://dx.doi.org/10.1038/nature05588			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17330042				2022-12-01	WOS:000244525600039
J	Guy, J; Gan, J; Selfridge, J; Cobb, S; Bird, A				Guy, Jacky; Gan, Jian; Selfridge, Jim; Cobb, Stuart; Bird, Adrian			Reversal of neurological defects in a mouse model of Rett syndrome	SCIENCE			English	Article							CPG-BINDING PROTEIN-2; MECP2; NEURONS; MICE; DISORDER; DNA	Rett syndrome is an autism spectrum disorder caused by mosaic expression of mutant copies of the X-linked MECP2 gene in neurons. However, neurons do not die, which suggests that this is not a neurodegenerative disorder. An important question for future therapeutic approaches to this and related disorders concerns phenotypic reversibility. Can viable but defective neurons be repaired, or is the damage done during development without normal MeCP2 irrevocable? Using a mouse model, we demonstrate robust phenotypic reversal, as activation of MeCP2 expression leads to striking loss of advanced neurological symptoms in both immature and mature adult animals.	Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland	University of Edinburgh; University of Glasgow	Bird, A (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Kings Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.	a.bird@ed.ac.uk		Gan, Jian/0000-0002-0155-6241; Guy, Jacky/0000-0002-8440-5667; SELFRIDGE, JIM/0000-0003-2473-4386; Bird, Adrian/0000-0002-8600-0372	Wellcome Trust [077224] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; ARMSTRONG D, 1995, J NEUROPATH EXP NEUR, V54, P195, DOI 10.1097/00005072-199503000-00006; Asaka Y, 2006, NEUROBIOL DIS, V21, P217, DOI 10.1016/j.nbd.2005.07.005; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Dragatsis I, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.3.e10; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Kriaucionis S, 2003, HUM MOL GENET, V12, pR221, DOI 10.1093/hmg/ddg286; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Neul JL, 2004, NEUROSCIENTIST, V10, P118, DOI 10.1177/1073858403260995	15	818	847	2	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2007	315	5815					1143	1147		10.1126/science.1138389	http://dx.doi.org/10.1126/science.1138389			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138UA	17289941	Green Accepted			2022-12-01	WOS:000244387600042
J	Okeoma, CM; Lovsin, N; Peterlin, BM; Ross, SR				Okeoma, Chioma M.; Lovsin, Nika; Peterlin, B. Matija; Ross, Susan R.			APOBEC3 inhibits mouse mammary tumour virus replication in vivo	NATURE			English	Article							HIV-1 INFECTION; T-CELLS; B-CELLS; PROTEIN; MICE; DNA; RETROVIRUSES; RECEPTOR; GENE	Genomes of all mammals encode apobec3 genes, which are thought to have a function in intrinsic cellular immunity to several viruses including human immunodeficiency virus type 1 (HIV-1)(1). APOBEC3 (A3) proteins are packaged into virions and inhibit retroviral replication in newly infected cells, at least in part by deaminating cytidines on the negative strand DNA intermediates(2). However, the role of A3 in innate resistance to mouse retroviruses is not understood. Here we show that A3 functions during retroviral infection in vivo and provides partial protection to mice against infection with mouse mammary tumour virus ( MMTV). Both mouse A3 and human A3G proteins interacted with the MMTV nucleocapsid in an RNA-dependent fashion and were packaged into virions. In addition, mouse A3-containing and human A3G-containing virions showed a marked decrease in titre. Last, A3(-/-) mice were more susceptible to MMTV infection, because virus spread was more rapid and extensive than in their wild-type littermates.	Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; Univ Penn, Abramson Family Canc Ctr, Philadelphia, PA 19104 USA; Univ Ljubljana, Fac Chem & Chem Technol, Dept Biochem, SI-1000 Ljubljana, Slovenia; Univ Calif San Francisco, Rosalinf Russell Med Res Ctr, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Rosalinf Russell Med Res Ctr, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Ljubljana; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ross, SR (corresponding author), Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.	rosss@mail.med.upenn.edu		Ross, Susan R/0000-0002-3094-3769; Okeoma, Chioma/0000-0001-7737-6493	NATIONAL CANCER INSTITUTE [T32CA009140] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baillie GJ, 2004, J VIROL, V78, P5784, DOI 10.1128/JVI.78.11.5784-5798.2004; Berkhout B, 2002, AIDS RES HUM RETROV, V18, P133, DOI 10.1089/08892220252779674; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Cullen BR, 2006, J VIROL, V80, P1067, DOI 10.1128/JVI.80.3.1067-1076.2006; Doehle BP, 2005, J VIROL, V79, P8201, DOI 10.1128/JVI.79.13.8201-8207.2005; Doehle BP, 2006, J VIROL, V80, P12102, DOI 10.1128/JVI.01600-06; Dzuris JL, 1997, J VIROL, V71, P6044, DOI 10.1128/JVI.71.8.6044-6048.1997; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; GOLOVKINA TV, 1995, P NATL ACAD SCI USA, V92, P4828, DOI 10.1073/pnas.92.11.4828; Golovkina TV, 1998, J VIROL, V72, P3066, DOI 10.1128/JVI.72.4.3066-3071.1998; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; Indik S, 2005, CANCER RES, V65, P6651, DOI 10.1158/0008-5472.CAN-04-2609; Kobayashi M, 2004, J VIROL, V78, P8238, DOI 10.1128/JVI.78.15.8238-8244.2004; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mikl MC, 2005, MOL CELL BIOL, V25, P7270, DOI 10.1128/MCB.25.16.7270-7277.2005; MORRIS VL, 1977, J MOL BIOL, V114, P73, DOI 10.1016/0022-2836(77)90284-4; NANDI S, 1973, ADV CANCER RES, V17, P353; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Rassa JC, 2002, P NATL ACAD SCI USA, V99, P2281, DOI 10.1073/pnas.042355399; Ross SR, 2000, MICROBES INFECT, V2, P1215, DOI 10.1016/S1286-4579(00)01275-2; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Uz-Zaman T, 2003, VIROLOGY, V314, P294, DOI 10.1016/S0042-6822(03)00429-X; Zhang YM, 2003, J VIROL, V77, P10468, DOI 10.1128/JVI.77.19.10468-10478.2003; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	29	155	159	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					927	930		10.1038/nature05540	http://dx.doi.org/10.1038/nature05540			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17259974				2022-12-01	WOS:000244341200052
J	Forest, F; Grenyer, R; Rouget, M; Davies, TJ; Cowling, RM; Faith, DP; Balmford, A; Manning, JC; Proches, S; van der Bank, M; Reeves, G; Hedderson, TAJ; Savolainen, V				Forest, Felix; Grenyer, Richard; Rouget, Mathieu; Davies, T. Jonathan; Cowling, Richard M.; Faith, Daniel P.; Balmford, Andrew; Manning, John C.; Proches, Serban; van der Bank, Michelle; Reeves, Gail; Hedderson, Terry A. J.; Savolainen, Vincent			Preserving the evolutionary potential of floras in biodiversity hotspots	NATURE			English	Article							CAPE FLORA; PLANT DIVERSITY; CONSERVATION; RADIATION; RICHNESS; HISTORY	One of the biggest challenges for conservation biology is to provide conservation planners with ways to prioritize effort. Much attention has been focused on biodiversity hotspots(1). However, the conservation of evolutionary process is now also acknowledged as a priority in the face of global change(2). Phylogenetic diversity (PD) is a biodiversity index that measures the length of evolutionary pathways that connect a given set of taxa(3,4). PD therefore identifies sets of taxa that maximize the accumulation of 'feature diversity'. Recent studies, however, concluded that taxon richness is a good surrogate for PD5-9. Here we show taxon richness to be decoupled from PD, using a biome-wide phylogenetic analysis of the flora of an undisputed biodiversity hotspot - the Cape of South Africa. We demonstrate that this decoupling has real-world importance for conservation planning. Finally, using a database of medicinal and economic plant use(10), we demonstrate that PD protection is the best strategy for preserving feature diversity in the Cape. We should be able to use PD to identify those key regions that maximize future options, both for the continuing evolution of life on Earth and for the benefit of society.	Kirstenbosch Res Ctr, S African Natl Biodivers Inst, ZA-7735 Claremont, South Africa; Univ Cape Town, Dept Bot, ZA-7700 Rondebosch, South Africa; Royal Bot Gardens, Jodrell Lab, Richmond TW9 3DS, Surrey, England; S African Natl Biodivers Inst, Biodivers Planning Unit, ZA-0001 Pretoria, South Africa; Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; Univ Georgia, Inst Ecol, Athens, GA 30602 USA; Nelson Mandela Metropolitan Univ, Dept Bot, ZA-6031 Port Elizabeth, South Africa; Australian Museum, Sydney, NSW 2010, Australia; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Stellenbosch, Ctr Invas Biol, ZA-7602 Matieland, South Africa; Univ Johannesburg, Dept Bot & Plant Biotechnol, ZA-2006 Auckland Pk, South Africa	South African National Biodiversity Institute; University of Cape Town; Royal Botanic Gardens, Kew; South African National Biodiversity Institute; University of Virginia; University System of Georgia; University of Georgia; Nelson Mandela University; Australian Museum; University of Cambridge; Stellenbosch University; University of Johannesburg	Forest, F (corresponding author), Kirstenbosch Res Ctr, S African Natl Biodivers Inst, Private Bag X7, ZA-7735 Claremont, South Africa.	f.forest@kew.org; v.savolainen@kew.org	Cowling, Richard/AFU-6261-2022; Rouget, Mathieu/B-7249-2008; Hedderson, Terry/AAD-8614-2021; Procheş, Şerban/A-2044-2008	Rouget, Mathieu/0000-0003-1836-7727; Procheş, Şerban/0000-0002-3415-6930; Savolainen, Vincent/0000-0001-5350-9984; Balmford, Andrew/0000-0002-0144-3589; Rouget, Mathieu/0000-0002-6172-3152				Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Cowling R. M., 2005, Plant diversity and complexity patterns: local, regional and global dimensions. Proceedings of an International Symposium held at the Royal Danish Academy of Sciences and Letters in Copenhagen, Denmark, 25-28 May, 2003, P273; Cowling RM, 2002, DIVERS DISTRIB, V8, P163, DOI 10.1046/j.1472-4642.2002.00143.x; Cowling RM, 1999, J BIOGEOGR, V26, P367, DOI 10.1046/j.1365-2699.1999.00275.x; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; ERWIN TL, 1991, SCIENCE, V253, P750, DOI 10.1126/science.253.5021.750; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Goldblatt P, 2002, ANN MO BOT GARD, V89, P281, DOI 10.2307/3298566; Goldblatt P, 2002, MOL PHYLOGENET EVOL, V25, P341, DOI 10.1016/S1055-7903(02)00235-X; GOLDBLATT P, 2000, CONSPECTUS CAPE FLOR; Linder HP, 2003, BIOL REV, V78, P597, DOI 10.1017/S1464793103006171; Linder HP, 2005, TRENDS PLANT SCI, V10, P536, DOI 10.1016/j.tplants.2005.09.006; LINDER HP, 1994, S AFR J SCI, V90, P329; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; Midgley G.F., 2001, J MEDITERRANEAN ECOL, V2, P137, DOI DOI 10.1111/EVO.12573; MOOERS AO, 2005, PHYLOGENY CONSERVATI; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Polasky S, 2001, BIOL CONSERV, V97, P99, DOI 10.1016/S0006-3207(00)00103-8; Proches S, 2006, P R SOC B, V273, P1143, DOI 10.1098/rspb.2005.3427; Richardson JE, 2001, NATURE, V412, P181, DOI 10.1038/35084067; Rodrigues ASL, 2005, CONSERV BIOL SER, V8, P101; Rodrigues ASL, 2002, BIOL CONSERV, V105, P103, DOI 10.1016/S0006-3207(01)00208-7; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; *SURV EC PLANTS AR, 1999, SEPASAL DAT; The Angiosperm Phylogeny Group, 2003, BOT J LINN SOC, V141, P399, DOI [DOI 10.1046/J.1095-8339.2003.T01-1-00158.X, 10.1046/j.1095-8339.2003.t01-1-00158.x]; Torres NM, 2004, GENET MOL BIOL, V27, P511, DOI 10.1590/S1415-47572004000400008; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366; [No title captured]	30	639	671	9	391	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 15	2007	445	7129					757	760		10.1038/nature05587	http://dx.doi.org/10.1038/nature05587			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17301791				2022-12-01	WOS:000244205200043
J	Gavin, MA; Rasmussen, JP; Fontenot, JD; Vasta, V; Manganiello, VC; Beavo, JA; Rudensky, AY				Gavin, Marc A.; Rasmussen, Jeffrey P.; Fontenot, Jason D.; Vasta, Valeria; Manganiello, Vincent C.; Beavo, Joseph A.; Rudensky, Alexander Y.			Foxp3-dependent programme of regulatory T-cell differentiation	NATURE			English	Article							TRANSCRIPTION FACTOR FOXP3; HELPER-CELLS; INFLAMMATION; ACTIVATION; RECEPTORS	Regulatory CD4(+) T cells (T-R cells), the development of which is critically dependent on X-linked transcription factor Foxp3 ( forkhead box P3), prevent self-destructive immune responses(1). Despite its important role, molecular and functional features conferred by Foxp3 to T-R precursor cells remain unknown. It has been suggested that Foxp3 expression is required for both survival of T-R precursors as well as their inability to produce interleukin (IL)-2 and independently proliferate after T-cell-receptor engagement, raising the possibility that such 'anergy' and T-R suppressive capacity are intimately linked(2-4). Here we show, by dissociating Foxp3-dependent features from those induced by the signals preceding and promoting its expression in mice, that the latter signals include several functional and transcriptional hallmarks of T-R cells. Although its function is required for T-R cell suppressor activity, Foxp3 to a large extent amplifies and fixes pre-established molecular features of T-R cells, including anergy and dependence on paracrine IL-2. Furthermore, Foxp3 solidifies T-R cell lineage stability through modification of cell surface and signalling molecules, resulting in adaptation to the signals required to induce and maintain T-R cells. This adaptation includes Foxp3-dependent repression of cyclic nucleotide phosphodiesterase 3B, affecting genes responsible for T-R cell homeostasis.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; NHLBI, NIH, Bethesda, MD 20892 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Rudensky, AY (corresponding author), Amgen Corp, Seattle, WA 98101 USA.	aruden@u.washington.edu		Rasmussen, Jeffrey/0000-0001-6997-3773	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002540, Z01HL002540] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Chan CWY, 2003, J IMMUNOL, V170, P4036, DOI 10.4049/jimmunol.170.8.4036; Choi YH, 2006, J CLIN INVEST, V116, P3240, DOI 10.1172/JCI24867; Erdmann AA, 2005, BLOOD, V105, P4707, DOI 10.1182/blood-2004-04-1407; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Sheppard FR, 2005, J LEUKOCYTE BIOL, V78, P1025, DOI 10.1189/jlb.0804442; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Torgersen KM, 2002, CELL SIGNAL, V14, P1, DOI 10.1016/S0898-6568(01)00214-5; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; WILLIAMS LM, IN PRESS NATURE IMMU; Yegutkin GG, 2006, J BIOL CHEM, V281, P29441, DOI 10.1074/jbc.M602480200; Yegutkin GG, 2002, BIOCHEM J, V367, P121, DOI 10.1042/BJ20020439; Zhang W, 2000, BLOOD, V95, P3380, DOI 10.1182/blood.V95.11.3380.011k25_3380_3386; ZHENG Y, NATURE IN PRESS	23	870	924	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2007	445	7129					771	775		10.1038/nature05543	http://dx.doi.org/10.1038/nature05543			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17220874	Bronze			2022-12-01	WOS:000244205200046
J	Lieberman, D; Tooby, J; Cosmides, L				Lieberman, Debra; Tooby, John; Cosmides, Leda			The architecture of human kin detection	NATURE			English	Article							INBREEDING DEPRESSION; SIBLING INCEST; SELECTION; EVOLUTION; SEX; PREFERENCES; HYPOTHESES; HISTORY	Evolved mechanisms for assessing genetic relatedness have been found in many species, but their existence in humans has been a matter of controversy. Here we report three converging lines of evidence, drawn from siblings, that support the hypothesis that kin detection mechanisms exist in humans. These operate by computing, for each familiar individual, a unitary regulatory variable ( the kinship index) that corresponds to a pairwise estimate of genetic relatedness between self and other. The cues that the system uses were identified by quantitatively matching individual exposure to potential cues of relatedness to variation in three outputs relevant to the system's evolved functions: sibling altruism, aversion to personally engaging in sibling incest, and moral opposition to third party sibling incest. As predicted, the kin detection system uses two distinct, ancestrally valid cues to compute relatedness: the familiar other's perinatal association with the individual's biological mother, and duration of sibling coresidence.	Univ Calif Santa Barbara, Ctr Evolut Psychol, Santa Barbara, CA 93106 USA; Univ Hawaii, Dept Psychol, Honolulu, HI 96822 USA	University of California System; University of California Santa Barbara; University of Hawaii System	Lieberman, D (corresponding author), Univ Calif Santa Barbara, Ctr Evolut Psychol, Santa Barbara, CA 93106 USA.	debra@debralieberman.com			OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000516] Funding Source: NIH RePORTER; NIH HHS [DP1 OD000516, DP1 OD000516-02] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		[Anonymous], 1995, SEXUAL ATTRACTION CH; Baglione V, 2003, SCIENCE, V300, P1947, DOI 10.1126/science.1082429; Bernstein I.S., 1991, P6; Bevc I, 2000, EVOL HUM BEHAV, V21, P151, DOI 10.1016/S1090-5138(99)00041-0; BITTLES AH, 1994, NAT GENET, V8, P117, DOI 10.1038/ng1094-117; Buchan JC, 2003, NATURE, V425, P179, DOI 10.1038/nature01866; Cade B.S., 2005, USER MANUAL BLOSSOM; Chapais B., 2004, KINSHIP BEHAV PRIMAT; Chapuisat M, 1999, HEREDITY, V82, P473, DOI 10.1038/sj.hdy.6885340; Charlesworth B, 1999, GENET RES, V74, P329, DOI 10.1017/S0016672399004152; COSMIDES LM, 1981, J THEOR BIOL, V89, P83, DOI 10.1016/0022-5193(81)90181-8; Crnokrak P, 1999, HEREDITY, V83, P260, DOI 10.1038/sj.hdy.6885530; Crozier R.H., 1996, EVOLUTION SOCIAL INS; DeBruine LM, 2005, P ROY SOC B-BIOL SCI, V272, P919, DOI 10.1098/rspb.2004.3003; Duffy JE, 1996, NATURE, V381, P512, DOI 10.1038/381512a0; Fessler DMT, 2004, EVOL HUM BEHAV, V25, P277, DOI 10.1016/j.evolhumbehav.2004.05.004; Fletcher DJ., 1987, KIN RECOGNITION ANIM; Gigerenzer G., 1999, SIMPLE HEURISTICS MA; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hepper PG, 1991, KIN RECOGNITION; Hewlett B. S., 2005, HUNTER GATHERER CHIL; Hill K., 1996, ACHE LIFE HIST ECOLO; Holmes WG, 2004, ANN ZOOL FENN, V41, P691; HOWELL N, 2000, DEMOGRAPHY DOBEL KUN; ITO Y, 1989, TRENDS ECOL EVOL, V4, P69, DOI 10.1016/0169-5347(89)90151-1; Kaplan H, 2000, EVOL ANTHROPOL, V9, P156, DOI 10.1002/1520-6505(2000)9:4<156::AID-EVAN5>3.0.CO;2-7; Lee Richard, 1968, MAN HUNTER; Lieberman D, 2003, P ROY SOC B-BIOL SCI, V270, P819, DOI 10.1098/rspb.2002.2290; Mielke PW., 2001, PERMUTATION METHODS; Ober C, 1997, AM J HUM GENET, V61, P497, DOI 10.1086/515511; Passera L, 2001, SCIENCE, V293, P1308, DOI 10.1126/science.1062076; Penn DJ, 1999, AM NAT, V153, P145, DOI 10.1086/303166; Queller D. C., 1989, Oxford Surveys in Evolutionary Biology, V6, P73; RICE WR, 1994, TRENDS ECOL EVOL, V9, P235, DOI 10.1016/0169-5347(94)90258-5; SHEPHER J, 1971, ARCH SEX BEHAV, V1, P293, DOI 10.1007/BF01638058; SHERMAN PW, 1977, SCIENCE, V197, P1246, DOI 10.1126/science.197.4310.1246; Silk JB, 2002, INT J PRIMATOL, V23, P849, DOI 10.1023/A:1015581016205; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; TOOBY J, 1982, J THEOR BIOL, V97, P557, DOI 10.1016/0022-5193(82)90358-7; Walters J.R., 1987, P359; Wedekind C, 1997, P ROY SOC B-BIOL SCI, V264, P1471, DOI 10.1098/rspb.1997.0204; Westermarck E., 1891, HIST HUMAN MARRIAGE; WILLIAMS GC, 1957, EVOLUTION, V11, P32, DOI 10.2307/2405809	43	340	350	1	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2007	445	7129					727	731		10.1038/nature05510	http://dx.doi.org/10.1038/nature05510			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17301784	Green Accepted			2022-12-01	WOS:000244205200036
J	Staudt, LM				Staudt, Louis M.			A closer look at follicular lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTHY-INDIVIDUALS; B-CELLS		NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Staudt, LM (corresponding author), NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.		Staudt, Louis/AAC-5324-2019					Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Giannelli F, 2003, BLOOD, V102, P1196, DOI 10.1182/blood-2002-05-1537; Roulland S, 2006, J EXP MED, V203, P2425, DOI 10.1084/jem.20061292	4	41	41	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2007	356	7					741	742		10.1056/NEJMcibr067155	http://dx.doi.org/10.1056/NEJMcibr067155			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135ZV	17301308				2022-12-01	WOS:000244193300016
J	Sinha, A; Levine, O; Knoll, MD; Muhib, F; Lieu, TA				Sinha, Anushua; Levine, Orin; Knoll, Maria D.; Muhib, Farzona; Lieu, Tracy A.			Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysis	LANCET			English	Article; Proceedings Paper	42nd Annual Meeting of the Infectious-Diseases-Society-of-America	SEP 30-OCT 03, 2004	Boston, MA	Infect Dis Soc Amer			INFLUENZAE TYPE-B; STREPTOCOCCUS-PNEUMONIAE; EFFICACY; DISEASE; IMMUNIZATION; SAFETY; GAMBIA	Background Routine vaccination of infants against Streptococcus pneumoniae (pneumococcus) needs substantial investment by governments and charitable organisations. Policymakers need information about the projected health benefits, costs, and cost-effectiveness of vaccination when considering these investments. Our aim was to incorporate these data into an economic analysis of pneumococcal vaccination of infants in countries eligible for financial support from the Global Alliance for Vaccines & immunization (GAVI). Methods We constructed a decision analysis model to compare pneumococcal vaccination of infants aged 6, 10, and 14 weeks with no vaccination in the 72 countries that were eligible as of 2005. We used published and unpublished data to estimate child mortality, effectiveness of pneumococcal conjugate vaccine, and immunisation. rates. Findings Pneumococcal vaccination at the rate of diptheria-tetanus-pertussis vaccine coverage was projected to prevent 262000 deaths per year (7%) in children aged 3-29 months in the 72 developing countries studied, thus averting 8.34 million disability-adjusted life years (DALYs) yearly. If every child could be reached, up to 407 000 deaths per year would be prevented. At a vaccine cost of International $5 per dose, vaccination would have a net cost of $838 million, a cost of $100 per DALY averted. Vaccination at this price was projected to be highly cost-effective in 68 of 72 countries when each country's per head gross domestic product per DALY averted was used as a benchmark. Interpretation At a vaccine cost of between $1 and $5 per dose, purchase and accelerated uptake of pneumococcal vaccine in the world's poorest countries is projected to substantially reduce childhood mortality and to be highly cost-effective.	Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Prevent Med & Community Hlth, Newark, NJ 07101 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Pilgrim Hlth Care, Dept Ambulatory Care & Prevent, Ctr Child Hlth Care Studies, Boston, MA USA; Childrens Hosp, Div Gen Pediat, Boston, MA 02115 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Boston Children's Hospital	Sinha, A (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Prevent Med & Community Hlth, MSB F506,185 S Orange Ave, Newark, NJ 07101 USA.	sinhaan1@umdnj.edu		Deloria Knoll, Maria/0000-0001-9041-2671				Berndt ER, 2005, HEALTH AFFAIR, V24, P653, DOI 10.1377/hlthaff.24.3.653; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P893; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; DRUMMOND MF, 2000, METHODS EC EVALUATIO; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; *FIN TASK FORC, IMM PROGR EXP FIN FU; Goetghebuer T, 2000, TROP MED INT HEALTH, V5, P207, DOI 10.1046/j.1365-3156.2000.00535.x; Hinman AR, 2004, AM J PREV MED, V26, P84, DOI 10.1016/j.amepre.2003.09.008; Jaffar S, 1997, TROP MED INT HEALTH, V2, P28, DOI 10.1046/j.1365-3156.1997.d01-131.x; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Kuntz KM, 2001, EC EVALUATION HLTH C, P141; Levine OS, 2004, J HEALTH POPUL NUTR, V22, P268; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Lieu TA, 2005, HEALTH AFFAIR, V24, P666, DOI 10.1377/hlthaff.24.3.666; LOPEZ AD, 2001, LIFE TABLES 191 COUN, P1; Miller MA, 2000, HEALTH ECON, V9, P19, DOI 10.1002/(SICI)1099-1050(200001)9:1<19::AID-HEC487>3.0.CO;2-C; Murray CJ, 1996, GLOBAL BURDEN DIS, V1996, P201; O'Brien KL, 2003, LANCET, V362, P355, DOI 10.1016/S0140-6736(03)14022-6; O'Brien KL, 2003, VACCINE, V21, P1815, DOI 10.1016/S0264-410X(02)00807-1; Poehling KA, 2006, JAMA-J AM MED ASSOC, V295, P1668, DOI 10.1001/jama.295.14.1668; Rushby JF, 2001, HEALTH POLICY PLANN, V16, P326, DOI 10.1093/heapol/16.3.326; Saving Newborn Lives, 2001, SAV NEWB LIV STAT WO, P1; SHANN F, 1986, PEDIATR INFECT DIS J, V5, P247, DOI 10.1097/00006454-198603000-00017; SHEPARD DS, 1995, VACCINE, V13, P707, DOI 10.1016/0264-410X(94)00063-S; TREMONTI G, 2005, 0127 G8 FIN MIN; *UNICEF, 2005 VACC PROJ QUANT; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; *WHO, 2005, 01229 WHO; WHO, UN COSTS PAT SERV; *WHO, 2002, 01230 WHO; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; *WORLD BANK, WDI ONL; World Health Organization, 1991, TECHN BAS WHO REC MA	34	102	111	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2007	369	9559					389	396		10.1016/S0140-6736(07)60195-0	http://dx.doi.org/10.1016/S0140-6736(07)60195-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	132LN	17276779				2022-12-01	WOS:000243944400033
J	Konradsen, F; Dawson, AH; Eddleston, M; Gunnell, D				Konradsen, Flemming; Dawson, Andrew H.; Eddleston, Michael; Gunnell, David			Pesticide self-poisoning: thinking outside the box	LANCET			English	Editorial Material							DEVELOPING-COUNTRIES; SUICIDE		Univ Copenhagen, Dept Int Hlth, DK-1014 Copenhagen K, Denmark; Univ Peradeniya, S Asian Clin Toxicol Res Collaborat, Peradeniya, Sri Lanka; Univ Newcastle, Sch Populat Hlth Sci, Fac Med & Hlth Sci, Newcastle, NSW 2308, Australia; Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; Univ Bristol, Dept Social Med, Bristol, Avon, England	University of Copenhagen; University of Peradeniya; University of Newcastle; University of Oxford; University of Bristol	Konradsen, F (corresponding author), Univ Copenhagen, Dept Int Hlth, DK-1014 Copenhagen K, Denmark.	f.konradsen@pubhealth.ku.dk	Dawson, Andrew/D-5085-2012; Gunnell, David/ABE-6653-2020; Dawson, Andrew H/U-8041-2019	Dawson, Andrew/0000-0002-8047-397X; Gunnell, David/0000-0002-0829-6470; Dawson, Andrew H/0000-0002-8047-397X; Konradsen, Flemming/0000-0003-1036-6949	Wellcome Trust [063560, 071669] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bertolote JM, 2006, B WORLD HEALTH ORGAN, V84, P260; *CROPL INT, 1998, GUID SAF EFF US CROP; Eddleston M, 2006, INJURY PREV, V12, P333, DOI 10.1136/ip.2006.012641; Gunnell D, 2003, INT J EPIDEMIOL, V32, P902, DOI 10.1093/ije/dyg307; Health organization, 2001, WORLD HLTH REPORT 20; Konradsen F, 2003, TOXICOLOGY, V192, P249, DOI 10.1016/S0300-483X(03)00339-1; MISHARA BL, 2005, ANN C INT ASS SUIC P; PIERIS R, 2005, FINAL REPORT USE SUR; *SYNG, 2006, SOC RES PROD STEW; , 2004, IMP PEST HLTH PREV I; 2006, IASP NEWS B      APR	11	34	34	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 20	2007	369	9557					169	170		10.1016/S0140-6736(07)60085-3	http://dx.doi.org/10.1016/S0140-6736(07)60085-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	128XG	17240268	Green Accepted, Green Published			2022-12-01	WOS:000243692400007
J	Berg, RW; Alaburda, A; Hounsgaard, J				Berg, Rune W.; Alaburda, Aidas; Hounsgaard, Jorn			Balanced inhibition and excitation drive spike activity in spinal half-centers	SCIENCE			English	Article							NEURONS IN-VIVO; NETWORK ACTIVITY; CORTICAL-NEURONS; SYNAPTIC INPUT; CONDUCTANCE; CORD; MOTONEURONS; VARIABILITY; MODULATION; MODELS	Many limb movements are composed of alternating flexions and extensions. However, the underlying spinal network mechanisms remain poorly defined. Here, we show that the intensity of synaptic excitation and inhibition in limb motoneurons varies in phase rather than out of phase during rhythmic scratchlike network activity in the turtle. Inhibition and excitation peak with the total neuron conductance during the depolarizing waves of scratch episodes. Furthermore, spike activity is driven by depolarizing synaptic transients rather than pacemaker properties. These findings show that balanced excitation and inhibition and irregular firing are fundamental motifs in certain spinal network functions.	Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; Vilnius State Univ, Fac Nat Sci, Dept Biochem & Biophys, LT-03101 Vilnius, Lithuania	University of Copenhagen; Vilnius University	Hounsgaard, J (corresponding author), Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark.	j.hounsgaard@mfi.ku.dk	Berg, Rune W/C-9717-2014; Berg, Rune W./X-7293-2019	Berg, Rune W/0000-0001-6376-9368; Berg, Rune W./0000-0001-6376-9368; hounsgaard, jorn/0000-0003-1523-0485				Alaburda A, 2005, J NEUROSCI, V25, P6316, DOI 10.1523/JNEUROSCI.0843-05.2005; Alaburda A, 2003, J NEUROSCI, V23, P8625; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Brown TG, 1911, P R SOC LOND B-CONTA, V84, P308, DOI 10.1098/rspb.1911.0077; CALVIN WH, 1968, J NEUROPHYSIOL, V31, P574, DOI 10.1152/jn.1968.31.4.574; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Delgado-Lezama R, 1999, PROG BRAIN RES, V123, P57, DOI 10.1016/S0079-6123(08)62844-7; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Diba K, 2004, J NEUROSCI, V24, P9723, DOI 10.1523/JNEUROSCI.1721-04.2004; GERSTEIN GL, 1964, BIOPHYS J, V4, P41, DOI 10.1016/S0006-3495(64)86768-0; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Grillner S, 2011, COMPR PHYSIOL, V26, P1179, DOI [10.1126/science.1245629, DOI 10.1002/CPHY.CP010226]; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V398, P575, DOI 10.1113/jphysiol.1988.sp017058; JANKOWSKA E, 1965, NATURE, V206, P198, DOI 10.1038/206198a0; KEIFER J, 1983, BRAIN RES, V266, P148, DOI 10.1016/0006-8993(83)91318-5; Kiehn O, 2000, BRAIN RES BULL, V53, P649, DOI 10.1016/S0361-9230(00)00398-1; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Sherrington C., 1947, INTEGRATIVE ACTION N; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Stein PSG, 2005, J COMP PHYSIOL A, V191, P213, DOI 10.1007/s00359-004-0568-6; Stern EA, 1997, J NEUROPHYSIOL, V77, P1697, DOI 10.1152/jn.1997.77.4.1697; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724	29	180	180	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 19	2007	315	5810					390	393		10.1126/science.1134960	http://dx.doi.org/10.1126/science.1134960			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126SI	17234950				2022-12-01	WOS:000243535400046
J	Goldston, D				Goldston, David			Climate of opportunity	NATURE			English	Editorial Material									Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA	Princeton University	Goldston, D (corresponding author), Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA.								0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 18	2007	445	7125					248	248		10.1038/445248a	http://dx.doi.org/10.1038/445248a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126HT	17230163	Bronze			2022-12-01	WOS:000243504700012
J	Stukel, TA; Fisher, ES; Wennberg, DE; Alter, DA; Gottlieb, DJ; Vermeulen, MJ				Stukel, Therese A.; Fisher, Elliott S.; Wennberg, David E.; Alter, David A.; Gottlieb, Daniel J.; Vermeulen, Marian J.			Analysis of observational studies in the presence of treatment selection bias - Effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-ANGIOGRAPHY; REGIONAL-VARIATIONS; ELDERLY-PATIENTS; THROMBOLYTIC THERAPY; MEDICARE PATIENTS; OUTCOMES; REGRESSION; RISK; STRATEGIES	Context Comparisons of outcomes between patients treated and untreated in observational studies may be biased due to differences in patient prognosis between groups, often because of unobserved treatment selection biases. Objective To compare 4 analytic methods for removing the effects of selection bias in observational studies: multivariable model risk adjustment, propensity score risk adjustment, propensity-based matching, and instrumental variable analysis. Design, Setting, and Patients A national cohort of 122 124 patients who were elderly ( aged 65-84 years), receiving Medicare, and hospitalized with acute myocardial infarction ( AMI) in 1994-1995, and who were eligible for cardiac catheterization. Baseline chart reviews were taken from the Cooperative Cardiovascular Project and linked to Medicare health administrative data to provide a rich set of prognostic variables. Patients were followed up for 7 years through December 31, 2001, to assess the association between long-term survival and cardiac catheterization within 30 days of hospital admission. Main Outcome Measure Risk-adjusted relative mortality rate using each of the analytic methods. Results Patients who received cardiac catheterization (n = 73 238) were younger and had lower AMI severity than those who did not. After adjustment for prognostic factors by using standard statistical risk-adjustment methods, cardiac catheterization was associated with a 50% relative decrease in mortality ( for multivariable model risk adjustment: adjusted relative risk [RR], 0.51; 95% confidence interval [CI], 0.50-0.52; for propensity score risk adjustment: adjusted RR, 0.54; 95% CI, 0.53-0.55; and for propensity-based matching: adjusted RR, 0.54; 95% CI, 0.52-0.56). Using regional catheterization rate as an instrument, instrumental variable analysis showed a 16% relative decrease in mortality ( adjusted RR, 0.84; 95% CI, 0.79-0.90). The survival benefits of routine invasive care from randomized clinical trials are between 8% and 21%. Conclusions Estimates of the observational association of cardiac catheterization with long-term AMI mortality are highly sensitive to analytic method. All standard risk-adjustment methods have the same limitations regarding removal of unmeasured treatment selection biases. Compared with standard modeling, instrumental variable analysis may produce less biased estimates of treatment effects, but is more suited to answering policy questions than specific clinical questions.	Inst Clin Evaluat Sci, Toronto, ON, Canada; Dartmouth Med Sch, Ctr Evaluat Clin Sci, Hanover, NH USA; Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; Sunnybrook Hlth Sci Ctr, Clin Epidemiol & Hlth Care Res Program, Toronto, ON, Canada; Vet Adm Outcomes Grp, White River Jct, VT USA; Maine Med Ctr, Ctr Outcomes Res & Evaluat, Portland, ME 04102 USA; St Michaels Hosp, Toronto Rehabil Inst, Div Cardiol, Toronto, ON M5B 1W8, Canada; St Michaels Hosp, Toronto Rehabil Inst, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; Dartmouth College; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Maine Medical Center; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto	Stukel, TA (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	stukel@ices.on.ca	Potter, Joseph E/A-3122-2008	Stukel, Therese/0000-0002-2951-1360	NIA NIH HHS [P01 AG019783-06, 1P01-AG19783-01, P01 AG019783] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Austin PC, 2005, STAT MED, V24, P1563, DOI 10.1002/sim.2053; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Braitman LE, 2002, ANN INTERN MED, V137, P693, DOI 10.7326/0003-4819-137-8-200210150-00015; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; COX DR, 1968, J ROY STAT SOC B, V30, P248, DOI 10.1111/j.2517-6161.1968.tb00724.x; Cox DR., 1984, ANAL SURVIVAL DATA; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Goodman DC, 2002, NEW ENGL J MED, V346, P1538, DOI 10.1056/NEJMoa011921; Harrell Jr FE, 2001, REGRESSION MODELING, DOI DOI 10.1007/978-3-319-19425-7; Harris KM, 1998, HEALTH SERV RES, V33, P1337; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; Krumholz HM, 1997, JAMA-J AM MED ASSOC, V277, P1683, DOI 10.1001/jama.277.21.1683; Landrum MB, 2001, HLTH SERV OUTCOMES R, V2, P221, DOI DOI 10.1023/A:1020367111374; Lee DS, 2005, JAMA-J AM MED ASSOC, V294, P1240, DOI 10.1001/jama.294.10.1240; LIN DY, 1994, STAT MED, V13, P2233, DOI 10.1002/sim.4780132105; Mamdani M, 2004, LANCET, V363, P1751, DOI 10.1016/S0140-6736(04)16299-5; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Parsons LS, REDUCING BIAS PROPEN; Pilote L, 1996, NEW ENGL J MED, V335, P1198, DOI 10.1056/NEJM199610173351606; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; ROSENBAUM PR, 1991, ANN INTERN MED, V115, P901, DOI 10.7326/0003-4819-115-11-901; Ryan TJ, 1999, J AM COLL CARDIOL, V34, P890, DOI 10.1016/S0735-1097(99)00351-4; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Selby JV, 1996, NEW ENGL J MED, V335, P1888, DOI 10.1056/NEJM199612193352506; Shah BR, 2005, J CLIN EPIDEMIOL, V58, P550, DOI 10.1016/j.jclinepi.2004.10.016; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; *STAT CORP, 2004, STATA STAT SOFTW REL; Stukel TA, 2005, JAMA-J AM MED ASSOC, V293, P1329, DOI 10.1001/jama.293.11.1329; U.S. Food and Drug Administration U.S. Department of Health and Human Services, FDA PUBL HLTH ADV DE; Wang PS, 2005, NEW ENGL J MED, V353, P2335, DOI 10.1056/NEJMoa052827; Wennberg D.E, 1999, DARTMOUTH ATLAS CARD; Wooldridge JM, 2000, INTRO ECONOMETRICS M	42	590	604	2	65	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2007	297	3					278	285		10.1001/jama.297.3.278	http://dx.doi.org/10.1001/jama.297.3.278			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	125VT	17227979	Green Accepted, Bronze			2022-12-01	WOS:000243472300022
J	Ferraz, G; Nichols, JD; Hines, JE; Stouffer, PC; Bierregaard, RO; Lovejoy, TE				Ferraz, Goncalo; Nichols, James D.; Hines, James E.; Stouffer, Philip C.; Bierregaard, Richard O., Jr.; Lovejoy, Thomas E.			A large-scale deforestation experiment: Effects of patch area and isolation on Amazon birds	SCIENCE			English	Article								As compared with extensive contiguous areas, small isolated habitat patches lack many species. Some species disappear after isolation; others are rarely found in any small patch, regardless of isolation. We used a 13-year data set of bird captures from a large landscape-manipulation experiment in a Brazilian Amazon forest to model the extinction-colonization dynamics of 55 species and tested basic predictions of island biogeography and metapopulation theory. From our models, we derived two metrics of species vulnerability to changes in isolation and patch area. We found a strong effect of area and a variable effect of isolation on the predicted patch occupancy by birds.	Inst Nacl de Pesquisas da Amazonia, Biol Dynam Forest Fragments Project, BR-69011 Manaus, Amazonas, Brazil; US Fish & Wildlife Serv, Patuxent Wildlife Res Ctr, Laurel, MD 20708 USA; Louisiana State Univ, Sch Renewable Nat Resources, Baton Rouge, LA 70803 USA; Louisiana State Univ, AgCenter, Baton Rouge, LA 70803 USA; Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA; H John Heinz III Ctr Sci Econ Environm, Washington, DC 20004 USA	Institute Nacional de Pesquisas da Amazonia; United States Department of the Interior; US Fish & Wildlife Service; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; University of North Carolina; University of North Carolina Charlotte	Ferraz, G (corresponding author), Inst Nacl de Pesquisas da Amazonia, Biol Dynam Forest Fragments Project, BR-69011 Manaus, Amazonas, Brazil.	gferraz@inpa.gov.br	stouffer, phil/AAF-7281-2020; Ferraz, Gonçalo/C-3860-2008	Ferraz, Gonçalo/0000-0001-8748-0462				Bierregaard R.O., 2001, LESSONS AMAZONIA ECO; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Burnham KP., 2002, MODEL SELECTION MULT, V2; Cohn-Haft Mario, 1997, Ornithological Monographs, V48, P205; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Gascon Claude, 2001, P31; Hanski I. A., 1999, METAPOPULATION ECOLO; Hines JE, 2004, PRESENCE VERSION 2 0; Laurance W.F., 2006, EMERGING THREATS TRO; MAC ARTHUR ROBERT H., 1967; MacKenzie D., 2017, OCCUPANCY ESTIMATION, VSecond; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; ROBBINS CS, 1989, WILDLIFE MONOGR, P1; STOUFFER PC, 1995, ECOLOGY, V76, P2429, DOI 10.2307/2265818; Trzcinski MK, 1999, ECOL APPL, V9, P586, DOI 10.1890/1051-0761(1999)009[0586:IEOFCA]2.0.CO;2; Van Houtan KS, 2006, EVOL ECOL RES, V8, P129	16	219	225	6	156	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2007	315	5809					238	241		10.1126/science.1133097	http://dx.doi.org/10.1126/science.1133097			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124XZ	17218527	Green Submitted			2022-12-01	WOS:000243407400046
J	Shimada, K; Gasser, SM				Shimada, Kenji; Gasser, Susan M.			The origin recognition complex functions in sister-chromatid cohesion in Saccharomyces cerevisiae	CELL			English	Article							DNA-DAMAGE CHECKPOINT; BUDDING YEAST; MCM PROTEINS; HETEROCHROMATIN PROTEIN-1; CHROMOSOME CONDENSATION; PRECOCIOUS SEPARATION; CELL-CYCLE; S-PHASE; REPLICATION; ORC	High-fidelity chromosomal segregation requires the properly timed establishment of sisterchromatid cohesion mediated by the Cohesin complex, and its resolution at the metaphaseto-anaphase transition. We have examined cell-cycle progression in a yeast strain from which the origin recognition complex protein Orc2 was depleted after the assembly of prereplication complexes. We find that Orc2 depletion causes a delay in progression through mitosis, reflecting activation of both the DNAdamage and Mad2-spindle checkpoints. Surprisingly, sister-chromatid cohesion is impaired in Orc2-depleted cells, although Cohesin subunits are properly associated with chromatin. Reexpression of Orc2 in late G2/M phase restores chromatid cohesion. Finally, the targeting of Orc2 to a specific chromosomal locus suppresses premature sister-chromatid separation locally in a temperature-sensitive cohesin mutant. We conclude that ORG mediates sisterchromatid interaction on a pathway that is additive with Cohesin-mediated pairing.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Gasser, SM (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.	susan.gasser@fmi.ch		Gasser, Susan/0000-0003-3610-9123				Badugu R, 2003, J BIOL CHEM, V278, P34491, DOI 10.1074/jbc.M305262200; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bell SP, 2002, GENE DEV, V16, P659, DOI 10.1101/gad.969602; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; Cenci G, 2003, NAT CELL BIOL, V5, P82, DOI 10.1038/ncb902; Chang CR, 2005, GENE DEV, V19, P3031, DOI 10.1101/gad.1356305; Chastain PD, 2004, J BIOL CHEM, V279, P36354, DOI 10.1074/jbc.M403501200; Clarke DJ, 2000, BIOESSAYS, V22, P351, DOI 10.1002/(SICI)1521-1878(200004)22:4<351::AID-BIES5>3.0.CO;2-W; D'Amours D, 2004, CELL, V117, P455, DOI 10.1016/S0092-8674(04)00413-1; de Gramont A, 2005, TRENDS BIOCHEM SCI, V30, P559, DOI 10.1016/j.tibs.2005.08.008; Dillin A, 1998, SCIENCE, V279, P1733, DOI 10.1126/science.279.5357.1733; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Du YCN, 2002, CELL, V109, P835, DOI 10.1016/S0092-8674(02)00773-0; Garber PM, 2002, GENETICS, V161, P521; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; Giannattasio M, 2004, EMBO J, V23, P429, DOI 10.1038/sj.emboj.7600051; Gillespie PJ, 2004, CURR BIOL, V14, P1598, DOI 10.1016/j.cub.2004.07.053; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; Hiragami K, 2005, CELL MOL LIFE SCI, V62, P2711, DOI 10.1007/s00018-005-5287-9; Hua XQH, 1998, J CELL BIOL, V140, P271, DOI 10.1083/jcb.140.2.271; Irlbacher H, 2005, GENE DEV, V19, P1811, DOI 10.1101/gad.334805; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; Kawasaki Y, 2006, GENES CELLS, V11, P745, DOI 10.1111/j.1365-2443.2006.00975.x; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Lam WW, 2006, GENE DEV, V20, P2973, DOI 10.1101/gad.1468806; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Loupart ML, 2000, CURR BIOL, V10, P1547, DOI 10.1016/S0960-9822(00)00844-7; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Megee PC, 1999, MOL CELL, V4, P445, DOI 10.1016/S1097-2765(00)80347-0; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Moore LL, 2005, MOL CELL BIOL, V25, P2583, DOI 10.1128/MCB.25.7.2583-2592.2005; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; NEWTON CS, 1993, COLD SPRING HARB SYM, V58, P415; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Pasero P, 1999, GENE DEV, V13, P2159, DOI 10.1101/gad.13.16.2159; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Pflumm MF, 2001, DEVELOPMENT, V128, P1697; Prasanth SG, 2004, EMBO J, V23, P2651, DOI 10.1038/sj.emboj.7600255; Prasanth SG, 2002, SCIENCE, V297, P1026, DOI 10.1126/science.1072802; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Schleiffer A, 2003, MOL CELL, V11, P571, DOI 10.1016/S1097-2765(03)00108-4; Shimada K, 2002, GENE DEV, V16, P3236, DOI 10.1101/gad.239802; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Sonoda E, 2001, DEV CELL, V1, P759, DOI 10.1016/S1534-5807(01)00088-0; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; STRUNNIKOV AV, 1993, J CELL BIOL, V123, P1635, DOI 10.1083/jcb.123.6.1635; Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5; Suter B, 2004, GENETICS, V167, P579, DOI 10.1534/genetics.103.024851; Takahashi TS, 2004, NAT CELL BIOL, V6, P991, DOI 10.1038/ncb1177; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Thomas SE, 2005, CELL, V123, P555, DOI 10.1016/j.cell.2005.08.043; Toth A, 1999, GENE DEV, V13, P320, DOI 10.1101/gad.13.3.320; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Uhlmann F, 2004, EXP CELL RES, V296, P80, DOI 10.1016/j.yexcr.2004.03.005; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Wyrick JJ, 2001, SCIENCE, V294, P2357, DOI 10.1126/science.1066101	61	79	79	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 12	2007	128	1					85	99		10.1016/j.cell.2006.11.045	http://dx.doi.org/10.1016/j.cell.2006.11.045			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GN	17218257	Bronze			2022-12-01	WOS:000244420400015
J	van Rooij, E; Sutherland, LB; Qi, XX; Richardson, JA; Hill, J; Olson, EN				van Rooij, Eva; Sutherland, Lillian B.; Qi, Xiaoxia; Richardson, James A.; Hill, Joseph; Olson, Eric N.			Control of stress-dependent cardiac growth and gene expression by a microRNA	SCIENCE			English	Article							MYOSIN HEAVY-CHAIN; THYROID-HORMONE RECEPTOR; HUMAN HEART; TRANSGENIC MICE; HYPERTROPHY; DIFFERENTIATION; HYPOTHYROIDISM; CARDIOMYOPATHY; PROLIFERATION; PHENOTYPE	The heart responds to diverse forms of stress by hypertrophic growth accompanied by fibrosis and eventual diminution of contractility, which results from down-regulation of alpha-myosin heavy chain (alpha MHC) and up-regulation of beta MHC, the primary contractile proteins of the heart. We found that a cardiac-specific microRNA (miR-208) encoded by an intron of the alpha MHC gene is required for cardiomyocyte hypertrophy, fibrosis, and expression of beta MHC in response to stress and hypothyroidism. Thus, the alpha MHC gene, in addition to encoding a major cardiac contractile protein, regulates cardiac growth and gene expression in response to stress and hormonal signaling through miR-208.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu						Abraham WT, 2002, MOL MED, V8, P750, DOI 10.1007/BF03402039; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen WJ, 2000, MOL CELL ENDOCRINOL, V162, P45, DOI 10.1016/S0303-7207(00)00203-3; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fatkin D, 2000, J CLIN INVEST, V106, P1351, DOI 10.1172/JCI11093; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Hill JA, 2000, CIRCULATION, V101, P2863, DOI 10.1161/01.CIR.101.24.2863; Ito M, 2001, TRENDS ENDOCRIN MET, V12, P127, DOI 10.1016/S1043-2760(00)00355-6; Jones WK, 1996, J CLIN INVEST, V98, P1906, DOI 10.1172/JCI118992; Kinugawa K, 2001, J CLIN ENDOCR METAB, V86, P5089, DOI 10.1210/jc.86.10.5089; Kinugawa K, 2001, CIRC RES, V89, P591, DOI 10.1161/hh1901.096706; Kiriazis H, 2000, ANNU REV PHYSIOL, V62, P321, DOI 10.1146/annurev.physiol.62.1.321; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Lowes BD, 1997, J CLIN INVEST, V100, P2315, DOI 10.1172/JCI119770; Mansen A, 2001, MOL ENDOCRINOL, V15, P2106, DOI 10.1210/me.15.12.2106; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Morkin E, 2000, MICROSC RES TECHNIQ, V50, P522, DOI 10.1002/1097-0029(20000915)50:6<522::AID-JEMT9>3.0.CO;2-U; Nakao K, 1997, J CLIN INVEST, V100, P2362, DOI 10.1172/JCI119776; Ojamaa K, 2000, ENDOCRINOLOGY, V141, P2139, DOI 10.1210/en.141.6.2139; Pantos C, 2006, HORM METAB RES, V38, P308, DOI 10.1055/s-2006-925404; Park SW, 2005, MOL CELL, V19, P643, DOI 10.1016/j.molcel.2005.08.008; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; SCHUYLER GT, 1990, BASIC RES CARDIOL, V85, P481, DOI 10.1007/BF01931494; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Vadaszova A, 2004, PHYSIOL RES, V53, pS57; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Wei T, 2005, J ENDOCRINOL INVEST, V28, P8, DOI 10.1007/BF03345522; Weiss A, 1996, ANNU REV CELL DEV BI, V12, P417, DOI 10.1146/annurev.cellbio.12.1.417; YAO JL, 1992, CIRC RES, V71, P831, DOI 10.1161/01.RES.71.4.831; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	38	1285	1349	2	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					575	579		10.1126/science.1139089	http://dx.doi.org/10.1126/science.1139089			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17379774				2022-12-01	WOS:000245983100038
J	Jazayeri, M; Movshon, JA				Jazayeri, Mehrdad; Movshon, J. Anthony			A new perceptual illusion reveals mechanisms of sensory decoding	NATURE			English	Article							VISUAL-MOTION; DISCRIMINATION; POPULATIONS; NEURONS; CORTEX; CAT	Perceptual illusions are usually thought to arise from the way sensory signals are encoded by the brain, and indeed are often used to infer the mechanisms of sensory encoding(1). But perceptual illusions might also result from the way the brain decodes sensory information(2), reflecting the strategies that optimize performance in particular tasks. In a fine discrimination task, the most accurate information comes from neurons tuned away from the discrimination boundary(3,4), and observers seem to use signals from these 'displaced' neurons to optimize their performance(5,6,7). We wondered whether using signals from these neurons might also bias perception. In a fine direction discrimination task using moving random-dot stimuli, we found that observers' perception of the direction of motion is indeed biased away from the boundary. This misperception can be accurately described by a decoding model that preferentially weights signals from neurons whose responses best discriminate those directions. In a coarse discrimination task, to which a different decoding rule applies(4), the same stimulus is not misperceived, suggesting that the illusion is a direct consequence of the decoding strategy that observers use to make fine perceptual judgments. The subjective experience of motion is therefore not mediated directly by the responses of sensory neurons, but is only developed after the responses of these neurons are decoded.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Jazayeri, M (corresponding author), NYU, Ctr Neural Sci, 4 Washington Pl, New York, NY 10003 USA.	mjaz@cns.nyu.edu			NEI NIH HHS [R01 EY002017, R01 EY004440, R01 EY002017-24, R01 EY004440-26] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY004440, R01EY002017] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BRITTEN KH, 1992, J NEUROSCI, V12, P4745; DEAN AF, 1981, EXP BRAIN RES, V44, P437; Eagleman DM, 2001, NAT REV NEUROSCI, V2, P920, DOI 10.1038/35104092; Gregory R. L., 1997, EYE BRAIN PSYCHOL SE; Hol K, 2001, VISION RES, V41, P685, DOI 10.1016/S0042-6989(00)00314-X; HUTTENLOCHER J, 1991, PSYCHOL REV, V98, P352, DOI 10.1037/0033-295X.98.3.352; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; PATTERSON RD, 1976, J ACOUST SOC AM, V59, P640, DOI 10.1121/1.380914; Rauber HJ, 1998, PERCEPTION, V27, P393, DOI 10.1068/p270393; REGAN D, 1985, J OPT SOC AM A, V2, P147, DOI 10.1364/JOSAA.2.000147; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6	13	118	118	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2007	446	7138					912	915		10.1038/nature05739	http://dx.doi.org/10.1038/nature05739			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IR	17410125	Green Accepted			2022-12-01	WOS:000245785700042
J	Saulsbury, FT				Saulsbury, Frank T.			Clinical update: Henoch-Schonlein purpura	LANCET			English	Article							NEPHRITIS; CHILDREN; THERAPY; GLYCOSYLATION; PREDNISONE; CHILDHOOD		Univ Virginia Hlth Syst, Dept Pediat, Div Immunol & Rheumatol, Charlottesville, VA 22908 USA	University of Virginia	Saulsbury, FT (corresponding author), Univ Virginia Hlth Syst, Dept Pediat, Div Immunol & Rheumatol, Charlottesville, VA 22908 USA.	fts@virginia.edu						Allen AC, 1998, NEPHROL DIAL TRANSPL, V13, P930, DOI 10.1093/ndt/13.4.930; Calvino MC, 2001, MEDICINE, V80, P279, DOI 10.1097/00005792-200109000-00001; Davin JC, 2001, KIDNEY INT, V59, P823, DOI 10.1046/j.1523-1755.2001.059003823.x; Foster BJ, 2000, J PEDIATR-US, V136, P370, DOI 10.1067/mpd.2000.103448; Huber AM, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-7; KOSKIMIES O, 1981, ARCH DIS CHILD, V56, P482, DOI 10.1136/adc.56.6.482; LIJIMA K, 1998, PEDIATR NEPHROL, V12, P244; NARCHI H, 2005, ARCH DIS CHILD, V90, P16; Niaudet P, 1998, PEDIATR NEPHROL, V12, P238, DOI 10.1007/s004670050446; Novak J, 2001, J CLIN IMMUNOL, V21, P310, DOI 10.1023/A:1012284402054; Ronkainen J, 2003, CLIN NEPHROL, V60, P80; Ronkainen J, 2002, LANCET, V360, P666, DOI 10.1016/S0140-6736(02)09835-5; Ronkainen J, 2006, J PEDIATR-US, V149, P241, DOI 10.1016/j.jpeds.2006.03.024; ROSENBLUM ND, 1987, PEDIATRICS, V79, P1018; Saulsbury FT, 1999, MEDICINE, V78, P395, DOI 10.1097/00005792-199911000-00005; Saulsbury FT, 1997, J RHEUMATOL, V24, P2246; Saulsbury FT, 2001, CURR OPIN RHEUMATOL, V13, P35, DOI 10.1097/00002281-200101000-00006; Shin JI, 2005, SCAND J RHEUMATOL, V34, P392, DOI 10.1080/03009740510026544; Trapani S, 2005, SEMIN ARTHRITIS RHEU, V35, P143, DOI 10.1016/j.semarthrit.2005.08.007; YOSHIKAWA N, 1981, CLIN NEPHROL, V16, P223	20	182	208	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2007	369	9566					976	978		10.1016/S0140-6736(07)60474-7	http://dx.doi.org/10.1016/S0140-6736(07)60474-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151JO	17382810				2022-12-01	WOS:000245286500010
J	Allingham, JS; Sproul, LR; Rayment, I; Gilbert, SP				Allingham, John S.; Sproul, Lisa R.; Rayment, Ivan; Gilbert, Susan P.			Vik1 modulates microtubule-Kar3 interactions through a motor domain that lacks an active site	CELL			English	Article							KINESIN-RELATED PROTEIN; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; MITOTIC SPINDLE; BUDDING YEAST; PLUS ENDS; KAR3; NCD; DROSOPHILA; CIK1	Conventional kinesin and class V and VI myosins coordinate the mechanochemical cycles of their motor domains for processive movement of cargo along microtubules or actin filaments. It is widely accepted that this coordination is achieved by allosteric communication or mechanical strain between the motor domains, which controls the nucleotide state and interaction with microtubules or actin. However, questions remain about the interplay between the strain and the nucleotide state. We present an analysis of Saccharomyces cerevisiae Kar3/Vik1, a heterodimeric C-terminal Kinesin-14 containing catalytic Kar3 and the nonmotor protein Vik1. The X-ray crystal structure of Vik1 exhibits a similar fold to the kinesin and myosin catalytic head, but lacks an ATP binding site. Vik1 binds more tightly to microtubules than Kar3 and facilitates cooperative microtubule decoration by Kar3/Vik1 heter-odimers, and yet allows motility. These results demand communication between Vik1 and Kar3 via a mechanism that coordinates their interactions with microtubules.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rayment, I (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53706 USA.	ivan_rayment@biochem.wisc.edu; spg1@pitt.edu	rayment, ivan/A-2720-2008; Allingham, John/AAW-9262-2020	rayment, ivan/0000-0001-9279-7835; Hoverman, Lisa/0000-0002-3396-6982	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K02AR047841, R01AR035186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054141, R01GM054141] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR13790, S10 RR013790] Funding Source: Medline; NIAMS NIH HHS [R01 AR035186, AR35186, K02-AR47841, K02 AR047841] Funding Source: Medline; NIGMS NIH HHS [R37 GM054141, GM54141, R01 GM054141] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alonso MC, 1998, EMBO J, V17, P945, DOI 10.1093/emboj/17.4.945; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barrett JG, 2000, MOL BIOL CELL, V11, P2373, DOI 10.1091/mbc.11.7.2373; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Chu HMA, 2005, EMBO J, V24, P3214, DOI 10.1038/sj.emboj.7600790; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; ENDOW SA, 1990, NATURE, V345, P81, DOI 10.1038/345081a0; Endres NF, 2006, NATURE, V439, P875, DOI 10.1038/nature04320; Gulick AM, 1998, BIOCHEMISTRY-US, V37, P1769, DOI 10.1021/bi972504o; HATSUMI M, 1992, J CELL SCI, V101, P547; Hildebrandt ER, 2000, BBA-MOL CELL RES, V1496, P99, DOI 10.1016/S0167-4889(00)00012-4; Hirose K, 1998, J MOL BIOL, V278, P389, DOI 10.1006/jmbi.1998.1709; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; KIMBLE M, 1983, J CELL SCI, V62, P301; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; Mackey AT, 2003, J BIOL CHEM, V278, P3527, DOI 10.1074/jbc.M206219200; Maddox P, 1999, J CELL BIOL, V144, P977, DOI 10.1083/jcb.144.5.977; Maddox PS, 2003, CURR BIOL, V13, P1423, DOI 10.1016/S0960-9822(03)00547-5; Manning BD, 1999, J CELL BIOL, V144, P1219, DOI 10.1083/jcb.144.6.1219; Manning BD, 2000, TRENDS CELL BIOL, V10, P281, DOI 10.1016/S0962-8924(00)01774-8; MCDONALD HB, 1990, CELL, V63, P1159, DOI 10.1016/0092-8674(90)90412-8; MCDONALD HB, 1990, CELL, V61, P991, DOI 10.1016/0092-8674(90)90064-L; MELUH PB, 1990, CELL, V60, P1029, DOI 10.1016/0092-8674(90)90351-E; Molk JN, 2006, J CELL BIOL, V172, P27, DOI 10.1083/jcb.200510032; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAGE BD, 1992, GENE DEV, V6, P1414, DOI 10.1101/gad.6.8.1414; PAGE BD, 1994, J CELL BIOL, V124, P507, DOI 10.1083/jcb.124.4.507; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Pidoux AL, 1996, MOL BIOL CELL, V7, P1639, DOI 10.1091/mbc.7.10.1639; ROUSSEL A, 1991, SILICON GRAPHICS GEO; Sablin EP, 2004, J BIOL CHEM, V279, P15707, DOI 10.1074/jbc.R300036200; Sablin EP, 1996, NATURE, V380, P555, DOI 10.1038/380555a0; Sablin EP, 1998, NATURE, V395, P813, DOI 10.1038/27463; Sack S, 1999, EUR J BIOCHEM, V262, P1, DOI 10.1046/j.1432-1327.1999.00341.x; SAUNDERS WS, 1992, CELL, V70, P451, DOI 10.1016/0092-8674(92)90169-D; SCHULZ GE, 1992, CURR OPIN STRUC BIOL, V2, P61; Sharp DJ, 2000, MOL BIOL CELL, V11, P241, DOI 10.1091/mbc.11.1.241; Song YH, 2001, EMBO J, V20, P6213, DOI 10.1093/emboj/20.22.6213; Sosa H, 1997, CELL, V90, P217, DOI 10.1016/S0092-8674(00)80330-X; Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Troxell CL, 2001, MOL BIOL CELL, V12, P3476, DOI 10.1091/mbc.12.11.3476; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Wendt TG, 2002, EMBO J, V21, P5969, DOI 10.1093/emboj/cdf622; Westhead DR, 1999, PROTEIN SCI, V8, P897; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Yun M, 2003, EMBO J, V22, P5382, DOI 10.1093/emboj/cdg531	51	64	64	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1161	1172		10.1016/j.cell.2006.12.046	http://dx.doi.org/10.1016/j.cell.2006.12.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382884	Bronze, Green Accepted			2022-12-01	WOS:000245396200021
J	Brandvain, Y; Barker, MS; Wade, MJ				Brandvain, Yaniv; Barker, Michael S.; Wade, Michael J.			Gene co-inheritance and gene transfer	SCIENCE			English	Article							EVOLUTION; NUCLEUS; RATES		Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Brandvain, Y (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	ybrandva@indiana.edu	Barker, Mike/AAE-7891-2019; Barker, Michael/A-9645-2010	Barker, Mike/0000-0001-7173-1319; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065414] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM65414] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Adams KL, 2002, P NATL ACAD SCI USA, V99, P9905, DOI 10.1073/pnas.042694899; Blanchard JL, 2000, TRENDS GENET, V16, P315, DOI 10.1016/S0168-9525(00)02053-9; ESHEL I, 1970, Theoretical Population Biology, V1, P88, DOI 10.1016/0040-5809(70)90043-2; Palmer JD, 2000, P NATL ACAD SCI USA, V97, P6960, DOI 10.1073/pnas.97.13.6960; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Wade MJ, 2006, EVOLUTION, V60, P643	7	13	16	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2007	315	5819					1685	1685		10.1126/science.1134789	http://dx.doi.org/10.1126/science.1134789			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379800				2022-12-01	WOS:000245106900030
J	Steinbrook, R				Steinbrook, Robert			HIV in India - The challenge ahead	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						LUCE E, 2007, SPITE GODS STRANGE R; Moses SA, 2006, AIDS S ASIA UNDERSTA; Steinbrook R, 2007, NEW ENGL J MED, V356, P1089, DOI 10.1056/NEJMp078009; *UN DEV PROGR, 2006, 2006 HUM DEV REP; World Health Organization, 2006, ANT THER HIV INF AD	5	45	45	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2007	356	12					1197	+		10.1056/NEJMp078011	http://dx.doi.org/10.1056/NEJMp078011			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148UP	17377154				2022-12-01	WOS:000245101900001
J	Buzsaki, G				Buzsaki, Gyoergy			The structure of consciousness - Subjective awareness may depend on neural networks in the brain supporting complex wiring schemes and dynamic patterns of activity.	NATURE			English	Editorial Material									Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.			Buzsaki, Gyorgy/0000-0002-3100-4800				Buzsaki G., 2006, RHYTHMS BRAIN; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033	2	43	46	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2007	446	7133					267	267		10.1038/446267a	http://dx.doi.org/10.1038/446267a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	145VC	17361165				2022-12-01	WOS:000244892900027
J	Pregibon, DC; Toner, M; Doyle, PS				Pregibon, Daniel C.; Toner, Mehmet; Doyle, Patrick S.			Multifunctional encoded particles for high-throughput biomolecule analysis	SCIENCE			English	Article							ARRAY; MICROCARRIERS; TECHNOLOGY; MICROARRAY	High-throughput screening for genetic analysis, combinatorial chemistry, and clinical diagnostics benefits from multiplexing, which allows for the simultaneous assay of several analytes but necessitates an encoding scheme for molecular identification. Current approaches for multiplexed analysis involve complicated or expensive processes for encoding, functionalizing, or decoding active substrates ( particles or surfaces) and often yield a very limited number of analyte-specific codes. We present a method based on continuous-flow lithography that combines particle synthesis and encoding and probe incorporation into a single process to generate multifunctional particles bearing over a million unique codes. By using such particles, we demonstrate a multiplexed, single-fluorescence detection of DNA oligomers with encoded particle libraries that can be scanned rapidly in a flow-through microfluidic channel. Furthermore, we demonstrate with high specificity the same multiplexed detection using individual multiprobe particles.	MIT, Dept Chem Engn, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, BioMEMS Resource Ctr, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Engn Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Doyle, PS (corresponding author), MIT, Dept Chem Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	pdoyle@mit.edu	Doyle, Patrick S/H-7031-2013; Abrams, William R/A-5782-2008	Doyle, Patrick S/0000-0003-2147-9172; 	NIBIB NIH HHS [P41 EB002503] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Battersby BJ, 2000, J AM CHEM SOC, V122, P2138, DOI 10.1021/ja993634i; Braeckmans K, 2003, NAT MATER, V2, P169, DOI 10.1038/nmat828; Braeckmans K, 2002, NAT REV DRUG DISCOV, V1, P447, DOI 10.1038/nrd817; Cunin F, 2002, NAT MATER, V1, P39, DOI 10.1038/nmat702; Dendukuri D, 2006, NAT MATER, V5, P365, DOI 10.1038/nmat1617; Evans M, 2003, ASSAY DRUG DEV TECHN, V1, P199; Fan JB, 2006, NAT REV GENET, V7, P632, DOI 10.1038/nrg1901; Fenniri H, 2003, J AM CHEM SOC, V125, P10546, DOI 10.1021/ja035665q; Ferguson JA, 2000, ANAL CHEM, V72, P5618, DOI 10.1021/ac0008284; Finkel NH, 2004, ANAL CHEM, V76, p353A; FODOR SPA, 1993, NATURE, V364, P555, DOI 10.1038/364555a0; Fulton RJ, 1997, CLIN CHEM, V43, P1749; Gershon D, 2002, NATURE, V416, P885, DOI 10.1038/416885a; Han MY, 2001, NAT BIOTECHNOL, V19, P631, DOI 10.1038/90228; Hergt R, 1998, IEEE T MAGN, V34, P3745, DOI 10.1109/20.718537; MacBeath G, 2000, SCIENCE, V289, P1760; MCHUGH TM, 1988, J CLIN MICROBIOL, V26, P1957, DOI 10.1128/JCM.26.10.1957-1961.1988; MORAN EJ, 1995, J AM CHEM SOC, V117, P10787, DOI 10.1021/ja00148a039; Nicewarner-Pena SR, 2001, SCIENCE, V294, P137, DOI 10.1126/science.294.5540.137; NICOLAOU KC, 1995, ANGEW CHEM INT EDIT, V34, P2289, DOI 10.1002/anie.199522891; Nolan JP, 2002, TRENDS BIOTECHNOL, V20, P9, DOI 10.1016/S0167-7799(01)01844-3; Pregibon DC, 2006, LANGMUIR, V22, P5122, DOI 10.1021/la0534625; Rehman FN, 1999, NUCLEIC ACIDS RES, V27, P649, DOI 10.1093/nar/27.2.649; Rubina AY, 2003, BIOTECHNIQUES, V34, P1008, DOI 10.2144/03345rr01; SERVICE RF, 1995, SCIENCE, V270, P577, DOI 10.1126/science.270.5236.577; Sha MY, 2006, ANAL BIOANAL CHEM, V384, P658, DOI 10.1007/s00216-005-0225-0; Su X, 2005, NANO LETT, V5, P49, DOI 10.1021/nl0484088; Vaino AR, 2000, P NATL ACAD SCI USA, V97, P7692, DOI 10.1073/pnas.97.14.7692; Vasiliskov AV, 1999, BIOTECHNIQUES, V27, P592, DOI 10.2144/99273rr06; Xu HX, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng043; Zhao XW, 2006, CHEM MATER, V18, P2443, DOI 10.1021/cm060283f; Zhi ZL, 2003, ANAL CHEM, V75, P4125, DOI 10.1021/ac034165c	32	599	667	14	350	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2007	315	5817					1393	1396		10.1126/science.1134929	http://dx.doi.org/10.1126/science.1134929			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347435				2022-12-01	WOS:000244752200028
J	Organ, CL; Shedlock, AM; Meade, A; Pagel, M; Edwards, SV				Organ, Chris L.; Shedlock, Andrew M.; Meade, Andrew; Pagel, Mark; Edwards, Scott V.			Origin of avian genome size and structure in non-avian dinosaurs	NATURE			English	Article							CELL-SIZE; DNA-CONTENT; C-VALUE; EVOLUTION; STRATEGIES; PATTERNS; GROWTH	Avian genomes are small and streamlined compared with those of other amniotes by virtue of having fewer repetitive elements and less non-coding DNA(1,2). This condition has been suggested to represent a key adaptation for flight in birds, by reducing the metabolic costs associated with having large genome and cell sizes(3,4). However, the evolution of genome architecture in birds, or any other lineage, is difficult to study because genomic information is often absent for long-extinct relatives. Here we use a novel bayesian comparative method to show that bone-cell size correlates well with genome size in extant vertebrates, and hence use this relationship to estimate the genome sizes of 31 species of extinct dinosaur, including several species of extinct birds. Our results indicate that the small genomes typically associated with avian flight evolved in the saurischian dinosaur lineage between 230 and 250 million years ago, long before this lineage gave rise to the first birds. By comparison, ornithischian dinosaurs are inferred to have had much larger genomes, which were probably typical for ancestral Dinosauria. Using comparative genomic data, we estimate that genome-wide interspersed mobile elements, a class of repetitive DNA, comprised 5 - 12% of the total genome size in the saurischian dinosaur lineage, but was 7 - 19% of total genome size in ornithischian dinosaurs, suggesting that repetitive elements became less active in the saurischian lineage. These genomic characteristics should be added to the list of attributes previously considered avian but now thought to have arisen in non-avian dinosaurs, such as feathers(5), pulmonary innovations 6, and parental care and nesting	Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; Univ Reading, Sch Biol Sci, Reading RG6 6AJ, Berks, England	Harvard University; University of Reading	Organ, CL (corresponding author), Harvard Univ, Museum Comparat Zool, 26 Oxford St, Cambridge, MA 02138 USA.	corgan@oeb.harvard.edu	Edwards, Scott V./D-9071-2018	Edwards, Scott V./0000-0003-2535-6217	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM075490] Funding Source: NIH RePORTER; Natural Environment Research Council [NE/C51992X/1] Funding Source: researchfish; NIGMS NIH HHS [F32 GM075490] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cavalier-Smith T., 1985, EVOLUTION GENOME SIZ, P104; Ellegren H, 2005, TRENDS ECOL EVOL, V20, P180, DOI 10.1016/j.tree.2005.01.015; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Gilks WR, 1996, MARKOV CHAIN MONTE C; Gregory T.R., 2005, ANIMAL GENOME SIZE D; Gregory TR, 1999, GENOME RES, V9, P317; Gregory TR, 2001, BLOOD CELL MOL DIS, V27, P830, DOI 10.1006/bcmd.2001.0457; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; HORNER JR, 1979, NATURE, V282, P296, DOI 10.1038/282296a0; Hughes A.L., 1999, ADAPTIVE EVOLUTION G; HUGHES AL, 1995, NATURE, V377, P391, DOI 10.1038/377391a0; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kozlowski J, 2003, P NATL ACAD SCI USA, V100, P14080, DOI 10.1073/pnas.2334605100; Langer MC, 2004, DINOSAURIA, 2ND EDITION, P25; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; MORRIS SC, 1988, SCIENCE, V241, P1230, DOI 10.1126/science.241.4870.1230; O'Connor PM, 2005, NATURE, V436, P253, DOI 10.1038/nature03716; Padian K, 2004, J VERTEBR PALEONTOL, V24, P555, DOI 10.1671/0272-4634(2004)024[0555:GISDAP]2.0.CO;2; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Petrov DA, 2001, TRENDS GENET, V17, P23, DOI 10.1016/S0168-9525(00)02157-0; RAUP DM, 1992, EXTINCTION BAD GENES, P3; Shedlock AM, 2006, SYST BIOL, V55, P902, DOI 10.1080/10635150601091924; Shedlock AM, 2007, P NATL ACAD SCI USA, V104, P2767, DOI 10.1073/pnas.0606204104; SZARSKI H, 1983, J THEOR BIOL, V105, P201, DOI 10.1016/S0022-5193(83)80002-2; THOMSON KS, 1978, J EXP ZOOL, V205, P315, DOI 10.1002/jez.1402050216; TIERSCH TR, 1991, J HERED, V82, P363, DOI 10.1093/oxfordjournals.jhered.a111105; VANDENBUSSCHE RA, 1995, MAMM GENOME, V6, P521, DOI 10.1007/BF00356168; Waltari E, 2002, AM NAT, V160, P539, DOI 10.1086/342079; Xu X, 2001, NATURE, V410, P200, DOI 10.1038/35065589	30	203	204	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2007	446	7132					180	184		10.1038/nature05621	http://dx.doi.org/10.1038/nature05621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17344851				2022-12-01	WOS:000244718100039
J	Roberts, I; Smith, R; Evans, S				Roberts, Ian; Smith, Richard; Evans, Stephen			Doubts over head injury studies	BRITISH MEDICAL JOURNAL			English	Editorial Material							HIGH-DOSE MANNITOL; RANDOMIZED-TRIAL					Ian.Roberts@Lshtm.ac.uk		Evans, Stephen/0000-0002-1474-2596				Couzin J, 2006, SCIENCE, V312, P38, DOI 10.1126/science.312.5770.38; Cruz J, 2004, J NEUROSURG, V100, P376, DOI 10.3171/jns.2004.100.3.0376; Cruz J, 2002, NEUROSURGERY, V51, P628, DOI 10.1097/00006123-200209000-00006; Cruz J, 2001, NEUROSURGERY, V49, P864; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; Marshall LF, 2004, J NEUROSURG, V100, P367, DOI 10.3171/jns.2004.100.3.0367; Wakai A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub2	7	30	32	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 24	2007	334	7590					392	394		10.1136/bmj.39118.480023.BE	http://dx.doi.org/10.1136/bmj.39118.480023.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	142MQ	17322250	Green Accepted, Green Published			2022-12-01	WOS:000244654400023
J	Roche, S; Rey, FA; Gaudin, Y; Bressanelli, S				Roche, Stephane; Rey, Felix A.; Gaudin, Yves; Bressanelli, Stephane			Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G	SCIENCE			English	Article							FUSION-INACTIVE CONFORMATION; RABIES VIRUS; MEMBRANE-FUSION; LOW-PH; INFLUENZA HEMAGGLUTININ; ENVELOPE GLYCOPROTEIN; CRYSTAL-STRUCTURE; AMINO-ACIDS; PROTEIN; MUTATIONS	Glycoprotein G of the vesicular stomatitis virus triggers membrane fusion via a low pH-induced structural rearrangement. Despite the equilibrium between the pre- and postfusion states, the structure of the prefusion form, determined to 3.0 angstrom resolution, shows that the fusogenic transition entails an extensive structural reorganization of G. Comparison with the structure of the postfusion form suggests a pathway for the conformational change. In the prefusion form, G has the shape of a tripod with the fusion loops exposed, which point toward the viral membrane, and with the antigenic sites located at the distal end of the molecule. A large number of G glycoproteins, perhaps organized as in the crystals, act cooperatively to induce membrane merging.	CNRS, UMR 2472, INRA,Lab Virol Mol & Struct, UMR 1157,Inst Fedaratif Rech 115, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); INRAE; Universite Paris Saclay	Gaudin, Y (corresponding author), CNRS, UMR 2472, INRA,Lab Virol Mol & Struct, UMR 1157,Inst Fedaratif Rech 115, F-91198 Gif Sur Yvette, France.	gaudin@vms.cnrs-gif.fr	Rey, Felix/B-6497-2012	Bressanelli, Stephane/0000-0002-0921-6727; Gaudin, Yves/0000-0002-0122-2954; Rey, Felix/0000-0002-9953-7988				BENMANSOUR A, 1991, J VIROL, V65, P4198, DOI 10.1128/JVI.65.8.4198-4203.1991; Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Carneiro FA, 2001, J BIOL CHEM, V276, P62, DOI 10.1074/jbc.M008753200; Carr CM, 1997, P NATL ACAD SCI USA, V94, P14306, DOI 10.1073/pnas.94.26.14306; Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; DOMS RW, 1987, J CELL BIOL, V105, P1957, DOI 10.1083/jcb.105.5.1957; DURRER P, 1995, J BIOL CHEM, V270, P17575, DOI 10.1074/jbc.270.29.17575; Forster F, 2005, P NATL ACAD SCI USA, V102, P4729, DOI 10.1073/pnas.0409178102; Fredericksen BL, 1996, VIROLOGY, V217, P49, DOI 10.1006/viro.1996.0092; Gaudin Y, 1997, J VIROL, V71, P3742, DOI 10.1128/JVI.71.5.3742-3750.1997; GAUDIN Y, 1995, J VIROL, V69, P5528, DOI 10.1128/JVI.69.9.5528-5534.1995; GAUDIN Y, 1991, J VIROL, V65, P4853, DOI 10.1128/JVI.65.9.4853-4859.1991; GAUDIN Y, 1992, VIROLOGY, V187, P627, DOI 10.1016/0042-6822(92)90465-2; Gaudin Y, 1996, J VIROL, V70, P7371, DOI 10.1128/JVI.70.11.7371-7378.1996; Gaudin Y, 2000, Subcell Biochem, V34, P379; GAUDIN Y, 1993, J VIROL, V67, P1365, DOI 10.1128/JVI.67.3.1365-1372.1993; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; Lafay F, 1996, J GEN VIROL, V77, P339, DOI 10.1099/0022-1317-77-2-339; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; LUO LZ, 1988, VIROLOGY, V163, P341, DOI 10.1016/0042-6822(88)90274-7; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Pak CC, 1997, BIOCHEMISTRY-US, V36, P8890, DOI 10.1021/bi9702851; Rao BL, 2004, LANCET, V364, P869, DOI 10.1016/S0140-6736(04)16982-1; Roche S, 2002, VIROLOGY, V297, P128, DOI 10.1006/viro.2002.1429; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; Rose J.K., 2001, FIELDS VIROLOGY, P1221; Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9; Tuffereau C, 1998, EMBO J, V17, P7250, DOI 10.1093/emboj/17.24.7250; VANDEPOL SB, 1986, VIROLOGY, V148, P312, DOI 10.1016/0042-6822(86)90328-4; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322; Yin HS, 2005, P NATL ACAD SCI USA, V102, P9288, DOI 10.1073/pnas.0503989102; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	37	269	284	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2007	315	5813					843	848		10.1126/science.1135710	http://dx.doi.org/10.1126/science.1135710			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289996				2022-12-01	WOS:000244069000069
J	Pielke, R; Prins, G; Rayner, S; Sarewitz, D				Pielke, Roger, Jr.; Prins, Gwyn; Rayner, Steve; Sarewitz, Daniel			Lifting the taboo on adaptation	NATURE			English	Editorial Material							CLIMATE-CHANGE		Univ Colorado, Boulder, CO 80309 USA; London Sch Econ, London, England; Columbia Univ, New York, NY 10027 USA; Univ Oxford, James Martin Inst, Oxford OX1 2JD, England; Arizona State Univ, Tempe, AZ 85287 USA	University of Colorado System; University of Colorado Boulder; University of London; London School Economics & Political Science; Columbia University; University of Oxford; Arizona State University; Arizona State University-Tempe	Pielke, R (corresponding author), Univ Colorado, Boulder, CO 80309 USA.	pielke@colorado.edu		rayner, steve/0000-0001-6779-9345				Bouwer LM, 2006, DISASTERS, V30, P49, DOI 10.1111/j.1467-9523.2006.00306.x; Burton I., 2005, POLICY OPTIONS, P33; Goklany IM, 2004, SCIENCE, V306, P55, DOI 10.1126/science.306.5693.55; Huq S, 2004, IDS BULL-I DEV STUD, V35, P15, DOI 10.1111/j.1759-5436.2004.tb00129.x; Pielke RA, 2005, ENVIRON SCI POLICY, V8, P548, DOI 10.1016/j.envsci.2005.06.013; Pielke RA, 2005, POPUL ENVIRON, V26, P255, DOI 10.1007/s11111-005-1877-6; Rodolfo KS, 2006, DISASTERS, V30, P118, DOI 10.1111/j.1467-9523.2006.00310.x; Stern N, 2006, EC CLIMATE CHANGE ST; THOMPSON M, 1998, HUMAN CHOICE CLIMATE, V1; *UNFCCC, 2002, DELH DECL CLIM CHANG	10	326	336	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2007	445	7128					597	598		10.1038/445597a	http://dx.doi.org/10.1038/445597a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	133UM	17287795	Bronze			2022-12-01	WOS:000244039400024
J	Pogach, L; Engelgau, M; Aron, D				Pogach, Leonard; Engelgau, Michael; Aron, David			Measuring progress toward achieving hemoglobin A(1c) goals in diabetes care - Pass/fail or partial credit	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GLYCEMIC CONTROL		VA New Jersey Healthcare Syst, HSR Ctr healthcare Knowledge Management, E Orange, NJ 07018 USA; Univ Med & Dent New Jersey, Newark, NJ 07103 USA; Ctr Dis Control & Prevent, Atlanta, GA USA; Case Western Reserve Univ, Louis Stokes Cleveland Vet Affairs Med Ctr, Cleveland, OH 44106 USA; Case Western Reserve Univ, Case Sch Med, Cleveland, OH 44106 USA	New Jersey Department of Health & Senior Services; Rutgers State University New Brunswick; Rutgers State University Medical Center; Centers for Disease Control & Prevention - USA; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University	Pogach, L (corresponding author), VA New Jersey Healthcare Syst, HSR Ctr healthcare Knowledge Management, 385 Tremont Ave, E Orange, NJ 07018 USA.	Leonard.Pogach@va.gov						Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; [Anonymous], 1996, DIABETES, V45, P1289; Berlowitz DR, 2005, HEALTH SERV RES, V40, P1836, DOI 10.1111/j.1475-6773.2005.00436.x; Brown AF, 2005, DIABETES CARE, V28, P2864, DOI 10.2337/diacare.28.12.2864; *COLL AM PATH, 2006, GLYC SURV 2006 GH2 A; Engelgau MM, 2005, ANN INTERN MED, V143, P301, DOI 10.7326/0003-4819-143-4-200508160-00011; Gavin L A, 2000, Endocr Pract, V6, P305; Hoerger TJ, 2002, JAMA-J AM MED ASSOC, V287, P2542; Hsu J, 2006, NEW ENGL J MED, V354, P2349, DOI 10.1056/NEJMsa054436; Huang ES, 2006, DIABETES CARE, V29, P259, DOI 10.2337/diacare.29.02.06.dc05-1443; Ickowicz E, 2003, J AM GERIATR SOC, V51, pS265; Lohr K.N., 1990, MEDICARE STRATEGY QU, V1; *NAT COMM QUAL ASS, 2006, HEDIS 2007, V2; *NAT COMM QUAL ASS, BRIDG EXC; Pogach LM, 2006, DIABETES CARE, V29, P241, DOI 10.2337/diacare.29.02.06.dc05-1468; Rodondi N, 2006, ANN INTERN MED, V144, P475, DOI 10.7326/0003-4819-144-7-200604040-00006; Rosenstock J, 2005, DIABETES CARE, V28, P950, DOI 10.2337/diacare.28.4.950; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427; Vijan S, 1997, ANN INTERN MED, V127, P788, DOI 10.7326/0003-4819-127-9-199711010-00003; AMBULATORY CARE QUAL	22	37	39	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2007	297	5					520	523		10.1001/jama.297.5.520	http://dx.doi.org/10.1001/jama.297.5.520			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133FP	17284702				2022-12-01	WOS:000243999100029
J	Sidorenko, A; Krupenkin, T; Taylor, A; Fratzl, P; Aizenberg, J				Sidorenko, Alexander; Krupenkin, Tom; Taylor, Ashley; Fratzl, Peter; Aizenberg, Joanna			Reversible switching of hydrogel-actuated nanostructures into complex micropatterns	SCIENCE			English	Article							SHAPE-MEMORY; PHOTONIC CRYSTALS; MICROSTRUCTURES; TENSEGRITY; SURFACES	Responsive behavior, which is intrinsic to natural systems, is becoming a key requirement for advanced artificial materials and devices, presenting a substantial scientific and engineering challenge. We designed dynamic actuation systems by integrating high-aspect-ratio silicon nanocolumns, either free-standing or substrate-attached, with a hydrogel layer. The nanocolumns were put in motion by the "muscle" of the hydrogel, which swells or contracts depending on the humidity level. This actuation resulted in a fast reversible reorientation of the nanocolumns from tilted to perpendicular to the surface. By further controlling the stress field in the hydrogel, the formation of a variety of elaborate reversibly actuated micropatterns was demonstrated. The mechanics of the actuation process have been assessed. Dynamic control over the movement and orientation of surface nanofeatures at the micron and submicron scales may have exciting applications in actuators, microfluidics, or responsive materials.	Bell Labs, Alcatel Lucent, Murray Hill, NJ 07974 USA; Max Planck Inst Colloids & Interfaces, D-14424 Potsdam, Germany	Alcatel-Lucent; AT&T; Max Planck Society	Aizenberg, J (corresponding author), Bell Labs, Alcatel Lucent, 600 Mt Ave, Murray Hill, NJ 07974 USA.	jaizenberg@alcatel-lucent.com	Fratzl, Peter/H-9095-2012	Fratzl, Peter/0000-0003-4437-7830; Sidorenko, Alexander/0000-0002-3109-7605				Asher SA, 2004, NAN SCI TEC, P145; Autumn K, 2002, P NATL ACAD SCI USA, V99, P12252, DOI 10.1073/pnas.192252799; Beebe DJ, 2000, NATURE, V404, P588, DOI 10.1038/35007047; BUCKMINSTERFULL.R, 1961, PORTFOLIO ART NEWS A, V4, P112; Chiellini F, 2001, MACROMOL RAPID COMM, V22, P1284, DOI 10.1002/1521-3927(20011001)22:15<1284::AID-MARC1284>3.0.CO;2-M; Defossez M, 2003, MECH RES COMMUN, V30, P311, DOI 10.1016/S0093-6413(03)00030-2; Delamarche E, 1997, ADV MATER, V9, P741, DOI 10.1002/adma.19970090914; Gates BD, 2004, ANGEW CHEM INT EDIT, V43, P2780, DOI 10.1002/anie.200353009; Geim AK, 2003, NAT MATER, V2, P461, DOI 10.1038/nmat917; Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575; Iyer KS, 2003, MACROMOLECULES, V36, P6519, DOI 10.1021/ma034460z; Krupenkin TN, 2004, LANGMUIR, V20, P3824, DOI 10.1021/la036093q; Lahann J, 2003, SCIENCE, V299, P371, DOI 10.1126/science.1078933; Lee SB, 2004, J AM CHEM SOC, V126, P13400, DOI 10.1021/ja048463i; Lendlein A, 2005, NATURE, V434, P879, DOI 10.1038/nature03496; Maurer MK, 2005, ADV FUNCT MATER, V15, P1401, DOI 10.1002/adfm.200400070; Mayer M, 2004, PROTEOMICS, V4, P2366, DOI 10.1002/pmic.200300748; Minko S, 2006, RESPONSIVE POLYM MAT; OSADA Y, 1995, NATURE, V376, P219, DOI 10.1038/376219a0; OSADA Y, 1992, NATURE, V355, P242, DOI 10.1038/355242a0; Park S, 2004, SCIENCE, V303, P348, DOI 10.1126/science.1093276; Ruppert EE., 2004, FUNCTIONAL EVOLUTION; Russell TP, 2002, SCIENCE, V297, P964, DOI 10.1126/science.1075997; Sun TL, 2005, ACCOUNTS CHEM RES, V38, P644, DOI 10.1021/ar040224c; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941; Zhai L, 2004, NANO LETT, V4, P1349, DOI 10.1021/nl049463j	26	467	481	13	687	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2007	315	5811					487	490		10.1126/science.1135516	http://dx.doi.org/10.1126/science.1135516			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255505				2022-12-01	WOS:000243726600038
J	Carlton, JM; Hirt, RP; Silva, JC; Delcher, AL; Schatz, M; Zhao, Q; Wortman, JR; Bidwell, SL; Alsmark, UCM; Besteiro, S; Sicheritz-Ponten, T; Noel, CJ; Dacks, JB; Foster, PG; Simillion, C; Van de Peer, Y; Miranda-Saavedra, D; Barton, GJ; Westrop, GD; Muller, S; Dessi, D; Fiori, PL; Ren, QH; Paulsen, I; Zhang, HB; Bastida-Corcuera, FD; Simoes-Barbosa, A; Brown, MT; Hayes, RD; Mukherjee, M; Okumura, CY; Schneider, R; Smith, AJ; Vanacova, S; Villalvazo, M; Haas, BJ; Pertea, M; Feldblyum, TV; Utterback, TR; Shu, CL; Osoegawa, K; de Jong, PJ; Hrdy, I; Horvathova, L; Zubacova, Z; Dolezal, P; Malik, SB; Logsdon, JM; Henze, K; Gupta, A; Wang, CC; Dunne, RL; Upcroft, JA; Upcroft, P; White, O; Salzberg, SL; Tang, P; Chiu, CH; Lee, YS; Embley, TM; Coombs, GH; Mottram, JC; Tachezy, J; Fraser-Liggett, CM; Johnson, PJ				Carlton, Jane M.; Hirt, Robert P.; Silva, Joana C.; Delcher, Arthur L.; Schatz, Michael; Zhao, Qi; Wortman, Jennifer R.; Bidwell, Shelby L.; Alsmark, U. Cecilia M.; Besteiro, Sebastien; Sicheritz-Ponten, Thomas; Noel, Christophe J.; Dacks, Joel B.; Foster, Peter G.; Simillion, Cedric; Van de Peer, Yves; Miranda-Saavedra, Diego; Barton, Geoffrey J.; Westrop, Gareth D.; Mueller, Sylke; Dessi, Daniele; Fiori, Pier Luigi; Ren, Qinghu; Paulsen, Ian; Zhang, Hanbang; Bastida-Corcuera, Felix D.; Simoes-Barbosa, Augusto; Brown, Mark T.; Hayes, Richard D.; Mukherjee, Mandira; Okumura, Cheryl Y.; Schneider, Rachel; Smith, Alias J.; Vanacova, Stepanka; Villalvazo, Maria; Haas, Brian J.; Pertea, Mihaela; Feldblyum, Tamara V.; Utterback, Terry R.; Shu, Chung-Li; Osoegawa, Kazutoyo; de Jong, Pieter J.; Hrdy, Ivan; Horvathova, Lenka; Zubacova, Zuzana; Dolezal, Pavel; Malik, Shehre-Banoo; Logsdon, John M., Jr.; Henze, Katrin; Gupta, Arti; Wang, Ching C.; Dunne, Rebecca L.; Upcroft, Jacqueline A.; Upcroft, Peter; White, Owen; Salzberg, Steven L.; Tang, Petrus; Chiu, Cheng-Hsun; Lee, Ying-Shiung; Embley, T. Martin; Coombs, Graham H.; Mottram, Jeremy C.; Tachezy, Jan; Fraser-Liggett, Claire M.; Johnson, Patricia J.			Draft genome sequence of the sexually transmitted pathogen Trichomonas vaginalis	SCIENCE			English	Article							ENTAMOEBA-HISTOLYTICA; TRITRICHOMONAS-FETUS; STRUCTURAL BASIS; DNA CONTENT; EUKARYOTES; CELLS; IDENTIFICATION; RESISTANCE; EVOLUTION; PROTEINS	We describe the genome sequence of the protist Trichomonas vaginalis, a sexually transmitted human pathogen. Repeats and transposable elements comprise about two-thirds of the similar to 160-megabase genome, reflecting a recent massive expansion of genetic material. This expansion, in conjunction with the shaping of metabolic pathways that likely transpired through lateral gene transfer from bacteria, and amplification of specific gene families implicated in pathogenesis and phagocytosis of host proteins may exemplify adaptations of the parasite during its transition to a urogenital environment. The genome sequence predicts previously unknown functions for the hydrogenosome, which support a common evolutionary origin of this unusual organelle with mitochondria.	Inst Genom Res, Rockville, MD 20850 USA; Univ Newcastle, Div Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; Univ Glasgow, Wellcome Ctr Mol Parasitol, Glasgow G12 8TA, Lanark, Scotland; Univ Glasgow, Div Infect & Immun, Glasgow Biomed Res Ctr, Glasgow G12 8TA, Lanark, Scotland; Tech Univ Denmark, Ctr Biol Sequence Anal, Biocentrum DTU, DK-2800 Lyngby, Denmark; Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; Nat Hist Museum, Dept Zool, London SW7 5BD, England; Univ Antwerp VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; Univ Dundee, Sch Life Sci Res, Dundee DD1 5EH, Scotland; Univ Sassari, Dept Biomed Sci, Div Exptl & Clin Microbiol, I-07100 Sassari, Italy; Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; J Craig Venter Joint Technol Ctr, Rockville, MD 20850 USA; Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; Charles Univ Prague, Dept Parasitol, Fac Sci, CR-12844 Prague, Czech Republic; Univ Iowa, Dept Biol Sci, Roy J Carver Ctr Comparat Genom, Iowa City, IA 52242 USA; Univ Dusseldorf, Inst Bot, D-402225 Dusseldorf, Germany; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; Univ Queensland, Dept Microbiol & Parasitol, Brisbane, Qld 4072, Australia; Queensland Inst Med Res, Brisbane, Qld 4029, Australia; Chang Gung Univ, Bioinformat Ctr, Mol Med Res Ctr, Tao Yuan 333, Taiwan; Chang Gung Mem Hosp, Mol Infect Dis Res Ctr, Tao Yuan 333, Taiwan; Chang Gung Mem Hosp, Med Genom Ctr, Tao Yuan 333, Taiwan; Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0NR, Lanark, Scotland	J. Craig Venter Institute; Newcastle University - UK; University System of Maryland; University of Maryland College Park; University of Glasgow; University of Glasgow; Technical University of Denmark; University of Calgary; Natural History Museum London; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Dundee; University of Sassari; University of California System; University of California Los Angeles; J. Craig Venter Institute; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Charles University Prague; University of Iowa; Heinrich Heine University Dusseldorf; University of California System; University of California San Francisco; University of Queensland; QIMR Berghofer Medical Research Institute; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; University of Strathclyde	Carlton, JM (corresponding author), NYU, Dept Med Parasitol, Sch Med, New York, NY 10011 USA.	jane.carlton@med.nyu.edu	Van de Peer, Yves/AAE-7666-2019; Salzberg, Steven/Q-6514-2019; Alsmark, Cecilia/AAO-1330-2021; Barton, Geoffrey/N-1037-2019; Miranda-Saavedra, Diego/C-2707-2012; Paulsen, Ian T/K-3832-2012; Logsdon, John M/B-7812-2009; Hirt, Robert/R-5429-2017; Malik, Shehre-Banoo/A-1385-2009; Barton, Geoffrey J/C-6267-2011; Hrdý, Ivan/K-8931-2017; Dolezal, Pavel/V-1907-2017; Horváthová, Lenka/AAC-3119-2021; Silva, Joana/GYQ-9526-2022; Besteiro, Sébastien/F-3622-2014; Fiori, Pier Luigi/GVU-9300-2022; Van de Peer, Yves/D-4388-2009; Vanacova, Stepanka/D-6858-2012; Dacks, Joel/AAE-3308-2021; Silva, Joana/GVT-6441-2022; Salzberg, Steven L/F-6162-2011; Schatz, Michael/L-2690-2019; Pertea, Mihaela/AAT-2705-2021; Sicheritz-Ponten, Thomas/A-4325-2017	Van de Peer, Yves/0000-0003-4327-3730; Salzberg, Steven/0000-0002-8859-7432; Barton, Geoffrey/0000-0002-9014-5355; Paulsen, Ian T/0000-0001-9015-9418; Hirt, Robert/0000-0002-3760-9958; Hrdý, Ivan/0000-0002-5595-9177; Dolezal, Pavel/0000-0003-1285-9026; Horváthová, Lenka/0000-0001-7618-8669; Besteiro, Sébastien/0000-0003-1853-1494; Fiori, Pier Luigi/0000-0001-6190-612X; Van de Peer, Yves/0000-0003-4327-3730; Vanacova, Stepanka/0000-0001-8807-0684; Dacks, Joel/0000-0003-4520-5694; Salzberg, Steven L/0000-0002-8859-7432; Schatz, Michael/0000-0002-4118-4446; Pertea, Mihaela/0000-0003-0762-8637; Westrop, Gareth/0000-0002-8011-6219; Sicheritz-Ponten, Thomas/0000-0001-6615-1141; Bastida, Felix/0000-0003-1036-9787; Hayes, Richard/0000-0002-5236-7918; Fraser, Claire/0000-0003-1462-2428; Foster, Peter/0000-0003-0194-9237; DESSI', Daniele/0000-0001-5713-741X; Embley, Thomas Martin/0000-0002-1484-340X; Malik, Shehre-Banoo/0000-0003-0833-0648; Simillion, Cedric/0000-0002-2026-6741; Mottram, Jeremy/0000-0001-5574-3766; Wortman, Jennifer/0000-0002-8713-1227; Tang, Petrus/0000-0002-2779-0116	Medical Research Council [G0000508, G9722968(65078), G0000508(56841), G9722968] Funding Source: Medline; NIAID NIH HHS [U01 AI050913, U01 AI050913-01A1, UO1 AI50913-01, U01 AI050913-02] Funding Source: Medline; NLM NIH HHS [R01 LM006845-08, R01 LM006845, R01 LM007938-04, R01 LM007938] Funding Source: Medline; Wellcome Trust [072031] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI050913] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006845, R01LM007938] Funding Source: NIH RePORTER; MRC [G0000508, G9722968] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Bastida-Corcuera FD, 2005, EUKARYOT CELL, V4, P1951, DOI 10.1128/EC.4.11.1951-1958.2005; BEACH DH, 1991, MOL BIOCHEM PARASIT, V44, P97, DOI 10.1016/0166-6851(91)90225-U; Benchimol M, 2004, MICROSC MICROANAL, V10, P528, DOI 10.1017/S1431927604040905; Bradley PJ, 1997, EMBO J, V16, P3484, DOI 10.1093/emboj/16.12.3484; Cavalier-Smith T, 2005, ANN BOT-LONDON, V95, P147, DOI 10.1093/aob/mci010; Davis PH, 2006, MOL BIOCHEM PARASIT, V145, P111, DOI 10.1016/j.molbiopara.2005.08.017; DIAS FBP, 1992, MICROBIOS, V71, P55; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; FIORI PL, 1993, FEMS MICROBIOL LETT, V109, P13, DOI 10.1111/j.1574-6968.1993.tb06136.x; Gregory TR, 2001, BIOL REV, V76, P65, DOI 10.1017/S1464793100005595; Honigberg B.M., 1990, P5; Ikegami A, 2004, INFECT IMMUN, V72, P4619, DOI 10.1128/IAI.72.8.4619-4627.2004; Klemba M, 2002, ANNU REV BIOCHEM, V71, P275, DOI 10.1146/annurev.biochem.71.090501.145453; Kleydman Y, 2004, MICROBIOL-SGM, V150, P1139, DOI 10.1099/mic.0.26939-0; Kutisova K, 2005, PARASITOLOGY, V131, P309, DOI 10.1017/S0031182005008000; Kwon DH, 2001, ANTIMICROB AGENTS CH, V45, P2609, DOI 10.1128/AAC.45.9.2609-2615.2001; Land KM, 2004, MOL MICROBIOL, V51, P115, DOI 10.1046/j.1365-2958.2003.03791.x; LEHKER MW, 1990, J EXP MED, V171, P2165, DOI 10.1084/jem.171.6.2165; Leiros HKS, 2004, J BIOL CHEM, V279, P55840, DOI 10.1074/jbc.M408044200; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; LOWE PN, 1986, MOL BIOCHEM PARASIT, V21, P65, DOI 10.1016/0166-6851(86)90080-0; MUILER M, 1998, EVOLUTIONARY RELATIO, P109; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; Ramesh MA, 2005, CURR BIOL, V15, P185, DOI 10.1016/j.cub.2005.01.003; Rendon-Maldonado JG, 1998, EXP PARASITOL, V89, P241, DOI 10.1006/expr.1998.4297; Richards TA, 2005, NATURE, V436, P1113, DOI 10.1038/nature03949; Schmid G, 2001, J REPROD MED, V46, P545; Schumacher MA, 2003, CELL, V115, P413, DOI 10.1016/S0092-8674(03)00887-0; SHUTER BJ, 1983, AM NAT, V122, P26, DOI 10.1086/284116; Silva JC, 2005, MOL BIOL EVOL, V22, P126, DOI 10.1093/molbev/msh260; SINGH BN, 1994, ARCH BIOCHEM BIOPHYS, V309, P273, DOI 10.1006/abbi.1994.1113; Sutak R, 2004, P NATL ACAD SCI USA, V101, P10368, DOI 10.1073/pnas.0401319101; TURNER AC, 1988, EXP PARASITOL, V67, P47, DOI 10.1016/0014-4894(88)90007-0; Vanacova S, 2005, P NATL ACAD SCI USA, V102, P4430, DOI 10.1073/pnas.0407500102; Vogel C, 2006, PLOS COMPUT BIOL, V2, P370, DOI 10.1371/journal.pcbi.0020048; Westrop GD, 2006, J BIOL CHEM, V281, P25062, DOI 10.1074/jbc.M600688200; WHO, 2001, GLOB PREV INC SEL CU; Yao CQ, 2003, MOL BIOCHEM PARASIT, V132, P1, DOI 10.1016/S0166-6851(03)00211-1; ZUO X, 1995, MICROBIOL-UK, V141, P2637, DOI 10.1099/13500872-141-10-2637	40	594	630	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2007	315	5809					207	212		10.1126/science.1132894	http://dx.doi.org/10.1126/science.1132894			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124XZ	17218520	Green Accepted			2022-12-01	WOS:000243407400037
J	Beeson, TD; Mastracchio, A; Hong, JB; Ashton, K; MacMillan, DWC				Beeson, Teresa D.; Mastracchio, Anthony; Hong, Jun-Bae; Ashton, Kate; MacMillan, David W. C.			Enantioselective organocatalysis using SOMO activation	SCIENCE			English	Article							ORGANIC CATALYSIS; TRANSITION-METAL; RADICAL-CATION; STRATEGIES; ENAMINES	The asymmetric alpha-addition of relatively nonpolar hydrocarbon substrates, such as allyl and aryl groups, to aldehydes and ketones remains a largely unsolved problem in organic synthesis, despite the wide potential utility of direct routes to such products. We reasoned that well-established chiral amine catalysis, which activates aldehydes toward electrophile addition by enamine formation, could be expanded to this important reaction class by applying a single-electron oxidant to create a transient radical species from the enamine. We demonstrated the concept of singly occupied molecular orbital (SOMO) activation with a highly selective alpha-allylation of aldehydes, and we here present preliminary results for enantioselective heteroarylations and cyclization/halogenation cascades.	Princeton Univ, Dept Chem, Merck Ctr Catalysis, Princeton, NJ 08544 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	Princeton University; California Institute of Technology	MacMillan, DWC (corresponding author), Princeton Univ, Dept Chem, Merck Ctr Catalysis, Princeton, NJ 08544 USA.	dmacmill@princeton.edu			NIGMS NIH HHS [R01 GM078201, R01 GM078201-01-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078201] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahrendt KA, 2000, J AM CHEM SOC, V122, P4243, DOI 10.1021/ja000092s; [Anonymous], [No title captured]; CRABTREE RH, 2000, ORGANOMETALLIC CHEM; Ibrahem I, 2006, ANGEW CHEM INT EDIT, V45, P1952, DOI 10.1002/anie.200504021; Jacobsen E. N., 1999, COMPREHENSIVE ASYMME, V1-3; Kirchgessner M, 2006, J ORG CHEM, V71, P9849, DOI 10.1021/jo061809i; Lee HB, 2001, J AM CHEM SOC, V123, P11322, DOI 10.1021/ja017043f; Lelais G, 2006, ALDRICHIM ACTA, V39, P79; LeTadicBiadatti MH, 1996, J CHEM SOC PERK T 2, P1467, DOI 10.1039/p29960001467; Lide D.R., 1995, HDB CHEM PHYS, P220; List B, 2000, J AM CHEM SOC, V122, P2395, DOI 10.1021/ja994280y; List B, 2006, CHEM COMMUN, P819, DOI 10.1039/b514296m; MULLER K, 1981, HELV CHIM ACTA, V64, P2497, DOI 10.1002/hlca.19810640802; NARASAKA K, 1992, CHEM LETT, P2099, DOI 10.1246/cl.1992.2099; NOYORI R, 1994, ASYMMETRIC CATALYSIS, P123; Ojima I., 2000, CATALYTIC ASYMMETRIC; Renaud P., 2001, RADICALS ORGANIC SYN, V2, P144; SEYDENPENNE J, 1995, CHIRAL AUXILIARIES L, P166; Sibi MP, 2007, J AM CHEM SOC, V129, P395, DOI 10.1021/ja066425o; Sutterer A, 2000, J AM CHEM SOC, V122, P5636, DOI 10.1021/ja001063k; Taylor MS, 2006, ANGEW CHEM INT EDIT, V45, P1520, DOI 10.1002/anie.200503132; Trost BM, 2003, CHEM REV, V103, P2921, DOI 10.1021/cr020027w; VIEHE HG, 1988, PURE APPL CHEM, V60, P1635, DOI 10.1351/pac198860111635; Yamamoto H., 2000, LEWIS ACIDS ORGANIC	24	530	533	9	388	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2007	316	5824					582	585		10.1126/science. 1142696	http://dx.doi.org/10.1126/science. 1142696			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	160ZC	17395791				2022-12-01	WOS:000245983100040
J	Goshima, G; Wollman, R; Goodwin, SS; Zhang, N; Scholey, JM; Vale, RD; Stuurman, N				Goshima, Gohta; Wollman, Roy; Goodwin, Sarah S.; Zhang, Nan; Scholey, Jonathan M.; Vale, Ronald D.; Stuurman, Nico			Genes required for mitotic spindle assembly in Drosophila S2 cells	SCIENCE			English	Article							ABNORMAL-SPINDLE; KINETOCHORE; MITOSIS; PROTEIN; CANCER; IDENTIFICATION; MELANOGASTER; INSTABILITY; PROGRESSION; COMPONENTS	The formation of a metaphase spindle, a bipolar microtubule array with centrally aligned chromosomes, is a prerequisite for the faithful segregation of a cell's genetic material. Using a full-genome RNA interference screen of Drosophila S2 cells, we identified about 200 genes that contribute to spindle assembly, more than half of which were unexpected. The screen, in combination with a variety of secondary assays, led to new insights into how spindle microtubules are generated; how centrosomes are positioned; and how centrioles, centrosomes, and kinetochores are assembled.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA; Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; Marine Biol Lab, Physiol Course, Woods Hole, MA 02543 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis; Marine Biological Laboratory - Woods Hole	Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 600 16th St, San Francisco, CA 94158 USA.	vale@cmp.ucsf.edu	Stuurman, Nico/AAV-4894-2021	Goodwin, Sarah/0000-0003-4686-0914; Stuurman, Nico/0000-0002-6179-8613	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038499] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R37 GM038499, R37 GM038499-21] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Bharadwaj R, 2004, J BIOL CHEM, V279, P13076, DOI 10.1074/jbc.M310224200; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Desai A, 2003, GENE DEV, V17, P2421, DOI 10.1101/gad.1126303; DOHENY KF, 1993, CELL, V73, P761, DOI 10.1016/0092-8674(93)90255-O; Fung SM, 2002, DEVELOPMENT, V129, P347; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Goshima G, 2005, CURR BIOL, V15, P1979, DOI 10.1016/j.cub.2005.09.054; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Li KJ, 1996, CELL, V85, P585, DOI 10.1016/S0092-8674(00)81258-1; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179; Mahoney NM, 2006, CURR BIOL, V16, P564, DOI 10.1016/j.cub.2006.01.053; Maiato H, 2004, J CELL BIOL, V167, P831, DOI 10.1083/jcb.200407090; McIntosh JR, 2002, ANNU REV CELL DEV BI, V18, P193, DOI 10.1146/annurev.cellbio.18.032002.132412; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Mitchison TJ, 2001, NAT CELL BIOL, V3, pE17, DOI 10.1038/35050656; Morales-Mulia S, 2005, MOL BIOL CELL, V16, P3176, DOI 10.1091/mbc.E04-12-1110; Muller H, 2006, SCIENCE, V314, P654, DOI 10.1126/science.1132834; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Rieder CL, 2003, SCIENCE, V300, P91, DOI 10.1126/science.1082177; Rodionov VI, 1997, SCIENCE, V275, P215, DOI 10.1126/science.275.5297.215; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Saunders RDC, 1997, J CELL BIOL, V137, P881, DOI 10.1083/jcb.137.4.881; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; TAKAHASHI K, 1994, MOL BIOL CELL, V5, P1145, DOI 10.1091/mbc.5.10.1145; Yanagida M, 1998, TRENDS CELL BIOL, V8, P144, DOI 10.1016/S0962-8924(98)01236-7; Yuen KWY, 2005, CURR OPIN CELL BIOL, V17, P576, DOI 10.1016/j.ceb.2005.09.012	35	418	433	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2007	316	5823					417	421		10.1126/science.1141314	http://dx.doi.org/10.1126/science.1141314			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17412918	Green Accepted			2022-12-01	WOS:000245813400048
J	Tse, D; Langston, RF; Kakeyama, M; Bethus, I; Spooner, PA; Wood, ER; Witter, MP; Morris, RGM				Tse, Dorothy; Langston, Rosamund F.; Kakeyama, Masaki; Bethus, Ingrid; Spooner, Patrick A.; Wood, Emma R.; Witter, Menno P.; Morris, Richard G. M.			Schemas and memory consolidation	SCIENCE			English	Article							REMOTE SPATIAL MEMORY; LONG-TERM-MEMORY; COMPLEMENTARY-LEARNING-SYSTEMS; RETROGRADE-AMNESIA; HIPPOCAMPAL-LESIONS; IBOTENATE LESIONS; COGNITIVE MEMORY; RATS; ORGANIZATION; DAMAGE	Memory encoding occurs rapidly, but the consolidation of memory in the neocortex has long been held to be a more gradual process. We now report, however, that systems consolidation can occur extremely quickly if an associative "schema" into which new information is incorporated has previously been created. In experiments using a hippocampal-dependent paired-associate task for rats, the memory of flavor-place associations became persistent over time as a putative neocortical schema gradually developed. New traces, trained for only one trial, then became assimilated and rapidly hippocampal-independent. Schemas also played a causal role in the creation of lasting associative memory representations during one-trial learning. The concept of neocortical schemas may unite psychological accounts of knowledge structures with neurobiological theories of systems memory consolidation.	Univ Edinburgh, Ctr Cognit & Neural Syst, Lab Cognit Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland; Univ Edinburgh, Neurosci Res Ctr, Edinburgh EH8 9JZ, Midlothian, Scotland; Univ Tokyo, Grad Sch, Div Environm Hlth SCi, Ctr Dis Biol & Integrat Med,Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; Med Tech Res Ctr, Ctr Biol Memory, NO-7489 Trondheim, Norway	University of Edinburgh; University of Edinburgh; University of Tokyo; University of Tokyo	Morris, RGM (corresponding author), Univ Edinburgh, Ctr Cognit & Neural Syst, Lab Cognit Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland.	r.g.m.morris@ed.ac.uk	Morris, Richard G M/C-9982-2013	Kakeyama, Masaki/0000-0001-9063-9673; Tse, Dorothy/0000-0003-2263-8139; MORRIS, Richard G M/0000-0001-8661-1520; Langston, Rosamund/0000-0002-4668-3105; Bethus, Ingrid/0000-0001-8356-6963	MRC [G9200370] Funding Source: UKRI; Medical Research Council [G9200370] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; [Anonymous], REMEMBERING; Bayley PJ, 2005, NEURON, V46, P799, DOI 10.1016/j.neuron.2005.04.034; Bayley PJ, 2002, J NEUROSCI, V22, P5741; BOLHUIS JJ, 1994, Q J EXP PSYCHOL-B, V47, P129; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Bransford J.D., 1979, HUMAN COGNITION LEAR; BRANSFORD JD, 1972, J VERB LEARN VERB BE, V11, P717, DOI 10.1016/S0022-5371(72)80006-9; Bunsey M, 1996, NATURE, V379, P255, DOI 10.1038/379255a0; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Clark RE, 2005, HIPPOCAMPUS, V15, P260, DOI 10.1002/hipo.20056; Craik KW., 1943, NATURE EXPLANATION; Day M, 2003, NATURE, V424, P205, DOI 10.1038/nature01769; DUDAI Y, 2001, ADV COGNITIVE SCI, P147; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; EICHENBAUM H, 1990, J NEUROSCI, V10, P3531; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; GREENOUGH WT, 1992, MINN SYM CHILD PSYCH, V24, P155; HARLOW HF, 1949, PSYCHOL REV, V56, P51, DOI 10.1037/h0062474; Hebb D.O., 2002, CLIN PSYCHOL; Johnson-Laird P.N., 1983, MENTAL MODELS COGNIT; Kesner RP, 2005, BEHAV NEUROSCI, V119, P781, DOI 10.1037/0735-7044.119.3.781; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Maguire EA, 1999, BRAIN, V122, P1839, DOI 10.1093/brain/122.10.1839; Martin SJ, 2005, NEUROPSYCHOLOGIA, V43, P609, DOI 10.1016/j.neuropsychologia.2004.07.007; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MCGONIGLE BO, 1977, NATURE, V267, P694, DOI 10.1038/267694a0; McNaughton, 2003, SLEEP BRAIN PLASTICI, P225, DOI DOI 10.1093/ACPROF:OSO/9780198574002.003.0013; Mishkin M, 1997, PHILOS T R SOC B, V352, P1461, DOI 10.1098/rstb.1997.0132; Miyashita Y, 2004, SCIENCE, V306, P435, DOI 10.1126/science.1101864; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; MORRIS RGM, 1990, EUR J NEUROSCI, V2, P1016, DOI 10.1111/j.1460-9568.1990.tb00014.x; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Rosenbaum RS, 2001, BEHAV BRAIN RES, V127, P183, DOI 10.1016/S0166-4328(01)00363-1; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Sutherland RJ, 2001, HIPPOCAMPUS, V11, P27, DOI 10.1002/1098-1063(2001)11:1<27::AID-HIPO1017>3.0.CO;2-4; Teng E, 1999, NATURE, V400, P675, DOI 10.1038/23276; TEYLER TJ, 1986, BEHAV NEUROSCI, V100, P147, DOI 10.1037/0735-7044.100.2.147; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Winocur G, 2005, NAT NEUROSCI, V8, P273, DOI 10.1038/nn1401; Wirth S, 2003, SCIENCE, V300, P1578, DOI 10.1126/science.1084324; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	53	729	735	3	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2007	316	5821					76	82		10.1126/science.1135935	http://dx.doi.org/10.1126/science.1135935			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412951	Green Published			2022-12-01	WOS:000245470500034
J	Rainey, PB				Rainey, Paul B.			Unity from conflict	NATURE			English	Editorial Material									Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of Auckland	Rainey, PB (corresponding author), Univ Auckland, Sch Biol Sci, Private Bag 92019, Auckland 1, New Zealand.		Rainey, Paul/A-3207-2008	Rainey, Paul/0000-0003-0879-5795				Maynard Smith J., 1995, MAJOR TRANSITIONS EV; Michod Richard E., 1999, DARWINIAN DYNAMICS; Okasha S, 2006, EVOLUTION LEVELS SEL, DOI DOI 10.1093/ACPROF:OSO/9780199267972.001.0001; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906	4	28	30	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2007	446	7136					616	616		10.1038/446616a	http://dx.doi.org/10.1038/446616a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17410161	Bronze			2022-12-01	WOS:000245438300022
J	Smith, GCS; Fleming, KM; White, IR				Smith, Gordon C. S.; Fleming, Kate M.; White, Ian R.			Birth order of twins and risk of perinatal death related to delivery in England, Northern Ireland, and Wales, 1994-2003: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							2ND TWIN; MORBIDITY; MORTALITY; MODE; OUTCOMES; WEIGHT; FETAL; TERM	Objective To determine the effect of birth order on the risk of perinatal death in twin pregnancies. Design Retrospective cohort study. Setting England, Northern Ireland, and Wales, 1994-2003. Participants 1377 twin pregnancies with one intrapartum stillbirth or neonatal death from causes other than congenital abnormality and one surviving infant. Main outcome measures The risk of perinatal death in the first and second twin estimated with conditional logistic regression. Results There was no association between birth order and, the risk of death overall (odds ratio 1.0, 95% confidence interval 0.9 to 1.1). However, there was a highly significant interaction with gestational age (P < 0.001). There was no association between birth order and the risk of death among infants born before 36 weeks' gestation but there was an increased risk of death among second twins born at term (2.3, 1.7 to 3.2, P < 0.001), which was stronger for deaths caused by intrapartum anoxia or trauma (3.4, 2.2 to 5.3). Among term births, there was a trend (P=0.1) towards a greater risk of the second twin dying from anoxia among those delivered vaginally (4.1, 1.8 to 9.5) compared with those delivered by caesarean section (1.8, 0.9 to 3.6). Conclusions In this cohort, compared with first twins, second twins born at term were at increased risk of perinatal death related to delivery. Vaginally delivered second twins had a fourfold risk of death caused by intrapartum anoxia.	Univ Cambridge, Dept Obstet & Gynaecol, Rosie Hosp, Cambridge CB2 2QQ, England; Inst Publ Hlth, MRC, Biostat Unit, Cambridge CB2 2SR, England	University of Cambridge; MRC Biostatistics Unit; University of Cambridge	Smith, GCS (corresponding author), Univ Cambridge, Dept Obstet & Gynaecol, Rosie Hosp, Box223, Cambridge CB2 2QQ, England.	gcss2@cam.ac.uk	Smith, Gordon/A-8070-2008; Fleming, Kate M/A-6475-2010	Smith, Gordon/0000-0003-2124-0997; Fleming, Kate M/0000-0002-6572-5016; White, Ian/0000-0002-6718-7661	MRC [MC_U105260558] Funding Source: UKRI; Medical Research Council [MC_U105260558] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Armson BA, 2006, OBSTET GYNECOL, V108, P556, DOI 10.1097/01.AOG.0000227747.37184.0a; Cahill AG, 2006, AM J OBSTET GYNECOL, V194, P909, DOI 10.1016/j.ajog.2006.02.031; GOODMAN SN, 1994, ANN INTERN MED, V121, P200, DOI 10.7326/0003-4819-121-3-199408010-00008; Hartley RS, 2005, J MATERN-FETAL NEO M, V17, P375, DOI 10.1080/147670505000132484; HEY EN, 1986, BRIT J OBSTET GYNAEC, V93, P1213, DOI 10.1111/j.1471-0528.1986.tb07854.x; Lydon-Rochelle MT, 2005, AM J PUBLIC HEALTH, V95, P1948, DOI 10.2105/AJPH.2004.044305; Sheay W, 2004, OBSTET GYNECOL, V103, P63, DOI 10.1097/01.AOG.0000101291.14773.F0; Smith GCS, 2005, BJOG-INT J OBSTET GY, V112, P1139, DOI 10.1111/j.1471-0528.2005.00631.x; Smith GCS, 2005, AM J OBSTET GYNECOL, V192, P17, DOI 10.1016/j.ajog.2004.08.014; Smith GCS, 2002, BRIT MED J, V325, P1004, DOI 10.1136/bmj.325.7371.1004; Thorngren-Jerneck K, 2001, OBSTET GYNECOL, V98, P65, DOI 10.1016/S0029-7844(01)01370-9; Yang Q, 2006, J PERINATOL, V26, P3, DOI 10.1038/sj.jp.7211408; Yang QY, 2006, AM J PERINAT, V23, P381, DOI 10.1055/s-2006-951286; Yang QY, 2005, AM J OBSTET GYNECOL, V192, P840, DOI 10.1016/j.ajog.2004.09.132	14	85	89	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2007	334	7593					576	578A		10.1136/bmj.39118.483819.55	http://dx.doi.org/10.1136/bmj.39118.483819.55			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AP	17337456	Bronze, Green Published			2022-12-01	WOS:000245404400036
J	Tang, RH; Han, SC; Zheng, HL; Cook, CW; Choi, CS; Woerner, TE; Jackson, RB; Pei, ZM				Tang, Ru-Hang; Han, Shengcheng; Zheng, Hailei; Cook, Charles W.; Choi, Christopher S.; Woerner, Todd E.; Jackson, Robert B.; Pei, Zhen-Ming			Coupling diurnal cytosolic Ca2+ oscillations to the CAS-IP3 pathway in Arabidopsis	SCIENCE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE; CALCIUM; DYNAMICS; PHYSIOLOGY	Various signaling pathways rely on changes in cytosolic calcium ion concentration ([Ca2+](i)). In plants, resting [Ca2+](i) oscillates diurnally. We show that in Arabidopsis thaliana, [Ca2+](i) oscillations are synchronized to extracellular Ca2+ concentration ([Ca2+](o)) oscillations largely through the Ca2+- sensing receptor CAS. CAS regulates concentrations of inositol 1,4,5- trisphosphate (IP3), which in turn directs release of Ca2+ from internal stores. The oscillating amplitudes of [Ca2+](o) and [Ca2+](i) are controlled by soil Ca2+ concentrations and transpiration rates. The phase and period of oscillations are likely determined by stomatal conductance. Thus, the internal concentration of Ca2+ in plant cells is constantly being actively revised.	Duke Univ, Dept Biol, Durham, NC 27708 USA; Xiamen Univ, Dept Biol, Xiamen 361005, Fujian, Peoples R China; Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen 361005, Fujian, Peoples R China; Duke Univ, Dept Chem, Durham, NC 27708 USA	Duke University; Xiamen University; Xiamen University; Duke University	Pei, ZM (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	zpei@duke.edu	Zheng, Hai-Lei/G-3432-2010	Zheng, Hai-Lei/0000-0001-8588-1529; Jackson, Robert/0000-0001-8846-7147; Pei, Zhen-Ming/0000-0003-1473-696X; Han, Shengcheng/0000-0002-4039-7589; Tang, Ruhang/0000-0003-4918-3525				Bartlett PJ, 2005, J BIOL CHEM, V280, P21837, DOI 10.1074/jbc.M411843200; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Colwell CS, 2000, EUR J NEUROSCI, V12, P571, DOI 10.1046/j.1460-9568.2000.00939.x; Dodd AN, 2005, TRENDS PLANT SCI, V10, P15, DOI 10.1016/j.tplants.2004.12.001; Gao DJ, 2004, PLANT PHYSIOL, V134, P898, DOI 10.1104/pp.103.032508; Han SC, 2003, NATURE, V425, P196, DOI 10.1038/nature01932; Hepler PK, 2005, PLANT CELL, V17, P2142, DOI 10.1105/tpc.105.032508; Hetherington AM, 2004, ANNU REV PLANT BIOL, V55, P401, DOI 10.1146/annurev.arplant.55.031903.141624; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Ikeda M, 2003, NEURON, V38, P253, DOI 10.1016/S0896-6273(03)00164-8; JOHNSON CH, 1995, SCIENCE, V269, P1863, DOI 10.1126/science.7569925; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Love J, 2004, PLANT CELL, V16, P956, DOI 10.1105/tpc.020214; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; McLaughlin SB, 1999, NEW PHYTOL, V142, P373, DOI 10.1046/j.1469-8137.1999.00420.x; Meijer HJG, 2003, ANNU REV PLANT BIOL, V54, P265, DOI 10.1146/annurev.arplant.54.031902.134748; Mueller-Roeber B, 2002, PLANT PHYSIOL, V130, P22, DOI 10.1104/pp.004770; Nash MS, 2001, NATURE, V413, P381, DOI 10.1038/35096643; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Webb AAR, 2003, NEW PHYTOL, V160, P281, DOI 10.1046/j.1469-8137.2003.00895.x; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164	26	120	137	3	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2007	315	5817					1423	1426		10.1126/science.1134457	http://dx.doi.org/10.1126/science.1134457			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347443				2022-12-01	WOS:000244752200037
J	Torres-Rosell, J; De Piccoli, G; Cordon-Preciado, V; Farmer, S; Jamuz, A; Machin, F; Pasero, P; Lisby, M; Haber, JE; Aragon, L				Torres-Rosell, Jordi; De Piccoli, Giacomo; Cordon-Preciado, Violeta; Farmer, Sarah; Jamuz, Adam; Machin, Felix; Pasero, Philippe; Lisby, Michael; Haber, James E.; Aragon, Luis			Anaphase onset before complete DNA replication with intact checkpoint responses	SCIENCE			English	Article							COMMON FRAGILE SITE; S-PHASE; BUDDING YEAST; ACTIVATION; ORIGINS; DAMAGE; GENES	Cellular checkpoints prevent mitosis in the presence of stalled replication forks. Whether checkpoints also ensure the completion of DNA replication before mitosis is unknown. Here, we show that in yeast smc5-smc6 mutants, which are related to cohesin and condensin, replication is delayed, most significantly at natural replication-impeding loci like the ribosomal DNA gene cluster. In the absence of Smc5-Smc6, chromosome nondisjunction occurs as a consequence of mitotic entry with unfinished replication despite intact checkpoint responses. Eliminating processes that obstruct replication fork progression restores the temporal uncoupling between replication and segregation in smc5-smc6 mutants. We propose that the completion of replication is not under the surveillance of known checkpoints.	Imperial Coll London, Fac Med, Ctr Clin Sci, MRC,Cell Cycle Grp, London W12 0NN, England; Inst Human Genet, CNRS, Unite Propre Rech 1142, F-34396 Montpellier, France; Univ Copenhagen, Inst Mol Biol & Physiol, Dept Genet, DK-1353 Copenhagen, Denmark; Brandeis Univ, Rosenstiel Ctr, Waltham, MA 02454 USA	Imperial College London; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Copenhagen; Brandeis University	Aragon, L (corresponding author), Imperial Coll London, Fac Med, Ctr Clin Sci, MRC,Cell Cycle Grp, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England.	luis.aragon@csc.mrc.ac.uk	Torres-Rosell, Jordi/A-4213-2010; Lisby, Michael/K-9814-2014; Pasero, Philippe/O-2340-2018; Machín, Félix/K-6569-2017	Torres-Rosell, Jordi/0000-0003-1308-6926; Lisby, Michael/0000-0002-4830-5247; Pasero, Philippe/0000-0001-5891-0822; Machín, Félix/0000-0003-4559-7798; Haber, James/0000-0002-1878-0610	MRC [MC_U120074328] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020056, R01GM061766, R37GM020056] Funding Source: NIH RePORTER; Medical Research Council [MC_U120074328] Funding Source: Medline; NIGMS NIH HHS [GM 20056, R01 GM061766-07, R01 GM061766, R01 GM061766-08] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; De Piccoli G, 2006, NAT CELL BIOL, V8, P1032, DOI 10.1038/ncb1466; Hellman A, 2000, MOL CELL BIOL, V20, P4420, DOI 10.1128/MCB.20.12.4420-4427.2000; Le Beau MM, 1998, HUM MOL GENET, V7, P755, DOI 10.1093/hmg/7.4.755; LEHMANN AR, 1995, MOL CELL BIOL, V15, P7067; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; LINSKENS MHK, 1988, MOL CELL BIOL, V8, P4927, DOI 10.1128/MCB.8.11.4927; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; NOGI Y, 1991, P NATL ACAD SCI USA, V88, P3962, DOI 10.1073/pnas.88.9.3962; Palakodeti A, 2004, GENE CHROMOSOME CANC, V39, P71, DOI 10.1002/gcc.10290; Pasero P, 2002, GENE DEV, V16, P2479, DOI 10.1101/gad.232902; Pasero P, 1999, GENE DEV, V13, P2159, DOI 10.1101/gad.13.16.2159; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Shimada K, 2002, GENE DEV, V16, P3236, DOI 10.1101/gad.239802; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Weinert T, 1998, CURR OPIN GENET DEV, V8, P185, DOI 10.1016/S0959-437X(98)80140-8; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	21	103	105	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2007	315	5817					1411	1415		10.1126/science.1134025	http://dx.doi.org/10.1126/science.1134025			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347440				2022-12-01	WOS:000244752200034
J	Bach, PB; Jett, JR; Pastorino, U; Tockman, MS; Swensen, SJ; Begg, CB				Bach, Peter B.; Jett, James R.; Pastorino, Ugo; Tockman, Melvyn S.; Swensen, Stephen J.; Begg, Colin B.			Computed tomography screening and lung cancer outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COLORECTAL-CANCER; MORTALITY; CT; NODULES; OVERDIAGNOSIS; COLONOSCOPY; CARCINOMA; RESECTION; SURVIVAL; PROJECT	Context Current and former smokers are currently being screened for lung cancer with computed tomography (CT), although there are limited data on the effect screening has on lung cancer outcomes. Randomized controlled trials assessing CT screening are currently under way. Objective To assess whether screening may increase the frequency of lung cancer diagnosis and lung cancer resection or may reduce the risk of a diagnosis of advanced lung cancer or death from lung cancer. Design, Setting, and Participants Longitudinal analysis of 3246 asymptomatic current or former smokers screened for lung cancer beginning in 1998 either at 1 of 2 academic medical centers in the United States or an academic medical center in Italy with follow-up for a median of 3.9 years. Intervention Annual CT scans with comprehensive evaluation and treatment of detected nodules. Main Outcome Measures Comparison of predicted with observed number of new lung cancer cases, lung cancer resections, advanced lung cancer cases, and deaths from lung cancer. Results There were 144 individuals diagnosed with lung cancer compared with 44.5 expected cases ( relative risk [RR], 3.2; 95% confidence interval [CI], 2.7-3.8; P <. 001). There were 109 individuals who had a lung resection compared with 10.9 expected cases ( RR, 10.0; 95% CI, 8.2-11.9; P <. 001). There was no evidence of a decline in the number of diagnoses of advanced lung cancers ( 42 individuals compared with 33.4 expected cases) or deaths from lung cancer ( 38 deaths due to lung cancer observed and 38.8 expected; RR, 1.0; 95% CI, 0.7- 1.3; P=. 90). Conclusions Screening for lung cancer with low-dose CT may increase the rate of lung cancer diagnosis and treatment, but may not meaningfully reduce the risk of advanced lung cancer or death from lung cancer. Until more conclusive data are available, asymptomatic individuals should not be screened outside of clinical research studies that have a reasonable likelihood of further clarifying the potential benefits and risks.	Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; Mayo Clin, Dept Radiol, Rochester, MN USA; Mayo Clin, Div Pulm Med & Oncol, Rochester, MN USA; Ist Tumori, Div Thorac Surg, Milan, Italy; H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Prevent & Control, Tampa, FL USA	Memorial Sloan Kettering Cancer Center; Mayo Clinic; Mayo Clinic; H Lee Moffitt Cancer Center & Research Institute	Bach, PB (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Box 221, New York, NY 10021 USA.		Peng, Bo/A-6920-2009; Pastorino, Ugo/C-2712-2017	Peng, Bo/0000-0001-8225-2284; Pastorino, Ugo/0000-0001-9974-7902	NATIONAL CANCER INSTITUTE [R01CA079935, K22CA094973] Funding Source: NIH RePORTER; NCI NIH HHS [UO1CA94973, R01CA79935] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bach PB, 2004, CHEST, V126, P1742, DOI 10.1378/chest.126.6.1742; Bach PB, 2003, CHEST, V123, p72S, DOI 10.1378/chest.123.1_suppl.72S; Bach PB, 2001, NEW ENGL J MED, V345, P181, DOI 10.1056/NEJM200107193450306; BACH PB, 2005, CHEST           0318; BACH PB, 2000, J NATL CANCER I, V95, P470; Cronin KA, 2006, JNCI-J NATL CANCER I, V98, P637, DOI 10.1093/jnci/djj163; Dammas S, 2001, LUNG CANCER, V33, P11, DOI 10.1016/S0169-5002(01)00190-8; FONTANA RS, 1986, J OCCUP ENVIRON MED, V28, P746, DOI 10.1097/00043764-198608000-00038; Gibson L, 1997, J Med Screen, V4, P44; GOLDBERG KB, 2002, NCI LUNG CANC SCREEN; HAKAMA M, 1985, BRIT J CANCER, V52, P669, DOI 10.1038/bjc.1985.241; Harpole DH, 1999, J THORAC CARDIOV SUR, V117, P969, DOI 10.1016/S0022-5223(99)70378-8; Henschke CI, 2004, RADIOLOGY, V231, P164, DOI 10.1148/radiol.2311030634; Henschke CI, 2001, ONCOLOGIST, V6, P147, DOI 10.1634/theoncologist.6-2-147; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Jemal A, 2004, CANCER-AM CANCER SOC, V101, P3, DOI 10.1002/cncr.20288; KJELLGREN O, 1986, GYNECOL OBSTET INVES, V22, P57, DOI 10.1159/000298892; KUBIK A, 1986, CANCER-AM CANCER SOC, V57, P2427, DOI 10.1002/1097-0142(19860615)57:12<2427::AID-CNCR2820571230>3.0.CO;2-M; Kubik AK, 2000, CANCER, V89, P2363, DOI 10.1002/1097-0142(20001201)89:11+<2363::AID-CNCR9>3.3.CO;2-N; LANGE P, 1990, THORAX, V45, P579, DOI 10.1136/thx.45.8.579; Lee TH, 2002, NEW ENGL J MED, V346, P529, DOI 10.1056/NEJM200202143460715; LEVIN ML, 1982, RECENT RES CANCER, V82, P138; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lindell RM, 2007, RADIOLOGY, V242, P555, DOI 10.1148/radiol.2422052090; Mannino DM, 2003, ARCH INTERN MED, V163, P1475, DOI 10.1001/archinte.163.12.1475; Marcus PM, 2000, J NATL CANCER I, V92, P1308, DOI 10.1093/jnci/92.16.1308; Melamed MR, 2000, CANCER, V89, P2356, DOI 10.1002/1097-0142(20001201)89:11+<2356::AID-CNCR8>3.0.CO;2-Z; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Pastorino U, 2003, LANCET, V362, P593, DOI 10.1016/S0140-6736(03)14188-8; Pinsky PF, 2005, CANCER-AM CANCER SOC, V103, P157, DOI 10.1002/cncr.20746; Schilling FH, 2002, NEW ENGL J MED, V346, P1047, DOI 10.1056/NEJMoa012277; Silvestri GA, 1998, CHEST, V114, P675, DOI 10.1378/chest.114.3.675; Sone S, 1998, LANCET, V351, P1242, DOI 10.1016/S0140-6736(97)08229-9; Stephan F, 2000, CHEST, V118, P1263, DOI 10.1378/chest.118.5.1263; STITIK FP, 1978, RADIOL CLIN N AM, V16, P347; Swensen SJ, 2003, RADIOLOGY, V226, P756, DOI 10.1148/radiol.2263020036; Swensen SJ, 2002, AM J RESP CRIT CARE, V165, P508, DOI 10.1164/ajrccm.165.4.2107006; Thiis-Evensen E, 1999, SCAND J GASTROENTERO, V34, P414; TOCKMAN MS, 2003, 10 INT C LUNG CANC A; *WHO, 2002, NUMB RAT REG DEATHS, V92, P1280; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Woods WG, 2002, NEW ENGL J MED, V346, P1041, DOI 10.1056/NEJMoa012387; Yankelevitz DF, 2000, RADIOLOGY, V217, P251, DOI 10.1148/radiology.217.1.r00oc33251; Yankelevitz DF, 2003, CANCER, V97, P1271, DOI 10.1002/cncr.11185; Zhukov TA, 2003, LUNG CANCER, V40, P267, DOI 10.1016/S0169-5002(03)00082-5; FOCUS LUNG CANC SCRE	46	427	446	2	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2007	297	9					953	961		10.1001/jama.297.9.953	http://dx.doi.org/10.1001/jama.297.9.953			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143CP	17341709				2022-12-01	WOS:000244697900024
J	Shea, K				Shea, Katriona			How the wood moves	SCIENCE			English	Editorial Material							DISPERSAL		Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA; Penn State Univ, Intercoll Grad Degree Program Ecol, Mueller Lab 208, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Shea, K (corresponding author), Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA.	k-shea@psu.edu	Shea, Katriona/B-7954-2008	Shea, Katriona/0000-0002-7607-8248				Bullock JM, 2006, PLANT ECOL, V186, P217, DOI 10.1007/s11258-006-9124-5; Garcia C, 2005, MOL ECOL, V14, P1821, DOI 10.1111/j.1365-294X.2005.02542.x; Jordano P, 2007, P NATL ACAD SCI USA, V104, P3278, DOI 10.1073/pnas.0606793104; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; SHAKESPEARE W, 1969, MACBETH; Sugden A, 2006, SCIENCE, V313, P775, DOI 10.1126/science.313.5788.775; Tolkien J.R.R., 1966, 2 TOWERS BEING 2 PAR, V2nd; Wyndham J., 1951, DOUBLEDAY	8	12	13	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2007	315	5816					1231	1232		10.1126/science.1136096	http://dx.doi.org/10.1126/science.1136096			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332401				2022-12-01	WOS:000244564700036
J	Paliwal, S; Iglesias, PA; Campbell, K; Hilioti, Z; Groisman, A; Levchenko, A				Paliwal, Saurabh; Iglesias, Pablo A.; Campbell, Kyle; Hilioti, Zoe; Groisman, Alex; Levchenko, Andre			MAPK-mediated bimodal gene expression and adaptive gradient sensing in yeast	NATURE			English	Article							PHEROMONE RESPONSE PATHWAY; SACCHAROMYCES-CEREVISIAE; SIGNAL-TRANSDUCTION; POSITIVE FEEDBACK; ESCHERICHIA-COLI; KINASE; KSS1; HYSTERESIS; GROWTH; DIFFERENTIATION	The mating pathway in Saccharomyces cerevisiae has been the focus of considerable research effort, yet many quantitative aspects of its regulation still remain unknown. Using an integrated approach involving experiments in microfluidic chips and computational modelling, we studied gene expression and phenotypic changes associated with the mating response under well-defined pheromone gradients. Here we report a combination of switch-like and graded pathway responses leading to stochastic phenotype determination in a specific range of pheromone concentrations. Furthermore, we show that these responses are critically dependent on mitogen-activated protein kinase (MAPK)-mediated regulation of the activity of the pheromone-response-specific transcription factor, Ste12, as well as on the autoregulatory feedback of Ste12. In particular, both the switch-like characteristics and sensitivity of gene expression in shmooing cells to pheromone concentration were significantly diminished in cells lacking Kss1, one of the MAP kinases activated in the mating pathway. In addition, the dynamic range of gradient sensing of Kss1-deficient cells was reduced compared with wild type. We thus provide unsuspected functional significance for this kinase in regulation of the mating response.	Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; Johns Hopkins Univ, Whitehead Inst Biomed Engn, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Elect Engn & Comp Engn, Baltimore, MD 21218 USA; Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA	Johns Hopkins University; Johns Hopkins University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Johns Hopkins University; University of California System; University of California San Diego	Levchenko, A (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	agroisman@ucsd.edu; alev@jhu.edu	Iglesias, Pablo A/A-5202-2008; Groisman, Alexander/AAU-7843-2021	Iglesias, Pablo A/0000-0002-0840-155X; HILIOTI, ZOE/0000-0003-4330-0129	NCRR NIH HHS [U54 RR020839] Funding Source: Medline; NIGMS NIH HHS [R01 GM072024] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072024] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Bardwell L, 1998, P NATL ACAD SCI USA, V95, P15400, DOI 10.1073/pnas.95.26.15400; Bardwell L, 1998, GENE DEV, V12, P2887, DOI 10.1101/gad.12.18.2887; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Biggar SR, 2001, EMBO J, V20, P3167, DOI 10.1093/emboj/20.12.3167; Colman-Lerner A, 2006, NATURE, V439, P502, DOI 10.1038/nature04476; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Cook JG, 1997, NATURE, V390, P85, DOI 10.1038/36355; ELION EA, 1993, MOL BIOL CELL, V4, P495, DOI 10.1091/mbc.4.5.495; Farley FW, 1999, GENETICS, V151, P1425; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Guthrie C., 1991, METHODS ENZYMOLOGY G; Isbister CM, 2003, J NEUROSCI, V23, P193; Janetopoulos C, 2004, P NATL ACAD SCI USA, V101, P8951, DOI 10.1073/pnas.0402152101; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; MA D, 1995, MOL BIOL CELL, V6, P889, DOI 10.1091/mbc.6.7.889; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Matheos D, 2004, J CELL BIOL, V165, P99, DOI 10.1083/jcb.200309089; MOORE SA, 1983, J BIOL CHEM, V258, P3849; NINFA AJ, 2004, SCI STKE, V232, pPE20; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Portiz MA, 2001, YEAST, V18, P1331, DOI 10.1002/yea.777; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; SEGALL JE, 1993, P NATL ACAD SCI USA, V90, P8332, DOI 10.1073/pnas.90.18.8332; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113	31	221	226	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2007	446	7131					46	51		10.1038/nature05561	http://dx.doi.org/10.1038/nature05561			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17310144				2022-12-01	WOS:000244525600033
J	Cai, HQ; Yu, S; Menon, S; Cai, YY; Lazarova, D; Fu, CM; Reinisch, K; Hay, JC; Ferro-Novick, S				Cai, Huaqing; Yu, Sidney; Menon, Shekar; Cai, Yiying; Lazarova, Darina; Fu, Chunmei; Reinisch, Karin; Hay, Jesse C.; Ferro-Novick, Susan			TRAPPI tethers COPII vesicles by binding the coat subunit Sec23	NATURE			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; TO-GOLGI TRANSPORT; ENDOPLASMIC-RETICULUM; FUSION; PROTEIN; DOCKING; INTERMEDIATE; HYDROLYSIS; COMPLEXES; SITES	The budding of endoplasmic reticulum (ER)-derived vesicles is dependent on the COPII coat complex(1). Coat assembly is initiated when Sar1-GTP recruits the cargo adaptor complex, Sec23/Sec24, by binding to its GTPase-activating protein ( GAP) Sec23 (ref. 2). This leads to the capture of transmembrane cargo by Sec24 (refs 3, 4) before the coat is polymerized by the Sec13/Sec31 complex(5). The initial interaction of a vesicle with its target membrane is mediated by tethers(6). We report here that in yeast and mammalian cells the tethering complex TRAPPI ( ref. 7) binds to the coat subunit Sec23. This event requires the Bet3 subunit. In vitro studies demonstrate that the interaction between Sec23 and Bet3 targets TRAPPI to COPII vesicles to mediate vesicle tethering. We propose that the binding of TRAPPI to Sec23 marks a coated vesicle for fusion with another COPII vesicle or the Golgi apparatus. An implication of these findings is that the intracellular destination of a transport vesicle may be determined in part by its coat and its associated cargo.	Howard Hughes Med Inst, New Haven, CT 06519 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06519 USA; Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	Howard Hughes Medical Institute; Yale University; University of Montana System; University of Montana	Ferro-Novick, S (corresponding author), Howard Hughes Med Inst, New Haven, CT 06519 USA.	susan.ferronovick@yale.edu	Bin Sidney Yu, Siu/R-4936-2018	Bin Sidney Yu, Siu/0000-0001-9643-2729; Cai, Huaqing/0000-0001-8434-6639	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080616] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM080616] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Barrowman J, 2000, EMBO J, V19, P862, DOI 10.1093/emboj/19.5.862; Bentley M, 2006, J BIOL CHEM, V281, P38825, DOI 10.1074/jbc.M606044200; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Cao XC, 1998, EMBO J, V17, P2156, DOI 10.1093/emboj/17.8.2156; Forster R, 2006, CURR BIOL, V16, P173, DOI 10.1016/j.cub.2005.11.076; Kim YG, 2006, CELL, V127, P817, DOI 10.1016/j.cell.2006.09.029; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Menon S, 2006, BIOCHEM BIOPH RES CO, V350, P669, DOI 10.1016/j.bbrc.2006.09.096; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; OKA T, 1994, J CELL BIOL, V124, P425, DOI 10.1083/jcb.124.4.425; Peyroche A, 2001, METHOD ENZYMOL, V329, P290; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; REXACH MF, 1991, J CELL BIOL, V114, P219, DOI 10.1083/jcb.114.2.219; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Sacher M, 2000, EUR J CELL BIOL, V79, P71, DOI 10.1078/S0171-9335(04)70009-6; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; Sacher M, 2001, MOL CELL, V7, P433, DOI 10.1016/S1097-2765(01)00190-3; Sato K, 2005, NAT STRUCT MOL BIOL, V12, P167, DOI 10.1038/nsmb893; Shorter J, 2002, J CELL BIOL, V157, P45, DOI 10.1083/jcb.200112127; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Wang W, 2000, J CELL BIOL, V151, P289, DOI 10.1083/jcb.151.2.289; Whyte JRC, 2002, J CELL SCI, V115, P2627; Xu DL, 2004, J CELL BIOL, V167, P997, DOI 10.1083/jcb.200408135; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644; Yu S, 2006, J CELL BIOL, V174, P359, DOI 10.1083/jcb.200603044	28	185	197	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					941	944		10.1038/nature05527	http://dx.doi.org/10.1038/nature05527			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17287728				2022-12-01	WOS:000244341200055
J	Garcia-Bassets, I; Kwon, YS; Telese, F; Prefontaine, GG; Hutt, KR; Cheng, CS; Ju, BG; Ohgi, KA; Wang, J; Escoubet-Lozach, L; Rose, DW; Glass, CK; Fu, XD; Rosenfeld, MG				Garcia-Bassets, Ivan; Kwon, Young-Soo; Telese, Francesca; Prefontaine, Gratien G.; Hutt, Kasey R.; Cheng, Christine S.; Ju, Bong-Gun; Ohgi, Kenneth A.; Wang, Jianxun; Escoubet-Lozach, Laure; Rose, David W.; Glass, Christopher K.; Fu, Xiang-Dong; Rosenfeld, Michael G.			Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors	CELL			English	Article							THYROID-HORMONE RECEPTOR; ANDROGEN-RECEPTOR; TRANSCRIPTIONAL ACTIVATION; ESTROGEN-RECEPTOR; CO-REPRESSOR; INDEPENDENT ACTIVATION; CHROMATIN-STRUCTURE; LYSINE METHYLATION; SIGNALING PATHWAY; BREAST-CANCER	Nuclear receptors undergo ligand-dependent conformational changes that are required for corepressor-coactivator exchange, but whether there is an actual requirement for specific epigenetic landmarks to impose ligand dependency for gene activation remains unknown. Here we report an unexpected and general strategy that is based on the requirement for specific cohorts of inhibitory histone methyltransferases (HMTs) to impose gene-specific gatekeeper functions that prevent unliganded nuclear receptors and other classes of regulated transcription factors from binding to their target gene promoters and causing constitutive gene activation in the absence of stimulating signals. This strategy, based at least in part on an HMT-dependent inhibitory histone code, imposes a requirement for specific histone demethylases, including LSD1, to permit ligand- and signal-dependent activation of regulated gene expression. These events link an inhibitory methylation component of the histone code to a broadly used strategy that circumvents pathological constitutive gene induction by physiologically regulated transcription factors.	Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Glass, CK (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ckg@ucsd.edu; xdfu@ucsd.edu; mrosenfeld@ucsd.edu	Garcia-Bassets, Ivan/F-5075-2010; Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592; Telese, Francesca/0000-0003-3877-0628; Garcia-Bassets, Ivan/0000-0002-6941-9585	NATIONAL CANCER INSTITUTE [R01CA052599, R33CA114184, R01CA097134] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039949, R01DK039949, P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER; NCI NIH HHS [CA97134, R01 CA097134, R33 CA114184, R01 CA052599, CA114184, CA52599] Funding Source: Medline; NHGRI NIH HHS [HG003119, R01 HG003119] Funding Source: Medline; NIDDK NIH HHS [R01 DK039949, DK063491, P30 DK063491, DK39949, R37 DK039949] Funding Source: Medline; NINDS NIH HHS [R01 NS034934, NS34934] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Carling T, 2004, MOL CELL BIOL, V24, P7032, DOI 10.1128/MCB.24.16.7032-7042.2004; Chan C, 2005, J IMMUNOL, V175, P461, DOI 10.4049/jimmunol.175.1.461; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; CULIG Z, 1994, CANCER RES, V54, P5474; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Du Y, 2001, CANCER RES, V61, P8094; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Forneris F, 2005, J BIOL CHEM, V280, P41360, DOI 10.1074/jbc.M509549200; Forneris F, 2006, J BIOL CHEM, V281, P35289, DOI 10.1074/jbc.M607411200; Gazzerro P, 2006, EXP CELL RES, V312, P340, DOI 10.1016/j.yexcr.2005.11.002; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; He LS, 1998, CANCER RES, V58, P4238; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kim J, 2005, J MOL ENDOCRINOL, V34, P107, DOI 10.1677/jme.1.01701; Kim J, 2003, NUCLEIC ACIDS RES, V31, P6741, DOI 10.1093/nar/gkg909; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kurahashi T, 2005, MOL BIOL CELL, V16, P4705, DOI 10.1091/mbc.E05-05-0470; Kwon YS, 2007, P NATL ACAD SCI USA, V104, P4852, DOI 10.1073/pnas.0700715104; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Li JW, 2002, MOL CELL BIOL, V22, P5688, DOI 10.1128/MCB.22.16.5688-5697.2002; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Ma H, 2001, CURR BIOL, V11, P1981, DOI 10.1016/S0960-9822(01)00600-5; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; Metivier R, 2004, EMBO J, V23, P3653, DOI 10.1038/sj.emboj.7600377; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nazareth LV, 1996, J BIOL CHEM, V271, P19900, DOI 10.1074/jbc.271.33.19900; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Privalsky ML, 2004, ANNU REV PHYSIOL, V66, P315, DOI 10.1146/annurev.physiol.66.032802.155556; Rogatsky I, 1999, J BIOL CHEM, V274, P22296, DOI 10.1074/jbc.274.32.22296; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Saccani S, 2002, GENE DEV, V16, P2219, DOI 10.1101/gad.232502; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Steele-Perkins G, 2001, GENE DEV, V15, P2250, DOI 10.1101/gad.870101; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Ueda T, 2002, J BIOL CHEM, V277, P38087, DOI 10.1074/jbc.M203313200; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yang L, 2002, ONCOGENE, V21, P148, DOI 10.1038/sj.onc.1204998; Yang XJ, 2003, CURR OPIN GENET DEV, V13, P143, DOI 10.1016/S0959-437X(03)00015-7; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032; Zwijsen RML, 1997, CELL, V88, P405, DOI 10.1016/S0092-8674(00)81879-6	74	347	374	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2007	128	3					505	518		10.1016/j.cell.2006.12.038	http://dx.doi.org/10.1016/j.cell.2006.12.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289570	Green Accepted, Bronze			2022-12-01	WOS:000244842700017
J	Johnson, MD; Oldach, D; Delwiche, CF; Stoecker, DK				Johnson, Matthew D.; Oldach, David; Delwiche, Charles F.; Stoecker, Diane K.			Retention of transcriptionally active cryptophyte nuclei by the ciliate Myrionecta rubra	NATURE			English	Article							MESODINIUM-RUBRUM; GENE-TRANSFER; ULTRASTRUCTURE; CHLOROPLASTS; CRYPTOMONAD; DINOFLAGELLATE; ENDOSYMBIONT; NUCLEOMORPH; CILIOPHORA; ALGAE	It is well documented that organelles can be retained and used by predatory organisms, but in most cases such sequestrations are limited to plastids of algal prey(1). Furthermore, sequestrations of prey organelles are typically highly ephemeral(2) as a result of the inability of the organelle to remain functional in the absence of numerous nuclear-encoded genes involved in its regulation, division and function(3). The marine photosynthetic ciliate Myrionecta rubra (Lohmann 1908) Jankowski 1976 ( the same as Mesodinium rubrum)(4) is known to possess organelles of cryptophyte origin(5-9), which has led to debate concerning their status as permanent symbiotic or temporary sequestered fixtures(5-13). Recently, M. rubra has been shown to steal plastids ( that is, chloroplasts) from the cryptomonad, Geminigera cryophila, and prey nuclei were observed to accumulate after feeding(10). Here we show that cryptophyte nuclei in M. rubra are retained for up to 30 days, are transcriptionally active and service plastids derived from multiple cryptophyte cells. Expression of a cryptophyte nuclear-encoded gene involved in plastid function declined in M. rubra as the sequestered nuclei disappeared from the population. Cytokinesis, plastid performance and their replication are dependent on recurrent stealing of cryptophyte nuclei. Karyoklepty ( from Greek karydi, kernel; kleftis, thief) represents a previously unknown evolutionary strategy for acquiring biochemical potential.	Univ Maryland, Horn Point Environm Lab, Ctr Environm Sci, Cambridge, MD 21613 USA; Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; Univ Maryland, College Pk, MD 20742 USA	University System of Maryland; University of Maryland Center for Environmental Science; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland College Park	Johnson, MD (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, 71 Dudley Rd, New Brunswick, NJ 08901 USA.	johnson@marine.rutgers.edu	stoecker, diane k/F-9341-2013; Johnson, Matthew/B-4344-2012; Delwiche, Charles F/C-6549-2008	Johnson, Matthew/0000-0003-4853-2674; Delwiche, Charles F/0000-0001-7854-8584				BLACKBOURN DJ, 1973, J PROTOZOOL, V20, P286, DOI 10.1111/j.1550-7408.1973.tb00877.x; Deane JA, 2000, PROTIST, V151, P239, DOI 10.1078/1434-4610-00022; FIELDS SD, 1991, J PHYCOL, V27, P525, DOI 10.1111/j.0022-3646.1991.00525.x; Gast RJ, 2007, ENVIRON MICROBIOL, V9, P39, DOI 10.1111/j.1462-2920.2006.01109.x; GILLOTT MA, 1980, J PHYCOL, V16, P558; GOFF LJ, 1995, PLANT CELL, V7, P1899; Gustafson DE, 2000, NATURE, V405, P1049, DOI 10.1038/35016570; Hansen PJ, 2006, MAR BIOL RES, V2, P169, DOI 10.1080/17451000600719577; HIBBERD DJ, 1977, J MAR BIOL ASSOC UK, V57, P45, DOI 10.1017/S0025315400021226; Johnson MD, 2006, J PHYCOL, V42, P1235, DOI 10.1111/j.1529-8817.2006.00275.x; Johnson MD, 2004, PROTIST, V155, P347, DOI 10.1078/1434461041844222; Johnson MD, 2005, AQUAT MICROB ECOL, V39, P303, DOI 10.3354/ame039303; Lindholm T., 1985, Advances in Aquatic Microbiology, V3, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LYNN DH, 2000, ILLUSTRATED GUIDE PR, P477; Maddison W. P., 1992, MACCLADE ANAL PHYLOG; Martin W, 1998, NATURE, V393, P162, DOI 10.1038/30234; Miller PE, 1998, J PHYCOL, V34, P371, DOI 10.1046/j.1529-8817.1998.340371.x; OAKLEY BR, 1978, BIOSYSTEMS, V10, P361, DOI 10.1016/0303-2647(78)90019-9; Saldarriaga JF, 2003, INT J SYST EVOL MICR, V53, P355, DOI 10.1099/ijs.0.02328-0; STOECKER DK, 1990, MAR BIOL, V107, P491, DOI 10.1007/BF01313434; TAYLOR FJR, 1971, J FISH RES BOARD CAN, V28, P391, DOI 10.1139/f71-052; TAYLOR FJR, 1969, NATURE, V224, P819, DOI 10.1038/224819a0; WILCOX LW, 1984, J PHYCOL, V20, P236, DOI 10.1111/j.0022-3646.1984.00236.x	24	146	152	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2007	445	7126					426	428		10.1038/nature05496	http://dx.doi.org/10.1038/nature05496			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	128WD	17251979				2022-12-01	WOS:000243689500039
J	Center, JR; Bliue, D; Nguyen, TV; Eisman, JA				Center, Jacqueline R.; Bliue, Dana; Nguyen, Tuan V.; Eisman, John A.			Risk of subsequent fracture after low-trauma fracture in men and women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIP FRACTURE; OSTEOPOROTIC FRACTURES; LIMB FRACTURES; ELDERLY-MEN; DUBBO; METAANALYSIS; MANAGEMENT; INCREASE; FOREARM; SPINE	Context There are few published long-term data on absolute risk of subsequent fracture ( refracture) following initial low-trauma fracture in women and fewer in men. Objective To examine long-term risk of subsequent fracture following initial osteoporotic fracture in men and women. Design, Setting, and Participants Prospective cohort study (Dubbo Osteoporosis Epidemiology Study) in Australia of 2245 community-dwelling women and 1760 men aged 60 years or older followed up for 16 years from July 1989 through April 2005. Main Outcome Measure Incidence of first ( initial) fracture and incidence of subsequent fracture according to sex, age group, and time since first fracture. Relative risk was determined by comparing risk of subsequent fracture with risk of initial fracture. Results There were 905 women and 337 men with an initial fracture, of whom 253 women and 71 men experienced a subsequent fracture. Relative risk (RR) of subsequent fracture in women was 1.95 (95% confidence interval [CI], 1.70-2.25) and in men was 3.47 ( 95% CI, 2.68-4.48). As a result, absolute risk of subsequent fracture was similar in women and men and at least as great as the initial fracture risk for a woman 10 years older. Thus, women and men aged 60 to 69 years had absolute refracture rates of 36/1000 person-years ( 95% CI, 26-48/1000) and 37/1000 person-years ( 95% CI, 23-59/1000), respectively. The increase in absolute fracture risk remained for up to 10 years, by which time 40% to 60% of surviving women and men experienced a subsequent fracture. All fracture locations apart from rib ( men) and ankle ( women) resulted in increased subsequent fracture risk, with highest RRs following hip ( RR, 9.97; 95% CI, 1.38-71.98) and clinical vertebral ( RR, 15.12; 95% CI, 6.06-37.69) fractures in younger men. In multivariate analyses, femoral neck bone mineral density, age, and smoking were predictors of subsequent fracture in women and femoral neck bone mineral density, physical activity, and calcium intake were predictors in men. Conclusion After an initial low-trauma fracture, absolute risk of subsequent fracture was similar for men and women. This increased risk occurred for virtually all clinical fractures and persisted for up to 10 years.	Univ New S Wales, Bone & Mineral Res Program, Garvan Inst Med Res, St Vincents Hosp, Sydney, NSW, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney	Center, JR (corresponding author), St Vincents Hosp, Garvan Inst Med Res, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	j.center@garvan.org.au	Center, Jacqueline/AAY-8712-2021; Bliuc, Dana/Y-7240-2018; Nguyen, Tuan V/B-6147-2008; Nguyen, Tuan V./AAD-9503-2020; Eisman, John A/C-2886-2014	Center, Jacqueline/0000-0002-5278-4527; Bliuc, Dana/0000-0001-9682-2313; Nguyen, Tuan V/0000-0002-3246-6281; Nguyen, Tuan V./0000-0002-3246-6281; 				Bliuc D, 2005, OSTEOPOROSIS INT, V16, P977, DOI 10.1007/s00198-004-1788-x; Briancon D, 2004, JOINT BONE SPINE, V71, P128, DOI 10.1016/S1297-319X(03)00060-5; *CARY NC, 2006, SAS 9 1 3 PROCEDURES; Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8; CENTER JR, 2003, INT C MET BON DIS CO; Cuddihy MT, 1999, OSTEOPOROSIS INT, V9, P469, DOI 10.1007/s001980050172; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Eisman J, 2004, J BONE MINER RES, V19, P1969, DOI 10.1359/JBMR.040905; Ettinger B, 2003, ARCH INTERN MED, V163, P2741, DOI 10.1001/archinte.163.22.2741; Haentjens P, 2004, J BONE MINER RES, V19, P1933, DOI 10.1359/JBMR.040917; Hasselman CT, 2003, J BONE JOINT SURG AM, V85A, P820, DOI 10.2106/00004623-200305000-00008; Ismail AA, 2006, OSTEOPOROSIS INT, V17, P41, DOI 10.1007/s00198-005-1887-3; Johnell O, 2001, OSTEOPOROSIS INT, V12, P207, DOI 10.1007/s001980170131; JONES G, 1994, OSTEOPOROSIS INT, V4, P277, DOI 10.1007/BF01623352; Kanis JA, 2004, BONE, V35, P375, DOI 10.1016/j.bone.2004.03.024; Kanis JA, 2004, OSTEOPOROSIS INT, V15, P108, DOI 10.1007/s00198-003-1516-y; Kanis JA, 2002, OSTEOPOROSIS INT, V13, P527, DOI 10.1007/s001980200069; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; LAURITZEN JB, 1993, ACTA ORTHOP SCAND, V64, P297, DOI 10.3109/17453679308993629; LORD SR, 1994, MED J AUSTRALIA, V160, P684, DOI 10.5694/j.1326-5377.1994.tb125905.x; Majumdar SR, 2005, ARCH INTERN MED, V165, P905, DOI 10.1001/archinte.165.8.905; Majumdar SR, 2004, ANN INTERN MED, V141, P366, DOI 10.7326/0003-4819-141-5-200409070-00011; MALLMIN H, 1993, CALCIFIED TISSUE INT, V52, P269, DOI 10.1007/BF00296650; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Nguyen ND, 2005, J BONE MINER RES, V20, P1921, DOI 10.1359/JBMR.050520; NGUYEN T, 1993, BRIT MED J, V307, P1111, DOI 10.1136/bmj.307.6912.1111; Port L, 2003, OSTEOPOROSIS INT, V14, P780, DOI 10.1007/s00198-003-1452-x; SIMONS LA, 1990, AUST NZ J MED, V20, P783, DOI 10.1111/j.1445-5994.1990.tb00423.x; van Staa TP, 2002, OSTEOPOROSIS INT, V13, P624, DOI 10.1007/s001980200084; VANHELDEN S, 2005, OSTEOPOROUS INT, V24, P24	30	431	446	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2007	297	4					387	394		10.1001/jama.297.4.387	http://dx.doi.org/10.1001/jama.297.4.387			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	128GE	17244835				2022-12-01	WOS:000243645400024
J	Kolsch, V; Seher, T; Fernandez-Ballester, GJ; Serrano, L; Leptin, M				Koelsch, Verena; Seher, Thomas; Fernandez-Ballester, Gregorio J.; Serrano, Luis; Leptin, Maria			Control of Drosophila gastrulation by apical localization of adherens junctions and RhoGEF2	SCIENCE			English	Article							CELL-SHAPE CHANGES; FOLDED-GASTRULATION; SIGNALING PATHWAY; RHO-GTPASE; PROTEIN; MORPHOLOGY; EXTENSION; TARGET; FURROW	A hallmark of epithelial invagination is the constriction of cells on their apical sides. During Drosophila gastrulation, apical constrictions under the control of the transcription factor Twist lead to the invagination of the mesoderm. Twist-controlled G protein signaling is involved in mediating the invagination but is not sufficient to account for the full activity of Twist. We identified a Twist target, the transmembrane protein T48, which acts in conjunction with G protein signaling to orchestrate shape changes. Together with G protein signaling, T48 recruits adherens junctions and the cytoskeletal regulator RhoGEF2 to the sites of apical constriction, ensuring rapid and intense changes in cell shape.	Univ Cologne, Inst Genet, D-50674 Cologne, Germany; Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche 03202, Spain; European Mol Biol Lab, D-69012 Heidelberg, Germany	University of Cologne; Universidad Miguel Hernandez de Elche; European Molecular Biology Laboratory (EMBL)	Leptin, M (corresponding author), Univ Cologne, Inst Genet, Zulpicher Str 47, D-50674 Cologne, Germany.	mleptin@uni-koeln.de	Serrano, Luis/B-3355-2013	Serrano, Luis/0000-0002-5276-1392				Barmchi MP, 2005, J CELL BIOL, V168, P575, DOI 10.1083/jcb.200407124; Barrett K, 1997, CELL, V91, P905, DOI 10.1016/S0092-8674(00)80482-1; COSTA M, 1994, CELL, V76, P1075, DOI 10.1016/0092-8674(94)90384-0; Dawes-Hoang RE, 2005, DEVELOPMENT, V132, P4165, DOI 10.1242/dev.01938; Grosshans J, 2005, DEVELOPMENT, V132, P1009, DOI 10.1242/dev.01669; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Izumi Y, 2004, J CELL BIOL, V164, P729, DOI 10.1083/jcb.200309162; Kwan KM, 2005, DEVELOPMENT, V132, P4599, DOI 10.1242/dev.02041; LEPTIN M, 1991, GENE DEV, V5, P1568, DOI 10.1101/gad.5.9.1568; LEPTIN M, 1990, DEVELOPMENT, V110, P73; Lin F, 2005, J CELL BIOL, V169, P777, DOI 10.1083/jcb.200501104; McGregor L, 2003, NAT GENET, V34, P203, DOI 10.1038/ng1142; Nikolaidou KK, 2004, CURR BIOL, V14, P1822, DOI 10.1016/j.cub.2004.09.080; PARKS S, 1991, CELL, V64, P447, DOI 10.1016/0092-8674(91)90652-F; Reina J, 2002, NAT STRUCT BIOL, V9, P621, DOI 10.1038/nsb815; Rogers SL, 2004, CURR BIOL, V14, P1827, DOI 10.1016/j.cub.2004.09.078; Seher TC, 2000, CURR BIOL, V10, P623, DOI 10.1016/S0960-9822(00)00502-9; STRUTT DI, 1994, MECH DEVELOP, V46, P27, DOI 10.1016/0925-4773(94)90035-3; SWEETON D, 1991, DEVELOPMENT, V112, P775; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X	20	234	234	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 19	2007	315	5810					384	386		10.1126/science.1134833	http://dx.doi.org/10.1126/science.1134833			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126SI	17234948				2022-12-01	WOS:000243535400044
J	Gillson, L; Hoffman, MT				Gillson, Lindsey; Hoffman, M. Timm			Rangeland ecology in a changing world	SCIENCE			English	Editorial Material							NONEQUILIBRIUM; ECOSYSTEMS	A synthesis of differnt models for assessing the balance between vegetation and livestock numbers in grazing lands may help policy-makers integrate human and ecosystem needs.	Univ Cape Town, Inst Plant Conservat, Dept Bot, ZA-7701 Rondebosch, South Africa	University of Cape Town	Gillson, L (corresponding author), Univ Cape Town, Inst Plant Conservat, Dept Bot, ZA-7701 Rondebosch, South Africa.	lindsey.gillson@uct.ac.za	Hoffman, Timm/K-4937-2016; Gillson, Lindsey/AAR-6531-2020	Hoffman, Timm/0000-0002-5843-2397; Gillson, Lindsey/0000-0001-9607-6760				Behnke R.H., 1993, RANGE ECOLOGY DISEQU; Benjaminsen TA, 2006, ANN ASSOC AM GEOGR, V96, P524, DOI 10.1111/j.1467-8306.2006.00704.x; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Briske DD, 2003, J APPL ECOL, V40, P601, DOI 10.1046/j.1365-2664.2003.00837.x; Campbell BM, 2006, ECOL ECON, V60, P75, DOI 10.1016/j.ecolecon.2006.05.010; Chambers FM, 1999, J APPL ECOL, V36, P719, DOI 10.1046/j.1365-2664.1999.00435.x; Cingolani AM, 2005, ECOL APPL, V15, P757, DOI 10.1890/03-5272; ELLIS JE, 1988, J RANGE MANAGE, V41, P450, DOI 10.2307/3899515; Gross JE, 2006, ENVIRON MODELL SOFTW, V21, P1264, DOI 10.1016/j.envsoft.2005.04.024; HASTINGS A, 1993, ANNU REV ECOL SYST, V24, P1, DOI 10.1146/annurev.es.24.110193.000245; Illius AW, 1999, ECOL APPL, V9, P798, DOI 10.1890/1051-0761(1999)009[0798:OTRONC]2.0.CO;2; Janssen MA, 2004, J ENVIRON ECON MANAG, V47, P140, DOI 10.1016/S0095-0696(03)00069-X; Li BL, 2002, ACTA BIOTHEOR, V50, P141, DOI 10.1023/A:1016562208170; Reynolds J.F., 2002, GLOBAL DESERTIFICATI; SCOONES I, 1999, ANNU REV ANTHROPOL, V28, P479, DOI DOI 10.1146/ANNUREV.ANTHR0.28.1.479; Sullivan S, 2002, J BIOGEOGR, V29, P1595, DOI 10.1046/j.1365-2699.2002.00799.x; Vetter S, 2005, J ARID ENVIRON, V62, P321, DOI 10.1016/j.jaridenv.2004.11.015; WESTOBY M, 1989, J RANGE MANAGE, V42, P266, DOI 10.2307/3899492	18	114	123	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2007	315	5808					53	54		10.1126/science.1136577	http://dx.doi.org/10.1126/science.1136577			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	122WU	17204634				2022-12-01	WOS:000243259100027
J	Yudushkin, IA; Schleifenbaum, A; Kinkhabwala, A; Neel, BG; Schultz, C; Bastiaens, PIH				Yudushkin, Ivan A.; Schleifenbaum, Andreas; Kinkhabwala, Ali; Neel, Benjamin G.; Schultz, Carsten; Bastiaens, Philippe I. H.			Live-cell Imaging of enzyme-substrate interaction reveals spatial regulation of PTP1B	SCIENCE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; GROWTH-FACTOR RECEPTOR; SIGNAL-TRANSDUCTION; ENDOPLASMIC-RETICULUM; INSULIN-RECEPTOR; PHOSPHORYLATION; DEPHOSPHORYLATION; SPECIFICITY; GRADIENTS; PEPTIDES	Endoplasmic reticulum-localized protein-tyrosine phosphatase PTP1B terminates growth factor signal transduction by dephosphorylation of receptor tyrosine kinases (RTKs). But how PTP1B allows for RTK signaling in the cytoplasm is unclear. In order to test whether PTP1B activity is spatially regulated, we developed a method based on Forster resonant energy transfer for imaging enzyme-substrate (ES) intermediates in live cells. We observed the establishment of a steady-state ES gradient across the cell. This gradient exhibited robustness to cell-to-cell variability, growth factor activation, and RTK localization, which demonstrated spatial regulation of PTP1B activity. Such regulation may be important for generating distinct cellular environments that permit RTK signal transduction and that mediate its eventual termination.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Hematol Oncol,Canc Biol Program, Boston, MA 02115 USA	European Molecular Biology Laboratory (EMBL); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Bastiaens, PIH (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	bastiaen@embl.de	Yudushkin, Ivan/ABH-9204-2020	Yudushkin, Ivan/0000-0002-6637-027X; Schultz, Carsten/0000-0002-5824-2171	NIDDK NIH HHS [R01 DK60838] Funding Source: Medline; PHS HHS [R37 49152] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060838] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; Boute N, 2003, EMBO REP, V4, P313, DOI 10.1038/sj.embor.embor767; Brown GC, 1999, FEBS LETT, V457, P452, DOI 10.1016/S0014-5793(99)01058-3; Chiarugi P, 2003, TRENDS BIOCHEM SCI, V28, P509, DOI 10.1016/S0968-0004(03)00174-9; Fan YX, 2004, J BIOL CHEM, V279, P38143, DOI 10.1074/jbc.M405760200; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Guo L, 2003, J AM SOC MASS SPECTR, V14, P1022, DOI 10.1016/S1044-0305(03)00206-X; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Kholodenko BN, 2000, BIOCHEM J, V350, P901, DOI 10.1042/0264-6021:3500901; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Nguyen A, 2004, NAT BIOTECHNOL, V22, P993, DOI 10.1038/nbt997; Niethammer P, 2004, SCIENCE, V303, P1862, DOI 10.1126/science.1094108; Offterdinger M, 2004, J BIOL CHEM, V279, P36972, DOI 10.1074/jbc.M405830200; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; Romsicki Y, 2004, J BIOL CHEM, V279, P12868, DOI 10.1074/jbc.M309600200; Sawano A, 2002, DEV CELL, V3, P245, DOI 10.1016/S1534-5807(02)00224-1; Vazquez ME, 2003, J AM CHEM SOC, V125, P10150, DOI 10.1021/ja0351847; Verveer P.J., 2001, METHODS CELLULAR IMA, P273; Verveer PJ, 2000, BIOPHYS J, V78, P2127, DOI 10.1016/S0006-3495(00)76759-2; WOODFORDTHOMAS TA, 1992, J CELL BIOL, V117, P401, DOI 10.1083/jcb.117.2.401; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1; ZHANG ZY, 1993, P NATL ACAD SCI USA, V90, P4446, DOI 10.1073/pnas.90.10.4446; ZHANG ZY, 1993, ANAL BIOCHEM, V211, P7, DOI 10.1006/abio.1993.1224	25	111	117	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 5	2007	315	5808					115	119		10.1126/science.1134966	http://dx.doi.org/10.1126/science.1134966			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17204654				2022-12-01	WOS:000243259100050
J	Patrick, JH; Keenan, MAE				Patrick, John H.; Keenan, Mary Ann E.			Gait analysis to assist walking after stroke	LANCET			English	Editorial Material							DEFORMITY; FOOT		Robert Jones & Agnes Hunt Orthopaed & Dist Hosp N, ORLAU Movement Anal Serv, Oswestry SY10 7AG, Shrops, England; Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19104 USA	University of Pennsylvania	Patrick, JH (corresponding author), Robert Jones & Agnes Hunt Orthopaed & Dist Hosp N, ORLAU Movement Anal Serv, Oswestry SY10 7AG, Shrops, England.	John.Patrick@rjah.nhs.uk	Keenan, Mary Ann/ABB-1551-2020					Carson MC, 2001, J BIOMECH, V34, P1299, DOI 10.1016/S0021-9290(01)00101-4; *DAN NAT I HLTH, 2002, DAN NAT HLTH POP FOR; Fuller DA, 2002, FOOT ANKLE INT, V23, P738, DOI 10.1177/107110070202300810; Gage Jr, 2004, CLIN DEV MED, P238; Jorgensen HS, 1999, STROKE, V30, P930, DOI 10.1161/01.STR.30.5.930; NENE AV, 2005, GAIT POST S, V22, pS18; PINZUR MS, 1986, J BONE JOINT SURG AM, V68A, P1249, DOI 10.2106/00004623-198668080-00016; Takahashi S, 2002, J BONE JOINT SURG BR, V84B, P978, DOI 10.1302/0301-620X.84B7.12905	8	22	25	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2007	369	9558					256	257		10.1016/S0140-6736(07)60124-X	http://dx.doi.org/10.1016/S0140-6736(07)60124-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131ZR	17258650				2022-12-01	WOS:000243912000008
J	Tawk, M; Araya, C; Lyons, DA; Reugels, AM; Girdler, GC; Bayley, PR; Hyde, DR; Tada, M; Clarke, JDW				Tawk, Marcel; Araya, Claudio; Lyons, Dave A.; Reugels, Alexander M.; Girdler, Gemma C.; Bayley, Philippa R.; Hyde, David R.; Tada, Masazumi; Clarke, Jonathan D. W.			A mirror-symmetric cell division that orchestrates neuroepithelial morphogenesis	NATURE			English	Article							SPINAL-CORD; GASTRULATION; MIGRATION; ORIENTATION; STRABISMUS; EXTENSION; MOVEMENTS; REQUIRES; CLOSURE; FATE	The development of cell polarity is an essential prerequisite for tissue morphogenesis during embryogenesis, particularly in the development of epithelia(1,2). In addition, oriented cell division can have a powerful influence on tissue morphogenesis(3). Here we identify a novel mode of polarized cell division that generates pairs of neural progenitors with mirror-symmetric polarity in the developing zebrafish neural tube and has dramatic consequences for the organization of embryonic tissue. We show that during neural rod formation the polarity protein Pard3 is localized to the cleavage furrow of dividing progenitors, and then mirror-symmetrically inherited by the two daughter cells. This allows the daughter cells to integrate into opposite sides of the developing neural tube. Furthermore, these mirror-symmetric divisions have powerful morphogenetic influence: when forced to occur in ectopic locations during neurulation, they orchestrate the development of mirror-image pattern formation and the consequent generation of ectopic neural tubes.	UCL, London WC1E 6BT, England; Univ Cologne, Inst Entwicklungsbiol, D-50923 Cologne, Germany; Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; Univ Notre Dame, Ctr Zebrafish Res, Notre Dame, IN 46556 USA	University of London; University College London; University of Cologne; University of Notre Dame; University of Notre Dame	Clarke, JDW (corresponding author), UCL, Gower St, London WC1E 6BT, England.	jonathan.clarke@ucl.ac.uk	Tawk, Marcel/M-2913-2018; Clarke, Jonathan/C-5347-2009; Tada, Masazumi/A-1431-2009; Zebrafish, UCL/A-3125-2009	Tawk, Marcel/0000-0003-4267-4743; Lyons, David/0000-0003-1166-4454	Biotechnology and Biological Sciences Research Council [BB/C516952/1] Funding Source: Medline; Medical Research Council [G0001188, G9900989] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0001188, G9900989] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bakkers J, 2004, DEVELOPMENT, V131, P525, DOI 10.1242/dev.00954; Carreira-Barbosa F, 2003, DEVELOPMENT, V130, P4037, DOI 10.1242/dev.00567; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Geldmacher-Voss B, 2003, DEVELOPMENT, V130, P3767, DOI 10.1242/dev.00603; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Goto T, 2002, DEV BIOL, V247, P165, DOI 10.1006/dbio.2002.0673; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; KIMMEL CB, 1994, DEVELOPMENT, V120, P265; Lowery LA, 2005, DEVELOPMENT, V132, P2057, DOI 10.1242/dev.01791; Lyons DA, 2003, DEVELOPMENT, V130, P3427, DOI 10.1242/dev.00569; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Papan C, 1997, DEV GENES EVOL, V207, P71, DOI 10.1007/s004270050093; Papan C, 1999, DEV GENES EVOL, V209, P135, DOI 10.1007/s004270050237; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Tada M, 2000, DEVELOPMENT, V127, P2227; von Trotha JW, 2006, DEV DYNAM, V235, P967, DOI 10.1002/dvdy.20715; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wei XY, 2004, DEV BIOL, V269, P286, DOI 10.1016/j.ydbio.2004.01.017; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39	21	157	159	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2007	446	7137					797	800		10.1038/nature05722	http://dx.doi.org/10.1038/nature05722			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17392791				2022-12-01	WOS:000245626800041
J	Benito-Leon, J; Louis, ED				Benito-Leon, Julian; Louis, Elan D.			Clinical update: diagnosis and treatment of essential tremor	LANCET			English	Article							PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; PROPRANOLOL; PRIMIDONE; STIMULATION		Univ Hosp 12 Octubre, Dept Neurol, E-28041 Madrid, Spain; Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10027 USA; Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA	Hospital Universitario 12 de Octubre; Columbia University; Columbia University	Benito-Leon, J (corresponding author), Univ Hosp 12 Octubre, Dept Neurol, E-28041 Madrid, Spain.	jbenitol@meditex.es	Benito-León, Julián/AAA-1331-2019	Benito-León, Julián/0000-0002-1769-4809				Benito-Leon J, 2006, NEUROLOGY, V66, P69, DOI 10.1212/01.wnl.0000192393.05850.ec; Benito-Leon J, 2006, NAT CLIN PRACT NEURO, V2, P666, DOI 10.1038/ncpneuro0347; Brin MF, 2001, NEUROLOGY, V56, P1523, DOI 10.1212/WNL.56.11.1523; CLEEVES L, 1988, J NEUROL NEUROSUR PS, V51, P379, DOI 10.1136/jnnp.51.3.379; FINDLEY LJ, 1985, J NEUROL NEUROSUR PS, V48, P911, DOI 10.1136/jnnp.48.9.911; GORMAN WP, 1986, J NEUROL NEUROSUR PS, V49, P64, DOI 10.1136/jnnp.49.1.64; HUBER SJ, 1988, NEUROLOGY, V38, P241, DOI 10.1212/WNL.38.2.241; Jain S, 2006, ARCH NEUROL-CHICAGO, V63, P1100, DOI 10.1001/archneur.63.8.1100; KOLLER WC, 1989, NEUROLOGY, V39, P1587, DOI 10.1212/WNL.39.12.1587; LEIGH PN, 1983, J NEUROL NEUROSUR PS, V46, P710, DOI 10.1136/jnnp.46.8.710; Lorenz D, 2006, MOVEMENT DISORD, V21, P1114, DOI 10.1002/mds.20884; Ondo W, 2000, MOVEMENT DISORD, V15, P678, DOI 10.1002/1531-8257(200007)15:4<678::AID-MDS1012>3.0.CO;2-0; Ondo WG, 2006, NEUROLOGY, V66, P672, DOI 10.1212/01.wnl.0000200779.03748.0f; Pahwa R, 2006, J NEUROSURG, V104, P506, DOI 10.3171/jns.2006.104.4.506; Putzke JD, 2006, J NEUROL NEUROSUR PS, V77, P1235, DOI 10.1136/jnnp.2006.086579; Schuurman PR, 2000, NEW ENGL J MED, V342, P461, DOI 10.1056/NEJM200002173420703; Shahed J, 2007, PARKINSONISM RELAT D, V13, P67, DOI 10.1016/j.parkreldis.2006.05.033; Zesiewicz TA, 2005, NEUROLOGY, V64, P2008, DOI 10.1212/01.WNL.0000163769.28552.CD	18	83	85	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2007	369	9568					1152	1154		10.1016/S0140-6736(07)60544-3	http://dx.doi.org/10.1016/S0140-6736(07)60544-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155RH	17416247				2022-12-01	WOS:000245595100010
J	Bianchi, DW; Fisk, NM				Bianchi, Diana W.; Fisk, Nicholas M.			Fetomaternal cell trafficking and the stem cell debate - Gender matters	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NONINVASIVE PRENATAL-DIAGNOSIS; FETAL MICROCHIMERISM; PROGENITOR CELLS; MATERNAL BLOOD; BONE-MARROW; PREGNANCY; WOMEN; LONG; TRANSPLANTATION; POSTPARTUM		Tufts Univ New England Med Ctr, Dept Pediat, Div Genet, Boston, MA 02111 USA; Tufts Univ New England Med Ctr, Dept Obstet, Div Genet, Boston, MA 02111 USA; Tufts Univ New England Med Ctr, Dept Gynecol, Div Genet, Boston, MA 02111 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; Queen Charlottes & Chelsea Hosp, London W6 0XG, England	Tufts Medical Center; Tufts Medical Center; Tufts Medical Center; Tufts University; Imperial College London; Imperial College London	Bianchi, DW (corresponding author), Tufts Univ New England Med Ctr, Dept Pediat, Div Genet, 750 Washington St,Box 394, Boston, MA 02111 USA.	Dbianchi@tufts-nemc.org	Fisk, Nicholas M/B-2126-2009	Fisk, Nicholas M/0000-0003-0031-7975	Medical Research Council [G0300340] Funding Source: Medline; NICHD NIH HHS [R01HD49469] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD049469] Funding Source: NIH RePORTER; MRC [G0300340] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams KM, 2003, BLOOD, V102, P3845, DOI 10.1182/blood-2003-05-1570; Bianchi DW, 2001, AM J OBSTET GYNECOL, V184, P703, DOI 10.1067/mob.2001.111072; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; Christner PJ, 2000, ARTHRITIS RHEUM, V43, P2598, DOI 10.1002/1529-0131(200011)43:11<2598::AID-ANR30>3.0.CO;2-8; Evans PC, 1999, BLOOD, V93, P2033, DOI 10.1182/blood.V93.6.2033.406k18_2033_2037; Guetta E, 2003, BLOOD CELL MOL DIS, V30, P13, DOI 10.1016/S1079-9796(03)00008-1; Imaizumi M, 2002, ENDOCRINOLOGY, V143, P247, DOI 10.1210/en.143.1.247; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Johnson KL, 2001, ARTHRITIS RHEUM, V44, P2107, DOI 10.1002/1529-0131(200109)44:9<2107::AID-ART361>3.0.CO;2-9; Johnson KL, 2002, HEPATOLOGY, V36, P1295, DOI 10.1053/jhep.2002.35622; Khosrotehrani K, 2004, JAMA-J AM MED ASSOC, V292, P75, DOI 10.1001/jama.292.1.75; Khosrotehrani K, 2003, ARTHRITIS RHEUM, V48, P3237, DOI 10.1002/art.11324; Klintschar M, 2006, EUR J ENDOCRINOL, V154, P237, DOI 10.1530/eje.1.02080; Koopmans M, 2005, AM J TRANSPLANT, V5, P1495, DOI 10.1111/j.1600-6143.2005.00858.x; LIEGEOIS A, 1977, TRANSPLANT P, V9, P273; Nelson JL, 1996, ARTHRITIS RHEUM, V39, P191, DOI 10.1002/art.1780390203; O'Donoghue K, 2004, LANCET, V364, P179, DOI 10.1016/S0140-6736(04)16631-2; O'Donoghue K, 2003, MOL HUM REPROD, V9, P497, DOI 10.1093/molehr/gag063; Ohtsuka T, 2001, ARCH DERMATOL RES, V293, P387, DOI 10.1007/s004030100245; Srivatsa B, 2001, LANCET, V358, P2034, DOI 10.1016/S0140-6736(01)07099-4; Stevens AM, 2004, LAB INVEST, V84, P1603, DOI 10.1038/labinvest.3700193; Tan XW, 2005, STEM CELLS, V23, P1443, DOI 10.1634/stemcells.2004-0169; Tokita K, 2001, LANCET, V358, P2047, DOI 10.1016/S0140-6736(01)07140-9; Wang Y, 2004, BIOCHEM BIOPH RES CO, V325, P961, DOI 10.1016/j.bbrc.2004.10.105; Yan Z, 2005, AM J MED, V118, P899, DOI 10.1016/j.amjmed.2005.03.037	25	25	26	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2007	297	13					1489	1491		10.1001/jama.297.13.1489	http://dx.doi.org/10.1001/jama.297.13.1489			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AM	17405974				2022-12-01	WOS:000245404100025
J	Hsieh, MM; Everhart, JE; Byrd-Holt, DD; Tisdale, JF; Rodgers, GP				Hsieh, Matthew M.; Everhart, James E.; Byrd-Holt, Danita D.; Tisdale, John F.; Rodgers, Griffin P.			Prevalence of neutropenia in the US population: Age, sex, smoking status, and ethnic differences	ANNALS OF INTERNAL MEDICINE			English	Article							BENIGN IDIOPATHIC NEUTROPENIA; FAMILIAL LEUKOPENIA; LEUKOCYTE COUNTS; INFECTION; MARROW; WHITE; BLACK; NEGROES; CELL	Background: Benign reductions in neutrophil counts may be more common at certain ages and in certain ethnic groups and may be affected by sex and smoking status. Objective: To determine differences in neutrophil counts in the U.S. population according to ethnicity, age, sex, and smoking status. Design: Population-based, cross-sectional study. Setting: Various locations in the United States. Participants: 25 222 participants in the 1999 to 2004 National Health and Nutrition Examination Survey who were 1 year of age or older. Measurements: Complete blood counts and comparison of means and the proportion of participants with neutropenia. Results: Relative to white participants, black participants had lower leukocyte counts (mean difference, 0.89 x 10(9) cells/L; P < 0.001), lower neutrophil counts (0.83 x 10(9) cells/L; P < 0.001), and similar lymphocyte counts (0.022 x 10(9) cells/L; P = 0.36), whereas Mexican-American participants had slightly higher mean leukocyte counts (0.16 x 10(9) cells/L; P = 0.014), higher neutrophil counts (0.11 x 10(9) cells/L; P = 0.026), and higher lymphocyte counts (0.095 x 10(9) cells/L; P < 0.001). The prevalence of neutropenia (neutrophil count < 1.5 x 10(9) cells/L) was 4.5% among black participants, 0.79% among white participants, and 0.38% among Mexican-American participants. The prevalence of neutropenia was higher among males and children younger than 5 years of age. Neutrophil counts less than 1.0 x 10(9) cells/L were observed in fewer than 1% of the overall sample (0.57% in black participants, 0.11% in white participants, and 0.08% in Mexican-American participants). Smoking was associated with higher leukocyte and neutrophil counts but had a smaller effect among black and Mexican-American participants than among white participants. Limitation: Because estimates are based on single measures, fluctuations over time could not be determined. Conclusions: In the United States, neutrophil counts are lower in black persons than in white persons and neutropenia is more prevalent in black persons. Neutrophil counts are slightly higher in Mexican -American persons than in white persons, and neutropenia is uncommon in both groups. The clinical implications of these findings are unclear, but they suggest that when determining the need for a diagnostic evaluation for neutropenia, clinicians should consider the patient's age, sex, ethnicity, and smoking status.	NIDDKD, Mol & Clin Hematol Branch, NIH, Bethesda, MD 20892 USA; Social & Sci Syst Inc, Silver Spring, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Social & Scientific Systems	Rodgers, GP (corresponding author), NIDDKD, Mol & Clin Hematol Branch, NIH, 9000 Rockville Pike,Bldg 10,9N 119, Bethesda, MD 20892 USA.	gr5n@nih.gov			Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		AGHAJI MAC, 1990, CENT AFR J MED, V36, P273; Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; BAIN BJ, 1975, BRIT MED J, V1, P306, DOI 10.1136/bmj.1.5953.306; Bain BJ, 2000, BRIT J HAEMATOL, V108, P483, DOI 10.1046/j.1365-2141.2000.01922.x; BODEY GP, 1966, ANN INTERN MED, V64, P328, DOI 10.7326/0003-4819-64-2-328; BROUN GO, 1966, NEW ENGL J MED, V275, P1410, DOI 10.1056/NEJM196612222752504; Cancer Therapy Evaluation Program, 2003, CANC THER EV PROGR C; CARAMIHAI E, 1975, J PEDIATR-US, V86, P252, DOI 10.1016/S0022-3476(75)80483-5; *CDCP NAT CTR HLTH, 2005, VITAL HLTH STAT, V11, P1; DANCEY JT, 1980, AM J MED, V68, P251, DOI 10.1016/0002-9343(80)90362-9; Ezeilo G C, 1972, East Afr Med J, V49, P94; Ezeilo G C, 1974, East Afr Med J, V51, P936; EZEILO GC, 1972, LANCET, V2, P1003; Forbes WH, 1941, AM J MED SCI, V201, P407, DOI 10.1097/00000441-194103000-00013; Freedman DS, 1997, INT J EPIDEMIOL, V26, P757, DOI 10.1093/ije/26.4.757; JUMEAN HG, 1983, ACTA HAEMATOL-BASEL, V69, P59, DOI 10.1159/000206841; KARAYALCIN G, 1972, LANCET, V1, P387; MANT MJ, 1987, CLIN LAB HAEMATOL, V9, P281, DOI 10.1111/j.1365-2257.1987.tb00092.x; MASON BA, 1979, AM J MED, V67, P201, DOI 10.1016/0002-9343(79)90391-7; McGrath C R, 1982, Vital Health Stat 11, P1; National Center for Health Statistics, 2007, NAT HLTH NUTR EX SUR; Neser M L, 1968, S Afr Med J, V42, P444; RANA SR, 1985, ANN CLIN LAB SCI, V15, P51; REED WW, 1991, ARCH INTERN MED, V151, P501, DOI 10.1001/archinte.151.3.501; RIPPEY JJ, 1967, LANCET, V2, P44; Shah BV, 1996, SUDAAN USERS MANUAL; SHAPER AG, 1971, LANCET, V2, P1021; SHOENFELD Y, 1985, BIOMED PHARMACOTHER, V39, P23; SHOENFELD Y, 1982, ARCH INTERN MED, V142, P797, DOI 10.1001/archinte.142.4.797; SHOENFELD Y, 1988, EUR J HAEMATOL, V41, P273; Watson HG, 2001, BRIT J HAEMATOL, V112, P826; WEINGARTEN MA, 1992, ACTA HAEMATOL-BASEL, V87, P126; WEINGARTEN MA, 1993, ISRAEL J MED SCI, V29, P297; Wright DG, 2006, CLIN HEMATOLOGY, P192; 1982, VITAL HLTH STAT, V11, pR1	35	232	238	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2007	146	7					486	492		10.7326/0003-4819-146-7-200704030-00004	http://dx.doi.org/10.7326/0003-4819-146-7-200704030-00004			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153VB	17404350				2022-12-01	WOS:000245463200002
J	Buschman, TJ; Miller, EK				Buschman, Timothy J.; Miller, Earl K.			Top-down versus bottom-up control of attention in the prefrontal and posterior parietal cortices	SCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; SELECTIVE VISUAL-ATTENTION; NEURAL MECHANISMS; SPATIAL ATTENTION; NEURONAL-ACTIVITY; EYE-MOVEMENTS; CORTEX; SYNCHRONIZATION; MODULATION; MACAQUE	Attention can be focused volitionally by "top-down" signals derived from task demands and automatically by "bottom-up" signals from salient stimuli. The frontal and parietal cortices are involved, but their neural activity has not been directly compared. Therefore, we recorded from them simultaneously in monkeys. Prefrontal neurons reflected the target location first during top-down attention, whereas parietal neurons signaled it earlier during bottom-up attention. Synchrony between frontal and parietal areas was stronger in lower frequencies during top-down attention and in higher frequencies during bottom-up attention. This result indicates that top-down and bottom-up signals arise from the frontal and sensory cortex, respectively, and different modes of attention may emphasize synchrony at different frequencies.	MIT, RIKEN MIT Neurosci Res Ctr, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT)	Miller, EK (corresponding author), MIT, RIKEN MIT Neurosci Res Ctr, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ekmiller@mit.edu	Buschman, Timothy J/B-3056-2009; Miller, Earl K./AAE-8187-2019	Buschman, Timothy J/0000-0003-1298-2761; Miller, Earl K./0000-0002-0582-6958	NINDS NIH HHS [R01NS035145] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035145] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; Chao LL, 1997, CEREB CORTEX, V7, P63, DOI 10.1093/cercor/7.1.63; Constantinidis C, 2005, J NEUROSCI, V25, P233, DOI 10.1523/JNEUROSCI.3379-04.2005; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Eglin M, 1991, CEREB CORTEX, V1, P262, DOI 10.1093/cercor/1.3.262; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Ferraina S, 2002, J NEUROPHYSIOL, V87, P845, DOI 10.1152/jn.00317.2001; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Miller BT, 2005, NEURON, V48, P535, DOI 10.1016/j.neuron.2005.11.002; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schall JD, 2002, PHILOS T ROY SOC B, V357, P1073, DOI 10.1098/rstb.2002.1098; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0	27	1499	1577	20	284	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2007	315	5820					1860	1862		10.1126/science.1138071	http://dx.doi.org/10.1126/science.1138071			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395832	Green Submitted			2022-12-01	WOS:000245280100048
J	Hattendorf, DA; Andreeva, A; Gangar, A; Brennwald, PJ; Weis, WI				Hattendorf, Douglas A.; Andreeva, Anna; Gangar, Akanksha; Brennwald, Patrick J.; Weis, William I.			Structure of the yeast polarity protein Sro7 reveals a SNARE regulatory mechanism	NATURE			English	Article							LETHAL-GIANT-LARVAE; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; EXOCYTOSIS; TOMOSYN; COMPLEX; PHOSPHORYLATION; RESIDUES; VESICLES; EFFECTOR	Polarized exocytosis requires coordination between the actin cytoskeleton and the exocytic machinery responsible for fusion of secretory vesicles at specific sites on the plasma membrane(1). Fusion requires formation of a complex between a vesicle-bound R-SNARE and plasma membrane Qa, Qb and Qc SNARE proteins(2). Proteins in the lethal giant larvae protein family, including lethal giant larvae and tomosyn in metazoans and Sro7 in yeast, interact with Q-SNAREs and are emerging as key regulators of polarized exocytosis(3). The crystal structure of Sro7 reveals two seven-bladed WD40 beta-propellers followed by a 60-residue- long 'tail', which is bound to the surface of the amino-terminal propeller. Deletion of the Sro7 tail enables binding to the Qbc SNARE region of Sec9 and this interaction inhibits SNARE complex assembly. The N-terminal domain of Sec9 provides a second, high-affinity Sro7 interaction that is unaffected by the tail. The results suggest that Sro7 acts as an allosteric regulator of exocytosis through interactions with factors that control the tail. Sequence alignments indicate that lethal giant larvae and tomosyn have a two-beta-propeller fold similar to that of Sro7, but only tomosyn appears to retain the regulatory tail.	Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	Stanford University; Stanford University; University of North Carolina; University of North Carolina Chapel Hill	Weis, WI (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, 299 Campus Dr W, Stanford, CA 94305 USA.	pjbrennw@med.unc.edu; bill.weis@stanford.edu	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150	NIGMS NIH HHS [R01 GM054712] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054712] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065; Adamo JE, 1999, MOL BIOL CELL, V10, P4121, DOI 10.1091/mbc.10.12.4121; Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Betschinger J, 2005, CURR BIOL, V15, P276, DOI 10.1016/j.cub.2005.01.012; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; BRENNWALD P, 1994, CELL, V79, P245, DOI 10.1016/0092-8674(94)90194-5; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Grosshans BL, 2006, J CELL BIOL, V172, P55, DOI 10.1083/jcb.200510016; Hatsuzawa K, 2003, J BIOL CHEM, V278, P31159, DOI 10.1074/jbc.M305500200; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kagami M, 1998, GENETICS, V149, P1717; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; Mohri K, 2004, J BIOL CHEM, V279, P31697, DOI 10.1074/jbc.M403351200; Musch A, 2002, MOL BIOL CELL, V13, P158, DOI 10.1091/mbc.01-10-0496; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; Pobbati AV, 2004, J BIOL CHEM, V279, P47192, DOI 10.1074/jbc.M408767200; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Vasioukhin V, 2006, DEV NEUROSCI-BASEL, V28, P13, DOI 10.1159/000090749; Voegtli WC, 2003, J BIOL CHEM, V278, P34373, DOI 10.1074/jbc.M302773200; Wirtz-Peitz F, 2006, TRENDS CELL BIOL, V16, P234, DOI 10.1016/j.tcb.2006.03.006; Zhang XY, 2005, J CELL BIOL, V170, P273, DOI 10.1083/jcb.200502055	27	68	72	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2007	446	7135					567	571		10.1038/nature05635	http://dx.doi.org/10.1038/nature05635			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392788				2022-12-01	WOS:000245242900055
J	Townley, R; Shapiro, L				Townley, Robert; Shapiro, Lawrence			Crystal structures of the adenylate sensor from fission yeast AMP-activated protein kinase	SCIENCE			English	Article							PARKINSON-WHITE-SYNDROME; FATTY-ACID OXIDATION; HYPERTROPHIC CARDIOMYOPATHY; CARDIAC-HYPERTROPHY; CYTOPLASMIC DOMAIN; GAMMA(2) SUBUNIT; SKELETAL-MUSCLE; BETA-SUBUNITS; SNF1; MUTATIONS	The 5'-AMP (adenosine monophosphate)-activated protein kinase (AMPK) coordinates metabolic function with energy availability by responding to changes in intracellular ATP (adenosine triphosphate) and AMP concentrations. Here, we report crystal structures at 2.9 and 2.6 angstrom resolution for ATP- and AMP-bound forms of a core alpha beta gamma adenylate-binding domain from the fission yeast AMPK homolog. ATP and AMP bind competitively to a single site in the g subunit, with their respective phosphate groups positioned near function-impairing mutants. Unexpectedly, ATP binds without counterions, amplifying its electrostatic effects on a critical regulatory region where all three subunits converge.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Edward S Harkness Eye Inst, New York, NY 10032 USA; Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Shapiro, L (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	LSS8@columbia.edu	Shapiro, Lawrence/AAE-7172-2019	Townley, Robert/0000-0002-9347-2431				Adams J, 2004, PROTEIN SCI, V13, P155, DOI 10.1110/ps.03340004; Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI14571; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Blair E, 2001, HUM MOL GENET, V10, P1215, DOI 10.1093/hmg/10.11.1215; Daniel T, 2002, J BIOL CHEM, V277, P51017, DOI 10.1074/jbc.M207093200; Gollob MH, 2001, CIRCULATION, V104, P3030, DOI 10.1161/hc5001.102111; Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Iseli TJ, 2005, J BIOL CHEM, V280, P13395, DOI 10.1074/jbc.M412993200; Jorgensen SB, 2006, J PHYSIOL-LONDON, V574, P17, DOI 10.1113/jphysiol.2006.109942; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Leff T, 2003, BIOCHEM SOC T, V31, P224; Lumbreras V, 2001, EMBO REP, V2, P55, DOI 10.1093/embo-reports/kve001; Meyer S, 2006, STRUCTURE, V14, P299, DOI 10.1016/j.str.2005.10.008; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; Miller MD, 2004, PROTEINS, V57, P213, DOI 10.1002/prot.20024; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Musi N, 2003, BIOCHEM SOC T, V31, P191, DOI 10.1042/bst0310191; Nayak V, 2006, STRUCTURE, V14, P477, DOI 10.1016/j.str.2005.12.008; Polekhina G, 2005, STRUCTURE, V13, P1453, DOI 10.1016/j.str.2005.07.008; Rudolph MJ, 2005, BIOCHEM BIOPH RES CO, V337, P1224, DOI 10.1016/j.bbrc.2005.09.181; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Tochio N, 2006, PROTEIN SCI, V15, P2534, DOI 10.1110/ps.062391106; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; Warden SM, 2001, BIOCHEM J, V354, P275, DOI 10.1042/0264-6021:3540275; Wilson WA, 1996, CURR BIOL, V6, P1426, DOI 10.1016/S0960-9822(96)00747-6; Wong KA, 2006, J BIOL CHEM, V281, P36434, DOI 10.1074/jbc.M607410200; WOODS A, 1994, J BIOL CHEM, V269, P19509; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhang RG, 1999, BIOCHEMISTRY-US, V38, P4691, DOI 10.1021/bi982858v; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	34	149	156	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2007	315	5819					1726	1729		10.1126/science.1137503	http://dx.doi.org/10.1126/science.1137503			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17289942				2022-12-01	WOS:000245106900044
J	Steg, PG; Bhatt, DL; Wilson, PWF; D'Agostino, R; Ohman, EM; Rother, J; Liau, CS; Hirsch, AT; Mas, JL; Ikeda, Y; Pencina, MJ; Goto, S				Steg, Ph. Gabriel; Bhatt, Deepak L.; Wilson, Peter W. F.; D'Agostino, Ralph, Sr.; Ohman, E. Magnus; Roether, Joachim; Liau, Chiau-Suong; Hirsch, Alan T.; Mas, Jean-Louis; Ikeda, Yasuo; Pencina, Michael J.; Goto, Shinya		REACH Registry Investigators	One-year cardiovascular event rates in outpatients with atherothrombosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE CORONARY SYNDROMES; PERIPHERAL ARTERIAL-DISEASE; TRANSIENT ISCHEMIC ATTACK; ATHEROSCLEROTIC VASCULAR-DISEASE; ACUTE MYOCARDIAL-INFARCTION; HEALTH-CARE PROFESSIONALS; RISK-FACTORS; NATIONAL-REGISTRY; GLOBAL REGISTRY; UNITED-STATES	Context Few data document current cardiovascular (CV) event rates in stable patients with atherothrombosis in a community setting. Differential event rates for patients with documented coronary artery disease (CAD), cerebrovascular disease (CVD), or peripheral arterial disease (PAD) or those at risk of these diseases have not been previously evaluated in a single international cohort. Objective To establish contemporary, international, 1-year CV event rates in outpatients with established arterial disease or with multiple risk factors for atherothrombosis. Design, Setting, and Participants The Reduction of Atherothrombosis for Continued Health (REACH) Registry is an international, prospective cohort of 68 236 patients with either established atherosclerotic arterial disease (CAD, PAD, CVD; n = 55 814) or at least 3 risk factors for atherothrombosis (n = 12 422), who were enrolled from 5587 physician practices in 44 countries in 2003- 2004. Main Outcome Measures Rates of CV death, myocardial infarction (MI), and stroke. Results As of July 2006, 1-year outcomes were available for 95.22% (n = 64 977) of participants. Cardiovascular death, MI, or stroke rates were 4.24% overall: 4.69% for those with established atherosclerotic arterial disease vs 2.15% for patients with multiple risk factors only. Among patients with established disease, CV death, MI, or stroke rates were 4.52% for patients with CAD, 6.47% for patients with CVD, and 5.35% for patients with PAD. The incidences of the end point of CV death, MI, or stroke or of hospitalization for atherothrombotic event(s) were 15.20% for CAD, 14.53% for CVD, and 21.14% for PAD patients with established disease. These event rates increased with the number of symptomatic arterial disease locations, ranging from 5.31% for patients with risk factors only to 12.58% for patients with 1, 21.14% for patients with 2, and 26.27% for patients with 3 symptomatic arterial disease locations (P < .001 for trend). Conclusions In this large, contemporary, international study, outpatients with established atherosclerotic arterial disease, or at risk of atherothrombosis, experienced relatively high annual CV event rates. Multiple disease locations increased the 1-year risk of CV events.	Hop Bichat Claude Bernard, Dept Cardiol, F-75018 Paris, France; Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA; Emory Univ, Sch Med, Div Cardiol, Atlanta, GA 30322 USA; Boston Univ, Dept Math & Stat, Stat & Consulting Unit, Boston, MA 02215 USA; Duke Univ, Div Cardiol, Durham, NC 27710 USA; Klinikum Minden, Dept Neurol, Minden, Germany; Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; Univ Minnesota, Sch Publ Hlth, Minneapolis Heart Inst Fdn, Minneapolis, MN USA; Hop St Anne, Ctr Raymond Garcin, Serv Neurol, F-75674 Paris, France; Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan; Tokai Univ, Sch Med, Dept Med, Kanagawa 2591100, Japan	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Cleveland Clinic Foundation; Emory University; Boston University; Duke University; Ruhr University Bochum; National Taiwan University; National Taiwan University Hospital; University of Minnesota System; University of Minnesota Twin Cities; Minneapolis Heart Institute Foundation; University of Minnesota System; University of Minnesota Twin Cities; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Keio University; Tokai University	Steg, PG (corresponding author), Hop Bichat Claude Bernard, Dept Cardiol, 46 Rue Henri Huchard, F-75018 Paris, France.	gabriel.steg@bch.aphp.fr	Statsenko, Mikhail E./N-7573-2015; Wilson, Peter W.F./J-2455-2016; STEG, Philippe Gabriel/Z-1567-2019; Goto, Shinya/AAU-6045-2020	Statsenko, Mikhail E./0000-0002-3306-0312; Goto, Shinya/0000-0002-6821-1504; STEG, Philippe Gabriel/0000-0001-6896-2941; Pencina, Michael/0000-0001-5798-8855				Adams RJ, 2003, STROKE, V34, P2310, DOI 10.1161/01.STR.0000090125.28466.E2; Agnelli G, 2001, AM HEART J, V141, P190, DOI 10.1067/mhj.2001.112404; Arima H, 2006, STROKE, V37, P1497, DOI 10.1161/01.STR.0000221212.36860.c9; Barron HV, 1998, CIRCULATION, V97, P1150, DOI 10.1161/01.CIR.97.12.1150; Belch JJF, 2003, ARCH INTERN MED, V163, P884, DOI 10.1001/archinte.163.8.884; Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Brown DL, 2005, STROKE, V36, P1285, DOI 10.1161/01.STR.0000165926.74213.e3; Budaj A, 2005, CIRCULATION, V111, P3242, DOI 10.1161/CIRCULATIONAHA.104.512806; CHANG IM, 1982, J CHRON DIS, V35, P669, DOI 10.1016/0021-9681(82)90019-4; Creager MA, 2004, CIRCULATION, V109, P2634, DOI 10.1161/01.CIR.0000128522.98016.19; Davidoff F, STRENGTHENING REPORT; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Diehm C, 2006, EUR HEART J, V27, P1743, DOI 10.1093/eurheartj/ehl092; Fox KAA, 2002, EUR HEART J, V23, P1177, DOI 10.1053/euhj.2001.3081; Hasdai D, 2002, EUR HEART J, V23, P1190, DOI 10.1053/euhj.2002.3193; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Hirsch AT, 2004, ANGIOLOGY, V55, P233, DOI 10.1177/000331970405500301; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; MAYNARD C, 1995, AM J CARDIOL, V76, P548, DOI 10.1016/S0002-9149(99)80152-0; Mehta RH, 2002, JAMA-J AM MED ASSOC, V287, P1269, DOI 10.1001/jama.287.10.1269; Menotti A, 1996, STROKE, V27, P381, DOI 10.1161/01.STR.27.3.381; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Ohman EM, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.11.004; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Sacco RL, 2006, CIRCULATION, V113, pE409, DOI 10.1161/circ.113.10.e409; Sacco RL, 2004, STROKE, V35, P2263, DOI 10.1161/01.STR.0000142374.33919.92; Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516; Steg PG, 2002, AM J CARDIOL, V90, P358, DOI 10.1016/S0002-9149(02)02489-X; Touze E, 2005, STROKE, V36, P2748, DOI 10.1161/01.STR.0000190118.02275.33; Vickrey BG, 2002, STROKE, V33, P901, DOI 10.1161/hs0402.105246; Wilterdink JL, 1998, NEUROLOGY, V51, pS23, DOI 10.1212/WNL.51.3_Suppl_3.S23; Witt BJ, 2005, ANN INTERN MED, V143, P785, DOI 10.7326/0003-4819-143-11-200512060-00006; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	35	989	1079	2	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2007	297	11					1197	1206		10.1001/jama.297.11.1197	http://dx.doi.org/10.1001/jama.297.11.1197			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	147XO	17374814	Bronze			2022-12-01	WOS:000245039300023
J	Rasch, B; Buechel, C; Gais, S; Born, J				Rasch, Bjoern; Buechel, Christian; Gais, Steffen; Born, Jan			Odor cues during slow-wave sleep prompt declarative memory consolidation	SCIENCE			English	Article							REACTIVATION; HIPPOCAMPUS; ACTIVATION; SYSTEMS	Sleep facilitates memory consolidation. A widely held model assumes that this is because newly encoded memories undergo covert reactivation during sleep. We cued new memories in humans during sleep by presenting an odor that had been presented as context during prior learning, and so showed that reactivation indeed causes memory consolidation during sleep. Re-exposure to the odor during slow-wave sleep (SWS) improved the retention of hippocampus-dependent declarative memories but not of hippocampus-independent procedural memories. Odor re-exposure was ineffective during rapid eye movement sleep or wakefulness or when the odor had been omitted during prior learning. Concurring with these findings, functional magnetic resonance imaging revealed significant hippocampal activation in response to odor re-exposure during SWS.	Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany; Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, D-20246 Hamburg, Germany	University of Lubeck; University of Hamburg; University Medical Center Hamburg-Eppendorf	Rasch, B (corresponding author), Univ Lubeck, Dept Neuroendocrinol, Ratzeburger Allee 160-23A, D-23538 Lubeck, Germany.	rasch@kfg.uni-luebeck.de; born@kfg.uni-luebeck.de	Born, Jan/K-2596-2016; Rasch, Björn/A-3119-2015	Born, Jan/0000-0002-1847-6248; Rasch, Björn/0000-0001-7607-3415				Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Carskadon MA, 2004, SLEEP, V27, P402; Chu S, 2002, MEM COGNITION, V30, P511, DOI 10.3758/BF03194952; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Dudai Y, 2006, CURR OPIN NEUROBIOL, V16, P174, DOI 10.1016/j.conb.2006.03.010; Gordon W.C., 1981, P319; Herz RS, 2004, NEUROPSYCHOLOGIA, V42, P371, DOI 10.1016/j.neuropsychologia.2003.08.009; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Molle M, 2004, P NATL ACAD SCI USA, V101, P13963, DOI 10.1073/pnas.0402820101; Parker A, 2001, APPL COGNITIVE PSYCH, V15, P159, DOI 10.1002/1099-0720(200103/04)15:2<159::AID-ACP694>3.0.CO;2-D; Peigneux P, 2003, NEUROIMAGE, V20, P125, DOI 10.1016/S1053-8119(03)00278-7; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Poellinger A, 2001, NEUROIMAGE, V13, P547, DOI 10.1006/nimg.2000.0713; Sommer T, 2005, LEARN MEMORY, V12, P343, DOI 10.1101/lm.90405; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Sutherland GR, 2000, CURR OPIN NEUROBIOL, V10, P180, DOI 10.1016/S0959-4388(00)00079-9; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Zelano C, 2005, NEURON, V48, P431, DOI 10.1016/j.neuron.2005.10.009	29	739	772	7	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2007	315	5817					1426	1429		10.1126/science.1138581	http://dx.doi.org/10.1126/science.1138581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143UP	17347444				2022-12-01	WOS:000244752200038
J	Ryan, PG; Bloomer, P; Moloney, CL; Grant, TJ; Delport, W				Ryan, Peter G.; Bloomer, Paulette; Moloney, Coleen L.; Grant, Tyron J.; Delport, Wayne			Ecological speciation in South Atlantic island finches	SCIENCE			English	Article							TRISTAN-DA-CUNHA; DARWINS FINCHES; INACCESSIBLE ISLAND; SYMPATRIC SPECIATION; DISRUPTIVE SELECTION; HYBRIDIZATION; EVOLUTION; PERSPECTIVE; NESOSPIZA; OCEAN	Examples of sympatric speciation in nature are rare and hotly debated. We describe the parallel speciation of finches on two small islands in the Tristan da Cunha archipelago in the South Atlantic Ocean. Nesospiza buntings are a classic example of a simple adaptive radiation, with two species on each island: an abundant small-billed dietary generalist and a scarce large-billed specialist. Their morphological diversity closely matches the available spectrum of seed sizes, and genetic evidence suggests that they evolved independently on each island. Speciation is complete on the smaller island, where there is a single habitat with strongly bimodal seed size abundance, but is incomplete on the larger island, where a greater diversity of habitats has resulted in three lineages. Our study suggests that the buntings have undergone parallel ecological speciation.	Univ Cape Town, Natl Res Fdn Ctr Excellence, Dept Sci & Technol, Percy FitzPatrick Inst, ZA-7701 Rondebosch, South Africa; Univ Pretoria, Dept Genet, Mol Ecol & Evolut Programme, ZA-0002 Pretoria, South Africa	National Research Foundation - South Africa; University of Cape Town; University of Pretoria	Ryan, PG (corresponding author), Univ Cape Town, Natl Res Fdn Ctr Excellence, Dept Sci & Technol, Percy FitzPatrick Inst, ZA-7701 Rondebosch, South Africa.	Peter.Ryan@uct.ac.za	Bloomer, Paulette/F-5501-2010; Delport, Wayne/C-1744-2008; Moloney, Coleen/B-4363-2009	Bloomer, Paulette/0000-0002-6357-0153; Moloney, Coleen/0000-0001-6663-8814; Ryan, Peter/0000-0002-3356-2056				ABBOTT I, 1978, J ZOOL, V184, P119; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Burger R, 2006, AM NAT, V167, P190, DOI 10.1086/499375; Burns KJ, 2002, EVOLUTION, V56, P1240; Coyne J.A., 2004, SPECIATION; Dieckmann U., 2004, ADAPTIVE SPECIATION; Gavrilets S, 2003, EVOLUTION, V57, P2197; Grant P.R., 1999, ECOLOGY EVOLUTION DA; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; Grant PR, 2005, AM NAT, V166, P56, DOI 10.1086/430331; Grant PR, 2004, EVOLUTION, V58, P1588; Kopp M, 2006, EVOLUTION, V60, P1537; Lack D., 1947, DARWINS FINCHES; Mayr E., 1982, GROWTH BIOL THOUGHT; OLLIER CD, 1984, Z GEOMORPHOL, V28, P367; Petren K, 2005, MOL ECOL, V14, P2943, DOI 10.1111/j.1365-294X.2005.02632.x; Polechova J, 2005, EVOLUTION, V59, P1194; PREECE RC, 1986, J BIOGEOGR, V13, P1, DOI 10.2307/2844847; ROUX JP, 1992, BOTHALIA, V22, P93, DOI 10.4102/abc.v22i1.828; Ryan PG, 2001, CONDOR, V103, P429, DOI 10.1650/0010-5422(2001)103[0429:MHIAHB]2.0.CO;2; RYAN PG, 1994, AUK, V111, P314, DOI 10.2307/4088596; RYAN PG, 1992, THESIS U CAPE TOWN; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Smith TB, 1996, ANNU REV ECOL SYST, V27, P111, DOI 10.1146/annurev.ecolsys.27.1.111; SMITH TB, 1993, NATURE, V363, P618, DOI 10.1038/363618a0; Sorenson MD, 2003, NATURE, V424, P928, DOI 10.1038/nature01863; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; Zink RM, 2002, AUK, V119, P864, DOI 10.1642/0004-8038(2002)119[0864:ANPOTE]2.0.CO;2	28	106	114	3	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2007	315	5817					1420	1423		10.1126/science.1138829	http://dx.doi.org/10.1126/science.1138829			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347442				2022-12-01	WOS:000244752200036
J	Simon, MD; Chu, FX; Racki, LR; de la Cruz, CC; Burlingame, AL; Panning, B; Narlikar, GJ; Shokat, KM				Simon, Matthew D.; Chu, Feixia; Racki, Lisa R.; de la Cruz, Cecile C.; Burlingame, Alma L.; Panning, Barbara; Narlikar, Geeta J.; Shokat, Kevan M.			The site-specific installation of methyl-lysine analogs into recombinant histones	CELL			English	Article							NUCLEOSOME MOBILITY; CHROMATIN-STRUCTURE; EPIGENETIC CONTROL; MOLECULAR-BASIS; PHD FINGER; H3; PROTEINS; LIGATION; BINDING; NURF	Histone lysine residues can be mono-, di-, or trimethylated. These posttranslational modifications regulate the affinity of effector proteins and may also impact chromatin structure independent of their role as adaptors. In order to study histone lysine methylation, particularly in the context of chromatin, we have developed a chemical approach to install analogs of methyl lysine into recombinant proteins. This approach allows for the rapid generation of large quantities of histones in which the site and degree of methylation can be specified. We demonstrate that these methyl-lysine analogs (MLAs) are functionally similar to their natural counterparts. These methylated histones, were used to examine the influence of specific lysine methylation on the binding of effecter proteins and the rates of nucleosme remodeling. This simple method of introducing site-specific and degree-specific methylation into recombinant histones provides a powerful tool to investigate the biochemical mechanisms by which lysine methylation influences chromatin structure and function.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Shokat, KM (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	shokat@cmp.ucsf.edu	Simon, Matthew/ABF-9127-2020	Simon, Matthew/0000-0001-7423-5265	Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [RR 019934, S10 RR019934, P41 RR001614, RR 001614] Funding Source: Medline; NIGMS NIH HHS [R01 GM085186] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614, S10RR019934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085186] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chu FX, 2006, MOL CELL PROTEOMICS, V5, P194, DOI 10.1074/mcp.M500285-MCP200; Clapier CR, 2001, MOL CELL BIOL, V21, P875, DOI 10.1128/MCB.21.3.875-883.2001; Clapier CR, 2002, NUCLEIC ACIDS RES, V30, P649, DOI 10.1093/nar/30.3.649; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eberharter A, 2001, EMBO J, V20, P3781, DOI 10.1093/emboj/20.14.3781; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; GLOSS LM, 1995, BIOCHEMISTRY-US, V34, P3990, DOI 10.1021/bi00012a017; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Hamiche A, 2001, P NATL ACAD SCI USA, V98, P14316, DOI 10.1073/pnas.251421398; He S, 2003, P NATL ACAD SCI USA, V100, P12033, DOI 10.1073/pnas.2035256100; He X, 2006, J BIOL CHEM, V281, P28636, DOI 10.1074/jbc.M603008200; Hopkins CE, 2005, ARCH BIOCHEM BIOPHYS, V443, P1, DOI 10.1016/j.abb.2005.08.020; ITANO HA, 1972, J BIOL CHEM, V247, P4819; Ivanova AV, 1998, NAT GENET, V19, P192, DOI 10.1038/566; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Kenyon G L, 1977, Methods Enzymol, V47, P407; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Lee DY, 2005, ENDOCR REV, V26, P147, DOI 10.1210/er.2004-0008; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Lindroth AM, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600430; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; MEANS GE, 1968, BIOCHEMISTRY-US, V7, P2192, DOI 10.1021/bi00846a023; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Muralidharan V, 2006, NAT METHODS, V3, P429, DOI 10.1038/NMETH886; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nekrasov M, 2005, EMBO REP, V6, P348, DOI 10.1038/sj.embor.7400376; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; RAFTERY MA, 1966, J BIOL CHEM, V241, P3457; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Shogren-Knaak MA, 2004, METHOD ENZYMOL, V375, P62; Shogren-Knaak MA, 2003, J BIOL CHEM, V278, P15744, DOI 10.1074/jbc.M301445200; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Strohner R, 2005, NAT STRUCT MOL BIOL, V12, P683, DOI 10.1038/nsmb966; Tamaru H, 2003, NAT GENET, V34, P75, DOI 10.1038/ng1143; Turner BM, 2005, NAT STRUCT MOL BIOL, V12, P110, DOI 10.1038/nsmb0205-110; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; Zubarev RA, 1998, J AM CHEM SOC, V120, P3265, DOI 10.1021/ja973478k	45	341	350	2	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2007	128	5					1003	1012		10.1016/j.cell.2006.12.041	http://dx.doi.org/10.1016/j.cell.2006.12.041			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350582	Bronze, Green Accepted			2022-12-01	WOS:000245073400022
J	Farb, A; Boam, AB				Farb, Andrew; Boam, Ashley B.			Stent thrombosis redux - The FDA perspective	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									US FDA, Intervent Cardiol Devices Branch, Off Device Evaluat, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Farb, A (corresponding author), US FDA, Intervent Cardiol Devices Branch, Off Device Evaluat, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA.							American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; CAMENZIND E, 2006, WORLD C CARD 2006 BA; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Muni NI, 2004, NEW ENGL J MED, V351, P1593, DOI 10.1056/NEJMp048262; Wenaweser P., 2006, WORLD C CARD 2006 BA	5	211	221	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2007	356	10					984	987		10.1056/NEJMp068304	http://dx.doi.org/10.1056/NEJMp068304			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143DC	17296827				2022-12-01	WOS:000244699200002
J	Jin, D; Liu, HX; Hirai, H; Torashima, T; Nagai, T; Lopatina, O; Shnayder, NA; Yamada, K; Noda, M; Seike, T; Fujita, K; Takasawa, S; Yokoyama, S; Koizumi, K; Shiraishi, Y; Tanaka, S; Hashii, M; Yoshihara, T; Higashida, K; Islam, MS; Yamada, N; Hayashi, K; Noguchi, N; Kato, I; Okamoto, H; Matsushima, A; Salmina, A; Munesue, T; Shimizu, N; Mochida, S; Asano, M; Higashida, H				Jin, Duo; Liu, Hong-Xiang; Hirai, Hirokazu; Torashima, Takashi; Nagai, Taku; Lopatina, Olga; Shnayder, Natalia A.; Yamada, Kiyofumi; Noda, Mami; Seike, Toshihiro; Fujita, Kyota; Takasawa, Shin; Yokoyama, Shigeru; Koizumi, Keita; Shiraishi, Yoshitake; Tanaka, Shigenori; Hashii, Minako; Yoshihara, Toru; Higashida, Kazuhiro; Islam, Mohammad Saharul; Yamada, Nobuaki; Hayashi, Kenshi; Noguchi, Naoya; Kato, Ichiro; Okamoto, Hiroshi; Matsushima, Akihiro; Salmina, Alla; Munesue, Toshio; Shimizu, Nobuaki; Mochida, Sumiko; Asano, Masahide; Higashida, Haruhiro			CD38 is critical for social behaviour by regulating oxytocin secretion	NATURE			English	Article							CYCLIC-ADP-RIBOSE; ADENINE-DINUCLEOTIDE PHOSPHATE; RELEASE; CA2+; RECOGNITION; BRAIN; NEUROPEPTIDES; NEUROBIOLOGY; TRANSDUCTION; VASOPRESSIN	CD38, a transmembrane glycoprotein with ADP-ribosyl cyclase activity, catalyses the formation of Ca2+ signalling molecules, but its role in the neuroendocrine system is unknown. Here we show that adult CD38 knockout (CD38(-/-)) female and male mice show marked defects in maternal nurturing and social behaviour, respectively, with higher locomotor activity. Consistently, the plasma level of oxytocin (OT), but not vasopressin, was strongly decreased in CD38(-/-) mice. Replacement of OT by subcutaneous injection or lentiviral-vector-mediated delivery of human CD38 in the hypothalamus rescued social memory and maternal care in CD38(-/-) mice. Depolarization-induced OT secretion and Ca2+ elevation in oxytocinergic neurohypophysial axon terminals were disrupted in CD38(-/-) mice; this was mimicked by CD38 metabolite antagonists in CD38(+/+) mice. These results reveal that CD38 has a key role in neuropeptide release, thereby critically regulating maternal and social behaviours, and may be an element in neurodevelopmental disorders.	Kanazawa Univ, 21st Century COE Program Innovat Brain Sci & Dev, Kanazawa, Ishikawa 9208640, Japan; Kanazawa Univ, Grad Sch Med, Dept Cellular Neurophysiol, Kanazawa, Ishikawa 9208640, Japan; Kanazawa Univ, Grad Sch Med, Dept Biophys Genet, Kanazawa, Ishikawa 9208640, Japan; Kanazawa Univ, Grad Sch Med, Dept Anat, Kanazawa, Ishikawa 9208640, Japan; Kanazawa Univ, Adv Sci Res Ctr, Kanazawa, Ishikawa 9208640, Japan; Japan Sci & Technol Agcy, SORST, Kanazawa, Ishikawa 9208640, Japan; Kanazawa Univ, Sch Nat Sci & Technol, Lab Neuropsychopharmacol, Kanazawa, Ishikawa 9201192, Japan; Kanazawa Univ, Inst Nat & Environm Technol, Kanazawa, Ishikawa 9201192, Japan; Kyushu Univ, Grad Sch Pharmaceut Sci, Lab Pathophysiol, Fukuoka 8128582, Japan; Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Grad Sch Med, Dept Adv Biol Sci Regenerat, Sendai, Miyagi 9808575, Japan; Kanazawa Univ Hosp, Cent Clin Lab, Kanazawa, Ishikawa 9208641, Japan; Kanazawa Univ Hosp, Dept Psychiat, Kanazawa, Ishikawa 9208641, Japan; Toyama Univ, Sch Med, Dept Biochem, Toyama 9300194, Japan; Nanao Natl Hosp, Nanao 9208531, Japan; Krasnoyarsk State Med Acad, Dept Med Chem & Biochem, Krasnoyarsk 660022, Russia; Tokyo Med Univ, Dept Physiol, Tokyo, Japan	Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University; Japan Science & Technology Agency (JST); Kanazawa University; Kanazawa University; Kyushu University; Tohoku University; Tohoku University; Kanazawa University; Kanazawa University; University of Toyama; Krasnoyarsk State Medical University; Tokyo Medical University	Higashida, H (corresponding author), Kanazawa Univ, 21st Century COE Program Innovat Brain Sci & Dev, Kanazawa, Ishikawa 9208640, Japan.	haruhiro@med.kanazawa-u.ac.jp	Noda, Mami/AAC-3949-2020; Nagai, Taku/I-7507-2014; Hirai, Hirokazu/ABP-1143-2022; Shnayder, Natalia/M-7084-2014; Salmina, Alla B./L-7977-2013; Yamada, Kiyofumi/I-7487-2014; Sokabe, Masahiro/I-1565-2012; Lopatina, Olga/I-9610-2014; higashida, haruhiro/L-3773-2015	Nagai, Taku/0000-0001-5050-7748; Shnayder, Natalia/0000-0002-2840-837X; Yamada, Kiyofumi/0000-0002-5280-5180; Lopatina, Olga/0000-0002-7884-2721; higashida, haruhiro/0000-0002-1779-0606; Hirai, Hirokazu/0000-0002-0721-4293				Argiolas A, 2005, PROG NEUROBIOL, V76, P1, DOI 10.1016/j.pneurobio.2005.06.002; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; BELIN V, 1986, J PHYSIOL-LONDON, V377, P369, DOI 10.1113/jphysiol.1986.sp016192; Bielsky IF, 2005, NEURON, V47, P503, DOI 10.1016/j.neuron.2005.06.031; Chini EN, 2002, BIOCHEM J, V362, P125, DOI 10.1042/0264-6021:3620125; De Crescenzo V, 2004, J NEUROSCI, V24, P1226, DOI 10.1523/JNEUROSCI.4286-03.2004; De Flora A, 2004, ANN NY ACAD SCI, V1028, P176, DOI 10.1196/annals.1322.021; Deaglio S, 2006, BLOOD, V108, P1135, DOI 10.1182/blood-2006-01-013003; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Fries ABW, 2005, P NATL ACAD SCI USA, V102, P17237, DOI 10.1073/pnas.0504767102; Gerasimenko JV, 2006, J CELL SCI, V119, P226, DOI 10.1242/jcs.02721; HATTON GI, 1990, PROG NEUROBIOL, V34, P437, DOI 10.1016/0301-0082(90)90017-B; Higashida H, 2001, PHARMACOL THERAPEUT, V90, P283, DOI 10.1016/S0163-7258(01)00142-5; Hollander E, 2003, NEUROPSYCHOPHARMACOL, V28, P193, DOI 10.1038/sj.npp.1300021; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Hunt PW, 2006, AIDS, V20, P691, DOI 10.1097/01.aids.0000216369.30948.18; Insel TR, 2004, ANNU REV NEUROSCI, V27, P697, DOI 10.1146/annurev.neuro.27.070203.144148; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; Johnson JD, 2002, P NATL ACAD SCI USA, V99, P14566, DOI 10.1073/pnas.222099799; Kato I, 1999, J BIOL CHEM, V274, P1869, DOI 10.1074/jbc.274.4.1869; Kendrick KM, 1997, BRAIN RES BULL, V44, P383, DOI 10.1016/S0361-9230(97)00218-9; Keverne EB, 2004, CURR OPIN NEUROBIOL, V14, P777, DOI 10.1016/j.conb.2004.10.006; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; KOSHIYAMA H, 1991, J BIOL CHEM, V266, P16985; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; Lim MM, 2005, INT J DEV NEUROSCI, V23, P235, DOI 10.1016/j.ijdevneu.2004.05.006; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; Modahl C, 1998, BIOL PSYCHIAT, V43, P270, DOI 10.1016/S0006-3223(97)00439-3; Okamoto H, 2002, DIABETES, V51, pS462, DOI 10.2337/diabetes.51.2007.S462; OuYang W, 2004, BRAIN RES, V1024, P203, DOI 10.1016/j.brainres.2004.07.068; POPIK P, 1992, PSYCHOPHARMACOLOGY, V106, P71, DOI 10.1007/BF02253591; Russell JA, 2003, FRONT NEUROENDOCRIN, V24, P27, DOI 10.1016/S0091-3022(02)00104-8; Sasaki N, 2005, CELL CALCIUM, V37, P45, DOI 10.1016/j.ceca.2004.06.007; Soares SM, 2005, ENDOCRINOLOGY, V146, P2186, DOI 10.1210/en.2004-1298; TAKASAWA S, 1993, J BIOL CHEM, V268, P26052; Takayanagi Y, 2005, P NATL ACAD SCI USA, V102, P16096, DOI 10.1073/pnas.0505312102; Torashima T, 2006, BRAIN RES, V1082, P11, DOI 10.1016/j.brainres.2006.01.104; Yagui K, 1998, DIABETOLOGIA, V41, P1024, DOI 10.1007/s001250051026; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Yamashita M, 2002, ENDOCRINOLOGY, V143, P4464, DOI 10.1210/en.2002-220516; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327	44	477	484	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2007	446	7131					41	45		10.1038/nature05526	http://dx.doi.org/10.1038/nature05526			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17287729				2022-12-01	WOS:000244525600032
J	McCann, K				McCann, Kevin			Protecting biostructure	NATURE			English	Editorial Material									Univ Guelph, Dept Zool, Guelph, ON N1G 2W1, Canada	University of Guelph	McCann, K (corresponding author), Univ Guelph, Dept Zool, Guelph, ON N1G 2W1, Canada.							Tewfik A, 2005, ECOLOGY, V86, P2726, DOI 10.1890/04-1537	1	139	143	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2007	446	7131					29	29		10.1038/446029a	http://dx.doi.org/10.1038/446029a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17330028	Bronze			2022-12-01	WOS:000244525600022
J	Kouzarides, T				Kouzarides, Tony			SnapShot: Histone-modifying enzymes	CELL			English	Editorial Material							LYSINE METHYLATION; GENE-EXPRESSION; CODE; H3		Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England	University of Cambridge	Kouzarides, T (corresponding author), Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England.			Kouzarides, Tony/0000-0002-8918-4162				Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	12	65	69	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 23	2007	128	4					802	+		10.1016/j.cell.2007.02.018	http://dx.doi.org/10.1016/j.cell.2007.02.018			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148TX	17320515	Bronze			2022-12-01	WOS:000245098600020
J	Siekmann, AF; Lawson, ND				Siekmann, Arndt F.; Lawson, Nathan D.			Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries	NATURE			English	Article							EMBRYONIC VASCULAR DEVELOPMENT; ENDOTHELIAL-GROWTH-FACTOR; EXPRESSION; ACTIVATION; PATHWAY; DIFFERENTIATION; SUPPRESSOR; RECEPTORS; HAIRLESS	Recent evidence indicates that growing blood-vessel sprouts consist of endothelial cells with distinct cell fates and behaviours(1,2); however, it is not clear what signals determine these sprout cell characteristics. Here we show that Notch signalling is necessary to restrict angiogenic cell behaviour to tip cells in developing segmental arteries in the zebrafish embryo. In the absence of the Notch signalling component Rbpsuh ( recombining binding protein suppressor of hairless) we observed excessive sprouting of segmental arteries, whereas Notch activation suppresses angiogenesis. Through mosaic analysis we find that cells lacking Rbpsuh preferentially localize to the terminal position in developing sprouts. In contrast, cells in which Notch signalling has been activated are excluded from the tip-cell position. In vivo time-lapse analysis reveals that endothelial tip cells undergo a stereotypical pattern of proliferation and migration during sprouting. In the absence of Notch, nearly all sprouting endothelial cells exhibit tip-cell behaviour, leading to excessive numbers of cells within segmental arteries. Furthermore, we find that flt4 (fms-related tyrosine kinase 4, also called vegfr3) is expressed in segmental artery tip cells and becomes ectopically expressed throughout the sprout in the absence of Notch. Loss of flt4 can partially restore normal endothelial cell number in Rbpsuh-deficient segmental arteries. Finally, loss of the Notch ligand dll4 (delta-like 4) also leads to an increased number of endothelial cells within segmental arteries. Together, these studies indicate that proper specification of cell identity, position and behaviour in a developing blood-vessel sprout is required for normal angiogenesis, and implicate the Notch signalling pathway in this process.	Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Lawson, ND (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Lazare Res Bldg,364 Plantat St, Worcester, MA 01605 USA.	nathan.lawson@umassmed.edu	Siekmann, Arndt/AAE-4769-2021	Lawson, Nathan/0000-0001-7788-9619; Siekmann, Arndt/0000-0001-6972-2173				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Childs S, 2002, DEVELOPMENT, V129, P973; Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Lawson ND, 2003, GENE DEV, V17, P1346, DOI 10.1101/gad.1072203; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; Nasevicius A, 2000, YEAST, V17, P294, DOI 10.1002/1097-0061(200012)17:4<294::AID-YEA54>3.0.CO;2-5; Roman BL, 2002, DEVELOPMENT, V129, P3009; Salameh A, 2005, BLOOD, V106, P3423, DOI 10.1182/blood-2005-04-1388; Scheer N, 2001, DEVELOPMENT, V128, P1099; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; Shutter JR, 2000, GENE DEV, V14, P1313; Sieger D, 2003, MECH DEVELOP, V120, P1083, DOI 10.1016/S0925-4773(03)00154-0; Smithers L, 2000, MECH DEVELOP, V90, P119, DOI 10.1016/S0925-4773(99)00231-2; Taylor KL, 2002, MICROVASC RES, V64, P372, DOI 10.1006/mvre.2002.2443; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5; WEINSTEIN BM, 1995, NAT MED, V1, P1143, DOI 10.1038/nm1195-1143; Westerfield M., 1993, ZEBRAFISH BOOK; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000	24	497	532	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2007	445	7129					781	784		10.1038/nature05577	http://dx.doi.org/10.1038/nature05577			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17259972				2022-12-01	WOS:000244205200048
J	Shuster, E				Shuster, Evelyne			Microarray genetic screening: a prenatal roadblock for life?	LANCET			English	Article							DIAGNOSIS; DNA		Philadelphia Vet Affairs Med Ctr, Off Med Eth, Philadelphia, PA USA; Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania	Shuster, E (corresponding author), Philadelphia Dept Vet Affairs, Univ & Woodland Ave, Philadelphia, PA 19104 USA.	Evelyn.shuster@med.va.gov						American College of Obstetricians and Gynecologists, 2007, OBSTET GYNECOL, V110, P217; Annas G., 1998, SOME CHOICE LAW MED; ANNAS GJ, 1975, FAM LAW QUART, V9, P463; Asch A, 1999, AM J PUBLIC HEALTH, V89, P1649, DOI 10.2105/AJPH.89.11.1649; ASCH A, 2006, 7 ANN JOINT APPL URB; ASCH A, 2003, FLORIDA STATE U L RE, V315, P47; *BAYL COLL MED, CHROM MICR AN; BOTKIN JR, 1995, HASTINGS CENT REP, V25, P32, DOI 10.2307/3562793; Buchanan A., 2000, CHANCE CHOICE GENETI; Canguilhem G., 2012, NORMAL PATHOLOGICAL, V3; Check E, 2005, NATURE, V438, P733, DOI 10.1038/438733a; *COMM STUD INB ERR, 1975, GEN SCREEN PROGR PRI; Cremonesi L, 2004, ANN NY ACAD SCI, V1022, P105, DOI 10.1196/annals.1318.017; ELIAS S, 1994, NEW ENGL J MED, V330, P1611, DOI 10.1056/NEJM199406023302213; Haddow JE, 1993, ESSENTIALS PRENATAL, P185; HARMON A, 2004, NY TIMES NEW YO 0620; Henn W, 1999, J MED ETHICS, V25, P200, DOI 10.1136/jme.25.2.200; Illes J, 2006, SCIENCE, V311, P783, DOI 10.1126/science.1124665; Kohane IS, 2006, JAMA-J AM MED ASSOC, V296, P212, DOI 10.1001/jama.296.2.212; Larrabee PB, 2004, AM J HUM GENET, V75, P485, DOI 10.1086/423288; NELSON JP, 2006, BMJ-BRIT MED J, V332, P443; NISAND MI, 2000, P INT S BIOETH RIGHT, P31; Rawls John, 1999, THEORY JUSTICE, DOI DOI 10.4159/9780674042605; REGALADO A, 2006, WALL STREET J N 0414; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; SHUSTER E, 2001, J LAW MED ETHICS, V29, P35; SHUSTER E, 1992, GENE MAPPING USING L, P115; Stone JH, 2006, NEW ENGL J MED, V354, P2748, DOI 10.1056/NEJMp058264; Suter SM, 2002, AM J LAW MED, V28, P233; TESTART J, 2004, VONT VALEURS, P365; WADE N, 2006, NY TIMES NEW YO 0718	31	53	53	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2007	369	9560					526	529		10.1016/S0140-6736(07)60239-6	http://dx.doi.org/10.1016/S0140-6736(07)60239-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	135XX	17292772				2022-12-01	WOS:000244188300035
J	Stephanopoulos, G				Stephanopoulos, Gregory			Challenges in engineering microbes for biofuels production	SCIENCE			English	Editorial Material							ESCHERICHIA-COLI; ETHANOL; PATHWAY	Economic and geopolitical factors ( high oil prices, environmental concerns, and supply instability) have been prompting policy-makers to put added emphasis on renewable energy sources. For the scientific community, recent advances, embodied in new insights into basic biology and technology that can be applied to metabolic engineering, are generating considerable excitement. There is justified optimism that the full potential of biofuel production from cellulosic biomass will be obtainable in the next 10 to 15 years.	MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Stephanopoulos, G (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	gregstep@mit.edu						Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969; BAILEY JE, 1991, SCIENCE, V252, P1668, DOI 10.1126/science.2047876; Boles E, 1997, FEMS MICROBIOL REV, V21, P85, DOI 10.1016/S0168-6445(97)00052-1; *DEP EN, 2005, BIOM BIOF ROADM EN F; Hahn-Hagerdal B, 2006, TRENDS BIOTECHNOL, V24, P549, DOI 10.1016/j.tibtech.2006.10.004; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; INGRAM LO, 1987, APPL ENVIRON MICROB, V53, P2420, DOI 10.1128/AEM.53.10.2420-2425.1987; Kuyper M, 2003, FEMS YEAST RES, V4, P69, DOI 10.1016/S1567-1356(03)00141-7; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; MCFARLAND KC, 2006, WORLD C IND BIOT BIO; PATNAIK R, 1995, BIOTECHNOL BIOENG, V46, P361, DOI 10.1002/bit.260460409; STEPHANOPOULOS G, 1993, TRENDS BIOTECHNOL, V11, P392, DOI 10.1016/0167-7799(93)90099-U; STEPHANOPOULOS G, 1991, SCIENCE, V252, P1675, DOI 10.1126/science.1904627; Stephanopoulos G, 2002, AICHE J, V48, P920, DOI 10.1002/aic.690480502; Takagi M, 1977, P BIOCONVERSION S, P551; ZHANG M, 1995, SCIENCE, V267, P240, DOI 10.1126/science.267.5195.240	16	540	583	4	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2007	315	5813					801	804		10.1126/science.1139612	http://dx.doi.org/10.1126/science.1139612			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289987				2022-12-01	WOS:000244069000055
J	Xin, HW; Liu, D; Wan, M; Safari, A; Kim, H; Sun, W; O'Connor, MS; Zhou, SY				Xin, Huawei; Liu, Dan; Wan, Ma; Safari, Amin; Kim, Hyeung; Sun, Wen; O'Connor, Matthew S.; Zhou Songyang			TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase	NATURE			English	Article							END-BINDING-PROTEIN; DNA-DAMAGE; LENGTH REGULATOR; COMPLEX; MAINTENANCE; SUBUNIT; PROTECTION; TERMINI; ENZYME; YEAST	Telomere dysfunction may result in chromosomal abnormalities, DNA damage responses, and even cancer(1). Early studies in lower organisms have helped to establish the crucial role of telomerase and telomeric proteins in maintaining telomere length and protecting telomere ends(2-7). In Oxytricha nova, telomere G-overhangs are protected by the TEBP-alpha/beta heterodimer(3,4). Human telomeres contain duplex telomeric repeats with 3' single-stranded G-overhangs, and may fold into a t-loop structure that helps to shield them from being recognized as DNA breaks(8,9). Additionally, the TEBP-alpha homologue, POT1, which binds telomeric single-stranded DNA (ssDNA)(10), associates with multiple telomeric proteins ( for example, TPP1, TIN2, TRF1, TRF2 and RAP1) to form the six-protein telosome/shelterin(11,12) and other subcomplexes. These telomeric protein complexes in turn interact with diverse pathways to form the telomere interactome(13) for telomere maintenance. However, the mechanisms by which the POT1-containing telosome communicates with telomerase to regulate telomeres remain to be elucidated. Here we demonstrate that TPP1 is a putative mammalian homologue of TEBP-beta and contains a predicted amino-terminal oligonucleotide/ oligosaccharide binding (OB) fold. TPP1-POT1 association enhanced POT1 affinity for telomeric ssDNA. In addition, the TPP1 OB fold, as well as POT1 - TPP1 binding, seemed critical for POT1-mediated telomerelength control and telomere-end protection in human cells. Disruption of POT1 - TPP1 interaction by dominant negative TPP1 expression or RNA interference (RNAi) resulted in telomerelength alteration and DNA damage responses. Furthermore, we offer evidence that TPP1 associates with the telomerase in a TPP1-OB-fold-dependent manner, providing a physical link between telomerase and the telosome/shelterin complex. Our findings highlight the critical role of TPP1 in telomere maintenance, and support a yin - yang model in which TPP1 and POT1 function as a unit to protect human telomeres, by both positively and negatively regulating telomerase access to telomere DNA.	Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine	Zhou, SY (corresponding author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	songyang@bcm.tmc.edu						Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bertuch AA, 2006, CURR OPIN CELL BIOL, V18, P247, DOI 10.1016/j.ceb.2006.04.005; Chadwick D., 1997, TELOMERES TELOMERASE; Chen JL, 2003, EMBO J, V22, P304, DOI 10.1093/emboj/cdg024; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; FANG GW, 1993, P NATL ACAD SCI USA, V90, P6056, DOI 10.1073/pnas.90.13.6056; FANG GW, 1993, CELL, V74, P875, DOI 10.1016/0092-8674(93)90467-5; GOTTSCHLING DE, 1986, CELL, V47, P195, DOI 10.1016/0092-8674(86)90442-3; GRAY JT, 1991, CELL, V67, P807, DOI 10.1016/0092-8674(91)90075-A; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HENDERSON E, 1987, CELL, V51, P899, DOI 10.1016/0092-8674(87)90577-0; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Horvath MP, 1998, CELL, V95, P963, DOI 10.1016/S0092-8674(00)81720-1; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Lingner J, 1998, CURR OPIN GENET DEV, V8, P226, DOI 10.1016/S0959-437X(98)80145-7; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; Shore D, 1997, BIOL CHEM, V378, P591; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Yang Q, 2005, MOL CELL BIOL, V25, P1070, DOI 10.1128/MCB.25.3.1070-1080.2005; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zhou SY, 2006, CRIT REV EUKAR GENE, V16, P103, DOI 10.1615/CritRevEukarGeneExpr.v16.i2.10	30	378	392	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2007	445	7127					559	562		10.1038/nature05469	http://dx.doi.org/10.1038/nature05469			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17237767				2022-12-01	WOS:000243867300048
J	Wagner, AK; Ross-Degnan, D; Gurwitz, JH; Zhang, F; Gilden, DB; Cosler, L; Soumerai, SB				Wagner, Anita K.; Ross-Degnan, Dennis; Gurwitz, Jerry H.; Zhang, Fang; Gilden, Daniel B.; Cosler, Leon; Soumerai, Stephen B.			Effect of New York state regulatory action on benzodiazepine prescribing and hip fracture rates	ANNALS OF INTERNAL MEDICINE			English	Article							TRIPLICATE PRESCRIPTION PROGRAM; RISK-FACTORS; MEDICATION USE; OLDER-PEOPLE; HALF-LIFE; FALLS; SURVEILLANCE; PATTERNS; DOSAGE; IMPACT	Background: Medicare Part D excludes benzodiazepines from coverage, and numerous state government policies limit use of benzodiazepines. No data indicate that such policies have decreased the incidence of hip fracture. Objective: To assess whether a statewide policy that decreased the use of benzodiazepines among elderly persons by more than 50% has decreased the incidence of hip fracture. Design: A quasi-experiment comparing changes in outcomes before and after a policy change in a study U.S. state (New York) and a control state (New Jersey). Setting: Two U.S. state Medicaid programs, 1988-1990. Patients: Medicaid enrollees in New York (n = 51529) and New Jersey (n = 42 029) who received or did not receive a benzodiazepine. Measurements: Benzodiazepine prescribing and hazard ratios for hip fracture, adjusted for age and eligibility category. Intervention: A statewide policy, implemented in New York in 1989, that required triplicate forms for benzodiazepine prescribing to allow surveillance by health authorities. Results: The triplicate prescription policy immediately resulted in a 60.3% (95% CI, -66.3% to -54.2%) reduction in benzodiazepine use among women and 58.5% (-64.3% to -52.8%) among men. Benzodiazepine use in New Jersey remained stable. Hazard ratios for hip fracture that were adjusted for age and eligibility category did not change in New York or New Jersey when the periods before and after use of the triplicate prescription policy were compared (change from 1.2 to 1.1 among female benzodiazepine recipients [P = 0.70], 1.3 to 1.1 [P = 0.08] among female nonrecipients, 0.8 to 1.1 [P = 0.56] among male recipients, and 1.1 to 1.3 [P = 0.46] among male nonrecipients). Limitations: Information was lacking on race, benzodiazepine dose, and other potential determinants of continued benzodiazepine prescribing. Conclusions: Policies that lead to substantial reductions in the use of benzodiazepines among elderly persons do not necessarily lead to decreased incidence of hip fracture. Limitations on coverage of benzodiazepines under Medicare Part D may not achieve this widely assumed clinical benefit.	Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; Harvard Pilgrim Hlth Care, Boston, MA 02215 USA; Univ Massachusetts, Sch Med, Meyers Primary Care Inst, Fallon Fdn, Worcester, MA 01605 USA; Fallon Community Hlth Plan, Worcester, MA USA; JEN Associates Inc, Cambridge, MA USA; New York State Dept Hlth, Albany Coll Pharm & Management Reports & Res Unit, Off Medicaid Management, Albany, NY USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Massachusetts System; University of Massachusetts Worcester; State University of New York (SUNY) System	Soumerai, SB (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA.	ssoumerai@hms.harvard.edu			AHRQ HHS [U 18 HS 11843] Funding Source: Medline; NIA NIH HHS [R01 AG19808-01A1] Funding Source: Medline; NIDA NIH HHS [R01DA10 371-01] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS011843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010371] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		[Anonymous], 1999, SAS STAT US GUID VER; Bambauer KZ, 2005, PSYCHIAT SERV, V56, P1143, DOI 10.1176/appi.ps.56.9.1143; Cook TD, 1979, QUASI EXPT DESIGN AN; CUMMING RG, 1993, MED J AUSTRALIA, V158, P414, DOI 10.5694/j.1326-5377.1993.tb121839.x; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; EADIE JL, 1993, IMPACT PRESCRIPTION, V179; ENSRUD KE, 1996, EPIDEMIOLOGY, V7, P335; FEDERSPIEL CF, 1976, MED CARE, V14, P166, DOI 10.1097/00005650-197602000-00006; GALES BJ, 1995, ANN PHARMACOTHER, V29, P354, DOI 10.1177/106002809502900402; GRISSO JA, 1991, NEW ENGL J MED, V324, P1326, DOI 10.1056/NEJM199105093241905; HENNESSEY S, 2005, PHARMACOEPIDEMIOLOGY; HERINGS RMC, 1995, ARCH INTERN MED, V155, P1801, DOI 10.1001/archinte.155.16.1801; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Karagas MR, 1996, AM J EPIDEMIOL, V143, P677; KEENE GS, 1993, BRIT MED J, V307, P1248, DOI 10.1136/bmj.307.6914.1248; Kleinbaum D, 1996, SURVIVAL ANAL SELF L; Koski K, 1998, GERONTOLOGY, V44, P232, DOI 10.1159/000022017; LIU BA, 1995, J AM GERIATR SOC, V43, P1141, DOI 10.1111/j.1532-5415.1995.tb07016.x; LURIE P, 1992, JAMA-J AM MED ASSOC, V268, P472; *NAT PHARM COUNC, 2003, PHARM BEN STAT MED A; Neutel CI, 1996, AGE AGEING, V25, P273, DOI 10.1093/ageing/25.4.273; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; Pearson SA, 2006, ARCH INTERN MED, V166, P572, DOI 10.1001/archinte.166.5.572; Pierfitte C, 2001, BMJ-BRIT MED J, V322, P704, DOI 10.1136/bmj.322.7288.704; RAY WA, 1992, J CLIN EPIDEMIOL, V45, P703, DOI 10.1016/0895-4356(92)90047-Q; RAY WA, 1989, JAMA-J AM MED ASSOC, V262, P3303, DOI 10.1001/jama.262.23.3303; RAY WA, 1987, NEW ENGL J MED, V316, P363, DOI 10.1056/NEJM198702123160702; Ray WA, 2000, J AM GERIATR SOC, V48, P682, DOI 10.1111/j.1532-5415.2000.tb04729.x; Ross-Degnan D, 2004, INT J PSYCHIAT MED, V34, P103, DOI 10.2190/8FR4-QYY1-7MYG-2AGJ; ROSSDEGNAN D, 1993, JAMA-J AM MED ASSOC, V270, P1937, DOI 10.1001/jama.270.16.1937; Schneeweiss S, 2005, J AM GERIATR SOC, V53, P948, DOI 10.1111/j.1532-5415.2005.53303.x; Sgadari A, 2000, J CLIN PSYCHOPHARM, V20, P234, DOI 10.1097/00004714-200004000-00017; Simoni-Wastila L, 2004, CLIN THER, V26, P322, DOI 10.1016/S0149-2918(04)90030-6; Sloan FA, 1999, AM J PUBLIC HEALTH, V89, P935, DOI 10.2105/AJPH.89.6.935; SOROCK GS, 1988, ARCH INTERN MED, V148, P2441, DOI 10.1001/archinte.148.11.2441; TAGGART HM, 1988, J AM GERIATR SOC, V36, P1006, DOI 10.1111/j.1532-5415.1988.tb04367.x; Tamblyn R, 2005, J AM GERIATR SOC, V53, P233, DOI 10.1111/j.1532-5415.2005.53108.x; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; VanHaaren AM, 2001, PHARMACOTHERAPY, V21, P1159, DOI 10.1592/phco.21.15.1159.33898; WADHWANI A, 2006, TENNESSEAN      0223; Wagner AK, 2004, ARCH INTERN MED, V164, P1567, DOI 10.1001/archinte.164.14.1567; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wang PS, 2001, AM J PSYCHIAT, V158, P892, DOI 10.1176/appi.ajp.158.987.892; WEINTRAUB M, 1991, JAMA-J AM MED ASSOC, V266, P2392, DOI 10.1001/jama.266.17.2392; WEINTRAUB M, 1993, CLIN PHARMACOL THER, V54, P252, DOI 10.1038/clpt.1993.145; ZULLICH SG, 1992, ANN PHARMACOTHER, V26, P539	46	52	53	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2007	146	2					96	103		10.7326/0003-4819-146-2-200701160-00004	http://dx.doi.org/10.7326/0003-4819-146-2-200701160-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131WF	17227933				2022-12-01	WOS:000243901000003
J	Doyle, M; Fookes, M; Ivens, A; Mangan, MW; Wain, J; Dorman, CJ				Doyle, Marie; Fookes, Maria; Ivens, Al; Mangan, Michael W.; Wain, John; Dorman, Charles J.			An H-NS-like stealth protein aids horizontal DNA transmission in bacteria	SCIENCE			English	Article							PLASMID; SEQUENCE; GENES; COLI; LER; R27; SFH	The Sfh protein is encoded by self-transmissible plasmids involved in human typhoid and is closely related to the global regulator H-NS. We have found that Sfh provides a stealth function that allows the plasmids to be transmitted to new bacterial hosts with minimal effects on their fitness. Introducing the plasmid without the sfh gene imposes a mild H-NS- phenotype and a severe loss of fitness due to titration of the cellular pool of H-NS by the A+T-rich plasmid. This stealth strategy seems to be used widely to aid horizontal DNA transmission and has important implications for bacterial evolution.	Trinity Coll Dublin, Dept Microbiol, Moyne Inst Prevent Med, Dublin 2, Ireland; Wellcome Trust Res Labs, Sanger Inst, Cambridge CB10 1SA, England	Trinity College Dublin; Wellcome Trust Sanger Institute	Dorman, CJ (corresponding author), Trinity Coll Dublin, Dept Microbiol, Moyne Inst Prevent Med, Dublin 2, Ireland.	cjdorman@tcd.ie	Dorman, Charles/P-3481-2019; Dorman, Charles J/N-9867-2015; Wain, John/B-3446-2013	Dorman, Charles/0000-0002-6018-9170; Dorman, Charles J/0000-0002-6018-9170; Wain, John/0000-0002-1257-1148; Mangan, Michael/0000-0001-9428-0397; Ivens, Al/0000-0002-0112-3876	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Beloin C, 2003, MOL GENET GENOMICS, V270, P66, DOI 10.1007/s00438-003-0897-0; Berdichevsky T, 2005, J BACTERIOL, V187, P349, DOI 10.1128/JB.187.1.349-357.2005; Bertin P, 1999, MOL MICROBIOL, V31, P319, DOI 10.1046/j.1365-2958.1999.01176.x; BOUMA JE, 1988, NATURE, V335, P351, DOI 10.1038/335351a0; Bustamante VH, 2001, MOL MICROBIOL, V39, P664, DOI 10.1046/j.1365-2958.2001.02209.x; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; Dahlberg C, 2003, GENETICS, V165, P1641; Deighan P, 2003, MOL MICROBIOL, V48, P1401, DOI 10.1046/j.1365-2958.2003.03515.x; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Forns N, 2005, J BACTERIOL, V187, P3950, DOI 10.1128/JB.187.12.3950-3959.2005; LENSKI RE, 1994, J BACTERIOL, V176, P3140, DOI 10.1128/jb.176.11.3140-3147.1994; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; More MI, 1996, J BACTERIOL, V178, P4392, DOI 10.1128/jb.178.15.4392-4399.1996; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Rimsky S, 2004, CURR OPIN MICROBIOL, V7, P109, DOI 10.1016/j.mib.2004.02.001; Sherburne CK, 2000, NUCLEIC ACIDS RES, V28, P2177, DOI 10.1093/nar/28.10.2177; TIETZE E, 1994, J BASIC MICROB, V34, P105, DOI 10.1002/jobm.3620340206; Wain J, 2004, T ROY SOC TROP MED H, V98, P423, DOI 10.1016/j.trstmh.2003.10.015; Wain J, 1998, J CLIN MICROBIOL, V36, P1683, DOI 10.1128/JCM.36.6.1683-1687.1998; Wei J, 2003, INFECT IMMUN, V71, P2775, DOI 10.1128/IAI.71.5.2775-2786.2003	21	161	162	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2007	315	5809					251	252		10.1126/science.1137550	http://dx.doi.org/10.1126/science.1137550			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124XZ	17218529				2022-12-01	WOS:000243407400050
J	Armstead, I; Donnison, I; Aubry, S; Harper, J; Hortensteiner, S; James, C; Mani, J; Moffet, M; Ougham, H; Roberts, L; Thomas, A; Weeden, N; Thomas, H; King, I				Armstead, Ian; Donnison, Iain; Aubry, Sylvain; Harper, John; Hortensteiner, Stefan; James, Caron; Mani, Jan; Moffet, Matt; Ougham, Helen; Roberts, Luned; Thomas, Ann; Weeden, Norman; Thomas, Howard; King, Ian			Cross-species identification of Mendel's/locus	SCIENCE			English	Article							STAY GREEN		Inst Grassland & Environm Res, Aberystwyth SY23 3EB, Dyfed, Wales; Univ Bern, Inst Plant Sci, CH-3013 Bern, Switzerland; Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA	Aberystwyth University; University of Bern; Montana State University System; Montana State University Bozeman	Armstead, I (corresponding author), Inst Grassland & Environm Res, Aberystwyth SY23 3EB, Dyfed, Wales.	ian.armstead@bbsrc.ac.uk	Donnison, Iain S/K-6138-2014; Thomas, Howard/G-6812-2011; King, Ian/N-4500-2014; Aubry, Sylvain/V-6364-2019	Donnison, Iain S/0000-0001-6276-555X; Aubry, Sylvain/0000-0002-7598-3609	Biotechnology and Biological Sciences Research Council [BBS/E/G/00003001] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Armstead I, 2006, NEW PHYTOL, V172, P592, DOI 10.1111/j.1469-8137.2006.01922.x; Cha KW, 2002, THEOR APPL GENET, V104, P526, DOI 10.1007/s001220100750; Hortensteiner S, 2006, ANNU REV PLANT BIOL, V57, P55, DOI 10.1146/annurev.arplant.57.032905.105212; Mendel G., 1866, VERHAND NATURF VER B, V4, P3, DOI DOI 10.5962/BHL.TITLE.61004; THOMAS H, 1993, ANN APPL BIOL, V123, P193, DOI 10.1111/j.1744-7348.1993.tb04086.x; Thomas H, 1996, BOT ACTA, V109, P3, DOI 10.1111/j.1438-8677.1996.tb00862.x	6	137	154	4	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 5	2007	315	5808					73	73		10.1126/science.1132912	http://dx.doi.org/10.1126/science.1132912			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17204643				2022-12-01	WOS:000243259100036
J	Chen, CH; Huang, HX; Ward, CM; Su, JT; Schaeffer, LV; Guo, M; Hay, BA				Chen, Chun-Hong; Huang, Haixia; Ward, Catherine M.; Su, Jessica T.; Schaeffer, Lorian V.; Guo, Ming; Hay, Bruce A.			A synthetic maternal-effect selfish genetic element drives population replacement in Drosophila	SCIENCE			English	Article							ANOPHELES-GAMBIAE; RESISTANCE; MOSQUITOS; DYNAMICS; SYSTEMS	One proposed strategy for controlling the transmission of insect-borne pathogens uses a drive mechanism to ensure the rapid spread of transgenes conferring disease refractoriness throughout wild populations. Here, we report the creation of maternal-effect selfish genetic elements in Drosophila that drive population replacement and are resistant to recombination-mediated dissociation of drive and disease refractoriness functions. These selfish elements use microRNA-mediated silencing of a maternally expressed gene essential for embryogenesis, which is coupled with early zygotic expression of a rescuing transgene.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Dept Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Dept Pharmacol, Los Angeles, CA 90095 USA	California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Hay, BA (corresponding author), CALTECH, Div Biol, Mail Code 156-29, Pasadena, CA 91125 USA.	haybruce@caltech.edu	Albers, Pieter/I-2563-2017; Mockler, Todd C/L-2609-2013; Chen, Chun-Hong/E-3990-2010; anand, amit/A-7222-2009; Chung, Sun-Lin/F-9574-2015	Mockler, Todd C/0000-0002-0462-5775; CHEN, CHUN-HONG/0000-0002-3028-5508	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070956, R01GM057422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048396, K08NS042580] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM70956, GM057422] Funding Source: Medline; NINDS NIH HHS [NS048396, NS042580] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEEMAN RW, 1992, SCIENCE, V256, P89, DOI 10.1126/science.1566060; Beeman RW, 1999, HEREDITY, V82, P529, DOI 10.1038/sj.hdy.6885150; Boete Christopher, 2002, Malaria Journal, V1, pUnpaginated; Capurro MD, 2000, AM J TROP MED HYG, V62, P427, DOI 10.4269/ajtmh.2000.62.427; Coetzee M, 2004, AM J TROP MED HYG, V70, P103, DOI 10.4269/ajtmh.2004.70.103; della Torre A, 2002, SCIENCE, V298, P115, DOI 10.1126/science.1078170; Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103; GEER BW, 1962, AM NAT, V96, P175, DOI 10.1086/282220; Gould F, 2004, ANNU REV ENTOMOL, V49, P193, DOI 10.1146/annurev.ento.49.061802.123344; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; James AA, 2005, TRENDS PARASITOL, V21, P64, DOI 10.1016/j.pt.2004.11.004; Kambris Z, 2003, EMBO REP, V4, P64, DOI 10.1038/sj.embor.embor714; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Moreira LA, 2002, J BIOL CHEM, V277, P40839, DOI 10.1074/jbc.M206647200; Nimmo DD, 2006, INSECT MOL BIOL, V15, P129, DOI 10.1111/j.1365-2583.2006.00615.x; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; RIBEIRO JMC, 1994, J MED ENTOMOL, V31, P10, DOI 10.1093/jmedent/31.1.10; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; Smith NGC, 1998, J THEOR BIOL, V191, P173, DOI 10.1006/jtbi.1997.0579; Vernick KD, 2005, CURR TOP MICROBIOL, V295, P383; Vlachou D, 2005, CURR OPIN MICROBIOL, V8, P415, DOI 10.1016/j.mib.2005.06.013; WADE MJ, 1994, GENETICS, V138, P1309	23	239	249	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2007	316	5824					597	600		10.1126/science.1138595	http://dx.doi.org/10.1126/science.1138595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17395794				2022-12-01	WOS:000245983100045
J	Passino, MA; Adams, RA; Sikorski, SL; Akassoglou, K				Passino, Melissa A.; Adams, Ryan A.; Sikorski, Shoana L.; Akassoglou, Katerina			Regulation of hepatic stellate cell differentiation by the neurotrophin receptor p75(NTR)	SCIENCE			English	Article							HEPATOCYTE GROWTH-FACTOR; PLASMINOGEN DEFICIENCY; LIVER-REGENERATION; ACTIN CYTOSKELETON; SIGNALING PATHWAYS; APOPTOSIS; RAT; P75; RHO; EXPRESSION	Differentiation of hepatic stellate cells (HSCs) to extracellular matrix- and growth factor-producing cells supports liver regeneration through promotion of hepatocyte proliferation. We show that the neurotrophin receptor p75(NTR), a tumor necrosis factor receptor superfamily member expressed in HSCs after fibrotic and cirrhotic liver injury in humans, is a regulator of liver repair. In mice, depletion of p75(NTR) exacerbated liver pathology and inhibited hepatocyte proliferation in vivo. p75(NTR-/-) HSCs failed to differentiate to myofibroblasts and did not support hepatocyte proliferation. Moreover, inhibition of p75(NTR) signaling to the small guanosine triphosphatase Rho resulted in impaired HSC differentiation. Our results identify signaling from p75(NTR) to Rho as a mechanism for the regulation of HSC differentiation to regeneration-promoting cells that support hepatocyte proliferation in the diseased liver.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Akassoglou, K (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	akass@ucsd.edu		Akassoglou, Katerina/0000-0002-2632-1465	NIGMS NIH HHS [5T32-GM07752] Funding Source: Medline; NINDS NIH HHS [NS051470, P30-NS047101] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051470, P30NS047101] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Balabaud C, 2004, J HEPATOL, V40, P1023, DOI 10.1016/j.jhep.2004.04.003; Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; Bataller R, 2001, SEMIN LIVER DIS, V21, P437, DOI 10.1055/s-2001-17558; Bugge TH, 1996, CELL, V87, P709, DOI 10.1016/S0092-8674(00)81390-2; Cassiman D, 2001, HEPATOLOGY, V33, P148, DOI 10.1053/jhep.2001.20793; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Hoshijima M, 1998, J BIOL CHEM, V273, P7725, DOI 10.1074/jbc.273.13.7725; HU ZY, 1993, AM J PATHOL, V142, P1823; Kato M, 1999, J HEPATOL, V31, P91, DOI 10.1016/S0168-8278(99)80168-8; Kisseleva T, 2006, J GASTROEN HEPATOL, V21, pS84, DOI 10.1111/j.1440-1746.2006.04584.x; LOMENHOERTH C, 1995, J NEUROCHEM, V64, P1780; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; MAHER JJ, 1993, J CLIN INVEST, V91, P2244, DOI 10.1172/JCI116451; Majdan M, 1997, J NEUROSCI, V17, P6988; Ng VL, 2001, J HEPATOL, V35, P781, DOI 10.1016/S0168-8278(01)00212-4; Novo E, 2006, GUT, V55, P1174, DOI 10.1136/gut.2005.082701; Oakley F, 2003, AM J PATHOL, V163, P1849, DOI 10.1016/S0002-9440(10)63544-4; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Roux PP, 2001, J BIOL CHEM, V276, P23097, DOI 10.1074/jbc.M011520200; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Teng KK, 2004, CELL MOL LIFE SCI, V61, P35, DOI 10.1007/s00018-003-3099-3; Trim N, 2000, AM J PATHOL, V156, P1235, DOI 10.1016/S0002-9440(10)64994-2; Uyama N, 2002, J HEPATOL, V36, P590, DOI 10.1016/S0168-8278(02)00023-5; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Zampieri N, 2006, BIOCHEM SOC T, V34, P607, DOI 10.1042/BST0340607	28	140	153	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1853	1856		10.1126/science.1137603	http://dx.doi.org/10.1126/science.1137603			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395831				2022-12-01	WOS:000245280100046
J	Check, E				Check, Erika			The hard copy	NATURE			English	News Item							HEMATOPOIETIC STEM-CELLS; BONE-MARROW; PROGENITOR CELLS; FUSION; BRAIN											Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Giles J, 2006, NATURE, V442, P344, DOI 10.1038/442344a; Jiang YH, 2002, EXP HEMATOL, V30, P896, DOI 10.1016/S0301-472X(02)00869-X; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Morshead CM, 2002, NAT MED, V8, P268, DOI 10.1038/nm0302-268; Serafini M, 2007, J EXP MED, V204, P129, DOI 10.1084/jem.20061115; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	10	21	28	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2007	446	7135					485	486		10.1038/446485a	http://dx.doi.org/10.1038/446485a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392761				2022-12-01	WOS:000245242900022
J	Kim, TH; Abdullaev, ZK; Smith, AD; Ching, KA; Loukinov, DI; Green, RD; Zhang, MQ; Lobanenkov, VV; Ren, B				Kim, Tae Hoon; Abdullaev, Ziedulla K.; Smith, Andrew D.; Ching, Keith A.; Loukinov, Dmitri I.; Green, Roland D.; Zhang, Michael Q.; Lobanenkov, Victor V.; Ren, Bing			Analysis of the vertebrate insulator protein CTCF-binding sites in the human genome	CELL			English	Article							ENHANCER-BLOCKING ACTIVITY; TRANSCRIPTION-FACTOR; X-INACTIVATION; WIDE ANALYSIS; H19 GENE; METHYLATION; BOUNDARIES; PROMOTER; SEQUENCE; RECEPTOR	Insulator elements affect gene expression by preventing the spread of heterochromatin and restricting transcriptional enhancers from activation of unrelated promoters. In vertebrates, insulator's function requires association with the CCCTC-binding factor (CTCF), a protein that recognizes long and diverse nucleotide sequences. While insulators are critical in gene regulation, only a few have been reported. Here, we describe 13,804 CTCF-binding sites in potential insulators of the human genome, discovered experimentally in primary human fibroblasts. Most of these sequences are located far from the transcriptional start sites, with their distribution strongly correlated with genes. The majority of them fit to a consensus motif highly conserved and suitable for predicting possible insulators driven by CTCF in other vertebrate genomes. In addition, CTCF localization is largely invariant across different cell types. Our results provide a resource for investigating insulator function and possible other general and evolutionarily conserved activities of CTCF sites.	Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; NIAID, Rockville, MD 20852 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; NimbleGen Syst Inc, Madison, WI 53711 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Cold Spring Harbor Laboratory; Roche Holding; Roche NimbleGen	Kim, TH (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St,SHMl 142B,POB 208005, New Haven, CT 06120 USA.	taehoon.kim@yale.edu; biren@ucsd.edu	Lobanenkov, Victor/ABD-5710-2021; Lobanenkov, Victor V./AGQ-8903-2022; Smith, Andrew D./G-4104-2013	Smith, Andrew D./0000-0002-3337-1970; Kim, Tae Hoon/0000-0003-3950-7557; Lobanenkov, Victor/0000-0001-6665-3635	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [R33CA105829, F32CA108313, F32 CA108313, R21 CA116365, R21CA116365-01, R33 CA105829] Funding Source: Medline; NCRR NIH HHS [P41 RR008605, P41 RR 08605] Funding Source: Medline; NHGRI NIH HHS [HG001696, R01 HG001696, U01 HG003151, U01HG003151] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA108313, R21CA116365, R33CA105829] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008605] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001696, U01HG003151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000860] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Awad TA, 1999, J BIOL CHEM, V274, P27092, DOI 10.1074/jbc.274.38.27092; BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Burcin M, 1997, MOL CELL BIOL, V17, P1281, DOI 10.1128/MCB.17.3.1281; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Dunn KL, 2003, BIOCHEM CELL BIOL, V81, P161, DOI 10.1139/o03-052; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Felsenfeld G, 2004, COLD SPRING HARB SYM, V69, P245, DOI 10.1101/sqb.2004.69.245; Filippova GN, 2002, CANCER RES, V62, P48; Filippova GN, 2005, DEV CELL, V8, P31, DOI 10.1016/j.devcel.2004.10.018; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Filippova GN, 1998, GENE CHROMOSOME CANC, V22, P26, DOI 10.1002/(SICI)1098-2264(199805)22:1<26::AID-GCC4>3.0.CO;2-9; Gerasimova TI, 2001, ANNU REV GENET, V35, P193, DOI 10.1146/annurev.genet.35.102401.090349; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Jeong S, 2004, NAT GENET, V36, P1036, DOI 10.1038/ng1004-1036; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim TH, 2006, ANNU REV GENOM HUM G, V7, P81, DOI 10.1146/annurev.genom.7.080505.115634; Kim TH, 2005, GENOME RES, V15, P830, DOI 10.1101/gr.3430605; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Klenova EA, 2002, SEMIN CANCER BIOL, V12, P399, DOI 10.1016/S1044-579X(02)00060-3; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lee JT, 2003, CURR BIOL, V13, pR242, DOI 10.1016/S0960-9822(03)00162-3; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Moon H, 2005, EMBO REP, V6, P165, DOI 10.1038/sj.embor.7400334; Mukhopadhyay R, 2004, GENOME RES, V14, P1594, DOI 10.1101/gr.2408304; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Pugacheva EM, 2005, HUM MOL GENET, V14, P953, DOI 10.1093/hmg/ddi089; RIDEOUT WM, 1990, SCIENCE, V249, P1288, DOI 10.1126/science.1697983; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smith AD, 2005, P NATL ACAD SCI USA, V102, P1560, DOI 10.1073/pnas.0406123102; Smith DR, 2005, WORD IMAGE, V21, P1, DOI 10.1080/0266628052000307175; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; UDVARDY A, 1985, J MOL BIOL, V185, P341, DOI 10.1016/0022-2836(85)90408-5; Vostrov AA, 1997, J BIOL CHEM, V272, P33353, DOI 10.1074/jbc.272.52.33353; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2	53	760	788	1	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1231	1245		10.1016/j.cell.2006.12.048	http://dx.doi.org/10.1016/j.cell.2006.12.048			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382889	Green Accepted, Bronze			2022-12-01	WOS:000245396200026
J	Liu, XG; Yue, YL; Li, B; Nie, YL; Li, W; Wu, WH; Ma, LG				Liu, Xigang; Yue, Yanling; Li, Bin; Nie, Yanli; Li, Wei; Wu, Wei-Hua; Ma, Ligeng			A G protein-coupled receptor is a plasma membrane receptor for the plant hormone abscisic acid	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; GAMMA-SUBUNIT; ION CHANNELS; GENE; SYSTEM; GPA1; GCR1	The plant hormone abscisic acid (ABA) regulates many physiological and developmental processes in plants. The mechanism of ABA perception at the cell surface is not understood. Here, we report that a G protein-coupled receptor genetically and physically interacts with the G protein a subunit GPA1 to mediate all known ABA responses in Arabidopsis. Overexpressing this receptor results in an ABA-hypersensitive phenotype. This receptor binds ABA with high affinity at physiological concentration with expected kinetics and stereospecificity. The binding of ABA to the receptor leads to the dissociation of the receptor-GPA1 complex in yeast. Our results demonstrate that this G protein-coupled receptor is a plasma membrane ABA receptor.	Natl Inst Biol Sci, Beijing 102206, Peoples R China; Hebei Normal Univ, Mol & Cellular Biol Lab, Shiziazhuang 050016, Hebei, Peoples R China; China Agr Univ, State Key Lab Plant Physiol & Biochem, Coll Biol Sci, Beijing 100094, Peoples R China	National Institute of Biological Sciences, Beijing; Hebei Normal University; China Agricultural University	Ma, LG (corresponding author), Natl Inst Biol Sci, 7 Sci Pk Rd,Zhongguancun Life Sci Pk, Beijing 102206, Peoples R China.	maligeng@nibs.ac.cn						ANDERSON BE, 1994, PLANT PHYSIOL, V104, P1177, DOI 10.1104/pp.104.4.1177; Assmann SM, 2005, SCIENCE, V310, P71, DOI 10.1126/science.1118580; Colucci G, 2002, P NATL ACAD SCI USA, V99, P4736, DOI 10.1073/pnas.072087699; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; GILROY S, 1992, P NATL ACAD SCI USA, V89, P3591, DOI 10.1073/pnas.89.8.3591; Jeannette E, 1999, PLANT J, V18, P13, DOI 10.1046/j.1365-313X.1999.00423.x; Jones AM, 2004, EMBO REP, V5, P572, DOI 10.1038/sj.embor.7400174; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; MA H, 1990, P NATL ACAD SCI USA, V87, P3821, DOI 10.1073/pnas.87.10.3821; MA H, 1994, PLANT MOL BIOL, V26, P1611, DOI 10.1007/BF00016493; Mason MG, 2001, BBA-GENE STRUCT EXPR, V1520, P147, DOI 10.1016/S0167-4781(01)00262-7; Mason MG, 2000, P NATL ACAD SCI USA, V97, P14784, DOI 10.1073/pnas.97.26.14784; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; Pandey S, 2006, PLANT PHYSIOL, V141, P243, DOI 10.1104/pp.106.079038; Pandey S, 2004, PLANT CELL, V16, P1616, DOI 10.1105/tpc.020321; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Plakidou-Dymock S, 1998, CURR BIOL, V8, P315, DOI 10.1016/S0960-9822(98)70131-9; Razem FA, 2006, NATURE, V439, P290, DOI 10.1038/nature04373; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Wang XQ, 2001, SCIENCE, V292, P2070, DOI 10.1126/science.1059046; WARD JM, 1995, PLANT CELL, V7, P833, DOI 10.1105/tpc.7.7.833; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	25	151	187	6	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2007	315	5819					1712	1716		10.1126/science.1135882	http://dx.doi.org/10.1126/science.1135882			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17347412				2022-12-01	WOS:000245106900040
J	Bazigou, E; Apitz, H; Johansson, J; Loren, CE; Hirst, EMA; Chen, PL; Palmer, RH; Salecker, I				Bazigou, Eleni; Apitz, Holger; Johansson, Jana; Loren, Christina E.; Hirst, Elizabeth M. A.; Chen, Pei-Ling; Palmer, Ruth H.; Salecker, Iris			Anterograde jelly belly and Alk receptor tyrosine kinase signaling mediates retinal axon targeting in Drosophila	CELL			English	Article							ANAPLASTIC LYMPHOMA KINASE; NON-HODGKINS-LYMPHOMA; VISUAL-SYSTEM; GLIAL-CELLS; NERVOUS-SYSTEM; SYNAPTIC SPECIFICITY; NEURONAL DEVELOPMENT; PHOTORECEPTOR AXONS; LAYER-SELECTION; ROLLING PEBBLES	Anaplastic lymphoma kinase (Alk) has been proposed to regulate neuronal development based on its expression pattern in vertebrates and invertebrates; however, its function in vivo is unknown. We demonstrate that Alk and its ligand Jelly belly (Jeb) play a central role as an anterograde, signaling pathway mediating neuronal circuit assembly in the Drosophila visual system. Alk is expressed and required in target neurons in the optic lobe, whereas Jeb is primarily generated by photoreceptor axons and functions in the eye to control target selection of R1-R6 axons in the lamina and R8 axons in the medulla. Impaired Jeb/Alk function affects layer-specific expression of three cell-adhesion molecules, Dumbfounded/Kirre, Roughest/IrreC, and Flamingo, in the medulla. Moreover, loss of flamingo in target neurons causes some R8-axon targeting errors observed in jeb and Alk mosaic animals. Together, these findings suggest that Jeb/Alk signaling helps R-cell axons to shape their environment for target recognition.	Umea Univ, Umea Ctr Mol Pathogenesis, S-90187 Umea, Sweden; Natl Inst Med Res, MRC, Div Mol Neurobiol, London NW7 1AA, England; Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Umea University; MRC National Institute for Medical Research; Stanford University	Palmer, RH (corresponding author), Umea Univ, Umea Ctr Mol Pathogenesis, S-90187 Umea, Sweden.	ruth.palmer@ucmp.umu.se; isaleck@nimr.mrc.ac.uk	Chen, Phang-Lang/J-5031-2013; Salecker, Iris/V-1228-2018	Salecker, Iris/0000-0003-3775-7763; Apitz, Holger/0000-0003-0551-2403	MRC [MC_U117581332] Funding Source: UKRI; Medical Research Council [MC_U117581332] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Chotard C, 2005, NEURON, V48, P237, DOI 10.1016/j.neuron.2005.09.019; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; Clandinin TR, 2001, NEURON, V32, P237, DOI 10.1016/S0896-6273(01)00474-3; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Englund C, 2003, NATURE, V425, P512, DOI 10.1038/nature01950; Fabian-Fine R, 2003, J NEUROSCI, V23, P10732; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; GONG QH, 1995, NEURON, V14, P91, DOI 10.1016/0896-6273(95)90243-0; HALTER DA, 1995, DEVELOPMENT, V121, P317; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Huang Z, 1998, CELL, V95, P693, DOI 10.1016/S0092-8674(00)81639-6; Huang Z, 1998, DEVELOPMENT, V125, P3753; Hurley SP, 2006, J COMP NEUROL, V495, P202, DOI 10.1002/cne.20887; Ito K, 1997, DEVELOPMENT, V124, P761; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Kadomatsu KJ, 2004, CANCER LETT, V204, P127, DOI 10.1016/S0304-3835(03)00450-6; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee HH, 2003, NATURE, V425, P507, DOI 10.1038/nature01916; Lee RC, 2003, NAT NEUROSCI, V6, P557, DOI 10.1038/nn1063; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Loren CE, 2003, EMBO REP, V4, P781, DOI 10.1038/sj.embor.embor897; Loren CE, 2001, GENES CELLS, V6, P531, DOI 10.1046/j.1365-2443.2001.00440.x; Marques G, 2005, J NEUROBIOL, V64, P417, DOI 10.1002/neu.20165; Mast JD, 2006, SEMIN CELL DEV BIOL, V17, P42, DOI 10.1016/j.semcdb.2005.11.004; Maurel-Zaffran C, 2001, NEURON, V32, P225, DOI 10.1016/S0896-6273(01)00471-8; Mehta SQ, 2005, NEURON, V46, P219, DOI 10.1016/j.neuron.2005.02.029; Meinertzhagen Ian A., 1993, P1363; Meiniel A, 2001, MICROSC RES TECHNIQ, V52, P484, DOI 10.1002/1097-0029(20010301)52:5<484::AID-JEMT1034>3.0.CO;2-0; Menon SD, 2005, J CELL BIOL, V169, P909, DOI 10.1083/jcb.200501126; Menon SD, 2001, DEV CELL, V1, P691, DOI 10.1016/S1534-5807(01)00075-2; MISMER D, 1987, GENETICS, V116, P565; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Motegi A, 2004, J CELL SCI, V117, P3319, DOI 10.1242/jcs.01183; Newsome TP, 2000, DEVELOPMENT, V127, P851; Oh SW, 2003, GENETICS, V163, P195; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Papatsenko D, 2001, MECH DEVELOP, V101, P143, DOI 10.1016/S0925-4773(00)00581-5; Perez SE, 1996, J NEUROBIOL, V30, P359, DOI 10.1002/(SICI)1097-4695(199607)30:3<359::AID-NEU5>3.0.CO;2-3; Poeck B, 2001, NEURON, V29, P99, DOI 10.1016/S0896-6273(01)00183-0; Prakash S, 2005, NAT NEUROSCI, V8, P443, DOI 10.1038/nn1415; Pulford K, 2004, J CELL PHYSIOL, V199, P330, DOI 10.1002/jcp.10472; RAYMOND PA, 1983, J NEUROSCI, V3, P1092; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; SALECKER I, 1995, J COMP NEUROL, V352, P33, DOI 10.1002/cne.903520104; Salinas PC, 2005, BIOCHEM SOC T, V33, P1295, DOI 10.1042/BST0331295; SCHNEIDER T, 1995, NEURON, V15, P259, DOI 10.1016/0896-6273(95)90032-2; Senti KA, 2003, CURR BIOL, V13, P828, DOI 10.1016/S0960-9822(03)00291-4; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Shinza-Kameda M, 2006, NEURON, V49, P205, DOI 10.1016/j.neuron.2005.11.013; Souttou B, 2001, J BIOL CHEM, V276, P9526, DOI 10.1074/jbc.M007333200; Stoica GE, 2002, J BIOL CHEM, V277, P35990, DOI 10.1074/jbc.M205749200; Stoica GE, 2001, J BIOL CHEM, V276, P16772, DOI 10.1074/jbc.M010660200; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229; Stute C, 2004, DEVELOPMENT, V131, P743, DOI 10.1242/dev.00972; Suh GSB, 2002, NEURON, V33, P35, DOI 10.1016/S0896-6273(01)00576-1; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Ting CY, 2005, DEVELOPMENT, V132, P953, DOI 10.1242/dev.01661; Vernersson E, 2006, GENE EXPR PATTERNS, V6, P448, DOI 10.1016/j.modgep.2005.11.006; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Weiss JB, 2001, CELL, V107, P387, DOI 10.1016/S0092-8674(01)00540-2; Yang LH, 2003, DEV CELL, V4, P359, DOI 10.1016/S1534-5807(03)00059-5; Ye B, 2005, TRENDS CELL BIOL, V15, P64, DOI 10.1016/j.tcb.2004.12.003; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	66	111	113	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2007	128	5					961	975		10.1016/j.cell.2007.02.024	http://dx.doi.org/10.1016/j.cell.2007.02.024			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350579	Bronze			2022-12-01	WOS:000245073400019
J	Bhutta, A; Gilliam, C; Honeycutt, M; Schexnayder, S; Green, J; Moss, M; Anand, KJS				Bhutta, Adnan; Gilliam, Craig; Honeycutt, Michele; Schexnayder, Stephen; Green, Jerril; Moss, Michele; Anand, K. J. S.			Reduction of bloodstream infections associated with catheters in paediatric intensive care unit: stepwise approach	BRITISH MEDICAL JOURNAL			English	Article							CRITICALLY-ILL PATIENTS; NOSOCOMIAL INFECTIONS; RISK-FACTORS; PREVENTION; GUIDELINE	Problem Bloodstream infections associated with catheters were the most common nosocomial infections in one paediatric intensive care unit in 1994-7, with rates well above the national average. Design Clinical data were collected prospectively to assess the rates of infection from 1994 onwards. The high rates in 1994-7 led to the stepwise introduction of interventions over a five year period. At quarterly intervals, prospective data continued to be collected during this period and an additional three year follow-up period. Setting A 292 bed tertiary care children's hospital. Key measures for improvement We aimed to reduce our infection rates to below the national mean rates for similar units by 2000 (a 25% reduction). Strategies for change A stepwise introduction of interventions designed to reduce infection rates, including maximal barrier precautions, transition to antibiotic impregnated central venous catheters, annual handwashing campaigns, and changing the skin disinfectant from povidone-iodine to chlorhexidine. Effects of change Significant decreases in rates of infection occurred over the intervention period. These were sustained over the three year follow-up. Annual rates decreased from 9.7/1000 days with a central venous catheter in 1997 to 3.0/1000 days in 2005, which translates to a relative risk reduction of 75% (95% confidence interval 35% to 126%), an absolute risk reduction of 6% (2% to 10%), and a number needed to treat of 16 (10 to 35). Lessons learnt A stepwise introduction of interventions leading to a greater than threefold reduction in nosocomial infections can be implemented successfully. This requires a multidisciplinary team, support from hospital leadership, ongoing data collection, shared data interpretation, and introduction of evidence based interventions.	Univ Arkansas Med Sci Hosp, Arkansas Childrens Hosp, Dept Pediat, Little Rock, AR 72202 USA; Arkansas Childrens Hosp, Little Rock, AR 72202 USA	Arkansas Children's Hospital; University of Arkansas System; University of Arkansas Medical Sciences; Arkansas Children's Hospital	Bhutta, A (corresponding author), Univ Arkansas Med Sci Hosp, Arkansas Childrens Hosp, Dept Pediat, 800 Marshall St,Slot 512-3, Little Rock, AR 72202 USA.	bhuttaadnant@uams.edu	Bhutta, Adnan T/ADN-9072-2022; Bhutta, Adnan/AAN-8551-2021; Anand, Kanwaljeet/B-3287-2014	Bhutta, Adnan/0000-0003-3362-5835; Anand, Kanwaljeet/0000-0001-6498-1483				[Anonymous], 2005, MMWR MORB MORTAL WKL; Bourn J., 2000, MANAGEMENT CONTROL H; Curtis JR, 2006, CRIT CARE MED, V34, P211, DOI 10.1097/01.CCM.0000190617.76104.AC; Garland JS, 2002, PEDIATRICS, V110, P1009, DOI 10.1542/peds.110.5.1009; Merrer J, 2001, JAMA-J AM MED ASSOC, V286, P700, DOI 10.1001/jama.286.6.700; MILLIKEN J, 1988, CRIT CARE MED, V16, P233, DOI 10.1097/00003246-198803000-00005; *NNIS, 1998, DAT SUMM OCT 1986 AP; O'Grady NP, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e51; Pearson ML, 1996, INFECT CONT HOSP EP, V17, P438; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; PRATT RJ, 2004, COMPARISON INT PRACT; Raad Issam, 1999, P165; Richards MJ, 1999, PEDIATRICS, V103, part. no., DOI 10.1542/peds.103.4.e39; SinghNaz N, 1996, CRIT CARE MED, V24, P875, DOI 10.1097/00003246-199605000-00024; Slonim Anthony D., 2001, Pediatr Crit Care Med, V2, P170, DOI 10.1097/00130478-200104000-00012; *US DEP HHS, 2006, CDCS ROL MON PREV HE; Veenstra DL, 1999, JAMA-J AM MED ASSOC, V282, P554, DOI 10.1001/jama.282.6.554; Weinstein RA, 1998, EMERG INFECT DIS, V4, P416, DOI 10.3201/eid0403.980320; Yogaraj JS, 2002, PEDIATRICS, V110, P481, DOI 10.1542/peds.110.3.481	19	64	66	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 17	2007	334	7589					362	365		10.1136/bmj.39064.457025.DE	http://dx.doi.org/10.1136/bmj.39064.457025.DE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	141EJ	17303886	Green Published			2022-12-01	WOS:000244560400035
J	Raviglione, MC; Smith, IM				Raviglione, Mario C.; Smith, Ian M.			XDR tuberculosis - Implications for global public health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									WHO, Stop TB Dept, Geneva, Switzerland	World Health Organization	Raviglione, MC (corresponding author), WHO, Stop TB Dept, Geneva, Switzerland.			RAVIGLIONE, Mario/0000-0002-9331-2067				[Anonymous], 2006, WKLY EPIDEMIOL REC, V81, P430; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; 2006, MMWR MORB MORTAL WKL, V55, P301	5	262	275	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2007	356	7					656	659		10.1056/NEJMp068273	http://dx.doi.org/10.1056/NEJMp068273			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135ZV	17301295				2022-12-01	WOS:000244193300002
J	Martianov, I; Ramadass, A; Barros, AS; Chow, N; Akoulitchev, A				Martianov, Igor; Ramadass, Aroul; Barros, Ana Serra; Chow, Natalie; Akoulitchev, Alexandre			Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript	NATURE			English	Article							RNA-POLYMERASE-II; CRYSTAL-STRUCTURE; TATA-ELEMENT; COMPLEX; EXPRESSION; CELLS; TFIIB; SPECIFICITY; PROMOTER; SITE	Alternative promoters within the same gene are a general phenomenon in gene expression(1,2). Mechanisms of their selective regulation vary from one gene to another and are still poorly understood. Here we show that in quiescent cells the mechanism of transcriptional repression of the major promoter of the gene encoding dihydrofolate reductase depends on a non-coding transcript initiated from the upstream minor promoter and involves both the direct interaction of the RNA and promoter-specific interference. The specificity and efficiency of repression is ensured by the formation of a stable complex between non-coding RNA and the major promoter, direct interaction of the non-coding RNA with the general transcription factor IIB and dissociation of the preinitiation complex from the major promoter. By using in vivo and in vitro assays such as inducible and reconstituted transcription, RNA bandshifts, RNA interference, chromatin immunoprecipitation and RNA immunoprecipitation, we show that the regulatory transcript produced from the minor promoter has a critical function in an epigenetic mechanism of promoter-specific transcriptional repression.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Univ Aveiro, Dept Biol, P-3810193 Aveiro, Portugal	University of Oxford; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universidade de Aveiro	Akoulitchev, A (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	alexandre.akoulitchev@path.ox.ac.uk		Martiyanov, Igor/0000-0001-6108-2036	Medical Research Council [G0200452] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0200452] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AKOULITCHEV S, 1995, NATURE, V377, P557, DOI 10.1038/377557a0; Ayoubi TAY, 1996, FASEB J, V10, P453, DOI 10.1096/fasebj.10.4.8647344; Blume SW, 2003, J CELL BIOCHEM, V88, P165, DOI 10.1002/jcb.10326; Carbone GM, 2003, NUCLEIC ACIDS RES, V31, P833, DOI 10.1093/nar/gkg198; GEE JE, 1992, J BIOL CHEM, V267, P11163; Gilbert C, 2004, MOL CELL, V14, P457, DOI 10.1016/S1097-2765(04)00239-4; HENDRICKSON SL, 1980, P NATL ACAD SCI-BIOL, V77, P5140, DOI 10.1073/pnas.77.9.5140; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Kazmi MA, 1996, BIOTECHNIQUES, V21, P304; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; Lagrange T, 1996, P NATL ACAD SCI USA, V93, P10620, DOI 10.1073/pnas.93.20.10620; LETAI AG, 1988, BIOCHEMISTRY-US, V27, P9108, DOI 10.1021/bi00426a007; MARCK C, 1978, NUCLEIC ACIDS RES, V5, P1017, DOI 10.1093/nar/5.3.1017; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; MASTERS JN, 1985, MOL CELL BIOL, V5, P493, DOI 10.1128/MCB.5.3.493; MORGAN AR, 1968, J MOL BIOL, V37, P63, DOI 10.1016/0022-2836(68)90073-9; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; ROBERTS SGE, 1994, NATURE, V371, P717, DOI 10.1038/371717a0; Xu ZL, 2003, GENE, V309, P145, DOI 10.1016/S0378-1119(03)00506-7	21	558	616	3	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2007	445	7128					666	670		10.1038/nature05519	http://dx.doi.org/10.1038/nature05519			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17237763				2022-12-01	WOS:000244039400048
J	Driscoll, R; Hudson, A; Jackson, SP				Driscoll, Robert; Hudson, Amanda; Jackson, Stephen P.			Yeast Rtt109 promotes genome stability by acetylating histone H3 on lysine 56	SCIENCE			English	Article							DNA-DAMAGE RESPONSE; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; S-PHASE; CHECKPOINT; REPAIR; INSTABILITY; INTEGRITY; NETWORK; HST3	Posttranslational modifications of the histone octamer play important roles in regulating responses to DNA damage. Here, we reveal that Saccharomyces cerevisiae Rtt109p promotes genome stability and resistance to DNA-damaging agents, and that it does this by functionally cooperating with the histone chaperone Asf1p to maintain normal chromatin structure. Furthermore, we show that, as for Asf1p, Rtt109p is required for histone H3 acetylation on lysine 56 (K56) in vivo. Moreover, we show that Rtt109p directly catalyzes this modification in vitro in a manner that is stimulated by Asf1p. These data establish Rtt109p as a member of a new class of histone acetyltransferases and show that its actions are critical for cell survival in the presence of DNA damage during S phase.	Univ Cambridge, Gurdon Inst, Wellcome Trust & Canc Res UK, Cambridge CB2 1QN, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England	Cancer Research UK; University of Cambridge; University of Cambridge	Jackson, SP (corresponding author), Univ Cambridge, Gurdon Inst, Wellcome Trust & Canc Res UK, Tennis Court Rd, Cambridge CB2 1QN, England.	s.jackson@gurdon.cam.ac.uk	Dry, Kate/I-2328-2014; Jackson, Stephen Philip/R-4548-2019	Jackson, Stephen Philip/0000-0001-9317-7937	Biotechnology and Biological Sciences Research Council [BBS/S/D/2004/12546] Funding Source: Medline; Cancer Research UK [A5290] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		AGUILERA A, 1989, GENETICS, V122, P503; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Dutnall RN, 1998, CELL, V94, P427, DOI 10.1016/S0092-8674(00)81584-6; Linger J, 2005, GENETICS, V171, P1513, DOI 10.1534/genetics.105.043000; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Ozdemir A, 2005, J BIOL CHEM, V280, P25949, DOI 10.1074/jbc.C500181200; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Prado F, 2004, EMBO REP, V5, P497, DOI 10.1038/sj.embor.7400128; Ramey CJ, 2004, MOL CELL BIOL, V24, P10313, DOI 10.1128/MCB.24.23.10313-10327.2004; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Scholes DT, 2001, GENETICS, V159, P1449; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120	19	342	347	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2007	315	5812					649	652		10.1126/science.1135862	http://dx.doi.org/10.1126/science.1135862			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272722	Green Accepted			2022-12-01	WOS:000243909400044
J	Tumpey, TM; Maines, TR; Van Hoeven, N; Glaser, L; Solorzano, A; Pappas, C; Cox, NJ; Swayne, DE; Palese, P; Katz, JM; Garcia-Sastre, A				Tumpey, Terrence M.; Maines, Taronna R.; Van Hoeven, Neal; Glaser, Laurel; Solorzano, Alicia; Pappas, Claudia; Cox, Nancy J.; Swayne, David E.; Palese, Peter; Katz, Jacqueline M.; Garcia-Sastre, Adolfo			A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission	SCIENCE			English	Article							RECEPTOR SPECIFICITY; PANDEMIC VIRUS; HUMAN AIRWAY; A VIRUSES; EVOLUTION; GENE; H2	The 1918 influenza pandemic was a catastrophic series of virus outbreaks that spread across the globe. Here, we show that only a modest change in the 1918 influenza hemagglutinin receptor binding site alters the transmissibility of this pandemic virus. Two amino acid mutations that cause a switch in receptor binding preference from the human alpha-2,6 to the avian alpha-2,3 sialic acid resulted in a virus incapable of respiratory droplet transmission between ferrets but that maintained its lethality and replication efficiency in the upper respiratory tract. Furthermore, poor transmission of a 1918 virus with dual alpha-2,6 and alpha-2,3 specificity suggests that a predominant human alpha-2,6 sialic acid binding preference is essential for optimal transmission of this pandemic virus. These findings confirm an essential role of hemagglutinin receptor specificity for the transmission of influenza viruses among mammals.	Ctr Dis Control & Prevent, Influenza Branch, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; USDA, SE Poultry Res Lab, Agr Res Lab, Athens, GA USA	Centers for Disease Control & Prevention - USA; Icahn School of Medicine at Mount Sinai; United States Department of Agriculture (USDA)	Tumpey, TM (corresponding author), Ctr Dis Control & Prevent, Influenza Branch, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Mailstop G-16,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	tft9@cdc.gov	Swayne, David/AAP-7166-2020	Garcia-Sastre, Adolfo/0000-0002-6551-1827; Palese, Peter/0000-0002-0337-5823; Solorzano, Alicia/0000-0003-0072-3463; Swayne, David/0000-0001-7472-1992	NIAID NIH HHS [U19 AI62623, P01 AI058113] Funding Source: Medline; PHS HHS [U54 AIO57158] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062623, P01AI058113] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; Bridges CB, 2002, J INFECT DIS, V185, P1005, DOI 10.1086/340044; Burnet FM, 1942, INFLUENZA SURVEY LAS; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Frost W.H., 1920, PUB HLTH REP, V35, P584, DOI DOI 10.2307/4575511; Gambaryan A, 2006, VIROLOGY, V344, P432, DOI 10.1016/j.virol.2005.08.035; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Katz JM, 1999, J INFECT DIS, V180, P1763, DOI 10.1086/315137; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Lamblin G, 2001, GLYCOCONJUGATE J, V18, P661, DOI 10.1023/A:1020867221861; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; PATTERSON KD, 1991, B HIST MED, V65, P4; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; Viboud C, 2006, VACCINE, V24, P6701, DOI 10.1016/j.vaccine.2006.05.067; WHO, EP PAND AL RESP EPR	25	449	505	4	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2007	315	5812					655	659		10.1126/science.1136212	http://dx.doi.org/10.1126/science.1136212			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272724				2022-12-01	WOS:000243909400046
J	Stern, E; Klemic, JF; Routenberg, DA; Wyrembak, PN; Turner-Evans, DB; Hamilton, AD; LaVan, DA; Fahmy, TM; Reed, MA				Stern, Eric; Klemic, James F.; Routenberg, David A.; Wyrembak, Pauline N.; Turner-Evans, Daniel B.; Hamilton, Andrew D.; LaVan, David A.; Fahmy, Tarek M.; Reed, Mark A.			Label-free immunodetection with CMOS-compatible semiconducting nanowires	NATURE			English	Article							ELECTRICAL DETECTION; SILICON NANOWIRES; NANOSENSORS; SENSORS; SURFACES; DEVICES; ARRAYS; DNA	Semiconducting nanowires have the potential to function as highly sensitive and selective sensors for the label-free detection of low concentrations of pathogenic microorganisms(1-10). Successful solution-phase nanowire sensing has been demonstrated for ions(3), small molecules(4), proteins(5,6), DNA(7) and viruses(8); however, 'bottom-up' nanowires ( or similarly configured carbon nanotubes(11)) used for these demonstrations require hybrid fabrication schemes(12,13), which result in severe integration issues that have hindered widespread application. Alternative 'top-down' fabrication methods of nanowire-like devices(9,10,14-17) produce disappointing performance because of process-induced material and device degradation. Here we report an approach that uses complementary metal oxide semiconductor (CMOS) field effect transistor compatible technology and hence demonstrate the specific label-free detection of below 100 femtomolar concentrations of antibodies as well as real-time monitoring of the cellular immune response. This approach eliminates the need for hybrid methods and enables system-scale integration of these sensors with signal processing and information systems. Additionally, the ability to monitor antibody binding and sense the cellular immune response in real time with readily available technology should facilitate widespread diagnostic applications.	Yale Univ, Dept Elect Engn, New Haven, CT 06511 USA; Yale Univ, Dept Biomed Engn, New Haven, CT 06511 USA; Yale Univ, Dept Mech Engn, New Haven, CT 06511 USA; Yale Univ, Dept Appl Phys, New Haven, CT 06511 USA; Yale Univ, Dept Chem, New Haven, CT 06511 USA	Yale University; Yale University; Yale University; Yale University; Yale University	Reed, MA (corresponding author), Yale Univ, Dept Elect Engn, POB 208284, New Haven, CT 06511 USA.	tarek.fahmy@yale.edu; mark.reed@yale.edu	LaVan, David/C-3943-2012; Turner-Evans, Daniel/J-4488-2016; Reed, Mark/A-9970-2011	LaVan, David/0000-0002-1952-0028; Turner-Evans, Daniel/0000-0002-8020-0170; Reed, Mark/0000-0001-6479-7256				Beeson C, 1996, J EXP MED, V184, P777, DOI 10.1084/jem.184.2.777; Bunimovich YL, 2004, LANGMUIR, V20, P10630, DOI 10.1021/la047913h; Chen RJ, 2004, J AM CHEM SOC, V126, P1563, DOI 10.1021/ja038702m; Cheng MMC, 2006, CURR OPIN CHEM BIOL, V10, P11, DOI 10.1016/j.cbpa.2006.01.006; Clement N, 2002, PHYSICA E, V13, P999, DOI 10.1016/S1386-9477(02)00288-6; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Elibol OH, 2003, APPL PHYS LETT, V83, P4613, DOI 10.1063/1.1630853; Englander O, 2005, NANO LETT, V5, P705, DOI 10.1021/nl050109a; Evoy S, 2004, MICROELECTRON ENG, V75, P31, DOI 10.1016/j.mee.2003.09.010; Hahm J, 2004, NANO LETT, V4, P51, DOI 10.1021/nl034853b; HERMANSON GT, 1996, BIOCONJUGATE TECHNIQ, pCH1; Huang Y, 2001, SCIENCE, V291, P630, DOI 10.1126/science.291.5504.630; ISRAELACHVILI JN, 1985, INTERMOLECULAR SURFA, pCH12; Laws GM, 2002, PHYS STATUS SOLIDI B, V233, P83, DOI 10.1002/1521-3951(200209)233:1<83::AID-PSSB83>3.0.CO;2-#; Li Z, 2004, NANO LETT, V4, P245, DOI 10.1021/nl034958e; Lim DV, 2005, CLIN MICROBIOL REV, V18, P583, DOI 10.1128/CMR.18.4.583-607.2005; Liu YX, 2003, IEEE ELECTR DEVICE L, V24, P484, DOI 10.1109/LED.2003.815004; Madou MJ, 2003, P IEEE, V91, P830, DOI 10.1109/JPROC.2003.813577; Patolsky F, 2004, P NATL ACAD SCI USA, V101, P14017, DOI 10.1073/pnas.0406159101; Saitoh M, 2003, IEEE T NANOTECHNOL, V2, P241, DOI 10.1109/TNANO.2003.820796; Sheehan PE, 2005, NANO LETT, V5, P803, DOI 10.1021/nl050298x; Strother T, 2000, NUCLEIC ACIDS RES, V28, P3535, DOI 10.1093/nar/28.18.3535; SUN SC, 1980, IEEE J SOLID-ST CIRC, V15, P562, DOI 10.1109/JSSC.1980.1051439; SZE SM, 1981, PHYSICS SEMICONDUCTO, P849; TABATA O, 1992, SENSOR ACTUAT A-PHYS, V34, P51, DOI 10.1016/0924-4247(92)80139-T; Tang T, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1881783; Trautmann A, 2005, NAT IMMUNOL, V6, P1213, DOI 10.1038/ni1205-1213; Wang DW, 2006, NANO LETT, V6, P1096, DOI 10.1021/nl052558g; Wang WU, 2005, P NATL ACAD SCI USA, V102, P3208, DOI 10.1073/pnas.0406368102; Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138	30	1111	1176	8	406	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2007	445	7127					519	522		10.1038/nature05498	http://dx.doi.org/10.1038/nature05498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17268465				2022-12-01	WOS:000243867300039
J	Psaty, BM; Weiss, NS				Psaty, Bruce M.; Weiss, Noel S.			NSAID trials and the choice of comparators - Questions of public health importance	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INHIBITORS; RISK		Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; Univ Washington, Dept Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; Grp Hlth, Ctr Hlth Studies, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Psaty, BM (corresponding author), Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA.							Cannon CP, 2006, LANCET, V368, P1771, DOI 10.1016/S0140-6736(06)69666-9; *COMM ASS US DRUG, IN PRESS FUT DRUG SA; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; McGettigan P, 2006, JAMA-J AM MED ASSOC, V296, P1633, DOI 10.1001/jama.296.13.jrv60011; Psaty BM, 2006, JAMA-J AM MED ASSOC, V295, P1704, DOI 10.1001/jama.295.14.1704	5	22	22	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 25	2007	356	4					328	330		10.1056/NEJMp068286	http://dx.doi.org/10.1056/NEJMp068286			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	128FT	17251528				2022-12-01	WOS:000243644300002
J	Sujeet, K; Shankar, S				Sujeet, Kumar; Shankar, Stuti			Prevertebral emphysema after a dental procedure	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Good Samaritan Hosp, Baltimore, MD 21239 USA		Sujeet, K (corresponding author), Good Samaritan Hosp, Baltimore, MD 21239 USA.	kumar.sujeet@medstar.net							0	13	13	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 11	2007	356	2					173	173		10.1056/NEJMicm053300	http://dx.doi.org/10.1056/NEJMicm053300			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	124NE	17215535				2022-12-01	WOS:000243373700010
J	Hu, K; Ji, L; Applegate, KT; Danuser, G; Waterman-Storer, CM				Hu, Ke; Ji, Lin; Applegate, Kathryn T.; Danuser, Gaudenz; Waterman-Storer, Clare M.			Differential transmission of actin motion within focal adhesions	SCIENCE			English	Article							EXTRACELLULAR-MATRIX; CELL-MIGRATION; STRESS FIBERS; ALPHA-ACTININ; PROTEIN; CYTOSKELETON; VINCULIN; TALIN; CONTRACTILITY; ASSOCIATION	Cell migration requires the transmission of motion generated in the actin cytoskeleton to the extracellular environment through a complex assembly of proteins in focal adhesions. We developed correlational fluorescent speckle microscopy to measure the coupling of focal-adhesion proteins to actin filaments. Different classes of focal-adhesion structural and regulatory molecules exhibited varying degrees of correlated motions with actin filaments, indicating hierarchical transmission of actin motion through focal adhesions. Interactions between vinculin, talin, and actin filaments appear to constitute a slippage interface between the cytoskeleton and integrins, generating a molecular clutch that is regulated during the morphodynamic transitions of cell migration.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Waterman-Storer, CM (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	gdanuser@scripps.edu; waterman@scripps.edu		Waterman, Clare/0000-0001-6142-6775; Danuser, Gaudenz/0000-0001-8583-2014	NIGMS NIH HHS [U54GM64346, GM67230] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM067230, U54GM064346, R01GM067230] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beckerle MC, 1997, BIOESSAYS, V19, P949, DOI 10.1002/bies.950191104; BURRIDGE K, 1984, NATURE, V308, P744, DOI 10.1038/308744a0; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Edlund M, 2001, CELL MOTIL CYTOSKEL, V48, P190, DOI 10.1002/1097-0169(200103)48:3<190::AID-CM1008>3.0.CO;2-C; Ezzell RM, 1997, EXP CELL RES, V231, P14, DOI 10.1006/excr.1996.3451; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; GEIGER B, 1979, CELL, V18, P193, DOI 10.1016/0092-8674(79)90368-4; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; Ji L, 2005, J MICROSC-OXFORD, V220, P150, DOI 10.1111/j.1365-2818.2005.01522.x; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LIN CH, 1995, NEURON, V14, P763, DOI 10.1016/0896-6273(95)90220-1; MARUYAMA K, 1965, J BIOCHEM-TOKYO, V58, P13, DOI 10.1093/oxfordjournals.jbchem.a128158; MUGURUMA M, 1990, BIOCHEM BIOPH RES CO, V171, P1217, DOI 10.1016/0006-291X(90)90815-5; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Schlaepfer DD, 1996, CELL STRUCT FUNCT, V21, P445, DOI 10.1247/csf.21.445; Tanaka T, 1996, FEBS LETT, V399, P53, DOI 10.1016/S0014-5793(96)01280-X; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; YAMADA KM, 1995, CURR OPIN CELL BIOL, V7, P681, DOI 10.1016/0955-0674(95)80110-3	26	389	395	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2007	315	5808					111	115		10.1126/science.1135085	http://dx.doi.org/10.1126/science.1135085			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17204653				2022-12-01	WOS:000243259100049
J	Sharp, D				Sharp, David			Fusion energy far away	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Sharp, D (corresponding author), Lancet, London NW1 7BY, England.							*EUR FUS DEV AGR, NUCL FUS BAS; GIRAUD JP, 2006, ITER REL IAEA FUS EN; *GREENP INT, 2005, NUCL FUS REACT PROJ; *ITER, 2001, ITER TECHN BAS 2001; *ITER, 2005, BEYOND ITER; Naranjo B, 2005, NATURE, V434, P1115, DOI 10.1038/nature03575; Sharp D, 2002, LANCET, V359, P908, DOI 10.1016/S0140-6736(02)08016-9	7	0	0	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN-FEB	2007	369	9558					259	260		10.1016/S0140-6736(07)60126-3	http://dx.doi.org/10.1016/S0140-6736(07)60126-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131ZR	17258652				2022-12-01	WOS:000243912000010
J	Yin, H; Slusky, JS; Berger, BW; Walters, RS; Vilaire, G; Litvinov, RI; Lear, JD; Caputo, GA; Bennett, JS; DeGrado, WF				Yin, Hang; Slusky, Joanna S.; Berger, Bryan W.; Walters, Robin S.; Vilaire, Gaston; Litvinov, Rustem I.; Lear, James D.; Caputo, Gregory A.; Bennett, Joel S.; DeGrado, William F.			Computational design of peptides that target transmembrane helices	SCIENCE			English	Article							MEMBRANE-PROTEINS; INTEGRIN ACTIVATION; ESCHERICHIA-COLI; DOMAIN; BINDING; RECEPTOR; MOTIFS; AFFINITY; STATE; HETERODIMERIZATION	A variety of methods exist for the design or selection of antibodies and other proteins that recognize the water-soluble regions of proteins; however, companion methods for targeting transmembrane (TM) regions are not available. Here, we describe a method for the computational design of peptides that target TM helices in a sequence-specific manner. To illustrate the method, peptides were designed that specifically recognize the TM helices of two closely related integrins (alpha(IIb)beta(3) and alpha(v)beta(3)) in micelles, bacterial membranes, and mammalian cells. These data show that sequence-specific recognition of helices in TM proteins can be achieved through optimization of the geometric complementarity of the target-host complex.	Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	DeGrado, WF (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	wdegrado@mail.med.upenn.edu	Berger, Bryan/D-7985-2014; Litvinov, Rustem/E-5291-2011; YIN, HANG/O-2097-2014	Berger, Bryan/0000-0002-6135-8677; Litvinov, Rustem/0000-0003-0643-1496; YIN, HANG/0000-0002-9762-4818; Caputo, Gregory/0000-0002-4510-2815; Slusky, Joanna/0000-0003-0842-6340	NCI NIH HHS [5T32 CA101968] Funding Source: Medline; NHLBI NIH HHS [HL54500, HL40387, P01 HL040387] Funding Source: Medline; NIGMS NIH HHS [GM54616, GM60610, 5T32 GM08275, T32 GM008275] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA101968] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL040387, P50HL054500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054616, R01GM054616, T32GM008275, R01GM060610] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adamian L, 2002, PROTEINS, V47, P209, DOI 10.1002/prot.10071; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989; Binz HK, 2005, CURR OPIN BIOTECH, V16, P459, DOI 10.1016/j.copbio.2005.06.005; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; DESJARLAIS JR, 1995, PROTEIN SCI, V4, P2006, DOI 10.1002/pro.5560041006; Doura AK, 2004, J MOL BIOL, V343, P1487, DOI 10.1016/j.jmb.2004.09.011; Ebie AZ, 2007, J MOL BIOL, V366, P517, DOI 10.1016/j.jmb.2006.11.035; Engelman DM, 2003, FEBS LETT, V555, P122, DOI 10.1016/S0014-5793(03)01106-2; FAIRMAN R, 1993, P NATL ACAD SCI USA, V90, P10429, DOI 10.1073/pnas.90.22.10429; Freeman-Cook LL, 2004, J MOL BIOL, V338, P907, DOI 10.1016/j.jmb.2004.03.044; Gerber D, 2005, FASEB J, V19, P1190, DOI 10.1096/fj.04-3498fje; Gerber D, 2004, J BIOL CHEM, V279, P21177, DOI 10.1074/jbc.M400847200; Gerber D, 2004, J MOL BIOL, V339, P243, DOI 10.1016/j.jmb.2004.03.004; Ghirlanda G, 1998, J MOL BIOL, V281, P379, DOI 10.1006/jmbi.1998.1912; Gottschalk KE, 2005, STRUCTURE, V13, P703, DOI 10.1016/j.str.2005.02.014; Harris JM, 2001, CLIN PHARMACOKINET, V40, P539, DOI 10.2165/00003088-200140070-00005; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kim S, 2005, P NATL ACAD SCI USA, V102, P14278, DOI 10.1073/pnas.0501234102; Kortemme T, 2004, CURR OPIN CHEM BIOL, V8, P91, DOI 10.1016/j.cbpa.2003.12.008; Langosch D, 1996, J MOL BIOL, V263, P525, DOI 10.1006/jmbi.1996.0595; Li W, 2005, P NATL ACAD SCI USA, V102, P1424, DOI 10.1073/pnas.0409334102; Litvinov RI, 2003, J BIOL CHEM, V278, P51285, DOI 10.1074/jbc.M304581200; Litvinov RI, 2002, P NATL ACAD SCI USA, V99, P7426, DOI 10.1073/pnas.112194999; Luo BH, 2005, P NATL ACAD SCI USA, V102, P3679, DOI 10.1073/pnas.0409440102; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Manolios N, 1997, NAT MED, V3, P84, DOI 10.1038/nm0197-84; Partridge AW, 2005, J BIOL CHEM, V280, P7294, DOI 10.1074/jbc.M412701200; Partridge AW, 2003, J BIOL CHEM, V278, P22056, DOI 10.1074/jbc.M210685200; Reina J, 2002, NAT STRUCT BIOL, V9, P621, DOI 10.1038/nsb815; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Senes A, 2001, P NATL ACAD SCI USA, V98, P9056, DOI 10.1073/pnas.161280798; Senes A, 2007, J MOL BIOL, V366, P436, DOI 10.1016/j.jmb.2006.09.020; Shifman JM, 2003, P NATL ACAD SCI USA, V100, P13274, DOI 10.1073/pnas.2234277100; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Winter G, 1998, FEBS LETT, V430, P92, DOI 10.1016/S0014-5793(98)00628-0; Yin H, 2006, J BIOL CHEM, V281, P36732, DOI 10.1074/jbc.M605877200	43	230	236	2	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2007	315	5820					1817	1822		10.1126/science.1136782	http://dx.doi.org/10.1126/science.1136782			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395823				2022-12-01	WOS:000245280100035
J	Modlin, JF				Modlin, John F.			Focus on research: Enterovirus deja vu	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Dartmouth Coll Sch Med, Dept Pediat, Lebanon, NH 03766 USA	Dartmouth College	Modlin, JF (corresponding author), Dartmouth Coll Sch Med, Dept Pediat, Lebanon, NH 03766 USA.							Paul, 1971, HIST POLIOMYELITIS; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304	2	23	25	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2007	356	12					1204	1205		10.1056/NEJMp078016	http://dx.doi.org/10.1056/NEJMp078016			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148UP	17377157				2022-12-01	WOS:000245101900004
J	Bhattacharya, T; Daniels, M; Heckerman, D; Foley, B; Frahm, N; Kadie, C; Carlson, J; Yusim, K; McMahon, B; Gaschen, B; Mallal, S; Mullins, JI; Nickle, DC; Herbeck, J; Rousseau, C; Learn, GH; Miura, T; Brander, C; Walker, B; Korber, B				Bhattacharya, Tanmoy; Daniels, Marcus; Heckerman, David; Foley, Brian; Frahm, Nicole; Kadie, Carl; Carlson, Jonathan; Yusim, Karina; McMahon, Ben; Gaschen, Brian; Mallal, Simon; Mullins, James I.; Nickle, David C.; Herbeck, Joshua; Rousseau, Christine; Learn, Gerald H.; Miura, Toshiyuki; Brander, Christian; Walker, Bruce; Korber, Bette			Founder effects in the assessment of HIV polymorphisms and HLA allele associations	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ESCAPE; RESPONSES; CTL; EPITOPES; FITNESS; GAG; MUTATIONS; DIVERSITY; VARIANTS	Escape from T cell-mediated immune responses affects the ongoing evolution of rapidly evolving viruses such as HIV. By applying statistical approaches that account for phylogenetic relationships among viral sequences, we show that viral lineage effects rather than immune escape often explain apparent human leukocyte antigen (HLA)-mediated immune-escape mutations defined by older analysis methods. Phylogenetically informed methods identified immune-susceptible locations with greatly improved accuracy, and the associations we identified with these methods were experimentally validated. This approach has practical implications for understanding the impact of host immunity on pathogen evolution and for defining relevant variants for inclusion in vaccine antigens.	Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Santa Fe Inst, Santa Fe, NM 87501 USA; Microsoft Corp, Res, Machine Learning & Appl Stat Grp, Redmond, WA 98052 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Partners AIDS Res Ctr, Boston, MA 02129 USA; Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, Perth, WA, Australia; Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; The Santa Fe Institute; Microsoft; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Washington; University of Washington Seattle; Royal Perth Hospital; University of Western Australia; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	Korber, B (corresponding author), Los Alamos Natl Lab, POB 1663, Los Alamos, NM 87545 USA.	btk@lanl.gov	Nickle, David/ABF-2727-2020; Learn, Jerry/E-3356-2012; Foley, Brian T/N-4527-2018; Mallal, Simon Alexander/HDM-9561-2022; Learn, Gerald H/B-6934-2011; Bhattacharya, Tanmoy/J-8956-2013	Foley, Brian T/0000-0002-1086-0296; Mallal, Simon Alexander/0000-0002-7036-1309; Learn, Gerald H/0000-0003-0434-7733; Bhattacharya, Tanmoy/0000-0002-1060-652X; Mcmahon, Benjamin/0000-0002-8226-1276; Korber, Bette/0000-0002-2026-5757; Brander, Christian/0000-0002-0548-5778; Walker, Bruce/0000-0002-8506-6740	NIAID NIH HHS [AI57005, AI27757] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, P01AI057005] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Altfeld M, 2001, J IMMUNOL, V167, P2743, DOI 10.4049/jimmunol.167.5.2743; Ammaranond P, 2005, AIDS RES HUM RETROV, V21, P395, DOI 10.1089/aid.2005.21.395; Corbet S, 2003, J GEN VIROL, V84, P2409, DOI 10.1099/vir.0.19152-0; De Groot AS, 2003, VACCINE, V21, P4486, DOI 10.1016/S0264-410X(03)00390-6; FRAHM N, 2005, HIV MOL IMMUNOLOGY, P3; Friedrich TC, 2004, J VIROL, V78, P2581, DOI 10.1128/JVI.78.5.2581-2585.2004; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; MARSH S, 2000, HLA FACTSBOOK, P99; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Mehra N, 2001, TISSUE ANTIGENS, V57, P502, DOI 10.1034/j.1399-0039.2001.057006502.x; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Peyerl FW, 2004, J VIROL, V78, P13901, DOI 10.1128/JVI.78.24.13901-13910.2004; Rodriguez William R, 2004, J Transl Med, V2, P15, DOI 10.1186/1479-5876-2-15; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Wells RS, 1997, IMMUNOGENETICS, V46, P173, DOI 10.1007/s002510050259; Yu XG, 2002, AIDS, V16, P321, DOI 10.1097/00002030-200202150-00002; Yusim K, 2002, J VIROL, V76, P8757, DOI 10.1128/JVI.76.17.8757-8768.2002	20	204	214	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1583	1586		10.1126/science.1131528	http://dx.doi.org/10.1126/science.1131528			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363674				2022-12-01	WOS:000244934800055
J	Weir, JT; Schluter, D				Weir, Jason T.; Schluter, Dolph			The latitudinal gradient in recent speciation and extinction rates of birds and mammals	SCIENCE			English	Article							NEW-WORLD BIRDS; DIVERSITY GRADIENT; DIVERSIFICATION; EVOLUTION; BIODIVERSITY; PATTERNS	Although the tropics harbor greater numbers of species than do temperate zones, it is not known whether the rates of speciation and extinction also follow a latitudinal gradient. By sampling birds and mammals, we found that the distribution of the evolutionary ages of sister species-pairs of species in which each is the other's closest relative-adheres to a latitudinal gradient. The time to divergence for sister species is shorter at high latitudes and longer in the tropics. Birth-death models fitting these data estimate that the highest recent speciation and extinction rates occur at high latitudes and decline toward the tropics. These results conflict with the prevailing view that links high tropical diversity to elevated tropical speciation rates. Instead, our findings suggest that faster turnover at high latitudes contributes to the latitudinal diversity gradient.	Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia	Weir, JT (corresponding author), Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada.	weir@zoology.ubc.ca	Weir, Jason/A-2920-2009	Schluter, Dolph/0000-0003-1683-7836				Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P457, DOI 10.1098/rspb.1998.0317; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; Bohm M, 2005, BIOL J LINN SOC, V85, P235, DOI 10.1111/j.1095-8312.2005.00488.x; Buzas MA, 2002, P NATL ACAD SCI USA, V99, P7841, DOI 10.1073/pnas.122241499; Cardillo M, 2005, ECOLOGY, V86, P2278, DOI 10.1890/05-0112; Cardillo M, 1999, P ROY SOC B-BIOL SCI, V266, P1221, DOI 10.1098/rspb.1999.0766; Crame JA, 2002, PALEOBIOLOGY, V28, P184; FISCHER AG, 1960, EVOLUTION, V14, P64, DOI 10.2307/2405923; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Hawkins BA, 2006, J BIOGEOGR, V33, P770, DOI 10.1111/j.1365-2699.2006.01452.x; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; HONEYCUTT RL, 1995, J MOL EVOL, V40, P260, DOI 10.1007/BF00163231; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; KENDALL DG, 1948, ANN MATH STAT, V19, P1, DOI 10.1214/aoms/1177730285; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Ricklefs RE, 2006, ECOLOGY, V87, P2468, DOI 10.1890/0012-9658(2006)87[2468:GVITDR]2.0.CO;2; Ricklefs Robert E., 2005, P16; Stebbins G.L., 1974, FLOWERING PLANTS EVO; Wallace AR, 1878, TROPICAL NATURE OTHE; Weir JT, 2006, EVOLUTION, V60, P842; Weir JT, 2004, P ROY SOC B-BIOL SCI, V271, P1881, DOI 10.1098/rspb.2004.2803; Yule G. V., 1924, Philosophical Transactions of the Royal Society London B, V213, P21	23	395	408	2	233	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2007	315	5818					1574	1576		10.1126/science.1135590	http://dx.doi.org/10.1126/science.1135590			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363673				2022-12-01	WOS:000244934800052
J	Klose, RJ; Yan, Q; Tothova, Z; Yamane, K; Erdjument-Bromage, H; Tempst, P; Gilliland, DG; Zhang, Y; Kaelin, WG				Klose, Robert J.; Yan, Qin; Tothova, Zuzana; Yamane, Kenichi; Erdjument-Bromage, Hediye; Tempst, Paul; Gilliland, D. Gary; Zhang, Yi; Kaelin, William G., Jr.			The retinoblastoma binding protein RBP2 is an H3K4 demethylase	CELL			English	Article							HISTONE H3; MYELOID PROGENITOR; OXIDATIVE DEMETHYLATION; LYSINE-4 METHYLATION; STRUCTURAL BASIS; MOLECULAR-BASIS; JARID1C GENE; PHD FINGER; FAMILY; DOMAIN	Changes in histone methylation status regulate chromatin structure and DNA-dependent processes such as transcription. Recent studies indicate that, analogous to other histone modifications, histone methylation is reversible. Retinoblastoma binding protein 2 (RBP2), a nuclear protein implicated in the regulation of transcription and differentiation by the retinoblastoma tumor suppressor protein, contains a JmjC domain recently defined as a histone demethylase signature motif. Here we report that RBP2 is a demethylase that specifically catalyzes demethylation on H3K4, whose methylation is normally associated with transcriptionally active genes. RBP2-/- mouse cells displayed enhanced transcription of certain cytokine genes, which, in the case of SDF1, was associated with increased H3K4 trimethylation. Furthermore, RBP2 specifically demethylated H3K4 in biochemical and cell-based assays. These studies provide mechanistic insights into transcriptional regulation by RBP2 and provide the first example of a mammalian enzyme capable of erasing trimethylated H3K4.	Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biochem & Biophys, Linenberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Hematol,Dept Med, Boston, MA 02115 USA; Mem Sloan Kettering Canc Ctr, Mol Biol Program, New York, NY 10021 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Memorial Sloan Kettering Cancer Center	Zhang, Y (corresponding author), Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu; william_kaelin@dfci.harvard.edu	Hu, Ruogu/B-2203-2008; Yan, Qin/E-8893-2012	Yan, Qin/0000-0003-4077-453X; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Zhang, Yi/0000-0002-2789-0811; Tempst, Paul/0000-0002-6680-3987	NATIONAL CANCER INSTITUTE [R01CA076120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068804] Funding Source: NIH RePORTER; NCI NIH HHS [CA 076120] Funding Source: Medline; NIGMS NIH HHS [GM 68804] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Broxmeyer HE, 2003, J LEUKOCYTE BIOL, V73, P630, DOI 10.1189/jlb.1002495; Broxmeyer HE, 2003, J IMMUNOL, V170, P421, DOI 10.4049/jimmunol.170.1.421; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Chan SW, 2001, J BIOL CHEM, V276, P28402, DOI 10.1074/jbc.M100313200; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; FATTAEY AR, 1993, ONCOGENE, V8, P3149; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Gildea JJ, 2000, GENETICS, V156, P645; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; KIM YW, 1994, MOL CELL BIOL, V14, P7256, DOI 10.1128/MCB.14.11.7256; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kortschak RD, 2000, TRENDS BIOCHEM SCI, V25, P294, DOI 10.1016/S0968-0004(00)01597-8; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Lu PJ, 1999, J BIOL CHEM, V274, P15633, DOI 10.1074/jbc.274.22.15633; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Osoegawa K, 2000, GENOME RES, V10, P116; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; QUARTIN RS, 1994, J VIROL, V68, P1334, DOI 10.1128/JVI.68.3.1334-1341.1994; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Santos C, 2006, EUR J HUM GENET, V14, P583, DOI 10.1038/sj.ejhg.5201608; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Tan K, 2003, J BIOL CHEM, V278, P20507, DOI 10.1074/jbc.M301994200; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tzschach A, 2006, HUM MUTAT, V27, P389, DOI 10.1002/humu.9420; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wilsker D, 2005, GENOMICS, V86, P242, DOI 10.1016/j.ygeno.2005.03.013; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yang MJ, 2006, MOL CELL, V23, P377, DOI 10.1016/j.molcel.2006.07.012	60	333	346	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2007	128	5					889	900		10.1016/j.cell.2007.02.013	http://dx.doi.org/10.1016/j.cell.2007.02.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17320163	Bronze			2022-12-01	WOS:000245073400014
J	Shann, F				Shann, Frank			Suckling and sugar reduce pain in babies	LANCET			English	Editorial Material							ORALLY-ADMINISTERED GLUCOSE; RANDOMIZED CONTROLLED-TRIAL; SUCROSE ANALGESIA; NEONATAL PAIN; INFANTS; NEWBORNS; YOUNGER; RELIEF; AGE		Royal Childrens Hosp, Intens Care Unit, Parkville, Vic 3052, Australia	Royal Children's Hospital Melbourne	Shann, F (corresponding author), Royal Childrens Hosp, Intens Care Unit, Flemington Rd, Parkville, Vic 3052, Australia.	frank.shann@rch.org.au	Shann, Frank/C-9510-2011					ANAND KJS, 1992, NEW ENGL J MED, V326, P1, DOI 10.1056/NEJM199201023260101; ANAND KJS, 1987, NEW ENGL J MED, V317, P1321, DOI 10.1056/NEJM198711193172105; Bilgen H, 2001, J PAIN, V2, P301, DOI 10.1054/jpai.2001.23140; Bucher HU, 2000, EARLY HUM DEV, V59, P51, DOI 10.1016/S0378-3782(00)00085-2; Carbajal R, 1999, BRIT MED J, V319, P1393, DOI 10.1136/bmj.319.7222.1393; Carbajal R, 2003, BMJ-BRIT MED J, V326, P13, DOI 10.1136/bmj.326.7379.13; Eriksson M, 2004, ACTA PAEDIATR, V93, P246, DOI 10.1080/08035250310008041; Gradin M, 2005, PEDIATRICS, V115, P1004, DOI 10.1542/peds.2004-1189; Gradin M, 2004, EARLY HUM DEV, V77, P57, DOI 10.1016/j.earlhumdev.2004.01.003; Guala A, 2001, Minerva Pediatr, V53, P271; Isik U, 2000, J PAIN, V1, P275, DOI 10.1054/jpai.2000.8919; Johnston CC, 2002, PEDIATRICS, V110, P523, DOI 10.1542/peds.110.3.523; Lewindon PJ, 1998, ARCH DIS CHILD, V78, P453, DOI 10.1136/adc.78.5.453; Lidow MS, 2002, PAIN, V99, P377, DOI 10.1016/S0304-3959(02)00258-0; Rogers AJ, 2006, ACAD EMERG MED, V13, P617, DOI 10.1197/j.aem.2006.01.026; Shah PS, 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004950.PUB2; STEVENS B, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001069.P1B2; WILLIS DM, 1977, PEDIATRICS, V60, P535	18	9	9	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 3	2007	369	9563					721	723		10.1016/S0140-6736(07)60335-3	http://dx.doi.org/10.1016/S0140-6736(07)60335-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	143MP	17336631				2022-12-01	WOS:000244726700007
J	Warkentin, TE				Warkentin, Theodore E.			Focus on research: Drug-induced immune-mediated thrombocytopenia - from purpura to thrombosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada	McMaster University	Warkentin, TE (corresponding author), McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada.							ACKROYD JF, 1949, CLIN SCI, V7, P249; Aster RH, 2006, J THROMB HAEMOST, V4, P678, DOI 10.1111/j.1538-7836.2006.01829.x; RHODES GR, 1973, SURG GYNECOL OBSTET, V136, P409; Tinmouth AT, 2006, TRANSFUS MED REV, V20, P294, DOI 10.1016/j.tmrv.2006.05.008; WARKENTIN TE, 2005, HEMATOLOGY BASIC PRI, P2305	5	67	71	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2007	356	9					891	893		10.1056/NEJMp068309	http://dx.doi.org/10.1056/NEJMp068309			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	140HV	17329695				2022-12-01	WOS:000244496400003
J	Levi, Z; Rozen, P; Hazazi, R; Vilkin, A; Waked, A; Maoz, E; Birkenfeld, S; Leshno, M; Niv, Y				Levi, Zohar; Rozen, Paul; Hazazi, Rachel; Vilkin, Alex; Waked, Amal; Maoz, Eran; Birkenfeld, Shlomo; Leshno, Moshe; Niv, Yaron			A quantitative immunochemical fecal occult blood test for colorectal neoplasia	ANNALS OF INTERNAL MEDICINE			English	Article							PERFORMANCE-CHARACTERISTICS; CHINESE POPULATION; CANCER; COLONOSCOPY; QUANTIFICATION; ADENOMAS; RISK	Background: Guaiac-based fecal occult blood tests (FOBTs) for colorectal cancer screening are not specific for human hemoglobin and have low sensitivity. Automated-development, immunochemical FOBT is quality-controlled, is specific for human hemoglobin, and does not require diet restriction. Objectives: To measure the sensitivity and specificity of quantitative immunochernical fecal hemoglobin measurements for detection of cancer and advanced adenoma in patients undergoing colonoscopy, to determine fecal hemoglobin thresholds that give the highest posttest probability for neoplasia, and to determine the number of immunochemical FOBTs needed. Design: Prospective, cross-sectional study. Setting: Ambulatory endoscopy services of the main health medical organization in Tel Aviv, Israel. Participants: 1000 consecutive ambulatory patients-some asymptornatic but at increased risk for colorectal neoplasia and some symptomatic-who were undergoing elective colonoscopy and volunteered to prepare immunochemical FOBTs. Intervention: The hemoglobin content of 3 bowel movements was measured, and the highest value was compared with colonoscopy findings. Measurements: Sensitivity, specificity, predictive values, likelihood ratios, and 95% Cls of fecal hemoglobin measurements for clinically significant neoplasia, their relationship to the amount of fecal hemoglobin measured, and the number of immunochemical FOBTs performed. Results: Colonoscopy identified clinically significant neoplasia in 91 patients (cancer in 17 patients and advanced adenomas in 74 patients). Using 3 immunochemical FOBTs and a hemoglobin threshold of 75 ng/mL of buffer, sensitivity and specificity were 94.1% (95% Cl, 82.9% to 100.0%) and 87.5% (Cl, 85.4% to 89.6%), respectively, for cancer and 67% (Cl, 57.4% to 76.7%) and 91.4% (Cl, 89.6% to 93.2%), respectively, for any clinically significant neoplasia. Limitations: The fecal sampling method is standardized, but the sample size depends on fecal consistency. Some patients were tested while discontinuing aspirin and anticoagulant therapies. Study patients were at increased risk, and results might not apply to average-risk populations. Conclusions: Quantitative immunochemical FOBT has good sensitivity and specificity for detection of clinically significant neoplasia. Test performance in screening average-risk populations is not known.	Beilinson Med Ctr, Dept Gastroenterol, Rabin Med Ctr, IL-49100 Petah Tiqwa, Israel; Clalit Hlth Serv, Tel Aviv, Israel; Clalit Hlth Serv, Bat Yam, Israel; Tel Aviv Univ, Sch Med, IL-69978 Tel Aviv, Israel	Rabin Medical Center; Clalit Health Services; Clalit Health Services; Tel Aviv University	Rozen, P (corresponding author), Beilinson Med Ctr, Dept Gastroenterol, Rabin Med Ctr, 39 Jabotinsky St, IL-49100 Petah Tiqwa, Israel.	paulro@clalit.org.il		Levi, Zohar/0000-0003-2456-8891				Allison JE, 1996, NEW ENGL J MED, V334, P155, DOI 10.1056/NEJM199601183340304; Bampton PA, 2005, GUT, V54, P803, DOI 10.1136/gut.2004.043786; Butterly LF, 2006, CLIN GASTROENTEROL H, V4, P343, DOI 10.1016/j.cgh.2005.12.021; Castiglione G, 2000, J MED SCREEN, V7, P35, DOI 10.1136/jms.7.1.35; Castiglione G, 2002, J MED SCREEN, V9, P99, DOI 10.1136/jms.9.3.99; Collins JF, 2005, ANN INTERN MED, V142, P81, DOI 10.7326/0003-4819-142-2-200501180-00006; Crotta S, 2004, EUR J GASTROEN HEPAT, V16, P33, DOI 10.1097/00042737-200401000-00006; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Fattah ASMA, 1998, HEPATO-GASTROENTEROL, V45, P712; Fenocchi E, 2006, EUR J CANCER PREV, V15, P384, DOI 10.1097/00008469-200610000-00002; Haug U, 2005, CANCER EPIDEM BIOMAR, V14, P422, DOI 10.1158/1055-9965.EPI-04-0411; Kunii Y, 2004, DIGEST DIS SCI, V49, P1899, DOI 10.1007/s10620-004-9590-3; Launoy GD, 2005, INT J CANCER, V115, P493, DOI 10.1002/ijc.20921; Levi Z, 2006, ALIMENT PHARM THER, V24, P1475, DOI 10.1111/j.1365-2036.2006.03152.x; Levi Z, 2006, ALIMENT PHARM THER, V23, P1359, DOI 10.1111/j.1365-2036.2006.02898.x; Lieberman DA, 2005, GASTROINTEST ENDOSC, V62, P875, DOI 10.1016/j.gie.2005.06.037; McCarthy DM, 2005, CLIN GASTROENTEROL H, V3, P1071, DOI 10.1016/S1542-3565(05)00851-7; Morikawa T, 2005, GASTROENTEROLOGY, V129, P422, DOI 10.1053/j.gastro.2005.05.056; Nakama H, 2000, EUR J CANCER, V36, P647, DOI 10.1016/S0959-8049(00)00020-4; Nakama H, 2001, EUR J CANCER, V37, P398, DOI 10.1016/S0959-8049(00)00387-7; Nakama H, 1998, HEPATO-GASTROENTEROL, V45, P1579; Nakama H, 1999, HEPATO-GASTROENTEROL, V46, P228; NIV Y, 1990, J CLIN GASTROENTEROL, V12, P393, DOI 10.1097/00004836-199008000-00007; PAUKER SG, 1980, NEW ENGL J MED, V302, P1109, DOI 10.1056/NEJM198005153022003; Pickhardt PJ, 2004, ANN INTERN MED, V141, P352, DOI 10.7326/0003-4819-141-5-200409070-00009; Robertson DJ, 2005, GASTROENTEROLOGY, V129, P34, DOI 10.1053/j.gastro.2005.05.012; Rozen P, 2006, MED SCI MONITOR, V12, pMT27; Rozen P, 1997, DIGEST DIS SCI, V42, P2064, DOI 10.1023/A:1018866400973; Rozen P, 2000, CANCER-AM CANCER SOC, V89, P46; Saito H, 2000, ONCOL REP, V7, P815; Selinger RRE, 2003, AM J MED, V114, P64, DOI 10.1016/S0002-9343(02)01350-5; SOX HC, 1988, MED DECIS MAKING, P142; Vilkin A, 2005, AM J GASTROENTEROL, V100, P2519, DOI 10.1111/j.1572-0241.2005.00231.x; Wong BCY, 2003, ALIMENT PHARM THER, V18, P941, DOI 10.1046/j.1365-2036.2003.01783.x; Wong WM, 2003, CANCER-AM CANCER SOC, V97, P2420, DOI 10.1002/cncr.11369; Young GP, 2002, AM J GASTROENTEROL, V97, P2499, DOI 10.1111/j.1572-0241.2002.06046.x; YOUNG GP, 2004, PRACT GASTROENTEROL, V18, P46; Young GP, 2005, COLORECTAL CANC CLIN, P97	38	254	265	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2007	146	4					244	255		10.7326/0003-4819-146-4-200702200-00003	http://dx.doi.org/10.7326/0003-4819-146-4-200702200-00003			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137CS	17310048				2022-12-01	WOS:000244271000002
J	Galbraith, CG; Yamada, KM; Galbraith, JA				Galbraith, Catherine G.; Yamada, Kenneth M.; Galbraith, James A.			Polymerizing actin fibers position integrins primed to probe for adhesion sites	SCIENCE			English	Article							CELL-MIGRATION; GROWTH CONES; MOTILITY; CYTOSKELETON; LAMELLIPODIA; FIBROBLASTS; LINKAGES; PROTEINS; LOCOMOTION; MOVEMENTS	Migrating cells extend protrusions, probing the surrounding matrix in search of permissive sites to form adhesions. We found that actin fibers polymerizing along the leading edge directed local protrusions and drove synchronous sideways movement of beta(1) integrin adhesion receptors. These movements lead to the clustering and positioning of conformationally activated, but unligated, beta(1) integrins along the leading edge of fibroblast lamellae and growth cone filopodia. Thus, rapid actin-based movement of primed integrins along the leading edge suggests a "sticky fingers" mechanism to probe for new adhesion sites and to direct migration.	Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA; Natl Inst Neurol Disorders & Stroke, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Yamada, KM (corresponding author), Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA.	kyamada@dir.nidcr.nih.gov		Yamada, Kenneth/0000-0003-1512-6805	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002551, Z01NS002551] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABERCROMBIE M, 1970, EXP CELL RES, V62, P389, DOI 10.1016/0014-4827(70)90570-7; ABERCROMBIE M, 1970, EXP CELL RES, V59, P393, DOI 10.1016/0014-4827(70)90646-4; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Danuser G, 2000, BIOPHYS J, V79, P191, DOI 10.1016/S0006-3495(00)76283-7; DEPASQUALE JA, 1991, J CELL BIOL, V113, P1351, DOI 10.1083/jcb.113.6.1351; Felsenfeld DP, 1999, NAT CELL BIOL, V1, P200, DOI 10.1038/12021; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; Kiosses WB, 2001, NAT CELL BIOL, V3, P316, DOI 10.1038/35060120; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Nishizaka T, 2000, P NATL ACAD SCI USA, V97, P692, DOI 10.1073/pnas.97.2.692; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Suter DM, 2001, J CELL BIOL, V155, P427, DOI 10.1083/jcb.200107063; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; THERIOT JA, 1992, NATURE, V357, P257, DOI 10.1038/357257a0; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470	26	210	216	3	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2007	315	5814					992	995		10.1126/science.1137904	http://dx.doi.org/10.1126/science.1137904			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303755	Green Submitted			2022-12-01	WOS:000244229800043
J	Giannone, G; Dubin-Thaler, BJ; Rossier, O; Cai, YF; Chaga, O; Jiang, GY; Beaver, W; Dobereiner, HG; Freund, Y; Borisy, G; Sheetz, MP				Giannone, Gregory; Dubin-Thaler, Benjamin J.; Rossier, Olivier; Cai, Yunfei; Chaga, Oleg; Jiang, Guoying; Beaver, William; Dobereiner, Hans-Gunther; Freund, Yoav; Borisy, Gary; Sheetz, Michael P.			Lamellipodial actin mechanically links myosin activity with adhesion-site formation	CELL			English	Article							LEADING-EDGE; CYTOSKELETON; TURNOVER; DYNAMICS; FORCE; PROTRUSION; CONTRACTIONS; FIBRONECTIN; RIGIDITY; COMPLEX	Cell motility proceeds by cycles of edge protrusion, adhesion, and retraction. Whether these functions are coordinated by biochemical or biomechanical processes is unknown. We find that myosin II pulls the rear of the lamellipodial actin network, causing upward bending, edge retraction, and initiation of new adhesion sites. The network then separates from the edge and condenses over the myosin. Protrusion resumes as lamellipodial actin regenerates from the front and extends rearward until it reaches newly assembled myosin, initiating the next cycle. Upward bending, observed by evanescence and electron microscopy, results in ruffle formation when adhesion strength is low. Correlative fluorescence and electron microscopy shows that the regenerating lamellipodium forms a cohesive, separable layer of actin above the lamellum. Thus, actin polymerization periodically builds a mechanical link, the lamellipodium, connecting myosin motors with the initiation of adhesion sites, suggesting that the major functions driving motility are coordinated by a biomechanical process.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Univ Bordeaux 2, CNRS, UMR 5091, F-33077 Bordeaux, France; Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; Columbia Univ, Dept Biol Sci, Sherman Fairchild Ctr, New York, NY 10027 USA	Columbia University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Northwestern University; University of California System; University of California San Diego; Columbia University	Sheetz, MP (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ms2001@columbia.edu	Beaver, William/A-1124-2009; Döbereiner, Hans-Günther/F-7302-2012; Rossier, Olivier M/I-6569-2013	Döbereiner, Hans-Günther/0000-0003-1691-634X; Rossier, Olivier M/0000-0002-6932-931X; Borisy, Gary/0000-0002-0266-8018; freund, yoav/0000-0002-3850-6184; Giannone, Gregory/0000-0002-0932-1690	NEI NIH HHS [PN1 EY016586] Funding Source: Medline; NATIONAL EYE INSTITUTE [PN1EY016586] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abraham VC, 1999, BIOPHYS J, V77, P1721, DOI 10.1016/S0006-3495(99)77018-9; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Bohnet S, 2006, BIOPHYS J, V90, P1810, DOI 10.1529/biophysj.105.064600; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Cameron LA, 2000, NAT REV MOL CELL BIO, V1, P110, DOI 10.1038/35040061; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Dobereiner HG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.038102; Dubin-Thaler BJ, 2004, BIOPHYS J, V86, P1794, DOI 10.1016/S0006-3495(04)74246-0; Dulyaninova NG, 2004, J CELL SCI, V117, P1481, DOI 10.1242/jcs.00993; FELDER S, 1990, J CELL BIOL, V111, P2513, DOI 10.1083/jcb.111.6.2513; Fradelizi J, 2001, NAT CELL BIOL, V3, P699, DOI 10.1038/35087009; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Gov NS, 2006, BIOPHYS J, V90, P454, DOI 10.1529/biophysj.105.062224; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Henson JH, 1999, MOL BIOL CELL, V10, P4075, DOI 10.1091/mbc.10.12.4075; Jiang GY, 2006, BIOPHYS J, V90, P1804, DOI 10.1529/biophysj.105.072462; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Marcy Y, 2004, P NATL ACAD SCI USA, V101, P5992, DOI 10.1073/pnas.0307704101; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mogilner A, 2006, CURR OPIN CELL BIOL, V18, P32, DOI 10.1016/j.ceb.2005.11.001; Nishizaka T, 2000, P NATL ACAD SCI USA, V97, P692, DOI 10.1073/pnas.97.2.692; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2005, BIOPHYS J, V89, P3456, DOI 10.1529/biophysj.104.058701; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Rottner K, 1999, NAT CELL BIOL, V1, P321, DOI 10.1038/13040; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Svitkina TM, 1998, METHOD ENZYMOL, V298, P570, DOI 10.1016/S0076-6879(98)98045-4; Tamada M, 2007, J CELL BIOL, V176, P27, DOI 10.1083/jcb.200609116; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Vallotton P, 2004, P NATL ACAD SCI USA, V101, P9660, DOI 10.1073/pnas.0300552101; Verkhovsky AB, 1999, BIOCHEM SOC SYMP, V65, P207; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Wolgemuth CW, 2005, BIOPHYS J, V89, P1643, DOI 10.1529/biophysj.105.066720; Yamazaki D, 2005, GENES CELLS, V10, P381, DOI 10.1111/j.1365-2443.2005.00845.x; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zhang XF, 2003, NEURON, V40, P931, DOI 10.1016/S0896-6273(03)00754-2	45	381	384	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2007	128	3					561	575		10.1016/j.cell.2006.12.039	http://dx.doi.org/10.1016/j.cell.2006.12.039			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289574	Bronze, Green Accepted			2022-12-01	WOS:000244842700021
J	Sprangers, R; Kay, LE				Sprangers, Remco; Kay, Lewis E.			Quantitative dynamics and binding studies of the 20S proteasome by NMR	NATURE			English	Article							MOLECULAR-WEIGHT PROTEINS; 723-RESIDUE ENZYME; METHYL-GROUPS; SPECTROSCOPY; RELAXATION; DEGRADATION; RESOLUTION; COMPLEX; ASSIGNMENTS; PARTICLE	The machinery used by the cell to perform essential biological processes is made up of large molecular assemblies. One such complex, the proteasome, is the central molecular machine for removal of damaged and misfolded proteins from the cell. Here we show that for the 670-kilodalton 20S proteasome core particle it is possible to overcome the molecular weight limitations that have traditionally hampered quantitative nuclear magnetic resonance (NMR) spectroscopy studies of such large systems. This is achieved by using an isotope labelling scheme where isoleucine, leucine and valine methyls are protonated in an otherwise highly deuterated background in concert with experiments that preserve the lifetimes of the resulting NMR signals. The methodology has been applied to the 20S core particle to reveal functionally important motions and interactions by recording spectra on complexes with molecular weights of up to a megadalton. Our results establish that NMR spectroscopy can provide detailed insight into supra-molecular structures over an order of magnitude larger than those routinely studied using methodology that is generally applicable.	Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Med Genet, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Chem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University of Toronto	Kay, LE (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada.	kay@pound.med.utoronto.ca						Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fiaux J, 2002, NATURE, V418, P207, DOI 10.1038/nature00860; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Korzhnev DM, 2004, J AM CHEM SOC, V126, P3964, DOI 10.1021/ja039587i; Kwon YD, 2004, J MOL BIOL, V335, P233, DOI 10.1016/j.jmb.2003.08.029; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Nederlof PM, 1995, P NATL ACAD SCI USA, V92, P12060, DOI 10.1073/pnas.92.26.12060; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Sharon M, 2006, J BIOL CHEM, V281, P9569, DOI 10.1074/jbc.M511951200; Sprangers R, 2005, P NATL ACAD SCI USA, V102, P16678, DOI 10.1073/pnas.0507370102; Tugarinov V, 2005, BIOCHEMISTRY-US, V44, P15970, DOI 10.1021/bi0519809; Tugarinov V, 2005, J AM CHEM SOC, V127, P8214, DOI 10.1021/ja0508830; Tugarinov V, 2004, ANNU REV BIOCHEM, V73, P107, DOI 10.1146/annurev.biochem.73.011303.074004; Tugarinov V, 2003, J AM CHEM SOC, V125, P13868, DOI 10.1021/ja030345s; Tugarinov V, 2003, J AM CHEM SOC, V125, P10420, DOI 10.1021/ja030153x; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; ZWICKL P, 1994, NAT STRUCT BIOL, V1, P765, DOI 10.1038/nsb1194-765	29	386	394	0	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2007	445	7128					618	622		10.1038/nature05512	http://dx.doi.org/10.1038/nature05512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17237764				2022-12-01	WOS:000244039400037
J	Xue, W; Zender, L; Miething, C; Dickins, RA; Hernando, E; Krizhanovsky, V; Cordon-Cardo, C; Lowe, SW				Xue, Wen; Zender, Lars; Miething, Cornelius; Dickins, Ross A.; Hernando, Eva; Krizhanovsky, Valery; Cordon-Cardo, Carlos; Lowe, Scott W.			Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas	NATURE			English	Article							CELL SENESCENCE; ONCOGENIC RAS; KILLER-CELLS; SUPPRESSION; CANCER; TUMORIGENESIS; PATHWAY; NEVI	Although cancer arises from a combination of mutations in oncogenes and tumour suppressor genes, the extent to which tumour suppressor gene loss is required for maintaining established tumours is poorly understood. p53 is an important tumour suppressor that acts to restrict proliferation in response to DNA damage or deregulation of mitogenic oncogenes, by leading to the induction of various cell cycle checkpoints, apoptosis or cellular senescence(1,2). Consequently, p53 mutations increase cell proliferation and survival, and in some settings promote genomic instability and resistance to certain chemotherapies(3). To determine the consequences of reactivating the p53 pathway in tumours, we used RNA interference (RNAi) to conditionally regulate endogenous p53 expression in a mosaic mouse model of liver carcinoma(4,5). We show that even brief reactivation of endogenous p53 in p53-deficient tumours can produce complete tumour regressions. The primary response to p53 was not apoptosis, but instead involved the induction of a cellular senescence program that was associated with differentiation and the upregulation of inflammatory cytokines. This program, although producing only cell cycle arrest in vitro, also triggered an innate immune response that targeted the tumour cells in vivo, thereby contributing to tumour clearance. Our study indicates that p53 loss can be required for the maintenance of aggressive carcinomas, and illustrates how the cellular senescence program can act together with the innate immune system to potently limit tumour growth.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; Mem Sloan Kettering Canc Ctr, Div Mol Pathol, New York, NY 10021 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Lowe, SW (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	lowe@cshl.edu	Dickins, Ross A/K-2852-2012; Miething, Cornelius/F-9498-2014; Krizhanovsky, Valery/D-1336-2010	Dickins, Ross A/0000-0003-4112-5304; Miething, Cornelius/0000-0003-4699-3805; Krizhanovsky, Valery/0000-0002-3977-5482; Xue, Wen/0000-0002-9797-8042; Hernando, Eva/0000-0003-1023-0312	NCI NIH HHS [P01 CA087497, P30 CA008748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA087497, P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Ghiringhelli F, 2006, IMMUNOL REV, V214, P229, DOI 10.1111/j.1600-065X.2006.00445.x; Gorgoulis VG, 2005, LAB INVEST, V85, P502, DOI 10.1038/labinvest.3700241; Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hong F, 2003, CANCER RES, V63, P9023; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Minamino T, 2003, CIRCULATION, V108, P2264, DOI 10.1161/01.CIR.0000093274.82929.22; Mundt B, 2002, FASEB J, V16, P94, DOI 10.1096/fj.02-0537fje; Roninson IB, 2003, CANCER RES, V63, P2705; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Staib F, 2003, HUM MUTAT, V21, P201, DOI 10.1002/humu.10176; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; VENTURA A, 2007, NATURE          0124, DOI DOI 10.1038/NATURE05541; Zender L, 2005, COLD SH Q B, V70, P251, DOI 10.1101/sqb.2005.70.059; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030	30	1766	1830	11	210	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2007	445	7128					656	660		10.1038/nature05529	http://dx.doi.org/10.1038/nature05529			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17251933	Green Accepted			2022-12-01	WOS:000244039400046
J	Yu, JK; Satou, Y; Holland, ND; Shin-I, T; Kohara, Y; Satoh, N; Bronner-Fraser, M; Holland, LZ				Yu, Jr-Kai; Satou, Yutaka; Holland, Nicholas D.; Shin-, Tadasu, I; Kohara, Yuji; Satoh, Noriyuki; Bronner-Fraser, Marianne; Holland, Linda Z.			Axial patterning in cephalochordates and the evolution of the organizer	NATURE			English	Article							TWISTED GASTRULATION; AMPHIOXUS EMBRYOS; NEURAL INDUCTION; XENOPUS EMBRYOS; HEAD ORGANIZER; GENE; MESODERM; ANTAGONISM; EXPRESSION; PHYLOGENY	The organizer of the vertebrate gastrula is an important signalling centre that induces and patterns dorsal axial structures. Although a topic of long-standing interest, the evolutionary origin of the organizer remains unclear. Here we show that the gastrula of the cephalochordate amphioxus expresses dorsal/ventral (D/V) patterning genes (for example, bone morphogenetic proteins (BMPs), Nodal and their antagonists) in patterns reminiscent of those of their vertebrate orthlogues, and that amphioxus embryos, like those of vertebrates, are ventralized by exogenous BMP protein. In addition, Wnt-antagonists (for example, Dkks and sFRP2-like) are expressed anteriorly, whereas Wnt genes themselves are expressed posteriorly, consistent with a role for Wnt signalling in anterior/posterior (A/P) patterning. These results suggest evolutionary conservation of the mechanisms for both D/V and A/P patterning of the early gastrula. In light of recent phylogenetic analyses placing cephalochordates basally in the chordate lineage, we propose that separate signalling centres for patterning the D/V and A/P axes may be an ancestral chordate character.	Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92037 USA; Kyoto Univ, Grad Sch Sci, Dept Zool, Sakyo Ku, Kyoto 6068502, Japan; Natl Inst Genet, Shizuoka 4118540, Japan; CALTECH, Div Biol 139 74, Pasadena, CA 91125 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Kyoto University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; California Institute of Technology	Holland, LZ (corresponding author), Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92037 USA.	lzholland@ucsd.edu	Satou, Yutaka/K-7131-2012; Yu, Jr-Kai/H-4822-2019; Satoh, Nori/C-4123-2009; Satou, Yutaka/AAJ-2194-2021	Satou, Yutaka/0000-0001-5193-0708; Yu, Jr-Kai/0000-0001-8591-0529; Satoh, Nori/0000-0002-4480-3572; Satou, Yutaka/0000-0001-5193-0708; Bronner, Marianne/0000-0003-4274-1862				Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Broun M, 2005, DEVELOPMENT, V132, P2907, DOI 10.1242/dev.01848; Chang CB, 2001, NATURE, V410, P483, DOI 10.1038/35068583; DALE L, 1992, DEVELOPMENT, V115, P573; Darras S, 2001, DEV BIOL, V236, P271, DOI 10.1006/dbio.2001.0339; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Ferrier DEK, 2001, DEV BIOL, V237, P270, DOI 10.1006/dbio.2001.0375; Gerhart J, 2001, INT J DEV BIOL, V45, P133; Hoang BH, 2004, CANCER RES, V64, P2734, DOI 10.1158/0008-5472.CAN-03-1952; Holland LZ, 2005, DEV DYNAM, V233, P1430, DOI 10.1002/dvdy.20473; Holland LZ, 2002, DEV BIOL, V241, P209, DOI 10.1006/dbio.2001.0503; Hufton AL, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-27; Imai KS, 2006, SCIENCE, V312, P1183, DOI 10.1126/science.1123404; JOLY JS, 1993, DEVELOPMENT, V119, P1261; Jones CM, 1999, CURR BIOL, V9, P946, DOI 10.1016/S0960-9822(99)80421-7; Kourakis MJ, 2005, TRENDS GENET, V21, P506, DOI 10.1016/j.tig.2005.07.002; Kozmik Z, 2001, GENESIS, V29, P172, DOI 10.1002/gene.1021; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Langeland JA, 2006, INT J BIOL SCI, V2, P110; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Lowe CJ, 2006, PLOS BIOL, V4, P1603, DOI 10.1371/journal.pbio.0040291; Matus DQ, 2006, P NATL ACAD SCI USA, V103, P11195, DOI 10.1073/pnas.0601257103; Matus DQ, 2006, CURR BIOL, V16, P499, DOI 10.1016/j.cub.2006.01.052; Neidert AH, 2000, EVOL DEV, V2, P303, DOI 10.1046/j.1525-142x.2000.00073.x; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; Nikaido M, 1997, MECH DEVELOP, V61, P75, DOI 10.1016/S0925-4773(96)00625-9; Passamaneck YJ, 2005, DEV DYNAM, V233, P1, DOI 10.1002/dvdy.20300; Pera EM, 2000, MECH DEVELOP, V96, P183, DOI 10.1016/S0925-4773(00)00394-4; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Schubert M., 2003, WNT SIGNALING DEV, P210; Scott IC, 2001, NATURE, V410, P475, DOI 10.1038/35068572; Stern CD, 2001, NAT REV NEUROSCI, V2, P92, DOI 10.1038/35053563; TUNG TC, 1962, SCI SINICA, V11, P805; Yu JK, 2002, EVOL DEV, V4, P418, DOI 10.1046/j.1525-142X.2002.02030.x; Zhang SC, 1997, DEV GENES EVOL, V206, P532, DOI 10.1007/s004270050083	39	186	195	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2007	445	7128					613	617		10.1038/nature05472	http://dx.doi.org/10.1038/nature05472			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17237766				2022-12-01	WOS:000244039400036
J	Tom, SM; Fox, CR; Trepel, C; Poldrack, RA				Tom, Sabrina M.; Fox, Craig R.; Trepel, Christopher; Poldrack, Russell A.			The neural basis of loss aversion in decision-making under risk	SCIENCE			English	Article							EVENT-RELATED FMRI; HUMAN BRAIN; PROSPECT-THEORY; EXPERIENCE; UTILITY; THEOREM; CORTEX; CHOICE; BIASES	People typically exhibit greater sensitivity to losses than to equivalent gains when making decisions. We investigated neural correlates of loss aversion while individuals decided whether to accept or reject gambles that offered a 50/50 chance of gaining or losing money. A broad set of areas ( including midbrain dopaminergic regions and their targets) showed increasing activity as potential gains increased. Potential losses were represented by decreasing activity in several of these same gain-sensitive areas. Finally, individual differences in behavioral loss aversion were predicted by a measure of neural loss aversion in several regions, including the ventral striatum and prefrontal cortex.	Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Anderson Sch Management, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Brain Res, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Poldrack, RA (corresponding author), Univ Calif Los Angeles, Dept Psychol, Franz Hall,Box 951563, Los Angeles, CA 90095 USA.	poldrack@ucla.edu	Fox, Craig/A-2293-2014		NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020750] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR020750] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ABDELLAOUI M, IN PRESS MANAGEMENT; BENARTZI S, 1995, Q J ECON, V110, P73, DOI 10.2307/2118511; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Camerer C, 2005, J MARKETING RES, V42, P129, DOI 10.1509/jmkr.42.2.129.62286; Chen MK, 2006, J POLIT ECON, V114, P517, DOI 10.1086/503550; CONGDON E, 2005, COGNIT NEUROSCI REV, V4, P262; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; De Martino B, 2006, SCIENCE, V313, P684, DOI 10.1126/science.1128356; Delgado MR, 2003, COGN AFFECT BEHAV NE, V3, P27, DOI 10.3758/CABN.3.1.27; Harbaugh WT, 2001, ECON LETT, V70, P175, DOI 10.1016/S0165-1765(00)00359-1; HARDIE BGS, 1993, MARKET SCI, V12, P378, DOI 10.1287/mksc.12.4.378; JOHNSON EJ, 2006, 2015 IZA I STUD LAB; Kahn I, 2002, NEURON, V33, P983, DOI 10.1016/S0896-6273(02)00626-8; Kahneman D, 1997, Q J ECON, V112, P375, DOI 10.1162/003355397555235; KAHNEMAN D, 1990, J POLIT ECON, V98, P1325, DOI 10.1086/261737; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; McClure SM, 2004, NEURON, V44, P379, DOI 10.1016/j.neuron.2004.09.019; Novemsky N, 2005, J MARKETING RES, V42, P119, DOI 10.1509/jmkr.42.2.119.62292; Rabin M, 2000, ECONOMETRICA, V68, P1281, DOI 10.1111/1468-0262.00158; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Yacubian J, 2006, J NEUROSCI, V26, P9530, DOI 10.1523/JNEUROSCI.2915-06.2006; Zuckerman M, 2000, J PERS, V68, P999, DOI 10.1111/1467-6494.00124	28	1048	1080	9	313	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2007	315	5811					515	518		10.1126/science.1134239	http://dx.doi.org/10.1126/science.1134239			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	129JU	17255512				2022-12-01	WOS:000243726600047
J	Poelwijk, FJ; Kiviet, DJ; Weinreich, DM; Tans, SJ				Poelwijk, Frank J.; Kiviet, Daniel J.; Weinreich, Daniel M.; Tans, Sander J.			Empirical fitness landscapes reveal accessible evolutionary paths	NATURE			English	Article							PROTEIN-DNA RECOGNITION; FLUCTUATING ENVIRONMENTS; ISOCITRATE DEHYDROGENASE; LAC REPRESSOR; MUTANT; ADAPTATION; ROBUSTNESS; DYNAMICS; EVOLVABILITY; SPECIFICITY		FOM Inst AMOLF, NL-1098 SJ Amsterdam, Netherlands; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	AMOLF; Harvard University	Tans, SJ (corresponding author), FOM Inst AMOLF, Kruislaan 407, NL-1098 SJ Amsterdam, Netherlands.	tans@amolf.nl	Weinreich, Dan/AAZ-6606-2021; Tans, Sander/AAS-2901-2020	Poelwijk, Frank/0000-0002-5696-4357				[Anonymous], 1993, ORIGINS ORDER; Arnold FH, 2001, TRENDS BIOCHEM SCI, V26, P100, DOI 10.1016/S0968-0004(00)01755-2; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Counago R, 2006, MOL CELL, V22, P441, DOI 10.1016/j.molcel.2006.04.012; DARWIN C, 1859, ORIGIN SPECIES, pCH6; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Gavrilets S, 2004, FITNESS LANDSCAPES O; Gillespie J.H., 1991, CAUSES MOL EVOLUTION; Hurley JH, 1996, BIOCHEMISTRY-US, V35, P5670, DOI 10.1021/bi953001q; HURLEY JH, 1991, BIOCHEMISTRY-US, V30, P8671, DOI 10.1021/bi00099a026; Kalodimos CG, 2002, EMBO J, V21, P2866, DOI 10.1093/emboj/cdf318; KIMURA M, 1962, GENETICS, V47, P713; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; LEHMING N, 1990, EMBO J, V9, P615, DOI 10.1002/j.1460-2075.1990.tb08153.x; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Lunzer M, 2005, SCIENCE, V310, P499, DOI 10.1126/science.1115649; MALCOLM BA, 1990, NATURE, V345, P86, DOI 10.1038/345086a0; PAULING L, 1963, ACTA CHEM SCAND, V17, pS9; Poelwijk FJ, 2006, PLOS COMPUT BIOL, V2, P467, DOI 10.1371/journal.pcbi.0020058; Salinas RK, 2005, CHEMBIOCHEM, V6, P1628, DOI 10.1002/cbic.200500049; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; STACKHOUSE J, 1990, FEBS LETT, V262, P104, DOI 10.1016/0014-5793(90)80164-E; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Ugalde JA, 2004, SCIENCE, V305, P1433, DOI 10.1126/science.1099597; Van Nimwegen E, 2000, B MATH BIOL, V62, P799, DOI 10.1006/bulm.2000.0180; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Weinreich DM, 2005, EVOLUTION, V59, P1165; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; Zhu GP, 2005, SCIENCE, V307, P1279, DOI 10.1126/science.1106974	38	345	347	2	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2007	445	7126					383	386		10.1038/nature05451	http://dx.doi.org/10.1038/nature05451			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	128WD	17251971				2022-12-01	WOS:000243689500029
J	Jacobson, PD; Parmet, WE				Jacobson, Peter D.; Parmet, Wendy E.			A new era of unapproved drugs - The case of Abigail Alliance v Von Eschenbach	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RATES		Univ Michigan, Sch Publ Hlth, Ctr Law Eth & Hlth, Ann Arbor, MI 48109 USA; Northeastern Univ, Sch Law, Boston, MA 02115 USA	University of Michigan System; University of Michigan; Northeastern University	Jacobson, PD (corresponding author), Univ Michigan, Sch Publ Hlth, Ctr Law Eth & Hlth, 109 Observ, Ann Arbor, MI 48109 USA.	pdj@umich.edu						*AB ALL, AB STOR; Costanza ME, 1995, CLIN CANCER RES, V1, P699; DiMasi JA, 2001, CLIN PHARMACOL THER, V69, P297, DOI 10.1067/mcp.2001.115446; Institute of Medicine, 2006, FUT DRUG SAF PROM PR; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Mayer M, 2006, CLIN TRIALS, V3, P149, DOI 10.1191/1740774506cn144oa; PILON R, 2006, WALL STREET J   0603, P9; 2005, WALL STREET J   1115, pA22	8	41	41	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 10	2007	297	2					205	208		10.1001/jama.297.2.205	http://dx.doi.org/10.1001/jama.297.2.205			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	124GI	17213404				2022-12-01	WOS:000243355900030
J	Sebat, J; Lakshmi, B; Malhotra, D; Troge, J; Lese-Martin, C; Walsh, T; Yamrom, B; Yoon, S; Krasnitz, A; Kendall, J; Leotta, A; Pai, D; Zhang, R; Lee, YH; Hicks, J; Spence, SJ; Lee, AT; Puura, K; Lehtimaki, T; Ledbetter, D; Gregersen, PK; Bregman, J; Sutcliffe, JS; Jobanputra, V; Chung, W; Warburton, D; King, MC; Skuse, D; Geschwind, DH; Gilliam, TC; Ye, K; Wigler, M				Sebat, Jonathan; Lakshmi, B.; Malhotra, Dheeraj; Troge, Jennifer; Lese-Martin, Christa; Walsh, Tom; Yamrom, Boris; Yoon, Seungtai; Krasnitz, Alex; Kendall, Jude; Leotta, Anthony; Pai, Deepa; Zhang, Ray; Lee, Yoon-Ha; Hicks, James; Spence, Sarah J.; Lee, Annette T.; Puura, Kaija; Lehtimaeki, Terho; Ledbetter, David; Gregersen, Peter K.; Bregman, Joel; Sutcliffe, James S.; Jobanputra, Vaidehi; Chung, Wendy; Warburton, Dorothy; King, Mary-Claire; Skuse, David; Geschwind, Daniel H.; Gilliam, T. Conrad; Ye, Kenny; Wigler, Michael			Strong association of de novo copy number mutations with autism	SCIENCE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; COMMON FRAGILE SITES; DELETION; GENE	We tested the hypothesis that de novo copy number variation (CNV) is associated with autism spectrum disorders (ASDs). We performed comparative genomic hybridization (CGH) on the genomic DNA of patients and unaffected subjects to detect copy number variants not present in their respective parents. Candidate genomic regions were validated by higher-resolution CGH, paternity testing, cytogenetics, fluorescence in situ hybridization, and microsatellite genotyping. Confirmed de novo CNVs were significantly associated with autism ( P = 0.0005). Such CNVs were identified in 12 out of 118 (10%) of patients with sporadic autism, in 2 out of 77 (3%) of patients with an affected first-degree relative, and in 2 out of 196 (1%) of controls. Most de novo CNVs were smaller than microscopic resolution. Affected genomic regions were highly heterogeneous and included mutations of single genes. These findings establish de novo germline mutation as a more significant risk factor for ASD than previously recognized.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; Univ Washington, Dept Med & Genome Sci, Seattle, WA 98195 USA; NIMH, Pediat & Neurodev Psychiat Branch, NIH, Bethesda, MD 20892 USA; N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY 11030 USA; Univ Tampere, Sch Med, Dept Child Psychiat, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Dept Clin Chem, FIN-33521 Tampere, Finland; N Shore Long Isl Jewish Hlth Syst, Fay J Lindner Ctr Autism & Dev Disorders, Bethpage, NY 11714 USA; Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37232 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10027 USA; Columbia Univ, Dept Pediat, New York, NY 10027 USA; UCL, Inst Child Hlth, Behav & Brain Sci Unit, London WC1N 1EH, England; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Program Neurogenet,Interdept Program Neurosci, Los Angeles, CA 90095 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA	Cold Spring Harbor Laboratory; Emory University; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Northwell Health; Tampere University; Tampere University; Tampere University Hospital; Northwell Health; Vanderbilt University; Columbia University; Columbia University; University of London; University College London; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Chicago; Yeshiva University; Albert Einstein College of Medicine	Wigler, M (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	sebat@cshl.edu; wigler@cshl.edu	Ye, Kenny/U-2341-2019; Warfield, Simon/B-3352-2009; Puura, Kaija/ADG-7880-2022; Ye, Kenny/GSM-7731-2022; Lehtimäki, Terho/AAD-1094-2022; Sutcliffe, James S/C-1348-2012	Ye, Kenny/0000-0002-1466-855X; Warfield, Simon/0000-0002-7659-3880; Lehtimäki, Terho/0000-0002-2555-4427; Sutcliffe, James S/0000-0001-5200-6007; King, Mary-Claire/0000-0001-9426-1743; Wigler, Michael/0000-0003-4396-1971; Sebat, Jonathan/0000-0002-9087-526X; Walsh, Tom/0000-0002-8875-0310	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064547, R01MH076431, R01MH061009] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH064547, R01 MH076431, R01 MH061009, R01 MH076431-01, MH076431, MH61009, MH64547] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bhalla K, 2004, J HUM GENET, V49, P308, DOI 10.1007/s10038-004-0145-4; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; *EUR CONS TUB SCLE, 1993, CELL, V75, P130; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fombonne E, 2005, J CLIN PSYCHIAT, V66, P3; Ghaziuddin M, 1999, J AUTISM DEV DISORD, V29, P259, DOI 10.1023/A:1023088207468; GOSPE SM, 1989, NEUROLOGY, V39, P1277, DOI 10.1212/WNL.39.10.1277; Huebner K, 2001, NAT REV CANCER, V1, P214, DOI 10.1038/35106058; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Igarashi T, 2001, J AM SOC NEPHROL, V12, P713, DOI 10.1681/ASN.V124713; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klauck SM, 2006, EUR J HUM GENET, V14, P714, DOI 10.1038/sj.ejhg.5201610; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Lucito R, 2003, GENOME RES, V13, P2291, DOI 10.1101/gr.1349003; Manning MA, 2004, PEDIATRICS, V114, P451, DOI 10.1542/peds.114.2.451; ORYE E, 1971, LANCET, V2, P1376; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Smith DI, 2006, CANCER LETT, V232, P48, DOI 10.1016/j.canlet.2005.06.049; Veenstra-VanderWeele J, 2004, MOL PSYCHIATR, V9, P819, DOI 10.1038/sj.mp.4001505; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757	30	1946	2136	27	403	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					445	449		10.1126/science.1138659	http://dx.doi.org/10.1126/science.1138659			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17363630	Green Accepted			2022-12-01	WOS:000245813400056
J	Huikeshoven, M; Koster, PHL; de Borgie, CAJM; Beek, JF; van Gemert, MJC; van der Horst, CMAM				Huikeshoven, Menno; Koster, Petra H. L.; de Borgie, Corianne A. J. M.; Beek, Johan F.; van Gemert, Martin J. C.; van der Horst, Chantal M. A. M.			Redarkening of port-wine stains 10 years after pulsed-dye-laser treatment	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EFFICACY	Background: Although pulsed-dye-laser therapy is currently the gold standard for the treatment of port-wine stains, few objective data are available on its long-term efficacy. Using objective color measurements, we performed a 10-year follow-up of a previously conducted prospective clinical study of the treatment of port-wine stains with a pulsed-dye laser. Methods: We invited the patients to undergo repeated color measurements performed by the same procedures as in the previous study. The results at long-term follow-up were compared with color measurements obtained before treatment and after completion of an average of five laser treatments of the complete port-wine stain. A questionnaire was used to investigate patients' satisfaction with the treatment and their perception of long-term changes in the stain. Results: Of the 89 patients from whom color measurements were obtained in the previous study, 51 were included in this study. The patients had received a median of seven additional treatment sessions since the last color measurement, which had been made after an average of five treatments. The median length of follow-up was 9.5 years. On average, the stain when measured at follow-up was significantly darker than it was when measured after the last of the initial five laser treatments (P=0.001), but it was still significantly lighter than it was when measured before treatment (P<0.001). Fifty-nine percent of patients were satisfied with the overall treatment result. Six percent of patients reported that the stain had become lighter since their last treatment, 59% that it was unchanged, and 35% that it had become darker. Conclusions: Using objective color measurements, we observed significant redarkening of port-wine stains at long-term follow-up after pulsed-dye-laser therapy. Patients should be informed about the possibility of redarkening before beginning treatment.	Univ Amsterdam, Acad Med Ctr, Dept Plast Reconstruct & Hand Surg, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Ctr Laser, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Huikeshoven, M (corresponding author), Univ Amsterdam, Acad Med Ctr G4 226, Dept Plast Reconstruct & Hand Surg, Meibergdreeef 9, NL-1105 AZ Amsterdam, Netherlands.	m.huikeshoven@amc.uva.nl		van der Horst, chantal/0000-0002-4937-3786				BARSKY SH, 1980, J INVEST DERMATOL, V74, P154, DOI 10.1111/1523-1747.ep12535052; BRAINARD DH, 1995, HDB OPTICS, V1; Breugem CC, 2005, PLAST RECONSTR SURG, V115, P578, DOI 10.1097/01.PRS.0000150150.69479.70; Hansen K, 2003, DERMATOL SURG, V29, P49, DOI 10.1046/j.1524-4725.2003.29010.x; Heger M, 2005, THROMB HAEMOSTASIS, V93, P242, DOI 10.1160/TH04-05-0291; Ho WS, 2002, LASER SURG MED, V30, P44, DOI 10.1002/lsm.10003; Koster PHL, 1998, PLAST RECONSTR SURG, V102, P1210, DOI 10.1097/00006534-199809040-00047; Michel S, 2000, BRIT J DERMATOL, V143, P1230, DOI 10.1046/j.1365-2133.2000.03893.x; MORK NJ, 1998, J EUR ACAD DERMATOL, V11, pS142; Orten SS, 1996, ARCH OTOLARYNGOL, V122, P1174; Ozluer SM, 2001, CLIN EXP DERMATOL, V26, P37, DOI 10.1046/j.1365-2230.2001.00756.x; ROSEN S, 1987, J AM ACAD DERMATOL, V17, P164, DOI 10.1016/S0190-9622(87)70186-8; TAN OT, 1989, NEW ENGL J MED, V320, P416, DOI 10.1056/NEJM198902163200702; TAN OT, 1992, MANAGEMENT TREATMENT, P83; Troilius A, 2000, DERMATOL SURG, V26, P190, DOI 10.1046/j.1524-4725.2000.09204.x; van der Horst CMAM, 1998, NEW ENGL J MED, V338, P1028, DOI 10.1056/NEJM199804093381504	16	91	97	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2007	356	12					1235	1240		10.1056/NEJMoa064329	http://dx.doi.org/10.1056/NEJMoa064329			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148UP	17377161				2022-12-01	WOS:000245101900008
J	Meyer, JR; Kassen, R				Meyer, Justin R.; Kassen, Rees			The effects of competition and predation on diversification in a model adaptive radiation	NATURE			English	Article							PROMOTES DIVERGENCE; EVOLUTION; DIVERSITY; PREY	Much of life's diversity is thought to have arisen through successive rounds of adaptive radiation - the rapid diversification of a lineage into a range of ecologically and phenotypically distinct species(1-3). Both resource competition and predation have been suggested as mechanisms driving this process(4,5), although the former is better studied than the latter(6,7). Here we show experimentally how predation by a protist, Tetrahymena thermophila, affects diversification in a model adaptive radiation of the bacterial prey, Pseudomonas fluorescens. We estimate the frequency-dependent fitness functions of competing niche-specialist prey in the presence and absence of predation, and use these to test hypotheses about the extent ( measured as the number of new genotypes) and rate of diversification. Competition and predation independently generated diversifying selection that we show is capable of driving prey diversification to similar extents but at different rates, diversification being markedly delayed in the presence of predators. The cause of this delay stems from weaker diversifying selection due to the reduction in prey density caused by predation. Our results suggest that predation may play an under-appreciated role in driving adaptive radiations.	Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada; Univ Ottawa, Ctr Adv Res Environm Genom, Ottawa, ON K1N 6N5, Canada	University of Ottawa; University of Ottawa	Meyer, JR (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada.	justin.raymond.meyer@gmail.com						BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; Bohannan BJM, 1999, AM NAT, V153, P73, DOI 10.1086/303151; Buckling A, 2002, NATURE, V420, P496, DOI 10.1038/nature01164; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; CLARKE B, 1988, FREQUENCY DEPENDENT; Fryer G., 1972, CICHLID FISHES GREAT; Goymer P, 2006, GENETICS, V173, P515, DOI 10.1534/genetics.106.055863; Grant P.R., 1998, EVOLUTION ISLANDS; Hall-Stoodley L, 2005, TRENDS MICROBIOL, V13, P7, DOI 10.1016/j.tim.2004.11.004; Hedges SB, 1996, NATURE, V381, P226, DOI 10.1038/381226a0; Jablonski D, 1996, ECOLOGY, V77, P1367, DOI 10.2307/2265534; Jablonski D, 1999, SCIENCE, V284, P2114, DOI 10.1126/science.284.5423.2114; Kassen R, 2004, NATURE, V431, P984, DOI 10.1038/nature02923; Lack D., 1947, DARWINS FINCHES; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; MacLean RC, 2004, P NATL ACAD SCI USA, V101, P8072, DOI 10.1073/pnas.0307195101; Nosil P, 2006, P NATL ACAD SCI USA, V103, P9090, DOI 10.1073/pnas.0601575103; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rundle HD, 2003, P NATL ACAD SCI USA, V100, P14943, DOI 10.1073/pnas.2036360100; SCHLUTER D, 1994, SCIENCE, V266, P798, DOI 10.1126/science.266.5186.798; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schrag SJ, 1996, AM NAT, V148, P348, DOI 10.1086/285929; SEPKOSKI JJ, 1984, PALEOBIOLOGY, V10, P246, DOI 10.1017/S0094837300008186; Simpson G.G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Travisano M, 2000, AM NAT, V156, pS35, DOI 10.1086/303414; Vamosi SM, 2005, CAN J ZOOL, V83, P894, DOI 10.1139/Z05-063; VANVALEN L, 1974, J THEOR BIOL, V44, P19, DOI 10.1016/S0022-5193(74)80026-3; WALKER TD, 1984, AM NAT, V124, P887, DOI 10.1086/284322; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337	30	152	153	3	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2007	446	7134					432	435		10.1038/nature05599	http://dx.doi.org/10.1038/nature05599			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17377581				2022-12-01	WOS:000245079500038
J	Gunawardane, LS; Saito, K; Nishida, KM; Miyoshi, K; Kawamura, Y; Nagami, T; Siomi, H; Siomi, MC				Gunawardane, Lalith S.; Saito, Kuniaki; Nishida, Kazumichi M.; Miyoshi, Keita; Kawamura, Yoshinori; Nagami, Tomoko; Siomi, Haruhiko; Siomi, Mikiko C.			A slicer-mediated mechanism for repeat-associated siRNA 5 ' end formation in Drosophila	SCIENCE			English	Article							RNA INTERFERENCE; ARGONAUTE; GERMLINE; PIWI	In Drosophila, repeat-associated small interfering RNAs (rasiRNAs) are produced in the germ line by a Dicer-independent pathway and function through the PIWI subfamily of Argonautes to ensure silencing of retrotransposons. We sequenced small RNAs associated with the PIWI subfamily member AGO3. Although other members of PIWI, Aubergine (Aub) and Piwi, associated with rasiRNAs derived mainly from the antisense strand of retrotransposons, AGO3-associated rasiRNAs arose mainly from the sense strand. Aub- and Piwi-associated rasiRNAs showed a strong preference for uracil at their 5' ends, and AGO3-associated rasiRNAs showed a strong preference for adenine at nucleotide 10. Comparisons between AGO3- and Aub- associated rasiRNAs revealed pairs of rasiRNAs showing complementarities in their first 10 nucleotides. Aub and AGO3 exhibited Slicer activity in vitro. These data support a model in which formation of a 5' terminus within rasiRNA precursors is guided by rasiRNAs originating from transcripts of the other strand in concert with the Slicer activity of PIWI.	Univ Tokushima, Inst Genome Res, Tokushima 7708503, Japan	Tokushima University	Siomi, MC (corresponding author), Univ Tokushima, Inst Genome Res, Tokushima 7708503, Japan.	siomi@genome.tokushima-u.ac.jp	Siomi, Haruhiko/A-7020-2015; Saito, Kuniaki/A-6967-2015	Siomi, Haruhiko/0000-0001-8690-3822; Saito, Kuniaki/0000-0001-8233-9283				Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin AA, 2004, MOL CELL BIOL, V24, P6742, DOI 10.1128/MCB.24.15.6742-6750.2004; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Harris AN, 2001, DEVELOPMENT, V128, P2823; Kalmykova AI, 2005, NUCLEIC ACIDS RES, V33, P2052, DOI 10.1093/nar/gki323; Kavi HH, 2005, FEBS LETT, V579, P5940, DOI 10.1016/j.febslet.2005.08.069; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Parker JS, 2006, TRENDS BIOCHEM SCI, V31, P622, DOI 10.1016/j.tibs.2006.09.010; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Vagin Vasily V, 2004, RNA Biol, V1, P54; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680	20	844	886	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1587	1590		10.1126/science.1140494	http://dx.doi.org/10.1126/science.1140494			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17322028				2022-12-01	WOS:000244934800056
J	Lupski, JR				Lupski, James R.			Structural variation in the human genome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COPY-NUMBER		Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.							Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731	5	89	94	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2007	356	11					1169	1171		10.1056/NEJMcibr067658	http://dx.doi.org/10.1056/NEJMcibr067658			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	145PO	17360997				2022-12-01	WOS:000244877200013
J	Boots, M; Mealor, M				Boots, Michael; Mealor, Michael			Local interactions select for lower pathogen infectivity	SCIENCE			English	Article							INDIAN MEAL MOTH; PLODIA-INTERPUNCTELLA; GRANULOSIS-VIRUS; EVOLUTION; VIRULENCE; TRANSMISSION; POPULATION; COOPERATION; DYNAMICS	Theory suggests that the current rapid increase in connectivity and consequential changes in the structure of human, agricultural, and wildlife populations may select for parasite strains with higher infectivity. We carried out a test of this spatial theory by experimentally altering individual host movement rates in a model host/pathogen system by altering the viscosity of their environment. In our microevolutionary selection experiments, the infectivity of the virus was, as predicted by the theory, reduced in the most viscous populations. We therefore provide empirical support for the theory that population structure affects the evolution of infectious organisms.	Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Boots, M (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	m.boots@sheffield.ac.uk			Natural Environment Research Council [NE/A503439/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Boots M, 1999, P ROY SOC B-BIOL SCI, V266, P1933, DOI 10.1098/rspb.1999.0869; Boots M, 2000, ECOL LETT, V3, P181; BOOTS M, 1993, FUNCT ECOL, V7, P528, DOI 10.2307/2390128; Boots M, 2004, SCIENCE, V303, P842, DOI 10.1126/science.1088542; Boots M, 1998, ECOL ENTOMOL, V23, P118, DOI 10.1046/j.1365-2311.1998.00115.x; BREMERMANN HJ, 1989, J MATH BIOL, V27, P179, DOI 10.1007/BF00276102; DIECKMANN U, 2002, ADAPTIVE DYNAMICS IN; Dieckmann U., 2000, GEOMETRY ECOLOGICAL; Ebert D, 1996, PARASITOL TODAY, V12, P96, DOI 10.1016/0169-4758(96)80668-5; Ewald P.W., 1994, EVOLUTION INFECT DIS; EWALD PW, 1993, SCI AM, V268, P86, DOI 10.1038/scientificamerican0493-86; EWALD PW, 1991, EPIDEMIOL INFECT, V106, P83, DOI 10.1017/S0950268800056478; FERRIERE R, 1995, P ROY SOC B-BIOL SCI, V259, P77, DOI 10.1098/rspb.1995.0012; Ferriere R, 1996, AM NAT, V147, P692, DOI 10.1086/285875; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; Haraguchi Y, 2000, J THEOR BIOL, V203, P85, DOI 10.1006/jtbi.1999.1065; JOHN DT, 1994, J PARASITOL, V80, P149, DOI 10.2307/3283359; Kerr B, 2006, NATURE, V442, P75, DOI 10.1038/nature04864; LEVIN S, 1981, AM NAT, V117, P308, DOI 10.1086/283708; MAY RM, 1983, PROC R SOC SER B-BIO, V219, P281, DOI 10.1098/rspb.1983.0075; RAND DA, 1995, P ROY SOC B-BIOL SCI, V259, P55, DOI 10.1098/rspb.1995.0009; SAIT SM, 1994, J ANIM ECOL, V63, P861, DOI 10.2307/5263; SAIT SM, 1994, J ANIM ECOL, V63, P541, DOI 10.2307/5220; van Baalen M, 1998, J THEOR BIOL, V193, P631, DOI 10.1006/jtbi.1998.0730	24	146	148	2	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2007	315	5816					1284	1286		10.1126/science.1137126	http://dx.doi.org/10.1126/science.1137126			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332415				2022-12-01	WOS:000244564700052
J	Mani, A; Radhakrishnan, J; Wang, H; Mani, A; Mani, MA; Nelson-Williams, C; Carew, KS; Mane, S; Najmabadi, H; Wu, D; Lifton, RP				Mani, Arya; Radhakrishnan, Jayaram; Wang, He; Mani, Alaleh; Mani, Mohammad-Ali; Nelson-Williams, Carol; Carew, Khary S.; Mane, Shrikant; Najmabadi, Hossein; Wu, Dan; Lifton, Richard P.			LRP6 mutation in a family with early coronary disease and metabolic risk factors	SCIENCE			English	Article							RECEPTOR-RELATED PROTEIN-5; HEART-DISEASE; DENSITY; GENE; MORTALITY	Coronary artery disease ( CAD) is the leading cause of death worldwide and is commonly caused by a constellation of risk factors called the metabolic syndrome. We characterized a family with autosomal dominant early CAD, features of the metabolic syndrome (hyperlipidemia, hypertension, and diabetes), and osteoporosis. These traits showed genetic linkage to a short segment of chromosome 12p, in which we identified a missense mutation in LRP6, which encodes a co-receptor in the Wnt signaling pathway. The mutation, which substitutes cysteine for arginine at a highly conserved residue of an epidermal growth factor-like domain, impairs Wnt signaling in vitro. These results link a single gene defect in Wnt signaling to CAD and multiple cardiovascular risk factors.	Howard Hughes Med Inst, Dept Internal Med, New Haven, CT 06510 USA; Howard Hughes Med Inst, Dept Genet & Mol Biophys, New Haven, CT 06510 USA; Howard Hughes Med Inst, Dept Biochem, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; Amirkabir Univ Technol, Dept Mat Sci, Tehran 15875 4413, Iran; Azad Univ Tehran, Dept Human Sci, Tehran 13185 786, Iran; Social Welf & Rehab Sci Univ, Ctr Gene Res, Tehran 19875 383, Iran	Howard Hughes Medical Institute; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Yale University; Amirkabir University of Technology; Islamic Azad University	Mani, A (corresponding author), Howard Hughes Med Inst, Dept Internal Med, New Haven, CT 06510 USA.	arya.mani@yale.edu; richard.lifton@yale.edu	Najmabadi, Hossein/P-8182-2017	Najmabadi, Hossein/0000-0002-6084-7778	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD041481] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL055007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK068229] Funding Source: NIH RePORTER; NHLBI NIH HHS [P50 HL55007] Funding Source: Medline; NIAMS NIH HHS [R01 AR051476-02, R01 AR051476-04, R01 AR051476-01A1, R01 AR051476-03, R01 AR051476] Funding Source: Medline; NICHD NIH HHS [K08 HD041481-01, K08 HD041481] Funding Source: Medline; NIDDK NIH HHS [P01DK68229] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Fujino T, 2003, P NATL ACAD SCI USA, V100, P229, DOI 10.1073/pnas.0133792100; Goldstein JL, 2001, SCIENCE, V292, P1310, DOI 10.1126/science.1061815; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Johansson J, 2002, J INTERN MED, V252, P551, DOI 10.1046/j.1365-2796.2002.01068.x; Kokubu C, 2004, DEVELOPMENT, V131, P5469, DOI 10.1242/dev.01405; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Magoori K, 2003, J BIOL CHEM, V278, P11331, DOI 10.1074/jbc.M211987200; Mansfield TA, 1997, NAT GENET, V16, P202, DOI 10.1038/ng0697-202; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Marcovitz PA, 2005, AM J CARDIOL, V96, P1059, DOI 10.1016/j.amjcard.2005.06.034; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Nabel EG, 2003, NEW ENGL J MED, V349, P60, DOI 10.1056/NEJMra035098; NORA JJ, 1980, CIRCULATION, V61, P503, DOI 10.1161/01.CIR.61.3.503; Poulsen P, 2001, DIABETOLOGIA, V44, P537, DOI 10.1007/s001250051659; SCHILDKRAUT JM, 1989, AM J CARDIOL, V64, P555, DOI 10.1016/0002-9149(89)90477-3; Tunstall-Pedoe H, 2000, LANCET, V355, P688, DOI 10.1016/S0140-6736(99)11181-4; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; ZAVARONI I, 1991, DIABETES METAB, V17, P109	26	451	517	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816					1278	1282		10.1126/science.1136370	http://dx.doi.org/10.1126/science.1136370			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332414	Green Accepted			2022-12-01	WOS:000244564700050
J	Rapp, M; Seppala, S; Granseth, E; von Heijne, G				Rapp, Mikaela; Seppala, Susanna; Granseth, Erik; von Heijne, Gunnar			Emulating membrane protein evolution by rational design	SCIENCE			English	Article							BACTERIAL MULTIDRUG TRANSPORTER; X-RAY-STRUCTURE; ESCHERICHIA-COLI; CONDUCTING CHANNEL; CRYSTAL-STRUCTURE; ABC TRANSPORTER; EMRE; MECHANISM; TOPOLOGY; SELECTIVITY	How do integral membrane proteins evolve in size and complexity? Using the small multidrug-resistance protein EmrE from Escherichia coli as a model, we experimentally demonstrated that the evolution of membrane proteins composed of two homologous but oppositely oriented domains can occur in a small number of steps: An original dual-topology protein evolves, through a gene-duplication event, to a heterodimer formed by two oppositely oriented monomers. This simple evolutionary pathway can explain the frequent occurrence of membrane proteins with an internal pseudo-two-fold symmetry axis in the plane of the membrane.	Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden; AlbaNova, Stockholm Bioinformat Ctr, SE-10691 Stockholm, Sweden	Stockholm University	von Heijne, G (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden.	gunnar@dbb.su.se	Rapp, Mikaela/K-2298-2015; von Heijne, Gunnar/AAH-9389-2019; von Heijne, Gunnar/F-5576-2011	von Heijne, Gunnar/0000-0002-4490-8569; Rapp, Mikaela/0000-0002-4401-9518; Seppala, Susanna/0000-0002-2983-3669				Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Butler PJG, 2004, J MOL BIOL, V340, P797, DOI 10.1016/j.jmb.2004.05.014; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Elbaz Y, 2004, P NATL ACAD SCI USA, V101, P1519, DOI 10.1073/pnas.0306533101; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Kikukawa T, 2006, BBA-BIOMEMBRANES, V1758, P673, DOI 10.1016/j.bbamem.2006.04.004; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Ninio S, 2004, FEBS LETT, V562, P193, DOI 10.1016/S0014-5793(04)00240-6; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Shimizu T, 2004, J MOL BIOL, V339, P1, DOI 10.1016/j.jmb.2004.03.048; Soskine M, 2006, J BIOL CHEM, V281, P36205, DOI 10.1074/jbc.M607186200; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yerushalmi H, 2000, J BIOL CHEM, V275, P5264, DOI 10.1074/jbc.275.8.5264; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629	27	103	104	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816					1282	1284		10.1126/science.1135406	http://dx.doi.org/10.1126/science.1135406			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17255477				2022-12-01	WOS:000244564700051
J	Sokolov, S; Scheuer, T; Catterall, WA				Sokolov, Stanislav; Scheuer, Todd; Catterall, William A.			Gating pore current in an inherited ion channelopathy	NATURE			English	Article							HYPOKALEMIC PERIODIC PARALYSIS; SODIUM-CHANNEL; VOLTAGE-SENSOR; SKELETAL-MUSCLE; ENHANCED INACTIVATION; FUNCTIONAL EXPRESSION; MUTATIONS; BRAIN; PERSPECTIVE; MODELS	Ion channelopathies are inherited diseases in which alterations in control of ion conductance through the central pore of ion channels impair cell function, leading to periodic paralysis, cardiac arrhythmia, renal failure, epilepsy, migraine and ataxia(1). Here we show that, in contrast with this well-established paradigm, three mutations in gating-charge-carrying arginine residues in an S4 segment that cause hypokalaemic periodic paralysis(2) induce a hyperpolarization- activated cationic leak through the voltage sensor of the skeletal muscle Na(V)1.4 channel. This 'gating pore current' is active at the resting membrane potential and closed by depolarizations that activate the voltage sensor. It has similar permeability to Na+, K+ and Cs+, but the organic monovalent cations tetraethylammonium and N-methyl-D-glucamine are much less permeant. The inorganic divalent cations Ba2+, Ca2+ and Zn2+ are not detectably permeant and block the gating pore at millimolar concentrations. Our results reveal gating pore current in naturally occurring disease mutations of an ion channel and show a clear correlation between mutations that cause gating pore current and hypokalaemic periodic paralysis. This gain-of-function gating pore current would contribute in an important way to the dominantly inherited membrane depolarization, action potential failure, flaccid paralysis and cytopathology that are characteristic of hypokalaemic periodic paralysis. A survey of other ion channelopathies reveals numerous examples of mutations that would be expected to cause gating pore current, raising the possibility of a broader impact of gating pore current in ion channelopathies.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	wcatt@u.washington.edu						ARMSTRONG CM, 1981, PHYSIOL REV, V61, P644, DOI 10.1152/physrev.1981.61.3.644; Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; BARCHI RL, 1983, J NEUROCHEM, V36, P1377; Bendahhou S, 2001, ANN NEUROL, V50, P417, DOI 10.1002/ana.1144; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bulman DE, 1999, NEUROLOGY, V53, P1932, DOI 10.1212/WNL.53.9.1932; Cannon SC, 2006, ANNU REV NEUROSCI, V29, P387, DOI 10.1146/annurev.neuro.29.051605.112815; CATTERALL WA, 1986, TRENDS NEUROSCI, V9, P7, DOI 10.1016/0166-2236(86)90004-4; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.bi.55.070186.004513; Gandhi CS, 2002, J GEN PHYSIOL, V120, P455, DOI 10.1085/jgp.20028678; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; Horn R, 2002, J GEN PHYSIOL, V120, P449, DOI 10.1085/jgp.20028658; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; Jurkat-Rott K, 2000, P NATL ACAD SCI USA, V97, P9549, DOI 10.1073/pnas.97.17.9549; Kuzmenkin A, 2002, BRAIN, V125, P835, DOI 10.1093/brain/awf071; Sokolov S, 2005, NEURON, V47, P183, DOI 10.1016/j.neuron.2005.06.012; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Stefani E, 1998, METHOD ENZYMOL, V293, P300; Struyk AF, 2000, J NEUROSCI, V20, P8610; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; Venance SL, 2006, BRAIN, V129, P8, DOI 10.1093/brain/awh639; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103	24	209	214	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2007	446	7131					76	78		10.1038/nature05598	http://dx.doi.org/10.1038/nature05598			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17330043				2022-12-01	WOS:000244525600040
J	Stanger, BZ; Tanaka, AJ; Melton, DA				Stanger, Ben Z.; Tanaka, Akemi J.; Melton, Douglas A.			Organ size is limited by the number of embryonic progenitor cells in the pancreas but not the liver	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; GENE-EXPRESSION; TRANSGENIC MICE; BETA-CATENIN; GROWTH; DIFFERENTIATION; COMPLEMENTATION; EPITHELIUM; LINEAGE; FGF10	The determinants of vertebrate organ size are poorly understood, but the process is thought to depend heavily on growth factors and other environmental cues. In the blood and central nervous system, for example, organ mass is determined primarily by growth-factor-regulated cell proliferation and apoptosis to achieve a final target size. Here, we report that the size of the mouse pancreas is constrained by an intrinsic programme established early in development, one that is essentially not subject to growth compensation. Specifically, final pancreas size is limited by the size of the progenitor cell pool that is set aside in the developing pancreatic bud. By contrast, the size of the liver is not constrained by reductions in the progenitor cell pool. These findings show that progenitor cell number, independently of regulation by growth factors, can be a key determinant of organ size.	Harvard Univ, Stem Cell Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Howard Hughes Med Inst, Cambridge, MA 02138 USA; Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital	Melton, DA (corresponding author), Harvard Univ, Stem Cell Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	bstanger@mail.med.upenn.edu; dmelton@harvard.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Stanger, Ben/0000-0003-0410-4037				Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Bhushan A, 2001, DEVELOPMENT, V128, P5109; Bort R, 2006, DEV BIOL, V290, P44, DOI 10.1016/j.ydbio.2005.11.006; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; BRYANT PJ, 1984, Q REV BIOL, V59, P387, DOI 10.1086/414040; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Deutsch G, 2001, DEVELOPMENT, V128, P871; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Gallant P, 2005, CANCER RES, V65, P6485, DOI 10.1158/0008-5472.CAN-05-1101; Gilbert S.F., 2000, DEV BIOL; Gu GQ, 2002, DEVELOPMENT, V129, P2447; GUZ Y, 1995, DEVELOPMENT, V121, P11; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Hart A, 2003, DEV DYNAM, V228, P185, DOI 10.1002/dvdy.10368; Heiser PW, 2006, DEVELOPMENT, V133, P2023, DOI 10.1242/dev.02366; Hidalgo A, 2003, MECH DEVELOP, V120, P1311, DOI 10.1016/j.mod.2003.06.004; Holland AM, 2002, P NATL ACAD SCI USA, V99, P12236, DOI 10.1073/pnas.192255099; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; KALTHOFF K, 1996, ANAL BIOL DEV; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Lavon I, 2000, NAT MED, V6, P573, DOI 10.1038/75057; Lee P, 1998, P NATL ACAD SCI USA, V95, P11371, DOI 10.1073/pnas.95.19.11371; Liegeois NJ, 1996, P NATL ACAD SCI USA, V93, P1303, DOI 10.1073/pnas.93.3.1303; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cellbio.11.1.35; Muller-Sieburg CE, 2000, BLOOD, V95, P2446, DOI 10.1182/blood.V95.7.2446.007k13_2446_2448; Murtaugh LC, 2005, DEVELOPMENT, V132, P4663, DOI 10.1242/dev.02063; Norgaard GA, 2003, DEV BIOL, V264, P323, DOI 10.1016/j.ydbio.2003.08.013; Offield MF, 1996, DEVELOPMENT, V122, P983; Papadopoulou S, 2005, DIABETES, V54, P2844, DOI 10.2337/diabetes.54.10.2844; Robin C, 2006, DEV CELL, V11, P171, DOI 10.1016/j.devcel.2006.07.002; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; Twitty VC, 1931, J EXP ZOOL, V59, P61, DOI 10.1002/jez.1400590105; Wang ZD, 2004, DEV BIOL, V275, P192, DOI 10.1016/j.ydbio.2004.06.026; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Westmacott A, 2006, INT J DEV BIOL, V50, P653, DOI 10.1387/ijdb.062146aw; WOLPERT L, 1981, BRIT MED BULL, V37, P215, DOI 10.1093/oxfordjournals.bmb.a071705	42	266	272	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					886	891		10.1038/nature05537	http://dx.doi.org/10.1038/nature05537			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17259975				2022-12-01	WOS:000244341200042
J	Zheng, Z; Chen, TG; Li, XL; Haura, E; Sharma, A; Bepler, G				Zheng, Zhong; Chen, Tingan; Li, Xueli; Haura, Eric; Sharma, Anupama; Bepler, Gerold			DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REDUCTASE SUBUNIT M1; PHASE-III TRIAL; RIBONUCLEOTIDE REDUCTASE; PROTEIN EXPRESSION; GEMCITABINE; CISPLATIN; SURVIVAL; MUTATIONS; PTEN; SUPPRESSION	Background: RRM1, the regulatory subunit of ribonucleotide reductase, is involved in carcinogenesis, tumor progression, and the response of non-small-cell lung cancer to treatment. Methods: We developed an automated quantitative determination of the RRM1 protein in routinely processed histologic specimens. In these specimens, we measured the expression of RRM1 and two other proteins that are relevant to non-small-cell lung cancer: the excision repair cross-complementation group 1 (ERCC1) protein and the phosphatase and tensin homologue (PTEN). We compared the results with the clinical outcomes in 187 patients with early-stage non-small-cell lung cancer who had received only surgical treatment. Results: RRM1 expression correlated with the expression of ERCC1 (P < 0.001) but not with the expression of PTEN (P=0.37). The median disease-free survival exceeded 120 months in the group of patients with tumors that had high expression of RRM1 and was 54.5 months in the group with low expression of RRM1 (hazard ratio for disease progression or death in the high-expression group, 0.46; P=0.004). The overall survival was more than 120 months for patients with tumors with high expression of RRM1 and 60.2 months for those with low expression of RRM1 (hazard ratio for death, 0.61; P=0.02). Among these 187 patients, the survival advantage was limited to the 30% of patients with tumors that had a high expression of both RRM1 and ERCC1. Conclusions: RRM1 and ERCC1 are determinants of survival after surgical treatment of early-stage, non-small-cell lung cancer.	H Lee Moffitt Canc Ctr & Res Inst, Div Thorac Oncol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute	Bepler, G (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Div Thorac Oncol, MRC-4W,Rm 4046,12902 Magnolia Dr, Tampa, FL 33612 USA.	beplerg@moffitt.usf.edu			NATIONAL CANCER INSTITUTE [R01CA102726, R21CA110487] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA102726, R21-CA110487] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BEPLER G, 1994, P NATL ACAD SCI USA, V91, P5513, DOI 10.1073/pnas.91.12.5513; Bepler G, 2004, J CLIN ONCOL, V22, P1878, DOI 10.1200/JCO.2004.12.002; Bepler G, 2002, J CLIN ONCOL, V20, P1353, DOI 10.1200/JCO.20.5.1353; BEPLER G, 2006, ASCO 2006 ED BOOK, P431; Bepler G, 2006, J CLIN ONCOL, V24, P4731, DOI 10.1200/JCO.2006.06.1101; Bergman AM, 2005, CANCER RES, V65, P9510, DOI 10.1158/0008-5472.CAN-05-0989; Bertheau P, 1998, J CLIN PATHOL, V51, P370, DOI 10.1136/jcp.51.5.370; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; CARBONE DP, 1994, CHEST, V106, pS377, DOI 10.1378/chest.106.6.377S; Ceppi P, 2006, ANN ONCOL, V17, P1818, DOI 10.1093/annonc/mdl300; Davidson JD, 2004, CANCER RES, V64, P3761, DOI 10.1158/0008-5472.CAN-03-3363; Fan HZ, 1997, P NATL ACAD SCI USA, V94, P13181, DOI 10.1073/pnas.94.24.13181; Gautam A, 2003, ONCOGENE, V22, P2135, DOI 10.1038/sj.onc.1206232; Gautam A, 2006, CANCER RES, V66, P6497, DOI 10.1158/0008-5472.CAN-05-4462; Gridelli C, 2003, J CLIN ONCOL, V21, P3025, DOI 10.1200/JCO.2003.06.099; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; McCabe A, 2005, JNCI-J NATL CANCER I, V97, P1808, DOI 10.1093/jnci/dji427; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; PEZZELLA F, 1993, NEW ENGL J MED, V329, P690, DOI 10.1056/NEJM199309023291003; Pitterle DM, 1999, MAMM GENOME, V10, P916, DOI 10.1007/s003359901114; RODENHUIS S, 1987, NEW ENGL J MED, V317, P929, DOI 10.1056/NEJM198710083171504; Rosell R, 2005, J CLIN ONCOL, V23, p621S; RUCKDESCHEL JC, 2004, CLIN ONCOLOGY, P1649; Sandler AB, 2000, J CLIN ONCOL, V18, P122, DOI 10.1200/JCO.2000.18.1.122; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Shi SR, 1997, J HISTOCHEM CYTOCHEM, V45, P327, DOI 10.1177/002215549704500301; Simon GR, 2005, CHEST, V127, P978, DOI 10.1378/chest.127.3.978; Treat J, 2005, J CLIN ONCOL, V23, p627S; Tsao MS, 2006, NEW ENGL J MED, V355, P1746; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736	32	397	436	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2007	356	8					800	808		10.1056/NEJMoa065411	http://dx.doi.org/10.1056/NEJMoa065411			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137XQ	17314339				2022-12-01	WOS:000244326700006
J	Li, HT; Xu, H; Zhou, Y; Zhang, J; Long, CZ; Li, SQ; Chen, S; Zhou, JM; Shao, F				Li, Hongtao; Xu, Hao; Zhou, Yan; Zhang, Jie; Long, Chengzu; Li, Shuqin; Chen, She; Zhou, Jian-Min; Shao, Feng			The phosphothreonine lyase activity of a bacterial type III effector family	SCIENCE			English	Article							VIRULENCE PLASMID; SECRETION SYSTEM; ACTIVATION; EXPRESSION; INFECTION	Pathogenic bacteria use the type III secretion system to deliver effector proteins into host cells to modulate the host signaling pathways. In this study, the Shigella type III effector OspF was shown to inactivate mitogen-activated protein kinases (MAPKs) [ extracellular signal-regulated kinases 1 and 2 ( Erk1/2), c-Jun N-terminal kinase, and p38]. OspF irreversibly removed phosphate groups from the phosphothreonine but not from the phosphotyrosine residue in the activation loop of MAPKs. Mass spectrometry revealed a mass loss of 98 daltons in p-Erk2, due to the abstraction of the a proton concomitant with cleavage of the C-OP bond in the phosphothreonine residue. This unexpected enzymatic activity, termed phosphothreonine lyase, appeared specific for MAPKs and was shared by other OspF family members.	Natl Inst Biol Sci, Beijing 102206, Peoples R China	National Institute of Biological Sciences, Beijing	Shao, F (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	shaofeng@nibs.ac.cn	Zhou, Jian-Min/A-3140-2013	Zhou, Jian-Min/0000-0002-9943-2975; Xu, Hao/0000-0003-3286-0710				Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; GULIG PA, 1993, INFECT IMMUN, V61, P504, DOI 10.1128/IAI.61.2.504-511.1993; Kane CD, 2002, J BACTERIOL, V184, P4409, DOI 10.1128/JB.184.16.4409-4419.2002; Kohler H, 2002, INFECT IMMUN, V70, P1150, DOI 10.1128/IAI.70.3.1150-1158.2002; Le Gall T, 2005, MICROBIOL-SGM, V151, P951, DOI 10.1099/mic.0.27639-0; Li XY, 2005, P NATL ACAD SCI USA, V102, P12990, DOI 10.1073/pnas.0502425102; Libby SJ, 1997, INFECT IMMUN, V65, P1786, DOI 10.1128/IAI.65.5.1786-1792.1997; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Ogawa M, 2006, CELL MICROBIOL, V8, P177, DOI 10.1111/j.1462-5822.2005.00652.x; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Philpott DJ, 2001, CURR OPIN IMMUNOL, V13, P410; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Zurawski DV, 2006, INFECT IMMUN, V74, P5964, DOI 10.1128/IAI.00594-06	17	315	333	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2007	315	5814					1000	1003		10.1126/science.1138960	http://dx.doi.org/10.1126/science.1138960			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303758				2022-12-01	WOS:000244229800046
J	O'Donnell, MJ; Kearon, C; Johnson, J; Robinson, M; Zondag, M; Turpie, I; Turpie, AG				O'Donnell, Martin J.; Kearon, Clive; Johnson, Judy; Robinson, Marlene; Zondag, Michelle; Turpie, Irene; Turpie, Alexander G.			Brief communication: Preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin	ANNALS OF INTERNAL MEDICINE			English	Article							PERIOPERATIVE MANAGEMENT; ELECTIVE SURGERY; ENOXAPARIN; PATIENT; THERAPY	Background: Preoperative low-molecular-weight heparin (LMWH) is often used when warfarin therapy is interrupted for surgery. Objective: To determine the preoperative anticoagulant activity of LMWH following a standardized "bridging" regimen. Design: Prospective cohort study. Setting: Single university hospital. Patients: Consecutive patients who had warfarin therapy interrupted before an invasive procedure. Intervention: Enoxaparin, 1 mg/kg of body weight, twice daily. The last dose was administered the evening before surgery. Measurements: Blood anti-factor Xa heparin levels measured shortly before surgery. Results: Preoperative anti-Xa heparin levels were obtained in 80 patients at an average of 14 hours after the last dose of enoxaparin was administered. The average anti-Xa heparin level was 0.6 U/mL. The anti-Xa heparin level, measured shortly before surgery, was 0.5 U/mL or greater in 54 (68%) patients and 1.0 U/mL or greater in 13 (16%) patients. A shorter interval since the last dose (P < 0.001) and a higher body mass index (P = 0.001) were associated with higher preoperative anti-Xa heparin levels. Limitations: The small sample size limits accurate estimates of the frequency of the clinical outcomes. A single regimen of LMWH was evaluated. Conclusions: Anti-Xa heparin levels often remain high at the time of surgery if a last dose of a twice-daily regimen of LMWH is given the evening before surgery.	McMaster Univ, Henderson Res Ctr, Hamilton, ON L8V 1C3, Canada; Hamilton Hlth Sci Fdn, Hamilton, ON, Canada	McMaster University	O'Donnell, MJ (corresponding author), McMaster Univ, Henderson Res Ctr, 70 Wing,Room 220,711 Concess St, Hamilton, ON L8V 1C3, Canada.	odonnm@mcmaster.ca	O'Donnell, Martin/ABE-7459-2020	O'Donnell, Martin/0000-0002-7347-7761				Ansell J, 2004, CHEST, V126, p204S, DOI 10.1378/chest.126.3_suppl.204S; Becker RC, 2002, AM HEART J, V143, P753, DOI 10.1067/mhj.2002.120774; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Douketis JD, 2004, ARCH INTERN MED, V164, P1319, DOI 10.1001/archinte.164.12.1319; Douketis JD, 2002, THROMB HAEMOSTASIS, V88, P37; Douketis JD, 2000, CAN J CARDIOL, V16, P326; Fareed J, 1998, AM J CARDIOL, V82, p3L, DOI 10.1016/S0002-9149(98)00105-2; Garcia DA, 2005, J THROMB THROMBOLYS, V18, P199, DOI 10.1007/s11239-005-0346-5; Heit JA, 2001, J THROMB THROMBOLYS, V12, P81, DOI 10.1023/A:1012746729537; Kearon C, 1997, NEW ENGL J MED, V336, P1506, DOI 10.1056/NEJM199705223362107; Kovacs MJ, 2004, CIRCULATION, V110, P1658, DOI 10.1161/01.CIR.0000142859.77578.C9; Montalescot G, 2004, CIRCULATION, V110, P392, DOI 10.1161/01.CIR.0000136830.65073.C7; O'Donnell M, 2006, CLIN GERIATR MED, V22, P199, DOI 10.1016/j.cger.2005.09.008; Spyropoulos AC, 2006, J THROMB HAEMOST, V4, P1246, DOI 10.1111/j.1538-7836.2006.01908.x; Turpie AG, 2004, BLOOD, V104, p202A, DOI 10.1182/blood.V104.11.703.703; Wilson SJ, 2001, HAEMOSTASIS, V31, P42	16	71	74	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 6	2007	146	3					184	187		10.7326/0003-4819-146-3-200702060-00007	http://dx.doi.org/10.7326/0003-4819-146-3-200702060-00007			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132QN	17283349				2022-12-01	WOS:000243957400004
J	Coombes, R				Coombes, Rebecca			Is killing pain worth the risk? MPs argue that the regulator went too far when it banned co-proxamol	BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmjgroup.com							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 27	2007	334	7586					186	187		10.1136/bmj.39104.415961.68	http://dx.doi.org/10.1136/bmj.39104.415961.68			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133QN	17255610	Green Published			2022-12-01	WOS:000244027600031
J	Basak, S; Kim, H; Kearns, JD; Tergaonkar, V; O'Dea, E; Werner, SL; Benedict, CA; Ware, CF; Ghosh, G; Verma, IM; Hoffmann, A				Basak, Soumen; Kim, Hana; Kearns, Jeffrey D.; Tergaonkar, Vinay; O'Dea, Ellen; Werner, Shannon L.; Benedict, Chris A.; Ware, Carl F.; Ghosh, Gourisankar; Verma, Inder M.; Hoffmann, Alexander			A fourth I kappa B protein within the NF-kappa B signaling module	CELL			English	Article							LYMPHOTOXIN-BETA-RECEPTOR; GENE-EXPRESSION; ACTIVATION PATHWAYS; LYMPHOID-TISSUES; TEMPORAL CONTROL; TARGET GENES; DNA-BINDING; IKK-ALPHA; NF-KAPPA-B2; KINASE	Inflammatory NF-kappa B/RelA activation is mediated by the three canonical inhibitors, I kappa B alpha, -beta, and -epsilon. We report here the characterization of a fourth inhibitor, nf kappa b2/p100, that forms two distinct inhibitory complexes with RelA, one of which mediates developmental NF-kappa B activation. Our genetic evidence confirms that p100 is required and sufficient as a fourth I kappa B protein for noncanonical NF-kappa B signaling downstream of NIK and IKK1. We develop a mathematical model of the four-I kappa B-containing NF-kappa B signaling module to account for NF-kappa B/BelA:p50 activation in response to inflammatory and developmental stimuli and find signaling crosstalk between them that determines gene-expression programs. Further combined computational and experimental studies reveal that mutant cells with altered balances between canonical and noncanonical I kappa B proteins may exhibit inappropriate inflammatory gene expression in response to developmental signals. Our results have important implications for physiological and pathological scenarios in which inflammatory and developmental signals converge.	Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif San Diego, Signaling Syst Lab, La Jolla, CA 92093 USA; Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute; La Jolla Institute for Immunology	Hoffmann, A (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	ahoffmann@ucsd.edu		Basak, Soumen/0000-0002-3586-1279	NCI NIH HHS [P01 CA069381, CA69381] Funding Source: Medline; NIAID NIH HHS [R21 AI061549, AI61549, R37AI33068] Funding Source: Medline; NIGMS NIH HHS [GM071573, P01 GM071862, R01 GM071573, GM071862] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033068, R21AI061549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM071862, R01GM071573] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alcamo E, 2002, J EXP MED, V195, P233, DOI 10.1084/jem.20011885; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Browning JL, 2005, IMMUNITY, V23, P539, DOI 10.1016/j.immuni.2005.10.002; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Derudder E, 2003, J BIOL CHEM, V278, P23278, DOI 10.1074/jbc.M300106200; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; HATADA EN, 1992, P NATL ACAD SCI USA, V89, P2489, DOI 10.1073/pnas.89.6.2489; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; INOUE J, 1992, CELL, V68, P1109, DOI 10.1016/0092-8674(92)90082-N; Ishimaru N, 2006, NAT IMMUNOL, V7, P763, DOI 10.1038/ni1351; Jiang X, 2003, J BIOL CHEM, V278, P919, DOI 10.1074/jbc.M208696200; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Knuesel M, 2003, MOL CELL PROTEOMICS, V2, P1225, DOI 10.1074/mcp.T300007-MCP200; Krappmann D, 1999, ONCOGENE, V18, P943, DOI 10.1038/sj.onc.1202351; Lo JC, 2006, BLOOD, V107, P1048, DOI 10.1182/blood-2005-06-2452; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; MERCURIO F, 1993, GENE DEV, V7, P705, DOI 10.1101/gad.7.4.705; Moorthy AK, 2003, J BIOL CHEM, V278, P556, DOI 10.1074/jbc.M207515200; Moorthy AK, 2006, EMBO J, V25, P1945, DOI 10.1038/sj.emboj.7601081; Mordmuller B, 2003, EMBO REP, V4, P82, DOI 10.1038/embor710; Muller JR, 2003, J BIOL CHEM, V278, P12006, DOI 10.1074/jbc.M210768200; NAUMANN M, 1993, ONCOGENE, V8, P2275; Ramakrishnan P, 2004, IMMUNITY, V21, P477, DOI 10.1016/j.immuni.2004.08.009; Rennert PD, 1998, IMMUNITY, V9, P71, DOI 10.1016/S1074-7613(00)80589-0; Schneider K, 2004, IMMUNOL REV, V202, P49, DOI 10.1111/j.0105-2896.2004.00206.x; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Tergaonkar V, 2005, NAT CELL BIOL, V7, P921, DOI 10.1038/ncb1296; Weih DS, 2001, J IMMUNOL, V167, P1909, DOI 10.4049/jimmunol.167.4.1909; Weih F, 2003, IMMUNOL REV, V195, P91, DOI 10.1034/j.1600-065X.2003.00064.x; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Zarnegar B, 2004, P NATL ACAD SCI USA, V101, P8108, DOI 10.1073/pnas.0402629101	40	292	302	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 26	2007	128	2					369	381		10.1016/j.cell.2006.12.033	http://dx.doi.org/10.1016/j.cell.2006.12.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254973	Bronze, Green Accepted			2022-12-01	WOS:000244420500020
J	Boyd, NF; Guo, H; Martin, LJ; Sun, LM; Stone, J; Fishell, E; Jong, RA; Hislop, G; Chiarelli, A; Minkin, S; Yaffe, MJ				Boyd, Norman F.; Guo, Helen; Martin, Lisa J.; Sun, Limei; Stone, Jennifer; Fishell, Eve; Jong, Roberta A.; Hislop, Greg; Chiarelli, Anna; Minkin, Salomon; Yaffe, Martin J.			Mammographic density and the risk and detection of breast cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PARENCHYMAL PATTERNS; SCREENING-PROGRAM; WOMEN; INTERVAL; CLASSIFICATION; FEATURES; FAILURE; SIGNS	BACKGROUND: Extensive mammographic density is associated with an increased risk of breast cancer and makes the detection of cancer by mammography difficult, but the influence of density on risk according to method of cancer detection is unknown. METHODS: We carried out three nested case-control studies in screened populations with 1112 matched case-control pairs. We examined the association of the measured percentage of density in the baseline mammogram with risk of breast cancer, according to method of cancer detection, time since the initiation of screening, and age. RESULTS: As compared with women with density in less than 10% of the mammogram, women with density in 75% or more had an increased risk of breast cancer (odds ratio, 4.7; 95% confidence interval [CI], 3.0 to 7.4), whether detected by screening (odds ratio, 3.5; 95% CI, 2.0 to 6.2) or less than 12 months after a negative screening examination (odds ratio, 17.8; 95% CI, 4.8 to 65.9). Increased risk of breast cancer, whether detected by screening or other means, persisted for at least 8 years after study entry and was greater in younger than in older women. For women younger than the median age of 56 years, 26% of all breast cancers and 50% of cancers detected less than 12 months after a negative screening test were attributable to density in 50% or more of the mammogram. CONCLUSIONS: Extensive mammographic density is strongly associated with the risk of breast cancer detected by screening or between screening tests. A substantial fraction of breast cancers can be attributed to this risk factor.	Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; Womens Hosp Med Ctr, Dept Radiol, Toronto, ON, Canada; Womens Hosp Med Ctr, Dept Imaging Res, Toronto, ON, Canada; Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; Canc Care Ontario, Ontario Breast Screening Program, Toronto, ON, Canada; British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Cancer Care Ontario; British Columbia Cancer Agency	Boyd, NF (corresponding author), Ontario Canc Inst, 610 Univ Ave,Room 10-415, Toronto, ON M5G 2M9, Canada.	boyd@uhnres.utoronto.ca	Stone, Jennifer/AAS-3805-2020	Stone, Jennifer/0000-0001-5077-0124				Boyd NF, 2005, LANCET ONCOL, V6, P798, DOI 10.1016/S1470-2045(05)70390-9; BOYD NF, 1995, J NATL CANCER I, V87, P670, DOI 10.1093/jnci/87.9.670; BOYD NF, 1982, BRIT J CANCER, V45, P185, DOI 10.1038/bjc.1982.32; Breslow NE., 1980, IARC SCI PUBLICATION, V32; Buist DSM, 2004, JNCI-J NATL CANCER I, V96, P1432, DOI 10.1093/jnci/djh269; BYNG JW, 1994, PHYS MED BIOL, V39, P1629, DOI 10.1088/0031-9155/39/10/008; Byrne C, 2001, CANCER CAUSE CONTROL, V12, P103, DOI 10.1023/A:1008935821885; BYRNE C, 1995, J NATL CANCER I, V87, P1622, DOI 10.1093/jnci/87.21.1622; Crystal P, 2003, AM J ROENTGENOL, V181, P177, DOI 10.2214/ajr.181.1.1810177; Gilliland FD, 2000, J NATL CANCER I, V92, P743, DOI 10.1093/jnci/92.9.743; Harvey JA, 2004, RADIOLOGY, V230, P29, DOI 10.1148/radiol.2301020870; JOHNS PC, 1987, PHYS MED BIOL, V32, P675, DOI 10.1088/0031-9155/32/6/002; Jong R, 1996, EUR J CANCER PREV, V5, P281, DOI 10.1097/00008469-199608000-00008; Knight JA, 1998, BREAST CANCER RES TR, V48, P65, DOI 10.1023/A:1005990806919; MA L, 1992, J NATL CANCER I, V84, P781, DOI 10.1093/jnci/84.10.781; Mandelson MT, 2000, J NATL CANCER I, V92, P1081, DOI 10.1093/jnci/92.13.1081; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; MEYER JE, 1984, RADIOLOGY, V150, P335, DOI 10.1148/radiology.150.2.6691085; MILLER AB, 1992, CAN MED ASSOC J, V147, P1477; MILLER AB, 1993, CAN MED ASSOC J, V148, P718; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Porter PL, 1999, J NATL CANCER I, V91, P2020, DOI 10.1093/jnci/91.23.2020; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3; Roubidoux MA, 2004, RADIOLOGY, V230, P42, DOI 10.1148/radiol.2301020589; SAFTLAS AF, 1991, CANCER, V67, P2833, DOI 10.1002/1097-0142(19910601)67:11<2833::AID-CNCR2820671121>3.0.CO;2-U; Sala E, 1998, J MED SCREEN, V5, P207, DOI 10.1136/jms.5.4.207; SICKLES EA, 1986, AM J ROENTGENOL, V146, P661, DOI 10.2214/ajr.146.4.661; Ursin G, 2003, CANCER EPIDEM BIOMAR, V12, P332; van Gils CH, 1998, EUR J EPIDEMIOL, V14, P315, DOI 10.1023/A:1007423824675; WHITEHEAD J, 1985, CANCER, V56, P1280, DOI 10.1002/1097-0142(19850915)56:6<1280::AID-CNCR2820560610>3.0.CO;2-8; WOLFE JN, 1987, AM J ROENTGENOL, V148, P1087, DOI 10.2214/ajr.148.6.1087; WOLFE JN, 1976, CANCER, V37, P2486, DOI 10.1002/1097-0142(197605)37:5<2486::AID-CNCR2820370542>3.0.CO;2-8; WOLFE JN, 1976, AM J ROENTGENOL, V126, P1130, DOI 10.2214/ajr.126.6.1130; Wright H, 2005, AM J SURG, V190, P572, DOI 10.1016/j.amjsurg.2005.06.014	34	1535	1567	3	95	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 18	2007	356	3					227	236		10.1056/NEJMoa062790	http://dx.doi.org/10.1056/NEJMoa062790			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126BV	17229950				2022-12-01	WOS:000243488100005
J	Yeung, RSM				Yeung, Rae S. M.			Phenotype and coronary outcome in Kawasaki's disease	LANCET			English	Editorial Material							ASSOCIATION; ANEURYSMS		Univ Toronto, Hosp Sick Children, Dept Paediat, Div Rheumatol, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Yeung, RSM (corresponding author), Univ Toronto, Hosp Sick Children, Dept Paediat, Div Rheumatol, Toronto, ON M5G 1X8, Canada.	rae.yeung@sickkids.ca		Yeung, Rae/0000-0003-2361-725X				Beiser AS, 1998, AM J CARDIOL, V81, P1116, DOI 10.1016/S0002-9149(98)00116-7; Benseler SM, 2006, ANN RHEUM DIS, V65, P245; Benseler SM, 2005, PEDIATRICS, V116, pE760, DOI 10.1542/peds.2005-0559; BURNS JC, 1991, J PEDIATR-US, V118, P680, DOI 10.1016/S0022-3476(05)80026-5; DANIELS SR, 1987, AM J DIS CHILD, V141, P205, DOI 10.1001/archpedi.1987.04460020095035; Gong GWK, 2006, J PEDIATR-US, V148, P800, DOI 10.1016/j.jpeds.2006.01.039; Harada Kensuke, 1991, Acta Paediatrica Japonica, V33, P805; Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865; KOREN G, 1986, J PEDIATR-US, V108, P388, DOI 10.1016/S0022-3476(86)80878-2; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; Rowley A H, 1991, Adv Pediatr, V38, P51; Sung RYT, 2006, PEDIATR INFECT DIS J, V25, P521, DOI 10.1097/01.inf.0000215263.96289.1c	12	9	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 13	2007	369	9556					85	87		10.1016/S0140-6736(07)60045-2	http://dx.doi.org/10.1016/S0140-6736(07)60045-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126TK	17223454				2022-12-01	WOS:000243538200007
J	Portner, HO; Knust, R				Poertner, Hans O.; Knust, Rainer			Climate change affects marine fishes through the oxygen limitation of thermal tolerance	SCIENCE			English	Article							TEMPERATURE-DEPENDENT BIOGEOGRAPHY; PHYSIOLOGICAL-BASIS; GADUS-MORHUA; TRADE-OFFS; COD; RECRUITMENT; PERFORMANCE; EVOLUTION; GROWTH; SEA	A cause-and-effect understanding of climate influences on ecosystems requires evaluation of thermal limits of member species and of their ability to cope with changing temperatures. Laboratory data available for marine fish and invertebrates from various climatic regions led to the hypothesis that, as a unifying principle, a mismatch between the demand for oxygen and the capacity of oxygen supply to tissues is the first mechanism to restrict whole-animal tolerance to thermal extremes. We show in the eelpout, Zoarces viviparus, a bioindicator fish species for environmental monitoring from North and Baltic Seas (Helcom), that thermally limited oxygen delivery closely matches environmental temperatures beyond which growth performance and abundance decrease. Decrements in aerobic performance in warming seas will thus be the first process to cause extinction or relocation to cooler waters.	Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Portner, HO (corresponding author), Alfred Wegener Inst Polar & Marine Res, Postfach 12 01 61, D-27515 Bremerhaven, Germany.	hpoertner@awi-bremerhaven.de	Pörtner, Hans-O./K-9429-2016	Pörtner, Hans-O./0000-0001-6535-6575				Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Fonds M, 1989, G31 INT COUNC EXPL S; Frederich M, 2000, AM J PHYSIOL-REG I, V279, pR1531, DOI 10.1152/ajpregu.2000.279.5.R1531; Hardewig I, 1999, J COMP PHYSIOL B, V169, P597, DOI 10.1007/s003600050260; HELAOUET P, IN PRESS MAR ECOL PR; Jensen MN, 2003, SCIENCE, V299, P38, DOI 10.1126/science.299.5603.38; Johnston IA, 1998, J EXP BIOL, V201, P1; KUNDZEWICZ ZW, 2001, IMPACTS ADAPTATION V, P641; Lannig G, 2004, AM J PHYSIOL-REG I, V287, pR902, DOI 10.1152/ajpregu.00700.2003; Linton TK, 1998, CAN J FISH AQUAT SCI, V55, P576, DOI 10.1139/cjfas-55-3-576; Mark FC, 2002, AM J PHYSIOL-REG I, V283, pR1254, DOI 10.1152/ajpregu.00167.2002; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Portner HO, 2006, DEEP-SEA RES PT II, V53, P1071, DOI 10.1016/j.dsr2.2006.02.015; Portner H.-O., 2005, FISH PHYSIOL, V22, P79, DOI DOI 10.1016/S1546-5098(04)22003-9; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portner HO, 2006, PHYSIOL BIOCHEM ZOOL, V79, P295, DOI 10.1086/499986; Portner HO, 2004, PHYSIOL BIOCHEM ZOOL, V77, P959, DOI 10.1086/423742; Portner HO, 2004, RESP PHYSIOL NEUROBI, V141, P243, DOI 10.1016/j.resp.2004.03.011; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; Portner HO, 2002, J EXP BIOL, V205, P2217; Portner HO, 2001, CONT SHELF RES, V21, P1975, DOI 10.1016/S0278-4343(01)00038-3; Rodnick KJ, 2004, J FISH BIOL, V64, P310, DOI 10.1111/j.0022-1112.2004.00292.x; Sartoris FJ, 2003, J FISH BIOL, V62, P1239, DOI 10.1046/j.1095-8649.2003.00099.x; Sheppard C, 2004, MAR POLLUT BULL, V49, P12, DOI 10.1016/j.marpolbul.2004.05.011; Sogard SM, 1997, B MAR SCI, V60, P1129; *SYST SOFTW INT, SIGMAPLOT; TIEWS K, 1983, ARCH FISCHEREIWISS, V34, P4; TIEWS K, 1990, VEROFF I KUST BINNEN, V103, P1; ULLEWEIT J, 1995, THESIS U BREMEN BREM; Van Dijk PLM, 1999, J EXP BIOL, V202, P3611; Wiltshire KH, 2004, HELGOLAND MAR RES, V58, P269, DOI 10.1007/s10152-004-0196-0; Zakhartsev MV, 2003, J COMP PHYSIOL B, V173, P365, DOI 10.1007/s00360-003-0342-z	32	1321	1344	8	640	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2007	315	5808					95	97		10.1126/science.1135471	http://dx.doi.org/10.1126/science.1135471			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17204649				2022-12-01	WOS:000243259100043
J	Koenigs, M; Young, L; Adolphs, R; Tranel, D; Cushman, F; Hauser, M; Damasio, A				Koenigs, Michael; Young, Liane; Adolphs, Ralph; Tranel, Daniel; Cushman, Fiery; Hauser, Marc; Damasio, Antonio			Damage to the prefrontal cortex increases utilitarian moral judgements	NATURE			English	Article							NETWORKS; EMOTION; FMRI	The psychological and neurobiological processes underlying moral judgement have been the focus of many recent empirical studies(1-11). Of central interest is whether emotions play a causal role in moral judgement, and, in parallel, how emotion-related areas of the brain contribute to moral judgement. Here we show that six patients with focal bilateral damage to the ventromedial prefrontal cortex (VMPC), a brain region necessary for the normal generation of emotions and, in particular, social emotions(12-14), produce an abnormally 'utilitarian' pattern of judgements on moral dilemmas that pit compelling considerations of aggregate welfare against highly emotionally aversive behaviours ( for example, having to sacrifice one person's life to save a number of other lives)(7,8). In contrast, the VMPC patients' judgements were normal in other classes of moral dilemmas. These findings indicate that, for a selective set of moral dilemmas, the VMPC is critical for normal judgements of right and wrong. The findings support a necessary role for emotion in the generation of those judgements.	Univ Iowa Hosp & Clin, Dept Neurol, Iowa City, IA 52242 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA; Univ So Calif, Dornsife Ctr Cognit Neuroimaging, Los Angeles, CA 90089 USA	University of Iowa; Harvard University; California Institute of Technology; California Institute of Technology; University of Southern California; University of Southern California	Adolphs, R (corresponding author), Univ Iowa Hosp & Clin, Dept Neurol, Iowa City, IA 52242 USA.	radolphs@hss.caltech.edu	Damasio, Antonio/AAD-1342-2019	Tranel, Daniel/0000-0002-1338-1389; Cushman, Fiery/0000-0002-6929-9982; Koenigs, Michael/0000-0002-5799-4881	NIDA NIH HHS [R01 DA022549-02, R01 DA022549] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022549] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anderson S. W., 1993, IOWA RATING SCALES P; Anderson SW, 2006, J INT NEUROPSYCH SOC, V12, P224, DOI 10.1017/S1355617706060346; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Beer JS, 2003, J PERS SOC PSYCHOL, V85, P594, DOI 10.1037/0022-3514.85.4.594; BLAIR RJR, 1995, COGNITION, V57, P1, DOI 10.1016/0010-0277(95)00676-P; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Cushman F, 2006, PSYCHOL SCI, V17, P1082, DOI 10.1111/j.1467-9280.2006.01834.x; Damasio A.R., 2003, LOOKING SPINOZA JOY; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; Damasio AR., 2006, DESCARTES ERROR EMOT; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; Frank RJ, 1997, NEUROIMAGE, V5, P13, DOI 10.1006/nimg.1996.0250; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Hauser M., 2006, MORAL MINDS; Hauser M, 2007, MIND LANG, V22, P1, DOI 10.1111/j.1468-0017.2006.00297.x; Heekeren HR, 2003, NEUROREPORT, V14, P1215, DOI 10.1097/00001756-200307010-00005; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Kohlberg L., 1981, ESSAYS MORAL DEV; Luo QA, 2006, NEUROIMAGE, V30, P1449, DOI 10.1016/j.neuroimage.2005.11.005; Mendez MF, 2005, COGN BEHAV NEUROL, V18, P193, DOI 10.1097/01.wnn.0000191292.17964.bb; MIKHAIL JM, 2000, THESIS CORNELL U; Moll J, 2002, NEUROIMAGE, V16, P696, DOI 10.1006/nimg.2002.1118; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; SAVER JL, 1991, NEUROPSYCHOLOGIA, V29, P1241, DOI 10.1016/0028-3932(91)90037-9; Valdesolo P, 2006, PSYCHOL SCI, V17, P476, DOI 10.1111/j.1467-9280.2006.01731.x; Wheatley T, 2005, PSYCHOL SCI, V16, P780, DOI 10.1111/j.1467-9280.2005.01614.x	29	956	990	16	290	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2007	446	7138					908	911		10.1038/nature05631	http://dx.doi.org/10.1038/nature05631			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	158IR	17377536	Green Published, Green Accepted			2022-12-01	WOS:000245785700041
J	Jung, J; Bonini, N				Jung, Joonil; Bonini, Nancy			CREB-binding protein modulates repeat instability in a Drosophila model for polyQ disease	SCIENCE			English	Article							MACHADO-JOSEPH-DISEASE; CAG REPEATS; DNA-REPAIR; POLYGLUTAMINE DISEASE; GENETIC INSTABILITY; LENGTH; TRANSCRIPTION; MECHANISMS; HUNTINGTIN; EXPANSION	Although expansion of trinucleotide repeats accounts for over 30 human diseases, mechanisms of repeat instability remain poorly understood. We show that a Drosophila model for the CAG/polyglutamine (polyQ) disease spinocerebellar ataxia type 3 recapitulates key features of human CAG-repeat instability, including large repeat changes and strong expansion bias. Instability is dramatically enhanced by transcription and modulated by nuclear excision repair and a regulator of DNA repair adenosine 3',5'- monophosphate (cAMP) response element-binding protein (CREB)-binding protein-a histone acetyltransferase (HAT) whose decreased activity contributes to polyQ disease. Pharmacological treatment to normalize acetylation suppressed instability. Thus, toxic consequences of pathogenic polyQ protein may include enhancing repeat instability.	Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania	Bonini, N (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	nbonini@sas.upenn.edu						Bodai L, 2003, CURR MED CHEM, V10, P2577, DOI 10.2174/0929867033456530; Chai YH, 2002, P NATL ACAD SCI USA, V99, P9310, DOI 10.1073/pnas.152101299; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Hasan S, 2002, J MOL MED, V80, P463, DOI 10.1007/s00109-002-0341-7; Jackson SM, 2005, GENE, V347, P35, DOI 10.1016/j.gene.2004.12.008; Jiang HB, 2003, HUM MOL GENET, V12, P1, DOI 10.1093/hmg/ddg002; Jin P, 2003, NEURON, V39, P739, DOI 10.1016/S0896-6273(03)00533-6; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kaytor MD, 1997, HUM MOL GENET, V6, P2135, DOI 10.1093/hmg/6.12.2135; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; Lin YF, 2006, NAT STRUCT MOL BIOL, V13, P179, DOI 10.1038/nsmb1042; Maciel P, 1999, EUR J HUM GENET, V7, P147, DOI 10.1038/sj.ejhg.5200264; Mangiarini L, 1997, NAT GENET, V15, P197, DOI 10.1038/ng0297-197; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; Marx J, 2005, SCIENCE, V310, P43, DOI 10.1126/science.310.5745.43; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Sato T, 1999, HUM MOL GENET, V8, P99, DOI 10.1093/hmg/8.1.99; Savouret C, 2003, EMBO J, V22, P2264, DOI 10.1093/emboj/cdg202; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Takiyama Y, 1997, HUM MOL GENET, V6, P1063, DOI 10.1093/hmg/6.7.1063; Tanaka F, 1999, AM J HUM GENET, V65, P966, DOI 10.1086/302578; Taylor JP, 2003, GENE DEV, V17, P1463, DOI 10.1101/gad.1087503; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Wells RD, 2005, NUCLEIC ACIDS RES, V33, P3785, DOI 10.1093/nar/gki697; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Zhang Y, 2002, HUM MOL GENET, V11, P791, DOI 10.1093/hmg/11.7.791	30	110	110	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1857	1859		10.1126/science.1139517	http://dx.doi.org/10.1126/science.1139517			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17332375				2022-12-01	WOS:000245280100047
J	Spar, D				Spar, Debora			The egg trade - Making sense of the market for human oocytes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Business, Boston, MA 02163 USA	Harvard University	Spar, D (corresponding author), Harvard Univ, Sch Business, Boston, MA 02163 USA.							*BBC, 2005, BBC NEWS ONL; GALPERN E, 2006, WOMENS HLTH ACTI MAY; Guidice L., 2007, ASSESSING MED RISKS; ORTIZ, 2006, 1260 SB; Practice Committe of the American Society for Reproductive Medicine, 2003, Fertil Steril, V80, P1309	5	30	30	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2007	356	13					1289	1291		10.1056/NEJMp078012	http://dx.doi.org/10.1056/NEJMp078012			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150MN	17392298				2022-12-01	WOS:000245221000001
J	Pelletier, F; Clutton-Brock, T; Pemberton, J; Tuljapurkar, S; Coulson, T				Pelletier, Fanie; Clutton-Brock, Tim; Pemberton, Josephine; Tuljapurkar, Shripad; Coulson, Tim			The evolutionary demography of ecological change: Linking trait variation and population growth	SCIENCE			English	Article							NATURAL-SELECTION; RAPID EVOLUTION; NEONATAL TRAITS; SOAY SHEEP; DENSITY; TIME	Population dynamics and evolutionary change are linked by the fundamental biological processes of birth and death. This means that population growth may correlate with the strength of selection, whereas evolutionary change can leave an ecological signature. We decompose population growth in an age-structured population into contributions from variation in a quantitative trait. We report that the distribution of body sizes within a population of Soay sheep can markedly influence population dynamics, accounting for up to one-fifth of observed population growth. Our results suggest that there is substantial opportunity for evolutionary dynamics to leave an ecological signature and visa versa.	Univ London Imperial Coll Sci Technol & Med, Ctr Populat Biol, Div Biol, Ascot SL5 7PY, Berks, England; Univ London Imperial Coll Sci Technol & Med, Ctr Populat Biol, NERC, Ascot SL5 7PY, Berks, England; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Imperial College London; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Cambridge; University of Edinburgh; Stanford University	Coulson, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Populat Biol, Div Biol, Silwood Pk, Ascot SL5 7PY, Berks, England.	t.coulson@imperial.ac.uk	Pemberton, Josephine M/F-3100-2010; Coulson, Tim/AAL-8148-2021	Coulson, Tim/0000-0001-9371-9003; Tuljapurkar, Shripad/0000-0001-5549-4245	NERC [cpb010001] Funding Source: UKRI; NIA NIH HHS [P01 AG022500-04, P01 AG 22500, P01 AG022500] Funding Source: Medline; Natural Environment Research Council [cpb010001, NER/A/S/2003/00461] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ARNOLD SJ, 1984, EVOLUTION, V38, P709, DOI 10.1111/j.1558-5646.1984.tb00344.x; BRODIE ED, 1995, TRENDS ECOL EVOL, V10, P313, DOI 10.1016/S0169-5347(00)89117-X; Catchpole EA, 2000, J R STAT SOC C-APPL, V49, P453, DOI 10.1111/1467-9876.00205; CLUTTONELROCK TH, 2004, SOAY SHEEP DYNAMICS; Coulson T, 2006, P ROY SOC B-BIOL SCI, V273, P547, DOI 10.1098/rspb.2005.3357; Coulson T, 2003, EVOLUTION, V57, P2879, DOI 10.1111/j.0014-3820.2003.tb01528.x; Falconer DS, 1996, INTRO QUANTITATIVE G; Fisher R.A., 1930, GENETICAL THEORY NAT; Forchhammer MC, 2001, J ANIM ECOL, V70, P721, DOI 10.1046/j.0021-8790.2001.00532.x; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Hanski I, 2006, PLOS BIOL, V4, P719, DOI 10.1371/journal.pbio.0040129; JORGENSON JT, 1993, CAN J ZOOL, V71, P2509, DOI 10.1139/z93-344; LANDE R, 1982, ECOLOGY, V63, P607, DOI 10.2307/1936778; Overall ADJ, 2005, MOL ECOL, V14, P3383, DOI 10.1111/j.1365-294X.2005.02682.x; R_Development_Core_Team, 2006, R LANG ENV STAT COMP; Saccheri I, 2006, TRENDS ECOL EVOL, V21, P341, DOI 10.1016/j.tree.2006.03.018; SCHLUTER D, 1988, EVOLUTION, V42, P849, DOI [10.2307/2408904, 10.1111/j.1558-5646.1988.tb02507.x]; SLOBODKIN LAWRENCE B., 1961; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0; Wilson AJ, 2006, PLOS BIOL, V4, P1270, DOI 10.1371/journal.pbio.0040216; WILSON AJ, 2004, J EVOLUTION BIOL, DOI DOI 10.1007/S10682-006-9106-Z	22	184	184	2	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1571	1574		10.1126/science.1139024	http://dx.doi.org/10.1126/science.1139024			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363672				2022-12-01	WOS:000244934800051
J	Bao, ZH; Weatherspoon, MR; Shian, S; Cai, Y; Graham, PD; Allan, SM; Ahmad, G; Dickerson, MB; Church, BC; Kang, ZT; Abernathy, HW; Summers, CJ; Liu, ML; Sandhage, KH				Bao, Zhihao; Weatherspoon, Michael R.; Shian, Samuel; Cai, Ye; Graham, Phillip D.; Allan, Shawn M.; Ahmad, Gul; Dickerson, Matthew B.; Church, Benjamin C.; Kang, Zhitao; Abernathy, Harry W., III; Summers, Christopher J.; Liu, Meilin; Sandhage, Kenneth H.			Chemical reduction of three-dimensional silica micro-assemblies into microporous silicon replicas	NATURE			English	Article							POROUS SILICON; GAS SENSOR; VAPOR; EMISSION; DIOXIDE; WATER	The carbothermal reduction of silica into silicon requires the use of temperatures well above the silicon melting point (>= 2,000 degrees C)(1). Solid silicon has recently been generated directly from silica at much lower temperatures (<= 850 degrees C) via electrochemical reduction in molten salts(2,3). However, the silicon products of such electrochemical reduction did not retain the microscale morphology of the starting silica reactants(2,3). Here we demonstrate a low-temperature ( 650 degrees C) magnesiothermic reduction process for converting three-dimensional nanostructured silica micro-assemblies into microporous nanocrystalline silicon replicas. The intricate nanostructured silica microshells (frustules) of diatoms ( unicellular algae) were converted into co-continuous, nanocrystalline mixtures of silicon and magnesia by reaction with magnesium gas. Selective magnesia dissolution then yielded an interconnected network of silicon nanocrystals that retained the starting three-dimensional frustule morphology. The silicon replicas possessed a high specific surface area (>500 m(2) g(-1)), and contained a significant population of micropores (<= 20 angstrom). The silicon replicas were photoluminescent, and exhibited rapid changes in impedance upon exposure to gaseous nitric oxide ( suggesting a possible application in microscale gas sensing). This process enables the syntheses of microporous nanocrystalline silicon microassemblies with multifarious three-dimensional shapes inherited from biological(4-6) or synthetic silica templates(7-9) for sensor, electronic, optical or biomedical applications(10-13).	Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Sandhage, KH (corresponding author), Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.	ken.sandhage@mse.gatech.edu	Ahmad, Gul/GZL-7770-2022; Shao, Zongping/AAY-8177-2020; Liu, Meilin/E-5782-2010; Shian, Samuel/H-3168-2013	Liu, Meilin/0000-0002-6188-2372; Kang, Zhitao/0000-0001-6736-7809; Bao, Zhihao/0000-0002-8708-7510				Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255; Balagurov LA, 1996, J APPL PHYS, V79, P7143, DOI 10.1063/1.361484; BANERJEE HD, 1982, MATER SCI ENG, V52, P173, DOI 10.1016/0025-5416(82)90046-5; Baratto C, 2001, THIN SOLID FILMS, V391, P261, DOI 10.1016/S0040-6090(01)00992-0; Barin I., 1995, THERMOCHEMICAL DATA, P994; BARRET EP, 1951, J AM CHEM SOC, V73, P380; Bengtsson M, 2000, PHYS STATUS SOLIDI A, V182, P495, DOI 10.1002/1521-396X(200011)182:1<495::AID-PSSA495>3.0.CO;2-4; BLAADEREN A, 1997, NATURE, V385, P321; Boarino L, 2000, MAT SCI ENG B-SOLID, V69, P210, DOI 10.1016/S0921-5107(99)00267-6; BOUVARD D, 1991, ACTA METALL MATER, V39, P3083, DOI 10.1016/0956-7151(91)90041-X; Cha JN, 2000, NATURE, V403, P289, DOI 10.1038/35002038; CULLIS AG, 1991, NATURE, V353, P335, DOI 10.1038/353335a0; Cullity B. D., 1978, ELEMENTS XRAY DIFFRA, P101; Fan HY, 2000, NATURE, V405, P56, DOI 10.1038/35011026; Gelloz B, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2001136; Hall SR, 2003, CHEM COMMUN, P2784, DOI 10.1039/b309877j; International Centre for Diffraction Data, POWD DIFFR FIL; Li XG, 2003, LANGMUIR, V19, P8490, DOI 10.1021/la034487b; Miron AS, 1999, J BIOTECHNOL, V70, P249; NAGAMORI M, 1986, METALL TRANS B, V17, P503, DOI 10.1007/BF02670216; Nohira T, 2003, NAT MATER, V2, P397, DOI 10.1038/nmat900; Round F. E, 2000, DIATOMS BIOL MORPHOL; Sandhage KH, 2002, ADV MATER, V14, P429, DOI 10.1002/1521-4095(20020318)14:6<429::AID-ADMA429>3.3.CO;2-3; SCHMID AM, 1981, CELL BIOL MONOGR, V8, P63; Seals L, 2002, J APPL PHYS, V91, P2519, DOI 10.1063/1.1436556; Shin HC, 2005, J POWER SOURCES, V139, P314, DOI 10.1016/j.jpowsour.2004.06.073; Watanabe K, 1996, SENSOR ACTUAT B-CHEM, V33, P194, DOI 10.1016/0925-4005(96)80097-9; WYNNYCKYJ JR, 1976, HIGH TEMP SCI, V8, P203; Yasuda K, 2005, J ELECTROCHEM SOC, V152, pD232, DOI 10.1149/1.2103947	29	632	680	17	737	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2007	446	7132					172	175		10.1038/nature05570	http://dx.doi.org/10.1038/nature05570			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17344850				2022-12-01	WOS:000244718100037
J	Balague, F; Mannion, AF; Pellise, F; Cedraschi, C				Balague, Federico; Mannion, Anne F.; Pellise, Ferran; Cedraschi, Christine			Clinical update: low back pain	LANCET			English	Article							EUROPEAN GUIDELINES; PRIMARY-CARE; PREDICTION; MANAGEMENT; DISABILITY; DISORDERS		Cantonal Hosp, Dept Rheumatol Phys Med & Rehabil, CH-1708 Fribourg, Switzerland; Schulthess Klin, Spine Unit, Zurich, Switzerland; Hosp Univ Vall Hebron, Spine Unit, Barcelona, Spain; Univ Hosp Geneva, Ctr Multidisciplinary Pain, Serv Clin Pharmacol & Toxicol, Geneva, Switzerland; Univ Hosp Geneva, Ctr Multidisciplinary Pain, Div Gen Med Rehabil, Geneva, Switzerland	Schulthess Clinic; Hospital Universitari Vall d'Hebron; University of Geneva; University of Geneva	Balague, F (corresponding author), Cantonal Hosp, Dept Rheumatol Phys Med & Rehabil, CH-1708 Fribourg, Switzerland.	balaguef@hopcantfr.ch	Mannion, Anne F./AAN-5908-2020; Mannion, Anne F./C-6615-2009; Pellise, Ferran/D-4488-2016	Mannion, Anne F./0000-0002-1203-1096; Mannion, Anne F./0000-0002-1203-1096; Pellise, Ferran/0000-0002-0644-7757				Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Balague F, 2006, JOINT BONE SPINE, V73, P508, DOI 10.1016/j.jbspin.2006.01.005; Bombardier C, 2000, SPINE, V25, P3100, DOI 10.1097/00007632-200012150-00003; Brennan GP, 2006, SPINE, V31, P623, DOI 10.1097/01.brs.0000202807.72292.a8; Burton AK, 2006, EUR SPINE J, V15, pS136, DOI 10.1007/s00586-006-1070-3; Cassidy JD, 2005, SPINE, V30, P2817, DOI 10.1097/01.brs.0000190448.69091.53; Deyo RA, 1998, SPINE, V23, P2003, DOI 10.1097/00007632-199809150-00018; Dunn KM, 2006, PAIN, V126, P10, DOI 10.1016/j.pain.2006.06.005; Ferrer M, 2006, SPINE, V31, P1372, DOI 10.1097/01.brs.0000218477.53318.bc; Hicks GE, 2005, ARCH PHYS MED REHAB, V86, P1753, DOI 10.1016/j.apmr.2005.03.033; Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273; Laerum E, 2006, J REHABIL MED, V38, P255, DOI 10.1080/16501970600613461; Mannion AF, 2005, EUR SPINE J, V14, P1014, DOI 10.1007/s00586-005-0911-9; Mannion AF, 2001, SPINE, V26, P920, DOI 10.1097/00007632-200104150-00015; Modic MT, 2005, RADIOLOGY, V237, P597, DOI 10.1148/radiol.2372041509; Ostelo RWJG, 2005, BEST PRACT RES CL RH, V19, P593, DOI 10.1016/j.berh.2005.03.003; van Tulder M, 2006, EUR SPINE J, V15, pS169, DOI 10.1007/s00586-006-1071-2; Von Korff M, 2000, SPINE, V25, P3140, DOI 10.1097/00007632-200012150-00009; Walsh TL, 2003, SPINE, V28, P607, DOI 10.1097/00007632-200303150-00017; Watkins E, 2006, MAYO CLIN PROC, V81, P167, DOI 10.4065/81.2.167	20	87	88	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 3	2007	369	9563					726	728		10.1016/S0140-6736(07)60340-7	http://dx.doi.org/10.1016/S0140-6736(07)60340-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	143MP	17336636				2022-12-01	WOS:000244726700012
J	Morris, SC; Caron, JB				Morris, Simon Conway; Caron, Jean-Bernard			Halwaxiids and the early evolution of the lophotrochozoans	SCIENCE			English	Article							WIWAXIA-CORRUGATA MATTHEW; BURGESS SHALE; FOSSIL; MOLLUSKS; MICRINA; WALCOTT; YUNNAN; CHINA	Halkieriids and wiwaxiids are cosmopolitan sclerite-bearing metazoans from the Lower and Middle Cambrian. Although they have similar scleritomes, their phylogenetic position is contested. A new scleritomous fossil from the Burgess Shale has the prominent anterior shell of the halkieriids but also bears wiwaxiid-like sclerites. This new fossil defines the monophyletic halwaxiids and indicates that they have a key place in early lophotrochozoan history.	Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada	University of Cambridge; Royal Ontario Museum	Morris, SC (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.	sc113@esc.cam.ac.uk; jcaron@rom.ca		Caron, Jean-Bernard/0000-0002-1670-5502				Aris-Brosou S, 2003, MOL BIOL EVOL, V20, P1947, DOI 10.1093/molbev/msg226; Bengtson S, 2005, EVOLVING FORM AND FUNCTION: FOSSILS AND DEVELOPMENT, P101; BENGTSON S, 1992, LETHAIA, V25, P401, DOI 10.1111/j.1502-3931.1992.tb01644.x; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; Budd GE, 2000, BIOL REV, V75, P253, DOI 10.1017/S000632310000548X; Budd GE, 1998, LETHAIA, V31, P197, DOI 10.1111/j.1502-3931.1998.tb00508.x; BUTTERFIELD NJ, 1990, PALEOBIOLOGY, V16, P287, DOI 10.1017/S0094837300010009; Caron JB, 2006, PALAIOS, V21, P451, DOI 10.2110/palo.2003.P05-070R; Caron JB, 2006, NATURE, V442, P159, DOI 10.1038/nature04894; Conway Morris S., 1995, N JB GEOL PALAONTOL, V195, P319; DURHAM JW, 1974, J PALEONTOL, V48, P750; Eibye-Jacobsen D, 2004, LETHAIA, V37, P317, DOI 10.1080/00241160410002027; Giribet G, 2006, P NATL ACAD SCI USA, V103, P7723, DOI 10.1073/pnas.0602578103; Gould S.J., 1989, WONDERFUL LIFE BURGE; JELL PA, 1981, ALCHERINGA, V5, P85, DOI 10.1080/03115518108565423; Li GX, 2004, J PALEONTOL, V78, P900, DOI 10.1666/0022-3360(2004)078<0900:TAMTFT>2.0.CO;2; MORRIS SC, 1995, PHILOS T ROY SOC B, V347, P305, DOI 10.1098/rstb.1995.0029; MORRIS SC, 1985, PHILOS T R SOC B, V307, P507, DOI 10.1098/rstb.1985.0005; Morris SC, 2006, PHILOS T R SOC B, V361, P1069, DOI 10.1098/rstb.2006.1846; Qian Y., 1989, FOSSILS STRATA, V24, P1; Rokas A, 2005, SCIENCE, V310, P1933, DOI 10.1126/science.1116759; Shu DG, 2004, NATURE, V430, P422, DOI 10.1038/nature02648; Siegmund H, 1997, LETHAIA, V30, P285; Vinther J, 2005, ZOOL SCR, V34, P81, DOI 10.1111/j.1463-6409.2005.00177.x; Williams A, 2002, PALAEONTOLOGY, V45, P845, DOI 10.1111/1475-4983.00264	25	88	93	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816					1255	1258		10.1126/science.1137187	http://dx.doi.org/10.1126/science.1137187			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332408				2022-12-01	WOS:000244564700044
J	Metzl, JM				Metzl, Jonathan M.			If direct-to-consumer advertisements come to Europe: lessons from the USA	LANCET			English	Article; Proceedings Paper	Meeting on Medicalisation in the 21st Century	JUN, 2005	New York, NY				ANTIDEPRESSANTS		Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; Univ Michigan, Womens Studies Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Metzl, JM (corresponding author), Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA.	jmetzl@umich.edu			NICHD NIH HHS [K12HD001438] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001438] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aikin K. J., 2003, DIRECT TO CONSUMER A; Alexander-Banys Bambi, 2002, J Pediatr Health Care, V16, P49, DOI 10.1016/S0891-5245(02)96294-2; ANGELL M, 2004, TRUTH DRUG CO THEY D, P83; AUTON F, 2004, INT J ADVER, V23, P1; Hollon MF, 2005, JAMA-J AM MED ASSOC, V293, P2030, DOI 10.1001/jama.293.16.2030; HONE F, 2004, PHARM EXEC, V24, P96; Kravitz RL, 2005, JAMA-J AM MED ASSOC, V293, P1995, DOI 10.1001/jama.293.16.1995; Metzl JM, 2004, SOC SCI MED, V58, P577, DOI 10.1016/S0277-9536(03)00369-1; Metzl Jonathan, 2003, PROZAC COUCH PRESCRI; Weissman JS, 2003, HEALTH AFFAIR, V22, pW82, DOI 10.1377/hlthaff.w3.82	10	12	13	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 24	2007	369	9562					704	706		10.1016/S0140-6736(07)60321-3	http://dx.doi.org/10.1016/S0140-6736(07)60321-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	141RO	17321319				2022-12-01	WOS:000244596600035
J	Greene, CH; Pershing, AJ				Greene, Charles H.; Pershing, Andrew J.			Climate drives sea change	SCIENCE			English	Editorial Material							MAINE; GULF; VARIABILITY		Cornell Univ, Dept Earth & Atmospher Sci, Ithaca, NY 14853 USA; Univ Maine, Portland, ME 04101 USA; Gulf Maine Res Inst, Portland, ME 04101 USA	Cornell University; University of Maine System; University of Maine Orono; Gulf of Maine Research Institute	Greene, CH (corresponding author), Cornell Univ, Dept Earth & Atmospher Sci, Ithaca, NY 14853 USA.	chg2@cornell.edu						Belkin IM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019334; Durbin EG, 2003, MAR ECOL PROG SER, V254, P81, DOI 10.3354/meps254081; Frank KT, 2006, ECOL LETT, V9, P1096, DOI 10.1111/j.1461-0248.2006.00961.x; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Hakkinen S, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015243; Lindsay RW, 2005, J CLIMATE, V18, P4879, DOI 10.1175/JCLI3587.1; Morison J, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026826; Mountain DG, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001044; Pershing AJ, 2005, ICES J MAR SCI, V62, P1511, DOI 10.1016/j.icesjms.2005.04.025; Smith PC, 2001, DEEP-SEA RES PT II, V48, P37, DOI 10.1016/S0967-0645(00)00081-3; Steele M, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002009; Vilhalmsson Hjalmar, 2005, P691; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2	13	186	199	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2007	315	5815					1084	1085		10.1126/science.1136495	http://dx.doi.org/10.1126/science.1136495			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	138UA	17322049				2022-12-01	WOS:000244387600023
J	Libert, S; Zwiener, J; Chu, XW; VanVoorhies, W; Roman, G; Pletcher, SD				Libert, Sergiy; Zwiener, Jessica; Chu, Xiaowen; VanVoorhies, Wayne; Roman, Gregg; Pletcher, Scott D.			Regulation of Drosophila life span by olfaction and food-derived odors	SCIENCE			English	Article							DIETARY RESTRICTION; MOLECULAR-BASIS; MELANOGASTER; REPRODUCTION; ELEGANS	Smell is an ancient sensory system present in organisms from bacteria to humans. In the nematode Caeonorhabditis elegans, gustatory and olfactory neurons regulate aging and longevity. Using the fruit fly, Drosophila melanogaster, we showed that exposure to nutrient-derived odorants can modulate life span and partially reverse the longevity-extending effects of dietary restriction. Furthermore, mutation of odorant receptor Or83b resulted in severe olfactory defects, altered adult metabolism, enhanced stress resistance, and extended life span. Our findings indicate that olfaction affects adult physiology and aging in Drosophila, possibly through the perceived availability of nutritional resources, and that olfactory regulation of life span is evolutionarily conserved.	Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; Baylor Coll Med, Interdept Program Cellular & Mol Biol, Houston, TX 77030 USA; New Mexico State Univ, Program Mol Biol, Las Cruces, NM 88003 USA; Univ Houston, Dept Biol & Biochem, Houston, TX 77024 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; New Mexico State University; University of Houston System; University of Houston; Baylor College of Medicine	Pletcher, SD (corresponding author), Baylor Coll Med, Huffington Ctr Aging, 1 Baylor Plaza, Houston, TX 77030 USA.	pletcher@bcm.tmc.edu	Libert, Sergiy/D-8136-2016; Chu, Xiaowen/AAF-2857-2020; Roman, Gregg/W-1586-2019	Libert, Sergiy/0000-0003-2497-5390; Chu, Xiaowen/0000-0001-9745-4372; Roman, Gregg/0000-0003-1519-4699	NCI NIH HHS [U54 CA132383, U56 CA096286] Funding Source: Medline; NIA NIH HHS [R01AG023166] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U56CA096286, U54CA132383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023166] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Bross TG, 2005, AGING CELL, V4, P309, DOI 10.1111/j.1474-9726.2005.00181.x; Carvalho GB, 2005, NAT METHODS, V2, P813, DOI 10.1038/NMETH798; CHIPPINDALE AK, 1993, J EVOLUTION BIOL, V6, P171, DOI 10.1046/j.1420-9101.1993.6020171.x; Dahanukar A, 2005, CURR OPIN NEUROBIOL, V15, P423, DOI 10.1016/j.conb.2005.06.001; Elmore T, 2003, J NEUROSCI, V23, P9906; Good TP, 2001, J INSECT PHYSIOL, V47, P1467, DOI 10.1016/S0022-1910(01)00138-X; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Orr WC, 2003, EXP GERONTOL, V38, P227, DOI 10.1016/S0531-5565(02)00263-2; Pletcher SD, 2005, AGEING RES REV, V4, P451, DOI 10.1016/j.arr.2005.06.007; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; TAFAR M, 2003, SCIENCE, V299, P1346; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Zheng JY, 2005, AGING CELL, V4, P209, DOI 10.1111/j.1474-9726.2005.00159.x	22	255	274	4	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2007	315	5815					1133	1137		10.1126/science.1136610	http://dx.doi.org/10.1126/science.1136610			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138UA	17272684	Green Published			2022-12-01	WOS:000244387600039
J	Sato, T; Atomi, H; Imanaka, T				Sato, Takaaki; Atomi, Haruyuki; Imanaka, Tadayuki			Archaeal type IIIRuBisCOs function in a pathway for AMP metabolism	SCIENCE			English	Article							RIBULOSE 1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; PYROCOCCUS-KODAKARAENSIS KOD1; METHIONINE SALVAGE PATHWAY; HYPERTHERMOPHILIC ARCHAEON; BISPHOSPHATE CARBOXYLASE/OXYGENASE; MAXIMUM-LIKELIHOOD; RUBISCO; PROTEIN; FIXATION	The type III ribulose-1,5-bisphosphate carboxylase-oxygenase (RuBisCO) present in the archaeon Thermococcus kodakaraensis was found to participate in adenosine 5'-monophosphate ( AMP) metabolism, a role that is distinct from that of classical RuBisCOs of the Calvin-Benson-Bassham cycle. Genes annotated as thymidine phosphorylase (deoA) and eucaryal translation initiation factor 2B (e2b2) were found to encode AMP phosphorylase and ribose-1,5-bisphosphate isomerase, respectively. These enzymes supplied the RuBisCO substrate, ribulose-1,5-bisphosphate, from AMP and phosphate. Archaea with type III RuBisCOs all harbor both DeoA and the corresponding E2b2 homologs. In this pathway, adenine was released from AMP and the phosphoribose moiety entered central-carbon metabolism.	Kyoto Univ, Dept Synth Chem & Biol Chem, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan	Kyoto University	Imanaka, T (corresponding author), Kyoto Univ, Dept Synth Chem & Biol Chem, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan.	imanaka@sbchem.kyoto-u.ac.jp		Atomi, Haruyuki/0000-0001-9687-6426				Ashida H, 2003, SCIENCE, V302, P286, DOI 10.1126/science.1086997; ELLIS RJ, 1979, TRENDS BIOCHEM SCI, V4, P241, DOI 10.1016/0968-0004(79)90212-3; Ezaki S, 1999, J BIOL CHEM, V274, P5078, DOI 10.1074/jbc.274.8.5078; Finn MW, 2004, J BACTERIOL, V186, P6360, DOI 10.1128/JB.186.19.6360-6366.2004; Finn MW, 2003, J BACTERIOL, V185, P3049, DOI 10.1128/JB.185.10.3049-3059.2003; Fukui T, 2005, GENOME RES, V15, P352, DOI 10.1101/gr.3003105; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hanson TE, 2001, P NATL ACAD SCI USA, V98, P4397, DOI 10.1073/pnas.081610398; Hugler M, 2003, ARCH MICROBIOL, V179, P160, DOI 10.1007/s00203-002-0512-5; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Kengen SWM, 1995, J BIOL CHEM, V270, P30453, DOI 10.1074/jbc.270.51.30453; Kitano K, 2001, STRUCTURE, V9, P473, DOI 10.1016/S0969-2126(01)00608-6; Maeda N, 1999, J MOL BIOL, V293, P57, DOI 10.1006/jmbi.1999.3145; Maeda N, 2002, J BIOL CHEM, V277, P31656, DOI 10.1074/jbc.M203117200; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Schiffer A, 2006, BIOCHEMISTRY-US, V45, P2960, DOI 10.1021/bi0521689; Sekowska A, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-9; Sekowska A, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-8; Shively JM, 1998, ANNU REV MICROBIOL, V52, P191, DOI 10.1146/annurev.micro.52.1.191; Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014; WALTER MR, 1990, J BIOL CHEM, V265, P14016; Watson GMF, 1997, FEMS MICROBIOL LETT, V146, P13, DOI 10.1016/S0378-1097(96)00417-X; Watson GMF, 1999, J BACTERIOL, V181, P1569, DOI 10.1128/JB.181.5.1569-1575.1999; WRAY JW, 1995, J BIOL CHEM, V270, P3147, DOI 10.1074/jbc.270.7.3147	26	150	157	3	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2007	315	5814					1003	1006		10.1126/science.1135999	http://dx.doi.org/10.1126/science.1135999			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303759				2022-12-01	WOS:000244229800047
J	Richardson, TL; Jackson, GA				Richardson, Tammi L.; Jackson, George A.			Small phytoplankton and carbon export from the surface ocean	SCIENCE			English	Article							EQUATORIAL PACIFIC; FOOD WEBS; COMMUNITY STRUCTURE; BIOGENIC CARBON; PICOPLANKTON; MODEL; COAGULATION; PARTICLES; FLUXES; TEP	Autotrophic picoplankton dominate primary production over large oceanic regions but are believed to contribute relatively little to carbon export from surface layers. Using analyses of data from the equatorial Pacific Ocean and Arabian Sea, we show that the relative direct and indirect contribution of picoplankton to export is proportional to their total net primary production, despite their small size. We suggest that all primary producers, not just the large cells, can contribute to export from the surface layer of the ocean at rates proportional to their production rates.	Univ S Carolina, Mat Sci Program, Columbia, SC 29208 USA; Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Texas A&M University System; Texas A&M University College Station	Richardson, TL (corresponding author), Univ S Carolina, Mat Sci Program, Columbia, SC 29208 USA.	richardson@biol.sc.edu	Richardson, Tammi/ABB-4163-2021	Richardson, Tammi/0000-0002-0667-3455				Albertano P, 1997, J PLANKTON RES, V19, P1405, DOI 10.1093/plankt/19.10.1405; Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; Boyd PW, 1999, DEEP-SEA RES PT I, V46, P63, DOI 10.1016/S0967-0637(98)00066-1; BUESSELER KO, 2006, 116 SCOR WORK GROUP; CADEE GC, 1985, MAR ECOL PROG SER, V24, P193, DOI 10.3354/meps024193; Chai F, 2002, DEEP-SEA RES PT II, V49, P2713, DOI 10.1016/S0967-0645(02)00055-3; GOMES HDR, 1992, J PLANKTON RES, V14, P1307, DOI 10.1093/plankt/14.9.1307; Jackson GA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023180; JACKSON GA, 1990, DEEP-SEA RES, V37, P1197, DOI 10.1016/0198-0149(90)90038-W; Jackson GA, 2001, DEEP-SEA RES PT I, V48, P95, DOI 10.1016/S0967-0637(00)00040-6; Klaas C, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001765; KLUT ME, 1991, CAN J FISH AQUAT SCI, V48, P1092, DOI 10.1139/f91-129; LAMPITT RS, 1993, MAR BIOL, V116, P689, DOI 10.1007/BF00355486; Landry MR, 1997, LIMNOL OCEANOGR, V42, P405, DOI 10.4319/lo.1997.42.3.0405; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; LEGENDRE L, 1995, AQUAT MICROB ECOL, V9, P69, DOI 10.3354/ame009069; Mari X, 2004, MAR ECOL PROG SER, V279, P13, DOI 10.3354/meps279013; MICHAELS AF, 1988, DEEP-SEA RES, V35, P473, DOI 10.1016/0198-0149(88)90126-4; NIVAL P, 1976, LIMNOL OCEANOGR, V21, P24, DOI 10.4319/lo.1976.21.1.0024; Noji TT, 1997, J PLANKTON RES, V19, P863, DOI 10.1093/plankt/19.7.863; Olli K, 1999, J MARINE SYST, V23, P165, DOI 10.1016/S0924-7963(99)00056-1; Passow U, 1999, J PLANKTON RES, V21, P2203, DOI 10.1093/plankt/21.11.2203; REVELANTE N, 1991, J EXP MAR BIOL ECOL, V146, P217, DOI 10.1016/0022-0981(91)90027-T; Richardson TL, 2006, DEEP-SEA RES PT II, V53, P555, DOI 10.1016/j.dsr2.2006.01.015; Richardson TL, 2004, DEEP-SEA RES PT I, V51, P1245, DOI 10.1016/j.dsr.2004.05.005; Rivkin RB, 1996, SCIENCE, V272, P1163, DOI 10.1126/science.272.5265.1163; Roman MR, 2001, DEEP-SEA RES PT II, V49, P175; Smayda T. J., 1970, Oceanogr. mar. Biol., V8, P353; Waite AM, 2000, LIMNOL OCEANOGR, V45, P87, DOI 10.4319/lo.2000.45.1.0087; [No title captured]	30	380	406	8	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2007	315	5813					838	840		10.1126/science.1133471	http://dx.doi.org/10.1126/science.1133471			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289995				2022-12-01	WOS:000244069000067
J	Wang, F; Podell, ER; Zaug, AJ; Yang, YT; Baciu, P; Cech, TR; Lei, M				Wang, Feng; Podell, Elaine R.; Zaug, Arthur J.; Yang, Yuting; Baciu, Paul; Cech, Thomas R.; Lei, Ming			The POT1-TPP1 telomere complex is a telomerase processivity factor	NATURE			English	Article							END-BINDING-PROTEIN; HUMAN POT1; LENGTH REGULATOR; OXYTRICHA-NOVA; DNA-BINDING; IN-VITRO; CHROMOSOME; SUBUNIT; TRF1; TIN2	Telomeres were originally defined as chromosome caps that prevent the natural ends of linear chromosomes from undergoing deleterious degradation and fusion events. POT1 ( protection of telomeres) protein binds the single-stranded G-rich DNA overhangs at human chromosome ends and suppresses unwanted DNA repair activities. TPP1 is a previously identified binding partner of POT1 that has been proposed to form part of a six-protein shelterin complex at telomeres. Here, the crystal structure of a domain of human TPP1 reveals an oligonucleotide/oligosaccharide-binding fold that is structurally similar to the beta-subunit of the telomere end-binding protein of a ciliated protozoan, suggesting that TPP1 is the missing beta-subunit of human POT1 protein. Telomeric DNA end-binding proteins have generally been found to inhibit rather than stimulate the action of the chromosome end-replicating enzyme, telomerase. In contrast, we find that TPP1 and POT1 form a complex with telomeric DNA that increases the activity and processivity of the human telomerase core enzyme. We propose that POT1 - TPP1 switches from inhibiting telomerase access to the telomere, as a component of shelterin, to serving as a processivity factor for telomerase during telomere extension.	Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Colorado, Howard Hughes Med Inst, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Lei, M (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, MSRBIII 5301D,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	leim@umich.edu	Wang, Feng/B-2474-2012					Baumann P, 2002, MOL CELL BIOL, V22, P8079, DOI 10.1128/MCB.22.22.8079-8087.2002; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Cech TR, 2004, CELL, V116, P273, DOI 10.1016/S0092-8674(04)00038-8; Chen JL, 2003, EMBO J, V22, P304, DOI 10.1093/emboj/cdg024; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dietmann S, 2001, NAT STRUCT BIOL, V8, P953, DOI 10.1038/nsb1101-953; FANG GW, 1991, NUCLEIC ACIDS RES, V19, P5515, DOI 10.1093/nar/19.20.5515; FANG GW, 1993, GENE DEV, V7, P870, DOI 10.1101/gad.7.5.870; FANG GW, 1993, CELL, V74, P875, DOI 10.1016/0092-8674(93)90467-5; GRAY JT, 1991, CELL, V67, P807, DOI 10.1016/0092-8674(91)90075-A; HICKE BJ, 1990, P NATL ACAD SCI USA, V87, P1481, DOI 10.1073/pnas.87.4.1481; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; HOLM L, 1991, J MOL BIOL, V218, P183, DOI 10.1016/0022-2836(91)90883-8; Horvath MP, 1998, CELL, V95, P963, DOI 10.1016/S0092-8674(00)81720-1; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; KURIYAN J, 1993, J MOL BIOL, V234, P915, DOI 10.1006/jmbi.1993.1644; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Lei M, 2005, J BIOL CHEM, V280, P20449, DOI 10.1074/jbc.M502212200; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loayza D, 2004, J BIOL CHEM, V279, P13241, DOI 10.1074/jbc.M312309200; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; Paeschke K, 2005, NAT STRUCT MOL BIOL, V12, P847, DOI 10.1038/nsmb982; Shay JW, 2002, CANCER CELL, V2, P257, DOI 10.1016/S1535-6108(02)00159-9; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zaug AJ, 2005, P NATL ACAD SCI USA, V102, P10864, DOI 10.1073/pnas.0504744102	38	499	520	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2007	445	7127					506	510		10.1038/nature05454	http://dx.doi.org/10.1038/nature05454			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17237768	Green Published			2022-12-01	WOS:000243867300036
J	Naqvi, NH; Rudrauf, D; Damasio, H; Bechara, A				Naqvi, Nasir H.; Rudrauf, David; Damasio, Hanna; Bechara, Antoine			Damage to the insula disrupts addiction to cigarette smoking	SCIENCE			English	Article							DECISION-MAKING; DRUG-ADDICTION; NEURAL SYSTEMS; CORTEX LESIONS; BRAIN ACTIVITY; NICOTINE; ACTIVATION; TOBACCO; STIMULI	A number of brain systems have been implicated in addictive behavior, but none have yet been shown to be necessary for maintaining the addiction to cigarette smoking. We found that smokers with brain damage involving the insula, a region implicated in conscious urges, were more likely than smokers with brain damage not involving the insula to undergo a disruption of smoking addiction, characterized by the ability to quit smoking easily, immediately, without relapse, and without persistence of the urge to smoke. This result suggests that the insula is a critical neural substrate in the addiction to smoking.	Univ Iowa, Carver Coll Med, Dept Neurol, Div Cognit Neurosci, Iowa City, IA 52242 USA; Univ Iowa, Carver Coll Med, Dept Neurol, Lab Computat Neuroimaging, Iowa City, IA 52242 USA; Univ So Calif, Dornsife Cognit Neurosci Imaging Ctr, Los Angeles, CA 90089 USA; Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA	University of Iowa; University of Iowa; University of Southern California; University of Southern California	Bechara, A (corresponding author), Univ Iowa, Carver Coll Med, Dept Neurol, Div Cognit Neurosci, 200 Hawkins Dr, Iowa City, IA 52242 USA.	bechara@usc.edu	Naqvi, Nasir/AAW-7933-2021	Bechara, Antoine/0000-0001-5127-2549	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS019632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F30DA016847, R21DA016708] Funding Source: NIH RePORTER; NIDA NIH HHS [R21 DA016708, F30 DA016847, R21 DA16708] Funding Source: Medline; NIGMS NIH HHS [T32 GM007337] Funding Source: Medline; NINDS NIH HHS [P01 NS019632] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		*APA, 2000, DIAGN STAT MAN MENT, P191; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Bonson KR, 2002, NEUROPSYCHOPHARMACOL, V26, P376, DOI 10.1016/S0893-133X(01)00371-2; Brody AL, 2002, ARCH GEN PSYCHIAT, V59, P1162, DOI 10.1001/archpsyc.59.12.1162; Buchhalter AR, 2005, ADDICTION, V100, P550, DOI 10.1111/j.1360-0443.2005.01030.x; Cereda C, 2002, NEUROLOGY, V59, P1950, DOI 10.1212/01.WNL.0000038905.75660.BD; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Damasio A.R., 1999, FEELING WHAT HAPPENS; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Grant S, 1996, P NATL ACAD SCI USA, V93, P12040, DOI 10.1073/pnas.93.21.12040; Hatsukami D, 1985, NIDA Res Monogr, V53, P56; Myrick H, 2004, NEUROPSYCHOPHARMACOL, V29, P393, DOI 10.1038/sj.npp.1300295; Naqvi NH, 2005, PHARMACOL BIOCHEM BE, V81, P821, DOI 10.1016/j.pbb.2005.06.005; Paulus MP, 2005, ARCH GEN PSYCHIAT, V62, P761, DOI 10.1001/archpsyc.62.7.761; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Pickworth WB, 1998, PSYCHONEUROENDOCRINO, V23, P131, DOI 10.1016/S0306-4530(97)00075-9; Pontieri FE, 1996, NATURE, V382, P255, DOI 10.1038/382255a0; Pritchard TC, 1999, BEHAV NEUROSCI, V113, P663, DOI 10.1037/0735-7044.113.4.663; Rose JE, 2006, PSYCHOPHARMACOLOGY, V184, P274, DOI 10.1007/s00213-005-0250-x; Sell LA, 2000, DRUG ALCOHOL DEPEN, V60, P207, DOI 10.1016/S0376-8716(99)00158-1; TIFFANY ST, 1990, PSYCHOL REV, V97, P147, DOI 10.1037/0033-295X.97.2.147; *US DEP HHS, 1988, 1988 SURG GEN REP HL, P377; Wang GJ, 1999, LIFE SCI, V64, P775, DOI 10.1016/S0024-3205(98)00619-5; WESTMAN EC, 1995, CHEST, V107, P1358, DOI 10.1378/chest.107.5.1358	29	800	879	3	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2007	315	5811					531	534		10.1126/science.1135926	http://dx.doi.org/10.1126/science.1135926			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255515	Green Accepted			2022-12-01	WOS:000243726600052
J	Paik, JH; Kollipara, R; Chu, G; Ji, HK; Xiao, YH; Ding, ZH; Miao, LL; Tothova, Z; Horner, JW; Carrasco, DR; Jiang, S; Gilliland, DG; Chin, L; Wong, WH; Castrillon, DH; DePinho, RA				Paik, Ji-Hye; Kollipara, Ramya; Chu, Gerald; Ji, Hongkai; Xiao, Yonghong; Ding, Zhihu; Miao, Lili; Tothova, Zuzana; Horner, James W.; Carrasco, Daniel R.; Jiang, Shan; Gilliland, D. Gary; Chin, Lynda; Wong, Wing H.; Castrillon, Diego H.; DePinho, Ronald A.			FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis	CELL			English	Article							TRANSCRIPTION FACTORS; TARGETED DISRUPTION; PTEN LEADS; GENE; AKT; SPROUTY; MICE; P27(KIP1); IDENTIFICATION; INHIBITION	Activated phosphoinositide 3-kinase (PI3K)AKT signaling appears to be an obligate event in the development of cancer. The highly related members of the mammalian FoxO transcription factor family, FoxO1, FoxO3, and FoxO4, represent one of several effector arms of PI3K-AKT signaling, prompting genetic analysis of the role of FoxOs in the neoplastic phenotypes linked to PI3K-AKT activation. While germline or somatic deletion of up to five FoxO alleles produced remarkably modest neoplastic phenotypes, broad somatic deletion of all FoxOs engendered a progressive cancer-prone condition characterized by thymic lymphomas and hemangionnas, demonstrating that the mammalian FoxOs are indeed bona fide tumor suppressors. Transcriptome and promoter analyses of differentially affected endothelium identified direct FoxO targets and revealed that FoxO regulation of these targets in vivo is highly context-specific, even in the same cell type. Functional studies validated Sprouty2 and PBX1, among others, as FoxO-regulated mediators of endothelial cell morphogenesis and vascular homeostasis.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Belfer Fdn,Inst Innovat Canc Sci,Ctr Appl Canc Sc, Boston, MA 02115 USA; Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; Stanford Univ, Dept Stat, Stanford, CA 94305 USA; Univ Texas, SW Med Sch, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Sch, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Stanford University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Castrillon, DH (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	diego.castrillon@utsouthwestern.edu; ron_depinho@dfci.harvard.edu		DePinho, Ronald/0000-0002-5625-577X	NCI NIH HHS [R01 CA084628, U01 CA084313, P01 CA117969, P01 CA095616] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA084313, P01CA095616, P01CA117969, R01CA084628] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Benezra R, 2001, TRENDS CARDIOVAS MED, V11, P237, DOI 10.1016/S1050-1738(01)00117-7; Biggs WH, 2001, MAMM GENOME, V12, P416, DOI 10.1007/s003350020002; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carreira CM, 2001, CANCER RES, V61, P8079; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Cook-Mills JM, 2002, MOL IMMUNOL, V39, P499, DOI 10.1016/S0161-5890(02)00206-7; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dong XY, 2006, CANCER RES, V66, P6998, DOI 10.1158/0008-5472.CAN-06-0411; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Freeman D, 2006, CANCER RES, V66, P6492, DOI 10.1158/0008-5472.CAN-05-4143; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Geisen C, 2003, ONCOGENE, V22, P1724, DOI 10.1038/sj.onc.1206340; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hayashi M, 2004, J CLIN INVEST, V113, P1138, DOI 10.1172/JCI200419890; Heryanto B, 2002, REPRODUCTION, V123, P107, DOI 10.1530/rep.0.1230107; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kang-Decker N, 2004, CANCER CELL, V5, P177, DOI 10.1016/S1535-6108(04)00022-4; Kato J, 2005, ARTERIOSCL THROM VAS, V25, P2480, DOI 10.1161/01.ATV.0000184759.91369.f8; Kramer S, 1999, DEVELOPMENT, V126, P2515; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Lee MH, 1996, GENE DEV, V10, P1621, DOI 10.1101/gad.10.13.1621; Li G, 2002, DEVELOPMENT, V129, P4159; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Martins CP, 2002, EMBO J, V21, P3739, DOI 10.1093/emboj/cdf364; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; Nikitenko LL, 2006, BRIT J CANCER, V94, P1, DOI 10.1038/sj.bjc.6602832; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; RAMIREZ F, 1993, BIOESSAYS, V15, P589, DOI 10.1002/bies.950150904; Reich A, 1999, DEVELOPMENT, V126, P4139; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Sakai A, 1998, BLOOD, V92, P3410, DOI 10.1182/blood.V92.9.3410.421a06_3410_3415; Schneider A, 2003, AM J PHYSIOL-RENAL, V284, pF411, DOI 10.1152/ajprenal.00235.2002; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Taketomi T, 2005, NAT NEUROSCI, V8, P855, DOI 10.1038/nn1485; Van der Heide LP, 2005, BIOCHEM J, V391, P623, DOI 10.1042/BJ20050525; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wanner M, 2001, J AM ACAD DERMATOL, V44, P183, DOI 10.1067/mjd.2001.110390; Wingrove JA, 1999, CELL, V98, P105, DOI 10.1016/S0092-8674(00)80610-8; Wu XL, 2005, P NATL ACAD SCI USA, V102, P14058, DOI 10.1073/pnas.0506714102; You MJ, 2002, P NATL ACAD SCI USA, V99, P1455, DOI 10.1073/pnas.022632099	64	821	849	0	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2007	128	2					309	323		10.1016/j.cell.2006.12.029	http://dx.doi.org/10.1016/j.cell.2006.12.029			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254969	Bronze, Green Accepted			2022-12-01	WOS:000244420500016
J	Sharp, D				Sharp, David			A device before its time	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							Charette F, 2006, NATURE, V444, P551, DOI 10.1038/444551a; Freeth T, 2006, NATURE, V444, P587, DOI 10.1038/nature05357; HANCOCK G, 1996, FINGERPRINTS GODS QU, P389; PRICE DJD, 1959, SCI AM           JUN; *WIK, BAGHD BATT; WRIGHT MT, UNDERSTANDING ANTIKY	6	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 20	2007	369	9557					176	176		10.1016/S0140-6736(07)60089-0	http://dx.doi.org/10.1016/S0140-6736(07)60089-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	128XG	17240272				2022-12-01	WOS:000243692400011
J	Butler, SJ; Vickery, JA; Norris, K				Butler, S. J.; Vickery, J. A.; Norris, K.			Farmland biodiversity and the footprint of agriculture	SCIENCE			English	Article							GENETICALLY-MODIFIED CROPS; AGRI-ENVIRONMENT SCHEMES; CONSERVATION; DECLINES; BRITAIN; IMPACTS; ECOLOGY; BIRDS	Sustainable development requires the reconciliation of demands for biodiversity conservation and increased agricultural production. Assessing the impact of novel farming practices on biodiversity and ecosystem services is fundamental to this process. Using farmland birds as a model system, we present a generic risk assessment framework that accurately predicts each species' current conservation status and population growth rate associated with past changes in agriculture. We demonstrate its value by assessing the potential impact on biodiversity of two controversial land uses, genetically modified herbicide-tolerant crops and agri-environment schemes. This framework can be used to guide policy and land management decisions and to assess progress toward sustainability targets.	Univ Reading, Sch Agr Policy & Dev, Ctr Agrienvironm Res, Reading RG6 6AR, Berks, England; British Trust Ornithol, Thetford IP24 2PU, Norfolk, England	University of Reading; British Trust for Ornithology	Butler, SJ (corresponding author), Univ Reading, Sch Agr Policy & Dev, Ctr Agrienvironm Res, Reading RG6 6AR, Berks, England.	s.j.butler@reading.ac.uk	Butler, Simon/H-1703-2011	Butler, Simon/0000-0002-5111-5639				*ACRE, 2006, MAN FOOTPR AGR COMP; Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; *DEFR, 2005, ENTR LEV STEW HDB; Freckleton RP, 2004, P ROY SOC B-BIOL SCI, V271, P325, DOI 10.1098/rspb.2003.2603; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; GREEN RE, 2004, SCIENCE         1223, DOI DOI 10.1126/SCIENCE.1106049; Gregory R.D., 2003, Ornis Hungarica, V12-13, P11; Gregory Richard D., 2002, British Birds, V95, P410; Hails RS, 2002, NATURE, V418, P685, DOI 10.1038/nature01016; Kleijn D, 2003, J APPL ECOL, V40, P947, DOI 10.1111/j.1365-2664.2003.00868.x; Kleijn D, 2001, NATURE, V413, P723, DOI 10.1038/35099540; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Newton I, 2004, IBIS, V146, P579, DOI 10.1111/j.1474-919X.2004.00375.x; Norris K, 2004, P ROY SOC B-BIOL SCI, V271, P123, DOI 10.1098/rspb.2003.2576; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Perry JN, 2004, NATURE, V428, P313, DOI 10.1038/nature02374; *RUR DEV SERV STRA, 2006, ES OPT UPT REP; Siriwardena GM, 1998, J APPL ECOL, V35, P24, DOI 10.1046/j.1365-2664.1998.00275.x; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 1999, P NATL ACAD SCI USA, V96, P5995, DOI 10.1073/pnas.96.11.5995; Whitfield J, 2006, NATURE, V439, P908, DOI 10.1038/439908a; Zeki S, 2003, PHILOS T ROY SOC B, V358, P1775, DOI 10.1098/rstb.2003.1412	27	294	308	6	337	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2007	315	5810					381	384		10.1126/science.1136607	http://dx.doi.org/10.1126/science.1136607			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126SI	17234947				2022-12-01	WOS:000243535400043
J	Melichar, HJ; Narayan, K; Der, SD; Hiraoka, Y; Gardiol, N; Jeannet, G; Held, W; Chambers, CA; Kang, JS				Melichar, Heather J.; Narayan, Kavitha; Der, Sandy D.; Hiraoka, Yoshiki; Gardiol, Noemie; Jeannet, Gregoire; Held, Werner; Chambers, Cynthia A.; Kang, Joonsoo			Regulation of gamma delta versus alpha beta T lymphocyte differentiation by the transcription factor SOX13	SCIENCE			English	Article							CELL-RECEPTOR; COLON-CARCINOMA; CATENIN; GENE; EXPRESSION; PATHWAY; TCF-1; PROTEINS	alpha beta and gamma delta T cells originate from a common, multipotential precursor population in the thymus, but the molecular mechanisms regulating this lineage-fate decision are unknown. We have identified Sox13 as a gamma delta-specific gene in the immune system. Using Sox13 transgenic mice, we showed that this transcription factor promotes gd T cell development while opposing ab T cell differentiation. Conversely, mice deficient in Sox13 expression exhibited impaired development of gd T cells but not ab T cells. One mechanism of SOX13 function is the inhibition of signaling by the developmentally important Wnt/T cell factor (TCF) pathway. Our data thus reveal a dominant pathway regulating the developmental fate of these two lineages of T lymphocytes.	Univ Massachusetts, Sch Med, Dept Pathol, Grad Program Immunol & Virol, Worcester, MA 01655 USA; Univ Toronto, Dept Lab Med & Pathobiol, Program Proteom & Bioinformat, Toronto, ON, Canada; Keio Univ, Sch Med, Dept Anat, Shinjuku Ku, Tokyo 1608582, Japan; Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland; Univ Lausanne, CH-1066 Epalinges, Switzerland	University of Massachusetts System; University of Massachusetts Worcester; University of Toronto; Keio University; Ludwig Institute for Cancer Research; University of Lausanne	Kang, JS (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Grad Program Immunol & Virol, 55 Lake Ave N, Worcester, MA 01655 USA.	Joonsoo.Kang@umassmed.edu		kang, joonsoo/0000-0001-8419-7995	NATIONAL CANCER INSTITUTE [R01CA100382] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA100382/92614] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLISON JP, 1987, IMMUNOL TODAY, V8, P293, DOI 10.1016/0167-5699(87)90014-4; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Held W, 1999, IMMUNITY, V11, P433, DOI 10.1016/S1074-7613(00)80118-1; Huang ZF, 2006, J IMMUNOL, V176, P4880, DOI 10.4049/jimmunol.176.8.4880; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; ISHIDA I, 1990, P NATL ACAD SCI USA, V87, P3067, DOI 10.1073/pnas.87.8.3067; Kan LX, 2004, DEV BIOL, V269, P580, DOI 10.1016/j.ydbio.2004.02.005; Kang J, 1997, Semin Immunol, V9, P171, DOI 10.1006/smim.1997.0069; Kang J, 2001, J EXP MED, V193, P689, DOI 10.1084/jem.193.6.689; Kaufmann SHE, 1996, P NATL ACAD SCI USA, V93, P2272, DOI 10.1073/pnas.93.6.2272; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Roose J, 1998, NUCLEIC ACIDS RES, V26, P469, DOI 10.1093/nar/26.2.469; Saint-Ruf C, 2000, NATURE, V406, P524, DOI 10.1038/35020093; Sampson EM, 2001, EMBO J, V20, P4500, DOI 10.1093/emboj/20.16.4500; Schilham MW, 1998, J IMMUNOL, V161, P3984; Silva-Santos B, 2005, SCIENCE, V307, P925, DOI 10.1126/science.1103978; Staal FJT, 2001, EUR J IMMUNOL, V31, P285, DOI 10.1002/1521-4141(200101)31:1<285::AID-IMMU285>3.3.CO;2-4; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2	23	127	128	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2007	315	5809					230	233		10.1126/science.1135344	http://dx.doi.org/10.1126/science.1135344			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124XZ	17218525				2022-12-01	WOS:000243407400044
J	Ferrer, M; Golyshina, OV; Beloqui, A; Golyshin, PN; Timmis, KN				Ferrer, Manuel; Golyshina, Olga V.; Beloqui, Ana; Golyshin, Peter N.; Timmis, Kenneth N.			The cellular machinery of Ferroplasma acidiphilum is iron-protein-dominated	NATURE			English	Article							SOUTHERN-OCEAN; WALL-LACKING; SP-NOV.; ENVIRONMENTS; PROKARYOTES; CLUSTERS; ARCHAEA; ACID	Ferroplasma is a genus of the Archaea, one of the three branches of the tree of life, and belongs to the order Thermoplasmatales ( Euryarchaeota), which contains the most acidophilic microbes yet known. Ferroplasma species live in acid mine drainage, acidic pools and environments containing sulphidic ores such as pyrite and characterized by pH values of 0 - 2 and high concentrations of ferrous iron and other heavy metals(1-3). F. acidiphilum strain Y-T is a chemoautotroph that grows optimally at pH 1.7 and gains energy by oxidizing ferrous iron and carbon by the fixation of carbon dioxide(1). Here we show that 86% of 189 investigated cellular proteins of F. acidiphilum are iron-metalloproteins. These include proteins with deduced structural, chaperone and catalytic roles, not described as iron-metalloproteins in any other organism so far investigated. The iron atoms in the proteins seem to organize and stabilize their three-dimensional structures, to act as 'iron rivets'. Analysis of proteins of the phylogenetic neighbour Picrophilus torridus and of the habitat neighbour Acidithiobacillus ferrooxidans revealed far fewer and only typical metalloproteins. F. acidiphilum therefore has a currently unique iron-protein-dominated cellular machinery and biochemical phylogeny.	CSIC, Inst Catalysis, Madrid 28049, Spain; HZI Helmholtz Ctr Infect Res, Dept Environm Microbiol, D-38124 Braunschweig, Germany; Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Catalisis y Petroleoquimica (ICP); Helmholtz Association; Helmholtz-Center for Infection Research; Braunschweig University of Technology; University of Essex	Ferrer, M (corresponding author), CSIC, Inst Catalysis, Madrid 28049, Spain.	mferrer@icp.csic.es	Beloqui, Ana/C-4512-2012; Ferrer, Manuel/K-4535-2014	Beloqui, Ana/0000-0002-7693-4163; Golyshin, Peter/0000-0002-5433-0350; Golyshina, Olga/0000-0001-5132-6850; Ferrer, Manuel/0000-0003-4962-4714				Agarwalla S, 2004, J BIOL CHEM, V279, P34123, DOI 10.1074/jbc.M405702200; BLOCHL E, 1992, P NATL ACAD SCI USA, V89, P8117, DOI 10.1073/pnas.89.17.8117; Boal AK, 2005, BIOCHEMISTRY-US, V44, P8397, DOI 10.1021/bi047494n; Buesseler KO, 2004, SCIENCE, V304, P414, DOI 10.1126/science.1086895; Dopson M, 2004, APPL ENVIRON MICROB, V70, P2079, DOI 10.1128/AEM.70.4.2079-2088.2004; Ferrer M, 2005, BIOCHEM J, V391, P269, DOI 10.1042/BJ20050346; Giometti CS, 2003, PROTEOMICS, V3, P777, DOI 10.1002/pmic.200300406; Golyshina OV, 2000, INT J SYST EVOL MICR, V50, P997, DOI 10.1099/00207713-50-3-997; Golyshina OV, 2005, ENVIRON MICROBIOL, V7, P1277, DOI 10.1111/j.1462-2920.2005.00861.x; Golyshina OV, 2006, ENVIRON MICROBIOL, V8, P416, DOI 10.1111/j.1462-2920.2005.00907.x; Hogbom M, 2005, MOL CELL PROTEOMICS, V4, P827, DOI 10.1074/mcp.T400023-MCP200; Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x; Major TA, 2004, FEMS MICROBIOL LETT, V239, P117, DOI 10.1016/j.femsle.2004.08.027; Pierrel F, 2002, J BIOL CHEM, V277, P13367, DOI 10.1074/jbc.C100609200; Schneider D, 2005, BBA-BIOENERGETICS, V1710, P1, DOI 10.1016/j.bbabio.2005.09.003; WACHTERSHAUSER G, 2002, SCIENCE, V296, P1982; Watson AJ, 2000, NATURE, V407, P730, DOI 10.1038/35037561	17	78	81	1	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2007	445	7123					91	94		10.1038/nature05362	http://dx.doi.org/10.1038/nature05362			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122KG	17203061				2022-12-01	WOS:000243225100042
J	Nishiyama, T; Ohsumi, K; Kishimoto, T				Nishiyama, Tomoko; Ohsumi, Keita; Kishimoto, Takeo			Phosphorylation of Erp1 by p90rsk is required for cytostatic factor arrest in Xenopus laevis eggs	NATURE			English	Article							ANAPHASE-PROMOTING COMPLEX; METAPHASE ARREST; MEIOTIC MATURATION; CELL-CYCLE; VERTEBRATE EGGS; MAP KINASE; INHIBITOR; EXIT; DEGRADATION; INDUCTION	Until fertilization, the meiotic cell cycle of vertebrate eggs is arrested at metaphase of meiosis II by a cytoplasmic activity termed cytostatic factor (CSF)(1), which causes inhibition of the anaphase-promoting complex/cyclosome (APC/C), a ubiquitin ligase that targets mitotic cyclins - regulatory proteins of meiosis and mitosis - for degradation(2,3). Recent studies indicate that Erp1/ Emi2, an inhibitor protein for the APC/C, has an essential role in establishing and maintaining CSF arrest(4-6), but its relationship to Mos, a mitogen-activated protein kinase ( MAPK) kinase kinase that also has an essential role in establishing CSF arrest 7 through activation of p90 ribosomal S6 kinase (p90rsk)(8,9), is unclear. Here we report that in Xenopus eggs Erp1 is a substrate of p90rsk, and that Mos-dependent phosphorylation of Erp1 by p90rsk at Thr 336, Ser 342 and Ser 344 is crucial for both stabilizing Erp1 and establishing CSF arrest in meiosis II oocytes. Semi-quantitative analysis with CSF-arrested egg extracts reveals that the Mos-dependent phosphorylation of Erp1 enhances, but does not generate, the activity of Erp1 that maintains metaphase arrest. Our results also suggest that Erp1 inhibits cyclin B degradation by binding the APC/C at its carboxy-terminal destruction box(10), and this binding is also enhanced by the Mos-dependent phosphorylation. Thus, Mos and Erp1 collaboratively establish and maintain metaphase II arrest in Xenopus eggs. The link between Mos and Erp1 provides a molecular explanation for the integral mechanism of CSF arrest in unfertilized vertebrate eggs.	Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Lab Cell & Dev Biol, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Ohsumi, K (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Lab Cell & Dev Biol, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	kohsumi@bio.titech.ac.jp						Bhatt RR, 1999, SCIENCE, V286, P1362, DOI 10.1126/science.286.5443.1362; Dumont J, 2005, J CELL BIOL, V169, P227, DOI 10.1083/jcb.200501027; Dupre A, 2002, EMBO J, V21, P4026, DOI 10.1093/emboj/cdf400; GOTOH Y, 1994, ONCOGENE, V9, P1891; Gross SD, 1999, SCIENCE, V286, P1365, DOI 10.1126/science.286.5443.1365; HACCARD O, 1993, SCIENCE, V262, P1262, DOI 10.1126/science.8235656; Hansen DV, 2006, P NATL ACAD SCI USA, V103, P608, DOI 10.1073/pnas.0509549102; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Iwabuchi M, 2000, EMBO J, V19, P4513, DOI 10.1093/emboj/19.17.4513; Kishimoto T, 2003, CURR OPIN CELL BIOL, V15, P654, DOI 10.1016/j.ceb.2003.10.010; Lefebvre C, 2002, J CELL BIOL, V157, P603, DOI 10.1083/jcb.200202052; Liu JJ, 2005, CURR BIOL, V15, P1458, DOI 10.1016/j.cub.2005.07.030; LOHKA MJ, 1985, J CELL BIOL, V101, P518, DOI 10.1083/jcb.101.2.518; LORCA T, 1993, NATURE, V366, P270, DOI 10.1038/366270a0; Masui Y, 2000, NAT REV MOL CELL BIO, V1, P228, DOI 10.1038/35043096; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Ohsumi K, 2004, P NATL ACAD SCI USA, V101, P12531, DOI 10.1073/pnas.0405300101; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Rauh NR, 2005, NATURE, V437, P1048, DOI 10.1038/nature04093; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; Schmidt A, 2006, J CELL SCI, V119, P1213, DOI 10.1242/jcs.02919; Schmidt A, 2005, GENE DEV, V19, P502, DOI 10.1101/gad.320705; Shoji S, 2006, EMBO J, V25, P834, DOI 10.1038/sj.emboj.7600953; Tung JJ, 2005, P NATL ACAD SCI USA, V102, P4318, DOI 10.1073/pnas.0501108102; Tunquist BJ, 2003, GENE DEV, V17, P683, DOI 10.1101/gad.1071303; Yamamoto TM, 2005, DEV BIOL, V279, P345, DOI 10.1016/j.ydbio.2004.12.025	29	91	92	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					1096	1099		10.1038/nature05696	http://dx.doi.org/10.1038/nature05696			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17410129				2022-12-01	WOS:000245950400053
J	Plaut, JJ; Picardi, G; Safaeinili, A; Ivanov, AB; Milkovich, SM; Cicchetti, A; Kofman, W; Mouginot, J; Farrell, WM; Phillips, RJ; Clifford, SM; Frigeri, A; Orosei, R; Federico, C; Williams, IP; Gurnett, DA; Nielsen, E; Hagfors, T; Heggy, E; Stofan, ER; Plettemeier, D; Watters, TR; Leuschen, CJ; Edenhofer, P				Plaut, Jeffrey J.; Picardi, Giovanni; Safaeinili, Ali; Ivanov, Anton B.; Milkovich, Sarah M.; Cicchetti, Andrea; Kofman, Wlodek; Mouginot, Jeremie; Farrell, William M.; Phillips, Roger J.; Clifford, Stephen M.; Frigeri, Alessandro; Orosei, Roberto; Federico, Costanzo; Williams, Iwan P.; Gurnett, Donald A.; Nielsen, Erling; Haegfors, Tor; Heggy, Essam; Stofan, Ellen R.; Plettemeier, Dirk; Watters, Thomas R.; Leuschen, Carlton J.; Edenhofer, Peter			Subsurface radar sounding of the south polar layered deposits of Mars	SCIENCE			English	Article							CAP; REGION	The ice-rich south polar layered deposits of Mars were probed with the Mars Advanced Radar for Subsurface and Ionospheric Sounding on the Mars Express orbiter. The radar signals penetrate deep into the deposits (more than 3.7 kilometers). For most of the area, a reflection is detected at a time delay that is consistent with an interface between the deposits and the substrate. The reflected power from this interface indicates minimal attenuation of the signal, suggesting a composition of nearly pure water ice. Maps were generated of the topography of the basal interface and the thickness of the layered deposits. A set of buried depressions is seen within 300 kilometers of the pole. The thickness map shows an asymmetric distribution of the deposits and regions of anomalous thickness. The total volume is estimated to be 1.6 x 10(6) cubic kilometers, which is equivalent to a global water layer approximately 11 meters thick.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Roma La Sapienza, Infocom Dept, I-00184 Rome, Italy; Lab Planetol Grenoble, F-38041 Grenoble, France; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Lunar & Planetary Inst, Houston, TX 77058 USA; Univ Perugia, Dipartimento Sci Terra, I-06123 Perugia, Italy; Ist Nazl Astrofis, Ist Fis Spazio Interplanetario, I-00133 Rome, Italy; Queen Mary Univ London, Sch Math Sci, Astron Unit, London E1 4NS, England; Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; Max Planck Inst Solar Syst Res, D-37191 Katlenburg Lindau, Germany; Proxemy Res, Laytonville, MD 20882 USA; Tech Univ Dresden, Fak Elekrtotech & Informat Tech, D-01062 Dresden, Germany; Smithsonian Inst, Ctr Earth & Planetary Studies, Natl Air & Space Museum, Washington, DC 20560 USA; Univ Kansas, Ctr Remote Sensing Ice Sheets, Lawrence, KS 66045 USA; Ruhr Univ Bochum, Fak Elektrotech & Informat Tech, D-44780 Bochum, Germany	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Sapienza University Rome; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Washington University (WUSTL); University of Perugia; Istituto Nazionale Astrofisica (INAF); University of London; Queen Mary University London; University of Iowa; Max Planck Society; Technische Universitat Dresden; Smithsonian Institution; University of Kansas; Ruhr University Bochum	Plaut, JJ (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.		Ivanov, Anton B/C-8944-2014; Heggy, Essam/AAL-8124-2020; Kofman, Wlodek/C-4556-2008; Frigeri, Alessandro/F-2151-2010; Heggy, Essam/E-8250-2013; Farrell, William/I-4865-2013; Mouginot, Jeremie/G-7045-2015	Ivanov, Anton B/0000-0001-8376-8581; Heggy, Essam/0000-0001-7476-2735; Kofman, Wlodek/0000-0002-6744-8796; Frigeri, Alessandro/0000-0002-9140-3977; Heggy, Essam/0000-0001-7476-2735; Mouginot, Jeremie/0000-0001-9155-5455; Williams, Iwan Prys/0000-0002-8069-1344; CICCHETTI, ANDREA/0000-0002-9588-6531				Bibring JP, 2004, NATURE, V428, P627, DOI 10.1038/nature02461; BLASIUS RK, 1982, ICARUS, V50, P140; Byrne S, 2003, SCIENCE, V299, P1051, DOI 10.1126/science.1080148; CLIFFORD SM, 1987, J GEOPHYS RES-SOLID, V92, P9135, DOI 10.1029/JB092iB09p09135; CUTTS JA, 1973, J GEOPHYS RES, V78, P4231, DOI 10.1029/JB078i020p04231; DAVIES C, 2004, EOS S, V85; HEGGY E, 2006, 4 INT C MARS POL SCI; HOWARD AD, 1982, ICARUS, V50, P161, DOI 10.1016/0019-1035(82)90123-3; KIEFFER HH, 1990, J GEOPHYS RES-SOLID, V95, P1481, DOI 10.1029/JB095iB02p01481; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; MURRAY BC, 1972, ICARUS, V17, P328, DOI 10.1016/0019-1035(72)90004-8; Picardi G, 2005, SCIENCE, V310, P1925, DOI 10.1126/science.1122165; Picardi G., 2004, EUROPEAN SPACE AGENC, P51; Schenk PM, 2000, J GEOPHYS RES-PLANET, V105, P24529, DOI 10.1029/1999JE001054; Sibson R., 1981, INTERPRETING MULTIVA, P21, DOI DOI 10.1002/ADVS.201700552; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; TANAKA K, 2005, 20051271 US GEOL SUR; Thomas P., 1992, MARS, P767; TOON OB, 1980, ICARUS, V44, P552, DOI 10.1016/0019-1035(80)90130-X	19	224	228	4	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2007	316	5821					92	95		10.1126/science.1139672	http://dx.doi.org/10.1126/science.1139672			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17363628				2022-12-01	WOS:000245470500038
J	Sansom, OJ; Meniel, VS; Muncan, V; Phesse, TJ; Wilkins, JA; Reed, KR; Vass, JK; Athineos, D; Clevers, H; Clarke, AR				Sansom, Owen J.; Meniel, Valerie S.; Muncan, Vanesa; Phesse, Toby J.; Wilkins, Julie A.; Reed, Karen R.; Vass, J. Keith; Athineos, Dimitris; Clevers, Hans; Clarke, Alan R.			Myc deletion rescues Apc deficiency in the small intestine	NATURE			English	Article							BETA-CATENIN; C-MYC; COLORECTAL-CANCER; APOPTOSIS; EXPRESSION; TARGET; CELLS; GENE; IDENTIFICATION; EPITHELIUM	The APC gene encodes the adenomatous polyposis coli tumour suppressor protein, germline mutation of which characterizes familial adenomatous polyposis (FAP), an autosomal intestinal cancer syndrome(1). Inactivation of APC is also recognized as the key early event in the development of sporadic colorectal cancers(2,3), and its loss results in constitutive activity of the beta-catenin-Tcf4 transcription complex(3). The proto-oncogene c-MYC has been identified as a target of the Wnt pathway in colorectal cancer cells in vitro(4), in normal crypts in vivo(5) and in intestinal epithelial cells acutely transformed on in vivo deletion of the APC gene(6); however, the significance of this is unclear. Therefore, to elucidate the role Myc has in the intestine after Apc loss, we have simultaneously deleted both Apc and Myc in the adult murine small intestine. Here we show that loss of Myc rescued the phenotypes of perturbed differentiation, migration, proliferation and apoptosis, which occur on deletion of Apc. Remarkably, this rescue occurred in the presence of high levels of nuclear beta-catenin. Array analysis revealed that Myc is required for the majority of Wnt target gene activation following Apc loss. These data establish Myc as the critical mediator of the early stages of neoplasia following Apc loss.	Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; Univ Cardiff Wales, Cardiff Sch Biosci, Cardiff CF10 3US, Wales; Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands	Beatson Institute; Cardiff University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Sansom, OJ (corresponding author), Beatson Inst Canc Res, Garscube Estate, Glasgow G61 1BD, Lanark, Scotland.	o.sansom@beatson.gla.ac.uk	Reed, Karen/B-8813-2011; clarke, alan r/P-2820-2014; Clarke, Alan R/A-6256-2008	Reed, Karen/0000-0002-7467-1718; Phesse, Toby/0000-0001-9568-4916; Sansom, Owen J./0000-0001-9540-3010; Athineos, Dimitris/0000-0001-5298-7941; Clarke, Alan/0000-0002-4281-426X	Medical Research Council [G0301154] Funding Source: Medline; MRC [G0301154] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bettess MD, 2005, MOL CELL BIOL, V25, P7868, DOI 10.1128/MCB.25.17.7868-7878.2005; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Hay T, 2005, ONCOGENE, V24, P3842, DOI 10.1038/sj.onc.1208533; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Li Q, 1999, MOL CELL BIOL, V19, P5339; Malliri A, 2006, J BIOL CHEM, V281, P543, DOI 10.1074/jbc.M507582200; Merritt AJ, 1997, ONCOGENE, V14, P2759, DOI 10.1038/sj.onc.1201126; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Olmeda D, 2003, MOL BIOL CELL, V14, P2844, DOI 10.1091/mbc.E03-01-0865; Oskarsson T, 2005, NAT CELL BIOL, V7, P215, DOI 10.1038/ncb0305-215; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Sansom OJ, 2005, J BIOL CHEM, V280, P28463, DOI 10.1074/jbc.M500191200; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0	23	475	481	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2007	446	7136					676	679		10.1038/nature05674	http://dx.doi.org/10.1038/nature05674			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17377531	Bronze			2022-12-01	WOS:000245438300042
J	Alon, U				Alon, Uri			Simplicity in biology	NATURE			English	Editorial Material									Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.							Alon U, 2006, INTRO SYSTEMS BIOL D; Ptashne M., 2002, GENES SIGNALS; Savageau M, 1976, BIOCH SYSTEMS ANAL S; Simon HA, 1996, ARCHITECTURE COMPLEX	4	52	54	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2007	446	7135					497	497		10.1038/446497a	http://dx.doi.org/10.1038/446497a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392770				2022-12-01	WOS:000245242900032
J	Armanios, MY; Chen, JJL; Cogan, JD; Alder, JK; Ingersoll, RG; Markin, C; Lawson, WE; Xie, MY; Vulto, I; Phillips, JA; Lansdorp, PM; Greider, CW; Loyd, JE				Armanios, Mary Y.; Chen, Julian J. -L.; Cogan, Joy D.; Alder, Jonathan K.; Ingersoll, Roxann G.; Markin, Cheryl; Lawson, William E.; Xie, Mingyi; Vulto, Irma; Phillips, John A., III; Lansdorp, Peter M.; Greider, Carol W.; Loyd, James E.			Telomerase mutations in families with idiopathic pulmonary fibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOMINANT DYSKERATOSIS-CONGENITA; REVERSE-TRANSCRIPTASE; APLASTIC-ANEMIA; CATALYTIC SUBUNIT; RNA; GENE; IDENTIFICATION; ANTICIPATION; SENESCENCE; SEQUENCE	BACKGROUND Idiopathic pulmonary fibrosis is progressive and often fatal; causes of familial clustering of the disease are unknown. Germ-line mutations in the genes hTERT and hTR, encoding telomerase reverse transcriptase and telomerase RNA, respectively, cause autosomal dominant dyskeratosis congenita, a rare hereditary disorder associated with premature death from aplastic anemia and pulmonary fibrosis. METHODS To test the hypothesis that familial idiopathic pulmonary fibrosis may be caused by short telomeres, we screened 73 probands from the Vanderbilt Familial Pulmonary Fibrosis Registry for mutations in hTERT and hTR. RESULTS Six probands (8%) had heterozygous mutations in hTERT or hTR; mutant telomerase resulted in short telomeres. Asymptomatic subjects with mutant telomerase also had short telomeres, suggesting that they may be at risk for the disease. We did not identify any of the classic features of dyskeratosis congenita in five of the six families. CONCLUSIONS Mutations in the genes encoding telomerase components can appear as familial idiopathic pulmonary fibrosis. Our findings support the idea that pathways leading to telomere shortening are involved in the pathogenesis of this disease.	Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21231 USA; Arizona State Univ, Dept Chem & Biochem, Temple, TX USA; Arizona State Univ, Sch Life Sci, Temple, TX USA; Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; Vet Affairs Med Ctr, Nashville, TN 37212 USA; Univ British Columbia, Terry Fox Lab, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, British Columbia Canc Agcy, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Arizona State University; Arizona State University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; University of British Columbia	Armanios, MY (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, 1650 Orleans St,CRB 186, Baltimore, MD 21231 USA.	marmani1@jhmi.edu	Alder, Jonathan/AAF-3540-2020; Chen, Julian J.-L./D-6488-2014	Chen, Julian J.-L./0000-0002-7253-2722; Loyd, James/0000-0002-5042-7390; , Roxann/0000-0002-4266-613X; Lansdorp, Peter/0000-0001-7435-1071; Greider, Carol/0000-0002-5494-8126; Alder, Jonathan/0000-0003-3741-6512; Cogan, Joy/0000-0001-8106-1216	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000095] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL085406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI029524, R01AI029524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027406] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR-00095] Funding Source: Medline; NHLBI NIH HHS [K08 HL085406] Funding Source: Medline; NIAID NIH HHS [AI29524] Funding Source: Medline; NIA NIH HHS [R01 AG027406] Funding Source: Medline; PHS HHS [K08 118416, K08 85406] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Agusti C, 2002, AM J RESP CRIT CARE, V166, P426; American Thoracic Society; European Respiratory Society American thoracic Society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; BAERLOCHER GM, IN PRESS NAT PROTOC; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Chen JL, 2003, GENE DEV, V17, P2747, DOI 10.1101/gad.1140303; Chen JL, 2000, CELL, V100, P503, DOI 10.1016/S0092-8674(00)80687-X; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x; Dokal I, 2003, BLOOD REV, V17, P217, DOI 10.1016/S0268-960X(03)00020-1; Drosopoulos WC, 2005, J BIOL CHEM, V280, P32801, DOI 10.1074/jbc.M506319200; Fogarty PF, 2003, LANCET, V362, P1628, DOI 10.1016/S0140-6736(03)14797-6; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hao LY, 2005, CELL, V123, P1121, DOI 10.1016/j.cell.2005.11.020; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Jacobs SA, 2006, NAT STRUCT MOL BIOL, V13, P218, DOI 10.1038/nsmb1054; Knight S, 1998, BRIT J HAEMATOL, V103, P990, DOI 10.1046/j.1365-2141.1998.01103.x; Lawson William E, 2006, Proc Am Thorac Soc, V3, P345, DOI 10.1513/pats.200512-137TK; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Loyd JE, 2003, AM J RESP CELL MOL, V29, pS47; Marshall RP, 2000, THORAX, V55, P143, DOI 10.1136/thorax.55.2.143; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; *NAT I ENV HLTH SC, TERT TEL REV TRANSCR; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Steele MP, 2005, AM J RESP CRIT CARE, V172, P1146, DOI 10.1164/rccm.200408-1104OC; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yamaguchi H, 2003, BLOOD, V102, P916, DOI 10.1182/blood-2003-01-0335	38	887	933	1	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2007	356	13					1317	1326		10.1056/NEJMoa066157	http://dx.doi.org/10.1056/NEJMoa066157			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150MN	17392301	Bronze			2022-12-01	WOS:000245221000005
J	Barrangou, R; Fremaux, C; Deveau, H; Richards, M; Boyaval, P; Moineau, S; Romero, DA; Horvath, P				Barrangou, Rodolphe; Fremaux, Christophe; Deveau, Helene; Richards, Melissa; Boyaval, Patrick; Moineau, Sylvain; Romero, Dennis A.; Horvath, Philippe			CRISPR provides acquired resistance against viruses in prokaryotes	SCIENCE			English	Article							DNA; REPEATS; ELEMENTS; STRAIN; EVOLUTIONARY; SEQUENCES; BACTERIA; SYSTEM; GENES; PHAGE	Clustered regularly interspaced short palindromic repeats (CRISPR) are a distinctive feature of the genomes of most Bacteria and Archaea and are thought to be involved in resistance to bacteriophages. We found that, after viral challenge, bacteria integrated new spacers derived from phage genomic sequences. Removal or addition of particular spacers modified the phage-resistance phenotype of the cell. Thus, CRISPR, together with associated cas genes, provided resistance against phages, and resistance specificity is determined by spacer-phage sequence similarity.	Danisco France SAS, F-86220 Dange St Romain, France; Danisco USA Inc, Madison, WI 53716 USA; Univ Laval, Dept Biochem & Microbiol, Felix Herelle Reference Ctr Bacterial Viruses, Grp Rech Ecol Buccale,Fac Sci & Genie, Ste Foy, PQ G1K 7P4, Canada	Laval University	Horvath, P (corresponding author), Danisco France SAS, Boite Postale 10, F-86220 Dange St Romain, France.	philippe.horvath@danisco.com	Moineau, Sylvain/I-7231-2019; Moineau, Sylvain/N-3578-2013; Barrangou, Rodolphe/I-2878-2014; HORVATH, Philippe/K-5266-2015	Moineau, Sylvain/0000-0002-2832-5101; Barrangou, Rodolphe/0000-0002-0648-3504; HORVATH, Philippe/0000-0003-2015-8123				Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Breitbart M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/j.tim.2005.04.003; Brussow H, 2001, ANNU REV MICROBIOL, V55, P283, DOI 10.1146/annurev.micro.55.1.283; Chibani-Chennoufi S, 2004, J BACTERIOL, V186, P3677, DOI 10.1128/JB.186.12.3677-3686.2004; DeBoy RT, 2006, J BACTERIOL, V188, P2364, DOI 10.1128/JB.188.7.2364-2374.2006; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; GROENEN PMA, 1993, MOL MICROBIOL, V10, P1057, DOI 10.1111/j.1365-2958.1993.tb00976.x; HAIT DH, 2005, PLOS COMPUT BIOL, V1, pE60; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Levesque C, 2005, APPL ENVIRON MICROB, V71, P4057, DOI 10.1128/AEM.71.7.4057-4068.2005; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2002, NUCLEIC ACIDS RES, V30, P482, DOI 10.1093/nar/30.2.482; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mongodin EF, 2005, J BACTERIOL, V187, P4935, DOI 10.1128/JB.187.14.4935-4944.2005; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Russell WM, 2001, APPL ENVIRON MICROB, V67, P4361, DOI 10.1128/AEM.67.9.4361-4364.2001; Sturino JM, 2006, NAT REV MICROBIOL, V4, P395, DOI 10.1038/nrmicro1393	19	3515	3998	100	2177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2007	315	5819					1709	1712		10.1126/science.1138140	http://dx.doi.org/10.1126/science.1138140			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379808				2022-12-01	WOS:000245106900039
J	Hijiya, N; Hudson, MM; Lensing, S; Zacher, M; Onciu, M; Behm, FG; Razzouk, BI; Ribeiro, RC; Rubnitz, JE; Sandlund, JT; Rivera, GK; Evans, WE; Relling, MV; Pui, CH				Hijiya, Nobuko; Hudson, Melissa M.; Lensing, Shelly; Zacher, Margie; Onciu, Mihaela; Behm, Fred G.; Razzouk, Bassem I.; Ribeiro, Raul C.; Rubnitz, Jeffrey E.; Sandlund, John T.; Rivera, Gaston K.; Evans, William E.; Relling, Mary V.; Pui, Ching-Hon			Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CANCER SURVIVOR; TOTAL-THERAPY; BRAIN-TUMORS; CRANIAL RADIOTHERAPY; MYELOID-LEUKEMIA; ADVERSE EVENTS; COMPETING RISK; 2ND NEOPLASMS; CHILDREN; CHEMOTHERAPY	Context Little is known about the incidence of secondary neoplasms after 15 to 20 years in children and adolescents who were treated for acute lymphoblastic leukemia. Objectives To investigate the cumulative incidence of secondary neoplasms in pediatric patients treated for acute lymphoblastic leukemia over 30 years and to characterize late-occurring tumors. Design, Setting, and Patients Retrospective study of 2169 patients with acute lymphoblastic leukemia treated between 1962 and 1998 at St Jude Children's Research Hospital, Memphis, Tenn, who achieved complete remission and had a median follow-up time of 18.7 years (range, 2.4-41.3 years). Main Outcome Measures Cumulative incidences of secondary neoplasms in first remission and standard incidence ratios of observed rates compared with rates of cancer development in the general US population. Results Secondary neoplasms developed as the first event in 123 patients and comprised 46 myeloid malignancies, 3 lymphomas, 14 basal cell carcinomas, 16 other carcinomas, 6 sarcomas, 16 meningiomas, and 22 other brain tumors. The cumulative incidence of secondary neoplasm was 4.17% (SE, 0.46%) at 15 years and increased substantially after 20 years, reaching 10.85% (SE, 1.27%) at 30 years. When meningiomas and basal cell carcinomas were excluded, the overall cumulative incidence was 3.99% (SE, 0.44%) at 15 years and 6.27% (SE, 0.83%) at 30 years, representing a 13.5-fold increase in overall risk compared with the general population. The cumulative incidence of each tumor type at 30 years was 2.19% (SE, 0.32%) for myeloid malignancy, 0.17% (SE, 0.10%) for lymphoma, 3.00% (SE, 0.59%) for brain tumor, 4.91% (SE, 1.04%) for carcinoma, and 0.57% (SE, 0.37%) for sarcoma. Conclusions The cumulative incidence of secondary neoplasms increases steadily over 30 years after treatment of acute lymphoblastic leukemia. Although the majority of the late-occurring secondary neoplasms are low-grade tumors, the increase in incidence of more aggressive malignant neoplasms is significantly higher than expected in the general population. These results suggest that lifelong follow-up of acute lymphoblastic leukemia survivors is needed to ascertain the full impact of treatment and other leukemia-related factors on secondary neoplasm development.	St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Biostat, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Epidemiol & Canc Control, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Dept Pediat, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Dept Pharmaceut Sci & Pharm, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Ctr Pediat Pharmacokinet & Therapeut, Memphis, TN 38163 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Hijiya, N (corresponding author), St Jude Childrens Hosp, Dept Oncol, MS 260,332 N Lauderdale St, Memphis, TN 38105 USA.	nobuko.hijiya@stjude.org	Pui, Ching-Hon/N-8076-2018; Hudson, Melissa M/N-4441-2018; Relling, Mary/N-5032-2018; Evans, William E./C-2069-2012; Rubnitz, Jeffrey E/N-2619-2018	Pui, Ching-Hon/0000-0003-0303-5658; Hudson, Melissa M/0000-0001-6984-2407; Evans, William E./0000-0002-9333-5322; Rubnitz, Jeffrey E/0000-0001-9885-3527; Razzouk, Bassem/0000-0003-0536-6135	NCI NIH HHS [CA-78224, CA-51001, CA-71907, CA-36401, CA-21765, CA-60419] Funding Source: Medline; NIGMS NIH HHS [GM-61393] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA036401, R01CA060419, R01CA078224, P01CA071907, R01CA051001, P30CA021765, R01CA036401, U01CA060419, R29CA051001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bassal M, 2006, J CLIN ONCOL, V24, P476, DOI 10.1200/JCO.2005.02.7235; Bhatia S, 2002, BLOOD, V99, P4257, DOI 10.1182/blood.V99.12.4257; Bogni A, 2006, LEUKEMIA, V20, P239, DOI 10.1038/sj.leu.2404059; Breslow N E, 1987, IARC Sci Publ, P1; Dalton VMK, 1998, J CLIN ONCOL, V16, P2848, DOI 10.1200/JCO.1998.16.8.2848; Edick MJ, 2005, GENE CHROMOSOME CANC, V42, P107, DOI 10.1002/gcc.20121; Evans WE, 1998, NEW ENGL J MED, V338, P499, DOI 10.1056/NEJM199802193380803; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gaynon PS, 2000, LEUKEMIA, V14, P2223, DOI 10.1038/sj.leu.2401939; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Kalbfleisch JD, 2002, STAT ANAL FAILURE TI, P247; Loning L, 2000, BLOOD, V95, P2770, DOI 10.1182/blood.V95.9.2770.009k16_2770_2775; *NCI DCCPS, 2004, SEER STAT DAT INC SE; NEGLIA JP, 1991, NEW ENGL J MED, V325, P1330, DOI 10.1056/NEJM199111073251902; Neglia JP, 2001, J NATL CANCER I, V93, P618, DOI 10.1093/jnci/93.8.618; Perkins JL, 2005, J CLIN ONCOL, V23, P3733, DOI 10.1200/JCO.2005.06.237; Pui CH, 2005, J CLIN ONCOL, V23, P7936, DOI 10.1200/JCO.2004.01.0033; PUI CH, 1995, LEUKEMIA, V9, P1680; Pui CH, 2003, NEW ENGL J MED, V349, P640, DOI 10.1056/NEJMoa035091; Pui CH, 2004, BLOOD, V104, P2690, DOI 10.1182/blood-2004-04-1616; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; PUI CH, 1991, J CLIN ONCOL, V9, P1341, DOI 10.1200/JCO.1991.9.8.1341; PUI CH, 1991, NEW ENGL J MED, V325, P1682, DOI 10.1056/NEJM199112123252402; Pui CH, 1998, BLOOD, V92, P411, DOI 10.1182/blood.V92.2.411.414k34_411_415; Relling MV, 2003, BLOOD, V101, P3862, DOI 10.1182/blood-2002-08-2405; Relling MV, 1999, LANCET, V354, P34, DOI 10.1016/S0140-6736(98)11079-6; RIVERA GK, 1991, LANCET, V337, P61, DOI 10.1016/0140-6736(91)90733-6; Schrappe M, 2000, BLOOD, V95, P3310; Silverman LB, 2001, BLOOD, V97, P1211, DOI 10.1182/blood.V97.5.1211; SIMONE J, 1972, CANCER-AM CANCER SOC, V30, P1488, DOI 10.1002/1097-0142(197212)30:6<1488::AID-CNCR2820300612>3.0.CO;2-D; Strojan P, 2000, INT J RADIAT ONCOL, V48, P65, DOI 10.1016/S0360-3016(00)00609-X; Walter AW, 1998, J CLIN ONCOL, V16, P3761, DOI 10.1200/JCO.1998.16.12.3761; Zwerdling T, 2002, J PEDIAT HEMATOL ONC, V24, P199, DOI 10.1097/00043426-200203000-00008	33	203	211	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2007	297	11					1207	1215		10.1001/jama.297.11.1207	http://dx.doi.org/10.1001/jama.297.11.1207			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	147XO	17374815	Bronze			2022-12-01	WOS:000245039300024
J	Franck, L; Chantler, C; Dixon, M				Franck, Linda; Chantler, Cyril; Dixon, Michael			Should NICE evaluate complementary and alternative medicine?	BRITISH MEDICAL JOURNAL			English	Article									UCL, Inst Child Hlth, London WC1N 1EH, England; Kings Fund, London W1G OAN, England; NHS Alliance, Nottingham DN22 6JD, England	University of London; University College London	Franck, L (corresponding author), UCL, Inst Child Hlth, London WC1N 1EH, England.	l.franck@ich.ucl.ac.uk	; Colquhoun, David/C-1664-2008	Franck, Linda/0000-0003-4291-9181; Colquhoun, David/0000-0002-4263-017X					0	15	15	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2007	334	7592					506	506		10.1136/bmj.39122.512211.BE	http://dx.doi.org/10.1136/bmj.39122.512211.BE			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148VV	17347233	Green Submitted, Green Published			2022-12-01	WOS:000245106400034
J	Cai, L; Marshall, TW; Uetrecht, AC; Schafer, DA; Bear, JE				Cai, Liang; Marshall, Thomas W.; Uetrecht, Andrea C.; Schafer, Dorothy A.; Bear, James E.			Coronin 1B coordinates Arp2/3 complex and cofilin activities at the leading edge	CELL			English	Article							ACTIN-DEPOLYMERIZING FACTOR; LIM-KINASE; ENA/VASP PROTEINS; CROSS-LINKING; POLYMERIZATION; SLINGSHOT; PHOSPHATASES; PROMOTES; FAMILY; CELLS	Actin filament formation and turnover within the treadmilling actin filament array at the leading edge of migrating cells are interdependent and coupled, but the mechanisms coordinating these two activities are not understood. We report that Coronin 1B interacts simultaneously with Arp2/3 complex and Slingshot (SSH1L) phosphatase, two regulators of actin filament formation and turnover, respectively. Coronin 1B inhibits filament nucleation by Arp2/3 complex and this inhibition is attenuated by phosphorylation of Coronin 1B at Serine 2, a site targeted by SSH1L. Coronin 1B also directs SSH1L to lamellipodia where SSH1L likely regulates Cofilin activity via dephosphorylation. Accordingly, depleting Coronin 1B increases phospho-Cofilin levels, and alters lamellipodial dynamics and actin filament architecture at the leading edge. We conclude that Coronin 1B's coordination of filament formation by Arp2/3 complex and filament turnover by Cofilin is required for effective lamellipodial protrusion and cell migration.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Cell & Dev Biol, Sch Med, Chapel Hill, NC 27599 USA; Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; Univ Virginia, Dept Cell Biol, Charlottesville, VA 22904 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Virginia; University of Virginia	Bear, JE (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	jbear@email.unc.edu			NCI NIH HHS [1U54 CA 119343, P30 CA016086, CA 16086] Funding Source: Medline; NIGMS NIH HHS [R01 GM083035, R01 GM067222, GM 067222, R01 GM083035-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U54CA119343, P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083035, R01GM067222] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; BRYAN J, 1985, J CELL BIOL, V101, P1236, DOI 10.1083/jcb.101.4.1236; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; Cohen PTW, 2002, J CELL SCI, V115, P241; CONDEELIS J, 1988, CELL MOTIL CYTOSKEL, V10, P77, DOI 10.1002/cm.970100113; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163; DesMarais V, 2004, J CELL SCI, V117, P3499, DOI 10.1242/jcs.01211; DesMarais V, 2005, J CELL SCI, V118, P19, DOI 10.1242/jcs.01631; DINUBILE MJ, 1995, MOL BIOL CELL, V6, P1659, DOI 10.1091/mbc.6.12.1659; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Goode BL, 1999, J CELL BIOL, V144, P83, DOI 10.1083/jcb.144.1.83; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Hinz B, 1999, EXP CELL RES, V251, P234, DOI 10.1006/excr.1999.4541; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; Maul RS, 2003, J CELL BIOL, V160, P399, DOI 10.1083/jcb.200212057; Mishima M, 1999, J CELL SCI, V112, P2833; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ohta Y, 2003, GENES CELLS, V8, P811, DOI 10.1046/j.1365-2443.2003.00678.x; Ponti A, 2005, BIOPHYS J, V89, P3456, DOI 10.1529/biophysj.104.058701; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Shao D, 2006, CELL MOTIL CYTOSKEL, V63, P395, DOI 10.1002/cm.20131; Sim ATR, 1999, CELL CALCIUM, V26, P209, DOI 10.1054/ceca.1999.0072; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Stanyon CA, 1999, INT J BIOCHEM CELL B, V31, P389, DOI 10.1016/S1357-2725(98)00116-2; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; SVITKINA TM, 2005, J CELLS, V3, P277; SYMONS MH, 1991, J CELL BIOL, V114, P503, DOI 10.1083/jcb.114.3.503; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Yamakita Y, 2003, J BIOL CHEM, V278, P17937, DOI 10.1074/jbc.M208739200; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	49	170	175	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2007	128	5					915	929		10.1016/j.cell.2007.01.031	http://dx.doi.org/10.1016/j.cell.2007.01.031			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350576	Green Accepted, Green Submitted, Bronze			2022-12-01	WOS:000245073400016
J	Qu, XP; Zou, ZJ; Sun, QH; Luby-Phelps, K; Cheng, PF; Hogan, RN; Gilpin, C; Levine, B				Qu, Xueping; Zou, Zhongju; Sun, Qihua; Luby-Phelps, Kate; Cheng, Pengfei; Hogan, Robert N.; Gilpin, Christopher; Levine, Beth			Autophagy gene-dependent clearance of apoptotic cells during embryonic development	CELL			English	Article							DEATH; PHOSPHATIDYLSERINE; DIFFERENTIATION; ENGULFMENT; SURVIVAL; SIGNALS; REDISTRIBUTION; INHIBITION; CAVITATION; MECHANISMS	Autophagy is commonly observed in metazoan organisms during programmed cell death (PCD), but its function in dying cells has been unclear. We studied the role of autophagy in embryonic cavitation, the earliest PCD process in mammalian development. Embryoid bodies (EBs) derived from cells lacking the autophagy genes, atg5 or beclin 1, fail to cavitate. This defect is due to persistence of cell corpses, rather than impairment of PCD. Dying cells in autophagy gene null EBs fail to express the "eat-me" signal, phosphaticlylserine exposure, and secrete lower levels of the "come-get-me" signal, lysophosphatidylcholine. These defects are associated with low levels of cellular ATIP and are reversed by treatment with the metabolic substrate, methylpyruvate. Moreover, mice lacking atg5 display a defect in apoptotic corpse engulfment during embryonic development. We conclude that autophagy contributes to dead-cell clearance during PCD by a mechanism that likely involves the generation of energy-dependent engulfment signals.	Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Ophthalmol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Levine, B (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA.	beth.levine@utsouthwestern.edu		Luby-Phelps, Katherine/0000-0002-8378-1409	NCI NIH HHS [R01 CA109618, CA 109618, R01 CA 084254] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084254, R56CA109618, R01CA109618] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baehrecke EH, 2003, CELL DEATH DIFFER, V10, P940, DOI 10.1038/sj.cdd.4401280; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Coucouvanis E, 1999, DEVELOPMENT, V126, P535; Grimsley C, 2003, TRENDS CELL BIOL, V13, P648, DOI 10.1016/j.tcb.2003.10.004; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Li SH, 2003, DEV CELL, V4, P613, DOI 10.1016/S1534-5807(03)00128-X; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lockshin RA, 2004, INT J BIOCHEM CELL B, V36, P2405, DOI 10.1016/j.biocel.2004.04.011; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Marguet D, 1999, NAT CELL BIOL, V1, P454, DOI 10.1038/15690; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Murray P, 2001, DIFFERENTIATION, V68, P227, DOI 10.1046/j.1432-0436.2001.680410.x; Ng YS, 2004, LAB INVEST, V84, P1209, DOI 10.1038/labinvest.3700150; POIRIER F, 1991, DEVELOPMENT, V113, P1105; Ravichandran KS, 2003, CELL, V113, P817, DOI 10.1016/S0092-8674(03)00471-9; SCHWEICHEL JU, 1973, TERATOLOGY, V7, P253, DOI 10.1002/tera.1420070306; Takacs-Vellai K, 2005, CURR BIOL, V15, P1513, DOI 10.1016/j.cub.2005.07.035; van den Eijnde SM, 1998, APOPTOSIS, V3, P9, DOI 10.1023/A:1009650917818; Xiao YJ, 2001, ANAL BIOCHEM, V290, P302, DOI 10.1006/abio.2001.5000; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	37	498	520	0	37	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2007	128	5					931	946		10.1016/j.cell.2006.12.044	http://dx.doi.org/10.1016/j.cell.2006.12.044			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350577	Bronze			2022-12-01	WOS:000245073400017
J	Greenman, C; Stephens, P; Smith, R; Dalgliesh, GL; Hunter, C; Bignell, G; Davies, H; Teague, J; Butler, A; Edkins, S; O'Meara, S; Vastrik, I; Schmidt, EE; Avis, T; Barthorpe, S; Bhamra, G; Buck, G; Choudhury, B; Clements, J; Cole, J; Dicks, E; Forbes, S; Gray, K; Halliday, K; Harrison, R; Hills, K; Hinton, J; Jenkinson, A; Jones, D; Menzies, A; Mironenko, T; Perry, J; Raine, K; Richardson, D; Shepherd, R; Small, A; Tofts, C; Varian, J; Webb, T; West, S; Widaa, S; Yates, A; Cahill, DP; Louis, DN; Goldstraw, P; Nicholson, AG; Brasseur, F; Looijenga, L; Weber, BL; Chiew, YE; Defazio, A; Greaves, MF; Green, AR; Campbell, P; Birney, E; Easton, DF; Chenevix-Trench, G; Tan, MH; Khoo, SK; Teh, BT; Yuen, ST; Leung, SY; Wooster, R; Futreal, PA; Stratton, MR				Greenman, Christopher; Stephens, Philip; Smith, Raffaella; Dalgliesh, Gillian L.; Hunter, Christopher; Bignell, Graham; Davies, Helen; Teague, Jon; Butler, Adam; Edkins, Sarah; O'Meara, Sarah; Vastrik, Imre; Schmidt, Esther E.; Avis, Tim; Barthorpe, Syd; Bhamra, Gurpreet; Buck, Gemma; Choudhury, Bhudipa; Clements, Jody; Cole, Jennifer; Dicks, Ed; Forbes, Simon; Gray, Kris; Halliday, Kelly; Harrison, Rachel; Hills, Katy; Hinton, Jon; Jenkinson, Andy; Jones, David; Menzies, Andy; Mironenko, Tatiana; Perry, Janet; Raine, Keiran; Richardson, Dave; Shepherd, Rebecca; Small, Alexandra; Tofts, Calli; Varian, Jennifer; Webb, Tony; West, Sofie; Widaa, Sara; Yates, Andy; Cahill, Daniel P.; Louis, David N.; Goldstraw, Peter; Nicholson, Andrew G.; Brasseur, Francis; Looijenga, Leendert; Weber, Barbara L.; Chiew, Yoke-Eng; deFazio, Anna; Greaves, Mel F.; Green, Anthony R.; Campbell, Peter; Birney, Ewan; Easton, Douglas F.; Chenevix-Trench, Georgia; Tan, Min-Han; Khoo, Sok Kean; Teh, Bin Tean; Yuen, Siu Tsan; Leung, Suet Yi; Wooster, Richard; Futreal, P. Andrew; Stratton, Michael R.			Patterns of somatic mutation in human cancer genomes	NATURE			English	Article							KINASE GENE FAMILY; HUMAN LUNG-CANCER; COLORECTAL CANCERS; SIGNALING PATHWAY; TUMOR-SUPPRESSOR; BREAST-CANCER; BETA RECEPTOR; PROTEIN; TITIN; INACTIVATION	Cancers arise owing to mutations in a subset of genes that confer growth advantage. The availability of the human genome sequence led us to propose that systematic resequencing of cancer genomes for mutations would lead to the discovery of many additional cancer genes. Here we report more than 1,000 somatic mutations found in 274 megabases (Mb) of DNA corresponding to the coding exons of 518 protein kinase genes in 210 diverse human cancers. There was substantial variation in the number and pattern of mutations in individual cancers reflecting different exposures, DNA repair defects and cellular origins. Most somatic mutations are likely to be 'passengers' that do not contribute to oncogenesis. However, there was evidence for 'driver' mutations contributing to the development of the cancers studied in approximately 120 genes. Systematic sequencing of cancer genomes therefore reveals the evolutionary diversity of cancers and implicates a larger repertoire of cancer genes than previously anticipated.	Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England; EMBL, European Bioinformat Inst, Cambridge CB10 1SD, England; Massachusetts Gen Hosp, Neurosurg Serv, Mol Pathol Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Royal Brompton Hosp, London SW3 6NP, England; Ludwig Inst Canc Res, B-1200 Brussels, Belgium; Erasmus MC, Daniel den Hoed Canc Ctr, Josephine Nefkens Inst, Lab Pathol Expt Pathooncol, NL-3000 DR Rotterdam, Netherlands; Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA; Westmead Hosp, Dept Gynaecol Oncol, Westmead, NSW 2145, Australia; Univ Sydney, Westmead Inst Canc Res, Westmead Millennium Inst, Westmead, NSW 2145, Australia; Inst Canc Res, Sutton SM2 5NG, Surrey, England; Addenbrookes NHS Trust, Dept Haematol, Cambridge CB2 0QQ, England; Univ Cambridge, Cambridge CB2 0QQ, England; Univ Cambridge, Canc Res UK Genet Epidemiol Unit, Cambridge CB1 8RN, England; Univ Queensland, Royal Brisbane Hosp, Queensland Inst Med Res, Herston, Qld 4029, Australia; Van Andel Res Inst, Grand Rapids, MI 49503 USA; Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China	University of Cambridge; Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Royal Brompton Hospital; Ludwig Institute for Cancer Research; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University of Pennsylvania; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of London; Institute of Cancer Research - UK; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cancer Research UK; University of Cambridge; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Queensland; Van Andel Institute; University of Hong Kong	Futreal, PA (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	paf@sanger.ac.uk; mrs@sanger.ac.uk	Choudhury, Bhudipa/D-3863-2011; Leung, Suet Yi/C-4340-2009; Dalgliesh, Gillian/B-7799-2008; deFazio, Anna/D-3939-2013; Chenevix-Trench, Georgia/AAV-2014-2020; DeFazio, Anna/O-2385-2019; Looijenga, Leendert/B-8145-2019; Yuen, Siu/K-6311-2014; Vastrik, Imre/C-2690-2009; Tan, Min Han/D-9205-2014; Leung, Suet Yi/T-9620-2019	Choudhury, Bhudipa/0000-0002-1392-6414; Dalgliesh, Gillian/0000-0001-8526-5064; deFazio, Anna/0000-0003-0057-4744; Chenevix-Trench, Georgia/0000-0002-1878-2587; DeFazio, Anna/0000-0003-0057-4744; Looijenga, Leendert/0000-0002-8146-1911; Tan, Min Han/0000-0002-0644-3457; Birney, Ewan/0000-0001-8314-8497; Vastrik, Imre/0000-0001-6658-9311; Gray, Kristian/0000-0002-7035-7107; Raine, Keiran/0000-0002-5634-1539; Leung, Suet Yi/0000-0001-8614-4619; Yates, Andrew/0000-0002-8886-4772; Buck, Gemma/0000-0001-5289-1050; Cahill, Daniel/0000-0003-2552-6546; Jenkinson, Andrew/0000-0002-0703-6984; Teh, Bin Tean/0000-0003-1514-1124; Richardson, David/0000-0003-0247-9118; Green, Anthony/0000-0002-9795-0218; Hunter, Christopher/0000-0002-1335-0881; Avis, Tim/0000-0001-6120-5729	Medical Research Council [G0300723B] Funding Source: researchfish; Wellcome Trust [077012, 088340] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)		Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Bignell G, 2006, GENE CHROMOSOME CANC, V45, P42, DOI 10.1002/gcc.20265; Bogoyevitch MA, 2004, BBA-PROTEINS PROTEOM, V1697, P89, DOI 10.1016/j.bbapap.2003.11.016; Brose MS, 2002, CANCER RES, V62, P6997; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Futreal PA, 2001, NATURE, V409, P850, DOI 10.1038/35057046; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Granzier HL, 2005, ADV PROTEIN CHEM, V71, P89, DOI 10.1016/S0065-3233(04)71003-7; Greenman C, 2006, GENETICS, V173, P2187, DOI 10.1534/genetics.105.044677; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Hunter C, 2006, CANCER RES, V66, P3987, DOI 10.1158/0008-5472.CAN-06-0127; Irusta PM, 2002, J BIOL CHEM, V277, P38627, DOI 10.1074/jbc.M204890200; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Karran P, 2003, BIOCHIMIE, V85, P1149, DOI 10.1016/j.biochi.2003.10.007; Kushida Tatsuya, 2006, Pac Symp Biocomput, P152; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lonardi S, 2005, CANCER TREAT REV, V31, P79, DOI 10.1016/j.ctrv.2004.12.005; Machado C, 2000, J CELL BIOL, V151, P639, DOI 10.1083/jcb.151.3.639; Machado C, 1998, J CELL BIOL, V141, P321, DOI 10.1083/jcb.141.2.321; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Su GH, 1998, CANCER RES, V58, P2339; Teng DHF, 1997, CANCER RES, V57, P4177; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang TL, 2002, P NATL ACAD SCI USA, V99, P3076, DOI 10.1073/pnas.261714699; Wilkie AOM, 2002, AM J MED GENET, V112, P266, DOI 10.1002/ajmg.10775; Yang ZH, 2003, GENETICS, V165, P695; Zastrow MS, 2006, J CELL SCI, V119, P239, DOI 10.1242/jcs.02728	39	2203	2787	1	239	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2007	446	7132					153	158		10.1038/nature05610	http://dx.doi.org/10.1038/nature05610			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17344846	Green Accepted			2022-12-01	WOS:000244718100033
J	Robinson, AL; Donahue, NM; Shrivastava, MK; Weitkamp, EA; Sage, AM; Grieshop, AP; Lane, TE; Pierce, JR; Pandis, SN				Robinson, Allen L.; Donahue, Neil M.; Shrivastava, Manish K.; Weitkamp, Emily A.; Sage, Amy M.; Grieshop, Andrew P.; Lane, Timothy E.; Pierce, Jeffrey R.; Pandis, Spyros N.			Rethinking organic aerosols: Semivolatile emissions and photochemical aging	SCIENCE			English	Article							AIR-POLLUTION SOURCES; SOURCE APPORTIONMENT; SECONDARY; DILUTION; MASS; OH; TROPOSPHERE; COMBUSTION; TRACERS; PM2.5	Most primary organic-particulate emissions are semivolatile; thus, they partially evaporate with atmospheric dilution, creating substantial amounts of low-volatility gas-phase material. Laboratory experiments show that photo-oxidation of diesel emissions rapidly generates organic aerosol, greatly exceeding the contribution from known secondary organic-aerosol precursors. We attribute this unexplained secondary organic-aerosol production to the oxidation of low-volatility gas-phase species. Accounting for partitioning and photochemical processing of primary emissions creates a more regionally distributed aerosol and brings model predictions into better agreement with observations. Controlling organic particulate-matter concentrations will require substantial changes in the approaches that are currently used to measure and regulate emissions.	Carnegie Mellon Univ, Ctr Atmospher Particle Studies, Pittsburgh, PA 15213 USA; Univ Patras, Dept Chem Engn, Patras 26500, Greece	Carnegie Mellon University; University of Patras	Robinson, AL (corresponding author), Carnegie Mellon Univ, Ctr Atmospher Particle Studies, Pittsburgh, PA 15213 USA.	alr@andrew.cmu.edu; nmd@andrew.cmu.edu	Robinson, Allen/I-5713-2012; Pierce, Jeffrey R/E-4681-2013; Pandis, Spyros/D-3680-2013; Pandis, Spyros/AAW-3089-2021; Studies, Center for Atmospheric Particle/AAR-6731-2020; Worsnop, Douglas R/D-2817-2009; Grieshop, Andrew/AAL-1174-2020; Donahue, Neil M/A-2329-2008; Robinson, Allen L/M-3046-2014	Robinson, Allen/0000-0003-1053-7090; Pierce, Jeffrey R/0000-0002-4241-838X; Pandis, Spyros/0000-0001-8085-9795; Worsnop, Douglas R/0000-0002-8928-8017; Grieshop, Andrew/0000-0002-6470-9946; Donahue, Neil M/0000-0003-3054-2364; Robinson, Allen L/0000-0002-1819-083X				Atkinson R, 2003, CHEM REV, V103, P4605, DOI 10.1021/cr0206420; Bahreini R, 2005, ENVIRON SCI TECHNOL, V39, P5674, DOI 10.1021/es048061a; Bloss WJ, 2005, FARADAY DISCUSS, V130, P425, DOI 10.1039/b419090d; Cabada JC, 2004, AEROSOL SCI TECH, V38, P140, DOI 10.1080/02786820390229084; Chung MY, 2003, ATMOS ENVIRON, V37, pS159, DOI 10.1016/S1352-2310(03)00388-1; de Gouw JA, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005623; Donahue NM, 2006, ENVIRON SCI TECHNOL, V40, P2635, DOI 10.1021/es052297c; Heald CL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023831; Heard DE, 2003, CHEM REV, V103, P5163, DOI 10.1021/cr020522s; HILDEMANN LM, 1989, AEROSOL SCI TECH, V10, P193, DOI 10.1080/02786828908959234; Johnson D, 2006, ATMOS CHEM PHYS, V6, P403, DOI 10.5194/acp-6-403-2006; Kanakidou M, 2005, ATMOS CHEM PHYS, V5, P1053, DOI 10.5194/acp-5-1053-2005; Koo BY, 2003, ATMOS ENVIRON, V37, P4757, DOI 10.1016/j.atmosenv.2003.08.016; Lim YB, 2005, ENVIRON SCI TECHNOL, V39, P9229, DOI 10.1021/es051447g; Lipsky EM, 2006, ENVIRON SCI TECHNOL, V40, P155, DOI 10.1021/es050319p; Odum JR, 1996, ENVIRON SCI TECHNOL, V30, P2580, DOI 10.1021/es950943+; Pun BK, 2003, ENVIRON SCI TECHNOL, V37, P3647, DOI 10.1021/es0341541; Schauer JJ, 1999, ENVIRON SCI TECHNOL, V33, P1578, DOI 10.1021/es980081n; Schauer JJ, 2002, ENVIRON SCI TECHNOL, V36, P1169, DOI 10.1021/es0108077; Schauer JJ, 2001, ENVIRON SCI TECHNOL, V35, P1716, DOI 10.1021/es001331e; Schauer JJ, 1996, ATMOS ENVIRON, V30, P3837, DOI 10.1016/1352-2310(96)00085-4; Shrivastava MK, 2006, ENVIRON SCI TECHNOL, V40, P2671, DOI 10.1021/es0522231; TURPIN BJ, 1995, ATMOS ENVIRON, V29, P3527, DOI 10.1016/1352-2310(94)00276-Q; Volkamer R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026899; VULUKURU S, 2006, J GEOPHYS RES, V111, pS1012; Zhang Q, 2005, ATMOS CHEM PHYS, V5, P3289, DOI 10.5194/acp-5-3289-2005; Zheng M, 2002, ENVIRON SCI TECHNOL, V36, P2361, DOI 10.1021/es011275x	27	1285	1315	43	911	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816					1259	1262		10.1126/science.1133061	http://dx.doi.org/10.1126/science.1133061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332409				2022-12-01	WOS:000244564700045
J	Hellstrom, M; Phng, LK; Hofmann, JJ; Wallgard, E; Coultas, L; Lindblom, P; Alva, J; Nilsson, AK; Karlsson, L; Gaiano, N; Yoon, K; Rossant, J; Iruela-Arispe, ML; Kalen, M; Gerhardt, H; Betsholtz, C				Hellstroem, Mats; Phng, Li-Kun; Hofmann, Jennifer J.; Wallgard, Elisabet; Coultas, Leigh; Lindblom, Per; Alva, Jackelyn; Nilsson, Ann-Katrin; Karlsson, Linda; Gaiano, Nicholas; Yoon, Keejung; Rossant, Janet; Iruela-Arispe, M. Luisa; Kalen, Mattias; Gerhardt, Holger; Betsholtz, Christer			Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis	NATURE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GAMMA-SECRETASE; BRANCHING MORPHOGENESIS; VASCULAR DEVELOPMENT; ARTERIAL; MOUSE; MATURATION; LETHALITY	In sprouting angiogenesis, specialized endothelial tip cells lead the outgrowth of blood-vessel sprouts towards gradients of vascular endothelial growth factor (VEGF)-A(1,2). VEGF-A is also essential for the induction of endothelial tip cells(2), but it is not known how single tip cells are selected to lead each vessel sprout, and how tip-cell numbers are determined. Here we present evidence that delta-like 4 (Dll4) -Notch1 signalling regulates the formation of appropriate numbers of tip cells to control vessel sprouting and branching in the mouse retina. We show that inhibition of Notch signalling using gamma-secretase inhibitors, genetic inactivation of one allele of the endothelial Notch ligand Dll4, or endothelial-specific genetic deletion of Notch1, all promote increased numbers of tip cells. Conversely, activation of Notch by a soluble jagged1 peptide leads to fewer tip cells and vessel branches. Dll4 and reporters of Notch signalling are distributed in a mosaic pattern among endothelial cells of actively sprouting retinal vessels. At this location, Notch1-deleted endothelial cells preferentially assume tip-cell characteristics. Together, our results suggest that Dll4 - Notch1 signalling between the endothelial cells within the angiogenic sprout serves to restrict tip-cell formation in response to VEGF, thereby establishing the adequate ratio between tip and stalk cells required for correct sprouting and branching patterns. This model offers an explanation for the dose-dependency and haploinsufficiency of the Dll4 gene(3-5), and indicates that modulators of Dll4 or Notch signalling, such as gamma-secretase inhibitors developed for Alzheimer's disease, might find usage as pharmacological regulators of angiogenesis.	Angiogenet Sweden AB, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Med, SE-17177 Stockholm, Sweden; Canc Res UK, Vasc Biol Lab, London Res Inst, London WC2A 3PX, England; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Hosp Sick Children, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Johns Hopkins Univ, Inst Cell Engn, Baltimore, MD 21205 USA	Karolinska Institutet; Karolinska Institutet; Cancer Research UK; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Johns Hopkins University	Hellstrom, M (corresponding author), Angiogenet Sweden AB, Scheeles Vag 2, SE-17177 Stockholm, Sweden.	mats.hellstrom@ki.se; holger.gerhardt@cancer.org.uk	Gerhardt, Holger/G-4610-2011; Phng, Li-Kun/L-7346-2013; Iruela-Arispe, M. Luisa/AAJ-1297-2020; Gerhardt, Holger/G-4610-2011	Gerhardt, Holger/0000-0002-3030-0384; Iruela-Arispe, M. Luisa/0000-0002-3050-4168; Gerhardt, Holger/0000-0001-9228-7472; Yoon, Keejung/0000-0002-2361-9039; Hellstrom, Mats/0000-0002-7088-9533				Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Claxton S, 2004, GENE EXPR PATTERNS, V5, P123, DOI 10.1016/j.modgep.2004.05.004; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Ghabrial AS, 2006, NATURE, V441, P746, DOI 10.1038/nature04829; Grunstein J, 2000, MOL CELL BIOL, V20, P7282, DOI 10.1128/MCB.20.19.7282-7291.2000; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Krebs LT, 2000, GENE DEV, V14, P1343; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Limbourg FP, 2005, CIRCULATION, V111, P1826, DOI 10.1161/01.CIR.0000160870.93058.DD; Llimargas M, 1999, DEVELOPMENT, V126, P2355; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Monvoisin A, 2006, DEV DYNAM, V235, P3413, DOI 10.1002/dvdy.20982; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Searfoss GH, 2003, J BIOL CHEM, V278, P46107, DOI 10.1074/jbc.M307757200; Shawber CJ, 2004, BIOESSAYS, V26, P225, DOI 10.1002/bies.20004; Shutter JR, 2000, GENE DEV, V14, P1313; Steneberg P, 1999, MECH DEVELOP, V87, P153, DOI 10.1016/S0925-4773(99)00157-4; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Weijzen S, 2002, J IMMUNOL, V169, P4273, DOI 10.4049/jimmunol.169.8.4273; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294	30	1201	1276	3	171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2007	445	7129					776	780		10.1038/nature05571	http://dx.doi.org/10.1038/nature05571			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17259973				2022-12-01	WOS:000244205200047
J	Basson, R				Basson, Rosemary			Sexuality in chronic illness: no longer ignored	LANCET			English	Editorial Material							TESTOSTERONE; DYSFUNCTION; MEN		Univ British Columbia, Dept Psychiat, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Basson, R (corresponding author), Univ British Columbia, Dept Psychiat, Vancouver, BC V5Z 1M9, Canada.	sexmed@interchange.ubc.ca						Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Basson R, 2007, LANCET, V369, P409, DOI 10.1016/S0140-6736(07)60197-4; BHASIN S, IN PRESS LANCET; Bhasin S, 2006, J CLIN ENDOCR METAB, V91, P1995, DOI 10.1210/jc.2005-2847; de Vries CS, 2006, MATURITAS, V53, P343, DOI 10.1016/j.maturitas.2005.06.004; Kaiser DR, 2004, J AM COLL CARDIOL, V43, P179, DOI 10.1016/j.jacc.2003.07.042; Labrie F, 2006, J STEROID BIOCHEM, V99, P182, DOI 10.1016/j.jsbmb.2006.02.004; Nurnberg HG, 2003, JAMA-J AM MED ASSOC, V289, P56, DOI 10.1001/jama.289.1.56; REES P, IN PRESS LANCET; SANTORO A, 2005, J CLIN ENDOCR METAB, V90, P2004; *WHO, GEND REPR RIGHTS	11	25	26	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2007	369	9559					350	352		10.1016/S0140-6736(07)60166-4	http://dx.doi.org/10.1016/S0140-6736(07)60166-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	132LN	17276757				2022-12-01	WOS:000243944400006
J	Sun, PQ; Yoshizuka, N; New, L; Moser, BA; Li, YL; Liao, R; Xie, CC; Chen, JM; Deng, QD; Yamout, M; Dong, MQ; Frangou, CG; Yates, JR; Wright, PE; Han, JH				Sun, Peiqing; Yoshizuka, Naoto; New, Liguo; Moser, Bettina A.; Li, Yilei; Liao, Rong; Xie, Changchuan; Chen, Jianming; Deng, Qingdong; Yamout, Mana; Dong, Meng-Qiu; Frangou, Costas G.; Yates, John R., III; Wright, Peter E.; Han, Jiahuai			PRAK is essential for ras-induced senescence and tumor suppression	CELL			English	Article							INDUCED PREMATURE SENESCENCE; CELL-CYCLE ARREST; ONCOGENIC RAS; HUMAN FIBROBLASTS; MOUSE SKIN; HUMAN P53; KINASE; ACTIVATION; PATHWAY; DEFICIENT	Like apoptosis, oncogene-induced senescence is a barrier to tumor development. However, relatively little is known about the signaling pathways mediating the senescence response. p38regulated/activated protein kinase (PRAK) is a p38 MAIPIK substrate whose physiological functions are poorly understood. Here we describe a role for PRAK in tumor suppression by demonstrating that PRAK mediates senescence upon activation by p38 in response to oncogenic ras. PRAK deficiency in mice enhances DMBA-induced skin carcinogenesis, coinciding with compromised senescence induction. In primary cells, inactivation of PRAK prevents senescence and promotes oncogenic transformation. Furthermore, we show that PRAK activates p53 by direct phosphorylation. We propose that phosphorylation of p53 by PRAK following activation of p38 MAPK by ras plays an important role in ras-induced senescence and tumor suppression.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; Xiamen Univ, Sch Life Sci, Key Lab, Minist Educ Cell Biol, Xiamen 361005, Peoples R China	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Fred Hutchinson Cancer Center; Xiamen University	Sun, PQ (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pqsun@scripps.edu; jhan@scripps.edu	Han, J/G-4671-2010; xie, chang/GYJ-2493-2022	Wright, Peter/0000-0002-1368-0223	NCI NIH HHS [CA106768, CA91922] Funding Source: Medline; NIAID NIH HHS [AI054696, AI041637] Funding Source: Medline; NIGMS NIH HHS [GM67101] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA091922, R01CA106768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067101] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Deng QD, 2005, CANCER RES, V65, P8298, DOI 10.1158/0008-5472.CAN-05-0054; Deng QD, 2004, J BIOL CHEM, V279, P1050, DOI 10.1074/jbc.M308644200; DIGIOVANNI J, 1992, PHARMACOL THERAPEUT, V54, P63, DOI 10.1016/0163-7258(92)90051-Z; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Haq R, 2002, CANCER RES, V62, P5076; Inoue K, 2001, GENE DEV, V15, P2934, DOI 10.1101/gad.929901; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kamijo T, 1999, CANCER RES, V59, P2217; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; Legge GB, 2004, J MOL BIOL, V343, P1081, DOI 10.1016/j.jmb.2004.08.087; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; New L, 2003, MOL BIOL CELL, V14, P2603, DOI 10.1091/mbc.E02-08-0538; New L, 1998, EMBO J, V17, P3372, DOI 10.1093/emboj/17.12.3372; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Seger YR, 2002, CANCER CELL, V2, P401, DOI 10.1016/S1535-6108(02)00183-6; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Shi Y, 2003, MOL CELL BIOL, V23, P7732, DOI 10.1128/MCB.23.21.7732-7741.2003; Shi Y, 2002, BIOL CHEM, V383, P1519, DOI 10.1515/BC.2002.173; Sreeramaneni R, 2005, MOL CELL BIOL, V25, P220, DOI 10.1128/MCB.25.1.220-232.2005; Sun PQ, 1998, SCIENCE, V282, P2270, DOI 10.1126/science.282.5397.2270; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	42	245	264	3	94	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2007	128	2					295	308		10.1016/j.cell.2006.11.050	http://dx.doi.org/10.1016/j.cell.2006.11.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254968	Bronze			2022-12-01	WOS:000244420500015
J	Gewin, V				Gewin, Virginia			Crunch time for multiple-gene tests	NATURE			English	News Item																			0	6	6	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2007	445	7126					354	355		10.1038/445354a	http://dx.doi.org/10.1038/445354a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	128WD	17251949				2022-12-01	WOS:000243689500010
J	Anderson, GF; Chu, E				Anderson, Gerard F.; Chu, Edward			Expanding priorities - Confronting chronic disease in countries with low income	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; Johns Hopkins Sch Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Anderson, GF (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.		Thorpe, Allison/A-2705-2011					World Bank. Oxford University, 2006, DIS CONTR PRIOR DEV; World Health Organization, 2005, PREVENTING CHRONIC D; 2006, GATES BUFFETT GIFT M	3	135	141	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 18	2007	356	3					209	211		10.1056/NEJMp068182	http://dx.doi.org/10.1056/NEJMp068182			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	126BV	17229946				2022-12-01	WOS:000243488100001
J	Nguyen, T; Vazquez, M; Toto, R				Nguyen, Thai; Vazquez, Miguel; Toto, Robert			Living kidney donation and hypertension risk	LANCET			English	Editorial Material							DONOR; TRANSPLANTATION; NEPHRECTOMY		Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Toto, R (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA.	Robert.toto@utsouthwestern.edu	Toto, Robert/AAQ-3336-2021					Boudville N, 2006, ANN INTERN MED, V145, P185, DOI 10.7326/0003-4819-145-3-200608010-00006; Cohen DJ, 2006, AM J TRANSPLANT, V6, P1153, DOI 10.1111/j.1600-6143.2006.01272.x; Davis CL, 2005, J AM SOC NEPHROL, V16, P2098, DOI 10.1681/ASN.2004100824; Davis CL, 2004, AM J KIDNEY DIS, V43, P508, DOI 10.1053/j.ajkd.2003.10.044; HOSTETTER T, 1981, AM J PHYSIOL, V241, P85; Johnson EM, 1997, TRANSPLANTATION, V64, P1124, DOI 10.1097/00007890-199710270-00007; KASISKE BL, 1995, KIDNEY INT, V48, P814, DOI 10.1038/ki.1995.355; McCune TR, 2004, CLIN TRANSPLANT, V18, P33, DOI 10.1111/j.1399-0012.2004.00215.x; NAJARIAN JS, 1992, LANCET, V340, P807, DOI 10.1016/0140-6736(92)92683-7; Praga M, 2000, KIDNEY INT, V58, P2111, DOI 10.1046/j.1523-1755.2000.00384.x; Waterman Amy D, 2006, Prog Transplant, V16, P17	11	4	4	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 13	2007	369	9556					87	88		10.1016/S0140-6736(07)60046-4	http://dx.doi.org/10.1016/S0140-6736(07)60046-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	126TK	17223455				2022-12-01	WOS:000243538200008
J	Collins, FS				Collins, Francis S.		Int Mouse Knockout Consortium	A mouse for all reasons	CELL			English	Editorial Material							MULTIPURPOSE; ALLELES; GENOME	Three major mouse knockout programs are underway worldwide, working together to mutate all protein-encoding genes in the mouse using a combination of gene trapping and gene targeting in mouse embryonic stem (ES) cells. Although the current emphasis is on production of this valuable resource, there are significant efforts to facilitate program coordination, to enhance the availability of this resource, and to plan for future efforts in mouse genetics research.	Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Tech Univ Munich, GSF, Natl Res Ctr Environm & Hlth, D-8000 Munich, Germany	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich		francisc@mail.nih.gov	Nagy, Andras/G-6465-2013; Lefebvre, Louis/O-9309-2016	Nagy, Andras/0000-0003-4311-0413; Lefebvre, Louis/0000-0001-5664-9480				Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Auwerx J, 2004, NAT GENET, V36, P925, DOI 10.1038/ng0904-925; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Friedel RH, 2005, P NATL ACAD SCI USA, V102, P13188, DOI 10.1073/pnas.0505474102; Schnutgen F, 2005, P NATL ACAD SCI USA, V102, P7221, DOI 10.1073/pnas.0502273102; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	9	323	353	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 12	2007	128	1					9	13		10.1016/j.cell.2006.12.018	http://dx.doi.org/10.1016/j.cell.2006.12.018			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GN	17218247	Bronze			2022-12-01	WOS:000244420400005
J	Galburt, EA; Grill, SW; Wiedmann, A; Lubkowska, L; Choy, J; Nogales, E; Kashlev, M; Bustamante, C				Galburt, Eric A.; Grill, Stephan W.; Wiedmann, Anna; Lubkowska, Lucyna; Choy, Jason; Nogales, Eva; Kashlev, Mikhail; Bustamante, Carlos			Backtracking determines the force sensitivity of RNAP II in a factor-dependent manner	NATURE			English	Article							ELONGATION-FACTOR TFIIS; POLYMERASE-II; TRANSCRIPT-CLEAVAGE; ARREST; DNA; MECHANISM; RESOLUTION; COMPLEXES; MOLECULES; BACTERIAL	RNA polymerase II ( RNAP II) is responsible for transcribing all messenger RNAs in eukaryotic cells during a highly regulated process that is conserved from yeast to human 1, and that serves as a central control point for cellular function. Here we investigate the transcription dynamics of single RNAP II molecules from Saccharomyces cerevisiae against force and in the presence and absence of TFIIS, a transcription elongation factor known to increase transcription through nucleosomal barriers(2\). Using a single-molecule dual-trap optical-tweezers assay combined with a novel method to enrich for active complexes, we found that the response of RNAP II to a hindering force is entirely determined by enzyme backtracking(3-6). Surprisingly, RNAP II molecules ceased to transcribe and were unable to recover from backtracks at a force of 7.5 +/- 2 pN, only one-third of the force determined for Escherichia coli RNAP(7,8). We show that backtrack pause durations follow a t(-3/2) power law, implying that during backtracking RNAP II diffuses in discrete base-pair steps, and indicating that backtracks may account for most of RNAP II pauses. Significantly, addition of TFIIS rescued backtracked enzymes and allowed transcription to proceed up to a force of 16.9 +/- 3.4 pN. Taken together, these results describe a regulatory mechanism of transcription elongation in eukaryotes by which transcription factors modify the mechanical performance of RNAP II, allowing it to operate against higher loads.	Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; NCI, Ctr Canc Res, Frederick, MD 21702 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bustamante, C (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu	Grill, Stephan/D-9427-2012	Galburt, Eric/0000-0003-4314-3215; Bustamante, Carlos/0000-0002-2970-0073				Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Awrey DE, 1998, J BIOL CHEM, V273, P22595, DOI 10.1074/jbc.273.35.22595; Borukhov S, 2005, MOL MICROBIOL, V55, P1315, DOI 10.1111/j.1365-2958.2004.04481.x; BUSTAMANTE C, 1994, SCIENCE, V265, P1600; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Forde NR, 2002, P NATL ACAD SCI USA, V99, P11682, DOI 10.1073/pnas.142417799; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Kireeva ML, 2003, METHOD ENZYMOL, V370, P138; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Komissarova N, 2003, METHOD ENZYMOL, V371, P233; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Kulish D, 2001, MOL CELL BIOL, V21, P4162, DOI 10.1128/MCB.21.13.4162-4168.2001; Li PTX, 2006, BIOPHYS J, V90, P250, DOI 10.1529/biophysj.105.068049; Moffitt JR, 2006, P NATL ACAD SCI USA, V103, P9006, DOI 10.1073/pnas.0603342103; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Palangat M, 2005, P NATL ACAD SCI USA, V102, P15036, DOI 10.1073/pnas.0409405102; REINES D, 1993, P NATL ACAD SCI USA, V90, P1917, DOI 10.1073/pnas.90.5.1917; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/S0968-0004(96)10050-5; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; Smith SB, 2003, METHOD ENZYMOL, V361, P134; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Weilbaecher RG, 2003, J BIOL CHEM, V278, P24189, DOI 10.1074/jbc.M211197200; YIN H, 1995, SCIENCE, V270, P1653, DOI 10.1126/science.270.5242.1653	28	212	219	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2007	446	7137					820	823		10.1038/nature05701	http://dx.doi.org/10.1038/nature05701			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17361130				2022-12-01	WOS:000245626800046
J	Harpole, WS; Tilman, D				Harpole, W. Stanley; Tilman, David			Grassland species loss resulting from reduced niche dimension	NATURE			English	Article							RESOURCE COMPETITION; LIMITING RESOURCES; DIVERSITY; BIODIVERSITY; ECOSYSTEM; RICHNESS; PRODUCTIVITY; ENRICHMENT; ECOLOGY	Intact ecosystems contain large numbers of competing but coexisting species. Although numerous alternative theories have provided potential explanations for this high biodiversity, there have been few field experiments testing between these theories. In particular, theory predicts that higher diversity of coexisting competitors could result from greater niche dimensionality(1), for example larger numbers of limiting resources or factors. Alternatively, diversity could be independent of niche dimensionality because large numbers of species can coexist when limited by just one or two factors if species have appropriate trade-offs(2). Here we show that plant coexistence and diversity result from the 'niche dimensionality' of a habitat. Plant species numbers decreased with increasing numbers of added limiting soil resources ( soil moisture, nitrogen, phosphorus and base cations), which is consistent with theoretical predictions that an increased supply of multiple limiting resources can reduce niche dimension. An observational field study gave similar results. The niche dimension hypothesis also explained diversity changes in the classic Park Grass Experiment at Rothamsted. Our results provide an alternative mechanistic explanation for the effects of nutrient eutrophication on the diversity of terrestrial, freshwater and marine ecosystems.	Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of California System; University of California Irvine; University of Minnesota System; University of Minnesota Twin Cities	Harpole, WS (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, 321 Steinhaus Hall, Irvine, CA 92697 USA.	wharpole@uci.edu	Tilman, David/ABD-5309-2021; Harpole, William S/C-2814-2013	Harpole, William S/0000-0002-3404-9174				Baer SG, 2003, ECOLOGY, V84, P724, DOI 10.1890/0012-9658(2003)084[0724:SRRPAD]2.0.CO;2; Braakhekke WG, 1999, J VEG SCI, V10, P187, DOI 10.2307/3237140; Brenchley W.E., 1958, PARK GRASS PLOTS ROT; Chase J.M., 2003, ECOLOGICAL NICHES LI; Crawley MJ, 2005, AM NAT, V165, P179, DOI 10.1086/427270; DITOMMASO A, 1989, VEGETATIO, V84, P9, DOI 10.1007/BF00054662; Foster BL, 1998, ECOLOGY, V79, P2593, DOI 10.1890/0012-9658(1998)079[2593:SRIASG]2.0.CO;2; GOLDBERG DE, 1990, ECOLOGY, V71, P213, DOI 10.2307/1940261; Gough L, 2000, OIKOS, V89, P428, DOI 10.1034/j.1600-0706.2000.890302.x; Grover JP, 2004, ECOL MONOGR, V74, P533, DOI 10.1890/03-4073; Herbert DA, 2004, ECOSYSTEMS, V7, P296, DOI 10.1007/s10021-003-0233-x; HUSTON MA, 1994, AM NAT, V144, P954, DOI 10.1086/285720; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Interlandi SJ, 2001, ECOLOGY, V82, P1270, DOI 10.2307/2679988; Lawes JB, 1882, PHILOS T R SOC LONDO, V173, P1181, DOI DOI 10.1098/RSTL.1882.0029; Leibold MA, 1999, EVOL ECOL RES, V1, P73; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; SILVERTOWN J, 1980, J APPL ECOL, V17, P491, DOI 10.2307/2402344; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Tilman D., 1982, Monographs in Population Biology, pi; Tilman D, 2001, P NATL ACAD SCI USA, V98, P5433, DOI 10.1073/pnas.091093198; Worm B, 2002, NATURE, V417, P848, DOI 10.1038/nature00830	24	380	417	19	440	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2007	446	7137					791	793		10.1038/nature05684	http://dx.doi.org/10.1038/nature05684			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17384633				2022-12-01	WOS:000245626800039
J	Ono, M; Yaguchi, H; Ohkura, N; Kitabayashi, I; Nagamura, Y; Nomura, T; Miyachi, Y; Tsukada, T; Sakaguchi, S				Ono, Masahiro; Yaguchi, Hiroko; Ohkura, Naganari; Kitabayashi, Issay; Nagamura, Yuko; Nomura, Takashi; Miyachi, Yoshiki; Tsukada, Toshihiko; Sakaguchi, Shimon			Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1	NATURE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; TRANSCRIPTION FACTOR FOXP3; RUNX1 BINDING-SITE; INTERLEUKIN-2 GENE; LEUKEMIA; DIFFERENTIATION; SUSCEPTIBILITY; HEMATOPOIESIS; COOPERATION; ACTIVATION	Naturally arising CD25(+)CD4(+) regulatory T cells (T-R cells) are engaged in the maintenance of immunological self-tolerance and immune homeostasis by suppressing aberrant or excessive immune responses, such as autoimmune disease and allergy(1-3). T-R cells specifically express the transcription factor Foxp3, a key regulator of T-R-cell development and function. Ectopic expression of Foxp3 in conventional T cells is indeed sufficient to confer suppressive activity, repress the production of cytokines such as interleukin-2 (IL-2) and interferon-gamma (IFN-gamma), and upregulate T-R-cell-associated molecules such as CD25, cytotoxic T-lymphocyte-associated antigen-4, and glucocorticoid-induced TNF-receptor-family-related protein(4-7). However, the method by which Foxp3 controls these molecular events has yet to be explained. Here we show that the transcription factor AML1 ( acute myeloid leukaemia 1)/Runx1 (Runt-related transcription factor 1), which is crucially required for normal haematopoiesis including thymic T-cell development(8-11), activates IL-2 and IFN-gamma gene expression in conventional CD4(+) T cells through binding to their respective promoters. In natural T-R cells, Foxp3 interacts physically with AML1. Several lines of evidence support a model in which the interaction suppresses IL-2 and IFN-gamma production, upregulates T-R-cell-associated molecules, and exerts suppressive activity. This transcriptional control of T-R-cell function by an interaction between Foxp3 and AML1 can be exploited to control physiological and pathological T-cell-mediated immune responses.	Kyoto Univ, Grad Sch Med, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto 6068507, Japan; Natl Canc Ctr, Res Inst, Div Mol Oncol, Chuo Ku, Tokyo 1040045, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi 3320012, Japan; Natl Canc Ctr, Res Inst, Tumor Endocrinol Project, Chuo Ku, Tokyo 1040045, Japan	Kyoto University; Kyoto University; National Cancer Center - Japan; Japan Science & Technology Agency (JST); National Cancer Center - Japan	Sakaguchi, S (corresponding author), Kyoto Univ, Grad Sch Med, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan.	shimon@frontier.kyoto-u.ac.jp	Sakaguchi, Shimon/C-9535-2009; Kitabayashi, Issay/G-2204-2017; Ono, Masahiro/H-2378-2011	Ono, Masahiro/0000-0002-9284-7326; Kitabayashi, Issay/0000-0002-8409-0407				Brenner O, 2004, P NATL ACAD SCI USA, V101, P16016, DOI 10.1073/pnas.0407180101; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Kanno Y, 1998, MOL CELL BIOL, V18, P4252, DOI 10.1128/MCB.18.7.4252; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kitabayashi I, 1998, EMBO J, V17, P2994, DOI 10.1093/emboj/17.11.2994; Komine O, 2003, J EXP MED, V198, P51, DOI 10.1084/jem.20021200; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; NOVAK TJ, 1990, NUCLEIC ACIDS RES, V18, P4523, DOI 10.1093/nar/18.15.4523; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Ono M, 2006, J IMMUNOL, V176, P4748, DOI 10.4049/jimmunol.176.8.4748; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; ROONEY JW, 1995, MOL CELL BIOL, V15, P6299; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165	28	494	523	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2007	446	7136					685	689		10.1038/nature05673	http://dx.doi.org/10.1038/nature05673			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17377532				2022-12-01	WOS:000245438300044
J	Hatakeyama, S; Sugaya, N; Ito, M; Yamazaki, M; Ichikawa, M; Kimura, K; Kiso, M; Shimizu, H; Kawakami, C; Koike, K; Mitamura, K; Kawaoka, Y				Hatakeyama, Shuji; Sugaya, Norio; Ito, Mutsumi; Yamazaki, Masahiko; Ichikawa, Masataka; Kimura, Kazuhiro; Kiso, Maki; Shimizu, Hideaki; Kawakami, Chiharu; Koike, Kazuhiko; Mitamura, Keiko; Kawaoka, Yoshihiro			Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IN-VITRO; OSELTAMIVIR; RESISTANT; ZANAMIVIR; SUSCEPTIBILITIES; SEQUENCE; MUTATION	Context Very little is known about the frequency of generation and transmissibility of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. Furthermore, transmission of resistant virus, whether influenza A or B, has not been recognized to date. Objective To assess the prevalence and transmissibility of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. Design, Setting, and Patients Investigation of the neuraminidase inhibitor sensitivity of influenza B isolates from 74 children before and after oseltamivir therapy and from 348 untreated patients with influenza ( including 66 adults) seen at 4 community hospitals in Japan during the 2004-2005 influenza season. Four hundred twenty-two viruses from untreated patients and 74 samples from patients after oseltamivir therapy were analyzed. Main Outcome Measure Sialidase inhibition assay was used to test the drug sensitivities of influenza B viruses. The neuraminidase and hemagglutinin genes of viruses showing reduced sensitivity to neuraminidase inhibitors were sequenced to identify mutations that have the potential to confer reduced sensitivity to these drugs. Results In 1 (1.4%) of the 74 children who had received oseltamivir, we identified a variant with reduced drug sensitivity possessing a Gly402Ser neuraminidase substitution. We also identified variants with reduced sensitivity carrying an Asp198Asn, Ile222Thr, or Ser250Gly mutation in 7 (1.7%) of the 422 viruses from untreated patients. Review of the clinical and viral genetic information available on these 7 patients indicated that 4 were likely infected in a community setting, while the remaining 3 were probably infected through contact with siblings shedding the mutant viruses. Conclusions In this population, influenza B viruses with reduced sensitivity to neuraminidase inhibitors do not arise as frequently as resistant influenza A viruses. However, they appear to be transmitted within communities and families, requiring continued close monitoring.	Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol,Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Grad Sch Med, Dept Infect Dis, Tokyo, Japan; Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Tokyo, Japan; Keiyu Hosp, Dept Pediat, Kanagawa, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan; Zama Childrens Clin, Kanagawa, Japan; Isehara Kyodo Hosp, Dept Pediat, Isehara, Kanagawa, Japan; Kawasaki City Inst Publ Hlth, Kanagawa, Japan; Yokohama City Inst Hlth, Kanagawa, Japan; Eiju Gen Hosp, Dept Pediat, Tokyo, Japan; Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA	University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); University of Wisconsin System; University of Wisconsin Madison	Kawaoka, Y (corresponding author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	kawaoka@ims.u-tokyo.ac.jp						[Anonymous], 2005, PRINCIPLES PRACTICE; BURMEISTER WP, 1992, EMBO J, V11, P49, DOI 10.1002/j.1460-2075.1992.tb05026.x; Carr J, 2002, ANTIVIR RES, V54, P79, DOI 10.1016/S0166-3542(01)00215-7; Cass LMR, 1999, CLIN PHARMACOKINET, V36, P21, DOI 10.2165/00003088-199936001-00003; COLMAN PM, 1993, J VIROL, V67, P2972, DOI 10.1128/JVI.67.6.2972-2980.1993; De Clercq E, 2004, J CLIN VIROL, V30, P115, DOI 10.1016/j.jcv.2004.02.009; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Gubareva LV, 2004, VIRUS RES, V103, P199, DOI 10.1016/j.virusres.2004.02.034; Gubareva LV, 1998, J INFECT DIS, V178, P1257, DOI 10.1086/314440; Gubareva LV, 2001, J INFECT DIS, V183, P523, DOI 10.1086/318537; HARPER SA, 2005, MMWR-MORBID MORTAL W, V54, P750; Harper Scott A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Hatakeyama S, 2005, J CLIN MICROBIOL, V43, P4139, DOI 10.1128/JCM.43.8.4139-4146.2005; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Herlocher ML, 2002, ANTIVIR RES, V54, P99, DOI 10.1016/S0166-3542(01)00214-5; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Le QM, 2005, NATURE, V438, P754, DOI 10.1038/438754b; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; McKimm-Breschkin J, 2003, ANTIMICROB AGENTS CH, V47, P2264, DOI 10.1128/AAC.47.7.2264-2272.2003; McKimm-Breschkin JL, 2000, ANTIVIR RES, V47, P1, DOI 10.1016/S0166-3542(00)00103-0; Mishin VP, 2005, ANTIMICROB AGENTS CH, V49, P4515, DOI 10.1128/AAC.49.11.4515-4520.2005; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Oo C, 2003, EUR J CLIN PHARMACOL, V59, P411, DOI 10.1007/s00228-003-0639-6; Pillay D, 1998, BMJ-BRIT MED J, V317, P660, DOI 10.1136/bmj.317.7159.660; *ROCH, 2005, FACTSH TAM; Ward P, 2005, J ANTIMICROB CHEMOTH, V55, P5, DOI 10.1093/jac/dki018; Whitley RJ, 2001, PEDIATR INFECT DIS J, V20, P127, DOI 10.1097/00006454-200102000-00002; *WHO, 2005, WKLY EPIDEMIOL REC, V80, P156	30	170	189	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2007	297	13					1435	1442		10.1001/jama.297.13.1435	http://dx.doi.org/10.1001/jama.297.13.1435			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AM	17405969				2022-12-01	WOS:000245404100020
J	Follows, MJ; Dutkiewicz, S; Grant, S; Chisholm, SW				Follows, Michael J.; Dutkiewicz, Stephanie; Grant, Scott; Chisholm, Sallie W.			Emergent biogeography of microbial communities in a model ocean	SCIENCE			English	Article							PROCHLOROCOCCUS ECOTYPES; MARINE; PHYTOPLANKTON	A marine ecosystem model seeded with many phytoplankton types, whose physiological traits were randomly assigned from ranges defined by field and laboratory data, generated an emergent community structure and biogeography consistent with observed global phytoplankton distributions. The modeled organisms included types analogous to the marine cyanobacterium Prochlorococcus. Their emergent global distributions and physiological properties simultaneously correspond to observations. This flexible representation of community structure can be used to explore relations between ecosystems, biogeochemical cycles, and climate change.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); University of Hawaii System; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Follows, MJ (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 54-1514 MIT, Cambridge, MA 02139 USA.	mick@mit.edu	Follows, Michael/G-9824-2011; chen, qi/C-8585-2011	Chisholm, Sallie/0000-0003-1480-2445				Anderson TR, 2005, J PLANKTON RES, V27, P1073, DOI 10.1093/plankt/fbi076; ARMSTRONG RA, 1980, AM NAT, V115, P151, DOI 10.1086/283553; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; Bouman HA, 2006, SCIENCE, V312, P918, DOI 10.1126/science.1122692; Dandonneau Y, 2006, DEEP-SEA RES PT I, V53, P689, DOI 10.1016/j.dsr.2006.01.002; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Gregg WW, 2003, DEEP-SEA RES PT II, V50, P3143, DOI 10.1016/j.dsr2.2003.07.013; Hood RR, 2006, DEEP-SEA RES PT II, V53, P459, DOI 10.1016/j.dsr2.2006.01.025; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kleidon A, 2000, GLOB CHANGE BIOL, V6, P507, DOI 10.1046/j.1365-2486.2000.00332.x; Le Quere C, 2005, GLOBAL CHANGE BIOL, V11, P2016, DOI 10.1111/j.1365-2468.2005.01004.x; Litchman E, 2006, BIOGEOSCIENCES, V3, P585, DOI 10.5194/bg-3-585-2006; Lomas MW, 2006, LIMNOL OCEANOGR, V51, P2453, DOI 10.4319/lo.2006.51.5.2453; MARGALEF R., 1968, PERSPECTIVES ECOLOGI; Moore JK, 2001, DEEP-SEA RES PT II, V49, P403, DOI 10.1016/S0967-0645(01)00108-4; Moore LR, 2002, LIMNOL OCEANOGR, V47, P989, DOI 10.4319/lo.2002.47.4.0989; Moore LR, 1999, LIMNOL OCEANOGR, V44, P628, DOI 10.4319/lo.1999.44.3.0628; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; PIMM SL, 1977, NATURE, V268, P329, DOI 10.1038/268329a0; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; THOMPSON PA, 1989, LIMNOL OCEANOGR, V34, P1014, DOI 10.4319/lo.1989.34.6.1014; TILMAN D, 1977, ECOLOGY, V58, P338, DOI 10.2307/1935608; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wunsch C, 2007, PHYSICA D, V230, P197, DOI 10.1016/j.physd.2006.09.040; Zubkov MV, 2000, PROG OCEANOGR, V45, P369, DOI 10.1016/S0079-6611(00)00008-2	27	562	567	4	208	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1843	1846		10.1126/science.1138544	http://dx.doi.org/10.1126/science.1138544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395828				2022-12-01	WOS:000245280100043
J	Stone, L; Olinky, R; Huppert, A				Stone, Lewi; Olinky, Ronen; Huppert, Amit			Seasonal dynamics of recurrent epidemics	NATURE			English	Article							CHAOS; MEASLES; MODEL; ENGLAND	Seasonality is a driving force that has a major effect on the spatiotemporal dynamics of natural systems and their populations(1-5). This is especially true for the transmission of common infectious diseases ( such as influenza, measles, chickenpox and pertussis), and is of great relevance for host-parasite relationships in general(1-23). Here we gain further insights into the nonlinear dynamics of recurrent diseases through the analysis of the classical seasonally forced SIR ( susceptible, infectious or recovered) epidemic model(6,7). Ouranalysis differs from other modelling studies in that the focus is more on post-epidemic dynamics than the outbreak itself. Despite the mathematical intractability of the forced SIR model, we identify a new threshold effect and give clear analytical conditions for predicting the occurrence of either a future epidemic outbreak, or a 'skip'-a year in which an epidemic fails to initiate. The threshold is determined by the population's susceptibility measured after the last outbreak and the rate at which new susceptible individuals are recruited into the population. Moreover, the time of occurrence ( that is, the phase) of an outbreak proves to be a useful parameter that carries important epidemiological information. In forced systems, seasonal changes can prevent late-peaking diseases ( that is, those having high phase) from spreading widely, thereby increasing population susceptibility, and controlling the triggering and intensity of future epidemics. These principles yield forecasting tools that should have relevance for the study of newly emerging and re-emerging diseases controlled by seasonal vectors.	Tel Aviv Univ, Fac Life Sci, Dept Zool, Biomath Unit, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Porter Sch Environm Studies, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Stone, L (corresponding author), Tel Aviv Univ, Fac Life Sci, Dept Zool, Biomath Unit, IL-69978 Tel Aviv, Israel.	lewi@post.tau.ac.il		Stone, Lewi/0000-0002-6465-579X				Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; ANDERSON R M, 1991; Andreasen V, 2003, J MATH BIOL, V46, P504, DOI 10.1007/s00285-002-0186-2; ARON JL, 1984, J THEOR BIOL, V110, P665, DOI 10.1016/S0022-5193(84)80150-2; Billings L, 2002, J MATH BIOL, V44, P31, DOI 10.1007/s002850100110; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; BOLKER BM, 1993, P ROY SOC B-BIOL SCI, V251, P75, DOI 10.1098/rspb.1993.0011; Casagrandi R, 2006, MATH BIOSCI, V200, P152, DOI 10.1016/j.mbs.2005.12.029; Dietz K, 1976, MATH MODELS MED, P1; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; ENGBERT R, 1994, CHAOS SOLITON FRACT, V4, P1147, DOI 10.1016/0960-0779(94)90028-0; FINE PEM, 1982, INT J EPIDEMIOL, V11, P5, DOI 10.1093/ije/11.1.5; Finkenstadt B, 1998, P ROY SOC B-BIOL SCI, V265, P211, DOI 10.1098/rspb.1998.0284; Finkenstadt BF, 2000, J R STAT SOC C-APPL, V49, P187, DOI 10.1111/1467-9876.00187; Huppert A, 2005, J THEOR BIOL, V236, P276, DOI 10.1016/j.jtbi.2005.03.012; Keeling MJ, 2001, PHYSICA D, V148, P317, DOI 10.1016/S0167-2789(00)00187-1; LONDON WP, 1973, AM J EPIDEMIOL, V98, P453, DOI 10.1093/oxfordjournals.aje.a121575; Madden LV, 2002, BIOSCIENCE, V52, P65, DOI 10.1641/0006-3568(2002)052[0065:APDATA]2.0.CO;2; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Murray J., 1993, MATH BIOL, V2nd, DOI DOI 10.1007/978-3-662-08539-4; OLINKY R, UNPUB P NATL ACAD SC; OLSEN LF, 1988, THEOR POPUL BIOL, V33, P344, DOI 10.1016/0040-5809(88)90019-6; OLSEN LF, 1990, SCIENCE, V249, P499, DOI 10.1126/science.2382131; Pascual M, 2005, PLOS MED, V2, P18, DOI 10.1371/journal.pmed.0020005; RAND DA, 1991, P ROY SOC B-BIOL SCI, V246, P179, DOI 10.1098/rspb.1991.0142; SCHAFFER WM, 1985, J THEOR BIOL, V112, P403, DOI 10.1016/S0022-5193(85)80294-0; SCHWARTZ IB, 1983, J MATH BIOL, V18, P233, DOI 10.1007/BF00276090; Shulgin B, 1998, B MATH BIOL, V60, P1123, DOI 10.1016/S0092-8240(98)90005-2; SUGIHARA G, 1990, NATURE, V344, P734, DOI 10.1038/344734a0	30	199	207	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2007	446	7135					533	536		10.1038/nature05638	http://dx.doi.org/10.1038/nature05638			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392785				2022-12-01	WOS:000245242900048
J	Iwase, S; Lan, F; Bayliss, P; de la Torre-Ubieta, L; Huarte, M; Qi, HH; Whetstine, JR; Bonni, A; Roberts, TM; Shi, Y				Iwase, Shigeki; Lan, Fei; Bayliss, Peter; de la Torre-Ubieta, Luis; Huarte, Maite; Qi, Hank H.; Whetstine, Johnathan R.; Bonni, Azad; Roberts, Thomas M.; Shi, Yang			The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases	CELL			English	Article							DOMAIN-CONTAINING PROTEINS; METHYLATION PATTERNS; ANDROGEN-RECEPTOR; MAMMALIAN-CELLS; ARID PROTEINS; BREAST-CANCER; JARID1C GENE; JMJD2 FAMILY; TRANSCRIPTION; CHROMATIN	Histone methylation regulates chromatin structure and transcription. The recently identified histone demethylase lysine-specific demethylase 1 (LSD1) is chemically restricted to demethylation of only mono- and di- but not tri-methylated histone H3 lysine 4 (H3K4me3). We show that the X-linked mental retardation (XLMR) gene SMCX (JARID1C), which encodes a JmjC-domain protein, reversed H3K4me3 to di- and mono- but not unmethylated products. Other SMCX family members, including SMCY, RBP2, and PLU-1, also demethylated H3K4me3. SMCX bound H3K9me3 via its N-terminal PHD (plant homeodomain) finger, which may help coordinate H3K4 demethylation and H3K9 methylation in transcriptional repression. Significantly, several XLMR-patient point mutations reduced SMCX demethylase activity and binding to H3K9me3 peptides, respectively. Importantly, studies in zebrafish and primary mammalian neurons demonstrated a role for SMCX in neuronal survival and dendritic development and a link to the demethylase activity. Our findings thus identify a family of H3K4me3 demethylases and uncover a critical link between histone modifications and XLMR.	Harvard Univ, Sch Med, Dana Farber Inst, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Inst, Dept Canc Biol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Shi, Y (corresponding author), Harvard Univ, Sch Med, Dana Farber Inst, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	yang_shi@hms.harvard.edu	Huarte, Maite/J-6903-2014; Hu, Ruogu/B-2203-2008; Iwase, Shigeki/J-8294-2019	Huarte, Maite/0000-0003-3753-6493; Iwase, Shigeki/0000-0003-2280-7422; de la Torre-Ubieta, Luis/0000-0001-8059-6243; Qi, Hank/0000-0002-3401-4940; Bayliss, Peter/0000-0003-4807-6365	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM070095, R01GM071004, R01GM058012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041021, R01NS051255] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 58012, GM 071004, GM 70095] Funding Source: Medline; NINDS NIH HHS [NS051255, NS41021] Funding Source: Medline; PHS HHS [NCI118487] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AGULNIK AI, 1994, HUM MOL GENET, V3, P873, DOI 10.1093/hmg/3.6.873; Ahmed S, 2004, MOL CELL BIOL, V24, P3660, DOI 10.1128/MCB.24.9.3660-3669.2004; Barrett A, 2002, INT J CANCER, V101, P581, DOI 10.1002/ijc.10644; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Chan J, 2001, DEV BIOL, V234, P470, DOI 10.1006/dbio.2001.0281; Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Govek EE, 2004, NAT NEUROSCI, V7, P364, DOI 10.1038/nn1210; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Kortschak RD, 2000, TRENDS BIOCHEM SCI, V25, P294, DOI 10.1016/S0968-0004(00)01597-8; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Lu PJ, 1999, J BIOL CHEM, V274, P15633, DOI 10.1074/jbc.274.22.15633; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Ropers HH, 2006, CURR OPIN GENET DEV, V16, P260, DOI 10.1016/j.gde.2006.04.017; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Santos C, 2006, EUR J HUM GENET, V14, P583, DOI 10.1038/sj.ejhg.5201608; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; SCOTT DM, 1995, NATURE, V376, P695, DOI 10.1038/376695a0; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Tan K, 2003, J BIOL CHEM, V278, P20507, DOI 10.1074/jbc.M301994200; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tzschach A, 2006, HUM MUTAT, V27, P389, DOI 10.1002/humu.9420; WANG W, 1995, SCIENCE, V269, P1588, DOI 10.1126/science.7667640; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wilsker D, 2002, CELL GROWTH DIFFER, V13, P95; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; YIN CY, 2006, IN PRESS DEB BI 1219; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	50	499	516	2	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1077	1088		10.1016/j.cell.2007.02.017	http://dx.doi.org/10.1016/j.cell.2007.02.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17320160	Bronze			2022-12-01	WOS:000245396200015
J	Jacobs, GH; Williams, GA; Cahill, H; Nathans, J				Jacobs, Gerald H.; Williams, Gary A.; Cahill, Hugh; Nathans, Jeremy			Emergence of novel color vision in mice engineered to express a human cone photopigment	SCIENCE			English	Article							PRIMATE; COEXPRESSION; RECEPTORS; RESPONSES; EVOLUTION; RETINA; MOUSE	Changes in the genes encoding sensory receptor proteins are an essential step in the evolution of new sensory capacities. In primates, trichromatic color vision evolved after changes in X chromosome-linked photopigment genes. To model this process, we studied knock-in mice that expressed a human long-wavelength-sensitive (L) cone photopigment in the form of an X-linked polymorphism. Behavioral tests demonstrated that heterozygous females, whose retinas contained both native mouse pigments and human L pigment, showed enhanced long-wavelength sensitivity and acquired a new capacity for chromatic discrimination. An inherent plasticity in the mammalian visual system thus permits the emergence of a new dimension of sensory experience based solely on gene-driven changes in receptor organization.	Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Psychol, Santa Barbara, CA 93106 USA; Johns Hopkins Med Sch, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Med Sch, Dept Ophthalmol, Baltimore, MD 21205 USA; Johns Hopkins Med Sch, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Med Sch, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Jacobs, GH (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA.	jacobs@psych.ucsb.edu		Nathans, Jeremy/0000-0001-8106-5460	NATIONAL EYE INSTITUTE [R01EY002052] Funding Source: NIH RePORTER; NEI NIH HHS [EY002052] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALPERN M, 1953, J PHYSL, V335, P655; Boycott B, 1999, INVEST OPHTH VIS SCI, V40, P1313; Brainard DH, 2000, J OPT SOC AM A, V17, P607, DOI 10.1364/JOSAA.17.000607; Dacey DM, 1999, PROG RETIN EYE RES, V18, P737, DOI 10.1016/S1350-9462(98)00013-5; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hofer H, 2005, J NEUROSCI, V25, P9669, DOI 10.1523/JNEUROSCI.2414-05.2005; Hunt DM, 1998, VISION RES, V38, P3299, DOI 10.1016/S0042-6989(97)00443-4; Jacobs GH, 2004, VISION RES, V44, P1615, DOI 10.1016/j.visres.2004.01.016; Jacobs GH, 1996, J OPT SOC AM A, V13, P641, DOI 10.1364/JOSAA.13.000641; JACOBS GH, 1991, NATURE, V353, P655, DOI 10.1038/353655a0; JACOBS GH, 1993, BIOL REV, V68, P413, DOI 10.1111/j.1469-185X.1993.tb00738.x; Jacobs GH, 1999, J NEUROSCI, V19, P3258; Jacobs GH, 1996, P NATL ACAD SCI USA, V93, P577, DOI 10.1073/pnas.93.2.577; JACOBS GH, 1987, P NATL ACAD SCI USA, V84, P2545, DOI 10.1073/pnas.84.8.2545; Lee Barry B, 2004, Clin Exp Optom, V87, P239; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Migeon BR, 2002, CYTOGENET GENOME RES, V99, P8, DOI 10.1159/000071568; MOLLON JD, 1989, J EXP BIOL, V146, P21; MOLLON JD, 1984, PROC R SOC SER B-BIO, V222, P373, DOI 10.1098/rspb.1984.0071; Onishi A, 2005, ZOOL SCI, V22, P1145, DOI 10.2108/zsj.22.1145; Sagdullaev BT, 2005, VISUAL NEUROSCI, V22, P649, DOI 10.1017/S0952523805225142; Smallwood PM, 2003, P NATL ACAD SCI USA, V100, P11706, DOI 10.1073/pnas.1934712100; Smallwood PM, 2002, P NATL ACAD SCI USA, V99, P1008, DOI 10.1073/pnas.022629799; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	27	143	149	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2007	315	5819					1723	1725		10.1126/science.1138838	http://dx.doi.org/10.1126/science.1138838			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379811				2022-12-01	WOS:000245106900043
J	Biskup, C; Kusch, J; Schulz, E; Nache, V; Schwede, F; Lehmann, F; Hagen, V; Benndorf, K				Biskup, Christoph; Kusch, Jana; Schulz, Eckhard; Nache, Vasilica; Schwede, Frank; Lehmann, Frank; Hagen, Volker; Benndorf, Klaus			Relating ligand binding to activation gating in CNGA2 channels	NATURE			English	Article							NUCLEOTIDE-GATED CHANNEL; FUNCTIONAL EXPRESSION; STRUCTURAL BASIS; MECHANISM; EFFICACY; STOICHIOMETRY	Cyclic nucleotide-gated (CNG) ion channels mediate sensory signal transduction in photoreceptors and olfactory cells. Structurally, CNG channels are heterotetramers composed of either two or three homologue subunits(1-4). Although it is well established that activation is a cooperative process of these subunits(5), it remains unknown whether the cooperativity is generated by the ligand binding, the gating, or both, and how the subunits interact. In this study, the action of homotetrameric olfactory-type CNGA2 channels(6) was studied in inside-out membrane patches by simultaneously determining channel activation and ligand binding, using the fluorescent cGMP analogue 8-DY547-cGMP as the ligand. At concentrations of 8-DY547-cGMP <1 mu M, steady-state binding was larger than steady-state activation, whereas at higher concentrations it was smaller, generating a crossover of the steady-state relationships. Global analysis of these relationships together with multiple activation time courses following cGMP jumps(7) showed that four ligands bind to the channels and that there is significant interaction between the binding sites. Among the binding steps, the second is most critical for channel opening: its association constant is three orders of magnitude smaller than the others and it triggers a switch from a mostly closed to a maximally open state. These results contribute to unravelling the role of the subunits in the cooperative mechanism of CNGA2 channel activation and could be of general relevance for the action of other ion channels and receptors.	Univ Jena, Inst Physiol 2, D-07740 Jena, Germany; Fachhsch Schmalkalden, Fachbereich Elektrotech, D-98574 Schmalkalden, Germany; BIOLOG Life Sci Inst, D-28199 Bremen, Germany; Dyomics GmbH, D-07745 Jena, Germany; Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany	Friedrich Schiller University of Jena; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Benndorf, K (corresponding author), Univ Jena, Inst Physiol 2, D-07740 Jena, Germany.	klaus.benndorf@mti.uni-jena.de	Kusch, Jana/ABC-9738-2020; Horstmann, Britta/C-2154-2008	Kusch, Jana/0000-0001-7206-8133; Benndorf, Klaus/0000-0002-0707-4083				Beato M, 2004, J NEUROSCI, V24, P895, DOI 10.1523/JNEUROSCI.4420-03.2004; Bonigk W, 1999, J NEUROSCI, V19, P5332; Bradley J, 2004, NAT NEUROSCI, V7, P705, DOI 10.1038/nn1266; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Burzomato V, 2004, J NEUROSCI, V24, P10924, DOI 10.1523/JNEUROSCI.3424-04.2004; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Colquhoun D, 2006, BRIT J PHARMACOL, V147, pS17, DOI 10.1038/sj.bjp.0706502; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Edsall J. T., 1958, BIOPHYSICAL CHEM; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; Li J, 1999, MOL PHARMACOL, V55, P883; Li J, 1997, Q REV BIOPHYS, V30, P177, DOI 10.1017/S0033583597003326; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Liu J, 2000, NEURON, V28, P899, DOI 10.1016/S0896-6273(00)00162-8; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nache V, 2005, J PHYSIOL-LONDON, V569, P91, DOI 10.1113/jphysiol.2005.092304; PICONES A, 1995, J PHYSIOL-LONDON, V485, P699, DOI 10.1113/jphysiol.1995.sp020763; Ruiz M, 1999, J GEN PHYSIOL, V113, P873, DOI 10.1085/jgp.113.6.873; Ruiz M, 1997, NATURE, V389, P389, DOI 10.1038/38744; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; Trudeau MC, 2004, J GEN PHYSIOL, V124, P211, DOI 10.1085/jgp.200409101; Wyman J, 1990, BINDING LINKAGE FUNC; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zheng J, 2004, NEURON, V42, P411, DOI 10.1016/S0896-6273(04)00253-3; Zheng Jie, 2003, Sci STKE, V2003, pPL7, DOI 10.1126/stke.2003.176.pl7; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201	30	89	90	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2007	446	7134					440	443		10.1038/nature05596	http://dx.doi.org/10.1038/nature05596			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17322905				2022-12-01	WOS:000245079500040
J	Collman, JP; Devaraj, NK; Decreau, RA; Yang, Y; Yan, YL; Ebina, W; Eberspacher, TA; Chidsey, CED				Collman, James P.; Devaraj, Neal K.; Decreau, Richard A.; Yang, Ying; Yan, Yi-Long; Ebina, Wataru; Eberspacher, Todd A.; Chidsey, Christopher E. D.			A cytochrome c oxidase model catalyzes oxygen to water reduction under rate-limiting electron flux	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; GOLD ELECTRODES; DIOXYGEN REDUCTION; TERMINAL ALKYNES; SITE; O-2; SURFACES; ANALOGS; BINDING; METALLOPORPHYRINS	We studied the selectivity of a functional model of cytochrome c oxidase's active site that mimics the coordination environment and relative locations of Fe-a3, Cu-B, and Tyr(244). To control electron flux, we covalently attached this model and analogs lacking copper and phenol onto self-assembled monolayer-coated gold electrodes. When the electron transfer rate was made rate limiting, both copper and phenol were required to enhance selective reduction of oxygen to water. This finding supports the hypothesis that, during steady-state turnover, the primary role of these redox centers is to rapidly provide all the electrons needed to reduce oxygen by four electrons, thus preventing the release of toxic partially reduced oxygen species.	Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University	Collman, JP (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	jpc@stanford.edu; chidsey@stanford.edu	Devaraj, Neal/B-4712-2014; DECREAU, Richard/I-4568-2012	DECREAU, Richard/0000-0003-4205-0092	NIGMS NIH HHS [R01 GM017880-35, R01 GM017880, GM-17880-35] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM017880, R37GM017880] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alleman KS, 1996, J PHYS CHEM-US, V100, P17050, DOI 10.1021/jp962193b; BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; Boulatov R, 2002, J AM CHEM SOC, V124, P11923, DOI 10.1021/ja026179q; Brunori M, 2005, J INORG BIOCHEM, V99, P324, DOI 10.1016/j.jinorgbio.2004.10.011; Cha SK, 2004, B KOREAN CHEM SOC, V25, P786; CHAZOTTE B, 1989, J BIOL CHEM, V264, P4978; CHIDSEY CED, 1991, SCIENCE, V251, P919, DOI 10.1126/science.251.4996.919; Collman JP, 2004, J ORG CHEM, V69, P3546, DOI 10.1021/jo0499625; Collman JP, 2006, LANGMUIR, V22, P2457, DOI 10.1021/la052947q; Collman JP, 2005, INORG CHEM, V44, P9628, DOI 10.1021/ic0516717; Collman JP, 2004, LANGMUIR, V20, P1051, DOI 10.1021/la0362977; Collman JP, 2002, INORG CHEM, V41, P2282, DOI 10.1021/ic011191p; Collman JP, 2002, ANGEW CHEM INT EDIT, V41, P3487, DOI 10.1002/1521-3773(20020916)41:18<3487::AID-ANIE3487>3.0.CO;2-Y; Collman JP, 1997, SCIENCE, V275, P949, DOI 10.1126/science.275.5302.949; COLLMAN JP, 1994, J AM CHEM SOC, V116, P9783, DOI 10.1021/ja00100a067; Collman JP, 1999, J AM CHEM SOC, V121, P1387, DOI 10.1021/ja983351a; Creager S, 1999, J AM CHEM SOC, V121, P1059, DOI 10.1021/ja983204c; CREAGER SE, 1993, LANGMUIR, V9, P2330, DOI 10.1021/la00033a014; Das TK, 1998, BIOCHEMISTRY-US, V37, P14471, DOI 10.1021/bi981500w; Degefa TH, 2004, J ELECTROANAL CHEM, V574, P49, DOI 10.1016/j.jelechem.2004.07.026; Devaraj NK, 2006, J PHYS CHEM B, V110, P15955, DOI 10.1021/jp057416p; FINKLEA HO, 1992, J AM CHEM SOC, V114, P3173, DOI 10.1021/ja00035a001; GUPTE SS, 1988, J BIOL CHEM, V263, P5248; Haas AS, 2001, J PHYS CHEM B, V105, P11351, DOI 10.1021/jp011834m; HUTCHISON JE, 1993, LANGMUIR, V9, P3277, DOI 10.1021/la00035a084; KATZ E, 1994, J ELECTROANAL CHEM, V368, P87, DOI 10.1016/0022-0728(93)03039-R; Lee JK, 2004, LANGMUIR, V20, P3844, DOI 10.1021/la049748b; MOGI T, 1995, FEBS LETT, V370, P259; Morgan JE, 2001, BIOCHEMISTRY-US, V40, P6882, DOI 10.1021/bi010246w; Offord DA, 1998, J AM CHEM SOC, V120, P4478, DOI 10.1021/ja973528l; Pfitzner U, 1998, J BIOENERG BIOMEMBR, V30, P89, DOI 10.1023/A:1020515713103; Proshlyakov DA, 2000, SCIENCE, V290, P1588, DOI 10.1126/science.290.5496.1588; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; SAWYER DT, 1981, ACCOUNTS CHEM RES, V14, P393, DOI 10.1021/ar00072a005; Shikama K, 1998, CHEM REV, V98, P1357, DOI 10.1021/cr970042e; Sigal GB, 1997, LANGMUIR, V13, P2749, DOI 10.1021/la961024f; Sigman JA, 2000, J AM CHEM SOC, V122, P8192, DOI 10.1021/ja0015343; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; ZAK J, 1993, LANGMUIR, V9, P2772, DOI 10.1021/la00035a006; Zou SZ, 2002, LANGMUIR, V18, P3241, DOI 10.1021/la011444r	41	408	411	5	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1565	1568		10.1126/science.1135844	http://dx.doi.org/10.1126/science.1135844			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363671	Green Accepted			2022-12-01	WOS:000244934800049
J	Kendall, M; Harris, F; Boyd, K; Sheikh, A; Murray, SA; Brown, D; Mallinson, I; Kearney, N; Worth, A				Kendall, Marilyn; Harris, Fiona; Boyd, Kirsty; Sheikh, Aziz; Murray, Scott A.; Brown, Duncan; Mallinson, Ian; Kearney, Nora; Worth, Allison			Key challenges and ways forward in researching the "good death": qualitative in-depth interview and focus group study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARE; CANCER; VIEWS; NEED	Objective To understand key challenges in researching end of life issues and identify ways of overcoming these. Design Qualitative study involving in-depth interviews with researchers and focus groups with people affected by cancer. Participants An international sample of 32 researchers; seven patients with experience of cancer; and four carers in south east Scotland. Results Researchers highlighted the difficulty of defining, the end of life, overprotective gatekeeping by ethics committees and clinical staff, the need to factor in high attrition rates associated with deterioration or death, and managing the emotions of participants and research staff. People affected by cancer and researchers suggested that many people nearing the end of life do want to be offered the chance to participate in research, provided it is conducted sensitively. Although such research can be demanding, most researchers believed it to be no more problematic than many other areas of research and that the challenges identified can be overcome. Conclusions The continuing taboos around death and dying act as barriers to the commissioning and conduct of end of life research. Some people facing death, however, may want to participate in research and should be allowed to do so. Ethics committees and clinical staff must balance understandable concern about non-maleficence with the right of people with advanced illness to participate in research. Despite the inherent difficulties, end of life research can be conducted with ethical and methodological rigour. Adequate psychological support must be provided for participants, researchers, and transcribers.	Univ Edinburgh, Primary Palliat Care Res Grp, Div Community Hlth Sci, Gen Practice Sect, Edinburgh EH8 9DX, Midlothian, Scotland; St Columbas Hosp, Edinburgh EH5 3RW, Midlothian, Scotland; Univ Stirling, Canc Care Res Ctr, Dept Nursing & Midwifery, Stirling FK9 4LA, Scotland	University of Edinburgh; University of Edinburgh; University of Stirling	Kendall, M (corresponding author), Univ Edinburgh, Primary Palliat Care Res Grp, Div Community Hlth Sci, Gen Practice Sect, Edinburgh EH8 9DX, Midlothian, Scotland.	Marilyn.Kendall@ed.ac.uk	Sheikh, Aziz/D-2818-2009; Harris, Fiona/B-5633-2008	Sheikh, Aziz/0000-0001-7022-3056; Boyd, Kirsty/0000-0002-5526-1078; Harris, Fiona/0000-0003-3258-5624				Addington-Hall J, 2002, EUR J CANCER CARE, V11, P220, DOI 10.1046/j.1365-2354.2002.00343.x; *ASS SOC ANTHR, ETH GUID GOOD RES PR; Beaver K., 1999, INT J PALLIAT NURS, V5, P13, DOI [10.12968/ijpn.1999.5.1.9926, DOI 10.12968/IJPN.1999.5.1.9926]; Bowling A, 2000, BRIT MED J, V320, P1205; *BRIT SOC ASS, STAT ETH PRACT; Clark J, 2003, BRIT MED J, V327, P174, DOI 10.1136/bmj.327.7408.174; Cook AM, 2002, PALLIATIVE MED, V16, P163, DOI 10.1191/0269216302pm551xx; Entwistle V, 2002, EUR J CANCER CARE, V11, P232, DOI 10.1046/j.1365-2354.2002.00344.x; Gray RE, 2003, QUAL INQ, V9, P254, DOI 10.1177/1077800402250957; Gray Ross, 2000, Health Expect, V3, P137, DOI 10.1046/j.1369-6513.2000.00071.x; Harris FM, 2005, WHAT ARE BEST WAYS S; Krishnasamy M, 2000, PALLIATIVE MED, V14, P410, DOI 10.1191/026921600701536246; Lawton J, 2001, QUAL HEALTH RES, V11, P693, DOI 10.1177/104973201129119389; Lee RM, 1993, DOING RES SENSITIVE; Riley J, 2005, LANCET, V365, P735; Rose K, 1998, QUAL HEALTH RES, V8, P556, DOI 10.1177/104973239800800409; ROWLING L, 1999, MORTALITY, V14, P167; Seale C., 1998, CONSTRUCTING DEATH S, DOI [10.1017/CBO9780511583421, DOI 10.1017/CBO9780511583421]; Seamark DA, 2000, PALLIATIVE MED, V14, P55, DOI 10.1191/026921600674088597; Seymour J, 2002, EUR J CANCER CARE, V11, P215, DOI 10.1046/j.1365-2354.2002.00342.x; Seymour J, 2005, INT J PALLIAT NURS, V11, P240, DOI 10.12968/ijpn.2005.11.5.240; Woods S, 2000, NURS ETHICS, V7, P314, DOI 10.1191/096973300676700359	22	79	79	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2007	334	7592					521	524		10.1136/bmj.39097.582639.55	http://dx.doi.org/10.1136/bmj.39097.582639.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148VV	17329313	Green Published, Bronze			2022-12-01	WOS:000245106400042
J	Mito, Y; Henikoff, JG; Henikoff, S				Mito, Yoshiko; Henikoff, Jorja G.; Henikoff, Steven			Histone replacement marks the boundaries of cis-regulatory domains	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; BITHORAX COMPLEX; GENE-EXPRESSION; CHROMATIN; PROTEINS; H3.3; DISPLACEMENT; TRANSCRIPTION; MAINTENANCE; PATTERNS	Cellular memory is maintained at homeotic genes by cis-regulatory elements whose mechanism of action is unknown. We have examined chromatin at Drosophila homeotic gene clusters by measuring, at high resolution, levels of histone replacement and nucleosome occupancy. Homeotic gene clusters display conspicuous peaks of histone replacement at boundaries of cis-regulatory domains superimposed over broad regions of low replacement. Peaks of histone replacement closely correspond to nuclease-hypersensitive sites, binding sites for Polycomb and trithorax group proteins, and sites of nucleosome depletion. Our results suggest the existence of a continuous process that disrupts nucleosomes and maintains accessibility of cis-regulatory elements.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Univ Washington, Cell & Mol Biol Program, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Henikoff, S (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave, Seattle, WA 98109 USA.	steveh@fhcrc.org		Henikoff, Steven/0000-0002-7621-8685				Barges S, 2000, DEVELOPMENT, V127, P779; BISISIC D, 2006, EMBO J, V25, P798; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Brock HW, 2005, DEV DYNAM, V232, P633, DOI 10.1002/dvdy.20298; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Ficz G, 2005, DEVELOPMENT, V132, P3963, DOI 10.1242/dev.01950; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Jin C, 2006, P NATL ACAD SCI USA, V103, P574, DOI 10.1073/pnas.0509974103; KARCH F, 1994, NUCLEIC ACIDS RES, V22, P3138, DOI 10.1093/nar/22.15.3138; Leibovitch BA, 2002, MOL CELL BIOL, V22, P6148, DOI 10.1128/MCB.22.17.6148-6157.2002; Maeda RK, 2006, DEVELOPMENT, V133, P1413, DOI 10.1242/dev.02323; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mohd-Sarip A, 2006, MOL CELL, V24, P91, DOI 10.1016/j.molcel.2006.08.007; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; Nagaich AK, 2004, MOL CELL, V14, P163, DOI 10.1016/S1097-2765(04)00178-9; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Platero JS, 1998, J CELL BIOL, V140, P1297; Schwartz BE, 2005, GENE DEV, V19, P804, DOI 10.1101/gad.1259805; Schwartz YB, 2005, MOL CELL BIOL, V25, P432, DOI 10.1128/MCB.25.1.432-439.2005; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Sun FL, 2004, MOL CELL BIOL, V24, P8210, DOI 10.1128/MCB.24.18.8210-8220.2004; Wirbelauer C, 2005, GENE DEV, V19, P1761, DOI 10.1101/gad.347705; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706	25	219	227	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2007	315	5817					1408	1411		10.1126/science.1134004	http://dx.doi.org/10.1126/science.1134004			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347439				2022-12-01	WOS:000244752200033
J	Wang, LD; Liu, JJ; Chin, DP				Wang, Longde; Liu, Jianjun; Chin, Daniel P.			Progress in tuberculosis control and the evolving public-health system in China	LANCET			English	Article								China has the world's second largest tuberculosis epidemic, but progress in tuberculosis control was slow during the 1990s. Detection of tuberculosis had stagnated at around 30% of the estimated total of new cases, and multidrug-resistant tuberculosis was a major problem. These signs of inadequate tuberculosis control can be linked to a malfunctioning health system. The spread of severe acute respiratory syndrome (SARS) in 2003, brought to light substantial weaknesses in the country's public-health system. After the SARS epidemic was brought under control, the government increased its commitment and leadership to tackle public-health problems and, among other efforts, increased public-health funding, revised laws that concerned the control of infectious diseases, implemented the world's largest internet-based disease reporting system, and started a programme to rebuild local public-health facilities. These measures contributed to acceleration in efforts to control tuberculosis. By 2005, the detection of cases of tuberculosis had increased to 80% of the estimated total new cases, permitting China to achieve the 2005 global tuberculosis control targets. At the same time, specific efforts to improve tuberculosis control also contributed to strengthening of the public-health system. We examine how the strengthening of a disease control programme and the public-health system worked together to achieve a desired health outcome.	Minist Hlth, Beijing, Peoples R China; Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; WHO, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; World Health Organization	Chin, DP (corresponding author), Room 401,23 Dongzhimenwai Dajie, Beijing 100600, Peoples R China.	chind@chn.wpro.who.int						Blumenthal D, 2005, NEW ENGL J MED, V353, P1165, DOI 10.1056/NEJMhpr051133; Cai J, 2003, MODEL TUBERCULOSIS C; China National Health Development Research Center, 2020, CHIN NAT HLTH ACC RE; *DEV RES CTR PROJ, 2005, CHINA DEV REV, V7, P1; LEI H, 2005, CHINA DEV REV, V7, P81; Ma J. Q., 2006, DIS SURVEILLANCE, V21, P1; *MIN HLTH PUBL INF, 2005, MIN HLTH REP STAT NA; *MIN PUBL HLTH PEO, 1990, NAT RAND SURV EP TUB; Ministry of Health of the People's Republic of China, 2002, REP NAT RAND SURV EP; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; *STAT COUNC PEOPL, 200175 GEN OFF STAT, P75; *STAT COUNC PEOPL, CHIN AIDS PREV CONTR; *STAT COUNC PEOPL, 2003, CHIN PREV MED S, V4, P1; *STOP TB PARTN, 2 STOP TB PARTN FOR; *UN HLTH PARTN GRO, 2005, HLTH SIT ASS PEOPL R; *UN STAT DIV, MILL IND DAT; WEN J, 10 NAT PEOPL C CHIN; *WHO, 2000, WHOCDSTB2000278 IUAT; *WHO, 2004, WHOHTMTB2004343 IUAT; *WHO REG COMM W PA, WPRRC51R4 WHO REG CO; *WHO STOP TB PARTN, 2006, WHOHTMSTB200635; *WHO UNAIDS MIN HL, 2006, 2005 UPD HIV AIDS EP; World Health Organization, 2006, WHOHTMTB2006362; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877; GEN OFFICE MINISTRY	25	184	194	3	27	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2007	369	9562					691	696		10.1016/S0140-6736(07)60316-X	http://dx.doi.org/10.1016/S0140-6736(07)60316-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	141RO	17321314	Green Published, Bronze			2022-12-01	WOS:000244596600030
J	Barreto, G; Schafer, A; Marhold, J; Stach, D; Swaminathan, SK; Handa, V; Doderlein, G; Maltry, N; Wu, W; Lyko, F; Niehrs, C				Barreto, Guillermo; Schaefer, Andrea; Marhold, Joachim; Stach, Dirk; Swaminathan, Suresh K.; Handa, Vikas; Doederlein, Gabi; Maltry, Nicole; Wu, Wei; Lyko, Frank; Niehrs, Christof			Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation	NATURE			English	Article							METHYLATION; EXPRESSION; PROTEIN; CELLS; CYCLE	DNA methylation is an epigenetic modification that is essential for gene silencing and genome stability in many organisms. Although methyltransferases that promote DNA methylation are well characterized, the molecular mechanism underlying active DNA demethylation is poorly understood and controversial(1,2). Here we show that Gadd45a ( growth arrest and DNA-damage-inducible protein 45 alpha), a nuclear protein involved in maintenance of genomic stability, DNA repair and suppression of cell growth 3,4, has a key role in active DNA demethylation. Gadd45a overexpression activates methylation-silenced reporter plasmids and promotes global DNA demethylation. Gadd45a knockdown silences gene expression and leads to DNA hypermethylation. During active demethylation of oct4 in Xenopus laevis oocytes(5), Gadd45a is specifically recruited to the site of demethylation. Active demethylation occurs by DNA repair and Gadd45a interacts with and requires the DNA repair endonuclease XPG. We conclude that Gadd45a relieves epigenetic gene silencing by promoting DNA repair, which erases methylation marks.	German Canc Res Ctr, Div Mol Embryol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Niehrs, C (corresponding author), German Canc Res Ctr, Div Mol Embryol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	niehrs@dkfz.de	Barreto, Guillermo/U-5718-2017	Barreto, Guillermo/0000-0002-7777-4712				Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Carrier F, 1999, MOL CELL BIOL, V19, P1673; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Cimbora DM, 2000, MOL CELL BIOL, V20, P5581, DOI 10.1128/MCB.20.15.5581-5591.2000; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Escher G, 2005, J LIPID RES, V46, P356, DOI 10.1194/jlr.D400014-JLR200; Fang JY, 2003, WORLD J GASTROENTERO, V9, P1976, DOI 10.3748/wjg.v9.i9.1976; Furukawa T, 2002, GENE CHROMOSOME CANC, V35, P1, DOI 10.1002/gcc.10100; Gidekel S, 2002, J BIOL CHEM, V277, P34521, DOI 10.1074/jbc.M203338200; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Hansis C, 2004, CURR BIOL, V14, P1475, DOI 10.1016/j.cub.2004.08.031; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Hollander MC, 2002, ONCOGENE, V21, P6228, DOI 10.1038/sj.onc.1205774; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Iyer N, 1996, BIOCHEMISTRY-US, V35, P2157, DOI 10.1021/bi9524124; Jaenisch R, 2004, COLD SPRING HARB SYM, V69, P19, DOI 10.1101/sqb.2004.69.19; Jost JP, 2001, NUCLEIC ACIDS RES, V29, P4452, DOI 10.1093/nar/29.21.4452; Kress C, 2001, FEBS LETT, V494, P135, DOI 10.1016/S0014-5793(01)02328-6; Li Q, 1999, ONCOGENE, V18, P3284, DOI 10.1038/sj.onc.1202663; PRIVES C, 1991, METHOD CELL BIOL, V36, P185; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Shou WY, 1996, MOL BIOL CELL, V7, P457, DOI 10.1091/mbc.7.3.457; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Smith ML, 1996, ONCOGENE, V13, P2255; Weiss A, 1996, CELL, V86, P709, DOI 10.1016/S0092-8674(00)80146-4; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yi YW, 2000, BIOCHEM BIOPH RES CO, V272, P193	29	568	610	1	68	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 8	2007	445	7128					671	675		10.1038/nature05515	http://dx.doi.org/10.1038/nature05515			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17268471				2022-12-01	WOS:000244039400049
J	Gross, T; Siepmann, A; Sturm, D; Windgassen, M; Scarcelli, JJ; Seedorf, M; Cole, CN; Krebber, H				Gross, Thomas; Siepmann, Anja; Sturm, Dorothee,; Windgassen, Merle; Scarcelli, John J.; Seedorf, Matthias; Cole, Charles N.; Krebber, Heike			The DEAD-box RNA helicase Dbp5 functions in translation termination	SCIENCE			English	Article							MESSENGER-RNA; POLY(A)-BINDING PROTEIN; EXPORT; CYTOPLASM; TRANSPORT; NONSENSE	In eukaryotes, termination of messenger RNA (mRNA) translation is mediated by the release factors eRF1 and eRF3. Using Saccharomyces cerevisiae as a model organism, we have identified a member of the DEAD-box protein (DBP) family, the DEAD-box RNA helicase and mRNA export factor Dbp5, as a player in translation termination. Dbp5 interacts genetically with both release factors and the polyadenlyate-binding protein Pab1. A physical interaction was specifically detected with eRF1. Moreover, we show that the helicase activity of Dbp5 is required for efficient stop-codon recognition, and intact Dbp5 is essential for recruitment of eRF3 into termination complexes. Therefore, Dbp5 controls the eRF3-eRF1 interaction and thus eRF3-mediated downstream events.	Univ Marburg, Inst Mol Biol & Tumorforsch, D-35037 Marburg, Germany; Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH 03755 USA; Univ Heidelberg, Zentrum Mol Biol, D-69129 Heidelberg, Germany	Philipps University Marburg; Dartmouth College; Ruprecht Karls University Heidelberg	Krebber, H (corresponding author), Univ Marburg, Inst Mol Biol & Tumorforsch, Emil Mannkopff Str 2, D-35037 Marburg, Germany.	krebber@imt.uni-marburg.de	Cole, Charles/GRR-1551-2022		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033998] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM033998] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942; Bidou L, 2000, RNA, V6, P952, DOI 10.1017/S1355838200000443; Cole CN, 2006, CURR OPIN CELL BIOL, V18, P299, DOI 10.1016/j.ceb.2006.04.006; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Cosson B, 2002, MOL CELL BIOL, V22, P3301, DOI 10.1128/MCB.22.10.3301-3315.2002; Hodge CA, 1999, EMBO J, V18, P5778, DOI 10.1093/emboj/18.20.5778; Jacobson A, 2005, NAT STRUCT MOL BIOL, V12, P474, DOI 10.1038/nsmb0605-474; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Schmitt C, 1999, EMBO J, V18, P4332, DOI 10.1093/emboj/18.15.4332; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Uchida N, 2002, J BIOL CHEM, V277, P50286, DOI 10.1074/jbc.M203029200; Zhao J, 2002, EMBO J, V21, P1177, DOI 10.1093/emboj/21.5.1177	13	106	107	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2007	315	5812					646	649		10.1126/science.1134641	http://dx.doi.org/10.1126/science.1134641			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272721				2022-12-01	WOS:000243909400043
J	Nelson, CD; Perry, SJ; Regier, DS; Prescott, SM; Topham, MK; Lefkowitz, RJ				Nelson, Christopher D.; Perry, Stephen J.; Regier, Debra S.; Prescott, Stephen M.; Topham, Matthew K.; Lefkowitz, Robert J.			Targeting of diacylglycerol degradation to M1 muscarinic receptors by beta-arrestins	SCIENCE			English	Article							PHOSPHATIDIC-ACID; KINASE-ZETA; TRANSFORMED CELLS; CLATHRIN ADAPTER; TRANSLOCATION; PROTEIN; ENDOCYTOSIS; MECHANISM; COMPLEX; CLONING	Seven-transmembrane receptor (7TMR) signaling is transduced by second messengers such as diacylglycerol (DAG) generated in response to the heterotrimeric guanine nucleotide-binding protein G(q) and is terminated by receptor desensitization and degradation of the second messengers. We show that beta-arrestins coordinate both processes for the G(q)-coupled M1 muscarinic receptor. beta-Arrestins physically interact with diacylglycerol kinases (DGKs), enzymes that degrade DAG. Moreover, beta-arrestins are essential for conversion of DAG to phosphatidic acid after agonist stimulation, and this activity requires recruitment of the beta-arrestin-DGK complex to activated 7TMRs. The dual function of beta-arrestins, limiting production of diacylglycerol (by receptor desensitization) while enhancing its rate of degradation, is analogous to their ability to recruit adenosine 3',5'-monophosphate phosphodiesterases to G(s)-coupled beta(2)-adrenergic receptors. Thus, beta-arrestins can serve similar regulatory functions for disparate classes of 7TMRs through structurally dissimilar enzymes that degrade chemically distinct second messengers.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Duke University	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.	lefko001@receptor-biol.duke.edu	Lefkowitz, Robert/AAW-2649-2021		NATIONAL CANCER INSTITUTE [R01CA095463] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037, R01HL070631, R37HL016037] Funding Source: NIH RePORTER; NCI NIH HHS [CA95463] Funding Source: Medline; NHLBI NIH HHS [HL70631, HL16037] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Bunting M, 1996, J BIOL CHEM, V271, P10230, DOI 10.1074/jbc.271.17.10230; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; KATO H, 1988, BIOCHEM BIOPH RES CO, V154, P959, DOI 10.1016/0006-291X(88)90233-1; KATO M, 1987, J BIOL CHEM, V262, P5696; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; LIMATOLA C, 1994, BIOCHEM J, V304, P1001, DOI 10.1042/bj3041001; Luo B, 2004, CELL SIGNAL, V16, P983, DOI 10.1016/j.cellsig.2004.03.016; Luo B, 2004, CELL SIGNAL, V16, P891, DOI 10.1016/j.cellsig.2004.01.010; Luo B, 2003, J BIOL CHEM, V278, P39542, DOI 10.1074/jbc.M307153200; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Santos T, 2002, J BIOL CHEM, V277, P30300, DOI 10.1074/jbc.M200999200; Siddhanta A, 1998, J BIOL CHEM, V273, P17995, DOI 10.1074/jbc.273.29.17995; STERNWEIS PC, 1992, PHILOS T ROY SOC B, V336, P35, DOI 10.1098/rstb.1992.0041; Tolias KF, 1998, MOL CELL BIOL, V18, P762, DOI 10.1128/MCB.18.2.762; VANDERBEND RL, 1994, J BIOL CHEM, V269, P4098	20	110	120	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2007	315	5812					663	666		10.1126/science.1134562	http://dx.doi.org/10.1126/science.1134562			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272726				2022-12-01	WOS:000243909400048
J	Schreier, WJ; Schrader, TE; Koller, FO; Gilch, P; Crespo-Hernandez, CE; Swaminathan, VN; Carell, T; Zinth, W; Kohler, B				Schreier, Wolfgang J.; Schrader, Tobias E.; Koller, Florian O.; Gilch, Peter; Crespo-Hernandez, Carlos E.; Swaminathan, Vijay N.; Carell, Thomas; Zinth, Wolfgang; Kohler, Bern			Thymine dimerization in DNA is an ultrafast photoreaction	SCIENCE			English	Article							EXCITED-STATE DYNAMICS; SINGLE-STRANDED-DNA; DIMER FORMATION; PYRIMIDINE DIMERS; INTERNAL-CONVERSION; CRYSTAL-STRUCTURE; PHOTOCHEMISTRY; BASES; POLYNUCLEOTIDES; PHOTODIMERIZATION	Femtosecond time-resolved infrared spectroscopy was used to study the formation of cyclobutane dimers in the all-thymine oligodeoxynucleotide (dT)(18) by ultraviolet light at 272 nanometers. The appearance of marker bands in the time-resolved spectra indicates that the dimers are fully formed similar to 1 picosecond after ultraviolet excitation. The ultrafast appearance of this mutagenic photolesion points to an excited-state reaction that is approximately barrierless for bases that are properly oriented at the instant of light absorption. The low quantum yield of this photoreaction is proposed to result from infrequent conformational states in the unexcited polymer, revealing a strong link between conformation before light absorption and photodamage.	Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; Univ Munich, Dept Phys, D-80538 Munich, Germany; Univ Munich, Fak Chem & Pharm, D-81377 Munich, Germany	University System of Ohio; Ohio State University; University of Munich; University of Munich	Zinth, W (corresponding author), Ohio State Univ, Dept Chem, 100 W 8th Ave, Columbus, OH 43210 USA.	wolfgang.zinth@physik.uni-muenchen.de; kohler@chemistry.ohio-state.edu	Kohler, Bern/A-1728-2011; Schreier, Wolfgang/B-1336-2012; Carell, Thomas/G-4799-2012; Crespo-Hernández, Carlos E./A-9915-2008	Kohler, Bern/0000-0001-5353-1655; Carell, Thomas/0000-0001-7898-2831; Crespo-Hernández, Carlos E./0000-0002-3594-0890; Zinth, Wolfgang/0000-0003-3695-9486	NIGMS NIH HHS [R01 GM064563-04, GM064563] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064563] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BECKER MM, 1989, J MOL BIOL, V210, P429, DOI 10.1016/0022-2836(89)90120-4; BECKER MM, 1984, NATURE, V309, P682, DOI 10.1038/309682a0; BECKER MM, 1989, J BIOL CHEM, V264, P4163; BERNARDI F, 1990, J AM CHEM SOC, V112, P1737, DOI 10.1021/ja00161a013; Butenandt J, 1998, CHEM-EUR J, V4, P642, DOI 10.1002/(SICI)1521-3765(19980416)4:4<642::AID-CHEM642>3.0.CO;2-K; Cadet J., 1990, BIOORGANIC PHOTOCHEM, V1, P1; Crespo-Hernandez CE, 2004, CHEM REV, V104, P1977, DOI 10.1021/cr0206770; Crespo-Hernandez CE, 2005, NATURE, V436, P1141, DOI 10.1038/nature03933; DEERING RA, 1963, BIOCHIM BIOPHYS ACTA, V68, P526; Douki T, 2006, J PHOTOCH PHOTOBIO B, V82, P45, DOI 10.1016/j.jphotobiol.2005.08.009; Fuss W, 2002, PHOTOCH PHOTOBIO SCI, V1, P60, DOI 10.1039/b107442c; GALE JM, 1987, P NATL ACAD SCI USA, V84, P6644, DOI 10.1073/pnas.84.19.6644; Hare PM, 2007, P NATL ACAD SCI USA, V104, P435, DOI 10.1073/pnas.0608055104; HOSSZU JL, 1967, BIOCHEM BIOPH RES CO, V29, P327, DOI 10.1016/0006-291X(67)90457-3; Kuimova MK, 2006, P NATL ACAD SCI USA, V103, P2150, DOI 10.1073/pnas.0506860103; Kundu LM, 2004, CHEM-EUR J, V10, P5697, DOI 10.1002/chem.200305731; LAMOLA AA, 1968, P NATL ACAD SCI USA, V59, P46, DOI 10.1073/pnas.59.1.46; LIAN TQ, 1994, J PHYS CHEM-US, V98, P11648, DOI 10.1021/j100096a005; LISEWSKI R, 1970, PHOTOCHEM PHOTOBIOL, V11, P327, DOI 10.1111/j.1751-1097.1970.tb06006.x; LYAMICHEV V, 1991, NUCLEIC ACIDS RES, V19, P4491, DOI 10.1093/nar/19.16.4491; Marguet S, 2005, J AM CHEM SOC, V127, P5780, DOI 10.1021/ja050648h; Martinez JM, 2001, J AM CHEM SOC, V123, P12279, DOI 10.1021/ja0108786; Melnikova VO, 2005, MUTAT RES-FUND MOL M, V571, P91, DOI 10.1016/j.mrfmmm.2004.11.015; Mills JB, 1999, J MOL BIOL, V285, P245, DOI 10.1006/jmbi.1998.2287; MITCHELL DL, 1984, PHOTOCHEM PHOTOBIOL, V40, P735; Park H, 2002, P NATL ACAD SCI USA, V99, P15965, DOI 10.1073/pnas.242422699; PEHRSON JR, 1989, P NATL ACAD SCI USA, V86, P9149, DOI 10.1073/pnas.86.23.9149; RAHN RO, 1968, PHOTOCHEM PHOTOBIOL, V7, P637, DOI 10.1111/j.1751-1097.1968.tb08046.x; RAHN RO, 1966, SCIENCE, V154, P503, DOI 10.1126/science.154.3748.503; Saenger W, 2013, PRINCIPLES NUCL ACID; SCHERER NF, 1990, J CHEM PHYS, V92, P5239, DOI 10.1063/1.458531; Schrader T, 2004, CHEM PHYS LETT, V392, P358, DOI 10.1016/j.cplett.2004.05.090; TAYLOR JS, 1994, ACCOUNTS CHEM RES, V27, P7; TRAMER Z, 1969, ACTA BIOCHIM POL, V16, P83; van Stokkum IHM, 2004, BBA-BIOENERGETICS, V1657, P82, DOI 10.1016/j.bbabio.2004.04.011; Vink AA, 2001, J PHOTOCH PHOTOBIO B, V65, P101, DOI 10.1016/S1011-1344(01)00245-7; WAGNER PJ, 1983, ACCOUNTS CHEM RES, V16, P461, DOI 10.1021/ar00096a006; Zhang SL, 1998, J PHYS CHEM A, V102, P461, DOI 10.1021/jp972385m	38	408	411	9	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2007	315	5812					625	629		10.1126/science.1135428	http://dx.doi.org/10.1126/science.1135428			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272716	Green Accepted			2022-12-01	WOS:000243909400037
J	Janson, ME; Loughlin, R; Loiodice, I; Fu, CH; Brunner, D; Nedelec, FJ; Tran, PT				Janson, Marcel E.; Loughlin, Rose; Loiodice, Isabelle; Fu, Chuanhai; Brunner, Damian; Nedelec, Francois J.; Tran, Phong T.			Crosslinkers and motors organize dynamic microtubules to form stable bipolar arrays in fission yeast	CELL			English	Article							SPINDLE MIDZONE FORMATION; SELF-ORGANIZATION; INTERPHASE MICROTUBULES; POLARITY ORIENTATION; BUNDLING ACTIVITY; MITOTIC SPINDLES; ACTIN-FILAMENTS; GAMMA-TUBULIN; KINESIN; CELLS	Microtubule (MI) nucleation not only occurs from centrosomes, but also in large part from dispersed nucleation sites. The subsequent sorting of short MTs into networks like the mitotic spindle requires molecular motors that laterally slide overlapping MTs and bundling proteins that statically connect MTs. How bundling proteins interfere with MT sliding is unclear. In bipolar MT bundles in fission yeast, we found that the bundler ase1p localized all along the length of antiparallel MTs, whereas the motor klp2p (kinesin-14) accumulated only at MT plus ends. Consequently, sliding forces could only overcome resistant bundling forces for short, newly nucleated MTs, which were transported to their correct position within bundles. Ase1p thus regulated sliding forces based on polarity and overlap length, and computer simulations showed these mechanisms to be sufficient to generate stable bipolar bundles. By combining motor and bundling proteins, cells can thus dynamically organize stable regions of overlap between cytoskeletal filaments.	Univ Penn, Philadelphia, PA 19104 USA; European Mol Biol Lab, Cell Biol & Biophys Program, D-69117 Heidelberg, Germany	University of Pennsylvania; European Molecular Biology Laboratory (EMBL)	Nedelec, FJ (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.	nedelec@embl.de; tranp@mail.med.upenn.edu	Tran, Phong/GZA-8504-2022; Nedelec, Francois/AAC-1673-2019; Fu, Chuanhai/E-1479-2011; Nedelec, Francois J/H-3317-2011; Tran, Phong/F-1357-2015; Brunner, Damian/F-2024-2011; Fu, Chuanhai/G-8303-2016	Nedelec, Francois/0000-0002-8141-5288; Nedelec, Francois J/0000-0002-8141-5288; Tran, Phong/0000-0002-2410-2277; Fu, Chuanhai/0000-0003-4354-3796; Brunner, Damian/0000-0001-5250-492X				Ambrose JC, 2005, MOL BIOL CELL, V16, P1584, DOI 10.1091/mbc.E04-10-0935; Baas PW, 2006, TRAFFIC, V7, P490, DOI 10.1111/j.1600-0854.2006.00392.x; Ban R, 2004, J BIOL CHEM, V279, P16394, DOI 10.1074/jbc.M313257200; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Carazo-Salas RE, 2006, NAT CELL BIOL, V8, P1102, DOI 10.1038/ncb1479; Carazo-Salas RE, 2005, SCIENCE, V309, P297, DOI 10.1126/science.1113465; Chakravarty A, 2004, MOL BIOL CELL, V15, P2116, DOI 10.1091/mbc.E03-08-0579; Daga RR, 2006, NAT CELL BIOL, V8, P1108, DOI 10.1038/ncb1480; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; Drummond DR, 2000, CURR BIOL, V10, P766, DOI 10.1016/S0960-9822(00)00570-4; Goshima G, 2005, J CELL BIOL, V171, P229, DOI 10.1083/jcb.200505107; Gruneberg U, 2006, J CELL BIOL, V172, P363, DOI 10.1083/jcb.200511061; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; HEIDEMANN SR, 1981, J CELL BIOL, V91, P661, DOI 10.1083/jcb.91.3.661; Hizlan D, 2006, J STRUCT BIOL, V153, P73, DOI 10.1016/j.jsb.2005.10.007; Janson ME, 2005, J CELL BIOL, V169, P297, DOI 10.1083/jcb.200410119; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Loiodice I, 2005, MOL BIOL CELL, V16, P1756, DOI 10.1091/mbc.E04-10-0899; Mahoney NM, 2006, CURR BIOL, V16, P564, DOI 10.1016/j.cub.2006.01.053; Maresca TJ, 2005, CURR BIOL, V15, P1755, DOI 10.1016/j.cub.2005.08.049; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; MEYER RK, 1990, J CELL BIOL, V110, P2013, DOI 10.1083/jcb.110.6.2013; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Murata T, 2005, NAT CELL BIOL, V7, P961, DOI 10.1038/ncb1306; Nedelec F, 2002, J CELL BIOL, V158, P1005, DOI 10.1083/jcb.200202051; NISLOW C, 1992, NATURE, V359, P543, DOI 10.1038/359543a0; Patel SR, 2005, BLOOD, V106, P4076, DOI 10.1182/blood-2005-06-2204; Sagolla MJ, 2003, J CELL SCI, V116, P4891, DOI 10.1242/jcs.00796; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Sharp DJ, 1997, J CELL SCI, V110, P2373; Smertenko AP, 2004, PLANT CELL, V16, P2035, DOI 10.1105/tpc.104.023937; Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066; Straube A, 2006, MOL BIOL CELL, V17, P907, DOI 10.1091/mbc.E05-06-0542; Tran PT, 1997, J CELL BIOL, V138, P105, DOI 10.1083/jcb.138.1.105; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5; Yamashita A, 2005, MOL BIOL CELL, V16, P1378, DOI 10.1091/mbc.e04-10-0859; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102; Zhu CJ, 2006, P NATL ACAD SCI USA, V103, P6196, DOI 10.1073/pnas.0506926103	41	161	164	1	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2007	128	2					357	368		10.1016/j.cell.2006.12.030	http://dx.doi.org/10.1016/j.cell.2006.12.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254972	Bronze			2022-12-01	WOS:000244420500019
J	't Hoen, EFM; Dukes, MNG				't Hoen, Ellen F. M.; Dukes, M. N. Graham			Compensation for diethylstilbestrol injury	LANCET			English	Editorial Material									Univ Amsterdam, Amsterdam Sch Social Sci Res, NL-1012 CX Amsterdam, Netherlands; Univ Oslo, N-0316 Oslo, Norway	University of Amsterdam; University of Oslo	't Hoen, EFM (corresponding author), Univ Amsterdam, Amsterdam Sch Social Sci Res, NL-1012 CX Amsterdam, Netherlands.	ellen.t.hoen@orange.fr		't Hoen, Ellen/0000-0003-4477-6866				BUITENDIJK S, 1984, 13 EUR S CLIN PHARM; *DES, 2005, REP RUL GOV COMP INJ; DIECKMANN WJ, 1953, AM J OBSTET GYNECOL, V66, P1062; Dodds EC, 1938, NATURE, V141, P247, DOI 10.1038/141247b0; Dukes M. N. G., 2005, LAW ETHICS PHARM IND; *GRANT CHEM CO INC, 1957, AM J OBSTET GYNECOL; Hatch EE, 2006, AM J EPIDEMIOL, V164, P682, DOI 10.1093/aje/kwj257; Palmer JR, 2006, CANCER EPIDEM BIOMAR, V15, P1509, DOI 10.1158/1055-9965.EPI-06-0109; SMITH OW, 1948, AM J OBSTET GYNECOL, V56, P821; *US NCI, DES RES UPD 1999 CUR	10	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 20	2007	369	9557					173	174		10.1016/S0140-6736(07)60087-7	http://dx.doi.org/10.1016/S0140-6736(07)60087-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	128XG	17240270				2022-12-01	WOS:000243692400009
J	Parton, W; Silver, WL; Burke, IC; Grassens, L; Harmon, ME; Currie, WS; King, JY; Adair, EC; Brandt, LA; Hart, SC; Fasth, B				Parton, William; Silver, Whendee L.; Burke, Ingrid C.; Grassens, Leo; Harmon, Mark E.; Currie, William S.; King, Jennifer Y.; Adair, E. Carol; Brandt, Leslie A.; Hart, Stephen C.; Fasth, Becky			Global-scale similarities in nitrogen release patterns during long-term decomposition	SCIENCE			English	Article							FINE-ROOT DECOMPOSITION; ULTRAVIOLET-B RADIATION; LITTER DECOMPOSITION; ORGANIC-MATTER; FOREST SOILS; LEAF-LITTER; MASS-LOSS; DYNAMICS; ECOSYSTEM; CLIMATE	Litter decomposition provides the primary source of mineral nitrogen (N) for biological activity in most terrestrial ecosystems. A 10-year decomposition experiment in 21 sites from seven biomes found that net N release from leaf litter is dominantly driven by the initial tissue N concentration and mass remaining regardless of climate, edaphic conditions, or biota. Arid grasslands exposed to high ultraviolet radiation were an exception, where net N release was insensitive to initial N. Roots released N linearly with decomposition and exhibited little net N immobilization. We suggest that fundamental constraints on decomposer physiologies lead to predictable global-scale patterns in net N release during decomposition.	Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; Univ Calif Berkeley, Dept Environm Sci Policy & Management, Ecosyst Sci Div, Berkeley, CA 94720 USA; Colorado State Univ, Dept Forest Rangeland & Watershed Stewardship, Ft Collins, CO 80523 USA; Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; LSI Log Inc, Loveland, CO 80227 USA; Oregon State Univ, Dept Forest Sci, Corvallis, OR 97331 USA; Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48103 USA; Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA; Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA; No Arizona Univ, Merriam Powell Ctr Environm Res, Flagstaff, AZ 86011 USA	Colorado State University; University of California System; University of California Berkeley; Colorado State University; Colorado State University; Oregon State University; University of Michigan System; University of Michigan; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Northern Arizona University; Northern Arizona University	Parton, W (corresponding author), Colorado State Univ, Nat Resource Ecol Lab, 200 W Lake,Campus Mail 1499, Ft Collins, CO 80523 USA.		Silver, Whendee L./H-1118-2012; Burke, Ingrid/A-1420-2009; King, Jennifer Y./I-5986-2015	Silver, Whendee L./0000-0003-0372-8745; Burke, Ingrid/0000-0003-4717-6399; King, Jennifer Y./0000-0003-3433-5952; Fasth, Becky/0000-0001-5006-6727; Adair, E. Carol/0000-0002-8567-9045				ABER JD, 1985, OECOLOGIA, V66, P317, DOI 10.1007/BF00378292; ABER JD, 1990, CAN J BOT, V68, P2201, DOI 10.1139/b90-287; ABER JD, 1982, CAN J BOT, V60, P2263, DOI 10.1139/b82-277; Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Austin AT, 2006, NATURE, V442, P555, DOI 10.1038/nature05038; Barrett JE, 2002, J VEG SCI, V13, P383, DOI 10.1111/j.1654-1103.2002.tb02062.x; BEARE MH, 1992, ECOL MONOGR, V62, P569, DOI 10.2307/2937317; Berg B, 2000, FOREST ECOL MANAG, V133, P13, DOI 10.1016/S0378-1127(99)00294-7; BERG B, 1989, CAN J BOT, V67, P1148, DOI 10.1139/b89-150; Cadisch G, 1997, DRIVEN NATURE PLANT; Chen H, 2002, CAN J FOREST RES, V32, P320, DOI [10.1139/x01-202, 10.1139/X01-202]; Currie WS, 2003, GLOBAL CHANGE BIOL, V9, P919, DOI 10.1046/j.1365-2486.2003.00637.x; Dornbush ME, 2002, ECOLOGY, V83, P2985, DOI 10.1890/0012-9658(2002)083[2985:QFRDAA]2.0.CO;2; Frey SD, 2000, SOIL BIOL BIOCHEM, V32, P689, DOI 10.1016/S0038-0717(99)00205-9; Frey SD, 2004, FOREST ECOL MANAG, V196, P159, DOI 10.1016/j.foreco.2004.03.018; Gholz HL, 2000, GLOBAL CHANGE BIOL, V6, P751, DOI 10.1046/j.1365-2486.2000.00349.x; Hobbie SE, 2000, ECOLOGY, V81, P1867, DOI 10.1890/0012-9658(2000)081[1867:NLODIH]2.0.CO;2; *LIDET, 1995, PUBLICATION US LONG, V19; LOUSIER JD, 1979, CAN J FOREST RES, V9, P449, DOI 10.1139/x79-073; Moody SA, 2001, PLANT ECOL, V154, P27, DOI 10.1023/A:1012965610170; MOORE B, 1994, AMBIO, V23, P4; Moore TR, 2006, ECOSYSTEMS, V9, P46, DOI 10.1007/s10021-004-0026-x; Moorhead DL, 1999, GLOBAL BIOGEOCHEM CY, V13, P575, DOI 10.1029/1998GB900014; Pancotto VA, 2005, GLOBAL CHANGE BIOL, V11, P1982, DOI 10.1111/j.1365-2486.2005.01027.x; Parton W.J., 1994, SSSA SPECIAL PUBLICA, V39, P147, DOI DOI 10.2136/SSSASPECPUB39.C9; Post WM, 1996, CLIMATIC CHANGE, V34, P253, DOI 10.1007/BF00224636; Prentice IC, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P183; Richards EH, 1931, BIOCHEM J, V25, P1769, DOI 10.1042/bj0251769; Rozema J, 1997, PLANT ECOL, V128, P284; SCHIMEL DS, 1991, ECOLOGY, V72, P672, DOI 10.2307/2937207; SEASTEDT TR, 1992, CAN J BOT, V70, P384, DOI 10.1139/b92-052; Silver WL, 2001, OECOLOGIA, V129, P407, DOI 10.1007/s004420100740; Silver WL, 2005, GLOBAL CHANGE BIOL, V11, P290, DOI 10.1111/j.1365-2486.2005.00903.x; SILVER WL, 1993, J ECOL, V81, P729, DOI 10.2307/2261670; Verhoef HA, 2000, BIOL FERT SOILS, V31, P366, DOI 10.1007/s003749900181; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87	36	813	937	38	566	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 19	2007	315	5810					361	364		10.1126/science.1134853	http://dx.doi.org/10.1126/science.1134853			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126SI	17234944				2022-12-01	WOS:000243535400037
J	Liu, R; Wang, XH; Chen, GY; Dalerba, P; Gurney, A; Hoey, T; Sherlock, G; Lewicki, J; Shedden, K; Clarke, MF				Liu, Rui; Wang, Xinhao; Chen, Grace Y.; Dalerba, Piero; Gurney, Austin; Hoey, Timothy; Sherlock, Gavin; Lewicki, John; Shedden, Kerby; Clarke, Michael F.			The prognostic role of a gene signature from tumorigenic breast-cancer cells.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EXPRESSION SIGNATURE; IDENTIFICATION; METASTASIS; SURVIVAL; PATTERNS; THERAPY	BACKGROUND: Breast cancers contain a minority population of cancer cells characterized by CD44 expression but low or undetectable levels of CD24 (CD44+CD24-/low) that have higher tumorigenic capacity than other subtypes of cancer cells. METHODS: We compared the gene-expression profile of CD44+CD24-/low tumorigenic breast-cancer cells with that of normal breast epithelium. Differentially expressed genes were used to generate a 186-gene ``invasiveness'' gene signature (IGS), which was evaluated for its association with overall survival and metastasis-free survival in patients with breast cancer or other types of cancer. RESULTS: There was a significant association between the IGS and both overall and metastasis-free survival (P<0.001, for both) in patients with breast cancer, which was independent of established clinical and pathological variables. When combined with the prognostic criteria of the National Institutes of Health, the IGS was used to stratify patients with high-risk early breast cancer into prognostic categories (good or poor); among patients with a good prognosis, the 10-year rate of metastasis-free survival was 81%, and among those with a poor prognosis, it was 57%. The IGS was also associated with the prognosis in medulloblastoma (P=0.004), lung cancer (P=0.03), and prostate cancer (P=0.01). The prognostic power of the IGS was increased when combined with the wound-response (WR) signature. CONCLUSIONS: The IGS is strongly associated with metastasis-free survival and overall survival for four different types of tumors. This genetic signature of tumorigenic breast-cancer cells was even more strongly associated with clinical outcomes when combined with the WR signature in breast cancer.	Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Stat, Ann Arbor, MI 48109 USA; Oncomed Pharmaceut, Mountain View, CA USA; Stanford Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University	Liu, R (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.		Dalerba, Piero/E-2543-2018; Sherlock, Gavin J/B-1831-2009; Sherlock, Gavin J/E-9110-2012	Dalerba, Piero/0000-0002-8815-4981; Sherlock, Gavin/0000-0002-1692-4983	NCI NIH HHS [T32 CA009357, CA126524, CA104987] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U54CA126524, T32CA009357, R01CA104987] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P6890, DOI 10.1073/pnas.1131491100; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Goldhirsch A, 2005, ANN ONCOL, V16, P1569, DOI 10.1093/annonc/mdi326; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1	18	773	839	0	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 18	2007	356	3					217	226		10.1056/NEJMoa063994	http://dx.doi.org/10.1056/NEJMoa063994			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126BV	17229949	Bronze			2022-12-01	WOS:000243488100004
J	Trotman, LC; Wang, XJ; Alimonti, A; Chen, ZB; Teruya-Feldstein, J; Yang, HJ; Pavletich, NP; Carver, BS; Cordon-Cardo, C; Erdjument-Bromage, H; Tempst, P; Chi, SG; Kim, HJ; Misteli, T; Jiang, XJ; Pandolfi, PP				Trotman, Lloyd C.; Wang, Xinjiang; Alimonti, Andrea; Chen, Zhenbang; Teruya-Feldstein, Julie; Yang, Haijuan; Pavletich, Nikola P.; Carver, Brett S.; Cordon-Cardo, Carlos; Erdjument-Bromage, Hediye; Tempst, Paul; Chi, Sung-Gil; Kim, Hyo-Jong; Misteli, Tom; Jiang, Xuejun; Pandolfi, Pier Paolo			Ubiquitination regulates PTEN nuclear import and tumor suppression	CELL			English	Article							PTEN/MMAC1 GENE; PROSTATE-CANCER; COWDEN-DISEASE; P53; MUTATIONS; PATHWAY; IDENTIFICATION; EXPRESSION; SYSTEM; ROLES	The PTEN tumor suppressor is frequently affected in cancer cells, and inherited PTEN mutation causes cancer-susceptibility conditions such as Cowden syndrome. PTEN acts as a plasma-membrane lipid-phosphatase antagonizing the phosphoinositide 3-kinase/AKT cell survival pathway. However, PTEN is also found in cell nuclei, but mechanism, function, and relevance of nuclear localization remain unclear. We show that nuclear PTEN is essential for tumor suppression and that PTEN nuclear import is mediated by its monoubiquitination. A lysine mutant of PTEN, K289E associated with Cowden syndrome, retains catalytic activity but fails to accumulate in nuclei of patient tissue due to an import defect. We identify this and another lysine residue as major monoubiquitination sites essential for PTEN import. While nuclear PTEN is stable, polyubiquitination leads to its degradation in the cytoplasm. Thus, we identify cancer-associated mutations of PTEN that target its posttranslational modification and demonstrate how a discrete molecular mechanism dictates tumor progression by differentiating between degradation and protection of IPTEN.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Cell Biol Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Struct Biol Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Howard Hughes Med Inst, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Urol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA; Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea; Kyung Hee Univ, Sch Med, Seoul 130701, South Korea; NCI, NIH, Bethesda, MD 20892 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Korea University; Kyung Hee University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	p-pandolfi@ski.mskcc.org		Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Alimonti, Andrea/0000-0002-9362-2313	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [R01-CA-82328, R01 CA082328, P30-CA-08748, P30 CA008748, R01 CA137050] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748, Z01BC010309, R01CA082328, R01CA137050] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bonneau D, 2000, HUM MUTAT, V16, P109, DOI 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chi SG, 1998, GASTROENTEROLOGY, V115, P1084, DOI 10.1016/S0016-5085(98)70078-2; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Duerr EM, 1998, ONCOGENE, V16, P2259, DOI 10.1038/sj.onc.1201756; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Georgescu MM, 2000, CANCER RES, V60, P7033; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lian ZL, 2005, ONCOGENE, V24, P7394, DOI 10.1038/sj.onc.1209089; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; Ma L, 2005, GENE DEV, V19, P1779, DOI 10.1101/gad.1314405; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Nagy R, 2004, ONCOGENE, V23, P6445, DOI 10.1038/sj.onc.1207714; Nelen MR, 1997, HUM MOL GENET, V6, P1383, DOI 10.1093/hmg/6.8.1383; Plafker SM, 2004, J CELL BIOL, V167, P649, DOI 10.1083/jcb.200406001; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Trotman LC, 2003, CANCER CELL, V3, P97, DOI 10.1016/S1535-6108(03)00022-9; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Walker SM, 2004, BIOCHEM J, V379, P301, DOI 10.1042/BJ20031839; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Whiteman DC, 2002, INT J CANCER, V99, P63, DOI 10.1002/ijc.10294; Zhou XP, 2002, AM J PATHOL, V161, P439, DOI 10.1016/S0002-9440(10)64200-9	43	553	599	1	44	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 12	2007	128	1					141	156		10.1016/j.cell.2006.11.040	http://dx.doi.org/10.1016/j.cell.2006.11.040			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GN	17218261	Green Accepted, Bronze			2022-12-01	WOS:000244420400019
J	Wang, XJ; Trotman, LC; Koppie, T; Alimonti, A; Chen, ZB; Gao, ZH; Wang, JR; Erdjument-Bromage, H; Tempst, P; Cordon-Cardo, C; Pandolfi, PP; Jiang, XJ				Wang, Xinjiang; Trotman, Lloyd C.; Koppie, Theresa; Alimonti, Andrea; Chen, Zhenbang; Gao, Zhonghua; Wang, Junru; Erdjument-Bromage, Hediye; Tempst, Paul; Cordon-Cardo, Carlos; Pandolfi, Pier Paolo; Jiang, Xuejun			NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN	CELL			English	Article							TUMOR-SUPPRESSOR PTEN; PROSTATE-CANCER; PROTEIN-DEGRADATION; CELL-MIGRATION; PATHWAY; GENE; PHOSPHORYLATION; DOMAIN; P53; RECRUITMENT	The tumor suppressor PTEN, a critical regulator for multiple cellular processes, is mutated or deleted frequently in various human cancers. Subtle reductions in PTEN expression levels have profound impacts on carcinogenesis. Here we show that PTEN level is regulated by ubiquitin-mediated proteasomal degradation, and purified its ubiquitin ligase as HECT-domain protein NEDD4-1. In cells NEDD4-1 negatively regulates PTEN stability by catalyzing PTEN polyubiquitination. Consistent with the tumor-suppressive role of PTEN, overexpression of NEDD4-1 potentiated cellular transformation. Strikingly, in a mouse cancer model and multiple human cancer samples where the genetic background of PTEN was normal but its protein levels were low, NEDD4-1 was highly expressed, suggesting that aberrant upregulation of NEDD4-1 can posttranslationally suppress PTEN in cancers. Elimination of NEDD4-1 expression inhibited xenotransplanted tumor growth in a PTENdependent manner. Therefore, NEDD4-1 is a potential proto-oncogene that negatively regulates PTEN via ubiquitination, a paradigm analogous to that of Mdm2 and p53.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Cell Biol Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Cenc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Jiang, XJ (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Cell Biol Program, 1275 York Ave,Box 522, New York, NY 10021 USA.	jiangx@mskcc.org		Erdjument-Bromage, Hediye/0000-0003-0224-3594; Tempst, Paul/0000-0002-6680-3987; Alimonti, Andrea/0000-0002-9362-2313	NCI NIH HHS [R01 CA113890, R01 CA137050] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA113890, R01CA137050] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adey NB, 2000, CANCER RES, V60, P35; Bakkers J, 2005, CELL CYCLE, V4, P790, DOI 10.4161/cc.4.6.1694; Blot V, 2004, J CELL SCI, V117, P2357, DOI 10.1242/jcs.01095; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; CIECHANOVER A, 1984, J CELL BIOCHEM, V24, P27, DOI 10.1002/jcb.240240104; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Fostier M, 1998, GENETICS, V150, P1477; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gray IC, 1998, BRIT J CANCER, V78, P1296, DOI 10.1038/bjc.1998.674; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kamynina E, 2001, AM J PHYSIOL-RENAL, V281, pF469, DOI 10.1152/ajprenal.2001.281.3.F469; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kwabi-Addo B, 2001, P NATL ACAD SCI USA, V98, P11563, DOI 10.1073/pnas.201167798; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Michael D, 2002, CURR OPIN GENET DEV, V12, P53, DOI 10.1016/S0959-437X(01)00264-7; Nagase T, 1995, DNA Res, V2, P37, DOI 10.1093/dnares/2.1.37; Pao W, 2003, P NATL ACAD SCI USA, V100, P8764, DOI 10.1073/pnas.1133333100; Raftopoulou M, 2004, SCIENCE, V303, P1179, DOI 10.1126/science.1092089; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Rougier JS, 2005, AM J PHYSIOL-CELL PH, V288, pC692, DOI 10.1152/ajpcell.00460.2004; Sambrook J, 2001, MOL CLONING LAB MANU, V3rd; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Strack B, 2000, P NATL ACAD SCI USA, V97, P13063, DOI 10.1073/pnas.97.24.13063; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; Wu WD, 2003, J BIOL CHEM, V278, P28258, DOI 10.1074/jbc.M303318200	42	509	542	1	34	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 12	2007	128	1					129	139		10.1016/j.cell.2006.11.039	http://dx.doi.org/10.1016/j.cell.2006.11.039			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GN	17218260	Bronze, Green Accepted			2022-12-01	WOS:000244420400018
J	Gomez-Consarnau, L; Gonzalez, JM; Coll-Llado, M; Gourdon, P; Pascher, T; Neutze, R; Pedros-Alio, C; Pinhassi, J				Gomez-Consarnau, Laura; Gonzalez, Jose M.; Coll-Llado, Montserrat; Gourdon, Pontus; Pascher, Torbjoern; Neutze, Richard; Pedros-Alio, Carlos; Pinhassi, Jarone			Light stimulates growth of proteorhodopsin-containing marine Flavobacteria	NATURE			English	Article							OCEAN; PHOTOTROPHY; BACTERIUM; SAR11; SEA	Proteorhodopsins are bacterial light-dependent proton pumps. Their discovery within genomic material from uncultivated marine bacterioplankton caused considerable excitement because it indicated a potential phototrophic function within these organisms, which had previously been considered strictly chemotrophic(1). Subsequent studies established that sequences encoding proteorhodopsin are broadly distributed throughout the world's oceans(2-5). Nevertheless, the role of proteorhodopsins in native marine bacteria is still unknown(6). Here we show, from an analysis of the complete genomes of three marine Flavobacteria, that cultivated bacteria in the phylum Bacteroidetes, one of the principal components of marine bacterioplankton, contain proteorhodopsin. Moreover, growth experiments in both natural and artificial seawater ( low in labile organic matter, which is typical of the world's oceans) establish that exposure to light results in a marked increase in the cell yield of one such bacterium (Dokdonia sp. strain MED134) when compared with cells grown in darkness. Thus, our results show that the phototrophy conferred by proteorhodopsin can provide critical amounts of energy, not only for respiration and maintenance but also for active growth of marine bacterioplankton in their natural environment.	Univ Kalmar, Dept Biol & Environm Sci, SE-39182 KAlmar, Sweden; Univ La Laguna, Dept Microbiol & Cell Biol, ES-38206 Tenerife, Spain; CSIC, CMIMA, Inst Ciencies Mar, ES-08003 Barcelona, Spain; Chalmers, Dept Biol & Chem Engn, SE-41296 Gothenburg, Sweden; Lund Univ, Kemictr, SE-22100 Lund, Sweden; Univ Gothenburg, Dept Chem Biochem & Biophys, SE-40530 Gothenburg, Sweden	Linnaeus University; University of Kalmar; Universidad de la Laguna; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Chalmers University of Technology; Lund University; University of Gothenburg	Pinhassi, J (corresponding author), Univ Kalmar, Dept Biol & Environm Sci, SE-39182 KAlmar, Sweden.	jarone.pinhassi@hik.se	Gomez-Consarnau, Laura/AAM-1319-2021; Gourdon, Pontus/HCI-8898-2022; Gourdon, Pontus/E-1076-2014; Gonzalez, Jose M./C-3333-2013; Neutze, Richard/A-7573-2010; Pedrós-Alió, Carlos/H-1222-2011	Gourdon, Pontus/0000-0002-8631-3539; Gonzalez, Jose M./0000-0002-9926-3323; Neutze, Richard/0000-0003-0986-6153; Pedrós-Alió, Carlos/0000-0003-1009-4277; Coll-Llado, Montserrat/0000-0003-0169-4107				Abell GCJ, 2005, FEMS MICROBIOL ECOL, V51, P265, DOI 10.1016/j.femsec.2004.09.001; Beja O, 2002, NATURE, V415, P630, DOI 10.1038/415630a; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Bielawski JP, 2004, P NATL ACAD SCI USA, V101, P14824, DOI 10.1073/pnas.0403999101; de la Torre JR, 2003, P NATL ACAD SCI USA, V100, P12830, DOI 10.1073/pnas.2133554100; Dioumaev AK, 2002, BIOCHEMISTRY-US, V41, P5348, DOI 10.1021/bi025563x; Frigaard NU, 2006, NATURE, V439, P847, DOI 10.1038/nature04435; Giovannoni S., 2000, P47; Giovannoni SJ, 2005, NATURE, V438, P82, DOI 10.1038/nature04032; Glockner FO, 1999, APPL ENVIRON MICROB, V65, P3721; Hagstrom A, 2002, APPL ENVIRON MICROB, V68, P3628, DOI 10.1128/AEM.68.7.3628-3633.2002; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Kolber ZS, 2000, NATURE, V407, P177, DOI 10.1038/35025044; Man DL, 2003, EMBO J, V22, P1725, DOI 10.1093/emboj/cdg183; Neutze R, 2002, BBA-BIOMEMBRANES, V1565, P144, DOI 10.1016/S0005-2736(02)00566-7; Pinhassi J, 2004, APPL ENVIRON MICROB, V70, P6753, DOI 10.1128/AEM.70.11.6753-6766.2004; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; Riemann L, 2000, APPL ENVIRON MICROB, V66, P578, DOI 10.1128/AEM.66.2.578-587.2000; Sabehi G, 2005, PLOS BIOL, V3, P1409, DOI 10.1371/journal.pbio.0030273; Sabehi G, 2004, ENVIRON MICROBIOL, V6, P903, DOI 10.1111/j.1462-2920.2004.00676.x; Sabehi G, 2003, ENVIRON MICROBIOL, V5, P842, DOI 10.1046/j.1462-2920.2003.00493.x; SHIBA T, 1979, APPL ENVIRON MICROB, V38, P43, DOI 10.1128/AEM.38.1.43-45.1979; Teramoto M, 2003, FEBS LETT, V545, P120, DOI 10.1016/S0014-5793(03)00513-1; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang WW, 2003, J BIOL CHEM, V278, P33985, DOI 10.1074/jbc.M305716200	26	265	278	4	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 11	2007	445	7124					210	213		10.1038/nature05381	http://dx.doi.org/10.1038/nature05381			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QF	17215843				2022-12-01	WOS:000243384300052
J	Platt, MJ; Cans, C; Johnson, A; Surman, G; Topp, M; Torrioli, MG; Krageloh-Mann, I				Platt, Mary Jane; Cans, Christine; Johnson, Ann; Surman, Geraldine; Topp, Monica; Torrioli, Maria Giulia; Krageloh-Mann, Inge			Trends in cerebral palsy among of very low birthweight (< 1500 g) or born prematurely (< 32 weeks) in 16 European centres: a database study	LANCET			English	Article							BRAIN-INJURY; INFANTS; POPULATION; PREVALENCE; ULTRASOUND; SURVIVAL; OUTCOMES; SWEDEN; RATES; GRAMS	Background The risk of cerebral palsy, the commonest physical disability of children in western Europe, is higher in infants of very low birthweight (VLBW)-those born weighing less than 1500 g-and those from multiple pregnancies than in infants of normal birthweight. An increasing proportion of infants from both of these groups survive into childhood. This paper describes changes in the frequency and distribution of cerebral palsy by sex and neurological subtype in infants with a birthweight below 1000 g and 1000-1499 g in the period 1980-96. Methods A group of 16 European centres, Surveillance of Cerebral Palsy in Europe, agreed a standard definition of cerebral palsy and inclusion and exclusion criteria. Data for children with cerebral palsy born in the years 1980-96 were pooled. The data were analysed to describe the distribution and prevalence of cerebral palsy in VLBW infants. Prevalence trends were expressed as both per 1000 livebirths and per 1000 neonatal survivors. Findings There were 1575 VLBW infants born with cerebral palsy; 414 (26%) were of birthweight less than 1000 g and 317 (20%) were from multiple pregnancies. 1426 (94%) had spastic cerebral palsy, which was unilateral (hemiplegic) in 336 (24%). The birth prevalence fell from 60.6 (99% CI 37.8-91.4) per 1000 liveborn VLBW infants in 1980 to 39.5 (28.6-53.0) per 1000 VLBW infants in 1996. This decline was related to a reduction in the frequency of bilateral spastic cerebral palsy among infants of birthweight 1000-1499 g. The frequency of cerebral palsy was higher in male than female babies in the group of birthweight 1000-1499 g (61.0 [53.8-68.2] vs 49.5 [42.8-56.2] per 1000 livebirths; p=0.0025) but not in the group of birthweight below 1000 g. Interpretation These data from a large population base provide evidence that the prevalence of cerebral palsy in children of birthweight less than 1500 g has fallen, which has important implications for parents, health services, and society.	Univ Liverpool, Div Publ Hlth, Liverpool L69 3GB, Merseyside, England; Registre Handicaps Enfant, Grenoble, France; Observ Perinatal Technol Imagerie Modelisat & Cog, Grenoble, France; Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford, England; Natl Inst Publ Hlth, Cerebral Palsy Registry, Copenhagen, Denmark; Hvidovre Univ Hosp, Dept Obstet & Gynaecol, Copenhagen, Denmark; Univ Cattolica Sacro Cuore, Fac Med & Chirurg Augostino Gemelli, Rome, Italy; Univ Childrens Hosp, Dept Child Neurol, Tubingen, Germany	University of Liverpool; University of Oxford; University of Copenhagen; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf	Platt, MJ (corresponding author), Univ Liverpool, Div Publ Hlth, Whelan Bldg, Liverpool L69 3GB, Merseyside, England.	mjplatt@liv.ac.uk	Platt, MJ/K-4588-2012; Cans, Christine/M-6153-2014	Platt, MJ/0000-0002-9372-9575; Cans, Christine/0000-0003-3071-9959; Johnson, Anne/0000-0003-1330-7100				[Anonymous], 1997, Arch Dis Child Fetal Neonatal Ed, V77, pF91; Bell R, 2004, ARCH DIS CHILD-FETAL, V89, pF531, DOI 10.1136/adc.2003.038414; Breart G, 2003, EUR J OBSTET GYN R B, V111, pS45, DOI 10.1016/j.ejogrb.2003.09.005; Cans C, 2002, DEV MED CHILD NEUROL, V44, P633; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; Clark SL, 2003, AM J OBSTET GYNECOL, V188, P628, DOI 10.1067/mob.2003.204; Colver AF, 2000, ARCH DIS CHILD-FETAL, V83, pF7, DOI 10.1136/fn.83.1.F7; Cooke RWI, 1999, ARCH DIS CHILD-FETAL, V80, pF115, DOI 10.1136/fn.80.2.F115; Doyle LW, 2000, J PAEDIATR CHILD H, V36, P7, DOI 10.1046/j.1440-1754.2000.00452.x; ENSDOKKUM ME, 1994, ARCH DIS CHILD-FETAL, V70, P96; Hamrick SEG, 2004, J PEDIATR-US, V145, P593, DOI 10.1016/j.jpeds.2004.05.042; Himmelmann K, 2005, ACTA PAEDIATR, V94, P287, DOI 10.1111/j.1651-2227.2005.tb03071.x; Krageloh-Mann I, 2004, EXP NEUROL, V190, pS84, DOI 10.1016/j.expneurol.2004.05.037; KRAGELOHMANN I, 1994, DEV MED CHILD NEUROL, V36, P473; Laptook AR, 2005, PEDIATRICS, V115, P673, DOI 10.1542/peds.2004-0667; OShea TM, 1997, PEDIATRICS, V100, P982, DOI 10.1542/peds.100.6.982; Piecuch RE, 1997, PEDIATRICS, V100, P633, DOI 10.1542/peds.100.4.633; Pison G, 2006, TWIN RES HUM GENET, V9, P250, DOI 10.1375/twin.9.2.250; Scher AI, 2002, PEDIATR RES, V52, P671, DOI [10.1203/01.PDR.0000032159.88318.5B, 10.1203/00006450-200211000-00011]; Shankaran S, 2004, AM J OBSTET GYNECOL, V191, P1084, DOI 10.1016/j.ajog.2004.05.032; Stanley F, 2000, CLIN DEV MED; Surman G, 2003, DEV MED CHILD NEUROL, V45, P456, DOI 10.1017/S0012162203000859; Tin W, 1997, BRIT J OBSTET GYNAEC, V104, P180, DOI 10.1111/j.1471-0528.1997.tb11041.x; Topp M, 2004, ACTA OBSTET GYN SCAN, V83, P548, DOI 10.1111/j.0001-6349.2004.00545.x; Topp M, 2001, PAEDIATR PERINAT EP, V15, P271, DOI 10.1046/j.1365-3016.2001.00354.x; Vohr BR, 1997, SEMIN PERINATOL, V21, P202, DOI 10.1016/S0146-0005(97)80064-X; Watson L, 1999, REPORT W AUSTR CEREB; Winter S, 2002, PEDIATRICS, V110, P1220, DOI 10.1542/peds.110.6.1220	28	270	294	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 6	2007	369	9555					43	50		10.1016/S0140-6736(07)60030-0	http://dx.doi.org/10.1016/S0140-6736(07)60030-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	125AK	17208641				2022-12-01	WOS:000243413700028
J	Kim, SY; Ferrell, JE				Kim, Sun Young; Ferrell, James E., Jr.			Substrate competition as a source of ultrasensitivity in the inactivation of Wee1	CELL			English	Article							ACTIVATED PROTEIN-KINASE; CELL-CYCLE REGULATION; LAEVIS EGG EXTRACTS; PHOSPHORYLATES CDC2; SWITCH-LIKE; MULTISITE PHOSPHORYLATION; DUAL PHOSPHORYLATION; BIOCHEMICAL SYSTEMS; BIOLOGICAL-SYSTEMS; INHIBITORY KINASE	The mitotic regulators Wee1 and Cdk1 can inactivate each other through inhibitory phosphorylations. This double-negative feedback loop is part of a bistable trigger that makes the transition into mitosis abrupt and decisive. To generate a bistable response, some component of a double-negative feedback loop must exhibit an ultrasensitive response to its upstream regulator. Here, we experimentally demonstrate that Wee1 exhibits a highly ultrasensitive response to Cdk1. Several mechanisms can, in principle, give rise to ultrasensitivity, including zero-order effects, multisite phosphorylation, and competition mechanisms. We found that the ultrasensitivity in the inactivation of Wee1 arises mainly through two competition mechanisms: competition between two sets of phosphorylation sites in Wee1 and between Wee1 and other high-affinity Cdk1 targets. Based on these findings, we were able to reconstitute a highly ultrasensitive Wee1 response with purified components. Competition provides a simple way of generating the equivalent of a highly cooperative allosteric response.	Stanford Univ, Sch Med, Ctr Clin Sci Res, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University	Ferrell, JE (corresponding author), Stanford Univ, Sch Med, Ctr Clin Sci Res, Dept Chem & Syst Biol, 269 W Campus Dr,Room 3155, Stanford, CA 94305 USA.	james.ferrell@stanford.edu	Kim, Sun/GSN-4867-2022		NIGMS NIH HHS [GM46383] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046383] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Bagowski CP, 2003, CURR BIOL, V13, P315, DOI 10.1016/S0960-9822(03)00083-6; Brown GC, 1997, TRENDS BIOCHEM SCI, V22, P288, DOI 10.1016/S0968-0004(97)82216-5; Burack WR, 1997, BIOCHEMISTRY-US, V36, P5929, DOI 10.1021/bi970535d; Chen MZ, 1997, MOL CELL BIOL, V17, P1904, DOI 10.1128/MCB.17.4.1904; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; Fattaey A, 1997, Prog Cell Cycle Res, V3, P233; Ferrell JE, 1998, TRENDS BIOCHEM SCI, V23, P461, DOI 10.1016/S0968-0004(98)01316-4; Ferrell JE, 1997, TRENDS BIOCHEM SCI, V22, P288, DOI 10.1016/S0968-0004(97)82217-7; Ferrell JE, 1997, J BIOL CHEM, V272, P19008, DOI 10.1074/jbc.272.30.19008; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Georgi AB, 2002, CURR BIOL, V12, P105, DOI 10.1016/S0960-9822(01)00662-5; GOLDBETER A, 1982, Q REV BIOPHYS, V15, P555, DOI 10.1017/S0033583500003449; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Hardie DG, 1999, BIOCHEM J, V338, P717, DOI 10.1042/0264-6021:3380717; Harvey SL, 2005, CELL, V122, P407, DOI 10.1016/j.cell.2005.05.029; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Kim SY, 2005, MOL CELL BIOL, V25, P10580, DOI 10.1128/MCB.25.23.10580-10590.2005; Klein P, 2003, CURR BIOL, V13, P1669, DOI 10.1016/j.cub.2003.09.027; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; LAPORTE DC, 1983, NATURE, V305, P286, DOI 10.1038/305286a0; Laurent M, 1999, TRENDS BIOCHEM SCI, V24, P418, DOI 10.1016/S0968-0004(99)01473-5; Liu F, 1997, MOL CELL BIOL, V17, P571, DOI 10.1128/MCB.17.2.571; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; MCGOWAN CH, 1995, EMBO J, V14, P2166, DOI 10.1002/j.1460-2075.1995.tb07210.x; MCGOWAN CH, 1993, EMBO J, V12, P75, DOI 10.1002/j.1460-2075.1993.tb05633.x; MEINKE MH, 1986, P NATL ACAD SCI USA, V83, P2865, DOI 10.1073/pnas.83.9.2865; MUELLER PR, 1995, MOL BIOL CELL, V6, P119, DOI 10.1091/mbc.6.1.119; MUELLER PR, 1995, SCIENCE, V270, P86, DOI 10.1126/science.270.5233.86; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; NOVAK B, 1993, J CELL SCI, V106, P1153; PARKER LL, 1995, P NATL ACAD SCI USA, V92, P9638, DOI 10.1073/pnas.92.21.9638; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Patra D, 1996, GENE DEV, V10, P1503, DOI 10.1101/gad.10.12.1503; Patra D, 1999, J BIOL CHEM, V274, P36839, DOI 10.1074/jbc.274.52.36839; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Shou WY, 1996, MOL BIOL CELL, V7, P457, DOI 10.1091/mbc.7.3.457; SMYTHE C, 1991, METHOD CELL BIOL, V35, P449; SOLOMON MJ, 1990, CELL, V63, P1013, DOI 10.1016/0092-8674(90)90504-8; SU JY, 1995, P NATL ACAD SCI USA, V92, P10187, DOI 10.1073/pnas.92.22.10187; TANG ZH, 1993, EMBO J, V12, P3427, DOI 10.1002/j.1460-2075.1993.tb06017.x; Thomas R., 1980, SPRINGER SERIES SYNE, V9, P180; Thron CD, 1996, BIOPHYS CHEM, V57, P239, DOI 10.1016/0301-4622(95)00075-5; Tyson JJ, 1996, TRENDS BIOCHEM SCI, V21, P89; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; WALTER CF, 1970, J THEOR BIOL, V27, P259, DOI 10.1016/0022-5193(70)90141-4; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x; Wells NJ, 1999, J CELL SCI, V112, P3361	60	182	183	0	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2007	128	6					1133	1145		10.1016/j.cell.2007.01.039	http://dx.doi.org/10.1016/j.cell.2007.01.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382882	Bronze			2022-12-01	WOS:000245396200019
J	Suel, GM; Kulkarni, RP; Dworkin, J; Garcia-Ojalvo, J; Elowitz, MB				Sueel, Guerol M.; Kulkarni, Rajan P.; Dworkin, Jonathan; Garcia-Ojalvo, Jordi; Elowitz, Michael B.			Tunability and noise dependence in differentiation dynamics	SCIENCE			English	Article							COMPETENCE TRANSCRIPTION FACTOR; SUBTILIS K-STATE; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; GENETIC COMPETENCE; COMK; EXPRESSION; NETWORKS; BISTABILITY; BACTERIA	The dynamic process of differentiation depends on the architecture, quantitative parameters, and noise of underlying genetic circuits. However, it remains unclear how these elements combine to control cellular behavior. We analyzed the probabilistic and transient differentiation of Bacillus subtilis cells into the state of competence. A few key parameters independently tuned the frequency of initiation and the duration of competence episodes and allowed the circuit to access different dynamic regimes, including oscillation. Altering circuit architecture showed that the duration of competence events can be made more precise. We used an experimental method to reduce global cellular noise and showed that noise levels are correlated with frequency of differentiation events. Together, the data reveal a noise-dependent circuit that is remarkably resilient and tunable in terms of its dynamic behavior.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Texas, Green Ctr Div Syst Biol, SW Med Ctr, Dallas, TX 75390 USA; Univ Texas, Dept Pharmacol, SW Med Ctr, Dallas, TX 75390 USA; CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA; Univ Politecn Catalunya, Dept Fis & Engn Nucl, E-08222 Terrassa, Spain	California Institute of Technology; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; California Institute of Technology; Columbia University; Universitat Politecnica de Catalunya	Elowitz, MB (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	melowitz@caltech.edu	Garcia-Ojalvo, Jordi/A-4574-2009	Garcia-Ojalvo, Jordi/0000-0002-3716-7520	NIGMS NIH HHS [GM079771, GM068763] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079771, P50GM068763] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alon U., 2006, MATH COMPUTATIONAL B, V10; [Anonymous], [No title captured]; Berka RM, 2002, MOL MICROBIOL, V43, P1331, DOI 10.1046/j.1365-2958.2002.02833.x; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Grossman AD, 1995, ANNU REV GENET, V29, P477, DOI 10.1146/annurev.ge.29.120195.002401; HAHN J, 1994, J BACTERIOL, V176, P5753, DOI 10.1128/JB.176.18.5753-5761.1994; Hoa TT, 2002, MOL MICROBIOL, V43, P15, DOI 10.1046/j.1365-2958.2002.02727.x; ISHINO F, 1989, J BACTERIOL, V171, P5523, DOI 10.1128/jb.171.10.5523-5530.1989; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Maki N, 2000, J BACTERIOL, V182, P4337, DOI 10.1128/JB.182.15.4337-4342.2000; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Ogura M, 1999, MOL MICROBIOL, V32, P799, DOI 10.1046/j.1365-2958.1999.01399.x; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Smits WK, 2005, MOL MICROBIOL, V56, P604, DOI 10.1111/j.1365-2958.2005.04488.x; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; TETART F, 1992, MOL MICROBIOL, V6, P621, DOI 10.1111/j.1365-2958.1992.tb01509.x; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Turgay K, 1998, EMBO J, V17, P6730; VANSINDEREN D, 1995, MOL MICROBIOL, V15, P455	23	349	363	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2007	315	5819					1716	1719		10.1126/science.1137455	http://dx.doi.org/10.1126/science.1137455			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379809				2022-12-01	WOS:000245106900041
J	Stone, MD; Mihalusova, M; O'Connor, CM; Prathapam, R; Collins, K; Zhuang, XW				Stone, Michael D.; Mihalusova, Mariana; O'Connor, Catherine M.; Prathapam, Ramadevi; Collins, Kathleen; Zhuang, Xiaowei			Stepwise protein-mediated RNA folding directs assembly of telomerase ribonucleoprotein	NATURE			English	Article							STEM-LOOP IV; REVERSE-TRANSCRIPTASE; ENERGY-TRANSFER; HOLOENZYME; SUBUNIT; PROCESSIVITY; COMPONENT; DISEASE	Telomerase is an essential cellular ribonucleoprotein (RNP) that solves the end replication problem and maintains chromosome stability by adding telomeric DNA to the termini of linear chromosomes(1-3). Genetic mutations that abrogate the normal assembly of telomerase RNP cause human disease(4). It is therefore of fundamental and medical importance to decipher cellular strategies for telomerase biogenesis, which will require new insights into how specific interactions occur in a precise order along the RNP assembly pathway. Here we use a single-molecule approach to dissect the individual assembly steps of telomerase. Direct observation of complex formation in real time revealed two sequential steps of protein-induced RNA folding, establishing a hierarchical RNP assembly mechanism: interaction with the telomerase holoenzyme protein p65 induces structural rearrangement of telomerase RNA, which in turn directs the binding of the telomerase reverse transcriptase to form the functional ternary complex. This hierarchical assembly process is facilitated by an evolutionarily conserved structural motif within the RNA. These results identify the RNA folding pathway during telomerase biogenesis and define the mechanism of action for an essential telomerase holoenzyme protein.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Harvard University; Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Zhuang, XW (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068518, R01GM054198] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM068518-01A2, R01 GM068518-05, R01 GM068518, R01 GM054198] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adilakshmi T, 2005, J MOL BIOL, V351, P508, DOI 10.1016/j.jmb.2005.06.020; Aigner S, 2003, BIOCHEMISTRY-US, V42, P5736, DOI 10.1021/bi034121y; Cech TR, 2004, CELL, V116, P273, DOI 10.1016/S0092-8674(04)00038-8; Chen Y, 2006, EMBO J, V25, P3156, DOI 10.1038/sj.emboj.7601195; Collins K, 2006, NAT REV MOL CELL BIO, V7, P484, DOI 10.1038/nrm1961; Cunningham DD, 2005, MOL CELL BIOL, V25, P4442, DOI 10.1128/MCB.25.11.4442-4454.2005; Greider Carol W., 2004, Cell, VS116, pS83, DOI 10.1016/S0092-8674(04)00053-4; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Harrington L, 2003, CANCER LETT, V194, P139, DOI 10.1016/S0304-3835(02)00701-2; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Lai CK, 2003, MOL CELL, V11, P1673, DOI 10.1016/S1097-2765(03)00232-6; Mason DX, 2003, MOL CELL BIOL, V23, P5606, DOI 10.1128/MCB.23.16.5606-5613.2003; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Moore MJ, 2000, METHOD ENZYMOL, V317, P109; O'Connor CM, 2005, J BIOL CHEM, V280, P17533, DOI 10.1074/jbc.M501211200; Prathapam R, 2005, NAT STRUCT MOL BIOL, V12, P252, DOI 10.1038/nsmb900; Richards RJ, 2006, RNA, V12, P1475, DOI 10.1261/rna.112306; Seto AG, 1999, NATURE, V401, P177, DOI 10.1038/43694; Sperger JM, 2001, BIOCHEMISTRY-US, V40, P7005, DOI 10.1021/bi0103359; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Talkington MWT, 2005, NATURE, V438, P628, DOI 10.1038/nature04261; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Witkin KL, 2004, GENE DEV, V18, P1107, DOI 10.1101/gad.1201704; Wong JMY, 2003, LANCET, V362, P983, DOI 10.1016/S0140-6736(03)14369-3; Ye AJ, 2002, INT J SYST EVOL MICR, V52, P2297, DOI [10.1099/ijs.0.02183-0, 10.1099/00207713-52-6-2297]; Zhuang XW, 2005, ANNU REV BIOPH BIOM, V34, P399, DOI 10.1146/annurev.biophys.34.040204.144641	26	147	150	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2007	446	7134					458	461		10.1038/nature05600	http://dx.doi.org/10.1038/nature05600			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17322903	Green Accepted			2022-12-01	WOS:000245079500044
J	[Anonymous]				[Anonymous]			Tuberculosis and HIV in India	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		INDIA TB, 2006, 2006 RNTCP STATUS RE; Khatri GR, 2002, NEW ENGL J MED, V347, P1420, DOI 10.1056/NEJMsa020098; Reid A, 2006, LANCET INFECT DIS, V6, P483, DOI 10.1016/S1473-3099(06)70549-7; Williams BG, 2005, P NATL ACAD SCI USA, V102, P9619, DOI 10.1073/pnas.0501615102; World Health Organization, 2006, WHOHTMTB2006362	5	10	10	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2007	356	12					1198	1199						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148UP	17377155				2022-12-01	WOS:000245101900002
J	Lee, HK; Lund, JM; Ramanathan, B; Mizushima, N; Iwasaki, A				Lee, Heung Kyu; Lund, Jennifer M.; Ramanathan, Balaji; Mizushima, Noboru; Iwasaki, Akiko			Autophagy-dependent viral recognition by plasmacytoid dendritic cells	SCIENCE			English	Article							SINGLE-STRANDED RNA; RIG-I; ANTIVIRAL RESPONSES; DEGRADATION; 3-KINASE	Plasmacytoid dendritic cells (pDCs) detect viruses in the acidified endosomes by means of Toll-like receptors (TLRs). Yet, pDC responses to certain single-stranded RNA (ssRNA) viruses occur only after live viral infection. We present evidence here that the recognition of such viruses by TLR7 requires transport of cytosolic viral replication intermediates into the lysosome by the process of autophagy. In addition, autophagy was found to be required for the production of interferon-alpha by pDCs. These results support a key role for autophagy in mediating ssRNA virus detection and interferon-alpha secretion by pDCs and suggest that cytosolic replication intermediates of viruses serve as pathogen signatures recognized by TLR7.	Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; Tokyo Med & Dent Univ, Dept Cell Physiol, Grad Sch, Tokyo, Japan; Tokyo Med & Dent Univ, Dept Cell Physiol, Fac Med, Tokyo, Japan; Japan Sci & Technol Agcy, Solut Oriented Res Sci & Technol, Kawaguchi, Japan	Yale University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST)	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06510 USA.	iwasaki@yale.edu	Mizushima, Noboru/C-3635-2009; Iwasaki, Akiko/Z-1591-2019; Lee, Heung Kyu/C-2073-2011	Mizushima, Noboru/0000-0002-6258-6444; Iwasaki, Akiko/0000-0002-7824-9856; Lee, Heung Kyu/0000-0002-3977-1510; Lund, Jennifer/0000-0003-3284-979X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054359, R01AI064705] Funding Source: NIH RePORTER; NIAID NIH HHS [AI054359, AI064705, AI07019] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Barchet W, 2002, J EXP MED, V195, P507, DOI 10.1084/jem.20011666; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Crozat K, 2004, P NATL ACAD SCI USA, V101, P6835, DOI 10.1073/pnas.0401347101; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Eloranta ML, 1999, SCAND J IMMUNOL, V49, P391; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hornung V, 2004, J IMMUNOL, V173, P5935, DOI 10.4049/jimmunol.173.10.5935; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Talloczy Z, 2006, AUTOPHAGY, V2, P24, DOI 10.4161/auto.2176; von Kobbe C, 2000, MOL CELL, V6, P1243, DOI 10.1016/S1097-2765(00)00120-9; Yasuda K, 2005, J IMMUNOL, V174, P6129, DOI 10.4049/jimmunol.174.10.6129	29	699	735	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2007	315	5817					1398	1401		10.1126/science.1136880	http://dx.doi.org/10.1126/science.1136880			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17272685				2022-12-01	WOS:000244752200030
J	Learmonth, ID; Case, CP				Learmonth, Ian D.; Case, C. Patrick			Metallic debris from orthopaedic implants	LANCET			English	Editorial Material							TOTAL HIP-REPLACEMENT; ARTHROPLASTY; COBALT		Univ Bristol, Dept Orthopaed Surg, Bristol BS2 8HW, Avon, England	University of Bristol	Learmonth, ID (corresponding author), Univ Bristol, Dept Orthopaed Surg, Bristol BS2 8HW, Avon, England.	Ian.Learmonth@bristol.ac.uk						Archibeck M J, 2001, Instr Course Lect, V50, P185; *CAN JOINT REPL RE, 2004, 2004 REP TOT HIP TOT, P30; Davies AP, 2005, J BONE JOINT SURG AM, V87A, P18, DOI 10.2106/JBJS.C.00949; GILLESPIE WJ, 1988, J BONE JOINT SURG BR, V70, P539, DOI 10.1302/0301-620X.70B4.3403594; Gillispie WJ, 1996, CLIN ORTHOP S, V329s, P290; Goldacre MJ, 2005, BRIT J CANCER, V92, P1298, DOI 10.1038/sj.bjc.6602511; Grubl A, 2006, J BONE JOINT SURG BR, V88B, P1003, DOI 10.1302/0301-620X.88B8; HARRIS WH, 1994, ACTA ORTHOP SCAND, V65, P113, DOI 10.3109/17453679408993734; Huk OL, 2004, J ARTHROPLASTY, V19, P84, DOI 10.1016/j.arth.2004.09.011; Korovessis P, 2006, J BONE JOINT SURG AM, V88A, P1183, DOI 10.2106/JBJS.D.02916; Ladon D, 2004, J ARTHROPLASTY, V19, P78, DOI 10.1016/j.arth.2004.09.010; Mahomed NN, 2003, J BONE JOINT SURG AM, V85A, P27, DOI 10.2106/00004623-200301000-00005; McGregor DB, 2000, EUR J CANCER, V36, P307, DOI 10.1016/S0959-8049(99)00312-3; *NAT I CLIN EXC, 2002, GUID US MET MET HIP; *UK DEP HLTH, 2006, STAT BIOL EFF WEAR D; VISURI T, 1991, ORTHOPEDICS, V14, P137; Visuri TI, 2006, P I MECH ENG H, V220, P399, DOI 10.1243/095441105X63282; Witzleb WC, 2006, ACTA ORTHOP, V77, P697, DOI 10.1080/17453670610012863	18	11	12	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 17	2007	369	9561					542	544		10.1016/S0140-6736(07)60251-7	http://dx.doi.org/10.1016/S0140-6736(07)60251-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	138MZ	17307087				2022-12-01	WOS:000244368000009
J	Lee, DM; Kiener, HP; Agarwal, SK; Noss, EH; Watts, GFM; Chisaka, O; Takeichi, M; Brenner, MB				Lee, David M.; Kiener, Hans P.; Agarwal, Sandeep K.; Noss, Erika H.; Watts, Gerald F. M.; Chisaka, Osamu; Takeichi, Masatoshi; Brenner, Michael B.			Cadherin-11 in synovial lining formation and pathology in arthritis	SCIENCE			English	Article							FIBROBLAST-LIKE SYNOVIOCYTES; RHEUMATOID-ARTHRITIS; JOINT DESTRUCTION; CELLS; DISEASE; ADHESION; ROLES; EPITHELIUM; ENZYME	The normal synovium forms a membrane at the edges of joints and provides lubrication and nutrients for the cartilage. In rheumatoid arthritis, the synovium is the site of inflammation, and it participates in an organized tissue response that damages cartilage and bone. We identified cadherin-11 as essential for the development of the synovium. Cadherin-11-deficient mice have a hypoplastic synovial lining, display a disorganized synovial reaction to inflammation, and are resistant to inflammatory arthritis. Cadherin-11 therapeutics prevent and reduce arthritis in mouse models. Thus, synovial cadherin-11 determines the behavior of synovial cells in their proinflammatory and destructive tissue response in inflammatory arthritis.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; Kyoto Univ, Dept Cell & Dev Biol, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan; RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Kyoto University; RIKEN	Brenner, MB (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, 1 Jimmy Fund Way, Boston, MA 02115 USA.	mbrenner@rics.bwh.harvard.edu	Takeichi, Masatoshi/G-5903-2012	Takeichi, Masatoshi/0000-0002-9931-3378; Watts, Gerald/0000-0003-2276-1524	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR002214, R01AR048114] Funding Source: NIH RePORTER; NIAMS NIH HHS [K08 AR2214, R01 AR48114] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ATHANASOU NA, 1991, ANN RHEUM DIS, V50, P311, DOI 10.1136/ard.50.5.311; Chen M, 2006, J EXP MED, V203, P837, DOI 10.1084/jem.20052371; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; HENDERSON B, 1985, SEMIN ARTHRITIS RHEU, V15, P1, DOI 10.1016/0049-0172(85)90007-1; HERMISTON ML, 1995, J CELL BIOL, V129, P489, DOI 10.1083/jcb.129.2.489; Higgins JMG, 1998, J CELL BIOL, V140, P197, DOI 10.1083/jcb.140.1.197; HOLLYWELL C, 1983, VIRCHOWS ARCH A, V400, P345, DOI 10.1007/BF00612195; Horikawa K, 1999, DEV BIOL, V215, P182, DOI 10.1006/dbio.1999.9463; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Ji H, 2002, J EXP MED, V196, P77, DOI 10.1084/jem.20020439; Kiener HP, 2006, AM J PATHOL, V168, P1486, DOI 10.2353/ajpath.2006.050999; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; KULKA JP, 1955, ARCH PATHOL, V59, P129; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; LEE DM, 2004, KELLEYS TXB RHEUMATO; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Matsumoto I, 2002, NAT IMMUNOL, V3, P360, DOI 10.1038/ni772; MEDOF ME, 1987, J EXP MED, V165, P848, DOI 10.1084/jem.165.3.848; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Pettit AR, 2001, AM J PATHOL, V159, P1689, DOI 10.1016/S0002-9440(10)63016-7; Redlich K, 2002, J CLIN INVEST, V110, P1419, DOI 10.1172/JCI200215582; SCHUMACHER HR, 1972, ARTHRITIS RHEUM-US, V15, P465, DOI 10.1002/art.1780150502; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Valencia X, 2004, J EXP MED, V200, P1673, DOI 10.1084/jem.20041545; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135	26	295	316	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2007	315	5814					1006	1010		10.1126/science.1137306	http://dx.doi.org/10.1126/science.1137306			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17255475				2022-12-01	WOS:000244229800048
J	Cordenonsi, M; Montagner, M; Adorno, M; Zacchigna, L; Martello, G; Mamidi, A; Soligo, S; Dupont, S; Piccolo, S				Cordenonsi, Michelangelo; Montagner, Marco; Adorno, Maddalena; Zacchigna, Luca; Martello, Graziano; Mamidi, Anant; Soligo, Sandra; Dupont, Sirio; Piccolo, Stefano			Integration of TGF-beta and Ras/MAPK signaling through p53 phosphorylation	SCIENCE			English	Article							MESODERM INDUCTION; REQUIRES FGF; TRANSDUCTION; ACTIVATION; KINASE	During development and tissue homeostasis, cells must integrate different signals. We investigated how cell behavior is controlled by the combined activity of transforming growth factor-beta (TGF-beta) and receptor tyrosine kinase (RTK) signaling, whose integration mechanism is unknown. We find that RTK/Ras/ MAPK (mitogen-activated protein kinase) activity induces p53 N-terminal phosphorylation, enabling the interaction of p53 with the TGF-beta-activated Smads. This mechanism confines mesoderm specification in Xenopus embryos and promotes TGF-beta cytostasis in human cells. These data indicate a mechanism to allow extracellular cues to specify the TGF-beta gene-expression program.	Univ Padua, Dept Med Biotechnol, Sect Histol & Embryol, Padua, Italy	University of Padua	Piccolo, S (corresponding author), Univ Padua, Dept Med Biotechnol, Sect Histol & Embryol, Padua, Italy.	piccolo@civ.bio.unipd.it	Cordenonsi, Michelangelo/K-7692-2016; Dupont, Sirio/AAP-8133-2021; Montagner, Marco/AAY-3236-2020	Cordenonsi, Michelangelo/0000-0002-8253-5724; Montagner, Marco/0000-0003-3080-2138; Mamidi, Anant/0000-0001-7953-7991; PICCOLO, STEFANO/0000-0002-2037-0004; Dupont, Sirio/0000-0002-6869-1966; Martello, Graziano/0000-0001-5520-085X	Telethon [GGP04030] Funding Source: Medline	Telethon(Fondazione Telethon)		Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; CORNELL RA, 1994, DEVELOPMENT, V120, P453; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Hu PPC, 1999, J BIOL CHEM, V274, P35381, DOI 10.1074/jbc.274.50.35381; Knippschild U, 1997, ONCOGENE, V15, P1727, DOI 10.1038/sj.onc.1201541; LABONNE C, 1994, DEVELOPMENT, V120, P463; LABONNE C, 1995, DEVELOPMENT, V121, P1475; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; MITSUDOMI T, 1992, ONCOGENE, V7, P171; Roper E, 2001, EMBO REP, V2, P145, DOI 10.1093/embo-reports/kve020; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	15	170	182	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2007	315	5813					840	843		10.1126/science.1135961	http://dx.doi.org/10.1126/science.1135961			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17234915				2022-12-01	WOS:000244069000068
J	Chu, I; Sun, J; Arnaout, A; Kahn, H; Hanna, W; Narod, S; Sun, P; Tan, CK; Hengst, L; Slingerland, J				Chu, Isabel; Sun, Jun; Arnaout, Angel; Kahn, Harriette; Hanna, Wedad; Narod, Steven; Sun, Ping; Tan, Cheng-Keat; Hengst, Ludger; Slingerland, Joyce			p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2	CELL			English	Article							GROWTH-FACTOR RECEPTOR; HUMAN-BREAST-CANCER; MEDIATED G(1) ARREST; CELL-CYCLE; DEPENDENT-KINASE; TYROSINE KINASE; C-SRC; ESTROGEN-RECEPTOR; CDK INHIBITOR; FACTOR-BETA	The kinase inhibitor p27(Kip1) regulates the G, cell cycle phase. Here, we present data indicating that the oncogenic kinase Src regulates p27 stability through phosphorylation of p27 at tyrosine 74 and tyrosine 88. Src inhibitors increase cellular p27 stability, and Src overexpression accelerates p27 proteolysis. Src-phosphorylated p27 is shown to inhibit cyclin E-Cdk2 poorly in vitro, and Src transfection reduces p27-cyclin E-Cdk2 complexes. Our data indicate that phosphorylation by Src impairs the Cdk2 inhibitory action of p27 and reduces its steady-state binding to cyclin E-Cdk2 to facilitate cyclin E-Cdk2-dependent p27 proteolysis. Furthermore, we find that Src-activated breast cancer lines show reduced p27 and observe a correlation between Src activation and reduced nuclear p27 in 482 primary human breast cancers. Importantly, we report that in tamoxifen-resistant breast cancer cell lines, Src inhibition can increase p27 levels and restore tamoxifen sensitivity. These data provide a new rationale for Src inhibitors in cancer therapy.	Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Braman Family Breast Canc Inst, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; Univ Toronto, Dept Pathol & Lab Med, Toronto, ON M4N 3M5, Canada; Univ Innsbruck, Bioctr, Div Med Biochem, A-6020 Innsbruck, Austria	University of Miami; University of Miami; University of Toronto; University of Innsbruck	Slingerland, J (corresponding author), Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Braman Family Breast Canc Inst, Miami, FL 33136 USA.	jslingerland@med.miami.edu	Narod, Steven A/AAA-6112-2022	Hengst, Ludger/0000-0002-0605-0223	NCI NIH HHS [R01 CA105118, R01 CA123415, R01-CA105118] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA105118, R01CA123415] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agrawal D, 1996, MOL CELL BIOL, V16, P4327; Alkarain A, 2004, J MAMMARY GLAND BIOL, V9, P67, DOI 10.1023/B:JOMG.0000023589.00994.5e; Belsches-Jablonski AP, 2001, ONCOGENE, V20, P1465, DOI 10.1038/sj.onc.1204205; BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Biscardi JS, 2000, BREAST CANCER RES, V2, P203, DOI 10.1186/bcr55; Cariou S, 2000, P NATL ACAD SCI USA, V97, P9042, DOI 10.1073/pnas.160016897; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Catzavelos C, 1997, NAT MED, V3, P227, DOI 10.1038/nm0297-227; Chen T, 2006, ANTI-CANCER DRUG, V17, P123, DOI 10.1097/00001813-200602000-00002; Chu I, 2005, CANCER RES, V65, P18; Ciarallo S, 2002, MOL CELL BIOL, V22, P2993, DOI 10.1128/MCB.22.9.2993-3002.2002; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Donovan JCH, 2001, J BIOL CHEM, V276, P40888, DOI 10.1074/jbc.M106448200; Egan C, 1999, ONCOGENE, V18, P1227, DOI 10.1038/sj.onc.1202233; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Florenes VA, 1996, ONCOGENE, V13, P2447; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Gonzalez L, 2006, J BIOL CHEM, V281, P20851, DOI 10.1074/jbc.M601570200; Gopfert U, 2003, HUM MOL GENET, V12, P1767, DOI 10.1093/hmg/ddg177; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Hara T, 2001, J BIOL CHEM, V276, P48937, DOI 10.1074/jbc.M107274200; Hara T, 2005, MOL CELL BIOL, V25, P9292, DOI 10.1128/MCB.25.21.9292-9303.2005; HENGST L, 1994, P NATL ACAD SCI USA, V91, P5291, DOI 10.1073/pnas.91.12.5291; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Hiscox S, 2006, BREAST CANCER RES TR, V97, P263, DOI 10.1007/s10549-005-9120-9; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Ishida N, 2002, J BIOL CHEM, V277, P14355, DOI 10.1074/jbc.C100762200; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Johnson D, 1998, ONCOGENE, V16, P2017, DOI 10.1038/sj.onc.1201727; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kardinal C, 2006, BLOOD, V107, P1133, DOI 10.1182/blood-2005-05-1771; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; KOFF A, 1993, SCIENCE, V260, P536, DOI 10.1126/science.8475385; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lane HA, 2000, MOL CELL BIOL, V20, P3210, DOI 10.1128/MCB.20.9.3210-3223.2000; Lenferink AEG, 2000, P NATL ACAD SCI USA, V97, P9609, DOI 10.1073/pnas.160564197; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; NICHOLSON S, 1990, J STEROID BIOCHEM, V37, P811, DOI 10.1016/0960-0760(90)90424-J; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; PIETRAS RJ, 1995, ONCOGENE, V10, P2435; Ple PA, 2004, J MED CHEM, V47, P871, DOI 10.1021/jm030317k; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Radeva G, 1997, J BIOL CHEM, V272, P13937, DOI 10.1074/jbc.272.21.13937; Riley D, 2001, ONCOGENE, V20, P5941, DOI 10.1038/sj.onc.1204826; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SLINGERLAND JM, 1994, MOL CELL BIOL, V14, P3683, DOI 10.1128/MCB.14.6.3683; Song RX, 2004, P NATL ACAD SCI USA, V101, P2076, DOI 10.1073/pnas.0308334100; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Tsutsui S, 2002, BREAST CANCER RES TR, V71, P67, DOI 10.1023/A:1013397232011; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Yang HY, 2000, J BIOL CHEM, V275, P24735, DOI 10.1074/jbc.C000147200	64	285	300	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 26	2007	128	2					281	294		10.1016/j.cell.2006.11.049	http://dx.doi.org/10.1016/j.cell.2006.11.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254967	Green Accepted, Bronze			2022-12-01	WOS:000244420500014
J	Tothova, Z; Kollipara, R; Huntly, BJ; Lee, BH; Castrillon, DH; Cullen, DE; McDowell, EP; Lazo-Kallanian, S; Williams, IR; Sears, C; Armstrong, SA; Passegue, E; DePinho, RA; Gilliland, DG				Tothova, Zuzana; Kollipara, Ramya; Huntly, Brian J.; Lee, Benjamin H.; Castrillon, Diego H.; Cullen, Dana E.; McDowell, Elizabeth P.; Lazo-Kallanian, Suzan; Williams, Ifor R.; Sears, Christopher; Armstrong, Scott A.; Passegue, Emmanuelle; DePinho, Ronald A.; Gilliland, D. Gary			FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress	CELL			English	Article							FORKHEAD TRANSCRIPTION FACTOR; LIFE-SPAN; PHOSPHOINOSITIDE 3-KINASE; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; PROLIFERATION; ACTIVATION; PROGENITOR; PROTEIN; KINASE	To understand the role of FoxO family members in hematopoiesis, we conditionally deleted FoxO1, FoxO3, and FoxO4 in the adult hematopoietic system. FoxO-deficient mice exhibited myeloid lineage expansion, lymphoid developmental abnormalities, and a marked decrease of the lineage-negative Sca-1(+), c-Kit(+) (LSK) compartment that contains the short- and long-term hematopoietic stem cell (HSC) populations. FoxO-deficient bone marrow had defective long-term repopulating activity that correlated with increased cell cycling and apoptosis of HSC. Notably, there was a marked context-dependent increase in reactive oxygen species (ROS) in FoxO-deficient HSC compared with wild-type HSC that correlated with changes in expression of genes that regulate ROS. Furthermore, in vivo treatment with the antioxidative agent N-acetyl-L-cysteine resulted in reversion of the FoxO-deficient HSC phenotype. Thus, FoxO proteins play essential roles in the response to physiologic oxidative stress and thereby mediate quiescence and enhanced survival in the HSC compartment, a function that is required for its long-term regenerative potential.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Hematol, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Genet, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Mit Div Hlth Sci & Technol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Appl Canc Sci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Robert A & Renee E Belfer Fdn Inst Innovat Canc S, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Univ Cambridge, Med Res Inst, Dept Haematol, Cambridge CB2 2XY, England; Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; Harvard Univ, Sch Med, Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Univ Calif San Francisco, Dev & Stem Cell Biol Program, San Francisco, CA 94143 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Cambridge; Emory University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of California System; University of California San Francisco	Gilliland, DG (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Hematol, Boston, MA 02115 USA.	ggilliland@rics.bwh.harvard.edu	Williams, Ifor R/D-3648-2011; huntly, brian JP/E-6725-2014	Williams, Ifor R/0000-0002-8810-2911; huntly, brian JP/0000-0003-0312-161X; Passegue, Emmanuelle/0000-0002-3516-297X; DePinho, Ronald/0000-0002-5625-577X	Medical Research Council [G116/187] Funding Source: Medline; MRC [G116/187] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Attar EC, 2004, LEUKEMIA, V18, P1760, DOI 10.1038/sj.leu.2403515; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Borkhardt A, 1997, ONCOGENE, V14, P195, DOI 10.1038/sj.onc.1200814; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Gu TL, 2004, BLOOD, V103, P4622, DOI 10.1182/blood-2003-03-0820; Hillion J, 1997, BLOOD, V90, P3714, DOI 10.1182/blood.V90.9.3714; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Komatsu N, 2003, J BIOL CHEM, V278, P6411, DOI 10.1074/jbc.M211562200; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Martinez-Gac L, 2004, MOL CELL BIOL, V24, P2181, DOI 10.1128/MCB.24.5.2181-2189.2004; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Moore KA, 1997, BLOOD, V89, P4337, DOI 10.1182/blood.V89.12.4337; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; PARRY P, 1994, GENE CHROMOSOME CANC, V11, P79, DOI 10.1002/gcc.2870110203; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Scheijen B, 2004, ONCOGENE, V23, P3338, DOI 10.1038/sj.onc.1207456; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747	43	1180	1229	3	97	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2007	128	2					325	339		10.1016/j.cell.2007.01.003	http://dx.doi.org/10.1016/j.cell.2007.01.003			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254970	Bronze			2022-12-01	WOS:000244420500017
J	Sergina, NV; Rausch, M; Wang, DH; Blair, J; Hann, B; Shokat, KM; Moasser, MM				Sergina, Natalia V.; Rausch, Megan; Wang, Donghui; Blair, Jimmy; Hann, Byron; Shokat, Kevan M.; Moasser, Mark M.			Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3	NATURE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR EGFR; BREAST-CANCER CELLS; ZD1839 IRESSA; TUMOR-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; NEU ONCOGENE; IN-VIVO; PROTEIN; GEFITINIB	Oncogenic tyrosine kinases have proved to be promising targets for the development of highly effective anticancer drugs. However, tyrosine kinase inhibitors (TKIs) against the human epidermal growth factor receptor ( HER) family show only limited activity against HER2-driven breast cancers, despite effective inhibition of epidermal growth factor receptor (EGFR) and HER2 in vivo(1-8). The reasons for this are unclear. Signalling in trans is a key feature of this multimember family and the critically important phosphatidylinositol-3- OH kinase ( PI( 3) K)/Akt pathway is driven predominantly through transphosphorylation of the kinase-inactive HER3 (refs 9, 10). Here we show that HER3 and consequently PI( 3) K/Akt signalling evade inhibition by current HER-family TKIs in vitro and in tumours in vivo. This is due to a compensatory shift in the HER3 phosphorylation - dephosphorylation equilibrium, driven by increased membrane HER3 expression driving the phosphorylation reaction and by reduced HER3 phosphatase activity impeding the dephosphorylation reaction. These compensatory changes are driven by Akt-mediated negative-feedback signalling. Although HER3 is not a direct target of TKIs, HER3 substrate resistance undermines their efficacy and has thus far gone undetected. The experimental abrogation of HER3 resistance by small interfering RNA knockdown restores potent pro-apoptotic activity to otherwise cytostatic HER TKIs, re-affirming the oncogene-addicted nature of HER2-driven tumours and the therapeutic promise of this oncoprotein target. However, because HER3 signalling is buffered against an incomplete inhibition of HER2 kinase, much more potent TKIs or combination strategies are required to silence oncogenic HER2 signalling effectively. The biologic marker with which to assess the efficacy of HER TKIs should be the transphosphorylation of HER3 rather than autophosphorylation.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Moasser, MM (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	mmoasser@medicine.ucsf.edu		Blair, Jimmy/0000-0003-0303-5981	NCI NIH HHS [R01 CA122216, R01 CA122216-01A1] Funding Source: Medline; NIAID NIH HHS [R01 AI044009] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA122216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044009] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akita RW, 2003, SEMIN ONCOL, V30, P15, DOI 10.1016/S0093-7754(03)00187-8; Anderson NG, 2001, INT J CANCER, V94, P774, DOI 10.1002/ijc.1557; BACUS SS, 2003, P AM SOC CLIN ONCOL, V22; Baselga J, 2005, J CLIN ONCOL, V23, P5323, DOI 10.1200/JCO.2005.08.326; Bianco R, 2003, ONCOGENE, V22, P2812, DOI 10.1038/sj.onc.1206388; BLACKWELL K, 2004, P AM SOC CLIN ONCOL, V23; BURRIS HA, 2003, BREAST CANC RES T S1, V82; Campiglio M, 2004, J CELL PHYSIOL, V198, P259, DOI 10.1002/jcp.10411; CAMPOS SM, 2004, P AM SOC CLIN ONCOL, V23; DEES EC, 2004, P AM SOC CLIN ONCOL, V23; Fry DW, 1998, P NATL ACAD SCI USA, V95, P12022, DOI 10.1073/pnas.95.20.12022; Haas-Kogan DA, 2005, JNCI-J NATL CANCER I, V97, P880, DOI 10.1093/jnci/dji161; Huron DR, 2003, CLIN CANCER RES, V9, P1267; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; KIM HH, 1994, J BIOL CHEM, V269, P24747; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McKillop D, 2005, MOL CANCER THER, V4, P641, DOI 10.1158/1535-7163.MCT-04-0329; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Moasser MM, 2001, CANCER RES, V61, P7184; Moody SE, 2002, CANCER CELL, V2, P451, DOI 10.1016/S1535-6108(02)00212-X; Moulder SL, 2001, CANCER RES, V61, P8887; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Offterdinger M, 2002, J CELL BIOL, V157, P929, DOI 10.1083/jcb.200109033; She QB, 2003, CLIN CANCER RES, V9, P4340; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Spector NL, 2005, J CLIN ONCOL, V23, P2502, DOI 10.1200/JCO.2005.12.157; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Tsou HR, 2001, J MED CHEM, V44, P2719, DOI 10.1021/jm0005555; WINER E, 2002, BREAST CANC RES T S1, V76	30	749	808	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2007	445	7126					437	441		10.1038/nature05474	http://dx.doi.org/10.1038/nature05474			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	128WD	17206155	Green Accepted			2022-12-01	WOS:000243689500042
J	Vukusic, P; Hallam, B; Noyes, J				Vukusic, Pete; Hallam, Benny; Noyes, Joe			Brilliant whiteness in ultrathin beetle scales	SCIENCE			English	Article							SCATTERING		Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England; Imerys Minerals Ltd, Par PL24 2SQ, Cornwall, England	University of Exeter	Vukusic, P (corresponding author), Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England.	P.Vukusic@ex.ac.uk			BBSRC [BB/E000177/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [JF16983, BB/E000177/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		FITZWATER S, 1985, J COATING TECHNOL, V57, P39; GANZ E, 1976, APPL OPTICS, V15, P2039, DOI 10.1364/AO.15.002039; Kinoshita S., 2005, STRUCTURAL COLORS BI; McNeil LE, 2000, ACTA MATER, V48, P4571, DOI 10.1016/S1359-6454(00)00243-3; Srinivasarao M, 1999, CHEM REV, V99, P1935, DOI 10.1021/cr970080y; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941	6	192	196	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 19	2007	315	5810					348	348		10.1126/science.1134666	http://dx.doi.org/10.1126/science.1134666			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126SI	17234940				2022-12-01	WOS:000243535400031
J	Chen, ZQ; Zhang, GC; Gong, XD; Lin, C; Gao, X; Liang, GJ; Yue, XL; Chen, XS; Cohen, MS				Chen, Zhi-Qiang; Zhang, Guo-Cheng; Gong, Xiang-Dong; Lin, Charles; Gao, Xing; Liang, Guo-Jun; Yue, Xiao-Li; Chen, Xiang-Sheng; Cohen, Myron S.			Syphilis in China: results of a national surveillance programme	LANCET			English	Article							SEXUALLY-TRANSMITTED-DISEASES; HIGH PREVALENCE; HEALTH-CARE; SEX WORKERS; HIV; SPREAD; INFECTION; TRANSMISSION; TRENDS; MEN	Background After a massive syphilis epidemic in the first half of the 20th century, China was able to eliminate this infection for 20 years (1960-80). However, substantial changes in Chinese society have been followed by a resurgent epidemic of sexually transmitted diseases. Sporadic reports have provided clues to the magnitude of the spread of syphilis, but a national surveillance effort is needed to provide data for planning and intervention. Methods We collected and assessed case report data from China's national sexually transmitted disease surveillance system and sentinel site network. Findings In 1993, the reported total rate of cases of syphilis in China was 0.2 cases per 100000, whereas primary and secondary syphilis alone represented 5.7 cases per 100000 persons in 2005. The rate of congenital syphilis increased greatly with an average yearly rise of 71.9%, from 0.01 cases per 100000 livebirths in 1991 to 19.68 cases per 100000 livebirths in 2005. Interpretation The results suggest that a range of unique biological and social forces are driving the spread of syphilis in China. A national campaign for detection and treatment of syphilis, and a credible prevention strategy, are urgently needed.	Chinese Acad Med Sci, Natl Ctr STD Control, Nanjing 210042, Peoples R China; Peking Union Med Coll Inst, Nanjing 210042, Peoples R China; Univ Calif San Francisco, Sch Med, San Francisco, CA USA; Univ N Carolina, Ctr Infect Dis, Chapel Hill, NC USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill	Chen, XS (corresponding author), Chinese Acad Med Sci, Natl Ctr STD Control, 12 Jiangwangmiao St, Nanjing 210042, Peoples R China.	chenxs@vip.163.com		Lin, Charles/0000-0002-5347-4811				Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P269; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P108; Blumenthal D, 2005, NEW ENGL J MED, V353, P1165, DOI 10.1056/NEJMhpr051133; Borisenko KK, 1999, INT J STD AIDS, V10, P665, DOI 10.1258/0956462991913240; Brown AE, 2004, SEX TRANSM INFECT, V80, P159, DOI 10.1136/sti.2004.009571; Buchacz K, 2004, AIDS, V18, P2075, DOI 10.1097/00002030-200410210-00012; Chang ZQ, 2004, HDB SEXUALLY TRANSMI; Chen J, 2000, EXP THERM FLUID SCI, V21, P206, DOI 10.1016/S0894-1777(00)00004-2; Chen XS, 2000, SEX TRANSM DIS, V27, P138, DOI 10.1097/00007435-200003000-00003; CHEN YL, 2001, CHIN J STD AIDS PREV, V8, P237; Choi KH, 1999, INT J STD AIDS, V10, P309, DOI 10.1258/0956462991914177; Cohen MS, 2000, SEX TRANSM DIS, V27, P143, DOI 10.1097/00007435-200003000-00004; Cohen MS, 1996, J INFECT DIS, V174, pS223, DOI 10.1093/infdis/174.Supplement_2.S223; COHEN MS, 1984, CHINESE HOSP SOCIALI; Ding YP, 2005, JAIDS-J ACQ IMM DEF, V38, P314; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Gil VE, 1996, SOC SCI MED, V42, P141, DOI 10.1016/0277-9536(95)00064-X; Golden MR, 2003, JAMA-J AM MED ASSOC, V290, P1510, DOI 10.1001/jama.290.11.1510; GONG XD, 2001, CHIN J SEX TRANSM IN, V1, P1; Grassly NC, 2005, NATURE, V433, P417, DOI 10.1038/nature03072; Hershatter Gail, 1997, DANGEROUS PLEASURES; Hesketh T, 2005, INT J STD AIDS, V16, P262, DOI 10.1258/0956462053420257; Ho D, 2005, NATURE, V435, P421, DOI 10.1038/435421a; Hopkins S, 2001, SEX TRANSM INFECT, V77, P316, DOI 10.1136/sti.77.5.316; HORN J, 1974, AWAY ALL PESTS ENGLI; HU CK, 1964, BEIJ SCI C, P167; Hu CKYG, 1959, CHINESE J DERMATOL, V7, P290; Jiang J, 2006, SEX TRANSM DIS, V33, P118, DOI 10.1097/01.olq.0000199763.14766.2b; Jing F, 2004, HEALTH POLICY PLANN, V19, pI40, DOI 10.1093/heapol/czh044; Lim MK, 2004, HEALTH AFFAIR, V23, P222, DOI 10.1377/hlthaff.23.6.222; Lin CC, 2006, SEX TRANSM DIS, V33, P726, DOI 10.1097/01.olq.0000222703.12018.58; Lin Z, 2001, CHIN J STD AIDS PREV, V7, P273; LIU M, 1958, CHINESE J DERMATOL, V6, P76; Mwapasa V, 2006, AIDS, V20, P1869, DOI 10.1097/01.aids.0000244206.41500.27; *NAT BUR STAT CHIN, NAT YEARL STAT DAT; Parish WL, 2003, JAMA-J AM MED ASSOC, V289, P1265, DOI 10.1001/jama.289.10.1265; Peeling RW, 2004, LANCET, V364, P1561, DOI 10.1016/S0140-6736(04)17327-3; Reynolds SJ, 2006, SEX TRANSM INFECT, V82, P121, DOI 10.1136/sti.2005.015040; *S BTS MOH, 1996, GB159741995 SBTSMOH; SIDEL VW, 1972, NEW ENGL J MED, V286, P1292, DOI 10.1056/NEJM197206152862404; Tucker JD, 2005, AIDS, V19, P539, DOI 10.1097/01.aids.0000163929.84154.87; van den Hoek A, 2001, AIDS, V15, P753, DOI 10.1097/00002030-200104130-00011; WANG J, 1923, CHUNG HUA I HSUEH TS, V9, P17; World Health Organisation (WHO), 2004, EXP 100 COND US PROG; Yu AL, 1999, CHIN J AIDS STD, V6, P33; Zhang HJ, 2002, CHIN J FAMILY PLAN, V5, P273; Zhang K, 1999, AIDS CARE, V11, P581, DOI 10.1080/09540129947730; Zhao RL, 2003, CHIN J AIDS STD S, P98	48	242	287	0	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 13	2007	369	9556					132	138		10.1016/S0140-6736(07)60074-9	http://dx.doi.org/10.1016/S0140-6736(07)60074-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	126TK	17223476	Green Published, Bronze			2022-12-01	WOS:000243538200032
J	Armakolas, A; Klar, AJS				Armakolas, Athanasios; Klar, Amar J. S.			Left-right dynein motor implicated in selective chromatid segregation in mouse cells	SCIENCE			English	Article							MOUSE-CHROMOSOME-7 DNA STRANDS; LEFT-RIGHT ASYMMETRY	During cell division, copies of mouse chromosome 7 are segregated selectively or randomly to daughter cells depending on the cell type. The mechanism for differential segregation is unknown. Because mouse left-right dynein (LRD) gene mutations result in randomization of visceral organs' laterality, we hypothesized that LRD may also function in selective chromatid segregation. Indeed, upon knock-down by RNA interference methods, LRD depletion disrupts biased segregation. LRD messenger RNA presence or absence correlates with the observed segregation patterns. This work supports the claim that LRD functions in a mechanism for selective chromatid segregation.	NCI, Gene Regulat & Chromosome Biol Lab, Ctr Canc Res, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Klar, AJS (corresponding author), NCI, Gene Regulat & Chromosome Biol Lab, Ctr Canc Res, POB B, Frederick, MD 21702 USA.	klar@ncifcrf.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010386, Z01BC010386] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Armakolas A, 2006, SCIENCE, V311, P1146, DOI 10.1126/science.1120519; Haber JE, 2006, SCIENCE, V313, DOI 10.1126/science.1127836; Hummel K. P., 1959, Journal of Heredity, V50, P9; Klar AJS, 2004, GENETICS, V167, P1833, DOI 10.1534/genetics.104.028217; KLAR AJS, 1994, TRENDS GENET, V10, P392, DOI 10.1016/0168-9525(94)90055-8; Klar AJS, 2006, SCIENCE, V313, DOI 10.1126/science.1128552; Liu PT, 2002, NAT GENET, V30, P66, DOI 10.1038/ng788; MESELSON M, 1958, P NATL ACAD SCI USA, V44, P671, DOI 10.1073/pnas.44.7.671; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Tabin C, 2005, J MOL HISTOL, V36, P317, DOI 10.1007/s10735-005-9000-y; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0	11	60	60	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2007	315	5808					100	101		10.1126/science.1129429	http://dx.doi.org/10.1126/science.1129429			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17204651				2022-12-01	WOS:000243259100045
J	Smith, CE; Llorente, B; Symington, LS				Smith, Catherine E.; Llorente, Bertrand; Symington, Lorraine S.			Template switching during break-induced replication	NATURE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; MEIOTIC RECOMBINATION; CHROMOSOMAL TRANSLOCATIONS; GENE CONVERSION; REPAIR; DNA; MODEL; GAPS; DUPLICATION; DROSOPHILA	DNA double-strand breaks (DSBs) are potentially lethal lesions that arise spontaneously during normal cellular metabolism, as a consequence of environmental genotoxins or radiation, or during programmed recombination processes. Repair of DSBs by homologous recombination generally occurs by gene conversion resulting from transfer of information from an intact donor duplex to both ends of the break site of the broken chromosome(1). In mitotic cells, gene conversion is rarely associated with reciprocal exchange and thus limits loss of heterozygosity for markers downstream of the site of repair and restricts potentially deleterious chromosome rearrangements(2-5). DSBs that arise by replication fork collapse or by erosion of uncapped telomeres have only one free end and are thought to repair by strand invasion into a homologous duplex DNA followed by replication to the chromosome end (break-induced replication, BIR)(6). BIR from one of the two ends of a DSB would result in loss of heterozygosity, suggesting that BIR is suppressed when DSBs have two ends so that repair occurs by the more conservative gene conversion mechanism. Here we show that BIR can occur by several rounds of strand invasion, DNA synthesis and dissociation. We further show that chromosome rearrangements can occur during BIR if dissociation and reinvasion occur within dispersed repeated sequences. This dynamic process could function to promote gene conversion by capture of the displaced invading strand at two-ended DSBs to prevent BIR.	Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Univ Paris 06, Inst Pasteur, UFR 927, F-75724 Paris 15, France; Inst Pasteur, CNRS, URA 2171, Unite Genet Mol Levures, F-75724 Paris 15, France	Columbia University; Columbia University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Symington, LS (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol, 701 W 169th St, New York, NY 10032 USA.	lss5@columbia.edu	llorente, bertrand/M-3501-2016	Smith, Catherine/0000-0001-6779-8035; Llorente, Bertrand/0000-0002-6291-5797	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041784] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM041784, R01 GM041784-19, R01 GM041784-18] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; Aguilera A, 2001, TRENDS GENET, V17, P318, DOI 10.1016/S0168-9525(01)02309-5; Bartsch S, 2000, MOL CELL BIOL, V20, P1194, DOI 10.1128/MCB.20.4.1194-1205.2000; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Davis AP, 2004, MOL CELL BIOL, V24, P2344, DOI 10.1128/MCB.24.6.2344-2351.2004; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Ferguson DO, 1996, P NATL ACAD SCI USA, V93, P5419, DOI 10.1073/pnas.93.11.5419; JINKSROBERTSON S, 1986, GENETICS, V114, P731; Koszul R, 2004, EMBO J, V23, P234, DOI 10.1038/sj.emboj.7600024; Kraus E, 2001, P NATL ACAD SCI USA, V98, P8255, DOI 10.1073/pnas.151008198; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; Lemoine S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-467; Malkova A, 2005, MOL CELL BIOL, V25, P933, DOI 10.1128/MCB.25.3.933-944.2005; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; McEachern MJ, 2006, ANNU REV BIOCHEM, V75, P111, DOI 10.1146/annurev.biochem.74.082803.133234; McVey M, 2004, GENETICS, V167, P699, DOI 10.1534/genetics.103.025411; Merker JD, 2003, GENETICS, V165, P47; Morrow DM, 1997, GENETICS, V147, P371; NASSIF N, 1994, MOL CELL BIOL, V14, P1613, DOI 10.1128/MCB.14.3.1613; Nickoloff JA, 1999, GENETICS, V153, P665; RAY A, 1989, P NATL ACAD SCI USA, V86, P6225, DOI 10.1073/pnas.86.16.6225; Schmidt KH, 2006, MOL CELL BIOL, V26, P5406, DOI 10.1128/MCB.00161-06; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; Stark JM, 2003, MOL CELL BIOL, V23, P733, DOI 10.1128/MCB.23.2.733-743.2003; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; WHITE MA, 1994, CURR GENET, V26, P21, DOI 10.1007/BF00326300	26	254	257	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2007	447	7140					102	105		10.1038/nature05723	http://dx.doi.org/10.1038/nature05723			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17410126				2022-12-01	WOS:000246149300052
J	Odling-Smee, L				Odling-Smee, Lucy			Biofuels bandwagon hits a rut	NATURE			English	News Item																			0	12	12	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2007	446	7135					483	483		10.1038/446483a	http://dx.doi.org/10.1038/446483a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392760	Bronze			2022-12-01	WOS:000245242900021
J	Veiga-Fernandes, H; Coles, MC; Foster, KE; Patel, A; Williams, A; Natarajan, D; Barlow, A; Pachnis, V; Kioussis, D				Veiga-Fernandes, Henrique; Coles, Mark C.; Foster, Katie E.; Patel, Amisha; Williams, Adam; Natarajan, Dipa; Barlow, Amanda; Pachnis, Vassilis; Kioussis, Dimitris			Tyrosine kinase receptor RET is a key regulator of Peyer's Patch organogenesis	NATURE			English	Article							PERIPHERAL LYMPHOID ORGANS; BETA-DEFICIENT MICE; ABNORMAL-DEVELOPMENT; LYMPHOTOXIN-ALPHA; NERVOUS-SYSTEM; LACKING GDNF; T-CELLS; EXPRESSION; DEFECTS; TISSUES	Normal organogenesis requires co-ordinate development and interaction of multiple cell types, and is seemingly governed by tissue specific factors. Lymphoid organogenesis during embryonic life is dependent on molecules the temporal expression of which is tightly regulated. During this process, haematopoietic 'inducer' cells interact with stromal 'organizer' cells, giving rise to the lymphoid organ primordia(1). Here we show that the haematopoietic cells in the gut exhibit a random pattern of motility before aggregation into the primordia of Peyer's patches, a major component of the gut-associated lymphoid tissue. We further show that a CD45(+)CD4(-)CD3(-)Il7R alpha(-) c-Kit(+) CD11c(+) haematopoietic population expressing lymphotoxin has an important role in the formation of Peyer's patches. A subset of these cells expresses the receptor tyrosine kinase RET, which is essential for mammalian enteric nervous system formation(2). We demonstrate that RET signalling is also crucial for Peyer's patch formation. Functional genetic analysis revealed that Gfra3-deficiency results in impairment of Peyer's patch development, suggesting that the signalling axis RET/GFR alpha 3/ARTN is involved in this process. To support this hypothesis, we show that the RET ligand ARTN is a strong attractant of gut haematopoietic cells, inducing the formation of ectopic Peyer's patch-like structures. Our work strongly suggests that the RET signalling pathway, by regulating the development of both the nervous and lymphoid system in the gut, has a key role in the molecular mechanisms that orchestrate intestine organogenesis.	Natl Inst Med Res, MRC, Div Mol Immunol, London NW7 1AA, England; Natl Inst Med Res, MRC, Div Mol Neurobiol, London NW7 1AA, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research	Kioussis, D (corresponding author), Natl Inst Med Res, MRC, Div Mol Immunol, Ridgeway Mill Hill, London NW7 1AA, England.	dkiouss@nimr.mrc.ac.uk		Veiga-Fernandes, Henrique/0000-0001-6216-1836; Pachnis, Vassilis/0000-0001-9733-7686	Medical Research Council [G0601156, MC_U117537087, MC_U117512796] Funding Source: Medline; MRC [MC_U117537087, MC_U117512796, G0601156] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adachi S, 1997, INT IMMUNOL, V9, P507, DOI 10.1093/intimm/9.4.507; Adachi S, 1998, INT IMMUNOL, V10, P1, DOI 10.1093/intimm/10.1.1; Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; BANKS TA, 1995, J IMMUNOL, V155, P1685; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Coles MC, 2006, P NATL ACAD SCI USA, V103, P13457, DOI 10.1073/pnas.0604183103; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; de Graaff E, 2001, GENE DEV, V15, P2433, DOI 10.1101/gad.205001; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Hashi H, 2001, J IMMUNOL, V166, P3702, DOI 10.4049/jimmunol.166.6.3702; Honma Y, 2002, NEURON, V35, P267, DOI 10.1016/S0896-6273(02)00774-2; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kim D, 2000, J EXP MED, V192, P1467, DOI 10.1084/jem.192.10.1467; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Nishino J, 1999, NEURON, V23, P725, DOI 10.1016/S0896-6273(01)80031-3; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; Peixoto A, 2004, GENOME RES, V14, P1938, DOI 10.1101/gr.2890204; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Vargas-Leal V, 2005, J IMMUNOL, V175, P2301, DOI 10.4049/jimmunol.175.4.2301; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643	33	200	207	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2007	446	7135					547	551		10.1038/nature05597	http://dx.doi.org/10.1038/nature05597			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17322904				2022-12-01	WOS:000245242900051
J	Baran, PS; Maimone, TJ; Richter, JM				Baran, Phil S.; Maimone, Thomas J.; Richter, Jeremy M.			Total synthesis of marine natural products without using protecting groups	NATURE			English	Article							ENANTIOSELECTIVE SYNTHESIS; HAPALOSIPHON-FONTINALIS; CARBONYL-COMPOUNDS; ORGANIC-SYNTHESIS; ALKALOIDS; HAPALINDOLES; PALLADIUM; INDOLES; CYCLIZATION; DISCOVERY	The field of organic synthesis has made phenomenal advances in the past fifty years, yet chemists still struggle to design synthetic routes that will enable them to obtain sufficient quantities of complex molecules for biological and medical studies. Total synthesis is therefore increasingly focused on preparing natural products in the most efficient manner possible. Here we describe the preparative-scale, enantioselective, total syntheses of members of the hapalindole, fischerindole, welwitindolinone and ambiguine families, each constructed without the need for protecting groups - the use of such groups adds considerably to the cost and complexity of syntheses. As a consequence, molecules that have previously required twenty or more steps to synthesize racemically in milligram amounts can now be obtained as single enantiomers in significant quantities in ten steps or less. Through the extension of the general principles demonstrated here, it should be possible to access other complex molecular architectures without using protecting groups.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Baran, PS (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pbaran@scripps.edu						Baran PS, 2006, J AM CHEM SOC, V128, P14028, DOI 10.1021/ja0659673; Baran PS, 2005, J AM CHEM SOC, V127, P15394, DOI 10.1021/ja056171r; Baran PS, 2005, ANGEW CHEM INT EDIT, V44, P609, DOI 10.1002/anie.200462048; Baran PS, 2004, J AM CHEM SOC, V126, P7450, DOI 10.1021/ja047874w; BERTZ SH, 1982, J AM CHEM SOC, V104, P5801, DOI 10.1021/ja00385a049; BURNS B, 1988, TETRAHEDRON LETT, V29, P4329, DOI 10.1016/S0040-4039(00)80489-X; Butler MS, 2004, J NAT PROD, V67, P2141, DOI 10.1021/np040106y; Corey E.J., 1995, LOGIC CHEM SYNTHESIS; Dorwald F. Z., 2005, SIDE REACTIONS ORGAN; ESCHENMOSER A, 1988, ANGEW CHEM INT EDIT, V27, P5, DOI 10.1002/anie.198800051; EVANS DA, 2004, SYNTHESIS DESIGN OXI; Faber K, 1997, BIOTRANSFORMATIONS O, DOI 10.1007/978-3-319-61590-5; Green T. W., 1999, PROTECTIVE GROUPS OR, V3rd; HEATHCOCK CH, 1992, ANGEW CHEM INT EDIT, V31, P665, DOI 10.1002/anie.199206653; HENDRICKSON JB, 1975, J AM CHEM SOC, V97, P5784, DOI 10.1021/ja00853a023; HERRMANN WA, 1995, ANGEW CHEM INT EDIT, V34, P1844, DOI 10.1002/anie.199518441; Hoffmann RW, 2006, SYNTHESIS-STUTTGART, P3531, DOI 10.1055/s-2006-950311; HOVEYDA AH, 1993, CHEM REV, V93, P1307, DOI 10.1021/cr00020a002; Hudlicky T, 1996, CHEM REV, V96, P3, DOI 10.1021/cr950012g; Kocienski P. J, 2005, PROTECTING GROUPS; LAROCK RC, 1987, TETRAHEDRON LETT, V28, P5291, DOI 10.1016/S0040-4039(00)96710-8; MEHTA G, 1994, J CHEM SOC CHEM COMM, P2759, DOI 10.1039/c39940002759; MOORE RE, 1984, J AM CHEM SOC, V106, P6456, DOI 10.1021/ja00333a079; MOORE RE, 1987, J ORG CHEM, V52, P1036, DOI 10.1021/jo00382a012; MURATAKE H, 1990, TETRAHEDRON, V46, P6351, DOI 10.1016/S0040-4020(01)96007-7; Nicolaou, 2003, CLASSICS TOTAL SYNTH; Nicolaou KC, 2006, ANGEW CHEM INT EDIT, V45, P7134, DOI 10.1002/anie.200601872; Nicolaou K.C., 1996, CLASSICS TOTAL SYNTH; Nicolaou KC, 2005, ANGEW CHEM INT EDIT, V44, P4442, DOI 10.1002/anie.200500368; Nicolaou KC, 2004, P NATL ACAD SCI USA, V101, P11929, DOI 10.1073/pnas.0403799101; OIKAWA Y, 1977, J ORG CHEM, V42, P1213, DOI 10.1021/jo00427a024; Raveh A, 2007, J NAT PROD, V70, P196, DOI 10.1021/np060495r; Reisman SE, 2006, J AM CHEM SOC, V128, P1448, DOI 10.1021/ja057640s; Schkeryantz JM, 1999, J AM CHEM SOC, V121, P11964, DOI 10.1021/ja9925249; Scholz U, 2000, NAT PROD REP, V17, P349, DOI 10.1039/a902278c; SEEBACH D, 1990, ANGEW CHEM INT EDIT, V29, P1320, DOI 10.1002/anie.199013201; Service RF, 1999, SCIENCE, V285, P184, DOI 10.1126/science.285.5425.184; SHELLHAMER DF, 1991, J CHEM SOC PERK T 2, P401, DOI 10.1039/p29910000401; Sierra M. A., 2004, DEAD ENDS DETOURS DI; SMITKA TA, 1992, J ORG CHEM, V57, P857, DOI 10.1021/jo00029a014; STRATMANN K, 1994, J AM CHEM SOC, V116, P9935, DOI 10.1021/ja00101a015; TROST BM, 1991, SCIENCE, V254, P1471, DOI 10.1126/science.1962206; Turro N. J., 1991, MODERN MOL PHOTOCHEM; Vanderwal CD, 2003, J AM CHEM SOC, V125, P5393, DOI 10.1021/ja021472b; Wender P. A., 1993, ORGANIC SYNTHESIS TH, P27; Wender PA, 1996, CHEM REV, V96, P1, DOI 10.1021/cr9500803; Wilson RM, 2006, J ORG CHEM, V71, P8329, DOI 10.1021/jo0610053; Wohler F., 1828, ANN PHYS CHEM, V88, P253, DOI DOI 10.1002/ANDP.18280880206	48	377	391	6	255	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2007	446	7134					404	408		10.1038/nature05569	http://dx.doi.org/10.1038/nature05569			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	148MO	17377577				2022-12-01	WOS:000245079500032
J	Mayr, C; Hemann, MT; Bartel, DP				Mayr, Christine; Hemann, Michael T.; Bartel, David P.			Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation	SCIENCE			English	Article							MESSENGER-RNAS; PROTEIN GENE; C GENE; MICRORNAS; EXPRESSION; SEQUENCE; LIPOMAS; ADENOMA; FUSION; FAMILY	MicroRNAs ( miRNAs) are similar to 22-nucleotide RNAs that can pair to sites within messenger RNAs to specify posttranscriptional repression of these messages. Aberrant miRNA expression can contribute to tumorigenesis, but which of the many miRNA-target relationships are relevant to this process has been unclear. Here, we report that chromosomal translocations previously associated with human tumors disrupt repression of High Mobility Group A2 (Hmga2) by let-7 miRNA. This disrupted repression promotes anchorage-independent growth, a characteristic of oncogenic transformation. Thus, losing miRNA-directed repression of an oncogene provides a mechanism for tumorigenesis, and disrupting a single miRNA-target interaction can produce an observable phenotype in mammalian cells.	MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bartel, DP (corresponding author), MIT, Howard Hughes Med Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068348] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748] Funding Source: Medline; NIDDK NIH HHS [R01 DK068348-03, R01 DK068348-01, R01 DK068348, R01 DK068348-02] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baldassarre G, 2001, P NATL ACAD SCI USA, V98, P7970, DOI 10.1073/pnas.141224998; Battista S, 1999, CANCER RES, V59, P4793; Borrmann L, 2001, ONCOGENE, V20, P4537, DOI 10.1038/sj.onc.1204577; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fedele M, 1998, ONCOGENE, V17, P413, DOI 10.1038/sj.onc.1201952; Fedele M, 2002, ONCOGENE, V21, P3190, DOI 10.1038/sj.onc.1205428; Fedele M, 2001, CARCINOGENESIS, V22, P1583, DOI 10.1093/carcin/22.10.1583; Geurts JMW, 1997, CANCER RES, V57, P13; Geurts JMW, 1997, CANCER GENET CYTOGEN, V95, P198, DOI 10.1016/S0165-4608(96)00411-6; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Inoue N, 2006, BLOOD, V108, P4232, DOI 10.1182/blood-2006-05-025148; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Mine N, 2001, JPN J CANCER RES, V92, P135, DOI 10.1111/j.1349-7006.2001.tb01075.x; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Petit MMR, 1996, GENOMICS, V36, P118, DOI 10.1006/geno.1996.0432; Schoenmakers EFPM, 1999, CANCER RES, V59, P19; SCHOENMAKERS EFPM, 1995, NAT GENET, V10, P436, DOI 10.1038/ng0895-436; Sgarra R, 2004, FEBS LETT, V574, P1, DOI 10.1016/j.febslet.2004.08.013; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	27	897	971	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1576	1579		10.1126/science.1137999	http://dx.doi.org/10.1126/science.1137999			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17322030	Green Accepted			2022-12-01	WOS:000244934800053
J	Natsume, R; Eitoku, M; Akai, Y; Sano, N; Horikoshi, M; Senda, T				Natsume, Ryo; Eitoku, Masamitsu; Akai, Yusuke; Sano, Norihiko; Horikoshi, Masami; Senda, Toshiya			Structure and function of the histone chaperone CIA/ASF1 complexed with histones H3 and H4	NATURE			English	Article							CHROMATIN; ASF1; TRANSCRIPTION; DEPOSITION; IDENTIFICATION; REPLICATION; HISTORIES; GENES; RAD53	CIA(CCG1-interacting factor A)/ASF1, which is the most conserved histone chaperone among the eukaryotes, was genetically identified as a factor for an anti-silencing function (Asf1)(1) by yeast genetic screening. Shortly after that, the CIA-histone-H3-H4 complex was isolated from Drosophila as a histone chaperone CAF-1 stimulator(2). Human CIA-I/II (ASF1a/b) was identified as a histone chaperone that interacts with the bromodomain - an acetylated-histone-recognizing domain - of CCG1, in the general transcription initiation factor TFIID3-5. Intensive studies have revealed that CIA/ASF1 mediates nucleosome assembly by forming a complex with another histone chaperone in human cells 6 and yeast 7, and is involved in DNA replication 1,2, transcription 4,8 - 10, DNA repair 1,2,11,12 and silencing/ anti-silencing(1,2,8,13-15) in yeast. CIA/ASF1 was shown as a major storage chaperone for soluble histones in proliferating human cells(6,16). Despite all these biochemical and biological functional analyses, the structure - function relationship of the nucleosome assembly/disassembly activity of CIA/ASF1 has remained elusive. Here we report the crystal structure, at 2.7 angstrom resolution, of CIA-I in complex with histones H3 and H4. The structure shows the histone H3 - H4 dimer's mutually exclusive interactions with another histone H3 - H4 dimer and CIA-I. The carboxy-terminal beta-strand of histone H4 changes its partner from the beta-strand in histone H2A to that of CIA-I through large conformational change. In vitro functional analysis demonstrated that CIA-I has a histone H3 - H4 tetramer-disrupting activity. Mutants with weak histone H3-H4 dimer binding activity showed critical functional effects on cellular processes related to transcription. The histone H3-H4 tetramer-disrupting activity of CIA/ASF1 and the crystal structure of the CIA/ASF1-histone-H3-H4 dimer complex should give insights into mechanisms of both nucleosome assembly/disassembly and nucleosome semi-conservative replication.	Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Koto Ku, Tokyo 1350064, Japan; JST, ERATO, Horikoshi Gene Selector Project, Tsukuba, Ibaraki 3002635, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Dev Biol Lab, Bunkyo Ku, Tokyo 1130032, Japan; JBIC, JBIRC, Koto Ku, Tokyo 1350064, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); University of Tokyo	Senda, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Koto Ku, 2-42 Aomi, Tokyo 1350064, Japan.	horikosh@iam.u-tokyo.ac.jp; tsenda@jbirc.aist.go.jp		Senda, Toshiya/0000-0002-5153-928X				Abr?moff MD., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chimura T, 2002, P NATL ACAD SCI USA, V99, P9334, DOI 10.1073/pnas.142627899; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; DeLano W. L., 2006, PYMOL MOL GRAPHICS S; Emili A, 2001, MOL CELL, V7, P13, DOI 10.1016/S1097-2765(01)00150-2; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; English CM, 2005, BIOCHEMISTRY-US, V44, P13673, DOI 10.1021/bi051333h; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Hu FH, 2001, GENE DEV, V15, P1061, DOI 10.1101/gad.873201; Le SY, 1997, YEAST, V13, P1029, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1029::AID-YEA160>3.0.CO;2-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Matsubara K, 2007, GENES CELLS, V12, P13, DOI 10.1111/j.1365-2443.2007.01031.x; Meijsing SH, 2001, GENE DEV, V15, P3169, DOI 10.1101/gad.929001; Mousson F, 2005, P NATL ACAD SCI USA, V102, P5975, DOI 10.1073/pnas.0500149102; Munakata T, 2000, GENES CELLS, V5, P221, DOI 10.1046/j.1365-2443.2000.00319.x; Osada S, 2001, GENE DEV, V15, P3155, DOI 10.1101/gad.907201; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; Sillje HHW, 2001, CURR BIOL, V11, P1068, DOI 10.1016/S0960-9822(01)00298-6; SILVERMAN SJ, 1984, MOL CELL BIOL, V4, P1246, DOI 10.1128/MCB.4.7.1246; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tang Y, 2006, NAT STRUCT MOL BIOL, V13, P921, DOI 10.1038/nsmb1147; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Umehara T, 2003, J BIOL CHEM, V278, P35660, DOI 10.1074/jbc.M303549200; Umehara T, 2002, GENES CELLS, V7, P59, DOI 10.1046/j.1356-9597.2001.00493.x; Yamaguchi Y, 2001, J BIOCHEM, V129, P185, DOI 10.1093/oxfordjournals.jbchem.a002842	30	228	231	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2007	446	7133					338	341		10.1038/nature05613	http://dx.doi.org/10.1038/nature05613			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17293877				2022-12-01	WOS:000244892900050
J	Curtis, MA; Kam, M; Nannmark, U; Anderson, MF; Axell, MZ; Wikkelso, C; Holtas, S; van Roon-Mom, WMC; Bjork-Eriksson, T; Nordborg, C; Frisen, J; Dragunow, M; Faull, RLM; Eriksson, PS				Curtis, Maurice A.; Kam, Monica; Nannmark, Ulf; Anderson, Michelle F.; Axell, Mathilda Zetterstrom; Wikkelso, Carsten; Holtas, Stig; van Roon-Mom, Willeke M. C.; Bjork-Eriksson, Thomas; Nordborg, Claes; Frisen, Jonas; Dragunow, Michael; Faull, Richard L. M.; Eriksson, Peter S.			Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension	SCIENCE			English	Article							PRECURSOR CELL-PROLIFERATION; SUBVENTRICULAR ZONE; DIAGNOSTIC-TOOL; ADULT; NEURONS; DOUBLECORTIN; BROMODEOXYURIDINE; PLASTICITY; MEDICINE; BIOLOGY	The rostral migratory stream (RMS) is the main pathway by which newly born subventricular zone cells reach the olfactory bulb ( OB) in rodents. However, the RMS in the adult human brain has been elusive. We demonstrate the presence of a human RMS, which is unexpectedly organized around a lateral ventricular extension reaching the OB, and illustrate the neuroblasts in it. The RMS ensheathing the lateral olfactory ventricular extension, as seen by magnetic resonance imaging, cell-specific markers, and electron microscopy, contains progenitor cells with migratory characteristics and cells that incorporate 5-bromo-2'-deoxyuridine and become mature neurons in the OB.	Univ Auckland, Fac Med & Hlth Sci, Dept Anat & Radiol, Auckland 1, New Zealand; Sahlgrens Acad, Inst Neurosci & Physiol, Ctr Brain Repair & Rehabil, SE-40530 Gothenburg, Sweden; Sahlgrens Acad, Inst Biomed, SE-40530 Gothenburg, Sweden; Sahlgrens Univ Hosp, Dept Radiol, SE-41345 Gothenburg, Sweden; Sahlgrens Univ Hosp, Dept Pathol, S-41345 Gothenburg, Sweden; Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; Univ Auckland, Fac Med & Hlth Sci, Dept Pharmacol, Auckland, New Zealand; Sahlgrens Univ Hosp, Dept Oncol, SE-41345 Gothenburg, Sweden	University of Auckland; University of Gothenburg; University of Gothenburg; Sahlgrenska University Hospital; Sahlgrenska University Hospital; Karolinska Institutet; University of Auckland; Sahlgrenska University Hospital	Eriksson, PS (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Dept Anat & Radiol, Private Bag 92019, Auckland 1, New Zealand.	rlm.faull@auckland.ac.nz; per@neuro.gu.se	van Roon-Mom, Willeke/Y-3039-2018	van Roon-Mom, Willeke/0000-0002-3035-0533; Faull, Richard/0000-0003-3385-9498; Curtis, Maurice/0000-0003-4496-0233; Bjork-Eriksson, Thomas/0000-0003-3680-5196				Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bedard A, 2002, EUR J NEUROSCI, V16, P1917, DOI 10.1046/j.1460-9568.2002.02263.x; BERNARD A, 2004, DEV BRAIN RES, V19, P159; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Chazal G, 2000, J NEUROSCI, V20, P1446; Curtis MA, 2005, J CHEM NEUROANAT, V30, P55, DOI 10.1016/j.jchemneu.2005.05.001; Doetsch F, 1997, J NEUROSCI, V17, P5046; DOLBEARE F, 1995, HISTOCHEM J, V27, P339; Dolbeare F, 1996, HISTOCHEM J, V28, P531, DOI 10.1007/BF02331377; Freundlieb N, 2006, J NEUROSCI, V26, P2321, DOI 10.1523/JNEUROSCI.4859-05.2006; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; Lee A, 2003, ANN NEUROL, V53, P668, DOI 10.1002/ana.10579; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Ocbina PJ, 2006, MOL CELL NEUROSCI, V33, P126, DOI 10.1016/j.mcn.2006.06.014; RAE ASL, 1994, CLIN NEUROPATHOL, V13, P17; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Tomasevic G, 1998, MOL BRAIN RES, V60, P168, DOI 10.1016/S0169-328X(98)00173-9; BRAIN ATLAS DOMESTIC	25	643	684	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816					1243	1249		10.1126/science.1136281	http://dx.doi.org/10.1126/science.1136281			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17303719				2022-12-01	WOS:000244564700041
J	Mitchell, GF; Vasan, RS; Keyes, MJ; Parise, H; Wang, TJ; Larson, MG; D'Agostino, RB; Kannel, WB; Levy, D; Benjamin, EJ				Mitchell, Gary F.; Vasan, Ramachandran S.; Keyes, Michelle J.; Parise, Helen; Wang, Thomas J.; Larson, Martin G.; D'Agostino, Ralph B., Sr.; Kannel, William B.; Levy, Daniel; Benjamin, Emelia J.			Pulse pressure and risk of new-onset atrial fibrillation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NATRIURETIC PEPTIDE LEVELS; SYSTOLIC HYPERTENSION; DIASTOLIC DYSFUNCTION; BLOOD-PRESSURE; HEART-FAILURE; HEALTHY-MEN; FRAMINGHAM; POPULATION; ADULTS; AGE	Context Atrial fibrillation (AF) is responsible for considerable morbidity and mortality, making identification of modifiable risk factors a priority. Increased pulse pressure, a reflection of aortic stiffness, increases cardiac load and may increase AF risk. Objective To examine relations between pulse pressure and incident AF. Design, Setting, and Participants Prospective, community-based observational cohort in Framingham, Mass, including 5331 Framingham Heart Study participants aged 35 years and older and initially free from AF (median age, 57 years; 55% women). Main Outcome Measures Incident AF. Results AF developed in 698 participants (13.1%) a median of 12 years after pulse pressure assessment. Cumulative 20-year AF incidence rates were 5.6% for pulse pressure of 40 mm Hg or less (25th percentile) and 23.3% for pulse pressure greater than 61 mm Hg (75th percentile). In models adjusted for age, sex, baseline and time-dependent change in mean arterial pressure, and clinical risk factors for AF (body mass index, smoking, valvular disease, diabetes, electrocardiographic left ventricular hypertrophy, hypertension treatment, and prevalent myocardial infarction or heart failure), pulse pressure was associated with increased risk for AF (adjusted hazard ratio [HR], 1.26 per 20-mm Hg increment; 95% confidence interval [CI], 1.12-1.43; P < .001). In contrast, mean arterial pressure was unrelated to incident AF (adjusted HR, 0.96 per 10-mm Hg increment; 95% CI, 0.88-1.05; P = .39). Systolic pressure was related to AF (HR, 1.14 per 20-mm Hg increment; 95% CI, 1.04-1.25; P = .006); however, if diastolic pressure was added, model fit improved and the diastolic relation was inverse (adjusted HR, 0.87 per 10-mm Hg increment; 95% CI, 0.78-0.96; P = .01), consistent with a pulse pressure effect. Among patients with interpretable echocardiographic images, the association between pulse pressure and AF persisted in models that adjusted for baseline left atrial dimension, left ventricular mass, and left ventricular fractional shortening (adjusted HR, 1.23; 95% CI, 1.09-1.39; P = .001). Conclusion Pulse pressure is an important risk factor for incident AF in a community-based sample. Further research is needed to determine whether interventions that reduce pulse pressure will limit the growing incidence of AF.	Cardiovasc Engn Inc, Waltham, MA 02453 USA; Boston Univ, Sch Med, Evans Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; Boston Univ, Sch Med, Sect Prevent Med, Boston, MA 02118 USA; Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; Natl Heart Lung & Blood Inst Framingham Study, Framingham, MA USA; NHLBI, Bethesda, MD 20892 USA	Cardiovascular Engineering; Boston University; Boston University; Boston University; Boston University; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Mitchell, GF (corresponding author), Cardiovasc Engn Inc, 51 Sawyer Rd,Suite 100, Waltham, MA 02453 USA.	garyfmitchell@mindspring.com	Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABB-2752-2021; Levy, Daniel/ABF-6873-2021; Benjamin, Emelia/E-7103-2011	Ramachandran, Vasan/0000-0001-7357-5970; Levy, Daniel/0000-0003-1843-8724; Benjamin, Emelia/0000-0003-4076-2336; Larson, Martin/0000-0002-9631-1254; Parise, Helen/0000-0001-7761-4973	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334, R01HL060040, R01HL070100] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-25195, R01-HL70100, K24-HL-04334, R01-HL60040] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1999, SAS STAT US GUID VER; Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Chae CU, 1999, JAMA-J AM MED ASSOC, V281, P634, DOI 10.1001/jama.281.7.634; Chae CU, 2001, HYPERTENSION, V38, P399, DOI 10.1161/01.HYP.38.3.399; COX DR, 1972, J R STAT SOC B, V34, P187; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Eijsbouts SCM, 2003, J CARDIOVASC ELECTR, V14, P269, DOI 10.1046/j.1540-8167.2003.02280.x; Gardin JM, 1997, HYPERTENSION, V29, P1095, DOI 10.1161/01.HYP.29.5.1095; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Healey JS, 2005, J AM COLL CARDIOL, V45, P1832, DOI 10.1016/j.jacc.2004.11.070; Huang JL, 2003, BASIC RES CARDIOL, V98, P16, DOI 10.1007/s00395-003-0385-z; Hundley WG, 2001, J AM COLL CARDIOL, V38, P796, DOI 10.1016/S0735-1097(01)01447-4; Kannel W., 1987, SOME RISK FACTORS RE; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; KANNEL WB, 1969, ANN INTERN MED, V71, P89, DOI 10.7326/0003-4819-71-1-89; Kato J, 2002, HYPERTENS RES, V25, P887; Leite-Moreira AF, 1999, CARDIOVASC RES, V43, P344, DOI 10.1016/S0008-6363(99)00099-1; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; Mitchell GF, 2003, CIRCULATION, V108, P1592, DOI 10.1161/01.CIR.0000093435.04334.1F; Mitchell GF, 1997, CIRCULATION, V96, P4254; Mitchell GF, 2002, CIRCULATION, V105, P2955, DOI 10.1161/01.CIR.0000020500.77568.3C; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; OKIN PM, 2006, JAMA-J AM MED ASSOC, V26, P1242; PRENTICE RL, 1978, BIOMETRICS, V34, P541, DOI 10.2307/2530374; Psaty BM, 1997, CIRCULATION, V96, P2455; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; SAVAGE DD, 1987, HYPERTENSION, V9, P40; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Tsang TSM, 2006, J AM COLL CARDIOL, V47, P1018, DOI 10.1016/j.jacc.2005.08.077; Tsang TSM, 2002, J AM COLL CARDIOL, V40, P1636, DOI 10.1016/S0735-1097(02)02373-2; Vasan RS, 2003, AM J CARDIOL, V91, P1079, DOI 10.1016/S0002-9149(03)00152-8; VAZIRI SM, 1994, CIRCULATION, V89, P724, DOI 10.1161/01.CIR.89.2.724; VAZIRI SM, 1995, HYPERTENSION, V25, P1155, DOI 10.1161/01.HYP.25.6.1155; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471; Wang TJ, 2002, AM J CARDIOL, V90, P254, DOI 10.1016/S0002-9149(02)02464-5; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yasmin, 2004, ARTERIOSCL THROM VAS, V24, P969, DOI 10.1161/01.ATV.zhq0504.0173; ZILE MR, 1990, PROG CARDIOVASC DIS, V32, P333, DOI 10.1016/0033-0620(90)90020-3	42	252	259	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2007	297	7					709	715		10.1001/jama.297.7.709	http://dx.doi.org/10.1001/jama.297.7.709			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137KI	17312290				2022-12-01	WOS:000244291100022
J	Mwaluko, G; Wringe, A; Todd, J; Glynn, JR; Crampin, AC; Jaffar, S; Kalluvya, S; Zaba, B				Mwaluko, Gabriel; Wringe, Alison; Todd, James; Glynn, Judith R.; Crampin, Amelia C.; Jaffar, Shabbar; Kalluvya, Samuel; Zaba, Basia			Use of data from HIV counselling and testing services for HIV surveillance in Africa	LANCET			English	Article									Univ London London Sch Hyg & Trop Med, Ctr Populat Studies, London WC1E 7HT, England; Tanzania Netherlands Project Support HIV AIDS Con, Mwanza, Tanzania; Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1E 7HT, England; Univ London London Sch Hyg & Trop Med, Karonga Prevent Study, London WC1E 7HT, England; Uganda Virus Res Inst, MRC Programme AIDS, Entebbe, Uganda; Bugando Univ, Coll Hlth Sci, HIV AIDS Unit, Mwanza, Tanzania; Natl Inst Med Res, TAZAMA Project, Dar Es Salaam, Tanzania	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Uganda Virus Research Institute; National Institute of Medical Research	Wringe, A (corresponding author), Univ London London Sch Hyg & Trop Med, Ctr Populat Studies, Keppel St, London WC1E 7HT, England.	alison.wringe@lshtm.ac.uk		Crampin, Amelia/0000-0002-1513-4330; Todd, Jim/0000-0001-5918-4914; Jaffar, Shabbar/0000-0002-9615-1588	Medical Research Council [G0700837] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baryarama F, 2004, JAIDS-J ACQ IMM DEF, V37, P1180, DOI 10.1097/01.qai.0000127063.76701.bb; Diaz T, 2005, AIDS, V19, pS1, DOI 10.1097/01.aids.0000172871.80723.3e; Global Fund to Fight AIDS Tuberculosis and Malaria, 2006, MON EV TOOLK HIV AID; Hladik W, 2005, AIDS, V19, pS19, DOI 10.1097/01.aids.0000172873.82509.5e; Slaymaker E, 2004, SEX TRANSM INFECT, V80, P13, DOI 10.1136/sti.2004.011635; *UN REP TANZ MIN H, 2003, HIV AIDS CAR TREATM	6	8	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	2007	369	9561					612	613		10.1016/S0140-6736(07)60281-5	http://dx.doi.org/10.1016/S0140-6736(07)60281-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	138MZ	17307108				2022-12-01	WOS:000244368000035
J	Kawaguchi, R; Yu, JM; Honda, J; Hu, J; Whitelegge, J; Ping, PP; Wiita, P; Bok, D; Sun, H				Kawaguchi, Riki; Yu, Jiamei; Honda, Jane; Hu, Jane; Whitelegge, Julian; Ping, Peipei; Wiita, Patrick; Bok, Dean; Sun, Hui			A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A	SCIENCE			English	Article							EPITHELIAL-CELLS; ESTER FORMATION; MICE LACKING; ACID; TRANSPORT; LECITHIN; GENE; ACYLTRANSFERASE; ACCUMULATION; LESSONS	Vitamin A has diverse biological functions. It is transported in the blood as a complex with retinol binding protein ( RBP), but the molecular mechanism by which vitamin A is absorbed by cells from the vitamin A-RBP complex is not clearly understood. We identified in bovine retinal pigment epithelium cells STRA6, a multitransmembrane domain protein, as a specific membrane receptor for RBP. STRA6 binds to RBP with high affinity and has robust vitamin A uptake activity from the vitamin A-RBP complex. It is widely expressed in embryonic development and in adult organ systems. The RBP receptor represents a major physiological mediator of cellular vitamin A uptake.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Pasarow Mass Spectrometry Lab, Semel Inst, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sun, H (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, 650 Charles E Young Dr S, Los Angeles, CA 90095 USA.	hsun@mednet.ucla.edu	Kawaguchi, Riki/AAV-6090-2020	Ping, Peipei/0000-0003-3583-3881	NEI NIH HHS [5T32EY07026] Funding Source: Medline; NATIONAL EYE INSTITUTE [T32EY007026] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Biesalski HK, 2003, MOL ASPECTS MED, V24, P431, DOI 10.1016/S0098-2997(03)00039-6; BLOMHOFF R, 1990, SCIENCE, V250, P399, DOI 10.1126/science.2218545; BOK D, 1976, EXP EYE RES, V22, P395, DOI 10.1016/0014-4835(76)90177-9; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; CHEN CC, 1977, J BIOL CHEM, V252, P5216; DOWLING JE, 1966, SCI AM, V215, P78, DOI 10.1038/scientificamerican1066-78; DRAGER UC, 2006, SCI STKE, pPE10; Evans R M, 1994, Harvey Lect, V90, P105; Ghyselinck NB, 2006, DEV DYNAM, V235, P1608, DOI 10.1002/dvdy.20795; Goodman DS, 1984, RETINOIDS, P41, DOI DOI 10.1016/B978-0-12-658102-7.50008-7; Hagen E, 1999, J NUTR BIOCHEM, V10, P345, DOI 10.1016/S0955-2863(99)00013-3; HELLER J, 1975, J BIOL CHEM, V250, P3613; KANAI N, 1995, SCIENCE, V268, P866, DOI 10.1126/science.7754369; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; MACDONALD PN, 1990, P NATL ACAD SCI USA, V87, P4265, DOI 10.1073/pnas.87.11.4265; Maret S, 2005, SCIENCE, V310, P111, DOI 10.1126/science.1117623; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; Misner DL, 2001, P NATL ACAD SCI USA, V98, P11714, DOI 10.1073/pnas.191369798; MONACO HL, 1995, SCIENCE, V268, P1039, DOI 10.1126/science.7754382; OTTONELLO S, 1987, J BIOL CHEM, V262, P3975; PASUTTO F, IN PRESS AM J HUM GE; Quadro L, 2005, ENDOCRINOLOGY, V146, P4479, DOI 10.1210/en.2005-0158; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Quadro L, 2000, J INFECT DIS, V182, pS97, DOI 10.1086/315920; RASK L, 1976, J BIOL CHEM, V251, P6360; Ross AC, 2006, J LIPID RES, V47, P1844, DOI 10.1194/jlr.M600061-JLR200; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; Seeliger MW, 1999, INVEST OPHTH VIS SCI, V40, P3; SHINGLETON JL, 1989, BIOCHEMISTRY-US, V28, P9641, DOI 10.1021/bi00451a015; SIVAPRASADARAO A, 1988, BIOCHEM J, V255, P571; SIVAPRASADARAO A, 1994, BIOCHEM J, V300, P437, DOI 10.1042/bj3000437; Sivaprasadarao A., 1994, Vitamin A in health and disease., P87; SMELAND S, 1995, BIOCHEM J, V305, P419, DOI 10.1042/bj3050419; Sommer A, 1997, NAT MED, V3, P1061, DOI 10.1038/nm1097-1061; Stephensen CB, 2001, ANNU REV NUTR, V21, P167, DOI 10.1146/annurev.nutr.21.1.167; Sundaram M, 1998, J BIOL CHEM, V273, P3336, DOI 10.1074/jbc.273.6.3336; Szeto W, 2001, CANCER RES, V61, P4197; Vahlquist A., 1994, Vitamin A in health and disease., P365; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711	41	573	594	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2007	315	5813					820	825		10.1126/science.1136244	http://dx.doi.org/10.1126/science.1136244			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17255476				2022-12-01	WOS:000244069000062
J	Shaw, RM; Fay, AJ; Puthenveedu, MA; von Zastrow, M; Jan, YN; Jan, LY				Shaw, Robin M.; Fay, Alex J.; Puthenveedu, Manojkumar A.; von Zastrow, Mark; Jan, Yuh-Nung; Jan, Lily Y.			Microtubule plus-end-tracking proteins target gap junctions directly from the cell interior to adherens junctions	CELL			English	Article							ADULT-RAT CARDIOMYOCYTES; N-CADHERIN; PLASMA-MEMBRANE; HUMAN-FIBROBLASTS; BETA-CATENIN; BORDER ZONE; CONNEXIN43; ADHESION; DYNEIN; EB1	Gap junctions are intercellular channels that connect the cytoplasms of adjacent cells. For gap junctions to properly control organ formation and electrical synchronization in the heart and the brain, connexin-based hemichannels must be correctly targeted to cell-cell borders. While it is generally accepted that gap junctions form via lateral diffusion of hemichannels following microtubule-mediated delivery to the plasma membrane, we provide evidence for direct targeting of hemichannels to cell-cell junctions through a pathway that is dependent on microtubules; through the adherens-junction proteins N-cadherin and beta-catenin through the microtubule plus-end-tracking protein (+TIP) EB1; and through its interacting protein p150(Glued). Based on live cell microscopy that includes fluorescence recovery after photobleaching (FRAP), total internal reflection fluorescence (TIRF), deconvolution, and siRNA knockdown, we propose that preferential tethering of microtubule plus ends at the adherens junction promotes delivery of connexin hemichannels directly to the cell-cell border. These findings support an unanticipated mechanism for protein delivery to points of cell-cell contact.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	lily.jan@ucsf.edu	; Puthenveedu, Manojkumar/A-3795-2016	Shaw, Robin/0000-0001-7429-6092; Jan, Yuh Nung/0000-0003-1367-6299; Puthenveedu, Manojkumar/0000-0002-3177-4231; Jan, Lily/0000-0003-3938-8498	NHLBI NIH HHS [K08 HL075449-01A1, K08 HL075449-02, K08 HL075449, HL 075449] Funding Source: Medline; NIDA NIH HHS [DA 10154, DA 10711] Funding Source: Medline; NIMH NIH HHS [MH 065334] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL075449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH065334, R01MH065334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R29DA010711, P01DA010154, R37DA010711, R01DA010711] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abraham MR, 2005, CIRC RES, V97, P159, DOI 10.1161/01.RES.0000174794.22491.a0; Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Angst BD, 1997, CIRC RES, V80, P88, DOI 10.1161/01.RES.80.1.88; Askham JM, 2002, MOL BIOL CELL, V13, P3627, DOI 10.1091/mbc.E02-01-0061; Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; Berrueta L, 1999, CURR BIOL, V9, P425, DOI 10.1016/S0960-9822(99)80190-0; Chausovsky A, 2000, NAT CELL BIOL, V2, P797, DOI 10.1038/35041037; DAVIDSON JS, 1984, EXP CELL RES, V155, P406, DOI 10.1016/0014-4827(84)90201-5; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Frenzel EM, 1996, DEV BIOL, V179, P1, DOI 10.1006/dbio.1996.0237; Fuchs E, 2001, GENE DEV, V15, P1, DOI 10.1101/gad.861501; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Giepmans BNG, 2001, CURR BIOL, V11, P1364, DOI 10.1016/S0960-9822(01)00424-9; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Gros DB, 1996, BIOESSAYS, V18, P719, DOI 10.1002/bies.950180907; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; Hertig CM, 1996, J CELL SCI, V109, P11; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; Hu KL, 2003, NEURON, V38, P417, DOI 10.1016/S0896-6273(03)00256-3; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Jordan K, 1999, MOL BIOL CELL, V10, P2033, DOI 10.1091/mbc.10.6.2033; Kaprielian RR, 1998, CIRCULATION, V97, P651, DOI 10.1161/01.CIR.97.7.651; Ko KS, 2001, J CELL SCI, V114, P1155; Koonce MP, 2004, TRENDS CELL BIOL, V14, P612, DOI 10.1016/j.tcb.2004.09.013; Kostin S, 1999, CIRC RES, V85, P154, DOI 10.1161/01.RES.85.2.154; Krutovskikh V, 2002, SEMIN CANCER BIOL, V12, P267, DOI 10.1016/S1044-579X(02)00013-5; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; Lauf U, 2002, P NATL ACAD SCI USA, V99, P10446, DOI 10.1073/pnas.162055899; Li JF, 2005, CIRC RES, V97, P474, DOI 10.1161/01.RES.0000181132.11393.18; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Luo Y, 2003, J CELL SCI, V116, P1471, DOI 10.1242/jcs.00339; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; Matsushita T, 1999, CIRC RES, V85, P1046; MEGE RM, 1988, P NATL ACAD SCI USA, V85, P7274, DOI 10.1073/pnas.85.19.7274; Mesnil M, 2002, BIOL CELL, V94, P493, DOI 10.1016/S0248-4900(02)00025-4; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Morrison EE, 1998, ONCOGENE, V17, P3471, DOI 10.1038/sj.onc.1202247; Musil LS, 1990, CURR OPIN CELL BIOL, V2, P875, DOI 10.1016/0955-0674(90)90086-T; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Oliveira R, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-7; Peters NS, 1997, CIRCULATION, V95, P988; Reinecke H, 2004, HUM GENE THER, V15, P627, DOI 10.1089/1043034041361253; Schuyler SC, 2001, J CELL SCI, V114, P247; Segretain D, 2004, BBA-BIOMEMBRANES, V1662, P3, DOI 10.1016/j.bbamem.2004.01.007; Shaw RM, 1997, CIRC RES, V81, P727; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; Waterman-Storer CM, 2000, MOL BIOL CELL, V11, P2471, DOI 10.1091/mbc.11.7.2471; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Williams EJ, 2000, MOL CELL NEUROSCI, V15, P456, DOI 10.1006/mcne.2000.0847	54	343	357	1	34	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2007	128	3					547	560		10.1016/j.cell.2006.12.037	http://dx.doi.org/10.1016/j.cell.2006.12.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289573	Bronze, Green Accepted			2022-12-01	WOS:000244842700020
J	Willis, SN; Fletcher, JI; Kaufmann, T; van Delft, MF; Chen, L; Czabotar, PE; Ierino, H; Lee, EF; Fairlie, WD; Bouillet, P; Strasser, A; Kluck, RM; Adams, JM; Huang, DCS				Willis, Simon N.; Fletcher, Jamie I.; Kaufmann, Thomas; van Delft, Mark F.; Chen, Lin; Czabotar, Peter E.; Ierino, Helen; Lee, Erinna F.; Fairlie, W. Douglas; Bouillet, Philippe; Strasser, Andreas; Kluck, Ruth M.; Adams, Jerry M.; Huang, David C. S.			Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak	SCIENCE			English	Article							BH3-ONLY PROTEINS; MITOCHONDRIAL-MEMBRANE; FAMILY-MEMBERS; CELL-DEATH; X-L; BIM; PUMA; RESPONSES; DOMAINS; HELIX	A central issue in the regulation of apoptosis by the Bcl-2 family is whether its BH3-only members initiate apoptosis by directly binding to the essential cell-death mediators Bax and Bak, or whether they can act indirectly, by engaging their pro-survival Bcl-2-like relatives. Contrary to the direct-activation model, we show that Bax and Bak can mediate apoptosis without discernable association with the putative BH3-only activators (Bim, Bid, and Puma), even in cells with no Bim or Bid and reduced Puma. Our results indicate that BH3-only proteins induce apoptosis at least primarily by engaging the multiple pro-survival relatives guarding Bax and Bak.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne	Huang, DCS (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Melbourne, Vic 3050, Australia.	huang_d@wehi.edu.au	Huang, David C. S./C-7586-2013; Strasser, Andreas/C-7581-2013; Adams, Jerry M/E-1199-2013; Lee, Erinna/N-1523-2015; Fairlie, Walter/M-8401-2015; Fletcher, Jamie/V-4667-2019; Bouillet, Philippe/E-1241-2013; Kluck, Ruth M/C-8413-2013	Huang, David C. S./0000-0002-3101-4873; Strasser, Andreas/0000-0002-5020-4891; Lee, Erinna/0000-0003-1255-9808; Fairlie, Walter/0000-0002-2498-1160; Bouillet, Philippe/0000-0002-9012-6058; Kluck, Ruth M/0000-0002-7101-1925; Adams, Jerry/0000-0002-4360-8628; van Delft, Mark/0000-0002-3866-4318; Czabotar, Peter/0000-0002-2594-496X; Fletcher, Jamie/0000-0003-2949-9469; Kaufmann, Thomas/0000-0001-9906-874X	NATIONAL CANCER INSTITUTE [R01CA080188, R01CA043540] Funding Source: NIH RePORTER; NCI NIH HHS [CA80188, CA43540] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission)		Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Cuconati A, 2002, J VIROL, V76, P4547, DOI 10.1128/JVI.76.9.4547-4558.2002; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Knudson CM, 1997, NAT GENET, V16, P358, DOI 10.1038/ng0897-358; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Ming L, 2006, J BIOL CHEM, V281, P16034, DOI 10.1074/jbc.M513587200; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ruffolo SC, 2003, J BIOL CHEM, V278, P25039, DOI 10.1074/jbc.M302930200; Shindler KS, 1997, J NEUROSCI, V17, P3112; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Zhu YN, 2004, P NATL ACAD SCI USA, V101, P7681, DOI 10.1073/pnas.0402293101	24	899	940	0	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2007	315	5813					856	859		10.1126/science.1133289	http://dx.doi.org/10.1126/science.1133289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289999				2022-12-01	WOS:000244069000072
J	Macpherson, LJ; Dubin, AE; Evans, MJ; Marr, F; Schultz, PG; Cravatt, BF; Patapoutian, A				Macpherson, Lindsey J.; Dubin, Adrienne E.; Evans, Michael J.; Marr, Felix; Schultz, Peter G.; Cravatt, Benjamin F.; Patapoutian, Ardem			Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines	NATURE			English	Article							CLICK CHEMISTRY; S-NITROSYLATION; COLD; KEAP1; PROTEIN; ELECTROPHILE; NOCICEPTION; REACTIVITY; SENSATION; INDUCERS	The nervous system senses peripheral damage through nociceptive neurons that transmit a pain signal(1,2). TRPA1 is a member of the Transient Receptor Potential (TRP) family of ion channels and is expressed in nociceptive neurons(3-5). TRPA1 is activated by a variety of noxious stimuli, including cold temperatures, pungent natural compounds, and environmental irritants(6-11). How such diverse stimuli activate TRPA1 is not known. We observed that most compounds known to activate TRPA1 are able to covalently bind cysteine residues. Here we use click chemistry to show that derivatives of two such compounds, mustard oil and cinnamaldehyde, covalently bind mouse TRPA1. Structurally unrelated cysteine-modifying agents such as iodoacetamide (IA) and (2-aminoethyl) methanethiosulphonate ( MTSEA) also bind and activate TRPA1. We identified by mass spectrometry fourteen cytosolic TRPA1 cysteines labelled by IA, three of which are required for normal channel function. In excised patches, reactive compounds activated TRPA1 currents that were maintained at least 10 min after washout of the compound in calcium-free solutions. Finally, activation of TRPA1 by disulphide-bond-forming MTSEA is blocked by the reducing agent dithiothreitol (DTT). Collectively, our data indicate that covalent modification of reactive cysteines within TRPA1 can cause channel activation, rapidly signalling potential tissue damage through the pain pathway.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Novartis	Patapoutian, A (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	ardem@scripps.edu		Macpherson, Lindsey/0000-0002-1089-3733				Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Dinkova-Kostova AT, 2001, P NATL ACAD SCI USA, V98, P3404, DOI 10.1073/pnas.051632198; Dinkova-Kostova AT, 2005, CHEM RES TOXICOL, V18, P1779, DOI 10.1021/tx050217c; Eggler AL, 2005, P NATL ACAD SCI USA, V102, P10070, DOI 10.1073/pnas.0502402102; Evans MJ, 2005, NAT BIOTECHNOL, V23, P1303, DOI 10.1038/nbt1149; Fearon IM, 1999, J PHYSIOL-LONDON, V514, P629, DOI 10.1111/j.1469-7793.1999.629ad.x; Getz EB, 1999, ANAL BIOCHEM, V273, P73, DOI 10.1006/abio.1999.4203; GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hong F, 2005, CHEM RES TOXICOL, V18, P1917, DOI 10.1021/tx0502138; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Macpherson LJ, 2006, MOL CELL NEUROSCI, V32, P335, DOI 10.1016/j.mcn.2006.05.005; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; Matalon S, 2003, AM J PHYSIOL-LUNG C, V285, pL1184, DOI 10.1152/ajplung.00281.2003; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Shapiro TA, 2001, CANCER EPIDEM BIOMAR, V10, P501; Speers AE, 2004, CHEM BIOL, V11, P535, DOI 10.1016/j.chembiol.2004.03.012; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wood JN, 1997, ANNU REV PHYSIOL, V59, P457, DOI 10.1146/annurev.physiol.59.1.457; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821	31	854	900	4	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2007	445	7127					541	545		10.1038/nature05544	http://dx.doi.org/10.1038/nature05544			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17237762				2022-12-01	WOS:000243867300044
J	Dudziak, D; Kamphorst, AO; Heidkamp, GF; Buchholz, VR; Trumpfheller, C; Yamazaki, S; Cheong, C; Liu, K; Lee, HW; Park, CG; Steinman, RM; Nussenzweig, MC				Dudziak, Diana; Kamphorst, Alice O.; Heidkamp, Gordon F.; Buchholz, Veit R.; Trumpfheller, Christine; Yamazaki, Sayuri; Cheong, Cheolho; Liu, Kang; Lee, Han-Woong; Park, Chae Gyu; Steinman, Ralph M.; Nussenzweig, Michel C.			Differential antigen processing by dendritic cell subsets in vivo	SCIENCE			English	Article							MONOCLONAL-ANTIBODY; CROSS-PRESENTATION; LYMPH-NODE; T-CELLS; CD8(+); MOUSE; COMPLEXES; PROTEOLYSIS; ACTIVATION; RECEPTOR	Dendritic cells (DCs) process and present self and foreign antigens to induce tolerance or immunity. In vitro models suggest that induction of immunity is controlled by regulating the presentation of antigen, but little is known about how DCs control antigen presentation in vivo. To examine antigen processing and presentation in vivo, we specifically targeted antigens to two major subsets of DCs by using chimeric monoclonal antibodies. Unlike CD8(+) DCs that express the cell surface protein CD205, CD8(-) DCs, which are positive for the 33D1 antigen, are specialized for presentation on major histocompatibility complex (MHC) class II. This difference in antigen processing is intrinsic to the DC subsets and is associated with increased expression of proteins involved in MHC processing.	Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10021 USA; Yonsei Univ, Coll Sci, Dept Biochem, Seoul 120749, South Korea; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; Rockefeller University; Yonsei University; Howard Hughes Medical Institute; Rockefeller University	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.	nussen@rockefeller.edu	Steinman, Ralph/F-7729-2012; Nussenzweig, Michel/AAE-7292-2019; Buchholz, Veit R./AAF-6966-2021; Dudziak, Diana/B-2432-2017	Buchholz, Veit R./0000-0003-0441-3913; Kamphorst, Alice/0000-0002-9230-9501; Park, Chae Gyu/0000-0003-1906-1308; Dudziak, Diana/0000-0001-9358-134X				Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bryant P, 2004, CURR OPIN IMMUNOL, V16, P96, DOI 10.1016/j.coi.2003.11.011; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; Dadaglio G, 1997, IMMUNITY, V6, P727, DOI 10.1016/S1074-7613(00)80448-3; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; den Haan JMM, 2002, J EXP MED, V196, P817, DOI 10.1084/jem.20020295; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; Guo M, 2000, HUM IMMUNOL, V61, P729, DOI 10.1016/S0198-8859(00)00144-0; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; NUSSENZWEIG MC, 1982, P NATL ACAD SCI-BIOL, V79, P161, DOI 10.1073/pnas.79.1.161; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Shastri N, 2005, IMMUNOL REV, V207, P31, DOI 10.1111/j.0105-2896.2005.00321.x; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; WITMER MD, 1984, AM J ANAT, V170, P465, DOI 10.1002/aja.1001700318; Yewdell JW, 1999, ADV IMMUNOL, V73, P1, DOI 10.1016/S0065-2776(08)60785-3	27	1016	1040	1	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 5	2007	315	5808					107	111		10.1126/science.1136080	http://dx.doi.org/10.1126/science.1136080			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17204652				2022-12-01	WOS:000243259100048
